Citrus Sinensis ID: 020641
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 323 | 2.2.26 [Sep-21-2011] | |||||||
| B9DFG5 | 408 | PTI1-like tyrosine-protei | no | no | 0.770 | 0.610 | 0.912 | 1e-126 | |
| O49339 | 366 | PTI1-like tyrosine-protei | no | no | 0.736 | 0.650 | 0.924 | 1e-124 | |
| Q8H1G6 | 361 | PTI1-like tyrosine-protei | no | no | 0.736 | 0.659 | 0.924 | 1e-123 | |
| Q41328 | 354 | Pto-interacting protein 1 | N/A | no | 0.752 | 0.686 | 0.835 | 1e-113 | |
| O80719 | 365 | Probable receptor-like pr | no | no | 0.786 | 0.695 | 0.816 | 1e-111 | |
| P93749 | 365 | Probable protein kinase A | no | no | 0.789 | 0.698 | 0.789 | 1e-111 | |
| Q8RWW0 | 744 | Receptor-like serine/thre | no | no | 0.690 | 0.299 | 0.523 | 2e-61 | |
| Q9SGY7 | 718 | Putative proline-rich rec | no | no | 0.705 | 0.317 | 0.512 | 5e-61 | |
| Q9FE20 | 456 | Serine/threonine-protein | no | no | 0.715 | 0.506 | 0.506 | 1e-60 | |
| Q9LQQ8 | 423 | Probable serine/threonine | no | no | 0.755 | 0.576 | 0.490 | 2e-60 |
| >sp|B9DFG5|PTI13_ARATH PTI1-like tyrosine-protein kinase 3 OS=Arabidopsis thaliana GN=PTI13 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 450 bits (1158), Expect = e-126, Method: Compositional matrix adjust.
Identities = 228/250 (91%), Positives = 237/250 (94%), Gaps = 1/250 (0%)
Query: 75 VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 134
VS VS+LKH+N VEL GYCVEGN R+LAYEFATMGSLHDILHGRKGVQGAQPGP LDW+
Sbjct: 159 VSRVSKLKHDNFVELFGYCVEGNFRILAYEFATMGSLHDILHGRKGVQGAQPGPTLDWIQ 218
Query: 135 RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 194
RVRIAVDAARGLEYLHEKVQP++IHRDIRSSNVLLFEDFKAKIADFNLSNQ+PDMAARLH
Sbjct: 219 RVRIAVDAARGLEYLHEKVQPAVIHRDIRSSNVLLFEDFKAKIADFNLSNQSPDMAARLH 278
Query: 195 STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWAT 254
STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWAT
Sbjct: 279 STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWAT 338
Query: 255 PRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSP 314
PRLSEDKVKQCVDPKLKGEYPPK VAKLAAVAALCVQYE+EFRPNMSIVVKALQPLL+S
Sbjct: 339 PRLSEDKVKQCVDPKLKGEYPPKAVAKLAAVAALCVQYESEFRPNMSIVVKALQPLLRSS 398
Query: 315 PPAA-PVSET 323
AA PV E
Sbjct: 399 TAAAVPVQEA 408
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 0EC: .EC: 2 |
| >sp|O49339|PTI12_ARATH PTI1-like tyrosine-protein kinase 2 OS=Arabidopsis thaliana GN=PTI12 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 444 bits (1143), Expect = e-124, Method: Compositional matrix adjust.
Identities = 220/238 (92%), Positives = 233/238 (97%)
Query: 75 VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 134
VS+VSRLKHENL++L+GYCV+ NLRVLAYEFATMGSLHDILHGRKGVQGAQPGP LDW+T
Sbjct: 117 VSMVSRLKHENLIQLVGYCVDENLRVLAYEFATMGSLHDILHGRKGVQGAQPGPTLDWLT 176
Query: 135 RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 194
RV+IAV+AARGLEYLHEKVQP +IHRDIRSSNVLLFED++AK+ADFNLSNQAPD AARLH
Sbjct: 177 RVKIAVEAARGLEYLHEKVQPPVIHRDIRSSNVLLFEDYQAKVADFNLSNQAPDNAARLH 236
Query: 195 STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWAT 254
STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWAT
Sbjct: 237 STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWAT 296
Query: 255 PRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLK 312
PRLSEDKVKQCVDPKLKGEYPPK VAKLAAVAALCVQYE+EFRPNMSIVVKALQPLLK
Sbjct: 297 PRLSEDKVKQCVDPKLKGEYPPKSVAKLAAVAALCVQYESEFRPNMSIVVKALQPLLK 354
|
Probable tyrosine-protein kinase involved in oxidative burst-mediated signaling leading to specific genes expression. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 0 EC: . EC: 2 |
| >sp|Q8H1G6|PTI11_ARATH PTI1-like tyrosine-protein kinase 1 OS=Arabidopsis thaliana GN=PTI11 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 441 bits (1134), Expect = e-123, Method: Compositional matrix adjust.
Identities = 220/238 (92%), Positives = 232/238 (97%)
Query: 75 VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 134
VS+VSRLKHENL++LLG+CV+GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGP LDW+T
Sbjct: 114 VSMVSRLKHENLIQLLGFCVDGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPTLDWIT 173
Query: 135 RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 194
RV+IAV+AARGLEYLHEK QP +IHRDIRSSNVLLFED+KAKIADFNLSNQAPD AARLH
Sbjct: 174 RVKIAVEAARGLEYLHEKSQPPVIHRDIRSSNVLLFEDYKAKIADFNLSNQAPDNAARLH 233
Query: 195 STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWAT 254
STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWAT
Sbjct: 234 STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWAT 293
Query: 255 PRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLK 312
PRLSEDKVKQC+DPKLK +YPPK VAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLK
Sbjct: 294 PRLSEDKVKQCIDPKLKADYPPKAVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLK 351
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 0 EC: . EC: 2 |
| >sp|Q41328|PTI1_SOLLC Pto-interacting protein 1 OS=Solanum lycopersicum GN=PTI1 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 408 bits (1049), Expect = e-113, Method: Compositional matrix adjust.
Identities = 203/243 (83%), Positives = 222/243 (91%)
Query: 75 VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 134
VS+VSRLK EN+VELLGYCV+G RVLAYE+A GSLHDILHGRKGV+GAQPGPVL W
Sbjct: 112 VSMVSRLKDENVVELLGYCVDGGFRVLAYEYAPNGSLHDILHGRKGVKGAQPGPVLSWAQ 171
Query: 135 RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 194
RV+IAV AA+GLEYLHEK QP IIHRDI+SSN+LLF+D AKIADF+LSNQAPDMAARLH
Sbjct: 172 RVKIAVGAAKGLEYLHEKAQPHIIHRDIKSSNILLFDDDVAKIADFDLSNQAPDMAARLH 231
Query: 195 STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWAT 254
STRVLGTFGYHAPEYAMTGQL+ KSDVYSFGVVLLELLTGRKPVDHT+PRGQQSLVTWAT
Sbjct: 232 STRVLGTFGYHAPEYAMTGQLSSKSDVYSFGVVLLELLTGRKPVDHTLPRGQQSLVTWAT 291
Query: 255 PRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSP 314
PRLSEDKVKQCVD +L +YPPK +AK+AAVAALCVQYEA+FRPNMSIVVKALQPLL P
Sbjct: 292 PRLSEDKVKQCVDARLNTDYPPKAIAKMAAVAALCVQYEADFRPNMSIVVKALQPLLPRP 351
Query: 315 PPA 317
P+
Sbjct: 352 VPS 354
|
A serine-threonine kinase involved in the hypersensitive response (HR)-mediated signaling cascade. Solanum lycopersicum (taxid: 4081) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O80719|Y2706_ARATH Probable receptor-like protein kinase At2g47060 OS=Arabidopsis thaliana GN=At2g47060 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 402 bits (1033), Expect = e-111, Method: Compositional matrix adjust.
Identities = 209/256 (81%), Positives = 228/256 (89%), Gaps = 2/256 (0%)
Query: 59 ERLKSPKNYPDDE-KQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHG 117
++L S K PD+E VS+VSRLKH+N V+LLGYCV+GN R+L+YEFA GSLHDILHG
Sbjct: 101 KKLDSNKQ-PDNEFLAQVSMVSRLKHDNFVQLLGYCVDGNSRILSYEFANNGSLHDILHG 159
Query: 118 RKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKI 177
RKGV+GAQPGPVL W RV+IAV AARGLEYLHEK P IIHRDI+SSNVLLFED AKI
Sbjct: 160 RKGVKGAQPGPVLSWYQRVKIAVGAARGLEYLHEKANPHIIHRDIKSSNVLLFEDDVAKI 219
Query: 178 ADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 237
ADF+LSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQL KSDVYSFGVVLLELLTGRKP
Sbjct: 220 ADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLNAKSDVYSFGVVLLELLTGRKP 279
Query: 238 VDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFR 297
VDH +PRGQQSLVTWATP+LSEDKVKQCVD +L G+YPPK VAKLAAVAALCVQYEA+FR
Sbjct: 280 VDHRLPRGQQSLVTWATPKLSEDKVKQCVDARLGGDYPPKAVAKLAAVAALCVQYEADFR 339
Query: 298 PNMSIVVKALQPLLKS 313
PNMSIVVKALQPLL +
Sbjct: 340 PNMSIVVKALQPLLNA 355
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P93749|Y2197_ARATH Probable protein kinase At2g41970 OS=Arabidopsis thaliana GN=At2g41970 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 401 bits (1030), Expect = e-111, Method: Compositional matrix adjust.
Identities = 203/257 (78%), Positives = 229/257 (89%), Gaps = 2/257 (0%)
Query: 68 PD-DEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQP 126
PD D +SVVSRLKH++ VELLGYC+E N R+L Y+FAT GSLHD+LHGRKGVQGA+P
Sbjct: 110 PDSDFTSQLSVVSRLKHDHFVELLGYCLEANNRILIYQFATKGSLHDVLHGRKGVQGAEP 169
Query: 127 GPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQA 186
GPVL+W RV+IA AA+GLE+LHEKVQP I+HRD+RSSNVLLF+DF AK+ADFNL+N +
Sbjct: 170 GPVLNWNQRVKIAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFVAKMADFNLTNAS 229
Query: 187 PDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQ 246
D AARLHSTRVLGTFGYHAPEYAMTGQ+TQKSDVYSFGVVLLELLTGRKPVDHTMP+GQ
Sbjct: 230 SDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHTMPKGQ 289
Query: 247 QSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKA 306
QSLVTWATPRLSEDKVKQC+DPKL ++PPK VAKLAAVAALCVQYEA+FRPNM+IVVKA
Sbjct: 290 QSLVTWATPRLSEDKVKQCIDPKLNNDFPPKAVAKLAAVAALCVQYEADFRPNMTIVVKA 349
Query: 307 LQPLLKSPPPAAPVSET 323
LQPLL S PA P S +
Sbjct: 350 LQPLLNS-KPAGPESTS 365
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q8RWW0|ALE2_ARATH Receptor-like serine/threonine-protein kinase ALE2 OS=Arabidopsis thaliana GN=ALE2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 236 bits (602), Expect = 2e-61, Method: Compositional matrix adjust.
Identities = 123/235 (52%), Positives = 162/235 (68%), Gaps = 12/235 (5%)
Query: 75 VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 134
V ++SRL H NLV+L+G C+EG R L YE GS+ LH +G LDW
Sbjct: 394 VEMLSRLHHRNLVKLIGICIEGRTRCLIYELVHNGSVESHLH-----EG-----TLDWDA 443
Query: 135 RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 194
R++IA+ AARGL YLHE P +IHRD ++SNVLL +DF K++DF L+ +A + + +
Sbjct: 444 RLKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQHI- 502
Query: 195 STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWAT 254
STRV+GTFGY APEYAMTG L KSDVYS+GVVLLELLTGR+PVD + P G+++LVTWA
Sbjct: 503 STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRRPVDMSQPSGEENLVTWAR 562
Query: 255 PRLSE-DKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQ 308
P L+ + ++Q VDP L G Y +AK+AA+A++CV E RP M VV+AL+
Sbjct: 563 PLLANREGLEQLVDPALAGTYNFDDMAKVAAIASMCVHQEVSHRPFMGEVVQALK 617
|
Required during the differentiation of the protoderm into shoots epidermis and cuticle. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SGY7|PEK11_ARATH Putative proline-rich receptor-like protein kinase PERK11 OS=Arabidopsis thaliana GN=PERK11 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 234 bits (598), Expect = 5e-61, Method: Compositional matrix adjust.
Identities = 123/240 (51%), Positives = 161/240 (67%), Gaps = 12/240 (5%)
Query: 72 KQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLD 131
K V ++SR+ H +LV L+GYC+ R L YEF +L LHG+ PVL+
Sbjct: 412 KAEVEIISRVHHRHLVSLVGYCISEQHRFLIYEFVPNNTLDYHLHGKNL-------PVLE 464
Query: 132 WMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAA 191
W RVRIA+ AA+GL YLHE P IIHRDI+SSN+LL ++F+A++ADF L+ + D A
Sbjct: 465 WSRRVRIAIGAAKGLAYLHEDCHPKIIHRDIKSSNILLDDEFEAQVADFGLA-RLNDTAQ 523
Query: 192 RLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVT 251
STRV+GTFGY APEYA +G+LT +SDV+SFGVVLLEL+TGRKPVD + P G++SLV
Sbjct: 524 SHISTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDTSQPLGEESLVE 583
Query: 252 WATPRLSE----DKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKAL 307
WA PRL E + + VDP+L+ +Y V K+ AA CV++ A RP M VV+AL
Sbjct: 584 WARPRLIEAIEKGDISEVVDPRLENDYVESEVYKMIETAASCVRHSALKRPRMVQVVRAL 643
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FE20|PBS1_ARATH Serine/threonine-protein kinase PBS1 OS=Arabidopsis thaliana GN=PBS1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 233 bits (594), Expect = 1e-60, Method: Compositional matrix adjust.
Identities = 120/237 (50%), Positives = 160/237 (67%), Gaps = 6/237 (2%)
Query: 75 VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 134
V ++S L H NLV L+GYC +G+ R+L YEF +GSL D LH + A LDW
Sbjct: 132 VLMLSLLHHPNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEA-----LDWNM 186
Query: 135 RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 194
R++IA AA+GLE+LH+K P +I+RD +SSN+LL E F K++DF L+ P
Sbjct: 187 RMKIAAGAAKGLEFLHDKANPPVIYRDFKSSNILLDEGFHPKLSDFGLAKLGPTGDKSHV 246
Query: 195 STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWAT 254
STRV+GT+GY APEYAMTGQLT KSDVYSFGVV LEL+TGRK +D MP G+Q+LV WA
Sbjct: 247 STRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSEMPHGEQNLVAWAR 306
Query: 255 PRLSE-DKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPL 310
P ++ K + DP+LKG +P + + + AVA++C+Q +A RP ++ VV AL L
Sbjct: 307 PLFNDRRKFIKLADPRLKGRFPTRALYQALAVASMCIQEQAATRPLIADVVTALSYL 363
|
Protein kinase required for plant defense mechanism mediated by the disease resistance (R) protein RPS5. In case of infection by Pseudomonas syringae, RPS5 specifically recognizes the avrPphB type III effector avirulence protein and triggers a defense reaction. AvrPphB may trigger RPS5-mediated defense mechanism via the cleavage of PBS1. Both kinase activity and cleavage by avrPphB are independently required to trigger the RPS5-mediated resistance. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LQQ8|RLCK7_ARATH Probable serine/threonine-protein kinase RLCKVII OS=Arabidopsis thaliana GN=At1g07870 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 233 bits (593), Expect = 2e-60, Method: Compositional matrix adjust.
Identities = 123/251 (49%), Positives = 169/251 (67%), Gaps = 7/251 (2%)
Query: 75 VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 134
V +S H NLV+L+G+C EG+ R+L YE+ GSL D LH G +P LDW T
Sbjct: 149 VLTLSLADHPNLVKLIGFCAEGDQRLLVYEYMPQGSLEDHLHVLP--SGKKP---LDWNT 203
Query: 135 RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 194
R++IA AARGLEYLH+++ P +I+RD++ SN+LL ED++ K++DF L+ P
Sbjct: 204 RMKIAAGAARGLEYLHDRMTPPVIYRDLKCSNILLGEDYQPKLSDFGLAKVGPSGDKTHV 263
Query: 195 STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWAT 254
STRV+GT+GY AP+YAMTGQLT KSD+YSFGVVLLEL+TGRK +D+T R Q+LV WA
Sbjct: 264 STRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDNTKTRKDQNLVGWAR 323
Query: 255 PRLSEDK-VKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKS 313
P + + + VDP L+G+YP +G+ + A++A+CVQ + RP +S VV AL L S
Sbjct: 324 PLFKDRRNFPKMVDPLLQGQYPVRGLYQALAISAMCVQEQPTMRPVVSDVVLALNFLASS 383
Query: 314 P-PPAAPVSET 323
P +P S +
Sbjct: 384 KYDPNSPSSSS 394
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 323 | ||||||
| 224133038 | 363 | predicted protein [Populus trichocarpa] | 0.758 | 0.674 | 0.951 | 1e-134 | |
| 449446223 | 366 | PREDICTED: PTI1-like tyrosine-protein ki | 0.736 | 0.650 | 0.953 | 1e-133 | |
| 223452408 | 366 | serine/threonine protein kinase [Glycine | 0.739 | 0.653 | 0.949 | 1e-130 | |
| 351722789 | 366 | protein kinase Pti1 [Glycine max] gi|298 | 0.739 | 0.653 | 0.945 | 1e-130 | |
| 297745178 | 401 | unnamed protein product [Vitis vinifera] | 0.761 | 0.613 | 0.967 | 1e-129 | |
| 359478064 | 495 | PREDICTED: PTI1-like tyrosine-protein ki | 0.761 | 0.496 | 0.967 | 1e-129 | |
| 326490425 | 367 | predicted protein [Hordeum vulgare subsp | 0.773 | 0.681 | 0.892 | 1e-129 | |
| 224093188 | 368 | predicted protein [Populus trichocarpa] | 0.736 | 0.646 | 0.970 | 1e-128 | |
| 255644386 | 366 | unknown [Glycine max] | 0.739 | 0.653 | 0.937 | 1e-128 | |
| 358248396 | 363 | PTI1-like tyrosine-protein kinase 3-like | 0.764 | 0.680 | 0.947 | 1e-128 |
| >gi|224133038|ref|XP_002327946.1| predicted protein [Populus trichocarpa] gi|118487306|gb|ABK95481.1| unknown [Populus trichocarpa] gi|222837355|gb|EEE75734.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 485 bits (1248), Expect = e-134, Method: Compositional matrix adjust.
Identities = 233/245 (95%), Positives = 242/245 (98%)
Query: 75 VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 134
VS+VSRLK+EN+VELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDW+
Sbjct: 117 VSMVSRLKNENVVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWIQ 176
Query: 135 RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 194
RV+IAVDAARGLEYLHEK+QP+IIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH
Sbjct: 177 RVKIAVDAARGLEYLHEKLQPAIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 236
Query: 195 STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWAT 254
STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWAT
Sbjct: 237 STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWAT 296
Query: 255 PRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSP 314
PRLSEDKVKQCVDPKLKGEYPPKGVAK+AAVAALCVQYE+EFRPNMSIVVKALQPLLKS
Sbjct: 297 PRLSEDKVKQCVDPKLKGEYPPKGVAKMAAVAALCVQYESEFRPNMSIVVKALQPLLKSV 356
Query: 315 PPAAP 319
PAAP
Sbjct: 357 APAAP 361
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449446223|ref|XP_004140871.1| PREDICTED: PTI1-like tyrosine-protein kinase 3-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 479 bits (1233), Expect = e-133, Method: Compositional matrix adjust.
Identities = 227/238 (95%), Positives = 235/238 (98%)
Query: 75 VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 134
VS VSRLKHENLVELLGYCVEGN+RVLAYE+ATMGSLHD+LHGRKGVQGAQPGPVLDWM
Sbjct: 117 VSTVSRLKHENLVELLGYCVEGNIRVLAYEYATMGSLHDVLHGRKGVQGAQPGPVLDWMQ 176
Query: 135 RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 194
RVRIAVD+A+GLEYLHEKVQP+IIHRDIRSSNVLLFEDFKAK+ADFNLSNQAPDMAARLH
Sbjct: 177 RVRIAVDSAKGLEYLHEKVQPAIIHRDIRSSNVLLFEDFKAKVADFNLSNQAPDMAARLH 236
Query: 195 STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWAT 254
STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWAT
Sbjct: 237 STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWAT 296
Query: 255 PRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLK 312
PRLSEDKVKQCVDP+LKGEYPPKGVAKLAAVA LCVQYEAEFRPNMSIVVKALQPLLK
Sbjct: 297 PRLSEDKVKQCVDPRLKGEYPPKGVAKLAAVATLCVQYEAEFRPNMSIVVKALQPLLK 354
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|223452408|gb|ACM89531.1| serine/threonine protein kinase [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 471 bits (1211), Expect = e-130, Method: Compositional matrix adjust.
Identities = 227/239 (94%), Positives = 232/239 (97%)
Query: 75 VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 134
VS+VSRLK +N VEL GYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGP LDW+
Sbjct: 117 VSMVSRLKDDNFVELHGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPTLDWIQ 176
Query: 135 RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 194
RVRIAVDAARGLEYLHEKVQP IIHRDIRSSNVL+FED+KAKIADFNLSNQAPDMAARLH
Sbjct: 177 RVRIAVDAARGLEYLHEKVQPPIIHRDIRSSNVLIFEDYKAKIADFNLSNQAPDMAARLH 236
Query: 195 STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWAT 254
STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWAT
Sbjct: 237 STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWAT 296
Query: 255 PRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKS 313
PRLSEDKVKQCVDPKLKGEYPPKGVAKL AVAALCVQYEAEFRPNMSIVVKALQPLLKS
Sbjct: 297 PRLSEDKVKQCVDPKLKGEYPPKGVAKLGAVAALCVQYEAEFRPNMSIVVKALQPLLKS 355
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|351722789|ref|NP_001237256.1| protein kinase Pti1 [Glycine max] gi|29838544|gb|AAO92595.1| protein kinase Pti1 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 470 bits (1209), Expect = e-130, Method: Compositional matrix adjust.
Identities = 226/239 (94%), Positives = 232/239 (97%)
Query: 75 VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 134
VS+VSRLK +N VE+ GYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGP LDW+
Sbjct: 117 VSMVSRLKDDNFVEMHGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPTLDWIQ 176
Query: 135 RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 194
RVRIAVDAARGLEYLHEKVQP IIHRDIRSSNVL+FED+KAKIADFNLSNQAPDMAARLH
Sbjct: 177 RVRIAVDAARGLEYLHEKVQPPIIHRDIRSSNVLIFEDYKAKIADFNLSNQAPDMAARLH 236
Query: 195 STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWAT 254
STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWAT
Sbjct: 237 STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWAT 296
Query: 255 PRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKS 313
PRLSEDKVKQCVDPKLKGEYPPKGVAKL AVAALCVQYEAEFRPNMSIVVKALQPLLKS
Sbjct: 297 PRLSEDKVKQCVDPKLKGEYPPKGVAKLGAVAALCVQYEAEFRPNMSIVVKALQPLLKS 355
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297745178|emb|CBI39170.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 469 bits (1206), Expect = e-129, Method: Compositional matrix adjust.
Identities = 238/246 (96%), Positives = 241/246 (97%)
Query: 75 VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 134
VS+VSRLKHENLVELLGYCV+GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWM
Sbjct: 156 VSMVSRLKHENLVELLGYCVDGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMQ 215
Query: 135 RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 194
RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH
Sbjct: 216 RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 275
Query: 195 STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWAT 254
STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWAT
Sbjct: 276 STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWAT 335
Query: 255 PRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSP 314
PRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLK+
Sbjct: 336 PRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKAA 395
Query: 315 PPAAPV 320
PA V
Sbjct: 396 APAPEV 401
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359478064|ref|XP_002272354.2| PREDICTED: PTI1-like tyrosine-protein kinase 3 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 468 bits (1204), Expect = e-129, Method: Compositional matrix adjust.
Identities = 238/246 (96%), Positives = 241/246 (97%)
Query: 75 VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 134
VS+VSRLKHENLVELLGYCV+GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWM
Sbjct: 250 VSMVSRLKHENLVELLGYCVDGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMQ 309
Query: 135 RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 194
RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH
Sbjct: 310 RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 369
Query: 195 STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWAT 254
STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWAT
Sbjct: 370 STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWAT 429
Query: 255 PRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSP 314
PRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLK+
Sbjct: 430 PRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKAA 489
Query: 315 PPAAPV 320
PA V
Sbjct: 490 APAPEV 495
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|326490425|dbj|BAJ84876.1| predicted protein [Hordeum vulgare subsp. vulgare] gi|326509979|dbj|BAJ87206.1| predicted protein [Hordeum vulgare subsp. vulgare] | Back alignment and taxonomy information |
|---|
Score = 466 bits (1199), Expect = e-129, Method: Compositional matrix adjust.
Identities = 223/250 (89%), Positives = 237/250 (94%)
Query: 63 SPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQ 122
S + D+ + VS+VSRLKHENLVE+LGY VEGN R+LAYEFATMGSLHD+LHGRKGVQ
Sbjct: 101 SENEHNDEFLKQVSLVSRLKHENLVEMLGYYVEGNYRILAYEFATMGSLHDVLHGRKGVQ 160
Query: 123 GAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNL 182
GAQPGPVLDWM RV+IA++AA+G+EYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNL
Sbjct: 161 GAQPGPVLDWMQRVKIAIEAAKGIEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNL 220
Query: 183 SNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTM 242
NQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTM
Sbjct: 221 LNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTM 280
Query: 243 PRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSI 302
PRGQQSLVTWATPRLSEDKVKQCVDP+LKGEYPPKGVAKL AVAALCVQYEAEFRPNMSI
Sbjct: 281 PRGQQSLVTWATPRLSEDKVKQCVDPRLKGEYPPKGVAKLGAVAALCVQYEAEFRPNMSI 340
Query: 303 VVKALQPLLK 312
VVKAL PLL+
Sbjct: 341 VVKALSPLLQ 350
|
Source: Hordeum vulgare subsp. vulgare Species: Hordeum vulgare Genus: Hordeum Family: Poaceae Order: Poales Class: Liliopsida Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224093188|ref|XP_002309825.1| predicted protein [Populus trichocarpa] gi|222852728|gb|EEE90275.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 464 bits (1194), Expect = e-128, Method: Compositional matrix adjust.
Identities = 231/238 (97%), Positives = 236/238 (99%)
Query: 75 VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 134
VS+VSRLKHEN VELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWM
Sbjct: 117 VSMVSRLKHENFVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMQ 176
Query: 135 RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 194
RVRIAVDAARG+EYLHEKVQP++IHRD+RSSNVLLFEDFKAKIADFNLSNQAPDMAARLH
Sbjct: 177 RVRIAVDAARGMEYLHEKVQPAVIHRDVRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 236
Query: 195 STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWAT 254
STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWAT
Sbjct: 237 STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWAT 296
Query: 255 PRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLK 312
PRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLK
Sbjct: 297 PRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLK 354
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255644386|gb|ACU22698.1| unknown [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 463 bits (1192), Expect = e-128, Method: Compositional matrix adjust.
Identities = 224/239 (93%), Positives = 230/239 (96%)
Query: 75 VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 134
VS+VS LK +N VEL GYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGP LDW+
Sbjct: 117 VSMVSGLKDDNFVELHGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPTLDWIQ 176
Query: 135 RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 194
RVRIAVDAARGLEYLHEKVQP IIHRDI+SSNVL+FED+KAKIADFNLSNQAPDMAARLH
Sbjct: 177 RVRIAVDAARGLEYLHEKVQPPIIHRDIQSSNVLIFEDYKAKIADFNLSNQAPDMAARLH 236
Query: 195 STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWAT 254
STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWAT
Sbjct: 237 STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWAT 296
Query: 255 PRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKS 313
PRLSE KVKQCVDPKLKGEYPPKGVAKL AVAALCVQYEAEFRPNMSIVVKALQPLLKS
Sbjct: 297 PRLSEGKVKQCVDPKLKGEYPPKGVAKLGAVAALCVQYEAEFRPNMSIVVKALQPLLKS 355
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|358248396|ref|NP_001239619.1| PTI1-like tyrosine-protein kinase 3-like [Glycine max] gi|223452369|gb|ACM89512.1| protein kinase Pti1 [Glycine max] gi|255638318|gb|ACU19471.1| unknown [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 463 bits (1191), Expect = e-128, Method: Compositional matrix adjust.
Identities = 234/247 (94%), Positives = 239/247 (96%)
Query: 75 VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 134
VS+VSRLK+ N VEL GYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGP LDW+
Sbjct: 117 VSMVSRLKNGNFVELHGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPTLDWIQ 176
Query: 135 RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 194
RVRIAVDAARGLEYLHEKVQP IIHRDIRSSNVL+FED+KAKIADFNLSNQAPDMAARLH
Sbjct: 177 RVRIAVDAARGLEYLHEKVQPPIIHRDIRSSNVLIFEDYKAKIADFNLSNQAPDMAARLH 236
Query: 195 STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWAT 254
STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWAT
Sbjct: 237 STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWAT 296
Query: 255 PRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSP 314
PRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSP
Sbjct: 297 PRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSP 356
Query: 315 PPAAPVS 321
PAAP S
Sbjct: 357 APAAPES 363
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 323 | ||||||
| TAIR|locus:2081277 | 408 | AT3G59350 [Arabidopsis thalian | 0.767 | 0.607 | 0.863 | 6.7e-134 | |
| TAIR|locus:2009115 | 361 | AT1G06700 [Arabidopsis thalian | 0.804 | 0.720 | 0.824 | 1.4e-120 | |
| TAIR|locus:2054502 | 366 | AT2G30740 [Arabidopsis thalian | 0.770 | 0.680 | 0.856 | 3.2e-113 | |
| TAIR|locus:2088990 | 364 | AT3G17410 [Arabidopsis thalian | 0.801 | 0.711 | 0.755 | 4.6e-103 | |
| TAIR|locus:2064557 | 365 | AT2G41970 [Arabidopsis thalian | 0.798 | 0.706 | 0.734 | 1.7e-100 | |
| TAIR|locus:2054492 | 338 | AT2G30730 [Arabidopsis thalian | 0.755 | 0.721 | 0.759 | 1.9e-99 | |
| TAIR|locus:2023767 | 363 | AT1G48210 [Arabidopsis thalian | 0.801 | 0.713 | 0.725 | 1.5e-97 | |
| TAIR|locus:2098083 | 361 | AT3G62220 [Arabidopsis thalian | 0.786 | 0.703 | 0.738 | 3.2e-97 | |
| TAIR|locus:2023752 | 364 | AT1G48220 [Arabidopsis thalian | 0.773 | 0.686 | 0.658 | 2.7e-84 | |
| TAIR|locus:2099009 | 400 | AT3G58690 [Arabidopsis thalian | 0.789 | 0.637 | 0.492 | 1.9e-58 |
| TAIR|locus:2081277 AT3G59350 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1112 (396.5 bits), Expect = 6.7e-134, Sum P(2) = 6.7e-134
Identities = 215/249 (86%), Positives = 224/249 (89%)
Query: 75 VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 134
VS VS+LKH+N VEL GYCVEGN R+LAYEFATMGSLHDILHGRKGVQGAQPGP LDW+
Sbjct: 159 VSRVSKLKHDNFVELFGYCVEGNFRILAYEFATMGSLHDILHGRKGVQGAQPGPTLDWIQ 218
Query: 135 RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 194
RVRIAVDAARGLEYLHEKVQP++IHRDIRSSNVLLFEDFKAKIADFNLSNQ+PDMAARLH
Sbjct: 219 RVRIAVDAARGLEYLHEKVQPAVIHRDIRSSNVLLFEDFKAKIADFNLSNQSPDMAARLH 278
Query: 195 STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWAT 254
STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWAT
Sbjct: 279 STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWAT 338
Query: 255 PRLSEDKVKQCVDPKLKGEYXXXXXXXXXXXXXXCVQYEAEFRPNMSIVVKALQPLLKSP 314
PRLSEDKVKQCVDPKLKGEY CVQYE+EFRPNMSIVVKALQPLL+S
Sbjct: 339 PRLSEDKVKQCVDPKLKGEYPPKAVAKLAAVAALCVQYESEFRPNMSIVVKALQPLLRSS 398
Query: 315 PPAA-PVSE 322
AA PV E
Sbjct: 399 TAAAVPVQE 407
|
|
| TAIR|locus:2009115 AT1G06700 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1113 (396.9 bits), Expect = 1.4e-120, Sum P(2) = 1.4e-120
Identities = 216/262 (82%), Positives = 231/262 (88%)
Query: 63 SPKNYPDDE-KQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGV 121
+P+ D E VS+VSRLKHENL++LLG+CV+GNLRVLAYEFATMGSLHDILHGRKGV
Sbjct: 101 APEAETDTEFLSQVSMVSRLKHENLIQLLGFCVDGNLRVLAYEFATMGSLHDILHGRKGV 160
Query: 122 QGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFN 181
QGAQPGP LDW+TRV+IAV+AARGLEYLHEK QP +IHRDIRSSNVLLFED+KAKIADFN
Sbjct: 161 QGAQPGPTLDWITRVKIAVEAARGLEYLHEKSQPPVIHRDIRSSNVLLFEDYKAKIADFN 220
Query: 182 LSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHT 241
LSNQAPD AARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHT
Sbjct: 221 LSNQAPDNAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHT 280
Query: 242 MPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYXXXXXXXXXXXXXXCVQYEAEFRPNMS 301
MPRGQQSLVTWATPRLSEDKVKQC+DPKLK +Y CVQYEAEFRPNMS
Sbjct: 281 MPRGQQSLVTWATPRLSEDKVKQCIDPKLKADYPPKAVAKLAAVAALCVQYEAEFRPNMS 340
Query: 302 IVVKALQPLLKSPPPAAPVSET 323
IVVKALQPLLK PP AAP E+
Sbjct: 341 IVVKALQPLLK-PPAAAPAPES 361
|
|
| TAIR|locus:2054502 AT2G30740 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1117 (398.3 bits), Expect = 3.2e-113, P = 3.2e-113
Identities = 214/250 (85%), Positives = 228/250 (91%)
Query: 75 VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 134
VS+VSRLKHENL++L+GYCV+ NLRVLAYEFATMGSLHDILHGRKGVQGAQPGP LDW+T
Sbjct: 117 VSMVSRLKHENLIQLVGYCVDENLRVLAYEFATMGSLHDILHGRKGVQGAQPGPTLDWLT 176
Query: 135 RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 194
RV+IAV+AARGLEYLHEKVQP +IHRDIRSSNVLLFED++AK+ADFNLSNQAPD AARLH
Sbjct: 177 RVKIAVEAARGLEYLHEKVQPPVIHRDIRSSNVLLFEDYQAKVADFNLSNQAPDNAARLH 236
Query: 195 STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWAT 254
STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWAT
Sbjct: 237 STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWAT 296
Query: 255 PRLSEDKVKQCVDPKLKGEYXXXXXXXXXXXXXXCVQYEAEFRPNMSIVVKALQPLLKSP 314
PRLSEDKVKQCVDPKLKGEY CVQYE+EFRPNMSIVVKALQPLLK P
Sbjct: 297 PRLSEDKVKQCVDPKLKGEYPPKSVAKLAAVAALCVQYESEFRPNMSIVVKALQPLLKPP 356
Query: 315 PPA-APVSET 323
PA APV E+
Sbjct: 357 APAPAPVPES 366
|
|
| TAIR|locus:2088990 AT3G17410 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1000 (357.1 bits), Expect = 4.6e-103, Sum P(2) = 4.6e-103
Identities = 198/262 (75%), Positives = 219/262 (83%)
Query: 59 ERLKSPKNYPDDE-KQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHG 117
++L S K PD E VS+VSRL+ EN+V LLGYCV+G LRVLAYE+A GSLHDILHG
Sbjct: 97 KKLDSSKQ-PDQEFLAQVSMVSRLRQENVVALLGYCVDGPLRVLAYEYAPNGSLHDILHG 155
Query: 118 RKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKI 177
RKGV+GAQPGPVL W RV+IAV AARGLEYLHEK P +IHRDI+SSNVLLF+D AKI
Sbjct: 156 RKGVKGAQPGPVLSWHQRVKIAVGAARGLEYLHEKANPHVIHRDIKSSNVLLFDDDVAKI 215
Query: 178 ADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 237
ADF+LSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG L+ KSDVYSFGVVLLELLTGRKP
Sbjct: 216 ADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGTLSTKSDVYSFGVVLLELLTGRKP 275
Query: 238 VDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYXXXXXXXXXXXXXXCVQYEAEFR 297
VDHT+PRGQQS+VTWATP+LSEDKVKQCVD +L GEY CVQYEA+FR
Sbjct: 276 VDHTLPRGQQSVVTWATPKLSEDKVKQCVDARLNGEYPPKAVAKLAAVAALCVQYEADFR 335
Query: 298 PNMSIVVKALQPLLKSPPPAAP 319
PNMSIVVKALQPLL +PP +AP
Sbjct: 336 PNMSIVVKALQPLL-NPPRSAP 356
|
|
| TAIR|locus:2064557 AT2G41970 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 997 (356.0 bits), Expect = 1.7e-100, P = 1.7e-100
Identities = 191/260 (73%), Positives = 216/260 (83%)
Query: 63 SPKNYPD-DEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGV 121
S PD D +SVVSRLKH++ VELLGYC+E N R+L Y+FAT GSLHD+LHGRKGV
Sbjct: 105 SSSEEPDSDFTSQLSVVSRLKHDHFVELLGYCLEANNRILIYQFATKGSLHDVLHGRKGV 164
Query: 122 QGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFN 181
QGA+PGPVL+W RV+IA AA+GLE+LHEKVQP I+HRD+RSSNVLLF+DF AK+ADFN
Sbjct: 165 QGAEPGPVLNWNQRVKIAYGAAKGLEFLHEKVQPPIVHRDVRSSNVLLFDDFVAKMADFN 224
Query: 182 LSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHT 241
L+N + D AARLHSTRVLGTFGYHAPEYAMTGQ+TQKSDVYSFGVVLLELLTGRKPVDHT
Sbjct: 225 LTNASSDTAARLHSTRVLGTFGYHAPEYAMTGQITQKSDVYSFGVVLLELLTGRKPVDHT 284
Query: 242 MPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYXXXXXXXXXXXXXXCVQYEAEFRPNMS 301
MP+GQQSLVTWATPRLSEDKVKQC+DPKL ++ CVQYEA+FRPNM+
Sbjct: 285 MPKGQQSLVTWATPRLSEDKVKQCIDPKLNNDFPPKAVAKLAAVAALCVQYEADFRPNMT 344
Query: 302 IVVKALQPLLKSPPPAAPVS 321
IVVKALQPLL S P A P S
Sbjct: 345 IVVKALQPLLNSKP-AGPES 363
|
|
| TAIR|locus:2054492 AT2G30730 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 987 (352.5 bits), Expect = 1.9e-99, P = 1.9e-99
Identities = 189/249 (75%), Positives = 212/249 (85%)
Query: 68 PDDEKQL-----VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQ 122
P+DE VS+VSRLKHENL++L+GYCV+ NLRVLAYEFATMGSLHDILHGRKGVQ
Sbjct: 81 PEDETNTEFLSQVSMVSRLKHENLIQLVGYCVDENLRVLAYEFATMGSLHDILHGRKGVQ 140
Query: 123 GAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNL 182
A PGP LDW+TRV+IAV+AARGLEYLHEKVQP +IHRDIRSSN+LLF+D++AKIADFNL
Sbjct: 141 DALPGPTLDWITRVKIAVEAARGLEYLHEKVQPQVIHRDIRSSNILLFDDYQAKIADFNL 200
Query: 183 SNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTM 242
SNQ+PD AARL STRVLG+FGY++PEYAMTG+LT KSDVY FGVVLLELLTGRKPVDHTM
Sbjct: 201 SNQSPDNAARLQSTRVLGSFGYYSPEYAMTGELTHKSDVYGFGVVLLELLTGRKPVDHTM 260
Query: 243 PRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYXXXXXXXXXXXXXXCVQYEAEFRPNMSI 302
PRGQQSLVTWATP+LSED V++CVDPKLKGEY CVQYE+ RP MS
Sbjct: 261 PRGQQSLVTWATPKLSEDTVEECVDPKLKGEYSPKSVAKLAAVAALCVQYESNCRPKMST 320
Query: 303 VVKALQPLL 311
VVKALQ LL
Sbjct: 321 VVKALQQLL 329
|
|
| TAIR|locus:2023767 AT1G48210 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 969 (346.2 bits), Expect = 1.5e-97, P = 1.5e-97
Identities = 190/262 (72%), Positives = 214/262 (81%)
Query: 59 ERLKSPKNYPDDE-KQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHG 117
++L S K PD E +S+VSRL+H+N+ L+GYCV+G LRVLAYEFA GSLHD LHG
Sbjct: 96 KKLDSSKQ-PDQEFLSQISMVSRLRHDNVTALMGYCVDGPLRVLAYEFAPKGSLHDTLHG 154
Query: 118 RKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKI 177
+KG +GA GPV+ W RV+IAV AARGLEYLHEKV P +IHRDI+SSNVLLF+D AKI
Sbjct: 155 KKGAKGALRGPVMTWQQRVKIAVGAARGLEYLHEKVSPQVIHRDIKSSNVLLFDDDVAKI 214
Query: 178 ADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 237
DF+LS+QAPDMAARLHSTRVLGTFGYHAPEYAMTG L+ KSDVYSFGVVLLELLTGRKP
Sbjct: 215 GDFDLSDQAPDMAARLHSTRVLGTFGYHAPEYAMTGTLSSKSDVYSFGVVLLELLTGRKP 274
Query: 238 VDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYXXXXXXXXXXXXXXCVQYEAEFR 297
VDHT+PRGQQSLVTWATP+LSEDKVKQCVD +L GEY CVQYEA FR
Sbjct: 275 VDHTLPRGQQSLVTWATPKLSEDKVKQCVDARLLGEYPPKAVGKLAAVAALCVQYEANFR 334
Query: 298 PNMSIVVKALQPLLKSPPPAAP 319
PNMSIVVKALQPLL +PP +AP
Sbjct: 335 PNMSIVVKALQPLL-NPPRSAP 355
|
|
| TAIR|locus:2098083 AT3G62220 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 966 (345.1 bits), Expect = 3.2e-97, P = 3.2e-97
Identities = 189/256 (73%), Positives = 214/256 (83%)
Query: 59 ERLKSPKNYPDDE-KQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHG 117
++L S K P++E VS+VSRLKH N VELLGY V+GN R+L +EFA GSLHDILHG
Sbjct: 97 KKLDSNKQ-PNEEFLAQVSMVSRLKHVNFVELLGYSVDGNSRILVFEFAQNGSLHDILHG 155
Query: 118 RKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKI 177
RKGV+GA+PGP+L W RV+IAV AARGLEYLHEK P +IHRDI+SSNVL+F++ AKI
Sbjct: 156 RKGVKGAKPGPLLSWHQRVKIAVGAARGLEYLHEKANPHVIHRDIKSSNVLIFDNDVAKI 215
Query: 178 ADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 237
ADF+LSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQL+ KSDVYSFGVVLLELLTGRKP
Sbjct: 216 ADFDLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLSAKSDVYSFGVVLLELLTGRKP 275
Query: 238 VDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYXXXXXXXXXXXXXXCVQYEAEFR 297
VDHT+PRGQQSLVTWATP+LSEDKVKQCVD +L G+Y CVQYEA+FR
Sbjct: 276 VDHTLPRGQQSLVTWATPKLSEDKVKQCVDSRLGGDYPPKAVAKLAAVAALCVQYEADFR 335
Query: 298 PNMSIVVKALQPLLKS 313
PNMSIVVKALQPLL +
Sbjct: 336 PNMSIVVKALQPLLNA 351
|
|
| TAIR|locus:2023752 AT1G48220 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 844 (302.2 bits), Expect = 2.7e-84, P = 2.7e-84
Identities = 166/252 (65%), Positives = 195/252 (77%)
Query: 64 PKNYPDDE-KQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQ 122
P PD E VS+VSRL HEN+V L+ YCV+G LRVLAYEFAT G+LHD+LHG+ GV
Sbjct: 100 PTKQPDQEFLSQVSMVSRLHHENVVALMAYCVDGPLRVLAYEFATYGTLHDVLHGQTGVI 159
Query: 123 GAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNL 182
GA GPV+ W RV+IA+ AARGLEYLH+KV P +IHRDI++SN+LLF+D AKI DF+L
Sbjct: 160 GALQGPVMTWQRRVKIALGAARGLEYLHKKVNPQVIHRDIKASNILLFDDDIAKIGDFDL 219
Query: 183 SNQAPDMAARLHSTRV-LGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHT 241
+QAP+MA RLHS R+ LG H PE+AMTG LT KSDVYSFGVVLLELLTGRKPVD T
Sbjct: 220 YDQAPNMAGRLHSCRMALGASRSHCPEHAMTGILTTKSDVYSFGVVLLELLTGRKPVDRT 279
Query: 242 MPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYXXXXXXXXXXXXXXCVQYEAEFRPNMS 301
+PRGQQ+LVTWATP+LS+DKVKQCVD +L GEY CV Y+ +FRP+MS
Sbjct: 280 LPRGQQNLVTWATPKLSKDKVKQCVDARLLGEYPPKAVAKLAAVSARCVHYDPDFRPDMS 339
Query: 302 IVVKALQPLLKS 313
IVVKALQPLL S
Sbjct: 340 IVVKALQPLLNS 351
|
|
| TAIR|locus:2099009 AT3G58690 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 600 (216.3 bits), Expect = 1.9e-58, P = 1.9e-58
Identities = 127/258 (49%), Positives = 171/258 (66%)
Query: 65 KNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGA 124
K ++ K V ++SRL+ L+ LLGYC + + ++L YEF G L + L+ G+
Sbjct: 122 KQGEEEFKMEVELLSRLRSPYLLALLGYCSDNSHKLLVYEFMANGGLQEHLY-LPNRSGS 180
Query: 125 QPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSN 184
P P LDW TR+RIAV+AA+GLEYLHE+V P +IHRD +SSN+LL +F AK++DF L+
Sbjct: 181 VP-PRLDWETRMRIAVEAAKGLEYLHEQVSPPVIHRDFKSSNILLDRNFNAKVSDFGLAK 239
Query: 185 QAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPR 244
D A STRVLGT GY APEYA+TG LT KSDVYS+GVVLLELLTGR PVD
Sbjct: 240 VGSDKAGGHVSTRVLGTQGYVAPEYALTGHLTTKSDVYSYGVVLLELLTGRVPVDMKRAT 299
Query: 245 GQQSLVTWATPRLSE-DKVKQCVDPKLKGEYXXXXXXXXXXXXXXCVQYEAEFRPNMSIV 303
G+ LV+WA P+L++ DKV +DP L+G+Y CVQ EA++RP M+ V
Sbjct: 300 GEGVLVSWALPQLADRDKVVDIMDPTLEGQYSTKEVVQVAAIAAMCVQAEADYRPLMADV 359
Query: 304 VKALQPLLKSPPPAAPVS 321
V++L PL+++ A+ +S
Sbjct: 360 VQSLVPLVRNRRSASKLS 377
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| B9DFG5 | PTI13_ARATH | 2, ., 7, ., 1, 0, ., 2 | 0.912 | 0.7708 | 0.6102 | no | no |
| O49339 | PTI12_ARATH | 2, ., 7, ., 1, 0, ., 2 | 0.9243 | 0.7368 | 0.6502 | no | no |
| Q41328 | PTI1_SOLLC | 2, ., 7, ., 1, 1, ., 1 | 0.8353 | 0.7523 | 0.6864 | N/A | no |
| Q8H1G6 | PTI11_ARATH | 2, ., 7, ., 1, 0, ., 2 | 0.9243 | 0.7368 | 0.6592 | no | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.946 |
| 3rd Layer | 2.7.11 | 0.963 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 323 | |||
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 4e-40 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 5e-40 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 4e-38 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 5e-38 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 7e-38 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 3e-32 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-31 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 3e-29 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-26 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-24 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 4e-23 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 6e-23 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 9e-23 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 9e-23 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-22 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 1e-22 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 4e-21 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 5e-21 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 3e-20 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-19 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-19 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 1e-19 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-19 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-19 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 3e-19 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 4e-19 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 6e-19 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 7e-19 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 8e-19 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 9e-19 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 1e-18 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-18 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-18 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 3e-18 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-18 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 4e-18 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 5e-18 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-17 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-17 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-17 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-17 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 2e-17 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-17 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-17 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 3e-17 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 4e-17 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 8e-17 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 8e-17 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-16 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-16 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-16 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-16 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 3e-16 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 3e-16 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 5e-16 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 6e-16 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 7e-16 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 1e-15 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 1e-15 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-15 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 1e-15 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-15 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-15 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-15 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 3e-15 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 3e-15 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 5e-15 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 7e-15 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 8e-15 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-14 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 1e-14 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-14 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 1e-14 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-14 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-14 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-14 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 3e-14 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 3e-14 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 3e-14 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 3e-14 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 4e-14 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 4e-14 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 4e-14 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 4e-14 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 5e-14 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 8e-14 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-13 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 1e-13 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-13 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-13 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-13 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 3e-13 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 3e-13 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 3e-13 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 4e-13 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 4e-13 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 4e-13 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 5e-13 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 6e-13 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 7e-13 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 8e-13 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 1e-12 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-12 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-12 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-12 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-12 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-12 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-12 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 3e-12 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 3e-12 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 3e-12 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 4e-12 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 4e-12 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 5e-12 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 5e-12 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 5e-12 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 6e-12 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 8e-12 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 8e-12 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 8e-12 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 8e-12 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 1e-11 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-11 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 1e-11 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 1e-11 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 1e-11 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 1e-11 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-11 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-11 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-11 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 3e-11 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 4e-11 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 4e-11 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 4e-11 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 5e-11 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 6e-11 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 7e-11 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 7e-11 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 7e-11 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 7e-11 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 8e-11 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 9e-11 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-10 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-10 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-10 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-10 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-10 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 3e-10 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 3e-10 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 3e-10 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 3e-10 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 3e-10 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 4e-10 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 4e-10 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 4e-10 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 4e-10 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 5e-10 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 5e-10 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 5e-10 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 5e-10 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 6e-10 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 7e-10 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 7e-10 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 7e-10 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 1e-09 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 1e-09 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-09 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 1e-09 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 1e-09 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-09 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-09 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-09 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 3e-09 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 3e-09 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 4e-09 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 5e-09 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 5e-09 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 8e-09 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 8e-09 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 9e-09 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-08 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-08 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-08 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 1e-08 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 1e-08 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 1e-08 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-08 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-08 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-08 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-08 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 2e-08 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 2e-08 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-08 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-08 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 3e-08 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 4e-08 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 4e-08 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 5e-08 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 6e-08 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 6e-08 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 6e-08 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 6e-08 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 7e-08 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 7e-08 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 8e-08 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 9e-08 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 9e-08 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-07 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 2e-07 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-07 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-07 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-07 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-07 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-07 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 3e-07 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 3e-07 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 4e-07 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 4e-07 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 4e-07 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 4e-07 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 6e-07 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 7e-07 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 7e-07 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 9e-07 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 9e-07 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 1e-06 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 1e-06 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 1e-06 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-06 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-06 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 1e-06 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 1e-06 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-06 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-06 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-06 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-06 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-06 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-06 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 3e-06 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 3e-06 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 3e-06 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 3e-06 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 3e-06 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 3e-06 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 4e-06 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 6e-06 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 6e-06 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 6e-06 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 6e-06 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 6e-06 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 7e-06 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 7e-06 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 9e-06 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-05 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 1e-05 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 1e-05 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 1e-05 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 1e-05 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 1e-05 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-05 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-05 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-05 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-05 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 2e-05 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 2e-05 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 2e-05 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 3e-05 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 3e-05 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 3e-05 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 4e-05 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 5e-05 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 5e-05 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 5e-05 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 6e-05 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 7e-05 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 8e-05 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 9e-05 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 1e-04 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 1e-04 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-04 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 2e-04 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 4e-04 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 5e-04 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 5e-04 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 6e-04 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 0.001 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 0.001 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 0.001 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 0.001 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 0.002 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 0.002 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 0.002 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 0.002 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 0.003 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 0.003 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 0.003 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 139 bits (353), Expect = 4e-40
Identities = 57/159 (35%), Positives = 80/159 (50%), Gaps = 15/159 (9%)
Query: 75 VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 134
+ ++ +L H N+V+L G + N L E+ GSL D+L +G L
Sbjct: 42 IEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKDLLKENEG--------KLSEDE 93
Query: 135 RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFED-FKAKIADFNLSNQAPDMAARL 193
+RI + GLEYLH IIHRD++ N+LL D K K+ADF LS + L
Sbjct: 94 ILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLL 150
Query: 194 HSTRVLGTFGYHAPE-YAMTGQLTQKSDVYSFGVVLLEL 231
+ GT Y APE G ++KSD++S GV+L EL
Sbjct: 151 KTIV--GTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 140 bits (356), Expect = 5e-40
Identities = 80/257 (31%), Positives = 114/257 (44%), Gaps = 33/257 (12%)
Query: 62 KSPKNYPDDE--KQLVS---VVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILH 116
K+ K +E K + V+ +L H N+V LLG C E L E+ G L D L
Sbjct: 29 KTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLR 88
Query: 117 GRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAK 176
+ V + L + A+ A+G+EYL K +HRD+ + N L+ ED K
Sbjct: 89 KSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVK 145
Query: 177 IADFNLS-NQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-G 234
I+DF LS + D R + L + APE G T KSDV+SFGV+L E+ T G
Sbjct: 146 ISDFGLSRDVYDDDYYRKKTGGKLPIR-WMAPESLKDGIFTSKSDVWSFGVLLWEIFTLG 204
Query: 235 RKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGV---AKLAAVAALCVQ 291
P P LS ++V + + KG PK +L + C Q
Sbjct: 205 ATPY----------------PGLSNEEVLEYL---RKGYRLPKPEYCPDELYELMLSCWQ 245
Query: 292 YEAEFRPNMSIVVKALQ 308
+ E RP S +V+ L+
Sbjct: 246 LDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 135 bits (343), Expect = 4e-38
Identities = 72/256 (28%), Positives = 113/256 (44%), Gaps = 41/256 (16%)
Query: 62 KSPKNYPDDEKQL-----VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILH 116
K+ K +++ ++ +L H N+V+LLG C E ++ E+ G L D L
Sbjct: 34 KTLKEDASEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLR 93
Query: 117 GRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAK 176
+ L + A+ ARG+EYL K + IHRD+ + N L+ E+ K
Sbjct: 94 KNRP-------KELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVK 143
Query: 177 IADFNLSNQAPDMAA-RLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-G 234
I+DF LS D ++ ++ + APE G+ T KSDV+SFGV+L E+ T G
Sbjct: 144 ISDFGLSRDLYDDDYYKVKGGKL--PIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLG 201
Query: 235 RKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEY---PPKGVAKLAAVAALCVQ 291
+P P +S +V + + KG PP +L + C
Sbjct: 202 EEP----------------YPGMSNAEVLEYLK---KGYRLPKPPNCPPELYKLMLQCWA 242
Query: 292 YEAEFRPNMSIVVKAL 307
+ E RP S +V+ L
Sbjct: 243 EDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 135 bits (342), Expect = 5e-38
Identities = 73/267 (27%), Positives = 110/267 (41%), Gaps = 64/267 (23%)
Query: 62 KSPKNYPDDEKQL-----VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILH 116
K+ K +++ ++ +L H N+V+LLG C E + E+ G L L
Sbjct: 34 KTLKEDASEQQIEEFLREARIMRKLDHPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLR 93
Query: 117 GRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAK 176
+ P L + A+ ARG+EYL K + IHRD+ + N L+ E+ K
Sbjct: 94 KNR--------PKLSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVK 142
Query: 177 IADFNLSNQAPDMAARLHSTRVLGTFGYH------------APEYAMTGQLTQKSDVYSF 224
I+DF LS R L Y+ APE G+ T KSDV+SF
Sbjct: 143 ISDFGLS-------------RDLYDDDYYRKRGGKLPIRWMAPESLKEGKFTSKSDVWSF 189
Query: 225 GVVLLELLT-GRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEY---PPKGVA 280
GV+L E+ T G +P P +S ++V + + G PP
Sbjct: 190 GVLLWEIFTLGEQPY----------------PGMSNEEVLEYLK---NGYRLPQPPNCPP 230
Query: 281 KLAAVAALCVQYEAEFRPNMSIVVKAL 307
+L + C + E RP S +V+ L
Sbjct: 231 ELYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 134 bits (341), Expect = 7e-38
Identities = 75/258 (29%), Positives = 116/258 (44%), Gaps = 43/258 (16%)
Query: 61 LKSPKNYPDDEKQL-----VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDIL 115
+K+ K +E++ S++ +L H N+V LLG C +G + E+ G L D L
Sbjct: 33 VKTLKEGASEEEREEFLEEASIMKKLSHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFL 92
Query: 116 HGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKA 175
+ G L +++A+ A+G+EYL K + +HRD+ + N L+ E+
Sbjct: 93 R--------KHGEKLTLKDLLQMALQIAKGMEYLESK---NFVHRDLAARNCLVTENLVV 141
Query: 176 KIADFNLSNQ-APDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT- 233
KI+DF LS D R L APE G+ T KSDV+SFGV+L E+ T
Sbjct: 142 KISDFGLSRDIYEDDYYRKRGGGKLPIKWM-APESLKDGKFTSKSDVWSFGVLLWEIFTL 200
Query: 234 GRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEY----PPKGVAKLAAVAALC 289
G +P P +S ++V + L+ Y P +L + C
Sbjct: 201 GEQPY----------------PGMSNEEVLE----LLEDGYRLPRPENCPDELYELMLQC 240
Query: 290 VQYEAEFRPNMSIVVKAL 307
Y+ E RP S +V+ L
Sbjct: 241 WAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 3e-32
Identities = 63/195 (32%), Positives = 89/195 (45%), Gaps = 18/195 (9%)
Query: 60 RLKSPKNYPDDEKQL---VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILH 116
LK ++ + ++ RL H N+V L+ + + L E+ G L D L
Sbjct: 31 ILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDAFEDKDHLYLVMEYCEGGDLFDYLS 90
Query: 117 GRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAK 176
L +IA+ RGLEYLH IIHRD++ N+LL E+ K
Sbjct: 91 RGG---------PLSEDEAKKIALQILRGLEYLHSN---GIIHRDLKPENILLDENGVVK 138
Query: 177 IADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQL-TQKSDVYSFGVVLLELLTGR 235
IADF L+ + ++ +T V GT Y APE + G K DV+S GV+L ELLTG+
Sbjct: 139 IADFGLAKKL-LKSSSSLTTFV-GTPWYMAPEVLLGGNGYGPKVDVWSLGVILYELLTGK 196
Query: 236 KPVDHTMPRGQQSLV 250
P Q L+
Sbjct: 197 PPFSGENILDQLQLI 211
|
Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 2e-31
Identities = 54/163 (33%), Positives = 78/163 (47%), Gaps = 15/163 (9%)
Query: 75 VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 134
+ ++ +LKH N+V L + + L E+ G L D+L R + +
Sbjct: 48 IKILKKLKHPNIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLS--------EDEA 99
Query: 135 RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 194
R LEYLH K I+HRD++ N+LL ED K+ADF L+ Q
Sbjct: 100 R-FYLRQILSALEYLHSK---GIVHRDLKPENILLDEDGHVKLADFGLARQLDP--GEKL 153
Query: 195 STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 237
+T V GT Y APE + + D++S GV+L ELLTG+ P
Sbjct: 154 TTFV-GTPEYMAPEVLLGKGYGKAVDIWSLGVILYELLTGKPP 195
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 3e-29
Identities = 45/166 (27%), Positives = 76/166 (45%), Gaps = 16/166 (9%)
Query: 75 VSVVSRLKHENLVELLGYCV--EGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDW 132
+ ++S L+H N+V G E N + E+ + GSL +L +
Sbjct: 50 IRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLP---------- 99
Query: 133 MTRVRI-AVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAA 191
+R GL YLH I+HRDI+ +N+L+ D K+ADF + + D+
Sbjct: 100 EPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIET 156
Query: 192 RLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 237
+ V GT + APE + + +D++S G ++E+ TG+ P
Sbjct: 157 GEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPP 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 104 bits (263), Expect = 1e-26
Identities = 52/167 (31%), Positives = 83/167 (49%), Gaps = 22/167 (13%)
Query: 75 VSVVSRLKHENLVELLG-YCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWM 133
+ ++ + KH N+V+ G Y + L + EF + GSL D+L +
Sbjct: 48 IQILKKCKHPNIVKYYGSYLKKDELW-IVMEFCSGGSLKDLLKSTNQT-----------L 95
Query: 134 TRVRIAV---DAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMA 190
T +IA + +GLEYLH IIHRDI+++N+LL D + K+ DF LS Q ++
Sbjct: 96 TESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQ---LS 149
Query: 191 ARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 237
++GT + APE K+D++S G+ +EL G+ P
Sbjct: 150 DTKARNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPP 196
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 99.4 bits (248), Expect = 2e-24
Identities = 59/165 (35%), Positives = 90/165 (54%), Gaps = 20/165 (12%)
Query: 76 SVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTR 135
SV++ L+H NLV+LLG ++GN + E+ GSL D L R G V+ +
Sbjct: 52 SVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSR----GRA---VITLAQQ 104
Query: 136 VRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHS 195
+ A+D G+EYL EK + +HRD+ + NVL+ ED AK++DF L+ +A
Sbjct: 105 LGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEA-------SQ 154
Query: 196 TRVLGTF--GYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKP 237
+ G + APE + + KSDV+SFG++L E+ + GR P
Sbjct: 155 GQDSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVP 199
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 95.8 bits (239), Expect = 4e-23
Identities = 71/223 (31%), Positives = 101/223 (45%), Gaps = 33/223 (14%)
Query: 72 KQLV---SVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGP 128
KQ++ ++ + +V G + E+ GSL IL K VQG P
Sbjct: 44 KQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKIL---KEVQGRIPER 100
Query: 129 VLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPD 188
+L +IAV +GL YLHEK + IIHRD++ SN+L+ + K+ DF +S Q +
Sbjct: 101 ILG-----KIAVAVLKGLTYLHEKHK--IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVN 153
Query: 189 MAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPV-----DHTMP 243
A+ T V GT Y APE + KSD++S G+ L+EL TGR P
Sbjct: 154 SLAK---TFV-GTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGI 209
Query: 244 RGQ-QSLVTWATPRLSEDK--------VKQCV--DPKLKGEYP 275
Q +V PRL K V C+ DP+ + Y
Sbjct: 210 FELLQYIVNEPPPRLPSGKFSPDFQDFVNLCLIKDPRERPSYK 252
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.0 bits (237), Expect = 6e-23
Identities = 53/171 (30%), Positives = 88/171 (51%), Gaps = 24/171 (14%)
Query: 72 KQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGP--- 128
Q + ++ LKH N+V+ +G + + E+A GSL I+ + GP
Sbjct: 47 MQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAENGSLRQIIK--------KFGPFPE 98
Query: 129 --VLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQA 186
V ++ +V +GL YLHE+ +IHRDI+++N+L +D K+ADF ++ +
Sbjct: 99 SLVAVYVYQV------LQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKL 149
Query: 187 PDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 237
D++ S V+GT + APE + SD++S G ++ELLTG P
Sbjct: 150 NDVSKDDAS--VVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPP 198
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 94.6 bits (235), Expect = 9e-23
Identities = 66/236 (27%), Positives = 118/236 (50%), Gaps = 37/236 (15%)
Query: 76 SVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILH--GRKGVQGAQPGPVLDWM 133
+V+++L H+NLV LLG + L ++ E + G+L + L GR V Q
Sbjct: 51 AVMTKLHHKNLVRLLGVILHNGLYIVM-ELMSKGNLVNFLRTRGRALVSVIQ-------- 101
Query: 134 TRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARL 193
++ ++D A G+EYL K ++HRD+ + N+L+ ED AK++DF L+ +
Sbjct: 102 -LLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGS---MGV 154
Query: 194 HSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTW 252
++++ + APE + + KSDV+S+GV+L E+ + GR P
Sbjct: 155 DNSKL--PVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPY-------------- 198
Query: 253 ATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQ 308
P++S +VK+CV+ + E P A + + C + E + RP+ + + L+
Sbjct: 199 --PKMSLKEVKECVEKGYRMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLE 252
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 94.8 bits (236), Expect = 9e-23
Identities = 63/183 (34%), Positives = 83/183 (45%), Gaps = 25/183 (13%)
Query: 63 SPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQ 122
+ DD + +++ L HENL+ L G + L + E A +GSL D L RK
Sbjct: 35 KLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLTHPLM-MVTELAPLGSLLDRL--RKDAL 91
Query: 123 GAQPGPVL-DWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFN 181
G L D+ AV A G+ YL K IHRD+ + N+LL D K KI DF
Sbjct: 92 GHFLISTLCDY------AVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFG 142
Query: 182 LSNQAPD------MAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-G 234
L P M L +V F + APE T + SDV+ FGV L E+ T G
Sbjct: 143 LMRALPQNEDHYVMEEHL---KV--PFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYG 197
Query: 235 RKP 237
+P
Sbjct: 198 EEP 200
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 94.5 bits (236), Expect = 1e-22
Identities = 60/216 (27%), Positives = 92/216 (42%), Gaps = 57/216 (26%)
Query: 75 VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGP---VLD 131
V ++ +L H N+++ E + E+A G L + +K + +P P +LD
Sbjct: 50 VKILKKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQK--KEGKPFPEEQILD 107
Query: 132 WMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAA 191
W ++ +A L+YLH + I+HRDI+ N+ L + K+ DF +S
Sbjct: 108 WFVQLCLA------LKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKV------ 152
Query: 192 RLHSTR-----VLGTFGYHAPE------YAMTGQLTQKSDVYSFGVVLLELLTGRKPVDH 240
L ST V+GT Y +PE Y KSD++S G VL EL T + P +
Sbjct: 153 -LSSTVDLAKTVVGTPYYLSPELCQNKPY------NYKSDIWSLGCVLYELCTLKHPFEG 205
Query: 241 TMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPP 276
L K+ LKG+YPP
Sbjct: 206 E---NLLELAL---------KI-------LKGQYPP 222
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 96.7 bits (239), Expect = 1e-22
Identities = 57/229 (24%), Positives = 92/229 (40%), Gaps = 26/229 (11%)
Query: 58 NERLKSPKNYPDDEKQLVSVVSRLKHE-NLVELLGYCVEGNLRVLAYEFATMGSLHDILH 116
++L+S + + + +++ L H N+V+L + + L E+ GSL D+L
Sbjct: 31 AKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLK 90
Query: 117 GRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLL-FEDFKA 175
L + ++ LEYLH K IIHRDI+ N+LL +
Sbjct: 91 KIGRKGPLSESEALFILAQI------LSALEYLHSK---GIIHRDIKPENILLDRDGRVV 141
Query: 176 KIADFNLSNQAPDMAARLHSTR----VLGTFGYHAPEYAM---TGQLTQKSDVYSFGVVL 228
K+ DF L+ PD + +GT GY APE + + SD++S G+ L
Sbjct: 142 KLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITL 201
Query: 229 LELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPK 277
ELLTG P + + + + + P L P
Sbjct: 202 YELLTGLPP--------FEGEKNSSATSQTLKIILELPTPSLASPLSPS 242
|
Length = 384 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 90.3 bits (225), Expect = 4e-21
Identities = 52/163 (31%), Positives = 80/163 (49%), Gaps = 27/163 (16%)
Query: 82 KHENLVELLG-YCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAV 140
+ +V+ G + EG + + E+ GSL D+L + P PVL ++ R
Sbjct: 57 ESPYVVKCYGAFYKEGEIS-IVLEYMDGGSLADLLKKVGKI----PEPVLAYIAR----- 106
Query: 141 DAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLG 200
+GL+YLH K IIHRDI+ SN+L+ + KIADF +S + + +T V G
Sbjct: 107 QILKGLDYLHTKRH--IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ-CNTFV-G 162
Query: 201 TFGYHAPE------YAMTGQLTQKSDVYSFGVVLLELLTGRKP 237
T Y +PE Y+ +D++S G+ LLE G+ P
Sbjct: 163 TVTYMSPERIQGESYSY------AADIWSLGLTLLECALGKFP 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.1 bits (224), Expect = 5e-21
Identities = 61/178 (34%), Positives = 90/178 (50%), Gaps = 26/178 (14%)
Query: 68 PDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPG 127
P+ Q ++ +L+H+ LV+L C E + E+ + GSL D L +G
Sbjct: 45 PEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEG--KKLRL 102
Query: 128 PVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAP 187
P L V +A A G+ YL + + IHRD+ + N+L+ E+ KIADF L
Sbjct: 103 PQL-----VDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGL----- 149
Query: 188 DMAARL-----HSTRVLGTF--GYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKP 237
ARL ++ R F + APE A G+ T KSDV+SFG++L E++T GR P
Sbjct: 150 ---ARLIEDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVP 204
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 3e-20
Identities = 55/176 (31%), Positives = 88/176 (50%), Gaps = 23/176 (13%)
Query: 75 VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDIL--HGRKGVQGAQPGPVLDW 132
+++ +HEN+V+ G C EG+ ++ +E+ G L+ L HG P +
Sbjct: 59 AELLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGE 118
Query: 133 MTR---VRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDM 189
+T ++IAV A G+ YL + +HRD+ + N L+ D KI DF +S
Sbjct: 119 LTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLVVKIGDFGMSRD---- 171
Query: 190 AARLHST---RVLGT----FGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKP 237
+++T RV G + PE M + T +SDV+SFGVVL E+ T G++P
Sbjct: 172 ---VYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 86.3 bits (214), Expect = 1e-19
Identities = 60/179 (33%), Positives = 87/179 (48%), Gaps = 14/179 (7%)
Query: 69 DDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGP 128
D+ ++ V +S+ H N+V+ V G+ L + + GSL DI ++ + P
Sbjct: 44 DELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDI------MKSSYPRG 97
Query: 129 VLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPD 188
LD + + +GLEYLH Q IHRDI++ N+LL ED KIADF +S D
Sbjct: 98 GLDEAIIATVLKEVLKGLEYLHSNGQ---IHRDIKAGNILLGEDGSVKIADFGVSASLAD 154
Query: 189 MAARLHSTR--VLGTFGYHAPEYAMTGQ--LTQKSDVYSFGVVLLELLTGRKPVDHTMP 243
R R +GT + APE M K+D++SFG+ +EL TG P P
Sbjct: 155 GGDRTRKVRKTFVGTPCWMAPE-VMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPP 212
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 1e-19
Identities = 59/228 (25%), Positives = 98/228 (42%), Gaps = 36/228 (15%)
Query: 76 SVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPV-LDWMT 134
V+++L ++ ++ + E+A G LH +L ++G +P P W
Sbjct: 51 RVLAKLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRG----RPLPEDQVW-- 104
Query: 135 RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 194
R + GL +LH K I+HRDI+S N+ L KI D ++ D
Sbjct: 105 --RFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSD--NTNF 157
Query: 195 STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWAT 254
+ ++GT Y +PE +KSDV++ GVVL E TG+ P D Q +L+
Sbjct: 158 ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFD---ANNQGALIL--- 211
Query: 255 PRLSEDKVKQCVDPKLKGEYPPKGV---AKLAAVAALCVQYEAEFRPN 299
K+ ++G +PP +LA + C+ + RP+
Sbjct: 212 ------KI-------IRGVFPPVSQMYSQQLAQLIDQCLTKDYRQRPD 246
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 86.3 bits (214), Expect = 1e-19
Identities = 54/169 (31%), Positives = 81/169 (47%), Gaps = 25/169 (14%)
Query: 76 SVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTR 135
SV+++L H +V L+G C L +L E A +G L L R+ + + + + +
Sbjct: 48 SVMAQLDHPCIVRLIGVCKGEPL-MLVMELAPLGPLLKYLKKRREIPVSD---LKELAHQ 103
Query: 136 VRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHS 195
V A G+ YL K +HRD+ + NVLL +AKI+DF +S A S
Sbjct: 104 V------AMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSR-----ALGAGS 149
Query: 196 TRVLGTFG------YHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKP 237
T ++APE G+ + KSDV+S+GV L E + G KP
Sbjct: 150 DYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKP 198
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 2e-19
Identities = 63/242 (26%), Positives = 98/242 (40%), Gaps = 33/242 (13%)
Query: 69 DDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGP 128
DD + V+ +L H NLV+L G C + + E+ G L + L RKG G +
Sbjct: 44 DDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTE--- 100
Query: 129 VLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPD 188
+ + D +EYL IHRD+ + N L+ ED K++DF L+ D
Sbjct: 101 -----WLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLD 152
Query: 189 MAARLHSTRVLGT---FGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRG 245
T GT + PE + + KSDV+SFGV++ E+ + K MP
Sbjct: 153 D----QYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGK-----MP-- 201
Query: 246 QQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305
R S +V + V + P ++ + C + E RP ++
Sbjct: 202 --------YERFSNSEVVESVSAGYRLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLS 253
Query: 306 AL 307
L
Sbjct: 254 QL 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 85.9 bits (213), Expect = 2e-19
Identities = 61/241 (25%), Positives = 98/241 (40%), Gaps = 33/241 (13%)
Query: 70 DEKQLVSVVSRLKHENLVELLGYCVEGNLRV--LAYEFATMGSLHDILHGRKGVQGAQPG 127
D ++ + ++ L HEN+V+ G C + R L E+ GSL D L +
Sbjct: 52 DFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHR-------- 103
Query: 128 PVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAP 187
++ + + +G++YL + IHRD+ + N+L+ + KI+DF L+ P
Sbjct: 104 DQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAKVLP 160
Query: 188 --DMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRK-------P 237
+ F Y APE T + + SDV+SFGV L EL T G
Sbjct: 161 EDKDYYYVKEPGESPIFWY-APECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEF 219
Query: 238 VDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFR 297
+ Q +VT L E + PP ++ + LC + E + R
Sbjct: 220 LRMIGIAQGQMIVTRLLELLKEGERLPR---------PPSCPDEVYDLMKLCWEAEPQDR 270
Query: 298 P 298
P
Sbjct: 271 P 271
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 3e-19
Identities = 58/191 (30%), Positives = 90/191 (47%), Gaps = 26/191 (13%)
Query: 68 PDDEKQLV---SVVSRLKHENLVELLGYCV---EGNLRVLAYEFATMGSLHDILHGRKGV 121
PD +KQ++ + K +V+ G + ++ + A E+ GSL D ++ +
Sbjct: 40 PDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGI-AMEYCEGGSL-DSIYKKVKK 97
Query: 122 QGAQPGPVLDWMTRV--RIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIAD 179
+G + G +V +IA +GL YLH + IIHRDI+ SN+LL + K+ D
Sbjct: 98 RGGRIG------EKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCD 148
Query: 180 FNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVD 239
F +S + + A T GT Y APE + SDV+S G+ LLE+ R P
Sbjct: 149 FGVSGELVNSLA---GTFT-GTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFP 204
Query: 240 HTMPRGQQSLV 250
P G+ L
Sbjct: 205 ---PEGEPPLG 212
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 4e-19
Identities = 60/235 (25%), Positives = 109/235 (46%), Gaps = 28/235 (11%)
Query: 75 VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 134
+ ++S L+H N++ + ++ N ++ E+A G+L+D + +KG Q + VL ++
Sbjct: 50 IVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKG-QLFEEEMVLWYLF 108
Query: 135 RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 194
++ AV Y+H+ I+HRDI++ N+ L + K+ DF +S
Sbjct: 109 QIVSAVS------YIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGS--EYSM 157
Query: 195 STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWAT 254
+ V+GT Y +PE + KSD+++ G VL ELLT ++ D T P +LV
Sbjct: 158 AETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNP---LNLVV--- 211
Query: 255 PRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQP 309
K+ Q + Y ++L ++ +Q + E RP V+
Sbjct: 212 ------KIVQGNYTPVVSVYS----SELISLVHSLLQQDPEKRPTADEVLDQPLL 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 6e-19
Identities = 50/159 (31%), Positives = 79/159 (49%), Gaps = 12/159 (7%)
Query: 75 VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 134
V + RL+H++L+ L C G + E GSL L +G Q ++D
Sbjct: 53 VQALKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEG-QVLPVASLID--- 108
Query: 135 RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 194
+A A G+ YL E+ + IHRD+ + N+L+ ED K+ADF L+ +
Sbjct: 109 ---MACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSS 162
Query: 195 STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT 233
++ + + APE A G + KSDV+SFG++L E+ T
Sbjct: 163 DKKI--PYKWTAPEAASHGTFSTKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 7e-19
Identities = 69/255 (27%), Positives = 113/255 (44%), Gaps = 24/255 (9%)
Query: 66 NYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDIL--HGRKGVQG 123
N D + +++ L+HE++V+ G CVEG+ ++ +E+ G L+ L HG V
Sbjct: 49 NARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLM 108
Query: 124 AQPGPV--LDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFN 181
A+ L + IA A G+ YL + +HRD+ + N L+ E+ KI DF
Sbjct: 109 AEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFG 165
Query: 182 LSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDH 240
+S + + PE M + T +SDV+S GVVL E+ T G++P
Sbjct: 166 MSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP--- 222
Query: 241 TMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNM 300
W +LS ++V +C+ + P ++ + C Q E R N+
Sbjct: 223 -----------WY--QLSNNEVIECITQGRVLQRPRTCPKEVYDLMLGCWQREPHMRLNI 269
Query: 301 SIVVKALQPLLKSPP 315
+ LQ L K+ P
Sbjct: 270 KEIHSLLQNLAKASP 284
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 8e-19
Identities = 66/209 (31%), Positives = 104/209 (49%), Gaps = 29/209 (13%)
Query: 76 SVVSRLKHENLVELLGYCVE--GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWM 133
SV+++L+H NLV+LLG VE G L ++ E+ GSL D L R VL
Sbjct: 51 SVMTQLRHSNLVQLLGVIVEEKGGLYIVT-EYMAKGSLVDYLRSRGR-------SVLGGD 102
Query: 134 TRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARL 193
++ ++D +EYL + +HRD+ + NVL+ ED AK++DF L+ + A+
Sbjct: 103 CLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKE----ASST 155
Query: 194 HSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT------GRKPVDHTMPR--- 244
T L + APE + + KSDV+SFG++L E+ + R P+ +PR
Sbjct: 156 QDTGKL-PVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK 214
Query: 245 GQQSLVTWATPRLSEDKVKQC--VDPKLK 271
G + P + D +KQC +D +
Sbjct: 215 GYKMDAPDGCPPVVYDVMKQCWHLDAATR 243
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 9e-19
Identities = 72/241 (29%), Positives = 111/241 (46%), Gaps = 33/241 (13%)
Query: 61 LKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKG 120
LK P+ Q V+ +L+HE LV+L E + ++ E+ + GSL D L G
Sbjct: 38 LKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVT-EYMSKGSLLDFLKG--- 93
Query: 121 VQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADF 180
+ G L V +A A G+ Y+ + +HRD+R++N+L+ E+ K+ADF
Sbjct: 94 ----EMGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADF 146
Query: 181 NLSNQAPDMAARLHSTRVLGTF--GYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKP 237
L+ D ++ R F + APE A+ G+ T KSDV+SFG++L EL T GR P
Sbjct: 147 GLARLIEDNE---YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 203
Query: 238 VDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFR 297
P + +V V+ + PP+ L + C + E E R
Sbjct: 204 Y----------------PGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEER 247
Query: 298 P 298
P
Sbjct: 248 P 248
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 1e-18
Identities = 55/156 (35%), Positives = 83/156 (53%), Gaps = 23/156 (14%)
Query: 137 RIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHST 196
+IAV + LEYLH K+ S+IHRD++ SNVL+ + + K+ DF +S D A+ T
Sbjct: 107 KIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAK---T 161
Query: 197 RVLGTFGYHAPEYAMTGQLTQ-----KSDVYSFGVVLLELLTGRKPVD--HTMPRGQQSL 249
G Y APE + +L Q KSDV+S G+ ++EL TGR P D T + + +
Sbjct: 162 IDAGCKPYMAPE-RINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQV 220
Query: 250 VTWATPRLSEDK--------VKQCV--DPKLKGEYP 275
V +P+L +K V +C+ + K + YP
Sbjct: 221 VEEPSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYP 256
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 1e-18
Identities = 63/246 (25%), Positives = 108/246 (43%), Gaps = 32/246 (13%)
Query: 68 PDDEK----QLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQG 123
P D K Q ++ + H N+V+L+G CV+ + E GSL L +K
Sbjct: 32 PPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKNR-- 89
Query: 124 AQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLS 183
L +++++DAA G+EYL K + IHRD+ + N L+ E+ KI+DF +S
Sbjct: 90 ------LTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMS 140
Query: 184 NQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTM 242
+ + + APE G+ T +SDV+S+G++L E + G P
Sbjct: 141 REEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPY---- 196
Query: 243 PRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSI 302
P +S + ++ ++ + P ++ + C Y+ E RP+ S
Sbjct: 197 ------------PGMSNQQTRERIESGYRMPAPQLCPEEIYRLMLQCWAYDPENRPSFSE 244
Query: 303 VVKALQ 308
+ LQ
Sbjct: 245 IYNELQ 250
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 83.2 bits (206), Expect = 2e-18
Identities = 63/178 (35%), Positives = 84/178 (47%), Gaps = 19/178 (10%)
Query: 71 EKQLVSVVSRL-------KHENLVELLGYCV-EGNLRVLAYEFATMGSLHDILHGR---- 118
EK L +VS + KH+N++ LLG C EG L V+ E+A G+L D L R
Sbjct: 56 EKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVV-EYAAHGNLRDFLRARRPPG 114
Query: 119 ---KGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKA 175
P L V A ARG+E+L K IHRD+ + NVL+ ED
Sbjct: 115 EYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNVLVTEDHVM 171
Query: 176 KIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT 233
KIADF L+ + +T + APE T +SDV+SFGV+L E+ T
Sbjct: 172 KIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 3e-18
Identities = 56/185 (30%), Positives = 85/185 (45%), Gaps = 26/185 (14%)
Query: 61 LKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKG 120
LK P D ++ +L+H L++L C + E GSL + L G G
Sbjct: 38 LKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAG 97
Query: 121 VQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADF 180
P + +A A G+ YL + + IHRD+ + NVL+ E+ K+ADF
Sbjct: 98 RALKLP-------QLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADF 147
Query: 181 NLSNQAPDMAARL-----HSTRVLGTF--GYHAPEYAMTGQLTQKSDVYSFGVVLLELLT 233
L AR+ + R F + APE A+ + + KSDV+SFG++L E++T
Sbjct: 148 GL--------ARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVT 199
Query: 234 -GRKP 237
GR P
Sbjct: 200 YGRMP 204
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 4e-18
Identities = 63/255 (24%), Positives = 119/255 (46%), Gaps = 22/255 (8%)
Query: 61 LKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKG 120
+K + ++ + +L+H N+V+L+G C L +E+ +L ++L
Sbjct: 720 VKEINDVNSIPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN--- 776
Query: 121 VQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADF 180
L W R +IA+ A+ L +LH + P+++ ++ +++ D K +
Sbjct: 777 ---------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIII--DGKDEP--- 822
Query: 181 NLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDH 240
+L P + T+ + Y APE T +T+KSD+Y FG++L+ELLTG+ P D
Sbjct: 823 HLRLSLPGLLCT--DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADA 880
Query: 241 TMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYP--PKGVAKLAAVAALCVQYEAEFRP 298
S+V WA S+ + +DP ++G+ + ++ +A C + RP
Sbjct: 881 EF-GVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARP 939
Query: 299 NMSIVVKALQPLLKS 313
+ V+K L+ +S
Sbjct: 940 CANDVLKTLESASRS 954
|
Length = 968 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 4e-18
Identities = 55/179 (30%), Positives = 86/179 (48%), Gaps = 15/179 (8%)
Query: 69 DDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK-------GV 121
+ +Q ++S L+H N+V LLG C + + +E+ G LH+ L
Sbjct: 53 QEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAES 112
Query: 122 QGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFN 181
LD + IA+ A G+EYL +HRD+ + N L+ E KI+DF
Sbjct: 113 GDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGLTVKISDFG 169
Query: 182 LSNQ--APDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKP 237
LS + D R+ S +L + PE + G+ T +SD++SFGVVL E+ + G +P
Sbjct: 170 LSRDIYSADY-YRVQSKSLL-PVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 82.0 bits (203), Expect = 5e-18
Identities = 51/170 (30%), Positives = 77/170 (45%), Gaps = 21/170 (12%)
Query: 75 VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 134
+ V+ LKH NLV+ G V + E+ + G+L ++L G +LD
Sbjct: 50 MKVLELLKHPNLVKYYGVEVHREKVYIFMEYCSGGTLEELLEH---------GRILDEHV 100
Query: 135 RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFN----LSNQAPDMA 190
+ GL YLH I+HRDI+ +N+ L + K+ DF L N M
Sbjct: 101 IRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMG 157
Query: 191 ARLHSTRVLGTFGYHAPEYAMTGQLTQK---SDVYSFGVVLLELLTGRKP 237
+ S GT Y APE G+ +D++S G V+LE+ TG++P
Sbjct: 158 EEVQSLA--GTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRP 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 1e-17
Identities = 47/164 (28%), Positives = 75/164 (45%), Gaps = 16/164 (9%)
Query: 74 LVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWM 133
L SV H N++ ++GN + E+A G L + + + ++
Sbjct: 53 LASV----NHPNIISYKEAFLDGNKLCIVMEYAPFGDLS-----KAISKRKKKRKLIPEQ 103
Query: 134 TRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARL 193
RI + RGL+ LHE+ I+HRD++S+N+LL + KI D +S A+
Sbjct: 104 EIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAK- 159
Query: 194 HSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 237
+GT Y APE + KSD++S G +L E+ T P
Sbjct: 160 ---TQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPP 200
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 1e-17
Identities = 52/193 (26%), Positives = 87/193 (45%), Gaps = 17/193 (8%)
Query: 48 QVEESYPSHENERLKSP-KNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFA 106
QVE P+ R S K+ + + + L H N+V+ LG+ + E+
Sbjct: 33 QVE--LPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEYLSIFLEYV 90
Query: 107 TMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSN 166
GS+ L G + + R GL YLH K I+HRD+++ N
Sbjct: 91 PGGSIGSCLR--------TYGRFEEQLVR-FFTEQVLEGLAYLHSK---GILHRDLKADN 138
Query: 167 VLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQ--LTQKSDVYSF 224
+L+ D KI+DF +S ++ D+ + + G+ + APE + + K D++S
Sbjct: 139 LLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSL 198
Query: 225 GVVLLELLTGRKP 237
G V+LE+ GR+P
Sbjct: 199 GCVVLEMFAGRRP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 80.7 bits (200), Expect = 2e-17
Identities = 63/217 (29%), Positives = 94/217 (43%), Gaps = 43/217 (19%)
Query: 75 VSVVSRLKHENLVELLG-YCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWM 133
+ ++ KH N+V+ Y V L V E+ GSL DI+ M
Sbjct: 66 ILIMKDCKHPNIVDYYDSYLVGDELWV-VMEYMDGGSLTDIITQNFVR-----------M 113
Query: 134 TRVRIAV---DAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMA 190
+IA + +GLEYLH + ++IHRDI+S N+LL +D K+ADF A
Sbjct: 114 NEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGF-------A 163
Query: 191 ARL---HSTR--VLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP-VDHTMPR 244
A+L S R V+GT + APE K D++S G++ +E+ G P + R
Sbjct: 164 AQLTKEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLR 223
Query: 245 GQQSLVTWATPRLSE---------DKVKQC--VDPKL 270
+ T P L D + +C DP+
Sbjct: 224 ALFLITTKGIPPLKNPEKWSPEFKDFLNKCLVKDPEK 260
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 80.0 bits (198), Expect = 2e-17
Identities = 60/206 (29%), Positives = 94/206 (45%), Gaps = 33/206 (16%)
Query: 82 KHENLVELLG-YCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAV 140
+V+ G Y +L ++ E+ GS+ DI+ +T IA
Sbjct: 56 DSPYIVKYYGSYFKNTDLWIVM-EYCGAGSVSDIMKITNKT-----------LTEEEIAA 103
Query: 141 ---DAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTR 197
+GLEYLH IHRDI++ N+LL E+ +AK+ADF +S Q D A+ ++
Sbjct: 104 ILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT-- 158
Query: 198 VLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMP-RGQQSLVTWATPR 256
V+GT + APE K+D++S G+ +E+ G+ P P R + P
Sbjct: 159 VIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPT 218
Query: 257 LSE---------DKVKQC--VDPKLK 271
LS+ D VK+C DP+ +
Sbjct: 219 LSDPEKWSPEFNDFVKKCLVKDPEER 244
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 2e-17
Identities = 58/185 (31%), Positives = 93/185 (50%), Gaps = 17/185 (9%)
Query: 60 RLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDIL---- 115
R + KN +D + V ++SRLK N++ LLG CV+ + + E+ G L+ L
Sbjct: 55 RPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHH 114
Query: 116 ------HGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLL 169
+G V A P + + + + +A+ A G++YL + +HRD+ + N L+
Sbjct: 115 LDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFVHRDLATRNCLV 171
Query: 170 FEDFKAKIADFNLSNQ--APDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVV 227
E+ KIADF +S A D R+ VL + A E + G+ T SDV++FGV
Sbjct: 172 GENLTIKIADFGMSRNLYAGDY-YRIQGRAVL-PIRWMAWECILMGKFTTASDVWAFGVT 229
Query: 228 LLELL 232
L E+L
Sbjct: 230 LWEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 2e-17
Identities = 52/170 (30%), Positives = 89/170 (52%), Gaps = 19/170 (11%)
Query: 72 KQL---VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGP 128
KQL ++++S+L+H N+V+ LG E + + E GSL +L G+ P P
Sbjct: 47 KQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLELVPGGSLAKLL----KKYGSFPEP 102
Query: 129 VLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPD 188
V+ TR + GLEYLH++ + +HRDI+ +N+L+ + K+ADF ++ Q +
Sbjct: 103 VIRLYTRQILL-----GLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVE 154
Query: 189 MAARLHSTRVLGTFGYHAPEYAM-TGQLTQKSDVYSFGVVLLELLTGRKP 237
+ + G+ + APE G +D++S G +LE+ TG+ P
Sbjct: 155 FSF---AKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPP 201
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 79.7 bits (197), Expect = 2e-17
Identities = 37/105 (35%), Positives = 50/105 (47%), Gaps = 7/105 (6%)
Query: 134 TRVRI-AVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAAR 192
+V+ + LEYLH K IIHRDI+ N+LL E I DFN++ +
Sbjct: 100 EQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTP---D 153
Query: 193 LHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 237
+T GT GY APE + D +S GV E L G++P
Sbjct: 154 TLTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRP 198
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 3e-17
Identities = 52/194 (26%), Positives = 95/194 (48%), Gaps = 18/194 (9%)
Query: 48 QVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFAT 107
QVE S ++ K ++ D + ++++ L+HEN+V+ LG ++ + + E+
Sbjct: 32 QVELPSVSASSKDRK--RSMLDALAREIALLKELQHENIVQYLGSSLDADHLNIFLEYVP 89
Query: 108 MGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNV 167
GS+ +L+ GA ++ R +GL YLH + IIHRDI+ +N+
Sbjct: 90 GGSVAALLNN----YGAFEETLVRNFVR-----QILKGLNYLHNR---GIIHRDIKGANI 137
Query: 168 LLFEDFKAKIADFNLSNQAP----DMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYS 223
L+ KI+DF +S + + G+ + APE T+K+D++S
Sbjct: 138 LVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWS 197
Query: 224 FGVVLLELLTGRKP 237
G +++E+LTG+ P
Sbjct: 198 LGCLVVEMLTGKHP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 4e-17
Identities = 58/178 (32%), Positives = 95/178 (53%), Gaps = 21/178 (11%)
Query: 63 SPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQ 122
SP+++ ++ + ++ +L+H+ LV+L E + ++ E+ + GSL D L +G
Sbjct: 44 SPESFLEEAQ----IMKKLRHDKLVQLYAVVSEEPIYIVT-EYMSKGSLLDFLKDGEGRA 98
Query: 123 GAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNL 182
P V +A A G+ Y+ + IHRD+RS+N+L+ + KIADF L
Sbjct: 99 LKLP-------NLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGL 148
Query: 183 SNQAPDMAARLHSTRVLGTF--GYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKP 237
+ D ++ R F + APE A+ G+ T KSDV+SFG++L EL+T GR P
Sbjct: 149 ARLIEDNE---YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 8e-17
Identities = 60/183 (32%), Positives = 89/183 (48%), Gaps = 29/183 (15%)
Query: 71 EKQLVSVVSRL-------KHENLVELLGYCV-EGNLRVLAYEFATMGSLHDILHGRKGVQ 122
+K L ++S + KH+N++ LLG C EG L V+ E+A G+L + L R+
Sbjct: 58 DKDLADLISEMELMKLIGKHKNIINLLGVCTQEGPLYVIV-EYAAKGNLREFLRARR--- 113
Query: 123 GAQPGP------------VLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLF 170
PGP L + V A ARG+EYL + IHRD+ + NVL+
Sbjct: 114 --PPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNVLVT 168
Query: 171 EDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLE 230
ED KIADF L+ D+ ++ + APE T +SDV+SFG+++ E
Sbjct: 169 EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWE 228
Query: 231 LLT 233
+ T
Sbjct: 229 IFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 8e-17
Identities = 58/177 (32%), Positives = 88/177 (49%), Gaps = 17/177 (9%)
Query: 71 EKQLVSVVSRL-------KHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK--GV 121
+K L +VS + KH+N++ LLG C + + E+A+ G+L + L R+ G+
Sbjct: 58 DKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGM 117
Query: 122 QGA-----QPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAK 176
+ P L + V A ARG+EYL + IHRD+ + NVL+ ED K
Sbjct: 118 DYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARNVLVTEDNVMK 174
Query: 177 IADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT 233
IADF L+ ++ +T + APE T +SDV+SFGV+L E+ T
Sbjct: 175 IADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 1e-16
Identities = 48/174 (27%), Positives = 85/174 (48%), Gaps = 15/174 (8%)
Query: 69 DDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGP 128
+D + V+ +L H LV+L G C E + L +EF G L D L ++G +
Sbjct: 44 EDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQE--- 100
Query: 129 VLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQA-P 187
T + + +D G+ YL ++IHRD+ + N L+ E+ K++DF ++
Sbjct: 101 -----TLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLD 152
Query: 188 DMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDH 240
D T+ + +PE + + KSDV+SFGV++ E+ + G+ P ++
Sbjct: 153 DQYTSSTGTKF--PVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYEN 204
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 1e-16
Identities = 55/193 (28%), Positives = 92/193 (47%), Gaps = 18/193 (9%)
Query: 56 HENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDIL 115
+ L + K Y +++ V ++ LKH N+V+ LG C++ N + EF GS+ IL
Sbjct: 35 DTSNVLAAEKEYEKLQEE-VDLLKSLKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSIL 93
Query: 116 HGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKA 175
+ G P PV T+ G+ YLH ++HRDI+ +NV+L +
Sbjct: 94 NRF----GPLPEPVFCKYTK-----QILDGVAYLHNN---CVVHRDIKGNNVMLMPNGII 141
Query: 176 KIADFNLSNQAPDMAARLHSTRVL----GTFGYHAPEYAMTGQLTQKSDVYSFGVVLLEL 231
K+ DF + + + + +L GT + APE +KSD++S G + E+
Sbjct: 142 KLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEM 201
Query: 232 LTGRKPVDHTMPR 244
TG+ P+ +M R
Sbjct: 202 ATGKPPLA-SMDR 213
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 2e-16
Identities = 59/177 (33%), Positives = 87/177 (49%), Gaps = 17/177 (9%)
Query: 71 EKQLVSVVSRL-------KHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK--GV 121
EK L ++S + KH+N++ LLG C + + E+A+ G+L + L R+ G+
Sbjct: 64 EKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGM 123
Query: 122 Q-----GAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAK 176
+ P L + V A ARG+EYL K IHRD+ + NVL+ ED K
Sbjct: 124 EYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMK 180
Query: 177 IADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT 233
IADF L+ + +T + APE T +SDV+SFGV+L E+ T
Sbjct: 181 IADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 2e-16
Identities = 52/175 (29%), Positives = 83/175 (47%), Gaps = 15/175 (8%)
Query: 71 EKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDIL--HGR-----KGVQG 123
E +L++V L+H+++V G C EG ++ +E+ G L+ L HG G +
Sbjct: 57 EAELLTV---LQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGED 113
Query: 124 AQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLS 183
PG L + IA A G+ YL +HRD+ + N L+ + KI DF +S
Sbjct: 114 VAPGQ-LTLGQMLAIASQIASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMS 169
Query: 184 NQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKP 237
R + + PE + + T +SD++SFGVVL E+ T G++P
Sbjct: 170 RDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 3e-16
Identities = 51/164 (31%), Positives = 81/164 (49%), Gaps = 13/164 (7%)
Query: 77 VVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRV 136
V++ + H ++V LLG C+ ++ L + +G L D + K G+Q +L+W
Sbjct: 62 VMASVDHPHVVRLLGICLSSQVQ-LITQLMPLGCLLDYVRNHKDNIGSQY--LLNW---- 114
Query: 137 RIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHST 196
V A+G+ YL EK ++HRD+ + NVL+ KI DF L+ H+
Sbjct: 115 --CVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAE 169
Query: 197 RVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVD 239
+ A E + T KSDV+S+GV + EL+T G KP +
Sbjct: 170 GGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYE 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 3e-16
Identities = 59/245 (24%), Positives = 98/245 (40%), Gaps = 26/245 (10%)
Query: 64 PKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQG 123
P + Q ++ + H N+V L+G C + + E G L
Sbjct: 33 PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTE----- 87
Query: 124 AQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLS 183
GP L +++ +AA G+EYL K IHRD+ + N L+ E KI+DF +S
Sbjct: 88 ---GPRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMS 141
Query: 184 NQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMP 243
+ D + APE G+ + +SDV+SFG++L E
Sbjct: 142 REEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAF----------- 190
Query: 244 RGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIV 303
SL LS + ++ ++ ++ P + + C +Y+ RP+ S V
Sbjct: 191 ----SLGAVPYANLSNQQTREAIEQGVRLPCPELCPDAVYRLMERCWEYDPGQRPSFSTV 246
Query: 304 VKALQ 308
+ LQ
Sbjct: 247 HQELQ 251
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 5e-16
Identities = 53/177 (29%), Positives = 85/177 (48%), Gaps = 12/177 (6%)
Query: 70 DEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDIL-----HGRKGVQGA 124
+ +Q S+++ L H N+V LLG + + +E+ G LH+ L H G
Sbjct: 53 EFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSD 112
Query: 125 QPGPV---LDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFN 181
+ G V LD + IA+ A G+EYL +H+D+ + N+L+ E KI+D
Sbjct: 113 EDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLG 169
Query: 182 LSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKP 237
LS + + L + PE M G+ + SD++SFGVVL E+ + G +P
Sbjct: 170 LSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 76.3 bits (187), Expect = 6e-16
Identities = 65/245 (26%), Positives = 108/245 (44%), Gaps = 31/245 (12%)
Query: 61 LKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKG 120
L+ ++ +D +Q ++V+S+ + + G ++ + E+ GS D+L
Sbjct: 39 LEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL----- 93
Query: 121 VQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADF 180
+PGP LD I + +GL+YLH + + IHRDI+++NVLL E + K+ADF
Sbjct: 94 ----EPGP-LDETQIATILREILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADF 145
Query: 181 NLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDH 240
++ Q D ++ +GT + APE K+D++S G+ +EL G P
Sbjct: 146 GVAGQLTD--TQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSE 203
Query: 241 TMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNM 300
P L+ P P L+G Y L C+ E FRP
Sbjct: 204 LHPMKVLFLIPKNNP------------PTLEGNYS----KPLKEFVEACLNKEPSFRPTA 247
Query: 301 SIVVK 305
++K
Sbjct: 248 KELLK 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 7e-16
Identities = 69/241 (28%), Positives = 102/241 (42%), Gaps = 33/241 (13%)
Query: 77 VVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRV 136
++S H N+V+LLG C+ + + E G L L R P+L +
Sbjct: 52 LMSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYL--RDARVERFGPPLLTLKELL 109
Query: 137 RIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFE-----DFKAKIADFNLSNQAPDMAA 191
I +D A+G YL Q IHRD+ + N L+ E D KI DF L A D+
Sbjct: 110 DICLDVAKGCVYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL---ARDIYK 163
Query: 192 ----RLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQ 247
R +L + APE + G+ T +SDV+SFGV++ E+LT GQQ
Sbjct: 164 SDYYRKEGEGLL-PVRWMAPESLLDGKFTTQSDVWSFGVLMWEILT----------LGQQ 212
Query: 248 SLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKAL 307
P L+ +V Q V + + P K+ + C + RP + + L
Sbjct: 213 PY-----PALNNQEVLQHVTAGGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEIL 267
Query: 308 Q 308
Q
Sbjct: 268 Q 268
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 1e-15
Identities = 63/237 (26%), Positives = 100/237 (42%), Gaps = 27/237 (11%)
Query: 77 VVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDIL-HGRKGVQGAQPGPVLDWMTR 135
++S+ H+N+V L+G E R + E G L L R + +P L
Sbjct: 62 IMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPE--RPSS-LTMKDL 118
Query: 136 VRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLF---EDFKAKIADFNLSNQAPDMAAR 192
+ A D A+G +YL E IHRDI + N LL AKIADF ++ +
Sbjct: 119 LFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYY 175
Query: 193 LHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVT 251
R + + PE + G T K+DV+SFGV+L E+ + G P
Sbjct: 176 RKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPY------------- 222
Query: 252 WATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQ 308
P + +V + V + + P + + C Q+ E RPN + +++ +Q
Sbjct: 223 ---PGRTNQEVMEFVTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 1e-15
Identities = 61/180 (33%), Positives = 93/180 (51%), Gaps = 17/180 (9%)
Query: 61 LKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKG 120
LK P+ Q ++ +L+H+ LV L E + ++ EF GSL D L ++G
Sbjct: 38 LKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVSEEPIYIVT-EFMGKGSLLDFL--KEG 94
Query: 121 VQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADF 180
G L V +A A G+ Y+ + IHRD+R++N+L+ ++ KIADF
Sbjct: 95 -----DGKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADF 146
Query: 181 NLSNQAPDMAARLHSTRVLGTF--GYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKP 237
L+ D ++ R F + APE A+ G+ T KSDV+SFG++L EL+T GR P
Sbjct: 147 GLARLIEDNE---YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 1e-15
Identities = 55/177 (31%), Positives = 88/177 (49%), Gaps = 17/177 (9%)
Query: 71 EKQLVSVVSRL-------KHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK--GV 121
EK L +VS + KH+N++ LLG C + + E+A+ G+L + L R+ G+
Sbjct: 61 EKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGM 120
Query: 122 QGAQ-----PGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAK 176
+ + P + + V ARG+EYL + IHRD+ + NVL+ E+ K
Sbjct: 121 EYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNVLVTENNVMK 177
Query: 177 IADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT 233
IADF L+ ++ +T + APE T +SDV+SFGV++ E+ T
Sbjct: 178 IADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 1e-15
Identities = 66/254 (25%), Positives = 112/254 (44%), Gaps = 27/254 (10%)
Query: 70 DEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDIL--HGRKGV-----Q 122
D ++ +++ L+HE++V+ G C +G+ ++ +E+ G L+ L HG + Q
Sbjct: 53 DFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQ 112
Query: 123 GAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNL 182
Q L + IA A G+ YL + +HRD+ + N L+ + KI DF +
Sbjct: 113 PRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGM 169
Query: 183 SNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHT 241
S + + PE M + T +SDV+SFGV+L E+ T G++P
Sbjct: 170 SRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP---- 225
Query: 242 MPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMS 301
W +LS +V +C+ E P ++ + C Q E + R N+
Sbjct: 226 ----------WF--QLSNTEVIECITQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIK 273
Query: 302 IVVKALQPLLKSPP 315
+ K L L K+ P
Sbjct: 274 EIYKILHALGKATP 287
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 1e-15
Identities = 37/102 (36%), Positives = 58/102 (56%), Gaps = 6/102 (5%)
Query: 137 RIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHST 196
+I++ RGL YL EK + I+HRD++ SN+L+ + K+ DF +S Q D A
Sbjct: 103 KISIAVLRGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA----N 156
Query: 197 RVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPV 238
+GT Y +PE T +SD++S G+ L+E+ GR P+
Sbjct: 157 SFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPI 198
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 2e-15
Identities = 49/160 (30%), Positives = 79/160 (49%), Gaps = 17/160 (10%)
Query: 83 HENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQ-----GAQPGPVLDWMTR-- 135
H N++ LLG C LA E+A G+L D L + ++ ++
Sbjct: 55 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 114
Query: 136 VRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHS 195
+ A D ARG++YL +K IHRD+ + N+L+ E++ AKIADF LS ++
Sbjct: 115 LHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR-----GQEVYV 166
Query: 196 TRVLGTFG--YHAPEYAMTGQLTQKSDVYSFGVVLLELLT 233
+ +G + A E T SDV+S+GV+L E+++
Sbjct: 167 KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 2e-15
Identities = 51/161 (31%), Positives = 81/161 (50%), Gaps = 17/161 (10%)
Query: 82 KHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQ-----GAQPGPVLDWMTR- 135
H N++ LLG C +A E+A G+L D L + ++ + G ++
Sbjct: 61 HHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQ 120
Query: 136 -VRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 194
++ A D A G++YL EK IHRD+ + NVL+ E+ +KIADF LS ++
Sbjct: 121 LLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLSR-----GEEVY 172
Query: 195 STRVLGTFG--YHAPEYAMTGQLTQKSDVYSFGVVLLELLT 233
+ +G + A E T KSDV+SFGV+L E+++
Sbjct: 173 VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 3e-15
Identities = 51/181 (28%), Positives = 79/181 (43%), Gaps = 28/181 (15%)
Query: 70 DEKQL------VSVVSRLKHENLVELL-GYCVEGNLRVLAYEFATMGSLHDI-LHGRKGV 121
E++L + ++S KH N+V L Y E L +L EF G+L I L +G+
Sbjct: 42 SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWIL-IEFCDGGALDSIMLELERGL 100
Query: 122 QGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFN 181
Q V M L +LH +IHRD+++ N+LL D K+ADF
Sbjct: 101 TEPQIRYVCRQMLE---------ALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFG 148
Query: 182 LSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQ-----KSDVYSFGVVLLELLTGRK 236
+S + + + +GT + APE K+D++S G+ L+EL
Sbjct: 149 VSAKNKSTLQKRDT--FIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEP 206
Query: 237 P 237
P
Sbjct: 207 P 207
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 3e-15
Identities = 57/188 (30%), Positives = 90/188 (47%), Gaps = 23/188 (12%)
Query: 61 LKSPKNYP--DDEKQL---VSVVSRL-KHENLVELLGYCVEGNLRVLAYEFATMGSLHDI 114
+K K Y DD + + V+ +L H N++ LLG C LA E+A G+L D
Sbjct: 39 IKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDF 98
Query: 115 LHGRKGVQ-------GAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNV 167
L + ++ L + A D ARG++YL +K IHRD+ + N+
Sbjct: 99 LRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNI 155
Query: 168 LLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFG--YHAPEYAMTGQLTQKSDVYSFG 225
L+ E++ AKIADF LS ++ + +G + A E T SDV+S+G
Sbjct: 156 LVGENYVAKIADFGLSR-----GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYG 210
Query: 226 VVLLELLT 233
V+L E+++
Sbjct: 211 VLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.1 bits (180), Expect = 5e-15
Identities = 53/177 (29%), Positives = 84/177 (47%), Gaps = 20/177 (11%)
Query: 68 PDDE----KQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQG 123
P D+ +Q +S++ +H N+V G + + + E+ GSL DI +G
Sbjct: 40 PGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQV---TRG 96
Query: 124 AQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLS 183
+ ++ R + +GL YLHE IHRDI+ +N+LL ED K+ADF +S
Sbjct: 97 PLSELQIAYVCR-----ETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVS 148
Query: 184 NQAPDMAARLHSTRVLGTFGYHAPEYA---MTGQLTQKSDVYSFGVVLLELLTGRKP 237
Q A+ S +GT + APE A G K D+++ G+ +EL + P
Sbjct: 149 AQLTATIAKRKS--FIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPP 203
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 7e-15
Identities = 64/241 (26%), Positives = 109/241 (45%), Gaps = 19/241 (7%)
Query: 72 KQLVSVVSRLKHENLVELLGYCVEGNLRV--LAYEFATMGSLHDILHGRKGVQGAQPGPV 129
K+ ++++ L HEN+V+ G C E + L E+ +GSL D L P
Sbjct: 54 KKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYL----------PKHK 103
Query: 130 LDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPD- 188
L+ + A G+ YLH + IHRD+ + NVLL D KI DF L+ P+
Sbjct: 104 LNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG 160
Query: 189 -MAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQ 247
R+ F Y A E + + SDV+SFGV L ELLT + P+ +
Sbjct: 161 HEYYRVREDGDSPVFWY-AVECLKENKFSYASDVWSFGVTLYELLTHCDS-KQSPPKKFE 218
Query: 248 SLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKAL 307
++ +++ ++ + ++ ++ P ++ + C + EA+FRP ++ L
Sbjct: 219 EMIGPKQGQMTVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPIL 278
Query: 308 Q 308
+
Sbjct: 279 K 279
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.6 bits (179), Expect = 8e-15
Identities = 34/96 (35%), Positives = 50/96 (52%), Gaps = 5/96 (5%)
Query: 145 GLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGY 204
LEYLH II+RD++ N+LL D K+ DF L+ + +R ++ GT Y
Sbjct: 105 ALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT--FCGTPEY 159
Query: 205 HAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDH 240
APE + + D +S GV+L E+LTG+ P
Sbjct: 160 LAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYA 195
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 1e-14
Identities = 54/160 (33%), Positives = 81/160 (50%), Gaps = 15/160 (9%)
Query: 76 SVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTR 135
+V+ +KH NLV+LLG C + EF T G+L D L R+ + VL +M
Sbjct: 54 AVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVLLYM-- 109
Query: 136 VRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHS 195
A + +EYL +K + IHRD+ + N L+ E+ K+ADF LS M ++
Sbjct: 110 ---ATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRL---MTGDTYT 160
Query: 196 TRVLGTF--GYHAPEYAMTGQLTQKSDVYSFGVVLLELLT 233
F + APE + + KSDV++FGV+L E+ T
Sbjct: 161 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 1e-14
Identities = 54/178 (30%), Positives = 86/178 (48%), Gaps = 8/178 (4%)
Query: 60 RLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK 119
R K +D + + ++SRLK+ N++ LLG CV + + E+ G L+ L R+
Sbjct: 53 RADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQRE 112
Query: 120 ---GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAK 176
A P + + +AV A G++YL + +HRD+ + N L+ + K
Sbjct: 113 IESTFTHANNIPSVSIANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIK 169
Query: 177 IADFNLS-NQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT 233
IADF +S N R+ VL + A E + G+ T SDV++FGV L E+ T
Sbjct: 170 IADFGMSRNLYSGDYYRIQGRAVL-PIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 1e-14
Identities = 62/233 (26%), Positives = 102/233 (43%), Gaps = 31/233 (13%)
Query: 77 VVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRV 136
++ + H N+V+L+G C + + E G L +K L V
Sbjct: 45 ILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKK--------DELKTKQLV 96
Query: 137 RIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHST 196
+ A+DAA G+ YL K + IHRD+ + N L+ E+ KI+DF +S Q D ++S+
Sbjct: 97 KFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDD---GIYSS 150
Query: 197 RVLGT--FGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWAT 254
L + APE G+ + +SDV+S+G++L E SL
Sbjct: 151 SGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETF---------------SLGVCPY 195
Query: 255 PRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKAL 307
P ++ + ++ V+ + P K + V C Y+ E RP S + K L
Sbjct: 196 PGMTNQQAREQVEKGYRMSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKEL 248
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 1e-14
Identities = 61/236 (25%), Positives = 95/236 (40%), Gaps = 21/236 (8%)
Query: 76 SVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHG-RKGVQGAQPGPVLDWMT 134
SV+ ++V LLG G ++ E G L L R +
Sbjct: 61 SVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQK 120
Query: 135 RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 194
+++A + A G+ YL K +HRD+ + N ++ ED KI DF ++ +
Sbjct: 121 FIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRK 177
Query: 195 STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWA 253
+ L + APE G T KSDV+SFGVVL E+ T +P
Sbjct: 178 GGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPY--------------- 222
Query: 254 TPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQP 309
LS ++V + V + P KL + +C QY + RP +V +L+
Sbjct: 223 -QGLSNEEVLKFVIDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 2e-14
Identities = 47/164 (28%), Positives = 71/164 (43%), Gaps = 16/164 (9%)
Query: 83 HENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGR-------------KGVQGAQPGPV 129
H N+V+LLG C G L +E+ G L++ L R +
Sbjct: 67 HPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLP 126
Query: 130 LDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDM 189
L ++ IA A G+ YL E+ +HRD+ + N L+ E+ KIADF LS
Sbjct: 127 LSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSA 183
Query: 190 AARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT 233
S + PE + T +SDV+++GVVL E+ +
Sbjct: 184 DYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 2e-14
Identities = 51/146 (34%), Positives = 77/146 (52%), Gaps = 18/146 (12%)
Query: 95 EGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPV-LDWMTRVRIAVDAARGLEYLHEKV 153
E N+ + EF GSL I +KG GP+ ++ + + IAV GL YL+
Sbjct: 75 ENNI-CMCMEFMDCGSLDRIY--KKG------GPIPVEILGK--IAVAVVEGLTYLYNVH 123
Query: 154 QPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG 213
+ I+HRDI+ SN+L+ + K+ DF +S + + A T V GT Y +PE G
Sbjct: 124 R--IMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIA---DTFV-GTSTYMSPERIQGG 177
Query: 214 QLTQKSDVYSFGVVLLELLTGRKPVD 239
+ T KSDV+S G+ ++EL G+ P
Sbjct: 178 KYTVKSDVWSLGISIIELALGKFPFA 203
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 2e-14
Identities = 63/220 (28%), Positives = 104/220 (47%), Gaps = 44/220 (20%)
Query: 63 SPKNYPDDEKQLVSVVSRLKHENLVELLGYCVE-GNLRVLAYEFATMGSLHDILHGRKGV 121
SPK + K+ V+V+S +KH N+V+ E GNL ++ ++ G L+ ++ ++GV
Sbjct: 39 SPKEREESRKE-VAVLSNMKHPNIVQYQESFEENGNLYIVM-DYCEGGDLYKKINAQRGV 96
Query: 122 QGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFN 181
+LDW ++ +A L+++H++ I+HRDI+S N+ L +D K+ DF
Sbjct: 97 L-FPEDQILDWFVQICLA------LKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFG 146
Query: 182 LSNQAPDMAARLHSTRVL-----GTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRK 236
+ A L+ST L GT Y +PE KSD+++ G VL E+ T
Sbjct: 147 I-------ARVLNSTVELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCT--- 196
Query: 237 PVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPP 276
+ H G +K V ++G YPP
Sbjct: 197 -LKHAFEAGN---------------MKNLVLKIIRGSYPP 220
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 3e-14
Identities = 60/243 (24%), Positives = 109/243 (44%), Gaps = 33/243 (13%)
Query: 69 DDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGP 128
D+ + V+ +L HE LV+L G C + + E+ + G L + L R+ + QP
Sbjct: 44 DEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYL--REHGKRFQPSQ 101
Query: 129 VLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPD 188
+L+ + D G+ YL K IHRD+ + N L+ + K++DF LS D
Sbjct: 102 LLE------MCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLD 152
Query: 189 MAARLHSTRVLGTF--GYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRG 245
+++ V F + PE + + + KSDV++FGV++ E+ + G+ P +
Sbjct: 153 DE---YTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYE------ 203
Query: 246 QQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305
R + + + V L+ P K+ A+ C +AE RP ++
Sbjct: 204 ----------RFNNSETVEKVSQGLRLYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLS 253
Query: 306 ALQ 308
+++
Sbjct: 254 SIE 256
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 3e-14
Identities = 47/176 (26%), Positives = 82/176 (46%), Gaps = 24/176 (13%)
Query: 76 SVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTR 135
+++ ++ H ++++L G C + +L E+A GSL L + V P + R
Sbjct: 55 NLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVG---PSYLGSDGNR 111
Query: 136 VRIAVDA------------------ARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKI 177
+D +RG++YL E ++HRD+ + NVL+ E K KI
Sbjct: 112 NSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAARNVLVAEGRKMKI 168
Query: 178 ADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT 233
+DF LS + + + ++ + A E T +SDV+SFGV+L E++T
Sbjct: 169 SDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 3e-14
Identities = 63/245 (25%), Positives = 108/245 (44%), Gaps = 31/245 (12%)
Query: 61 LKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKG 120
L+ ++ +D +Q ++V+S+ + G ++G + E+ GS D+L
Sbjct: 39 LEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLL----- 93
Query: 121 VQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADF 180
+PGP L+ I + +GL+YLH + + IHRDI+++NVLL E K+ADF
Sbjct: 94 ----KPGP-LEETYIATILREILKGLDYLHSERK---IHRDIKAANVLLSEQGDVKLADF 145
Query: 181 NLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDH 240
++ Q D ++ +GT + APE K+D++S G+ +EL G P
Sbjct: 146 GVAGQLTD--TQIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSD 203
Query: 241 TMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNM 300
P L+ +P P L+G+Y C+ + FRP
Sbjct: 204 LHPMRVLFLIPKNSP------------PTLEGQYS----KPFKEFVEACLNKDPRFRPTA 247
Query: 301 SIVVK 305
++K
Sbjct: 248 KELLK 252
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.1 bits (175), Expect = 3e-14
Identities = 51/170 (30%), Positives = 87/170 (51%), Gaps = 17/170 (10%)
Query: 69 DDEKQLVSVVSRLKHENLVELLGYCVEG-NLRVLAYEFATMGSLHDILHGRKGVQGAQPG 127
+D +Q + +S+ + + + G ++G L ++ E+ GS D+L +PG
Sbjct: 44 EDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIM-EYCGGGSCLDLL---------KPG 93
Query: 128 PVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAP 187
LD I + GLEYLHE+ IHRDI+++N+LL E+ K+ADF +S Q
Sbjct: 94 K-LDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLT 149
Query: 188 DMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 237
++ ++ +GT + APE +K+D++S G+ +EL G P
Sbjct: 150 STMSKRNTF--VGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPP 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 4e-14
Identities = 53/165 (32%), Positives = 85/165 (51%), Gaps = 16/165 (9%)
Query: 76 SVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTR 135
+++ L+H+ LV L + + E+ GSL D L +G + P ++D+ +
Sbjct: 53 NLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLP-KLIDFSAQ 111
Query: 136 VRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHS 195
+ A G+ Y+ K + IHRD+R++NVL+ E KIADF L+ D ++
Sbjct: 112 I------AEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNE---YT 159
Query: 196 TRVLGTF--GYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKP 237
R F + APE G T KSDV+SFG++L E++T G+ P
Sbjct: 160 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIP 204
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 4e-14
Identities = 51/177 (28%), Positives = 88/177 (49%), Gaps = 7/177 (3%)
Query: 60 RLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDIL--HG 117
R + KN +D + + ++SRLK N++ LL C+ + + E+ G L+ L H
Sbjct: 55 REDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHE 114
Query: 118 RKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKI 177
+ + + T + +A A G++YL + +HRD+ + N L+ +++ KI
Sbjct: 115 PQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRNCLVGKNYTIKI 171
Query: 178 ADFNLS-NQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT 233
ADF +S N R+ VL + + E + G+ T SDV++FGV L E+LT
Sbjct: 172 ADFGMSRNLYSGDYYRIQGRAVL-PIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 4e-14
Identities = 57/185 (30%), Positives = 90/185 (48%), Gaps = 27/185 (14%)
Query: 61 LKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKG 120
LK P+ +++ +L+H LV L + + ++ E+ GSL D L +G
Sbjct: 38 LKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVTQEPIYIIT-EYMENGSLVDFLKTPEG 96
Query: 121 VQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADF 180
++ L + +A A G+ ++ K + IHRD+R++N+L+ E KIADF
Sbjct: 97 IK-------LTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADF 146
Query: 181 NLSNQAPDMAARL-----HSTRVLGTF--GYHAPEYAMTGQLTQKSDVYSFGVVLLELLT 233
L ARL ++ R F + APE G T KSDV+SFG++L E++T
Sbjct: 147 GL--------ARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVT 198
Query: 234 -GRKP 237
GR P
Sbjct: 199 YGRIP 203
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 4e-14
Identities = 47/170 (27%), Positives = 82/170 (48%), Gaps = 23/170 (13%)
Query: 75 VSVVSRLKHENLVELLGYCVE-GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWM 133
+ +++RL H +++ +LG E + + E+ GS+ +L + G + +
Sbjct: 54 IRLMARLNHPHIIRMLGATCEDSHFNLFV-EWMAGGSVSHLLS--------KYGAFKEAV 104
Query: 134 TRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFK-AKIADFNLSNQAPDMAAR 192
+ RGL YLHE IIHRD++ +N+L+ + +IADF A +AA+
Sbjct: 105 I-INYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFG---AAARLAAK 157
Query: 193 LHST-----RVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 237
++LGT + APE Q + DV+S G V++E+ T + P
Sbjct: 158 GTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 5e-14
Identities = 51/178 (28%), Positives = 79/178 (44%), Gaps = 33/178 (18%)
Query: 70 DEKQLVSVVSRLK-------HENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQ 122
E++ +++S LK HEN+V LLG C G ++ E+ G L + L ++
Sbjct: 80 SERE--ALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRES- 136
Query: 123 GAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNL 182
L + + A+G+ +L K + IHRD+ + NVLL KI DF L
Sbjct: 137 ------FLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFGL 187
Query: 183 -------SNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT 233
SN ARL + APE T +SDV+S+G++L E+ +
Sbjct: 188 ARDIMNDSNYVVKGNARL-------PVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 8e-14
Identities = 55/229 (24%), Positives = 95/229 (41%), Gaps = 18/229 (7%)
Query: 79 SRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRI 138
+L H+N+V LLG C E + E+ +G L L K P L +V +
Sbjct: 63 RKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVAL 122
Query: 139 AVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRV 198
A G+++L +HRD+ + N L+ + K++ +LS + +
Sbjct: 123 CTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNAL 179
Query: 199 LGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLS 258
+ + APE + KSDV+SFGV++ E+ T + +P S
Sbjct: 180 I-PLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGE-----LPFYGLS---------D 224
Query: 259 EDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKAL 307
E+ + + KL+ P ++L + C + RP+ S +V AL
Sbjct: 225 EEVLNRLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSAL 273
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 1e-13
Identities = 45/128 (35%), Positives = 62/128 (48%), Gaps = 10/128 (7%)
Query: 138 IAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTR 197
IAV + L YL E+++ IIHRD++ SN+LL + K+ DF +S Q D A+ TR
Sbjct: 112 IAVATVKALNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAK---TR 166
Query: 198 VLGTFGYHAPEYAMTGQLTQ---KSDVYSFGVVLLELLTGRKPVDHTMPRGQQ--SLVTW 252
G Y APE +SDV+S G+ L E+ TG+ P Q +V
Sbjct: 167 DAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKG 226
Query: 253 ATPRLSED 260
P LS
Sbjct: 227 DPPILSNS 234
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 1e-13
Identities = 45/158 (28%), Positives = 80/158 (50%), Gaps = 13/158 (8%)
Query: 81 LKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAV 140
L H +V LLG C +L+ L + + +GSL D + + P +L+W V
Sbjct: 66 LDHAYIVRLLGICPGASLQ-LVTQLSPLGSLLDHVRQHRDSLD--PQRLLNW------CV 116
Query: 141 DAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLG 200
A+G+ YL E ++HR++ + N+LL D +IADF +++ + +
Sbjct: 117 QIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKT 173
Query: 201 TFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKP 237
+ A E + G+ T +SDV+S+GV + E+++ G +P
Sbjct: 174 PIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEP 211
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 2e-13
Identities = 61/245 (24%), Positives = 107/245 (43%), Gaps = 31/245 (12%)
Query: 61 LKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKG 120
L+ ++ +D +Q ++V+S+ + + G ++G + E+ GS D+L
Sbjct: 39 LEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLL----- 93
Query: 121 VQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADF 180
+ GP D + + +GL+YLH + + IHRDI+++NVLL E K+ADF
Sbjct: 94 ----RAGP-FDEFQIATMLKEILKGLDYLHSEKK---IHRDIKAANVLLSEQGDVKLADF 145
Query: 181 NLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDH 240
++ Q D ++ +GT + APE K+D++S G+ +EL G P
Sbjct: 146 GVAGQLTD--TQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSD 203
Query: 241 TMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNM 300
P V + P+ + P L GE+ C+ + FRP
Sbjct: 204 MHPM----RVLFLIPKNNP--------PTLTGEF----SKPFKEFIDACLNKDPSFRPTA 247
Query: 301 SIVVK 305
++K
Sbjct: 248 KELLK 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 2e-13
Identities = 56/177 (31%), Positives = 83/177 (46%), Gaps = 20/177 (11%)
Query: 63 SPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEG---NLRVLAYEFATMGSLHDILHGRK 119
S + D ++ + ++ L+H+N+V+ G C NLR L E+ GSL D L +
Sbjct: 44 STAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR-LVMEYLPYGSLRDYLQKHR 102
Query: 120 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIAD 179
LD + A +G+EYL K +HRD+ + N+L+ + + KI D
Sbjct: 103 --------ERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGD 151
Query: 180 FNLSNQAPDMAARLHSTRVLG---TFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT 233
F L+ P + R G F Y APE + + SDV+SFGVVL EL T
Sbjct: 152 FGLTKVLP-QDKEYYKVREPGESPIFWY-APESLTESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-13
Identities = 65/249 (26%), Positives = 117/249 (46%), Gaps = 36/249 (14%)
Query: 61 LKSPKNYPDDEKQLV---SVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHG 117
LK+ N P + +L+ +V+ +L + +V ++G C E +L E A +G L+ L
Sbjct: 30 LKNDNNDPALKDELLREANVMQQLDNPYIVRMIGIC-EAESWMLVMELAELGPLNKFLQK 88
Query: 118 RKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKI 177
K V + + + +V + G++YL E + +HRD+ + NVLL AKI
Sbjct: 89 NKHVTEKN---ITELVHQVSM------GMKYLEET---NFVHRDLAARNVLLVTQHYAKI 136
Query: 178 ADFNLSNQAPDMAARLHSTRVLGTF--GYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-G 234
+DF LS +A + + G + ++APE + + KSDV+SFGV++ E + G
Sbjct: 137 SDFGLS-KALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYG 195
Query: 235 RKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEA 294
+KP + ++V Q ++ + E P + ++ + LC Y
Sbjct: 196 QKPYK----------------GMKGNEVTQMIESGERMECPQRCPPEMYDLMKLCWTYGV 239
Query: 295 EFRPNMSIV 303
+ RP ++V
Sbjct: 240 DERPGFAVV 248
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 3e-13
Identities = 56/234 (23%), Positives = 98/234 (41%), Gaps = 19/234 (8%)
Query: 76 SVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTR 135
SV+ ++V LLG +G ++ E T G L L + P + +
Sbjct: 61 SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKK 120
Query: 136 -VRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 194
+++A + A G+ YL+ +HRD+ + N ++ EDF KI DF ++ +
Sbjct: 121 MIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK 177
Query: 195 STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWAT 254
+ L + +PE G T SDV+SFGVVL E+ T L
Sbjct: 178 GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT---------------LAEQPY 222
Query: 255 PRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQ 308
+S ++V + V + P L + +C QY + RP+ ++ +++
Sbjct: 223 QGMSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 3e-13
Identities = 54/165 (32%), Positives = 87/165 (52%), Gaps = 17/165 (10%)
Query: 76 SVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTR 135
+V+ L+H+ LV+L + + ++ EF GSL D L +G QP P L
Sbjct: 53 NVMKTLQHDKLVKLHAVVTKEPIYIIT-EFMAKGSLLDFLKSDEG--SKQPLPKL----- 104
Query: 136 VRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHS 195
+ + A G+ ++ ++ + IHRD+R++N+L+ KIADF L+ D ++
Sbjct: 105 IDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNE---YT 158
Query: 196 TRVLGTF--GYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKP 237
R F + APE G T KSDV+SFG++L+E++T GR P
Sbjct: 159 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIP 203
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 3e-13
Identities = 50/179 (27%), Positives = 91/179 (50%), Gaps = 13/179 (7%)
Query: 62 KSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGV 121
K P + K+ V +++++KH N+V E + E+ G L ++ ++GV
Sbjct: 37 KMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGV 96
Query: 122 QGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFK-AKIADF 180
++ +L W ++ + GL+++H++ I+HRDI+S N+ L ++ AK+ DF
Sbjct: 97 LFSE-DQILSWFVQI------SLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDF 146
Query: 181 NLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVD 239
++ Q D + L T +GT Y +PE K+D++S G VL EL T + P +
Sbjct: 147 GIARQLND-SMELAYT-CVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFE 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.3 bits (168), Expect = 4e-13
Identities = 32/92 (34%), Positives = 50/92 (54%), Gaps = 5/92 (5%)
Query: 145 GLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGY 204
GL+YLH I+HRDI+ SN+L+ D K+ADF L+ + ++ RV+ T Y
Sbjct: 112 GLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI-TLWY 167
Query: 205 HAPEYAM-TGQLTQKSDVYSFGVVLLELLTGR 235
PE + + + D++S G +L EL G+
Sbjct: 168 RPPELLLGATRYGPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 4e-13
Identities = 55/172 (31%), Positives = 83/172 (48%), Gaps = 16/172 (9%)
Query: 66 NYPDDEKQLVSVVSRLKHENLVELLGYCVE--GNLRVLAYEFATMGSLHDILHGRKGVQG 123
N+ D K+ + ++ L HEN+V+ G C E GN L EF GSL + L K
Sbjct: 48 NHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNK-- 105
Query: 124 AQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLS 183
++ +++ AV +G++YL + +HRD+ + NVL+ + + KI DF L+
Sbjct: 106 ------INLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLT 156
Query: 184 NQAPDMAARLHSTRVLGT--FGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT 233
L + F Y APE + + SDV+SFGV L ELLT
Sbjct: 157 KAIETDKEYYTVKDDLDSPVFWY-APECLIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 4e-13
Identities = 61/242 (25%), Positives = 113/242 (46%), Gaps = 32/242 (13%)
Query: 65 KNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGA 124
K+ D+ + ++ +L + +V ++G C L +L E A+ G L+ L G+K
Sbjct: 36 KSVRDEMMREAEIMHQLDNPYIVRMIGVCEAEAL-MLVMEMASGGPLNKFLSGKK--DEI 92
Query: 125 QPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSN 184
V++ M +V + G++YL K + +HRD+ + NVLL AKI+DF LS
Sbjct: 93 TVSNVVELMHQVSM------GMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLS- 142
Query: 185 QAPDMAARLHSTRVLGTF--GYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHT 241
+A + R G + ++APE + + +SDV+S+G+ + E + G+KP
Sbjct: 143 KALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYK-- 200
Query: 242 MPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMS 301
++ +V ++ + + P + ++ A+ C Y+ E RPN +
Sbjct: 201 --------------KMKGPEVMSFIEQGKRLDCPAECPPEMYALMKDCWIYKWEDRPNFA 246
Query: 302 IV 303
V
Sbjct: 247 KV 248
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 5e-13
Identities = 49/168 (29%), Positives = 77/168 (45%), Gaps = 18/168 (10%)
Query: 75 VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 134
+++ S LKH N+V+ LG E + E GSL +L + G + + T
Sbjct: 56 IALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNE-QTIIFYT 114
Query: 135 RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFE-DFKAKIADFNLSNQAPDMAARL 193
+ GL+YLH+ I+HRDI+ NVL+ KI+DF S + A +
Sbjct: 115 K-----QILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKR----LAGI 162
Query: 194 H--STRVLGTFGYHAPEYAMTGQ--LTQKSDVYSFGVVLLELLTGRKP 237
+ + GT Y APE G +D++S G ++E+ TG+ P
Sbjct: 163 NPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPP 210
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 6e-13
Identities = 60/236 (25%), Positives = 98/236 (41%), Gaps = 23/236 (9%)
Query: 76 SVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPG---PVLDW 132
SV+ ++V LLG +G ++ E G L L + PG P L
Sbjct: 61 SVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQE 120
Query: 133 MTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAAR 192
M +++A + A G+ YL+ K +HRD+ + N ++ DF KI DF ++ +
Sbjct: 121 M--IQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYY 175
Query: 193 LHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTW 252
+ L + APE G T SD++SFGVVL E+ SL
Sbjct: 176 RKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEI---------------TSLAEQ 220
Query: 253 ATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQ 308
LS ++V + V + P ++ + +C Q+ + RP +V L+
Sbjct: 221 PYQGLSNEQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 7e-13
Identities = 59/198 (29%), Positives = 97/198 (48%), Gaps = 21/198 (10%)
Query: 72 KQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLD 131
+Q + ++ KH N+V G + + + EF GSL DI H V G +
Sbjct: 54 QQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYH----VTGPLSESQIA 109
Query: 132 WMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAA 191
+++R + +GL YLH K + +HRDI+ +N+LL ++ K+ADF +S Q A
Sbjct: 110 YVSR-----ETLQGLYYLHSKGK---MHRDIKGANILLTDNGHVKLADFGVSAQITATIA 161
Query: 192 RLHSTRVLGTFGYHAPEYAMT---GQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQS 248
+ S +GT + APE A G Q D+++ G+ +EL + P+ P
Sbjct: 162 KRKS--FIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF 219
Query: 249 LVT---WATPRLSEDKVK 263
L+T + P+L +DK+K
Sbjct: 220 LMTKSNFQPPKL-KDKMK 236
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 8e-13
Identities = 51/174 (29%), Positives = 82/174 (47%), Gaps = 15/174 (8%)
Query: 75 VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQP--GPVLDW 132
V ++SRL N+ LLG C + E+ G L+ L L +
Sbjct: 70 VKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSF 129
Query: 133 MTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAAR 192
T + +A A G+ YL + +HRD+ + N L+ +++ KIADF +S ++ +
Sbjct: 130 STLLYMATQIASGMRYLESL---NFVHRDLATRNCLVGKNYTIKIADFGMSR---NLYSS 183
Query: 193 LHSTRVLGT----FGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT--GRKPVDH 240
+ RV G + A E + G+ T KSDV++FGV L E+LT +P +H
Sbjct: 184 DYY-RVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEH 236
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 1e-12
Identities = 44/160 (27%), Positives = 68/160 (42%), Gaps = 14/160 (8%)
Query: 81 LKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAV 140
L H N+++ LG C+E +L EF +G L + L +G+ R+A
Sbjct: 52 LNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQK----DVLQRMAC 107
Query: 141 DAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLG 200
+ A GL +LH Q IH D+ N L D KI D+ L+ + +
Sbjct: 108 EVASGLLWLH---QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAV 164
Query: 201 TFGYHAPEYA-------MTGQLTQKSDVYSFGVVLLELLT 233
+ APE + T+KS+++S GV + EL T
Sbjct: 165 PLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFT 204
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.4 bits (163), Expect = 1e-12
Identities = 49/169 (28%), Positives = 74/169 (43%), Gaps = 29/169 (17%)
Query: 75 VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 134
+S++ LKH N+V+LL L +E+ M L L R G P + M
Sbjct: 49 ISLLKELKHPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPG--PLSPNLIKSIMY 105
Query: 135 RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 194
++ RGL Y H I+HRD++ N+L+ D K+ADF L AR
Sbjct: 106 QL------LRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGL--------ARAF 148
Query: 195 S------TRVLGTFGYHAPEYAMTGQLTQKS--DVYSFGVVLLELLTGR 235
T + T Y APE + G + D++S G + E++TG+
Sbjct: 149 GIPLRTYTHEVVTLWYRAPEILL-GSKHYSTAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 66.4 bits (163), Expect = 1e-12
Identities = 34/111 (30%), Positives = 53/111 (47%), Gaps = 21/111 (18%)
Query: 145 GLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADF--------NLSNQAPDMAARLHST 196
LEYLH K IIHRD++ N+LL +D KI DF N S ++ A +
Sbjct: 114 ALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDS 170
Query: 197 R----------VLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 237
+ +GT Y +PE + SD+++ G ++ ++LTG+ P
Sbjct: 171 QIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP 221
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 2e-12
Identities = 46/180 (25%), Positives = 81/180 (45%), Gaps = 19/180 (10%)
Query: 62 KSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAY-EFATMGSLHDILHGRKG 120
K + + + ++ L+HE +V+ G C+ + + + E+ GS+ D L
Sbjct: 42 PETKKEVNALECEIQLLKNLQHERIVQYYG-CLRDDETLSIFMEYMPGGSVKDQL----- 95
Query: 121 VQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADF 180
G + + +TR + G+EYLH + I+HRDI+ +N+L K+ DF
Sbjct: 96 ---KAYGALTETVTR-KYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDF 148
Query: 181 NLSNQAPDMAARLHST---RVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 237
S + T V GT + +PE +K+DV+S G ++E+LT + P
Sbjct: 149 GASKRL--QTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPP 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 2e-12
Identities = 37/105 (35%), Positives = 55/105 (52%), Gaps = 9/105 (8%)
Query: 137 RIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHST 196
++ V + L YL EK +IHRD++ SN+LL K+ DF +S + D A+ T
Sbjct: 118 KMTVAIVKALHYLKEK--HGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK---T 172
Query: 197 RVLGTFGYHAPEY----AMTGQLTQKSDVYSFGVVLLELLTGRKP 237
R G Y APE + ++DV+S G+ L+EL TG+ P
Sbjct: 173 RSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFP 217
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 65.7 bits (161), Expect = 2e-12
Identities = 33/99 (33%), Positives = 46/99 (46%), Gaps = 9/99 (9%)
Query: 145 GLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLS------NQAPDMAARLHSTRV 198
LEYLH IIHRD++ N+L+ + K+ DF LS Q R+
Sbjct: 105 ALEYLH---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRI 161
Query: 199 LGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 237
+GT Y APE + ++ D +S G +L E L G P
Sbjct: 162 VGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPP 200
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 2e-12
Identities = 52/184 (28%), Positives = 89/184 (48%), Gaps = 22/184 (11%)
Query: 137 RIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHST 196
++++ RGL YL EK Q I+HRD++ SN+L+ + K+ DF +S Q D A
Sbjct: 107 KVSIAVLRGLAYLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA----N 160
Query: 197 RVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPR 256
+GT Y +PE + +SD++S G+ L+EL GR P+ P ++ + P
Sbjct: 161 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPI--PPPDAKELEAIFGRPV 218
Query: 257 L-SEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSPP 315
+ E+ + P+ + P + V+ + + RP M+I + L ++ PP
Sbjct: 219 VDGEEGEPHSISPRPRP--PGRPVSG----------HGMDSRPAMAI-FELLDYIVNEPP 265
Query: 316 PAAP 319
P P
Sbjct: 266 PKLP 269
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 3e-12
Identities = 49/168 (29%), Positives = 81/168 (48%), Gaps = 25/168 (14%)
Query: 75 VSVVSRLKHENLVELLG-YCVEGNLRVLAYEFATMGSLHDIL-HGRKGVQGAQPGPVLDW 132
V ++ +H N+VE+ Y V L V+ EF G+L DI+ H R
Sbjct: 67 VVIMRDYQHPNIVEMYSSYLVGDELWVV-MEFLEGGALTDIVTHTR-------------- 111
Query: 133 MTRVRIA---VDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDM 189
M +IA + + L +LH + +IHRDI+S ++LL D + K++DF Q
Sbjct: 112 MNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKE 168
Query: 190 AARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 237
R S ++GT + APE + D++S G++++E++ G P
Sbjct: 169 VPRRKS--LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 3e-12
Identities = 47/134 (35%), Positives = 63/134 (47%), Gaps = 20/134 (14%)
Query: 104 EFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIR 163
EF GSL V P VL RIAV +GL YL I+HRD++
Sbjct: 79 EFMDGGSLD--------VYRKIPEHVLG-----RIAVAVVKGLTYLWSL---KILHRDVK 122
Query: 164 SSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYS 223
SN+L+ + K+ DF +S Q + A+ + +GT Y APE Q SDV+S
Sbjct: 123 PSNMLVNTRGQVKLCDFGVSTQLVNSIAKTY----VGTNAYMAPERISGEQYGIHSDVWS 178
Query: 224 FGVVLLELLTGRKP 237
G+ +EL GR P
Sbjct: 179 LGISFMELALGRFP 192
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 3e-12
Identities = 50/149 (33%), Positives = 71/149 (47%), Gaps = 26/149 (17%)
Query: 101 LAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAV------------DAARGLEY 148
L Y F T G L+ IL +G D TR+ V + A L++
Sbjct: 63 LHYAFQTEGKLYLILDFLRGG---------DLFTRLSKEVMFTEEDVKFYLAELALALDH 113
Query: 149 LHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPE 208
LH II+RD++ N+LL E+ K+ DF LS ++ D + +S GT Y APE
Sbjct: 114 LHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVEYMAPE 168
Query: 209 YAMTGQLTQKSDVYSFGVVLLELLTGRKP 237
TQ +D +SFGV++ E+LTG P
Sbjct: 169 VVNRRGHTQSADWWSFGVLMFEMLTGSLP 197
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 65.3 bits (160), Expect = 4e-12
Identities = 48/159 (30%), Positives = 74/159 (46%), Gaps = 18/159 (11%)
Query: 81 LKHENLVELLG-YCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIA 139
LKH N++ LL + + N+ L +EF L ++ + V P + +M
Sbjct: 59 LKHPNIIGLLDVFGHKSNI-NLVFEFME-TDLEKVIKDKSIV--LTPADIKSYM------ 108
Query: 140 VDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVL 199
+ RGLEYLH I+HRD++ +N+L+ D K+ADF L+ R + +V+
Sbjct: 109 LMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGS-PNRKMTHQVV 164
Query: 200 GTFGYHAPEYAM-TGQLTQKSDVYSFGVVLLELLTGRKP 237
T Y APE D++S G + ELL R P
Sbjct: 165 -TRWYRAPELLFGARHYGVGVDMWSVGCIFAELLL-RVP 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.0 bits (159), Expect = 4e-12
Identities = 46/167 (27%), Positives = 74/167 (44%), Gaps = 21/167 (12%)
Query: 82 KHENLVELLGYCVEGNLRV------LAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTR 135
H N+ G ++ N L E GS+ D++ G + + ++ R
Sbjct: 61 NHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILR 120
Query: 136 VRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHS 195
+ RGL YLHE +IHRDI+ N+LL ++ + K+ DF +S Q R ++
Sbjct: 121 -----ETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNT 172
Query: 196 TRVLGTFGYHAPE-----YAMTGQLTQKSDVYSFGVVLLELLTGRKP 237
+GT + APE +SDV+S G+ +EL G+ P
Sbjct: 173 --FIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPP 217
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 5e-12
Identities = 52/207 (25%), Positives = 97/207 (46%), Gaps = 34/207 (16%)
Query: 68 PDDE----KQLVSVVSRLKH---ENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKG 120
PDD+ ++ V+++S+L+ N+ + G ++G + E+A GS+ ++
Sbjct: 39 PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLM----- 93
Query: 121 VQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADF 180
+ GP+ + V I + L+Y+H+ +IHRDI+++N+L+ K+ DF
Sbjct: 94 ----KAGPIAEKYISV-IIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDF 145
Query: 181 NLSNQAPDMAARLHSTR-----VLGTFGYHAPEYAMTGQL-TQKSDVYSFGVVLLELLTG 234
+ AA L+ +GT + APE G+ K+D++S G+ + E+ TG
Sbjct: 146 GV-------AALLNQNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATG 198
Query: 235 RKPV-DHTMPRGQQSLVTWATPRLSED 260
P D R + PRL ++
Sbjct: 199 NPPYSDVDAFRAMMLIPKSKPPRLEDN 225
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 5e-12
Identities = 35/99 (35%), Positives = 48/99 (48%), Gaps = 9/99 (9%)
Query: 145 GLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGY 204
G+E LH Q IIHRDI+ N+L+ + K+ DF LS L + + +GT Y
Sbjct: 109 GVEDLH---QRGIIHRDIKPENLLIDQTGHLKLTDFGLSR------NGLENKKFVGTPDY 159
Query: 205 HAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMP 243
APE + + SD +S G V+ E L G P P
Sbjct: 160 LAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETP 198
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 5e-12
Identities = 61/237 (25%), Positives = 96/237 (40%), Gaps = 31/237 (13%)
Query: 83 HENLVELLGYCVEGNLR------VLAYEFATMGSLHD-ILHGRKGVQGAQPGPV-LDWMT 134
H N++ L+G C++ V+ F G LH +L+ R G P L
Sbjct: 59 HPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDC-----PQYLPTQM 113
Query: 135 RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 194
V+ D A G+EYL K S IHRD+ + N +L E+ +ADF LS + +
Sbjct: 114 LVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQ 170
Query: 195 STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWAT 254
+ A E T KSDV+SFGV + E+ T RGQ
Sbjct: 171 GRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIAT----------RGQTPY----- 215
Query: 255 PRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLL 311
P + ++ + + + PP + L ++ + C + RP+ + L+ L
Sbjct: 216 PGVENSEIYDYLRQGNRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKAL 272
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 6e-12
Identities = 48/172 (27%), Positives = 78/172 (45%), Gaps = 13/172 (7%)
Query: 67 YPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQP 126
+D + V+ +L H LV+L G C + + EF G L + L R+G
Sbjct: 42 SEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKD- 100
Query: 127 GPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQA 186
+L + + D G+EYL + S IHRD+ + N L+ K++DF ++
Sbjct: 101 --ML-----LSMCQDVCEGMEYLE---RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYV 150
Query: 187 PDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKP 237
D S+ + PE + + KSDV+SFGV++ E+ T G+ P
Sbjct: 151 LD-DEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMP 201
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 8e-12
Identities = 48/166 (28%), Positives = 78/166 (46%), Gaps = 17/166 (10%)
Query: 81 LKHENLVELLGYCVEGNLR------VLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 134
H N+++L+G C E + ++ F G LH L + + P+ T
Sbjct: 58 FDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPL---QT 114
Query: 135 RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQ--APDMAAR 192
++ VD A G+EYL + + IHRD+ + N +L ED +ADF LS + + D +
Sbjct: 115 LLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQ 171
Query: 193 LHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKP 237
++ + A E T KSDV++FGV + E+ T G+ P
Sbjct: 172 GRIAKM--PVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTP 215
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 8e-12
Identities = 43/166 (25%), Positives = 81/166 (48%), Gaps = 14/166 (8%)
Query: 75 VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 134
V+ L H N++E +E ++ E+A G+L + + R +L +
Sbjct: 50 CQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKR-CNSLLDEDTILHFFV 108
Query: 135 RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLL-FEDFKAKIADFNLSNQAPDMAARL 193
++ +A L ++H K+ I+HRD+++ N+LL KI DF +S ++++
Sbjct: 109 QILLA------LHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKI---LSSKS 156
Query: 194 HSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVD 239
+ V+GT Y +PE QKSD+++ G VL EL + ++ +
Sbjct: 157 KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFE 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 8e-12
Identities = 58/171 (33%), Positives = 81/171 (47%), Gaps = 32/171 (18%)
Query: 75 VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILH-GRKGVQGAQPGPVLDWM 133
V + +L+H N +E G + + L E+ +GS DIL +K +Q
Sbjct: 66 VRFLQQLRHPNTIEYKGCYLREHTAWLVMEYC-LGSASDILEVHKKPLQ----------- 113
Query: 134 TRVRIAV---DAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADF-NLSNQAPDM 189
V IA A +GL YLH IHRDI++ N+LL E K+ADF + S +P
Sbjct: 114 -EVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVSP-- 167
Query: 190 AARLHSTRVLGTFGYHAPE--YAM-TGQLTQKSDVYSFGVVLLELLTGRKP 237
+ +GT + APE AM GQ K DV+S G+ +E L RKP
Sbjct: 168 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIE-LAERKP 212
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 64.4 bits (156), Expect = 8e-12
Identities = 52/185 (28%), Positives = 85/185 (45%), Gaps = 18/185 (9%)
Query: 75 VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 134
+ V+ LK+ N+V L + G+ + E+ GSL D++ +D
Sbjct: 67 ILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVV----------TETCMDEAQ 116
Query: 135 RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQ-APDMAARL 193
+ + + LE+LH +IHRDI+S NVLL D K+ DF Q P+ + R
Sbjct: 117 IAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKR- 172
Query: 194 HSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMP-RGQQSLVTW 252
+ ++GT + APE K D++S G++ +E++ G P + P R + T
Sbjct: 173 --STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN 230
Query: 253 ATPRL 257
TP L
Sbjct: 231 GTPEL 235
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 64.2 bits (157), Expect = 1e-11
Identities = 42/160 (26%), Positives = 71/160 (44%), Gaps = 14/160 (8%)
Query: 77 VVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRV 136
+ +H +V+LL G+ VL E+ L ++L P+ + +
Sbjct: 52 ALQACQHPYVVKLLDVFPHGSGFVLVMEY-MPSDLSEVLRDE-------ERPLPEAQVK- 102
Query: 137 RIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHST 196
+G+ Y+H I+HRD++ +N+L+ D KIADF L+ + RL+S
Sbjct: 103 SYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSH 159
Query: 197 RVLGTFGYHAPEYAMTGQ-LTQKSDVYSFGVVLLELLTGR 235
+V T Y APE + D+++ G + ELL G
Sbjct: 160 QV-ATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 64.0 bits (155), Expect = 1e-11
Identities = 59/209 (28%), Positives = 94/209 (44%), Gaps = 28/209 (13%)
Query: 69 DDEKQLVSVVSRLK----HENLVELLGYCVEGN------LRVLAYEFATMGSLHDILHGR 118
D+E+++ ++ LK H N+ G ++ N L EF GS+ D++
Sbjct: 44 DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNT 103
Query: 119 KGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIA 178
KG + +W+ I + RGL +LH Q +IHRDI+ NVLL E+ + K+
Sbjct: 104 KGNTLKE-----EWIAY--ICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLV 153
Query: 179 DFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQ-----KSDVYSFGVVLLELLT 233
DF +S Q R ++ +GT + APE + KSD++S G+ +E+
Sbjct: 154 DFGVSAQLDRTVGRRNT--FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAE 211
Query: 234 GRKPVDHTMPRGQQSLVTW-ATPRLSEDK 261
G P+ P L+ PRL K
Sbjct: 212 GAPPLCDMHPMRALFLIPRNPAPRLKSKK 240
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 1e-11
Identities = 48/232 (20%), Positives = 99/232 (42%), Gaps = 41/232 (17%)
Query: 78 VSRLKHENLVELLGYCVE---GNLRV-LAYEFATMGSLHDILHGRKGVQGAQPGPVLDWM 133
+ R+ N++++ G+ ++ R+ L E+ T G L ++L K L +
Sbjct: 72 LRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEKD---------LSFK 122
Query: 134 TRVRIAVDAARGLEYLHEKV-QPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAAR 192
T++ +A+D +GL L++ +P ++++ S + L+ E++K KI L + +
Sbjct: 123 TKLDMAIDCCKGLYNLYKYTNKP---YKNLTSVSFLVTENYKLKIICHGLEK----ILSS 175
Query: 193 LHSTRVLGTFGYHAPEYAMT--GQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLV 250
V Y + + + T K D+YS GVVL E+ TG+ P ++
Sbjct: 176 PPFKNV-NFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFEN---------- 224
Query: 251 TWATPRLSEDKVKQCVDPKLKGEY-PPKGVAKLAAVAALCVQYEAEFRPNMS 301
L+ ++ + K P ++ + C +++ RPN+
Sbjct: 225 ------LTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIK 270
|
Length = 283 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 1e-11
Identities = 55/191 (28%), Positives = 85/191 (44%), Gaps = 31/191 (16%)
Query: 104 EFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIR 163
E+ GSL D L+ P VL RI +GL++L E+ IIHRD++
Sbjct: 79 EYMDAGSL-DKLYAGGVATEGIPEDVL-----RRITYAVVKGLKFLKEEHN--IIHRDVK 130
Query: 164 SSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQ------ 217
+NVL+ + + K+ DF +S + A L T + G Y APE +G Q
Sbjct: 131 PTNVLVNGNGQVKLCDFGVSGN---LVASLAKTNI-GCQSYMAPERIKSGGPNQNPTYTV 186
Query: 218 KSDVYSFGVVLLELLTGRKP----VDHTMPRGQQSLVTWATPRL-------SEDKVKQCV 266
+SDV+S G+ +LE+ GR P + ++V P L ++D V +C+
Sbjct: 187 QSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYSDDAQDFVAKCL 246
Query: 267 --DPKLKGEYP 275
P + Y
Sbjct: 247 NKIPNRRPTYA 257
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 1e-11
Identities = 49/183 (26%), Positives = 83/183 (45%), Gaps = 22/183 (12%)
Query: 137 RIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHST 196
++++ +GL YL EK + I+HRD++ SN+L+ + K+ DF +S Q D A
Sbjct: 107 KVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA----N 160
Query: 197 RVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPR 256
+GT Y +PE + +SD++S G+ L+E+ GR P+ P + L
Sbjct: 161 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIP---PPDAKELELMFGCP 217
Query: 257 LSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSPPP 316
+ D + P+ + P Y + RP M+I + L ++ PPP
Sbjct: 218 VEGDPAESETSPRPRPPGRPLS------------SYGPDSRPPMAI-FELLDYIVNEPPP 264
Query: 317 AAP 319
P
Sbjct: 265 KLP 267
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 1e-11
Identities = 53/171 (30%), Positives = 80/171 (46%), Gaps = 36/171 (21%)
Query: 77 VVSRLKHENLVELLGYCV--EGN-LRVLAYEFATMGSLHDILHG--RKGVQGAQPGPVLD 131
++ H N++ LLG C+ EG+ L VL Y + HG R ++ P +
Sbjct: 49 IMKDFSHPNVLSLLGICLPSEGSPLVVLPY----------MKHGDLRNFIRSETHNPTVK 98
Query: 132 WMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPD--- 188
+ + + A+G+EYL K +HRD+ + N +L E F K+ADF L+ D
Sbjct: 99 DL--IGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEY 153
Query: 189 ------MAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT 233
A+L + A E T + T KSDV+SFGV+L EL+T
Sbjct: 154 YSVHNHTGAKL-------PVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 2e-11
Identities = 56/189 (29%), Positives = 85/189 (44%), Gaps = 26/189 (13%)
Query: 77 VVSRLKHENLVELL-GYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTR 135
V+ KH N+V L Y V L V+ E+ GSL D++ M
Sbjct: 69 VMRENKHPNIVNYLDSYLVGDELWVVM-EYLAGGSLTDVV-------------TETCMDE 114
Query: 136 VRIAV---DAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQ-APDMAA 191
+IA + + LE+LH +IHRDI+S N+LL D K+ DF Q P+ +
Sbjct: 115 GQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 171
Query: 192 RLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMP-RGQQSLV 250
R + ++GT + APE K D++S G++ +E++ G P + P R +
Sbjct: 172 R---STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA 228
Query: 251 TWATPRLSE 259
T TP L
Sbjct: 229 TNGTPELQN 237
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 2e-11
Identities = 64/242 (26%), Positives = 104/242 (42%), Gaps = 35/242 (14%)
Query: 77 VVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRV 136
+++ + H +LV LLG C+ ++ L + G L D +H K G+Q +L+W ++
Sbjct: 62 IMASMDHPHLVRLLGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQL--LLNWCVQI 118
Query: 137 RIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHST 196
A+G+ YL E+ ++HRD+ + NVL+ KI DF L+ ++
Sbjct: 119 ------AKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNAD 169
Query: 197 RVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATP 255
+ A E + T +SDV+S+GV + EL+T G KP D + T P
Sbjct: 170 GGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYD--------GIPTREIP 221
Query: 256 RLSEDKVKQCVDPKLKGE---YPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLK 312
L E KGE PP + V C +A+ RP + + +
Sbjct: 222 DLLE-----------KGERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMAR 270
Query: 313 SP 314
P
Sbjct: 271 DP 272
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-11
Identities = 54/205 (26%), Positives = 95/205 (46%), Gaps = 27/205 (13%)
Query: 40 RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELL-GYCVEGNL 98
R L ++ Y E KS D K+ V +++++KH N+V + +G+L
Sbjct: 15 RALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAV-LLAKMKHPNIVAFKESFEADGHL 73
Query: 99 RVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSII 158
++ E+ G L + ++G + +L W ++ + V +++HEK ++
Sbjct: 74 YIVM-EYCDGGDLMQKIKLQRGKLFPED-TILQWFVQMCLGV------QHIHEK---RVL 122
Query: 159 HRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRV------LGTFGYHAPEYAMT 212
HRDI+S N+ L ++ K K+ DF +ARL ++ +GT Y PE
Sbjct: 123 HRDIKSKNIFLTQNGKVKLGDFG--------SARLLTSPGAYACTYVGTPYYVPPEIWEN 174
Query: 213 GQLTQKSDVYSFGVVLLELLTGRKP 237
KSD++S G +L EL T + P
Sbjct: 175 MPYNNKSDIWSLGCILYELCTLKHP 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.7 bits (153), Expect = 3e-11
Identities = 39/165 (23%), Positives = 68/165 (41%), Gaps = 21/165 (12%)
Query: 75 VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 134
+ ++ L H N+++LL L +EF I ++G+ + L +
Sbjct: 49 IKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMDTDLYKLIKDRQRGLPESLIKSYL-YQL 107
Query: 135 RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQA-PDMAARL 193
+GL + H I+HRD++ N+L+ + K+ADF L+ +
Sbjct: 108 --------LQGLAFCH---SHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYT 156
Query: 194 H--STRVLGTFGYHAPEYAMT-GQLTQKSDVYSFGVVLLELLTGR 235
H TR Y APE + + D++S G + ELL+ R
Sbjct: 157 HYVVTR-----WYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 4e-11
Identities = 56/203 (27%), Positives = 94/203 (46%), Gaps = 27/203 (13%)
Query: 75 VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDIL-HGRKGVQGAQPGPVLDWM 133
V ++ +HEN+VE+ + G+ + EF G+L DI+ H R M
Sbjct: 68 VVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTR--------------M 113
Query: 134 TRVRIA---VDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMA 190
+IA + + L LH + +IHRDI+S ++LL D + K++DF Q
Sbjct: 114 NEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV 170
Query: 191 ARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMP-RGQQSL 249
R S ++GT + APE + D++S G++++E++ G P + P + + +
Sbjct: 171 PRRKS--LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI 228
Query: 250 VTWATPRLSEDKVKQCVDPKLKG 272
P+L K V P LKG
Sbjct: 229 RDNLPPKL---KNLHKVSPSLKG 248
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 4e-11
Identities = 57/234 (24%), Positives = 99/234 (42%), Gaps = 33/234 (14%)
Query: 75 VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSL-HDILHGRKGVQGAQPGPVLDWM 133
+ ++ +L H N+++ L +E N + E A G L I H +K ++
Sbjct: 53 IDLLKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQ------KRLIPER 106
Query: 134 TRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARL 193
T + V LE++H K I+HRDI+ +NV + K+ D L
Sbjct: 107 TIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAA 163
Query: 194 HSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWA 253
HS ++GT Y +PE KSD++S G +L E+ + P + +L +
Sbjct: 164 HS--LVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD----KMNLYSLC 217
Query: 254 TPRLSEDKVKQCVDPKLKGEYPP----KGVAKLAAVAALCVQYEAEFRPNMSIV 303
K+++C +YPP +L + + C+ + E RP++S V
Sbjct: 218 ------KKIEKC-------DYPPLPADHYSEELRDLVSRCINPDPEKRPDISYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 4e-11
Identities = 49/171 (28%), Positives = 74/171 (43%), Gaps = 23/171 (13%)
Query: 71 EKQLVSVVSRLKHENLVELLGYCVEGNLRV-LAYEFATMGSLHDILHGRKGVQGAQPGPV 129
EK++ + +H LV L C + V E+A G L ++H V
Sbjct: 49 EKRIFETANSERHPFLVNLFA-CFQTEDHVCFVMEYAAGGDL--MMHIHTDV-------- 97
Query: 130 LDWMTRVRIAVDAAR---GLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQA 186
+ R AA GL+YLHE I++RD++ N+LL + KIADF L +
Sbjct: 98 ---FSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKE- 150
Query: 187 PDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 237
M ++ GT + APE T+ D + GV++ E+L G P
Sbjct: 151 -GMGFGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESP 200
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 5e-11
Identities = 53/204 (25%), Positives = 90/204 (44%), Gaps = 27/204 (13%)
Query: 75 VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 134
+ V+ K+ N+V L + G+ + E+ GSL D++ +D
Sbjct: 68 ILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV----------TETCMDEGQ 117
Query: 135 RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQ-APDMAARL 193
+ + + LE+LH +IHRDI+S N+LL D K+ DF Q P+ + R
Sbjct: 118 IAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR- 173
Query: 194 HSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMP-RGQQSLVTW 252
+ ++GT + APE K D++S G++ +E++ G P + P R + T
Sbjct: 174 --STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN 231
Query: 253 ATPRLS---------EDKVKQCVD 267
TP L D + +C+D
Sbjct: 232 GTPELQNPEKLSAIFRDFLNRCLD 255
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 6e-11
Identities = 52/171 (30%), Positives = 77/171 (45%), Gaps = 31/171 (18%)
Query: 75 VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSL-HDILHGRKGVQGAQPGPVLDWM 133
++++ L+H N+VEL V +L + F M D+ +LD M
Sbjct: 57 ITLLLNLRHPNIVELKEVVVGKHLDSI---FLVMEYCEQDL------------ASLLDNM 101
Query: 134 TR------VR-IAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQA 186
V+ + + RGL+YLHE IIHRD++ SN+LL + KIADF L+
Sbjct: 102 PTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTY 158
Query: 187 PDMAARLHSTRVLGTFGYHAPE--YAMTGQLTQKSDVYSFGVVLLELLTGR 235
A T + T Y APE T T D+++ G +L ELL +
Sbjct: 159 GLPAK--PMTPKVVTLWYRAPELLLGCTTY-TTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 61.9 bits (151), Expect = 7e-11
Identities = 36/94 (38%), Positives = 51/94 (54%), Gaps = 11/94 (11%)
Query: 144 RGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPD-MAARLHSTRVLGTF 202
RGL+Y+H IIHRD++ SN+ + ED + KI DF L+ D M T + T
Sbjct: 129 RGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEM------TGYVATR 179
Query: 203 GYHAPEYAMT-GQLTQKSDVYSFGVVLLELLTGR 235
Y APE + Q D++S G ++ ELLTG+
Sbjct: 180 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 7e-11
Identities = 66/259 (25%), Positives = 104/259 (40%), Gaps = 33/259 (12%)
Query: 57 ENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILH 116
EN K+ K D+ + V S + LLG C+ ++ L + G L D +
Sbjct: 46 ENTSPKANKEILDEAYVMAGVGSPY----VCRLLGICLTSTVQ-LVTQLMPYGCLLDYVR 100
Query: 117 GRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAK 176
K G+Q +L+W V A+G+ YL E ++HRD+ + NVL+ K
Sbjct: 101 ENKDRIGSQD--LLNW------CVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVK 149
Query: 177 IADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GR 235
I DF L+ H+ + A E + + T +SDV+S+GV + EL+T G
Sbjct: 150 ITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGA 209
Query: 236 KPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAE 295
KP D R L+ RL + PP + + C ++E
Sbjct: 210 KPYDGIPAREIPDLLE-KGERLPQ---------------PPICTIDVYMIMVKCWMIDSE 253
Query: 296 FRPNMSIVVKALQPLLKSP 314
RP +V + + P
Sbjct: 254 CRPRFRELVDEFSRMARDP 272
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 7e-11
Identities = 49/170 (28%), Positives = 82/170 (48%), Gaps = 17/170 (10%)
Query: 72 KQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLD 131
+Q + +V KH N+V G + + E+ GSL DI H V G +
Sbjct: 54 QQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYH----VTGPLSELQIA 109
Query: 132 WMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAA 191
++ R + +GL YLH K + +HRDI+ +N+LL ++ K+ADF ++ + A
Sbjct: 110 YVCR-----ETLQGLAYLHSKGK---MHRDIKGANILLTDNGDVKLADFGVAAKITATIA 161
Query: 192 RLHSTRVLGTFGYHAPEYAM---TGQLTQKSDVYSFGVVLLELLTGRKPV 238
+ S +GT + APE A G Q D+++ G+ +EL + P+
Sbjct: 162 KRKS--FIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPM 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 7e-11
Identities = 30/93 (32%), Positives = 46/93 (49%), Gaps = 6/93 (6%)
Query: 145 GLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGY 204
GLE+LH++ I++RD++ NVLL + +I+D L A ++ GT GY
Sbjct: 107 GLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGL---AVELKGGKKIKGRAGTPGY 160
Query: 205 HAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 237
APE D ++ G L E++ GR P
Sbjct: 161 MAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 8e-11
Identities = 36/93 (38%), Positives = 54/93 (58%), Gaps = 5/93 (5%)
Query: 145 GLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGY 204
GL++LH+K II+RD++ NVLL +D KIADF + + +M ++ GT Y
Sbjct: 108 GLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKE--NMNGEGKASTFCGTPDY 162
Query: 205 HAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 237
APE + + D +SFGV+L E+L G+ P
Sbjct: 163 IAPEILKGQKYNESVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 61.6 bits (150), Expect = 9e-11
Identities = 34/102 (33%), Positives = 57/102 (55%), Gaps = 7/102 (6%)
Query: 139 AVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRV 198
A + GL++LHE+ II+RD++ NVLL + KIADF + + + + ++
Sbjct: 102 AAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEG--ILGGVTTSTF 156
Query: 199 LGTFGYHAPEYAMTGQLTQKS-DVYSFGVVLLELLTGRKPVD 239
GT Y APE ++ Q + D ++ GV+L E+L G+ P +
Sbjct: 157 CGTPDYIAPE-ILSYQPYGPAVDWWALGVLLYEMLAGQSPFE 197
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 1e-10
Identities = 49/173 (28%), Positives = 80/173 (46%), Gaps = 21/173 (12%)
Query: 75 VSVVSRLKHENLVELLGYCVEGNLRVLA-YEFATMGSLHDILHGRKGVQGAQPGPVLDWM 133
++ +RL H N+V LL + A +E+ +L ++L GA P
Sbjct: 29 TALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPGRTLREVL----AADGALPA-----G 79
Query: 134 TRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFE---DFKAKIADFNLSNQAPDM- 189
R+ + L H + I+HRD++ N+++ + AK+ DF + P +
Sbjct: 80 ETGRLMLQVLDALACAHNQ---GIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVR 136
Query: 190 -AARLHSTR---VLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPV 238
A TR VLGT Y APE +T SD+Y++G++ LE LTG++ V
Sbjct: 137 DADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQRVV 189
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 60.3 bits (147), Expect = 2e-10
Identities = 46/191 (24%), Positives = 75/191 (39%), Gaps = 47/191 (24%)
Query: 71 EKQL----VSVVSRLKHENLVELLG---------------YCVEGNLRVLAYEFATMGSL 111
EKQ V+++ LKH N+V YC G+L L
Sbjct: 42 EKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDL----------AQL 91
Query: 112 HDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPS--IIHRDIRSSNVLL 169
I +K + + + +T++ +A L H + P ++HRD++ +N+ L
Sbjct: 92 --IQKCKKERKYIEEEFIWRILTQLLLA------LYECHNRSDPGNTVLHRDLKPANIFL 143
Query: 170 FEDFKAKIADFNLS---NQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGV 226
+ K+ DF L+ A T V GT Y +PE +KSD++S G
Sbjct: 144 DANNNVKLGDFGLAKILGHDSSFA----KTYV-GTPYYMSPEQLNHMSYDEKSDIWSLGC 198
Query: 227 VLLELLTGRKP 237
++ EL P
Sbjct: 199 LIYELCALSPP 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 2e-10
Identities = 54/169 (31%), Positives = 84/169 (49%), Gaps = 28/169 (16%)
Query: 75 VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 134
V + +LKH N +E G ++ + L E+ +GS D+L K +P +
Sbjct: 72 VKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYC-LGSASDLLEVHK-----KP------LQ 119
Query: 135 RVRIAV---DAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAA 191
V IA A +GL YLH ++IHRDI++ N+LL E + K+ADF ++++
Sbjct: 120 EVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSP--- 173
Query: 192 RLHSTRVLGTFGYHAPEYAMT---GQLTQKSDVYSFGVVLLELLTGRKP 237
+ +GT + APE + GQ K DV+S G+ +E L RKP
Sbjct: 174 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIE-LAERKP 218
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 60.5 bits (146), Expect = 2e-10
Identities = 53/167 (31%), Positives = 83/167 (49%), Gaps = 21/167 (12%)
Query: 75 VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 134
V + R+KH N +E G + + L E+ +GS D+L K +P L +
Sbjct: 76 VKFLQRIKHPNSIEYKGCYLREHTAWLVMEYC-LGSASDLLEVHK-----KP---LQEVE 126
Query: 135 RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 194
I A +GL YLH ++IHRDI++ N+LL E + K+ADF + +A+ +
Sbjct: 127 IAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFG----SASIASPAN 179
Query: 195 STRVLGTFGYHAPEYAMT---GQLTQKSDVYSFGVVLLELLTGRKPV 238
S +GT + APE + GQ K DV+S G+ +EL + P+
Sbjct: 180 S--FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 224
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 2e-10
Identities = 34/93 (36%), Positives = 51/93 (54%), Gaps = 5/93 (5%)
Query: 145 GLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGY 204
GL++LH K I++RD++ N+LL D KIADF + + +M + GT Y
Sbjct: 108 GLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKE--NMLGDAKTCTFCGTPDY 162
Query: 205 HAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 237
APE + + D +SFGV+L E+L G+ P
Sbjct: 163 IAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 3e-10
Identities = 45/168 (26%), Positives = 78/168 (46%), Gaps = 22/168 (13%)
Query: 76 SVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTR 135
S++ + H N++ L G + ++ E+ GSL L G
Sbjct: 57 SIMGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGK--------FTVGQL 108
Query: 136 VRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHS 195
V + A G++YL E +HRD+ + N+L+ + K++DF LS + D A ++
Sbjct: 109 VGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEAT-YT 164
Query: 196 TR-----VLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKP 237
T+ + T APE + T SDV+SFG+V+ E+++ G +P
Sbjct: 165 TKGGKIPIRWT----APEAIAYRKFTSASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 3e-10
Identities = 35/93 (37%), Positives = 52/93 (55%), Gaps = 5/93 (5%)
Query: 145 GLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGY 204
GL++LH K II+RD++ NV+L D KIADF + + ++ ++ GT Y
Sbjct: 108 GLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKE--NVFGDNRASTFCGTPDY 162
Query: 205 HAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 237
APE + T D +SFGV+L E+L G+ P
Sbjct: 163 IAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 3e-10
Identities = 37/97 (38%), Positives = 55/97 (56%), Gaps = 12/97 (12%)
Query: 144 RGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSN-QAPDMAARLHSTRVLGTF 202
RGL+Y+H ++HRD++ SN+L+ E+ KI DF L+ Q P M + STR
Sbjct: 119 RGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYV-STRY---- 170
Query: 203 GYHAPEYAMTGQ-LTQKSDVYSFGVVLLELLTGRKPV 238
Y APE +T Q + D++S G + E+L G KP+
Sbjct: 171 -YRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEG-KPL 205
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 3e-10
Identities = 49/185 (26%), Positives = 84/185 (45%), Gaps = 18/185 (9%)
Query: 75 VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 134
+ V+ K+ N+V L + G+ + E+ GSL D++ +D
Sbjct: 67 ILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV----------TETCMDEGQ 116
Query: 135 RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQ-APDMAARL 193
+ + + L++LH +IHRDI+S N+LL D K+ DF Q P+ + R
Sbjct: 117 IAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR- 172
Query: 194 HSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMP-RGQQSLVTW 252
+ ++GT + APE K D++S G++ +E++ G P + P R + T
Sbjct: 173 --STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN 230
Query: 253 ATPRL 257
TP L
Sbjct: 231 GTPEL 235
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.6 bits (145), Expect = 3e-10
Identities = 45/162 (27%), Positives = 69/162 (42%), Gaps = 14/162 (8%)
Query: 75 VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 134
V V+ +L+HEN+V L L +E+ +L ++L A PG +
Sbjct: 51 VKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVER-TLLELLE-------ASPGGLPPDAV 102
Query: 135 RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 194
R + + Y H +IIHRDI+ N+L+ E K+ DF + A
Sbjct: 103 R-SYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARPAS-P 157
Query: 195 STRVLGTFGYHAPEYAMTGQLTQKS-DVYSFGVVLLELLTGR 235
T + T Y APE + K DV++ G ++ ELL G
Sbjct: 158 LTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGE 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 4e-10
Identities = 49/182 (26%), Positives = 88/182 (48%), Gaps = 27/182 (14%)
Query: 72 KQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGR------------K 119
K + SRL+H N+V LLG + + + + + LH+ L R K
Sbjct: 56 KHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDK 115
Query: 120 GVQGA-QPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIA 178
V+ +P + +T++ A G+E+L ++H+D+ + NVL+F+ KI+
Sbjct: 116 TVKSTLEPADFVHIVTQI------AAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKIS 166
Query: 179 DFNLSNQ--APDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GR 235
D L + A D + ++ L + +PE M G+ + SD++S+GVVL E+ + G
Sbjct: 167 DLGLFREVYAADYYKLMGNS--LLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGL 224
Query: 236 KP 237
+P
Sbjct: 225 QP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 4e-10
Identities = 53/229 (23%), Positives = 100/229 (43%), Gaps = 23/229 (10%)
Query: 75 VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 134
+ ++ +L H N+++ L +E N + E A G L ++ K + P + W
Sbjct: 53 IDLLKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTV-W-- 109
Query: 135 RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 194
+ V +E++H + ++HRDI+ +NV + K+ D L H
Sbjct: 110 --KYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAH 164
Query: 195 STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWAT 254
S ++GT Y +PE KSD++S G +L E+ + P + +L +
Sbjct: 165 S--LVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP----FYGDKMNLFSLC- 217
Query: 255 PRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIV 303
K++QC P L E+ + KL + ++C+ + + RP++ V
Sbjct: 218 -----QKIEQCDYPPLPTEHYSE---KLRELVSMCIYPDPDQRPDIGYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 4e-10
Identities = 45/148 (30%), Positives = 70/148 (47%), Gaps = 17/148 (11%)
Query: 101 LAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHR 160
L EF GS+ D++ KG + DW+ I + RGL +LH +IHR
Sbjct: 96 LVMEFCGAGSVTDLVKNTKGNALKE-----DWIAY--ICREILRGLAHLHAH---KVIHR 145
Query: 161 DIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQ-----L 215
DI+ NVLL E+ + K+ DF +S Q R ++ +GT + APE +
Sbjct: 146 DIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT--FIGTPYWMAPEVIACDENPDATY 203
Query: 216 TQKSDVYSFGVVLLELLTGRKPVDHTMP 243
+SD++S G+ +E+ G P+ P
Sbjct: 204 DYRSDIWSLGITAIEMAEGAPPLCDMHP 231
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 4e-10
Identities = 66/239 (27%), Positives = 109/239 (45%), Gaps = 37/239 (15%)
Query: 72 KQLVSVVSRLKHENLVELL-GYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVL 130
+Q ++S+LKH N+V + E L + F G L+ L +KG + V+
Sbjct: 47 EQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKG-KLLPENQVV 105
Query: 131 DWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFN----LSNQA 186
+W ++ +A L+YLHEK I+HRD+++ NV L K+ D L NQ
Sbjct: 106 EWFVQIAMA------LQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC 156
Query: 187 PDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQ 246
DMA+ L +GT Y +PE KSDV++ G + E+ T + + +
Sbjct: 157 -DMASTL-----IGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFN---AKDM 207
Query: 247 QSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305
SLV R+ E K+ P + +Y P +L + A + E RP++ +++
Sbjct: 208 NSLVY----RIIEGKL-----PPMPKDYSP----ELGELIATMLSKRPEKRPSVKSILR 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 5e-10
Identities = 43/120 (35%), Positives = 58/120 (48%), Gaps = 9/120 (7%)
Query: 144 RGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSN-QAPDMAARLHSTRVLGTF 202
RGL+YLH I+HRDI+ N+L+ + KI DF L+ + PD H T+ + T
Sbjct: 114 RGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPD--ESKHMTQEVVTQ 168
Query: 203 GYHAPEYAMTGQ-LTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVT--WATPRLSE 259
Y APE M + T D++S G + ELL R P Q L+T TP L
Sbjct: 169 YYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEA 228
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 5e-10
Identities = 56/240 (23%), Positives = 99/240 (41%), Gaps = 31/240 (12%)
Query: 76 SVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTR 135
S++ + H N++ L G + ++ EF G+L L G V+ +
Sbjct: 57 SIMGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDG-----QFTVIQLVGM 111
Query: 136 VRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHS 195
+R A G++YL E + +HRD+ + N+L+ + K++DF LS D +
Sbjct: 112 LR---GIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTY 165
Query: 196 TRVLG---TFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVT 251
T LG + APE + T SDV+S+G+V+ E+++ G +P
Sbjct: 166 TSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPY------------- 212
Query: 252 WATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLL 311
W +S V ++ + P L + C Q + RP +V L ++
Sbjct: 213 W---DMSNQDVINAIEQDYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKMI 269
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 5e-10
Identities = 53/195 (27%), Positives = 86/195 (44%), Gaps = 23/195 (11%)
Query: 53 YPSHENERL----KSPKNYPDDEK-----QLVSVVSRLKHENLVELLGYCVEGNLRVLAY 103
Y S ENE++ K+ KN Q ++ + H ++V+L+G E + ++
Sbjct: 27 YMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITENPVWIV-M 85
Query: 104 EFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIR 163
E A +G L L K LD + + + + L YL K +HRDI
Sbjct: 86 ELAPLGELRSYLQVNKYS--------LDLASLILYSYQLSTALAYLESK---RFVHRDIA 134
Query: 164 SSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYS 223
+ NVL+ K+ DF LS + + + +++ + APE + T SDV+
Sbjct: 135 ARNVLVSSPDCVKLGDFGLS-RYLEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWM 193
Query: 224 FGVVLLELLT-GRKP 237
FGV + E+L G KP
Sbjct: 194 FGVCMWEILMLGVKP 208
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 5e-10
Identities = 52/168 (30%), Positives = 78/168 (46%), Gaps = 15/168 (8%)
Query: 81 LKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAV 140
L+H NL++ LG C E +L EF +G L L + + P P T R+A
Sbjct: 52 LQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDP----TTLQRMAC 107
Query: 141 DAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLG 200
+ A GL +LH+ + IH D+ N LL D KI D+ LS+ + ++
Sbjct: 108 EIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWV 164
Query: 201 TFGYHAPEYA--MTGQL-----TQKSDVYSFGVVLLELLT-GRKPVDH 240
+ APE + G L T++S+V+S GV + EL G +P H
Sbjct: 165 PLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRH 212
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 6e-10
Identities = 36/93 (38%), Positives = 50/93 (53%), Gaps = 9/93 (9%)
Query: 144 RGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFG 203
RGL+Y+H IIHRD++ SN+ + ED + KI DF L+ D T + T
Sbjct: 131 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVATRW 182
Query: 204 YHAPEYAMTG-QLTQKSDVYSFGVVLLELLTGR 235
Y APE + Q D++S G ++ ELLTGR
Sbjct: 183 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 7e-10
Identities = 58/239 (24%), Positives = 103/239 (43%), Gaps = 29/239 (12%)
Query: 77 VVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRV 136
V++ + + ++ LLG C+ ++++ + G L D + K G+Q +L+W
Sbjct: 62 VMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQY--LLNW---- 114
Query: 137 RIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHST 196
V A+G+ YL E+ ++HRD+ + NVL+ KI DF L+ H+
Sbjct: 115 --CVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAE 169
Query: 197 RVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATP 255
+ A E + T +SDV+S+GV + EL+T G KP D +P + S +
Sbjct: 170 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASEISSILEKGE 228
Query: 256 RLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSP 314
RL + PP + + C +A+ RP ++ + + P
Sbjct: 229 RLPQ---------------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 272
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 7e-10
Identities = 50/190 (26%), Positives = 89/190 (46%), Gaps = 24/190 (12%)
Query: 75 VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDIL-HGRKGVQGAQPGPVLDWM 133
V ++ HEN+V++ + G+ + EF G+L DI+ H R M
Sbjct: 70 VVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTHTR--------------M 115
Query: 134 TRVRIA---VDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMA 190
+IA + R L YLH + +IHRDI+S ++LL D + K++DF Q
Sbjct: 116 NEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV 172
Query: 191 ARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMP-RGQQSL 249
+ S ++GT + APE + D++S G++++E++ G P + P + + +
Sbjct: 173 PKRKS--LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRI 230
Query: 250 VTWATPRLSE 259
PR+ +
Sbjct: 231 RDNLPPRVKD 240
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 7e-10
Identities = 39/118 (33%), Positives = 55/118 (46%), Gaps = 9/118 (7%)
Query: 135 RVRIAV-DAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQ-APDMAAR 192
VR+ + + L++LH Q II+RDI+ N+LL + + DF LS + + R
Sbjct: 106 EVRVYIAEIVLALDHLH---QLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEER 162
Query: 193 LHSTRVLGTFGYHAPEYAMTGQLTQKS--DVYSFGVVLLELLTGRKPVDHTMPRGQQS 248
+S GT Y APE G D +S GV+ ELLTG P + QS
Sbjct: 163 AYS--FCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQS 218
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.4 bits (142), Expect = 1e-09
Identities = 42/162 (25%), Positives = 73/162 (45%), Gaps = 18/162 (11%)
Query: 81 LKHENLVELLGYCVEGNLRV--LAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRI 138
LKHEN+V L+ +E + L +++A I R+ + + P ++ +
Sbjct: 59 LKHENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVK-----SL 113
Query: 139 AVDAARGLEYLHEKVQPSIIHRDIRSSNVLL----FEDFKAKIADFNLSN--QAPDMAAR 192
G+ YLH ++HRD++ +N+L+ E KI D L+ AP +
Sbjct: 114 LWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAP-LKPL 169
Query: 193 LHSTRVLGTFGYHAPEYAMTGQ-LTQKSDVYSFGVVLLELLT 233
V+ T Y APE + + T+ D+++ G + ELLT
Sbjct: 170 ADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 1e-09
Identities = 49/168 (29%), Positives = 80/168 (47%), Gaps = 23/168 (13%)
Query: 75 VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 134
V + +L+H N ++ G + + L E+ +GS D+L K +P L +
Sbjct: 66 VRFLQKLRHPNTIQYRGCYLREHTAWLVMEYC-LGSASDLLEVHK-----KP---LQEVE 116
Query: 135 RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADF-NLSNQAPDMAARL 193
+ A +GL YLH ++IHRD+++ N+LL E K+ DF + S AP
Sbjct: 117 IAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------ 167
Query: 194 HSTRVLGTFGYHAPEYAMT---GQLTQKSDVYSFGVVLLELLTGRKPV 238
+ +GT + APE + GQ K DV+S G+ +EL + P+
Sbjct: 168 -ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 214
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 1e-09
Identities = 33/92 (35%), Positives = 52/92 (56%), Gaps = 5/92 (5%)
Query: 146 LEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYH 205
L YLH++ + I+HRD+ +N++L ED K I DF L+ Q + T V+GT Y
Sbjct: 126 LRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPES---KLTSVVGTILYS 180
Query: 206 APEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 237
PE +K+DV++FG +L ++ T + P
Sbjct: 181 CPEIVKNEPYGEKADVWAFGCILYQMCTLQPP 212
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 58.1 bits (141), Expect = 1e-09
Identities = 32/99 (32%), Positives = 55/99 (55%), Gaps = 9/99 (9%)
Query: 144 RGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSN---QAPDMAARLHSTRVLG 200
RGL+Y+H ++IHRD++ SN+L+ ED + +I DF ++ +P T +
Sbjct: 118 RGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKY-FMTEYVA 173
Query: 201 TFGYHAPEYAMT-GQLTQKSDVYSFGVVLLELLTGRKPV 238
T Y APE ++ + T D++S G + E+L GR+ +
Sbjct: 174 TRWYRAPELLLSLPEYTTAIDMWSVGCIFAEML-GRRQL 211
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 1e-09
Identities = 36/93 (38%), Positives = 51/93 (54%), Gaps = 9/93 (9%)
Query: 144 RGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFG 203
RGL+Y+H IIHRD++ SNV + ED + +I DF L+ QA D T + T
Sbjct: 129 RGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFGLARQADD-----EMTGYVATRW 180
Query: 204 YHAPEYAMTG-QLTQKSDVYSFGVVLLELLTGR 235
Y APE + Q D++S G ++ ELL G+
Sbjct: 181 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 2e-09
Identities = 37/98 (37%), Positives = 54/98 (55%), Gaps = 11/98 (11%)
Query: 146 LEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFG-- 203
+ ++H K +IHRDI+S+N+LL + K+ DF S M A S V TF
Sbjct: 156 VHHVHSK---HMIHRDIKSANILLCSNGLVKLGDFGFSK----MYAATVSDDVGRTFCGT 208
Query: 204 --YHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVD 239
Y APE ++K+D++S GV+L ELLT ++P D
Sbjct: 209 PYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFD 246
|
Length = 496 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.3 bits (139), Expect = 2e-09
Identities = 33/102 (32%), Positives = 52/102 (50%), Gaps = 21/102 (20%)
Query: 144 RGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHS-------- 195
RGL+Y+H +++HRD++ SN+LL + KI DF L AR+
Sbjct: 117 RGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGL--------ARIADPEHDHTGF 165
Query: 196 -TRVLGTFGYHAPEYAMTGQLTQKS-DVYSFGVVLLELLTGR 235
T + T Y APE + + K+ D++S G +L E+L+ R
Sbjct: 166 LTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 2e-09
Identities = 37/103 (35%), Positives = 51/103 (49%), Gaps = 9/103 (8%)
Query: 139 AVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNL--SNQAPDMAARLHST 196
A + A GL +LH K II+RD++ NV+L + KIADF + N R
Sbjct: 107 AAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTR---- 159
Query: 197 RVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVD 239
GT Y APE + D ++FGV+L E+L G+ P D
Sbjct: 160 TFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 3e-09
Identities = 52/172 (30%), Positives = 74/172 (43%), Gaps = 22/172 (12%)
Query: 83 HENLVELLG------YCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRV 136
H N+V+ G V G L L E GS+ +++ G G LD
Sbjct: 78 HPNVVKFYGMFYKADKLVGGQLW-LVLELCNGGSVTELVKGL-----LICGQRLDEAMIS 131
Query: 137 RIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHST 196
I A GL++LH IIHRD++ +N+LL + K+ DF +S Q + RL
Sbjct: 132 YILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQL--TSTRLRRN 186
Query: 197 RVLGTFGYHAPEYAMTGQLTQKS-----DVYSFGVVLLELLTGRKPVDHTMP 243
+GT + APE Q S DV+S G+ +EL G P+ P
Sbjct: 187 TSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHP 238
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 3e-09
Identities = 38/99 (38%), Positives = 57/99 (57%), Gaps = 9/99 (9%)
Query: 144 RGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLS---NQAPDMAARLHSTRVLG 200
GL+Y+H +++HRD++ N+L+ D + KI DF L+ ++ P A T +
Sbjct: 116 CGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAG-FMTEYVA 171
Query: 201 TFGYHAPEYAMTGQLTQKS-DVYSFGVVLLELLTGRKPV 238
T Y APE ++ Q K+ DV+S G +L ELL GRKPV
Sbjct: 172 TRWYRAPEIMLSFQSYTKAIDVWSVGCILAELL-GRKPV 209
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 56.8 bits (138), Expect = 4e-09
Identities = 34/94 (36%), Positives = 52/94 (55%), Gaps = 5/94 (5%)
Query: 144 RGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQA-PDMAARLHSTRVLGTF 202
RGL+YLH ++IHRD++ SN+L+ + KI DF L+ PD + T + T
Sbjct: 114 RGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTR 170
Query: 203 GYHAPEYAMTGQ-LTQKSDVYSFGVVLLELLTGR 235
Y APE ++ T+ D++S G + ELLT +
Sbjct: 171 WYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 5e-09
Identities = 67/251 (26%), Positives = 112/251 (44%), Gaps = 35/251 (13%)
Query: 62 KSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGV 121
KS +NY + + S++S+L H++LV G CV G+ ++ E+ GSL L K
Sbjct: 37 KSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKN- 95
Query: 122 QGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLF--EDFKAKIAD 179
+++ ++ +A A L +L +K + H ++ + NVLL ED K
Sbjct: 96 -------LINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPP 145
Query: 180 F-NLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQ-LTQKSDVYSFGVVLLELLTG-RK 236
F LS+ + L +L + PE Q L+ +D +SFG L E+ +G K
Sbjct: 146 FIKLSDPGISITV-LPKEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDK 204
Query: 237 PVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEF 296
P+ Q+ L + ED+ Q PK +LA + C+ YE +F
Sbjct: 205 PLSALDS--QKKL------QFYEDR-HQLPAPKW---------TELANLINQCMDYEPDF 246
Query: 297 RPNMSIVVKAL 307
RP+ +++ L
Sbjct: 247 RPSFRAIIRDL 257
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 5e-09
Identities = 48/164 (29%), Positives = 79/164 (48%), Gaps = 22/164 (13%)
Query: 75 VSVVSRLKHENLVELLG-YCVEGNLRVLAYEFATMGSLHDI-LHGRKGVQGAQPGPVLDW 132
+ +++ H +V+LLG + +G L ++ EF G++ I L +G+ Q +
Sbjct: 60 IEILATCNHPYIVKLLGAFYWDGKLWIMI-EFCPGGAVDAIMLELDRGLTEPQIQVICRQ 118
Query: 133 MTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAAR 192
M L+YLH IIHRD+++ NVLL D K+ADF +S + R
Sbjct: 119 MLE---------ALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQR 166
Query: 193 LHSTRVLGTFGYHAPEYAMTGQLTQ-----KSDVYSFGVVLLEL 231
S +GT + APE M + K+D++S G+ L+E+
Sbjct: 167 RDS--FIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 8e-09
Identities = 35/136 (25%), Positives = 63/136 (46%), Gaps = 8/136 (5%)
Query: 144 RGLEYLHEKVQPSIIHRDIRSSNVLL-FEDFKAKIADFNLSN-QAPDMAARLHSTRVLGT 201
RGL+Y+H +++HRD++ +NV + ED KI DF L+ P + + + + L T
Sbjct: 125 RGLKYIHSA---NVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVT 181
Query: 202 FGYHAPEYAMT-GQLTQKSDVYSFGVVLLELLTGRK--PVDHTMPRGQQSLVTWATPRLS 258
Y +P ++ T+ D+++ G + E+LTG+ H + + Q L + R
Sbjct: 182 KWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREE 241
Query: 259 EDKVKQCVDPKLKGEY 274
+ V P
Sbjct: 242 DRNELLNVIPSFVRND 257
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 8e-09
Identities = 36/101 (35%), Positives = 52/101 (51%), Gaps = 12/101 (11%)
Query: 144 RGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFG 203
+GL+Y+H IIHRD++ N+ + ED + KI DF L+ Q TR
Sbjct: 129 KGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVVTR-----W 180
Query: 204 YHAPEYAMTG-QLTQKSDVYSFGVVLLELLTGR---KPVDH 240
Y APE + TQ D++S G ++ E+LTG+ K DH
Sbjct: 181 YRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDH 221
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 9e-09
Identities = 50/164 (30%), Positives = 82/164 (50%), Gaps = 17/164 (10%)
Query: 83 HENLVELLGYCV----EGNLRV--LAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRV 136
H N+++L+G + +G L + + F G LH L + G +P L T V
Sbjct: 60 HPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSR--IGEEPF-TLPLQTLV 116
Query: 137 RIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQ--APDMAARLH 194
R +D A G+EYL K + IHRD+ + N +L E+ +ADF LS + + D +
Sbjct: 117 RFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGC 173
Query: 195 STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKP 237
++++ + A E T SDV++FGV + E++T G+ P
Sbjct: 174 ASKL--PVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTP 215
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 1e-08
Identities = 36/99 (36%), Positives = 53/99 (53%), Gaps = 13/99 (13%)
Query: 144 RGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNL---SNQAPDMAARLHSTRVLG 200
RGL+Y+H +++HRD++ SN+LL + KI DF L +++ D TR
Sbjct: 119 RGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTR--- 172
Query: 201 TFGYHAPEYAMT-GQLTQKSDVYSFGVVLLELLTGRKPV 238
Y APE + + T DV+S G + ELL GRKP+
Sbjct: 173 --WYRAPELLLNCSEYTTAIDVWSVGCIFAELL-GRKPL 208
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 1e-08
Identities = 50/166 (30%), Positives = 82/166 (49%), Gaps = 26/166 (15%)
Query: 75 VSVVSRLKHENLVELL-GYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWM 133
+ +++ H N+V+LL + E NL +L EF G++ ++ ++ +P +
Sbjct: 53 IDILASCDHPNIVKLLDAFYYENNLWILI-EFCAGGAVDAVM-----LELERP------L 100
Query: 134 TRVRIAVDAARGLE---YLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMA 190
T +I V + LE YLHE IIHRD+++ N+L D K+ADF +S +
Sbjct: 101 TEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI 157
Query: 191 ARLHSTRVLGTFGYHAPEYAMTGQLTQ-----KSDVYSFGVVLLEL 231
R S +GT + APE M K+DV+S G+ L+E+
Sbjct: 158 QRRDS--FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 1e-08
Identities = 48/168 (28%), Positives = 82/168 (48%), Gaps = 25/168 (14%)
Query: 75 VSVVSRLKHENLVELL-GYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWM 133
V ++ +H+N+VE+ Y V L VL EF G+L DI+ + +
Sbjct: 69 VVIMRDYQHQNVVEMYKSYLVGEELWVLM-EFLQGGALTDIVSQTR-------------L 114
Query: 134 TRVRIAV---DAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQ-APDM 189
+IA + L YLH + +IHRDI+S ++LL D + K++DF Q + D+
Sbjct: 115 NEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV 171
Query: 190 AARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 237
R ++GT + APE + D++S G++++E++ G P
Sbjct: 172 PKR---KSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPP 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 1e-08
Identities = 36/98 (36%), Positives = 51/98 (52%), Gaps = 17/98 (17%)
Query: 143 ARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSN---QAPDMA----ARLHS 195
ARG+E+L + IHRD+ + N+LL E+ KI DF L+ + PD ARL
Sbjct: 183 ARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL-- 237
Query: 196 TRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT 233
+ APE T +SDV+SFGV+L E+ +
Sbjct: 238 -----PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 1e-08
Identities = 53/203 (26%), Positives = 89/203 (43%), Gaps = 33/203 (16%)
Query: 122 QGAQPGPVLD--WMTRVRI------AVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDF 173
P D W + + + + ARG+E+L + IHRD+ + N+LL E+
Sbjct: 155 GSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENN 211
Query: 174 KAKIADFNLSN---QAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLE 230
KI DF L+ + PD R S R+ + APE T +SDV+SFGV+L E
Sbjct: 212 VVKICDFGLARDIYKDPDY-VRKGSARL--PLKWMAPESIFDKVYTTQSDVWSFGVLLWE 268
Query: 231 LLT-GRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALC 289
+ + G P + +++E+ ++ D + P ++ + C
Sbjct: 269 IFSLGASP--------------YPGVQINEEFCQRLKD-GTRMRAPENATPEIYRIMLAC 313
Query: 290 VQYEAEFRPNMSIVVKALQPLLK 312
Q + + RP S +V+ L LL+
Sbjct: 314 WQGDPKERPTFSALVEILGDLLQ 336
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 1e-08
Identities = 34/106 (32%), Positives = 51/106 (48%), Gaps = 3/106 (2%)
Query: 128 PVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAP 187
P L +M V + A G+E+L K + +HRD+ + NVL+ E KI DF L+
Sbjct: 234 PALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAARNVLICEGKLVKICDFGLARDIM 290
Query: 188 DMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT 233
+ + + APE T SDV+SFG++L E+ T
Sbjct: 291 RDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 2e-08
Identities = 53/210 (25%), Positives = 91/210 (43%), Gaps = 33/210 (15%)
Query: 60 RLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK 119
L + + P + +S++ LKHEN+V L N +L +E+ L +
Sbjct: 34 HLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMD-KDLKKYMDTH- 91
Query: 120 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIAD 179
GV+GA LD T +G+ + HE ++HRD++ N+L+ + + K+AD
Sbjct: 92 GVRGA-----LDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLAD 143
Query: 180 FNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKS-DVYSFGVVLLELLTGR--- 235
F L+ +A + S V+ T Y AP+ + + S D++S G ++ E++TGR
Sbjct: 144 FGLA-RAFGIPVNTFSNEVV-TLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLF 201
Query: 236 -----------------KPVDHTMPRGQQS 248
P + T P Q
Sbjct: 202 PGTNNEDQLLKIFRIMGTPTESTWPGISQL 231
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 2e-08
Identities = 29/81 (35%), Positives = 47/81 (58%)
Query: 157 IIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLT 216
++HRD++S+N+ L K+ DF S Q D + ++ GT Y APE + +
Sbjct: 190 MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYS 249
Query: 217 QKSDVYSFGVVLLELLTGRKP 237
+K+D++S GV+L ELLT +P
Sbjct: 250 KKADMWSLGVILYELLTLHRP 270
|
Length = 478 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 2e-08
Identities = 53/229 (23%), Positives = 98/229 (42%), Gaps = 23/229 (10%)
Query: 75 VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 134
+ ++ +L H N+++ +E N + E A G L ++ K + P + W
Sbjct: 53 IDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTV-W-- 109
Query: 135 RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 194
+ V LE++H + ++HRDI+ +NV + K+ D L H
Sbjct: 110 --KYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAH 164
Query: 195 STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWAT 254
S ++GT Y +PE KSD++S G +L E+ + P + SL
Sbjct: 165 S--LVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPF-YGDKMNLYSLCK--- 218
Query: 255 PRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIV 303
K++QC P L ++ + + +L +C+ + E RP+++ V
Sbjct: 219 ------KIEQCDYPPLPSDHYSEELRQL---VNMCINPDPEKRPDITYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 2e-08
Identities = 33/101 (32%), Positives = 53/101 (52%), Gaps = 5/101 (4%)
Query: 139 AVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRV 198
A + + GL +LH + II+RD++ NV+L + KIADF + + M + +
Sbjct: 107 AAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKE--HMVDGVTTRTF 161
Query: 199 LGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVD 239
GT Y APE + D +++GV+L E+L G+ P D
Sbjct: 162 CGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 2e-08
Identities = 62/241 (25%), Positives = 102/241 (42%), Gaps = 38/241 (15%)
Query: 73 QLVSVVSRLKHENLVELLGYCV-EGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLD 131
+ S++S+L H++LV+L G CV + N+ V E+ G L LH K L
Sbjct: 50 ETASLMSQLSHKHLVKLYGVCVRDENIMVE--EYVKFGPLDVFLHREKN------NVSLH 101
Query: 132 WMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLL--FEDFKAKIADFNLSNQAPDM 189
W V A A L YL +K ++H ++ N+L+ + + + LS+ +
Sbjct: 102 WKLDV--AKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI 156
Query: 190 AARLHSTRVLGTFGYHAPEYAMTGQ--LTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQ 246
RV + APE GQ LT +D +SFG LLE+ + G +P+
Sbjct: 157 TVLSREERVERI-PWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPL-------- 207
Query: 247 QSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKA 306
+T SE + + + P A+LA + C Y+ RP+ +++
Sbjct: 208 ------STLSSSEKERFY----QDQHRLPMPDCAELANLINQCWTYDPTKRPSFRAILRD 257
Query: 307 L 307
L
Sbjct: 258 L 258
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 2e-08
Identities = 34/95 (35%), Positives = 54/95 (56%), Gaps = 6/95 (6%)
Query: 145 GLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGY 204
GL Y H+K + +HRDI+ SN+LL + K+ADF L+ +R ++ +V+ T Y
Sbjct: 128 GLNYCHKK---NFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVI-TLWY 183
Query: 205 HAPEYAMTGQLTQKS-DVYSFGVVLLELLTGRKPV 238
PE + + + DV+S G +L EL T +KP+
Sbjct: 184 RPPELLLGEERYGPAIDVWSCGCILGELFT-KKPI 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 2e-08
Identities = 50/173 (28%), Positives = 78/173 (45%), Gaps = 24/173 (13%)
Query: 83 HENLVELLGY-----CVEGNLRVLAYEFATMGSLHDILHG--RKGVQGAQPGPVLDWMTR 135
H N+V+ G G+ L E GS+ D++ G ++G + +P
Sbjct: 74 HPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEP-------II 126
Query: 136 VRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHS 195
I +A GL++LH IHRD++ +N+LL + K+ DF +S Q + RL
Sbjct: 127 AYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQL--TSTRLRR 181
Query: 196 TRVLGTFGYHAPEY-AMTGQL----TQKSDVYSFGVVLLELLTGRKPVDHTMP 243
+GT + APE A QL + DV+S G+ +EL G P+ P
Sbjct: 182 NTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHP 234
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 2e-08
Identities = 42/167 (25%), Positives = 82/167 (49%), Gaps = 14/167 (8%)
Query: 75 VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 134
+S++ L+H N+V L ++ + L +EF +M D+ +K + G +D
Sbjct: 50 ISLLKELQHPNIVCLQDVLMQESRLYLIFEFLSM----DL---KKYLDSLPKGQYMDAEL 102
Query: 135 RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 194
+G+ + H + ++HRD++ N+L+ K+ADF L+ +A + R++
Sbjct: 103 VKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLA-RAFGIPVRVY 158
Query: 195 STRVLGTFGYHAPEYAMTGQL-TQKSDVYSFGVVLLELLTGRKPVDH 240
+ V+ T Y APE + + D++S G + E+ T +KP+ H
Sbjct: 159 THEVV-TLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMAT-KKPLFH 203
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 3e-08
Identities = 43/166 (25%), Positives = 77/166 (46%), Gaps = 17/166 (10%)
Query: 76 SVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTR 135
S++ + H N++ L G + ++ E+ GSL L G +
Sbjct: 57 SIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQ--------FTVIQL 108
Query: 136 VRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHS 195
V + A G++YL + +HRD+ + N+L+ + K++DF LS D ++
Sbjct: 109 VGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYT 165
Query: 196 TRVLG---TFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKP 237
TR G + APE + T SDV+S+G+V+ E+++ G +P
Sbjct: 166 TR--GGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERP 209
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 4e-08
Identities = 45/162 (27%), Positives = 73/162 (45%), Gaps = 17/162 (10%)
Query: 75 VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 134
+ ++ +L+HENLV L+ L +EF L D+ G LD
Sbjct: 51 IRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNG---------LDESR 101
Query: 135 RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 194
+ RG+E+ H +IIHRDI+ N+L+ + K+ DF A +AA
Sbjct: 102 VRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGF---ARTLAAPGE 155
Query: 195 S-TRVLGTFGYHAPEYAMTGQLTQKS-DVYSFGVVLLELLTG 234
T + T Y APE + ++ D+++ G ++ E+LTG
Sbjct: 156 VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 53.0 bits (128), Expect = 4e-08
Identities = 31/92 (33%), Positives = 46/92 (50%), Gaps = 6/92 (6%)
Query: 146 LEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYH 205
EYLH + II+RD++ N+LL + K+ DF + + + + GT Y
Sbjct: 106 FEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKS-GQKTWT--FCGTPEYV 159
Query: 206 APEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 237
APE + D +S G++L ELLTGR P
Sbjct: 160 APEIILNKGYDFSVDYWSLGILLYELLTGRPP 191
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 5e-08
Identities = 48/167 (28%), Positives = 75/167 (44%), Gaps = 31/167 (18%)
Query: 81 LKHENLVELLGYCVE-GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIA 139
L H+N++ +L C+E G + Y + G+L L + A L V +A
Sbjct: 65 LSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLG-EANNPQALSTQQLVHMA 123
Query: 140 VDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVL 199
+ A G+ YLH++ +IH+DI + N ++ E+ + KI D LS R L
Sbjct: 124 IQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDNALS-------------RDL 167
Query: 200 GTFGYH-------------APEYAMTGQLTQKSDVYSFGVVLLELLT 233
YH A E + + + SDV+SFGV+L EL+T
Sbjct: 168 FPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 6e-08
Identities = 39/110 (35%), Positives = 51/110 (46%), Gaps = 22/110 (20%)
Query: 141 DAAR----GLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLS---NQAPDMAARL 193
D AR G+ YLH + I+HRDI+ SN+L+ KIADF +S Q D
Sbjct: 172 DVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPC--- 225
Query: 194 HSTRVLGTFGYHAPEYAMTGQLTQ------KSDVYSFGVVLLELLTGRKP 237
+GT Y +PE T L D++S GV +LE GR P
Sbjct: 226 --NSSVGTIAYMSPERINT-DLNHGAYDGYAGDIWSLGVSILEFYLGRFP 272
|
Length = 353 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 6e-08
Identities = 54/242 (22%), Positives = 101/242 (41%), Gaps = 37/242 (15%)
Query: 76 SVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTR 135
S++ + H N++ L G + ++ E+ G+L L G
Sbjct: 58 SIMGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGE--------FSSYQL 109
Query: 136 VRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHS 195
V + A G++YL + + +HRD+ + N+L+ + + K++DF LS D ++
Sbjct: 110 VGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYT 166
Query: 196 TRVLGTFG-----YHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSL 249
T + G + APE + T SDV+SFG+V+ E+++ G +P
Sbjct: 167 T----SGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPY----------- 211
Query: 250 VTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQP 309
W +S +V + ++ + P + + + C Q + RP +V L
Sbjct: 212 --W---DMSNHEVMKAINDGFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDK 266
Query: 310 LL 311
LL
Sbjct: 267 LL 268
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 6e-08
Identities = 35/101 (34%), Positives = 54/101 (53%), Gaps = 5/101 (4%)
Query: 139 AVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRV 198
A + A GL +LH K II+RD++ NV+L + KIADF + + +M + +
Sbjct: 107 AAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKE--NMWDGVTTKTF 161
Query: 199 LGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVD 239
GT Y APE + D ++FGV+L E+L G+ P +
Sbjct: 162 CGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 52.6 bits (127), Expect = 6e-08
Identities = 31/96 (32%), Positives = 52/96 (54%), Gaps = 7/96 (7%)
Query: 144 RGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFG 203
G+ +LH+ I+HRD+++SN+LL KI DF L+ + T+++ T
Sbjct: 117 SGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPY--TQLVVTLW 171
Query: 204 YHAPEYAM-TGQLTQKSDVYSFGVVLLELLTGRKPV 238
Y APE + + + D++S G + ELLT +KP+
Sbjct: 172 YRAPELLLGAKEYSTAIDMWSVGCIFAELLT-KKPL 206
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 7e-08
Identities = 33/94 (35%), Positives = 48/94 (51%), Gaps = 7/94 (7%)
Query: 145 GLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTR-VLGTFG 203
GLE+LH Q II+RD++ NVLL D +I+D L A ++ T+ GT G
Sbjct: 109 GLEHLH---QRRIIYRDLKPENVLLDNDGNVRISDLGL---AVELKDGQSKTKGYAGTPG 162
Query: 204 YHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 237
+ APE + D ++ GV L E++ R P
Sbjct: 163 FMAPELLQGEEYDFSVDYFALGVTLYEMIAARGP 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 7e-08
Identities = 44/166 (26%), Positives = 76/166 (45%), Gaps = 15/166 (9%)
Query: 75 VSVVSRLKHENLVELLGYCVEGNLRVLA--YEFATMGSLHDILHGRKGVQGAQPGPVLDW 132
+ ++ L+HE +V+ G + + L E+ GS+ D L G + +
Sbjct: 55 IQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAY--------GALTES 106
Query: 133 MTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAAR 192
+TR + G+ YLH + I+HRDI+ +N+L K+ DF S + +
Sbjct: 107 VTR-KYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMS 162
Query: 193 LHSTR-VLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 237
R V GT + +PE +K+DV+S G ++E+LT + P
Sbjct: 163 GTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 8e-08
Identities = 32/93 (34%), Positives = 50/93 (53%), Gaps = 6/93 (6%)
Query: 145 GLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGY 204
GLE LH Q I++RD++ N+LL + +I+D L+ P+ + RV GT GY
Sbjct: 114 GLEDLH---QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE--GQTIKGRV-GTVGY 167
Query: 205 HAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 237
APE + T D ++ G +L E++ G+ P
Sbjct: 168 MAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 9e-08
Identities = 32/95 (33%), Positives = 49/95 (51%), Gaps = 6/95 (6%)
Query: 144 RGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQA-PDMAARLHSTRVLGTF 202
R L+Y+H ++ HRD++ N+L D K KI DF L+ A D + T + T
Sbjct: 114 RALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 170
Query: 203 GYHAPEY--AMTGQLTQKSDVYSFGVVLLELLTGR 235
Y APE + + T D++S G + E+LTG+
Sbjct: 171 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 9e-08
Identities = 29/93 (31%), Positives = 49/93 (52%), Gaps = 6/93 (6%)
Query: 145 GLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGY 204
GLE LH + + ++RD++ N+LL + +I+D L+ + P+ RV GT GY
Sbjct: 114 GLEDLH---RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPE--GESIRGRV-GTVGY 167
Query: 205 HAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 237
APE + T D + G ++ E++ G+ P
Sbjct: 168 MAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 1e-07
Identities = 34/100 (34%), Positives = 52/100 (52%), Gaps = 8/100 (8%)
Query: 139 AVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRV 198
A + GLE++H + +++RD++ +N+LL E +I+D L A D + + V
Sbjct: 103 ATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGL---ACDFSKKKPHASV 156
Query: 199 LGTFGYHAPEYAMTGQLTQKS-DVYSFGVVLLELLTGRKP 237
GT GY APE G S D +S G +L +LL G P
Sbjct: 157 -GTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 2e-07
Identities = 47/185 (25%), Positives = 77/185 (41%), Gaps = 22/185 (11%)
Query: 57 ENERLKSPKNYPDDE---------KQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFAT 107
ERLK K P E Q ++S+L H +V+ +E + + E+
Sbjct: 26 AEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIITEYCE 85
Query: 108 MGSLHDILHGRKGVQGAQPGP-VLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSN 166
L L K V +W ++ + V Y+H++ I+HRD+++ N
Sbjct: 86 GRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVH------YMHQR---RILHRDLKAKN 136
Query: 167 VLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGV 226
+ L + KI DF +S M + +T GT Y +PE KSD++S G
Sbjct: 137 IFLKNNL-LKIGDFGVSRLL--MGSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGC 193
Query: 227 VLLEL 231
+L E+
Sbjct: 194 ILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 2e-07
Identities = 47/186 (25%), Positives = 78/186 (41%), Gaps = 28/186 (15%)
Query: 145 GLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGY 204
GLE++H + +++RD++ +N+LL E +I+D L A D + + V GT GY
Sbjct: 109 GLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGL---ACDFSKKKPHASV-GTHGY 161
Query: 205 HAPEYAMTGQLTQKS-DVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVK 263
APE G S D +S G +L +LL G P R ++ + D++
Sbjct: 162 MAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPF-----RQHKT-----KDKHEIDRMT 211
Query: 264 QCVDPKLKGEYPPKGVAKLAAVAALCVQ----------YEAEFRPNMSIVVKALQPLLKS 313
+ +L + P+ + L + V E + P + + L K
Sbjct: 212 LTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLDWQMVFLQKY 271
Query: 314 PPPAAP 319
PPP P
Sbjct: 272 PPPLIP 277
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 2e-07
Identities = 41/164 (25%), Positives = 72/164 (43%), Gaps = 13/164 (7%)
Query: 75 VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 134
+ + H N+V L G GN ++ E+ + G+L L +G A G ++ +
Sbjct: 57 ALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVA--GQLMGMLP 114
Query: 135 RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 194
+ A G++YL E +H+ + + VL+ D KI+ F Q A
Sbjct: 115 GL------ASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFR-RLQEDKSEAIYT 164
Query: 195 STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKP 237
+ + APE + SDV+SFG+V+ E+++ G +P
Sbjct: 165 TMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 2e-07
Identities = 50/190 (26%), Positives = 86/190 (45%), Gaps = 41/190 (21%)
Query: 60 RLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK 119
RL+ + P + VS++ LKH N+V +LHDI+H +
Sbjct: 39 RLEHEEGAPCTAIREVSLLKNLKHANIV----------------------TLHDIIHTER 76
Query: 120 GV------------QGAQPGPVLDWMTRVRIAV-DAARGLEYLHEKVQPSIIHRDIRSSN 166
+ Q L M V+I + RGL Y H++ I+HRD++ N
Sbjct: 77 CLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQN 133
Query: 167 VLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAM-TGQLTQKSDVYSFG 225
+L+ E + K+ADF L+ +A + + +S V+ T Y P+ + + + + D++ G
Sbjct: 134 LLINEKGELKLADFGLA-RAKSVPTKTYSNEVV-TLWYRPPDVLLGSTEYSTPIDMWGVG 191
Query: 226 VVLLELLTGR 235
+L E+ TGR
Sbjct: 192 CILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 2e-07
Identities = 29/109 (26%), Positives = 51/109 (46%), Gaps = 19/109 (17%)
Query: 145 GLEYLHEKVQPSIIHRDIRSSNVLL-------FEDFKAKIA-----DFNLSNQAPDMAAR 192
+EY+H K ++HRD++ N+LL D+ A I + L +
Sbjct: 125 TIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNIC 181
Query: 193 LHST----RVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 237
S +++GT Y APE + ++ +D+Y+ GV+L ++LT P
Sbjct: 182 YSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP 230
|
Length = 932 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 2e-07
Identities = 31/98 (31%), Positives = 47/98 (47%), Gaps = 8/98 (8%)
Query: 146 LEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYH 205
L YLH +++RD++ N++L +D KI DF L + A + + GT Y
Sbjct: 108 LGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGTPEYL 162
Query: 206 APEYAMTGQLTQKSDVYSFGVVLLELLTGRKPV---DH 240
APE + D + GVV+ E++ GR P DH
Sbjct: 163 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH 200
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 3e-07
Identities = 47/180 (26%), Positives = 76/180 (42%), Gaps = 42/180 (23%)
Query: 77 VVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHG--RKGVQGAQPGPVLDWMT 134
+++ +KHEN++ L+ VEG+ L + DI+ +K V+D
Sbjct: 73 IMNEIKHENIMGLVDVYVEGDFINL---------VMDIMASDLKK---------VVDRKI 114
Query: 135 RVR------IAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLS----- 183
R+ I + GL LH+ +HRD+ +N+ + KIADF L+
Sbjct: 115 RLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICKIADFGLARRYGY 171
Query: 184 -------NQAPDMAARLHSTRVLGTFGYHAPEYAM-TGQLTQKSDVYSFGVVLLELLTGR 235
++ M R T + T Y APE M + D++S G + ELLTG+
Sbjct: 172 PPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 3e-07
Identities = 39/116 (33%), Positives = 58/116 (50%), Gaps = 18/116 (15%)
Query: 130 LDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNL------- 182
LD +R + A+G+++L K + IHRD+ + NVLL + AKI DF L
Sbjct: 209 LDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMND 265
Query: 183 SNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKP 237
SN ARL + APE T +SDV+S+G++L E+ + G+ P
Sbjct: 266 SNYVVKGNARL-------PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSP 314
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 4e-07
Identities = 46/146 (31%), Positives = 71/146 (48%), Gaps = 28/146 (19%)
Query: 144 RGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQA-PDMAARLHSTRVLGTF 202
GL+Y+H IIHRD++ N+ + ED + KI DF L+ A +M T + T
Sbjct: 128 CGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGLARHADAEM------TGYVVTR 178
Query: 203 GYHAPEYAMTG-QLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDK 261
Y APE + Q D++S G ++ E+LTG+ T+ +G+ L D+
Sbjct: 179 WYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK-----TLFKGKDYL----------DQ 223
Query: 262 VKQCVDPKLKGEYPPKGVAKLAAVAA 287
+ Q + K+ G P+ V KL AA
Sbjct: 224 LTQIL--KVTGVPGPEFVQKLEDKAA 247
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 4e-07
Identities = 37/103 (35%), Positives = 53/103 (51%), Gaps = 18/103 (17%)
Query: 143 ARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSN---QAPDMA----ARLHS 195
A+G+E+L + IHRD+ + N+LL E+ KI DF L+ + PD ARL
Sbjct: 189 AKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL-- 243
Query: 196 TRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKP 237
+ APE T +SDV+SFGV+L E+ + G P
Sbjct: 244 -----PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 281
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 4e-07
Identities = 31/92 (33%), Positives = 47/92 (51%), Gaps = 5/92 (5%)
Query: 146 LEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYH 205
LEYLH + +++RDI+ N++L +D KI DF L + A + + GT Y
Sbjct: 108 LEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGTPEYL 162
Query: 206 APEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 237
APE + D + GVV+ E++ GR P
Sbjct: 163 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 4e-07
Identities = 45/168 (26%), Positives = 76/168 (45%), Gaps = 19/168 (11%)
Query: 75 VSVVSRLKHENLVELLGYCVEGNLRVLA--YEFATMGSLHDILHGRKGVQGAQPGPVLDW 132
+ ++ L HE +V+ G + R L+ E GS+ D L G + +
Sbjct: 55 IQLLKNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSY--------GALTEN 106
Query: 133 MTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAAR 192
+TR + G+ YLH + I+HRDI+ +N+L K+ DF S + +
Sbjct: 107 VTR-KYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTIC-- 160
Query: 193 LHST---RVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 237
L T V GT + +PE +K+D++S G ++E+LT + P
Sbjct: 161 LSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 6e-07
Identities = 31/91 (34%), Positives = 44/91 (48%), Gaps = 8/91 (8%)
Query: 147 EYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHA 206
EYLH K II+RD++ N+LL K+ DF + + PD L GT Y A
Sbjct: 132 EYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFTL-----CGTPEYLA 183
Query: 207 PEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 237
PE + + D ++ GV+L E + G P
Sbjct: 184 PEVIQSKGHGKAVDWWTMGVLLYEFIAGYPP 214
|
Length = 329 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 7e-07
Identities = 30/101 (29%), Positives = 50/101 (49%), Gaps = 5/101 (4%)
Query: 139 AVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRV 198
A + L +LHE+ II+RD++ NVLL D K+ D+ + + + ++
Sbjct: 102 AAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEG--LGPGDTTSTF 156
Query: 199 LGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVD 239
GT Y APE + D ++ GV++ E++ GR P D
Sbjct: 157 CGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 49.9 bits (120), Expect = 7e-07
Identities = 32/102 (31%), Positives = 52/102 (50%), Gaps = 19/102 (18%)
Query: 144 RGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNL---------SNQAPDMAARLH 194
+ L+Y+H ++IHRD++ SN+LL D + K+ADF L + + P +
Sbjct: 118 KALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVL----- 169
Query: 195 STRVLGTFGYHAPEYAMTGQLTQKS-DVYSFGVVLLELLTGR 235
T + T Y APE + K D++S G +L E+L G+
Sbjct: 170 -TDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.2 bits (118), Expect = 9e-07
Identities = 35/101 (34%), Positives = 54/101 (53%), Gaps = 21/101 (20%)
Query: 144 RGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHS-----TRV 198
RG+++LH I+HRD++ N+L+ D + KIADF L AR++S T V
Sbjct: 118 RGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGL--------ARIYSFEMALTSV 166
Query: 199 LGTFGYHAPEYAMTGQLTQKS--DVYSFGVVLLELLTGRKP 237
+ T Y APE + Q + + D++S G + EL R+P
Sbjct: 167 VVTLWYRAPEVLL--QSSYATPVDMWSVGCIFAELFR-RRP 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 49.2 bits (118), Expect = 9e-07
Identities = 30/101 (29%), Positives = 46/101 (45%), Gaps = 13/101 (12%)
Query: 145 GLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNL---------SNQAPDMAARLHS 195
G+ YLHE I+HRDI+++N+L+ KIADF L + +
Sbjct: 127 GINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKY 183
Query: 196 TRVLGTFGYHAPEYAM-TGQLTQKSDVYSFGVVLLELLTGR 235
T ++ T Y PE + + T D++ G V E+ T R
Sbjct: 184 TNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 1e-06
Identities = 35/96 (36%), Positives = 48/96 (50%), Gaps = 8/96 (8%)
Query: 145 GLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQ-APDMAARLHSTRVLGTFG 203
LE+LH + II+RDI+ N+LL + + DF LS + D R +S GT
Sbjct: 117 ALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYS--FCGTIE 171
Query: 204 YHAPEYAMTGQLTQKS--DVYSFGVVLLELLTGRKP 237
Y AP+ G D +S GV++ ELLTG P
Sbjct: 172 YMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 1e-06
Identities = 28/93 (30%), Positives = 46/93 (49%), Gaps = 6/93 (6%)
Query: 146 LEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYH 205
LE+LH+ I++RD++ N+LL + DF LS ++ + GT Y
Sbjct: 109 LEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSK--ANLTDNKTTNTFCGTTEYL 163
Query: 206 APEYAMTGQ-LTQKSDVYSFGVVLLELLTGRKP 237
APE + + T+ D +S GV++ E+ G P
Sbjct: 164 APEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSP 196
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 1e-06
Identities = 31/93 (33%), Positives = 47/93 (50%), Gaps = 5/93 (5%)
Query: 145 GLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGY 204
L+YLH I++RD++ N++L +D KI DF L + AA + + GT Y
Sbjct: 107 ALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKT--FCGTPEY 161
Query: 205 HAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 237
APE + D + GVV+ E++ GR P
Sbjct: 162 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 1e-06
Identities = 29/89 (32%), Positives = 46/89 (51%), Gaps = 6/89 (6%)
Query: 144 RGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFG 203
GL YLH IIHRD+++ N+ + + + I D + Q P +A + GT
Sbjct: 168 EGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAA-QFPVVAPAFLG--LAGTVE 221
Query: 204 YHAPEYAMTGQLTQKSDVYSFGVVLLELL 232
+APE + K+D++S G+VL E+L
Sbjct: 222 TNAPEVLARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 1e-06
Identities = 40/141 (28%), Positives = 66/141 (46%), Gaps = 10/141 (7%)
Query: 101 LAYEFATMGSLHDILHGRKG----VQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPS 156
L Y F T G L+ IL G + + G ++ ++ + + LE+LH++
Sbjct: 65 LIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLS-EISLALEHLHQQ---G 120
Query: 157 IIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLT 216
II+RD++ N+LL K+ DF L ++ H+ GT Y APE M
Sbjct: 121 IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHT--FCGTIEYMAPEILMRSGHG 178
Query: 217 QKSDVYSFGVVLLELLTGRKP 237
+ D +S G ++ ++LTG P
Sbjct: 179 KAVDWWSLGALMYDMLTGAPP 199
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 1e-06
Identities = 35/120 (29%), Positives = 57/120 (47%), Gaps = 11/120 (9%)
Query: 145 GLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGY 204
G+ +LH I++RD++ NVLL + +++D L+ + D T+ GT GY
Sbjct: 107 GILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT---ITQRAGTNGY 160
Query: 205 HAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPV-DHTMPRGQQSLVTWATPRLSEDKVK 263
APE + D ++ G + E++ GR P DH ++ L R ED+VK
Sbjct: 161 MAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKR----RTLEDEVK 216
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 1e-06
Identities = 39/161 (24%), Positives = 69/161 (42%), Gaps = 19/161 (11%)
Query: 81 LKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAV 140
L+H N+++ LG CVE +L +E+ +G L L + + + R+A
Sbjct: 52 LQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNS-----QLLLLQRMAC 106
Query: 141 DAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNL--SNQAPDMAARLHSTRV 198
+ A G+ ++H+ + +H D+ N L D K+ D+ + S D
Sbjct: 107 EIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET--EDDK 161
Query: 199 LGTFGYHAPEYA-------MTGQLTQKSDVYSFGVVLLELL 232
+ APE +T + T+ S+V++ GV L EL
Sbjct: 162 CVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELF 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 2e-06
Identities = 33/100 (33%), Positives = 51/100 (51%), Gaps = 17/100 (17%)
Query: 144 RGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHS-----TRV 198
RGL++LH I+HRD++ N+L+ + K+ADF L AR++S T V
Sbjct: 119 RGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGL--------ARIYSCQMALTPV 167
Query: 199 LGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPV 238
+ T Y APE + D++S G + E+ RKP+
Sbjct: 168 VVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPL 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 2e-06
Identities = 47/191 (24%), Positives = 86/191 (45%), Gaps = 43/191 (22%)
Query: 60 RLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK 119
RL+ + P + VS++ LKH N+V +LHDI+H K
Sbjct: 40 RLEHEEGAPCTAIREVSLLKDLKHANIV----------------------TLHDIVHTDK 77
Query: 120 GVQGA-------------QPGPVLDWMTRVRIAV-DAARGLEYLHEKVQPSIIHRDIRSS 165
+ G ++ M V+I + RGL Y H + ++HRD++
Sbjct: 78 SLTLVFEYLDKDLKQYMDDCGNIMS-MHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQ 133
Query: 166 NVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAM-TGQLTQKSDVYSF 224
N+L+ E + K+ADF L+ +A + + +S V+ T Y P+ + + + + + D++
Sbjct: 134 NLLINERGELKLADFGLA-RAKSVPTKTYSNEVV-TLWYRPPDVLLGSSEYSTQIDMWGV 191
Query: 225 GVVLLELLTGR 235
G + E+ +GR
Sbjct: 192 GCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 2e-06
Identities = 31/101 (30%), Positives = 49/101 (48%), Gaps = 5/101 (4%)
Query: 139 AVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRV 198
A + L +LH+K II+RD++ NVLL + K+ADF + + + ++
Sbjct: 102 AAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEG--IFNGKTTSTF 156
Query: 199 LGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVD 239
GT Y APE D ++ GV+L E+L G P +
Sbjct: 157 CGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFE 197
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 2e-06
Identities = 30/93 (32%), Positives = 49/93 (52%), Gaps = 6/93 (6%)
Query: 145 GLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGY 204
GLE LH + I++RD++ N+LL + +I+D L+ + P+ RV GT GY
Sbjct: 114 GLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPE--GETIRGRV-GTVGY 167
Query: 205 HAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 237
APE + T D + G ++ E++ G+ P
Sbjct: 168 MAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 2e-06
Identities = 42/166 (25%), Positives = 77/166 (46%), Gaps = 15/166 (9%)
Query: 75 VSVVSRLKHENLVELLGYCVEGNLRVLA--YEFATMGSLHDILHGRKGVQGAQPGPVLDW 132
+ ++ L+H+ +V+ G + + L+ E+ GS+ D L G + +
Sbjct: 55 IQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAY--------GALTEN 106
Query: 133 MTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAAR 192
+TR R +G+ YLH + I+HRDI+ +N+L K+ DF S + +
Sbjct: 107 VTR-RYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMS 162
Query: 193 LHSTR-VLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 237
+ V GT + +PE +K+DV+S ++E+LT + P
Sbjct: 163 GTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 2e-06
Identities = 71/270 (26%), Positives = 105/270 (38%), Gaps = 60/270 (22%)
Query: 98 LRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAAR--------GLEYL 149
L L Y F T LH IL V G + L R + D R LE+L
Sbjct: 67 LVTLHYAFQTEAKLHLIL---DYVSGGEMFTHL--YQRDNFSEDEVRFYSGEIILALEHL 121
Query: 150 HEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQ-APDMAARLHSTRVLGTFGYHAPE 208
H + I++RDI+ N+LL + + DF LS + + R +S GT Y APE
Sbjct: 122 H---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYS--FCGTIEYMAPE 176
Query: 209 Y--AMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPR---------- 256
G + D +S G+++ ELLTG P R QS V+ +
Sbjct: 177 IIRGKGGH-GKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIG 235
Query: 257 -LSEDKVKQ--CVDPKLKGEYPPKGVAKL-----------AAVAALCVQYEAEFRP---- 298
++D + + DPK + P+G +++ A+A V FRP
Sbjct: 236 PEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLDWEALALRKVN--PPFRPSIRN 293
Query: 299 -----NMSIVVKALQPLLK---SPPPAAPV 320
N + L+P+ +PP A V
Sbjct: 294 ELDVGNFAEEFTNLEPVYSPAGTPPSGARV 323
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 3e-06
Identities = 47/190 (24%), Positives = 83/190 (43%), Gaps = 41/190 (21%)
Query: 60 RLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK 119
RL+ + P + VS++ LKH N+V +LHDI+H K
Sbjct: 40 RLEHEEGAPCTAIREVSLLKDLKHANIV----------------------TLHDIIHTEK 77
Query: 120 GV------------QGAQPGPVLDWMTRVRIAV-DAARGLEYLHEKVQPSIIHRDIRSSN 166
+ Q M V++ + RGL Y H + ++HRD++ N
Sbjct: 78 SLTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQN 134
Query: 167 VLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAM-TGQLTQKSDVYSFG 225
+L+ E + K+ADF L+ +A + + +S V+ T Y P+ + + + + D++ G
Sbjct: 135 LLINERGELKLADFGLA-RAKSIPTKTYSNEVV-TLWYRPPDILLGSTDYSTQIDMWGVG 192
Query: 226 VVLLELLTGR 235
+ E+ TGR
Sbjct: 193 CIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.1 bits (115), Expect = 3e-06
Identities = 33/126 (26%), Positives = 46/126 (36%), Gaps = 36/126 (28%)
Query: 139 AVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLS--------------- 183
A+D+ L + IHRDI+ N+L+ D K+ADF L
Sbjct: 113 ALDSVHKLGF---------IHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLND 163
Query: 184 -NQAPDMAARLHSTR-----------VLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLEL 231
+ L R +GT Y APE + D +S GV+L E+
Sbjct: 164 SHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEM 223
Query: 232 LTGRKP 237
L G P
Sbjct: 224 LYGFPP 229
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 3e-06
Identities = 29/101 (28%), Positives = 50/101 (49%), Gaps = 5/101 (4%)
Query: 139 AVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRV 198
+ + + L YLHE+ II+RD++ NVLL + K+ D+ + + + ++
Sbjct: 102 SAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG--LRPGDTTSTF 156
Query: 199 LGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVD 239
GT Y APE D ++ GV++ E++ GR P D
Sbjct: 157 CGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 3e-06
Identities = 33/110 (30%), Positives = 53/110 (48%), Gaps = 6/110 (5%)
Query: 128 PVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAP 187
P D + A + GLE L + I++RD++ N+LL + +I+D L+ Q P
Sbjct: 97 PGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIP 153
Query: 188 DMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 237
+ RV GT GY APE + T D + G ++ E++ G+ P
Sbjct: 154 E--GETVRGRV-GTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 3e-06
Identities = 29/93 (31%), Positives = 48/93 (51%), Gaps = 4/93 (4%)
Query: 145 GLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGY 204
L+YLH + ++++RD++ N++L +D KI DF L + A + + GT Y
Sbjct: 107 ALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT--FCGTPEY 162
Query: 205 HAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 237
APE + D + GVV+ E++ GR P
Sbjct: 163 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 3e-06
Identities = 32/100 (32%), Positives = 51/100 (51%), Gaps = 17/100 (17%)
Query: 144 RGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHS-----TRV 198
RGL++LH ++HRD++ N+L+ + K+ADF L AR++S T V
Sbjct: 121 RGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGL--------ARIYSFQMALTSV 169
Query: 199 LGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPV 238
+ T Y APE + D++S G + E+ RKP+
Sbjct: 170 VVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPL 208
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 4e-06
Identities = 27/99 (27%), Positives = 50/99 (50%), Gaps = 5/99 (5%)
Query: 139 AVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRV 198
A + L +LH + +I+RD++ N+LL + K+ADF + + + + +T
Sbjct: 102 AAEVTLALMFLH---RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEG--ILNGVTTTTF 156
Query: 199 LGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 237
GT Y APE + D ++ GV++ E++ G+ P
Sbjct: 157 CGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 6e-06
Identities = 29/90 (32%), Positives = 46/90 (51%), Gaps = 6/90 (6%)
Query: 145 GLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGY 204
G+++LH IIHRD++ SN+++ D KI DF L+ A T + T Y
Sbjct: 135 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA---CTNFMMTPYVVTRYY 188
Query: 205 HAPEYAMTGQLTQKSDVYSFGVVLLELLTG 234
APE + + D++S G ++ EL+ G
Sbjct: 189 RAPEVILGMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 46.5 bits (111), Expect = 6e-06
Identities = 43/156 (27%), Positives = 75/156 (48%), Gaps = 23/156 (14%)
Query: 83 HENLVELLGYCVEGNLRVLAYEFATM-GSLHDILHGRKGVQGAQPGP---VLDWMTRVRI 138
H N++ L+ + LA F M +L++++ GRK +P P V +M ++
Sbjct: 57 HPNILRLIEVLFDRKTGRLALVFELMDMNLYELIKGRK-----RPLPEKRVKSYMYQL-- 109
Query: 139 AVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRV 198
+ L+++H I HRDI+ N+L+ +D K+ADF + ++ T
Sbjct: 110 ----LKSLDHMHRN---GIFHRDIKPENILIKDD-ILKLADF---GSCRGIYSKPPYTEY 158
Query: 199 LGTFGYHAPEYAMT-GQLTQKSDVYSFGVVLLELLT 233
+ T Y APE +T G K D+++ G V E+L+
Sbjct: 159 ISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 6e-06
Identities = 29/91 (31%), Positives = 46/91 (50%), Gaps = 3/91 (3%)
Query: 143 ARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTF 202
ARG+E+L K + +HRD+ + NVLL + KI DF L+ + +
Sbjct: 247 ARGMEFLASK---NCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPV 303
Query: 203 GYHAPEYAMTGQLTQKSDVYSFGVVLLELLT 233
+ APE T SDV+S+G++L E+ +
Sbjct: 304 KWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 46.8 bits (112), Expect = 6e-06
Identities = 30/94 (31%), Positives = 46/94 (48%), Gaps = 10/94 (10%)
Query: 145 GLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVL-GTFG 203
LEYLH I++RD++ N+LL D KI DF + + T L GT
Sbjct: 113 ALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG------RTYTLCGTPE 163
Query: 204 YHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 237
Y APE ++ + D ++ G+++ E+L G P
Sbjct: 164 YLAPEIILSKGYGKAVDWWALGILIYEMLAGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 6e-06
Identities = 28/92 (30%), Positives = 43/92 (46%), Gaps = 4/92 (4%)
Query: 144 RGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFG 203
R ++YLHE IIHRDI++ N+ + + DF + D+ A + GT
Sbjct: 193 RAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWA-GTIA 248
Query: 204 YHAPEYAMTGQLTQKSDVYSFGVVLLELLTGR 235
+APE D++S G+VL E+ T
Sbjct: 249 TNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 7e-06
Identities = 42/163 (25%), Positives = 80/163 (49%), Gaps = 16/163 (9%)
Query: 75 VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 134
+S++ L H N+V+LL N L +EF LH L +K + + + +
Sbjct: 50 ISLLKELNHPNIVKLLDVIHTENKLYLVFEF-----LHQDL--KKFMDASPLSGIP--LP 100
Query: 135 RVRIAV-DAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARL 193
++ + +GL + H ++HRD++ N+L+ + K+ADF L+ +A + R
Sbjct: 101 LIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA-RAFGVPVRT 156
Query: 194 HSTRVLGTFGYHAPEYAMTGQL-TQKSDVYSFGVVLLELLTGR 235
++ V+ T Y APE + + + D++S G + E++T R
Sbjct: 157 YTHEVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 46.6 bits (111), Expect = 7e-06
Identities = 42/181 (23%), Positives = 71/181 (39%), Gaps = 35/181 (19%)
Query: 73 QLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDIL--HGRKGVQGAQPGPVL 130
Q + +L+H N++ + + + + GS D+L H +G
Sbjct: 48 QEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEG---------- 97
Query: 131 DWMTRVRIAV---DAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLS---- 183
+ + IA D L+Y+H K IHR +++S++LL D K ++ S
Sbjct: 98 --LPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMI 152
Query: 184 ----NQAPDMAARLHSTRVLGTFGYHAPEY---AMTGQLTQKSDVYSFGVVLLELLTGRK 236
Q S + L + +PE + G +KSD+YS G+ EL G
Sbjct: 153 KHGKRQRVVHDFPKSSVKNLP---WLSPEVLQQNLQG-YNEKSDIYSVGITACELANGHV 208
Query: 237 P 237
P
Sbjct: 209 P 209
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 9e-06
Identities = 27/84 (32%), Positives = 41/84 (48%), Gaps = 5/84 (5%)
Query: 158 IHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT----G 213
IHRD++ N+LL + K+ADF + D + +GT Y +PE + G
Sbjct: 164 IHRDVKPDNMLLDKSGHLKLADFGTCMKM-DANGMVRCDTAVGTPDYISPEVLKSQGGDG 222
Query: 214 QLTQKSDVYSFGVVLLELLTGRKP 237
++ D +S GV L E+L G P
Sbjct: 223 YYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 1e-05
Identities = 29/92 (31%), Positives = 47/92 (51%), Gaps = 8/92 (8%)
Query: 146 LEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYH 205
LEYLH K I++RD++ N+LL ++ K+ DF + + D L GT Y
Sbjct: 114 LEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWTL-----CGTPEYL 165
Query: 206 APEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 237
APE + + D ++ G+++ E+L G P
Sbjct: 166 APEVIQSKGHNKAVDWWALGILIYEMLVGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 1e-05
Identities = 45/169 (26%), Positives = 63/169 (37%), Gaps = 57/169 (33%)
Query: 158 IHRDIRSSNVLLFEDFKAKIADFNL--------------------------SNQAPD--- 188
IHRDI+ N+L+ D K+ DF L SN+ D
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPAN 182
Query: 189 ------------MAARLH----STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELL 232
AAR H + ++GT Y APE + TQ D +S GV+L E+L
Sbjct: 183 CRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 242
Query: 233 TGRKPVDHTMP-RGQQSLVTWAT-----------PRLSEDKVKQCVDPK 269
G+ P P Q ++ W T P S+ +K C P+
Sbjct: 243 VGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLCRGPE 291
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 1e-05
Identities = 32/117 (27%), Positives = 52/117 (44%), Gaps = 6/117 (5%)
Query: 121 VQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADF 180
V + P P+ +T R ++A L YLH + IIHRD+++ N+ L E A + DF
Sbjct: 176 VDRSGPLPLEQAITIQRRLLEA---LAYLHGR---GIIHRDVKTENIFLDEPENAVLGDF 229
Query: 181 NLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 237
+ + GT ++PE K+D++S G+VL E+
Sbjct: 230 GAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVT 286
|
Length = 392 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 1e-05
Identities = 34/103 (33%), Positives = 49/103 (47%), Gaps = 18/103 (17%)
Query: 143 ARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNL-------SNQAPDMAARLHS 195
A+G+ +L K + IHRD+ + N+LL KI DF L SN ARL
Sbjct: 224 AKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARL-- 278
Query: 196 TRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKP 237
+ APE T +SDV+S+G++L E+ + G P
Sbjct: 279 -----PVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSP 316
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 1e-05
Identities = 28/94 (29%), Positives = 47/94 (50%), Gaps = 5/94 (5%)
Query: 146 LEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYH 205
L +LHE+ II+RD++ NVLL + K+ D+ + + + ++ GT Y
Sbjct: 109 LNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEG--IRPGDTTSTFCGTPNYI 163
Query: 206 APEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVD 239
APE D ++ GV++ E++ GR P D
Sbjct: 164 APEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.7 bits (109), Expect = 1e-05
Identities = 44/197 (22%), Positives = 71/197 (36%), Gaps = 55/197 (27%)
Query: 77 VVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRV 136
+++ L H L L L ++ G L +L QPG
Sbjct: 54 ILATLDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQ-------RQPGK-------- 98
Query: 137 RIAVDAAR--------GLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQA-- 186
++ + AR LEYLH I++RD++ N+LL E ++DF+LS Q+
Sbjct: 99 CLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDV 155
Query: 187 -------------PDMAARLHSTRVL------------GTFGYHAPEYAMTGQ-LTQKSD 220
+ + GT Y APE ++G D
Sbjct: 156 EPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPE-VISGDGHGSAVD 214
Query: 221 VYSFGVVLLELLTGRKP 237
++ G++L E+L G P
Sbjct: 215 WWTLGILLYEMLYGTTP 231
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 1e-05
Identities = 30/99 (30%), Positives = 44/99 (44%), Gaps = 5/99 (5%)
Query: 139 AVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRV 198
A + A L YLH +II+RD++ N+LL + DF L + + ++
Sbjct: 102 AAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKE--GIEHSKTTSTF 156
Query: 199 LGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 237
GT Y APE + D + G VL E+L G P
Sbjct: 157 CGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 2e-05
Identities = 33/94 (35%), Positives = 50/94 (53%), Gaps = 9/94 (9%)
Query: 146 LEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIA--DFNLSNQAPDMAARLHSTRVLGTFG 203
LE LH+ ++I+RD++ N+LL D++ IA DF L +M + GT
Sbjct: 106 LENLHKF---NVIYRDLKPENILL--DYQGHIALCDFGLCKL--NMKDDDKTNTFCGTPE 158
Query: 204 YHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 237
Y APE + T+ D ++ GV+L E+LTG P
Sbjct: 159 YLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPP 192
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 45.5 bits (107), Expect = 2e-05
Identities = 43/176 (24%), Positives = 84/176 (47%), Gaps = 15/176 (8%)
Query: 60 RLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK 119
RL+ + P + S++ LKH N+V L L +E+ L +
Sbjct: 39 RLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYVHT-DLCQYMDKHP 97
Query: 120 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIAD 179
G G P V ++ ++ RGL Y+H++ I+HRD++ N+L+ + + K+AD
Sbjct: 98 G--GLHPENVKLFLFQL------LRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLAD 146
Query: 180 FNLSNQAPDMAARLHSTRVLGTFGYHAPEYAM-TGQLTQKSDVYSFGVVLLELLTG 234
F L+ +A + + +S V+ T Y P+ + + + + D++ G + +E++ G
Sbjct: 147 FGLA-RAKSVPSHTYSNEVV-TLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 2e-05
Identities = 36/112 (32%), Positives = 48/112 (42%), Gaps = 14/112 (12%)
Query: 132 WMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAA 191
+M + AVDA LHE IHRD++ N L+ K+ DF LS A
Sbjct: 106 YMAEMFEAVDA------LHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYA- 155
Query: 192 RLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMP 243
+S V+G+ Y APE D +S G +L E L G P + P
Sbjct: 156 --NS--VVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTP 203
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 45.5 bits (107), Expect = 2e-05
Identities = 42/166 (25%), Positives = 71/166 (42%), Gaps = 27/166 (16%)
Query: 77 VVSRLKHENLV---ELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWM 133
+ RL HEN++ E+L + Y+F ++D + P+L
Sbjct: 216 ALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYD------EAFDWKDRPLL-KQ 268
Query: 134 TRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARL 193
TR I +EY+H+K +IHRDI+ N+ L D K + DF A
Sbjct: 269 TR-AIMKQLLCAVEYIHDKK---LIHRDIKLENIFLNCDGKIVLGDFG-------TAMPF 317
Query: 194 HSTRV------LGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT 233
R +GT ++PE + +D++S G++LL++L+
Sbjct: 318 EKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 2e-05
Identities = 61/239 (25%), Positives = 102/239 (42%), Gaps = 40/239 (16%)
Query: 76 SVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTR 135
S++S++ H +L + G CV G+ ++ EF G L L KG PV W +
Sbjct: 68 SLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRV-----PV-AW--K 119
Query: 136 VRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIAD-----FNLSNQAPDMA 190
+ +A A L YL +K +++H ++ + N+LL + +A+ LS+
Sbjct: 120 ITVAQQLASALSYLEDK---NLVHGNVCAKNILL---ARLGLAEGTSPFIKLSDPGVSFT 173
Query: 191 ARLHSTRVLGTFGYHAPEYAMTG-QLTQKSDVYSFGVVLLEL-LTGRKPVDHTMPRGQQS 248
A RV + APE G L+ +D +SFG LLE+ G P+ P ++
Sbjct: 174 ALSREERV-ERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKE- 231
Query: 249 LVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKAL 307
R E K + P +LA + + C+ YE RP+ +++ L
Sbjct: 232 -------RFYEKKHR----------LPEPSCKELATLISQCLTYEPTQRPSFRTILRDL 273
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 2e-05
Identities = 37/151 (24%), Positives = 57/151 (37%), Gaps = 45/151 (29%)
Query: 146 LEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNL----------------------S 183
+E +H+ IHRDI+ N+L+ D K+ DF L S
Sbjct: 114 IESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDS 170
Query: 184 NQAPDMAARLHSTR-------------------VLGTFGYHAPEYAMTGQLTQKSDVYSF 224
+ + + + R ++GT Y APE + TQ D +S
Sbjct: 171 MEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV 230
Query: 225 GVVLLELLTGRKPVDHTMPRG-QQSLVTWAT 254
GV+L E+L G+ P P Q ++ W T
Sbjct: 231 GVILYEMLVGQPPFLADTPAETQLKVINWET 261
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 3e-05
Identities = 37/124 (29%), Positives = 54/124 (43%), Gaps = 17/124 (13%)
Query: 127 GPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQA 186
G + M R+ A + LEYLH I+HRD++ N+L+ K+ DF LS
Sbjct: 96 GALPVDMARMYFA-ETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIG 151
Query: 187 -PDMAARLHS------TR------VLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT 233
+ L+ TR V GT Y APE + + D ++ G++L E L
Sbjct: 152 LMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLV 211
Query: 234 GRKP 237
G P
Sbjct: 212 GCVP 215
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 3e-05
Identities = 44/175 (25%), Positives = 79/175 (45%), Gaps = 41/175 (23%)
Query: 75 VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGV------------Q 122
S++ LKH N+V +LHDI+H +K + Q
Sbjct: 54 ASLLKDLKHANIV----------------------TLHDIIHTKKTLTLVFEYLDTDLKQ 91
Query: 123 GAQPGPVLDWMTRVRIAV-DAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFN 181
M VR+ + RGL Y H++ ++HRD++ N+L+ E + K+ADF
Sbjct: 92 YMDDCGGGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFG 148
Query: 182 LSNQAPDMAARLHSTRVLGTFGYHAPEYAM-TGQLTQKSDVYSFGVVLLELLTGR 235
L+ +A + ++ +S V+ T Y P+ + + + + D++ G + E+ TGR
Sbjct: 149 LA-RAKSVPSKTYSNEVV-TLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 3e-05
Identities = 28/96 (29%), Positives = 53/96 (55%), Gaps = 6/96 (6%)
Query: 144 RGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFG 203
+GL + H +++HRD++ N+L+ ++ + K+ADF L+ +A + R +S V+ T
Sbjct: 110 KGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLA-RAFGIPVRCYSAEVV-TLW 164
Query: 204 YHAPEYAMTGQLTQKS-DVYSFGVVLLELLTGRKPV 238
Y P+ +L S D++S G + EL +P+
Sbjct: 165 YRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 4e-05
Identities = 28/91 (30%), Positives = 46/91 (50%), Gaps = 6/91 (6%)
Query: 145 GLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGY 204
G+++LH IIHRD++ SN+++ D KI DF L+ A T + T Y
Sbjct: 138 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYY 191
Query: 205 HAPEYAMTGQLTQKSDVYSFGVVLLELLTGR 235
APE + + D++S G ++ E++ G
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 5e-05
Identities = 27/93 (29%), Positives = 53/93 (56%), Gaps = 6/93 (6%)
Query: 144 RGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFG 203
RGL Y+H + I+HRD++ N+L+ + K+ADF L+ +A + ++ +S+ V+ T
Sbjct: 114 RGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLA-RAKSIPSQTYSSEVV-TLW 168
Query: 204 YHAPEYAM-TGQLTQKSDVYSFGVVLLELLTGR 235
Y P+ + + D++ G + +E+L G+
Sbjct: 169 YRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 5e-05
Identities = 27/85 (31%), Positives = 42/85 (49%), Gaps = 5/85 (5%)
Query: 157 IIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT---- 212
+IHRD++ N+LL + K+ADF + D + +GT Y +PE +
Sbjct: 163 LIHRDVKPDNMLLDKHGHLKLADFGTCMKM-DETGMVRCDTAVGTPDYISPEVLKSQGGD 221
Query: 213 GQLTQKSDVYSFGVVLLELLTGRKP 237
G ++ D +S GV L E+L G P
Sbjct: 222 GYYGRECDWWSVGVFLFEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 5e-05
Identities = 22/67 (32%), Positives = 39/67 (58%), Gaps = 7/67 (10%)
Query: 145 GLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLS---NQAPDMAARLHSTRVLGT 201
GL Y+H I+HRD++++N+L+ +D K+ADF L+ + + + ++ RV+ T
Sbjct: 131 GLYYIHRN---KILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVV-T 186
Query: 202 FGYHAPE 208
Y PE
Sbjct: 187 LWYRPPE 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 6e-05
Identities = 42/163 (25%), Positives = 69/163 (42%), Gaps = 29/163 (17%)
Query: 80 RLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIA 139
+LKH NLV L+ L +E+ L+++ +GV +I
Sbjct: 56 QLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGV---------PEHLIKKII 106
Query: 140 VDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHS---- 195
+ + + H + + IHRD++ N+L+ + + K+ DF AR+ +
Sbjct: 107 WQTLQAVNFCH---KHNCIHRDVKPENILITKQGQIKLCDFGF--------ARILTGPGD 155
Query: 196 --TRVLGTFGYHAPEYAMTG--QLTQKSDVYSFGVVLLELLTG 234
T + T Y APE + G Q DV++ G V ELLTG
Sbjct: 156 DYTDYVATRWYRAPEL-LVGDTQYGPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 7e-05
Identities = 29/93 (31%), Positives = 46/93 (49%), Gaps = 10/93 (10%)
Query: 145 GLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPD--MAARLHSTRVLGTF 202
G+++LH IIHRD++ SN+++ D KI DF L+ A M TR
Sbjct: 130 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY---- 182
Query: 203 GYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGR 235
Y APE + + D++S G ++ E++ G
Sbjct: 183 -YRAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 8e-05
Identities = 46/176 (26%), Positives = 82/176 (46%), Gaps = 17/176 (9%)
Query: 75 VSVVSRLKHENLVELLG-YCVEGNLRV-LAYEFATMGSLHDILHGRKGVQGAQPGPVLDW 132
++++ LKH N++ L + + +V L +++A H I R +P +
Sbjct: 49 IALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRG 108
Query: 133 MTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLF----EDFKAKIADFNLS---NQ 185
M + + G+ YLH ++HRD++ +N+L+ E + KIAD + N
Sbjct: 109 MVK-SLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNS 164
Query: 186 APDMAARLHSTRVLGTFGYHAPEYAMTGQ-LTQKSDVYSFGVVLLELLTGRKPVDH 240
A L V+ TF Y APE + + T+ D+++ G + ELLT +P+ H
Sbjct: 165 PLKPLADLDP--VVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS-EPIFH 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 9e-05
Identities = 31/102 (30%), Positives = 48/102 (47%), Gaps = 12/102 (11%)
Query: 145 GLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGY 204
G+++LH IIHRD++ SN+++ D KI DF L+ A T + T Y
Sbjct: 131 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYY 184
Query: 205 HAPEYAMTGQLTQKSDVYSFGVVLLE------LLTGRKPVDH 240
APE + + D++S G ++ E L GR +D
Sbjct: 185 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ 226
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 1e-04
Identities = 38/120 (31%), Positives = 50/120 (41%), Gaps = 13/120 (10%)
Query: 138 IAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFN----LSNQAPDMAARL 193
I A RGL YLH Q IHR+I++S++L+ D ++ + L
Sbjct: 106 ILFGALRGLNYLH---QNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVY 162
Query: 194 H----STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSL 249
ST VL + G KSD+YS G+ EL TGR P M R Q L
Sbjct: 163 DFPQFSTSVLPWLSPELLRQDLYG-YNVKSDIYSVGITACELATGRVPF-QDMLRTQMLL 220
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 1e-04
Identities = 46/176 (26%), Positives = 81/176 (46%), Gaps = 17/176 (9%)
Query: 75 VSVVSRLKHENLVELLGYCVEGNLRV--LAYEFATMGSLHDILHGRKGVQGAQPGPVLDW 132
++++ LKH N++ L + + R L +++A H I R +P +
Sbjct: 49 IALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRS 108
Query: 133 MTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLF----EDFKAKIADFNLS---NQ 185
M + + G+ YLH ++HRD++ +N+L+ E + KIAD + N
Sbjct: 109 MVK-SLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNS 164
Query: 186 APDMAARLHSTRVLGTFGYHAPEYAMTGQ-LTQKSDVYSFGVVLLELLTGRKPVDH 240
A L V+ TF Y APE + + T+ D+++ G + ELLT +P+ H
Sbjct: 165 PLKPLADLDP--VVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS-EPIFH 217
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.1 bits (100), Expect = 2e-04
Identities = 46/187 (24%), Positives = 81/187 (43%), Gaps = 32/187 (17%)
Query: 60 RLKSPKNYPDDEKQLVSVVSRLK---HENLVELLGYCVEGNLRVLAYEFATM-GSLHDIL 115
++K ++ L V S K H N+V+L E + +E+ M G+L+ ++
Sbjct: 31 KMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEY--MEGNLYQLM 88
Query: 116 HGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKA 175
RKG + + ++ +GL ++H+ HRD++ N+L+
Sbjct: 89 KDRKGKP-FSESVIRSIIYQI------LQGLAHIHKH---GFFHRDLKPENLLVSGPEVV 138
Query: 176 KIADFNLSNQAPDMAARLHSTRVLGTFGYHAPE-------YAMTGQLTQKSDVYSFGVVL 228
KIADF L A ++ +R T + T Y APE Y + D+++ G ++
Sbjct: 139 KIADFGL---AREIRSRPPYTDYVSTRWYRAPEILLRSTSY------SSPVDIWALGCIM 189
Query: 229 LELLTGR 235
EL T R
Sbjct: 190 AELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 2e-04
Identities = 43/171 (25%), Positives = 69/171 (40%), Gaps = 18/171 (10%)
Query: 85 NLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAAR 144
N+V L Y V + L + A G L + + V W + +A+DA
Sbjct: 46 NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEEC---VKRWAAEMVVALDA-- 100
Query: 145 GLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGY 204
LH + I+ RD+ +N+LL + ++ F+ ++ D + Y
Sbjct: 101 ----LHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM-----Y 148
Query: 205 HAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATP 255
APE + T+ D +S G +L ELLTG K + P G + T P
Sbjct: 149 CAPEVGGISEETEACDWWSLGAILFELLTG-KTLVECHPSGINTHTTLNIP 198
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 4e-04
Identities = 31/94 (32%), Positives = 47/94 (50%), Gaps = 6/94 (6%)
Query: 149 LHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPE 208
+H Q +HRDI+ NVLL + ++ADF S + + S+ +GT Y +PE
Sbjct: 115 IHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFG-SCLKMNQDGTVQSSVAVGTPDYISPE 173
Query: 209 Y--AM---TGQLTQKSDVYSFGVVLLELLTGRKP 237
AM G+ + D +S GV + E+L G P
Sbjct: 174 ILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 5e-04
Identities = 31/111 (27%), Positives = 54/111 (48%), Gaps = 15/111 (13%)
Query: 132 WMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAA 191
++ + IA+D+ L Y +HRDI+ N+L+ + ++ADF + +
Sbjct: 107 YLAEMVIAIDSVHQLHY---------VHRDIKPDNILMDMNGHIRLADFGSCLKLME-DG 156
Query: 192 RLHSTRVLGTFGYHAPEY--AM---TGQLTQKSDVYSFGVVLLELLTGRKP 237
+ S+ +GT Y +PE AM G+ + D +S GV + E+L G P
Sbjct: 157 TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 5e-04
Identities = 31/95 (32%), Positives = 43/95 (45%), Gaps = 7/95 (7%)
Query: 149 LHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPE 208
+H Q +HRDI+ NVL+ K+ADF S ++S +GT Y APE
Sbjct: 115 IHSVHQMGYVHRDIKPENVLIDRTGHIKLADFG-SAARLTANKMVNSKLPVGTPDYIAPE 173
Query: 209 YAMTGQLTQKS------DVYSFGVVLLELLTGRKP 237
T K D +S GV+ E++ GR P
Sbjct: 174 VLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSP 208
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 6e-04
Identities = 43/182 (23%), Positives = 81/182 (44%), Gaps = 21/182 (11%)
Query: 55 SHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELL-GYCVEGNLRVLAYEFATMGSLHD 113
S ENE +K + + + ++ LK EN+VEL + G L L +E+ L
Sbjct: 37 SEENEEVK------ETTLRELKMLRTLKQENIVELKEAFRRRGKL-YLVFEYVEKNMLEL 89
Query: 114 ILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDF 173
+ + G P V ++ ++ + + + H+ I+HRDI+ N+L+ +
Sbjct: 90 L---EEMPNGVPPEKVRSYIYQL------IKAIHWCHKN---DIVHRDIKPENLLISHND 137
Query: 174 KAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT 233
K+ DF + + + + T + T Y +PE + + D++S G +L EL
Sbjct: 138 VLKLCDFGFARNLSE-GSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSD 196
Query: 234 GR 235
G+
Sbjct: 197 GQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.0 bits (94), Expect = 0.001
Identities = 44/164 (26%), Positives = 76/164 (46%), Gaps = 15/164 (9%)
Query: 75 VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 134
+S++ L H N+V LL N L +EF + D+ K + P LD
Sbjct: 49 ISLLKELNHPNIVRLLDVVHSENKLYLVFEFLDL----DL----KKYMDSSPLTGLDPPL 100
Query: 135 RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 194
+G+ Y H ++HRD++ N+L+ + K+ADF L+ +A + R +
Sbjct: 101 IKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLA-RAFGVPVRTY 156
Query: 195 STRVLGTFGYHAPEYAMTG-QLTQKSDVYSFGVVLLELLTGRKP 237
+ V+ T Y APE + Q + D++S G + E++ R+P
Sbjct: 157 THEVV-TLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVN-RRP 198
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 39.8 bits (94), Expect = 0.001
Identities = 31/97 (31%), Positives = 46/97 (47%), Gaps = 16/97 (16%)
Query: 145 GLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKI--ADFNLSNQAPDMAARLHSTRVL-GT 201
L LH+ +IIH DI+ NVL ++ K +I D+ L + + GT
Sbjct: 121 ALNDLHKH---NIIHNDIKLENVL-YDRAKDRIYLCDYGLCK-------IIGTPSCYDGT 169
Query: 202 FGYHAPEYAMTGQLTQKS-DVYSFGVVLLELLTGRKP 237
Y +PE + G S D ++ GV+ ELLTG+ P
Sbjct: 170 LDYFSPE-KIKGHNYDVSFDWWAVGVLTYELLTGKHP 205
|
Length = 267 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.001
Identities = 30/99 (30%), Positives = 43/99 (43%), Gaps = 5/99 (5%)
Query: 139 AVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRV 198
A + A L YLH +I++RD++ N+LL + DF L + + +T
Sbjct: 102 AAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDT--TTTF 156
Query: 199 LGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 237
GT Y APE D + G VL E+L G P
Sbjct: 157 CGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.001
Identities = 29/99 (29%), Positives = 44/99 (44%), Gaps = 5/99 (5%)
Query: 139 AVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRV 198
A + A + YLH +II+RD++ N+LL + DF L + + ++
Sbjct: 102 AAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEG--VEPEETTSTF 156
Query: 199 LGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 237
GT Y APE + D + G VL E+L G P
Sbjct: 157 CGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.002
Identities = 33/111 (29%), Positives = 53/111 (47%), Gaps = 15/111 (13%)
Query: 132 WMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAA 191
++ + +A+D+ L Y +HRDI+ NVLL ++ ++ADF S
Sbjct: 107 YLAEMVLAIDSVHQLGY---------VHRDIKPDNVLLDKNGHIRLADFG-SCLRLLADG 156
Query: 192 RLHSTRVLGTFGYHAPEY--AM---TGQLTQKSDVYSFGVVLLELLTGRKP 237
+ S +GT Y +PE AM G+ + D +S GV + E+L G P
Sbjct: 157 TVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 39.5 bits (92), Expect = 0.002
Identities = 19/51 (37%), Positives = 29/51 (56%), Gaps = 4/51 (7%)
Query: 133 MTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLS 183
M I+ + A L+YLH + IIHRD++ N+L+ + K+ DF LS
Sbjct: 105 MAVKYIS-EVALALDYLH---RHGIIHRDLKPDNMLISNEGHIKLTDFGLS 151
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.002
Identities = 29/99 (29%), Positives = 45/99 (45%), Gaps = 5/99 (5%)
Query: 139 AVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRV 198
A + A L YLH +I++RD++ N+LL + DF L + ++ ++
Sbjct: 102 AAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKE--NIEHNGTTSTF 156
Query: 199 LGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 237
GT Y APE + D + G VL E+L G P
Sbjct: 157 CGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 38.8 bits (90), Expect = 0.002
Identities = 28/95 (29%), Positives = 47/95 (49%), Gaps = 14/95 (14%)
Query: 146 LEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTR---VLGTF 202
EYL +I++RD++ N+LL +D K+ DF A++ TR + GT
Sbjct: 144 FEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGF--------AKVVDTRTYTLCGTP 192
Query: 203 GYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 237
Y APE + + +D ++ G+ + E+L G P
Sbjct: 193 EYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPP 227
|
Length = 340 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 38.5 bits (90), Expect = 0.003
Identities = 35/141 (24%), Positives = 55/141 (39%), Gaps = 40/141 (28%)
Query: 133 MTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNL---------- 182
TR IA + ++ +H + IHRDI+ N+LL K++DF L
Sbjct: 102 ETRFYIA-ETILAIDSIH---KLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRT 157
Query: 183 -----------SNQAPDMAARLHSTR---------------VLGTFGYHAPEYAMTGQLT 216
SN ++ + S R +GT Y APE +
Sbjct: 158 EFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYN 217
Query: 217 QKSDVYSFGVVLLELLTGRKP 237
++ D +S GV++ E+L G P
Sbjct: 218 KECDWWSLGVIMYEMLVGYPP 238
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 38.5 bits (89), Expect = 0.003
Identities = 26/84 (30%), Positives = 41/84 (48%), Gaps = 5/84 (5%)
Query: 158 IHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT----G 213
IHRD++ N+LL + K+ADF + + + +GT Y +PE + G
Sbjct: 164 IHRDVKPDNMLLDKSGHLKLADFGTCMKM-NKEGMVRCDTAVGTPDYISPEVLKSQGGDG 222
Query: 214 QLTQKSDVYSFGVVLLELLTGRKP 237
++ D +S GV L E+L G P
Sbjct: 223 YYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 38.5 bits (89), Expect = 0.003
Identities = 36/141 (25%), Positives = 53/141 (37%), Gaps = 46/141 (32%)
Query: 158 IHRDIRSSNVLLFEDFKAKIADFNL----------------------SNQAPDM------ 189
IHRDI+ N+L+ D K+ DF L S + D+
Sbjct: 123 IHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSN 182
Query: 190 -------------AARLH----STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELL 232
A + H + ++GT Y APE + TQ D +S GV+L E+L
Sbjct: 183 CRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEML 242
Query: 233 TGRKPVDHTMP-RGQQSLVTW 252
G+ P P Q ++ W
Sbjct: 243 VGQPPFLAPTPTETQLKVINW 263
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 323 | |||
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.98 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.98 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.98 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.97 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.97 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.97 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.96 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.96 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.95 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.95 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.94 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.93 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.93 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.93 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.9 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.9 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.9 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.89 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.87 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.86 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.86 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.86 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.85 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.85 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.84 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.83 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.83 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.81 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.78 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.77 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.76 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.75 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.72 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.72 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.69 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.67 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.66 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.6 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.58 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.57 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.53 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.5 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.4 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.39 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.32 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.32 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.3 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.23 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.22 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.21 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.16 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.06 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.04 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.98 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.98 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.93 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.89 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.86 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.78 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.68 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.4 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.38 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.36 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.21 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.21 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.13 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.1 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.09 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.97 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.96 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 97.9 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.9 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.82 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.76 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.75 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.7 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.42 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.33 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.22 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.13 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 96.86 | |
| PLN02236 | 344 | choline kinase | 96.3 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.29 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.24 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.12 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 96.01 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 95.93 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 95.92 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 95.29 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 95.1 | |
| PTZ00384 | 383 | choline kinase; Provisional | 95.03 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 94.8 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 94.67 | |
| PHA00451 | 362 | protein kinase | 94.5 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 94.43 | |
| PRK10271 | 188 | thiK thiamine kinase; Provisional | 94.15 | |
| COG0510 | 269 | ycfN Thiamine kinase and related kinases [Coenzyme | 93.9 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 93.78 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 93.77 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 93.4 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 92.89 | |
| smart00587 | 196 | CHK ZnF_C4 abd HLH domain containing kinases domai | 91.89 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 91.49 | |
| PF05445 | 434 | Pox_ser-thr_kin: Poxvirus serine/threonine protein | 91.43 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 90.67 |
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-52 Score=348.70 Aligned_cols=252 Identities=23% Similarity=0.313 Sum_probs=211.0
Q ss_pred CCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEe
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVE 95 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 95 (323)
..+.+..||+|..|+||+|++..+++++|+|.+.. .......+++.+|+++++.++||+||.+++.|..
T Consensus 80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~-----------~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~ 148 (364)
T KOG0581|consen 80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILL-----------NIDPALQKQILRELEILRSCQSPYIVGFYGAFYS 148 (364)
T ss_pred HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecc-----------cCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEe
Confidence 34556689999999999999999999999997742 2334456888999999999999999999999999
Q ss_pred CCe-EEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCCCceeCCCCCCCEEEccCC
Q 020641 96 GNL-RVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHE-KVQPSIIHRDIRSSNVLLFEDF 173 (323)
Q Consensus 96 ~~~-~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~-~~~~~i~h~dikp~nili~~~~ 173 (323)
+.. ..++||||++|||.++++.... +++...-+++.++++||.|||. . +|+||||||.|+|++.+|
T Consensus 149 ~~~~isI~mEYMDgGSLd~~~k~~g~---------i~E~~L~~ia~~VL~GL~YLh~~~---~IIHRDIKPsNlLvNskG 216 (364)
T KOG0581|consen 149 NGEEISICMEYMDGGSLDDILKRVGR---------IPEPVLGKIARAVLRGLSYLHEER---KIIHRDIKPSNLLVNSKG 216 (364)
T ss_pred CCceEEeehhhcCCCCHHHHHhhcCC---------CCHHHHHHHHHHHHHHHHHHhhcc---CeeeccCCHHHeeeccCC
Confidence 984 9999999999999999987632 8999999999999999999996 7 999999999999999999
Q ss_pred eEEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhh
Q 020641 174 KAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWA 253 (323)
Q Consensus 174 ~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 253 (323)
++||||||.+....+. ......||..|||||.+.+..|+.++||||||++++|+++|+.||.........
T Consensus 217 eVKicDFGVS~~lvnS----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~------ 286 (364)
T KOG0581|consen 217 EVKICDFGVSGILVNS----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLD------ 286 (364)
T ss_pred CEEeccccccHHhhhh----hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCC------
Confidence 9999999999887664 235567999999999999999999999999999999999999999765111000
Q ss_pred cccccccccchhcCCCcCCCCCH-HHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 254 TPRLSEDKVKQCVDPKLKGEYPP-KGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
.-+.+..+++.. ....|. .++++++.|+..||++||.+|||+.|+++
T Consensus 287 ----~~~Ll~~Iv~~p-pP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~ 334 (364)
T KOG0581|consen 287 ----IFELLCAIVDEP-PPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQ 334 (364)
T ss_pred ----HHHHHHHHhcCC-CCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 011122222211 223344 48889999999999999999999999986
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-50 Score=356.35 Aligned_cols=249 Identities=23% Similarity=0.314 Sum_probs=214.8
Q ss_pred CccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeC
Q 020641 17 PGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEG 96 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 96 (323)
|..-.-||+|||+.||.+++..++..+|+|++.++...+. ..++.+.+|+++.++|+|||||+++++|++.
T Consensus 20 Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~---------~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs 90 (592)
T KOG0575|consen 20 YKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKP---------KQREKVLNEIEIHRSLKHPNIVQFYHFFEDS 90 (592)
T ss_pred eeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCc---------chHHHHHHHHHHHHhcCCCcEEeeeeEeecC
Confidence 4444478999999999999999999999999987654443 3458889999999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEE
Q 020641 97 NLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAK 176 (323)
Q Consensus 97 ~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~ 176 (323)
+..|+|.|.|..++|..+++++.. +++.++..+++||+.|+.|||+. +|+|||||..|++++++.++|
T Consensus 91 ~nVYivLELC~~~sL~el~Krrk~---------ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VK 158 (592)
T KOG0575|consen 91 NNVYIVLELCHRGSLMELLKRRKP---------LTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVK 158 (592)
T ss_pred CceEEEEEecCCccHHHHHHhcCC---------CCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEE
Confidence 999999999999999999986543 99999999999999999999999 999999999999999999999
Q ss_pred EeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhccc
Q 020641 177 IADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPR 256 (323)
Q Consensus 177 l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 256 (323)
|+|||+|+........ ..+.+|||.|+|||++.....+..+||||+||++|-|++|++||+...-......+.
T Consensus 159 IgDFGLAt~le~~~Er--k~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik----- 231 (592)
T KOG0575|consen 159 IGDFGLATQLEYDGER--KKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIK----- 231 (592)
T ss_pred ecccceeeeecCcccc--cceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHH-----
Confidence 9999999988754332 356689999999999999999999999999999999999999998664333322222
Q ss_pred ccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 257 LSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
.... ..|...+.+..+||.++|+.||.+|||+++|+.
T Consensus 232 ----------~~~Y--~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 232 ----------LNEY--SMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred ----------hcCc--ccccccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 2221 234466778999999999999999999999997
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-50 Score=343.53 Aligned_cols=249 Identities=21% Similarity=0.266 Sum_probs=206.6
Q ss_pred ccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeCCeEEE
Q 020641 22 RLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVL 101 (323)
Q Consensus 22 ~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 101 (323)
.||.|+||.|-+|...++++.+|+|++.+........+ ......+.+|+++|++++||||++++++|+.+...|+
T Consensus 179 ~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~-----~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~Ym 253 (475)
T KOG0615|consen 179 TLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRA-----IAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSSYM 253 (475)
T ss_pred eecCCceeEEEEEEEcccCcEEEeeeeehhhccccccc-----ccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCceEE
Confidence 89999999999999999999999999987765544321 1223447899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccC---CeEEEe
Q 020641 102 AYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFED---FKAKIA 178 (323)
Q Consensus 102 v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~---~~~~l~ 178 (323)
||||++||.|.+.+-++.. +.+..-+.+++|++.|+.|||++ ||+||||||+|||++.+ ..+||+
T Consensus 254 VlE~v~GGeLfd~vv~nk~---------l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKIt 321 (475)
T KOG0615|consen 254 VLEYVEGGELFDKVVANKY---------LREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKIT 321 (475)
T ss_pred EEEEecCccHHHHHHhccc---------cccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEec
Confidence 9999999999999988764 77778899999999999999999 99999999999999876 789999
Q ss_pred eccccCCCCccccccccccccCccccCCCccccCCCC---CcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhcc
Q 020641 179 DFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQL---TQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATP 255 (323)
Q Consensus 179 Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~---~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~ 255 (323)
|||+|...... ....+.+||+.|.|||++.+... ..+.|+||+||++|-+++|.+||.+.....
T Consensus 322 DFGlAK~~g~~---sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~---------- 388 (475)
T KOG0615|consen 322 DFGLAKVSGEG---SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP---------- 388 (475)
T ss_pred ccchhhccccc---eehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc----------
Confidence 99999877643 34567789999999999986654 347799999999999999999998654321
Q ss_pred cccccccchhc-CCCcCC--CCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 256 RLSEDKVKQCV-DPKLKG--EYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 256 ~~~~~~~~~~~-~~~~~~--~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
.+.+.+ ...+.- ..-...+++..++|.+||..||++|||+.|+++
T Consensus 389 -----sl~eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 389 -----SLKEQILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred -----cHHHHHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 111111 111111 122466789999999999999999999999886
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-50 Score=326.39 Aligned_cols=265 Identities=18% Similarity=0.224 Sum_probs=213.8
Q ss_pred CccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeC
Q 020641 17 PGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEG 96 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 96 (323)
|+.+.++|+|+||.||++++..+|+.||+|.+.... ......+...+|+++|+++.|+|+|.++++|...
T Consensus 4 YE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Ese----------dd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrk 73 (396)
T KOG0593|consen 4 YEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESE----------DDPVVKKIALREIRMLKQLKHENLVNLIEVFRRK 73 (396)
T ss_pred HhhhhccccCcceEEEEeccCCcccEEEEEeeccCC----------ccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhc
Confidence 566778999999999999999999999999665321 1122346678999999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEE
Q 020641 97 NLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAK 176 (323)
Q Consensus 97 ~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~ 176 (323)
...++|+|||+. ++.+.+...... ++...+.++++|++.|+.|+|++ +++||||||+|||++.++.+|
T Consensus 74 rklhLVFE~~dh-TvL~eLe~~p~G--------~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvK 141 (396)
T KOG0593|consen 74 RKLHLVFEYCDH-TVLHELERYPNG--------VPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVK 141 (396)
T ss_pred ceeEEEeeecch-HHHHHHHhccCC--------CCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEE
Confidence 999999999998 777777666544 88999999999999999999999 999999999999999999999
Q ss_pred EeeccccCCCCccccccccccccCccccCCCccccC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhh----
Q 020641 177 IADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT-GQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVT---- 251 (323)
Q Consensus 177 l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~---- 251 (323)
|||||.|+...... ...+....|.+|+|||++.+ .+|+...||||+||++.||++|++.|.+..+.+....+.
T Consensus 142 LCDFGFAR~L~~pg--d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG 219 (396)
T KOG0593|consen 142 LCDFGFARTLSAPG--DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLG 219 (396)
T ss_pred eccchhhHhhcCCc--chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHc
Confidence 99999998776422 23355567999999999997 789999999999999999999999999887655433332
Q ss_pred ----------hhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 252 ----------WATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 252 ----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
..++...+-.+++.-.+.......+..+.-+.+|++.||+.||++|+|-++++.
T Consensus 220 ~L~prhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 220 NLIPRHQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred ccCHHHHHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 222333333333322222222223445668999999999999999999999874
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-49 Score=334.55 Aligned_cols=256 Identities=23% Similarity=0.301 Sum_probs=209.5
Q ss_pred cccCCCCCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccce
Q 020641 10 LGAHAPSPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVEL 89 (323)
Q Consensus 10 ~~~~~~~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~ 89 (323)
.++....|.+-.+||.|+||+||+++...++..+|+|++.++....+. .+....|+.+|+.++|||||.+
T Consensus 5 ~~~~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~----------~e~L~~Ei~iLkel~H~nIV~l 74 (429)
T KOG0595|consen 5 SMRVVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKL----------VELLLSEIKILKELKHPNIVRL 74 (429)
T ss_pred cccccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHH----------HHHHHHHHHHHHhcCCcceeeE
Confidence 345556778888999999999999999999999999998876543332 3566889999999999999999
Q ss_pred eeEEEeCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEE
Q 020641 90 LGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLL 169 (323)
Q Consensus 90 ~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili 169 (323)
++++..++..|+|||||.||+|.++++.... +++.++...+.||+.|+++||++ +|+||||||.|||+
T Consensus 75 ~d~~~~~~~i~lVMEyC~gGDLs~yi~~~~~---------l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLL 142 (429)
T KOG0595|consen 75 LDCIEDDDFIYLVMEYCNGGDLSDYIRRRGR---------LPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILL 142 (429)
T ss_pred EEEEecCCeEEEEEEeCCCCCHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEe
Confidence 9999999999999999999999999988753 99999999999999999999999 99999999999999
Q ss_pred ccC------CeEEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCC
Q 020641 170 FED------FKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMP 243 (323)
Q Consensus 170 ~~~------~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 243 (323)
+.. ..+||+|||+|+....... ..+.+|++.|||||++...+|+.|+|+||+|+++|++++|+.||.....
T Consensus 143 s~~~~~~~~~~LKIADFGfAR~L~~~~~---a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~ 219 (429)
T KOG0595|consen 143 STTARNDTSPVLKIADFGFARFLQPGSM---AETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETP 219 (429)
T ss_pred ccCCCCCCCceEEecccchhhhCCchhH---HHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCH
Confidence 765 5689999999998875443 3567799999999999999999999999999999999999999975543
Q ss_pred cccchhhhhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHH
Q 020641 244 RGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVV 304 (323)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl 304 (323)
.+-...+. .........+...+..+.+++...++.||.+|.+..+-+
T Consensus 220 ~eL~~~~~--------------k~~~~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~ 266 (429)
T KOG0595|consen 220 KELLLYIK--------------KGNEIVPVLPAELSNPLRELLISLLQRNPKDRISFEDFF 266 (429)
T ss_pred HHHHHHHh--------------ccccccCchhhhccCchhhhhhHHHhcCccccCchHHhh
Confidence 21111000 011122233344455566778888888888887766544
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-48 Score=341.50 Aligned_cols=258 Identities=31% Similarity=0.463 Sum_probs=213.1
Q ss_pred cccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeCC-eE
Q 020641 21 VRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGN-LR 99 (323)
Q Consensus 21 ~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~ 99 (323)
.+||.|+||+||.+....+.. +|+|.+......... .+.|.+|+.+|++++||||+++++++.++. ..
T Consensus 47 ~~iG~G~~g~V~~~~~~g~~~-vavK~~~~~~~~~~~----------~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~ 115 (362)
T KOG0192|consen 47 EVLGSGSFGTVYKGKWRGTDV-VAVKIISDPDFDDES----------RKAFRREASLLSRLRHPNIVQFYGACTSPPGSL 115 (362)
T ss_pred hhcccCCceeEEEEEeCCcee-EEEEEecchhcChHH----------HHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCce
Confidence 369999999999888865543 777766543322221 578999999999999999999999999988 79
Q ss_pred EEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC-ceeCCCCCCCEEEccCC-eEEE
Q 020641 100 VLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPS-IIHRDIRSSNVLLFEDF-KAKI 177 (323)
Q Consensus 100 ~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~-i~h~dikp~nili~~~~-~~~l 177 (323)
++||||+.+|+|.+++...... .+++..+..++.+|+.|+.|||+. + |+|||||++|+|++.++ ++||
T Consensus 116 ~iVtEy~~~GsL~~~l~~~~~~-------~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI 185 (362)
T KOG0192|consen 116 CIVTEYMPGGSLSVLLHKKRKR-------KLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKI 185 (362)
T ss_pred EEEEEeCCCCcHHHHHhhcccC-------CCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEE
Confidence 9999999999999999774111 299999999999999999999999 9 99999999999999997 9999
Q ss_pred eeccccCCCCccccccccccccCccccCCCcccc--CCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhcc
Q 020641 178 ADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAM--TGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATP 255 (323)
Q Consensus 178 ~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~--~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~ 255 (323)
+|||+++...... .......||+.|+|||++. ...++.++||||||+++|||+||+.||......
T Consensus 186 ~DFGlsr~~~~~~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~----------- 252 (362)
T KOG0192|consen 186 ADFGLSREKVISK--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPV----------- 252 (362)
T ss_pred CCCccceeecccc--ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHH-----------
Confidence 9999997665432 2233356999999999999 568999999999999999999999999866531
Q ss_pred cccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhhcCCCC
Q 020641 256 RLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSPPP 316 (323)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~~~~~~ 316 (323)
.....++....+...+..++..+..++.+||+.||..||++.+|+..|+.+......
T Consensus 253 ----~~~~~v~~~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~ 309 (362)
T KOG0192|consen 253 ----QVASAVVVGGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISS 309 (362)
T ss_pred ----HHHHHHHhcCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhcc
Confidence 111222233444455666888899999999999999999999999999998875554
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-49 Score=321.98 Aligned_cols=259 Identities=19% Similarity=0.275 Sum_probs=206.2
Q ss_pred CCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceee-EEE
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLG-YCV 94 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~-~~~ 94 (323)
.|+...+||+|+||+||+|.+..++..+|.|.+.-. ......++....|+.+|++++||||+++++ .|.
T Consensus 20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~----------~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~ 89 (375)
T KOG0591|consen 20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFG----------MMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFI 89 (375)
T ss_pred HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchh----------hccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhh
Confidence 355666999999999999999999999998855422 122223477889999999999999999998 455
Q ss_pred eCC-eEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCC-CCceeCCCCCCCEEEccC
Q 020641 95 EGN-LRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQ-PSIIHRDIRSSNVLLFED 172 (323)
Q Consensus 95 ~~~-~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~-~~i~h~dikp~nili~~~ 172 (323)
+++ .+++|||+|++|+|.+.++..... +..+++.++|+++.|++.||.++|.+.. +.++||||||.||+++.+
T Consensus 90 ~~~evlnivmE~c~~GDLsqmIk~~K~q-----kr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~ 164 (375)
T KOG0591|consen 90 EDNEVLNIVMELCDAGDLSQMIKHFKKQ-----KRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTAN 164 (375)
T ss_pred ccchhhHHHHHhhcccCHHHHHHHHHhc-----cccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCC
Confidence 444 489999999999999999765432 2239999999999999999999999421 138999999999999999
Q ss_pred CeEEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhh
Q 020641 173 FKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTW 252 (323)
Q Consensus 173 ~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 252 (323)
|.+||+|||+++.+..... ......|||.|++||.+.+.+|+.++||||+||++|||..-.+||.+.+-
T Consensus 165 gvvKLGDfGL~r~l~s~~t--fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~--------- 233 (375)
T KOG0591|consen 165 GVVKLGDFGLGRFLSSKTT--FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNL--------- 233 (375)
T ss_pred CceeeccchhHhHhcchhH--HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccH---------
Confidence 9999999999988765332 23456799999999999999999999999999999999999999986631
Q ss_pred hcccccccccchhcCCCcCCCCC-HHHHHHHHHHHHHccCCCCCCCCChHHHHHHH
Q 020641 253 ATPRLSEDKVKQCVDPKLKGEYP-PKGVAKLAAVAALCVQYEAEFRPNMSIVVKAL 307 (323)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l 307 (323)
..+.+.+.+.--...| .-.++++.++|..|+..||+.||+...++.-+
T Consensus 234 -------~~L~~KI~qgd~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di 282 (375)
T KOG0591|consen 234 -------LSLCKKIEQGDYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDI 282 (375)
T ss_pred -------HHHHHHHHcCCCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHH
Confidence 1222222222222234 56688999999999999999999854444333
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-48 Score=340.45 Aligned_cols=255 Identities=28% Similarity=0.424 Sum_probs=218.3
Q ss_pred ccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeCCeE
Q 020641 20 FVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLR 99 (323)
Q Consensus 20 ~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 99 (323)
..+||+|-||.||++....+.. +|+|.+.. ..-..+.|.+|+++|++|+|+||++++++|..+..+
T Consensus 211 ~~~LG~G~FG~V~~g~~~~~~~-vavk~ik~-------------~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~pi 276 (468)
T KOG0197|consen 211 IRELGSGQFGEVWLGKWNGSTK-VAVKTIKE-------------GSMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPI 276 (468)
T ss_pred HHHhcCCccceEEEEEEcCCCc-ccceEEec-------------cccChhHHHHHHHHHHhCcccCeEEEEEEEecCCce
Confidence 3489999999999999876533 45553321 123347788999999999999999999999999899
Q ss_pred EEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEEEee
Q 020641 100 VLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIAD 179 (323)
Q Consensus 100 ~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~l~D 179 (323)
||||||+..|+|.++++..... .+.....+.++.||++|++||+++ ++|||||..+|||+++++.+||+|
T Consensus 277 yIVtE~m~~GsLl~yLr~~~~~-------~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsD 346 (468)
T KOG0197|consen 277 YIVTEYMPKGSLLDYLRTREGG-------LLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISD 346 (468)
T ss_pred EEEEEecccCcHHHHhhhcCCC-------ccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcc
Confidence 9999999999999999874333 288999999999999999999999 999999999999999999999999
Q ss_pred ccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhccccc
Q 020641 180 FNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPRLS 258 (323)
Q Consensus 180 fg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~ 258 (323)
||+|+...+.... ......-+..|.|||.+....++.++||||||++||||+| |+.|+.. .+
T Consensus 347 FGLAr~~~d~~Y~-~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~----------------ms 409 (468)
T KOG0197|consen 347 FGLARLIGDDEYT-ASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPG----------------MS 409 (468)
T ss_pred cccccccCCCcee-ecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCC----------------CC
Confidence 9999954433222 2222223667999999999999999999999999999999 9999853 45
Q ss_pred ccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhhcCCC
Q 020641 259 EDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSPP 315 (323)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~~~~~ 315 (323)
..++.+.++.+.+...|..+|..++++|..||+.+|++|||++.+...|+++.....
T Consensus 410 n~ev~~~le~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~~~ 466 (468)
T KOG0197|consen 410 NEEVLELLERGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTSTE 466 (468)
T ss_pred HHHHHHHHhccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhccc
Confidence 778888999999999999999999999999999999999999999999999876543
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-47 Score=305.90 Aligned_cols=277 Identities=21% Similarity=0.249 Sum_probs=220.4
Q ss_pred CccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeC
Q 020641 17 PGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEG 96 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 96 (323)
|....+||+|.||.||+|++..+++.||+|.+.... ..+.......+|++.|+.++|+||+.++++|...
T Consensus 4 Y~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~----------~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~ 73 (318)
T KOG0659|consen 4 YEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGN----------AKDGINRTALREIKLLQELKHPNIIELIDVFPHK 73 (318)
T ss_pred hhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccc----------cccCccHHHHHHHHHHHHccCcchhhhhhhccCC
Confidence 445568999999999999999999999999665432 2233345668999999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEE
Q 020641 97 NLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAK 176 (323)
Q Consensus 97 ~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~ 176 (323)
....+|+||++. +|...+++...- ++..++..++.++++|++|||.+ .|+||||||.|+|++.+|.+|
T Consensus 74 ~~l~lVfEfm~t-dLe~vIkd~~i~--------l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lK 141 (318)
T KOG0659|consen 74 SNLSLVFEFMPT-DLEVVIKDKNII--------LSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLK 141 (318)
T ss_pred CceEEEEEeccc-cHHHHhcccccc--------cCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEE
Confidence 999999999987 999999887643 88999999999999999999999 999999999999999999999
Q ss_pred EeeccccCCCCccccccccccccCccccCCCccccCC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhcc
Q 020641 177 IADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG-QLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATP 255 (323)
Q Consensus 177 l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~ 255 (323)
|+|||+++.+.......... .-|.+|+|||++.|. .|+...||||+||++.||+.|.+-|.+..+.++...+...-.
T Consensus 142 iADFGLAr~f~~p~~~~~~~--V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LG 219 (318)
T KOG0659|consen 142 IADFGLARFFGSPNRIQTHQ--VVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALG 219 (318)
T ss_pred eecccchhccCCCCcccccc--eeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcC
Confidence 99999999887654433222 468999999999875 689999999999999999999998888776554443333222
Q ss_pred cccccccchhc-----------CCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhhcCCCCCCC
Q 020641 256 RLSEDKVKQCV-----------DPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSPPPAAP 319 (323)
Q Consensus 256 ~~~~~~~~~~~-----------~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~~~~~~~~~ 319 (323)
+...+..+++. ............+.+..+|+.+||.+||.+|+|++|.++ ...++..|+|.+
T Consensus 220 TP~~~~WP~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~--~~yf~~~P~pt~ 292 (318)
T KOG0659|consen 220 TPTPDQWPEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALK--HPYFKSLPLPTP 292 (318)
T ss_pred CCCcccCccccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhc--chhhhcCCCCCC
Confidence 22222222111 111122244456677899999999999999999999998 566665555544
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-47 Score=329.10 Aligned_cols=281 Identities=18% Similarity=0.214 Sum_probs=217.4
Q ss_pred CCCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEE
Q 020641 15 PSPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCV 94 (323)
Q Consensus 15 ~~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 94 (323)
..|+.+.+||+|.||.||+|++..+++.||+|.+..+ ........-..+|+.+|++|+||||+++.+.+.
T Consensus 117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d----------~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt 186 (560)
T KOG0600|consen 117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFD----------NEKEGFPITAIREIKILRRLDHPNIIKLEEIVT 186 (560)
T ss_pred HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecc----------cCCCcchHHHHHHHHHHHhcCCCcccceeeEEE
Confidence 4456667999999999999999999999999966533 233455566789999999999999999999988
Q ss_pred eC--CeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccC
Q 020641 95 EG--NLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFED 172 (323)
Q Consensus 95 ~~--~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~ 172 (323)
+. ..+|||+|||++ +|.-++....-+ |++.+++.++.||+.||.|||.+ |++|||||..|||||.+
T Consensus 187 ~~~~~siYlVFeYMdh-DL~GLl~~p~vk--------ft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~ 254 (560)
T KOG0600|consen 187 SKLSGSIYLVFEYMDH-DLSGLLSSPGVK--------FTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNN 254 (560)
T ss_pred ecCCceEEEEEecccc-hhhhhhcCCCcc--------cChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCC
Confidence 76 689999999998 999998765433 99999999999999999999999 99999999999999999
Q ss_pred CeEEEeeccccCCCCccccccccccccCccccCCCccccCC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhh
Q 020641 173 FKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG-QLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVT 251 (323)
Q Consensus 173 ~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~ 251 (323)
|.+||+|||+|+.+....... .+...-|.+|+|||++.|. .|+.+.|+||+||++.||+.|++.|.+.....+...+.
T Consensus 255 G~LKiaDFGLAr~y~~~~~~~-~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIf 333 (560)
T KOG0600|consen 255 GVLKIADFGLARFYTPSGSAP-YTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIF 333 (560)
T ss_pred CCEEeccccceeeccCCCCcc-cccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHH
Confidence 999999999999766544332 2333469999999999975 68999999999999999999999998876544433332
Q ss_pred hhccc-----ccccccchhcCCCcCCC-------CCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhhcCCCCCCC
Q 020641 252 WATPR-----LSEDKVKQCVDPKLKGE-------YPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSPPPAAP 319 (323)
Q Consensus 252 ~~~~~-----~~~~~~~~~~~~~~~~~-------~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~~~~~~~~~ 319 (323)
..=.. |....++.......... .....+....+|+..+|..||.+|.|+.+.++ .+.+...|.+++
T Consensus 334 klcGSP~e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~--seyF~t~p~~~~ 411 (560)
T KOG0600|consen 334 KLCGSPTEDYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ--SEYFTTEPLPCD 411 (560)
T ss_pred HHhCCCChhccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc--CcccccCCCCCC
Confidence 11111 11111110000000011 12234567889999999999999999999987 666655555544
Q ss_pred C
Q 020641 320 V 320 (323)
Q Consensus 320 ~ 320 (323)
+
T Consensus 412 p 412 (560)
T KOG0600|consen 412 P 412 (560)
T ss_pred c
Confidence 3
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-48 Score=333.31 Aligned_cols=265 Identities=19% Similarity=0.288 Sum_probs=215.0
Q ss_pred CCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCC-CCcccceeeEEE
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLK-HENLVELLGYCV 94 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~ 94 (323)
.|..+.+||.|.||+||+|+...++..||+|...++.+.-.+.. -.+|+..|++++ ||||+++.+++.
T Consensus 11 RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~-----------nLREvksL~kln~hpniikL~Evi~ 79 (538)
T KOG0661|consen 11 RYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECM-----------NLREVKSLRKLNPHPNIIKLKEVIR 79 (538)
T ss_pred HHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHH-----------HHHHHHHHHhcCCCCcchhhHHHhh
Confidence 35566799999999999999999999999997776655533322 258999999996 999999999999
Q ss_pred eCC-eEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCC
Q 020641 95 EGN-LRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDF 173 (323)
Q Consensus 95 ~~~-~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~ 173 (323)
+.+ .+|+|||||+. +|.++++++.. .+++..+..|+.||++||+|+|++ |+.|||+||+|||+..+.
T Consensus 80 d~~~~L~fVfE~Md~-NLYqLmK~R~r--------~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~ 147 (538)
T KOG0661|consen 80 DNDRILYFVFEFMDC-NLYQLMKDRNR--------LFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGND 147 (538)
T ss_pred ccCceEeeeHHhhhh-hHHHHHhhcCC--------cCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccc
Confidence 888 99999999986 99999998843 299999999999999999999999 999999999999999999
Q ss_pred eEEEeeccccCCCCccccccccccccCccccCCCccccC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhh
Q 020641 174 KAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT-GQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTW 252 (323)
Q Consensus 174 ~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 252 (323)
.+||+|||+|+....... .+....|.+|+|||++.. .-|+.+.|+|++||+++|+.+-++.|.+.+..++-..+..
T Consensus 148 ~iKiaDFGLARev~SkpP---YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~ 224 (538)
T KOG0661|consen 148 VIKIADFGLAREVRSKPP---YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICE 224 (538)
T ss_pred eeEecccccccccccCCC---cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHH
Confidence 999999999998775443 355567999999998864 5679999999999999999999999998877655554443
Q ss_pred hcccccccccc------hhcCCCcC-------CCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHH
Q 020641 253 ATPRLSEDKVK------QCVDPKLK-------GEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKA 306 (323)
Q Consensus 253 ~~~~~~~~~~~------~~~~~~~~-------~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~ 306 (323)
........... ..++-.+. ...-...+.+..++|.+|+++||++|||+.++++.
T Consensus 225 VLGtP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 225 VLGTPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HhCCCccccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 33333222222 22221111 11112367889999999999999999999999873
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-47 Score=319.83 Aligned_cols=256 Identities=19% Similarity=0.225 Sum_probs=214.2
Q ss_pred CCCccccc--cCCCCCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcC
Q 020641 4 DYHPRALG--AHAPSPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRL 81 (323)
Q Consensus 4 ~~~~~~~~--~~~~~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l 81 (323)
++.|.... .+...++....||+|+||.||+|+...+++.+|.|+..++.+-.. ......++|..+|.++
T Consensus 12 ~~~p~~~~~~~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~---------~e~~~~~~Er~IL~~v 82 (357)
T KOG0598|consen 12 SYKPSNNAEMVGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEK---------KEVRHTKAERNILSKI 82 (357)
T ss_pred ccCCCcccccCChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhh---------hhHHHHHHHHHHHHhC
Confidence 45555553 445566777799999999999999999999999999887655443 2347788999999999
Q ss_pred CCCcccceeeEEEeCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCC
Q 020641 82 KHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRD 161 (323)
Q Consensus 82 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~d 161 (323)
+||.|++++..|++...+|+|+||+.||.|...+++... +++..+.-++..|+.||.|||++ ||+|||
T Consensus 83 ~hPFiv~l~ysFQt~~kLylVld~~~GGeLf~hL~~eg~---------F~E~~arfYlaEi~lAL~~LH~~---gIiyRD 150 (357)
T KOG0598|consen 83 KHPFIVKLIYSFQTEEKLYLVLDYLNGGELFYHLQREGR---------FSEDRARFYLAEIVLALGYLHSK---GIIYRD 150 (357)
T ss_pred CCCcEeeeEEecccCCeEEEEEeccCCccHHHHHHhcCC---------cchhHHHHHHHHHHHHHHHHHhC---Ceeecc
Confidence 999999999999999999999999999999999987654 99999999999999999999999 999999
Q ss_pred CCCCCEEEccCCeEEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCC
Q 020641 162 IRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHT 241 (323)
Q Consensus 162 ikp~nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 241 (323)
+||+|||++.+|.++|+|||++....... ......+||+.|+|||++.+.+++..+|.||||+++|+|++|..||...
T Consensus 151 lKPENILLd~~GHi~LtDFgL~k~~~~~~--~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~ 228 (357)
T KOG0598|consen 151 LKPENILLDEQGHIKLTDFGLCKEDLKDG--DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAE 228 (357)
T ss_pred CCHHHeeecCCCcEEEeccccchhcccCC--CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCc
Confidence 99999999999999999999998654432 2335578999999999999999999999999999999999999999866
Q ss_pred CCcccchhhhhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCC
Q 020641 242 MPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRP 298 (323)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp 298 (323)
+.......+ +... ....+.-.+.+.++++.++|..||++|.
T Consensus 229 ~~~~~~~~I---------------~~~k-~~~~p~~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 229 DVKKMYDKI---------------LKGK-LPLPPGYLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred cHHHHHHHH---------------hcCc-CCCCCccCCHHHHHHHHHHhccCHHHhc
Confidence 542221111 1111 1223344667899999999999999996
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=326.07 Aligned_cols=270 Identities=51% Similarity=0.826 Sum_probs=228.4
Q ss_pred cccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeCC-eE
Q 020641 21 VRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGN-LR 99 (323)
Q Consensus 21 ~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~ 99 (323)
.+||+|+||.||++....+ +.+|+|..... .... ..+|.+|++++.+++|+|+++++|+|.+.+ ..
T Consensus 81 ~~ig~Ggfg~VYkG~l~~~-~~vAVK~~~~~-----------~~~~-~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~ 147 (361)
T KOG1187|consen 81 NLIGEGGFGTVYKGVLSDG-TVVAVKRLSSN-----------SGQG-EREFLNEVEILSRLRHPNLVKLLGYCLEGGEHR 147 (361)
T ss_pred cceecCCCeEEEEEEECCC-CEEEEEEecCC-----------CCcc-hhHHHHHHHHHhcCCCcCcccEEEEEecCCceE
Confidence 3799999999999988776 67777733211 0111 355999999999999999999999999998 59
Q ss_pred EEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEEEee
Q 020641 100 VLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIAD 179 (323)
Q Consensus 100 ~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~l~D 179 (323)
+||+||+.+|+|.+.+...... .++|....+|+.++|.||+|||..+.+.|+|||||+.|||+|.+++.||+|
T Consensus 148 ~LVYEym~nGsL~d~L~~~~~~-------~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsD 220 (361)
T KOG1187|consen 148 LLVYEYMPNGSLEDHLHGKKGE-------PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSD 220 (361)
T ss_pred EEEEEccCCCCHHHHhCCCCCC-------CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccC
Confidence 9999999999999999876532 289999999999999999999999877799999999999999999999999
Q ss_pred ccccCCCCc-cccccccccc-cCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccc
Q 020641 180 FNLSNQAPD-MAARLHSTRV-LGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRL 257 (323)
Q Consensus 180 fg~~~~~~~-~~~~~~~~~~-~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 257 (323)
||+|..... .... ... .||.+|++||.......+.++||||||+++.||++|+.+.+............|....+
T Consensus 221 FGLa~~~~~~~~~~---~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~ 297 (361)
T KOG1187|consen 221 FGLAKLGPEGDTSV---STTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLL 297 (361)
T ss_pred ccCcccCCccccce---eeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHH
Confidence 999966554 2211 111 68999999999988889999999999999999999999888665555555788888888
Q ss_pred cccccchhcCCCcC-CCCCH-HHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhhcC
Q 020641 258 SEDKVKQCVDPKLK-GEYPP-KGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKS 313 (323)
Q Consensus 258 ~~~~~~~~~~~~~~-~~~~~-~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~~~ 313 (323)
....+.+++|+.+. ...+. .....+..+..+|++.+|.+||++.||++.|+.+...
T Consensus 298 ~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~ 355 (361)
T KOG1187|consen 298 EEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL 355 (361)
T ss_pred HCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence 78899999999987 55554 6778899999999999999999999999999776654
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-46 Score=328.90 Aligned_cols=254 Identities=22% Similarity=0.355 Sum_probs=214.7
Q ss_pred ccCCCCCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCccccee
Q 020641 11 GAHAPSPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELL 90 (323)
Q Consensus 11 ~~~~~~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~ 90 (323)
+.....|..++++|+|+.|.||.|....+++.||+|.+.... ..-.+-+.+|+.+|+..+|+|||.++
T Consensus 269 ~dP~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~------------Q~~keLilnEi~Vm~~~~H~NiVnfl 336 (550)
T KOG0578|consen 269 GDPRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRK------------QPKKELLLNEILVMRDLHHPNIVNFL 336 (550)
T ss_pred CChhhhhcchhhhccccccceeeeeeccCCceEEEEEEEecc------------CCchhhhHHHHHHHHhccchHHHHHH
Confidence 344456777889999999999999999999999999776432 22235678999999999999999999
Q ss_pred eEEEeCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEc
Q 020641 91 GYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLF 170 (323)
Q Consensus 91 ~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~ 170 (323)
+.|...+.+|+||||++||+|.|.+.... +++.++..+++.++.||+|||.+ ||+|||||.+|||++
T Consensus 337 ~Sylv~deLWVVMEym~ggsLTDvVt~~~----------~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~ 403 (550)
T KOG0578|consen 337 DSYLVGDELWVVMEYMEGGSLTDVVTKTR----------MTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLT 403 (550)
T ss_pred HHhcccceeEEEEeecCCCchhhhhhccc----------ccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEec
Confidence 99999999999999999999999998776 89999999999999999999999 999999999999999
Q ss_pred cCCeEEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhh
Q 020641 171 EDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLV 250 (323)
Q Consensus 171 ~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~ 250 (323)
.+|.+||+|||....+..... ......|||.|+|||++....|+++.||||||++++||+.|++||-.........++
T Consensus 404 ~~g~vKltDFGFcaqi~~~~~--KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLI 481 (550)
T KOG0578|consen 404 MDGSVKLTDFGFCAQISEEQS--KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI 481 (550)
T ss_pred cCCcEEEeeeeeeeccccccC--ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHH
Confidence 999999999999887765443 235566999999999999999999999999999999999999999643321111111
Q ss_pred hhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 251 TWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
.. +.......+...+..+++|+.+||..|+++|+|+.|+|+
T Consensus 482 a~--------------ng~P~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~ 522 (550)
T KOG0578|consen 482 AT--------------NGTPKLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLE 522 (550)
T ss_pred hh--------------cCCCCcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence 10 111122345667788999999999999999999999997
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-46 Score=325.66 Aligned_cols=253 Identities=19% Similarity=0.221 Sum_probs=210.8
Q ss_pred CCCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcC-CCCcccceeeEE
Q 020641 15 PSPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRL-KHENLVELLGYC 93 (323)
Q Consensus 15 ~~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~ 93 (323)
..+.+-.-||+|+|++|++|++..+++.+|+|+..++.+-.... .+.+..|-++|.+| .||.|++++..|
T Consensus 73 ~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~K---------vkYV~~Ek~~l~~L~~hPgivkLy~TF 143 (604)
T KOG0592|consen 73 NDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKK---------VKYVTREKEALTQLSGHPGIVKLYFTF 143 (604)
T ss_pred hhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcc---------cchhhHHHHHHHHhhCCCCeEEEEEEe
Confidence 34445457899999999999999999999999888765544333 24456677788888 999999999999
Q ss_pred EeCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCC
Q 020641 94 VEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDF 173 (323)
Q Consensus 94 ~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~ 173 (323)
.+...+|+|+||+.+|+|.++|++... +++..+..++.+|+.||.|||+. ||+||||||+|||+++++
T Consensus 144 QD~~sLYFvLe~A~nGdll~~i~K~Gs---------fde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dm 211 (604)
T KOG0592|consen 144 QDEESLYFVLEYAPNGDLLDLIKKYGS---------FDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDG 211 (604)
T ss_pred ecccceEEEEEecCCCcHHHHHHHhCc---------chHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCC
Confidence 999999999999999999999988753 99999999999999999999999 999999999999999999
Q ss_pred eEEEeeccccCCCCccccc---------ccc--ccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCC
Q 020641 174 KAKIADFNLSNQAPDMAAR---------LHS--TRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTM 242 (323)
Q Consensus 174 ~~~l~Dfg~~~~~~~~~~~---------~~~--~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 242 (323)
+++|.|||.|..+...... ... ....||..|.+||++.....+..+|+|+|||++|+|+.|.+||...+
T Consensus 212 hikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~N 291 (604)
T KOG0592|consen 212 HIKITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAAN 291 (604)
T ss_pred cEEEeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCcccc
Confidence 9999999999877543222 111 34679999999999999999999999999999999999999998665
Q ss_pred CcccchhhhhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 243 PRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
..... ++++.- .-.++...++...+|+++.|..||.+|+|+++|-+
T Consensus 292 eyliF---------------qkI~~l--~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~ 337 (604)
T KOG0592|consen 292 EYLIF---------------QKIQAL--DYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKA 337 (604)
T ss_pred HHHHH---------------HHHHHh--cccCCCCCCHHHHHHHHHHHccCccccccHHHHhh
Confidence 42221 122211 12345555678999999999999999999998876
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-45 Score=316.03 Aligned_cols=267 Identities=24% Similarity=0.288 Sum_probs=213.4
Q ss_pred ccCCCCCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCccccee
Q 020641 11 GAHAPSPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELL 90 (323)
Q Consensus 11 ~~~~~~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~ 90 (323)
....-.|++.+.||.|..++||+|....++.+||+|++..+.+... .+.+++|+..|+.++||||++++
T Consensus 22 p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~-----------ld~l~kE~~~msl~~HPNIv~~~ 90 (516)
T KOG0582|consen 22 PLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND-----------LDALRKEVQTMSLIDHPNIVTYH 90 (516)
T ss_pred CCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh-----------HHHHHHHHHHhhhcCCCCcceEE
Confidence 4455678888999999999999999999999999998886654433 37789999999999999999999
Q ss_pred eEEEeCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEc
Q 020641 91 GYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLF 170 (323)
Q Consensus 91 ~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~ 170 (323)
..|..+..+|+||+||.+||+.+.++..-... +.+..+..+++++++||.|||.+ |.+|||||+.|||++
T Consensus 91 ~sFvv~~~LWvVmpfMa~GS~ldIik~~~~~G-------l~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~ 160 (516)
T KOG0582|consen 91 CSFVVDSELWVVMPFMAGGSLLDIIKTYYPDG-------LEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILID 160 (516)
T ss_pred EEEEecceeEEeehhhcCCcHHHHHHHHcccc-------ccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEc
Confidence 99999999999999999999999998765433 99999999999999999999999 999999999999999
Q ss_pred cCCeEEEeeccccCCCCccccccc-c-ccccCccccCCCcccc--CCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccc
Q 020641 171 EDFKAKIADFNLSNQAPDMAARLH-S-TRVLGTFGYHAPEYAM--TGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQ 246 (323)
Q Consensus 171 ~~~~~~l~Dfg~~~~~~~~~~~~~-~-~~~~g~~~y~aPE~~~--~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~ 246 (323)
.+|.++|+|||.+..+...+.... . ....|++.|+|||++. ..+|+.|+||||||++..||.+|..||....+..-
T Consensus 161 ~dG~VkLadFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkv 240 (516)
T KOG0582|consen 161 SDGTVKLADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKV 240 (516)
T ss_pred CCCcEEEcCceeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHH
Confidence 999999999998765543332211 1 4456999999999864 46799999999999999999999999986643221
Q ss_pred chhhhhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 247 QSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
.... ..+..... ... ..........+..+++++..||.+||.+|||++++++
T Consensus 241 Ll~t-Lqn~pp~~--~t~----~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 241 LLLT-LQNDPPTL--LTS----GLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred HHHH-hcCCCCCc--ccc----cCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 1100 00000000 000 1111112234458999999999999999999999986
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-47 Score=324.02 Aligned_cols=250 Identities=24% Similarity=0.353 Sum_probs=214.0
Q ss_pred CCCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEE
Q 020641 15 PSPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCV 94 (323)
Q Consensus 15 ~~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 94 (323)
..|..+.+||.|+||.||++.+..+++.+|+|++.. ...+...+++++|+.++.+++++||.++++.+.
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~L-----------e~~~deIediqqei~~Ls~~~~~~it~yygsyl 81 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDL-----------EEAEDEIEDIQQEISVLSQCDSPNITEYYGSYL 81 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEech-----------hhcchhhHHHHHHHHHHHhcCcchHHhhhhhee
Confidence 344555789999999999999999999999997763 334555688999999999999999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCe
Q 020641 95 EGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFK 174 (323)
Q Consensus 95 ~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~ 174 (323)
.+..+|++||||.||++.+.++...- +.+..+..++++++.|+.|||.. +.+|||||+.||++..+|.
T Consensus 82 ~g~~LwiiMey~~gGsv~~lL~~~~~---------~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~ 149 (467)
T KOG0201|consen 82 KGTKLWIIMEYCGGGSVLDLLKSGNI---------LDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGD 149 (467)
T ss_pred ecccHHHHHHHhcCcchhhhhccCCC---------CccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCc
Confidence 99999999999999999999987652 47778889999999999999999 9999999999999999999
Q ss_pred EEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhc
Q 020641 175 AKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWAT 254 (323)
Q Consensus 175 ~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~ 254 (323)
++|+|||++....+..... .+..||+.|||||++.+..|+.++||||||++.+||++|.+|+.....
T Consensus 150 vkl~DfgVa~ql~~~~~rr--~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hP----------- 216 (467)
T KOG0201|consen 150 VKLADFGVAGQLTNTVKRR--KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHP----------- 216 (467)
T ss_pred EEEEecceeeeeechhhcc--ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCc-----------
Confidence 9999999998887655443 566799999999999999999999999999999999999999976543
Q ss_pred ccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 255 PRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
..+.-.+...........++..+++|+..||.+||+.||||.++++
T Consensus 217 -----mrvlflIpk~~PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 217 -----MRVLFLIPKSAPPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred -----ceEEEeccCCCCCccccccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 2222222222222333466778999999999999999999999987
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-46 Score=297.01 Aligned_cols=264 Identities=19% Similarity=0.232 Sum_probs=210.9
Q ss_pred CCCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEE
Q 020641 15 PSPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCV 94 (323)
Q Consensus 15 ~~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 94 (323)
..|....+||+|||+-||+++...+++.+|+|.+.- ...+..+..++|++..++++|||+++++++..
T Consensus 21 ~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c------------~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l 88 (302)
T KOG2345|consen 21 KRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILC------------HSQEDIEEALREIDNHRKFNSPNVLRLVDHQL 88 (302)
T ss_pred ceEEEeeeecCCCceeeeeecccCcccchhhheeec------------cchHHHHHHHHHHHHHHhhCCcchHHHHHHHH
Confidence 345566699999999999999999999999986542 22344577899999999999999999999875
Q ss_pred eCC-----eEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC--ceeCCCCCCCE
Q 020641 95 EGN-----LRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPS--IIHRDIRSSNV 167 (323)
Q Consensus 95 ~~~-----~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~--i~h~dikp~ni 167 (323)
.+. ..|++++|+..|||.+.+........ .+++..+..++.++++||.+||.. . +.||||||.||
T Consensus 89 ~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~-----~~sE~~iL~if~gic~gL~~lH~~---~~~yAH~DiKP~NI 160 (302)
T KOG2345|consen 89 REEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGN-----FVSEAQILWIFLGICRGLEALHEK---EPPYAHRDIKPANI 160 (302)
T ss_pred HhhccCceeEEEEeehhccccHHHHHHHHhhcCC-----ccCHHHHHHHHHHHHHHHHHHhcc---CCcccccCCCccee
Confidence 433 48999999999999999987654322 399999999999999999999999 7 99999999999
Q ss_pred EEccCCeEEEeeccccCCCCccccccc-------cccccCccccCCCcccc---CCCCCcccchHHHHHHHHHHHhCCCC
Q 020641 168 LLFEDFKAKIADFNLSNQAPDMAARLH-------STRVLGTFGYHAPEYAM---TGQLTQKSDVYSFGVVLLELLTGRKP 237 (323)
Q Consensus 168 li~~~~~~~l~Dfg~~~~~~~~~~~~~-------~~~~~g~~~y~aPE~~~---~~~~~~~~Di~slG~~l~~l~~g~~p 237 (323)
|+++.+.++|.|||+++.....-.... -.....|..|+|||++. +...++++|||||||++|.|++|..|
T Consensus 161 Lls~~~~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sP 240 (302)
T KOG2345|consen 161 LLSDSGLPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESP 240 (302)
T ss_pred EecCCCceEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCc
Confidence 999999999999999987754322111 11223688999999885 45678999999999999999999999
Q ss_pred CCCCCCcccchhhhhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhh
Q 020641 238 VDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLL 311 (323)
Q Consensus 238 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~ 311 (323)
|+....+..... ..+.++.+........++.+.+++++||+.||.+||++.+++..+++++
T Consensus 241 fe~~~~~GgSla-------------LAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 241 FERIYQQGGSLA-------------LAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred chHHhhcCCeEE-------------EeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 975533222111 1222223333333347788999999999999999999999999999875
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-45 Score=324.60 Aligned_cols=259 Identities=21% Similarity=0.261 Sum_probs=209.6
Q ss_pred CCCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCC-CCcccceeeEE
Q 020641 15 PSPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLK-HENLVELLGYC 93 (323)
Q Consensus 15 ~~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~ 93 (323)
-.|..-..||+|+||.|+++.+..+++.+|+|++.++..... . ....+.+.+|+.++++++ ||||+++++++
T Consensus 17 g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~------~-~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~ 89 (370)
T KOG0583|consen 17 GKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSK------S-QKLDELIKREISILRRLRSHPNIIRLLEVF 89 (370)
T ss_pred CceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhccccc------c-cccchhhHHHHHHHHHhccCCCEeEEEEEE
Confidence 345555689999999999999999999999996655421111 1 123456678999999997 99999999999
Q ss_pred EeCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccC-
Q 020641 94 VEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFED- 172 (323)
Q Consensus 94 ~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~- 172 (323)
.....+|+||||+.||+|.+++.+... +.+..+..+++|++.|+.|||+. ||+||||||+|++++.+
T Consensus 90 ~t~~~~~ivmEy~~gGdL~~~i~~~g~---------l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~ 157 (370)
T KOG0583|consen 90 ATPTKIYIVMEYCSGGDLFDYIVNKGR---------LKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNE 157 (370)
T ss_pred ecCCeEEEEEEecCCccHHHHHHHcCC---------CChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCC
Confidence 999999999999999999999988332 88999999999999999999999 99999999999999999
Q ss_pred CeEEEeeccccCCCCccccccccccccCccccCCCccccCCC-CC-cccchHHHHHHHHHHHhCCCCCCCCCCcccchhh
Q 020641 173 FKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQ-LT-QKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLV 250 (323)
Q Consensus 173 ~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~-~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~ 250 (323)
+++||+|||++.... .........+|++.|+|||++.+.. |+ .++||||+|++||.|++|..||...........
T Consensus 158 ~~~Kl~DFG~s~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~k- 234 (370)
T KOG0583|consen 158 GNLKLSDFGLSAISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRK- 234 (370)
T ss_pred CCEEEeccccccccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHH-
Confidence 999999999998774 1222345667999999999999877 85 799999999999999999999987433211111
Q ss_pred hhhcccccccccchhcCCCcCCCCCHHH-HHHHHHHHHHccCCCCCCCCChHHHHHHHhhhhcC
Q 020641 251 TWATPRLSEDKVKQCVDPKLKGEYPPKG-VAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKS 313 (323)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~~~ 313 (323)
+.... -..+... +.++..++.+||..||..|+|+.+|+ ....++.
T Consensus 235 --------------i~~~~--~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~--~h~w~~~ 280 (370)
T KOG0583|consen 235 --------------IRKGE--FKIPSYLLSPEARSLIEKMLVPDPSTRITLLEIL--EHPWFQK 280 (370)
T ss_pred --------------HhcCC--ccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHh--hChhhcc
Confidence 11111 1223333 77899999999999999999999999 3555543
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-46 Score=340.75 Aligned_cols=272 Identities=25% Similarity=0.420 Sum_probs=230.6
Q ss_pred ccccccCCCCCCccceeccceee-----eeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeE
Q 020641 18 GYFVRLDKGPEDDLYLKKRVKMR-----RWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGY 92 (323)
Q Consensus 18 ~~~~~lg~G~~~~V~~~~~~~~~-----~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 92 (323)
++..+||+|+||.||+++-..-. ..||+|....+ ...+.+++|++|++++..++|||||+++|+
T Consensus 489 ~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~-----------a~~~~~~dF~REaeLla~l~H~nIVrLlGV 557 (774)
T KOG1026|consen 489 VFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDK-----------AENQARQDFRREAELLAELQHPNIVRLLGV 557 (774)
T ss_pred eehhhhcCchhhhhhhhhccCCCCCccceehhHhhhccc-----------ccHHHHHHHHHHHHHHHhccCCCeEEEEEE
Confidence 45569999999999999887543 45666633211 122246899999999999999999999999
Q ss_pred EEeCCeEEEEEeecCCCCHHHHhccCCCCCCCC-----CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCE
Q 020641 93 CVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQ-----PGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNV 167 (323)
Q Consensus 93 ~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~ni 167 (323)
|.+++..++|+|||..|+|.+|+.......... ....++..+.+.++.||+.|+.||-++ .++||||-.+|+
T Consensus 558 C~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNC 634 (774)
T KOG1026|consen 558 CREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNC 634 (774)
T ss_pred EccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhc
Confidence 999999999999999999999998765432221 134499999999999999999999999 999999999999
Q ss_pred EEccCCeEEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCccc
Q 020641 168 LLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQ 246 (323)
Q Consensus 168 li~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~ 246 (323)
||.++..|||+|||+++..-............-+.+||+||.+...+++.++||||+||++||+++ |+-||.+.
T Consensus 635 LVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~gl----- 709 (774)
T KOG1026|consen 635 LVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGL----- 709 (774)
T ss_pred eeccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCccccc-----
Confidence 999999999999999988776666655544456789999999999999999999999999999998 99999755
Q ss_pred chhhhhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhhcCCCCCCC
Q 020641 247 QSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSPPPAAP 319 (323)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~~~~~~~~~ 319 (323)
.+.++.+.+..+-....|..++.++++||.+||+.+|.+|||++||-..|+.+....+.-..
T Consensus 710 -----------Sn~EVIe~i~~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s~~~~~ 771 (774)
T KOG1026|consen 710 -----------SNQEVIECIRAGQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQASPKYSS 771 (774)
T ss_pred -----------chHHHHHHHHcCCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcCccccc
Confidence 35666666666666788999999999999999999999999999999999999887765443
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-45 Score=317.00 Aligned_cols=263 Identities=22% Similarity=0.269 Sum_probs=210.1
Q ss_pred CccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccC--CCCCchHHHHHHHHHhcCCCCcccceeeEEE
Q 020641 17 PGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKS--PKNYPDDEKQLVSVVSRLKHENLVELLGYCV 94 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 94 (323)
|+....||+|.||.|-+|++..+++.+|+|++.++.......-.... .....+++++|+.+|++|.|+|||+++++..
T Consensus 99 y~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEvLD 178 (576)
T KOG0585|consen 99 YELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEVLD 178 (576)
T ss_pred eehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEeec
Confidence 45555899999999999999999999999999988766554322221 1122368999999999999999999999998
Q ss_pred eC--CeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccC
Q 020641 95 EG--NLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFED 172 (323)
Q Consensus 95 ~~--~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~ 172 (323)
+. +.+|||+|||..|.+...-.+.. -+++.++++++++++.||.|||.+ ||+||||||+|+|++++
T Consensus 179 DP~s~~~YlVley~s~G~v~w~p~d~~---------els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~~~ 246 (576)
T KOG0585|consen 179 DPESDKLYLVLEYCSKGEVKWCPPDKP---------ELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLSSD 246 (576)
T ss_pred CcccCceEEEEEeccCCccccCCCCcc---------cccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEcCC
Confidence 65 57899999999887755432221 188999999999999999999999 99999999999999999
Q ss_pred CeEEEeeccccCCCCcc---ccccccccccCccccCCCccccCCC----CCcccchHHHHHHHHHHHhCCCCCCCCCCcc
Q 020641 173 FKAKIADFNLSNQAPDM---AARLHSTRVLGTFGYHAPEYAMTGQ----LTQKSDVYSFGVVLLELLTGRKPVDHTMPRG 245 (323)
Q Consensus 173 ~~~~l~Dfg~~~~~~~~---~~~~~~~~~~g~~~y~aPE~~~~~~----~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 245 (323)
|++||+|||.+.....+ ..........|||.|+|||+..+.. .+.+.||||+|++||.|++|+.||.+...
T Consensus 247 g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~-- 324 (576)
T KOG0585|consen 247 GTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFE-- 324 (576)
T ss_pred CcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchH--
Confidence 99999999998766322 1111122356999999999987632 35689999999999999999999976543
Q ss_pred cchhhhhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHH
Q 020641 246 QQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKA 306 (323)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~ 306 (323)
.+...++++..+.....++..+++++||+++|.+||+.|.++.+|...
T Consensus 325 -------------~~l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~H 372 (576)
T KOG0585|consen 325 -------------LELFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLH 372 (576)
T ss_pred -------------HHHHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheec
Confidence 223344555555555555778899999999999999999999998754
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=314.48 Aligned_cols=252 Identities=25% Similarity=0.337 Sum_probs=200.6
Q ss_pred cccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeCC-
Q 020641 19 YFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGN- 97 (323)
Q Consensus 19 ~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~- 97 (323)
.-..||+|+||+||++.+.++++..|+|..... .... .+.+.+|+.+|++++|||||++++......
T Consensus 21 ~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~-----------~~~~-~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~ 88 (313)
T KOG0198|consen 21 KGKLLGRGSFGSVYLATNKKTGELMAVKSVELE-----------DSPT-SESLEREIRILSRLNHPNIVQYYGSSSSREN 88 (313)
T ss_pred hhccccCccceEEEEEEecCCCcceeeeeeecc-----------cchh-HHHHHHHHHHHHhCCCCCEEeeCCccccccC
Confidence 334789999999999999999999999855432 0000 466899999999999999999999855444
Q ss_pred -eEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEcc-CCeE
Q 020641 98 -LRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFE-DFKA 175 (323)
Q Consensus 98 -~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~-~~~~ 175 (323)
.++++|||+.+|+|.+++.+... . +++..+..+.+|+++|+.|||++ |++|+||||+|||++. ++.+
T Consensus 89 ~~~~i~mEy~~~GsL~~~~~~~g~-~-------l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~ 157 (313)
T KOG0198|consen 89 DEYNIFMEYAPGGSLSDLIKRYGG-K-------LPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDV 157 (313)
T ss_pred eeeEeeeeccCCCcHHHHHHHcCC-C-------CCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeE
Confidence 68999999999999999998764 2 99999999999999999999999 9999999999999999 7999
Q ss_pred EEeeccccCCCCc-cccccccccccCccccCCCccccC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhh
Q 020641 176 KIADFNLSNQAPD-MAARLHSTRVLGTFGYHAPEYAMT-GQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWA 253 (323)
Q Consensus 176 ~l~Dfg~~~~~~~-~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 253 (323)
||+|||++..... ...........||+.|+|||++.. .....++|||||||++.||+||+.||.......
T Consensus 158 KlaDFG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~-------- 229 (313)
T KOG0198|consen 158 KLADFGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEA-------- 229 (313)
T ss_pred EeccCccccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchH--------
Confidence 9999999886653 111122234569999999999985 334459999999999999999999997641100
Q ss_pred cccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHH
Q 020641 254 TPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKAL 307 (323)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l 307 (323)
..+..+.........+...+.+..+|+.+|+.+||+.|||+.++++.-
T Consensus 230 ------~~~~~ig~~~~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hp 277 (313)
T KOG0198|consen 230 ------EALLLIGREDSLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHP 277 (313)
T ss_pred ------HHHHHHhccCCCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhCh
Confidence 111111111111245566778899999999999999999999999854
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=319.83 Aligned_cols=268 Identities=23% Similarity=0.311 Sum_probs=201.8
Q ss_pred CccccccCCCCCCccceeccc-----eeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcC-CCCccccee
Q 020641 17 PGYFVRLDKGPEDDLYLKKRV-----KMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRL-KHENLVELL 90 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~~~-----~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~ 90 (323)
+....+||.|+||.||+|.+. .+++.+|+|...... .......+.+|+.+++.+ +||||++++
T Consensus 9 ~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~-----------~~~~~~~~~~E~~~l~~l~~h~niv~~~ 77 (338)
T cd05102 9 LRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA-----------TASEHKALMSELKILIHIGNHLNVVNLL 77 (338)
T ss_pred ceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc-----------chHHHHHHHHHHHHHHHhccCcceeeEE
Confidence 455568999999999999753 345567887553211 011235688999999999 899999999
Q ss_pred eEEEeCC-eEEEEEeecCCCCHHHHhccCCCCCC----------------------------------------------
Q 020641 91 GYCVEGN-LRVLAYEFATMGSLHDILHGRKGVQG---------------------------------------------- 123 (323)
Q Consensus 91 ~~~~~~~-~~~lv~e~~~~~sL~~~~~~~~~~~~---------------------------------------------- 123 (323)
+++...+ ..+++|||+.+|+|.+++........
T Consensus 78 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (338)
T cd05102 78 GACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGST 157 (338)
T ss_pred eEecCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCccc
Confidence 9887644 57999999999999999975421100
Q ss_pred -------CCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEEEeeccccCCCCccccccccc
Q 020641 124 -------AQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHST 196 (323)
Q Consensus 124 -------~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~ 196 (323)
......+++..+..++.|++.||.|||+. |++||||||+||+++.++.++|+|||++.............
T Consensus 158 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~ 234 (338)
T cd05102 158 NPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKG 234 (338)
T ss_pred ccchhccccccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhccc
Confidence 00012478889999999999999999999 99999999999999999999999999997654322222222
Q ss_pred cccCccccCCCccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccccccccchhcCCCcCCCCC
Q 020641 197 RVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYP 275 (323)
Q Consensus 197 ~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (323)
...++..|+|||.+.+..++.++||||||+++|+|++ |..||........ ....+........+
T Consensus 235 ~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~---------------~~~~~~~~~~~~~~ 299 (338)
T cd05102 235 SARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE---------------FCQRLKDGTRMRAP 299 (338)
T ss_pred CCCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHH---------------HHHHHhcCCCCCCC
Confidence 3345678999999998889999999999999999997 9999975432111 00001111111223
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhhcC
Q 020641 276 PKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKS 313 (323)
Q Consensus 276 ~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~~~ 313 (323)
...+..+.+++.+||+.||.+|||+.||++.|++++.+
T Consensus 300 ~~~~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~~ 337 (338)
T cd05102 300 ENATPEIYRIMLACWQGDPKERPTFSALVEILGDLLQE 337 (338)
T ss_pred CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 34566799999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-44 Score=299.61 Aligned_cols=277 Identities=20% Similarity=0.231 Sum_probs=217.1
Q ss_pred ccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeC-
Q 020641 18 GYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEG- 96 (323)
Q Consensus 18 ~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~- 96 (323)
+-+.||++|.||.||+|++.++++.||+|.+.-+. ....+.--..+|+.+|.+++||||+.+-+++...
T Consensus 79 e~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmek----------ek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~ 148 (419)
T KOG0663|consen 79 EKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEK----------EKEGFPITSLREINILLKARHPNIVEVKEVVVGSN 148 (419)
T ss_pred HHHhhcccCcceeEEEeccCCcceeEEeeeccccc----------ccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccc
Confidence 34449999999999999999999999999654332 3344556678999999999999999999988755
Q ss_pred -CeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeE
Q 020641 97 -NLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKA 175 (323)
Q Consensus 97 -~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~ 175 (323)
+..|+|||||++ +|..++....+. +....++.++.|++.|+.|||.. .|+|||+|++|+|++..|.+
T Consensus 149 ~d~iy~VMe~~Eh-DLksl~d~m~q~--------F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~l 216 (419)
T KOG0663|consen 149 MDKIYIVMEYVEH-DLKSLMETMKQP--------FLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGIL 216 (419)
T ss_pred cceeeeeHHHHHh-hHHHHHHhccCC--------CchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcE
Confidence 478999999998 999999876533 99999999999999999999999 99999999999999999999
Q ss_pred EEeeccccCCCCccccccccccccCccccCCCccccCC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhc
Q 020641 176 KIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG-QLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWAT 254 (323)
Q Consensus 176 ~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~ 254 (323)
|++|||+|+.+...... .+...-|.+|+|||++.+. .|+...|+||+||++.||+++++.|.+.....+...+...-
T Consensus 217 KiaDFGLAR~ygsp~k~--~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~ll 294 (419)
T KOG0663|consen 217 KIADFGLAREYGSPLKP--YTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLL 294 (419)
T ss_pred EecccchhhhhcCCccc--CcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHh
Confidence 99999999998775332 3444569999999999875 58999999999999999999999998876654433332221
Q ss_pred ccccccccchh-----c---------CCCcCCCCCHH-HHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhhcCCCCCCC
Q 020641 255 PRLSEDKVKQC-----V---------DPKLKGEYPPK-GVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSPPPAAP 319 (323)
Q Consensus 255 ~~~~~~~~~~~-----~---------~~~~~~~~~~~-~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~~~~~~~~~ 319 (323)
........+.. + -..++..+... .++.-.+|+..+|.+||.+|.|++|.++ ...+.+.|.|-+
T Consensus 295 GtPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~--h~~F~e~P~p~~ 372 (419)
T KOG0663|consen 295 GTPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK--HEYFRETPLPID 372 (419)
T ss_pred CCCccccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc--ccccccCCCCCC
Confidence 11111111111 1 11111122212 4577889999999999999999999998 677777665544
Q ss_pred C
Q 020641 320 V 320 (323)
Q Consensus 320 ~ 320 (323)
+
T Consensus 373 P 373 (419)
T KOG0663|consen 373 P 373 (419)
T ss_pred h
Confidence 3
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-44 Score=323.13 Aligned_cols=243 Identities=23% Similarity=0.273 Sum_probs=209.8
Q ss_pred ccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeCCeEEE
Q 020641 22 RLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVL 101 (323)
Q Consensus 22 ~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 101 (323)
.||.|+.|.|-+|++-.||+.+|+|++.+.. .........+.+|+-+|+.+.||||+.+++++++...+|+
T Consensus 19 TLG~Gstg~vrlakh~~TGqlaaiKii~k~~---------~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lyl 89 (786)
T KOG0588|consen 19 TLGKGSTGCVRLAKHAETGQLAAIKIIPKRS---------ELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYL 89 (786)
T ss_pred cccCCCCceehhhhcccccceeEEEeecccc---------ccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEE
Confidence 6899999999999999999999999988664 3445556778899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEEEeecc
Q 020641 102 AYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFN 181 (323)
Q Consensus 102 v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~l~Dfg 181 (323)
|.||+.+|-|++++..... +++..+.+.++||+.|+.|||.. +|+|||+||+|+|++.++++||+|||
T Consensus 90 vlEyv~gGELFdylv~kG~---------l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFG 157 (786)
T KOG0588|consen 90 VLEYVPGGELFDYLVRKGP---------LPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFG 157 (786)
T ss_pred EEEecCCchhHHHHHhhCC---------CCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccc
Confidence 9999999999999987664 88999999999999999999999 99999999999999999999999999
Q ss_pred ccCCCCccccccccccccCccccCCCccccCCCCC-cccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhccccccc
Q 020641 182 LSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLT-QKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSED 260 (323)
Q Consensus 182 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~-~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 260 (323)
+|..-..+.- -.+.+|.+.|.|||++.|.+|+ .++||||.|++||.|++|+.||++.+...-...+.
T Consensus 158 MAsLe~~gkl---LeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~--------- 225 (786)
T KOG0588|consen 158 MASLEVPGKL---LETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQ--------- 225 (786)
T ss_pred eeecccCCcc---ccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHH---------
Confidence 9976554332 2455799999999999999995 68999999999999999999998554321111111
Q ss_pred ccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 261 KVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
.+ .-+.|...+.+.++|+.+||..||..|.|++||++
T Consensus 226 -------~G-~f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~k 262 (786)
T KOG0588|consen 226 -------RG-VFEMPSNISSEAQDLLRRMLDVDPSTRITTEEILK 262 (786)
T ss_pred -------cC-cccCCCcCCHHHHHHHHHHhccCccccccHHHHhh
Confidence 11 12345677788999999999999999999999998
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-45 Score=320.35 Aligned_cols=247 Identities=23% Similarity=0.268 Sum_probs=209.6
Q ss_pred CccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeC
Q 020641 17 PGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEG 96 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 96 (323)
|-.+.-+|+|+||.||+++.+.+.++||+|++.+.....++. +.+.+|+++++.++||||+.++++|+..
T Consensus 4 yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l----------~~l~~ev~i~r~lkHpniv~m~esfEt~ 73 (808)
T KOG0597|consen 4 YHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKEL----------KNLRQEVRILRSLKHPNIVEMLESFETS 73 (808)
T ss_pred hhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHH----------HHHHHHHHHHHhcCCcchhhHHHhhccc
Confidence 345568999999999999999999999999988654333322 5578999999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEE
Q 020641 97 NLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAK 176 (323)
Q Consensus 97 ~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~ 176 (323)
.+.|+|+||+.| +|..++..... ++++.+..+..+++.|++|||+. +|+|||+||.|||+...+.+|
T Consensus 74 ~~~~vVte~a~g-~L~~il~~d~~---------lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~K 140 (808)
T KOG0597|consen 74 AHLWVVTEYAVG-DLFTILEQDGK---------LPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLK 140 (808)
T ss_pred ceEEEEehhhhh-hHHHHHHhccC---------CCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCcee
Confidence 999999999987 99999987664 99999999999999999999999 999999999999999999999
Q ss_pred EeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhccc
Q 020641 177 IADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPR 256 (323)
Q Consensus 177 l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 256 (323)
+||||+|+-... +....+...|||-|+|||++.+.+|+..+|+||+||++||++.|++||......
T Consensus 141 lcdFg~Ar~m~~--~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~------------ 206 (808)
T KOG0597|consen 141 LCDFGLARAMST--NTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSIT------------ 206 (808)
T ss_pred echhhhhhhccc--CceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHH------------
Confidence 999999987654 233345567999999999999999999999999999999999999999633210
Q ss_pred ccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 257 LSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
.-+..++... ...+...+..+..|+...|.+||..|.|+.+++.
T Consensus 207 ---~Lv~~I~~d~--v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 207 ---QLVKSILKDP--VKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred ---HHHHHHhcCC--CCCcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence 0111111111 1244577788999999999999999999999975
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=332.98 Aligned_cols=277 Identities=21% Similarity=0.255 Sum_probs=218.6
Q ss_pred CCccccccCCCCCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcC-CC
Q 020641 5 YHPRALGAHAPSPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRL-KH 83 (323)
Q Consensus 5 ~~~~~~~~~~~~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h 83 (323)
+....+.-+.....+..-|.+|||+.||+|.+...+..+|+|.... ..+..-+.+++|+++|+.| .|
T Consensus 27 ~~G~~~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~------------~de~~L~~v~~EI~~MK~L~gh 94 (738)
T KOG1989|consen 27 FVGQTFTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYV------------NDEEALNAVKREIDIMKLLSGH 94 (738)
T ss_pred CCceEEEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeec------------CCHHHHHHHHHHHHHHHHhcCC
Confidence 3344445555555555678999999999999999966666654431 1233347789999999999 69
Q ss_pred CcccceeeE-EEe---C---CeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 020641 84 ENLVELLGY-CVE---G---NLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPS 156 (323)
Q Consensus 84 ~~i~~~~~~-~~~---~---~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~ 156 (323)
+|||.+++. ... . -.++|+||||.||+|-|+++.+.... |++.++++|++++++|+.+||.. .+.
T Consensus 95 ~nIV~yidss~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~-------lte~eVLkIf~dv~~AVa~mH~~-~pP 166 (738)
T KOG1989|consen 95 KNIVSYIDSSAINRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTR-------LTEDEVLKIFYDVCEAVAAMHYL-KPP 166 (738)
T ss_pred CceeeEeccccccccCCCceeEEEeehhhccCCcHHHHHHHHHhcc-------CChHHHHHHHHHHHHHHHHHhcC-CCc
Confidence 999999993 321 1 24689999999999999998776543 99999999999999999999997 444
Q ss_pred ceeCCCCCCCEEEccCCeEEEeeccccCCCCccccc-cccc------cccCccccCCCccc---cCCCCCcccchHHHHH
Q 020641 157 IIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAAR-LHST------RVLGTFGYHAPEYA---MTGQLTQKSDVYSFGV 226 (323)
Q Consensus 157 i~h~dikp~nili~~~~~~~l~Dfg~~~~~~~~~~~-~~~~------~~~g~~~y~aPE~~---~~~~~~~~~Di~slG~ 226 (323)
|+|||||-+|||++.++++||||||.++........ .... ...-|+.|+|||++ .+.++++|+|||+|||
T Consensus 167 iIHRDLKiENvLls~~g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGc 246 (738)
T KOG1989|consen 167 IIHRDLKIENVLLSADGNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGC 246 (738)
T ss_pred cchhhhhhhheEEcCCCCEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHH
Confidence 999999999999999999999999998754322211 0000 01158899999977 5788999999999999
Q ss_pred HHHHHHhCCCCCCCCCCcccchhhhhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHH
Q 020641 227 VLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKA 306 (323)
Q Consensus 227 ~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~ 306 (323)
+||-|++...||+... ...+++..+.....+..+..+.+||..||+.||.+||++-+|++.
T Consensus 247 lLYkLCy~t~PFe~sg-------------------~laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~ 307 (738)
T KOG1989|consen 247 LLYKLCYFTTPFEESG-------------------KLAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEE 307 (738)
T ss_pred HHHHHHHhCCCcCcCc-------------------ceeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHH
Confidence 9999999999997442 234445555555567889999999999999999999999999999
Q ss_pred HhhhhcCCCCCCCC
Q 020641 307 LQPLLKSPPPAAPV 320 (323)
Q Consensus 307 l~~~~~~~~~~~~~ 320 (323)
+..+...+.|....
T Consensus 308 ~~~l~~~~~~~~~~ 321 (738)
T KOG1989|consen 308 IFELANKPCPIPDI 321 (738)
T ss_pred HHHHhcCCCCcccc
Confidence 99999888876543
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=307.62 Aligned_cols=254 Identities=19% Similarity=0.224 Sum_probs=202.0
Q ss_pred CccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeC
Q 020641 17 PGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEG 96 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 96 (323)
|..+..||+|+||+||++.+..+++.+|+|.+.++.... ......+.+|+.+++.++|+||+++++.+.+.
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~---------~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~ 72 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKK---------RKGEAMALNEKRILEKVNSRFVVSLAYAYETK 72 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhh---------hhhHHHHHHHHHHHHhcCCCcEEEEEEEEccC
Confidence 456678999999999999999999999999765432211 11224567899999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEE
Q 020641 97 NLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAK 176 (323)
Q Consensus 97 ~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~ 176 (323)
+..++||||+.+|+|.+++...... .+++..+..++.|++.||.|||+. |++||||||+||+++.++.++
T Consensus 73 ~~~~lv~e~~~~g~L~~~~~~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~k 142 (285)
T cd05631 73 DALCLVLTIMNGGDLKFHIYNMGNP-------GFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIR 142 (285)
T ss_pred CeEEEEEEecCCCcHHHHHHhhCCC-------CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEE
Confidence 9999999999999999888643321 288899999999999999999999 999999999999999999999
Q ss_pred EeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhccc
Q 020641 177 IADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPR 256 (323)
Q Consensus 177 l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 256 (323)
|+|||++........ .....|+..|+|||.+.+..++.++|||||||++|+|++|+.||............
T Consensus 143 l~Dfg~~~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~------ 213 (285)
T cd05631 143 ISDLGLAVQIPEGET---VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEV------ 213 (285)
T ss_pred EeeCCCcEEcCCCCe---ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHH------
Confidence 999999876533221 12345899999999999889999999999999999999999999865432111100
Q ss_pred ccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCC-----hHHHHH
Q 020641 257 LSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPN-----MSIVVK 305 (323)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps-----~~evl~ 305 (323)
...+. ......+...+..+.+|+.+||+.||.+||+ ++++++
T Consensus 214 ------~~~~~-~~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 214 ------DRRVK-EDQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred ------HHHhh-cccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 00000 0111233445678999999999999999997 788886
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-44 Score=304.66 Aligned_cols=250 Identities=21% Similarity=0.272 Sum_probs=213.5
Q ss_pred CCCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEE
Q 020641 15 PSPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCV 94 (323)
Q Consensus 15 ~~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 94 (323)
..|++..+||+|.||.|-+|.+...++.||+|.+.+..+.. ++..-.+++|+++|+.++||||+.++++|+
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkd---------eqDlvhIRREIeIMSsLNHPhII~IyEVFE 123 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKD---------EQDLVHIRREIEIMSSLNHPHIIQIYEVFE 123 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhccc---------HHHHHHHHHHHHHHhhcCCCceeehhhhhc
Confidence 45777789999999999999999999999999887665443 333467899999999999999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCe
Q 020641 95 EGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFK 174 (323)
Q Consensus 95 ~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~ 174 (323)
..+...+||||..+|.|.|++.++.. +++..+..+++||..|+.|||++ +++|||+|.+|||+|.|++
T Consensus 124 NkdKIvivMEYaS~GeLYDYiSer~~---------LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~N 191 (668)
T KOG0611|consen 124 NKDKIVIVMEYASGGELYDYISERGS---------LSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNN 191 (668)
T ss_pred CCceEEEEEEecCCccHHHHHHHhcc---------ccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCC
Confidence 99999999999999999999988764 99999999999999999999999 9999999999999999999
Q ss_pred EEEeeccccCCCCccccccccccccCccccCCCccccCCCC-CcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhh
Q 020641 175 AKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQL-TQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWA 253 (323)
Q Consensus 175 ~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 253 (323)
+||.|||++..+..... ..+++|++.|.+||++.|.+| ++..|-||||++||-|+.|..||++.+.
T Consensus 192 iKIADFGLSNly~~~kf---LqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dh---------- 258 (668)
T KOG0611|consen 192 IKIADFGLSNLYADKKF---LQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDH---------- 258 (668)
T ss_pred eeeeccchhhhhccccH---HHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchH----------
Confidence 99999999977654332 356779999999999999988 5899999999999999999999986653
Q ss_pred cccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHH
Q 020641 254 TPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKA 306 (323)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~ 306 (323)
...+.++-...++ .+..+.+..-||++||-.||+.|.|+++|...
T Consensus 259 -----k~lvrQIs~GaYr---EP~~PSdA~gLIRwmLmVNP~RRATieDiAsH 303 (668)
T KOG0611|consen 259 -----KRLVRQISRGAYR---EPETPSDASGLIRWMLMVNPERRATIEDIASH 303 (668)
T ss_pred -----HHHHHHhhccccc---CCCCCchHHHHHHHHHhcCcccchhHHHHhhh
Confidence 2222222222222 23334567889999999999999999999763
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-43 Score=303.45 Aligned_cols=255 Identities=19% Similarity=0.274 Sum_probs=200.3
Q ss_pred CCCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEE
Q 020641 15 PSPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCV 94 (323)
Q Consensus 15 ~~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 94 (323)
........+|+|+++.||+++. +++.+|+|....... ......+.+.+|+.++++++||||+++++++.
T Consensus 20 i~~~~~~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~---------~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~ 88 (283)
T PHA02988 20 IDKYTSVLIKENDQNSIYKGIF--NNKEVIIRTFKKFHK---------GHKVLIDITENEIKNLRRIDSNNILKIYGFII 88 (283)
T ss_pred cCCCCCeEEeeCCceEEEEEEE--CCEEEEEEecccccc---------ccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEE
Confidence 3334345789999999999987 577888886543211 11122467789999999999999999999987
Q ss_pred e----CCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCCCceeCCCCCCCEEE
Q 020641 95 E----GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHE-KVQPSIIHRDIRSSNVLL 169 (323)
Q Consensus 95 ~----~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~-~~~~~i~h~dikp~nili 169 (323)
+ ....++||||+.+|+|.+++..... +++.....++.|++.|+.+||+ . +++||||||+||++
T Consensus 89 ~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~---------~~~~~~~~i~~~i~~~l~~lH~~~---~~~Hrdlkp~nill 156 (283)
T PHA02988 89 DIVDDLPRLSLILEYCTRGYLREVLDKEKD---------LSFKTKLDMAIDCCKGLYNLYKYT---NKPYKNLTSVSFLV 156 (283)
T ss_pred ecccCCCceEEEEEeCCCCcHHHHHhhCCC---------CChhHHHHHHHHHHHHHHHHHhcC---CCCCCcCChhhEEE
Confidence 6 3467999999999999999976432 8888999999999999999997 5 88999999999999
Q ss_pred ccCCeEEEeeccccCCCCccccccccccccCccccCCCccccC--CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccc
Q 020641 170 FEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT--GQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQ 247 (323)
Q Consensus 170 ~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~ 247 (323)
+.++.++|+|||++....... ....|+..|+|||.+.+ ..++.++||||||+++|+|++|+.||.........
T Consensus 157 ~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~ 231 (283)
T PHA02988 157 TENYKLKIICHGLEKILSSPP-----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIY 231 (283)
T ss_pred CCCCcEEEcccchHhhhcccc-----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHH
Confidence 999999999999987543321 22347889999999876 67899999999999999999999999755321110
Q ss_pred hhhhhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhhc
Q 020641 248 SLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLK 312 (323)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~~ 312 (323)
..+.....+...+..++..+.+++.+||+.||++|||+.|+++.|+.+..
T Consensus 232 ---------------~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~ 281 (283)
T PHA02988 232 ---------------DLIINKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF 281 (283)
T ss_pred ---------------HHHHhcCCCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence 11111111222334567789999999999999999999999999988753
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-43 Score=302.92 Aligned_cols=265 Identities=24% Similarity=0.366 Sum_probs=206.2
Q ss_pred CCccccccCCCCCCccceeccceee-----eeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCccccee
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRVKMR-----RWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELL 90 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~~~~-----~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~ 90 (323)
.+....+||+|+||.||++.....+ +.+++|..... ........+.+|+.+++.++|+||++++
T Consensus 6 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~-----------~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 74 (283)
T cd05048 6 AVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKEN-----------AEPKVQQEFRQEAELMSDLQHPNIVCLL 74 (283)
T ss_pred HcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccC-----------CCHHHHHHHHHHHHHHHhcCCcccceEE
Confidence 4566779999999999999876654 55666644311 1112235688999999999999999999
Q ss_pred eEEEeCCeEEEEEeecCCCCHHHHhccCCCCCCCC-------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCC
Q 020641 91 GYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQ-------PGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIR 163 (323)
Q Consensus 91 ~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dik 163 (323)
+++......+++|||+.+++|.+++.......... ....+++..+..++.|++.|+.|||+. |++|+|||
T Consensus 75 ~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlk 151 (283)
T cd05048 75 GVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLA 151 (283)
T ss_pred EEEcCCCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---Ceeccccc
Confidence 99999889999999999999999997653322110 113488899999999999999999999 99999999
Q ss_pred CCCEEEccCCeEEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCC
Q 020641 164 SSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTM 242 (323)
Q Consensus 164 p~nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~ 242 (323)
|+||++++++.++|+|||++................+++.|+|||.+.+..++.++||||||+++|+|++ |..||....
T Consensus 152 p~Nil~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~ 231 (283)
T cd05048 152 ARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFS 231 (283)
T ss_pred cceEEEcCCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCC
Confidence 9999999999999999999875433222222233346788999999988889999999999999999998 999997543
Q ss_pred CcccchhhhhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhh
Q 020641 243 PRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPL 310 (323)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~ 310 (323)
.. ++...+........+..++..+.+++.+||+.||.+|||+.||++.|+.+
T Consensus 232 ~~----------------~~~~~i~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~ 283 (283)
T cd05048 232 NQ----------------EVIEMIRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW 283 (283)
T ss_pred HH----------------HHHHHHHcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence 21 11111211222233456678899999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=312.79 Aligned_cols=244 Identities=19% Similarity=0.212 Sum_probs=197.9
Q ss_pred ccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeCCeEEE
Q 020641 22 RLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVL 101 (323)
Q Consensus 22 ~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 101 (323)
.||+|+||.||+|++..+++.+|+|++.+.... .......+.+|+.++++++||||+++++++...+..++
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~---------~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~l 72 (323)
T cd05571 2 LLGKGTFGKVILVREKATGKYYAMKILKKEVII---------AKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCF 72 (323)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh---------hhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEE
Confidence 489999999999999999999999977543211 11223566789999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEEEeecc
Q 020641 102 AYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFN 181 (323)
Q Consensus 102 v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~l~Dfg 181 (323)
||||+.+++|.+++..... +++..+..++.||+.||.|||+. ||+||||||+||+++.++.++|+|||
T Consensus 73 v~e~~~~~~L~~~l~~~~~---------~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG 140 (323)
T cd05571 73 VMEYANGGELFFHLSRERV---------FSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFG 140 (323)
T ss_pred EEeCCCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCC
Confidence 9999999999999976432 88999999999999999999999 99999999999999999999999999
Q ss_pred ccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccccccc
Q 020641 182 LSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDK 261 (323)
Q Consensus 182 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 261 (323)
++........ ......|++.|+|||.+.+..++.++|||||||++|+|++|..||..........
T Consensus 141 ~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~------------- 205 (323)
T cd05571 141 LCKEGISDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFE------------- 205 (323)
T ss_pred CCcccccCCC--cccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHH-------------
Confidence 9865322111 1233458999999999998899999999999999999999999997543211100
Q ss_pred cchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCC-----ChHHHHH
Q 020641 262 VKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRP-----NMSIVVK 305 (323)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-----s~~evl~ 305 (323)
..... ....+...+..+.+++.+||+.||++|| ++.++++
T Consensus 206 --~~~~~--~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 206 --LILME--EIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred --HHHcC--CCCCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 00000 0122344567799999999999999999 7998875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=308.65 Aligned_cols=248 Identities=19% Similarity=0.222 Sum_probs=201.2
Q ss_pred CCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEe
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVE 95 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 95 (323)
.|.....||+|+||.||+|.+..+++.+|+|+........ ....+.+.+|+++++.++||||+++++++.+
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~---------~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 72 (291)
T cd05612 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIR---------LKQEQHVHNEKRVLKEVSHPFIIRLFWTEHD 72 (291)
T ss_pred CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhh---------hHHHHHHHHHHHHHHhCCCCcHhhhHhhhcc
Confidence 3566778999999999999999999999999765332111 1123567889999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeE
Q 020641 96 GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKA 175 (323)
Q Consensus 96 ~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~ 175 (323)
.+..++||||+.+++|.+++..... +++..+..++.|++.||.|||+. |++|+||||+||+++.++.+
T Consensus 73 ~~~~~lv~e~~~~~~L~~~~~~~~~---------~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~ 140 (291)
T cd05612 73 QRFLYMLMEYVPGGELFSYLRNSGR---------FSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHI 140 (291)
T ss_pred CCeEEEEEeCCCCCCHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCE
Confidence 9999999999999999999976532 88889999999999999999999 99999999999999999999
Q ss_pred EEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhcc
Q 020641 176 KIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATP 255 (323)
Q Consensus 176 ~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~ 255 (323)
+|+|||++...... .....|++.|+|||.+.+..++.++||||||+++|+|++|..||..........
T Consensus 141 kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~------- 208 (291)
T cd05612 141 KLTDFGFAKKLRDR-----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYE------- 208 (291)
T ss_pred EEEecCcchhccCC-----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH-------
Confidence 99999998765432 123458999999999998889999999999999999999999997553211111
Q ss_pred cccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCC-----hHHHHHH
Q 020641 256 RLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPN-----MSIVVKA 306 (323)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps-----~~evl~~ 306 (323)
.+.... ...+...+..+.+++.+||+.||.+||+ ++|+++.
T Consensus 209 --------~i~~~~--~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 209 --------KILAGK--LEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred --------HHHhCC--cCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 011100 1123334567999999999999999995 8888763
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-44 Score=289.55 Aligned_cols=241 Identities=20% Similarity=0.259 Sum_probs=206.7
Q ss_pred CCCCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEE
Q 020641 14 APSPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYC 93 (323)
Q Consensus 14 ~~~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 93 (323)
...++.+..||.|+||.|-+++...++.++|.|+..+...-... ..+...+|-.+|+.+.||.++++++.+
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklK---------QveH~~nEk~vL~~v~~PFlv~l~~t~ 113 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLK---------QVEHTHNEKRVLKAVSHPFLVKLYGTF 113 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHH---------HHHHHhhHHHHHhhccCceeEEEEEee
Confidence 34556667899999999999999999999999988765433221 136678899999999999999999999
Q ss_pred EeCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCC
Q 020641 94 VEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDF 173 (323)
Q Consensus 94 ~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~ 173 (323)
.+.+..|+||||..||.|++++++... +++..+.-++.|++.|+.|||+. +|++||+||+|||+|.+|
T Consensus 114 ~d~~~lymvmeyv~GGElFS~Lrk~~r---------F~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G 181 (355)
T KOG0616|consen 114 KDNSNLYMVMEYVPGGELFSYLRKSGR---------FSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNG 181 (355)
T ss_pred ccCCeEEEEEeccCCccHHHHHHhcCC---------CCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCC
Confidence 999999999999999999999988654 99999999999999999999999 999999999999999999
Q ss_pred eEEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhh
Q 020641 174 KAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWA 253 (323)
Q Consensus 174 ~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 253 (323)
.+||+|||.|...... ..+.+|||.|+|||.+...+++.++|-||||+++|||+.|..||...+......
T Consensus 182 ~iKitDFGFAK~v~~r-----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~----- 251 (355)
T KOG0616|consen 182 HIKITDFGFAKRVSGR-----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYE----- 251 (355)
T ss_pred cEEEEeccceEEecCc-----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHH-----
Confidence 9999999999876543 356679999999999999999999999999999999999999998775532222
Q ss_pred cccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCC
Q 020641 254 TPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFR 297 (323)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~R 297 (323)
+++...+ .+|.-.+.++++|+...|+.|-.+|
T Consensus 252 ----------KI~~~~v--~fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 252 ----------KILEGKV--KFPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred ----------HHHhCcc--cCCcccCHHHHHHHHHHHhhhhHhh
Confidence 2222222 3455667789999999999999999
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=310.14 Aligned_cols=253 Identities=21% Similarity=0.293 Sum_probs=216.1
Q ss_pred CCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEe
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVE 95 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 95 (323)
.|.++..+|.|+||.++++++...+..+++|.+...... ...+....+|+.+++++.||||+.+.+.|.+
T Consensus 5 ~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t----------~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~ 74 (426)
T KOG0589|consen 5 NYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLT----------EPERRSAIQEMDLLSKLLHPNIVEYKDSFEE 74 (426)
T ss_pred hhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccC----------chhhHHHHHHHHHHHhccCCCeeeeccchhc
Confidence 567788999999999999999999988888866533222 2223467899999999999999999999998
Q ss_pred CCe-EEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCe
Q 020641 96 GNL-RVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFK 174 (323)
Q Consensus 96 ~~~-~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~ 174 (323)
++. .++||+||+||++.+.+.+.... .++++.+.+|+.|++.|+.|||++ +|+|||||+.||+++.++.
T Consensus 75 ~~~~l~Ivm~Y~eGg~l~~~i~~~k~~-------~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~ 144 (426)
T KOG0589|consen 75 DGQLLCIVMEYCEGGDLAQLIKEQKGV-------LFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKK 144 (426)
T ss_pred CCceEEEEEeecCCCCHHHHHHHHhhc-------cccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCc
Confidence 888 89999999999999999887633 399999999999999999999999 9999999999999999999
Q ss_pred EEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhc
Q 020641 175 AKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWAT 254 (323)
Q Consensus 175 ~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~ 254 (323)
++|+|||+|+...... .......||+.|++||++.+.+|+.++|||||||++|||++-+.+|...+-
T Consensus 145 VkLgDfGlaK~l~~~~--~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m----------- 211 (426)
T KOG0589|consen 145 VKLGDFGLAKILNPED--SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNM----------- 211 (426)
T ss_pred eeecchhhhhhcCCch--hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccch-----------
Confidence 9999999999887644 234566799999999999999999999999999999999999999976542
Q ss_pred ccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHH
Q 020641 255 PRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKA 306 (323)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~ 306 (323)
..+...+.+......+...+.+++.++..||+.+|..||++.+++..
T Consensus 212 -----~~Li~ki~~~~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 212 -----SELILKINRGLYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred -----HHHHHHHhhccCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 11222222333456677888899999999999999999999999975
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-43 Score=303.87 Aligned_cols=267 Identities=15% Similarity=0.157 Sum_probs=201.2
Q ss_pred CCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEe
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVE 95 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 95 (323)
.|.....||+|+||.||++++..+++.+++|.+.... ......+.+.+|+.+++.++|+||+++++++..
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~----------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 71 (287)
T cd07848 2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSE----------ENEEVKETTLRELKMLRTLKQENIVELKEAFRR 71 (287)
T ss_pred CceEEEEecccCCEEEEEEEECCCCcEEEEEEEeccc----------ccccchhhHHHHHHHHHhCCCccccchhhhEec
Confidence 3566778999999999999999999999998664321 112334677899999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeE
Q 020641 96 GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKA 175 (323)
Q Consensus 96 ~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~ 175 (323)
....++||||+.++++..+..... .+++..+..++.|++.||.|||+. |++|+||||+||+++.++.+
T Consensus 72 ~~~~~lv~e~~~~~~l~~~~~~~~---------~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~ 139 (287)
T cd07848 72 RGKLYLVFEYVEKNMLELLEEMPN---------GVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVL 139 (287)
T ss_pred CCEEEEEEecCCCCHHHHHHhcCC---------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcE
Confidence 999999999999876665543221 188899999999999999999999 99999999999999999999
Q ss_pred EEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhcc
Q 020641 176 KIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATP 255 (323)
Q Consensus 176 ~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~ 255 (323)
+|+|||++......... ......|++.|+|||.+.+..++.++|+|||||++|+|++|+.||.................
T Consensus 140 kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~ 218 (287)
T cd07848 140 KLCDFGFARNLSEGSNA-NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLG 218 (287)
T ss_pred EEeeccCcccccccccc-cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhC
Confidence 99999998765432211 12234588999999999888899999999999999999999999976543221111111111
Q ss_pred ccccccc---------chhcCCCcC------CCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 256 RLSEDKV---------KQCVDPKLK------GEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 256 ~~~~~~~---------~~~~~~~~~------~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
..+.... .....+... .......+..+.+++.+||+.||++|||++++++
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 219 PLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred CCCHHHHHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 1110000 000000000 0111234667999999999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-43 Score=314.15 Aligned_cols=266 Identities=22% Similarity=0.345 Sum_probs=202.7
Q ss_pred CccccccCCCCCCccceeccceee-----eeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcC-CCCccccee
Q 020641 17 PGYFVRLDKGPEDDLYLKKRVKMR-----RWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRL-KHENLVELL 90 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~~~~~~-----~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~ 90 (323)
++....||+|+||.||++.+...+ ..+|+|+..... .......+.+|+.+++.+ +|+||++++
T Consensus 40 ~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~-----------~~~~~~~~~~E~~il~~l~~h~nIv~~~ 108 (374)
T cd05106 40 LQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASA-----------HTDEREALMSELKILSHLGQHKNIVNLL 108 (374)
T ss_pred ceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCC-----------CHHHHHHHHHHHHHHHhhccCCceeeEe
Confidence 556668999999999999865433 457777654221 111235678999999999 899999999
Q ss_pred eEEEeCCeEEEEEeecCCCCHHHHhccCCCCC------------------------------------------------
Q 020641 91 GYCVEGNLRVLAYEFATMGSLHDILHGRKGVQ------------------------------------------------ 122 (323)
Q Consensus 91 ~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~------------------------------------------------ 122 (323)
+++..+...++||||+.+|+|.+++.......
T Consensus 109 ~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 188 (374)
T cd05106 109 GACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVS 188 (374)
T ss_pred eEecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcc
Confidence 99999999999999999999999986432100
Q ss_pred -------------CCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEEEeeccccCCCCcc
Q 020641 123 -------------GAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDM 189 (323)
Q Consensus 123 -------------~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~l~Dfg~~~~~~~~ 189 (323)
.......+++..+..++.|++.||.|||+. |++||||||+||+++.++.++|+|||++......
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~ 265 (374)
T cd05106 189 SSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMND 265 (374)
T ss_pred ccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCC
Confidence 001112378889999999999999999999 9999999999999999999999999998765433
Q ss_pred ccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccccccccchhcCC
Q 020641 190 AARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDP 268 (323)
Q Consensus 190 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (323)
..........++..|+|||.+.+..++.++||||||+++|+|++ |+.||........ ..+.+..
T Consensus 266 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~---------------~~~~~~~ 330 (374)
T cd05106 266 SNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK---------------FYKMVKR 330 (374)
T ss_pred cceeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHH---------------HHHHHHc
Confidence 22222222335667999999988889999999999999999997 9999975432111 1111111
Q ss_pred CcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhh
Q 020641 269 KLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLL 311 (323)
Q Consensus 269 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~ 311 (323)
......+...+.++.+++.+||+.||++|||+.+|++.|++++
T Consensus 331 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 331 GYQMSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred ccCccCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 1111222234567999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-43 Score=313.45 Aligned_cols=266 Identities=20% Similarity=0.288 Sum_probs=202.3
Q ss_pred CCccccccCCCCCCccceecc-----ceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcC-CCCcccce
Q 020641 16 SPGYFVRLDKGPEDDLYLKKR-----VKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRL-KHENLVEL 89 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~-----~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~ 89 (323)
.+....+||+|+||.||+|++ ..++..+|+|+..... .....+.+.+|+.+++.+ +||||+++
T Consensus 36 ~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~-----------~~~~~~~~~~Ei~il~~l~~HpnIv~l 104 (375)
T cd05104 36 RLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSA-----------HLTEREALMSELKVLSYLGNHINIVNL 104 (375)
T ss_pred HeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCc-----------CcHHHHHHHHHHHHHHHhcCCcceeee
Confidence 345556899999999999974 3456678888654211 112235678899999999 89999999
Q ss_pred eeEEEeCCeEEEEEeecCCCCHHHHhccCCCCCCC---------------------------------------------
Q 020641 90 LGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGA--------------------------------------------- 124 (323)
Q Consensus 90 ~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~--------------------------------------------- 124 (323)
++++..+...++||||+.+|+|.+++.........
T Consensus 105 ~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 184 (375)
T cd05104 105 LGACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKAD 184 (375)
T ss_pred eeeeccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccc
Confidence 99999999999999999999999999754311000
Q ss_pred ---------------------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEEEeecccc
Q 020641 125 ---------------------QPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLS 183 (323)
Q Consensus 125 ---------------------~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~l~Dfg~~ 183 (323)
.....+++..+..++.|++.||.|||+. |++|+||||+||+++.++.++|+|||++
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a 261 (375)
T cd05104 185 KRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLA 261 (375)
T ss_pred cccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccc
Confidence 0112478889999999999999999999 9999999999999999999999999998
Q ss_pred CCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhccccccccc
Q 020641 184 NQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPRLSEDKV 262 (323)
Q Consensus 184 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 262 (323)
................++..|+|||.+.+..++.++||||||+++|+|++ |..||....... ..
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~---------------~~ 326 (375)
T cd05104 262 RDIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS---------------KF 326 (375)
T ss_pred eeccCcccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH---------------HH
Confidence 76544322222222335667999999998899999999999999999998 899986543211 11
Q ss_pred chhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhh
Q 020641 263 KQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPL 310 (323)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~ 310 (323)
.+.+........+...+.++.+++.+||+.||++|||+.||++.|++.
T Consensus 327 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 327 YKMIKEGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred HHHHHhCccCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 111111111222233456799999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=311.64 Aligned_cols=248 Identities=20% Similarity=0.238 Sum_probs=201.3
Q ss_pred CCCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEE
Q 020641 15 PSPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCV 94 (323)
Q Consensus 15 ~~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 94 (323)
..|.....||+|+||.||+|++..+++.+|+|++.+.... .....+.+.+|+.++++++||||+++++++.
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~---------~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 88 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREIL---------KMKQVQHVAQEKSILMELSHPFIVNMMCSFQ 88 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHh---------hhhhHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence 4556667999999999999999999999999977543211 1122467889999999999999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCe
Q 020641 95 EGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFK 174 (323)
Q Consensus 95 ~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~ 174 (323)
.++..++||||+.+++|.+++..... +++..+..++.|++.||.|||+. |++|+||||+||+++.++.
T Consensus 89 ~~~~~~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~ 156 (329)
T PTZ00263 89 DENRVYFLLEFVVGGELFTHLRKAGR---------FPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGH 156 (329)
T ss_pred cCCEEEEEEcCCCCChHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCC
Confidence 99999999999999999999976532 78889999999999999999999 9999999999999999999
Q ss_pred EEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhc
Q 020641 175 AKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWAT 254 (323)
Q Consensus 175 ~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~ 254 (323)
++|+|||++....... ....|++.|+|||.+.+..++.++|||||||++|+|++|..||.........
T Consensus 157 ~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~------- 224 (329)
T PTZ00263 157 VKVTDFGFAKKVPDRT-----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIY------- 224 (329)
T ss_pred EEEeeccCceEcCCCc-----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHH-------
Confidence 9999999987654321 2345899999999999888999999999999999999999999754321110
Q ss_pred ccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCC-----hHHHHH
Q 020641 255 PRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPN-----MSIVVK 305 (323)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps-----~~evl~ 305 (323)
..+.... ...+...+..+.+++.+||+.||.+||+ +.++++
T Consensus 225 --------~~i~~~~--~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 270 (329)
T PTZ00263 225 --------EKILAGR--LKFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKN 270 (329)
T ss_pred --------HHHhcCC--cCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 0111111 1122234567899999999999999997 677774
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-43 Score=309.96 Aligned_cols=256 Identities=18% Similarity=0.182 Sum_probs=204.0
Q ss_pred CCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEe
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVE 95 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 95 (323)
.|....+||+|+||.||+|++..+++.+|+|++.+..... ......+.+|++++..++|+||+++++++..
T Consensus 2 ~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~---------~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~ 72 (333)
T cd05600 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFK---------LNEVRHVLTERDILTTTKSEWLVKLLYAFQD 72 (333)
T ss_pred CcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhh---------hhHHHHHHHHHHHHHhCCCCCCccEEEEEEc
Confidence 3566779999999999999999999999999776432111 1223567889999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeE
Q 020641 96 GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKA 175 (323)
Q Consensus 96 ~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~ 175 (323)
++..|+||||+.+++|.+++..... +++..+..++.|++.||.|||+. |++||||||+||+++.++.+
T Consensus 73 ~~~~~lv~e~~~g~~L~~~l~~~~~---------l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~ 140 (333)
T cd05600 73 DEYLYLAMEYVPGGDFRTLLNNLGV---------LSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHI 140 (333)
T ss_pred CCEEEEEEeCCCCCCHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCE
Confidence 9999999999999999999975432 88899999999999999999999 99999999999999999999
Q ss_pred EEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhcc
Q 020641 176 KIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATP 255 (323)
Q Consensus 176 ~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~ 255 (323)
+|+|||++..... ......|++.|+|||.+.+..++.++|||||||++|+|++|..||................
T Consensus 141 kL~Dfg~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~- 214 (333)
T cd05600 141 KLTDFGLSKGIVT-----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWK- 214 (333)
T ss_pred EEEeCcCCccccc-----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhcc-
Confidence 9999999876543 2234458999999999998899999999999999999999999997554321111110000
Q ss_pred cccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHH
Q 020641 256 RLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKA 306 (323)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~ 306 (323)
..+............+.++.+++.+||..+|.+|||+.++++.
T Consensus 215 --------~~~~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 215 --------ETLQRPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred --------ccccCCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 0000000000012346679999999999999999999999964
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=307.44 Aligned_cols=266 Identities=18% Similarity=0.230 Sum_probs=203.2
Q ss_pred CCCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEE
Q 020641 15 PSPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCV 94 (323)
Q Consensus 15 ~~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 94 (323)
..|+...+||+|+||.||++++..++..+++|+...+. .......+.+|++++++++|+||+++++++.
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~-----------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 73 (331)
T cd06649 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI-----------KPAIRNQIIRELQVLHECNSPYIVGFYGAFY 73 (331)
T ss_pred ccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc-----------CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEE
Confidence 35667779999999999999999999999998765321 1122367889999999999999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCe
Q 020641 95 EGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFK 174 (323)
Q Consensus 95 ~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~ 174 (323)
.++..++||||+.+++|.+++..... +++..+..++.|++.|+.|||+.. +++|+||||+||+++.++.
T Consensus 74 ~~~~~~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~ 142 (331)
T cd06649 74 SDGEISICMEHMDGGSLDQVLKEAKR---------IPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGE 142 (331)
T ss_pred ECCEEEEEeecCCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCc
Confidence 99999999999999999999976432 888999999999999999999851 5999999999999999999
Q ss_pred EEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhc
Q 020641 175 AKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWAT 254 (323)
Q Consensus 175 ~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~ 254 (323)
++|+|||++....... .....|++.|+|||.+.+..++.++|||||||++|+|++|+.||................
T Consensus 143 ~kl~Dfg~~~~~~~~~----~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~ 218 (331)
T cd06649 143 IKLCDFGVSGQLIDSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPV 218 (331)
T ss_pred EEEccCcccccccccc----cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccc
Confidence 9999999987553321 223458999999999998889999999999999999999999996543211100000000
Q ss_pred ----cc-----------------------cc---ccccchhc-CCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHH
Q 020641 255 ----PR-----------------------LS---EDKVKQCV-DPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIV 303 (323)
Q Consensus 255 ----~~-----------------------~~---~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev 303 (323)
.. .. .......+ ............+.++.+|+.+||+.||++|||+.|+
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~el 298 (331)
T cd06649 219 VDGEEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKML 298 (331)
T ss_pred cccccCCccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHH
Confidence 00 00 00000000 0000111112356789999999999999999999999
Q ss_pred HHH
Q 020641 304 VKA 306 (323)
Q Consensus 304 l~~ 306 (323)
++.
T Consensus 299 l~h 301 (331)
T cd06649 299 MNH 301 (331)
T ss_pred hcC
Confidence 873
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-43 Score=303.20 Aligned_cols=265 Identities=19% Similarity=0.277 Sum_probs=199.7
Q ss_pred CCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEe
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVE 95 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 95 (323)
.|....+||.|+||.||++.+..+++.+|+|...... .......+.+|+++++.++|+||+++++++..
T Consensus 6 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----------~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 74 (288)
T cd07871 6 TYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEH-----------EEGAPCTAIREVSLLKNLKHANIVTLHDIIHT 74 (288)
T ss_pred cceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccc-----------cCCcchhHHHHHHHHHhCCCCCEeeEEEEEcC
Confidence 4677779999999999999999999999998664221 11223567789999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeE
Q 020641 96 GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKA 175 (323)
Q Consensus 96 ~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~ 175 (323)
.+..++||||+.+ +|.+++..... .+++..+..++.|++.||.|||+. |++||||||+||+++.++.+
T Consensus 75 ~~~~~lv~e~~~~-~l~~~l~~~~~--------~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~ 142 (288)
T cd07871 75 ERCLTLVFEYLDS-DLKQYLDNCGN--------LMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGEL 142 (288)
T ss_pred CCeEEEEEeCCCc-CHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCE
Confidence 9999999999986 99998865432 278889999999999999999999 99999999999999999999
Q ss_pred EEeeccccCCCCccccccccccccCccccCCCccccC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhc
Q 020641 176 KIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT-GQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWAT 254 (323)
Q Consensus 176 ~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~ 254 (323)
+|+|||++........ ......+++.|+|||.+.+ ..++.++||||+|+++|+|++|+.||................
T Consensus 143 kl~DfG~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~ 220 (288)
T cd07871 143 KLADFGLARAKSVPTK--TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLL 220 (288)
T ss_pred EECcCcceeeccCCCc--cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence 9999999865432211 1223357889999998865 567899999999999999999999997654322211111110
Q ss_pred cccccc---------ccchhcCCCcCC----CCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 255 PRLSED---------KVKQCVDPKLKG----EYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 255 ~~~~~~---------~~~~~~~~~~~~----~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
...... .......+.... ......+.+..+++.+||+.||.+|||++|+++
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 221 GTPTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred CCCChHHhhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 000111 111111111100 011223567899999999999999999999985
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-43 Score=308.67 Aligned_cols=243 Identities=18% Similarity=0.184 Sum_probs=195.3
Q ss_pred cCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeCCeEEEE
Q 020641 23 LDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLA 102 (323)
Q Consensus 23 lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 102 (323)
||+|+||.||++++..+++.+|+|++.+... ........+.+|+.++++++||||+++++++...+..++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~---------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 71 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHI---------VSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLV 71 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHh---------hhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEE
Confidence 7999999999999999999999997653221 1122235677899999999999999999999999999999
Q ss_pred EeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEEEeeccc
Q 020641 103 YEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNL 182 (323)
Q Consensus 103 ~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~l~Dfg~ 182 (323)
|||+.+|+|.+++..... +++..+..++.|++.||.|||+. |++||||||+||+++.++.++|+|||+
T Consensus 72 ~e~~~~g~L~~~l~~~~~---------~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~ 139 (312)
T cd05585 72 LAFINGGELFHHLQREGR---------FDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGL 139 (312)
T ss_pred EcCCCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcc
Confidence 999999999999976432 88899999999999999999999 999999999999999999999999999
Q ss_pred cCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhccccccccc
Q 020641 183 SNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKV 262 (323)
Q Consensus 183 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 262 (323)
+........ ......|++.|+|||.+.+..++.++|||||||++|+|++|..||........ .
T Consensus 140 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~---------------~ 202 (312)
T cd05585 140 CKLNMKDDD--KTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEM---------------Y 202 (312)
T ss_pred cccCccCCC--ccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHH---------------H
Confidence 875332211 12334589999999999998999999999999999999999999975432110 0
Q ss_pred chhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCC---hHHHHH
Q 020641 263 KQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPN---MSIVVK 305 (323)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps---~~evl~ 305 (323)
...... ....+...+..+.+++.+||+.||.+||+ +.|++.
T Consensus 203 ~~~~~~--~~~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~ 246 (312)
T cd05585 203 RKILQE--PLRFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKN 246 (312)
T ss_pred HHHHcC--CCCCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence 111111 11233445677999999999999999986 455543
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=311.18 Aligned_cols=274 Identities=16% Similarity=0.226 Sum_probs=204.4
Q ss_pred cCCCCCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceee
Q 020641 12 AHAPSPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLG 91 (323)
Q Consensus 12 ~~~~~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~ 91 (323)
....+|....+||+|+||.||+|.+..+++.+|+|... ...+.+|++++++++||||+++++
T Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------------------~~~~~~E~~il~~l~HpnIv~~~~ 150 (391)
T PHA03212 89 IEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------------------RGGTATEAHILRAINHPSIIQLKG 150 (391)
T ss_pred cccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------------------hhhhHHHHHHHHhCCCCCCCCEeE
Confidence 34467888889999999999999999999999998321 134678999999999999999999
Q ss_pred EEEeCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEcc
Q 020641 92 YCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFE 171 (323)
Q Consensus 92 ~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~ 171 (323)
++......++|+|++. ++|.+++..... +++..++.++.|++.||.|||+. ||+||||||+||+++.
T Consensus 151 ~~~~~~~~~lv~e~~~-~~L~~~l~~~~~---------l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~ 217 (391)
T PHA03212 151 TFTYNKFTCLILPRYK-TDLYCYLAAKRN---------IAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINH 217 (391)
T ss_pred EEEECCeeEEEEecCC-CCHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcC
Confidence 9999999999999996 589888865432 88899999999999999999999 9999999999999999
Q ss_pred CCeEEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccc----
Q 020641 172 DFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQ---- 247 (323)
Q Consensus 172 ~~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~---- 247 (323)
++.++|+|||++......... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.........
T Consensus 218 ~~~vkL~DFG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~ 296 (391)
T PHA03212 218 PGDVCLGDFGAACFPVDINAN-KYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSD 296 (391)
T ss_pred CCCEEEEeCCccccccccccc-ccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchh
Confidence 999999999998653322111 122345899999999999888999999999999999999999887543221110
Q ss_pred hhhh----hhcc---ccc---ccccchhc---------CCCcCCC--CCHHHHHHHHHHHHHccCCCCCCCCChHHHHHH
Q 020641 248 SLVT----WATP---RLS---EDKVKQCV---------DPKLKGE--YPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKA 306 (323)
Q Consensus 248 ~~~~----~~~~---~~~---~~~~~~~~---------~~~~~~~--~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~ 306 (323)
.... .... ..+ ...+.... .+..+.. .....+.++.+++.+||+.||.+|||++|+++
T Consensus 297 ~~l~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~- 375 (391)
T PHA03212 297 RQIKLIIRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD- 375 (391)
T ss_pred HHHHHHHHHhcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc-
Confidence 0000 0000 000 00000000 0000000 01134568999999999999999999999996
Q ss_pred HhhhhcCCCCCCC
Q 020641 307 LQPLLKSPPPAAP 319 (323)
Q Consensus 307 l~~~~~~~~~~~~ 319 (323)
...+...+.|.|
T Consensus 376 -hp~f~~~~~~~~ 387 (391)
T PHA03212 376 -FAAFQDIPDPYP 387 (391)
T ss_pred -ChhhccCCCCCC
Confidence 555554444433
|
|
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=298.70 Aligned_cols=266 Identities=20% Similarity=0.310 Sum_probs=202.5
Q ss_pred CCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEe
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVE 95 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 95 (323)
.+....+||+|+||.||++.+..+++.+++++..+.... ........++..|+..+++++|+||+++++++..
T Consensus 8 ~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~-------~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~ 80 (279)
T cd05111 8 ELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQD-------RSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG 80 (279)
T ss_pred hceeccccCccCCcceEEEEEcCCCCceeeEEEEeeccc-------ccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC
Confidence 345566899999999999998877765444433322111 1112223567778888999999999999998764
Q ss_pred CCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeE
Q 020641 96 GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKA 175 (323)
Q Consensus 96 ~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~ 175 (323)
...++++||+.+|+|.+++...... +++..+..++.|++.|+.|||+. |++|+||||+||+++.++.+
T Consensus 81 -~~~~~i~e~~~~gsL~~~l~~~~~~--------~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~ 148 (279)
T cd05111 81 -ASLQLVTQLSPLGSLLDHVRQHRDS--------LDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIV 148 (279)
T ss_pred -CccEEEEEeCCCCcHHHHHHhcccC--------CCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcE
Confidence 4568899999999999999754322 88999999999999999999999 99999999999999999999
Q ss_pred EEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhc
Q 020641 176 KIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWAT 254 (323)
Q Consensus 176 ~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~ 254 (323)
+|+|||++................++..|++||.+.+..++.++||||||+++|++++ |..||.+......
T Consensus 149 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~-------- 220 (279)
T cd05111 149 QIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEV-------- 220 (279)
T ss_pred EEcCCccceeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH--------
Confidence 9999999876543322222233446778999999988889999999999999999998 9999975532111
Q ss_pred ccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhhcCCCC
Q 020641 255 PRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSPPP 316 (323)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~~~~~~ 316 (323)
.+.+........+..++..+.+++.+||..||++|||+.|+++.|..+...+|+
T Consensus 221 --------~~~~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~~~~ 274 (279)
T cd05111 221 --------PDLLEKGERLAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARDPPR 274 (279)
T ss_pred --------HHHHHCCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhCCcc
Confidence 111111111111222345688999999999999999999999999999887643
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=297.85 Aligned_cols=255 Identities=21% Similarity=0.253 Sum_probs=199.9
Q ss_pred CccccccCCCCCCccceeccc---eeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEE
Q 020641 17 PGYFVRLDKGPEDDLYLKKRV---KMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYC 93 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~~~---~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 93 (323)
+.....||+|+||.||++... ..+..+++|...... .......+.+|+.++++++||||+++++++
T Consensus 7 ~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~-----------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 75 (266)
T cd05064 7 IKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC-----------SDKQRRGFLAEALTLGQFDHSNIVRLEGVI 75 (266)
T ss_pred eEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC-----------CHHHHHHHHHHHHHHhcCCCCCcCeEEEEE
Confidence 455568999999999999764 345677877554221 111235688999999999999999999999
Q ss_pred EeCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCC
Q 020641 94 VEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDF 173 (323)
Q Consensus 94 ~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~ 173 (323)
..++..++||||+.+++|.+++..... .+++..++.++.|++.|+.|||+. |++|+||||+||+++.++
T Consensus 76 ~~~~~~~lv~e~~~~~~L~~~l~~~~~--------~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~ 144 (266)
T cd05064 76 TRGNTMMIVTEYMSNGALDSFLRKHEG--------QLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDL 144 (266)
T ss_pred ecCCCcEEEEEeCCCCcHHHHHHhCCC--------CCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCC
Confidence 999999999999999999999976432 188999999999999999999999 999999999999999999
Q ss_pred eEEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccchhhhh
Q 020641 174 KAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTW 252 (323)
Q Consensus 174 ~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~ 252 (323)
.++++|||.+......... ......++..|+|||.+.+..++.++||||||+++|++++ |..||.......
T Consensus 145 ~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~------- 216 (266)
T cd05064 145 VCKISGFRRLQEDKSEAIY-TTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD------- 216 (266)
T ss_pred cEEECCCcccccccccchh-cccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH-------
Confidence 9999999987654322111 1112234678999999988899999999999999999875 999997553211
Q ss_pred hcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhh
Q 020641 253 ATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPL 310 (323)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~ 310 (323)
..+.+........+..++..+.+++.+||+.+|.+|||+.+|++.|.++
T Consensus 217 ---------~~~~~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 217 ---------VIKAVEDGFRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred ---------HHHHHHCCCCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 1111111111223445667899999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-44 Score=281.64 Aligned_cols=245 Identities=24% Similarity=0.302 Sum_probs=209.0
Q ss_pred cccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeCCeEE
Q 020641 21 VRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRV 100 (323)
Q Consensus 21 ~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 100 (323)
..||+|.||.||+|+..+++..+|+|+..++.... .....++.+|+++-+.|+||||++++++|.+....|
T Consensus 28 r~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~---------~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riy 98 (281)
T KOG0580|consen 28 RPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILK---------TQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIY 98 (281)
T ss_pred ccccCCccccEeEeeeccCCcEEEEeeeeHHHHHH---------hcchhhhhheeEeecccCCccHHhhhhheeccceeE
Confidence 47899999999999999999999999988765333 334477899999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEEEeec
Q 020641 101 LAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADF 180 (323)
Q Consensus 101 lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~l~Df 180 (323)
+++||..+|++...++.....+ +++.....++.|++.|+.|+|.+ +++||||||+|+|++.++.++++||
T Consensus 99 LilEya~~gel~k~L~~~~~~~-------f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdf 168 (281)
T KOG0580|consen 99 LILEYAPRGELYKDLQEGRMKR-------FDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADF 168 (281)
T ss_pred EEEEecCCchHHHHHHhccccc-------ccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCC
Confidence 9999999999999998665543 88889999999999999999999 9999999999999999999999999
Q ss_pred cccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhccccccc
Q 020641 181 NLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSED 260 (323)
Q Consensus 181 g~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 260 (323)
|-+...+.. .....+||..|++||+..+...+...|+|++|++.||++.|..||+.........
T Consensus 169 GwsV~~p~~----kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYk------------ 232 (281)
T KOG0580|consen 169 GWSVHAPSN----KRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYK------------ 232 (281)
T ss_pred CceeecCCC----CceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHH------------
Confidence 987654421 2245679999999999999999999999999999999999999998665222211
Q ss_pred ccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 261 KVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
++..- +...|...+....++|.+|+..+|.+|.+..|+++
T Consensus 233 ---rI~k~--~~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~ 272 (281)
T KOG0580|consen 233 ---RIRKV--DLKFPSTISGGAADLISRLLVKNPIERLALTEVMD 272 (281)
T ss_pred ---HHHHc--cccCCcccChhHHHHHHHHhccCccccccHHHHhh
Confidence 11111 12334566778999999999999999999999986
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-43 Score=307.95 Aligned_cols=245 Identities=20% Similarity=0.213 Sum_probs=198.5
Q ss_pred ccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeCCeEEE
Q 020641 22 RLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVL 101 (323)
Q Consensus 22 ~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 101 (323)
.||+|+||.||++++..+++.+|+|++.+.... .......+.+|+.+++.++||||+++++++...+..++
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~---------~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 72 (328)
T cd05593 2 LLGKGTFGKVILVREKASGKYYAMKILKKEVII---------AKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCF 72 (328)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh---------hhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEE
Confidence 589999999999999999999999977643211 12223567889999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEEEeecc
Q 020641 102 AYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFN 181 (323)
Q Consensus 102 v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~l~Dfg 181 (323)
||||+.+++|.+++..... +++..+..++.||+.||.|||+. |++||||||+||+++.++.++|+|||
T Consensus 73 v~Ey~~~g~L~~~l~~~~~---------l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG 140 (328)
T cd05593 73 VMEYVNGGELFFHLSRERV---------FSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFG 140 (328)
T ss_pred EEeCCCCCCHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCc
Confidence 9999999999998865432 88999999999999999999999 99999999999999999999999999
Q ss_pred ccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccccccc
Q 020641 182 LSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDK 261 (323)
Q Consensus 182 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 261 (323)
++........ ......|++.|+|||.+.+..++.++|||||||++|+|++|+.||..........
T Consensus 141 ~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~------------- 205 (328)
T cd05593 141 LCKEGITDAA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFE------------- 205 (328)
T ss_pred CCccCCCccc--ccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHH-------------
Confidence 9875332111 1233458999999999998889999999999999999999999997543211100
Q ss_pred cchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCC-----ChHHHHHH
Q 020641 262 VKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRP-----NMSIVVKA 306 (323)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-----s~~evl~~ 306 (323)
..... ....+...+.++.+++.+||..||.+|| ++.++++.
T Consensus 206 --~~~~~--~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 206 --LILME--DIKFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred --HhccC--CccCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 00000 0123344567799999999999999997 89998863
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=291.55 Aligned_cols=271 Identities=20% Similarity=0.201 Sum_probs=211.2
Q ss_pred CCCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCc-ccceeeEE
Q 020641 15 PSPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHEN-LVELLGYC 93 (323)
Q Consensus 15 ~~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~-i~~~~~~~ 93 (323)
..++.+.+||+|.||+||.|++..+++.||+|++..+.-. +.......+|+.+++.++|+| |+.+++++
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~----------EG~P~taiREisllk~L~~~~~iv~L~dv~ 80 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEE----------EGVPSTAIREISLLKRLSHANHIVRLHDVI 80 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccc----------cCCCchhhHHHHHHHHhCCCcceEEEEeee
Confidence 3456677999999999999999999999999977643211 234566789999999999999 99999999
Q ss_pred EeCC------eEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCE
Q 020641 94 VEGN------LRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNV 167 (323)
Q Consensus 94 ~~~~------~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~ni 167 (323)
...+ ..++|+||.+. +|.+++....... ..++...+..+++||+.||+|||++ +|+||||||.||
T Consensus 81 ~~~~~~~~~~~l~lvfe~~d~-DL~~ymd~~~~~~-----~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNl 151 (323)
T KOG0594|consen 81 HTSNNHRGIGKLYLVFEFLDR-DLKKYMDSLPKKP-----QGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNL 151 (323)
T ss_pred eecccccccceEEEEEEeecc-cHHHHHHhccccc-----cCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceE
Confidence 9877 88999999986 9999998765321 1267789999999999999999999 999999999999
Q ss_pred EEccCCeEEEeeccccCCCCccccccccccccCccccCCCccccCC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCccc
Q 020641 168 LLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG-QLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQ 246 (323)
Q Consensus 168 li~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~ 246 (323)
+++++|.+||+|||+|+........ .....+|.+|+|||++.+. .|+...||||+||++.||++++..|.+......
T Consensus 152 Li~~~G~lKlaDFGlAra~~ip~~~--yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~q 229 (323)
T KOG0594|consen 152 LISSSGVLKLADFGLARAFSIPMRT--YTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQ 229 (323)
T ss_pred EECCCCcEeeeccchHHHhcCCccc--ccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHH
Confidence 9999999999999999865533322 3455689999999999987 689999999999999999999999988876444
Q ss_pred chhhhhhcccccccccchhc-----CCCcC-CCCCH-------HHHHHHHHHHHHccCCCCCCCCChHHHHHH
Q 020641 247 QSLVTWATPRLSEDKVKQCV-----DPKLK-GEYPP-------KGVAKLAAVAALCVQYEAEFRPNMSIVVKA 306 (323)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~-----~~~~~-~~~~~-------~~~~~l~~li~~cl~~~P~~Rps~~evl~~ 306 (323)
...+...-........+... ..... ...+. ....+..+++.+||+.+|.+|.|+...++.
T Consensus 230 l~~If~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 230 LFRIFRLLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred HHHHHHHcCCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 33333222222222222111 11111 01011 112478899999999999999999999985
|
|
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=294.13 Aligned_cols=249 Identities=23% Similarity=0.358 Sum_probs=197.5
Q ss_pred ccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeCCeEEE
Q 020641 22 RLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVL 101 (323)
Q Consensus 22 ~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 101 (323)
+||+|+||.||++.+..+++.+++|..... ...+....+.+|+++++.++|+||+++++++......++
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~-----------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 70 (252)
T cd05084 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRET-----------LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYI 70 (252)
T ss_pred ccCcccCccEEEEEEecCCceEEEEecCcc-----------CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEE
Confidence 689999999999999999999999865321 112233668899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEEEeecc
Q 020641 102 AYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFN 181 (323)
Q Consensus 102 v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~l~Dfg 181 (323)
||||+.+++|.+++..... .+++..++.++.|++.||.|||+. |++|+||+|+||+++.++.++|+|||
T Consensus 71 v~e~~~~~~L~~~~~~~~~--------~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg 139 (252)
T cd05084 71 VMELVQGGDFLTFLRTEGP--------RLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFG 139 (252)
T ss_pred EEeeccCCcHHHHHHhCCC--------CCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccc
Confidence 9999999999999865432 178899999999999999999999 99999999999999999999999999
Q ss_pred ccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhccccccc
Q 020641 182 LSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPRLSED 260 (323)
Q Consensus 182 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 260 (323)
.+.................+..|+|||.+.+..++.++|+||||+++|++++ |..||.......
T Consensus 140 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~--------------- 204 (252)
T cd05084 140 MSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQ--------------- 204 (252)
T ss_pred cCcccccccccccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHH---------------
Confidence 9875433211111111123456999999988889999999999999999997 888886443211
Q ss_pred ccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHh
Q 020641 261 KVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQ 308 (323)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~ 308 (323)
....+........+...+..+.+++.+||+.+|++|||+.++++.|+
T Consensus 205 -~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 205 -TREAIEQGVRLPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred -HHHHHHcCCCCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 11111111122233445668999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-43 Score=293.28 Aligned_cols=264 Identities=21% Similarity=0.268 Sum_probs=207.8
Q ss_pred cccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEe---
Q 020641 19 YFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVE--- 95 (323)
Q Consensus 19 ~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--- 95 (323)
.+..||.|+||.|..|.+..+++.||+|.+.... ......++..+|+.+|+.++|+||+.+.+++..
T Consensus 26 ~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F----------~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~ 95 (359)
T KOG0660|consen 26 LIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPF----------ENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSR 95 (359)
T ss_pred ccccccCcceeeEEEEEEcCCCCEeehhhhhhhh----------hchHHHHHHHHHHHHHHHhcCCCcceEEeecccccc
Confidence 3568999999999999999999999998665222 123345778999999999999999999999875
Q ss_pred --CCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCC
Q 020641 96 --GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDF 173 (323)
Q Consensus 96 --~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~ 173 (323)
-+..|+|+|+|+. +|.+.++.+.. ++...+..+++|++.|+.|+|+. +++|||+||.|++++.+.
T Consensus 96 ~~f~DvYiV~elMet-DL~~iik~~~~---------L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c 162 (359)
T KOG0660|consen 96 DKFNDVYLVFELMET-DLHQIIKSQQD---------LTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADC 162 (359)
T ss_pred cccceeEEehhHHhh-HHHHHHHcCcc---------ccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCC
Confidence 3578999999965 99999987653 88999999999999999999999 999999999999999999
Q ss_pred eEEEeeccccCCCCccccccccccccCccccCCCcccc-CCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhh
Q 020641 174 KAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAM-TGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTW 252 (323)
Q Consensus 174 ~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 252 (323)
.+||+|||+|+...........+...-|.+|+|||++. ...|+.+.||||+||++.||++|+..|.+.+...+-..+..
T Consensus 163 ~lKI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~ 242 (359)
T KOG0660|consen 163 DLKICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILE 242 (359)
T ss_pred CEEeccccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHH
Confidence 99999999999875432233335556799999999775 56899999999999999999999999988765444333333
Q ss_pred hcccccccccchh--------cCCCcC---CC---CCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 253 ATPRLSEDKVKQC--------VDPKLK---GE---YPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 253 ~~~~~~~~~~~~~--------~~~~~~---~~---~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
.....+.+.+..+ +..... .. ..+..++...+|+.+||..||.+|+|++|.++
T Consensus 243 ~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~ 309 (359)
T KOG0660|consen 243 LLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALA 309 (359)
T ss_pred hcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence 2222222222221 111111 00 11244568899999999999999999999986
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=321.56 Aligned_cols=253 Identities=19% Similarity=0.251 Sum_probs=199.2
Q ss_pred CccccccCCCCCCccceecccee-eeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEe
Q 020641 17 PGYFVRLDKGPEDDLYLKKRVKM-RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVE 95 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~~~~~-~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 95 (323)
|.....||.|++|.||+|.+..+ ++.+++|..... .......+..|+.+++.++||||+++++++..
T Consensus 69 y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~------------~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~ 136 (478)
T PTZ00267 69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN------------DERQAAYARSELHCLAACDHFGIVKHFDDFKS 136 (478)
T ss_pred EEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC------------CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEE
Confidence 55666899999999999998877 677777744211 11122456789999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeE
Q 020641 96 GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKA 175 (323)
Q Consensus 96 ~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~ 175 (323)
.+..|+||||+.+|+|.+++...... ...+++..+..++.|++.||.|||+. ||+||||||+||+++.++.+
T Consensus 137 ~~~~~lv~E~~~gg~L~~~l~~~~~~-----~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~ 208 (478)
T PTZ00267 137 DDKLLLIMEYGSGGDLNKQIKQRLKE-----HLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGII 208 (478)
T ss_pred CCEEEEEEECCCCCCHHHHHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcE
Confidence 99999999999999999988643211 11288889999999999999999999 99999999999999999999
Q ss_pred EEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhcc
Q 020641 176 KIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATP 255 (323)
Q Consensus 176 ~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~ 255 (323)
+|+|||++................||+.|+|||.+.+..++.++|||||||++|+|++|+.||........
T Consensus 209 kL~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~--------- 279 (478)
T PTZ00267 209 KLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREI--------- 279 (478)
T ss_pred EEEeCcCceecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHH---------
Confidence 99999999765543322223445689999999999888899999999999999999999999965432110
Q ss_pred cccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 256 RLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
+...+... ....+...+..+.+++.+||..||++|||+.+++.
T Consensus 280 ------~~~~~~~~-~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 280 ------MQQVLYGK-YDPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred ------HHHHHhCC-CCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 01111111 11223345567999999999999999999999864
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-43 Score=307.58 Aligned_cols=244 Identities=21% Similarity=0.231 Sum_probs=197.4
Q ss_pred ccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeCCeEEE
Q 020641 22 RLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVL 101 (323)
Q Consensus 22 ~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 101 (323)
.||+|+||.||++++..+++.+|+|+...+... .......+.+|+.+++.++||||+++++.+......++
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~---------~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~l 72 (323)
T cd05595 2 LLGKGTFGKVILVREKATGRYYAMKILRKEVII---------AKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCF 72 (323)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh---------hhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEE
Confidence 589999999999999999999999977643221 11223566789999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEEEeecc
Q 020641 102 AYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFN 181 (323)
Q Consensus 102 v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~l~Dfg 181 (323)
||||+.+++|.+++..... +++..+..++.||+.||.|||+. |++||||||+||+++.++.++|+|||
T Consensus 73 v~E~~~~~~L~~~l~~~~~---------~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg 140 (323)
T cd05595 73 VMEYANGGELFFHLSRERV---------FTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFG 140 (323)
T ss_pred EEeCCCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccH
Confidence 9999999999998865432 88999999999999999999999 99999999999999999999999999
Q ss_pred ccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccccccc
Q 020641 182 LSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDK 261 (323)
Q Consensus 182 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 261 (323)
++........ ......|++.|+|||.+.+..++.++|||||||++|+|++|+.||..........
T Consensus 141 ~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~------------- 205 (323)
T cd05595 141 LCKEGISDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFE------------- 205 (323)
T ss_pred HhccccCCCC--ccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHH-------------
Confidence 8865322111 1233458999999999998889999999999999999999999997543211110
Q ss_pred cchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCC-----ChHHHHH
Q 020641 262 VKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRP-----NMSIVVK 305 (323)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-----s~~evl~ 305 (323)
...... ...+...+..+.+++.+||+.||.+|| ++.++++
T Consensus 206 --~~~~~~--~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 206 --LILMEE--IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred --HHhcCC--CCCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 111111 112334567799999999999999998 8888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-43 Score=310.01 Aligned_cols=256 Identities=27% Similarity=0.420 Sum_probs=206.7
Q ss_pred ccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeCCeEEE
Q 020641 22 RLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVL 101 (323)
Q Consensus 22 ~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 101 (323)
+||.|+||+||++++..+ ||+|++..+..... ..+.|++|+.++++-+|.||+-+.|+|..+.. .+
T Consensus 399 rIGsGsFGtV~Rg~whGd---VAVK~Lnv~~pt~~----------qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AI 464 (678)
T KOG0193|consen 399 RIGSGSFGTVYRGRWHGD---VAVKLLNVDDPTPE----------QLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AI 464 (678)
T ss_pred eeccccccceeecccccc---eEEEEEecCCCCHH----------HHHHHHHHHHHHhhcchhhheeeehhhcCCce-ee
Confidence 899999999999998765 78886654433322 34789999999999999999999999999987 99
Q ss_pred EEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEEEeecc
Q 020641 102 AYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFN 181 (323)
Q Consensus 102 v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~l~Dfg 181 (323)
|+-+|+|.+|+.++.-...+ +.....++|++|+++|+.|||.+ +|+|+|+|..||++.++++|||+|||
T Consensus 465 iTqwCeGsSLY~hlHv~etk--------fdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDFG 533 (678)
T KOG0193|consen 465 ITQWCEGSSLYTHLHVQETK--------FDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDFG 533 (678)
T ss_pred eehhccCchhhhhccchhhh--------hhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEeccc
Confidence 99999999999999765533 89999999999999999999999 99999999999999999999999999
Q ss_pred ccCCCCccccccccccccCccccCCCcccc---CCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhccccc
Q 020641 182 LSNQAPDMAARLHSTRVLGTFGYHAPEYAM---TGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLS 258 (323)
Q Consensus 182 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 258 (323)
++................|...|+|||++. ..+|++.+||||||+++|||++|..||........-..+. +.+
T Consensus 534 Latvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVG---rG~- 609 (678)
T KOG0193|consen 534 LATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVG---RGY- 609 (678)
T ss_pred ceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEec---ccc-
Confidence 997665443333344556888999999886 4578999999999999999999999998433221111111 110
Q ss_pred ccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhhcCC
Q 020641 259 EDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSP 314 (323)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~~~~ 314 (323)
+.+.. ......++.++.+|+..||.+++++||++.+|+..|+.++...
T Consensus 610 -------l~pd~-s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~ 657 (678)
T KOG0193|consen 610 -------LMPDL-SKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPSL 657 (678)
T ss_pred -------cCccc-hhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhcc
Confidence 00000 1123456778999999999999999999999999999888743
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-42 Score=295.00 Aligned_cols=255 Identities=25% Similarity=0.338 Sum_probs=204.8
Q ss_pred CccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeC
Q 020641 17 PGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEG 96 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 96 (323)
+....+||+|++|.||++.+..+++.+++|..... ......+.+|+++++.++|+||+++++++...
T Consensus 8 ~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-------------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 74 (263)
T cd05052 8 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-------------TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE 74 (263)
T ss_pred eEEeeecCCcccceEEEEEEecCCceEEEEEecCC-------------chHHHHHHHHHHHHHhCCCCChhheEEEEcCC
Confidence 44555899999999999999998888998865321 11135678899999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEE
Q 020641 97 NLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAK 176 (323)
Q Consensus 97 ~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~ 176 (323)
...+++|||+.+++|.+++...... .+++..+..++.|++.|+.+||+. |++|+||||+||++++++.++
T Consensus 75 ~~~~lv~e~~~~~~L~~~~~~~~~~-------~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~k 144 (263)
T cd05052 75 PPFYIITEFMTYGNLLDYLRECNRQ-------EVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVK 144 (263)
T ss_pred CCcEEEEEeCCCCcHHHHHHhCCCC-------CCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEE
Confidence 9999999999999999999764322 288889999999999999999999 999999999999999999999
Q ss_pred EeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcc
Q 020641 177 IADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATP 255 (323)
Q Consensus 177 l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~ 255 (323)
|+|||.+.......... .....++..|+|||.+.+..++.++||||||+++|+|++ |..||.......
T Consensus 145 l~df~~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~---------- 213 (263)
T cd05052 145 VADFGLSRLMTGDTYTA-HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---------- 213 (263)
T ss_pred eCCCccccccccceeec-cCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH----------
Confidence 99999987655432211 112224567999999988889999999999999999998 999986543211
Q ss_pred cccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhh
Q 020641 256 RLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLL 311 (323)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~ 311 (323)
....+........+...+..+.+++.+||+.||++|||+.++++.|+.++
T Consensus 214 ------~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 263 (263)
T cd05052 214 ------VYELLEKGYRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETMF 263 (263)
T ss_pred ------HHHHHHCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhhC
Confidence 11111112222334455678999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=303.67 Aligned_cols=258 Identities=17% Similarity=0.186 Sum_probs=207.7
Q ss_pred CCCCCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeE
Q 020641 13 HAPSPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGY 92 (323)
Q Consensus 13 ~~~~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 92 (323)
+...++.+..||+|+||.||+|+-..+|.++|+|++.+... ........++.|=.+|...+++.||+++..
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M---------~~~~Qv~hV~aERdiL~~~ds~~vVKLyYs 209 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEM---------LKKNQVEHVRAERDILAEVDSPWVVKLYYS 209 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHH---------HhhhhHHHHHHHHHHhhhcCCCcEEEEEEE
Confidence 44566777789999999999999999999999998875532 233445778888899998999999999999
Q ss_pred EEeCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccC
Q 020641 93 CVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFED 172 (323)
Q Consensus 93 ~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~ 172 (323)
|.+...+||||||.+||++-.++.+... +++..+..++.+++.||..+|+. |++||||||+|+|||.+
T Consensus 210 FQD~~~LYLiMEylPGGD~mTLL~~~~~---------L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~ 277 (550)
T KOG0605|consen 210 FQDKEYLYLIMEYLPGGDMMTLLMRKDT---------LTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAK 277 (550)
T ss_pred ecCCCeeEEEEEecCCccHHHHHHhcCc---------CchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCC
Confidence 9999999999999999999999987653 99999999999999999999999 99999999999999999
Q ss_pred CeEEEeeccccCCCCcc---------------------cccc-----c-------------------cccccCccccCCC
Q 020641 173 FKAKIADFNLSNQAPDM---------------------AARL-----H-------------------STRVLGTFGYHAP 207 (323)
Q Consensus 173 ~~~~l~Dfg~~~~~~~~---------------------~~~~-----~-------------------~~~~~g~~~y~aP 207 (323)
|.+||+|||++.-.... .... . .....|||.|+||
T Consensus 278 GHiKLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAP 357 (550)
T KOG0605|consen 278 GHIKLSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAP 357 (550)
T ss_pred CCEeeccccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccch
Confidence 99999999997322110 0000 0 0023499999999
Q ss_pred ccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHH
Q 020641 208 EYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAA 287 (323)
Q Consensus 208 E~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 287 (323)
|++.+.+|+...|.|||||++|||+.|.+||...........+...... +..+.....+.+..+||.
T Consensus 358 EVll~kgY~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~-------------l~fP~~~~~s~eA~DLI~ 424 (550)
T KOG0605|consen 358 EVLLGKGYGKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRET-------------LKFPEEVDLSDEAKDLIT 424 (550)
T ss_pred HHHhcCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhh-------------ccCCCcCcccHHHHHHHH
Confidence 9999999999999999999999999999999877654433322211111 122233344578999999
Q ss_pred HccCCCCCCCCC---hHHHHH
Q 020641 288 LCVQYEAEFRPN---MSIVVK 305 (323)
Q Consensus 288 ~cl~~~P~~Rps---~~evl~ 305 (323)
+||. ||+.|.- ++||-+
T Consensus 425 rll~-d~~~RLG~~G~~EIK~ 444 (550)
T KOG0605|consen 425 RLLC-DPENRLGSKGAEEIKK 444 (550)
T ss_pred HHhc-CHHHhcCcccHHHHhc
Confidence 9999 9999974 566544
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-43 Score=311.54 Aligned_cols=259 Identities=31% Similarity=0.393 Sum_probs=215.9
Q ss_pred cccCCCCCCccceeccceeee---e-eeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeC
Q 020641 21 VRLDKGPEDDLYLKKRVKMRR---W-LCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEG 96 (323)
Q Consensus 21 ~~lg~G~~~~V~~~~~~~~~~---~-~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 96 (323)
.+||+|+||.||+++....+. . ||+|....+. ...+....++++|.++|++++|+||++++|+....
T Consensus 163 kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~---------~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~ 233 (474)
T KOG0194|consen 163 KKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSS---------ELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLE 233 (474)
T ss_pred ceeecccccEEEEEEEEecCCceeeeeEEEeecccc---------cccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCC
Confidence 599999999999998887532 2 6766443211 12233457899999999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEE
Q 020641 97 NLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAK 176 (323)
Q Consensus 97 ~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~ 176 (323)
..+++|||+|.||+|.+++++.... ++..+...++.+.+.||.|||++ +++||||-.+|+|++.++.+|
T Consensus 234 ~Pl~ivmEl~~gGsL~~~L~k~~~~--------v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vK 302 (474)
T KOG0194|consen 234 EPLMLVMELCNGGSLDDYLKKNKKS--------LPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVK 302 (474)
T ss_pred CccEEEEEecCCCcHHHHHHhCCCC--------CCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEE
Confidence 9999999999999999999987653 99999999999999999999999 999999999999999999999
Q ss_pred EeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcc
Q 020641 177 IADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATP 255 (323)
Q Consensus 177 l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~ 255 (323)
|+|||+++....-... .....-+..|+|||.+....++.++||||||+++||+++ |..||.+...
T Consensus 303 ISDFGLs~~~~~~~~~--~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~------------ 368 (474)
T KOG0194|consen 303 ISDFGLSRAGSQYVMK--KFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKN------------ 368 (474)
T ss_pred eCccccccCCcceeec--cccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCH------------
Confidence 9999998765411111 111124678999999998999999999999999999998 8889975542
Q ss_pred cccccccchhc-CCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhhcCCCCC
Q 020641 256 RLSEDKVKQCV-DPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSPPPA 317 (323)
Q Consensus 256 ~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~~~~~~~ 317 (323)
.++...+ ....+...+...+..+..++.+||..+|++|||+.++.+.|+.+.....++
T Consensus 369 ----~~v~~kI~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~~ 427 (474)
T KOG0194|consen 369 ----YEVKAKIVKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEAF 427 (474)
T ss_pred ----HHHHHHHHhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccccc
Confidence 2333333 556667777788899999999999999999999999999999999877653
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-42 Score=300.79 Aligned_cols=271 Identities=24% Similarity=0.329 Sum_probs=199.4
Q ss_pred CCccccccCCCCCCccceeccce----------------eeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHh
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRVK----------------MRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVS 79 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~~----------------~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~ 79 (323)
.+....+||+|+||.||+|.+.. ++..+|+|...... .......+.+|+++++
T Consensus 6 ~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-----------~~~~~~~~~~E~~~l~ 74 (304)
T cd05096 6 HLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA-----------NKNARNDFLKEVKILS 74 (304)
T ss_pred hCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC-----------CHHHHHHHHHHHHHHh
Confidence 34455689999999999997543 33457776543211 1122356889999999
Q ss_pred cCCCCcccceeeEEEeCCeEEEEEeecCCCCHHHHhccCCCCCC----------CCCCCCCCHHHHHHHHHHHHHHHHHh
Q 020641 80 RLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQG----------AQPGPVLDWMTRVRIAVDAARGLEYL 149 (323)
Q Consensus 80 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~i~~~l~~l 149 (323)
+++|+||+++++++...+..++||||+.+++|.+++........ ......+++..+..++.|++.||.||
T Consensus 75 ~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~l 154 (304)
T cd05096 75 RLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL 154 (304)
T ss_pred hcCCCCeeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHH
Confidence 99999999999999999999999999999999999865432111 11223478889999999999999999
Q ss_pred hcCCCCCceeCCCCCCCEEEccCCeEEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHH
Q 020641 150 HEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLL 229 (323)
Q Consensus 150 h~~~~~~i~h~dikp~nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~ 229 (323)
|+. |++|+||||+||+++.++.++|+|||++................++..|+|||.+.+..++.++||||||+++|
T Consensus 155 H~~---~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ 231 (304)
T cd05096 155 SSL---NFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLW 231 (304)
T ss_pred HHC---CccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHH
Confidence 999 99999999999999999999999999987654332222223334577899999998888999999999999999
Q ss_pred HHHh--CCCCCCCCCCcccchhhhhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHH
Q 020641 230 ELLT--GRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKAL 307 (323)
Q Consensus 230 ~l~~--g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l 307 (323)
+|++ +..||........ ........... ........+..++..+.+++.+||+.||.+|||+.+|.+.|
T Consensus 232 el~~~~~~~p~~~~~~~~~---~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l 302 (304)
T cd05096 232 EILMLCKEQPYGELTDEQV---IENAGEFFRDQ------GRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFL 302 (304)
T ss_pred HHHHccCCCCCCcCCHHHH---HHHHHHHhhhc------cccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHH
Confidence 9986 6677765432111 11000000000 00001112334567799999999999999999999999988
Q ss_pred hh
Q 020641 308 QP 309 (323)
Q Consensus 308 ~~ 309 (323)
++
T Consensus 303 ~~ 304 (304)
T cd05096 303 TE 304 (304)
T ss_pred hC
Confidence 63
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-42 Score=298.06 Aligned_cols=268 Identities=24% Similarity=0.357 Sum_probs=205.0
Q ss_pred CccccccCCCCCCccceeccce-----eeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceee
Q 020641 17 PGYFVRLDKGPEDDLYLKKRVK-----MRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLG 91 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~~~~-----~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~ 91 (323)
+.....||+|+||.||++++.. ++..+++|..... .....+.+.+|++.+++++|+||+++++
T Consensus 7 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~------------~~~~~~~~~~e~~~l~~l~h~~i~~~~~ 74 (291)
T cd05094 7 IVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP------------TLAARKDFQREAELLTNLQHEHIVKFYG 74 (291)
T ss_pred eEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCc------------cHHHHHHHHHHHHHHhcCCCCCcceEEE
Confidence 4445689999999999998643 3444555533211 1112356788999999999999999999
Q ss_pred EEEeCCeEEEEEeecCCCCHHHHhccCCCC-------CCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCC
Q 020641 92 YCVEGNLRVLAYEFATMGSLHDILHGRKGV-------QGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRS 164 (323)
Q Consensus 92 ~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp 164 (323)
++..+...++||||+.+++|.+++...... ........+++..++.++.||+.|+.|||++ |++|+||||
T Consensus 75 ~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp 151 (291)
T cd05094 75 VCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLAT 151 (291)
T ss_pred EEccCCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCc
Confidence 999999999999999999999999764321 0011222388999999999999999999999 999999999
Q ss_pred CCEEEccCCeEEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCC
Q 020641 165 SNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMP 243 (323)
Q Consensus 165 ~nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~ 243 (323)
+||+++.++.++|+|||++................++..|+|||.+.+..++.++||||||+++|+|++ |..||.....
T Consensus 152 ~Nil~~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 231 (291)
T cd05094 152 RNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSN 231 (291)
T ss_pred ceEEEccCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999875543322222233446788999999988889999999999999999998 9999865432
Q ss_pred cccchhhhhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhhcCCC
Q 020641 244 RGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSPP 315 (323)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~~~~~ 315 (323)
... . +.+........+...+..+.+++.+||+.+|.+|||+.+|++.|+++.+..|
T Consensus 232 ~~~---~-------------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~~~ 287 (291)
T cd05094 232 TEV---I-------------ECITQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKATP 287 (291)
T ss_pred HHH---H-------------HHHhCCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhhcC
Confidence 110 0 1111111111223345679999999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-42 Score=293.38 Aligned_cols=257 Identities=22% Similarity=0.299 Sum_probs=202.1
Q ss_pred CccccccCCCCCCccceecccee---eeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEE
Q 020641 17 PGYFVRLDKGPEDDLYLKKRVKM---RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYC 93 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~~~~~---~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 93 (323)
+.....||+|+||.||++....+ ...+++|...... .......+.+|+.+++.++|+||+++++++
T Consensus 6 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~-----------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 74 (266)
T cd05033 6 VTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS-----------SDKQRLDFLTEASIMGQFDHPNIIRLEGVV 74 (266)
T ss_pred ceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC-----------ChHHHHHHHHHHHHHHhCCCCCcceEeEEE
Confidence 45556899999999999988654 4467777553211 112235678899999999999999999999
Q ss_pred EeCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCC
Q 020641 94 VEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDF 173 (323)
Q Consensus 94 ~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~ 173 (323)
......+++|||+.+++|.+++...... +++..+..++.|++.|+.|||+. +++|+||+|+||+++.++
T Consensus 75 ~~~~~~~iv~e~~~~~~L~~~~~~~~~~--------~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~ 143 (266)
T cd05033 75 TKSRPVMIITEYMENGSLDKFLRENDGK--------FTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNL 143 (266)
T ss_pred ecCCceEEEEEcCCCCCHHHHHHhccCC--------CCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCC
Confidence 9999999999999999999999764432 88999999999999999999999 999999999999999999
Q ss_pred eEEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccchhhhh
Q 020641 174 KAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTW 252 (323)
Q Consensus 174 ~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~ 252 (323)
.++|+|||++................++..|+|||.+.+..++.++||||||+++|++++ |..||......
T Consensus 144 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~-------- 215 (266)
T cd05033 144 VCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ-------- 215 (266)
T ss_pred CEEECccchhhcccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH--------
Confidence 999999999987652222212222334678999999988889999999999999999997 99998644221
Q ss_pred hcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhh
Q 020641 253 ATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLL 311 (323)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~ 311 (323)
.....+........+...+..+.+++.+||+.+|++||++.+|++.|++++
T Consensus 216 --------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~~ 266 (266)
T cd05033 216 --------DVIKAVEDGYRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKMI 266 (266)
T ss_pred --------HHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence 111111111111223345677999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-42 Score=297.76 Aligned_cols=254 Identities=19% Similarity=0.237 Sum_probs=201.7
Q ss_pred CccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeC
Q 020641 17 PGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEG 96 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 96 (323)
|+....||+|+||.||++.+..+++.+|+|......... ......+.+|+.+++.++|+||+++++.+..+
T Consensus 2 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 72 (285)
T cd05605 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKK---------RKGEAMALNEKQILEKVNSRFVVSLAYAYETK 72 (285)
T ss_pred ceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhh---------hhhHHHHHHHHHHHHhcCCCCEeeeeeeecCC
Confidence 556678999999999999999999999998765332211 11234567899999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEE
Q 020641 97 NLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAK 176 (323)
Q Consensus 97 ~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~ 176 (323)
+..++||||+.+++|.+++...... .+++..+..++.|++.|+.|||+. |++|+||||+||++++++.++
T Consensus 73 ~~~~lv~e~~~~~~L~~~~~~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~ 142 (285)
T cd05605 73 DALCLVLTLMNGGDLKFHIYNMGNP-------GFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIR 142 (285)
T ss_pred CeEEEEEeccCCCcHHHHHHhcCcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEE
Confidence 9999999999999999888654322 288999999999999999999999 999999999999999999999
Q ss_pred EeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhccc
Q 020641 177 IADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPR 256 (323)
Q Consensus 177 l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 256 (323)
|+|||++........ .....|+..|+|||.+.+..++.++||||+|+++|++++|..||..........
T Consensus 143 l~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~-------- 211 (285)
T cd05605 143 ISDLGLAVEIPEGET---IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKRE-------- 211 (285)
T ss_pred EeeCCCceecCCCCc---cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHH--------
Confidence 999999876543221 123357899999999988889999999999999999999999997543211100
Q ss_pred ccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCC-----ChHHHHH
Q 020641 257 LSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRP-----NMSIVVK 305 (323)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-----s~~evl~ 305 (323)
.+...+.. .....+...+..+.+++.+||+.||++|| ++.++++
T Consensus 212 ----~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05605 212 ----EVERRVKE-DQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA 260 (285)
T ss_pred ----HHHHHhhh-cccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence 01111111 11223345667799999999999999999 8889965
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-42 Score=293.50 Aligned_cols=255 Identities=25% Similarity=0.365 Sum_probs=205.3
Q ss_pred CCCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEE
Q 020641 15 PSPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCV 94 (323)
Q Consensus 15 ~~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 94 (323)
..|.+..+||.|+||.||++.+.. ++.+++|+..... ......+.+|+.+++.++|+||+++++++.
T Consensus 6 ~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~------------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 72 (261)
T cd05148 6 EEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDD------------LLKQQDFQKEVQALKRLRHKHLISLFAVCS 72 (261)
T ss_pred HHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccc------------hhhHHHHHHHHHHHhcCCCcchhheeeeEe
Confidence 345667799999999999999988 7778887654221 112356888999999999999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCe
Q 020641 95 EGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFK 174 (323)
Q Consensus 95 ~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~ 174 (323)
.....++||||+.+++|.+++....... +++..+..++.|++.|+.|||+. |++|+||+|+||+++.++.
T Consensus 73 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~-------~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~ 142 (261)
T cd05148 73 VGEPVYIITELMEKGSLLAFLRSPEGQV-------LPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLV 142 (261)
T ss_pred cCCCeEEEEeecccCCHHHHHhcCCCCC-------CCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCce
Confidence 9999999999999999999997654322 88999999999999999999999 9999999999999999999
Q ss_pred EEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhh
Q 020641 175 AKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWA 253 (323)
Q Consensus 175 ~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~ 253 (323)
++|+|||.+.......... ....++..|++||...+..++.++|+||||+++|+|++ |+.||.......
T Consensus 143 ~kl~d~g~~~~~~~~~~~~--~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~-------- 212 (261)
T cd05148 143 CKVADFGLARLIKEDVYLS--SDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHE-------- 212 (261)
T ss_pred EEEccccchhhcCCccccc--cCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHH--------
Confidence 9999999987654322111 12235678999999988889999999999999999998 899996543211
Q ss_pred cccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhh
Q 020641 254 TPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPL 310 (323)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~ 310 (323)
....+....+...+...+..+.+++.+||+.||.+|||+.++++.|+.+
T Consensus 213 --------~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 213 --------VYDQITAGYRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred --------HHHHHHhCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 1111111222233445567899999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-42 Score=301.99 Aligned_cols=261 Identities=21% Similarity=0.314 Sum_probs=203.7
Q ss_pred CCCccccccCCCCCCccceeccceeeee----eeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCccccee
Q 020641 15 PSPGYFVRLDKGPEDDLYLKKRVKMRRW----LCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELL 90 (323)
Q Consensus 15 ~~~~~~~~lg~G~~~~V~~~~~~~~~~~----~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~ 90 (323)
..|....+||+|+||.||++++..++.. +++|..... ......+++.+|+.+++.++|+||++++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~-----------~~~~~~~~~~~e~~~l~~l~h~niv~~~ 75 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-----------TSPKANKEILDEAYVMASVDNPHVCRLL 75 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEecccc-----------CCHHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence 3466777999999999999987666554 566644211 1122346788899999999999999999
Q ss_pred eEEEeCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEc
Q 020641 91 GYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLF 170 (323)
Q Consensus 91 ~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~ 170 (323)
+++... ..+++++|+.+|+|.+++...... +++..+..++.|++.||.|||+. |++|+||||+||+++
T Consensus 76 g~~~~~-~~~~v~e~~~~g~l~~~l~~~~~~--------~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~ 143 (316)
T cd05108 76 GICLTS-TVQLITQLMPFGCLLDYVREHKDN--------IGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVK 143 (316)
T ss_pred EEEcCC-CceeeeecCCCCCHHHHHHhcccc--------CCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEec
Confidence 998875 467999999999999999765432 78889999999999999999999 999999999999999
Q ss_pred cCCeEEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccchh
Q 020641 171 EDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSL 249 (323)
Q Consensus 171 ~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~ 249 (323)
.++.++|+|||++................++..|+|||.+.+..++.++||||||+++|+|++ |..||.......
T Consensus 144 ~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~---- 219 (316)
T cd05108 144 TPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---- 219 (316)
T ss_pred CCCcEEEccccccccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH----
Confidence 999999999999986654322222222234667999999998899999999999999999997 999997542211
Q ss_pred hhhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhhcCC
Q 020641 250 VTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSP 314 (323)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~~~~ 314 (323)
+.+.+........+..++..+.+++.+||..+|.+|||+.+++..|.++...+
T Consensus 220 ------------~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~ 272 (316)
T cd05108 220 ------------ISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 272 (316)
T ss_pred ------------HHHHHhCCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence 11111111222223345567999999999999999999999999999988755
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-42 Score=296.50 Aligned_cols=248 Identities=17% Similarity=0.194 Sum_probs=193.6
Q ss_pred cCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeCCeEEEE
Q 020641 23 LDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLA 102 (323)
Q Consensus 23 lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 102 (323)
||+|+||.||++.+..+++.+++|+...+..... ........|++++++++||||+++++++..+...++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~---------~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv 71 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKK---------SGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLV 71 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcc---------hhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEE
Confidence 7999999999999999999999987654322111 1123456689999999999999999999999999999
Q ss_pred EeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEEEeeccc
Q 020641 103 YEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNL 182 (323)
Q Consensus 103 ~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~l~Dfg~ 182 (323)
|||+.+++|.+++....... +++..+..++.|++.|+.|||+. |++|+||||+||+++.++.++|+|||+
T Consensus 72 ~e~~~g~~L~~~~~~~~~~~-------~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~ 141 (277)
T cd05607 72 MSLMNGGDLKYHIYNVGERG-------LEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGL 141 (277)
T ss_pred EecCCCCCHHHHHHhccccC-------CCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeecee
Confidence 99999999999886543222 88889999999999999999999 999999999999999999999999999
Q ss_pred cCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhccccccccc
Q 020641 183 SNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKV 262 (323)
Q Consensus 183 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 262 (323)
+........ .....|+..|+|||.+.+..++.++|+|||||++|+|++|..||............ .
T Consensus 142 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~-----------~ 207 (277)
T cd05607 142 AVELKDGKT---ITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEEL-----------K 207 (277)
T ss_pred eeecCCCce---eeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHH-----------H
Confidence 876543221 12335788999999998888999999999999999999999999754321111000 0
Q ss_pred chhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHH
Q 020641 263 KQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVV 304 (323)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl 304 (323)
...+..... ......+.++.+++.+||+.||++||++.|++
T Consensus 208 ~~~~~~~~~-~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~ 248 (277)
T cd05607 208 RRTLEDEVK-FEHQNFTEESKDICRLFLAKKPEDRLGSREKN 248 (277)
T ss_pred HHhhccccc-cccccCCHHHHHHHHHHhccCHhhCCCCccch
Confidence 011111110 01123456799999999999999999996654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-42 Score=299.58 Aligned_cols=266 Identities=19% Similarity=0.236 Sum_probs=197.5
Q ss_pred CCCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEE
Q 020641 15 PSPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCV 94 (323)
Q Consensus 15 ~~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 94 (323)
..|....+||.|+||.||+|++..+++.+|+|+..... .......+.+|+.+++.++|+||+++++++.
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-----------~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 73 (303)
T cd07869 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQE-----------EEGTPFTAIREASLLKGLKHANIVLLHDIIH 73 (303)
T ss_pred ccceEeeeEEecCCEEEEEEEECCCCCEEEEEEecccc-----------ccccchhHHHHHHHHhhCCCCCcCeEEEEEe
Confidence 45677789999999999999999999999999764221 1222346778999999999999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCe
Q 020641 95 EGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFK 174 (323)
Q Consensus 95 ~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~ 174 (323)
.....++||||+.+ +|.+++...... ++...+..++.|++.||.|||+. |++|+||||+||+++.++.
T Consensus 74 ~~~~~~lv~e~~~~-~l~~~~~~~~~~--------~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~ 141 (303)
T cd07869 74 TKETLTLVFEYVHT-DLCQYMDKHPGG--------LHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGE 141 (303)
T ss_pred cCCeEEEEEECCCc-CHHHHHHhCCCC--------CCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCC
Confidence 99999999999964 888888654322 88889999999999999999999 9999999999999999999
Q ss_pred EEEeeccccCCCCccccccccccccCccccCCCccccC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchh-hhh
Q 020641 175 AKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT-GQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSL-VTW 252 (323)
Q Consensus 175 ~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~-~~~ 252 (323)
++|+|||++........ ......+++.|+|||.+.+ ..++.++|||||||++|+|++|..||........... ...
T Consensus 142 ~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~ 219 (303)
T cd07869 142 LKLADFGLARAKSVPSH--TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFL 219 (303)
T ss_pred EEECCCCcceeccCCCc--cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHH
Confidence 99999999865432211 1233457889999998865 4578899999999999999999999986533211110 000
Q ss_pred hcccccccccchh-----cCC-CcCCCCC---------HHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 253 ATPRLSEDKVKQC-----VDP-KLKGEYP---------PKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 253 ~~~~~~~~~~~~~-----~~~-~~~~~~~---------~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
............. ..+ ......+ ...+..+.+++.+||+.||.+|||+.|+++
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 220 VLGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred HhCCCChhhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 0000000000000 000 0000000 012356889999999999999999999997
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=307.76 Aligned_cols=249 Identities=18% Similarity=0.171 Sum_probs=199.9
Q ss_pred CCCccccccCCCCCCccceeccceee-eeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEE
Q 020641 15 PSPGYFVRLDKGPEDDLYLKKRVKMR-RWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYC 93 (323)
Q Consensus 15 ~~~~~~~~lg~G~~~~V~~~~~~~~~-~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 93 (323)
..|....+||+|+||.||+|.+..++ ..+|+|.+.+.... .....+.+.+|+++++.++||||+++++++
T Consensus 30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~---------~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~ 100 (340)
T PTZ00426 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKII---------KQKQVDHVFSERKILNYINHPFCVNLYGSF 100 (340)
T ss_pred hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhh---------hhhhHHHHHHHHHHHHhCCCCCCcceEEEE
Confidence 34666779999999999999876654 67888866533211 122345678899999999999999999999
Q ss_pred EeCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCC
Q 020641 94 VEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDF 173 (323)
Q Consensus 94 ~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~ 173 (323)
.+....++||||+.+|+|.+++..... +++..+..++.|++.||.|||+. |++||||||+|||++.++
T Consensus 101 ~~~~~~~lv~Ey~~~g~L~~~i~~~~~---------~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~ 168 (340)
T PTZ00426 101 KDESYLYLVLEFVIGGEFFTFLRRNKR---------FPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDG 168 (340)
T ss_pred EeCCEEEEEEeCCCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCC
Confidence 999999999999999999999976542 88899999999999999999999 999999999999999999
Q ss_pred eEEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhh
Q 020641 174 KAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWA 253 (323)
Q Consensus 174 ~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 253 (323)
.++|+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|..||..........
T Consensus 169 ~ikL~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~----- 238 (340)
T PTZ00426 169 FIKMTDFGFAKVVDTR-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQ----- 238 (340)
T ss_pred CEEEecCCCCeecCCC-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHH-----
Confidence 9999999998765321 123458999999999988889999999999999999999999997553211110
Q ss_pred cccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCC-----ChHHHHHH
Q 020641 254 TPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRP-----NMSIVVKA 306 (323)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-----s~~evl~~ 306 (323)
.+.... ...+...+..+.+++.+||+.||.+|+ |++++++.
T Consensus 239 ----------~i~~~~--~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 239 ----------KILEGI--IYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred ----------HHhcCC--CCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 111111 112333456789999999999999995 89988763
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-43 Score=310.87 Aligned_cols=256 Identities=18% Similarity=0.208 Sum_probs=204.2
Q ss_pred CCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEe
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVE 95 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 95 (323)
.|....+||.|+||+||+|++..+++.+|+|++.+.... .......+.+|++++..++|+||+++++++.+
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~---------~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~ 72 (350)
T cd05573 2 DFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMI---------KRNQIAHVRAERDILADADSPWIVKLYYSFQD 72 (350)
T ss_pred CceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHh---------hccHHHHHHHHHHHHHhcCCCCccchhhheec
Confidence 356667999999999999999999999999977643211 12234678889999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeE
Q 020641 96 GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKA 175 (323)
Q Consensus 96 ~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~ 175 (323)
++..++||||+.+++|.+++..... ++...+..++.|++.||.|||+. |++|+||||+||+++.++.+
T Consensus 73 ~~~~~lv~e~~~~~~L~~~l~~~~~---------l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~ 140 (350)
T cd05573 73 EEHLYLVMEYMPGGDLMNLLIRKDV---------FPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHI 140 (350)
T ss_pred CCeEEEEEcCCCCCCHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCE
Confidence 9999999999999999999976522 88999999999999999999999 99999999999999999999
Q ss_pred EEeeccccCCCCccc---------------------------cccccccccCccccCCCccccCCCCCcccchHHHHHHH
Q 020641 176 KIADFNLSNQAPDMA---------------------------ARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVL 228 (323)
Q Consensus 176 ~l~Dfg~~~~~~~~~---------------------------~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l 228 (323)
+|+|||++....... .........|++.|+|||.+.+..++.++|||||||++
T Consensus 141 kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il 220 (350)
T cd05573 141 KLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVIL 220 (350)
T ss_pred EeecCCCCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhh
Confidence 999999987654322 00112234589999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCCCcccchhhhhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCC-hHHHHHH
Q 020641 229 LELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPN-MSIVVKA 306 (323)
Q Consensus 229 ~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps-~~evl~~ 306 (323)
|+|++|+.||...........+. .+. ...........+..+.++|.+||. ||.+||+ +.++++.
T Consensus 221 ~ell~g~~Pf~~~~~~~~~~~i~------------~~~-~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 221 YEMLYGFPPFYSDTLQETYNKII------------NWK-ESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred hhhccCCCCCCCCCHHHHHHHHh------------ccC-CcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 99999999997654221111000 000 111111112246779999999997 9999999 9999873
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=303.59 Aligned_cols=247 Identities=21% Similarity=0.254 Sum_probs=195.0
Q ss_pred ccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHH---HhcCCCCcccceeeEEE
Q 020641 18 GYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSV---VSRLKHENLVELLGYCV 94 (323)
Q Consensus 18 ~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~---l~~l~h~~i~~~~~~~~ 94 (323)
.....||+|+||.||++.+..+++.+|+|+..+..... ....+.+.+|.++ ++.++||||+++++++.
T Consensus 2 ~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~---------~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~ 72 (324)
T cd05589 2 RCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIA---------RDEVESLMCEKRIFETANSERHPFLVNLFACFQ 72 (324)
T ss_pred eEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhh---------hhHHHHHHHHHHHHHhccccCCCChhceeeEEE
Confidence 45668999999999999999999999999776432111 1122445555554 45678999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCe
Q 020641 95 EGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFK 174 (323)
Q Consensus 95 ~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~ 174 (323)
..+..|+||||+.+++|...+.... +++..+..++.|++.||.|||+. |++||||||+||+++.++.
T Consensus 73 ~~~~~~lv~E~~~~~~L~~~~~~~~----------l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~ 139 (324)
T cd05589 73 TEDHVCFVMEYAAGGDLMMHIHTDV----------FSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGF 139 (324)
T ss_pred cCCEEEEEEcCCCCCcHHHHhhcCC----------CCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCc
Confidence 9999999999999999998886532 89999999999999999999999 9999999999999999999
Q ss_pred EEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhc
Q 020641 175 AKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWAT 254 (323)
Q Consensus 175 ~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~ 254 (323)
++|+|||++........ ......|++.|+|||.+.+..++.++|||||||++|+|++|+.||.........
T Consensus 140 ~kL~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~------- 210 (324)
T cd05589 140 VKIADFGLCKEGMGFGD--RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVF------- 210 (324)
T ss_pred EEeCcccCCccCCCCCC--cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHH-------
Confidence 99999998865332211 123445899999999999888999999999999999999999999755321111
Q ss_pred ccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCC-----ChHHHHH
Q 020641 255 PRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRP-----NMSIVVK 305 (323)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-----s~~evl~ 305 (323)
..+.... ...+...+..+.+++.+||+.||.+|| ++.++++
T Consensus 211 --------~~i~~~~--~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 211 --------DSIVNDE--VRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred --------HHHHhCC--CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 0111111 112334567799999999999999999 5777766
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-42 Score=292.48 Aligned_cols=255 Identities=23% Similarity=0.316 Sum_probs=200.3
Q ss_pred CCCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEE
Q 020641 15 PSPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCV 94 (323)
Q Consensus 15 ~~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 94 (323)
..+....+||+|++|.||++.... +..+++|..... ....+.+.+|+.++++++|+||+++++.+.
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~-~~~v~iK~~~~~-------------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 71 (261)
T cd05072 6 ESIKLVKKLGAGQFGEVWMGYYNN-STKVAVKTLKPG-------------TMSVQAFLEEANLMKTLQHDKLVRLYAVVT 71 (261)
T ss_pred HHeEEeeecCCcCCceEEEEEecC-CceEEEEEccCC-------------chhHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence 345677799999999999998654 445666643211 112367889999999999999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCe
Q 020641 95 EGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFK 174 (323)
Q Consensus 95 ~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~ 174 (323)
.....++++||+.+++|.+++...... .+++..+..++.|++.|+.|||+. +++|+||+|+||+++.++.
T Consensus 72 ~~~~~~lv~e~~~~~~L~~~l~~~~~~-------~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~ 141 (261)
T cd05072 72 KEEPIYIITEYMAKGSLLDFLKSDEGG-------KVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLM 141 (261)
T ss_pred CCCCcEEEEecCCCCcHHHHHHHhcCC-------CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCc
Confidence 999999999999999999999764322 288889999999999999999999 9999999999999999999
Q ss_pred EEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhh
Q 020641 175 AKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWA 253 (323)
Q Consensus 175 ~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~ 253 (323)
++|+|||++......... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||......... .
T Consensus 142 ~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~---~-- 215 (261)
T cd05072 142 CKIADFGLARVIEDNEYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVM---S-- 215 (261)
T ss_pred EEECCCccceecCCCcee-ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHH---H--
Confidence 999999999765442221 1122335678999999988888999999999999999998 99999754321111 1
Q ss_pred cccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhh
Q 020641 254 TPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPL 310 (323)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~ 310 (323)
.+............+..+.+++.+||+.+|++|||++++++.|+++
T Consensus 216 -----------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 216 -----------ALQRGYRMPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred -----------HHHcCCCCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 0111111122233456799999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=301.54 Aligned_cols=265 Identities=18% Similarity=0.222 Sum_probs=200.2
Q ss_pred CCCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEE
Q 020641 15 PSPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCV 94 (323)
Q Consensus 15 ~~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 94 (323)
..|+...+||.|+||.||++.+..++..+++|+..... .......+.+|+++++.++|+||+++++++.
T Consensus 5 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~-----------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 73 (333)
T cd06650 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI-----------KPAIRNQIIRELQVLHECNSPYIVGFYGAFY 73 (333)
T ss_pred hhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc-----------CHHHHHHHHHHHHHHHHCCCCcccceeEEEE
Confidence 35677779999999999999999999999888654321 1112356889999999999999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCe
Q 020641 95 EGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFK 174 (323)
Q Consensus 95 ~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~ 174 (323)
.++..++||||+.+++|.+++..... +++..+..++.|++.|+.|||... +++|+||||+||+++.++.
T Consensus 74 ~~~~~~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~ 142 (333)
T cd06650 74 SDGEISICMEHMDGGSLDQVLKKAGR---------IPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGE 142 (333)
T ss_pred ECCEEEEEEecCCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCC
Confidence 99999999999999999999975432 788899999999999999999741 7999999999999999999
Q ss_pred EEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhc
Q 020641 175 AKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWAT 254 (323)
Q Consensus 175 ~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~ 254 (323)
++|+|||++....... .....|+..|+|||.+.+..++.++|+|||||++|+|++|+.||................
T Consensus 143 ~kL~Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~ 218 (333)
T cd06650 143 IKLCDFGVSGQLIDSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPV 218 (333)
T ss_pred EEEeeCCcchhhhhhc----cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcc
Confidence 9999999986543321 123457899999999988889999999999999999999999997543211110000000
Q ss_pred c-cc------------------------cccc---cchhc-CCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 255 P-RL------------------------SEDK---VKQCV-DPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 255 ~-~~------------------------~~~~---~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
. .. +... ....+ ............+.++.+|+.+||+.||++|||+.|+++
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~ 298 (333)
T cd06650 219 EGDPAESETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMV 298 (333)
T ss_pred cCCccccccCcccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhh
Confidence 0 00 0000 00000 000000011123567999999999999999999999975
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=305.49 Aligned_cols=266 Identities=18% Similarity=0.213 Sum_probs=195.1
Q ss_pred CccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeC
Q 020641 17 PGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEG 96 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 96 (323)
|....+||+|+||.||++.+..+++.+|+|...... ........+.+|+++++.++||||+++++++...
T Consensus 2 y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----------~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 71 (338)
T cd07859 2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVF----------EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPP 71 (338)
T ss_pred eEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhh----------ccchhHHHHHHHHHHHHhCCCCCEeeecceEecc
Confidence 455668999999999999999999999998654221 0111235678999999999999999999988643
Q ss_pred -----CeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEcc
Q 020641 97 -----NLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFE 171 (323)
Q Consensus 97 -----~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~ 171 (323)
...|+||||+. ++|.+++..... +++..+..++.|++.||.|||+. |++|+||||+||+++.
T Consensus 72 ~~~~~~~~~lv~e~~~-~~L~~~l~~~~~---------~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~ 138 (338)
T cd07859 72 SRREFKDIYVVFELME-SDLHQVIKANDD---------LTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANA 138 (338)
T ss_pred CCCCCceEEEEEecCC-CCHHHHHHhccc---------CCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECC
Confidence 25799999996 589999875432 88999999999999999999999 9999999999999999
Q ss_pred CCeEEEeeccccCCCCcccc-ccccccccCccccCCCccccC--CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccch
Q 020641 172 DFKAKIADFNLSNQAPDMAA-RLHSTRVLGTFGYHAPEYAMT--GQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQS 248 (323)
Q Consensus 172 ~~~~~l~Dfg~~~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~ 248 (323)
++.++|+|||++........ ........|++.|+|||++.+ ..++.++|||||||++|+|++|+.||..........
T Consensus 139 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~ 218 (338)
T cd07859 139 DCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLD 218 (338)
T ss_pred CCcEEEccCccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHH
Confidence 99999999999875432211 111233458999999998865 578899999999999999999999997654321111
Q ss_pred hhhhhcccccccccc-----------hhcCCCcCCC---CCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 249 LVTWATPRLSEDKVK-----------QCVDPKLKGE---YPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 249 ~~~~~~~~~~~~~~~-----------~~~~~~~~~~---~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
............... ..+....... .....+..+.+++.+||+.||++|||++|+++
T Consensus 219 ~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~ 289 (338)
T cd07859 219 LITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA 289 (338)
T ss_pred HHHHHhCCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 100000000000000 0000000000 00123457899999999999999999999996
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=307.13 Aligned_cols=244 Identities=20% Similarity=0.240 Sum_probs=196.5
Q ss_pred ccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeCCeEEE
Q 020641 22 RLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVL 101 (323)
Q Consensus 22 ~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 101 (323)
.||+|+||.||++++..+++.+|+|++.+..... ......+.+|+++++.++|+||+++++++......++
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~---------~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~l 72 (325)
T cd05594 2 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVA---------KDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCF 72 (325)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhh---------hhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEE
Confidence 5899999999999999999999999776432211 1223566788999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCCCceeCCCCCCCEEEccCCeEEEeec
Q 020641 102 AYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHE-KVQPSIIHRDIRSSNVLLFEDFKAKIADF 180 (323)
Q Consensus 102 v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~-~~~~~i~h~dikp~nili~~~~~~~l~Df 180 (323)
||||+.+++|.+++..... +++..+..++.||+.||.|||+ . |++||||||+||+++.++.++|+||
T Consensus 73 v~E~~~~~~L~~~l~~~~~---------l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Df 140 (325)
T cd05594 73 VMEYANGGELFFHLSRERV---------FSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDF 140 (325)
T ss_pred EEeCCCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecC
Confidence 9999999999998865432 8899999999999999999997 8 9999999999999999999999999
Q ss_pred cccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhccccccc
Q 020641 181 NLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSED 260 (323)
Q Consensus 181 g~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 260 (323)
|++........ ......|++.|+|||++.+..++.++|||||||++|+|++|..||............
T Consensus 141 g~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i---------- 208 (325)
T cd05594 141 GLCKEGIKDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI---------- 208 (325)
T ss_pred CCCeecCCCCc--ccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHH----------
Confidence 99864322111 122345899999999999889999999999999999999999999754321111000
Q ss_pred ccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCC-----ChHHHHH
Q 020641 261 KVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRP-----NMSIVVK 305 (323)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-----s~~evl~ 305 (323)
... ....+...+.++.+++.+||+.||++|+ ++.++++
T Consensus 209 -----~~~--~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~ 251 (325)
T cd05594 209 -----LME--EIRFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQ 251 (325)
T ss_pred -----hcC--CCCCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhc
Confidence 000 0112334566799999999999999997 8999875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-42 Score=301.28 Aligned_cols=244 Identities=20% Similarity=0.235 Sum_probs=192.7
Q ss_pred ccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcC-CCCcccceeeEEEeCCeEE
Q 020641 22 RLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRL-KHENLVELLGYCVEGNLRV 100 (323)
Q Consensus 22 ~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~ 100 (323)
.||+|+||.||+|++..+++.+|+|++....... ....+....|..++..+ +||||+++++++..+...+
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~---------~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~ 72 (316)
T cd05592 2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLE---------DDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLF 72 (316)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhh---------hhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEE
Confidence 5899999999999999999999999776432111 12224445566666655 8999999999999999999
Q ss_pred EEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEEEeec
Q 020641 101 LAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADF 180 (323)
Q Consensus 101 lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~l~Df 180 (323)
+||||+.+|+|.+++..... +++..+..++.|++.||.|||+. |++||||||+||+++.++.++|+||
T Consensus 73 lv~e~~~gg~L~~~~~~~~~---------~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Df 140 (316)
T cd05592 73 FVMEYLNGGDLMFHIQSSGR---------FDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADF 140 (316)
T ss_pred EEEcCCCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccC
Confidence 99999999999999875432 88899999999999999999999 9999999999999999999999999
Q ss_pred cccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhccccccc
Q 020641 181 NLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSED 260 (323)
Q Consensus 181 g~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 260 (323)
|++....... .......|++.|+|||.+.+..++.++|||||||++|+|++|..||..........
T Consensus 141 g~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~------------ 206 (316)
T cd05592 141 GMCKENMNGE--GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFD------------ 206 (316)
T ss_pred cCCeECCCCC--CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHH------------
Confidence 9987543222 12233458999999999998889999999999999999999999997553211100
Q ss_pred ccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChH-HHHH
Q 020641 261 KVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMS-IVVK 305 (323)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~-evl~ 305 (323)
.+.. .....+...+.++.+++.+||+.||.+||++. ++++
T Consensus 207 ---~i~~--~~~~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 207 ---SILN--DRPHFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred ---HHHc--CCCCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 0000 01122334556789999999999999999875 5543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=295.45 Aligned_cols=268 Identities=24% Similarity=0.336 Sum_probs=204.4
Q ss_pred CccccccCCCCCCccceeccc-----eeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceee
Q 020641 17 PGYFVRLDKGPEDDLYLKKRV-----KMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLG 91 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~~~-----~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~ 91 (323)
+.....||.|+||.||++... .++..+++|..... .....+.+.+|++++++++|+||+++++
T Consensus 7 ~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~------------~~~~~~~~~~e~~~l~~l~h~~i~~~~~ 74 (288)
T cd05093 7 IVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA------------SDNARKDFHREAELLTNLQHEHIVKFYG 74 (288)
T ss_pred eeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc------------CHHHHHHHHHHHHHHHhCCCCCcceEEE
Confidence 445558999999999999853 34455666644311 1122356889999999999999999999
Q ss_pred EEEeCCeEEEEEeecCCCCHHHHhccCCCCCC----CCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCE
Q 020641 92 YCVEGNLRVLAYEFATMGSLHDILHGRKGVQG----AQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNV 167 (323)
Q Consensus 92 ~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~ni 167 (323)
++......++|+||+.+++|.+++........ ......+++..++.++.|++.||.|||+. |++|+||||+||
T Consensus 75 ~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Ni 151 (288)
T cd05093 75 VCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNC 151 (288)
T ss_pred EEecCCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceE
Confidence 99999999999999999999999975432100 01112389999999999999999999999 999999999999
Q ss_pred EEccCCeEEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCccc
Q 020641 168 LLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQ 246 (323)
Q Consensus 168 li~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~ 246 (323)
+++.++.++|+|||.+................++..|+|||.+.+..++.++|+||||+++|+|++ |..||........
T Consensus 152 li~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~ 231 (288)
T cd05093 152 LVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEV 231 (288)
T ss_pred EEccCCcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 999999999999999876543322222233335778999999988889999999999999999998 9999865532111
Q ss_pred chhhhhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhhcCCC
Q 020641 247 QSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSPP 315 (323)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~~~~~ 315 (323)
. . .+.. ......+...+..+.+++.+||+.||.+|||+.++++.|+++.+..+
T Consensus 232 ~---~------------~i~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~~~ 284 (288)
T cd05093 232 I---E------------CITQ-GRVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKASP 284 (288)
T ss_pred H---H------------HHHc-CCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHhcc
Confidence 0 0 0000 00011122345679999999999999999999999999999987644
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=294.07 Aligned_cols=263 Identities=23% Similarity=0.369 Sum_probs=202.6
Q ss_pred CccccccCCCCCCccceecccee-----eeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceee
Q 020641 17 PGYFVRLDKGPEDDLYLKKRVKM-----RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLG 91 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~~~~~-----~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~ 91 (323)
+.+...||+|+||.||++.+... ++.+++|..... ......+.+.+|+++++.++|+||+++++
T Consensus 7 ~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~-----------~~~~~~~~~~~e~~~l~~l~~~~i~~~~~ 75 (280)
T cd05049 7 IVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKET-----------ASNDARKDFEREAELLTNFQHENIVKFYG 75 (280)
T ss_pred hhHHhhccccCCceEeeeeeccccCcCCcceEEEEeeccc-----------CCHHHHHHHHHHHHHHHhcCCCCchheee
Confidence 45566899999999999987543 466777754321 11112467889999999999999999999
Q ss_pred EEEeCCeEEEEEeecCCCCHHHHhccCCCCCC-----CCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCC
Q 020641 92 YCVEGNLRVLAYEFATMGSLHDILHGRKGVQG-----AQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSN 166 (323)
Q Consensus 92 ~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~n 166 (323)
++..+...+++|||+.+++|.+++........ ......+++..+..++.|++.|+.+||+. |++|+||||+|
T Consensus 76 ~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~n 152 (280)
T cd05049 76 VCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRN 152 (280)
T ss_pred EEecCCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---Ceeccccccce
Confidence 99999999999999999999999976532110 11123388889999999999999999999 99999999999
Q ss_pred EEEccCCeEEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcc
Q 020641 167 VLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRG 245 (323)
Q Consensus 167 ili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~ 245 (323)
|+++.++.++|+|||++................++..|+|||.+.+..++.++||||||+++|+|++ |..||.......
T Consensus 153 ili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~ 232 (280)
T cd05049 153 CLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE 232 (280)
T ss_pred EEEcCCCeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 9999999999999999875433222122223335678999999998899999999999999999998 999986543211
Q ss_pred cchhhhhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhh
Q 020641 246 QQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQP 309 (323)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~ 309 (323)
. ...+........+...+..+.+++.+||..||++|||+.||++.|++
T Consensus 233 ~----------------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 233 V----------------IECITQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred H----------------HHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 1 11111111112233456779999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-42 Score=307.74 Aligned_cols=268 Identities=21% Similarity=0.286 Sum_probs=203.6
Q ss_pred CCccccccCCCCCCccceeccceee-----eeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCC-CCcccce
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRVKMR-----RWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLK-HENLVEL 89 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~~~~-----~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~ 89 (323)
+++...+||.|+||.||.+.+...+ ..+|+|++.... .....+.+.+|+++++++. ||||+++
T Consensus 38 ~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~-----------~~~~~~~~~~Ei~~l~~l~~HpnIv~l 106 (400)
T cd05105 38 GLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA-----------RSSEKQALMSELKIMTHLGPHLNIVNL 106 (400)
T ss_pred ceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC-----------ChHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 3444468999999999999875432 357777553221 1122367889999999995 9999999
Q ss_pred eeEEEeCCeEEEEEeecCCCCHHHHhccCCCCCC----------------------------------------------
Q 020641 90 LGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQG---------------------------------------------- 123 (323)
Q Consensus 90 ~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~---------------------------------------------- 123 (323)
++++.+....++||||+.+|+|.+++..+.....
T Consensus 107 ~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 186 (400)
T cd05105 107 LGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTT 186 (400)
T ss_pred EEEEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhccccccccccccccc
Confidence 9999999999999999999999999865321000
Q ss_pred -----------------------------------------CCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCC
Q 020641 124 -----------------------------------------AQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDI 162 (323)
Q Consensus 124 -----------------------------------------~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di 162 (323)
......+++..+..++.|++.||.|||+. +++|+||
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~di 263 (400)
T cd05105 187 QYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDL 263 (400)
T ss_pred ccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCC
Confidence 00012378888899999999999999999 9999999
Q ss_pred CCCCEEEccCCeEEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCC
Q 020641 163 RSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHT 241 (323)
Q Consensus 163 kp~nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~ 241 (323)
||+||+++.++.++|+|||++................++..|+|||.+.+..++.++||||||+++|+|++ |..||...
T Consensus 264 kp~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~ 343 (400)
T cd05105 264 AARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGM 343 (400)
T ss_pred ChHhEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCccc
Confidence 99999999999999999999876543222222233346778999999988889999999999999999997 99998654
Q ss_pred CCcccchhhhhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhhc
Q 020641 242 MPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLK 312 (323)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~~ 312 (323)
.... .....+........+...+..+.+++.+||+.||++|||+.+|.+.|+++++
T Consensus 344 ~~~~---------------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 344 IVDS---------------TFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred chhH---------------HHHHHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 2111 0111111111222334556789999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=295.08 Aligned_cols=267 Identities=23% Similarity=0.337 Sum_probs=204.2
Q ss_pred CccccccCCCCCCccceecccee-----eeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceee
Q 020641 17 PGYFVRLDKGPEDDLYLKKRVKM-----RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLG 91 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~~~~~-----~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~ 91 (323)
++...+||+|+||.||++.+... ...+++|...... .......+.+|+.+++.++||||+++++
T Consensus 2 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~-----------~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 70 (290)
T cd05045 2 LVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA-----------SSSELRDLLSEFNLLKQVNHPHVIKLYG 70 (290)
T ss_pred ccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC-----------CHHHHHHHHHHHHHHhhCCCCCEeeEEE
Confidence 34556899999999999987532 2446665443211 0111356888999999999999999999
Q ss_pred EEEeCCeEEEEEeecCCCCHHHHhccCCCCCC---------------CCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 020641 92 YCVEGNLRVLAYEFATMGSLHDILHGRKGVQG---------------AQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPS 156 (323)
Q Consensus 92 ~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~ 156 (323)
.+...+..++++||+.+++|.+++........ ......+++..++.++.|++.||.|||+. +
T Consensus 71 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ 147 (290)
T cd05045 71 ACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---K 147 (290)
T ss_pred EEecCCCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---C
Confidence 99999999999999999999999865321100 01112388899999999999999999999 9
Q ss_pred ceeCCCCCCCEEEccCCeEEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHh-CC
Q 020641 157 IIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GR 235 (323)
Q Consensus 157 i~h~dikp~nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~ 235 (323)
++|+||||+||++++++.++|+|||++................++..|+|||.+.+..++.++||||||+++++|++ |.
T Consensus 148 ivH~dikp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~ 227 (290)
T cd05045 148 LVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGG 227 (290)
T ss_pred eehhhhhhheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCC
Confidence 99999999999999999999999999875533222211222335678999999888889999999999999999998 99
Q ss_pred CCCCCCCCcccchhhhhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhhcC
Q 020641 236 KPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKS 313 (323)
Q Consensus 236 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~~~ 313 (323)
.||...... .+.+.+........+...+..+.+++.+||+.+|++||++.++++.|++++..
T Consensus 228 ~p~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~~ 289 (290)
T cd05045 228 NPYPGIAPE----------------RLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMVK 289 (290)
T ss_pred CCCCCCCHH----------------HHHHHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHhc
Confidence 999654321 11122222222333445567899999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-42 Score=309.23 Aligned_cols=255 Identities=20% Similarity=0.206 Sum_probs=198.0
Q ss_pred CccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeC
Q 020641 17 PGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEG 96 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 96 (323)
+..+.+||+|+||+||+|++..+++.+|+|++.+..... ......+.+|+++++.++|+||+++++++.+.
T Consensus 3 f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~---------~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~ 73 (381)
T cd05626 3 FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLN---------RNQVAHVKAERDILAEADNEWVVKLYYSFQDK 73 (381)
T ss_pred ceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhh---------hHHHHHHHHHHHHHHhcCCCCeeeeEEEEecC
Confidence 566779999999999999999999999999776432211 12235688999999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEE
Q 020641 97 NLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAK 176 (323)
Q Consensus 97 ~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~ 176 (323)
...++||||+.+|+|.+++..... +++..+..++.|++.||.|||+. ||+||||||+||+++.++.++
T Consensus 74 ~~~~lv~E~~~gg~L~~~l~~~~~---------~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~k 141 (381)
T cd05626 74 DNLYFVMDYIPGGDMMSLLIRMEV---------FPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIK 141 (381)
T ss_pred CEEEEEEecCCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEE
Confidence 999999999999999999976432 88889999999999999999999 999999999999999999999
Q ss_pred EeeccccCCCCcccc---------------------------------------------ccccccccCccccCCCcccc
Q 020641 177 IADFNLSNQAPDMAA---------------------------------------------RLHSTRVLGTFGYHAPEYAM 211 (323)
Q Consensus 177 l~Dfg~~~~~~~~~~---------------------------------------------~~~~~~~~g~~~y~aPE~~~ 211 (323)
|+|||++........ ........||+.|+|||.+.
T Consensus 142 L~DFGl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~ 221 (381)
T cd05626 142 LTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLL 221 (381)
T ss_pred EeeCcCCcccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHc
Confidence 999998753311000 00011245899999999998
Q ss_pred CCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHH--c
Q 020641 212 TGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAAL--C 289 (323)
Q Consensus 212 ~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~--c 289 (323)
+..++.++|||||||++|+|++|..||............. . + ............+.++.+++.+ |
T Consensus 222 ~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~--~--~---------~~~~~~~~~~~~s~~~~dli~~ll~ 288 (381)
T cd05626 222 RKGYTQLCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVI--N--W---------ENTLHIPPQVKLSPEAVDLITKLCC 288 (381)
T ss_pred CCCCCCccceeehhhHHHHHHhCCCCCcCCCHHHHHHHHH--c--c---------ccccCCCCCCCCCHHHHHHHHHHcc
Confidence 8889999999999999999999999997654321111100 0 0 0001111112345678889888 5
Q ss_pred cCCCCCCCCChHHHHH
Q 020641 290 VQYEAEFRPNMSIVVK 305 (323)
Q Consensus 290 l~~~P~~Rps~~evl~ 305 (323)
+..+|..||++.++++
T Consensus 289 ~~~~~~~R~~~~~~l~ 304 (381)
T cd05626 289 SAEERLGRNGADDIKA 304 (381)
T ss_pred CcccccCCCCHHHHhc
Confidence 5566667999999987
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-42 Score=316.75 Aligned_cols=260 Identities=20% Similarity=0.249 Sum_probs=203.8
Q ss_pred cCCCCCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceee
Q 020641 12 AHAPSPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLG 91 (323)
Q Consensus 12 ~~~~~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~ 91 (323)
.....|.....||+|+||+||++++..+++.+|+|++...... ......+.+|+..+..++|+||+++++
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~----------~~~~~~~~~Ei~~l~~~~h~~iv~~~~ 98 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMS----------EADKNRAQAEVCCLLNCDFFSIVKCHE 98 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCC----------HHHHHHHHHHHHHHhcCCCCcEEEeec
Confidence 3445666666999999999999999999999999977543221 112356778999999999999999888
Q ss_pred EEEeCC--------eEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCC
Q 020641 92 YCVEGN--------LRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIR 163 (323)
Q Consensus 92 ~~~~~~--------~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dik 163 (323)
.+.... ..++||||+.+|+|.+++...... ...+++..+..++.|++.||.|||+. |++|||||
T Consensus 99 ~~~~~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~-----~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLK 170 (496)
T PTZ00283 99 DFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKT-----NRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIK 170 (496)
T ss_pred ceecccccCcccceEEEEEEeCCCCCcHHHHHHHhhcc-----CCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCC
Confidence 765332 368999999999999999754321 11388999999999999999999999 99999999
Q ss_pred CCCEEEccCCeEEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCC
Q 020641 164 SSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMP 243 (323)
Q Consensus 164 p~nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 243 (323)
|+||+++.++.++|+|||++................||+.|+|||.+.+..++.++||||||+++|+|++|+.||.....
T Consensus 171 P~NILl~~~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~ 250 (496)
T PTZ00283 171 SANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENM 250 (496)
T ss_pred HHHEEEeCCCCEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH
Confidence 99999999999999999998765433222223445689999999999988899999999999999999999999975432
Q ss_pred cccchhhhhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 244 RGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
... +...+. ......+...+..+.+++.+||+.||.+|||+.++++
T Consensus 251 ~~~---------------~~~~~~-~~~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~ 296 (496)
T PTZ00283 251 EEV---------------MHKTLA-GRYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLN 296 (496)
T ss_pred HHH---------------HHHHhc-CCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHh
Confidence 110 001111 1111234455678999999999999999999999986
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=289.04 Aligned_cols=255 Identities=22% Similarity=0.287 Sum_probs=213.3
Q ss_pred CccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeC
Q 020641 17 PGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEG 96 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 96 (323)
+..+.+||.|.-|+||+|+...++.+.|+|++.++...... -..+...|-++|++++||-+..+|..|+.+
T Consensus 79 f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rk---------Kl~Ra~tE~eIL~~lDHPFlPTLYa~fet~ 149 (459)
T KOG0610|consen 79 FRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRK---------KLKRAQTEREILSLLDHPFLPTLYASFETD 149 (459)
T ss_pred HHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhh---------HHHHHHHHHHHHHhcCCCccchhhheeecc
Confidence 34455899999999999999999999999999877655422 235677889999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEE
Q 020641 97 NLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAK 176 (323)
Q Consensus 97 ~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~ 176 (323)
+..|++||||.||+|..+++++..+. +++..+.-++..++.||.|||.. ||++||+||+|||+.++|.+.
T Consensus 150 ~~~cl~meyCpGGdL~~LrqkQp~~~-------fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIM 219 (459)
T KOG0610|consen 150 KYSCLVMEYCPGGDLHSLRQKQPGKR-------FSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIM 219 (459)
T ss_pred ceeEEEEecCCCccHHHHHhhCCCCc-------cchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEE
Confidence 99999999999999999999876554 99999999999999999999999 999999999999999999999
Q ss_pred EeeccccCCCCc---------------------------------cccc---------------------cccccccCcc
Q 020641 177 IADFNLSNQAPD---------------------------------MAAR---------------------LHSTRVLGTF 202 (323)
Q Consensus 177 l~Dfg~~~~~~~---------------------------------~~~~---------------------~~~~~~~g~~ 202 (323)
|+||.++....- .... .......||-
T Consensus 220 LsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGTh 299 (459)
T KOG0610|consen 220 LSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTH 299 (459)
T ss_pred eeeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCcccccccccc
Confidence 999998633210 0000 0111234899
Q ss_pred ccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccccccccchhcCCCcCCCCCHHHHHHH
Q 020641 203 GYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKL 282 (323)
Q Consensus 203 ~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 282 (323)
.|+|||++.|.+-+.+.|-|+||+++|||++|..||.+.+. .+.+.+++.+.+.-......+..+
T Consensus 300 EYlAPEvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~---------------~~Tl~NIv~~~l~Fp~~~~vs~~a 364 (459)
T KOG0610|consen 300 EYLAPEVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNN---------------KETLRNIVGQPLKFPEEPEVSSAA 364 (459)
T ss_pred ccccceeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCc---------------hhhHHHHhcCCCcCCCCCcchhHH
Confidence 99999999999999999999999999999999999997765 344555555555444444677889
Q ss_pred HHHHHHccCCCCCCCCC----hHHHHH
Q 020641 283 AAVAALCVQYEAEFRPN----MSIVVK 305 (323)
Q Consensus 283 ~~li~~cl~~~P~~Rps----~~evl~ 305 (323)
++||++.|.+||.+|.. +.||-+
T Consensus 365 kDLIr~LLvKdP~kRlg~~rGA~eIK~ 391 (459)
T KOG0610|consen 365 KDLIRKLLVKDPSKRLGSKRGAAEIKR 391 (459)
T ss_pred HHHHHHHhccChhhhhccccchHHhhc
Confidence 99999999999999997 777653
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-43 Score=292.88 Aligned_cols=262 Identities=20% Similarity=0.225 Sum_probs=200.0
Q ss_pred CCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEe
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVE 95 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 95 (323)
.+.....+|.|+||.||.++...+...+|+|....+. +.-.+|+++|+.++||||+++.-+|..
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~----------------r~knrEl~im~~l~HpNIV~L~~~f~~ 88 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDK----------------RYKNRELQIMRKLDHPNIVRLLYFFSS 88 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCC----------------CcCcHHHHHHHhcCCcCeeeEEEEEEe
Confidence 3445558899999999999999999999988555321 111468899999999999999988874
Q ss_pred CC-----eEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEc
Q 020641 96 GN-----LRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLF 170 (323)
Q Consensus 96 ~~-----~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~ 170 (323)
.. ...+||||++. +|.++++.....+ ..++...++-+.+||+.|+.|||+. ||+||||||.|+|+|
T Consensus 89 ~~~~d~~~lnlVleymP~-tL~~~~r~~~~~~-----~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD 159 (364)
T KOG0658|consen 89 STESDEVYLNLVLEYMPE-TLYRVIRHYTRAN-----QRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVD 159 (364)
T ss_pred cCCCchhHHHHHHHhchH-HHHHHHHHHhhcC-----CCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEc
Confidence 43 23689999987 9999998531111 1278888999999999999999999 999999999999999
Q ss_pred cC-CeEEEeeccccCCCCccccccccccccCccccCCCccccCC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCcccch
Q 020641 171 ED-FKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG-QLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQS 248 (323)
Q Consensus 171 ~~-~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~ 248 (323)
.+ |.+||||||+|......... .....+..|+|||++.+. .|+.+.||||.||++.||+-|++.|.+.+...+..
T Consensus 160 ~~tg~LKicDFGSAK~L~~~epn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~ 236 (364)
T KOG0658|consen 160 PDTGVLKICDFGSAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLV 236 (364)
T ss_pred CCCCeEEeccCCcceeeccCCCc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHH
Confidence 76 99999999999877554332 344568889999999875 68999999999999999999999999876544333
Q ss_pred hhh------------hhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 249 LVT------------WATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 249 ~~~------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
.+. .++........+++.............++++.+|+.++|.++|.+|.++.|++.
T Consensus 237 eIik~lG~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~ 305 (364)
T KOG0658|consen 237 EIIKVLGTPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA 305 (364)
T ss_pred HHHHHhCCCCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 222 222222222222222222112234556778999999999999999999999884
|
|
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=295.69 Aligned_cols=267 Identities=26% Similarity=0.357 Sum_probs=204.7
Q ss_pred CCCccccccCCCCCCccceeccceee-----eeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcC-CCCcccc
Q 020641 15 PSPGYFVRLDKGPEDDLYLKKRVKMR-----RWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRL-KHENLVE 88 (323)
Q Consensus 15 ~~~~~~~~lg~G~~~~V~~~~~~~~~-----~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~ 88 (323)
..+....+||+|+||.||++...... ..+++|...... .......+.+|+++++++ +|+||++
T Consensus 12 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~-----------~~~~~~~~~~E~~~l~~l~~h~~i~~ 80 (293)
T cd05053 12 DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA-----------TEKDLSDLVSEMEMMKMIGKHKNIIN 80 (293)
T ss_pred hHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC-----------CHHHHHHHHHHHHHHHhhcCCCCeee
Confidence 34556668999999999999876443 567777554211 011224578899999999 8999999
Q ss_pred eeeEEEeCCeEEEEEeecCCCCHHHHhccCCCCCCC-------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCC
Q 020641 89 LLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGA-------QPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRD 161 (323)
Q Consensus 89 ~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~d 161 (323)
+++++..+...+++|||+.+++|.+++......... .....+++..+..++.|++.|+.|||+. +++|+|
T Consensus 81 ~~~~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~d 157 (293)
T cd05053 81 LLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRD 157 (293)
T ss_pred EEEEEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---Cccccc
Confidence 999999999999999999999999999754311100 1223488999999999999999999999 999999
Q ss_pred CCCCCEEEccCCeEEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHh-CCCCCCC
Q 020641 162 IRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDH 240 (323)
Q Consensus 162 ikp~nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~ 240 (323)
|||+||+++.++.++|+|||.+................++..|+|||.+.+..++.++|||||||++|++++ |..||..
T Consensus 158 lkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~ 237 (293)
T cd05053 158 LAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPG 237 (293)
T ss_pred cceeeEEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCC
Confidence 999999999999999999999876654332222222335667999999888889999999999999999997 9999864
Q ss_pred CCCcccchhhhhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhh
Q 020641 241 TMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLL 311 (323)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~ 311 (323)
..... ..+.+........+...+..+.+++.+||..||++|||+.|+++.|++++
T Consensus 238 ~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 238 IPVEE----------------LFKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred CCHHH----------------HHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 43211 11111111122233445667999999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-42 Score=302.85 Aligned_cols=246 Identities=20% Similarity=0.260 Sum_probs=195.4
Q ss_pred cccCCCCCCccceeccc---eeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeCC
Q 020641 21 VRLDKGPEDDLYLKKRV---KMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGN 97 (323)
Q Consensus 21 ~~lg~G~~~~V~~~~~~---~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 97 (323)
.+||+|+||.||+|++. .+++.+|+|+........ .......+.+|+++++.++||||+++++.+..++
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~--------~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~ 73 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVR--------NQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGG 73 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHh--------hhhhHHHHHHHHHHHHhCCCCchhceeeEEecCC
Confidence 47999999999999864 467888998765332111 1122356778999999999999999999999999
Q ss_pred eEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEEE
Q 020641 98 LRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKI 177 (323)
Q Consensus 98 ~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~l 177 (323)
..|+||||+.+++|.+++..... +.+..+..++.|++.||.|||+. |++||||||+||+++.++.++|
T Consensus 74 ~~~lv~e~~~~~~L~~~~~~~~~---------~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl 141 (323)
T cd05584 74 KLYLILEYLSGGELFMHLEREGI---------FMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKL 141 (323)
T ss_pred eEEEEEeCCCCchHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEE
Confidence 99999999999999999976532 77888899999999999999999 9999999999999999999999
Q ss_pred eeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccc
Q 020641 178 ADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRL 257 (323)
Q Consensus 178 ~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 257 (323)
+|||++........ ......|++.|+|||.+.+..++.++||||||+++|+|++|+.||........
T Consensus 142 ~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~----------- 208 (323)
T cd05584 142 TDFGLCKESIHEGT--VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKT----------- 208 (323)
T ss_pred eeCcCCeecccCCC--cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHH-----------
Confidence 99999864332211 12234589999999999988889999999999999999999999975532111
Q ss_pred cccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCC-----ChHHHHH
Q 020641 258 SEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRP-----NMSIVVK 305 (323)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-----s~~evl~ 305 (323)
........ ...+...+..+.+++.+||+.+|++|| ++.++++
T Consensus 209 ----~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 209 ----IDKILKGK--LNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred ----HHHHHcCC--CCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 11111111 122344566799999999999999999 7888876
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-42 Score=306.38 Aligned_cols=248 Identities=22% Similarity=0.276 Sum_probs=192.4
Q ss_pred CccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeC
Q 020641 17 PGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEG 96 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 96 (323)
++...+||.|+||.||++++..+++.+++|+..... .......+.+|+++++.++|+||+++++++...
T Consensus 76 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 144 (353)
T PLN00034 76 LERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH-----------EDTVRRQICREIEILRDVNHPNVVKCHDMFDHN 144 (353)
T ss_pred HhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC-----------cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccC
Confidence 455568999999999999999999999999764221 122346788999999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEE
Q 020641 97 NLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAK 176 (323)
Q Consensus 97 ~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~ 176 (323)
+..++||||+.+++|.+... .....+..++.||+.||.|||+. |++|+||||+||+++.++.++
T Consensus 145 ~~~~lv~e~~~~~~L~~~~~-------------~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~k 208 (353)
T PLN00034 145 GEIQVLLEFMDGGSLEGTHI-------------ADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVK 208 (353)
T ss_pred CeEEEEEecCCCCccccccc-------------CCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEE
Confidence 99999999999999865321 55677889999999999999999 999999999999999999999
Q ss_pred EeeccccCCCCccccccccccccCccccCCCccccC-----CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhh
Q 020641 177 IADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT-----GQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVT 251 (323)
Q Consensus 177 l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~ 251 (323)
|+|||++........ ......|+..|+|||.+.. ...+.++|||||||++|+|++|+.||.............
T Consensus 209 L~DfG~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~ 286 (353)
T PLN00034 209 IADFGVSRILAQTMD--PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMC 286 (353)
T ss_pred Ecccccceecccccc--cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHH
Confidence 999999876543211 1123458999999998743 223568999999999999999999997332111000000
Q ss_pred hhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHH
Q 020641 252 WATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKA 306 (323)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~ 306 (323)
.+........+...+.++.++|.+||+.||++|||+.|+++.
T Consensus 287 -------------~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 287 -------------AICMSQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred -------------HHhccCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000011112234456779999999999999999999999983
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=294.06 Aligned_cols=251 Identities=19% Similarity=0.216 Sum_probs=196.8
Q ss_pred cCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeCCeEEEE
Q 020641 23 LDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLA 102 (323)
Q Consensus 23 lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 102 (323)
||+|+||+||++.+..+++.+++|+..+..... ....+.+..|+++++.++|+||+++.+++......++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~---------~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv 71 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKK---------RKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLV 71 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhh---------hHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEE
Confidence 799999999999999999999998765432111 11225667899999999999999999999999999999
Q ss_pred EeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEEEeeccc
Q 020641 103 YEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNL 182 (323)
Q Consensus 103 ~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~l~Dfg~ 182 (323)
|||+.+|+|.+.+...... ...+++..+..++.|++.||.|||+. |++|+||||+||+++.++.++|+|||+
T Consensus 72 ~e~~~~g~L~~~~~~~~~~-----~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~ 143 (280)
T cd05608 72 MTIMNGGDLRYHIYNVDEE-----NPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGL 143 (280)
T ss_pred EeCCCCCCHHHHHHhcccc-----CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCcc
Confidence 9999999999887542211 11288999999999999999999999 999999999999999999999999999
Q ss_pred cCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhccccccccc
Q 020641 183 SNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKV 262 (323)
Q Consensus 183 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 262 (323)
+........ ......|++.|+|||.+.+..++.++|+||||+++|+|++|+.||............ .
T Consensus 144 ~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~-----------~ 210 (280)
T cd05608 144 AVELKDGQS--KTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKEL-----------K 210 (280)
T ss_pred ceecCCCCc--cccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHH-----------H
Confidence 875543221 122345889999999999989999999999999999999999999754321110000 0
Q ss_pred chhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCC-----ChHHHHH
Q 020641 263 KQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRP-----NMSIVVK 305 (323)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-----s~~evl~ 305 (323)
...... ....+...+..+.+++.+||+.||++|| +++++++
T Consensus 211 ~~~~~~--~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 211 QRILND--SVTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred Hhhccc--CCCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 001111 0122344567899999999999999999 6788886
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-42 Score=296.94 Aligned_cols=247 Identities=20% Similarity=0.257 Sum_probs=212.1
Q ss_pred ccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeCC
Q 020641 18 GYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGN 97 (323)
Q Consensus 18 ~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 97 (323)
..=..||.|.|+.|-+|++.-+|..||+|++.+.+.... ....+.+|++-|+.++||||+++|++.....
T Consensus 21 DLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~----------st~hlfqEVRCMKLVQHpNiVRLYEViDTQT 90 (864)
T KOG4717|consen 21 DLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTL----------STGHLFQEVRCMKLVQHPNIVRLYEVIDTQT 90 (864)
T ss_pred hhhhhhcCCceehhhhhhhhcccceeEEEEecccccchh----------hhhHHHHHHHHHHHhcCcCeeeeeehhcccc
Confidence 333489999999999999999999999998886544332 2367789999999999999999999999999
Q ss_pred eEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEcc-CCeEE
Q 020641 98 LRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFE-DFKAK 176 (323)
Q Consensus 98 ~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~-~~~~~ 176 (323)
.+|+|+|.-++|+|+|+|.+.... +++..+.+++.||+.||.|+|+. +++|||+||+|+++.+ -|-+|
T Consensus 91 KlyLiLELGD~GDl~DyImKHe~G--------l~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVK 159 (864)
T KOG4717|consen 91 KLYLILELGDGGDLFDYIMKHEEG--------LNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVK 159 (864)
T ss_pred eEEEEEEecCCchHHHHHHhhhcc--------ccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceE
Confidence 999999999999999999877654 99999999999999999999999 9999999999998865 58899
Q ss_pred EeeccccCCCCccccccccccccCccccCCCccccCCCCC-cccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhcc
Q 020641 177 IADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLT-QKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATP 255 (323)
Q Consensus 177 l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~-~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~ 255 (323)
|.|||.+..+..+... ...+|...|.|||++.|..|+ ++.||||||++||.|++|+.||+..++.
T Consensus 160 LTDFGFSNkf~PG~kL---~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDS----------- 225 (864)
T KOG4717|consen 160 LTDFGFSNKFQPGKKL---TTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDS----------- 225 (864)
T ss_pred eeeccccccCCCcchh---hcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccch-----------
Confidence 9999999877665443 556799999999999999996 6899999999999999999999866542
Q ss_pred cccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 256 RLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
+.+..+++=. -..|.-.+.+.++||.+||..||++|.|+++|..
T Consensus 226 ----ETLTmImDCK--YtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 226 ----ETLTMIMDCK--YTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred ----hhhhhhhccc--ccCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 2333333322 2467778899999999999999999999999986
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=295.88 Aligned_cols=266 Identities=18% Similarity=0.245 Sum_probs=191.8
Q ss_pred CCccccccCCCCCCccceeccce-eeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcC---CCCcccceee
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRVK-MRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRL---KHENLVELLG 91 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~~i~~~~~ 91 (323)
.|.....||+|+||.||+|++.. +++.+|+|........ ......+.+|+.+++.+ +||||+++++
T Consensus 2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~----------~~~~~~~~~e~~~l~~l~~~~hpniv~~~~ 71 (290)
T cd07862 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGE----------EGMPLSTIREVAVLRHLETFEHPNVVRLFD 71 (290)
T ss_pred CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCC----------CCchHHHHHHHHHHHhhcccCCCCcceEEE
Confidence 35566789999999999999865 4678888865432111 11223445666666554 7999999999
Q ss_pred EEEe-----CCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCC
Q 020641 92 YCVE-----GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSN 166 (323)
Q Consensus 92 ~~~~-----~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~n 166 (323)
++.. ....++||||+.+ +|.+++...... .+++..+..++.|++.||.|||+. |++|+||||+|
T Consensus 72 ~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~-------~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~N 140 (290)
T cd07862 72 VCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEP-------GVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQN 140 (290)
T ss_pred EEecccCCCCCcEEEEEccCCC-CHHHHHHhCCCC-------CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHH
Confidence 8852 3468999999974 999998754322 288999999999999999999999 99999999999
Q ss_pred EEEccCCeEEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccc
Q 020641 167 VLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQ 246 (323)
Q Consensus 167 ili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~ 246 (323)
|+++.++.++|+|||++...... .......|++.|+|||.+.+..++.++||||||+++|+|++|..||........
T Consensus 141 il~~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~ 217 (290)
T cd07862 141 ILVTSSGQIKLADFGLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ 217 (290)
T ss_pred EEEcCCCCEEEccccceEeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHH
Confidence 99999999999999998754432 122334589999999999888899999999999999999999999986543221
Q ss_pred chhhhhhcccccccccchh-------cCCCcC---CCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 247 QSLVTWATPRLSEDKVKQC-------VDPKLK---GEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~-------~~~~~~---~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
...+............... ..+... .......+..+.+++.+||+.||++|||+.|+++
T Consensus 218 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 218 LGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred HHHHHHHhCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 1111100000000000000 000000 0011234567899999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-42 Score=302.37 Aligned_cols=239 Identities=20% Similarity=0.233 Sum_probs=191.8
Q ss_pred ccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcC-CCCcccceeeEEEeCCeEE
Q 020641 22 RLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRL-KHENLVELLGYCVEGNLRV 100 (323)
Q Consensus 22 ~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~ 100 (323)
.||+|+||.||+|++..+++.+|+|++.+.... .......+..|..++..+ +||||+++++++...+..|
T Consensus 2 ~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~---------~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~ 72 (320)
T cd05590 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVIL---------QDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLF 72 (320)
T ss_pred eeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHh---------hccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEE
Confidence 589999999999999999999999976543211 112235567788888776 7999999999999999999
Q ss_pred EEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEEEeec
Q 020641 101 LAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADF 180 (323)
Q Consensus 101 lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~l~Df 180 (323)
+||||+.+++|.+++..... +++..+..++.|++.||.|||+. |++||||||+||+++.++.++|+||
T Consensus 73 iv~Ey~~~g~L~~~i~~~~~---------l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~Df 140 (320)
T cd05590 73 FVMEFVNGGDLMFHIQKSRR---------FDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADF 140 (320)
T ss_pred EEEcCCCCchHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeC
Confidence 99999999999999876532 88999999999999999999999 9999999999999999999999999
Q ss_pred cccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhccccccc
Q 020641 181 NLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSED 260 (323)
Q Consensus 181 g~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 260 (323)
|++........ ......|++.|+|||.+.+..++.++|||||||++|+|++|+.||.........
T Consensus 141 G~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~------------- 205 (320)
T cd05590 141 GMCKEGIFNGK--TTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLF------------- 205 (320)
T ss_pred CCCeecCcCCC--cccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHH-------------
Confidence 99865322111 123345899999999999888999999999999999999999999755321110
Q ss_pred ccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCCh
Q 020641 261 KVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNM 300 (323)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~ 300 (323)
..+.... ...+...+.++.+++.+||+.||++||++
T Consensus 206 --~~i~~~~--~~~~~~~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 206 --EAILNDE--VVYPTWLSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred --HHHhcCC--CCCCCCCCHHHHHHHHHHcccCHHHCCCC
Confidence 0011100 11233356679999999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=299.50 Aligned_cols=269 Identities=22% Similarity=0.316 Sum_probs=202.4
Q ss_pred CCccccccCCCCCCccceeccce-----eeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcC-CCCcccce
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRVK-----MRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRL-KHENLVEL 89 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~~-----~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~ 89 (323)
.+.....||.|+||.||+|.... +++.+++|.+.... .....+.+.+|+.+++++ +|+||+++
T Consensus 8 ~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~-----------~~~~~~~~~~E~~~~~~l~~h~niv~~ 76 (337)
T cd05054 8 RLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA-----------TASEYKALMTELKILIHIGHHLNVVNL 76 (337)
T ss_pred HhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC-----------CHHHHHHHHHHHHHHHhhccCcchhhe
Confidence 35556689999999999997554 34678887553211 011124567899999999 89999999
Q ss_pred eeEEEe-CCeEEEEEeecCCCCHHHHhccCCCCCC---------------------------------------------
Q 020641 90 LGYCVE-GNLRVLAYEFATMGSLHDILHGRKGVQG--------------------------------------------- 123 (323)
Q Consensus 90 ~~~~~~-~~~~~lv~e~~~~~sL~~~~~~~~~~~~--------------------------------------------- 123 (323)
++++.. +...++++||+.+++|.+++........
T Consensus 77 ~~~~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (337)
T cd05054 77 LGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDV 156 (337)
T ss_pred eeeEecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhc
Confidence 998764 4567899999999999999864321100
Q ss_pred -------CCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEEEeeccccCCCCccccccccc
Q 020641 124 -------AQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHST 196 (323)
Q Consensus 124 -------~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~ 196 (323)
......+++..+..++.|++.||.|||+. ||+||||||.||+++.++.++|+|||++.............
T Consensus 157 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~ 233 (337)
T cd05054 157 EEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKG 233 (337)
T ss_pred ccchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhcc
Confidence 00012488999999999999999999999 99999999999999999999999999997654332222223
Q ss_pred cccCccccCCCccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccccccccchhcCCCcCCCCC
Q 020641 197 RVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYP 275 (323)
Q Consensus 197 ~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (323)
...++..|+|||.+.+..++.++|||||||++|+|++ |..||........ ....+........+
T Consensus 234 ~~~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~---------------~~~~~~~~~~~~~~ 298 (337)
T cd05054 234 DARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE---------------FCRRLKEGTRMRAP 298 (337)
T ss_pred CCCCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH---------------HHHHHhccCCCCCC
Confidence 3345678999999999999999999999999999998 9999975322110 11111111111223
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhhcC
Q 020641 276 PKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKS 313 (323)
Q Consensus 276 ~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~~~ 313 (323)
...+..+.+++.+||+.+|++||++.||++.|++++..
T Consensus 299 ~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~~ 336 (337)
T cd05054 299 EYATPEIYSIMLDCWHNNPEDRPTFSELVEILGDLLQE 336 (337)
T ss_pred ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 34456799999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=289.42 Aligned_cols=262 Identities=18% Similarity=0.248 Sum_probs=205.5
Q ss_pred CCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEe
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVE 95 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 95 (323)
+|.....||.|+||.||++++..+++.+++|....... ........+.+|+++++.++||||+++++++..
T Consensus 3 ~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 73 (267)
T cd08228 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEM---------MDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIE 73 (267)
T ss_pred ceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeecccc---------CCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEE
Confidence 45566789999999999999999999999885532111 111223567889999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeE
Q 020641 96 GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKA 175 (323)
Q Consensus 96 ~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~ 175 (323)
.+..++++||+.+++|.+++....... ..++...+..++.|++.|+.|||+. |++|+||+|+||+++.++.+
T Consensus 74 ~~~~~~v~e~~~~~~L~~~~~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~ 145 (267)
T cd08228 74 DNELNIVLELADAGDLSQMIKYFKKQK-----RLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVV 145 (267)
T ss_pred CCeEEEEEEecCCCcHHHHHHHhhhcc-----CCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCE
Confidence 999999999999999999886432111 1278889999999999999999999 99999999999999999999
Q ss_pred EEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhcc
Q 020641 176 KIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATP 255 (323)
Q Consensus 176 ~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~ 255 (323)
+|+|||.+......... .....++..|+|||.+.+..++.++|+||||+++|+|++|..||.........
T Consensus 146 ~l~d~g~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~-------- 215 (267)
T cd08228 146 KLGDLGLGRFFSSKTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFS-------- 215 (267)
T ss_pred EECccccceeccchhHH--HhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHH--------
Confidence 99999998765433221 12334788999999998888899999999999999999999998644221100
Q ss_pred cccccccchhcCC-CcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhh
Q 020641 256 RLSEDKVKQCVDP-KLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPL 310 (323)
Q Consensus 256 ~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~ 310 (323)
....+.. ..........+..+.+++.+||..+|++|||+.+|++.++++
T Consensus 216 ------~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 216 ------LCQKIEQCDYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred ------HHHHHhcCCCCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 0011111 111112234567899999999999999999999999999876
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=308.57 Aligned_cols=255 Identities=17% Similarity=0.183 Sum_probs=200.1
Q ss_pred CCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEe
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVE 95 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 95 (323)
.|.....||.|+||.||+|++..+++.+|+|++.+.... .......+.+|+++++.++|+||+++++++.+
T Consensus 2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---------~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~ 72 (364)
T cd05599 2 DFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEML---------EKEQVAHVRAERDILAEADNPWVVKLYYSFQD 72 (364)
T ss_pred CceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhh---------hhhHHHHHHHHHHHHHhCCCCCCcceEEEEEc
Confidence 466778999999999999999999999999977543211 12223567889999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeE
Q 020641 96 GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKA 175 (323)
Q Consensus 96 ~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~ 175 (323)
++..++||||+.+|+|.+++..... +++..+..++.|++.||.|||+. |++||||||+||+++.++.+
T Consensus 73 ~~~~~lv~E~~~~g~L~~~l~~~~~---------l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~ 140 (364)
T cd05599 73 ENYLYLIMEYLPGGDMMTLLMKKDT---------FTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHI 140 (364)
T ss_pred CCeEEEEECCCCCcHHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCE
Confidence 9999999999999999999976432 89999999999999999999999 99999999999999999999
Q ss_pred EEeeccccCCCCcccccc------------------------------------ccccccCccccCCCccccCCCCCccc
Q 020641 176 KIADFNLSNQAPDMAARL------------------------------------HSTRVLGTFGYHAPEYAMTGQLTQKS 219 (323)
Q Consensus 176 ~l~Dfg~~~~~~~~~~~~------------------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~ 219 (323)
+|+|||++.......... ......||+.|+|||++.+..++.++
T Consensus 141 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 220 (364)
T cd05599 141 KLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKEC 220 (364)
T ss_pred EEeecccceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCee
Confidence 999999986442211000 01123589999999999988999999
Q ss_pred chHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCC
Q 020641 220 DVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPN 299 (323)
Q Consensus 220 Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps 299 (323)
|||||||++|+|++|..||............. .+ ............+..+.+++.+|+. +|.+|++
T Consensus 221 DiwSlG~il~el~~G~~Pf~~~~~~~~~~~i~------------~~-~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~ 286 (364)
T cd05599 221 DWWSLGVIMYEMLVGYPPFCSDNPQETYRKII------------NW-KETLQFPDEVPLSPEAKDLIKRLCC-EAERRLG 286 (364)
T ss_pred eeecchhHHHHhhcCCCCCCCCCHHHHHHHHH------------cC-CCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCC
Confidence 99999999999999999997554321110000 00 0000011111345678999999996 9999998
Q ss_pred ---hHHHHH
Q 020641 300 ---MSIVVK 305 (323)
Q Consensus 300 ---~~evl~ 305 (323)
+.++++
T Consensus 287 ~~~~~~ll~ 295 (364)
T cd05599 287 NNGVNEIKS 295 (364)
T ss_pred CCCHHHHhc
Confidence 888877
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-42 Score=302.04 Aligned_cols=251 Identities=20% Similarity=0.229 Sum_probs=196.5
Q ss_pred ccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcC-CCCcccceeeEEEeCCeEE
Q 020641 22 RLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRL-KHENLVELLGYCVEGNLRV 100 (323)
Q Consensus 22 ~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~ 100 (323)
.||+|+||.||++++..+++.+|+|++.++.... ......+..|..++..+ +||||+++++++...+..|
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~---------~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~ 72 (329)
T cd05588 2 VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVND---------DEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLF 72 (329)
T ss_pred eEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhh---------hhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEE
Confidence 5899999999999999999999999776432211 12235677889999888 7999999999999999999
Q ss_pred EEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEEEeec
Q 020641 101 LAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADF 180 (323)
Q Consensus 101 lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~l~Df 180 (323)
+||||+.+++|.+++..... +++..+..++.|++.||.|||++ |++||||||+||+++.++.++|+||
T Consensus 73 lv~e~~~~g~L~~~~~~~~~---------l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Df 140 (329)
T cd05588 73 FVIEFVSGGDLMFHMQRQRK---------LPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDY 140 (329)
T ss_pred EEEeCCCCCCHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcC
Confidence 99999999999998865432 89999999999999999999999 9999999999999999999999999
Q ss_pred cccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccc--chhhhhhccccc
Q 020641 181 NLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQ--QSLVTWATPRLS 258 (323)
Q Consensus 181 g~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~~ 258 (323)
|++....... .......|++.|+|||++.+..++.++|+|||||++|+|++|+.||........ .....+.
T Consensus 141 g~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~----- 213 (329)
T cd05588 141 GMCKEGIRPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYL----- 213 (329)
T ss_pred ccccccccCC--CccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHH-----
Confidence 9986432211 112334589999999999998999999999999999999999999974322110 0000000
Q ss_pred ccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCC------hHHHHH
Q 020641 259 EDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPN------MSIVVK 305 (323)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps------~~evl~ 305 (323)
........ ...+...+..+.+++.+||+.||.+||| +.++++
T Consensus 214 ---~~~~~~~~--~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 214 ---FQVILEKQ--IRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred ---HHHHHcCC--CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 00111111 1233445667999999999999999997 567764
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-42 Score=302.60 Aligned_cols=255 Identities=19% Similarity=0.216 Sum_probs=197.7
Q ss_pred CccccccCCCCCCccceeccc---eeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcC-CCCcccceeeE
Q 020641 17 PGYFVRLDKGPEDDLYLKKRV---KMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRL-KHENLVELLGY 92 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~~~---~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~ 92 (323)
|....+||+|+||.||++++. .+++.+|+|++.+.... ......+.+..|+.+++.+ .|+||++++++
T Consensus 2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~--------~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~ 73 (332)
T cd05614 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALV--------QKAKTVEHTRTERNVLEHVRQSPFLVTLHYA 73 (332)
T ss_pred ceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHh--------hhhhHHHHHHHHHHHHHhccCCCCcccEEEE
Confidence 556678999999999998875 46788999876543211 1122335678899999999 69999999999
Q ss_pred EEeCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccC
Q 020641 93 CVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFED 172 (323)
Q Consensus 93 ~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~ 172 (323)
+...+..++||||+.+|+|.+++..... +++..+..++.|++.||.|||+. |++||||||+||+++.+
T Consensus 74 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~---------~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~ 141 (332)
T cd05614 74 FQTEAKLHLILDYVSGGEMFTHLYQRDN---------FSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSE 141 (332)
T ss_pred EecCCEEEEEEeCCCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCC
Confidence 9999999999999999999999865432 88999999999999999999999 99999999999999999
Q ss_pred CeEEEeeccccCCCCccccccccccccCccccCCCccccCC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhh
Q 020641 173 FKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG-QLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVT 251 (323)
Q Consensus 173 ~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~ 251 (323)
+.++|+|||++......... ......|++.|+|||.+.+. .++.++|||||||++|+|++|..||.............
T Consensus 142 ~~~kl~DfG~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~ 220 (332)
T cd05614 142 GHVVLTDFGLSKEFLSEEKE-RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVS 220 (332)
T ss_pred CCEEEeeCcCCccccccCCC-ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHH
Confidence 99999999998764332211 11234589999999998765 47889999999999999999999997543222111110
Q ss_pred hhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCC-----ChHHHHH
Q 020641 252 WATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRP-----NMSIVVK 305 (323)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-----s~~evl~ 305 (323)
. .... .....+...+..+.+++.+||+.||++|| +++++++
T Consensus 221 ~-----------~~~~--~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 221 R-----------RILK--CDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred H-----------HHhc--CCCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 0 0000 01122334566799999999999999999 7778875
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=304.69 Aligned_cols=257 Identities=17% Similarity=0.153 Sum_probs=197.0
Q ss_pred CCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEe
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVE 95 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 95 (323)
.|+....||+|+||+||+|.+..+++.+|+|+..+.... .......+.+|+.++..++|+||+++++.+.+
T Consensus 2 ~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~---------~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~ 72 (363)
T cd05628 2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADML---------EKEQVGHIRAERDILVEADSLWVVKMFYSFQD 72 (363)
T ss_pred CceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHH---------HhhHHHHHHHHHHHHHhCCCCCcceEEEEEec
Confidence 356677999999999999999999999999977543211 12223567889999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeE
Q 020641 96 GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKA 175 (323)
Q Consensus 96 ~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~ 175 (323)
....|+||||+.+|+|.+++..... +++..+..++.|++.||.|||+. ||+||||||+||+++.++.+
T Consensus 73 ~~~~~lv~E~~~gg~L~~~l~~~~~---------l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~v 140 (363)
T cd05628 73 KLNLYLIMEFLPGGDMMTLLMKKDT---------LTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHV 140 (363)
T ss_pred CCeEEEEEcCCCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCE
Confidence 9999999999999999999976432 88999999999999999999999 99999999999999999999
Q ss_pred EEeeccccCCCCccccc---------------------------------cccccccCccccCCCccccCCCCCcccchH
Q 020641 176 KIADFNLSNQAPDMAAR---------------------------------LHSTRVLGTFGYHAPEYAMTGQLTQKSDVY 222 (323)
Q Consensus 176 ~l~Dfg~~~~~~~~~~~---------------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~ 222 (323)
+|+|||++......... .......||+.|+|||++.+..++.++|||
T Consensus 141 kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~Dvw 220 (363)
T cd05628 141 KLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWW 220 (363)
T ss_pred EEeeccCcccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhh
Confidence 99999998654321100 001234589999999999998999999999
Q ss_pred HHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccC--CCCCCCCCh
Q 020641 223 SFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQ--YEAEFRPNM 300 (323)
Q Consensus 223 slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~--~~P~~Rps~ 300 (323)
||||++|+|++|..||...........+. .+. ..+........+.++.+++.+++. .++..||++
T Consensus 221 SlGvil~ell~G~~Pf~~~~~~~~~~~i~------------~~~-~~~~~p~~~~~s~~~~~li~~l~~~~~~r~~r~~~ 287 (363)
T cd05628 221 SLGVIMYEMLIGYPPFCSETPQETYKKVM------------NWK-ETLIFPPEVPISEKAKDLILRFCCEWEHRIGAPGV 287 (363)
T ss_pred hhHHHHHHHHhCCCCCCCCCHHHHHHHHH------------cCc-CcccCCCcCCCCHHHHHHHHHHcCChhhcCCCCCH
Confidence 99999999999999997554321111000 000 000001111234568888887554 233456899
Q ss_pred HHHHHH
Q 020641 301 SIVVKA 306 (323)
Q Consensus 301 ~evl~~ 306 (323)
+||++.
T Consensus 288 ~ei~~h 293 (363)
T cd05628 288 EEIKTN 293 (363)
T ss_pred HHHhCC
Confidence 999874
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=287.79 Aligned_cols=250 Identities=24% Similarity=0.374 Sum_probs=196.1
Q ss_pred ccCCCCCCccceecc--ceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeCCeE
Q 020641 22 RLDKGPEDDLYLKKR--VKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLR 99 (323)
Q Consensus 22 ~lg~G~~~~V~~~~~--~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 99 (323)
+||+|+||.||++.. ..++..+++|+..... ......+.+.+|+.+++.++|+||+++++++.. ...
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~----------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~ 70 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDN----------NDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESW 70 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCC----------CcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCc
Confidence 589999999999854 4567788888654221 111234678899999999999999999998864 457
Q ss_pred EEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEEEee
Q 020641 100 VLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIAD 179 (323)
Q Consensus 100 ~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~l~D 179 (323)
++||||+.+++|.+++..... +++..+..++.|++.|+.+||++ |++|+||||.||+++.++.++|+|
T Consensus 71 ~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~D 138 (257)
T cd05116 71 MLVMELAELGPLNKFLQKNKH---------VTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISD 138 (257)
T ss_pred EEEEecCCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECC
Confidence 899999999999999965432 88999999999999999999999 999999999999999999999999
Q ss_pred ccccCCCCcccccc-ccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccc
Q 020641 180 FNLSNQAPDMAARL-HSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPRL 257 (323)
Q Consensus 180 fg~~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~ 257 (323)
||++.......... ......++..|+|||.+....++.++|+||||+++|+|++ |..||......
T Consensus 139 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~------------- 205 (257)
T cd05116 139 FGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN------------- 205 (257)
T ss_pred CccccccCCCCCeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH-------------
Confidence 99987654322211 1112224578999999888888899999999999999998 99999754321
Q ss_pred cccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhh
Q 020641 258 SEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPL 310 (323)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~ 310 (323)
.+.+.+........+...+.++.++|.+||+.||++|||+.+|.+.|++.
T Consensus 206 ---~~~~~i~~~~~~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 206 ---EVTQMIESGERMECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred ---HHHHHHHCCCCCCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 11111222222233445667899999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-42 Score=301.87 Aligned_cols=244 Identities=18% Similarity=0.201 Sum_probs=195.0
Q ss_pred ccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcC-CCCcccceeeEEEeCCeEE
Q 020641 22 RLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRL-KHENLVELLGYCVEGNLRV 100 (323)
Q Consensus 22 ~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~ 100 (323)
.||+|+||.||++++..+++.+|+|++.+.... .......+..|.+++..+ +||||+++++++...+..|
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~---------~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~ 72 (321)
T cd05591 2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVIL---------QDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLF 72 (321)
T ss_pred ccccCCCeEEEEEEECCCCCEEEEEEEeHHHhh---------hhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEE
Confidence 589999999999999999999999977543211 122235567788888866 8999999999999999999
Q ss_pred EEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEEEeec
Q 020641 101 LAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADF 180 (323)
Q Consensus 101 lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~l~Df 180 (323)
+||||+.+++|.+.+..... +++..+..++.|++.||.|||+. |++||||||+||+++.++.++|+||
T Consensus 73 lv~E~~~~~~L~~~l~~~~~---------~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Df 140 (321)
T cd05591 73 FVMEYVNGGDLMFQIQRSRK---------FDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADF 140 (321)
T ss_pred EEEeCCCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeec
Confidence 99999999999999865432 88889999999999999999999 9999999999999999999999999
Q ss_pred cccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhccccccc
Q 020641 181 NLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSED 260 (323)
Q Consensus 181 g~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 260 (323)
|++........ ......|++.|+|||.+.+..++.++||||||+++|+|++|+.||.........
T Consensus 141 g~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~------------- 205 (321)
T cd05591 141 GMCKEGILNGV--TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLF------------- 205 (321)
T ss_pred ccceecccCCc--cccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHH-------------
Confidence 98865332211 123345899999999999888999999999999999999999999755321111
Q ss_pred ccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCC-------ChHHHHH
Q 020641 261 KVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRP-------NMSIVVK 305 (323)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-------s~~evl~ 305 (323)
..+.... ...+...+.++.+++.+||+.||++|| ++.++++
T Consensus 206 --~~i~~~~--~~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~ 253 (321)
T cd05591 206 --ESILHDD--VLYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ 253 (321)
T ss_pred --HHHHcCC--CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence 0111110 112223456799999999999999999 7777764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-42 Score=306.60 Aligned_cols=252 Identities=16% Similarity=0.167 Sum_probs=199.2
Q ss_pred CCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEe
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVE 95 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 95 (323)
.|....+||+|+||.||++++..+++.+|+|+..+.... .......+.+|+.+++.++||||+++++++.+
T Consensus 44 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~---------~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~ 114 (370)
T cd05596 44 DFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMI---------KRSDSAFFWEERDIMAHANSEWIVQLHYAFQD 114 (370)
T ss_pred HcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh---------hhhhHHHHHHHHHHHHhCCCCCcceEEEEEec
Confidence 456666899999999999999999999999977532211 11223557789999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeE
Q 020641 96 GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKA 175 (323)
Q Consensus 96 ~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~ 175 (323)
++..++||||+.+|+|.+++.... ++...+..++.|++.||.|||+. |++||||||+||+++.++.+
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~l~~~~----------l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~ 181 (370)
T cd05596 115 DKYLYMVMEYMPGGDLVNLMSNYD----------IPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHL 181 (370)
T ss_pred CCEEEEEEcCCCCCcHHHHHHhcC----------CCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCE
Confidence 999999999999999999986542 78888999999999999999999 99999999999999999999
Q ss_pred EEeeccccCCCCccccccccccccCccccCCCccccCC----CCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhh
Q 020641 176 KIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG----QLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVT 251 (323)
Q Consensus 176 ~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~----~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~ 251 (323)
+|+|||++........ .......|++.|+|||.+.+. .++.++|||||||++|+|++|..||.........
T Consensus 182 kL~DfG~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~---- 256 (370)
T cd05596 182 KLADFGTCMKMDANGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTY---- 256 (370)
T ss_pred EEEeccceeeccCCCc-ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHH----
Confidence 9999999876543211 112334589999999988643 3788999999999999999999999765431111
Q ss_pred hhcccccccccchhcCCC--cCCCCCHHHHHHHHHHHHHccCCCCCC--CCChHHHHH
Q 020641 252 WATPRLSEDKVKQCVDPK--LKGEYPPKGVAKLAAVAALCVQYEAEF--RPNMSIVVK 305 (323)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~cl~~~P~~--Rps~~evl~ 305 (323)
.++.... .........+..+.+++.+||+.+|.. |+|+.|+++
T Consensus 257 -----------~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~ 303 (370)
T cd05596 257 -----------SKIMDHKNSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKS 303 (370)
T ss_pred -----------HHHHcCCCcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhc
Confidence 1111111 111111234678999999999999987 999999976
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=294.45 Aligned_cols=258 Identities=21% Similarity=0.322 Sum_probs=200.1
Q ss_pred ccccccCCCCCCccceeccc-----eeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcC-CCCcccceee
Q 020641 18 GYFVRLDKGPEDDLYLKKRV-----KMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRL-KHENLVELLG 91 (323)
Q Consensus 18 ~~~~~lg~G~~~~V~~~~~~-----~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~ 91 (323)
.....||+|+||.||++.+. .++..+++|+..... .....+.+.+|+.+++++ +|+||+++++
T Consensus 38 ~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-----------~~~~~~~~~~E~~~l~~l~~h~~iv~~~~ 106 (302)
T cd05055 38 SFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA-----------HSSEREALMSELKIMSHLGNHENIVNLLG 106 (302)
T ss_pred EEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC-----------ChHHHHHHHHHHHHHHhccCCCCcceEEE
Confidence 34448999999999999753 334467776543211 011235788999999999 8999999999
Q ss_pred EEEeCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEcc
Q 020641 92 YCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFE 171 (323)
Q Consensus 92 ~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~ 171 (323)
++...+..+++|||+.+++|.+++...... .+++..+..++.|++.||.|||++ +++|+||||+||+++.
T Consensus 107 ~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~-------~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~ 176 (302)
T cd05055 107 ACTIGGPILVITEYCCYGDLLNFLRRKRES-------FLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTH 176 (302)
T ss_pred EEecCCceEEEEEcCCCCcHHHHHHhCCCC-------CCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcC
Confidence 999999999999999999999999754322 178999999999999999999999 9999999999999999
Q ss_pred CCeEEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccchhh
Q 020641 172 DFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLV 250 (323)
Q Consensus 172 ~~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~ 250 (323)
++.++|+|||++................++..|+|||.+.+..++.++||||||+++|+|++ |..||........
T Consensus 177 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~---- 252 (302)
T cd05055 177 GKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK---- 252 (302)
T ss_pred CCeEEECCCcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHH----
Confidence 99999999999876544322212222345678999999988889999999999999999998 9999875432111
Q ss_pred hhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhh
Q 020641 251 TWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLL 311 (323)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~ 311 (323)
..+.+........+...+..+.+++.+||+.+|++|||+.|+++.|++++
T Consensus 253 -----------~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~~ 302 (302)
T cd05055 253 -----------FYKLIKEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQL 302 (302)
T ss_pred -----------HHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhhC
Confidence 11111111111222334567999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-42 Score=301.26 Aligned_cols=246 Identities=20% Similarity=0.240 Sum_probs=193.1
Q ss_pred ccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcC-CCCcccceeeEEEeCCeEE
Q 020641 22 RLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRL-KHENLVELLGYCVEGNLRV 100 (323)
Q Consensus 22 ~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~ 100 (323)
.||+|+||.||++++..+++.+|+|+..+..... ......+..|..++.++ +||||+++++++...+..+
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~---------~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~ 72 (329)
T cd05618 2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVND---------DEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF 72 (329)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcc---------hhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEE
Confidence 5899999999999999999999999776442221 12235567888888777 8999999999999999999
Q ss_pred EEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEEEeec
Q 020641 101 LAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADF 180 (323)
Q Consensus 101 lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~l~Df 180 (323)
+||||+.+++|.+++..... +++..+..++.|++.||.|||+. |++||||||+||+++.++.++|+||
T Consensus 73 lv~E~~~~~~L~~~~~~~~~---------l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~Df 140 (329)
T cd05618 73 FVIEYVNGGDLMFHMQRQRK---------LPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDY 140 (329)
T ss_pred EEEeCCCCCCHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeC
Confidence 99999999999998865432 88999999999999999999999 9999999999999999999999999
Q ss_pred cccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccc--hhhhhhccccc
Q 020641 181 NLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQ--SLVTWATPRLS 258 (323)
Q Consensus 181 g~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~--~~~~~~~~~~~ 258 (323)
|++........ ......|++.|+|||++.+..++.++||||||+++|+|++|+.||......... ....+..
T Consensus 141 G~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~---- 214 (329)
T cd05618 141 GMCKEGLRPGD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLF---- 214 (329)
T ss_pred CccccccCCCC--ccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHH----
Confidence 99865322111 123345899999999999999999999999999999999999999643221110 0000000
Q ss_pred ccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCCh
Q 020641 259 EDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNM 300 (323)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~ 300 (323)
...... ....+...+..+.+++.+||+.||++|||+
T Consensus 215 ----~~i~~~--~~~~p~~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 215 ----QVILEK--QIRIPRSLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred ----HHHhcC--CCCCCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence 001111 112344556779999999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-41 Score=287.36 Aligned_cols=253 Identities=25% Similarity=0.355 Sum_probs=199.2
Q ss_pred CccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeC
Q 020641 17 PGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEG 96 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 96 (323)
+.+..+||+|++|.||++.+..+ +.+++|..... ....+.+.+|++++++++|+||+++++++...
T Consensus 8 ~~~~~~lg~g~~~~v~~~~~~~~-~~v~iK~~~~~-------------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 73 (261)
T cd05068 8 IQLLRKLGAGQFGEVWEGLWNNT-TPVAVKTLKPG-------------TMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLE 73 (261)
T ss_pred eeeEEEecccCCccEEEEEecCC-eEEEEEeeCCC-------------cccHHHHHHHHHHHHHCCCCCccceeEEEecC
Confidence 55667999999999999987554 55777754321 11235688999999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEE
Q 020641 97 NLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAK 176 (323)
Q Consensus 97 ~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~ 176 (323)
+..+++|||+.+++|.+++...... .+++..+..++.|++.|+.+||+. |++|+||||+||+++.++.++
T Consensus 74 ~~~~lv~e~~~~~~L~~~~~~~~~~-------~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~ 143 (261)
T cd05068 74 EPIYIVTELMKYGSLLEYLQGGAGR-------ALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICK 143 (261)
T ss_pred CCeeeeeecccCCcHHHHHhccCCC-------CCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEE
Confidence 9999999999999999999765422 288999999999999999999999 999999999999999999999
Q ss_pred EeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcc
Q 020641 177 IADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATP 255 (323)
Q Consensus 177 l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~ 255 (323)
|+|||++......... .......+..|+|||...+..++.++|+||||+++|+|++ |+.||.......
T Consensus 144 l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---------- 212 (261)
T cd05068 144 VADFGLARVIKEDIYE-AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAE---------- 212 (261)
T ss_pred ECCcceEEEccCCccc-ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHH----------
Confidence 9999998765422111 1111123457999999988889999999999999999999 999997543211
Q ss_pred cccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhh
Q 020641 256 RLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPL 310 (323)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~ 310 (323)
+...+........+...+..+.+++.+||+.+|++||++.++++.|+.+
T Consensus 213 ------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 213 ------VLQQVDQGYRMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred ------HHHHHHcCCCCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 1111111111122334567899999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=309.74 Aligned_cols=256 Identities=20% Similarity=0.194 Sum_probs=199.5
Q ss_pred CCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEe
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVE 95 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 95 (323)
.|..+.+||+|+||.||+|++..+++.+|+|++.+.... .......+.+|+++++.++|+||+++++.+.+
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~---------~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~ 72 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVL---------MRNQAAHVKAERDILAEADNEWVVKLYYSFQD 72 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHH---------hhhhHHHHHHHHHHHHhCCCCCcceEEEEEEc
Confidence 466778999999999999999999999999977543211 12234668899999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeE
Q 020641 96 GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKA 175 (323)
Q Consensus 96 ~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~ 175 (323)
++..++||||+.+|+|.+++..... ++...+..++.||+.||.|||+. ||+||||||+||+++.++.+
T Consensus 73 ~~~~~lv~E~~~~g~L~~~i~~~~~---------~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~i 140 (376)
T cd05598 73 KDNLYFVMDYIPGGDMMSLLIRLGI---------FEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHI 140 (376)
T ss_pred CCEEEEEEeCCCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCE
Confidence 9999999999999999999976432 78889999999999999999999 99999999999999999999
Q ss_pred EEeeccccCCCCcccc-----------------------------------------ccccccccCccccCCCccccCCC
Q 020641 176 KIADFNLSNQAPDMAA-----------------------------------------RLHSTRVLGTFGYHAPEYAMTGQ 214 (323)
Q Consensus 176 ~l~Dfg~~~~~~~~~~-----------------------------------------~~~~~~~~g~~~y~aPE~~~~~~ 214 (323)
+|+|||++........ ........||+.|+|||++.+..
T Consensus 141 kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 220 (376)
T cd05598 141 KLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTG 220 (376)
T ss_pred EEEeCCCCccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCC
Confidence 9999998753211000 00011245899999999999989
Q ss_pred CCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCC
Q 020641 215 LTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEA 294 (323)
Q Consensus 215 ~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P 294 (323)
++.++|||||||++|+|++|+.||............. .+ ............+..+.+++.+|+ .+|
T Consensus 221 ~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~----~~---------~~~~~~~~~~~~s~~~~~li~~l~-~~p 286 (376)
T cd05598 221 YTQLCDWWSVGVILYEMLVGQPPFLADTPAETQLKVI----NW---------ETTLHIPSQAKLSREASDLILRLC-CGA 286 (376)
T ss_pred CCcceeeeeccceeeehhhCCCCCCCCCHHHHHHHHh----cc---------CccccCCCCCCCCHHHHHHHHHHh-cCH
Confidence 9999999999999999999999997654321111000 00 000111112234566888888876 599
Q ss_pred CCCC---ChHHHHHH
Q 020641 295 EFRP---NMSIVVKA 306 (323)
Q Consensus 295 ~~Rp---s~~evl~~ 306 (323)
.+|+ |+.++++.
T Consensus 287 ~~R~~~~t~~ell~h 301 (376)
T cd05598 287 EDRLGKNGADEIKAH 301 (376)
T ss_pred hhcCCCCCHHHHhCC
Confidence 9999 88998864
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-42 Score=301.04 Aligned_cols=237 Identities=25% Similarity=0.413 Sum_probs=199.8
Q ss_pred ccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeCCeEEE
Q 020641 22 RLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVL 101 (323)
Q Consensus 22 ~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 101 (323)
=||.|++|.||+.+. .++.||+|.+. +.-..+++-|++|+|+||+.+.++|.....+++
T Consensus 131 WlGSGaQGAVF~Grl--~netVAVKKV~-------------------elkETdIKHLRkLkH~NII~FkGVCtqsPcyCI 189 (904)
T KOG4721|consen 131 WLGSGAQGAVFLGRL--HNETVAVKKVR-------------------ELKETDIKHLRKLKHPNIITFKGVCTQSPCYCI 189 (904)
T ss_pred hhccCcccceeeeec--cCceehhHHHh-------------------hhhhhhHHHHHhccCcceeeEeeeecCCceeEE
Confidence 579999999999886 34556666332 111345777999999999999999999999999
Q ss_pred EEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEEEeecc
Q 020641 102 AYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFN 181 (323)
Q Consensus 102 v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~l~Dfg 181 (323)
|||||..|.|...++.... ++......|..+|+.|+.|||.. .|+|||+|.-||||+.+..+||+|||
T Consensus 190 iMEfCa~GqL~~VLka~~~---------itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFG 257 (904)
T KOG4721|consen 190 IMEFCAQGQLYEVLKAGRP---------ITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFG 257 (904)
T ss_pred eeeccccccHHHHHhccCc---------cCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEecccc
Confidence 9999999999999988764 88889999999999999999999 99999999999999999999999999
Q ss_pred ccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccccccc
Q 020641 182 LSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDK 261 (323)
Q Consensus 182 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 261 (323)
-+........ .-.+.||..|||||++...+.++|.||||||++||||+||+.||.+.+... +.|
T Consensus 258 TS~e~~~~ST---kMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA----IIw--------- 321 (904)
T KOG4721|consen 258 TSKELSDKST---KMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA----IIW--------- 321 (904)
T ss_pred chHhhhhhhh---hhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhe----eEE---------
Confidence 8877655432 234569999999999999999999999999999999999999998654321 111
Q ss_pred cchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhh
Q 020641 262 VKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQP 309 (323)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~ 309 (323)
.+=.+.+....|..+++-+.-|+++||+..|..|||+.+|+..|+=
T Consensus 322 --GVGsNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldI 367 (904)
T KOG4721|consen 322 --GVGSNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDI 367 (904)
T ss_pred --eccCCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhh
Confidence 1223444556788889999999999999999999999999998863
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-42 Score=308.97 Aligned_cols=256 Identities=18% Similarity=0.171 Sum_probs=197.5
Q ss_pred CCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEe
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVE 95 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 95 (323)
.|..+.+||.|+||.||++.+..+++.+|+|+..+.... .....+.+.+|+++++.++||||+++++++.+
T Consensus 2 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~---------~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~ 72 (377)
T cd05629 2 DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMF---------KKDQLAHVKAERDVLAESDSPWVVSLYYSFQD 72 (377)
T ss_pred CceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHH---------HhHHHHHHHHHHHHHHhCCCCCcceEEEEEEc
Confidence 456677999999999999999999999999976543211 11223567889999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeE
Q 020641 96 GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKA 175 (323)
Q Consensus 96 ~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~ 175 (323)
+...|+||||+.+|+|.+++..... +++..+..++.|++.||.|||+. |++||||||+||+++.++.+
T Consensus 73 ~~~~~lv~E~~~gg~L~~~l~~~~~---------~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~ 140 (377)
T cd05629 73 AQYLYLIMEFLPGGDLMTMLIKYDT---------FSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHI 140 (377)
T ss_pred CCeeEEEEeCCCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCE
Confidence 9999999999999999999975432 88889999999999999999999 99999999999999999999
Q ss_pred EEeeccccCCCCccccc---------------------------------------------cccccccCccccCCCccc
Q 020641 176 KIADFNLSNQAPDMAAR---------------------------------------------LHSTRVLGTFGYHAPEYA 210 (323)
Q Consensus 176 ~l~Dfg~~~~~~~~~~~---------------------------------------------~~~~~~~g~~~y~aPE~~ 210 (323)
+|+|||+++........ .......||+.|+|||++
T Consensus 141 kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 220 (377)
T cd05629 141 KLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIF 220 (377)
T ss_pred EEeecccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHH
Confidence 99999998633211000 000123589999999999
Q ss_pred cCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHcc
Q 020641 211 MTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCV 290 (323)
Q Consensus 211 ~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 290 (323)
.+..++.++|||||||++|+|++|..||...........+. . +. ..+........+.++.+++.+||
T Consensus 221 ~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~--~--~~---------~~~~~p~~~~~s~~~~dli~~lL 287 (377)
T cd05629 221 LQQGYGQECDWWSLGAIMFECLIGWPPFCSENSHETYRKII--N--WR---------ETLYFPDDIHLSVEAEDLIRRLI 287 (377)
T ss_pred ccCCCCCceeeEecchhhhhhhcCCCCCCCCCHHHHHHHHH--c--cC---------CccCCCCCCCCCHHHHHHHHHHh
Confidence 98899999999999999999999999997554311111000 0 00 00000011124567999999999
Q ss_pred CCCCCCC---CChHHHHHH
Q 020641 291 QYEAEFR---PNMSIVVKA 306 (323)
Q Consensus 291 ~~~P~~R---ps~~evl~~ 306 (323)
. +|.+| +|+.|+++.
T Consensus 288 ~-~~~~r~~r~~~~~~l~h 305 (377)
T cd05629 288 T-NAENRLGRGGAHEIKSH 305 (377)
T ss_pred c-CHhhcCCCCCHHHHhcC
Confidence 7 77776 599998874
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=288.01 Aligned_cols=257 Identities=21% Similarity=0.241 Sum_probs=202.6
Q ss_pred CCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEe
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVE 95 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 95 (323)
++..-..||.|++|.||.+.+..+++.+++|.......... .......+.+|++++++++|+||+++++++..
T Consensus 3 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~-------~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 75 (263)
T cd06625 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPE-------TKKEVNALECEIQLLKNLQHERIVQYYGCLRD 75 (263)
T ss_pred cccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchh-------hHHHHHHHHHHHHHHHhCCCCCeeeeEEEEcc
Confidence 34555689999999999999999999999986543221111 11123567889999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeE
Q 020641 96 GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKA 175 (323)
Q Consensus 96 ~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~ 175 (323)
....++|+||+.+++|.+++..... ++...+..++.|++.|+.+||+. |++|+||+|+||+++.++.+
T Consensus 76 ~~~~~~v~e~~~~~~l~~~~~~~~~---------~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~ 143 (263)
T cd06625 76 DETLSIFMEYMPGGSVKDQLKAYGA---------LTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNV 143 (263)
T ss_pred CCeEEEEEEECCCCcHHHHHHHhCC---------CCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCE
Confidence 9999999999999999999876432 78889999999999999999999 99999999999999999999
Q ss_pred EEeeccccCCCCccccccc-cccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhc
Q 020641 176 KIADFNLSNQAPDMAARLH-STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWAT 254 (323)
Q Consensus 176 ~l~Dfg~~~~~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~ 254 (323)
+|+|||.+........... .....++..|+|||.+.+..++.++||||||+++|+|++|+.||.........
T Consensus 144 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~------- 216 (263)
T cd06625 144 KLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAI------- 216 (263)
T ss_pred EEeecccceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHH-------
Confidence 9999999865433221111 12334678899999999888999999999999999999999999754321110
Q ss_pred ccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHH
Q 020641 255 PRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKA 306 (323)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~ 306 (323)
............+...+..+.+++.+||..+|.+|||+.++++.
T Consensus 217 --------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 217 --------FKIATQPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred --------HHHhccCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 11111111122344556779999999999999999999999873
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=299.61 Aligned_cols=243 Identities=21% Similarity=0.215 Sum_probs=192.5
Q ss_pred ccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcC-CCCcccceeeEEEeCCeEE
Q 020641 22 RLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRL-KHENLVELLGYCVEGNLRV 100 (323)
Q Consensus 22 ~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~ 100 (323)
.||+|+||.||++++..+++.+|+|+..+.... ..........|..++... +|+||+++++++.+.+..|
T Consensus 2 ~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~---------~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~ 72 (316)
T cd05620 2 VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVL---------IDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLF 72 (316)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh---------hcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEE
Confidence 589999999999999999999999977643211 111234556677777765 9999999999999999999
Q ss_pred EEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEEEeec
Q 020641 101 LAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADF 180 (323)
Q Consensus 101 lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~l~Df 180 (323)
+||||+.+++|.+++..... +++..+..++.|++.||.|||+. |++||||||+||+++.++.++|+||
T Consensus 73 lv~E~~~~g~L~~~i~~~~~---------~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Df 140 (316)
T cd05620 73 FVMEFLNGGDLMFHIQDKGR---------FDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADF 140 (316)
T ss_pred EEECCCCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCcc
Confidence 99999999999999876432 88889999999999999999999 9999999999999999999999999
Q ss_pred cccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhccccccc
Q 020641 181 NLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSED 260 (323)
Q Consensus 181 g~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 260 (323)
|++........ ......|++.|+|||.+.+..++.++||||||+++|+|++|..||........ ....
T Consensus 141 g~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~---~~~~------- 208 (316)
T cd05620 141 GMCKENVFGDN--RASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDEL---FESI------- 208 (316)
T ss_pred CCCeecccCCC--ceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHH---HHHH-------
Confidence 98864322111 12334589999999999998999999999999999999999999975432111 0000
Q ss_pred ccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChH-HHH
Q 020641 261 KVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMS-IVV 304 (323)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~-evl 304 (323)
... ....+...+.++.+++.+||+.||.+||++. +++
T Consensus 209 -----~~~--~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 209 -----RVD--TPHYPRWITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred -----HhC--CCCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 000 0112233456799999999999999999984 565
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=300.15 Aligned_cols=249 Identities=20% Similarity=0.210 Sum_probs=197.1
Q ss_pred CccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCC-CcccceeeEEEe
Q 020641 17 PGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKH-ENLVELLGYCVE 95 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~ 95 (323)
|.....||+|+||.||+|++..+++.+|+|++.+.... .....+.+..|.+++..+.| ++|+.+++++..
T Consensus 2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~---------~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~ 72 (324)
T cd05587 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVII---------QDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT 72 (324)
T ss_pred ceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhh---------hhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEc
Confidence 55677899999999999999999999999977643221 12223567788889988865 568889999999
Q ss_pred CCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeE
Q 020641 96 GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKA 175 (323)
Q Consensus 96 ~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~ 175 (323)
.+..|+||||+.+|+|.+++..... +++..+..++.|++.||.|||+. |++||||||+||+++.++.+
T Consensus 73 ~~~~~lv~E~~~~g~L~~~~~~~~~---------~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~ 140 (324)
T cd05587 73 MDRLYFVMEYVNGGDLMYHIQQVGK---------FKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHI 140 (324)
T ss_pred CCEEEEEEcCCCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCE
Confidence 9999999999999999999965432 88899999999999999999999 99999999999999999999
Q ss_pred EEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhcc
Q 020641 176 KIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATP 255 (323)
Q Consensus 176 ~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~ 255 (323)
+|+|||++........ ......|++.|+|||++.+..++.++|||||||++|+|++|+.||.........
T Consensus 141 kL~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~-------- 210 (324)
T cd05587 141 KIADFGMCKENIFGGK--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELF-------- 210 (324)
T ss_pred EEeecCcceecCCCCC--ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHH--------
Confidence 9999998764322111 123345899999999999888999999999999999999999999754321110
Q ss_pred cccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCCh-----HHHHH
Q 020641 256 RLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNM-----SIVVK 305 (323)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~-----~evl~ 305 (323)
..+... ....+...+..+.+++.+||..||.+|++. .++++
T Consensus 211 -------~~i~~~--~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 256 (324)
T cd05587 211 -------QSIMEH--NVSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIRE 256 (324)
T ss_pred -------HHHHcC--CCCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 011110 112233456679999999999999999976 56654
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=292.08 Aligned_cols=263 Identities=21% Similarity=0.303 Sum_probs=203.1
Q ss_pred CccccccCCCCCCccceecccee-----eeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceee
Q 020641 17 PGYFVRLDKGPEDDLYLKKRVKM-----RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLG 91 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~~~~~-----~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~ 91 (323)
+....+||.|+||.||++++..+ ++.+++|+..... .....+.+.+|+.+++.++|+||+++++
T Consensus 7 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~-----------~~~~~~~~~~e~~~~~~l~h~~iv~~~~ 75 (283)
T cd05091 7 VRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA-----------EGPLREEFKHEAMMRSRLQHPNIVCLLG 75 (283)
T ss_pred HHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC-----------CHHHHHHHHHHHHHHhcCCCCCcCeEEE
Confidence 45566899999999999987653 5678888654221 1112366888999999999999999999
Q ss_pred EEEeCCeEEEEEeecCCCCHHHHhccCCCCC-------CCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCC
Q 020641 92 YCVEGNLRVLAYEFATMGSLHDILHGRKGVQ-------GAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRS 164 (323)
Q Consensus 92 ~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp 164 (323)
++......++++||+.+++|.+++....... .......+++..+..++.|++.||.|||+. |++|+||||
T Consensus 76 ~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp 152 (283)
T cd05091 76 VVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLAT 152 (283)
T ss_pred EEcCCCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---Cccccccch
Confidence 9999999999999999999999985432110 001122378888999999999999999999 999999999
Q ss_pred CCEEEccCCeEEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCC
Q 020641 165 SNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMP 243 (323)
Q Consensus 165 ~nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~ 243 (323)
+||++++++.++|+|||++................+++.|+|||.+.+..++.++||||||+++|+|++ |..||.....
T Consensus 153 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~ 232 (283)
T cd05091 153 RNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN 232 (283)
T ss_pred hheEecCCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH
Confidence 999999999999999999876543332222233345778999999988889999999999999999998 8888865432
Q ss_pred cccchhhhhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhh
Q 020641 244 RGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQP 309 (323)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~ 309 (323)
. ...+.+........+..++..+.+++.+||+.+|.+||++.+|+..|+.
T Consensus 233 ~----------------~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 233 Q----------------DVIEMIRNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred H----------------HHHHHHHcCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 1 1111111111223345667789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-41 Score=286.56 Aligned_cols=253 Identities=28% Similarity=0.411 Sum_probs=198.3
Q ss_pred CccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeC
Q 020641 17 PGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEG 96 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 96 (323)
+....+||+|+||.||++++..+.+ +++|+..... ...+.+.+|++++++++|+||+++++.+..
T Consensus 8 ~~~~~~lg~g~~~~v~~~~~~~~~~-valK~~~~~~-------------~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~- 72 (262)
T cd05071 8 LRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGT-------------MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE- 72 (262)
T ss_pred eeEeeecCCCCCCcEEEEEecCCce-EEEEecccCc-------------cCHHHHHHHHHHHHhCCCCCcceEEEEECC-
Confidence 5666699999999999998876654 6777554211 123568899999999999999999998754
Q ss_pred CeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEE
Q 020641 97 NLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAK 176 (323)
Q Consensus 97 ~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~ 176 (323)
...++||||+.+++|.+++...... .+++..+..++.|++.||.+||+. +++|+||+|+||+++.++.++
T Consensus 73 ~~~~lv~e~~~~~~L~~~~~~~~~~-------~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~ 142 (262)
T cd05071 73 EPIYIVTEYMSKGSLLDFLKGEMGK-------YLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCK 142 (262)
T ss_pred CCcEEEEEcCCCCcHHHHHhhcccc-------CCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEE
Confidence 4579999999999999999754322 278899999999999999999999 999999999999999999999
Q ss_pred EeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcc
Q 020641 177 IADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATP 255 (323)
Q Consensus 177 l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~ 255 (323)
|+|||.+......... ......++..|+|||...+..++.++|+||||+++|+|++ |..||.........
T Consensus 143 L~dfg~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~-------- 213 (262)
T cd05071 143 VADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL-------- 213 (262)
T ss_pred eccCCceeeccccccc-cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHH--------
Confidence 9999998755432211 1122335678999999888889999999999999999999 88888654321110
Q ss_pred cccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhh
Q 020641 256 RLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLL 311 (323)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~ 311 (323)
..+........+...+..+.+++.+||+.+|++|||+.+++++|++.+
T Consensus 214 --------~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~ 261 (262)
T cd05071 214 --------DQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 261 (262)
T ss_pred --------HHHhcCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence 001111111223455677999999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=291.34 Aligned_cols=264 Identities=22% Similarity=0.324 Sum_probs=200.1
Q ss_pred CCccccccCCCCCCccceeccc----eeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceee
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRV----KMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLG 91 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~----~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~ 91 (323)
++++..+||+|+||.||++... .+++.+++|..... ........+.+|+++++.++|+||+++++
T Consensus 6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~-----------~~~~~~~~~~~E~~~l~~l~h~niv~~~~ 74 (283)
T cd05090 6 AVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDI-----------NNPQQWGEFQQEASLMAELHHPNIVCLLG 74 (283)
T ss_pred hceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCC-----------CCHHHHHHHHHHHHHHhhCCCCCeeeEEE
Confidence 4566779999999999999853 34456666644311 11122356788999999999999999999
Q ss_pred EEEeCCeEEEEEeecCCCCHHHHhccCCCCC--------CCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCC
Q 020641 92 YCVEGNLRVLAYEFATMGSLHDILHGRKGVQ--------GAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIR 163 (323)
Q Consensus 92 ~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dik 163 (323)
++..+...+++|||+.+++|.+++....... .......+++..+..++.|++.|+.|||+. |++|+|||
T Consensus 75 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlk 151 (283)
T cd05090 75 VVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLA 151 (283)
T ss_pred EEecCCceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---Ceehhccc
Confidence 9999999999999999999999986432110 001122378889999999999999999999 99999999
Q ss_pred CCCEEEccCCeEEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCC
Q 020641 164 SSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTM 242 (323)
Q Consensus 164 p~nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~ 242 (323)
|+||+++.++.++|+|||++................++..|+|||.+.+..++.++|+||||+++|+|++ |..||....
T Consensus 152 p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~ 231 (283)
T cd05090 152 ARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFS 231 (283)
T ss_pred cceEEEcCCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC
Confidence 9999999999999999999876543222222233335677999999988889999999999999999998 999986542
Q ss_pred CcccchhhhhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhh
Q 020641 243 PRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQP 309 (323)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~ 309 (323)
.. .+.+.+........+...+..+.+++.+||+.||++||++.+|++.|..
T Consensus 232 ~~----------------~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 232 NQ----------------EVIEMVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HH----------------HHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 21 1111111111112233455679999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=298.58 Aligned_cols=244 Identities=22% Similarity=0.242 Sum_probs=192.9
Q ss_pred ccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcC-CCCcccceeeEEEeCCeEE
Q 020641 22 RLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRL-KHENLVELLGYCVEGNLRV 100 (323)
Q Consensus 22 ~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~ 100 (323)
.||+|+||.||++.+..+++.+|+|+........ .........|..++... +||||+++++++.+....+
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~---------~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~ 72 (316)
T cd05619 2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLM---------DDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLF 72 (316)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhh---------cchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEE
Confidence 5899999999999999999999999776432111 12234556677777765 9999999999999999999
Q ss_pred EEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEEEeec
Q 020641 101 LAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADF 180 (323)
Q Consensus 101 lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~l~Df 180 (323)
+||||+.+|+|.+++..... +++..+..++.|++.||.|||+. |++||||||+||+++.++.++|+||
T Consensus 73 lv~ey~~~g~L~~~l~~~~~---------~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Df 140 (316)
T cd05619 73 FVMEYLNGGDLMFHIQSCHK---------FDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADF 140 (316)
T ss_pred EEEeCCCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccC
Confidence 99999999999999976432 88889999999999999999999 9999999999999999999999999
Q ss_pred cccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhccccccc
Q 020641 181 NLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSED 260 (323)
Q Consensus 181 g~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 260 (323)
|++........ ......|++.|+|||.+.+..++.++|||||||++|+|++|..||..............
T Consensus 141 g~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~-------- 210 (316)
T cd05619 141 GMCKENMLGDA--KTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRM-------- 210 (316)
T ss_pred CcceECCCCCC--ceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--------
Confidence 98864322111 12334589999999999988899999999999999999999999975432111000000
Q ss_pred ccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChH-HHHH
Q 020641 261 KVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMS-IVVK 305 (323)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~-evl~ 305 (323)
.. ...+...+.++.+++.+||+.||++||++. ++.+
T Consensus 211 -----~~----~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 211 -----DN----PCYPRWLTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred -----CC----CCCCccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 00 112233456789999999999999999997 6643
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=291.21 Aligned_cols=263 Identities=22% Similarity=0.333 Sum_probs=198.7
Q ss_pred CCccccccCCCCCCccceeccc-----eeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCccccee
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRV-----KMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELL 90 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~-----~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~ 90 (323)
.++...+||+|+||.||++... .++..+++|..... .....+.+.+|+++++.++|+||++++
T Consensus 6 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~------------~~~~~~~~~~e~~~l~~l~h~~i~~~~ 73 (280)
T cd05092 6 DIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA------------SESARQDFQREAELLTVLQHQHIVRFY 73 (280)
T ss_pred hceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC------------CHHHHHHHHHHHHHHhcCCCCCCceEE
Confidence 3456679999999999999643 34555666643211 112236788999999999999999999
Q ss_pred eEEEeCCeEEEEEeecCCCCHHHHhccCCCCC------CCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCC
Q 020641 91 GYCVEGNLRVLAYEFATMGSLHDILHGRKGVQ------GAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRS 164 (323)
Q Consensus 91 ~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp 164 (323)
+++......+++|||+.+++|.+++....... .......+++..+..++.|++.|+.|||+. |++|+||||
T Consensus 74 ~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp 150 (280)
T cd05092 74 GVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLAT 150 (280)
T ss_pred EEEecCCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccH
Confidence 99999999999999999999999997643210 001112388899999999999999999999 999999999
Q ss_pred CCEEEccCCeEEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCC
Q 020641 165 SNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMP 243 (323)
Q Consensus 165 ~nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~ 243 (323)
+||++++++.++|+|||++................+++.|+|||.+.+..++.++||||||+++|+|++ |..||.....
T Consensus 151 ~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~ 230 (280)
T cd05092 151 RNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSN 230 (280)
T ss_pred hhEEEcCCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCH
Confidence 999999999999999999865433222111222335678999999988889999999999999999998 9999864432
Q ss_pred cccchhhhhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhh
Q 020641 244 RGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQP 309 (323)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~ 309 (323)
.... ...........+..++..+.+++.+||+.||++||++.+|++.|+.
T Consensus 231 ~~~~----------------~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 231 TEAI----------------ECITQGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred HHHH----------------HHHHcCccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 1110 0011111112223445679999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-42 Score=307.60 Aligned_cols=254 Identities=20% Similarity=0.190 Sum_probs=196.4
Q ss_pred CccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeC
Q 020641 17 PGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEG 96 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 96 (323)
+..+.+||+|+||.||+|++..+++.+|+|+..+.... .......+.+|+++++.++|+||+++++.+.+.
T Consensus 3 f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~---------~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~ 73 (382)
T cd05625 3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVL---------LRNQVAHVKAERDILAEADNEWVVRLYYSFQDK 73 (382)
T ss_pred cEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhh---------hHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeC
Confidence 56677999999999999999999999999976543211 112235678899999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEE
Q 020641 97 NLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAK 176 (323)
Q Consensus 97 ~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~ 176 (323)
...|+||||+.+|+|.+++.+... +++..+..++.||+.||.|||+. ||+||||||+|||++.++.++
T Consensus 74 ~~~~lv~E~~~gg~L~~~l~~~~~---------~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~k 141 (382)
T cd05625 74 DNLYFVMDYIPGGDMMSLLIRMGI---------FPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIK 141 (382)
T ss_pred CEEEEEEeCCCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEE
Confidence 999999999999999999976432 88889999999999999999999 999999999999999999999
Q ss_pred EeeccccCCCCcccc---------------------------------------------ccccccccCccccCCCcccc
Q 020641 177 IADFNLSNQAPDMAA---------------------------------------------RLHSTRVLGTFGYHAPEYAM 211 (323)
Q Consensus 177 l~Dfg~~~~~~~~~~---------------------------------------------~~~~~~~~g~~~y~aPE~~~ 211 (323)
|+|||++........ ........||+.|+|||++.
T Consensus 142 L~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~ 221 (382)
T cd05625 142 LTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLL 221 (382)
T ss_pred EeECCCCccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhc
Confidence 999999753211000 00011235899999999999
Q ss_pred CCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccC
Q 020641 212 TGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQ 291 (323)
Q Consensus 212 ~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 291 (323)
+..++.++|||||||++|+|++|+.||............. . + ............+.+..+++.+|+
T Consensus 222 ~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~--~----------~-~~~~~~p~~~~~s~~~~~li~~l~- 287 (382)
T cd05625 222 RTGYTQLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVI--N----------W-QTSLHIPPQAKLSPEASDLIIKLC- 287 (382)
T ss_pred CCCCCCeeeEEechHHHHHHHhCCCCCCCCCHHHHHHHHH--c----------c-CCCcCCCCcccCCHHHHHHHHHHc-
Confidence 9999999999999999999999999997554321111100 0 0 001111112234566888888876
Q ss_pred CCCCCCCC---hHHHHH
Q 020641 292 YEAEFRPN---MSIVVK 305 (323)
Q Consensus 292 ~~P~~Rps---~~evl~ 305 (323)
.+|.+|++ +.++++
T Consensus 288 ~~p~~R~~~~~~~ei~~ 304 (382)
T cd05625 288 RGPEDRLGKNGADEIKA 304 (382)
T ss_pred cCHhHcCCCCCHHHHhc
Confidence 59999997 888765
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-41 Score=286.21 Aligned_cols=251 Identities=24% Similarity=0.358 Sum_probs=195.1
Q ss_pred ccCCCCCCccceeccc--eeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeCCeE
Q 020641 22 RLDKGPEDDLYLKKRV--KMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLR 99 (323)
Q Consensus 22 ~lg~G~~~~V~~~~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 99 (323)
.||+|+||.||++... ..+..+++|..... ......+.+.+|+.++++++|+||+++++++.. ...
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~-----------~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~ 69 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNE-----------NEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EAL 69 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccc-----------cChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCe
Confidence 5899999999998764 34556777755321 112234678899999999999999999998864 467
Q ss_pred EEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEEEee
Q 020641 100 VLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIAD 179 (323)
Q Consensus 100 ~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~l~D 179 (323)
++||||+.+++|.+++..... .+++..+..++.|++.|+.+||+. |++|+||||+||+++.++.++|+|
T Consensus 70 ~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~d 138 (257)
T cd05115 70 MLVMEMASGGPLNKFLSGKKD--------EITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISD 138 (257)
T ss_pred EEEEEeCCCCCHHHHHHhCCC--------CCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEecc
Confidence 999999999999999875432 289999999999999999999999 999999999999999999999999
Q ss_pred ccccCCCCcccccc-ccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccc
Q 020641 180 FNLSNQAPDMAARL-HSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPRL 257 (323)
Q Consensus 180 fg~~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~ 257 (323)
||++.......... ......++..|+|||.+.+..++.++||||||+++|++++ |..||......
T Consensus 139 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~------------- 205 (257)
T cd05115 139 FGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP------------- 205 (257)
T ss_pred CCccccccCCccceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH-------------
Confidence 99987543322111 1111223568999999888888999999999999999996 99999754321
Q ss_pred cccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhh
Q 020641 258 SEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLL 311 (323)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~ 311 (323)
.+...+........+...+.++.+++.+||..+|++||++.+|.+.|+.+.
T Consensus 206 ---~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~~ 256 (257)
T cd05115 206 ---EVMSFIEQGKRLDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTYY 256 (257)
T ss_pred ---HHHHHHHCCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhhc
Confidence 111112222222334455678999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=299.46 Aligned_cols=244 Identities=20% Similarity=0.225 Sum_probs=195.7
Q ss_pred ccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcC-CCCcccceeeEEEeCCeEE
Q 020641 22 RLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRL-KHENLVELLGYCVEGNLRV 100 (323)
Q Consensus 22 ~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~ 100 (323)
.||.|+||.||++++..+++.+|+|++.+..... ......+..|..+++.+ +|+||+++++++...+..+
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~---------~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~ 72 (318)
T cd05570 2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQ---------DDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLF 72 (318)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhh---------hhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEE
Confidence 5899999999999999999999999776432111 12235567788888877 7999999999999999999
Q ss_pred EEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEEEeec
Q 020641 101 LAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADF 180 (323)
Q Consensus 101 lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~l~Df 180 (323)
+||||+.+++|.+++..... +++..+..++.|++.||.|||+. |++|+||||+||+++.++.++|+||
T Consensus 73 lv~e~~~~~~L~~~~~~~~~---------l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Df 140 (318)
T cd05570 73 FVMEYVNGGDLMFHIQRSGR---------FDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADF 140 (318)
T ss_pred EEEcCCCCCCHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEeccc
Confidence 99999999999999876532 88999999999999999999999 9999999999999999999999999
Q ss_pred cccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhccccccc
Q 020641 181 NLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSED 260 (323)
Q Consensus 181 g~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 260 (323)
|++........ ......|++.|+|||.+.+..++.++|+|||||++|+|++|+.||.........
T Consensus 141 g~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~------------- 205 (318)
T cd05570 141 GMCKEGILGGV--TTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELF------------- 205 (318)
T ss_pred CCCeecCcCCC--cccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHH-------------
Confidence 98864322111 122345889999999999999999999999999999999999999754321110
Q ss_pred ccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCCh-----HHHHH
Q 020641 261 KVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNM-----SIVVK 305 (323)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~-----~evl~ 305 (323)
....... ...+...+..+.+++.+||+.||.+|||+ .++++
T Consensus 206 --~~i~~~~--~~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 206 --QSILEDE--VRYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred --HHHHcCC--CCCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 0011111 11233456679999999999999999999 88865
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-41 Score=289.34 Aligned_cols=260 Identities=25% Similarity=0.322 Sum_probs=200.0
Q ss_pred CccccccCCCCCCccceeccce-----eeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceee
Q 020641 17 PGYFVRLDKGPEDDLYLKKRVK-----MRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLG 91 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~~~~-----~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~ 91 (323)
+.....||+|++|.||+|.+.. ++..+++|...... .......+.+|+.+++.++|+||+++++
T Consensus 8 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~-----------~~~~~~~~~~e~~~l~~l~~~~i~~~~~ 76 (277)
T cd05036 8 ITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC-----------SEQDESDFLMEALIMSKFNHQNIVRLIG 76 (277)
T ss_pred cEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC-----------CHHHHHHHHHHHHHHHhCCCCCEeeEEE
Confidence 4555689999999999999877 66777877543211 0111256788999999999999999999
Q ss_pred EEEeCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEcc
Q 020641 92 YCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFE 171 (323)
Q Consensus 92 ~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~ 171 (323)
++.+....++||||+.+++|.+++........ ....+++..+..++.||+.|+.|||+. +++|+||||+||+++.
T Consensus 77 ~~~~~~~~~lv~e~~~g~~L~~~i~~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~ 151 (277)
T cd05036 77 VSFERLPRFILLELMAGGDLKSFLRENRPRPE--RPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTC 151 (277)
T ss_pred EEccCCCcEEEEecCCCCCHHHHHHHhCCCCC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEec
Confidence 99988889999999999999999976542211 122389999999999999999999999 9999999999999987
Q ss_pred CC---eEEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccc
Q 020641 172 DF---KAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQ 247 (323)
Q Consensus 172 ~~---~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~ 247 (323)
++ .++|+|||++.................+..|+|||.+.+..++.++|||||||++|+|++ |..||.......
T Consensus 152 ~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~-- 229 (277)
T cd05036 152 KGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE-- 229 (277)
T ss_pred cCCCcceEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH--
Confidence 64 589999999876533222111122223567999999988889999999999999999997 999997543211
Q ss_pred hhhhhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHh
Q 020641 248 SLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQ 308 (323)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~ 308 (323)
....+........+...+..+.+++.+||+.+|++|||+.+|++.|+
T Consensus 230 --------------~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 230 --------------VMEFVTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred --------------HHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 11111111112233445677999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-42 Score=324.34 Aligned_cols=260 Identities=25% Similarity=0.349 Sum_probs=213.7
Q ss_pred ccCCCCCCccceeccceeee-----eeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeC
Q 020641 22 RLDKGPEDDLYLKKRVKMRR-----WLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEG 96 (323)
Q Consensus 22 ~lg~G~~~~V~~~~~~~~~~-----~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 96 (323)
-||+|+||.||.+.-....- .+|+|... .....+...+|.+|..+|+.++||||++++|++.+.
T Consensus 699 ~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~-----------~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~ 767 (1025)
T KOG1095|consen 699 VLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLK-----------RLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDS 767 (1025)
T ss_pred eeccccccceEEEEEecCCCCccceEEEEEecc-----------ccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCC
Confidence 68999999999887665322 25555332 122234458899999999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEE
Q 020641 97 NLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAK 176 (323)
Q Consensus 97 ~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~ 176 (323)
...++++|||++|+|..++++......+ ...++....+.++.++++|+.||+++ +++||||..+|+|++....+|
T Consensus 768 ~~~~i~leyM~gGDL~sflr~~r~~~~~--~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VK 842 (1025)
T KOG1095|consen 768 GPPLILLEYMEGGDLLSFLRESRPAPFQ--PSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVK 842 (1025)
T ss_pred CCcEEEehhcccCcHHHHHHhcccccCC--CCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEE
Confidence 9999999999999999999887544332 23499999999999999999999999 999999999999999999999
Q ss_pred EeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcc
Q 020641 177 IADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATP 255 (323)
Q Consensus 177 l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~ 255 (323)
|+|||+|+..-............-+..|+|||.+....++.++||||||+++||+++ |..||....
T Consensus 843 IaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~------------- 909 (1025)
T KOG1095|consen 843 IADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRS------------- 909 (1025)
T ss_pred EcccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcc-------------
Confidence 999999996554443333333334568999999999999999999999999999999 999997553
Q ss_pred cccccccch-hcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhhcCC
Q 020641 256 RLSEDKVKQ-CVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSP 314 (323)
Q Consensus 256 ~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~~~~ 314 (323)
+.++.. ++... +...|..+++.++++|..||+.+|++||++..|++.+.++++..
T Consensus 910 ---n~~v~~~~~~gg-RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~ 965 (1025)
T KOG1095|consen 910 ---NFEVLLDVLEGG-RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAA 965 (1025)
T ss_pred ---hHHHHHHHHhCC-ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhh
Confidence 233333 33333 66778899999999999999999999999999999999888543
|
|
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=300.46 Aligned_cols=240 Identities=19% Similarity=0.211 Sum_probs=189.5
Q ss_pred ccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHH-HHhcCCCCcccceeeEEEeCCeEE
Q 020641 22 RLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVS-VVSRLKHENLVELLGYCVEGNLRV 100 (323)
Q Consensus 22 ~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~ 100 (323)
.||+|+||.||++++..+++.+|+|++.+..... ......+..|.. +++.++||||+++++.+...+..+
T Consensus 2 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---------~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~ 72 (323)
T cd05575 2 VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILK---------KKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLY 72 (323)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhh---------hhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEE
Confidence 5899999999999999999999999775432211 111233444444 567789999999999999999999
Q ss_pred EEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEEEeec
Q 020641 101 LAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADF 180 (323)
Q Consensus 101 lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~l~Df 180 (323)
+||||+.+++|.+++..... +++..+..++.||+.||.|||++ |++||||||+||+++.++.++|+||
T Consensus 73 lv~e~~~~g~L~~~l~~~~~---------~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Df 140 (323)
T cd05575 73 FVLDYVNGGELFFHLQRERS---------FPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDF 140 (323)
T ss_pred EEEcCCCCCCHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEecc
Confidence 99999999999999876432 88899999999999999999999 9999999999999999999999999
Q ss_pred cccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhccccccc
Q 020641 181 NLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSED 260 (323)
Q Consensus 181 g~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 260 (323)
|++........ ......|++.|+|||.+.+..++.++|||||||++|+|++|..||........
T Consensus 141 g~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~-------------- 204 (323)
T cd05575 141 GLCKEGIEHSK--TTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEM-------------- 204 (323)
T ss_pred CCCcccccCCC--ccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHH--------------
Confidence 99865332211 22334589999999999988999999999999999999999999975432111
Q ss_pred ccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChH
Q 020641 261 KVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMS 301 (323)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ 301 (323)
...+.... ...+...+..+.+++.+||+.||.+||++.
T Consensus 205 -~~~i~~~~--~~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 205 -YDNILNKP--LRLKPNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred -HHHHHcCC--CCCCCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 00111111 112223466799999999999999999984
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-41 Score=287.89 Aligned_cols=261 Identities=21% Similarity=0.271 Sum_probs=198.3
Q ss_pred cccccCCCCCCccceecccee---eeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEe
Q 020641 19 YFVRLDKGPEDDLYLKKRVKM---RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVE 95 (323)
Q Consensus 19 ~~~~lg~G~~~~V~~~~~~~~---~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 95 (323)
....||+|+||.||.+..... +..+++|....+.. .......+.+|++.++.++|+||+++++.+..
T Consensus 3 ~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~----------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 72 (273)
T cd05035 3 LGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIH----------TYSEIEEFLSEAACMKDFDHPNVMKLIGVCFE 72 (273)
T ss_pred cccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcC----------CHHHHHHHHHHHHHHHhCCCCCeeeEEeeecc
Confidence 345789999999999987653 36788875532211 11123567899999999999999999998876
Q ss_pred CCe------EEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEE
Q 020641 96 GNL------RVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLL 169 (323)
Q Consensus 96 ~~~------~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili 169 (323)
... .++++||+.+++|.+++....... ....+++..+..++.|++.||.|||+. +++|+||||+||++
T Consensus 73 ~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~---~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~ 146 (273)
T cd05035 73 ASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGG---LPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCML 146 (273)
T ss_pred CCccccCcccEEEEeccCCCCHHHHHHHhhccC---CcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEE
Confidence 544 799999999999999985542111 112388999999999999999999999 99999999999999
Q ss_pred ccCCeEEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccch
Q 020641 170 FEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQS 248 (323)
Q Consensus 170 ~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~ 248 (323)
++++.++|+|||++................++..|+|||.+.+..++.++||||||+++|+|++ |..||.......
T Consensus 147 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~--- 223 (273)
T cd05035 147 REDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHE--- 223 (273)
T ss_pred CCCCeEEECCccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHH---
Confidence 9999999999999876543322211222234668999999988889999999999999999999 889986543211
Q ss_pred hhhhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhh
Q 020641 249 LVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLL 311 (323)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~ 311 (323)
+.+.+........+...+..+.+++.+||+.||++|||+.|+++.|++++
T Consensus 224 -------------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~~ 273 (273)
T cd05035 224 -------------IYDYLRHGNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENIL 273 (273)
T ss_pred -------------HHHHHHcCCCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhhC
Confidence 11111111112233445678999999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=284.40 Aligned_cols=250 Identities=24% Similarity=0.333 Sum_probs=194.8
Q ss_pred CccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeC
Q 020641 17 PGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEG 96 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 96 (323)
+....+||+|+||.||++..... ..+++|..... ......+.+|+++++.++||||+++++++...
T Consensus 6 ~~~~~~lg~G~~~~vy~~~~~~~-~~~a~K~~~~~-------------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 71 (256)
T cd05114 6 LTFMKELGSGQFGVVHLGKWRAQ-IKVAIKAINEG-------------AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQ 71 (256)
T ss_pred cEEeeEecCCcCceEEEEEeccC-ceEEEEecccC-------------CccHHHHHHHHHHHHHCCCCCceeEEEEEccC
Confidence 45567899999999999987543 45666643311 11135688899999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEE
Q 020641 97 NLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAK 176 (323)
Q Consensus 97 ~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~ 176 (323)
...++||||+.+++|.+++...... +++..+..++.|++.|+.|||+. |++|+||+|+||+++.++.++
T Consensus 72 ~~~~iv~e~~~~~~L~~~~~~~~~~--------~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~k 140 (256)
T cd05114 72 KPLYIVTEFMENGCLLNYLRQRQGK--------LSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVK 140 (256)
T ss_pred CCEEEEEEcCCCCcHHHHHHhCccC--------CCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEE
Confidence 9999999999999999998754321 88899999999999999999999 999999999999999999999
Q ss_pred EeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcc
Q 020641 177 IADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATP 255 (323)
Q Consensus 177 l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~ 255 (323)
|+|||.+......... ......++..|+|||.+.+..++.++|+||||+++|+|++ |+.||........ .....
T Consensus 141 l~d~g~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~---~~~i~- 215 (256)
T cd05114 141 VSDFGMTRYVLDDEYT-SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEV---VEMIS- 215 (256)
T ss_pred ECCCCCccccCCCcee-ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHH---HHHHH-
Confidence 9999988765432221 1122234567999999988889999999999999999999 8999965432111 11100
Q ss_pred cccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHh
Q 020641 256 RLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQ 308 (323)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~ 308 (323)
. ......+...+..+.+++.+||+.+|++|||+.++++.|.
T Consensus 216 -----------~-~~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 216 -----------R-GFRLYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred -----------C-CCCCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 0 0011112223467999999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=303.34 Aligned_cols=241 Identities=21% Similarity=0.235 Sum_probs=192.5
Q ss_pred cccCCCCCCccceeccc---eeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeCC
Q 020641 21 VRLDKGPEDDLYLKKRV---KMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGN 97 (323)
Q Consensus 21 ~~lg~G~~~~V~~~~~~---~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 97 (323)
..||+|+||.||++++. .+++.+|+|++.+.... ......+.+|++++++++|+||+++++++..+.
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~----------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 71 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLK----------VRDRVRTKMERDILAEVNHPFIVKLHYAFQTEG 71 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhh----------hhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCC
Confidence 46899999999999874 46788888877543211 112345678999999999999999999999999
Q ss_pred eEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEEE
Q 020641 98 LRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKI 177 (323)
Q Consensus 98 ~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~l 177 (323)
..|+||||+.+++|.+++.+... +++..+..++.|++.||.|||+. |++|+||||+||+++.++.++|
T Consensus 72 ~~~lv~e~~~~~~L~~~l~~~~~---------l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL 139 (318)
T cd05582 72 KLYLILDFLRGGDLFTRLSKEVM---------FTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKL 139 (318)
T ss_pred EEEEEEcCCCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEE
Confidence 99999999999999999865432 88999999999999999999999 9999999999999999999999
Q ss_pred eeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccc
Q 020641 178 ADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRL 257 (323)
Q Consensus 178 ~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 257 (323)
+|||++........ ......|++.|+|||.+.+..++.++||||||+++|+|++|+.||.........
T Consensus 140 ~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~---------- 207 (318)
T cd05582 140 TDFGLSKESIDHEK--KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETM---------- 207 (318)
T ss_pred eeccCCcccCCCCC--ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHH----------
Confidence 99999876543211 122345899999999998888899999999999999999999999754321110
Q ss_pred cccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHH
Q 020641 258 SEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSI 302 (323)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~e 302 (323)
..+... ....+...+..+.+++.+||+.||.+|||+.+
T Consensus 208 -----~~i~~~--~~~~p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 208 -----TMILKA--KLGMPQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred -----HHHHcC--CCCCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 001110 01223345677999999999999999999544
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-41 Score=288.97 Aligned_cols=269 Identities=24% Similarity=0.319 Sum_probs=202.5
Q ss_pred ccccccCCCCCCccceec----cceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEE
Q 020641 18 GYFVRLDKGPEDDLYLKK----RVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYC 93 (323)
Q Consensus 18 ~~~~~lg~G~~~~V~~~~----~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 93 (323)
.....||+|+||.||++. ...++..+++|...... .......+.+|+++++.++|+||+++++++
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~-----------~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 75 (283)
T cd05080 7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC-----------GQQNTSGWKKEINILKTLYHENIVKYKGCC 75 (283)
T ss_pred eeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc-----------ChHHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 455689999999998764 34567778888654221 112236678899999999999999999987
Q ss_pred EeC--CeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEcc
Q 020641 94 VEG--NLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFE 171 (323)
Q Consensus 94 ~~~--~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~ 171 (323)
... ...+++|||+.+++|.+++.... +++..+..++.|++.|+.|||+. |++|+||||+||+++.
T Consensus 76 ~~~~~~~~~lv~e~~~~~~l~~~~~~~~----------l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~ 142 (283)
T cd05080 76 SEQGGKGLQLIMEYVPLGSLRDYLPKHK----------LNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDN 142 (283)
T ss_pred ecCCCceEEEEecCCCCCCHHHHHHHcC----------CCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcC
Confidence 653 46799999999999999996543 89999999999999999999999 9999999999999999
Q ss_pred CCeEEEeeccccCCCCccccccc-cccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhh
Q 020641 172 DFKAKIADFNLSNQAPDMAARLH-STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLV 250 (323)
Q Consensus 172 ~~~~~l~Dfg~~~~~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~ 250 (323)
++.++|+|||++........... .....++..|+|||.+.+..++.++||||||+++|+|++|..||.......... .
T Consensus 143 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~-~ 221 (283)
T cd05080 143 DRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEM-I 221 (283)
T ss_pred CCcEEEeecccccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhh-h
Confidence 99999999999876654322111 112234567999999988888999999999999999999999986543211100 0
Q ss_pred hhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhh
Q 020641 251 TWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLL 311 (323)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~ 311 (323)
...........+.+.++.......+...+..+.+++.+||+.+|++|||+.++++.|+++.
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 222 GPKQGQMTVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred cccccccchhhhhhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 0111111111222222222233334556678999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-41 Score=299.93 Aligned_cols=272 Identities=17% Similarity=0.196 Sum_probs=199.2
Q ss_pred CCccccccC----CCCCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhc
Q 020641 5 YHPRALGAH----APSPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSR 80 (323)
Q Consensus 5 ~~~~~~~~~----~~~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~ 80 (323)
|.+...+.. ...|.....||+|+||.||++.+..+++.+|+|...... ........+.+|+.+++.
T Consensus 7 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----------~~~~~~~~~~~E~~~l~~ 76 (359)
T cd07876 7 FYSVQVADSTFTVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPF----------QNQTHAKRAYRELVLLKC 76 (359)
T ss_pred cceecccchhhhhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccc----------cchhHHHHHHHHHHHHHh
Confidence 444444442 245566679999999999999999999999999664321 112223667789999999
Q ss_pred CCCCcccceeeEEEeCC------eEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCC
Q 020641 81 LKHENLVELLGYCVEGN------LRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQ 154 (323)
Q Consensus 81 l~h~~i~~~~~~~~~~~------~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~ 154 (323)
++|+||+++++++.... ..|+||||+.+ +|.+.+... ++...+..++.|++.||.|||+.
T Consensus 77 l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~-----------~~~~~~~~~~~qi~~~L~~LH~~-- 142 (359)
T cd07876 77 VNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIHME-----------LDHERMSYLLYQMLCGIKHLHSA-- 142 (359)
T ss_pred CCCCCEeeeeeeeccCCCccccceeEEEEeCCCc-CHHHHHhcc-----------CCHHHHHHHHHHHHHHHHHHHhC--
Confidence 99999999999986543 47999999976 677766432 77888999999999999999999
Q ss_pred CCceeCCCCCCCEEEccCCeEEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhC
Q 020641 155 PSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTG 234 (323)
Q Consensus 155 ~~i~h~dikp~nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g 234 (323)
|++||||||+||+++.++.++|+|||++....... ......|++.|+|||.+.+..++.++||||||+++|+|++|
T Consensus 143 -~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg 218 (359)
T cd07876 143 -GIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKG 218 (359)
T ss_pred -CcccCCCCHHHEEECCCCCEEEecCCCccccccCc---cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhC
Confidence 99999999999999999999999999987543221 12234578999999999998999999999999999999999
Q ss_pred CCCCCCCCCcccchhhhhh----------------------cccccccccc----hhcCCCcCCCCCHHHHHHHHHHHHH
Q 020641 235 RKPVDHTMPRGQQSLVTWA----------------------TPRLSEDKVK----QCVDPKLKGEYPPKGVAKLAAVAAL 288 (323)
Q Consensus 235 ~~pf~~~~~~~~~~~~~~~----------------------~~~~~~~~~~----~~~~~~~~~~~~~~~~~~l~~li~~ 288 (323)
+.||...+........... .......... .+..+. ........+..+.+++.+
T Consensus 219 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~ 297 (359)
T cd07876 219 SVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPS-ESERDKLKTSQARDLLSK 297 (359)
T ss_pred CCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhcccccccc-ccccccccchhHHHHHHH
Confidence 9999865431110000000 0000000000 000000 001111234678999999
Q ss_pred ccCCCCCCCCChHHHHH
Q 020641 289 CVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 289 cl~~~P~~Rps~~evl~ 305 (323)
||..||++|||+.|+++
T Consensus 298 mL~~dP~~R~t~~e~l~ 314 (359)
T cd07876 298 MLVIDPDKRISVDEALR 314 (359)
T ss_pred HhccCcccCCCHHHHhc
Confidence 99999999999999998
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-41 Score=289.61 Aligned_cols=261 Identities=22% Similarity=0.319 Sum_probs=201.8
Q ss_pred CCccccccCCCCCCccceeccceeeee----eeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceee
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRVKMRRW----LCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLG 91 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~~~~~~----~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~ 91 (323)
.+..+.+||.|+||.||++++..++.. +|+|...... .......+.+|..+++.+.|+||+++++
T Consensus 8 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~-----------~~~~~~~~~~e~~~l~~~~~~~i~~~~~ 76 (279)
T cd05109 8 ELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT-----------SPKANKEILDEAYVMAGVGSPYVCRLLG 76 (279)
T ss_pred heeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC-----------CHHHHHHHHHHHHHHHhcCCCCCceEEE
Confidence 456667899999999999997766653 5666543211 1112356778999999999999999999
Q ss_pred EEEeCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEcc
Q 020641 92 YCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFE 171 (323)
Q Consensus 92 ~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~ 171 (323)
++... ..+++++|+.+|+|.+++...... +++..+..++.|++.||.|||++ +++|+||||+||++++
T Consensus 77 ~~~~~-~~~l~~~~~~~g~l~~~l~~~~~~--------~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~ 144 (279)
T cd05109 77 ICLTS-TVQLVTQLMPYGCLLDYVRENKDR--------IGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKS 144 (279)
T ss_pred EEcCC-CcEEEEEcCCCCCHHHHHhhccCC--------CCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcC
Confidence 98765 468999999999999999764322 88999999999999999999999 9999999999999999
Q ss_pred CCeEEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccchhh
Q 020641 172 DFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLV 250 (323)
Q Consensus 172 ~~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~ 250 (323)
++.++|+|||++................++..|+|||...+..++.++||||||+++|+|++ |..||.......
T Consensus 145 ~~~~kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~----- 219 (279)
T cd05109 145 PNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE----- 219 (279)
T ss_pred CCcEEECCCCceeecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH-----
Confidence 99999999999876543222211222234667999999988889999999999999999998 999986442211
Q ss_pred hhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhhcCCC
Q 020641 251 TWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSPP 315 (323)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~~~~~ 315 (323)
+...+........+...+..+.+++.+||..||+.|||+.++++.|..+...+.
T Consensus 220 -----------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~~ 273 (279)
T cd05109 220 -----------IPDLLEKGERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDPS 273 (279)
T ss_pred -----------HHHHHHCCCcCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCCc
Confidence 111111111112233455679999999999999999999999999999877663
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=294.99 Aligned_cols=250 Identities=26% Similarity=0.428 Sum_probs=191.5
Q ss_pred cccCCCCCCccceeccc----eeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeC
Q 020641 21 VRLDKGPEDDLYLKKRV----KMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEG 96 (323)
Q Consensus 21 ~~lg~G~~~~V~~~~~~----~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 96 (323)
..||.|.||.||+|... ..+..+++|..... ...+..+.+.+|++.+++++||||+++++++...
T Consensus 5 ~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~-----------~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~ 73 (259)
T PF07714_consen 5 KQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS-----------SSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIEN 73 (259)
T ss_dssp EEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT-----------SSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESS
T ss_pred eEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc-----------cccccceeeeeccccccccccccccccccccccc
Confidence 47999999999999988 45666777755211 0111247889999999999999999999999988
Q ss_pred CeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEE
Q 020641 97 NLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAK 176 (323)
Q Consensus 97 ~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~ 176 (323)
...++|+||+.+|+|.+++...... .+++..+..++.|++.|+.|||+. +++|++|+++||+++.++.+|
T Consensus 74 ~~~~lv~e~~~~g~L~~~L~~~~~~-------~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~K 143 (259)
T PF07714_consen 74 EPLFLVMEYCPGGSLDDYLKSKNKE-------PLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVK 143 (259)
T ss_dssp SSEEEEEE--TTEBHHHHHHHTCTT-------TSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEE
T ss_pred ccccccccccccccccccccccccc-------cccccccccccccccccccccccc---ccccccccccccccccccccc
Confidence 8899999999999999999887222 289999999999999999999999 999999999999999999999
Q ss_pred EeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcc
Q 020641 177 IADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATP 255 (323)
Q Consensus 177 l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~ 255 (323)
|+|||++................+...|+|||.+.+..++.++||||||+++|||++ |+.||.......
T Consensus 144 l~~f~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~---------- 213 (259)
T PF07714_consen 144 LSDFGLSRPISEKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEE---------- 213 (259)
T ss_dssp EESTTTGEETTTSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHH----------
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc----------
Confidence 999999876633222222233346778999999988889999999999999999999 789986553211
Q ss_pred cccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHH
Q 020641 256 RLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKAL 307 (323)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l 307 (323)
+...+....+...+..++..+.+++.+||+.||++|||+.+|++.|
T Consensus 214 ------~~~~~~~~~~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 214 ------IIEKLKQGQRLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp ------HHHHHHTTEETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ------ccccccccccceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 1111111122223444567799999999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-41 Score=285.21 Aligned_cols=251 Identities=22% Similarity=0.294 Sum_probs=202.1
Q ss_pred CccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeC
Q 020641 17 PGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEG 96 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 96 (323)
|.....||+|++|.||++.+..+++.+++|........ ......+.+|+++++.++|+||+++++.+...
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~----------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 71 (256)
T cd08529 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMN----------RREREEAIDEARVLAKLDSSYIIRYYESFLDK 71 (256)
T ss_pred ceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCC----------HHHHHHHHHHHHHHHhcCCCCeehheeeeccC
Confidence 45556899999999999999999999998865432211 22346788999999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEE
Q 020641 97 NLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAK 176 (323)
Q Consensus 97 ~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~ 176 (323)
+..++||||+.+++|.+++...... .++...++.++.|++.|+.|||+. |++|+||+|+||+++.++.++
T Consensus 72 ~~~~lv~e~~~~~~L~~~l~~~~~~-------~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~ 141 (256)
T cd08529 72 GKLNIVMEYAENGDLHKLLKMQRGR-------PLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVK 141 (256)
T ss_pred CEEEEEEEeCCCCcHHHHHHHhcCC-------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEE
Confidence 9999999999999999999764322 288899999999999999999999 999999999999999999999
Q ss_pred EeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhccc
Q 020641 177 IADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPR 256 (323)
Q Consensus 177 l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 256 (323)
|+|||++......... .....+++.|+|||...+..++.++|+||||+++++|++|..||.......
T Consensus 142 l~df~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----------- 208 (256)
T cd08529 142 IGDLGVAKLLSDNTNF--ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGA----------- 208 (256)
T ss_pred EcccccceeccCccch--hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH-----------
Confidence 9999988765432211 223357889999999988889999999999999999999999997553110
Q ss_pred ccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 257 LSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
....... ......+...+..+.+++.+||+.+|++||++.++++
T Consensus 209 ----~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 252 (256)
T cd08529 209 ----LILKIIR-GVFPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLR 252 (256)
T ss_pred ----HHHHHHc-CCCCCCccccCHHHHHHHHHHccCCcccCcCHHHHhh
Confidence 0011111 1111223345677999999999999999999999986
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-42 Score=303.79 Aligned_cols=255 Identities=16% Similarity=0.145 Sum_probs=200.6
Q ss_pred CCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEe
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVE 95 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 95 (323)
.|....+||+|+||+||++++..+++.+|+|+....... .......+.+|+.+++.++|+||+++++++.+
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~---------~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~ 72 (330)
T cd05601 2 DFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLL---------AQETVSFFEEERDILSISNSPWIPQLQYAFQD 72 (330)
T ss_pred CceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhh---------hhhHHHHHHHHHHHHHhCCCCCCcceeeEEec
Confidence 356667999999999999999999999999977643211 12234667889999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeE
Q 020641 96 GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKA 175 (323)
Q Consensus 96 ~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~ 175 (323)
.+..++||||+.+++|.+++...... +++..+..++.|++.||.|||+. |++||||||+||+++.++.+
T Consensus 73 ~~~~~lv~e~~~~~~L~~~l~~~~~~--------l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~ 141 (330)
T cd05601 73 KDNLYLVMEYQPGGDLLSLLNRYEDQ--------FDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHI 141 (330)
T ss_pred CCeEEEEECCCCCCCHHHHHHHhcCC--------CCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCE
Confidence 99999999999999999999765322 88999999999999999999999 99999999999999999999
Q ss_pred EEeeccccCCCCccccccccccccCccccCCCcccc------CCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchh
Q 020641 176 KIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAM------TGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSL 249 (323)
Q Consensus 176 ~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~------~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~ 249 (323)
+|+|||++......... ......|++.|+|||++. ...++.++||||||+++|+|++|..||...........
T Consensus 142 kL~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~ 220 (330)
T cd05601 142 KLADFGSAARLTANKMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNN 220 (330)
T ss_pred EeccCCCCeECCCCCce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHH
Confidence 99999998765432221 122335899999999886 45577899999999999999999999975432111100
Q ss_pred hhhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 250 VTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
+. .. ............+..+.+++.+||+ +|.+|||+.++++
T Consensus 221 i~------------~~-~~~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 221 IM------------NF-QRFLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred HH------------cC-CCccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 00 00 0001111122346679999999998 9999999999985
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=297.96 Aligned_cols=244 Identities=21% Similarity=0.220 Sum_probs=194.5
Q ss_pred CccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcC-CCCcccceeeEEEe
Q 020641 17 PGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRL-KHENLVELLGYCVE 95 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~ 95 (323)
|.....||+|+||.||++++..+++.+|+|+..+.... .......+..|..++..+ .|++|+++++++..
T Consensus 2 f~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~---------~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~ 72 (323)
T cd05616 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVI---------QDDDVECTMVEKRVLALSGKPPFLTQLHSCFQT 72 (323)
T ss_pred ceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh---------hhhHHHHHHHHHHHHHhccCCCeEeeEEEEEec
Confidence 45567899999999999999999999999977643211 112234566777888777 68999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeE
Q 020641 96 GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKA 175 (323)
Q Consensus 96 ~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~ 175 (323)
.+..++||||+.+|+|.+++..... +++..+..++.|++.||.|||+. |++||||||+||+++.++.+
T Consensus 73 ~~~~~lv~E~~~~g~L~~~~~~~~~---------~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~ 140 (323)
T cd05616 73 MDRLYFVMEYVNGGDLMYQIQQVGR---------FKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHI 140 (323)
T ss_pred CCEEEEEEcCCCCCCHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcE
Confidence 9999999999999999999865432 88899999999999999999999 99999999999999999999
Q ss_pred EEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhcc
Q 020641 176 KIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATP 255 (323)
Q Consensus 176 ~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~ 255 (323)
+|+|||++........ ......|++.|+|||.+.+..++.++|||||||++|+|++|+.||.........
T Consensus 141 kL~DfG~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~-------- 210 (323)
T cd05616 141 KIADFGMCKENMWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELF-------- 210 (323)
T ss_pred EEccCCCceecCCCCC--ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHH--------
Confidence 9999999865332111 123345899999999999999999999999999999999999999755321111
Q ss_pred cccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCCh
Q 020641 256 RLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNM 300 (323)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~ 300 (323)
..+.... ...+...+.++.+++.+||+.||.+|++.
T Consensus 211 -------~~i~~~~--~~~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 211 -------QSIMEHN--VAYPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred -------HHHHhCC--CCCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 1111111 12334456779999999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-41 Score=289.09 Aligned_cols=264 Identities=21% Similarity=0.296 Sum_probs=198.5
Q ss_pred CCccccccCCCCCCccceeccce-----eeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCccccee
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRVK-----MRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELL 90 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~~-----~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~ 90 (323)
.+....+||+|+||.||++.+.. ++..+++|...... .......+.+|+.+++.++|+||++++
T Consensus 7 ~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-----------~~~~~~~~~~e~~~l~~l~~~~iv~~~ 75 (277)
T cd05062 7 KITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA-----------SMRERIEFLNEASVMKEFNCHHVVRLL 75 (277)
T ss_pred HceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC-----------CHHHHHHHHHHHHHHHhCCCCCeeeEE
Confidence 35566789999999999987542 34567777543110 011235678899999999999999999
Q ss_pred eEEEeCCeEEEEEeecCCCCHHHHhccCCCCCC-CCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEE
Q 020641 91 GYCVEGNLRVLAYEFATMGSLHDILHGRKGVQG-AQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLL 169 (323)
Q Consensus 91 ~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili 169 (323)
+++..+...++||||+.+++|.+++........ ......+++..+..++.|++.||.|||+. |++|+||||+||++
T Consensus 76 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~ 152 (277)
T cd05062 76 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMV 152 (277)
T ss_pred EEEcCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEE
Confidence 999999999999999999999999965432111 11122367888999999999999999999 99999999999999
Q ss_pred ccCCeEEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccch
Q 020641 170 FEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQS 248 (323)
Q Consensus 170 ~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~ 248 (323)
+.++.++|+|||++................++..|+|||.+.+..++.++||||||+++|+|++ |..||.........
T Consensus 153 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~- 231 (277)
T cd05062 153 AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVL- 231 (277)
T ss_pred cCCCCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHH-
Confidence 9999999999999875543322222222335678999999988889999999999999999998 78898654321110
Q ss_pred hhhhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhh
Q 020641 249 LVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQP 309 (323)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~ 309 (323)
. ...... ....+...+..+.+++.+||+.||++|||+.|+++.|+.
T Consensus 232 --~------------~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 232 --R------------FVMEGG-LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred --H------------HHHcCC-cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 0 000100 112233455679999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=286.85 Aligned_cols=251 Identities=20% Similarity=0.254 Sum_probs=201.4
Q ss_pred CccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeC
Q 020641 17 PGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEG 96 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 96 (323)
|++..+||.|+||.||++++..+++.+++|.+.... .....+.+.+|+.+++.++|+||+++++.+...
T Consensus 2 y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~-----------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 70 (255)
T cd08219 2 YNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK-----------SSSAVEDSRKEAVLLAKMKHPNIVAFKESFEAD 70 (255)
T ss_pred ceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCc-----------chHHHHHHHHHHHHHHhCCCCCcceEEEEEEEC
Confidence 456678999999999999999999988888653211 112236678899999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEE
Q 020641 97 NLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAK 176 (323)
Q Consensus 97 ~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~ 176 (323)
+..++++||+.+++|.+++...... .++...+..++.|++.|+.+||+. |++|+||+|+||+++.++.++
T Consensus 71 ~~~~lv~e~~~~~~l~~~~~~~~~~-------~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~ 140 (255)
T cd08219 71 GHLYIVMEYCDGGDLMQKIKLQRGK-------LFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVK 140 (255)
T ss_pred CEEEEEEeeCCCCcHHHHHHhccCC-------CCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEE
Confidence 9999999999999999988654322 278889999999999999999999 999999999999999999999
Q ss_pred EeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhccc
Q 020641 177 IADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPR 256 (323)
Q Consensus 177 l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 256 (323)
++|||.+........ ......+++.|+|||.+.+..++.++|+||||+++|+|++|..||.........
T Consensus 141 l~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~--------- 209 (255)
T cd08219 141 LGDFGSARLLTSPGA--YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLI--------- 209 (255)
T ss_pred EcccCcceeeccccc--ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHH---------
Confidence 999999875543221 122345788999999998888999999999999999999999999754321110
Q ss_pred ccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHH
Q 020641 257 LSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKA 306 (323)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~ 306 (323)
.. +........+...+..+.+++.+||+.||++|||+.+|+..
T Consensus 210 ------~~-~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 210 ------LK-VCQGSYKPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred ------HH-HhcCCCCCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 00 01111112334456679999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-41 Score=292.66 Aligned_cols=271 Identities=23% Similarity=0.338 Sum_probs=206.4
Q ss_pred CCCCccccccCCCCCCccceeccc-------eeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcC-CCCc
Q 020641 14 APSPGYFVRLDKGPEDDLYLKKRV-------KMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRL-KHEN 85 (323)
Q Consensus 14 ~~~~~~~~~lg~G~~~~V~~~~~~-------~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~ 85 (323)
...+.....||+|+||.||+++.. ..+..+++|+..... .......+.+|+.+++.+ +|+|
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~-----------~~~~~~~~~~E~~~l~~l~~h~~ 82 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA-----------TEKDLSDLVSEMEMMKMIGKHKN 82 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc-----------chHHHHHHHHHHHHHHhhccCCC
Confidence 344555568999999999999753 234467777543210 111235678899999999 8999
Q ss_pred ccceeeEEEeCCeEEEEEeecCCCCHHHHhccCCCCCC-------CCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCce
Q 020641 86 LVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQG-------AQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSII 158 (323)
Q Consensus 86 i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~ 158 (323)
|+++++++......+++|||+.+++|.+++........ ..+...+++..+..++.|++.||.|||+. |++
T Consensus 83 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---giv 159 (304)
T cd05101 83 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCI 159 (304)
T ss_pred chheeEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---Cee
Confidence 99999999999999999999999999999976532110 01223488889999999999999999999 999
Q ss_pred eCCCCCCCEEEccCCeEEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHh-CCCC
Q 020641 159 HRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKP 237 (323)
Q Consensus 159 h~dikp~nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~p 237 (323)
|+||||+||+++.++.++|+|||.+................++..|+|||.+.+..++.++||||||+++|++++ |..|
T Consensus 160 H~dlkp~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p 239 (304)
T cd05101 160 HRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 239 (304)
T ss_pred ecccccceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCC
Confidence 999999999999999999999999876654332222223335678999999988889999999999999999998 7888
Q ss_pred CCCCCCcccchhhhhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhhcCC
Q 020641 238 VDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSP 314 (323)
Q Consensus 238 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~~~~ 314 (323)
|...... .+.+.+........+..++..+.+++.+||+.+|++|||+.|+++.|++++...
T Consensus 240 ~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~ 300 (304)
T cd05101 240 YPGIPVE----------------ELFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLT 300 (304)
T ss_pred cccCCHH----------------HHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhh
Confidence 8644211 111111111112233455678999999999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-41 Score=289.51 Aligned_cols=263 Identities=24% Similarity=0.317 Sum_probs=201.0
Q ss_pred CccccccCCCCCCccceeccceee-----eeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceee
Q 020641 17 PGYFVRLDKGPEDDLYLKKRVKMR-----RWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLG 91 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~~~~~~-----~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~ 91 (323)
+.+...||.|+||.||++.+.... ..+++|...... .......+.+|+.+++.++|+||+++++
T Consensus 8 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-----------~~~~~~~~~~e~~~l~~~~~~~i~~~~~ 76 (277)
T cd05032 8 ITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA-----------SMRERIEFLNEASVMKEFNCHHVVRLLG 76 (277)
T ss_pred eeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc-----------CHHHHHHHHHHHHHHHhCCCCceeEEEE
Confidence 445568999999999999887544 667777543110 0111256788999999999999999999
Q ss_pred EEEeCCeEEEEEeecCCCCHHHHhccCCCCCCC-CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEc
Q 020641 92 YCVEGNLRVLAYEFATMGSLHDILHGRKGVQGA-QPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLF 170 (323)
Q Consensus 92 ~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~ 170 (323)
++..+...++||||+.+++|.+++......... .....+++..+..++.|++.|+.|||+. +++|+||||+||+++
T Consensus 77 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~ 153 (277)
T cd05032 77 VVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVA 153 (277)
T ss_pred EEcCCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEc
Confidence 999999999999999999999999754322111 1122378889999999999999999999 999999999999999
Q ss_pred cCCeEEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccchh
Q 020641 171 EDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSL 249 (323)
Q Consensus 171 ~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~ 249 (323)
.++.++|+|||++................++..|+|||.+.+..++.++||||||+++|++++ |..||........
T Consensus 154 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~--- 230 (277)
T cd05032 154 EDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEV--- 230 (277)
T ss_pred CCCCEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHH---
Confidence 999999999999875543322112223346778999999988889999999999999999998 9999864432111
Q ss_pred hhhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhh
Q 020641 250 VTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQP 309 (323)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~ 309 (323)
.+.+........+...+..+.+++.+||+.+|++|||+.++++.|++
T Consensus 231 -------------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 231 -------------LKFVIDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred -------------HHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 11111111122333446789999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-41 Score=295.89 Aligned_cols=259 Identities=20% Similarity=0.257 Sum_probs=216.3
Q ss_pred CCCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCC-CCcccceeeEE
Q 020641 15 PSPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLK-HENLVELLGYC 93 (323)
Q Consensus 15 ~~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~ 93 (323)
..|+....||.|.||.||.++...+++.+|+|++.+....... ..+.+.+|+++|+++. ||||+.+.++|
T Consensus 35 ~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~---------~~~~v~~Ev~il~~l~~hpniv~l~~~~ 105 (382)
T KOG0032|consen 35 EKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKE---------DREDVRREVAILQQLSGHPNIVQLKDAF 105 (382)
T ss_pred ccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccc---------cHHHHHHHHHHHHhccCCCCEEEEEEEE
Confidence 3456666999999999999999999999999988876554432 4578899999999996 99999999999
Q ss_pred EeCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccC-
Q 020641 94 VEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFED- 172 (323)
Q Consensus 94 ~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~- 172 (323)
++....++|||++.||.|.+.+.... +++..+..++.|++.++.|||+. |++|||+||+|+|+...
T Consensus 106 e~~~~~~lvmEL~~GGeLfd~i~~~~----------~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~ 172 (382)
T KOG0032|consen 106 EDPDSVYLVMELCEGGELFDRIVKKH----------YSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKD 172 (382)
T ss_pred EcCCeEEEEEEecCCchHHHHHHHcc----------CCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeecccc
Confidence 99999999999999999999998761 89999999999999999999999 99999999999999543
Q ss_pred ---CeEEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchh
Q 020641 173 ---FKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSL 249 (323)
Q Consensus 173 ---~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~ 249 (323)
+.++++|||++..... .......+||+.|+|||++....|+...||||+|+++|.|++|..||...........
T Consensus 173 ~~~~~ik~~DFGla~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~ 249 (382)
T KOG0032|consen 173 EGSGRIKLIDFGLAKFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLA 249 (382)
T ss_pred CCCCcEEEeeCCCceEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHH
Confidence 4799999999988766 2233556799999999999999999999999999999999999999987654332221
Q ss_pred hhhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhhcC
Q 020641 250 VTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKS 313 (323)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~~~ 313 (323)
+.... .......-...+..+.++++.||..||..|+|+.++++. .++..
T Consensus 250 i~~~~-------------~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H--pWi~~ 298 (382)
T KOG0032|consen 250 ILRGD-------------FDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH--PWIKS 298 (382)
T ss_pred HHcCC-------------CCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC--ccccC
Confidence 11111 122233445567889999999999999999999999993 44443
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-42 Score=276.68 Aligned_cols=260 Identities=20% Similarity=0.273 Sum_probs=207.4
Q ss_pred cccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcC-CCCcccceeeEEEeCCeE
Q 020641 21 VRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRL-KHENLVELLGYCVEGNLR 99 (323)
Q Consensus 21 ~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~ 99 (323)
.-||.|..++|-.+....++...+.|++......... .+..+..+...+|+.+|+++ .||+|+++.++++.+...
T Consensus 23 eilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~----e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~ 98 (411)
T KOG0599|consen 23 EILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESG----ETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAFV 98 (411)
T ss_pred HHhcccchhhhhhhhhcccccceeEEEEEecccccCC----ccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcchh
Confidence 3689999999999999999887777766533222111 11233456677899999999 899999999999999999
Q ss_pred EEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEEEee
Q 020641 100 VLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIAD 179 (323)
Q Consensus 100 ~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~l~D 179 (323)
++|+|.|..|.|+|++...-. ++++....+++|+++|+.|||.. +|+|||+||+|||+++|.+++|+|
T Consensus 99 FlVFdl~prGELFDyLts~Vt---------lSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isD 166 (411)
T KOG0599|consen 99 FLVFDLMPRGELFDYLTSKVT---------LSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISD 166 (411)
T ss_pred hhhhhhcccchHHHHhhhhee---------ecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEec
Confidence 999999999999999987643 99999999999999999999999 999999999999999999999999
Q ss_pred ccccCCCCccccccccccccCccccCCCccccC------CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhh
Q 020641 180 FNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT------GQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWA 253 (323)
Q Consensus 180 fg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~------~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 253 (323)
||.++....+... ...+|||+|+|||.+.. .+|+...|+|++|+++|-|+.|..||......
T Consensus 167 FGFa~~l~~GekL---relCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQm--------- 234 (411)
T KOG0599|consen 167 FGFACQLEPGEKL---RELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQM--------- 234 (411)
T ss_pred cceeeccCCchhH---HHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHH---------
Confidence 9999998876554 55679999999998853 46788999999999999999999999532110
Q ss_pred cccccccccchhcCCCcCC--CCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH--HHhhhhcCC
Q 020641 254 TPRLSEDKVKQCVDPKLKG--EYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK--ALQPLLKSP 314 (323)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~--~l~~~~~~~ 314 (323)
.++..+.+....- +-=.+.+....++|.+||+.||.+|.|++|+++ ++.+++.+.
T Consensus 235 ------lMLR~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~~~~~ 293 (411)
T KOG0599|consen 235 ------LMLRMIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQIAQQQ 293 (411)
T ss_pred ------HHHHHHHhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHHHHhc
Confidence 1111222222221 112455678999999999999999999999986 455554433
|
|
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=300.65 Aligned_cols=243 Identities=18% Similarity=0.191 Sum_probs=190.1
Q ss_pred ccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHH-HHHhcCCCCcccceeeEEEeCCeEE
Q 020641 22 RLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLV-SVVSRLKHENLVELLGYCVEGNLRV 100 (323)
Q Consensus 22 ~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~-~~l~~l~h~~i~~~~~~~~~~~~~~ 100 (323)
.||+|+||.||+|++..+++.+|+|++.+..... ......+..|. .+++.++|+||+++++++...+..+
T Consensus 2 ~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~---------~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~ 72 (325)
T cd05602 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILK---------KKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLY 72 (325)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHh---------hhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEE
Confidence 5899999999999999999999999776432111 11112333333 4567789999999999999999999
Q ss_pred EEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEEEeec
Q 020641 101 LAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADF 180 (323)
Q Consensus 101 lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~l~Df 180 (323)
+||||+.+++|.+++..... ++...+..++.||+.||.|||+. |++||||||+||+++.++.++|+||
T Consensus 73 lv~e~~~~~~L~~~~~~~~~---------~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~Df 140 (325)
T cd05602 73 FVLDYINGGELFYHLQRERC---------FLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDF 140 (325)
T ss_pred EEEeCCCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccC
Confidence 99999999999999976432 77888899999999999999999 9999999999999999999999999
Q ss_pred cccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhccccccc
Q 020641 181 NLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSED 260 (323)
Q Consensus 181 g~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 260 (323)
|++........ ......|++.|+|||++.+..++.++|||||||++|+|++|..||.........
T Consensus 141 G~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~------------- 205 (325)
T cd05602 141 GLCKENIEHNG--TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMY------------- 205 (325)
T ss_pred CCCcccccCCC--CcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHH-------------
Confidence 99865332111 123445899999999999989999999999999999999999999754321110
Q ss_pred ccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHH
Q 020641 261 KVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVV 304 (323)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl 304 (323)
....... .......+..+.+++.+||+.||.+||++.+.+
T Consensus 206 --~~i~~~~--~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~ 245 (325)
T cd05602 206 --DNILNKP--LQLKPNITNSARHLLEGLLQKDRTKRLGAKDDF 245 (325)
T ss_pred --HHHHhCC--cCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCH
Confidence 0111110 112234556799999999999999999887433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=284.58 Aligned_cols=263 Identities=20% Similarity=0.243 Sum_probs=206.9
Q ss_pred CCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEe
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVE 95 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 95 (323)
+|.....||.|++|.||++.+..+++.+++|....... ......+.+.+|++++++++|+|++++++.+..
T Consensus 3 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---------~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~ 73 (267)
T cd08224 3 NFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEM---------MDAKARQDCLKEIDLLKQLDHPNVIKYLASFIE 73 (267)
T ss_pred ceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccc---------cchhhHHHHHHHHHHHHhCCCCCeeeeeeeeec
Confidence 45667789999999999999998899888886542111 112234678899999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeE
Q 020641 96 GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKA 175 (323)
Q Consensus 96 ~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~ 175 (323)
.+..+++|||+.+++|.+++...... ...++...+..++.+++.|+.+||+. |++|+||+|+||+++.++.+
T Consensus 74 ~~~~~lv~e~~~~~~L~~~l~~~~~~-----~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~ 145 (267)
T cd08224 74 NNELNIVLELADAGDLSRMIKHFKKQ-----KRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVV 145 (267)
T ss_pred CCeEEEEEecCCCCCHHHHHHHhccc-----CCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcE
Confidence 99999999999999999998653211 11288899999999999999999999 99999999999999999999
Q ss_pred EEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhcc
Q 020641 176 KIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATP 255 (323)
Q Consensus 176 ~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~ 255 (323)
+|+|||.+........ ......++..|.|||.+.+..++.++|+||||+++|+|++|..||........
T Consensus 146 ~l~d~~~~~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--------- 214 (267)
T cd08224 146 KLGDLGLGRFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY--------- 214 (267)
T ss_pred EEeccceeeeccCCCc--ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHH---------
Confidence 9999998865443221 11223478889999999888899999999999999999999999964431100
Q ss_pred cccccccchhcCCCcCCCCCH-HHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhh
Q 020641 256 RLSEDKVKQCVDPKLKGEYPP-KGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLL 311 (323)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~-~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~ 311 (323)
.+.+.+........+. ..+..+.+++.+||..+|++|||+.+|++.|+++.
T Consensus 215 -----~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 215 -----SLCKKIEKCDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred -----HHHhhhhcCCCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 0001111111112222 45668999999999999999999999999998863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-41 Score=293.90 Aligned_cols=270 Identities=19% Similarity=0.262 Sum_probs=200.7
Q ss_pred CCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEe
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVE 95 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 95 (323)
.|....+||+|+||.||++.+..+++.+++|...... .......+.+|++++++++|+||+++++++..
T Consensus 7 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 75 (309)
T cd07872 7 TYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEH-----------EEGAPCTAIREVSLLKDLKHANIVTLHDIVHT 75 (309)
T ss_pred ceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccc-----------cCCcchhHHHHHHHHHhCCCCCcceEEEEEee
Confidence 4666679999999999999999999999998664221 11223456789999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeE
Q 020641 96 GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKA 175 (323)
Q Consensus 96 ~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~ 175 (323)
++..++||||+.+ +|.+++..... .++...+..++.|++.||.|||+. |++||||||+||+++.++.+
T Consensus 76 ~~~~~lv~e~~~~-~l~~~~~~~~~--------~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~ 143 (309)
T cd07872 76 DKSLTLVFEYLDK-DLKQYMDDCGN--------IMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGEL 143 (309)
T ss_pred CCeEEEEEeCCCC-CHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCE
Confidence 9999999999986 88888865432 278889999999999999999999 99999999999999999999
Q ss_pred EEeeccccCCCCccccccccccccCccccCCCccccC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhc
Q 020641 176 KIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT-GQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWAT 254 (323)
Q Consensus 176 ~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~ 254 (323)
+|+|||++........ ......+++.|+|||.+.+ ..++.++||||||+++|+|++|+.||................
T Consensus 144 kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~ 221 (309)
T cd07872 144 KLADFGLARAKSVPTK--TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLL 221 (309)
T ss_pred EECccccceecCCCcc--ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Confidence 9999999865433221 1123347889999998865 457889999999999999999999997654322211111110
Q ss_pred ccccccccchh---------cCCCcC----CCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH--HHhhh
Q 020641 255 PRLSEDKVKQC---------VDPKLK----GEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK--ALQPL 310 (323)
Q Consensus 255 ~~~~~~~~~~~---------~~~~~~----~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~--~l~~~ 310 (323)
..........+ -.+... .......+.++.+++.+||+.||.+|||+.|+++ +++.+
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~ 292 (309)
T cd07872 222 GTPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSL 292 (309)
T ss_pred CCCCHHHHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhc
Confidence 00000000000 000000 0011234567899999999999999999999998 44443
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=303.78 Aligned_cols=254 Identities=15% Similarity=0.174 Sum_probs=198.9
Q ss_pred CCCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEE
Q 020641 15 PSPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCV 94 (323)
Q Consensus 15 ~~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 94 (323)
..|....+||+|+||.||++++..+++.+|+|+..+.... .......+.+|+.+++.++||||+++++++.
T Consensus 43 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~---------~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~ 113 (370)
T cd05621 43 EDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMI---------KRSDSAFFWEERDIMAFANSPWVVQLFCAFQ 113 (370)
T ss_pred HHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhh---------hhhhHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence 4566777899999999999999999999999977542211 1112355778999999999999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCe
Q 020641 95 EGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFK 174 (323)
Q Consensus 95 ~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~ 174 (323)
.+...|+||||+.+|+|.+++.... ++...+..++.||+.||.|||+. ||+||||||+||+++.++.
T Consensus 114 ~~~~~~lv~Ey~~gg~L~~~l~~~~----------~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~ 180 (370)
T cd05621 114 DDKYLYMVMEYMPGGDLVNLMSNYD----------VPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGH 180 (370)
T ss_pred cCCEEEEEEcCCCCCcHHHHHHhcC----------CCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCC
Confidence 9999999999999999999996542 78889999999999999999999 9999999999999999999
Q ss_pred EEEeeccccCCCCccccccccccccCccccCCCccccCCC----CCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhh
Q 020641 175 AKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQ----LTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLV 250 (323)
Q Consensus 175 ~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~----~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~ 250 (323)
++|+|||++........ .......||+.|+|||++.+.. ++.++|+|||||++|+|++|..||........
T Consensus 181 ~kL~DFG~a~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~---- 255 (370)
T cd05621 181 LKLADFGTCMKMDETGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGT---- 255 (370)
T ss_pred EEEEecccceecccCCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHH----
Confidence 99999999876532211 1123445899999999986543 67899999999999999999999975532111
Q ss_pred hhhcccccccccchhcCCC--cCCCCCHHHHHHHHHHHHHccCCCCCC--CCChHHHHHH
Q 020641 251 TWATPRLSEDKVKQCVDPK--LKGEYPPKGVAKLAAVAALCVQYEAEF--RPNMSIVVKA 306 (323)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~cl~~~P~~--Rps~~evl~~ 306 (323)
..++.+.. .........+..+.+++.+||..++.. |+|+.|+++.
T Consensus 256 -----------~~~i~~~~~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 256 -----------YSKIMDHKNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred -----------HHHHHhCCcccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 11111111 111111234667899999999855543 8899999884
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=284.15 Aligned_cols=257 Identities=29% Similarity=0.384 Sum_probs=203.5
Q ss_pred ccCCCCCCccceecccee---eeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeCCe
Q 020641 22 RLDKGPEDDLYLKKRVKM---RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNL 98 (323)
Q Consensus 22 ~lg~G~~~~V~~~~~~~~---~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 98 (323)
.||+|+||.||++.+... +..+++|....... ....+.+.+|++.++.++|+||+++++++.....
T Consensus 2 ~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~-----------~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~ 70 (262)
T cd00192 2 KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDAS-----------EEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEP 70 (262)
T ss_pred ccccCCceEEEEEEEecCCCCCceEEeEeeccccc-----------hhHHHHHHHHHHHHhhcCCCChheeeeeecCCCc
Confidence 589999999999999876 77788876543211 1124678899999999999999999999999999
Q ss_pred EEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEEEe
Q 020641 99 RVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIA 178 (323)
Q Consensus 99 ~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~l~ 178 (323)
.+++|||+.+++|.+++..............+++..++.++.|++.|+.+||++ |++|+||+|+||+++.++.++|+
T Consensus 71 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~ 147 (262)
T cd00192 71 LYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKIS 147 (262)
T ss_pred eEEEEEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEc
Confidence 999999999999999998753211011112389999999999999999999999 99999999999999999999999
Q ss_pred eccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccc
Q 020641 179 DFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPRL 257 (323)
Q Consensus 179 Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~ 257 (323)
|||.+................++..|+|||.+....++.++||||||+++|+|++ |..||.......
T Consensus 148 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~------------ 215 (262)
T cd00192 148 DFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEE------------ 215 (262)
T ss_pred ccccccccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHH------------
Confidence 9999987654332222333446888999999988888999999999999999999 699997652211
Q ss_pred cccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHh
Q 020641 258 SEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQ 308 (323)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~ 308 (323)
+.+.+........+...+.++.+++.+||+.+|.+|||+.|+++.|+
T Consensus 216 ----~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 216 ----VLEYLRKGYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred ----HHHHHHcCCCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 11111111122334455778999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-41 Score=292.84 Aligned_cols=268 Identities=25% Similarity=0.346 Sum_probs=203.2
Q ss_pred CCccccccCCCCCCccceecccee-------eeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcC-CCCccc
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRVKM-------RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRL-KHENLV 87 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~~~-------~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~ 87 (323)
.+....+||+|+||.||++++... ...+++|...... .......+.+|+++++.+ +|+||+
T Consensus 19 ~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~-----------~~~~~~~~~~e~~~l~~l~~h~~i~ 87 (307)
T cd05098 19 RLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA-----------TEKDLSDLISEMEMMKMIGKHKNII 87 (307)
T ss_pred HeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC-----------ChHHHHHHHHHHHHHHHhcCCCCEe
Confidence 344555999999999999986532 2346666543210 011235677899999999 899999
Q ss_pred ceeeEEEeCCeEEEEEeecCCCCHHHHhccCCCCC-------CCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeC
Q 020641 88 ELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQ-------GAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHR 160 (323)
Q Consensus 88 ~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~ 160 (323)
++++++......++||||+.+++|.+++....... .......+++..+..++.|++.||.|||+. |++|+
T Consensus 88 ~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~ 164 (307)
T cd05098 88 NLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHR 164 (307)
T ss_pred eEEEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---Ccccc
Confidence 99999999999999999999999999997653211 011222488899999999999999999999 99999
Q ss_pred CCCCCCEEEccCCeEEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHh-CCCCCC
Q 020641 161 DIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVD 239 (323)
Q Consensus 161 dikp~nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~ 239 (323)
||||+||+++.++.++|+|||.+................++..|+|||.+.+..++.++|+||||+++|+|++ |..||.
T Consensus 165 dlkp~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~ 244 (307)
T cd05098 165 DLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYP 244 (307)
T ss_pred cccHHheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCC
Confidence 9999999999999999999999876543221111122224568999999988889999999999999999998 888986
Q ss_pred CCCCcccchhhhhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhhcC
Q 020641 240 HTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKS 313 (323)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~~~ 313 (323)
..... .+...+........+...+.++.+++.+||..+|++|||+.++++.|++++..
T Consensus 245 ~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~ 302 (307)
T cd05098 245 GVPVE----------------ELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILAL 302 (307)
T ss_pred cCCHH----------------HHHHHHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHH
Confidence 44221 11111111112233345567899999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=284.58 Aligned_cols=250 Identities=25% Similarity=0.356 Sum_probs=195.7
Q ss_pred ccCCCCCCccceeccceee---eeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeCCe
Q 020641 22 RLDKGPEDDLYLKKRVKMR---RWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNL 98 (323)
Q Consensus 22 ~lg~G~~~~V~~~~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 98 (323)
+||+|+||.||+++....+ ..+++|........ ...+.+.+|+++++.++|+||+++++++. ...
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~-----------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~ 69 (257)
T cd05060 2 ELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA-----------AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEP 69 (257)
T ss_pred ccCccCceeEEEeEeeccCCCcceEEEEecccccch-----------HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCc
Confidence 6899999999999876655 67777755432111 23367888999999999999999999876 446
Q ss_pred EEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEEEe
Q 020641 99 RVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIA 178 (323)
Q Consensus 99 ~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~l~ 178 (323)
.++||||+.+++|.+++..... +++..+..++.|++.|+.+||.. +++|+||||+||+++.++.++|+
T Consensus 70 ~~~v~e~~~~~~L~~~l~~~~~---------~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~ 137 (257)
T cd05060 70 LMLVMELAPLGPLLKYLKKRRE---------IPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKIS 137 (257)
T ss_pred eEEEEEeCCCCcHHHHHHhCCC---------CCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEec
Confidence 7999999999999999976542 88999999999999999999999 99999999999999999999999
Q ss_pred eccccCCCCcccccc-ccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhccc
Q 020641 179 DFNLSNQAPDMAARL-HSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPR 256 (323)
Q Consensus 179 Dfg~~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~ 256 (323)
|||.+.......... ......++..|+|||.+.+..++.++||||||+++|++++ |..||....... ....
T Consensus 138 df~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~---~~~~---- 210 (257)
T cd05060 138 DFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAE---VIAM---- 210 (257)
T ss_pred cccccceeecCCcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHH---HHHH----
Confidence 999987554322211 1111223467999999988889999999999999999998 999997543211 1111
Q ss_pred ccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhh
Q 020641 257 LSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLL 311 (323)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~ 311 (323)
+........+...+..+.+++.+||..+|++|||+.++++.|+++.
T Consensus 211 ---------~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 211 ---------LESGERLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred ---------HHcCCcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 1111111233445567999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=284.31 Aligned_cols=252 Identities=27% Similarity=0.389 Sum_probs=196.3
Q ss_pred CCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEe
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVE 95 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 95 (323)
.++...+||+|++|.||++.+..+ ..+++|..... ....+.+.+|+.++++++|+|++++++++..
T Consensus 7 ~~~~~~~ig~g~~~~v~~~~~~~~-~~~~~k~~~~~-------------~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~ 72 (260)
T cd05070 7 SLQLIKKLGNGQFGEVWMGTWNGN-TKVAVKTLKPG-------------TMSPESFLEEAQIMKKLRHDKLVQLYAVVSE 72 (260)
T ss_pred HhhhhheeccccCceEEEEEecCC-ceeEEEEecCC-------------CCCHHHHHHHHHHHHhcCCCceEEEEeEECC
Confidence 356667999999999999987644 44666654421 1123568899999999999999999998754
Q ss_pred CCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeE
Q 020641 96 GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKA 175 (323)
Q Consensus 96 ~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~ 175 (323)
...+++|||+.+++|.+++...... .+++..+..++.|++.|+.|||+. |++|+||+|+||++++++.+
T Consensus 73 -~~~~lv~e~~~~~~L~~~~~~~~~~-------~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~ 141 (260)
T cd05070 73 -EPIYIVTEYMSKGSLLDFLKDGEGR-------ALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVC 141 (260)
T ss_pred -CCcEEEEEecCCCcHHHHHHhcCCC-------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceE
Confidence 4578999999999999999764322 288999999999999999999999 99999999999999999999
Q ss_pred EEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhc
Q 020641 176 KIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWAT 254 (323)
Q Consensus 176 ~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~ 254 (323)
+|+|||.+......... ......++..|+|||...+..++.++|+||||+++|+|++ |..||.......
T Consensus 142 ~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~--------- 211 (260)
T cd05070 142 KIADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNRE--------- 211 (260)
T ss_pred EeCCceeeeeccCcccc-cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHH---------
Confidence 99999998755432211 1112234567999999888889999999999999999999 899996543211
Q ss_pred ccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhh
Q 020641 255 PRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQP 309 (323)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~ 309 (323)
....+........+...+..+.+++.+||..+|++|||+.++.++|++
T Consensus 212 -------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 212 -------VLEQVERGYRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred -------HHHHHHcCCCCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 111111111222344556789999999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=282.86 Aligned_cols=249 Identities=25% Similarity=0.374 Sum_probs=197.6
Q ss_pred ccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeCCeEEE
Q 020641 22 RLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVL 101 (323)
Q Consensus 22 ~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 101 (323)
+||.|++|.||++.+.. ++.+++|........ .....+.+|++++++++|+||+++++++......++
T Consensus 2 ~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~-----------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 69 (251)
T cd05041 2 KIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPP-----------DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYI 69 (251)
T ss_pred ccccCCCceEEEEEEeC-CCcEEEEeccccCCH-----------HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEE
Confidence 68999999999999887 888888865432111 123678899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEEEeecc
Q 020641 102 AYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFN 181 (323)
Q Consensus 102 v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~l~Dfg 181 (323)
|+||+.+++|.+++...... ++...+..++.+++.++.+||++ +++|+||+|+||+++.++.++|+|||
T Consensus 70 v~e~~~~~~l~~~l~~~~~~--------~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g 138 (251)
T cd05041 70 VMELVPGGSLLTFLRKKKNR--------LTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFG 138 (251)
T ss_pred EEEcCCCCcHHHHHHhcCCC--------CCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeecc
Confidence 99999999999998654321 78889999999999999999999 99999999999999999999999999
Q ss_pred ccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhccccccc
Q 020641 182 LSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPRLSED 260 (323)
Q Consensus 182 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 260 (323)
.+................++..|+|||.+.+..++.++|+||||+++|+|++ |..||........
T Consensus 139 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~-------------- 204 (251)
T cd05041 139 MSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQT-------------- 204 (251)
T ss_pred ccccccCCcceeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHH--------------
Confidence 9875542221111112223567999999988889999999999999999999 8888865432111
Q ss_pred ccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhh
Q 020641 261 KVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQP 309 (323)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~ 309 (323)
...+........+...+..+.+++.+||+.+|++|||+.|+++.|+.
T Consensus 205 --~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~~ 251 (251)
T cd05041 205 --RERIESGYRMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQI 251 (251)
T ss_pred --HHHHhcCCCCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhhC
Confidence 11111111122334456789999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=286.39 Aligned_cols=259 Identities=23% Similarity=0.277 Sum_probs=195.3
Q ss_pred cccCCCCCCccceeccceeee--eeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeC--
Q 020641 21 VRLDKGPEDDLYLKKRVKMRR--WLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEG-- 96 (323)
Q Consensus 21 ~~lg~G~~~~V~~~~~~~~~~--~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-- 96 (323)
.+||+|+||.||++++..++. .+++|...... ......+.+.+|+.+++.++|+||+++++.+...
T Consensus 5 ~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~----------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 74 (272)
T cd05075 5 KTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAI----------CTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVE 74 (272)
T ss_pred cccCcccCceEEEeEEccCCCeeeEEEEecccCc----------CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCc
Confidence 479999999999999877665 46766443211 1122246778899999999999999999987432
Q ss_pred ----CeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccC
Q 020641 97 ----NLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFED 172 (323)
Q Consensus 97 ----~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~ 172 (323)
...++++||+.+|+|.+++...... .....+++..+..++.|++.|+.|||+. +++|+||||+||+++.+
T Consensus 75 ~~~~~~~~~v~e~~~~~~l~~~~~~~~~~---~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~ 148 (272)
T cd05075 75 SEGYPSPVVILPFMKHGDLHSFLLYSRLG---DCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNEN 148 (272)
T ss_pred ccCCCCcEEEEEeCCCCcHHHHHHHhccc---CCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCC
Confidence 2468999999999999988533211 0112388999999999999999999999 99999999999999999
Q ss_pred CeEEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccchhhh
Q 020641 173 FKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVT 251 (323)
Q Consensus 173 ~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~ 251 (323)
+.++|+|||++................+++.|++||...+..++.++||||||+++|+|++ |..||..........
T Consensus 149 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~--- 225 (272)
T cd05075 149 MNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYD--- 225 (272)
T ss_pred CCEEECCCCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH---
Confidence 9999999999876543322111122235678999999988889999999999999999999 889997543211100
Q ss_pred hhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhh
Q 020641 252 WATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLL 311 (323)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~ 311 (323)
.+........+...+..+.+++.+||+.||++|||+.+|++.|++++
T Consensus 226 -------------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 272 (272)
T cd05075 226 -------------YLRQGNRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKAL 272 (272)
T ss_pred -------------HHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence 00000011122344567999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=287.17 Aligned_cols=260 Identities=23% Similarity=0.334 Sum_probs=202.7
Q ss_pred CccccccCCCCCCccceeccceeee----eeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeE
Q 020641 17 PGYFVRLDKGPEDDLYLKKRVKMRR----WLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGY 92 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~~~~~~~----~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 92 (323)
+....+||+|+||.||++.+..+++ .+++|....... ......+.+|+.++++++|+||++++++
T Consensus 9 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~-----------~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 77 (279)
T cd05057 9 LEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS-----------PKANKEILDEAYVMASVDHPHVVRLLGI 77 (279)
T ss_pred cEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC-----------HHHHHHHHHHHHHHHhCCCCCcceEEEE
Confidence 4555689999999999999876654 356664432211 2223667889999999999999999999
Q ss_pred EEeCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccC
Q 020641 93 CVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFED 172 (323)
Q Consensus 93 ~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~ 172 (323)
+.. ...++++||+.+++|.+++...... +++..+..++.|++.|+.|||+. |++|+||+|+||+++.+
T Consensus 78 ~~~-~~~~~v~e~~~~g~L~~~l~~~~~~--------~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~ 145 (279)
T cd05057 78 CLS-SQVQLITQLMPLGCLLDYVRNHKDN--------IGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTP 145 (279)
T ss_pred Eec-CceEEEEecCCCCcHHHHHHhccCC--------CCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCC
Confidence 887 6789999999999999999765332 88999999999999999999999 99999999999999999
Q ss_pred CeEEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccchhhh
Q 020641 173 FKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVT 251 (323)
Q Consensus 173 ~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~ 251 (323)
+.++|+|||.+................++..|+|||.+....++.++|+||||+++|++++ |..||.......
T Consensus 146 ~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~------ 219 (279)
T cd05057 146 QHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE------ 219 (279)
T ss_pred CeEEECCCcccccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHH------
Confidence 9999999999876553322211122223567999999888888999999999999999998 999997543211
Q ss_pred hhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhhcCCC
Q 020641 252 WATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSPP 315 (323)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~~~~~ 315 (323)
+.+.+........+..++..+.+++.+||..+|..|||+.++++.|.++.+.++
T Consensus 220 ----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~~~ 273 (279)
T cd05057 220 ----------IPDLLEKGERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARDPQ 273 (279)
T ss_pred ----------HHHHHhCCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhCCc
Confidence 111111111122233345679999999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=283.71 Aligned_cols=247 Identities=23% Similarity=0.314 Sum_probs=210.7
Q ss_pred ccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeCC
Q 020641 18 GYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGN 97 (323)
Q Consensus 18 ~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 97 (323)
..+.|||+|+||+||+|.+..+|..+|+|.... +...+++..|+.++++|+.++++++++.+....
T Consensus 36 Di~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV--------------~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~s 101 (502)
T KOG0574|consen 36 DIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV--------------DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHS 101 (502)
T ss_pred HHHHHhcCCcchHHHHHHHhccCcEEEEEecCc--------------cchHHHHHHHHHHHHHcCCchhhhhhhhhccCC
Confidence 344599999999999999999999999985542 233477889999999999999999999999999
Q ss_pred eEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEEE
Q 020641 98 LRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKI 177 (323)
Q Consensus 98 ~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~l 177 (323)
.+|+|||||..|++.|.++.+... +++..+..+++..++||.|||.. .-+|||||..|||++.+|..||
T Consensus 102 DLWIVMEYCGAGSiSDI~R~R~K~--------L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKL 170 (502)
T KOG0574|consen 102 DLWIVMEYCGAGSISDIMRARRKP--------LSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKL 170 (502)
T ss_pred ceEeehhhcCCCcHHHHHHHhcCC--------ccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhh
Confidence 999999999999999999876543 99999999999999999999999 9999999999999999999999
Q ss_pred eeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccc
Q 020641 178 ADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRL 257 (323)
Q Consensus 178 ~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 257 (323)
.|||.+..+...... .....||+.|+|||++..-.|+.++||||||++..||..|++||.+..+...-. +.+..
T Consensus 171 ADFGVAGQLTDTMAK--RNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIF----MIPT~ 244 (502)
T KOG0574|consen 171 ADFGVAGQLTDTMAK--RNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIF----MIPTK 244 (502)
T ss_pred hhccccchhhhhHHh--hCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeE----eccCC
Confidence 999999887664433 355679999999999999999999999999999999999999998665422111 11111
Q ss_pred cccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 258 SEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
+..-...|..++.++.+|+++||-++|++|-|+.++++
T Consensus 245 ----------PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~ 282 (502)
T KOG0574|consen 245 ----------PPPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCE 282 (502)
T ss_pred ----------CCCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence 11112346788899999999999999999999999886
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-41 Score=284.85 Aligned_cols=250 Identities=24% Similarity=0.320 Sum_probs=194.6
Q ss_pred CccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeC
Q 020641 17 PGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEG 96 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 96 (323)
+....+||+|+||.||+++.... ..+++|...... ...+.+.+|+.++++++||||+++++++...
T Consensus 6 ~~~~~~lg~G~~~~vy~~~~~~~-~~~aik~~~~~~-------------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 71 (256)
T cd05113 6 LTFLKELGTGQFGVVKYGKWRGQ-YDVAIKMIKEGS-------------MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQ 71 (256)
T ss_pred eEEeeEecCcccceEEEEEecCC-CcEEEEEcCCCc-------------ccHHHHHHHHHHHhcCCCCCeeeEEEEEccC
Confidence 45666899999999999976543 346666443211 1135688999999999999999999999988
Q ss_pred CeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEE
Q 020641 97 NLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAK 176 (323)
Q Consensus 97 ~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~ 176 (323)
...+++|||+.+++|.+++...... +++..++.++.|++.|+.|||+. |++|+||+|+||+++.++.++
T Consensus 72 ~~~~lv~e~~~~~~l~~~i~~~~~~--------~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~k 140 (256)
T cd05113 72 RPIYIVTEYMSNGCLLNYLREHGKR--------FQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVK 140 (256)
T ss_pred CCcEEEEEcCCCCcHHHHHHhcCCC--------CCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEE
Confidence 8899999999999999999764321 88999999999999999999999 999999999999999999999
Q ss_pred EeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcc
Q 020641 177 IADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATP 255 (323)
Q Consensus 177 l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~ 255 (323)
|+|||.+......... ......++..|++||...+..++.++||||||+++|+|++ |..||.........
T Consensus 141 l~d~g~~~~~~~~~~~-~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~-------- 211 (256)
T cd05113 141 VSDFGLSRYVLDDEYT-SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETV-------- 211 (256)
T ss_pred ECCCccceecCCCcee-ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHH--------
Confidence 9999988754332211 1122235667999999988889999999999999999998 99998654321110
Q ss_pred cccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHh
Q 020641 256 RLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQ 308 (323)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~ 308 (323)
..+........+...+..+.+++.+||+.+|.+|||+.+|++.|+
T Consensus 212 --------~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 212 --------EKVSQGLRLYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred --------HHHhcCCCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 001111111112234567999999999999999999999998774
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=299.78 Aligned_cols=262 Identities=24% Similarity=0.363 Sum_probs=201.2
Q ss_pred cccCCCCCCccceeccc-----eeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCC-CCcccceeeEEE
Q 020641 21 VRLDKGPEDDLYLKKRV-----KMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLK-HENLVELLGYCV 94 (323)
Q Consensus 21 ~~lg~G~~~~V~~~~~~-----~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~ 94 (323)
.+||+|+||.||++++. ..++.+|+|++.... .....+.+.+|++++.++. |+||+++++++.
T Consensus 43 ~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~-----------~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~ 111 (401)
T cd05107 43 RTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA-----------RSSEKQALMSELKIMSHLGPHLNIVNLLGACT 111 (401)
T ss_pred hhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC-----------ChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc
Confidence 48999999999999853 345678888664221 1112356889999999996 999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHhccCCCCC----------------------------------------------------
Q 020641 95 EGNLRVLAYEFATMGSLHDILHGRKGVQ---------------------------------------------------- 122 (323)
Q Consensus 95 ~~~~~~lv~e~~~~~sL~~~~~~~~~~~---------------------------------------------------- 122 (323)
.....++|+||+.+|+|.+++.......
T Consensus 112 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (401)
T cd05107 112 KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVP 191 (401)
T ss_pred cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccc
Confidence 9999999999999999999997543110
Q ss_pred -------------------------------------CCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCC
Q 020641 123 -------------------------------------GAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSS 165 (323)
Q Consensus 123 -------------------------------------~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~ 165 (323)
.......+++..+..++.|++.||.|||+. +++|+||||+
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~ 268 (401)
T cd05107 192 MQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAAR 268 (401)
T ss_pred hhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcc
Confidence 001123478888999999999999999999 9999999999
Q ss_pred CEEEccCCeEEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCc
Q 020641 166 NVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPR 244 (323)
Q Consensus 166 nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~ 244 (323)
||+++.++.++|+|||++................++..|+|||.+.+..++.++||||||+++|+|++ |..||......
T Consensus 269 NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~ 348 (401)
T cd05107 269 NVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMN 348 (401)
T ss_pred eEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCch
Confidence 99999999999999999875433222111223346778999999988889999999999999999998 89998644221
Q ss_pred ccchhhhhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhh
Q 020641 245 GQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLL 311 (323)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~ 311 (323)
. .....+....+...+...+.++.+++.+||..+|.+||++.+|++.|++++
T Consensus 349 ~---------------~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 349 E---------------QFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred H---------------HHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 1 111111111122233445678999999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=284.00 Aligned_cols=249 Identities=25% Similarity=0.330 Sum_probs=195.9
Q ss_pred CccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeC
Q 020641 17 PGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEG 96 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 96 (323)
+.....||+|+||.||++.+. ++..+++|...... .....+.+|+++++.++|+||+++++++...
T Consensus 6 ~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~-------------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (256)
T cd05059 6 LTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGA-------------MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQ 71 (256)
T ss_pred cchhhhhccCCCceEEEeEec-CCccEEEEEeccCC-------------CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCC
Confidence 455668999999999999875 45566777543211 1125678899999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEE
Q 020641 97 NLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAK 176 (323)
Q Consensus 97 ~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~ 176 (323)
...++||||+.+++|.+++...... +++..+..++.|++.|+.+||+. |++|+||||+||+++.++.++
T Consensus 72 ~~~~lv~e~~~~~~L~~~l~~~~~~--------~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~k 140 (256)
T cd05059 72 RPIFIVTEYMANGCLLNYLRERKGK--------LGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVK 140 (256)
T ss_pred CceEEEEecCCCCCHHHHHHhcccC--------CCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEE
Confidence 9999999999999999999754322 88999999999999999999999 999999999999999999999
Q ss_pred EeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcc
Q 020641 177 IADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATP 255 (323)
Q Consensus 177 l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~ 255 (323)
|+|||.+......... ......++..|+|||.+.+..++.++|+||||+++|++++ |..||.........
T Consensus 141 l~dfg~~~~~~~~~~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~-------- 211 (256)
T cd05059 141 VSDFGLARYVLDDQYT-SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVV-------- 211 (256)
T ss_pred ECCcccceeccccccc-ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHH--------
Confidence 9999988755432111 1111223457999999988889999999999999999998 89999754321111
Q ss_pred cccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHH
Q 020641 256 RLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKAL 307 (323)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l 307 (323)
..+........+...+..+.+++.+||+.+|++|||+.|+++.|
T Consensus 212 --------~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 212 --------ESVSAGYRLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred --------HHHHcCCcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 11111111222334567899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=297.72 Aligned_cols=246 Identities=20% Similarity=0.215 Sum_probs=193.4
Q ss_pred ccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcC-CCCcccceeeEEEeCCeEE
Q 020641 22 RLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRL-KHENLVELLGYCVEGNLRV 100 (323)
Q Consensus 22 ~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~ 100 (323)
.||+|+||.||++++..+++.+|+|+..++.... ....+.+.+|..++.++ .|+||+.+++++...+..+
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~---------~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~ 72 (327)
T cd05617 2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHD---------DEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLF 72 (327)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhh---------hhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEE
Confidence 5899999999999999999999999876442211 12235677888988888 7999999999999999999
Q ss_pred EEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEEEeec
Q 020641 101 LAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADF 180 (323)
Q Consensus 101 lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~l~Df 180 (323)
+||||+.+++|.+++..... +++..+..++.|++.||.|||+. |++||||||+||+++.++.++|+||
T Consensus 73 lv~e~~~~~~L~~~~~~~~~---------l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Df 140 (327)
T cd05617 73 LVIEYVNGGDLMFHMQRQRK---------LPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDY 140 (327)
T ss_pred EEEeCCCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEecc
Confidence 99999999999998865432 89999999999999999999999 9999999999999999999999999
Q ss_pred cccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhccccccc
Q 020641 181 NLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSED 260 (323)
Q Consensus 181 g~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 260 (323)
|++........ ......|++.|+|||.+.+..++.++||||||+++|+|++|..||...............
T Consensus 141 g~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~------- 211 (327)
T cd05617 141 GMCKEGLGPGD--TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYL------- 211 (327)
T ss_pred ccceeccCCCC--ceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHH-------
Confidence 98864322111 123345899999999999989999999999999999999999999643321111000000
Q ss_pred ccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCCh
Q 020641 261 KVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNM 300 (323)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~ 300 (323)
........ ...+...+..+.+++.+||+.||.+|+++
T Consensus 212 -~~~~~~~~--~~~p~~~~~~~~~li~~~L~~dP~~R~~~ 248 (327)
T cd05617 212 -FQVILEKP--IRIPRFLSVKASHVLKGFLNKDPKERLGC 248 (327)
T ss_pred -HHHHHhCC--CCCCCCCCHHHHHHHHHHhccCHHHcCCC
Confidence 00111111 12333455678999999999999999985
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=291.49 Aligned_cols=266 Identities=25% Similarity=0.319 Sum_probs=200.4
Q ss_pred CCccccccCCCCCCccceeccceeeee--eeeccccccccCccccccccCCCCCchHHHHHHHHHhcC-CCCcccceeeE
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRVKMRRW--LCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRL-KHENLVELLGY 92 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~~~~~~--~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~ 92 (323)
.+.+...||+|+||.||+|.+..++.. +++|.... .........+.+|++++.++ +|+||++++++
T Consensus 8 ~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~-----------~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~ 76 (303)
T cd05088 8 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKE-----------YASKDDHRDFAGELEVLCKLGHHPNIINLLGA 76 (303)
T ss_pred hceeeeeecCCCCceEEEEEEccCCceeeEEEEEecc-----------cCCHHHHHHHHHHHHHHHHhcCCCCcceEEEE
Confidence 455666899999999999998776643 34442211 01122235678899999999 89999999999
Q ss_pred EEeCCeEEEEEeecCCCCHHHHhccCCCCCCC-------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCC
Q 020641 93 CVEGNLRVLAYEFATMGSLHDILHGRKGVQGA-------QPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSS 165 (323)
Q Consensus 93 ~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~ 165 (323)
+...+..++||||+.+++|.+++......... .....+++..+..++.|++.|+.|||+. |++|+||||+
T Consensus 77 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~ 153 (303)
T cd05088 77 CEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAAR 153 (303)
T ss_pred ECCCCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---Cccccccchh
Confidence 99999999999999999999999755321100 1122488999999999999999999999 9999999999
Q ss_pred CEEEccCCeEEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCc
Q 020641 166 NVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPR 244 (323)
Q Consensus 166 nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~ 244 (323)
||+++.++.++|+|||++........ .....++..|+|||.+.+..++.++||||||+++|+|++ |..||......
T Consensus 154 Nili~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~ 230 (303)
T cd05088 154 NILVGENYVAKIADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA 230 (303)
T ss_pred eEEecCCCcEEeCccccCcccchhhh---cccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH
Confidence 99999999999999999864321111 111223567999999888888999999999999999998 99999644321
Q ss_pred ccchhhhhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhhcCC
Q 020641 245 GQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSP 314 (323)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~~~~ 314 (323)
.. . +.+........+...+..+.+++.+||+.+|++|||+.++++.|.+++..-
T Consensus 231 ~~---~-------------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~ 284 (303)
T cd05088 231 EL---Y-------------EKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 284 (303)
T ss_pred HH---H-------------HHHhcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 11 0 011111111122234567999999999999999999999999998887543
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=288.65 Aligned_cols=265 Identities=19% Similarity=0.237 Sum_probs=192.6
Q ss_pred CccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhc---CCCCcccceeeEE
Q 020641 17 PGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSR---LKHENLVELLGYC 93 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~---l~h~~i~~~~~~~ 93 (323)
|+...+||+|+||.||+|.+..+++.+++|........ ........+|+.+++. ++|+||+++++++
T Consensus 2 y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~----------~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~ 71 (288)
T cd07863 2 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNE----------DGLPLSTVREVALLKRLEAFDHPNIVRLMDVC 71 (288)
T ss_pred ceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCC----------CCCchHHHHHHHHHHHhhhcCCCCeeeeeeee
Confidence 55667899999999999999999999999966532111 1122344556666554 4799999999988
Q ss_pred Ee-----CCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEE
Q 020641 94 VE-----GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVL 168 (323)
Q Consensus 94 ~~-----~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nil 168 (323)
.. ....++++||+.+ +|.+++...... .+++..+..++.|++.||.|||+. |++|+||||+||+
T Consensus 72 ~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~-------~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nil 140 (288)
T cd07863 72 ATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPP-------GLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENIL 140 (288)
T ss_pred ccccCCCCceEEEEEccccc-CHHHHHHhcCCC-------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEE
Confidence 64 3457999999985 899988754322 288999999999999999999999 9999999999999
Q ss_pred EccCCeEEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccch
Q 020641 169 LFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQS 248 (323)
Q Consensus 169 i~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~ 248 (323)
++.++.++|+|||++........ .....++..|+|||.+.+..++.++|||||||++|+|++|..||..........
T Consensus 141 i~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~ 217 (288)
T cd07863 141 VTSGGQVKLADFGLARIYSCQMA---LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLG 217 (288)
T ss_pred ECCCCCEEECccCccccccCccc---CCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHH
Confidence 99999999999999876543221 123347889999999988889999999999999999999999997554321111
Q ss_pred hhhhhcccccccccchh-------cCCCc---CCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 249 LVTWATPRLSEDKVKQC-------VDPKL---KGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 249 ~~~~~~~~~~~~~~~~~-------~~~~~---~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
................. ..+.. ........+..+.+++.+||+.||++|||+.|++.
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 218 KIFDLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred HHHHHhCCCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 10000000000000000 00000 00111234567899999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=283.84 Aligned_cols=253 Identities=25% Similarity=0.353 Sum_probs=197.2
Q ss_pred CCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEe
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVE 95 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 95 (323)
.+++..+||+|+||.||+|.... ++.+++|..... ......+.+|+.++++++|+||+++++++..
T Consensus 7 ~~~~~~~ig~G~~g~v~~~~~~~-~~~~a~K~~~~~-------------~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 72 (260)
T cd05067 7 TLKLVKKLGAGQFGEVWMGYYNG-HTKVAIKSLKQG-------------SMSPEAFLAEANLMKQLQHPRLVRLYAVVTQ 72 (260)
T ss_pred HceeeeeeccCccceEEeeecCC-CceEEEEEecCC-------------CCcHHHHHHHHHHHHhcCCcCeeeEEEEEcc
Confidence 45667799999999999998654 455777754321 1123578899999999999999999998754
Q ss_pred CCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeE
Q 020641 96 GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKA 175 (323)
Q Consensus 96 ~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~ 175 (323)
...+++|||+.+++|.+++...... .+++..+..++.|++.||.|||+. |++|+||+|+||+++.++.+
T Consensus 73 -~~~~~v~e~~~~~~L~~~~~~~~~~-------~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~ 141 (260)
T cd05067 73 -EPIYIITEYMENGSLVDFLKTPEGI-------KLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCC 141 (260)
T ss_pred -CCcEEEEEcCCCCCHHHHHHhcCCC-------CCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCE
Confidence 4689999999999999998654322 288889999999999999999999 99999999999999999999
Q ss_pred EEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhc
Q 020641 176 KIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWAT 254 (323)
Q Consensus 176 ~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~ 254 (323)
+|+|||++......... ......++..|+|||.+.+..++.++||||||+++|++++ |+.||........
T Consensus 142 ~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~-------- 212 (260)
T cd05067 142 KIADFGLARLIEDNEYT-AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEV-------- 212 (260)
T ss_pred EEccCcceeecCCCCcc-cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHH--------
Confidence 99999998765422111 1122235678999999988888999999999999999998 9999975432111
Q ss_pred ccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhh
Q 020641 255 PRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPL 310 (323)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~ 310 (323)
...+........+...+.++.+++.+||+.+|++|||++++++.|+++
T Consensus 213 --------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 260 (260)
T cd05067 213 --------IQNLERGYRMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLEDF 260 (260)
T ss_pred --------HHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhcC
Confidence 111111111222334456799999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-42 Score=272.90 Aligned_cols=251 Identities=18% Similarity=0.201 Sum_probs=203.4
Q ss_pred CccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeC
Q 020641 17 PGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEG 96 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 96 (323)
|+...-||+|.|+.|+++.+..+++.+++|++..+.+... ..+++.+|+++.+.++||||+++.+.+.+.
T Consensus 13 y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~----------~~e~l~rEarIC~~LqHP~IvrL~~ti~~~ 82 (355)
T KOG0033|consen 13 YDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR----------DFQKLEREARICRKLQHPNIVRLHDSIQEE 82 (355)
T ss_pred hhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccc----------cHHHHHHHHHHHHhcCCCcEeehhhhhccc
Confidence 4455589999999999999999999999998876544433 447889999999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccC---C
Q 020641 97 NLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFED---F 173 (323)
Q Consensus 97 ~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~---~ 173 (323)
...|+|+|+++|++|..-+-.+. .+++..+.-.++||++++.|+|.+ ||+|||+||.|+++.+. -
T Consensus 83 ~~~ylvFe~m~G~dl~~eIV~R~---------~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A 150 (355)
T KOG0033|consen 83 SFHYLVFDLVTGGELFEDIVARE---------FYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGA 150 (355)
T ss_pred ceeEEEEecccchHHHHHHHHHH---------HHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCC
Confidence 99999999999999977765553 288888999999999999999999 99999999999999543 4
Q ss_pred eEEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhh
Q 020641 174 KAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWA 253 (323)
Q Consensus 174 ~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 253 (323)
-+||+|||+|.....+. .-....|||.|+|||++...+++..+|||+.|++||-|+.|..||.+.........+...
T Consensus 151 ~vKL~~FGvAi~l~~g~---~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g 227 (355)
T KOG0033|consen 151 AVKLADFGLAIEVNDGE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAG 227 (355)
T ss_pred ceeecccceEEEeCCcc---ccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhcc
Confidence 58999999998876332 234456999999999999999999999999999999999999999864321111111100
Q ss_pred cccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 254 TPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
.-. +....-+..++..++|+++||..||.+|+|+.|.++
T Consensus 228 ~yd-------------~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 228 AYD-------------YPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred ccC-------------CCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence 000 011122344567999999999999999999999875
|
|
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=288.36 Aligned_cols=272 Identities=22% Similarity=0.299 Sum_probs=198.5
Q ss_pred CCccccccCCCCCCccceec----cceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceee
Q 020641 16 SPGYFVRLDKGPEDDLYLKK----RVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLG 91 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~----~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~ 91 (323)
.+.....||+|+||.||.+. +..+++.+++|..... .....+.+.+|+++++.++|+||+++++
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~------------~~~~~~~~~~e~~~l~~l~h~~iv~~~~ 72 (284)
T cd05081 5 HLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS------------TAEHLRDFEREIEILKSLQHDNIVKYKG 72 (284)
T ss_pred cceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC------------CHHHHHHHHHHHHHHHhCCCCCeeEEEE
Confidence 45667789999999999987 4456777888754321 1112356789999999999999999999
Q ss_pred EEEe--CCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEE
Q 020641 92 YCVE--GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLL 169 (323)
Q Consensus 92 ~~~~--~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili 169 (323)
++.. ....++|+||+.+++|.+++...... +++..+..++.|++.||.|||+. |++|+||||+||++
T Consensus 73 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~--------l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili 141 (284)
T cd05081 73 VCYSAGRRNLRLVMEYLPYGSLRDYLQKHRER--------LDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILV 141 (284)
T ss_pred EEccCCCCceEEEEEecCCCCHHHHHHhcCcC--------CCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEE
Confidence 8754 34679999999999999999654322 88899999999999999999999 99999999999999
Q ss_pred ccCCeEEEeeccccCCCCccccccc-cccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccch
Q 020641 170 FEDFKAKIADFNLSNQAPDMAARLH-STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQS 248 (323)
Q Consensus 170 ~~~~~~~l~Dfg~~~~~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~ 248 (323)
+.++.++|+|||++........... .....++..|+|||.+.+..++.++||||||+++++|++|..++..........
T Consensus 142 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~ 221 (284)
T cd05081 142 ESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRM 221 (284)
T ss_pred CCCCeEEECCCcccccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhh
Confidence 9999999999999886543222111 111123446999999988889999999999999999999887764332110000
Q ss_pred hhhhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhh
Q 020641 249 LVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPL 310 (323)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~ 310 (323)
.............+.+.+........+...+..+.+++.+||..+|++|||+.||++.|+.+
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 222 MGNDKQGQMIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred cccccccccchHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 00000000000011112222222223345567899999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-41 Score=299.30 Aligned_cols=264 Identities=17% Similarity=0.180 Sum_probs=195.6
Q ss_pred CCCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEE
Q 020641 15 PSPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCV 94 (323)
Q Consensus 15 ~~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 94 (323)
..|.....||+|+||.||++.+..+++.+++|...... ........+.+|+.+++.++|+||+++++++.
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----------~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 86 (355)
T cd07874 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF----------QNQTHAKRAYRELVLMKCVNHKNIISLLNVFT 86 (355)
T ss_pred hceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcc----------cChHHHHHHHHHHHHHHHhCCCchhceeeeee
Confidence 45566678999999999999999999999998654321 11222356778999999999999999999886
Q ss_pred eC------CeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEE
Q 020641 95 EG------NLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVL 168 (323)
Q Consensus 95 ~~------~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nil 168 (323)
.. ...++||||+.+ ++.+.+... ++...+..++.|++.||.|||+. |++||||||+||+
T Consensus 87 ~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~-----------l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nil 151 (355)
T cd07874 87 PQKSLEEFQDVYLVMELMDA-NLCQVIQME-----------LDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIV 151 (355)
T ss_pred ccccccccceeEEEhhhhcc-cHHHHHhhc-----------CCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEE
Confidence 43 357999999976 777777532 78889999999999999999999 9999999999999
Q ss_pred EccCCeEEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccch
Q 020641 169 LFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQS 248 (323)
Q Consensus 169 i~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~ 248 (323)
++.++.++|+|||++........ .....|+..|+|||.+.+..++.++|||||||++|+|++|+.||..........
T Consensus 152 l~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~ 228 (355)
T cd07874 152 VKSDCTLKILDFGLARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWN 228 (355)
T ss_pred ECCCCCEEEeeCcccccCCCccc---cCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 99999999999999876543211 223457899999999998899999999999999999999999997654211100
Q ss_pred hhhh--------------------hc--ccccccccchhcCCCc---CCCCCHHHHHHHHHHHHHccCCCCCCCCChHHH
Q 020641 249 LVTW--------------------AT--PRLSEDKVKQCVDPKL---KGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIV 303 (323)
Q Consensus 249 ~~~~--------------------~~--~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev 303 (323)
.... .. ................ ........+..+.+++.+||..||++|||+.|+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~el 308 (355)
T cd07874 229 KVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEA 308 (355)
T ss_pred HHHHHhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHH
Confidence 0000 00 0000000000000000 001112234678999999999999999999999
Q ss_pred HHH
Q 020641 304 VKA 306 (323)
Q Consensus 304 l~~ 306 (323)
++.
T Consensus 309 l~h 311 (355)
T cd07874 309 LQH 311 (355)
T ss_pred hcC
Confidence 983
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=288.32 Aligned_cols=272 Identities=23% Similarity=0.327 Sum_probs=200.6
Q ss_pred CccccccCCCCCCccceecc----ceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeE
Q 020641 17 PGYFVRLDKGPEDDLYLKKR----VKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGY 92 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~~----~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 92 (323)
++.+.+||+|+||.||+++. ..+++.+++|..... ........+.+|+++++.++|+||++++++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~-----------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 74 (284)
T cd05079 6 LKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPE-----------SGGNHIADLKKEIEILRNLYHENIVKYKGI 74 (284)
T ss_pred hhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCcc-----------ccHHHHHHHHHHHHHHHhCCCCCeeeeeeE
Confidence 45566899999999999973 456777888855321 112224678899999999999999999999
Q ss_pred EEeC--CeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEc
Q 020641 93 CVEG--NLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLF 170 (323)
Q Consensus 93 ~~~~--~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~ 170 (323)
+... ...++||||+++++|.+++..... .+++..+..++.|++.||.|||+. |++|+||||+||+++
T Consensus 75 ~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~--------~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~ 143 (284)
T cd05079 75 CTEDGGNGIKLIMEFLPSGSLKEYLPRNKN--------KINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVE 143 (284)
T ss_pred EecCCCCceEEEEEccCCCCHHHHHHhccC--------CCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEc
Confidence 8875 568999999999999999865432 188999999999999999999999 999999999999999
Q ss_pred cCCeEEEeeccccCCCCccccc-cccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchh
Q 020641 171 EDFKAKIADFNLSNQAPDMAAR-LHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSL 249 (323)
Q Consensus 171 ~~~~~~l~Dfg~~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~ 249 (323)
.++.++|+|||++......... .......++..|+|||.+.+..++.++||||||+++|+|+++..|+...........
T Consensus 144 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~ 223 (284)
T cd05079 144 SEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMI 223 (284)
T ss_pred CCCCEEECCCccccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhc
Confidence 9999999999998765432221 111233466789999998888899999999999999999998776543211000000
Q ss_pred hhhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhh
Q 020641 250 VTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLL 311 (323)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~ 311 (323)
... ............+........+...+..+.+|+.+||+.||++|||+.++++.|+.++
T Consensus 224 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~~ 284 (284)
T cd05079 224 GPT-HGQMTVTRLVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAIL 284 (284)
T ss_pred ccc-cccccHHHHHHHHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhhC
Confidence 000 0000000011111111122223445678999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-41 Score=289.94 Aligned_cols=254 Identities=19% Similarity=0.239 Sum_probs=199.6
Q ss_pred CccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeC
Q 020641 17 PGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEG 96 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 96 (323)
|+....||+|+||+||++.+..+++.+++|......... ......+.+|+.++++++|++|+.+++.+...
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~---------~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~ 72 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKK---------RKGESMALNEKQILEKVNSRFVVSLAYAYETK 72 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccc---------hHHHHHHHHHHHHHHhCCCCCeeeeeEEEecC
Confidence 345568999999999999999999999998664322111 11224567899999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEE
Q 020641 97 NLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAK 176 (323)
Q Consensus 97 ~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~ 176 (323)
+..++||||+.+++|.+++...... .+++..+..++.|++.||.|||+. |++|+||||+||+++.++.++
T Consensus 73 ~~~~lv~e~~~g~~L~~~l~~~~~~-------~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~ 142 (285)
T cd05630 73 DALCLVLTLMNGGDLKFHIYHMGEA-------GFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIR 142 (285)
T ss_pred CEEEEEEEecCCCcHHHHHHHhccc-------CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEE
Confidence 9999999999999999998644322 288899999999999999999999 999999999999999999999
Q ss_pred EeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhccc
Q 020641 177 IADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPR 256 (323)
Q Consensus 177 l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 256 (323)
|+|||++........ .....|+..|+|||.+.+..++.++|+||||+++|+|++|..||............
T Consensus 143 l~Dfg~~~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~------ 213 (285)
T cd05630 143 ISDLGLAVHVPEGQT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEV------ 213 (285)
T ss_pred EeeccceeecCCCcc---ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHH------
Confidence 999999865433221 12235889999999999888999999999999999999999999754321110000
Q ss_pred ccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCC-----hHHHHH
Q 020641 257 LSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPN-----MSIVVK 305 (323)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps-----~~evl~ 305 (323)
..... ......+...+..+.+++.+||+.||++||| ++|+++
T Consensus 214 ------~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 214 ------ERLVK-EVQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred ------Hhhhh-hhhhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 00000 0011123344567999999999999999999 888887
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=288.44 Aligned_cols=254 Identities=22% Similarity=0.298 Sum_probs=202.4
Q ss_pred ccCCCCCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCccccee
Q 020641 11 GAHAPSPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELL 90 (323)
Q Consensus 11 ~~~~~~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~ 90 (323)
|.-...|..+.+||.|++|.||++.+..+++.+++|...... ....+.+.+|+.+++.++|+||++++
T Consensus 16 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~------------~~~~~~~~~e~~~l~~~~h~~v~~~~ 83 (296)
T cd06654 16 GDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ------------QPKKELIINEILVMRENKNPNIVNYL 83 (296)
T ss_pred CCcccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCC------------cchHHHHHHHHHHHHhCCCCCEeeEE
Confidence 344456677779999999999999998888888888654221 11236678899999999999999999
Q ss_pred eEEEeCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEc
Q 020641 91 GYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLF 170 (323)
Q Consensus 91 ~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~ 170 (323)
+.+..+...++||||+.+++|.+++.... +++..+..++.|++.||.|||+. |++|+||||+||+++
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~----------~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~ 150 (296)
T cd06654 84 DSYLVGDELWVVMEYLAGGSLTDVVTETC----------MDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLG 150 (296)
T ss_pred EEEEeCCEEEEeecccCCCCHHHHHHhcC----------CCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEc
Confidence 99999999999999999999999986532 78889999999999999999999 999999999999999
Q ss_pred cCCeEEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhh
Q 020641 171 EDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLV 250 (323)
Q Consensus 171 ~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~ 250 (323)
.++.++|+|||.+........ ......+++.|+|||.+.+..++.++||||||+++|+|++|+.||..........
T Consensus 151 ~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~-- 226 (296)
T cd06654 151 MDGSVKLTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY-- 226 (296)
T ss_pred CCCCEEECccccchhcccccc--ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHH--
Confidence 999999999998875432211 1122347889999999988888999999999999999999999997543211110
Q ss_pred hhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 251 TWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
... .........+...+..+.+++.+||..+|++|||+.++++
T Consensus 227 ~~~------------~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 227 LIA------------TNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred HHh------------cCCCCCCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence 000 0000011123345567999999999999999999999998
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=289.31 Aligned_cols=269 Identities=25% Similarity=0.294 Sum_probs=203.0
Q ss_pred CCccccccCCCCCCccceeccceeee--eeeeccccccccCccccccccCCCCCchHHHHHHHHHhcC-CCCcccceeeE
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRVKMRR--WLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRL-KHENLVELLGY 92 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~~~~~--~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~ 92 (323)
.+.+...||+|+||.||++.+..++. .+++|.... .......+.+.+|+.++.++ +||||++++++
T Consensus 3 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~-----------~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 71 (297)
T cd05089 3 DIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKE-----------FASENDHRDFAGELEVLCKLGHHPNIINLLGA 71 (297)
T ss_pred cceeeeeecCCCcceEEEEEecCCCCcceeEEEEccc-----------cCCHHHHHHHHHHHHHHHhhcCCCchhheEEE
Confidence 35556689999999999998876654 244443221 01112235688899999999 79999999999
Q ss_pred EEeCCeEEEEEeecCCCCHHHHhccCCCCCC-------CCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCC
Q 020641 93 CVEGNLRVLAYEFATMGSLHDILHGRKGVQG-------AQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSS 165 (323)
Q Consensus 93 ~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~ 165 (323)
+......++++||+.+++|.+++........ ......+++..+..++.|++.|+.+||+. |++|+||||+
T Consensus 72 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~ 148 (297)
T cd05089 72 CENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAAR 148 (297)
T ss_pred EccCCcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcc
Confidence 9999999999999999999999965432110 01112488899999999999999999999 9999999999
Q ss_pred CEEEccCCeEEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCc
Q 020641 166 NVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPR 244 (323)
Q Consensus 166 nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~ 244 (323)
||+++.++.++|+|||++........ ......+..|+|||...+..++.++||||||+++|+|++ |..||......
T Consensus 149 Nill~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~ 225 (297)
T cd05089 149 NVLVGENLASKIADFGLSRGEEVYVK---KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCA 225 (297)
T ss_pred eEEECCCCeEEECCcCCCccccceec---cCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence 99999999999999999864322111 111123457999999988889999999999999999997 99999654321
Q ss_pred ccchhhhhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhhcCCCCC
Q 020641 245 GQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSPPPA 317 (323)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~~~~~~~ 317 (323)
. +...+........+...+..+.+++.+||+.+|.+|||+.++++.|.++.....+.
T Consensus 226 ~----------------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~~~ 282 (297)
T cd05089 226 E----------------LYEKLPQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARKAY 282 (297)
T ss_pred H----------------HHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhccc
Confidence 1 11111111122233345677999999999999999999999999999998765443
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=284.94 Aligned_cols=257 Identities=21% Similarity=0.295 Sum_probs=199.7
Q ss_pred CccccccCCCCCCccceeccceeee---eeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEE
Q 020641 17 PGYFVRLDKGPEDDLYLKKRVKMRR---WLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYC 93 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~~~~~~~---~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 93 (323)
+.....||+|+||.||++.+..++. .+++|...... .....+.+.+|+++++.++|+||+++++++
T Consensus 7 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~-----------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 75 (268)
T cd05063 7 ITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY-----------TEKQRQDFLSEASIMGQFSHHNIIRLEGVV 75 (268)
T ss_pred ceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC-----------CHHHHHHHHHHHHHHhcCCCCCeeEEEEEE
Confidence 4455689999999999999876543 56776543211 111235678899999999999999999999
Q ss_pred EeCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCC
Q 020641 94 VEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDF 173 (323)
Q Consensus 94 ~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~ 173 (323)
......++||||+.+++|.+++...... +++..+..++.|++.|+.|||+. |++|+||||+||+++.++
T Consensus 76 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~--------~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~ 144 (268)
T cd05063 76 TKFKPAMIITEYMENGALDKYLRDHDGE--------FSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNL 144 (268)
T ss_pred ccCCCcEEEEEcCCCCCHHHHHHhcCCC--------CCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCC
Confidence 9999999999999999999999754322 88899999999999999999999 999999999999999999
Q ss_pred eEEEeeccccCCCCccccccc-cccccCccccCCCccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccchhhh
Q 020641 174 KAKIADFNLSNQAPDMAARLH-STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVT 251 (323)
Q Consensus 174 ~~~l~Dfg~~~~~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~ 251 (323)
.++|+|||++........... ......+..|+|||.+.+..++.++|+||||+++|++++ |..||.......
T Consensus 145 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~------ 218 (268)
T cd05063 145 ECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHE------ 218 (268)
T ss_pred cEEECCCccceecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHH------
Confidence 999999999875543221111 111123457999999988888999999999999999997 999996443211
Q ss_pred hhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhh
Q 020641 252 WATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLL 311 (323)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~ 311 (323)
....+........+...+..+.+++.+||+.+|++||++.+|++.|++++
T Consensus 219 ----------~~~~i~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~~ 268 (268)
T cd05063 219 ----------VMKAINDGFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKLL 268 (268)
T ss_pred ----------HHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence 11111111122223345677999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=307.58 Aligned_cols=267 Identities=19% Similarity=0.229 Sum_probs=193.2
Q ss_pred CCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEe
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVE 95 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 95 (323)
.|....+||+|+||.||+|.+..+++.+|+|..... .....+|+.+++.++|+||+++++++..
T Consensus 67 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~----------------~~~~~~Ei~il~~l~h~niv~l~~~~~~ 130 (440)
T PTZ00036 67 SYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQD----------------PQYKNRELLIMKNLNHINIIFLKDYYYT 130 (440)
T ss_pred eEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecC----------------cchHHHHHHHHHhcCCCCCcceeeeEee
Confidence 355556899999999999999999999999855321 1234579999999999999999987643
Q ss_pred C--------CeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCE
Q 020641 96 G--------NLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNV 167 (323)
Q Consensus 96 ~--------~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~ni 167 (323)
. ...++||||+.+ +|.+++...... ...+++..+..++.||+.||.|||+. ||+||||||+||
T Consensus 131 ~~~~~~~~~~~l~lvmE~~~~-~l~~~~~~~~~~-----~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NI 201 (440)
T PTZ00036 131 ECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARN-----NHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNL 201 (440)
T ss_pred cccccCCCceEEEEEEecCCc-cHHHHHHHHhhc-----CCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHE
Confidence 2 246799999986 788777532111 11288999999999999999999999 999999999999
Q ss_pred EEccCC-eEEEeeccccCCCCccccccccccccCccccCCCccccCC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCcc
Q 020641 168 LLFEDF-KAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG-QLTQKSDVYSFGVVLLELLTGRKPVDHTMPRG 245 (323)
Q Consensus 168 li~~~~-~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 245 (323)
+++.++ .++|+|||++........ .....|++.|+|||++.+. .++.++|||||||++|+|++|..||.+.....
T Consensus 202 Ll~~~~~~vkL~DFGla~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~ 278 (440)
T PTZ00036 202 LIDPNTHTLKLCDFGSAKNLLAGQR---SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVD 278 (440)
T ss_pred EEcCCCCceeeeccccchhccCCCC---cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH
Confidence 998664 699999999976543221 1234578999999988754 68999999999999999999999997654322
Q ss_pred cchhhhhhccccccc------------ccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH--HHhhh
Q 020641 246 QQSLVTWATPRLSED------------KVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK--ALQPL 310 (323)
Q Consensus 246 ~~~~~~~~~~~~~~~------------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~--~l~~~ 310 (323)
..............+ .........+....+...+.++.+|+.+||.+||.+|||+.|+++ +++.+
T Consensus 279 ~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~ 357 (440)
T PTZ00036 279 QLVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDL 357 (440)
T ss_pred HHHHHHHHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhh
Confidence 111111100000000 001111111111223334568999999999999999999999984 44444
|
|
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=290.54 Aligned_cols=266 Identities=24% Similarity=0.332 Sum_probs=201.2
Q ss_pred CccccccCCCCCCccceeccce-------eeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcC-CCCcccc
Q 020641 17 PGYFVRLDKGPEDDLYLKKRVK-------MRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRL-KHENLVE 88 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~~~~-------~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~ 88 (323)
+....+||+|+||.||++++.. ....+++|+..... .......+.+|+.+++++ +|+||++
T Consensus 14 ~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~-----------~~~~~~~~~~E~~~l~~l~~h~~iv~ 82 (314)
T cd05099 14 LVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA-----------TDKDLADLISEMELMKLIGKHKNIIN 82 (314)
T ss_pred eeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC-----------ChHHHHHHHHHHHHHHhccCCCCeee
Confidence 3445689999999999997642 34457777543211 011135678899999999 7999999
Q ss_pred eeeEEEeCCeEEEEEeecCCCCHHHHhccCCCCC-------CCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCC
Q 020641 89 LLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQ-------GAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRD 161 (323)
Q Consensus 89 ~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~d 161 (323)
+++++......+++|||+.+++|.+++....... .......+++..+..++.|++.|+.|||+. |++|+|
T Consensus 83 ~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~d 159 (314)
T cd05099 83 LLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRD 159 (314)
T ss_pred EEEEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---Ceeecc
Confidence 9999999889999999999999999997643210 001122488899999999999999999999 999999
Q ss_pred CCCCCEEEccCCeEEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHh-CCCCCCC
Q 020641 162 IRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDH 240 (323)
Q Consensus 162 ikp~nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~ 240 (323)
|||+||+++.++.++|+|||.+................++..|+|||.+.+..++.++||||||+++|+|++ |..||..
T Consensus 160 lkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~ 239 (314)
T cd05099 160 LAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPG 239 (314)
T ss_pred ccceeEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCC
Confidence 999999999999999999999976543222111122234567999999988889999999999999999999 8999864
Q ss_pred CCCcccchhhhhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhhc
Q 020641 241 TMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLK 312 (323)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~~ 312 (323)
...... .+.+........+..++..+.+++.+||+.+|++|||+.++++.|+++..
T Consensus 240 ~~~~~~----------------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~ 295 (314)
T cd05099 240 IPVEEL----------------FKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLA 295 (314)
T ss_pred CCHHHH----------------HHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence 432111 11111111112234456679999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=287.10 Aligned_cols=255 Identities=17% Similarity=0.210 Sum_probs=199.3
Q ss_pred CccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeC
Q 020641 17 PGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEG 96 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 96 (323)
+.....||+|+||+||++.+..+++.+|+|+....... .......+.+|++++++++|+||+.+.+.+..+
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~---------~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~ 72 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIK---------KRKGESMALNEKQILEKVNSQFVVNLAYAYETK 72 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhh---------hhhHHHHHHHHHHHHHHcCCcCceeEEEEEecC
Confidence 34556899999999999999999999999976533211 111234567899999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEE
Q 020641 97 NLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAK 176 (323)
Q Consensus 97 ~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~ 176 (323)
+..+++|||+.+++|.+++...... .+++..+..++.|++.||.|||+. |++|+||||+||+++.++.++
T Consensus 73 ~~~~lv~e~~~~~~L~~~~~~~~~~-------~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~k 142 (285)
T cd05632 73 DALCLVLTIMNGGDLKFHIYNMGNP-------GFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIR 142 (285)
T ss_pred CEEEEEEEeccCccHHHHHHHhcCC-------CCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEE
Confidence 9999999999999999888654322 289999999999999999999999 999999999999999999999
Q ss_pred EeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhccc
Q 020641 177 IADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPR 256 (323)
Q Consensus 177 l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 256 (323)
|+|||++........ .....|+..|+|||.+.+..++.++|+||||+++|+|++|..||.............
T Consensus 143 l~Dfg~~~~~~~~~~---~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~----- 214 (285)
T cd05632 143 ISDLGLAVKIPEGES---IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVD----- 214 (285)
T ss_pred EecCCcceecCCCCc---ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-----
Confidence 999998865432211 123358999999999988889999999999999999999999997543211110000
Q ss_pred ccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCC-----hHHHHHH
Q 020641 257 LSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPN-----MSIVVKA 306 (323)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps-----~~evl~~ 306 (323)
..+.. .....+...+..+.+|+.+||+.||++||| +.++++.
T Consensus 215 -------~~~~~-~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 215 -------RRVLE-TEEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred -------Hhhhc-cccccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 00000 001123344567899999999999999999 6777763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=282.26 Aligned_cols=251 Identities=27% Similarity=0.397 Sum_probs=195.3
Q ss_pred CccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeC
Q 020641 17 PGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEG 96 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 96 (323)
+....+||+|++|.||++.+..+.+ +++|..... ....+.+.+|++++++++|+|++++++++..
T Consensus 8 ~~~~~~ig~g~~~~v~~~~~~~~~~-~~lK~~~~~-------------~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~- 72 (260)
T cd05069 8 LRLDVKLGQGCFGEVWMGTWNGTTK-VAIKTLKPG-------------TMMPEAFLQEAQIMKKLRHDKLVPLYAVVSE- 72 (260)
T ss_pred eeeeeeecCcCCCeEEEEEEcCCce-EEEEEcccC-------------CccHHHHHHHHHHHHhCCCCCeeeEEEEEcC-
Confidence 5555689999999999998866654 566643311 1123668899999999999999999988754
Q ss_pred CeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEE
Q 020641 97 NLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAK 176 (323)
Q Consensus 97 ~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~ 176 (323)
+..+++|||+.+++|.+++...... .+++..+..++.|++.||.|||+. |++|+||+|+||++++++.++
T Consensus 73 ~~~~~v~e~~~~~~L~~~~~~~~~~-------~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~ 142 (260)
T cd05069 73 EPIYIVTEFMGKGSLLDFLKEGDGK-------YLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCK 142 (260)
T ss_pred CCcEEEEEcCCCCCHHHHHhhCCCC-------CCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEE
Confidence 4578999999999999999764322 278889999999999999999999 999999999999999999999
Q ss_pred EeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcc
Q 020641 177 IADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATP 255 (323)
Q Consensus 177 l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~ 255 (323)
|+|||.+......... ......++..|+|||...+..++.++|+||||+++|+|++ |..||........ ..+
T Consensus 143 l~dfg~~~~~~~~~~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~---~~~--- 215 (260)
T cd05069 143 IADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREV---LEQ--- 215 (260)
T ss_pred ECCCccceEccCCccc-ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHH---
Confidence 9999998755332211 1122235678999999888889999999999999999999 9999975432111 111
Q ss_pred cccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhh
Q 020641 256 RLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQP 309 (323)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~ 309 (323)
+........+...+..+.+++.+||+.||++||++.+|+++|++
T Consensus 216 ----------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 216 ----------VERGYRMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred ----------HHcCCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 11111112233456789999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=285.12 Aligned_cols=254 Identities=23% Similarity=0.325 Sum_probs=197.9
Q ss_pred CCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEe
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVE 95 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 95 (323)
.|+...+||+|+||.||++++..+++.+++|+...+. ......+.+|+.++++++|+||+++++.+..
T Consensus 10 ~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~------------~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~ 77 (267)
T cd06646 10 DYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP------------GDDFSLIQQEIFMVKECKHCNIVAYFGSYLS 77 (267)
T ss_pred hcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCc------------cchHHHHHHHHHHHHhcCCCCeeeeeEEEEe
Confidence 4677779999999999999999999999998664221 1122457889999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeE
Q 020641 96 GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKA 175 (323)
Q Consensus 96 ~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~ 175 (323)
....++||||+.+++|.+++..... +++..+..++.|++.|+.|||+. |++|+||+|+||+++.++.+
T Consensus 78 ~~~~~iv~e~~~~~~L~~~~~~~~~---------~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~ 145 (267)
T cd06646 78 REKLWICMEYCGGGSLQDIYHVTGP---------LSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDV 145 (267)
T ss_pred CCEEEEEEeCCCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCE
Confidence 9999999999999999999865432 88899999999999999999999 99999999999999999999
Q ss_pred EEeeccccCCCCccccccccccccCccccCCCcccc---CCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhh
Q 020641 176 KIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAM---TGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTW 252 (323)
Q Consensus 176 ~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 252 (323)
+|+|||++........ ......++..|+|||.+. ...++.++|+||||+++|+|++|..||............
T Consensus 146 ~l~dfg~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~-- 221 (267)
T cd06646 146 KLADFGVAAKITATIA--KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLM-- 221 (267)
T ss_pred EECcCccceeeccccc--ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheee--
Confidence 9999999876532211 112334788999999874 344678999999999999999999998644321111000
Q ss_pred hcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHH
Q 020641 253 ATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKAL 307 (323)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l 307 (323)
..... ..+. .......+..+.+++.+||+.+|++|||++++++.+
T Consensus 222 ~~~~~--------~~~~--~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 222 SKSNF--------QPPK--LKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred ecCCC--------CCCC--CccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 00000 0000 011123456799999999999999999999998743
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=297.43 Aligned_cols=263 Identities=17% Similarity=0.188 Sum_probs=195.4
Q ss_pred CCCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEE
Q 020641 15 PSPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCV 94 (323)
Q Consensus 15 ~~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 94 (323)
..|.....||+|+||.||++.+..+++.+++|...... ........+.+|+.+++.++|+||+++++++.
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----------~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~ 93 (364)
T cd07875 24 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF----------QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFT 93 (364)
T ss_pred cceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccc----------cCchhHHHHHHHHHHHHhcCCCCccccceeec
Confidence 34566668999999999999999999999998664321 11223356788999999999999999999875
Q ss_pred eC------CeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEE
Q 020641 95 EG------NLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVL 168 (323)
Q Consensus 95 ~~------~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nil 168 (323)
.. ...|+||||+.+ +|.+.+... ++...+..++.|++.||.|||+. |++||||||+||+
T Consensus 94 ~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~-----------~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIl 158 (364)
T cd07875 94 PQKSLEEFQDVYIVMELMDA-NLCQVIQME-----------LDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIV 158 (364)
T ss_pred ccccccccCeEEEEEeCCCC-CHHHHHHhc-----------CCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEE
Confidence 43 357999999976 788877532 77889999999999999999999 9999999999999
Q ss_pred EccCCeEEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccch
Q 020641 169 LFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQS 248 (323)
Q Consensus 169 i~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~ 248 (323)
++.++.++|+|||++....... ......++..|+|||.+.+..++.++|||||||++|+|++|+.||..........
T Consensus 159 l~~~~~~kL~DfG~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~ 235 (364)
T cd07875 159 VKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWN 235 (364)
T ss_pred ECCCCcEEEEeCCCccccCCCC---cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 9999999999999997653321 1223457899999999999999999999999999999999999997654321111
Q ss_pred hhhhh-c---------------------ccccccccchhcCCC---cCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHH
Q 020641 249 LVTWA-T---------------------PRLSEDKVKQCVDPK---LKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIV 303 (323)
Q Consensus 249 ~~~~~-~---------------------~~~~~~~~~~~~~~~---~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev 303 (323)
..... . .........+..... .........+..+.+++.+||+.||.+|||+.|+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~ 315 (364)
T cd07875 236 KVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA 315 (364)
T ss_pred HHHHhcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHH
Confidence 00000 0 000000000000000 0001111234578999999999999999999999
Q ss_pred HH
Q 020641 304 VK 305 (323)
Q Consensus 304 l~ 305 (323)
++
T Consensus 316 L~ 317 (364)
T cd07875 316 LQ 317 (364)
T ss_pred hc
Confidence 88
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=283.81 Aligned_cols=264 Identities=18% Similarity=0.222 Sum_probs=205.3
Q ss_pred CCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEe
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVE 95 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 95 (323)
.|.....||.|++|.||++.+..+++.+++|....... .......++.+|+.+++.++|+||+++++++..
T Consensus 3 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~---------~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~ 73 (267)
T cd08229 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDL---------MDAKARADCIKEIDLLKQLNHPNVIKYYASFIE 73 (267)
T ss_pred hhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhh---------hhHHHHHHHHHHHHHHHHccCCchhhhhheeEe
Confidence 35566689999999999999998888888885543211 111223677889999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeE
Q 020641 96 GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKA 175 (323)
Q Consensus 96 ~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~ 175 (323)
++..+++|||+.+++|.+++...... ...+++..++.++.|++.|+.|||+. |++|+||+|+||+++.++.+
T Consensus 74 ~~~~~~v~e~~~~~~L~~~~~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~ 145 (267)
T cd08229 74 DNELNIVLELADAGDLSRMIKHFKKQ-----KRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVV 145 (267)
T ss_pred CCeEEEEEEecCCCCHHHHHHHhhcc-----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCE
Confidence 99999999999999999998643211 11288999999999999999999999 99999999999999999999
Q ss_pred EEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhcc
Q 020641 176 KIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATP 255 (323)
Q Consensus 176 ~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~ 255 (323)
+|+|||.+......... .....++..|+|||.+.+..++.++|+||||+++|+|++|..||......... ...
T Consensus 146 ~l~dfg~~~~~~~~~~~--~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~-~~~---- 218 (267)
T cd08229 146 KLGDLGLGRFFSSKTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYS-LCK---- 218 (267)
T ss_pred EECcchhhhccccCCcc--cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHH-Hhh----
Confidence 99999988765432211 12234788999999998888899999999999999999999999643221000 000
Q ss_pred cccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhh
Q 020641 256 RLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLL 311 (323)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~ 311 (323)
...............+..+.+++.+||..||++|||+.+|++.+.++.
T Consensus 219 --------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 219 --------KIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred --------hhhcCCCCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 000001111112345678999999999999999999999999988763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=289.63 Aligned_cols=264 Identities=19% Similarity=0.228 Sum_probs=200.5
Q ss_pred CCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEe
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVE 95 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 95 (323)
.+....+||+|+||.||++++..+++.+++|....+. .......+.+|++++++++||||+++++.+..
T Consensus 2 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~-----------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 70 (308)
T cd06615 2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI-----------KPAIRNQIIRELKVLHECNSPYIVGFYGAFYS 70 (308)
T ss_pred CceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc-----------CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee
Confidence 3566779999999999999999999888888654221 11223567889999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCCCceeCCCCCCCEEEccCCe
Q 020641 96 GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHE-KVQPSIIHRDIRSSNVLLFEDFK 174 (323)
Q Consensus 96 ~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~-~~~~~i~h~dikp~nili~~~~~ 174 (323)
++..++||||+++++|.+++..... +++..+..++.|++.|+.|||+ . +++|+||+|+||+++.++.
T Consensus 71 ~~~~~lv~ey~~~~~L~~~l~~~~~---------~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dl~p~nil~~~~~~ 138 (308)
T cd06615 71 DGEISICMEHMDGGSLDQVLKKAGR---------IPENILGKISIAVLRGLTYLREKH---KIMHRDVKPSNILVNSRGE 138 (308)
T ss_pred CCEEEEEeeccCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHhhC---CEEECCCChHHEEEecCCc
Confidence 9999999999999999999976532 8889999999999999999997 6 8999999999999999999
Q ss_pred EEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhc
Q 020641 175 AKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWAT 254 (323)
Q Consensus 175 ~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~ 254 (323)
++|+|||++....... .....++..|+|||.+.+..++.++|+||||+++|+|++|..||................
T Consensus 139 ~~l~dfg~~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~ 214 (308)
T cd06615 139 IKLCDFGVSGQLIDSM----ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPV 214 (308)
T ss_pred EEEccCCCcccccccc----cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCcc
Confidence 9999999886543321 123457889999999888888999999999999999999999996543221111111000
Q ss_pred cccccc--------------------ccc-hhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHH
Q 020641 255 PRLSED--------------------KVK-QCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKA 306 (323)
Q Consensus 255 ~~~~~~--------------------~~~-~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~ 306 (323)
...... ... ...............+.++.+++.+||..+|++|||+.++++.
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 215 SEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred ccccccCCcccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000000 000 0000000000111245679999999999999999999999874
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=285.20 Aligned_cols=257 Identities=21% Similarity=0.324 Sum_probs=200.1
Q ss_pred CccccccCCCCCCccceeccceeee---eeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEE
Q 020641 17 PGYFVRLDKGPEDDLYLKKRVKMRR---WLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYC 93 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~~~~~~~---~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 93 (323)
+.....||.|+||.||++....+++ .+++|+..... .......+..|+.+++.++||||+++++++
T Consensus 6 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~-----------~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~ 74 (269)
T cd05065 6 VKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY-----------TEKQRRDFLSEASIMGQFDHPNIIHLEGVV 74 (269)
T ss_pred eEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC-----------CHHHHHHHHHHHHHHHhCCCcCcceEEEEE
Confidence 3445589999999999999876654 57887654221 111236788999999999999999999999
Q ss_pred EeCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCC
Q 020641 94 VEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDF 173 (323)
Q Consensus 94 ~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~ 173 (323)
..+...++||||+.+++|.+++...... +++..+..++.|++.|+.+||+. |++|+||+|+||+++.++
T Consensus 75 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~--------~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~ 143 (269)
T cd05065 75 TKSRPVMIITEFMENGALDSFLRQNDGQ--------FTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNL 143 (269)
T ss_pred CCCCceEEEEecCCCCcHHHHHhhCCCC--------CCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCC
Confidence 9999999999999999999998764322 88999999999999999999999 999999999999999999
Q ss_pred eEEEeeccccCCCCcccccccccccc---CccccCCCccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccchh
Q 020641 174 KAKIADFNLSNQAPDMAARLHSTRVL---GTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSL 249 (323)
Q Consensus 174 ~~~l~Dfg~~~~~~~~~~~~~~~~~~---g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~ 249 (323)
.++|+|||.+................ .+..|+|||.+.+..++.++||||||+++|++++ |..||.......
T Consensus 144 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~---- 219 (269)
T cd05065 144 VCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD---- 219 (269)
T ss_pred cEEECCCccccccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHH----
Confidence 99999999987554322211111111 2357999999988889999999999999999886 999996543211
Q ss_pred hhhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhh
Q 020641 250 VTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLL 311 (323)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~ 311 (323)
....+........+.+++..+.+++.+||..+|++||++.+|+..|++++
T Consensus 220 ------------~~~~i~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~ 269 (269)
T cd05065 220 ------------VINAIEQDYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKMI 269 (269)
T ss_pred ------------HHHHHHcCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhhC
Confidence 11111111112223445677999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=304.49 Aligned_cols=261 Identities=18% Similarity=0.219 Sum_probs=194.8
Q ss_pred CCCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEE
Q 020641 15 PSPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCV 94 (323)
Q Consensus 15 ~~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 94 (323)
.+|.+..+||.|+||.||++.+..+++.+++|... ...+.+|++++++++|+||+++++++.
T Consensus 169 ~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------------------~~~~~~E~~iL~~L~HpnIv~l~~~~~ 230 (461)
T PHA03211 169 LGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------------------YASSVHEARLLRRLSHPAVLALLDVRV 230 (461)
T ss_pred CCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------------------ccCHHHHHHHHHHCCCCCCCcEEEEEE
Confidence 35667779999999999999999999988887321 133568999999999999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCe
Q 020641 95 EGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFK 174 (323)
Q Consensus 95 ~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~ 174 (323)
.+...++||+++. ++|.+++..... .+++..+..++.|++.||.|||+. ||+||||||+|||++.++.
T Consensus 231 ~~~~~~lv~e~~~-~~L~~~l~~~~~--------~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~ 298 (461)
T PHA03211 231 VGGLTCLVLPKYR-SDLYTYLGARLR--------PLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPED 298 (461)
T ss_pred ECCEEEEEEEccC-CCHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCC
Confidence 9999999999996 589988865432 289999999999999999999999 9999999999999999999
Q ss_pred EEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccc-----chh
Q 020641 175 AKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQ-----QSL 249 (323)
Q Consensus 175 ~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-----~~~ 249 (323)
++|+|||++................||..|+|||++.+..++.++|||||||++|+|++|..|+........ ...
T Consensus 299 vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l 378 (461)
T PHA03211 299 ICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQI 378 (461)
T ss_pred EEEcccCCceecccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHH
Confidence 999999998765432222222234589999999999998999999999999999999998776543221100 000
Q ss_pred hhhhcc-cccccccch---------hcC---CCcCCC-----C--CHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 250 VTWATP-RLSEDKVKQ---------CVD---PKLKGE-----Y--PPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 250 ~~~~~~-~~~~~~~~~---------~~~---~~~~~~-----~--~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
...... ......... ... ...... . ....+..+.+|+.+||+.||.+|||+.|+++
T Consensus 379 ~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~ 454 (461)
T PHA03211 379 LRIIRQAQVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLR 454 (461)
T ss_pred HHHHHhhccccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhh
Confidence 100000 000000000 000 000000 0 0123457889999999999999999999997
|
|
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=288.02 Aligned_cols=264 Identities=24% Similarity=0.341 Sum_probs=200.6
Q ss_pred CCccccccCCCCCCccceeccce-----eeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCccccee
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRVK-----MRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELL 90 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~~-----~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~ 90 (323)
.+....+||.|+||.||+|.+.. ++..+++|...... .......+.+|+.++++++|+||++++
T Consensus 6 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~-----------~~~~~~~~~~ei~~l~~l~h~~iv~~~ 74 (288)
T cd05050 6 NIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-----------SADMQADFQREAALMAEFDHPNIVKLL 74 (288)
T ss_pred hceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc-----------CHHHHHHHHHHHHHHHhcCCCchheEE
Confidence 45666799999999999998753 56677777554221 011235688899999999999999999
Q ss_pred eEEEeCCeEEEEEeecCCCCHHHHhccCCCCCCC-------------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCc
Q 020641 91 GYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGA-------------QPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSI 157 (323)
Q Consensus 91 ~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~-------------~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i 157 (323)
+++..+...++++||+.+++|.+++......... .....+++..++.++.|++.||.+||.. ++
T Consensus 75 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i 151 (288)
T cd05050 75 GVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KF 151 (288)
T ss_pred EEEcCCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence 9999999999999999999999999754321110 1112378889999999999999999999 99
Q ss_pred eeCCCCCCCEEEccCCeEEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHh-CCC
Q 020641 158 IHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRK 236 (323)
Q Consensus 158 ~h~dikp~nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~ 236 (323)
+|+||||+||+++.++.++|+|||.+.................+..|+|||.+.+..++.++||||||+++|+|++ |..
T Consensus 152 ~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~ 231 (288)
T cd05050 152 VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQ 231 (288)
T ss_pred ecccccHhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCC
Confidence 9999999999999999999999998865432221111222234667999999888889999999999999999997 888
Q ss_pred CCCCCCCcccchhhhhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhh
Q 020641 237 PVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQP 309 (323)
Q Consensus 237 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~ 309 (323)
||........ ...+........+...+..+.+++.+||+.+|++|||+.|+++.|++
T Consensus 232 p~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 232 PYYGMAHEEV----------------IYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred CCCCCCHHHH----------------HHHHhcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 8864432111 01111111111233456779999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=315.68 Aligned_cols=274 Identities=18% Similarity=0.203 Sum_probs=207.8
Q ss_pred CCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEe
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVE 95 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 95 (323)
.|....+||+|+||.||+|.+..+++.+|+|+...... ......+++.+|++++++++||||+++++++.+
T Consensus 3 rYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~---------~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d 73 (932)
T PRK13184 3 RYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLS---------ENPLLKKRFLREAKIAADLIHPGIVPVYSICSD 73 (932)
T ss_pred CeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccc---------cCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEee
Confidence 35666799999999999999999999999997653211 112234678899999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHhccCCCCCC--CCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCC
Q 020641 96 GNLRVLAYEFATMGSLHDILHGRKGVQG--AQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDF 173 (323)
Q Consensus 96 ~~~~~lv~e~~~~~sL~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~ 173 (323)
++..+++|||++|++|.+++........ .......++..+..++.|++.||.|||+. |++||||||+||+++.++
T Consensus 74 ~~~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg 150 (932)
T PRK13184 74 GDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFG 150 (932)
T ss_pred CCEEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCC
Confidence 9999999999999999999865321110 01112266778899999999999999999 999999999999999999
Q ss_pred eEEEeeccccCCCCcccc----------------ccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCC
Q 020641 174 KAKIADFNLSNQAPDMAA----------------RLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 237 (323)
Q Consensus 174 ~~~l~Dfg~~~~~~~~~~----------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p 237 (323)
.++|+|||++........ ........||+.|+|||.+.+..++.++|||||||++|+|++|..|
T Consensus 151 ~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~P 230 (932)
T PRK13184 151 EVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP 230 (932)
T ss_pred CEEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCC
Confidence 999999999876521100 0011224589999999999998999999999999999999999999
Q ss_pred CCCCCCcccchhhhhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCC-ChHHHHHHHhhhhcCCC
Q 020641 238 VDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRP-NMSIVVKALQPLLKSPP 315 (323)
Q Consensus 238 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-s~~evl~~l~~~~~~~~ 315 (323)
|.......... . ..+............+..+.+++.+||+.||++|| +++++++.|+..+...+
T Consensus 231 F~~~~~~ki~~----~----------~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~~p 295 (932)
T PRK13184 231 YRRKKGRKISY----R----------DVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQGSP 295 (932)
T ss_pred CCCcchhhhhh----h----------hhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhcCc
Confidence 97533211100 0 00000000011124456799999999999999995 78888888888876433
|
|
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=285.44 Aligned_cols=251 Identities=23% Similarity=0.271 Sum_probs=196.7
Q ss_pred CccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeC
Q 020641 17 PGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEG 96 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 96 (323)
+++...||.|+||.||++.+..+++.+++|...... .......+.+|++++++++|+||+++++.+...
T Consensus 3 ~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~-----------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 71 (279)
T cd06619 3 IQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI-----------TVELQKQIMSELEILYKCDSPYIIGFYGAFFVE 71 (279)
T ss_pred chheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC-----------ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEEC
Confidence 456678999999999999999999999999664321 111235688999999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEE
Q 020641 97 NLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAK 176 (323)
Q Consensus 97 ~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~ 176 (323)
+..++||||+.+++|..+.. +++..+..++.|++.|+.|||+. |++|+||||+||+++.++.++
T Consensus 72 ~~~~lv~e~~~~~~l~~~~~-------------~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~ 135 (279)
T cd06619 72 NRISICTEFMDGGSLDVYRK-------------IPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVK 135 (279)
T ss_pred CEEEEEEecCCCCChHHhhc-------------CCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEE
Confidence 99999999999999865521 77888899999999999999999 999999999999999999999
Q ss_pred EeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhccc
Q 020641 177 IADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPR 256 (323)
Q Consensus 177 l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 256 (323)
|+|||++....... .....++..|+|||.+.+..++.++|+||||+++|+|++|..||............
T Consensus 136 l~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~------ 205 (279)
T cd06619 136 LCDFGVSTQLVNSI----AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMP------ 205 (279)
T ss_pred EeeCCcceeccccc----ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccch------
Confidence 99999987553321 22345788999999999888999999999999999999999999754321111000
Q ss_pred ccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHH
Q 020641 257 LSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKA 306 (323)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~ 306 (323)
........+...........+.++.+++.+||+.+|++||+++|+++.
T Consensus 206 --~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 206 --LQLLQCIVDEDPPVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred --HHHHHHHhccCCCCCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 000000011111111122345679999999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=292.54 Aligned_cols=270 Identities=16% Similarity=0.219 Sum_probs=196.8
Q ss_pred cccccCCC--CCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeC
Q 020641 19 YFVRLDKG--PEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEG 96 (323)
Q Consensus 19 ~~~~lg~G--~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 96 (323)
+...||+| +|++||++.+..+++.+|+|....+... ....+.+.+|+++++.++||||+++++++..+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~----------~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~ 71 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACT----------NEMVTFLQGELHVSKLFNHPNIVPYRATFIAD 71 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhcc----------HHHHHHHHHHHHHHHhcCCCCeeeEEEEEEEC
Confidence 34578998 7889999999999999999966433211 11235577899999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEE
Q 020641 97 NLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAK 176 (323)
Q Consensus 97 ~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~ 176 (323)
+..++||||+.+++|.+++...... .+++..+..++.|++.||.|||+. |++|+||||+||+++.++.++
T Consensus 72 ~~~~lv~e~~~~~~l~~~~~~~~~~-------~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~ 141 (327)
T cd08227 72 NELWVVTSFMAYGSAKDLICTHFMD-------GMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVY 141 (327)
T ss_pred CEEEEEEeccCCCcHHHHHHhhccC-------CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEE
Confidence 9999999999999999999654322 188899999999999999999999 999999999999999999999
Q ss_pred EeeccccCCCCcccccc-----ccccccCccccCCCccccC--CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchh
Q 020641 177 IADFNLSNQAPDMAARL-----HSTRVLGTFGYHAPEYAMT--GQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSL 249 (323)
Q Consensus 177 l~Dfg~~~~~~~~~~~~-----~~~~~~g~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~ 249 (323)
++||+............ ......++..|+|||.+.+ ..++.++|||||||++|+|++|..||.........
T Consensus 142 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~-- 219 (327)
T cd08227 142 LSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQML-- 219 (327)
T ss_pred EcccchhhccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHH--
Confidence 99998654332211100 0112235677999999875 45889999999999999999999999754321100
Q ss_pred hhhhcccc---------cccccc-------------h---------hcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCC
Q 020641 250 VTWATPRL---------SEDKVK-------------Q---------CVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRP 298 (323)
Q Consensus 250 ~~~~~~~~---------~~~~~~-------------~---------~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp 298 (323)
........ ..+... . ..............+..+.+++.+||+.||++||
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rp 299 (327)
T cd08227 220 LEKLNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARP 299 (327)
T ss_pred HHHhcCCccccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcC
Confidence 00000000 000000 0 0000000112234466899999999999999999
Q ss_pred ChHHHHH--HHhhh
Q 020641 299 NMSIVVK--ALQPL 310 (323)
Q Consensus 299 s~~evl~--~l~~~ 310 (323)
|+.|+++ +++++
T Consensus 300 t~~ell~~p~f~~~ 313 (327)
T cd08227 300 SASTLLNHSFFKQI 313 (327)
T ss_pred CHHHHhcChhhhhc
Confidence 9999987 45544
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=302.16 Aligned_cols=265 Identities=19% Similarity=0.186 Sum_probs=196.2
Q ss_pred CccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeC
Q 020641 17 PGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEG 96 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 96 (323)
++...+||.|+||.||++.+..+++.+|+|....... .....+.+.+|+++++.++|+||+++++++...
T Consensus 2 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----------~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 71 (372)
T cd07853 2 VEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQ----------NLVSCKRVFRELKMLCFFKHDNVLSALDILQPP 71 (372)
T ss_pred CcccceeeeCCCEEEEEEEECCCCCEEEEEecccccc----------chHHHHHHHHHHHHHHhCCCCCcCCHhheecCC
Confidence 4556689999999999999999999999986542210 011235678899999999999999999999877
Q ss_pred C-----eEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEcc
Q 020641 97 N-----LRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFE 171 (323)
Q Consensus 97 ~-----~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~ 171 (323)
. ..|+|+||+.+ +|.+.+..... +++..+..++.|++.||.|||+. |++||||||+||+++.
T Consensus 72 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~---------l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~ 138 (372)
T cd07853 72 HIDPFEEIYVVTELMQS-DLHKIIVSPQP---------LSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNS 138 (372)
T ss_pred CccccceEEEEeecccc-CHHHHHhcCCC---------CCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECC
Confidence 6 78999999975 88888865432 88999999999999999999999 9999999999999999
Q ss_pred CCeEEEeeccccCCCCccccccccccccCccccCCCccccCC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhh
Q 020641 172 DFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG-QLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLV 250 (323)
Q Consensus 172 ~~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~ 250 (323)
++.++|+|||++........ .......++..|+|||.+.+. .++.++|||||||++|+|++|+.||...........+
T Consensus 139 ~~~~kL~Dfg~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i 217 (372)
T cd07853 139 NCVLKICDFGLARVEEPDES-KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLI 217 (372)
T ss_pred CCCEEeccccceeecccCcc-ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHH
Confidence 99999999999875433221 112233478899999988764 4788999999999999999999999765432211111
Q ss_pred hhhccccccccc-------chhcCCC-cC-------CCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 251 TWATPRLSEDKV-------KQCVDPK-LK-------GEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 251 ~~~~~~~~~~~~-------~~~~~~~-~~-------~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
...........+ ...+... .. .......+.++.+++.+||+.||++|||+.|+++
T Consensus 218 ~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 287 (372)
T cd07853 218 TDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALA 287 (372)
T ss_pred HHHcCCCCHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhc
Confidence 110000000000 0000000 00 0112233567899999999999999999999986
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=290.46 Aligned_cols=256 Identities=19% Similarity=0.230 Sum_probs=202.8
Q ss_pred CCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEe
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVE 95 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 95 (323)
.|.....||.|++|+||++.+..+++.+++|......... ....+.+.+|+++++.++|+||+++++.+..
T Consensus 2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~---------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 72 (316)
T cd05574 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIK---------RNKVKRVLTEQEILATLDHPFLPTLYASFQT 72 (316)
T ss_pred ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccch---------HHHHHHHHHHHHHHHhCCCCCchhheeeeec
Confidence 3556678999999999999999999999999776432211 1234678899999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeE
Q 020641 96 GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKA 175 (323)
Q Consensus 96 ~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~ 175 (323)
+...++||||+.+++|.+++...... .+++..+..++.|++.||.|||+. |++|+||||+||+++.++.+
T Consensus 73 ~~~~~lv~e~~~~~~L~~~~~~~~~~-------~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~ 142 (316)
T cd05574 73 ETYLCLVMDYCPGGELFRLLQRQPGK-------CLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHI 142 (316)
T ss_pred CCEEEEEEEecCCCCHHHHHHhCCCC-------ccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCE
Confidence 99999999999999999999754322 288999999999999999999999 99999999999999999999
Q ss_pred EEeeccccCCCCccccc---------------------------cccccccCccccCCCccccCCCCCcccchHHHHHHH
Q 020641 176 KIADFNLSNQAPDMAAR---------------------------LHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVL 228 (323)
Q Consensus 176 ~l~Dfg~~~~~~~~~~~---------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l 228 (323)
+|+|||++......... .......|+..|+|||.+.+..++.++||||||+++
T Consensus 143 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll 222 (316)
T cd05574 143 MLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILL 222 (316)
T ss_pred EEeecchhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHH
Confidence 99999987654321110 011123478889999999988899999999999999
Q ss_pred HHHHhCCCCCCCCCCcccchhhhhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCC----hHHHH
Q 020641 229 LELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPN----MSIVV 304 (323)
Q Consensus 229 ~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps----~~evl 304 (323)
|+|++|..||........ ..+..............+..+.+++.+||..||++||| +.+++
T Consensus 223 ~~l~~g~~pf~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll 287 (316)
T cd05574 223 YEMLYGTTPFKGSNRDET---------------FSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIK 287 (316)
T ss_pred HHHhhCCCCCCCCchHHH---------------HHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHH
Confidence 999999999975543211 11111111111112225678999999999999999999 88888
Q ss_pred H
Q 020641 305 K 305 (323)
Q Consensus 305 ~ 305 (323)
+
T Consensus 288 ~ 288 (316)
T cd05574 288 Q 288 (316)
T ss_pred c
Confidence 7
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=282.83 Aligned_cols=258 Identities=26% Similarity=0.336 Sum_probs=196.1
Q ss_pred ccCCCCCCccceeccceeeee--eeeccccccccCccccccccCCCCCchHHHHHHHHHhcC-CCCcccceeeEEEeCCe
Q 020641 22 RLDKGPEDDLYLKKRVKMRRW--LCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRL-KHENLVELLGYCVEGNL 98 (323)
Q Consensus 22 ~lg~G~~~~V~~~~~~~~~~~--~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~ 98 (323)
.||+|+||.||++++..++.. +++|..... ......+.+.+|+++++++ +||||+++++++...+.
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~-----------~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 70 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-----------ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY 70 (270)
T ss_pred cCCCCCCceEEEEEEcCCCCeeEEEEEEcccc-----------CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCC
Confidence 489999999999998877653 455533211 1112235678899999999 89999999999999999
Q ss_pred EEEEEeecCCCCHHHHhccCCCCCC-------CCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEcc
Q 020641 99 RVLAYEFATMGSLHDILHGRKGVQG-------AQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFE 171 (323)
Q Consensus 99 ~~lv~e~~~~~sL~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~ 171 (323)
.+++|||+.+++|.+++........ ......+++..+..++.|++.|+.|||+. |++|+||||+||+++.
T Consensus 71 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~ 147 (270)
T cd05047 71 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGE 147 (270)
T ss_pred ceEEEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcC
Confidence 9999999999999999976432110 01122488999999999999999999999 9999999999999999
Q ss_pred CCeEEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccchhh
Q 020641 172 DFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLV 250 (323)
Q Consensus 172 ~~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~ 250 (323)
++.++|+|||++........ ......+..|+|||.+....++.++|+||||+++|+|++ |..||.......
T Consensus 148 ~~~~kl~dfgl~~~~~~~~~---~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~----- 219 (270)
T cd05047 148 NYVAKIADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE----- 219 (270)
T ss_pred CCeEEECCCCCccccchhhh---ccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHH-----
Confidence 99999999998753322111 111223567999999888888999999999999999997 999996442211
Q ss_pred hhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhhc
Q 020641 251 TWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLK 312 (323)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~~ 312 (323)
..+.+........+...+..+.+++.+||+.||.+|||+.++++.|.++++
T Consensus 220 -----------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~~ 270 (270)
T cd05047 220 -----------LYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 270 (270)
T ss_pred -----------HHHHHhCCCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhhC
Confidence 011111111112223345679999999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-41 Score=294.34 Aligned_cols=244 Identities=20% Similarity=0.224 Sum_probs=193.8
Q ss_pred CccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcC-CCCcccceeeEEEe
Q 020641 17 PGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRL-KHENLVELLGYCVE 95 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~ 95 (323)
+.+...||+|+||.||+|++..+++.+|+|+..+.... .....+.+..|..++..+ .|++|+++++++..
T Consensus 2 f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~---------~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~ 72 (323)
T cd05615 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVI---------QDDDVECTMVEKRVLALQDKPPFLTQLHSCFQT 72 (323)
T ss_pred ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhh---------hhhHHHHHHHHHHHHHhccCCCchhheeeEEec
Confidence 45567899999999999999999999999977643211 112235567788888888 56788889999999
Q ss_pred CCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeE
Q 020641 96 GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKA 175 (323)
Q Consensus 96 ~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~ 175 (323)
.+..|+||||+.+|+|.+++..... +++..+..++.|++.||.|||+. |++||||||+||+++.++.+
T Consensus 73 ~~~~~lv~Ey~~~g~L~~~i~~~~~---------l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~i 140 (323)
T cd05615 73 VDRLYFVMEYVNGGDLMYHIQQVGK---------FKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHI 140 (323)
T ss_pred CCEEEEEEcCCCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCE
Confidence 9999999999999999999876432 88999999999999999999999 99999999999999999999
Q ss_pred EEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhcc
Q 020641 176 KIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATP 255 (323)
Q Consensus 176 ~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~ 255 (323)
+|+|||++........ ......|++.|+|||.+.+..++.++|+||||+++|+|++|..||........
T Consensus 141 kL~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~--------- 209 (323)
T cd05615 141 KIADFGMCKEHMVDGV--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDEL--------- 209 (323)
T ss_pred EEeccccccccCCCCc--cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHH---------
Confidence 9999999875332111 12334589999999999888899999999999999999999999975532111
Q ss_pred cccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCCh
Q 020641 256 RLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNM 300 (323)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~ 300 (323)
...+.... ...+...+..+.+++.+||+.+|.+|++.
T Consensus 210 ------~~~i~~~~--~~~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 210 ------FQSIMEHN--VSYPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred ------HHHHHhCC--CCCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 11111111 12233456678999999999999999974
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=282.05 Aligned_cols=254 Identities=27% Similarity=0.392 Sum_probs=199.6
Q ss_pred CCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEe
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVE 95 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 95 (323)
.+....+||.|++|.||++.+.. ++.+++|..... ....+.+.+|+.+++.++|+||+++++++..
T Consensus 7 ~~~i~~~ig~g~~~~v~~~~~~~-~~~~~vK~~~~~-------------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 72 (261)
T cd05034 7 SLKLERKLGAGQFGEVWMGTWNG-TTKVAVKTLKPG-------------TMSPEAFLQEAQIMKKLRHDKLVQLYAVCSE 72 (261)
T ss_pred heeeeeeeccCcceEEEEEEEcC-CceEEEEEecCC-------------ccCHHHHHHHHHHHhhCCCCCEeeeeeeeec
Confidence 34455689999999999998754 456777755421 1123678899999999999999999999998
Q ss_pred CCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeE
Q 020641 96 GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKA 175 (323)
Q Consensus 96 ~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~ 175 (323)
....+++|||+.+++|.+++...... .+++..+..++.|++.|+.|||+. |++|+||+|+||+++.++.+
T Consensus 73 ~~~~~~v~e~~~~~~L~~~i~~~~~~-------~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~ 142 (261)
T cd05034 73 EEPIYIVTEYMSKGSLLDFLKSGEGK-------KLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVC 142 (261)
T ss_pred CCceEEEEeccCCCCHHHHHhccccC-------CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCE
Confidence 88999999999999999999765422 288999999999999999999999 99999999999999999999
Q ss_pred EEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhc
Q 020641 176 KIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWAT 254 (323)
Q Consensus 176 ~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~ 254 (323)
+|+|||.+........ .......++..|+|||.+.+..++.++|+||||+++|++++ |+.||....... ...
T Consensus 143 ~l~d~g~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~---~~~--- 215 (261)
T cd05034 143 KIADFGLARLIEDDEY-TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNRE---VLE--- 215 (261)
T ss_pred EECccccceeccchhh-hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHH---
Confidence 9999999876543211 11122224567999999988889999999999999999998 999996543211 111
Q ss_pred ccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhh
Q 020641 255 PRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPL 310 (323)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~ 310 (323)
.+........+...+..+.+++.+||+.+|++||++.++++.|+++
T Consensus 216 ----------~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~~ 261 (261)
T cd05034 216 ----------QVERGYRMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLEDY 261 (261)
T ss_pred ----------HHHcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhcC
Confidence 1111111222333466799999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=286.63 Aligned_cols=271 Identities=22% Similarity=0.305 Sum_probs=199.0
Q ss_pred CCccccccCCCCCCccceecccee----------------eeeeeeccccccccCccccccccCCCCCchHHHHHHHHHh
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRVKM----------------RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVS 79 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~~~----------------~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~ 79 (323)
.+....+||+|+||.||++.+... ...+++|..... ........+.+|+.+++
T Consensus 6 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~-----------~~~~~~~~~~~E~~~l~ 74 (296)
T cd05095 6 RLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLRED-----------ANKNARNDFLKEIKIMS 74 (296)
T ss_pred hceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEecccc-----------CCHHHHHHHHHHHHHHH
Confidence 356677999999999999865432 334555543211 11222467889999999
Q ss_pred cCCCCcccceeeEEEeCCeEEEEEeecCCCCHHHHhccCCCCCC--CCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCc
Q 020641 80 RLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQG--AQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSI 157 (323)
Q Consensus 80 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i 157 (323)
.++|+||+++++++..+...+++|||+.+++|.+++........ ......+++..+..++.|++.|+.|||+. |+
T Consensus 75 ~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i 151 (296)
T cd05095 75 RLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NF 151 (296)
T ss_pred hCCCCCcceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---Ce
Confidence 99999999999999999999999999999999999976432211 12223488889999999999999999999 99
Q ss_pred eeCCCCCCCEEEccCCeEEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHh--CC
Q 020641 158 IHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT--GR 235 (323)
Q Consensus 158 ~h~dikp~nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~--g~ 235 (323)
+|+||||+||+++.++.++|+|||++................++..|++||...+..++.++|+||||+++|+|++ |.
T Consensus 152 ~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~ 231 (296)
T cd05095 152 VHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKE 231 (296)
T ss_pred ecccCChheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCC
Confidence 9999999999999999999999999876543222111222334678999998888889999999999999999998 77
Q ss_pred CCCCCCCCcccchhhhhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhh
Q 020641 236 KPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQP 309 (323)
Q Consensus 236 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~ 309 (323)
.||......... ......... .........+..++..+.+++.+||+.||.+|||+.+|++.|++
T Consensus 232 ~p~~~~~~~~~~---~~~~~~~~~------~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 232 QPYSQLSDEQVI---ENTGEFFRD------QGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred CCccccChHHHH---HHHHHHHhh------ccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 888644321110 000000000 00000111223345789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=296.31 Aligned_cols=240 Identities=19% Similarity=0.206 Sum_probs=188.7
Q ss_pred ccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHH-HHHhcCCCCcccceeeEEEeCCeEE
Q 020641 22 RLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLV-SVVSRLKHENLVELLGYCVEGNLRV 100 (323)
Q Consensus 22 ~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~-~~l~~l~h~~i~~~~~~~~~~~~~~ 100 (323)
.||+|+||.||+|++..+++.+|+|++.+..... ......+..|. .+++.++|+||+++++.+...+..+
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~---------~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~ 72 (321)
T cd05603 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILK---------KKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLY 72 (321)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHH---------hhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEE
Confidence 5899999999999999999999999776432211 11123344444 4577889999999999999999999
Q ss_pred EEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEEEeec
Q 020641 101 LAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADF 180 (323)
Q Consensus 101 lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~l~Df 180 (323)
+||||+.+++|.+.+..... +++..+..++.||+.||.|||+. |++||||||+||+++.++.++|+||
T Consensus 73 lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Df 140 (321)
T cd05603 73 FVLDYVNGGELFFHLQRERC---------FLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDF 140 (321)
T ss_pred EEEcCCCCCCHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccC
Confidence 99999999999988865432 88889999999999999999999 9999999999999999999999999
Q ss_pred cccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhccccccc
Q 020641 181 NLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSED 260 (323)
Q Consensus 181 g~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 260 (323)
|++........ ......|++.|+|||.+.+..++.++|||||||++|+|++|..||...+.... .
T Consensus 141 g~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~---------- 205 (321)
T cd05603 141 GLCKEGVEPEE--TTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQM---Y---------- 205 (321)
T ss_pred CCCccCCCCCC--ccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHH---H----------
Confidence 99865322111 12334589999999999888899999999999999999999999975532111 0
Q ss_pred ccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChH
Q 020641 261 KVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMS 301 (323)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ 301 (323)
..+.... ...+...+..+.+++.+||+.||.+||++.
T Consensus 206 --~~i~~~~--~~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 206 --DNILHKP--LQLPGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred --HHHhcCC--CCCCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 0011110 122334456799999999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=286.31 Aligned_cols=266 Identities=22% Similarity=0.320 Sum_probs=199.6
Q ss_pred CCccccccCCCCCCccceeccce-----eeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCccccee
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRVK-----MRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELL 90 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~~-----~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~ 90 (323)
.+....+||+|+||.||++.... .+..+++|...... .......+.+|+.+++.++|+||++++
T Consensus 7 ~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-----------~~~~~~~~~~e~~~l~~l~~~~i~~~~ 75 (288)
T cd05061 7 KITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA-----------SLRERIEFLNEASVMKGFTCHHVVRLL 75 (288)
T ss_pred HceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC-----------CHHHHHHHHHHHHHHHhCCCCCeeeEE
Confidence 35566799999999999986542 23457777443110 011124577899999999999999999
Q ss_pred eEEEeCCeEEEEEeecCCCCHHHHhccCCCCCC-CCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEE
Q 020641 91 GYCVEGNLRVLAYEFATMGSLHDILHGRKGVQG-AQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLL 169 (323)
Q Consensus 91 ~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili 169 (323)
+++..+...++||||+.+|+|.+++........ .......+...+..++.|++.||.|||+. +++|+||||+||++
T Consensus 76 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili 152 (288)
T cd05061 76 GVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMV 152 (288)
T ss_pred EEEcCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEE
Confidence 999999999999999999999999975432111 11122367778899999999999999999 99999999999999
Q ss_pred ccCCeEEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccch
Q 020641 170 FEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQS 248 (323)
Q Consensus 170 ~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~ 248 (323)
+.++.++|+|||++................++..|+|||.+.+..++.++|+||||+++|+|++ |..||.......
T Consensus 153 ~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~--- 229 (288)
T cd05061 153 AHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ--- 229 (288)
T ss_pred cCCCcEEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHH---
Confidence 9999999999999875543222211222335677999999988889999999999999999998 788986543211
Q ss_pred hhhhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhh
Q 020641 249 LVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLL 311 (323)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~ 311 (323)
..+.+........+...+..+.+++.+||+.||++|||+.++++.|++.+
T Consensus 230 -------------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 230 -------------VLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred -------------HHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 11111000011122334568999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-41 Score=299.98 Aligned_cols=242 Identities=21% Similarity=0.262 Sum_probs=203.1
Q ss_pred ccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcC-CCCcccceeeEEEeC
Q 020641 18 GYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRL-KHENLVELLGYCVEG 96 (323)
Q Consensus 18 ~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~ 96 (323)
....-||+|+||.|+++....+++++|+|+..+..+ ..++..+..+.|.+++... +||-++.++..|.+.
T Consensus 371 ~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~I---------l~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~ 441 (694)
T KOG0694|consen 371 RLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDI---------LQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTK 441 (694)
T ss_pred EEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccce---------eccccHHHHHHHHHHHHHhccCCeEeecccccccC
Confidence 344478999999999999999999999998875532 3344557778888888877 799999999999999
Q ss_pred CeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEE
Q 020641 97 NLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAK 176 (323)
Q Consensus 97 ~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~ 176 (323)
.++|+||||..||++.-+.+... +++..+.-++..++.||.|||++ ||++||||.+|||+|..|.+|
T Consensus 442 ~~l~fvmey~~Ggdm~~~~~~~~----------F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~k 508 (694)
T KOG0694|consen 442 EHLFFVMEYVAGGDLMHHIHTDV----------FSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVK 508 (694)
T ss_pred CeEEEEEEecCCCcEEEEEeccc----------ccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEE
Confidence 99999999999999555554333 99999999999999999999999 999999999999999999999
Q ss_pred EeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhccc
Q 020641 177 IADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPR 256 (323)
Q Consensus 177 l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 256 (323)
|+|||+....-.... ..++.+|||.|+|||++.+..|+.+.|-|||||++|+|+.|+.||.+.+...-
T Consensus 509 iADFGlcKe~m~~g~--~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~---------- 576 (694)
T KOG0694|consen 509 IADFGLCKEGMGQGD--RTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEV---------- 576 (694)
T ss_pred ecccccccccCCCCC--ccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHH----------
Confidence 999999987654333 45778899999999999999999999999999999999999999986653211
Q ss_pred ccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCCh
Q 020641 257 LSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNM 300 (323)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~ 300 (323)
..+++... ..+|.-++.+..++++++|.+||++|.-.
T Consensus 577 -----FdsI~~d~--~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 577 -----FDSIVNDE--VRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred -----HHHHhcCC--CCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 11222211 24567778889999999999999999844
|
|
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=282.87 Aligned_cols=257 Identities=20% Similarity=0.284 Sum_probs=199.1
Q ss_pred CccccccCCCCCCccceeccceee---eeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEE
Q 020641 17 PGYFVRLDKGPEDDLYLKKRVKMR---RWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYC 93 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 93 (323)
+.....||+|+||.||++.+..++ ..+++|...... .......+.+|+.++++++||||+++++++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~-----------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 74 (267)
T cd05066 6 IKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY-----------TEKQRRDFLSEASIMGQFDHPNIIHLEGVV 74 (267)
T ss_pred eEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC-----------CHHHHHHHHHHHHHHHhCCCCCcceEEEEE
Confidence 345568999999999999876443 356666543211 011235778899999999999999999999
Q ss_pred EeCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCC
Q 020641 94 VEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDF 173 (323)
Q Consensus 94 ~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~ 173 (323)
..++..++||||+.+++|.+++...... +++..+..++.|++.|+.+||+. |++|+||||+||+++.++
T Consensus 75 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~--------~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~ 143 (267)
T cd05066 75 TKSKPVMIVTEYMENGSLDAFLRKHDGQ--------FTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNL 143 (267)
T ss_pred ecCCccEEEEEcCCCCCHHHHHHhcCCC--------CCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCC
Confidence 9999999999999999999999764322 88899999999999999999999 999999999999999999
Q ss_pred eEEEeeccccCCCCccccccc-cccccCccccCCCccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccchhhh
Q 020641 174 KAKIADFNLSNQAPDMAARLH-STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVT 251 (323)
Q Consensus 174 ~~~l~Dfg~~~~~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~ 251 (323)
.++|+|||++........... .....++..|+|||.+.+..++.++|+||||+++|++++ |..||........ ..
T Consensus 144 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~---~~ 220 (267)
T cd05066 144 VCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDV---IK 220 (267)
T ss_pred eEEeCCCCcccccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHH---HH
Confidence 999999999876544322111 111223567999999988889999999999999999886 9999975432111 00
Q ss_pred hhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhh
Q 020641 252 WATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLL 311 (323)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~ 311 (323)
. +........+...+..+.+++.+||+.+|.+|||+.++++.|++++
T Consensus 221 ~-------------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~ 267 (267)
T cd05066 221 A-------------IEEGYRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKLI 267 (267)
T ss_pred H-------------HhCCCcCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhhC
Confidence 0 0011111222344567999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=289.14 Aligned_cols=260 Identities=23% Similarity=0.317 Sum_probs=200.0
Q ss_pred CccccccCCCCCCccceeccceeeee----eeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeE
Q 020641 17 PGYFVRLDKGPEDDLYLKKRVKMRRW----LCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGY 92 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~~~~~~~~----~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 92 (323)
+..+..||+|+||.||++.+..+++. +++|...... .......+.+|+.+++.++|+||++++++
T Consensus 9 ~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~-----------~~~~~~~~~~e~~~~~~l~h~niv~~~~~ 77 (303)
T cd05110 9 LKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT-----------GPKANVEFMDEALIMASMDHPHLVRLLGV 77 (303)
T ss_pred ceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC-----------CHHHHHHHHHHHHHHHhCCCCCcccEEEE
Confidence 45566899999999999998877654 4555432110 11112467889999999999999999999
Q ss_pred EEeCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccC
Q 020641 93 CVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFED 172 (323)
Q Consensus 93 ~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~ 172 (323)
+... ..+++++|+.+|+|.+++...... +++..+..++.|++.||.|||+. |++|+||||+||+++.+
T Consensus 78 ~~~~-~~~~v~e~~~~g~l~~~~~~~~~~--------~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~ 145 (303)
T cd05110 78 CLSP-TIQLVTQLMPHGCLLDYVHEHKDN--------IGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSP 145 (303)
T ss_pred EcCC-CceeeehhcCCCCHHHHHHhcccC--------CCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCC
Confidence 8765 467899999999999998764322 78889999999999999999999 99999999999999999
Q ss_pred CeEEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccchhhh
Q 020641 173 FKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVT 251 (323)
Q Consensus 173 ~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~ 251 (323)
+.++|+|||++................++..|+|||.+.+..++.++||||||+++|++++ |..||........
T Consensus 146 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~----- 220 (303)
T cd05110 146 NHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREI----- 220 (303)
T ss_pred CceEEccccccccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH-----
Confidence 9999999999976543322222222335678999999988889999999999999999997 9999965432111
Q ss_pred hhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhhcCCC
Q 020641 252 WATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSPP 315 (323)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~~~~~ 315 (323)
...+........+..++..+.+++.+||..+|++||++.++++.|+.+...+.
T Consensus 221 -----------~~~~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~~ 273 (303)
T cd05110 221 -----------PDLLEKGERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDPQ 273 (303)
T ss_pred -----------HHHHHCCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhchh
Confidence 11111111111223345679999999999999999999999999999886654
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=287.48 Aligned_cols=271 Identities=23% Similarity=0.341 Sum_probs=201.0
Q ss_pred CCccccccCCCCCCccceeccceeee----------------eeeeccccccccCccccccccCCCCCchHHHHHHHHHh
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRVKMRR----------------WLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVS 79 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~~~~~----------------~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~ 79 (323)
.+....+||+|+||.||++++...+. .+++|...... .....+.+.+|+++++
T Consensus 6 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~-----------~~~~~~~~~~e~~~l~ 74 (296)
T cd05051 6 PLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA-----------SDNAREDFLKEVKILS 74 (296)
T ss_pred hCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc-----------CHHHHHHHHHHHHHHH
Confidence 45667799999999999998876553 34555433211 1123467788999999
Q ss_pred cCCCCcccceeeEEEeCCeEEEEEeecCCCCHHHHhccCCCCCCC--CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCc
Q 020641 80 RLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGA--QPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSI 157 (323)
Q Consensus 80 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i 157 (323)
+++|+||+++++++..+...++++|++.+++|.+++......... .....+++..++.++.|++.||.|||+. |+
T Consensus 75 ~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i 151 (296)
T cd05051 75 RLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NF 151 (296)
T ss_pred hcCCCCEeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cc
Confidence 999999999999999999999999999999999999765421111 1112389999999999999999999999 99
Q ss_pred eeCCCCCCCEEEccCCeEEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHh--CC
Q 020641 158 IHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT--GR 235 (323)
Q Consensus 158 ~h~dikp~nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~--g~ 235 (323)
+|+||||+||+++.++.++|+|||.+................++..|+|||.+.+..++.++||||||+++|+|++ +.
T Consensus 152 ~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~ 231 (296)
T cd05051 152 VHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCRE 231 (296)
T ss_pred cccccchhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCC
Confidence 9999999999999999999999999875543322222233446778999999888889999999999999999998 77
Q ss_pred CCCCCCCCcccchhhhhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhh
Q 020641 236 KPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQP 309 (323)
Q Consensus 236 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~ 309 (323)
.||....... ........... .........+...+.++.+++.+||+.||.+|||+.+|++.|++
T Consensus 232 ~p~~~~~~~~---~~~~~~~~~~~------~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 232 QPYEHLTDQQ---VIENAGHFFRD------DGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred CCCCCcChHH---HHHHHHhcccc------ccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 7886443211 11111100000 00011111223345679999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-41 Score=296.15 Aligned_cols=241 Identities=20% Similarity=0.202 Sum_probs=189.5
Q ss_pred ccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHH-HHhcCCCCcccceeeEEEeCCeEE
Q 020641 22 RLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVS-VVSRLKHENLVELLGYCVEGNLRV 100 (323)
Q Consensus 22 ~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~ 100 (323)
.||+|+||.||+|++..+++.+|+|+..++.... ......+..|.. +++.++||||+++++.+...+..+
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~---------~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~ 72 (325)
T cd05604 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLN---------RKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLY 72 (325)
T ss_pred ceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhh---------hhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEE
Confidence 5899999999999999999999999776432111 111234445544 467789999999999999999999
Q ss_pred EEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEEEeec
Q 020641 101 LAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADF 180 (323)
Q Consensus 101 lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~l~Df 180 (323)
+||||+.+++|.+++..... +++..+..++.||+.||.|||+. |++||||||+||+++.++.++|+||
T Consensus 73 lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~Df 140 (325)
T cd05604 73 FVLDFVNGGELFFHLQRERS---------FPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDF 140 (325)
T ss_pred EEEcCCCCCCHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeec
Confidence 99999999999998865432 88999999999999999999999 9999999999999999999999999
Q ss_pred cccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhccccccc
Q 020641 181 NLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSED 260 (323)
Q Consensus 181 g~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 260 (323)
|++........ ......|++.|+|||.+.+..++.++|||||||++|+|++|..||........
T Consensus 141 G~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~-------------- 204 (325)
T cd05604 141 GLCKEGIAQSD--TTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEM-------------- 204 (325)
T ss_pred CCcccCCCCCC--CcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHH--------------
Confidence 99865322111 12334589999999999988899999999999999999999999975432111
Q ss_pred ccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHH
Q 020641 261 KVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSI 302 (323)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~e 302 (323)
......... ......+..+.+++.+||+.+|.+||++.+
T Consensus 205 -~~~~~~~~~--~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~ 243 (325)
T cd05604 205 -YDNILHKPL--VLRPGASLTAWSILEELLEKDRQRRLGAKE 243 (325)
T ss_pred -HHHHHcCCc--cCCCCCCHHHHHHHHHHhccCHHhcCCCCC
Confidence 011111111 112234567889999999999999998863
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=282.70 Aligned_cols=256 Identities=25% Similarity=0.345 Sum_probs=198.1
Q ss_pred ccCCCCCCccceeccceee------eeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEe
Q 020641 22 RLDKGPEDDLYLKKRVKMR------RWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVE 95 (323)
Q Consensus 22 ~lg~G~~~~V~~~~~~~~~------~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 95 (323)
.||+|+||.||+++..... +.+++|...... .......+.+|+.+++.++|+||+++++++..
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~-----------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 70 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA-----------TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLL 70 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhccc-----------chhhHHHHHHHHHHHHhcCCCCeeeEeeeecC
Confidence 5899999999999886544 567777553221 11224568899999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCC--
Q 020641 96 GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDF-- 173 (323)
Q Consensus 96 ~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~-- 173 (323)
....++||||+.+++|.+++....... .....+++..+..++.|++.|+.|||+. +++|+||+|+||+++.++
T Consensus 71 ~~~~~~v~e~~~~~~L~~~l~~~~~~~--~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~ 145 (269)
T cd05044 71 NEPQYIIMELMEGGDLLSYLRDARVER--FGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYD 145 (269)
T ss_pred CCCeEEEEeccCCCcHHHHHHHhhhcc--cCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCC
Confidence 889999999999999999997543211 0122378899999999999999999999 999999999999999877
Q ss_pred ---eEEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccchh
Q 020641 174 ---KAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSL 249 (323)
Q Consensus 174 ---~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~ 249 (323)
.++|+|||++................++..|+|||.+.+..++.++||||||+++|+|++ |..||.......
T Consensus 146 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~---- 221 (269)
T cd05044 146 ADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQE---- 221 (269)
T ss_pred CCcceEECCcccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHH----
Confidence 899999999875543322222222335678999999988889999999999999999998 999996443211
Q ss_pred hhhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhh
Q 020641 250 VTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQP 309 (323)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~ 309 (323)
....+........+...+..+.+++.+||..+|.+||++.+|++.|++
T Consensus 222 ------------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 222 ------------VLQHVTAGGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred ------------HHHHHhcCCccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 111111111122334456789999999999999999999999999864
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=289.16 Aligned_cols=255 Identities=26% Similarity=0.384 Sum_probs=197.7
Q ss_pred CccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeC
Q 020641 17 PGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEG 96 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 96 (323)
|+....||+|+||+||++++..+++.+++|+.......... .....+|+.++++++|+||+++++++...
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~----------~~~~~~e~~~~~~l~~~~i~~~~~~~~~~ 70 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEE----------REENIREIKILRRLRHPNIVQILDVFQDD 70 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHH----------HHHHHHHHHHHHHHTBTTBCHEEEEEEES
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccc----------cchhhhhhhcccccccccccccccccccc
Confidence 35567899999999999999999999999977644222211 12234589999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEE
Q 020641 97 NLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAK 176 (323)
Q Consensus 97 ~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~ 176 (323)
...++|||++.+++|.+++..... ++...+..++.|++.||.+||+. |++|+||||+||+++.++.++
T Consensus 71 ~~~~~v~~~~~~~~L~~~l~~~~~---------~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~ 138 (260)
T PF00069_consen 71 NYLYIVMEYCPGGSLQDYLQKNKP---------LSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVK 138 (260)
T ss_dssp SEEEEEEEEETTEBHHHHHHHHSS---------BBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEE
T ss_pred cccccccccccccccccccccccc---------ccccccccccccccccccccccc---ccccccccccccccccccccc
Confidence 999999999999999999983322 89999999999999999999999 999999999999999999999
Q ss_pred EeeccccCCCCccccccccccccCccccCCCcccc-CCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhcc
Q 020641 177 IADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAM-TGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATP 255 (323)
Q Consensus 177 l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~ 255 (323)
|+|||.+..... .........++..|+|||.+. +..++.++|+||||+++|+|++|..||.................
T Consensus 139 l~Dfg~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~ 216 (260)
T PF00069_consen 139 LIDFGSSVKLSE--NNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILK 216 (260)
T ss_dssp ESSGTTTEESTS--TTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHH
T ss_pred cccccccccccc--cccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhccc
Confidence 999999864311 111223445788999999988 78889999999999999999999999986621111111110000
Q ss_pred cccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 256 RLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
....... .........+.+++.+||+.||++|||+.++++
T Consensus 217 ~~~~~~~----------~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 217 RPLPSSS----------QQSREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp THHHHHT----------TSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred ccccccc----------cccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000000 000111268999999999999999999999985
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-41 Score=299.26 Aligned_cols=254 Identities=15% Similarity=0.163 Sum_probs=197.7
Q ss_pred CCCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEE
Q 020641 15 PSPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCV 94 (323)
Q Consensus 15 ~~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 94 (323)
..|.....||+|+||.||++++..+++.+|+|+..+..... ......+.+|..+++.++||||+++++.+.
T Consensus 43 ~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~---------~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~ 113 (371)
T cd05622 43 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIK---------RSDSAFFWEERDIMAFANSPWVVQLFYAFQ 113 (371)
T ss_pred hhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhh---------hHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence 45667779999999999999999999999999775422111 112345778999999999999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCe
Q 020641 95 EGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFK 174 (323)
Q Consensus 95 ~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~ 174 (323)
.+...++||||+.+|+|.+++.... ++...+..++.||+.||.|||+. ||+||||||+||+++.++.
T Consensus 114 ~~~~~~lv~Ey~~gg~L~~~~~~~~----------~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ 180 (371)
T cd05622 114 DDRYLYMVMEYMPGGDLVNLMSNYD----------VPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGH 180 (371)
T ss_pred cCCEEEEEEcCCCCCcHHHHHHhcC----------CCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCC
Confidence 9999999999999999999997543 78888999999999999999999 9999999999999999999
Q ss_pred EEEeeccccCCCCccccccccccccCccccCCCccccCCC----CCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhh
Q 020641 175 AKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQ----LTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLV 250 (323)
Q Consensus 175 ~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~----~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~ 250 (323)
++|+|||++........ .......||+.|+|||++.+.. ++.++|||||||++|+|++|..||.........
T Consensus 181 ikL~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~--- 256 (371)
T cd05622 181 LKLADFGTCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTY--- 256 (371)
T ss_pred EEEEeCCceeEcCcCCc-ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHH---
Confidence 99999999876543221 1123445899999999986543 788999999999999999999999755321111
Q ss_pred hhhcccccccccchhcCCC--cCCCCCHHHHHHHHHHHHHccCCCCCC--CCChHHHHHH
Q 020641 251 TWATPRLSEDKVKQCVDPK--LKGEYPPKGVAKLAAVAALCVQYEAEF--RPNMSIVVKA 306 (323)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~cl~~~P~~--Rps~~evl~~ 306 (323)
..+.... .........+..+.+++.+||..++.. |+++.|+++.
T Consensus 257 ------------~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h 304 (371)
T cd05622 257 ------------SKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 304 (371)
T ss_pred ------------HHHHcCCCcccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence 1111110 111112345677999999999844432 6789988873
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=297.96 Aligned_cols=260 Identities=17% Similarity=0.241 Sum_probs=194.3
Q ss_pred CCccccccCCCCCCccceeccc--eeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEE
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRV--KMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYC 93 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 93 (323)
.|..+.+||.|+||.||++... ..++.+++|..... ....+|++++++++|+||+++++++
T Consensus 93 ~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----------------~~~~~E~~il~~l~h~~iv~~~~~~ 155 (392)
T PHA03207 93 QYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----------------KTPGREIDILKTISHRAIINLIHAY 155 (392)
T ss_pred ceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----------------ccHHHHHHHHHhcCCCCccceeeeE
Confidence 3666779999999999998654 34566777644321 2346799999999999999999999
Q ss_pred EeCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCC
Q 020641 94 VEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDF 173 (323)
Q Consensus 94 ~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~ 173 (323)
......+++||++.+ +|.+++.... .+++..++.++.||+.||.|||+. ||+||||||+||+++.++
T Consensus 156 ~~~~~~~lv~e~~~~-~l~~~l~~~~---------~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~ 222 (392)
T PHA03207 156 RWKSTVCMVMPKYKC-DLFTYVDRSG---------PLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPE 222 (392)
T ss_pred eeCCEEEEEehhcCC-CHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCC
Confidence 999999999999964 8999884332 189999999999999999999999 999999999999999999
Q ss_pred eEEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhh
Q 020641 174 KAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWA 253 (323)
Q Consensus 174 ~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 253 (323)
.++|+|||++................||+.|+|||++.+..++.++|||||||++|+|++|+.||...............
T Consensus 223 ~~~l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i 302 (392)
T PHA03207 223 NAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSI 302 (392)
T ss_pred CEEEccCccccccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHH
Confidence 99999999987655433332233456899999999999889999999999999999999999999765432211111000
Q ss_pred ccc-------cccc---ccc---hhcCCCcCCCCC-------HHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 254 TPR-------LSED---KVK---QCVDPKLKGEYP-------PKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 254 ~~~-------~~~~---~~~---~~~~~~~~~~~~-------~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
... .... .+. .......+.... ...+.++.++|.+||..||++|||+.|++.
T Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~ 374 (392)
T PHA03207 303 IRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILS 374 (392)
T ss_pred HHHhccCccccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhh
Confidence 000 0000 000 000000010000 123457889999999999999999999998
|
|
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=288.25 Aligned_cols=271 Identities=20% Similarity=0.260 Sum_probs=200.7
Q ss_pred CCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEe
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVE 95 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 95 (323)
.|....+||.|+||.||++++..+++.+++|...... .......+.+|+.+++.++|+||+++++++..
T Consensus 7 ~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~-----------~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~ 75 (301)
T cd07873 7 TYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEH-----------EEGAPCTAIREVSLLKDLKHANIVTLHDIIHT 75 (301)
T ss_pred ceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEeccc-----------ccCchhHHHHHHHHHHhcCCCCcceEEEEEec
Confidence 4566679999999999999999999999998653221 11223467789999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeE
Q 020641 96 GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKA 175 (323)
Q Consensus 96 ~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~ 175 (323)
.+..++||||+.+ +|.+++...... +++..+..++.|++.||.|||+. |++|+||||+||+++.++.+
T Consensus 76 ~~~~~lv~e~~~~-~l~~~l~~~~~~--------~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~ 143 (301)
T cd07873 76 EKSLTLVFEYLDK-DLKQYLDDCGNS--------INMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGEL 143 (301)
T ss_pred CCeEEEEEecccc-CHHHHHHhcCCC--------CCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcE
Confidence 9999999999975 899988654322 88889999999999999999999 99999999999999999999
Q ss_pred EEeeccccCCCCccccccccccccCccccCCCccccCC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhc
Q 020641 176 KIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG-QLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWAT 254 (323)
Q Consensus 176 ~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~ 254 (323)
+|+|||++........ ......+++.|+|||.+.+. .++.++||||||+++|+|++|+.||................
T Consensus 144 kl~dfg~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~ 221 (301)
T cd07873 144 KLADFGLARAKSIPTK--TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRIL 221 (301)
T ss_pred EECcCcchhccCCCCC--cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHc
Confidence 9999999865432211 11223468899999987653 47889999999999999999999997654321111110000
Q ss_pred ccccccccchhcC---------CCcCC----CCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH--HHhhhh
Q 020641 255 PRLSEDKVKQCVD---------PKLKG----EYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK--ALQPLL 311 (323)
Q Consensus 255 ~~~~~~~~~~~~~---------~~~~~----~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~--~l~~~~ 311 (323)
..........++. +.... ......+..+.+++.+||+.||.+|||+.|+++ +++.+-
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~ 293 (301)
T cd07873 222 GTPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLG 293 (301)
T ss_pred CCCChhhchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence 0000000011000 00000 111234567899999999999999999999997 554443
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=280.64 Aligned_cols=252 Identities=21% Similarity=0.277 Sum_probs=199.5
Q ss_pred CCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEe
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVE 95 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 95 (323)
+|++...||+|++|.||++++..+++.+++|....+.. .....+.+.+|++++++++|+|++++++.+..
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----------~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 70 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNA----------SRRERKAAEQEAQLLSQLKHPNIVAYRESWEG 70 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhc----------CHHHHHHHHHHHHHHHhCCCCCeeeeeeeecC
Confidence 46778899999999999999999888888886543211 11223567889999999999999999988764
Q ss_pred -CCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCe
Q 020641 96 -GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFK 174 (323)
Q Consensus 96 -~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~ 174 (323)
....++++||+.+++|.+++...... .+++..++.++.|++.|+.+||+. |++|+||+|+||+++.++.
T Consensus 71 ~~~~~~lv~e~~~~~~l~~~l~~~~~~-------~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~ 140 (257)
T cd08223 71 EDGLLYIVMGFCEGGDLYHKLKEQKGK-------LLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNI 140 (257)
T ss_pred CCCEEEEEecccCCCcHHHHHHHhcCC-------CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCc
Confidence 44679999999999999999764322 288999999999999999999999 9999999999999999999
Q ss_pred EEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhc
Q 020641 175 AKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWAT 254 (323)
Q Consensus 175 ~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~ 254 (323)
++|+|||++........ ......+++.|+|||.+.+..++.++|+||||+++++|++|+.||.........
T Consensus 141 ~~l~df~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~------- 211 (257)
T cd08223 141 IKVGDLGIARVLENQCD--MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLV------- 211 (257)
T ss_pred EEEecccceEEecccCC--ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHH-------
Confidence 99999999865533221 123345788999999998888899999999999999999999999744321100
Q ss_pred ccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 255 PRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
..... ......+...+..+.+++.+||+.||++|||+.++++
T Consensus 212 --------~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 212 --------YRIIE-GKLPPMPKDYSPELGELIATMLSKRPEKRPSVKSILR 253 (257)
T ss_pred --------HHHHh-cCCCCCccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 00000 0011223455678999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-40 Score=280.10 Aligned_cols=250 Identities=26% Similarity=0.340 Sum_probs=196.8
Q ss_pred ccCCCCCCccceeccce-eee--eeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeCCe
Q 020641 22 RLDKGPEDDLYLKKRVK-MRR--WLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNL 98 (323)
Q Consensus 22 ~lg~G~~~~V~~~~~~~-~~~--~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 98 (323)
.||+|++|.||++.+.. .++ .+++|+....... ...+.+.+|+.++++++|+||+++++.+.. ..
T Consensus 2 ~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~-----------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~ 69 (257)
T cd05040 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS-----------DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HP 69 (257)
T ss_pred cCCccCcccEEeeeEecCCCCceEEEEeecCCcccH-----------HHHHHHHHHHHHHhhcCCCCccceeEEEcC-Ce
Confidence 58999999999998865 332 5777766433211 334778899999999999999999999988 88
Q ss_pred EEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEEEe
Q 020641 99 RVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIA 178 (323)
Q Consensus 99 ~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~l~ 178 (323)
.++++||+.+++|.+++...... .+++..++.++.|++.||.+||+. |++|+||+|+||+++.++.++|+
T Consensus 70 ~~~v~e~~~~~~L~~~l~~~~~~-------~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~ 139 (257)
T cd05040 70 LMMVTELAPLGSLLDRLRKDALG-------HFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIG 139 (257)
T ss_pred EEEEEEecCCCcHHHHHHhcccc-------cCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEec
Confidence 99999999999999999765421 288999999999999999999999 99999999999999999999999
Q ss_pred eccccCCCCcccccc-ccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhccc
Q 020641 179 DFNLSNQAPDMAARL-HSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPR 256 (323)
Q Consensus 179 Dfg~~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~ 256 (323)
|||++.......... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||.............
T Consensus 140 dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~----- 214 (257)
T cd05040 140 DFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKID----- 214 (257)
T ss_pred cccccccccccccceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-----
Confidence 999987664422211 1122346778999999988889999999999999999998 999996543221111000
Q ss_pred ccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHh
Q 020641 257 LSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQ 308 (323)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~ 308 (323)
........+...+..+.+++.+||+.+|++|||+.++++.|.
T Consensus 215 ----------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 215 ----------KEGERLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred ----------hcCCcCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 000111122344667999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=286.87 Aligned_cols=271 Identities=22% Similarity=0.302 Sum_probs=198.3
Q ss_pred CCccccccCCCCCCccceeccceeee--------------eeeeccccccccCccccccccCCCCCchHHHHHHHHHhcC
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRVKMRR--------------WLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRL 81 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~~~~~--------------~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l 81 (323)
.+....+||+|+||.||++.+..++. .+++|...... .......+.+|+++++++
T Consensus 6 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-----------~~~~~~~~~~ei~~l~~l 74 (295)
T cd05097 6 QLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV-----------TKTARNDFLKEIKIMSRL 74 (295)
T ss_pred hCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC-----------CHHHHHHHHHHHHHHHhC
Confidence 45566799999999999998865433 35666443210 111235688999999999
Q ss_pred CCCcccceeeEEEeCCeEEEEEeecCCCCHHHHhccCCCCC---CCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCce
Q 020641 82 KHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQ---GAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSII 158 (323)
Q Consensus 82 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~ 158 (323)
+|+|++++++++......++||||+.+++|.+++....... .......+++..+..++.|++.|+.|||+. |++
T Consensus 75 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~ 151 (295)
T cd05097 75 KNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFV 151 (295)
T ss_pred CCCCcCeEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---Cee
Confidence 99999999999999999999999999999999996543110 011112378889999999999999999999 999
Q ss_pred eCCCCCCCEEEccCCeEEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHh--CCC
Q 020641 159 HRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT--GRK 236 (323)
Q Consensus 159 h~dikp~nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~--g~~ 236 (323)
|+||||+||+++.++.++|+|||++................++..|+|||.+.+..++.++|+||||+++|+|++ +..
T Consensus 152 H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~ 231 (295)
T cd05097 152 HRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQ 231 (295)
T ss_pred ccccChhhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCC
Confidence 999999999999999999999999875533222222222335678999999988889999999999999999988 667
Q ss_pred CCCCCCCcccchhhhhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhh
Q 020641 237 PVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQP 309 (323)
Q Consensus 237 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~ 309 (323)
||........ ........... ........+...+..+.+++.+||+.||++|||+.+|++.|++
T Consensus 232 p~~~~~~~~~---~~~~~~~~~~~------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 232 PYSLLSDEQV---IENTGEFFRNQ------GRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred CCcccChHHH---HHHHHHhhhhc------cccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 7765432111 00000000000 0000011122345679999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-41 Score=300.80 Aligned_cols=255 Identities=17% Similarity=0.180 Sum_probs=197.4
Q ss_pred CCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEe
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVE 95 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 95 (323)
.++.+..||+|+||.||+|.+..+++.+|+|+..+... ........+.+|..++..++|+||+++++.+.+
T Consensus 2 ~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~---------~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~ 72 (360)
T cd05627 2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADM---------LEKEQVAHIRAERDILVEADGAWVVKMFYSFQD 72 (360)
T ss_pred CceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHH---------hhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEc
Confidence 35667789999999999999999999999997753221 112234677889999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeE
Q 020641 96 GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKA 175 (323)
Q Consensus 96 ~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~ 175 (323)
.+..++||||+.+|+|.+++..... +++..+..++.|++.||.|||+. |++||||||+||+++.++.+
T Consensus 73 ~~~~~lv~E~~~gg~L~~~l~~~~~---------l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~v 140 (360)
T cd05627 73 KRNLYLIMEFLPGGDMMTLLMKKDT---------LSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHV 140 (360)
T ss_pred CCEEEEEEeCCCCccHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCE
Confidence 9999999999999999999975432 88999999999999999999999 99999999999999999999
Q ss_pred EEeeccccCCCCccccc---------------------------------cccccccCccccCCCccccCCCCCcccchH
Q 020641 176 KIADFNLSNQAPDMAAR---------------------------------LHSTRVLGTFGYHAPEYAMTGQLTQKSDVY 222 (323)
Q Consensus 176 ~l~Dfg~~~~~~~~~~~---------------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~ 222 (323)
+|+|||++......... .......||+.|+|||++.+..++.++|||
T Consensus 141 kL~DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~Diw 220 (360)
T cd05627 141 KLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWW 220 (360)
T ss_pred EEeeccCCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceec
Confidence 99999998644221100 001123589999999999999999999999
Q ss_pred HHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCC---
Q 020641 223 SFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPN--- 299 (323)
Q Consensus 223 slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps--- 299 (323)
||||++|+|++|+.||...........+. .+ ...+........+.++.+++.+|+ .||.+|++
T Consensus 221 SlGvilyel~tG~~Pf~~~~~~~~~~~i~------------~~-~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~ 286 (360)
T cd05627 221 SLGVIMYEMLIGYPPFCSETPQETYRKVM------------NW-KETLVFPPEVPISEKAKDLILRFC-TDSENRIGSNG 286 (360)
T ss_pred cccceeeecccCCCCCCCCCHHHHHHHHH------------cC-CCceecCCCCCCCHHHHHHHHHhc-cChhhcCCCCC
Confidence 99999999999999997654321111000 00 000000111124567888998876 49999985
Q ss_pred hHHHHH
Q 020641 300 MSIVVK 305 (323)
Q Consensus 300 ~~evl~ 305 (323)
+.++++
T Consensus 287 ~~ei~~ 292 (360)
T cd05627 287 VEEIKS 292 (360)
T ss_pred HHHHhc
Confidence 566665
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-40 Score=286.56 Aligned_cols=260 Identities=21% Similarity=0.321 Sum_probs=205.5
Q ss_pred CCCCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEE
Q 020641 14 APSPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYC 93 (323)
Q Consensus 14 ~~~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 93 (323)
...|....+||.|++|.||++.+..+++.+++|..... .....+.+.+|+.+++.++|+||+++++.+
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~------------~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~ 85 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQ------------QQPKKELIINEILVMRENKNPNIVNYLDSY 85 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecC------------ccchHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 34566667999999999999999989999999865421 111235678899999999999999999999
Q ss_pred EeCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCC
Q 020641 94 VEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDF 173 (323)
Q Consensus 94 ~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~ 173 (323)
..+...++||||+.+++|.+++.+.. +++..+..++.|++.|+.+||+. |++|+||||+||+++.++
T Consensus 86 ~~~~~~~lv~e~~~~~~L~~~~~~~~----------~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~ 152 (297)
T cd06656 86 LVGDELWVVMEYLAGGSLTDVVTETC----------MDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDG 152 (297)
T ss_pred ecCCEEEEeecccCCCCHHHHHHhCC----------CCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCC
Confidence 99999999999999999999986543 78889999999999999999999 999999999999999999
Q ss_pred eEEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhh
Q 020641 174 KAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWA 253 (323)
Q Consensus 174 ~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 253 (323)
.++|+|||.+........ ......+++.|+|||.+.+..++.++|+||||+++|++++|..||............
T Consensus 153 ~~~l~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~--- 227 (297)
T cd06656 153 SVKLTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI--- 227 (297)
T ss_pred CEEECcCccceEccCCcc--CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeee---
Confidence 999999998865433221 112334788999999998888899999999999999999999999754321111000
Q ss_pred cccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhhcCCCC
Q 020641 254 TPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSPPP 316 (323)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~~~~~~ 316 (323)
..........+...+..+.+++.+||..+|++|||+.++++ ..++..+.+
T Consensus 228 -----------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~--~~~~~~~~~ 277 (297)
T cd06656 228 -----------ATNGTPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ--HPFLKLAKP 277 (297)
T ss_pred -----------ccCCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc--Cchhccccc
Confidence 00000011123345567899999999999999999999998 455544443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-40 Score=279.71 Aligned_cols=249 Identities=29% Similarity=0.432 Sum_probs=200.0
Q ss_pred CCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEe
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVE 95 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 95 (323)
.+.....||.|++|.||++... ++.+++|...... ...+.+.+|+.+++.++|+||+++++++..
T Consensus 7 ~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~-------------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 71 (256)
T cd05039 7 ELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDS-------------TAAQAFLAEASVMTTLRHPNLVQLLGVVLQ 71 (256)
T ss_pred hccceeeeecCCCceEEEEEec--CcEEEEEEeccch-------------hHHHHHHHHHHHHHhcCCcceeeeEEEEcC
Confidence 4556668999999999999875 5667777554221 134678899999999999999999999998
Q ss_pred CCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeE
Q 020641 96 GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKA 175 (323)
Q Consensus 96 ~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~ 175 (323)
....++||||+.+++|.+++...... .+++..+..++.|++.|+.|||+. |++|+||||+||+++.++.+
T Consensus 72 ~~~~~~v~e~~~~~~L~~~~~~~~~~-------~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~ 141 (256)
T cd05039 72 GNPLYIVTEYMAKGSLVDYLRSRGRA-------VITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVA 141 (256)
T ss_pred CCCeEEEEEecCCCcHHHHHHhcCCC-------CCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCE
Confidence 88999999999999999999765432 289999999999999999999999 99999999999999999999
Q ss_pred EEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhc
Q 020641 176 KIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWAT 254 (323)
Q Consensus 176 ~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~ 254 (323)
+|+|||.+........ ....+..|+|||.+.+..++.++|+||||+++|++++ |..||......
T Consensus 142 ~l~d~g~~~~~~~~~~-----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---------- 206 (256)
T cd05039 142 KVSDFGLAKEASQGQD-----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---------- 206 (256)
T ss_pred EEcccccccccccccc-----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHH----------
Confidence 9999999876532211 2224567999999988888999999999999999997 99998644221
Q ss_pred ccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhh
Q 020641 255 PRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPL 310 (323)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~ 310 (323)
.+...+........+...+..+.+++.+||..+|++|||+.+++++|+++
T Consensus 207 ------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 207 ------DVVPHVEKGYRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred ------HHHHHHhcCCCCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 11111111112223344567899999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-40 Score=278.70 Aligned_cols=247 Identities=26% Similarity=0.370 Sum_probs=193.5
Q ss_pred ccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeCCeEEE
Q 020641 22 RLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVL 101 (323)
Q Consensus 22 ~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 101 (323)
.||.|+||.||++... +++.+++|...... .......+.+|+++++.++|+||+++++++......++
T Consensus 2 ~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~-----------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 69 (250)
T cd05085 2 LLGKGNFGEVFKGTLK-DKTPVAVKTCKEDL-----------PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYI 69 (250)
T ss_pred ccCCCCCceEEEEEec-CCcEEEEEecCCcC-----------CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEE
Confidence 5899999999999854 56677777543221 11122467889999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEEEeecc
Q 020641 102 AYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFN 181 (323)
Q Consensus 102 v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~l~Dfg 181 (323)
||||+.+++|.+++...... +++..+..++.|++.++.++|+. |++|+||+|+||+++.++.++|+|||
T Consensus 70 v~e~~~~~~L~~~~~~~~~~--------~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g 138 (250)
T cd05085 70 VMELVPGGDFLSFLRKKKDE--------LKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFG 138 (250)
T ss_pred EEECCCCCcHHHHHHhcCCC--------CCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCc
Confidence 99999999999998654322 78899999999999999999999 99999999999999999999999999
Q ss_pred ccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhccccccc
Q 020641 182 LSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPRLSED 260 (323)
Q Consensus 182 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 260 (323)
++......... ......++..|+|||.+.+..++.++||||||+++|++++ |..||.........
T Consensus 139 ~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~------------- 204 (250)
T cd05085 139 MSRQEDDGIYS-SSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAR------------- 204 (250)
T ss_pred cceeccccccc-cCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHH-------------
Confidence 88654322111 1112234567999999988888999999999999999998 99999754321110
Q ss_pred ccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHh
Q 020641 261 KVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQ 308 (323)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~ 308 (323)
..+........+...+..+.+++.+||+.+|++|||+.|+++.|.
T Consensus 205 ---~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 205 ---EQVEKGYRMSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred ---HHHHcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 111111112223345678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-40 Score=290.66 Aligned_cols=269 Identities=25% Similarity=0.348 Sum_probs=203.5
Q ss_pred CccccccCCCCCCccceeccceee-------eeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcC-CCCcccc
Q 020641 17 PGYFVRLDKGPEDDLYLKKRVKMR-------RWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRL-KHENLVE 88 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~~~~~~-------~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~ 88 (323)
+....+||+|+||.||+|.+...+ ..+++|..... ......+.+.+|+++++++ +|+||++
T Consensus 14 ~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~-----------~~~~~~~~~~~E~~~l~~l~~h~~iv~ 82 (334)
T cd05100 14 LTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD-----------ATDKDLSDLVSEMEMMKMIGKHKNIIN 82 (334)
T ss_pred eeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccc-----------cCHHHHHHHHHHHHHHHhhcCCCCeee
Confidence 445558999999999999865432 24566644311 1112235678899999999 8999999
Q ss_pred eeeEEEeCCeEEEEEeecCCCCHHHHhccCCCCCC-------CCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCC
Q 020641 89 LLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQG-------AQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRD 161 (323)
Q Consensus 89 ~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~d 161 (323)
+++++......++++||+.+++|.+++........ ..+...+++..+..++.|++.||.|||+. |++|+|
T Consensus 83 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~d 159 (334)
T cd05100 83 LLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRD 159 (334)
T ss_pred eeEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---Ceeccc
Confidence 99999999999999999999999999976432100 01223488889999999999999999999 999999
Q ss_pred CCCCCEEEccCCeEEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHh-CCCCCCC
Q 020641 162 IRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDH 240 (323)
Q Consensus 162 ikp~nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~ 240 (323)
|||+||+++.++.++|+|||++................++..|+|||.+.+..++.++||||||+++|+|++ |..||..
T Consensus 160 lkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~ 239 (334)
T cd05100 160 LAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPG 239 (334)
T ss_pred cccceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCC
Confidence 999999999999999999999876544322222222234567999999988889999999999999999998 8888865
Q ss_pred CCCcccchhhhhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhhcCCC
Q 020641 241 TMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSPP 315 (323)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~~~~~ 315 (323)
..... ....+........+...+..+.+++.+||+.+|++|||+.|+++.|++++....
T Consensus 240 ~~~~~----------------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~~ 298 (334)
T cd05100 240 IPVEE----------------LFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVTS 298 (334)
T ss_pred CCHHH----------------HHHHHHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhcC
Confidence 43211 111111111122233455679999999999999999999999999999985543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-40 Score=289.29 Aligned_cols=204 Identities=22% Similarity=0.307 Sum_probs=160.3
Q ss_pred cccCCCCCCccceeccc--eeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEe--C
Q 020641 21 VRLDKGPEDDLYLKKRV--KMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVE--G 96 (323)
Q Consensus 21 ~~lg~G~~~~V~~~~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~ 96 (323)
.+||+|+||.||+|++. .+++.+++|..... .......+|+.++++++||||+++++++.. +
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~--------------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 72 (317)
T cd07868 7 CKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGT--------------GISMSACREIALLRELKHPNVISLQKVFLSHAD 72 (317)
T ss_pred cccccCCCeEEEEEEEccCCCCceEEEEEECCC--------------CCcHHHHHHHHHHHhcCCCCCcceeeeEecCCC
Confidence 48999999999999965 45677888754321 122456789999999999999999998864 4
Q ss_pred CeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEE----ccC
Q 020641 97 NLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLL----FED 172 (323)
Q Consensus 97 ~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili----~~~ 172 (323)
...++++||+.+ +|.+++..............++...+..++.|++.||.|||+. |++||||||+||++ +.+
T Consensus 73 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~ 148 (317)
T cd07868 73 RKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPER 148 (317)
T ss_pred cEEEEEEeccCC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCc
Confidence 568999999875 8988886443222111222388999999999999999999999 99999999999999 456
Q ss_pred CeEEEeeccccCCCCccccc-cccccccCccccCCCccccC-CCCCcccchHHHHHHHHHHHhCCCCCCCCC
Q 020641 173 FKAKIADFNLSNQAPDMAAR-LHSTRVLGTFGYHAPEYAMT-GQLTQKSDVYSFGVVLLELLTGRKPVDHTM 242 (323)
Q Consensus 173 ~~~~l~Dfg~~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 242 (323)
+.++|+|||++......... .......||+.|+|||.+.+ ..++.++||||+||++|+|++|+.||....
T Consensus 149 ~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~ 220 (317)
T cd07868 149 GRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred CcEEEeecCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence 78999999999765432211 12233457999999998876 457899999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-41 Score=297.35 Aligned_cols=244 Identities=18% Similarity=0.161 Sum_probs=187.3
Q ss_pred cCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcC---CCCcccceeeEEEeCCeE
Q 020641 23 LDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRL---KHENLVELLGYCVEGNLR 99 (323)
Q Consensus 23 lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~~~~~ 99 (323)
||+|+||+||+|++..+++.+|+|++.+..... .........|..++..+ +||||+++++.+......
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~---------~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~ 71 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVA---------KKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDL 71 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhh---------hhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeE
Confidence 799999999999999999999999875432111 11113334455555544 799999999999999999
Q ss_pred EEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEEEee
Q 020641 100 VLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIAD 179 (323)
Q Consensus 100 ~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~l~D 179 (323)
|+||||+.+++|.+++..... +++..+..++.||+.||.|||+. |++||||||+||+++.++.++|+|
T Consensus 72 ~lv~e~~~~g~L~~~l~~~~~---------~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~D 139 (330)
T cd05586 72 YLVTDYMSGGELFWHLQKEGR---------FSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCD 139 (330)
T ss_pred EEEEcCCCCChHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEec
Confidence 999999999999999875432 88999999999999999999999 999999999999999999999999
Q ss_pred ccccCCCCccccccccccccCccccCCCccccCC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhccccc
Q 020641 180 FNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG-QLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLS 258 (323)
Q Consensus 180 fg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 258 (323)
||++........ ......|+..|+|||.+.+. .++.++|||||||++|+|++|..||..........
T Consensus 140 fg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~---------- 207 (330)
T cd05586 140 FGLSKANLTDNK--TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYR---------- 207 (330)
T ss_pred CCcCcCCCCCCC--CccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHH----------
Confidence 999865432211 12344589999999988754 47899999999999999999999997543211100
Q ss_pred ccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCC----ChHHHHH
Q 020641 259 EDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRP----NMSIVVK 305 (323)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp----s~~evl~ 305 (323)
.+...... ......+..+.+++.+||+.||++|| ++.++++
T Consensus 208 -----~i~~~~~~-~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 208 -----NIAFGKVR-FPKNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred -----HHHcCCCC-CCCccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 00000000 01112456789999999999999998 5666665
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-41 Score=298.91 Aligned_cols=197 Identities=23% Similarity=0.294 Sum_probs=171.4
Q ss_pred ccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCC-CC-----cccceee
Q 020641 18 GYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLK-HE-----NLVELLG 91 (323)
Q Consensus 18 ~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~-----~i~~~~~ 91 (323)
.+..-||+|.||.|.+|.+.++++.||+|++.. ...+..+...|+.+|..++ |. |+|++++
T Consensus 189 ~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN-------------~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d 255 (586)
T KOG0667|consen 189 EVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKN-------------KKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLD 255 (586)
T ss_pred EEEEEecccccceeEEEEecCCCcEEEEEeecc-------------ChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeee
Confidence 445589999999999999999999999997752 3455577788899998885 43 8999999
Q ss_pred EEEeCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEcc
Q 020641 92 YCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFE 171 (323)
Q Consensus 92 ~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~ 171 (323)
+|...++.|||+|.+.. +|.++++.+.-.. ++...+..++.||+.||.+||+. ||+|+||||+|||+..
T Consensus 256 ~F~fr~HlciVfELL~~-NLYellK~n~f~G-------lsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~ 324 (586)
T KOG0667|consen 256 YFYFRNHLCIVFELLST-NLYELLKNNKFRG-------LSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKD 324 (586)
T ss_pred ccccccceeeeehhhhh-hHHHHHHhcCCCC-------CCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeecc
Confidence 99999999999998875 9999999887554 99999999999999999999999 9999999999999964
Q ss_pred C--CeEEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCC
Q 020641 172 D--FKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMP 243 (323)
Q Consensus 172 ~--~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 243 (323)
- ..+|++|||+++....... ....+..|+|||++.|.+|+.+.|||||||++.||++|.+.|.+.+.
T Consensus 325 ~~r~~vKVIDFGSSc~~~q~vy-----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne 393 (586)
T KOG0667|consen 325 PKRSRIKVIDFGSSCFESQRVY-----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNE 393 (586)
T ss_pred CCcCceeEEecccccccCCcce-----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCH
Confidence 3 4799999999987654332 34457789999999999999999999999999999999998877653
|
|
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=281.50 Aligned_cols=249 Identities=22% Similarity=0.328 Sum_probs=202.1
Q ss_pred CCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEe
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVE 95 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 95 (323)
.|..+.+||.|+||.||.+.+..++..+++|+...... ......+.+|+.++++++|+||+++++++.+
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~-----------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 73 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA-----------EDEIEDIQQEITVLSQCDSPYVTKYYGSYLK 73 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecccc-----------HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE
Confidence 34556789999999999999999999999986642211 1123678889999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeE
Q 020641 96 GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKA 175 (323)
Q Consensus 96 ~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~ 175 (323)
++..++||||+.+++|.+++.... ++...+..++.|++.|+.+||+. +++|+||+|+||+++.++.+
T Consensus 74 ~~~~~lv~e~~~~~~L~~~i~~~~----------l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~ 140 (277)
T cd06640 74 GTKLWIIMEYLGGGSALDLLRAGP----------FDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDV 140 (277)
T ss_pred CCEEEEEEecCCCCcHHHHHhcCC----------CCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCE
Confidence 999999999999999999986532 78889999999999999999999 99999999999999999999
Q ss_pred EEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhcc
Q 020641 176 KIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATP 255 (323)
Q Consensus 176 ~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~ 255 (323)
+|+|||++........ ......++..|+|||.+.+..++.++|+||||+++|+|++|..||.........
T Consensus 141 ~l~dfg~~~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~-------- 210 (277)
T cd06640 141 KLADFGVAGQLTDTQI--KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVL-------- 210 (277)
T ss_pred EEcccccceeccCCcc--ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHh--------
Confidence 9999999866543221 122334678899999998888899999999999999999999999754321110
Q ss_pred cccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHH
Q 020641 256 RLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKA 306 (323)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~ 306 (323)
..+............+..+.+++.+||+.+|++||++.+++..
T Consensus 211 --------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 211 --------FLIPKNNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred --------hhhhcCCCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 0111111123345667889999999999999999999999764
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=278.85 Aligned_cols=253 Identities=24% Similarity=0.350 Sum_probs=201.6
Q ss_pred CCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEe
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVE 95 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 95 (323)
.+....+||.|+||.||++.+..+++.+++|+..... ....+.+.+|++++++++|+||+++++.+..
T Consensus 4 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~------------~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~ 71 (262)
T cd06613 4 DYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEP------------GDDFEIIQQEISMLKECRHPNIVAYFGSYLR 71 (262)
T ss_pred ceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCc------------hhhHHHHHHHHHHHHhCCCCChhceEEEEEe
Confidence 4566678999999999999999888889988765321 1134778899999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeE
Q 020641 96 GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKA 175 (323)
Q Consensus 96 ~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~ 175 (323)
....+++|||+.+++|.+++...... ++...+..++.|++.|+.|||+. |++|+||+|+||+++.++.+
T Consensus 72 ~~~~~l~~e~~~~~~l~~~~~~~~~~--------l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~ 140 (262)
T cd06613 72 RDKLWIVMEYCGGGSLQDIYQVTRGP--------LSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDV 140 (262)
T ss_pred CCEEEEEEeCCCCCcHHHHHHhhccC--------CCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCE
Confidence 99999999999999999998765222 88999999999999999999999 99999999999999999999
Q ss_pred EEeeccccCCCCccccccccccccCccccCCCccccCC---CCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhh
Q 020641 176 KIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG---QLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTW 252 (323)
Q Consensus 176 ~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~---~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 252 (323)
+|+|||.+........ ......++..|+|||.+.+. .++.++|+||||+++|+|++|..||............
T Consensus 141 ~l~d~g~~~~~~~~~~--~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~-- 216 (262)
T cd06613 141 KLADFGVSAQLTATIA--KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLI-- 216 (262)
T ss_pred EECccccchhhhhhhh--ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--
Confidence 9999999876543221 12234578889999998766 7889999999999999999999999754321111000
Q ss_pred hcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 253 ATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
..... . ..........+..+.+++.+||..+|.+|||+.+|+.
T Consensus 217 ~~~~~---------~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 217 SKSNF---------P-PPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred HhccC---------C-CccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00000 0 0011123445678999999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-40 Score=283.32 Aligned_cols=267 Identities=23% Similarity=0.316 Sum_probs=202.7
Q ss_pred CCccccccCCCCCCccceeccce----eeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceee
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRVK----MRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLG 91 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~~----~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~ 91 (323)
.+.+...||+|+||.||.+.+.. ++..+++|..... ......+.+.+|+.+++.++|+||+++++
T Consensus 7 ~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~-----------~~~~~~~~~~~e~~~l~~l~h~ni~~~~~ 75 (280)
T cd05043 7 RVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH-----------ASEIQVTLLLQESCLLYGLSHQNILPILH 75 (280)
T ss_pred heEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC-----------CCHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 44555689999999999999876 3466666644311 11122366788999999999999999999
Q ss_pred EEEe-CCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEc
Q 020641 92 YCVE-GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLF 170 (323)
Q Consensus 92 ~~~~-~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~ 170 (323)
++.. +...+++++|+.+++|.+++........ .....+++..+..++.|++.||.|||+. +++|+||||+||+++
T Consensus 76 ~~~~~~~~~~~~~~~~~~~~L~~~l~~~~~~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~ 151 (280)
T cd05043 76 VCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEA-NNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVID 151 (280)
T ss_pred EEecCCCCCEEEEEcCCCCcHHHHHHhcccccc-ccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEc
Confidence 8776 4678999999999999999866432110 0112389999999999999999999999 999999999999999
Q ss_pred cCCeEEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccchh
Q 020641 171 EDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSL 249 (323)
Q Consensus 171 ~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~ 249 (323)
.++.++|+|||+++...............++..|+|||.+.+..++.++||||||+++|++++ |+.||.......
T Consensus 152 ~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---- 227 (280)
T cd05043 152 EELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE---- 227 (280)
T ss_pred CCCcEEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHH----
Confidence 999999999999876543222211222335677999999988889999999999999999998 999997543211
Q ss_pred hhhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhhcC
Q 020641 250 VTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKS 313 (323)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~~~ 313 (323)
+...+........+..+++.+.+++.+||+.+|++|||+.++++.|+++.+.
T Consensus 228 ------------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 279 (280)
T cd05043 228 ------------MAAYLKDGYRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ 279 (280)
T ss_pred ------------HHHHHHcCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence 1111111111112233456799999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-40 Score=291.62 Aligned_cols=269 Identities=23% Similarity=0.305 Sum_probs=200.5
Q ss_pred CCccccccCCCCCCccceecc-----ceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcC-CCCcccce
Q 020641 16 SPGYFVRLDKGPEDDLYLKKR-----VKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRL-KHENLVEL 89 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~-----~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~ 89 (323)
.+.....||.|+||.||+|.+ ..+++.+|+|...... .......+.+|+.++.++ +|+||+++
T Consensus 8 ~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~-----------~~~~~~~~~~E~~~l~~l~~h~niv~~ 76 (343)
T cd05103 8 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-----------THSEHRALMSELKILIHIGHHLNVVNL 76 (343)
T ss_pred HhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC-----------ChHHHHHHHHHHHHHHhccCCccHhhh
Confidence 456667899999999999984 3456788888654221 111235678899999999 78999999
Q ss_pred eeEEEeC-CeEEEEEeecCCCCHHHHhccCCCCCC---------------------------------------------
Q 020641 90 LGYCVEG-NLRVLAYEFATMGSLHDILHGRKGVQG--------------------------------------------- 123 (323)
Q Consensus 90 ~~~~~~~-~~~~lv~e~~~~~sL~~~~~~~~~~~~--------------------------------------------- 123 (323)
++++... ...+++|||+.+|+|.+++........
T Consensus 77 ~~~~~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (343)
T cd05103 77 LGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEK 156 (343)
T ss_pred cceeecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCC
Confidence 9987654 567899999999999999865321000
Q ss_pred -------------CCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEEEeeccccCCCCccc
Q 020641 124 -------------AQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMA 190 (323)
Q Consensus 124 -------------~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~l~Dfg~~~~~~~~~ 190 (323)
......+++..+..++.|++.||.|||+. |++|+||||.||+++.++.++|+|||++.......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~ 233 (343)
T cd05103 157 SLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDP 233 (343)
T ss_pred ccccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCc
Confidence 00112377888899999999999999999 99999999999999999999999999987653322
Q ss_pred cccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccccccccchhcCCC
Q 020641 191 ARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPK 269 (323)
Q Consensus 191 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (323)
.........++..|+|||.+.+..++.++||||||+++|+|++ |..||........ ....+...
T Consensus 234 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~---------------~~~~~~~~ 298 (343)
T cd05103 234 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE---------------FCRRLKEG 298 (343)
T ss_pred chhhcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHH---------------HHHHHhcc
Confidence 2112222335677999999988889999999999999999997 9999865432111 00001111
Q ss_pred cCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhhcC
Q 020641 270 LKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKS 313 (323)
Q Consensus 270 ~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~~~ 313 (323)
.....+...+..+.+++.+||+.||++|||+.||++.|+.+++.
T Consensus 299 ~~~~~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~~ 342 (343)
T cd05103 299 TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 342 (343)
T ss_pred CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 11111222345799999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=315.81 Aligned_cols=257 Identities=20% Similarity=0.282 Sum_probs=195.0
Q ss_pred CCCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEE
Q 020641 15 PSPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCV 94 (323)
Q Consensus 15 ~~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 94 (323)
..|.++.+||.|+||+||+|++..++..+++|++...... ......+..|+.+++.++||||++++++|.
T Consensus 13 ~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~----------e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~ 82 (1021)
T PTZ00266 13 NEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLK----------EREKSQLVIEVNVMRELKHKNIVRYIDRFL 82 (1021)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccC----------HHHHHHHHHHHHHHHHcCCCCcCeEEEEEE
Confidence 3456666999999999999999999999999876533211 122366889999999999999999999885
Q ss_pred e--CCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCC----CCCceeCCCCCCCEE
Q 020641 95 E--GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKV----QPSIIHRDIRSSNVL 168 (323)
Q Consensus 95 ~--~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~----~~~i~h~dikp~nil 168 (323)
. ...+|+||||+.+++|.+++....... ..+++..++.++.||+.||.|||+.. ..+|+|+||||+|||
T Consensus 83 de~~~~lyIVMEY~~gGSL~~lL~k~~~~~-----g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNIL 157 (1021)
T PTZ00266 83 NKANQKLYILMEFCDAGDLSRNIQKCYKMF-----GKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIF 157 (1021)
T ss_pred ecCCCEEEEEEeCCCCCcHHHHHHHHhhcc-----CCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeE
Confidence 4 457899999999999999997532110 12899999999999999999999851 015999999999999
Q ss_pred Ecc-----------------CCeEEEeeccccCCCCccccccccccccCccccCCCccccC--CCCCcccchHHHHHHHH
Q 020641 169 LFE-----------------DFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT--GQLTQKSDVYSFGVVLL 229 (323)
Q Consensus 169 i~~-----------------~~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~Di~slG~~l~ 229 (323)
++. .+.++|+|||++........ .....|++.|+|||++.+ ..++.++|||||||++|
T Consensus 158 L~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~---~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILY 234 (1021)
T PTZ00266 158 LSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESM---AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIY 234 (1021)
T ss_pred eecCccccccccccccccCCCCceEEccCCcccccccccc---ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHH
Confidence 964 23489999999876543221 223458999999998864 45789999999999999
Q ss_pred HHHhCCCCCCCCCCcccchhhhhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 230 ELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 230 ~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
+|++|..||........ .. ..+.... .......+.++.+||.+||..+|.+|||+.|++.
T Consensus 235 ELLTGk~PF~~~~~~~q--li-------------~~lk~~p-~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 235 ELCSGKTPFHKANNFSQ--LI-------------SELKRGP-DLPIKGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred HHHHCCCCCCcCCcHHH--HH-------------HHHhcCC-CCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 99999999975432111 00 0000000 0011223567999999999999999999999984
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-40 Score=284.56 Aligned_cols=271 Identities=22% Similarity=0.320 Sum_probs=204.3
Q ss_pred CccccccCCCCCCccceeccc----eeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeE
Q 020641 17 PGYFVRLDKGPEDDLYLKKRV----KMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGY 92 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~~~----~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 92 (323)
+....+||+|+||.||++... .++..+++|........ ...+.+.+|+++++.++|+||++++++
T Consensus 6 ~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~-----------~~~~~~~~ei~~l~~l~~~~i~~~~~~ 74 (284)
T cd05038 6 LKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE-----------QHRSDFEREIEILRTLDHENIVKYKGV 74 (284)
T ss_pred chhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch-----------HHHHHHHHHHHHHHhCCCCChheEEee
Confidence 455568999999999999854 34777888865422111 124678999999999999999999999
Q ss_pred EEe--CCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEc
Q 020641 93 CVE--GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLF 170 (323)
Q Consensus 93 ~~~--~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~ 170 (323)
+.. ....+++|||+.+++|.+++...... +++..+..++.|++.||.+||+. |++|+||||+||+++
T Consensus 75 ~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~--------~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~ 143 (284)
T cd05038 75 CEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQ--------INLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVE 143 (284)
T ss_pred eecCCCCceEEEEecCCCCCHHHHHHhCccc--------cCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEc
Confidence 887 55789999999999999999765432 88999999999999999999999 999999999999999
Q ss_pred cCCeEEEeeccccCCCCcccccc-ccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchh
Q 020641 171 EDFKAKIADFNLSNQAPDMAARL-HSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSL 249 (323)
Q Consensus 171 ~~~~~~l~Dfg~~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~ 249 (323)
.++.++|+|||.+.......... ......++..|++||...+..++.++|+||||+++++|++|..||...........
T Consensus 144 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~ 223 (284)
T cd05038 144 SEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMI 223 (284)
T ss_pred CCCCEEEcccccccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcccc
Confidence 99999999999988765322211 11122345669999999888889999999999999999999999865432111100
Q ss_pred hhhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhh
Q 020641 250 VTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPL 310 (323)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~ 310 (323)
.. .........+...+........+..++..+.+++.+||+.+|++|||+.||+++|+++
T Consensus 224 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 224 GI-AQGQMIVTRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred cc-ccccccHHHHHHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 00 0000001111222222223333445567899999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-40 Score=278.84 Aligned_cols=252 Identities=23% Similarity=0.290 Sum_probs=202.2
Q ss_pred CccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeC
Q 020641 17 PGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEG 96 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 96 (323)
|+.+..||.|+||.||.+++..+++.+++|........ ......+.+|++++++++|+||+++++++.+.
T Consensus 2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~----------~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~ 71 (256)
T cd08221 2 YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLS----------EKERRDALNEIVILSLLQHPNIIAYYNHFMDD 71 (256)
T ss_pred ceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccc----------hhHHHHHHHHHHHHHhCCCCCeeEEEeEEecC
Confidence 56677899999999999999999988888855422111 12235678999999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEE
Q 020641 97 NLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAK 176 (323)
Q Consensus 97 ~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~ 176 (323)
...+++|||+.+++|.+++...... .+++..+..++.|++.++.+||+. |++|+||+|+||+++.++.++
T Consensus 72 ~~~~~~~e~~~~~~L~~~~~~~~~~-------~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~k 141 (256)
T cd08221 72 NTLLIEMEYANGGTLYDKIVRQKGQ-------LFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIK 141 (256)
T ss_pred CeEEEEEEecCCCcHHHHHHhcccc-------CCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEE
Confidence 9999999999999999999765322 288999999999999999999999 999999999999999999999
Q ss_pred EeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhccc
Q 020641 177 IADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPR 256 (323)
Q Consensus 177 l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 256 (323)
|+|||.+........ ......+++.|.|||.+.+..++.++|+||||+++|+|++|..||........
T Consensus 142 l~d~~~~~~~~~~~~--~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~---------- 209 (256)
T cd08221 142 LGDFGISKILGSEYS--MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNL---------- 209 (256)
T ss_pred ECcCcceEEcccccc--cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHH----------
Confidence 999999875543321 12334578999999999888889999999999999999999999975432111
Q ss_pred ccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHH
Q 020641 257 LSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKA 306 (323)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~ 306 (323)
...+.... ....+...+.++.+++.+||+.+|.+|||+.++++.
T Consensus 210 -----~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 210 -----VVKIVQGN-YTPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred -----HHHHHcCC-CCCCccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence 11111111 111223446679999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-40 Score=285.20 Aligned_cols=257 Identities=22% Similarity=0.328 Sum_probs=204.6
Q ss_pred CCCCCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeE
Q 020641 13 HAPSPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGY 92 (323)
Q Consensus 13 ~~~~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 92 (323)
....|....+||.|++|.||++.+..+++.+++|..... .....+.+.+|+.+++.++|+||++++++
T Consensus 17 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~------------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 84 (296)
T cd06655 17 PKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQ------------KQPKKELIINEILVMKELKNPNIVNFLDS 84 (296)
T ss_pred CcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecc------------cCchHHHHHHHHHHHHhcCCCceeeeeee
Confidence 334577777999999999999999999999998865321 11223667889999999999999999999
Q ss_pred EEeCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccC
Q 020641 93 CVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFED 172 (323)
Q Consensus 93 ~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~ 172 (323)
+..+...++|+||+.+++|.+++.... +++..+..++.|++.|+.+||+. |++|+||+|+||+++.+
T Consensus 85 ~~~~~~~~lv~e~~~~~~L~~~~~~~~----------l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~ 151 (296)
T cd06655 85 FLVGDELFVVMEYLAGGSLTDVVTETC----------MDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMD 151 (296)
T ss_pred EecCceEEEEEEecCCCcHHHHHHhcC----------CCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCC
Confidence 999999999999999999999986542 88999999999999999999999 99999999999999999
Q ss_pred CeEEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhh
Q 020641 173 FKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTW 252 (323)
Q Consensus 173 ~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 252 (323)
+.++|+|||++........ ......++..|+|||.+.+..++.++|+||||+++|++++|..||.............
T Consensus 152 ~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~- 228 (296)
T cd06655 152 GSVKLTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA- 228 (296)
T ss_pred CCEEEccCccchhcccccc--cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-
Confidence 9999999998875443221 1123357889999999988889999999999999999999999997654311111000
Q ss_pred hcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhhc
Q 020641 253 ATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLK 312 (323)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~~ 312 (323)
. ........+...+..+.+++.+||..||++|||+.+++. ..+++
T Consensus 229 ~-------------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~--~~~~~ 273 (296)
T cd06655 229 T-------------NGTPELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ--HPFLK 273 (296)
T ss_pred h-------------cCCcccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhh--ChHhh
Confidence 0 000001123345567999999999999999999999986 44443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=282.08 Aligned_cols=252 Identities=25% Similarity=0.339 Sum_probs=196.4
Q ss_pred CCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEe
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVE 95 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 95 (323)
.+....+||.|+||.||+|++..+++.+++|...... ......+.+|+.+++.++||||+++++.+..
T Consensus 10 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~------------~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~ 77 (267)
T cd06645 10 DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP------------GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLR 77 (267)
T ss_pred HHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc------------hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEe
Confidence 4566669999999999999999999999998654221 1112457789999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeE
Q 020641 96 GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKA 175 (323)
Q Consensus 96 ~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~ 175 (323)
....++++||+.+++|.+++..... +++..+..++.|++.|+.|||+. |++|+||||+||+++.++.+
T Consensus 78 ~~~~~lv~e~~~~~~L~~~~~~~~~---------~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~ 145 (267)
T cd06645 78 RDKLWICMEFCGGGSLQDIYHVTGP---------LSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHV 145 (267)
T ss_pred CCEEEEEEeccCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCE
Confidence 9999999999999999999865432 88999999999999999999999 99999999999999999999
Q ss_pred EEeeccccCCCCccccccccccccCccccCCCcccc---CCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhh
Q 020641 176 KIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAM---TGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTW 252 (323)
Q Consensus 176 ~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 252 (323)
+|+|||++........ ......|+..|+|||.+. ...++.++|+||||+++|+|++|..||.............
T Consensus 146 ~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~- 222 (267)
T cd06645 146 KLADFGVSAQITATIA--KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMT- 222 (267)
T ss_pred EECcceeeeEccCccc--ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhh-
Confidence 9999999865432211 123345889999999874 4457889999999999999999999986443211110000
Q ss_pred hcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 253 ATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
..... .+.. ......+..+.+++.+||+.+|++|||+.+|++
T Consensus 223 -~~~~~--------~~~~--~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 223 -KSNFQ--------PPKL--KDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred -ccCCC--------CCcc--cccCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 00000 0000 001123456899999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-40 Score=278.72 Aligned_cols=248 Identities=28% Similarity=0.393 Sum_probs=194.8
Q ss_pred CCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEE-
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCV- 94 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~- 94 (323)
.+.....||+|+||.||++... +..+++|.... ....+.+.+|+.++++++|+|++++++++.
T Consensus 7 ~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~--------------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 70 (256)
T cd05082 7 ELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKN--------------DATAQAFLAEASVMTQLRHSNLVQLLGVIVE 70 (256)
T ss_pred hCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCC--------------CchHHHHHHHHHHHHhCCCCCeeeEEEEEEc
Confidence 4566678999999999998754 55567764421 122356889999999999999999998764
Q ss_pred eCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCe
Q 020641 95 EGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFK 174 (323)
Q Consensus 95 ~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~ 174 (323)
.++..++++||+.+++|.+++...... .+++..+..++.|++.|+.+||+. |++|+||||+||+++.++.
T Consensus 71 ~~~~~~lv~e~~~~~~L~~~~~~~~~~-------~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~ 140 (256)
T cd05082 71 EKGGLYIVTEYMAKGSLVDYLRSRGRS-------VLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNV 140 (256)
T ss_pred CCCceEEEEECCCCCcHHHHHHhcCCC-------CCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCc
Confidence 556789999999999999999764332 278889999999999999999999 9999999999999999999
Q ss_pred EEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhh
Q 020641 175 AKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWA 253 (323)
Q Consensus 175 ~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~ 253 (323)
++|+|||++....... ....++..|+|||.+.+..++.++||||||+++|+|++ |+.||.......
T Consensus 141 ~kl~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~-------- 207 (256)
T cd05082 141 AKVSDFGLTKEASSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD-------- 207 (256)
T ss_pred EEecCCccceeccccC-----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH--------
Confidence 9999999886543321 12234567999999988889999999999999999997 999986432211
Q ss_pred cccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhh
Q 020641 254 TPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPL 310 (323)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~ 310 (323)
+...+........+..++..+.+++.+||+.+|++|||+.++++.|+.+
T Consensus 208 --------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 208 --------VVPRVEKGYKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred --------HHHHHhcCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 1111111111223344567899999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=278.55 Aligned_cols=253 Identities=23% Similarity=0.305 Sum_probs=190.0
Q ss_pred ccCCCCCCccceeccce---eeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEE-eCC
Q 020641 22 RLDKGPEDDLYLKKRVK---MRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCV-EGN 97 (323)
Q Consensus 22 ~lg~G~~~~V~~~~~~~---~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~ 97 (323)
.||+|+||.||++.+.. .+..+++|..... ......+.+.+|+.+++.++||||+++++++. .++
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~-----------~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 70 (262)
T cd05058 2 VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI-----------TDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEG 70 (262)
T ss_pred cccccCCceEEEEEEecCCCceEEEEEEecCcc-----------CCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCC
Confidence 58999999999998653 3456777754311 00112356788999999999999999999775 455
Q ss_pred eEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEEE
Q 020641 98 LRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKI 177 (323)
Q Consensus 98 ~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~l 177 (323)
..++++||+.+++|.+++...... .++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|
T Consensus 71 ~~~lv~e~~~~~~L~~~~~~~~~~--------~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl 139 (262)
T cd05058 71 SPLVVLPYMKHGDLRNFIRSETHN--------PTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKV 139 (262)
T ss_pred CcEEEEecCCCCCHHHHHHhcCCC--------CCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEE
Confidence 679999999999999999754322 66778889999999999999999 9999999999999999999999
Q ss_pred eeccccCCCCcccc--ccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhC-CCCCCCCCCcccchhhhhhc
Q 020641 178 ADFNLSNQAPDMAA--RLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTG-RKPVDHTMPRGQQSLVTWAT 254 (323)
Q Consensus 178 ~Dfg~~~~~~~~~~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g-~~pf~~~~~~~~~~~~~~~~ 254 (323)
+|||++........ ........++..|+|||.+.+..++.++||||||+++|+|++| ..||........
T Consensus 140 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~-------- 211 (262)
T cd05058 140 ADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDI-------- 211 (262)
T ss_pred CCccccccccCCcceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHH--------
Confidence 99999875432111 1111223356789999998888899999999999999999995 556653321110
Q ss_pred ccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhhc
Q 020641 255 PRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLK 312 (323)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~~ 312 (323)
...+........+...+..+.+++.+||..+|++||++.+|++.|+++..
T Consensus 212 --------~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 212 --------TVYLLQGRRLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred --------HHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 00010001111122345679999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=283.52 Aligned_cols=251 Identities=22% Similarity=0.273 Sum_probs=196.9
Q ss_pred CCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEe
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVE 95 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 95 (323)
.|+...+||.|+||.||++++..+++.+++|+.... .....+.+.+|+.+++.++|+||+++++.+..
T Consensus 13 ~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~------------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 80 (292)
T cd06644 13 VWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK------------SEEELEDYMVEIEILATCNHPYIVKLLGAFYW 80 (292)
T ss_pred hhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC------------CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEe
Confidence 355667999999999999999999999998876422 11223667889999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeE
Q 020641 96 GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKA 175 (323)
Q Consensus 96 ~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~ 175 (323)
++..++||||+.+++|..++...... +++..+..++.|++.++.+||+. |++|+||+|+||+++.++.+
T Consensus 81 ~~~~~lv~e~~~~~~l~~~~~~~~~~--------l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~ 149 (292)
T cd06644 81 DGKLWIMIEFCPGGAVDAIMLELDRG--------LTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDI 149 (292)
T ss_pred CCeEEEEEecCCCCcHHHHHHhhcCC--------CCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCE
Confidence 99999999999999998887654322 88999999999999999999999 99999999999999999999
Q ss_pred EEeeccccCCCCccccccccccccCccccCCCcccc-----CCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhh
Q 020641 176 KIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAM-----TGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLV 250 (323)
Q Consensus 176 ~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~ 250 (323)
+|+|||.+........ ......++..|+|||.+. ...++.++|+||||+++|+|++|..||......... .
T Consensus 150 kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~--~ 225 (292)
T cd06644 150 KLADFGVSAKNVKTLQ--RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVL--L 225 (292)
T ss_pred EEccCccceecccccc--ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHH--H
Confidence 9999998765432211 112334788899999874 345678999999999999999999999654321100 0
Q ss_pred hhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 251 TWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
..... ..+ ....+...+.++.+++.+||..||++||++.++++
T Consensus 226 ~~~~~----------~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 226 KIAKS----------EPP--TLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred HHhcC----------CCc--cCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 00000 000 01122344567999999999999999999999987
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=294.57 Aligned_cols=253 Identities=25% Similarity=0.344 Sum_probs=221.2
Q ss_pred ccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeCCeEEE
Q 020641 22 RLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVL 101 (323)
Q Consensus 22 ~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 101 (323)
|||.|-||.||-..+.+..-.+|+|.+. +..-..++|..|..+|+.+.|||+++++++|.....+|+
T Consensus 274 KLGGGQYGeVYeGvWKkyslTvAVKtLK-------------EDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYI 340 (1157)
T KOG4278|consen 274 KLGGGQYGEVYEGVWKKYSLTVAVKTLK-------------EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYI 340 (1157)
T ss_pred ccCCCcccceeeeeeeccceeeehhhhh-------------hcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEE
Confidence 9999999999999999888888877443 223335789999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEEEeecc
Q 020641 102 AYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFN 181 (323)
Q Consensus 102 v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~l~Dfg 181 (323)
|+|||..|+|.+++++..... ++..-.+.++.||..|+.||.++ +++|||+..+|+|+.++..+|+.|||
T Consensus 341 iTEfM~yGNLLdYLRecnr~e-------v~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFG 410 (1157)
T KOG4278|consen 341 ITEFMCYGNLLDYLRECNRSE-------VPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFG 410 (1157)
T ss_pred EEecccCccHHHHHHHhchhh-------cchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccc
Confidence 999999999999998876543 77777889999999999999999 99999999999999999999999999
Q ss_pred ccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhccccccc
Q 020641 182 LSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPRLSED 260 (323)
Q Consensus 182 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 260 (323)
+++.+.......+.... =+.-|.|||.+....++.++|||+||++|||+.| |-.||.+.+ -.
T Consensus 411 LsRlMtgDTYTAHAGAK-FPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGid----------------lS 473 (1157)
T KOG4278|consen 411 LSRLMTGDTYTAHAGAK-FPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGID----------------LS 473 (1157)
T ss_pred hhhhhcCCceecccCcc-CcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCcc----------------HH
Confidence 99988765443333222 2567999999999999999999999999999998 888986543 34
Q ss_pred ccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhhcCC
Q 020641 261 KVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSP 314 (323)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~~~~ 314 (323)
.+..+++..++..-+..|++.+++||+.||+++|.+||++.|+-+.|+.++.+-
T Consensus 474 qVY~LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~s 527 (1157)
T KOG4278|consen 474 QVYGLLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSSS 527 (1157)
T ss_pred HHHHHHhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhccc
Confidence 567788899999999999999999999999999999999999999999998654
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=307.94 Aligned_cols=256 Identities=21% Similarity=0.340 Sum_probs=221.5
Q ss_pred ccCCCCCCccceeccceeee---eeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeCCe
Q 020641 22 RLDKGPEDDLYLKKRVKMRR---WLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNL 98 (323)
Q Consensus 22 ~lg~G~~~~V~~~~~~~~~~---~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 98 (323)
-||.|.||.|++.+....++ .||+|-+... ..+..+.+|..|..+|-+++||||+++.+++...+.
T Consensus 636 VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~G-----------ytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~P 704 (996)
T KOG0196|consen 636 VIGAGEFGEVCSGRLKLPGKREITVAIKTLKAG-----------YTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKP 704 (996)
T ss_pred EEecccccceecccccCCCCcceeEEEeeeccC-----------ccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCce
Confidence 47999999999999887653 4777744321 112234778999999999999999999999999999
Q ss_pred EEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEEEe
Q 020641 99 RVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIA 178 (323)
Q Consensus 99 ~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~l~ 178 (323)
..+|+|||++|+|..|++.+.++ +++.+...+++.|+.|+.||-+. |++||||..+|||++.|..+|++
T Consensus 705 vMIiTEyMENGsLDsFLR~~DGq--------ftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCKVs 773 (996)
T KOG0196|consen 705 VMIITEYMENGSLDSFLRQNDGQ--------FTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCKVS 773 (996)
T ss_pred eEEEhhhhhCCcHHHHHhhcCCc--------eEeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEEec
Confidence 99999999999999999887754 89999999999999999999999 99999999999999999999999
Q ss_pred eccccCCCCcccccc-ccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhccc
Q 020641 179 DFNLSNQAPDMAARL-HSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPR 256 (323)
Q Consensus 179 Dfg~~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~ 256 (323)
|||+++...+..... ......-+.+|.|||.+...+++.++||||+|+++||.++ |+.||-+
T Consensus 774 DFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWd---------------- 837 (996)
T KOG0196|consen 774 DFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWD---------------- 837 (996)
T ss_pred cccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccc----------------
Confidence 999998775544211 1111123578999999999999999999999999999987 9999853
Q ss_pred ccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhhcCCC
Q 020641 257 LSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSPP 315 (323)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~~~~~ 315 (323)
+++.++.+.++.+++-..|-+++..|++||..||++|-..||.+.+|+..|++++..|.
T Consensus 838 mSNQdVIkaIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~ 896 (996)
T KOG0196|consen 838 MSNQDVIKAIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPN 896 (996)
T ss_pred cchHHHHHHHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCch
Confidence 45677888889999999999999999999999999999999999999999999997664
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=295.07 Aligned_cols=261 Identities=21% Similarity=0.241 Sum_probs=193.5
Q ss_pred CCCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEE
Q 020641 15 PSPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCV 94 (323)
Q Consensus 15 ~~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 94 (323)
..|.....||.|+||.||++.+..+++.+|+|....... .......+.+|+.++++++|+||+++++++.
T Consensus 15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 84 (343)
T cd07878 15 ERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQ----------SLIHARRTYRELRLLKHMKHENVIGLLDVFT 84 (343)
T ss_pred hhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhh----------hhHHHHHHHHHHHHHHhcCCCchhhhhhhhc
Confidence 456777799999999999999999999999986643211 1112355778999999999999999999876
Q ss_pred eC------CeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEE
Q 020641 95 EG------NLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVL 168 (323)
Q Consensus 95 ~~------~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nil 168 (323)
.. ...+++++++ +++|.+++.... +++..+..++.|++.||.|||+. |++||||||+||+
T Consensus 85 ~~~~~~~~~~~~~~~~~~-~~~l~~~~~~~~----------l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil 150 (343)
T cd07878 85 PATSIENFNEVYLVTNLM-GADLNNIVKCQK----------LSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVA 150 (343)
T ss_pred ccccccccCcEEEEeecC-CCCHHHHHhcCC----------CCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEE
Confidence 43 3568999988 569998886432 89999999999999999999999 9999999999999
Q ss_pred EccCCeEEEeeccccCCCCccccccccccccCccccCCCccccC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccc
Q 020641 169 LFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT-GQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQ 247 (323)
Q Consensus 169 i~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~ 247 (323)
++.++.++|+|||++...... .....|++.|+|||.+.+ ..++.++|||||||++|+|++|..||.........
T Consensus 151 ~~~~~~~kl~Dfg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~ 225 (343)
T cd07878 151 VNEDCELRILDFGLARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQL 225 (343)
T ss_pred ECCCCCEEEcCCccceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHH
Confidence 999999999999998765432 123457899999999876 56789999999999999999999999754321111
Q ss_pred hhhhhhcccccc--------cccchhcCCCcCCCC-------CHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 248 SLVTWATPRLSE--------DKVKQCVDPKLKGEY-------PPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 248 ~~~~~~~~~~~~--------~~~~~~~~~~~~~~~-------~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
............ ......+.. +.... ....++.+.+++.+||+.||.+|||+.|+++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~ 297 (343)
T cd07878 226 KRIMEVVGTPSPEVLKKISSEHARKYIQS-LPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALA 297 (343)
T ss_pred HHHHHHhCCCCHHHHHhcchhhHHHHhhc-cccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000000000000 000000000 00000 0112345789999999999999999999996
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=278.04 Aligned_cols=251 Identities=24% Similarity=0.393 Sum_probs=195.8
Q ss_pred CCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEe
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVE 95 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 95 (323)
.+.+..+||.|+||.||++.+.. ++.+++|...... .....+.+|++++++++|+|++++++++..
T Consensus 5 ~~~~~~~ig~g~~g~v~~~~~~~-~~~~~~k~~~~~~-------------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 70 (256)
T cd05112 5 ELTLVQEIGSGQFGLVWLGYWLE-KRKVAIKTIREGA-------------MSEEDFIEEAQVMMKLSHPKLVQLYGVCTE 70 (256)
T ss_pred HeEEEeeecCcccceEEEEEEeC-CCeEEEEECCCCC-------------CCHHHHHHHHHHHHhCCCCCeeeEEEEEcc
Confidence 45667799999999999998754 4556777543211 113568899999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeE
Q 020641 96 GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKA 175 (323)
Q Consensus 96 ~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~ 175 (323)
....++++||+.+++|.+++...... +++..+..++.|++.++.+||+. +++|+||+|+||+++.++.+
T Consensus 71 ~~~~~~v~e~~~~~~L~~~~~~~~~~--------~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~ 139 (256)
T cd05112 71 RSPICLVFEFMEHGCLSDYLRAQRGK--------FSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVV 139 (256)
T ss_pred CCceEEEEEcCCCCcHHHHHHhCccC--------CCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeE
Confidence 99999999999999999998754322 78889999999999999999999 99999999999999999999
Q ss_pred EEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhc
Q 020641 176 KIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWAT 254 (323)
Q Consensus 176 ~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~ 254 (323)
+|+|||.+......... ......++..|+|||.+.+..++.++|+||||+++|+|++ |..||........ .
T Consensus 140 ~l~d~g~~~~~~~~~~~-~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~---~---- 211 (256)
T cd05112 140 KVSDFGMTRFVLDDQYT-SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEV---V---- 211 (256)
T ss_pred EECCCcceeecccCccc-ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHH---H----
Confidence 99999988654332111 1112224568999999988889999999999999999998 9999965432110 0
Q ss_pred ccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHh
Q 020641 255 PRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQ 308 (323)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~ 308 (323)
+.+........+...+..+.+++.+||+.+|++|||+.++++.|+
T Consensus 212 ---------~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 212 ---------ETINAGFRLYKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred ---------HHHhCCCCCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 001111111112224567999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=291.67 Aligned_cols=252 Identities=19% Similarity=0.327 Sum_probs=203.5
Q ss_pred CCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcC-CCCcccceeeEEE
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRL-KHENLVELLGYCV 94 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~ 94 (323)
-|+...+||.||.+.||+|.....+.++++|+.... ....-.+-+.+|+.+|.++ .|.+|+.++++-.
T Consensus 362 ~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~-----------~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv 430 (677)
T KOG0596|consen 362 EYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLE-----------ADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEV 430 (677)
T ss_pred hhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhh-----------cCHHHHHHHHHHHHHHHHhcCCceEEEEeeeec
Confidence 345556999999999999999888877777755422 2233347789999999999 8999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCe
Q 020641 95 EGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFK 174 (323)
Q Consensus 95 ~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~ 174 (323)
.++.+|+||||-+. +|..+++..... .....++.+..|++.++.++|.. ||+|.|+||.|+|+-+ |.
T Consensus 431 ~d~~lYmvmE~Gd~-DL~kiL~k~~~~--------~~~~~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlVk-G~ 497 (677)
T KOG0596|consen 431 TDGYLYMVMECGDI-DLNKILKKKKSI--------DPDWFLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLVK-GR 497 (677)
T ss_pred cCceEEEEeecccc-cHHHHHHhccCC--------CchHHHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEEe-ee
Confidence 99999999997765 999999876543 44348889999999999999999 9999999999999965 59
Q ss_pred EEEeeccccCCCCccccccccccccCccccCCCccccCCC-----------CCcccchHHHHHHHHHHHhCCCCCCCCCC
Q 020641 175 AKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQ-----------LTQKSDVYSFGVVLLELLTGRKPVDHTMP 243 (323)
Q Consensus 175 ~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-----------~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 243 (323)
+||+|||+|..+.............||..|++||.+.... .+.++|||||||+||+|+.|+.||.....
T Consensus 498 LKLIDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n 577 (677)
T KOG0596|consen 498 LKLIDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN 577 (677)
T ss_pred EEeeeechhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH
Confidence 9999999999888777777777788999999999885322 45689999999999999999999974421
Q ss_pred cccchhhhhhcccccccccchhcCCCcCCCCCHHHH-HHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 244 RGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGV-AKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
...++..+.++.-..+++.-.. .++.++++.||.+||++|||..++|+
T Consensus 578 --------------~~aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 578 --------------QIAKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred --------------HHHHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence 1233455556554444443222 23999999999999999999999987
|
|
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-40 Score=281.03 Aligned_cols=257 Identities=23% Similarity=0.303 Sum_probs=185.8
Q ss_pred ccCCCCCCccceecccee--eeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeCCeE
Q 020641 22 RLDKGPEDDLYLKKRVKM--RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLR 99 (323)
Q Consensus 22 ~lg~G~~~~V~~~~~~~~--~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 99 (323)
+||+|+||.||+++.... ...+++|..... ........+.+|+..++.++|+||+++++.+......
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~-----------~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~ 70 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRAS-----------ATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPY 70 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCcc-----------CChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCce
Confidence 589999999999865432 234455432211 1112235678899999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEEEee
Q 020641 100 VLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIAD 179 (323)
Q Consensus 100 ~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~l~D 179 (323)
++||||+.+|+|.+++........ ...++..+..++.|++.|+.|||+. |++|+||||+||+++.++.++|+|
T Consensus 71 ~lv~e~~~~g~L~~~l~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~d 143 (269)
T cd05042 71 LLVLEFCPLGDLKNYLRSNRGMVA----QMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGD 143 (269)
T ss_pred EEEEEeCCCCcHHHHHHhcccccc----ccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEec
Confidence 999999999999999976543211 1156778889999999999999999 999999999999999999999999
Q ss_pred ccccCCCCccccccccccccCccccCCCccccC-------CCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccchhhh
Q 020641 180 FNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT-------GQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVT 251 (323)
Q Consensus 180 fg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-------~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~ 251 (323)
||++................++..|+|||.+.. ..++.++||||||+++|+|++ |..||............
T Consensus 144 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~- 222 (269)
T cd05042 144 YGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQV- 222 (269)
T ss_pred cccccccccchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHH-
Confidence 999865433222111223335677999998642 356789999999999999999 78888654321110000
Q ss_pred hhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHh
Q 020641 252 WATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQ 308 (323)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~ 308 (323)
.. ........+ ..+...+..+.+++..|| .||++|||+.+|++.|.
T Consensus 223 -~~-----~~~~~~~~~----~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 223 -VR-----EQDIKLPKP----QLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred -hh-----ccCccCCCC----cccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 00 000001111 123345567888999999 59999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=278.61 Aligned_cols=254 Identities=23% Similarity=0.334 Sum_probs=196.7
Q ss_pred CCCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEE
Q 020641 15 PSPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCV 94 (323)
Q Consensus 15 ~~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 94 (323)
.++....+||+|+||.||++.+... ..+++|..... ......+.+|++++++++|+||+++++.+.
T Consensus 6 ~~~~~~~~lg~g~~~~vy~~~~~~~-~~~~iK~~~~~-------------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 71 (260)
T cd05073 6 ESLKLEKKLGAGQFGEVWMATYNKH-TKVAVKTMKPG-------------SMSVEAFLAEANVMKTLQHDKLVKLHAVVT 71 (260)
T ss_pred cceeEEeEecCccceEEEEEEecCC-ccEEEEecCCC-------------hhHHHHHHHHHHHHHhcCCCCcceEEEEEc
Confidence 3456667999999999999986544 34666643311 112356888999999999999999999988
Q ss_pred eCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCe
Q 020641 95 EGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFK 174 (323)
Q Consensus 95 ~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~ 174 (323)
. ...+++|||+.+++|.+++...... .+++..+..++.|++.|+.+||+. |++|+||+|+||+++.++.
T Consensus 72 ~-~~~~~v~e~~~~~~L~~~~~~~~~~-------~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~ 140 (260)
T cd05073 72 K-EPIYIITEFMAKGSLLDFLKSDEGS-------KQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLV 140 (260)
T ss_pred C-CCeEEEEEeCCCCcHHHHHHhCCcc-------ccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCc
Confidence 7 6789999999999999999764322 278889999999999999999999 9999999999999999999
Q ss_pred EEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhh
Q 020641 175 AKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWA 253 (323)
Q Consensus 175 ~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~ 253 (323)
++|+|||.+......... ......++..|+|||.+....++.++|+||||+++|++++ |..||........
T Consensus 141 ~~l~d~~~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~------- 212 (260)
T cd05073 141 CKIADFGLARVIEDNEYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEV------- 212 (260)
T ss_pred EEECCCcceeeccCCCcc-cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHH-------
Confidence 999999998765432211 1122235677999999988888999999999999999998 9999975432111
Q ss_pred cccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhh
Q 020641 254 TPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPL 310 (323)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~ 310 (323)
...+........+...+..+.+++.+||+.+|++||++.++.+.|+++
T Consensus 213 ---------~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~~ 260 (260)
T cd05073 213 ---------IRALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDF 260 (260)
T ss_pred ---------HHHHhCCCCCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhcC
Confidence 111111111122334556799999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=279.93 Aligned_cols=257 Identities=24% Similarity=0.287 Sum_probs=187.5
Q ss_pred ccCCCCCCccceeccce--eeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeCCeE
Q 020641 22 RLDKGPEDDLYLKKRVK--MRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLR 99 (323)
Q Consensus 22 ~lg~G~~~~V~~~~~~~--~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 99 (323)
.||+|+||.||++.... +...+++|..... ........+.+|+.++++++|+||+++++.+.+....
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~-----------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 70 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVS-----------ASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPY 70 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCC-----------CChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCc
Confidence 58999999999997543 3445566533211 0111224678899999999999999999999988889
Q ss_pred EEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEEEee
Q 020641 100 VLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIAD 179 (323)
Q Consensus 100 ~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~l~D 179 (323)
++||||+.+++|.+++....... ....++..+..++.|++.|+.|||+. +++|+||||+||+++.++.++|+|
T Consensus 71 ~lv~e~~~~g~L~~~l~~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~d 143 (269)
T cd05087 71 LLVMEFCPLGDLKGYLRSCRKAE----LMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGD 143 (269)
T ss_pred EEEEECCCCCcHHHHHHHhhhcc----cccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECC
Confidence 99999999999999997543211 11256778889999999999999999 999999999999999999999999
Q ss_pred ccccCCCCccccccccccccCccccCCCccccCC-------CCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccchhhh
Q 020641 180 FNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG-------QLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVT 251 (323)
Q Consensus 180 fg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-------~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~ 251 (323)
||.+................++..|+|||.+.+. .++.++|+||||+++|+|++ |..||.......... ..
T Consensus 144 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~-~~ 222 (269)
T cd05087 144 YGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLT-YT 222 (269)
T ss_pred ccccccccCcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHH-HH
Confidence 9998654433222222334467889999987532 35789999999999999996 999997543221100 00
Q ss_pred hhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHh
Q 020641 252 WATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQ 308 (323)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~ 308 (323)
.. ........+.. ....+..+.+++.+|| .+|++|||+.||+..|+
T Consensus 223 ~~------~~~~~~~~~~~----~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 223 VR------EQQLKLPKPRL----KLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred hh------cccCCCCCCcc----CCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 00 00011111111 1233456889999999 58999999999998875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=291.57 Aligned_cols=258 Identities=16% Similarity=0.228 Sum_probs=190.5
Q ss_pred CCCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEE
Q 020641 15 PSPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCV 94 (323)
Q Consensus 15 ~~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 94 (323)
.+|....+||+|+||.||++++..+++.+++|+... .....|+.++++++|+||+++++++.
T Consensus 66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~------------------~~~~~E~~~l~~l~h~~iv~~~~~~~ 127 (357)
T PHA03209 66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQK------------------GTTLIEAMLLQNVNHPSVIRMKDTLV 127 (357)
T ss_pred cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCc------------------cccHHHHHHHHhCCCCCCcChhheEE
Confidence 467777899999999999999999999999885321 12246889999999999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCe
Q 020641 95 EGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFK 174 (323)
Q Consensus 95 ~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~ 174 (323)
.....++|+|++.+ +|.+++..... .+++..+..++.|++.||.|||+. ||+||||||+||+++.++.
T Consensus 128 ~~~~~~lv~e~~~~-~l~~~l~~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~ 195 (357)
T PHA03209 128 SGAITCMVLPHYSS-DLYTYLTKRSR--------PLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQ 195 (357)
T ss_pred eCCeeEEEEEccCC-cHHHHHHhccC--------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCC
Confidence 99999999999965 89888865432 288999999999999999999999 9999999999999999999
Q ss_pred EEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCC-CCCCCCcccchh----
Q 020641 175 AKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP-VDHTMPRGQQSL---- 249 (323)
Q Consensus 175 ~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p-f~~~~~~~~~~~---- 249 (323)
++|+|||++....... ......|+..|+|||++.+..++.++|||||||++|+|+++..+ |...........
T Consensus 196 ~kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~ 272 (357)
T PHA03209 196 VCIGDLGAAQFPVVAP---AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCH 272 (357)
T ss_pred EEEecCccccccccCc---ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHH
Confidence 9999999986433211 12234589999999999988999999999999999999985544 443222110000
Q ss_pred ---hhhhc-cccccccc---------chhcCC--CcCCC-------CCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 250 ---VTWAT-PRLSEDKV---------KQCVDP--KLKGE-------YPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 250 ---~~~~~-~~~~~~~~---------~~~~~~--~~~~~-------~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
..... ........ ...++. ..+.. .....+.++.++|.+||+.||.+|||+.|+++
T Consensus 273 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~ 350 (357)
T PHA03209 273 SHLLKIISTLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILN 350 (357)
T ss_pred HHHHHHHHHhccChhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhc
Confidence 00000 00000000 000000 00000 00123446778999999999999999999986
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=289.37 Aligned_cols=274 Identities=16% Similarity=0.182 Sum_probs=204.1
Q ss_pred CCCccccccC----CCCCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHh
Q 020641 4 DYHPRALGAH----APSPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVS 79 (323)
Q Consensus 4 ~~~~~~~~~~----~~~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~ 79 (323)
+|||..+|.. ...|.....||+|+||.||++.+..+++.+++|...+.. ........+.+|+.+++
T Consensus 1 ~~~~~~~~~~~~~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~----------~~~~~~~~~~~E~~~l~ 70 (353)
T cd07850 1 QFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPF----------QNVTHAKRAYRELVLMK 70 (353)
T ss_pred CceeecccchhhhhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccc----------cChhHHHHHHHHHHHHH
Confidence 5788888773 355777779999999999999999999999999654221 11122356678999999
Q ss_pred cCCCCcccceeeEEEeC------CeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCC
Q 020641 80 RLKHENLVELLGYCVEG------NLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKV 153 (323)
Q Consensus 80 ~l~h~~i~~~~~~~~~~------~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~ 153 (323)
+++|+||+++++++... ...|+||||+.+ +|.+.+... ++...+..++.|++.||.+||+.
T Consensus 71 ~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~-----------l~~~~~~~~~~ql~~aL~~LH~~- 137 (353)
T cd07850 71 LVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIQMD-----------LDHERMSYLLYQMLCGIKHLHSA- 137 (353)
T ss_pred hcCCCCCcceeeeeccCCCccccCcEEEEEeccCC-CHHHHHhhc-----------CCHHHHHHHHHHHHHHHHHHHhC-
Confidence 99999999999988643 356999999975 898888543 77888999999999999999999
Q ss_pred CCCceeCCCCCCCEEEccCCeEEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHh
Q 020641 154 QPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT 233 (323)
Q Consensus 154 ~~~i~h~dikp~nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~ 233 (323)
|++|+||||+||+++.++.++|+|||++........ .....++..|+|||.+.+..++.++||||||+++|+|++
T Consensus 138 --gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~ 212 (353)
T cd07850 138 --GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR 212 (353)
T ss_pred --CeeeCCCCHHHEEECCCCCEEEccCccceeCCCCCC---CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHH
Confidence 999999999999999999999999999876543221 122347888999999999999999999999999999999
Q ss_pred CCCCCCCCCCcccchhhh--------------------hhccc--ccccccchhc----CCCcCCCCCHHHHHHHHHHHH
Q 020641 234 GRKPVDHTMPRGQQSLVT--------------------WATPR--LSEDKVKQCV----DPKLKGEYPPKGVAKLAAVAA 287 (323)
Q Consensus 234 g~~pf~~~~~~~~~~~~~--------------------~~~~~--~~~~~~~~~~----~~~~~~~~~~~~~~~l~~li~ 287 (323)
|+.||...+.......+. +.... .......+.. .+......+...+..+.+++.
T Consensus 213 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 292 (353)
T cd07850 213 GTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLS 292 (353)
T ss_pred CCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHH
Confidence 999997554211100000 00000 0000000000 011111112234667899999
Q ss_pred HccCCCCCCCCChHHHHH
Q 020641 288 LCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 288 ~cl~~~P~~Rps~~evl~ 305 (323)
+||+.||++|||+.|+++
T Consensus 293 ~~L~~dP~~R~t~~eiL~ 310 (353)
T cd07850 293 KMLVIDPEKRISVDDALQ 310 (353)
T ss_pred HHcCCChhhCcCHHHHhc
Confidence 999999999999999996
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-40 Score=290.82 Aligned_cols=258 Identities=15% Similarity=0.116 Sum_probs=195.2
Q ss_pred CCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEe
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVE 95 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 95 (323)
.|....+||+|+||.||++++..+++.+|+|+..+... ......+.+.+|..++..++|+||+++++++.+
T Consensus 2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~---------~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~ 72 (331)
T cd05597 2 DFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEM---------LKRAETACFREERDVLVNGDRRWITNLHYAFQD 72 (331)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHH---------hhhhhHHHHHHHHHHHHhCCCCCCCceEEEEec
Confidence 35667799999999999999999999999997753211 111223567889999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeE
Q 020641 96 GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKA 175 (323)
Q Consensus 96 ~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~ 175 (323)
++..|+||||+.+++|.+++...... +++..+..++.|++.||.|||++ |++||||||+||+++.++.+
T Consensus 73 ~~~~~lv~e~~~g~~L~~~l~~~~~~--------~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~ 141 (331)
T cd05597 73 ENNLYLVMDYYVGGDLLTLLSKFEDR--------LPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHI 141 (331)
T ss_pred CCeEEEEEecCCCCcHHHHHHHhcCC--------CCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCE
Confidence 99999999999999999999753322 88999999999999999999999 99999999999999999999
Q ss_pred EEeeccccCCCCccccccccccccCccccCCCccccC-----CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhh
Q 020641 176 KIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT-----GQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLV 250 (323)
Q Consensus 176 ~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~ 250 (323)
+|+|||++......... ......|++.|+|||++.. ..++.++|||||||++|+|++|+.||...........+
T Consensus 142 kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i 220 (331)
T cd05597 142 RLADFGSCLRLLADGTV-QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI 220 (331)
T ss_pred EEEECCceeecCCCCCc-cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHH
Confidence 99999998654332211 1122348999999998863 34678999999999999999999999754321111000
Q ss_pred hhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCC--CCCCChHHHHHH
Q 020641 251 TWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEA--EFRPNMSIVVKA 306 (323)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P--~~Rps~~evl~~ 306 (323)
. . .... . .. .......+..+.+++.+||..++ ..|+++.++++.
T Consensus 221 ~--~----~~~~---~--~~-~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 221 M--N----HKEH---F--QF-PPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred H--c----CCCc---c--cC-CCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 0 0 0000 0 00 01112256678999999886533 337899988875
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=278.11 Aligned_cols=256 Identities=21% Similarity=0.256 Sum_probs=197.1
Q ss_pred CCCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEE
Q 020641 15 PSPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCV 94 (323)
Q Consensus 15 ~~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 94 (323)
..+.....||+|+||.||++.+..+++.+++|.......... .......+.+|+.+++.++|+||+++++++.
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 74 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPE-------TSKEVSALECEIQLLKNLQHERIVQYYGCLR 74 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCch-------hHHHHHHHHHHHHHHHHcCCCCeeeEEEEEE
Confidence 345666789999999999999999999999886543321111 1112356788999999999999999999887
Q ss_pred e--CCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccC
Q 020641 95 E--GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFED 172 (323)
Q Consensus 95 ~--~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~ 172 (323)
. ....++++||+.+++|.+++..... +++..+..++.|++.||.+||+. +++|+||+|+||+++.+
T Consensus 75 ~~~~~~~~l~~e~~~~~~L~~~l~~~~~---------l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~ 142 (266)
T cd06651 75 DRAEKTLTIFMEYMPGGSVKDQLKAYGA---------LTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSA 142 (266)
T ss_pred cCCCCEEEEEEeCCCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCC
Confidence 5 3578999999999999999975432 78888999999999999999999 99999999999999999
Q ss_pred CeEEEeeccccCCCCccccc-cccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhh
Q 020641 173 FKAKIADFNLSNQAPDMAAR-LHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVT 251 (323)
Q Consensus 173 ~~~~l~Dfg~~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~ 251 (323)
+.++|+|||++......... .......++..|+|||.+.+..++.++|+||||+++|+|++|+.||.........
T Consensus 143 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~---- 218 (266)
T cd06651 143 GNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAI---- 218 (266)
T ss_pred CCEEEccCCCccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHH----
Confidence 99999999998754322111 1112234788899999998888899999999999999999999999754321110
Q ss_pred hhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 252 WATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
............+...+..+.+++ +||..+|++|||+.||++
T Consensus 219 -----------~~~~~~~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 219 -----------FKIATQPTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred -----------HHHhcCCCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 111111111223344556788888 788899999999999976
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-41 Score=295.07 Aligned_cols=252 Identities=23% Similarity=0.307 Sum_probs=204.4
Q ss_pred cccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeCCeEE
Q 020641 21 VRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRV 100 (323)
Q Consensus 21 ~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 100 (323)
.-||.|+||.||-|++..++..||+|...-.- +...+--+++..|+..|++++|||++.+-++|......|
T Consensus 32 rEIGHGSFGAVYfArd~~n~evVAIKKMsySG---------KQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaW 102 (948)
T KOG0577|consen 32 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSG---------KQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAW 102 (948)
T ss_pred HHhcCCccceeEEeeccCccceeeeeeccccc---------cccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHH
Confidence 47899999999999999999999998554221 111222377889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEEEeec
Q 020641 101 LAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADF 180 (323)
Q Consensus 101 lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~l~Df 180 (323)
+|||||-| |-.|++.=... ++.+..+..|+.+.+.||.|||+. +.+|||||..|||+++.|.|||+||
T Consensus 103 LVMEYClG-SAsDlleVhkK--------plqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDF 170 (948)
T KOG0577|consen 103 LVMEYCLG-SASDLLEVHKK--------PLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADF 170 (948)
T ss_pred HHHHHHhc-cHHHHHHHHhc--------cchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccc
Confidence 99999986 77777743322 288999999999999999999999 9999999999999999999999999
Q ss_pred cccCCCCccccccccccccCccccCCCcccc---CCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccc
Q 020641 181 NLSNQAPDMAARLHSTRVLGTFGYHAPEYAM---TGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRL 257 (323)
Q Consensus 181 g~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 257 (323)
|+|..... ...+.|||.|+|||++. ...|+-+.||||||++..+|...++|....+.......+.
T Consensus 171 GSAsi~~P------AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIA------ 238 (948)
T KOG0577|consen 171 GSASIMAP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA------ 238 (948)
T ss_pred cchhhcCc------hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHH------
Confidence 99876543 24567999999999885 4678999999999999999999999986554432222222
Q ss_pred cccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhhcCCCC
Q 020641 258 SEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSPPP 316 (323)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~~~~~~ 316 (323)
.+....-..++++..+..|+..||++-|.+|||.++++. ...+....|
T Consensus 239 ---------QNesPtLqs~eWS~~F~~Fvd~CLqKipqeRptse~ll~--H~fv~R~Rp 286 (948)
T KOG0577|consen 239 ---------QNESPTLQSNEWSDYFRNFVDSCLQKIPQERPTSEELLK--HRFVLRERP 286 (948)
T ss_pred ---------hcCCCCCCCchhHHHHHHHHHHHHhhCcccCCcHHHHhh--cchhccCCC
Confidence 111112235788899999999999999999999999987 444444433
|
|
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=276.53 Aligned_cols=251 Identities=27% Similarity=0.389 Sum_probs=199.4
Q ss_pred cccccCCCCCCccceeccceee----eeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEE
Q 020641 19 YFVRLDKGPEDDLYLKKRVKMR----RWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCV 94 (323)
Q Consensus 19 ~~~~lg~G~~~~V~~~~~~~~~----~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 94 (323)
....||.|+||.||++++...+ ..+++|...... .....+.+.+|+++++.++|+||+++++++.
T Consensus 3 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~-----------~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 71 (258)
T smart00219 3 LGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDA-----------DEQQIEEFLREARIMRKLDHPNIVKLLGVCT 71 (258)
T ss_pred ccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCC-----------ChHHHHHHHHHHHHHHhcCCCchheEEEEEc
Confidence 4568999999999999998866 778888653221 1113467889999999999999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCe
Q 020641 95 EGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFK 174 (323)
Q Consensus 95 ~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~ 174 (323)
..+..+++|||+.+++|.+++....... +++..+..++.|++.|+.+||+. |++|+||+|+||+++.++.
T Consensus 72 ~~~~~~~i~e~~~~~~l~~~~~~~~~~~-------~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~ 141 (258)
T smart00219 72 EEEPLMIVMEYMEGGDLLDYLRKNRPKE-------LSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLV 141 (258)
T ss_pred CCCeeEEEEeccCCCCHHHHHHhhhhcc-------CCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCe
Confidence 9999999999999999999997654321 78899999999999999999999 9999999999999999999
Q ss_pred EEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhh
Q 020641 175 AKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWA 253 (323)
Q Consensus 175 ~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~ 253 (323)
++|+|||.+............ ...++..|+|||.+.+..++.++|+||||+++++|++ |..||.......
T Consensus 142 ~~l~dfg~~~~~~~~~~~~~~-~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~-------- 212 (258)
T smart00219 142 VKISDFGLSRDLYDDDYYKKK-GGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEE-------- 212 (258)
T ss_pred EEEcccCCceecccccccccc-cCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHH--------
Confidence 999999998766543222111 2236788999999888888999999999999999998 888886532211
Q ss_pred cccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHH
Q 020641 254 TPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKAL 307 (323)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l 307 (323)
..+.+........+...+.++.+++.+||..+|++|||+.|+++.|
T Consensus 213 --------~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 213 --------VLEYLKKGYRLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred --------HHHHHhcCCCCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 1111111111222333567899999999999999999999999865
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=280.10 Aligned_cols=249 Identities=24% Similarity=0.341 Sum_probs=194.7
Q ss_pred CccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcC-CCCcccceeeEEEe
Q 020641 17 PGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRL-KHENLVELLGYCVE 95 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~ 95 (323)
|....+||+|+||.||++.+..+++.+++|+.... ......+.+|+.+++++ +|+||+++++.+..
T Consensus 8 y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~-------------~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 74 (272)
T cd06637 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-------------GDEEEEIKQEINMLKKYSHHRNIATYYGAFIK 74 (272)
T ss_pred hhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcC-------------CccHHHHHHHHHHHHHhcCCCCeeeEeeEEee
Confidence 45556899999999999999999999999866421 11235678899999988 79999999999875
Q ss_pred C------CeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEE
Q 020641 96 G------NLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLL 169 (323)
Q Consensus 96 ~------~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili 169 (323)
. ...+++|||+.+++|.+++...... .+++..+..++.|++.|+.|||+. +++|+||+|+||++
T Consensus 75 ~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~-------~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili 144 (272)
T cd06637 75 KNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGN-------TLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLL 144 (272)
T ss_pred cCCCCCCcEEEEEEEcCCCCcHHHHHHhccCC-------CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEE
Confidence 3 4679999999999999999764322 288999999999999999999999 99999999999999
Q ss_pred ccCCeEEEeeccccCCCCccccccccccccCccccCCCcccc-----CCCCCcccchHHHHHHHHHHHhCCCCCCCCCCc
Q 020641 170 FEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAM-----TGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPR 244 (323)
Q Consensus 170 ~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 244 (323)
+.++.++|+|||++........ ......|+..|+|||.+. +..++.++|+||||+++|+|++|..||......
T Consensus 145 ~~~~~~~l~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~ 222 (272)
T cd06637 145 TENAEVKLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM 222 (272)
T ss_pred CCCCCEEEccCCCceecccccc--cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHH
Confidence 9999999999999875433211 123345788999999886 335778999999999999999999999654321
Q ss_pred ccchhhhhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 245 GQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
...... .............+..+.+++.+||..+|.+|||+.++++
T Consensus 223 ~~~~~~---------------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 223 RALFLI---------------PRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred HHHHHH---------------hcCCCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 111100 0001111122234567999999999999999999999975
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=279.63 Aligned_cols=257 Identities=23% Similarity=0.302 Sum_probs=198.7
Q ss_pred CccccccCCCCCCccceecccee---eeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEE
Q 020641 17 PGYFVRLDKGPEDDLYLKKRVKM---RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYC 93 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~~~~~---~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 93 (323)
+....+||+|+||.||++.+... ...+++|...... .....+.+.+|+.+++.++|+||+++++++
T Consensus 8 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~-----------~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~ 76 (270)
T cd05056 8 ITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT-----------SPSVREKFLQEAYIMRQFDHPHIVKLIGVI 76 (270)
T ss_pred ceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC-----------CHHHHHHHHHHHHHHHhCCCCchhceeEEE
Confidence 44556899999999999987654 3346666443211 012346788999999999999999999988
Q ss_pred EeCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCC
Q 020641 94 VEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDF 173 (323)
Q Consensus 94 ~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~ 173 (323)
... ..++||||+.+++|.+++..... .+++..+..++.|++.||.|||+. |++|+||||+||+++.++
T Consensus 77 ~~~-~~~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~ 144 (270)
T cd05056 77 TEN-PVWIVMELAPLGELRSYLQVNKY--------SLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPD 144 (270)
T ss_pred cCC-CcEEEEEcCCCCcHHHHHHhCCC--------CCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCC
Confidence 765 46899999999999999976432 188999999999999999999999 999999999999999999
Q ss_pred eEEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccchhhhh
Q 020641 174 KAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTW 252 (323)
Q Consensus 174 ~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~ 252 (323)
.++|+|||++.......... .....++..|+|||.+....++.++||||||+++|++++ |..||...........
T Consensus 145 ~~~l~d~g~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~--- 220 (270)
T cd05056 145 CVKLGDFGLSRYLEDESYYK-ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGR--- 220 (270)
T ss_pred CeEEccCceeeeccccccee-cCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHH---
Confidence 99999999987654432111 122234567999999888888999999999999999986 9999975543211110
Q ss_pred hcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhhcC
Q 020641 253 ATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKS 313 (323)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~~~ 313 (323)
+........+..++..+.+++.+||..+|.+|||+.++++.|+++..+
T Consensus 221 -------------~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~ 268 (270)
T cd05056 221 -------------IENGERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268 (270)
T ss_pred -------------HHcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 111111122345567899999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=281.46 Aligned_cols=249 Identities=21% Similarity=0.293 Sum_probs=195.1
Q ss_pred ccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeCC
Q 020641 18 GYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGN 97 (323)
Q Consensus 18 ~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 97 (323)
+...+||.|+||.||++.+..++..+++|...... ....+.+.+|+++++.++|+|++++++.+..++
T Consensus 8 ~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~------------~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~ 75 (282)
T cd06643 8 EIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS------------EEELEDYMVEIDILASCDHPNIVKLLDAFYYEN 75 (282)
T ss_pred HHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC------------HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCC
Confidence 44568999999999999999999888888654221 112356788999999999999999999999999
Q ss_pred eEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEEE
Q 020641 98 LRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKI 177 (323)
Q Consensus 98 ~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~l 177 (323)
..++|+||+.+++|.+++..... .+++..+..++.|++.||.|||+. |++|+||+|+||+++.++.++|
T Consensus 76 ~~~~v~e~~~~~~l~~~~~~~~~--------~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl 144 (282)
T cd06643 76 NLWILIEFCAGGAVDAVMLELER--------PLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKL 144 (282)
T ss_pred EEEEEEEecCCCcHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEE
Confidence 99999999999999988764322 188999999999999999999999 9999999999999999999999
Q ss_pred eeccccCCCCccccccccccccCccccCCCcccc-----CCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhh
Q 020641 178 ADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAM-----TGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTW 252 (323)
Q Consensus 178 ~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 252 (323)
+|||++........ ......++..|+|||.+. +..++.++|+||||+++|+|++|..||......... ...
T Consensus 145 ~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~--~~~ 220 (282)
T cd06643 145 ADFGVSAKNTRTIQ--RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVL--LKI 220 (282)
T ss_pred cccccccccccccc--ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHH--HHH
Confidence 99999865433221 122334788999999874 345678999999999999999999999754321110 010
Q ss_pred hcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 253 ATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
.... .+ ....+...+..+.+++.+||+.||.+|||+.++++
T Consensus 221 ~~~~----------~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 261 (282)
T cd06643 221 AKSE----------PP--TLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQ 261 (282)
T ss_pred hhcC----------CC--CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0000 00 01122334567999999999999999999999986
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=280.45 Aligned_cols=264 Identities=23% Similarity=0.359 Sum_probs=199.7
Q ss_pred CCccccccCCCCCCccceecccee-----eeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCccccee
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRVKM-----RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELL 90 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~~~-----~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~ 90 (323)
.+..+.+||.|+||.||+++...+ .+.+++|..... ......+.+.+|++++++++|+||++++
T Consensus 6 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~-----------~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 74 (275)
T cd05046 6 NLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKT-----------KDENLQSEFRRELDMFRKLSHKNVVRLL 74 (275)
T ss_pred hceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCc-----------cchHHHHHHHHHHHHHHhcCCcceeeeE
Confidence 456677899999999999997644 344555533211 1112346789999999999999999999
Q ss_pred eEEEeCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEc
Q 020641 91 GYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLF 170 (323)
Q Consensus 91 ~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~ 170 (323)
+++.+....++||||+.+++|.+++..............+++..+..++.|++.||.|||+. +++|+||||+||+++
T Consensus 75 ~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~ 151 (275)
T cd05046 75 GLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVS 151 (275)
T ss_pred EEECCCCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEe
Confidence 99999889999999999999999997654222111112389999999999999999999999 999999999999999
Q ss_pred cCCeEEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccchh
Q 020641 171 EDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSL 249 (323)
Q Consensus 171 ~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~ 249 (323)
.++.++++|||++........ .......++..|+|||.+.+..++.++||||||+++|+|++ |..||........
T Consensus 152 ~~~~~~l~~~~~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~--- 227 (275)
T cd05046 152 SQREVKVSLLSLSKDVYNSEY-YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEV--- 227 (275)
T ss_pred CCCcEEEcccccccccCcccc-cccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHH---
Confidence 999999999998764432211 11222335677999999888888999999999999999998 8889864322110
Q ss_pred hhhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhh
Q 020641 250 VTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQP 309 (323)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~ 309 (323)
. ............+...+..+.+++.+||+.+|.+|||+.|+++.|.+
T Consensus 228 ~------------~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~~ 275 (275)
T cd05046 228 L------------NRLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE 275 (275)
T ss_pred H------------HHHHcCCcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhcC
Confidence 0 01111111122233456689999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=281.83 Aligned_cols=266 Identities=17% Similarity=0.173 Sum_probs=196.7
Q ss_pred CccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeC
Q 020641 17 PGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEG 96 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 96 (323)
|....+||.|++|.||++++..++..+++|...... ........+.+|+.++++++|+||+++++++..+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~----------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 71 (285)
T cd07861 2 YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLES----------EEEGVPSTAIREISLLKELQHPNIVCLQDVLMQE 71 (285)
T ss_pred ceEeeEecccCceEEEEEEECCCCcEEEEEEecccc----------ccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeC
Confidence 456678999999999999999889999998654221 1123346678899999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEE
Q 020641 97 NLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAK 176 (323)
Q Consensus 97 ~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~ 176 (323)
...++||||+. ++|.+++...... ..+++..+..++.|++.||.|||+. |++|+||+|+||+++.++.++
T Consensus 72 ~~~~~v~e~~~-~~l~~~~~~~~~~------~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~ 141 (285)
T cd07861 72 SRLYLIFEFLS-MDLKKYLDSLPKG------QYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIK 141 (285)
T ss_pred CeEEEEEecCC-CCHHHHHhcCCCC------CcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEE
Confidence 99999999997 5898888654321 1288999999999999999999999 999999999999999999999
Q ss_pred EeeccccCCCCccccccccccccCccccCCCccccCC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhc-
Q 020641 177 IADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG-QLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWAT- 254 (323)
Q Consensus 177 l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~- 254 (323)
|+|||++........ ......+++.|+|||.+.+. .++.++|+||||+++|+|++|+.||................
T Consensus 142 l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~ 219 (285)
T cd07861 142 LADFGLARAFGIPVR--VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILG 219 (285)
T ss_pred ECcccceeecCCCcc--cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhC
Confidence 999999865432211 11223467889999987654 46889999999999999999999997654321111000000
Q ss_pred ----cccccc--------ccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 255 ----PRLSED--------KVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 255 ----~~~~~~--------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
..+... ....+..... .......+.++.+++.+||..||++|||+.+|++
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 220 TPTEDVWPGVTSLPDYKNTFPKWKKGSL-RSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred CCChhhhhcchhhHHHHhhccccCcchh-HHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 000000 0000000000 0111234667899999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=281.57 Aligned_cols=247 Identities=23% Similarity=0.334 Sum_probs=199.0
Q ss_pred CccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeC
Q 020641 17 PGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEG 96 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 96 (323)
|..+..||.|+||.||++.+..+++.+++|+..... .....+.+.+|+.++++++|+||+++++++..+
T Consensus 6 y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~-----------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 74 (277)
T cd06642 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE-----------AEDEIEDIQQEITVLSQCDSPYITRYYGSYLKG 74 (277)
T ss_pred HHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEecccc-----------chHHHHHHHHHHHHHHcCCCCccHhhhcccccC
Confidence 344568999999999999999888889998654221 112236788999999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEE
Q 020641 97 NLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAK 176 (323)
Q Consensus 97 ~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~ 176 (323)
+..++|+||+.+++|.+++.... +++..+..++.|++.|+.|||+. |++|+||+|+||+++.++.++
T Consensus 75 ~~~~lv~e~~~~~~L~~~~~~~~----------~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~ 141 (277)
T cd06642 75 TKLWIIMEYLGGGSALDLLKPGP----------LEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVK 141 (277)
T ss_pred CceEEEEEccCCCcHHHHhhcCC----------CCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEE
Confidence 99999999999999999986532 88899999999999999999999 999999999999999999999
Q ss_pred EeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhccc
Q 020641 177 IADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPR 256 (323)
Q Consensus 177 l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 256 (323)
|+|||++........ ......++..|+|||.+.+..++.++|+||||+++|+|++|..||.........
T Consensus 142 l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~--------- 210 (277)
T cd06642 142 LADFGVAGQLTDTQI--KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVL--------- 210 (277)
T ss_pred EccccccccccCcch--hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHH---------
Confidence 999999876543221 112234788899999998888899999999999999999999998644321100
Q ss_pred ccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 257 LSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
..+............+..+.+++.+||+.+|++|||+.++++
T Consensus 211 -------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 252 (277)
T cd06642 211 -------FLIPKNSPPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLK 252 (277)
T ss_pred -------hhhhcCCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 001111111223345667999999999999999999999998
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=295.31 Aligned_cols=247 Identities=21% Similarity=0.278 Sum_probs=202.9
Q ss_pred cccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeCCe
Q 020641 19 YFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNL 98 (323)
Q Consensus 19 ~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 98 (323)
.+.-||.|+||.||+|.+..++.+.|.|++..+ +.+..+++.-|+++|..|+||+|+++++.|...+.
T Consensus 36 IiGELGDGAFGKVyKA~nket~~lAAaKvIetk------------seEELEDylVEIeILa~CdHP~ivkLl~ayy~enk 103 (1187)
T KOG0579|consen 36 IIGELGDGAFGKVYKAVNKETKLLAAAKVIETK------------SEEELEDYLVEIEILAECDHPVIVKLLSAYYFENK 103 (1187)
T ss_pred HHhhhcCccchhhhhhhcccchhhhhhhhhccc------------chhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCc
Confidence 344789999999999999999988888866532 23334778899999999999999999999999999
Q ss_pred EEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEEEe
Q 020641 99 RVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIA 178 (323)
Q Consensus 99 ~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~l~ 178 (323)
+|++.|||.||.+...+-.-.. .+++.++..+++|++.||.|||++ +|+|||+|..|||++-+|.++|+
T Consensus 104 LwiliEFC~GGAVDaimlEL~r--------~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLA 172 (1187)
T KOG0579|consen 104 LWILIEFCGGGAVDAIMLELGR--------VLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLA 172 (1187)
T ss_pred eEEEEeecCCchHhHHHHHhcc--------ccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeee
Confidence 9999999999999888865433 299999999999999999999999 99999999999999999999999
Q ss_pred eccccCCCCccccccccccccCccccCCCcccc-----CCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhh
Q 020641 179 DFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAM-----TGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWA 253 (323)
Q Consensus 179 Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 253 (323)
|||.+..... .......++|||.|+|||+.. ..+|+.++||||||++|.+|..+.+|....+...-
T Consensus 173 DFGVSAKn~~--t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRV------- 243 (1187)
T KOG0579|consen 173 DFGVSAKNKS--TRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV------- 243 (1187)
T ss_pred cccccccchh--HHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHH-------
Confidence 9999865432 333345678999999999875 46789999999999999999999999876543211
Q ss_pred cccccccccchhcCCCcC-CCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 254 TPRLSEDKVKQCVDPKLK-GEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
+.++...... ..-|..++..+.+|+.+||.+||..||++.++++
T Consensus 244 --------llKiaKSePPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 244 --------LLKIAKSEPPTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred --------HHHHhhcCCCcccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 1111111110 1234567788999999999999999999999987
|
|
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=279.45 Aligned_cols=247 Identities=24% Similarity=0.335 Sum_probs=200.1
Q ss_pred CccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeC
Q 020641 17 PGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEG 96 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 96 (323)
|.....||.|++|.||++++..+++.+++|...... .......+.+|+++++.++|+||+++++.+.++
T Consensus 3 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~-----------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 71 (274)
T cd06609 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE-----------AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKG 71 (274)
T ss_pred hhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc-----------cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEEC
Confidence 455668999999999999999999999999764221 112235678899999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEE
Q 020641 97 NLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAK 176 (323)
Q Consensus 97 ~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~ 176 (323)
...++|+||+.+++|.+++.... +++..+..++.|++.|+.+||+. +++|+||+|+||++++++.++
T Consensus 72 ~~~~~v~e~~~~~~L~~~~~~~~----------~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~ 138 (274)
T cd06609 72 SKLWIIMEYCGGGSCLDLLKPGK----------LDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVK 138 (274)
T ss_pred CeEEEEEEeeCCCcHHHHHhhcC----------CCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEE
Confidence 99999999999999999997642 88999999999999999999999 999999999999999999999
Q ss_pred EeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhccc
Q 020641 177 IADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPR 256 (323)
Q Consensus 177 l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 256 (323)
|+|||++........ ......++..|+|||.+.+..++.++|+||||+++|+|++|..||..........
T Consensus 139 l~d~g~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~-------- 208 (274)
T cd06609 139 LADFGVSGQLTSTMS--KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLF-------- 208 (274)
T ss_pred Ecccccceeeccccc--ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHH--------
Confidence 999999876654321 1233457888999999988889999999999999999999999997543211000
Q ss_pred ccccccchhcCCCcCCCCCHH-HHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 257 LSEDKVKQCVDPKLKGEYPPK-GVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~-~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
.+........+.. .+..+.+++.+||..+|++|||++++++
T Consensus 209 --------~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 209 --------LIPKNNPPSLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred --------HhhhcCCCCCcccccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 0000000111111 4567999999999999999999999976
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=275.87 Aligned_cols=250 Identities=22% Similarity=0.286 Sum_probs=200.3
Q ss_pred CccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeC
Q 020641 17 PGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEG 96 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 96 (323)
|+....||.|++|.||++.+..+++.+++|....... .......+.+|++++++++|+|++++++.+..+
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~----------~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~ 71 (256)
T cd08220 2 YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQM----------TKDERLAAQNECQVLKLLSHPNIIEYYENFLED 71 (256)
T ss_pred ceEEEEecccCceEEEEEEEcCCCcEEEEEEEecccc----------ccHHHHHHHHHHHHHhhCCCCchhheeeeEecC
Confidence 5566789999999999999999999999987653321 122246788999999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccC-CeE
Q 020641 97 NLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFED-FKA 175 (323)
Q Consensus 97 ~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~-~~~ 175 (323)
+..++||||+.+++|.+++...... .+++..+..++.|++.++.+||++ |++|+||+|+||+++.+ +.+
T Consensus 72 ~~~~lv~e~~~~~~L~~~~~~~~~~-------~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~ 141 (256)
T cd08220 72 KALMIVMEYAPGGTLAEYIQKRCNS-------LLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVV 141 (256)
T ss_pred CEEEEEEecCCCCCHHHHHHHhccc-------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEE
Confidence 9999999999999999999764322 288899999999999999999999 99999999999999865 467
Q ss_pred EEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhcc
Q 020641 176 KIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATP 255 (323)
Q Consensus 176 ~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~ 255 (323)
+|+|||.+........ .....++..|+|||.+.+..++.++|+||||+++|+|++|..||........ ..
T Consensus 142 ~l~d~~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~---~~---- 211 (256)
T cd08220 142 KIGDFGISKILSSKSK---AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPAL---VL---- 211 (256)
T ss_pred EEccCCCceecCCCcc---ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHH---HH----
Confidence 9999999876543221 1234478899999999888889999999999999999999999965432111 00
Q ss_pred cccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 256 RLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
.... ......+...+..+.+++.+||+.+|++|||+.|+++
T Consensus 212 --------~~~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 212 --------KIMS-GTFAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred --------HHHh-cCCCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 0000 0111223345667999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-40 Score=284.56 Aligned_cols=258 Identities=21% Similarity=0.350 Sum_probs=201.8
Q ss_pred CccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeC
Q 020641 17 PGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEG 96 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 96 (323)
+..+.+||.|+||.||++.+..++..+++|..... .....+.+.+|+..++.++|+||+++++.+..+
T Consensus 24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~------------~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~ 91 (292)
T cd06658 24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLR------------KQQRRELLFNEVVIMRDYHHENVVDMYNSYLVG 91 (292)
T ss_pred HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecc------------hHHHHHHHHHHHHHHHhCCCCcHHHHHHheecC
Confidence 34456899999999999999988999999865321 112235678899999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEE
Q 020641 97 NLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAK 176 (323)
Q Consensus 97 ~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~ 176 (323)
+..++||||+.+++|.+++.... +++..+..++.|++.|+.|||+. |++|+||+|+||+++.++.++
T Consensus 92 ~~~~lv~e~~~~~~L~~~~~~~~----------l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~k 158 (292)
T cd06658 92 DELWVVMEFLEGGALTDIVTHTR----------MNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIK 158 (292)
T ss_pred CeEEEEEeCCCCCcHHHHHhcCC----------CCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEE
Confidence 99999999999999999885432 78889999999999999999999 999999999999999999999
Q ss_pred EeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhccc
Q 020641 177 IADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPR 256 (323)
Q Consensus 177 l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 256 (323)
|+|||++........ ......++..|+|||.+.+..++.++|+||||+++|+|++|+.||...........
T Consensus 159 L~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~------- 229 (292)
T cd06658 159 LSDFGFCAQVSKEVP--KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRR------- 229 (292)
T ss_pred EccCcchhhcccccc--cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-------
Confidence 999998865433221 12234578899999999888889999999999999999999999975432111000
Q ss_pred ccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhhcCCCCC
Q 020641 257 LSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSPPPA 317 (323)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~~~~~~~ 317 (323)
......+.. ......+..+.+++.+||..||.+|||++++++ ..++...++|
T Consensus 230 -----~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~--~~~~~~~~~~ 281 (292)
T cd06658 230 -----IRDNLPPRV--KDSHKVSSVLRGFLDLMLVREPSQRATAQELLQ--HPFLKLAGPP 281 (292)
T ss_pred -----HHhcCCCcc--ccccccCHHHHHHHHHHccCChhHCcCHHHHhh--ChhhhccCCc
Confidence 000011111 011234557899999999999999999999998 4555544443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-40 Score=290.26 Aligned_cols=254 Identities=15% Similarity=0.128 Sum_probs=194.7
Q ss_pred CCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEe
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVE 95 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 95 (323)
.|....+||+|+||.||++++..+++.+|+|+..+... ........+.+|..++..++|+||+++++++.+
T Consensus 2 ~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~---------~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~ 72 (331)
T cd05624 2 DFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEM---------LKRAETACFREERNVLVNGDCQWITTLHYAFQD 72 (331)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHH---------HhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEc
Confidence 35566789999999999999999999999997653211 111223557788999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeE
Q 020641 96 GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKA 175 (323)
Q Consensus 96 ~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~ 175 (323)
.+..|+||||+.+|+|.+++...... +++..+..++.|++.||.|||+. |++||||||+||+++.++.+
T Consensus 73 ~~~~~lv~Ey~~gg~L~~~l~~~~~~--------l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~ 141 (331)
T cd05624 73 ENYLYLVMDYYVGGDLLTLLSKFEDR--------LPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHI 141 (331)
T ss_pred CCEEEEEEeCCCCCcHHHHHHHhcCC--------CCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCE
Confidence 99999999999999999999764322 88899999999999999999999 99999999999999999999
Q ss_pred EEeeccccCCCCccccccccccccCccccCCCccccC-----CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhh
Q 020641 176 KIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT-----GQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLV 250 (323)
Q Consensus 176 ~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~ 250 (323)
+|+|||++......... ......|++.|+|||.+.+ ..++.++|+||||+++|+|++|+.||..........
T Consensus 142 kl~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~-- 218 (331)
T cd05624 142 RLADFGSCLKMNQDGTV-QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYG-- 218 (331)
T ss_pred EEEeccceeeccCCCce-eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHH--
Confidence 99999998655432211 1123458999999998865 457889999999999999999999997543211100
Q ss_pred hhhcccccccccchhcCCCcCC---CCCHHHHHHHHHHHHHccCCCCCC--CCChHHHHH
Q 020641 251 TWATPRLSEDKVKQCVDPKLKG---EYPPKGVAKLAAVAALCVQYEAEF--RPNMSIVVK 305 (323)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~~P~~--Rps~~evl~ 305 (323)
.+.....+. ......+..+.+++.+||..+++. |++++++++
T Consensus 219 -------------~i~~~~~~~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~ 265 (331)
T cd05624 219 -------------KIMNHEERFQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKK 265 (331)
T ss_pred -------------HHHcCCCcccCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhc
Confidence 011100000 111234567999999999865544 457888765
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-40 Score=289.49 Aligned_cols=255 Identities=14% Similarity=0.128 Sum_probs=195.5
Q ss_pred CCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEe
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVE 95 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 95 (323)
.|....+||+|+||.||++++..+++.+++|+..+.... .......+.+|..++..++|++|+++++.+.+
T Consensus 2 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~---------~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~ 72 (332)
T cd05623 2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEML---------KRAETACFREERDVLVNGDNQWITTLHYAFQD 72 (332)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHH---------HhhHHHHHHHHHHHHhhCCCCCEeeEEEEEec
Confidence 355667999999999999999999999999976532111 11223557888999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeE
Q 020641 96 GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKA 175 (323)
Q Consensus 96 ~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~ 175 (323)
....++||||+.+|+|.+++...... +++..+..++.|++.|+.|||+. |++||||||+||+++.++.+
T Consensus 73 ~~~~~lv~ey~~~g~L~~~l~~~~~~--------l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~ 141 (332)
T cd05623 73 ENNLYLVMDYYVGGDLLTLLSKFEDR--------LPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHI 141 (332)
T ss_pred CCEEEEEEeccCCCcHHHHHHHhcCC--------CCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCE
Confidence 99999999999999999999764322 88889999999999999999999 99999999999999999999
Q ss_pred EEeeccccCCCCccccccccccccCccccCCCcccc-----CCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhh
Q 020641 176 KIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAM-----TGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLV 250 (323)
Q Consensus 176 ~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~ 250 (323)
+|+|||++........ .......|++.|+|||++. ...++.++|||||||++|+|++|+.||..........
T Consensus 142 kL~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~-- 218 (332)
T cd05623 142 RLADFGSCLKLMEDGT-VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYG-- 218 (332)
T ss_pred EEeecchheecccCCc-ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHH--
Confidence 9999999865432211 1122345899999999886 3457889999999999999999999997543211110
Q ss_pred hhhcccccccccchhcCCCcCC---CCCHHHHHHHHHHHHHccCCCCCC--CCChHHHHHH
Q 020641 251 TWATPRLSEDKVKQCVDPKLKG---EYPPKGVAKLAAVAALCVQYEAEF--RPNMSIVVKA 306 (323)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~~P~~--Rps~~evl~~ 306 (323)
.+.....+. ......+..+.+++.+|+..++.. |+++.|+++.
T Consensus 219 -------------~i~~~~~~~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 219 -------------KIMNHKERFQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred -------------HHhCCCccccCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 111110000 111234677999999988654443 6889988765
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=284.88 Aligned_cols=204 Identities=21% Similarity=0.304 Sum_probs=158.9
Q ss_pred cccCCCCCCccceeccce--eeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEe--C
Q 020641 21 VRLDKGPEDDLYLKKRVK--MRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVE--G 96 (323)
Q Consensus 21 ~~lg~G~~~~V~~~~~~~--~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~ 96 (323)
.+||+|+||.||+|+... +++.+++|.... ......+.+|+++++.++|+||+++++++.. +
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~--------------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 72 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEG--------------TGISMSACREIALLRELKHPNVIALQKVFLSHSD 72 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecC--------------CCCcHHHHHHHHHHHhCCCCCeeeEEEEEeccCC
Confidence 379999999999999654 556777774431 1123457889999999999999999998853 4
Q ss_pred CeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEE----ccC
Q 020641 97 NLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLL----FED 172 (323)
Q Consensus 97 ~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili----~~~ 172 (323)
...++|+||+.+ +|.+++..............+++..+..++.|++.||.|||+. |++|+||||+||++ +.+
T Consensus 73 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~ 148 (317)
T cd07867 73 RKVWLLFDYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPER 148 (317)
T ss_pred CeEEEEEeeeCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCC
Confidence 578999999876 8888875432211111122388899999999999999999999 99999999999999 456
Q ss_pred CeEEEeeccccCCCCccccc-cccccccCccccCCCccccC-CCCCcccchHHHHHHHHHHHhCCCCCCCCC
Q 020641 173 FKAKIADFNLSNQAPDMAAR-LHSTRVLGTFGYHAPEYAMT-GQLTQKSDVYSFGVVLLELLTGRKPVDHTM 242 (323)
Q Consensus 173 ~~~~l~Dfg~~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 242 (323)
+.++|+|||++......... .......+++.|+|||.+.+ ..++.++||||||+++|+|++|+.||....
T Consensus 149 ~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~ 220 (317)
T cd07867 149 GRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred CcEEEeeccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccccc
Confidence 78999999999765433221 11233457899999998876 457899999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=279.37 Aligned_cols=254 Identities=21% Similarity=0.336 Sum_probs=198.5
Q ss_pred cccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeCCeEE
Q 020641 21 VRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRV 100 (323)
Q Consensus 21 ~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 100 (323)
..||.|++|.||+|.+..+++.+++|............ .......+.+.+|+.++++++|+||+++++++......+
T Consensus 6 ~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~---~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (267)
T cd06628 6 ALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSK---DRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHLN 82 (267)
T ss_pred ceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchh---HHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCccE
Confidence 36899999999999998888888888665332211110 001112356788999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEEEeec
Q 020641 101 LAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADF 180 (323)
Q Consensus 101 lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~l~Df 180 (323)
+++||+.+++|.+++..... ++...+..++.|++.|+.+||+. |++|+||+|+||++++++.++|+||
T Consensus 83 lv~e~~~~~~L~~~l~~~~~---------l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~df 150 (267)
T cd06628 83 IFLEYVPGGSVAALLNNYGA---------FEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDF 150 (267)
T ss_pred EEEEecCCCCHHHHHHhccC---------ccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEeccc
Confidence 99999999999999976432 78889999999999999999999 9999999999999999999999999
Q ss_pred cccCCCCccccc----cccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhccc
Q 020641 181 NLSNQAPDMAAR----LHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPR 256 (323)
Q Consensus 181 g~~~~~~~~~~~----~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 256 (323)
|.+......... .......|+..|+|||.+.+..++.++|+||||+++|+|++|+.||........
T Consensus 151 g~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~---------- 220 (267)
T cd06628 151 GISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQA---------- 220 (267)
T ss_pred CCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHH----------
Confidence 998766421111 111223478889999999888889999999999999999999999975432110
Q ss_pred ccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 257 LSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
..+... ......+...+..+.+++.+||+.||.+||++.++++
T Consensus 221 -----~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 221 -----IFKIGE-NASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred -----HHHHhc-cCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 000000 1112233455678999999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=284.32 Aligned_cols=251 Identities=20% Similarity=0.269 Sum_probs=199.5
Q ss_pred CCCCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEE
Q 020641 14 APSPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYC 93 (323)
Q Consensus 14 ~~~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 93 (323)
...+..+.+||.|+||.||++.+..+++.+++|+..... ....+.+.+|+..++.++||||+++++++
T Consensus 20 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~------------~~~~~~~~~e~~~l~~l~hp~i~~~~~~~ 87 (297)
T cd06659 20 RSLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRK------------QQRRELLFNEVVIMRDYQHQNVVEMYKSY 87 (297)
T ss_pred hhhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecc------------cchHHHHHHHHHHHHhCCCCchhhhhhhe
Confidence 344556679999999999999999889999998663211 12236678899999999999999999999
Q ss_pred EeCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCC
Q 020641 94 VEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDF 173 (323)
Q Consensus 94 ~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~ 173 (323)
..++..++++||+.+++|.+++.... +++..+..++.|++.|+.+||+. |++|+||+|+||+++.++
T Consensus 88 ~~~~~~~iv~e~~~~~~L~~~~~~~~----------~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~ 154 (297)
T cd06659 88 LVGEELWVLMEFLQGGALTDIVSQTR----------LNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDG 154 (297)
T ss_pred eeCCeEEEEEecCCCCCHHHHHhhcC----------CCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCC
Confidence 99999999999999999999885532 88999999999999999999999 999999999999999999
Q ss_pred eEEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhh
Q 020641 174 KAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWA 253 (323)
Q Consensus 174 ~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 253 (323)
.++|+|||++........ ......++..|+|||.+.+..++.++|+||||+++|+|++|+.||.......... ..
T Consensus 155 ~~kL~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~---~~ 229 (297)
T cd06659 155 RVKLSDFGFCAQISKDVP--KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMK---RL 229 (297)
T ss_pred cEEEeechhHhhcccccc--cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HH
Confidence 999999998865433211 1123457889999999988889999999999999999999999997443211100 00
Q ss_pred cccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 254 TPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
.... . .........+..+.+++.+||+.+|++|||+.++++
T Consensus 230 ~~~~---------~--~~~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~ 270 (297)
T cd06659 230 RDSP---------P--PKLKNAHKISPVLRDFLERMLTREPQERATAQELLD 270 (297)
T ss_pred hccC---------C--CCccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 0000 0 001112234567899999999999999999999998
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=278.27 Aligned_cols=240 Identities=24% Similarity=0.439 Sum_probs=185.0
Q ss_pred ccCCCCCCccceeccceeeee-------eeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEE
Q 020641 22 RLDKGPEDDLYLKKRVKMRRW-------LCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCV 94 (323)
Q Consensus 22 ~lg~G~~~~V~~~~~~~~~~~-------~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 94 (323)
.||.|+||.||++.+...+.. +++|.... ......+.+.+|+.+++.++|+||+++++++.
T Consensus 2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~------------~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~ 69 (258)
T cd05078 2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDK------------SHRNYSESFFEAASMMSQLSHKHLVLNYGVCV 69 (258)
T ss_pred CCCcccchhheeeeecccccccccccchhhHHhhcc------------hhHHHHHHHHHHHHHHHhCCCCChhheeeEEE
Confidence 689999999999988655432 44443221 11223456788999999999999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCe
Q 020641 95 EGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFK 174 (323)
Q Consensus 95 ~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~ 174 (323)
.+...++||||+.+|+|.+++...... +++..+..++.|++.|+.|||+. |++|+||||+||+++.++.
T Consensus 70 ~~~~~~lv~e~~~~g~L~~~l~~~~~~--------~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~ 138 (258)
T cd05078 70 CGDESIMVQEYVKFGSLDTYLKKNKNL--------INISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREED 138 (258)
T ss_pred eCCCcEEEEecCCCCcHHHHHhcCCCC--------CCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccc
Confidence 988999999999999999999765432 88889999999999999999999 9999999999999987764
Q ss_pred --------EEEeeccccCCCCccccccccccccCccccCCCccccC-CCCCcccchHHHHHHHHHHHhCC-CCCCCCCCc
Q 020641 175 --------AKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT-GQLTQKSDVYSFGVVLLELLTGR-KPVDHTMPR 244 (323)
Q Consensus 175 --------~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~-~pf~~~~~~ 244 (323)
++++|||.+...... ....++..|+|||.+.+ ..++.++||||||+++|+|++|. .||......
T Consensus 139 ~~~~~~~~~~l~d~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~ 212 (258)
T cd05078 139 RKTGNPPFIKLSDPGISITVLPK------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQ 212 (258)
T ss_pred cccCCCceEEecccccccccCCc------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHH
Confidence 699999987654321 22346788999999876 45788999999999999999985 555433221
Q ss_pred ccchhhhhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHh
Q 020641 245 GQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQ 308 (323)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~ 308 (323)
.... .... ....+.....++.+++.+||+.||++|||+.++++.|.
T Consensus 213 ~~~~----------------~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 213 KKLQ----------------FYED--RHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred HHHH----------------HHHc--cccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 1100 0000 11122333467999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=275.52 Aligned_cols=249 Identities=24% Similarity=0.337 Sum_probs=201.0
Q ss_pred CCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEe
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVE 95 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 95 (323)
.|....+||.|++|.||++.+..+++.+++|...... ..+.+.+|+++++.++|+||+++++.+..
T Consensus 4 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~--------------~~~~~~~e~~~~~~l~~~~i~~~~~~~~~ 69 (256)
T cd06612 4 VFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE--------------DLQEIIKEISILKQCDSPYIVKYYGSYFK 69 (256)
T ss_pred cchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH--------------HHHHHHHHHHHHHhCCCCcEeeeeeeeec
Confidence 4566678999999999999999888888888653210 04778999999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeE
Q 020641 96 GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKA 175 (323)
Q Consensus 96 ~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~ 175 (323)
....|+++||+.+++|.+++..... .+++..+..++.|++.|+.+||+. +++|+||+|+||+++.++.+
T Consensus 70 ~~~~~l~~e~~~~~~L~~~l~~~~~--------~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~ 138 (256)
T cd06612 70 NTDLWIVMEYCGAGSVSDIMKITNK--------TLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQA 138 (256)
T ss_pred CCcEEEEEecCCCCcHHHHHHhCcc--------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcE
Confidence 9999999999999999999865432 289999999999999999999999 99999999999999999999
Q ss_pred EEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhcc
Q 020641 176 KIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATP 255 (323)
Q Consensus 176 ~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~ 255 (323)
+|+|||++........ ......++..|+|||.+.+..++.++||||||+++|+|++|+.||............
T Consensus 139 ~l~dfg~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~----- 211 (256)
T cd06612 139 KLADFGVSGQLTDTMA--KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMI----- 211 (256)
T ss_pred EEcccccchhcccCcc--ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhh-----
Confidence 9999999876654321 122334788899999998888999999999999999999999999754322111000
Q ss_pred cccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 256 RLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
... .......+...+..+.+++.+||+.||++|||+.|+++
T Consensus 212 -------~~~--~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 212 -------PNK--PPPTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred -------ccC--CCCCCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 000 00011123345567999999999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=280.28 Aligned_cols=266 Identities=19% Similarity=0.247 Sum_probs=198.9
Q ss_pred CCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEe
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVE 95 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 95 (323)
.|+...+||+|++|.||++.+..+++.+++|...... ......+.+.+|++++++++|+|++++++.+..
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~----------~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~ 71 (286)
T cd07847 2 KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESE----------DDPVIKKIALREIRMLKQLKHPNLVNLIEVFRR 71 (286)
T ss_pred ceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecc----------cCccccHHHHHHHHHHHhCCCCCEeeeeeEEee
Confidence 3566778999999999999999889999998654221 112233567899999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeE
Q 020641 96 GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKA 175 (323)
Q Consensus 96 ~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~ 175 (323)
+...++||||+++++|..++..... +++..+..++.|++.||.|||+. |++|+||+|+||+++.++.+
T Consensus 72 ~~~~~~v~e~~~~~~l~~~~~~~~~---------~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~ 139 (286)
T cd07847 72 KRKLHLVFEYCDHTVLNELEKNPRG---------VPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQI 139 (286)
T ss_pred CCEEEEEEeccCccHHHHHHhCCCC---------CCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcE
Confidence 9999999999999888877654322 88999999999999999999999 99999999999999999999
Q ss_pred EEeeccccCCCCccccccccccccCccccCCCccccC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhc
Q 020641 176 KIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT-GQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWAT 254 (323)
Q Consensus 176 ~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~ 254 (323)
+|+|||++........ ......++..|+|||.+.+ ..++.++|+||||+++|+|++|..||................
T Consensus 140 ~l~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~ 217 (286)
T cd07847 140 KLCDFGFARILTGPGD--DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTL 217 (286)
T ss_pred EECccccceecCCCcc--cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Confidence 9999999876644321 1122346788999998875 457889999999999999999999997654322111110000
Q ss_pred ccc--------ccccc-chhcCCCcCCC-----CCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 255 PRL--------SEDKV-KQCVDPKLKGE-----YPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 255 ~~~--------~~~~~-~~~~~~~~~~~-----~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
... ..... .....+..... .....+..+.+++.+||+.+|++|||+.|++.
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 218 GDLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred CCCChHHhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 000 00000 00000000000 01123567999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=276.65 Aligned_cols=251 Identities=19% Similarity=0.255 Sum_probs=201.4
Q ss_pred CccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeC
Q 020641 17 PGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEG 96 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 96 (323)
|....+||+|+||.||++.+..+++.+++|........ ......+.+|+.++++++|+||+++++++...
T Consensus 2 y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~----------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (256)
T cd08218 2 YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMS----------PKEREESRKEVAVLSNMKHPNIVQYQESFEEN 71 (256)
T ss_pred ceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCC----------hHHHHHHHHHHHHHHhCCCCCeeeeEeeecCC
Confidence 56677999999999999999999998998865432111 11235678999999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEE
Q 020641 97 NLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAK 176 (323)
Q Consensus 97 ~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~ 176 (323)
+..++|+||+.+++|.+++...... .+++..+..++.|++.|+.+||+. |++|+||+|+||+++.++.++
T Consensus 72 ~~~~lv~e~~~~~~l~~~~~~~~~~-------~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~ 141 (256)
T cd08218 72 GNLYIVMDYCEGGDLYKKINAQRGV-------LFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIK 141 (256)
T ss_pred CeEEEEEecCCCCcHHHHHHhccCC-------CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEE
Confidence 9999999999999999998754322 178889999999999999999999 999999999999999999999
Q ss_pred EeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhccc
Q 020641 177 IADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPR 256 (323)
Q Consensus 177 l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 256 (323)
|+|||.+......... .....|++.|+|||.+.+..++.++|+||||+++++|++|..||.......
T Consensus 142 l~d~~~~~~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~----------- 208 (256)
T cd08218 142 LGDFGIARVLNSTVEL--ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKN----------- 208 (256)
T ss_pred EeeccceeecCcchhh--hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHH-----------
Confidence 9999998765442221 122347888999999988888999999999999999999999996432211
Q ss_pred ccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 257 LSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
.+.+.+.. .....+...+.++.+++.+||+.+|++||++.+|++
T Consensus 209 ----~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 209 ----LVLKIIRG-SYPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred ----HHHHHhcC-CCCCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 01111111 111233455678999999999999999999999987
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=280.19 Aligned_cols=266 Identities=20% Similarity=0.225 Sum_probs=200.7
Q ss_pred CccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeC
Q 020641 17 PGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEG 96 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 96 (323)
|+...+||.|++|.||++.+..+++.+++|.+.... ......+.+.+|++++++++|+||+++++++..+
T Consensus 3 y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~----------~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 72 (288)
T cd07833 3 YEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESE----------DDEDVKKTALREVKVLRQLRHENIVNLKEAFRRK 72 (288)
T ss_pred eeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhc----------ccccchhHHHHHHHHHHhcCCCCeeehhheEEEC
Confidence 556678999999999999999999999998664321 1233457789999999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEE
Q 020641 97 NLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAK 176 (323)
Q Consensus 97 ~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~ 176 (323)
+..++++||+.++.+..+..... .++...+..++.|++.|+.|||+. +++|+||+|+||+++.++.++
T Consensus 73 ~~~~iv~e~~~~~~l~~~~~~~~---------~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~k 140 (288)
T cd07833 73 GRLYLVFEYVERTLLELLEASPG---------GLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLK 140 (288)
T ss_pred CEEEEEEecCCCCHHHHHHhcCC---------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEE
Confidence 99999999999866665554322 188999999999999999999999 999999999999999999999
Q ss_pred EeeccccCCCCccccccccccccCccccCCCccccCC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhcc
Q 020641 177 IADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG-QLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATP 255 (323)
Q Consensus 177 l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~ 255 (323)
|+|||.+......... ......++..|+|||.+.+. .++.++|+||||+++|+|++|..||.................
T Consensus 141 l~d~g~~~~~~~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~ 219 (288)
T cd07833 141 LCDFGFARALRARPAS-PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLG 219 (288)
T ss_pred EEeeecccccCCCccc-cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence 9999998776543321 12234578889999999877 788999999999999999999999975533211111100000
Q ss_pred ccccc--------------ccchhcCCC-cCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 256 RLSED--------------KVKQCVDPK-LKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 256 ~~~~~--------------~~~~~~~~~-~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
..... .......+. .....+...+..+.+++++||..+|++|||++++++
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 220 PLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred CCCHHHhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 00000 000000000 000122234678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=281.33 Aligned_cols=260 Identities=21% Similarity=0.265 Sum_probs=201.8
Q ss_pred CCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEe
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVE 95 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 95 (323)
.++...+||+|+||+||++.+..+++.+++|+.... ........+.+|+++++.++|+||+++++.+..
T Consensus 6 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~-----------~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 74 (284)
T cd06620 6 DLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIG-----------AKSSVRKQILRELQIMHECRSPYIVSFYGAFLN 74 (284)
T ss_pred HHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEec-----------CcchHHHHHHHHHHHHHHcCCCCcceEeeeEec
Confidence 456667999999999999999999999998865422 112234678899999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCCCceeCCCCCCCEEEccCCe
Q 020641 96 GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHE-KVQPSIIHRDIRSSNVLLFEDFK 174 (323)
Q Consensus 96 ~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~-~~~~~i~h~dikp~nili~~~~~ 174 (323)
....++|+||+.+++|.+++..... +++..+..++.+++.++.|||+ . +++|+||+|+||+++.++.
T Consensus 75 ~~~~~lv~e~~~~~~L~~~~~~~~~---------~~~~~~~~~~~~i~~~l~~LH~~~---~i~H~dl~p~nil~~~~~~ 142 (284)
T cd06620 75 ENNICMCMEFMDCGSLDRIYKKGGP---------IPVEILGKIAVAVVEGLTYLYNVH---RIMHRDIKPSNILVNSRGQ 142 (284)
T ss_pred CCEEEEEEecCCCCCHHHHHHhccC---------CCHHHHHHHHHHHHHHHHHHHHhc---CeeccCCCHHHEEECCCCc
Confidence 9999999999999999999866432 8899999999999999999996 6 8999999999999999999
Q ss_pred EEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhc
Q 020641 175 AKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWAT 254 (323)
Q Consensus 175 ~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~ 254 (323)
++|+|||++....... .....|+..|+|||.+.+..++.++|+|||||++|++++|..||..............
T Consensus 143 ~~l~d~gl~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~-- 216 (284)
T cd06620 143 IKLCDFGVSGELINSI----ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPM-- 216 (284)
T ss_pred EEEccCCcccchhhhc----cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhh--
Confidence 9999999876543221 1234578899999998888889999999999999999999999985543211000000
Q ss_pred ccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHH
Q 020641 255 PRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKA 306 (323)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~ 306 (323)
.. .......+............+..+.+++.+||+.||++|||+.|+++.
T Consensus 217 -~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~ 266 (284)
T cd06620 217 -GI-LDLLQQIVQEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAM 266 (284)
T ss_pred -HH-HHHHHHHhhccCCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 00 000111111111111112356679999999999999999999999985
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=281.79 Aligned_cols=247 Identities=19% Similarity=0.246 Sum_probs=200.5
Q ss_pred CCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEe
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVE 95 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 95 (323)
.|.....||.|++|.||++.+..+++.+++|+....... .....+.+.+|++++++++|+||+++++++..
T Consensus 2 ~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~---------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 72 (290)
T cd05580 2 DFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIV---------KLKQVEHVLNEKRILQSIRHPFLVNLYGSFQD 72 (290)
T ss_pred ceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhh---------hhhHHHHHHHHHHHHHhCCCCCccceeeEEEc
Confidence 355667899999999999999999999999876533211 12224668899999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeE
Q 020641 96 GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKA 175 (323)
Q Consensus 96 ~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~ 175 (323)
++..++||||+.+++|.+++..... ++...+..++.|++.||.+||+. |++|+||+|+||+++.++.+
T Consensus 73 ~~~~~~v~e~~~~~~L~~~~~~~~~---------l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~ 140 (290)
T cd05580 73 DSNLYLVMEYVPGGELFSHLRKSGR---------FPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYI 140 (290)
T ss_pred CCeEEEEEecCCCCCHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCE
Confidence 9999999999999999999976532 88999999999999999999999 99999999999999999999
Q ss_pred EEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhcc
Q 020641 176 KIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATP 255 (323)
Q Consensus 176 ~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~ 255 (323)
+|+|||++...... .....+++.|+|||.+.+...+.++|+||||+++|+|++|..||........
T Consensus 141 kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--------- 206 (290)
T cd05580 141 KITDFGFAKRVKGR-----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQI--------- 206 (290)
T ss_pred EEeeCCCccccCCC-----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHH---------
Confidence 99999998765443 2233578899999999888889999999999999999999999975432100
Q ss_pred cccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCC-----ChHHHHH
Q 020641 256 RLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRP-----NMSIVVK 305 (323)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-----s~~evl~ 305 (323)
....... ....+...+..+.+++.+||..||.+|+ ++.|+++
T Consensus 207 ------~~~~~~~--~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 207 ------YEKILEG--KVRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred ------HHHHhcC--CccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 0011110 1122334467899999999999999999 7777763
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=276.85 Aligned_cols=246 Identities=22% Similarity=0.246 Sum_probs=199.4
Q ss_pred cCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeCCeEEEE
Q 020641 23 LDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLA 102 (323)
Q Consensus 23 lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 102 (323)
||.|++|.||++++..+++.+++|+..+.... .....+.+.+|+.+++.++|+||+++++.+.++...+++
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~---------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 71 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIV---------ETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYML 71 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcch---------hhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEE
Confidence 79999999999999998999999977543211 122346789999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEEEeeccc
Q 020641 103 YEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNL 182 (323)
Q Consensus 103 ~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~l~Dfg~ 182 (323)
+||+.+++|.+++.+... ++...+..++.|++.|+.+||+. +++|+||+|+||+++.++.++|+|||.
T Consensus 72 ~e~~~~~~L~~~l~~~~~---------l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~ 139 (262)
T cd05572 72 MEYCLGGELWTILRDRGL---------FDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGF 139 (262)
T ss_pred EecCCCCcHHHHHhhcCC---------CCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCc
Confidence 999999999999976532 78889999999999999999999 999999999999999999999999999
Q ss_pred cCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhccccccccc
Q 020641 183 SNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKV 262 (323)
Q Consensus 183 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 262 (323)
+....... ......++..|++||.+.+..++.++|+||||+++|+|++|..||........ ...
T Consensus 140 ~~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-------------~~~ 203 (262)
T cd05572 140 AKKLKSGQ---KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPM-------------EIY 203 (262)
T ss_pred ccccCccc---ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHH-------------HHH
Confidence 87665432 11233478899999998888889999999999999999999999975542110 011
Q ss_pred chhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCC-----hHHHHH
Q 020641 263 KQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPN-----MSIVVK 305 (323)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps-----~~evl~ 305 (323)
.+..........+...+..+.+++.+||+.+|++||+ +.|+++
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 204 NDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred HHHhccCCCCCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 1111111222334444678999999999999999999 788776
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=277.07 Aligned_cols=265 Identities=22% Similarity=0.270 Sum_probs=201.0
Q ss_pred CccccccCCCCCCccceeccce-eeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhc-CCCCcccceeeEEE
Q 020641 17 PGYFVRLDKGPEDDLYLKKRVK-MRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSR-LKHENLVELLGYCV 94 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~-l~h~~i~~~~~~~~ 94 (323)
|.....||+|+||.||++.+.. +++.+++|.......... +..........++.+|+.++.+ ++|+||+++++++.
T Consensus 2 y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~--~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~ 79 (269)
T cd08528 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFG--KDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFL 79 (269)
T ss_pred chhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccc--cccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEc
Confidence 5566789999999999999988 677888886653322111 1111222334556778888865 59999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCCCceeCCCCCCCEEEccCC
Q 020641 95 EGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHE-KVQPSIIHRDIRSSNVLLFEDF 173 (323)
Q Consensus 95 ~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~-~~~~~i~h~dikp~nili~~~~ 173 (323)
.++..+++|||+.+++|.+++...... ...+++..++.++.|++.++.+||. . +++|+||+|+||+++.++
T Consensus 80 ~~~~~~lv~e~~~~~~l~~~l~~~~~~-----~~~~~~~~~~~~~~~l~~~l~~lh~~~---~i~H~dl~~~nil~~~~~ 151 (269)
T cd08528 80 ENDRLYIVMDLIEGAPLGEHFNSLKEK-----KQRFTEERIWNIFVQMVLALRYLHKEK---RIVHRDLTPNNIMLGEDD 151 (269)
T ss_pred cCCeEEEEEecCCCCcHHHHHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHhccCC---ceeecCCCHHHEEECCCC
Confidence 999999999999999999988542111 1128889999999999999999996 6 899999999999999999
Q ss_pred eEEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhh
Q 020641 174 KAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWA 253 (323)
Q Consensus 174 ~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 253 (323)
.++|+|||.+....... ......++..|++||.+.+..++.++|+||||+++|+|++|+.||.........
T Consensus 152 ~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~------ 222 (269)
T cd08528 152 KVTITDFGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLA------ 222 (269)
T ss_pred cEEEecccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHH------
Confidence 99999999987654432 223345788999999998888899999999999999999999999644321100
Q ss_pred cccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhh
Q 020641 254 TPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQP 309 (323)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~ 309 (323)
....+...........+..+.+++.+||+.||++||++.|+.+.+.+
T Consensus 223 ---------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~~ 269 (269)
T cd08528 223 ---------TKIVEAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMISD 269 (269)
T ss_pred ---------HHHhhccCCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhcC
Confidence 00111111111112345679999999999999999999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=299.59 Aligned_cols=268 Identities=16% Similarity=0.199 Sum_probs=190.1
Q ss_pred CCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCC------CCcccce
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLK------HENLVEL 89 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~~ 89 (323)
.|....+||+|+||+||+|.+..+++.+|+|++... .........|+.+++.++ |.+++++
T Consensus 130 ~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~-------------~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i 196 (467)
T PTZ00284 130 RFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNV-------------PKYTRDAKIEIQFMEKVRQADPADRFPLMKI 196 (467)
T ss_pred cEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecc-------------hhhHHHHHHHHHHHHHHhhcCcccCcceeee
Confidence 355556899999999999999999999999976421 011233445566555554 4568888
Q ss_pred eeEEEeC-CeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCCCceeCCCCCCCE
Q 020641 90 LGYCVEG-NLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHE-KVQPSIIHRDIRSSNV 167 (323)
Q Consensus 90 ~~~~~~~-~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~-~~~~~i~h~dikp~ni 167 (323)
++++... ...++||+++ +++|.+++.+... +++..+..++.||+.||.|||. . ||+||||||+||
T Consensus 197 ~~~~~~~~~~~~iv~~~~-g~~l~~~l~~~~~---------l~~~~~~~i~~qi~~aL~yLH~~~---gIiHrDlKP~NI 263 (467)
T PTZ00284 197 QRYFQNETGHMCIVMPKY-GPCLLDWIMKHGP---------FSHRHLAQIIFQTGVALDYFHTEL---HLMHTDLKPENI 263 (467)
T ss_pred EEEEEcCCceEEEEEecc-CCCHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHE
Confidence 8888755 4788999988 5689988865432 8899999999999999999997 7 999999999999
Q ss_pred EEccCC----------------eEEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHH
Q 020641 168 LLFEDF----------------KAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLEL 231 (323)
Q Consensus 168 li~~~~----------------~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l 231 (323)
|++.++ .+||+|||.+...... .....||+.|+|||++.+..++.++|||||||++|+|
T Consensus 264 Ll~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~~-----~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~el 338 (467)
T PTZ00284 264 LMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDERHS-----RTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYEL 338 (467)
T ss_pred EEecCCcccccccccccCCCCceEEECCCCccccCccc-----cccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHH
Confidence 998765 4999999987543221 2344689999999999999999999999999999999
Q ss_pred HhCCCCCCCCCCcccchhhhhhcccccc--------cccchhc----------CCC-----cCC--CCCHHHHHHHHHHH
Q 020641 232 LTGRKPVDHTMPRGQQSLVTWATPRLSE--------DKVKQCV----------DPK-----LKG--EYPPKGVAKLAAVA 286 (323)
Q Consensus 232 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~----------~~~-----~~~--~~~~~~~~~l~~li 286 (323)
++|+.||...........+.......+. .....+. ++. ... .........+.+||
T Consensus 339 ltG~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli 418 (467)
T PTZ00284 339 YTGKLLYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLI 418 (467)
T ss_pred HhCCCCCCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHH
Confidence 9999999765432211111111000000 0000000 000 000 00011235688999
Q ss_pred HHccCCCCCCCCChHHHHH--HHhhhhcCC
Q 020641 287 ALCVQYEAEFRPNMSIVVK--ALQPLLKSP 314 (323)
Q Consensus 287 ~~cl~~~P~~Rps~~evl~--~l~~~~~~~ 314 (323)
.+||++||.+|||+.|+++ +|.+....+
T Consensus 419 ~~mL~~dP~~R~ta~e~L~Hp~~~~~~~~~ 448 (467)
T PTZ00284 419 YGLLHYDRQKRLNARQMTTHPYVLKYYPEC 448 (467)
T ss_pred HHhCCcChhhCCCHHHHhcCccccccCCcc
Confidence 9999999999999999998 666655433
|
|
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=276.74 Aligned_cols=258 Identities=23% Similarity=0.338 Sum_probs=201.4
Q ss_pred ccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeCC
Q 020641 18 GYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGN 97 (323)
Q Consensus 18 ~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 97 (323)
..-..||+|++|.||++.+..+++.+++|........... .....+.+.+|+.++++++|+||+++++++.+++
T Consensus 3 ~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 76 (268)
T cd06630 3 LKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSE------QEEVVEALRKEIRLMARLNHPHIIRMLGATCEDS 76 (268)
T ss_pred cccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchh------HHHHHHHHHHHHHHHHHcCCCceehhhceeccCC
Confidence 3445799999999999999999999999865432211110 0113467889999999999999999999999999
Q ss_pred eEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCC-eEE
Q 020641 98 LRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDF-KAK 176 (323)
Q Consensus 98 ~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~-~~~ 176 (323)
..++|+||+.+++|.+++..... +++..+..++.|++.|+.+||+. |++|+||+|+||+++.++ .++
T Consensus 77 ~~~~v~e~~~~~~L~~~l~~~~~---------~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~ 144 (268)
T cd06630 77 HFNLFVEWMAGGSVSHLLSKYGA---------FKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLR 144 (268)
T ss_pred eEEEEEeccCCCcHHHHHHHhCC---------CCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEE
Confidence 99999999999999999975432 88889999999999999999999 999999999999998775 699
Q ss_pred EeeccccCCCCccccc--cccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhc
Q 020641 177 IADFNLSNQAPDMAAR--LHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWAT 254 (323)
Q Consensus 177 l~Dfg~~~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~ 254 (323)
|+|||.+......... .......++..|+|||.+.+..++.++|+||+|+++++|++|..||............
T Consensus 145 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~---- 220 (268)
T cd06630 145 IADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALI---- 220 (268)
T ss_pred EcccccccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHH----
Confidence 9999998766533111 1122334788999999998888899999999999999999999999644322111100
Q ss_pred ccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 255 PRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
............+...+.++.+++.+||..+|++|||+.++++
T Consensus 221 --------~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 221 --------FKIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred --------HHHhccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 0111111122344556778999999999999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=282.10 Aligned_cols=265 Identities=17% Similarity=0.226 Sum_probs=195.0
Q ss_pred CccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeC
Q 020641 17 PGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEG 96 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 96 (323)
|+...+||.|++|.||+|.+..+++.+++|...... ........+.+|++++++++|+||+++++++.+.
T Consensus 2 y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~----------~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~ 71 (284)
T cd07839 2 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD----------DDEGVPSSALREICLLKELKHKNIVRLYDVLHSD 71 (284)
T ss_pred ceeEEEecccCCeEEEEEEECCCCcEEEEEEeeccc----------ccccCccchhHHHHHHHhcCCCCeeeHHHHhccC
Confidence 556678999999999999999999999988664321 1122335567899999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEE
Q 020641 97 NLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAK 176 (323)
Q Consensus 97 ~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~ 176 (323)
...++++||+.+ +|.+++...... +++..+..++.||++||.|||+. |++|+||||+||+++.++.++
T Consensus 72 ~~~~lv~e~~~~-~l~~~~~~~~~~--------~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~ 139 (284)
T cd07839 72 KKLTLVFEYCDQ-DLKKYFDSCNGD--------IDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELK 139 (284)
T ss_pred CceEEEEecCCC-CHHHHHHhcCCC--------CCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEE
Confidence 999999999975 888887653322 89999999999999999999999 999999999999999999999
Q ss_pred EeeccccCCCCccccccccccccCccccCCCccccCC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchh-hhhhc
Q 020641 177 IADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG-QLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSL-VTWAT 254 (323)
Q Consensus 177 l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~-~~~~~ 254 (323)
|+|||++........ ......++..|+|||.+.+. .++.++||||||+++|+|++|..||........... .....
T Consensus 140 l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~ 217 (284)
T cd07839 140 LADFGLARAFGIPVR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLL 217 (284)
T ss_pred ECccchhhccCCCCC--CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHh
Confidence 999999875433221 11223468889999988764 468899999999999999999998653332111100 00000
Q ss_pred ccccccc---cchhcC----CCcC-----CCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 255 PRLSEDK---VKQCVD----PKLK-----GEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 255 ~~~~~~~---~~~~~~----~~~~-----~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
....... .....+ +... .......+..+.+++.+||+.||.+|||+.++++
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 218 GTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred CCCChHHhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 0000000 000000 0000 0111234578899999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=277.73 Aligned_cols=253 Identities=24% Similarity=0.329 Sum_probs=201.2
Q ss_pred CCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEe
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVE 95 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 95 (323)
.++...+||.|++|.||++.+..+++.+++|....... ......+.+|++.++.++|+||+++++.+..
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-----------~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~ 70 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN-----------EAIQKQILRELDILHKCNSPYIVGFYGAFYN 70 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC-----------hHHHHHHHHHHHHHHHCCCCchhhhheeeec
Confidence 35667789999999999999999999999986653211 1233667889999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCCCceeCCCCCCCEEEccCCe
Q 020641 96 GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHE-KVQPSIIHRDIRSSNVLLFEDFK 174 (323)
Q Consensus 96 ~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~-~~~~~i~h~dikp~nili~~~~~ 174 (323)
.+..++++||+.+++|.+++..... .++...+..++.|++.|+.+||+ . |++|+||+|+||+++.++.
T Consensus 71 ~~~~~lv~e~~~~~~L~~~~~~~~~--------~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~ 139 (265)
T cd06605 71 NGDISICMEYMDGGSLDKILKEVQG--------RIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQ 139 (265)
T ss_pred CCEEEEEEEecCCCcHHHHHHHccC--------CCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCC
Confidence 9999999999999999999976531 28889999999999999999999 8 9999999999999999999
Q ss_pred EEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhc
Q 020641 175 AKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWAT 254 (323)
Q Consensus 175 ~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~ 254 (323)
++|+|||.+......... ...++..|+|||.+.+..++.++|+||||+++|+|++|..||.......... .
T Consensus 140 ~~l~d~g~~~~~~~~~~~----~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~-~---- 210 (265)
T cd06605 140 IKLCDFGVSGQLVNSLAK----TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGI-F---- 210 (265)
T ss_pred EEEeecccchhhHHHHhh----cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccH-H----
Confidence 999999988655332211 1457889999999988889999999999999999999999997543211100 0
Q ss_pred ccccccccchhcCCCcCCCCCHH-HHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 255 PRLSEDKVKQCVDPKLKGEYPPK-GVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
.......... ....+.. .+..+.++|.+||..||++|||+.+++.
T Consensus 211 -----~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 211 -----ELLQYIVNEP-PPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred -----HHHHHHhcCC-CCCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence 0011111111 1111222 5677999999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=281.03 Aligned_cols=251 Identities=22% Similarity=0.278 Sum_probs=198.3
Q ss_pred CCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEe
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVE 95 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 95 (323)
+|+...+||.|++|.||++.+..++..+++|..... .....+.+.+|++++++++|+||+++++.+..
T Consensus 6 ~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~------------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 73 (280)
T cd06611 6 IWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE------------SEEELEDFMVEIDILSECKHPNIVGLYEAYFY 73 (280)
T ss_pred HHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC------------CHHHHHHHHHHHHHHHhCCCCceeEEEEEEec
Confidence 466677999999999999999888889999866421 11123567889999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeE
Q 020641 96 GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKA 175 (323)
Q Consensus 96 ~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~ 175 (323)
+...++||||+.+++|.+++...... +++..+..++.|++.|+.|||+. |++|+||+|+||+++.++.+
T Consensus 74 ~~~~~lv~e~~~~~~L~~~~~~~~~~--------l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~ 142 (280)
T cd06611 74 ENKLWILIEFCDGGALDSIMLELERG--------LTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDV 142 (280)
T ss_pred CCeEEEEeeccCCCcHHHHHHHhcCC--------CCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCE
Confidence 99999999999999999998764322 88999999999999999999999 99999999999999999999
Q ss_pred EEeeccccCCCCccccccccccccCccccCCCcccc-----CCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhh
Q 020641 176 KIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAM-----TGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLV 250 (323)
Q Consensus 176 ~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~ 250 (323)
+|+|||.+........ ......+++.|+|||.+. ...++.++|+||||+++|+|++|..||..........
T Consensus 143 ~l~d~g~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~-- 218 (280)
T cd06611 143 KLADFGVSAKNKSTLQ--KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLL-- 218 (280)
T ss_pred EEccCccchhhccccc--ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHH--
Confidence 9999998765433221 122334788999999874 3446779999999999999999999997553211110
Q ss_pred hhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 251 TWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
..... ..+ ....+...+..+.+++.+||+.+|.+|||+.++++
T Consensus 219 ~~~~~----------~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (280)
T cd06611 219 KILKS----------EPP--TLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLK 261 (280)
T ss_pred HHhcC----------CCC--CcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhc
Confidence 00000 000 01122345567999999999999999999999987
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=277.85 Aligned_cols=240 Identities=24% Similarity=0.373 Sum_probs=180.9
Q ss_pred ccCCCCCCccceeccceeeee------------------------eeeccccccccCccccccccCCCCCchHHHHHHHH
Q 020641 22 RLDKGPEDDLYLKKRVKMRRW------------------------LCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSV 77 (323)
Q Consensus 22 ~lg~G~~~~V~~~~~~~~~~~------------------------~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~ 77 (323)
+||+|+||.||++....++.. +++|.... ........+.+|+.+
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~------------~~~~~~~~~~~~~~~ 69 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDP------------SHRDIALAFFETASL 69 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecCh------------HHHHHHHHHHHHHHH
Confidence 699999999999886543322 33332211 011123567788899
Q ss_pred HhcCCCCcccceeeEEEeCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCc
Q 020641 78 VSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSI 157 (323)
Q Consensus 78 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i 157 (323)
++.++|+||+++++++..+...++||||+++++|.+++...... +++..+..++.|++.||.|||++ |+
T Consensus 70 ~~~l~h~niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~--------~~~~~~~~i~~qi~~~l~~lH~~---~i 138 (274)
T cd05076 70 MSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGR--------VPVAWKITVAQQLASALSYLEDK---NL 138 (274)
T ss_pred HhcCCCCCeeeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCC--------CCHHHHHHHHHHHHHHHHHHHcC---Cc
Confidence 99999999999999999999999999999999999998654322 88899999999999999999999 99
Q ss_pred eeCCCCCCCEEEccCC-------eEEEeeccccCCCCccccccccccccCccccCCCccccC-CCCCcccchHHHHHHHH
Q 020641 158 IHRDIRSSNVLLFEDF-------KAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT-GQLTQKSDVYSFGVVLL 229 (323)
Q Consensus 158 ~h~dikp~nili~~~~-------~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~~l~ 229 (323)
+|+||||+||+++..+ .++++|||.+...... ....++..|+|||.+.+ ..++.++||||||+++|
T Consensus 139 iH~dlkp~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~ 212 (274)
T cd05076 139 VHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLL 212 (274)
T ss_pred cCCCCCcccEEEeccCcccCccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHH
Confidence 9999999999997643 4799999987543221 11236778999998865 56789999999999999
Q ss_pred HHH-hCCCCCCCCCCcccchhhhhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHh
Q 020641 230 ELL-TGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQ 308 (323)
Q Consensus 230 ~l~-~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~ 308 (323)
+++ +|..||.......... ..... ...+......+.+++.+||+.+|++|||+.+|++.|.
T Consensus 213 el~~~g~~p~~~~~~~~~~~----------------~~~~~--~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 213 EICFDGEVPLKERTPSEKER----------------FYEKK--HRLPEPSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred HHHhCCCCCccccChHHHHH----------------HHHhc--cCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 995 6999987543211100 00000 0111122346899999999999999999999998773
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=275.47 Aligned_cols=253 Identities=18% Similarity=0.220 Sum_probs=200.1
Q ss_pred CccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEe-
Q 020641 17 PGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVE- 95 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~- 95 (323)
|.....||.|+||.||++.+..+++.+++|........ ....+.+.+|+++++.++|+||+++++.+..
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~----------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (265)
T cd08217 2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMT----------EKEKQQLVSEVNILRELKHPNIVRYYDRIIDR 71 (265)
T ss_pred ceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCC----------HHHHHHHHHHHHHHHhcCCCccceeeeeeecC
Confidence 45667899999999999999999998998865432111 1223567889999999999999999997763
Q ss_pred -CCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhh-----cCCCCCceeCCCCCCCEEE
Q 020641 96 -GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLH-----EKVQPSIIHRDIRSSNVLL 169 (323)
Q Consensus 96 -~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh-----~~~~~~i~h~dikp~nili 169 (323)
+...+++|||+.+++|.+++...... ...+++..++.++.|++.|+.+|| +. +++|+||+|+||++
T Consensus 72 ~~~~~~~~~e~~~~~~L~~~l~~~~~~-----~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~---~i~h~dl~p~nili 143 (265)
T cd08217 72 SNQTLYIVMEYCEGGDLAQLIQKCKKE-----RKYIEEEFIWRILTQLLLALYECHNRSDPGN---TVLHRDLKPANIFL 143 (265)
T ss_pred CCCEEEEEehhccCCCHHHHHHHHhhc-----ccCCCHHHHHHHHHHHHHHHHHHhcCccccC---cceecCCCHHHEEE
Confidence 45679999999999999999754211 112889999999999999999999 77 99999999999999
Q ss_pred ccCCeEEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchh
Q 020641 170 FEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSL 249 (323)
Q Consensus 170 ~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~ 249 (323)
+.++.++|+|||++......... .....++..|+|||.+.+..++.++|+||||+++++|++|..||.......
T Consensus 144 ~~~~~~kl~d~g~~~~~~~~~~~--~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---- 217 (265)
T cd08217 144 DANNNVKLGDFGLAKILGHDSSF--AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQ---- 217 (265)
T ss_pred ecCCCEEEecccccccccCCccc--ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHH----
Confidence 99999999999998876543221 223357889999999988888999999999999999999999997553110
Q ss_pred hhhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 250 VTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
+.+.+........+...+..+.+++.+||+.+|++|||+.+|++
T Consensus 218 ------------~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~ 261 (265)
T cd08217 218 ------------LASKIKEGKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQ 261 (265)
T ss_pred ------------HHHHHhcCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 11111111112234455678999999999999999999999987
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-39 Score=277.11 Aligned_cols=245 Identities=19% Similarity=0.234 Sum_probs=189.8
Q ss_pred ccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHH---HHHhcCCCCcccceeeEEEeCCe
Q 020641 22 RLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLV---SVVSRLKHENLVELLGYCVEGNL 98 (323)
Q Consensus 22 ~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~---~~l~~l~h~~i~~~~~~~~~~~~ 98 (323)
.||+|+||.||++.+..+++.+++|+..+........ .....++. .++...+|+||+.+++.+...+.
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 71 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQG---------ETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDK 71 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchH---------HHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCe
Confidence 3899999999999999999999999776443221111 12223333 33444579999999999999999
Q ss_pred EEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEEEe
Q 020641 99 RVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIA 178 (323)
Q Consensus 99 ~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~l~ 178 (323)
.++||||+.+++|.+++..... +++..+..++.|++.|+.|||+. +++|+||||+||+++.++.++|+
T Consensus 72 ~~lv~e~~~~~~L~~~i~~~~~---------l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~ 139 (279)
T cd05633 72 LCFILDLMNGGDLHYHLSQHGV---------FSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRIS 139 (279)
T ss_pred EEEEEecCCCCCHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEc
Confidence 9999999999999999875432 89999999999999999999999 99999999999999999999999
Q ss_pred eccccCCCCccccccccccccCccccCCCcccc-CCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccc
Q 020641 179 DFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAM-TGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRL 257 (323)
Q Consensus 179 Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 257 (323)
|||++....... .....|+..|+|||.+. +..++.++|+||+|+++|+|++|..||............. .
T Consensus 140 dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~-~---- 210 (279)
T cd05633 140 DLGLACDFSKKK----PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR-M---- 210 (279)
T ss_pred cCCcceeccccC----ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHH-H----
Confidence 999986543321 12235889999999886 4567899999999999999999999997553321111000 0
Q ss_pred cccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCC-----ChHHHHH
Q 020641 258 SEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRP-----NMSIVVK 305 (323)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-----s~~evl~ 305 (323)
........+...+.++.+++.+||+.||.+|| |++++++
T Consensus 211 ---------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~ 254 (279)
T cd05633 211 ---------TLTVNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKE 254 (279)
T ss_pred ---------hhcCCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHh
Confidence 00111223445667899999999999999999 6999988
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=277.38 Aligned_cols=248 Identities=19% Similarity=0.211 Sum_probs=195.8
Q ss_pred cCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeCCeEEEE
Q 020641 23 LDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLA 102 (323)
Q Consensus 23 lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 102 (323)
||+|+||+||+|.+..+++.+++|...+.... .......+.+|++++++++|+||+++++.+...+..|+|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~---------~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 71 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLK---------KRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLV 71 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhh---------hhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEE
Confidence 69999999999999999999999876543211 112235567899999999999999999999999999999
Q ss_pred EeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEEEeeccc
Q 020641 103 YEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNL 182 (323)
Q Consensus 103 ~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~l~Dfg~ 182 (323)
|||+.+++|.+++...... .+++..+..++.|++.|+.|||+. |++|+||+|+||+++.++.++|+|||.
T Consensus 72 ~e~~~~~~L~~~l~~~~~~-------~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~ 141 (277)
T cd05577 72 MTLMNGGDLKYHIYNVGEP-------GFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGL 141 (277)
T ss_pred EecCCCCcHHHHHHHcCcC-------CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcc
Confidence 9999999999999765422 288999999999999999999999 999999999999999999999999998
Q ss_pred cCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhccccccccc
Q 020641 183 SNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKV 262 (323)
Q Consensus 183 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 262 (323)
+....... ......++..|+|||.+.+..++.++|+||||+++|+|++|+.||.............
T Consensus 142 ~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~----------- 207 (277)
T cd05577 142 AVELKGGK---KIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELK----------- 207 (277)
T ss_pred hhhhccCC---ccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHH-----------
Confidence 86543311 1122346788999999888888999999999999999999999997554311111110
Q ss_pred chhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCC-----ChHHHHH
Q 020641 263 KQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRP-----NMSIVVK 305 (323)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-----s~~evl~ 305 (323)
.... ......+...+..+.+++.+||+.||.+|| ++.++++
T Consensus 208 -~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 208 -RRTL-EMAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred -hccc-cccccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 0000 011223344567899999999999999999 6666764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-39 Score=275.09 Aligned_cols=256 Identities=20% Similarity=0.285 Sum_probs=184.4
Q ss_pred ccCCCCCCccceeccceeee--eeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeCCeE
Q 020641 22 RLDKGPEDDLYLKKRVKMRR--WLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLR 99 (323)
Q Consensus 22 ~lg~G~~~~V~~~~~~~~~~--~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 99 (323)
.||+|+||.||+++....+. .+++|.... .......+.+.+|+.+++.++||||+++++.+......
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~-----------~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~ 70 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKA-----------NASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPY 70 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecC-----------CCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCcc
Confidence 58999999999987544332 223332211 01122346788999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEEEee
Q 020641 100 VLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIAD 179 (323)
Q Consensus 100 ~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~l~D 179 (323)
++||||+.+++|.+++...... ....+...+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|
T Consensus 71 ~lv~e~~~~~~L~~~l~~~~~~-----~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~D 142 (268)
T cd05086 71 LLVFEYCELGDLKSYLSQEQWH-----RRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGD 142 (268)
T ss_pred EEEEecCCCCcHHHHHHhhhcc-----cccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecc
Confidence 9999999999999999764321 11266778889999999999999999 999999999999999999999999
Q ss_pred ccccCCCCccccccccccccCccccCCCccccC-------CCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccchhhh
Q 020641 180 FNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT-------GQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVT 251 (323)
Q Consensus 180 fg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-------~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~ 251 (323)
||++................++..|+|||.+.. ..++.++||||||+++|+|++ |..||............
T Consensus 143 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~- 221 (268)
T cd05086 143 YGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHV- 221 (268)
T ss_pred cccccccCcchhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-
Confidence 998754322111111223457888999998742 245779999999999999997 57788643321110000
Q ss_pred hhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHh
Q 020641 252 WATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQ 308 (323)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~ 308 (323)
. ........++.. ....+..+.+++..|| .+|++|||+.+|++.|.
T Consensus 222 -----~-~~~~~~~~~~~~----~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 222 -----I-KDQQVKLFKPQL----ELPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred -----H-hhcccccCCCcc----CCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 0 001111112222 2234567899999999 67999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=272.30 Aligned_cols=238 Identities=23% Similarity=0.376 Sum_probs=185.9
Q ss_pred ccCCCCCCccceeccceeee----------eeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceee
Q 020641 22 RLDKGPEDDLYLKKRVKMRR----------WLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLG 91 (323)
Q Consensus 22 ~lg~G~~~~V~~~~~~~~~~----------~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~ 91 (323)
+||+|+||.||++.+..++. .+++|..... ......+.+|+.+++.++|+||+++++
T Consensus 2 ~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~-------------~~~~~~~~~e~~~l~~l~h~~i~~~~~ 68 (259)
T cd05037 2 HLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSD-------------HRDSLAFFETASLMSQLSHKHLVKLYG 68 (259)
T ss_pred cccccccceEEEEEEeccCCccccCCccceeeeeeccccc-------------hhhHHHHHHHHHHHHcCCCcchhheee
Confidence 68999999999999987763 2344322211 111477889999999999999999999
Q ss_pred EEEeCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEcc
Q 020641 92 YCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFE 171 (323)
Q Consensus 92 ~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~ 171 (323)
++.. ...++||||+.+++|.+++...... +++..+..++.|++.||.|||+. |++|+||||+||+++.
T Consensus 69 ~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~--------~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~ 136 (259)
T cd05037 69 VCVR-DENIMVEEYVKFGPLDVFLHREKNN--------VSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVAR 136 (259)
T ss_pred EEec-CCcEEEEEcCCCCcHHHHHHhhccC--------CCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEec
Confidence 9888 6789999999999999999765431 88899999999999999999999 9999999999999998
Q ss_pred CC-------eEEEeeccccCCCCccccccccccccCccccCCCccccCC--CCCcccchHHHHHHHHHHHh-CCCCCCCC
Q 020641 172 DF-------KAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG--QLTQKSDVYSFGVVLLELLT-GRKPVDHT 241 (323)
Q Consensus 172 ~~-------~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~l~~-g~~pf~~~ 241 (323)
++ .++|+|||++...... ....++..|+|||.+.+. .++.++|+||||+++|+|++ |..||...
T Consensus 137 ~~~~~~~~~~~kl~Dfg~a~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~ 210 (259)
T cd05037 137 YGLNEGYVPFIKLSDPGIPITVLSR------EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTL 210 (259)
T ss_pred CccccCCceeEEeCCCCcccccccc------cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccC
Confidence 87 7999999998765431 122356789999998776 78899999999999999999 57777655
Q ss_pred CCcccchhhhhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHh
Q 020641 242 MPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQ 308 (323)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~ 308 (323)
.......... .. ...+......+.+++.+||..+|.+|||+.++++.|.
T Consensus 211 ~~~~~~~~~~---------------~~---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 211 SSSEKERFYQ---------------DQ---HRLPMPDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred CchhHHHHHh---------------cC---CCCCCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 3211111000 00 0011111267999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=276.77 Aligned_cols=261 Identities=20% Similarity=0.298 Sum_probs=197.5
Q ss_pred ccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeCCeE
Q 020641 20 FVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLR 99 (323)
Q Consensus 20 ~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 99 (323)
-..||.|++|.||++.+..+++.+++|............ ........+.+.+|+.+++.++|+|++++++++...+..
T Consensus 6 ~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~--~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (272)
T cd06629 6 GELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRH--DSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEYL 83 (272)
T ss_pred cceecccCceEEEEEeecCCCceeeeeeeechhhhhccc--chHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCce
Confidence 347999999999999999889989988654221111110 001112235678899999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEEEee
Q 020641 100 VLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIAD 179 (323)
Q Consensus 100 ~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~l~D 179 (323)
++|+||+.+++|.+++..... ++...+..++.|++.|+.+||+. +++|+||+|+||+++.++.++|+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~---------l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d 151 (272)
T cd06629 84 SIFLEYVPGGSIGSCLRTYGR---------FEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISD 151 (272)
T ss_pred EEEEecCCCCcHHHHHhhccC---------CCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEee
Confidence 999999999999999976532 88889999999999999999999 999999999999999999999999
Q ss_pred ccccCCCCccccccccccccCccccCCCccccCCC--CCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccc
Q 020641 180 FNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQ--LTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRL 257 (323)
Q Consensus 180 fg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~--~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 257 (323)
||.+................++..|+|||.+.... ++.++|+||||+++|++++|..||......... .....
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~--~~~~~--- 226 (272)
T cd06629 152 FGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAM--FKLGN--- 226 (272)
T ss_pred ccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHH--HHhhc---
Confidence 99987654332222223344788999999887654 788999999999999999999999643221100 00000
Q ss_pred cccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 258 SEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
...............+..+.+++.+||..+|++|||+.+|++
T Consensus 227 ------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 227 ------KRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred ------cccCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence 000001111122334678999999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=286.82 Aligned_cols=251 Identities=26% Similarity=0.358 Sum_probs=214.1
Q ss_pred ccCCCCCCccceecccee--ee--eeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeCC
Q 020641 22 RLDKGPEDDLYLKKRVKM--RR--WLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGN 97 (323)
Q Consensus 22 ~lg~G~~~~V~~~~~~~~--~~--~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 97 (323)
.||.|-||.||.+..... +. -||+|.-. .... .+..+.|.+|..+|+.++||||++++|+|.+..
T Consensus 396 ~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK----------~d~t-~d~tekflqEa~iMrnfdHphIikLIGv~~e~P 464 (974)
T KOG4257|consen 396 LIGEGQFGDVYKGVYTDPEKGERIAVAVKTCK----------TDCT-PDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQP 464 (974)
T ss_pred hhcCCcccceeeeEecccccCcceeeeeehhc----------cCCC-hhhHHHHHHHHHHHHhCCCcchhheeeeeeccc
Confidence 789999999998876543 22 24444111 1111 223688999999999999999999999999775
Q ss_pred eEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEEE
Q 020641 98 LRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKI 177 (323)
Q Consensus 98 ~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~l 177 (323)
.|+|||.+.-|.|..+++.+... ++..+...++.||+.|+.|||+. .++||||..+|||+.+..-+||
T Consensus 465 -~WivmEL~~~GELr~yLq~nk~s--------L~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKL 532 (974)
T KOG4257|consen 465 -MWIVMELAPLGELREYLQQNKDS--------LPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKL 532 (974)
T ss_pred -eeEEEecccchhHHHHHHhcccc--------chHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeee
Confidence 69999999999999999877654 88889999999999999999999 9999999999999999999999
Q ss_pred eeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhccc
Q 020641 178 ADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPR 256 (323)
Q Consensus 178 ~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~ 256 (323)
+|||+++........... ...-+.-|+|||.+.-..++.++|||.||+++||++. |..||.+.
T Consensus 533 aDFGLSR~~ed~~yYkaS-~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgv--------------- 596 (974)
T KOG4257|consen 533 ADFGLSRYLEDDAYYKAS-RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGV--------------- 596 (974)
T ss_pred cccchhhhccccchhhcc-ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccc---------------
Confidence 999999988776554433 3335677999999999999999999999999999986 99999755
Q ss_pred ccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhhc
Q 020641 257 LSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLK 312 (323)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~~ 312 (323)
.+.++...++++-+.+.|+.|++.|+.++.+||.++|.+||++.++.+.|.++..
T Consensus 597 -kNsDVI~~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 597 -KNSDVIGHIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred -cccceEEEecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 3566677778888889999999999999999999999999999999999998876
|
|
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=275.64 Aligned_cols=256 Identities=21% Similarity=0.282 Sum_probs=195.9
Q ss_pred CccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeC
Q 020641 17 PGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEG 96 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 96 (323)
+.....||.|+||.||++.+. +++.+++|....+...... .......+.+|++++++++|+||+++++++.+.
T Consensus 2 ~~~~~~ig~g~~~~v~~~~~~-~~~~~avk~~~~~~~~~~~------~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 74 (265)
T cd06631 2 WTKGEVLGKGAYGTVYCGLTN-QGQLIAVKQVELDTSNVLA------AEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDD 74 (265)
T ss_pred ccccceEeccCCeEEEEEEEc-CCCeEEEEEeecCccchhh------HHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecC
Confidence 344557999999999999864 6677777754432111110 011235688899999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEE
Q 020641 97 NLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAK 176 (323)
Q Consensus 97 ~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~ 176 (323)
...++++||+.+++|.+++.+... +++..+..++.|++.|+.+||+. +++|+||+|+||+++.++.++
T Consensus 75 ~~~~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~ 142 (265)
T cd06631 75 NTISIFMEFVPGGSISSILNRFGP---------LPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIK 142 (265)
T ss_pred CeEEEEEecCCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEE
Confidence 999999999999999999976432 78889999999999999999999 999999999999999999999
Q ss_pred EeeccccCCCCccc----cccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhh
Q 020641 177 IADFNLSNQAPDMA----ARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTW 252 (323)
Q Consensus 177 l~Dfg~~~~~~~~~----~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 252 (323)
|+|||.+....... .........++..|+|||.+.+..++.++|+||||+++|+|++|..||.............
T Consensus 143 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~- 221 (265)
T cd06631 143 LIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIG- 221 (265)
T ss_pred eccchhhHhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhh-
Confidence 99999886542111 1111123347889999999988888999999999999999999999997543211110000
Q ss_pred hcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 253 ATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
. ........+...+..+.+++.+||+.+|.+||++.++++
T Consensus 222 -~------------~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 222 -A------------HRGLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred -h------------ccCCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0 000111223345667999999999999999999999885
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-39 Score=276.45 Aligned_cols=247 Identities=23% Similarity=0.331 Sum_probs=199.0
Q ss_pred CccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeC
Q 020641 17 PGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEG 96 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 96 (323)
+....+||.|+||.||++.+..+++.+++|+..... .......+.+|+.++++++|+||+++++++..+
T Consensus 6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~-----------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 74 (277)
T cd06641 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE-----------AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKD 74 (277)
T ss_pred hhhheeEeecCCeEEEEEEECCCCcEEEEEEecccc-----------chHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeC
Confidence 445668999999999999998889999998653211 112236788999999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEE
Q 020641 97 NLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAK 176 (323)
Q Consensus 97 ~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~ 176 (323)
...++||||+.+++|.+++.... +++..+..++.|++.++.+||+. |++|+||+|+||+++.++.++
T Consensus 75 ~~~~lv~e~~~~~~l~~~i~~~~----------~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~ 141 (277)
T cd06641 75 TKLWIIMEYLGGGSALDLLEPGP----------LDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVK 141 (277)
T ss_pred CeEEEEEEeCCCCcHHHHHhcCC----------CCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEE
Confidence 99999999999999999986532 88999999999999999999999 999999999999999999999
Q ss_pred EeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhccc
Q 020641 177 IADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPR 256 (323)
Q Consensus 177 l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 256 (323)
|+|||++........ ......++..|+|||.+.+..++.++|+||||+++|+|++|..||..........
T Consensus 142 l~dfg~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~-------- 211 (277)
T cd06641 142 LADFGVAGQLTDTQI--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLF-------- 211 (277)
T ss_pred Eeecccceecccchh--hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHH--------
Confidence 999998865543221 1223347888999999988888999999999999999999999997543211100
Q ss_pred ccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 257 LSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
.+........+...+..+.+++.+||+.+|.+||++.++++
T Consensus 212 --------~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 252 (277)
T cd06641 212 --------LIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLK 252 (277)
T ss_pred --------HHhcCCCCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 00011111223345667999999999999999999999998
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-39 Score=275.15 Aligned_cols=250 Identities=24% Similarity=0.324 Sum_probs=193.3
Q ss_pred cccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeCCe
Q 020641 19 YFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNL 98 (323)
Q Consensus 19 ~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 98 (323)
....||+|+||.||++.+..+++.+++|...... ....+.+.+|+.+++.++|+||+++++++..+..
T Consensus 12 ~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~------------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 79 (268)
T cd06624 12 ERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD------------SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGF 79 (268)
T ss_pred ceEEEecCCceEEEEeEecCCCcEEEEEEecCCC------------HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCE
Confidence 3458999999999999998888888888543211 1123568899999999999999999999999999
Q ss_pred EEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEcc-CCeEEE
Q 020641 99 RVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFE-DFKAKI 177 (323)
Q Consensus 99 ~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~-~~~~~l 177 (323)
.++++||+.+++|.+++...... ...+...+..++.|++.|+.|||+. |++|+||||+||+++. ++.++|
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~~~~------~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l 150 (268)
T cd06624 80 FKIFMEQVPGGSLSALLRSKWGP------LKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKI 150 (268)
T ss_pred EEEEEecCCCCCHHHHHHHhccc------CCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEE
Confidence 99999999999999999754221 0027778889999999999999999 9999999999999976 679999
Q ss_pred eeccccCCCCccccccccccccCccccCCCccccCC--CCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhcc
Q 020641 178 ADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG--QLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATP 255 (323)
Q Consensus 178 ~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~ 255 (323)
+|||.+........ ......++..|+|||.+.+. .++.++|+||||+++|+|++|..||.......... +
T Consensus 151 ~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~---~--- 222 (268)
T cd06624 151 SDFGTSKRLAGINP--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAM---F--- 222 (268)
T ss_pred ecchhheecccCCC--ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhH---h---
Confidence 99999865533211 12223478899999988654 37889999999999999999999996442211100 0
Q ss_pred cccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 256 RLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
...........+...++.+.+++.+||+.+|++|||+.|+++
T Consensus 223 --------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 223 --------KVGMFKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred --------hhhhhccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 000001111233445677999999999999999999999986
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=276.66 Aligned_cols=250 Identities=20% Similarity=0.228 Sum_probs=202.4
Q ss_pred CccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeC
Q 020641 17 PGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEG 96 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 96 (323)
|+....||.|+||.||++++..+++.+++|+..+..... ....+.+.+|++++++++||||+++++.+..+
T Consensus 2 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~---------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 72 (258)
T cd05578 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVE---------KGSVRNVLNERRILQELNHPFLVNLWYSFQDE 72 (258)
T ss_pred ceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcc---------hhHHHHHHHHHHHHHhCCCCChHHHHHhhcCC
Confidence 566778999999999999999899999999776432111 12346788999999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEE
Q 020641 97 NLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAK 176 (323)
Q Consensus 97 ~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~ 176 (323)
...++|+||+.+++|.+++.... .++...+..++.|++.|+.|||+. |++|+||+|+||++++++.++
T Consensus 73 ~~~~lv~e~~~~~~L~~~l~~~~---------~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~ 140 (258)
T cd05578 73 ENMYLVVDLLLGGDLRYHLSQKV---------KFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVH 140 (258)
T ss_pred CeEEEEEeCCCCCCHHHHHHhcC---------CcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEE
Confidence 99999999999999999997652 188999999999999999999999 999999999999999999999
Q ss_pred EeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhccc
Q 020641 177 IADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPR 256 (323)
Q Consensus 177 l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 256 (323)
|+|||.+........ .....|+..|+|||.+.+..++.++|+||||+++|+|++|..||............
T Consensus 141 l~d~~~~~~~~~~~~---~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~------ 211 (258)
T cd05578 141 ITDFNIATKVTPDTL---TTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIR------ 211 (258)
T ss_pred EeecccccccCCCcc---ccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHH------
Confidence 999999876544321 22344788899999998888899999999999999999999999755432111110
Q ss_pred ccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCCh--HHHH
Q 020641 257 LSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNM--SIVV 304 (323)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~--~evl 304 (323)
+.... .....+...+..+.+++.+||+.||.+||++ +|++
T Consensus 212 -------~~~~~-~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 212 -------AKQET-ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred -------HHhcc-ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 11110 1123344456789999999999999999999 6654
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-39 Score=278.00 Aligned_cols=252 Identities=21% Similarity=0.279 Sum_probs=197.4
Q ss_pred CccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeC
Q 020641 17 PGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEG 96 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 96 (323)
++.+..||+|+||.||++.+..+++.+++|.+..+. .......+.+|++++++++|+||+++++.+...
T Consensus 3 ~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-----------~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~ 71 (286)
T cd06622 3 IEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL-----------DESKFNQIIMELDILHKAVSPYIVDFYGAFFIE 71 (286)
T ss_pred hhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc-----------CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecC
Confidence 566779999999999999999899989888553210 111125678899999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCCCceeCCCCCCCEEEccCCeE
Q 020641 97 NLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHE-KVQPSIIHRDIRSSNVLLFEDFKA 175 (323)
Q Consensus 97 ~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~-~~~~~i~h~dikp~nili~~~~~~ 175 (323)
+..++||||+.+++|.+++..... ...+++..+..++.|++.|+.|||+ . +++|+||+|+||+++.++.+
T Consensus 72 ~~~~lv~e~~~~~~l~~~~~~~~~------~~~~~~~~~~~~~~~i~~~l~~LH~~~---~i~H~dl~p~nil~~~~~~~ 142 (286)
T cd06622 72 GAVYMCMEYMDAGSLDKLYAGGVA------TEGIPEDVLRRITYAVVKGLKFLKEEH---NIIHRDVKPTNVLVNGNGQV 142 (286)
T ss_pred CeEEEEEeecCCCCHHHHHHhccc------cCCCCHHHHHHHHHHHHHHHHHHHhcC---CEeeCCCCHHHEEECCCCCE
Confidence 999999999999999999876421 0128999999999999999999996 6 89999999999999999999
Q ss_pred EEeeccccCCCCccccccccccccCccccCCCccccCC------CCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchh
Q 020641 176 KIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG------QLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSL 249 (323)
Q Consensus 176 ~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~------~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~ 249 (323)
+|+|||.+....... .....++..|+|||.+.+. .++.++|+||||+++|+|++|..||..........
T Consensus 143 ~l~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~- 217 (286)
T cd06622 143 KLCDFGVSGNLVASL----AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFA- 217 (286)
T ss_pred EEeecCCcccccCCc----cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHH-
Confidence 999999987553321 1223477889999988543 34789999999999999999999996432211100
Q ss_pred hhhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 250 VTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
.+..... ......+...+.++.+++.+||+.+|++||++.++++
T Consensus 218 -----------~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 218 -----------QLSAIVD-GDPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred -----------HHHHHhh-cCCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence 0011111 1112234456778999999999999999999999997
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=278.52 Aligned_cols=251 Identities=23% Similarity=0.305 Sum_probs=194.1
Q ss_pred CCCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcC-CCCcccceeeEE
Q 020641 15 PSPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRL-KHENLVELLGYC 93 (323)
Q Consensus 15 ~~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~ 93 (323)
..++...+||.|+||.||++++..+++.+++|+.... ......+..|+.+++++ +|+||+++++++
T Consensus 16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~-------------~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~ 82 (282)
T cd06636 16 GIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-------------EDEEEEIKLEINMLKKYSHHRNIATYYGAF 82 (282)
T ss_pred hhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC-------------hHHHHHHHHHHHHHHHhcCCCcEEEEeeeh
Confidence 3445566899999999999999999999999865321 11235677888999888 799999999998
Q ss_pred Ee------CCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCE
Q 020641 94 VE------GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNV 167 (323)
Q Consensus 94 ~~------~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~ni 167 (323)
.. ....+++|||+.+++|.+++...... .+++..+..++.|++.|+.|||+. |++|+||+|+||
T Consensus 83 ~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~-------~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~ni 152 (282)
T cd06636 83 IKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGN-------ALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNV 152 (282)
T ss_pred hcccccCCCCEEEEEEEeCCCCcHHHHHHHccCC-------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHE
Confidence 53 45789999999999999999764322 278888999999999999999999 999999999999
Q ss_pred EEccCCeEEEeeccccCCCCccccccccccccCccccCCCcccc-----CCCCCcccchHHHHHHHHHHHhCCCCCCCCC
Q 020641 168 LLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAM-----TGQLTQKSDVYSFGVVLLELLTGRKPVDHTM 242 (323)
Q Consensus 168 li~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 242 (323)
+++.++.++|+|||.+........ ......|+..|+|||.+. ...++.++|+||||+++|+|++|..||....
T Consensus 153 li~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~ 230 (282)
T cd06636 153 LLTENAEVKLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMH 230 (282)
T ss_pred EECCCCCEEEeeCcchhhhhcccc--CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccC
Confidence 999999999999999875532211 122345788999999875 3457789999999999999999999996543
Q ss_pred CcccchhhhhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 243 PRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
...... ...............+..+.++|.+||+.||.+|||+.|+++
T Consensus 231 ~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 231 PMRALF---------------LIPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred HHhhhh---------------hHhhCCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 211110 000111111112345667999999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=273.44 Aligned_cols=254 Identities=20% Similarity=0.238 Sum_probs=196.5
Q ss_pred CccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeC
Q 020641 17 PGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEG 96 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 96 (323)
+.....||+|+||.||++.+..+++.+++|......... ......+.+.+|+.++++++|+||+++++++.+.
T Consensus 4 ~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~-------~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 76 (265)
T cd06652 4 WRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESP-------ETSKEVNALECEIQLLKNLLHERIVQYYGCLRDP 76 (265)
T ss_pred ceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCc-------ccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccC
Confidence 445568999999999999999999999998654221100 0111235778899999999999999999988763
Q ss_pred --CeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCe
Q 020641 97 --NLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFK 174 (323)
Q Consensus 97 --~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~ 174 (323)
...+++|||+.+++|.+++..... +++..+..++.|++.||.+||+. +++|+||+|+||+++.++.
T Consensus 77 ~~~~~~~v~e~~~~~~L~~~l~~~~~---------~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~ 144 (265)
T cd06652 77 MERTLSIFMEHMPGGSIKDQLKSYGA---------LTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGN 144 (265)
T ss_pred CCceEEEEEEecCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCC
Confidence 467899999999999999875432 78888999999999999999999 9999999999999999999
Q ss_pred EEEeeccccCCCCccccc-cccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhh
Q 020641 175 AKIADFNLSNQAPDMAAR-LHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWA 253 (323)
Q Consensus 175 ~~l~Dfg~~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 253 (323)
++|+|||.+......... .......++..|+|||.+.+..++.++|+||||+++|+|++|+.||........
T Consensus 145 ~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~------- 217 (265)
T cd06652 145 VKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAA------- 217 (265)
T ss_pred EEECcCccccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHH-------
Confidence 999999988754322111 111223478899999999888889999999999999999999999975422111
Q ss_pred cccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 254 TPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
..+..........+...+..+.+++.+||. +|++|||++||++
T Consensus 218 --------~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 218 --------IFKIATQPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred --------HHHHhcCCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 111111111223355666789999999995 9999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-39 Score=272.31 Aligned_cols=245 Identities=24% Similarity=0.372 Sum_probs=193.0
Q ss_pred CccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeC
Q 020641 17 PGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEG 96 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 96 (323)
+.....||+|+||.||++.. +++.+++|..... ...+.+.+|+.+++.++|+|++++++++...
T Consensus 8 ~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~--------------~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~ 71 (254)
T cd05083 8 LTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCD--------------VTAQAFLEETAVMTKLHHKNLVRLLGVILHN 71 (254)
T ss_pred ceeeeeeccCCCCceEeccc--CCCceEEEeecCc--------------chHHHHHHHHHHHHhCCCCCcCeEEEEEcCC
Confidence 44556899999999999874 5666777754311 1235788999999999999999999998765
Q ss_pred CeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEE
Q 020641 97 NLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAK 176 (323)
Q Consensus 97 ~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~ 176 (323)
. .+++|||+.+++|.+++...... .+++..+..++.|++.|+.+||+. |++|+||||+||+++.++.++
T Consensus 72 ~-~~~v~e~~~~~~L~~~l~~~~~~-------~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~k 140 (254)
T cd05083 72 G-LYIVMELMSKGNLVNFLRTRGRA-------LVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAK 140 (254)
T ss_pred C-cEEEEECCCCCCHHHHHHhcCcC-------CCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEE
Confidence 4 69999999999999999765322 278889999999999999999999 999999999999999999999
Q ss_pred EeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcc
Q 020641 177 IADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATP 255 (323)
Q Consensus 177 l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~ 255 (323)
|+|||.+....... .....+..|+|||.+.+..++.++|+||||+++|+|++ |..||........
T Consensus 141 l~Dfg~~~~~~~~~-----~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~--------- 206 (254)
T cd05083 141 VSDFGLARVGSMGV-----DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEV--------- 206 (254)
T ss_pred ECCCccceeccccC-----CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHH---------
Confidence 99999886543211 12224567999999988889999999999999999997 9999975532111
Q ss_pred cccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhh
Q 020641 256 RLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQP 309 (323)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~ 309 (323)
...+....+...+...+..+.+++.+||+.+|++|||+.++++.|++
T Consensus 207 -------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 207 -------KECVEKGYRMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred -------HHHHhCCCCCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 11111112222234456779999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=274.51 Aligned_cols=260 Identities=21% Similarity=0.290 Sum_probs=195.0
Q ss_pred cccccCCCCCCccceeccc---eeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEe
Q 020641 19 YFVRLDKGPEDDLYLKKRV---KMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVE 95 (323)
Q Consensus 19 ~~~~lg~G~~~~V~~~~~~---~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 95 (323)
....||+|+||.||+|... .+++.+++|+...+... ....+.+.+|+++++.++||||+++++++..
T Consensus 3 ~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~----------~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 72 (273)
T cd05074 3 LGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFS----------SSDIEEFLREAACMKEFDHPNVIKLIGVSLR 72 (273)
T ss_pred chhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCC----------hHHHHHHHHHHHHHhcCCCCCcceEEEEEcc
Confidence 3457999999999999864 35678888866533211 1123567889999999999999999998865
Q ss_pred CC------eEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEE
Q 020641 96 GN------LRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLL 169 (323)
Q Consensus 96 ~~------~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili 169 (323)
.. ..+++++|+.+++|.+++....... ....+++..+..++.|++.|+.|||+. |++|+||||+||++
T Consensus 73 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~---~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili 146 (273)
T cd05074 73 SRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGE---EPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCML 146 (273)
T ss_pred CCCCCcccceEEEEecCCCCcHHHHHHHhcccC---CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEE
Confidence 42 3478899999999998875332111 011278889999999999999999999 99999999999999
Q ss_pred ccCCeEEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccch
Q 020641 170 FEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQS 248 (323)
Q Consensus 170 ~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~ 248 (323)
+.++.++|+|||.+................+++.|++||.+....++.++||||||+++|+|++ |..||.........
T Consensus 147 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~- 225 (273)
T cd05074 147 NENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIY- 225 (273)
T ss_pred cCCCCEEECcccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHH-
Confidence 9999999999999876543222111222234677999999888888999999999999999999 88998654321110
Q ss_pred hhhhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhh
Q 020641 249 LVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPL 310 (323)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~ 310 (323)
.... .......+...+..+.+++.+||+.+|++|||+.++++.|+++
T Consensus 226 --~~~~-------------~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 226 --NYLI-------------KGNRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred --HHHH-------------cCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0000 0000111233456799999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=280.28 Aligned_cols=266 Identities=21% Similarity=0.268 Sum_probs=198.5
Q ss_pred CCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEe
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVE 95 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 95 (323)
.|+...+||+|+||.||++.+..+++.+++|...+... .....+.+.+|+++++.++|+||+++++++..
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~----------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 71 (286)
T cd07846 2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESED----------DKMVKKIAMREIRMLKQLRHENLVNLIEVFRR 71 (286)
T ss_pred ceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccC----------cchhhHHHHHHHHHHHhcCCcchhhHHHhccc
Confidence 35667799999999999999998889999986643211 11234667889999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeE
Q 020641 96 GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKA 175 (323)
Q Consensus 96 ~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~ 175 (323)
+...++|+||+.+++|.++...... +++..+..++.|++.|+.|||+. |++|+||+|+||++++++.+
T Consensus 72 ~~~~~lv~e~~~~~~l~~~~~~~~~---------~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~ 139 (286)
T cd07846 72 KKRLYLVFEFVDHTVLDDLEKYPNG---------LDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVV 139 (286)
T ss_pred CCeEEEEEecCCccHHHHHHhccCC---------CCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcE
Confidence 9999999999999888887654321 88999999999999999999999 99999999999999999999
Q ss_pred EEeeccccCCCCccccccccccccCccccCCCccccC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhc
Q 020641 176 KIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT-GQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWAT 254 (323)
Q Consensus 176 ~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~ 254 (323)
+|+|||++........ ......++..|+|||.+.+ ..++.++||||||+++|+|++|..||................
T Consensus 140 ~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~ 217 (286)
T cd07846 140 KLCDFGFARTLAAPGE--VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCL 217 (286)
T ss_pred EEEeeeeeeeccCCcc--ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHh
Confidence 9999999876543221 1223347888999998865 346789999999999999999999996543211111111000
Q ss_pred ccccccc---------cchhcCCCcC-----CCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 255 PRLSEDK---------VKQCVDPKLK-----GEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 255 ~~~~~~~---------~~~~~~~~~~-----~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
....... ......+... .......+..+.+++.+||+.+|++||++.++++
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 218 GNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred CCCchhhHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 0000000 0000000000 0112234678999999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=292.05 Aligned_cols=254 Identities=20% Similarity=0.299 Sum_probs=198.4
Q ss_pred CCCCCcccc---ccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccce
Q 020641 13 HAPSPGYFV---RLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVEL 89 (323)
Q Consensus 13 ~~~~~~~~~---~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~ 89 (323)
..++..|.+ .||+|+|-+||+|.|..++..||---. ............+++..|+.+|+.|+|+||+++
T Consensus 35 ~~p~gRy~k~~evLGrGafKtVYka~De~~giEVAWnqv--------k~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirf 106 (632)
T KOG0584|consen 35 KDPTGRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQV--------KIRDVTQSPEELERLYSEVHLLKSLKHPNIIRF 106 (632)
T ss_pred cCCCCceeehhhhcccccceeeeeccccccchhhHHHHH--------hHHHhhcChHHHHHHHHHHHHHccCCCCceeee
Confidence 334444443 899999999999999888876553211 111222333445899999999999999999999
Q ss_pred eeEEEeCCe--EEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCE
Q 020641 90 LGYCVEGNL--RVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNV 167 (323)
Q Consensus 90 ~~~~~~~~~--~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~ni 167 (323)
++++.+... ..+|+|.+..|+|..|+++... ++...++.|++||++||.|||++ ++.|+|||||-+||
T Consensus 107 y~SW~d~~n~~in~iTEL~TSGtLr~Y~kk~~~---------vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNI 176 (632)
T KOG0584|consen 107 YDSWVDTDNKTINFITELFTSGTLREYRKKHRR---------VNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNI 176 (632)
T ss_pred eeheecCCCceeeeeeecccCCcHHHHHHHhcc---------CCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceE
Confidence 999986654 7899999999999999988765 88889999999999999999998 77899999999999
Q ss_pred EEccC-CeEEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccc
Q 020641 168 LLFED-FKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQ 246 (323)
Q Consensus 168 li~~~-~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~ 246 (323)
+|+.+ |.|||+|+|+|+...... .....|||.|||||++. ..|++..||||||+++.||+|+.+||..=..
T Consensus 177 FinG~~G~VKIGDLGLAtl~r~s~----aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n--- 248 (632)
T KOG0584|consen 177 FVNGNLGEVKIGDLGLATLLRKSH----AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTN--- 248 (632)
T ss_pred EEcCCcCceeecchhHHHHhhccc----cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCC---
Confidence 99876 899999999998765433 23367999999999886 8899999999999999999999999963322
Q ss_pred chhhhhhcccccccccchhcCCCcCCC-CCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 247 QSLVTWATPRLSEDKVKQCVDPKLKGE-YPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
...+.+.+-.+.... +..--.+++++||.+||.. ..+|||+.|+|+
T Consensus 249 ------------~AQIYKKV~SGiKP~sl~kV~dPevr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 249 ------------PAQIYKKVTSGIKPAALSKVKDPEVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred ------------HHHHHHHHHcCCCHHHhhccCCHHHHHHHHHHhcC-chhccCHHHHhh
Confidence 111222222222111 0111135799999999999 999999999987
|
|
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=276.94 Aligned_cols=282 Identities=21% Similarity=0.220 Sum_probs=206.4
Q ss_pred CccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeC
Q 020641 17 PGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEG 96 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 96 (323)
|.....||.|++|.||++.+..+++.+++|......... ........+.+|+++++.++|+||+++++++.+.
T Consensus 2 y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~-------~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~ 74 (298)
T cd07841 2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKE-------AKDGINFTALREIKLLQELKHPNIIGLLDVFGHK 74 (298)
T ss_pred ceeeeeeeeccccEEEEEEECCCCcEEEEEEEecccccc-------ccchhhHHHHHHHHHHhhcCCCCChhhhheeecC
Confidence 445568999999999999999889999998765432211 1122335667899999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEE
Q 020641 97 NLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAK 176 (323)
Q Consensus 97 ~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~ 176 (323)
+..++||||+ +++|.+++..... .+++..+..++.|+++||.|||+. |++|+||+|+||+++.++.++
T Consensus 75 ~~~~lv~e~~-~~~L~~~i~~~~~--------~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~ 142 (298)
T cd07841 75 SNINLVFEFM-ETDLEKVIKDKSI--------VLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLK 142 (298)
T ss_pred CEEEEEEccc-CCCHHHHHhccCC--------CCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEE
Confidence 9999999999 7899999976541 288999999999999999999999 999999999999999999999
Q ss_pred EeeccccCCCCccccccccccccCccccCCCccccC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhcc
Q 020641 177 IADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT-GQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATP 255 (323)
Q Consensus 177 l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~ 255 (323)
|+|||++......... .....++..|+|||.+.+ ..++.++|+||||+++|+|++|..||.................
T Consensus 143 l~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~ 220 (298)
T cd07841 143 LADFGLARSFGSPNRK--MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALG 220 (298)
T ss_pred EccceeeeeccCCCcc--ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcC
Confidence 9999998765443211 122335778999998754 4578899999999999999999888765443211111000000
Q ss_pred cccc------cccchhcCCCcCC-----CCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhhcCCCCCCCCC
Q 020641 256 RLSE------DKVKQCVDPKLKG-----EYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSPPPAAPVS 321 (323)
Q Consensus 256 ~~~~------~~~~~~~~~~~~~-----~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~~~~~~~~~~~ 321 (323)
.... ............. ......+..+.+++.+||+.+|++|||+.|+++ ..++...+-+.+.+
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~--~~~~~~~~~~~~~~ 295 (298)
T cd07841 221 TPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE--HPYFSNDPAPTPPS 295 (298)
T ss_pred CCchhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh--CccccCCCCCCCCC
Confidence 0000 0000111000000 111234578999999999999999999999999 66666655555443
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=275.83 Aligned_cols=266 Identities=19% Similarity=0.244 Sum_probs=198.7
Q ss_pred CccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeC
Q 020641 17 PGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEG 96 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 96 (323)
|.....||.|++|.||+|.+..+++.+++|....... .......+.+|+.++++++|+||+++++++..+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~----------~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~ 71 (286)
T cd07832 2 YKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRL----------EGGIPNQALREIKALQACQHPYVVKLLDVFPHG 71 (286)
T ss_pred ceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccc----------cchhhHHHHHHHHHHHhCCCCCCcceeeEEecC
Confidence 4556689999999999999998999999886643211 122346788999999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEE
Q 020641 97 NLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAK 176 (323)
Q Consensus 97 ~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~ 176 (323)
...++|+||+ +++|.+++..... .+++..+..++.|++.|+.|||+. |++|+||+|+||+++.++.++
T Consensus 72 ~~~~~v~e~~-~~~L~~~~~~~~~--------~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~ 139 (286)
T cd07832 72 SGFVLVMEYM-PSDLSEVLRDEER--------PLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLK 139 (286)
T ss_pred CeeEEEeccc-CCCHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEE
Confidence 9999999999 8899999865432 289999999999999999999999 999999999999999999999
Q ss_pred EeeccccCCCCccccccccccccCccccCCCccccCC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhcc
Q 020641 177 IADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG-QLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATP 255 (323)
Q Consensus 177 l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~ 255 (323)
|+|||.+........ .......++..|+|||.+.+. .++.++||||+|+++++|++|..||.................
T Consensus 140 l~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~ 218 (286)
T cd07832 140 IADFGLARLFSEEEP-RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLG 218 (286)
T ss_pred EeeeeecccccCCCC-CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcC
Confidence 999999876644321 112234578899999988654 458899999999999999999888865432111100000000
Q ss_pred cccc------cccchh---cCCCcC----CCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 256 RLSE------DKVKQC---VDPKLK----GEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 256 ~~~~------~~~~~~---~~~~~~----~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
.... ..+..+ ..+... .....+.+..+.+++.+||+.+|++|||++++++
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~ 281 (286)
T cd07832 219 TPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR 281 (286)
T ss_pred CCChHHHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 0000 000000 000000 0011233578999999999999999999999986
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-39 Score=279.81 Aligned_cols=258 Identities=18% Similarity=0.195 Sum_probs=198.9
Q ss_pred CCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEe
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVE 95 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 95 (323)
.|.....||+|+||.||++.+..+++.+++|....... ........+.+|+++++.++|+||+++++.+..
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~---------~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~ 72 (305)
T cd05609 2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNL---------ILRNQIQQVFVERDILTFAENPFVVSMFCSFET 72 (305)
T ss_pred CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhh---------hhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEec
Confidence 45667799999999999999999999999986543211 111223567789999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeE
Q 020641 96 GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKA 175 (323)
Q Consensus 96 ~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~ 175 (323)
++..++||||+.+++|.+++..... +++..+..++.|++.|+.|||+. |++|+||||+||+++.++.+
T Consensus 73 ~~~~~lv~e~~~g~~L~~~l~~~~~---------~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~ 140 (305)
T cd05609 73 KRHLCMVMEYVEGGDCATLLKNIGA---------LPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHI 140 (305)
T ss_pred CCEEEEEEecCCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCE
Confidence 9999999999999999999966432 88889999999999999999999 99999999999999999999
Q ss_pred EEeeccccCCCCccc-------------cccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCC
Q 020641 176 KIADFNLSNQAPDMA-------------ARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTM 242 (323)
Q Consensus 176 ~l~Dfg~~~~~~~~~-------------~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 242 (323)
+|+|||++....... .........++..|+|||.+.+..++.++|+||||+++|++++|..||.+..
T Consensus 141 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~ 220 (305)
T cd05609 141 KLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDT 220 (305)
T ss_pred EEeeCCCccccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999875321100 0001112346788999999988889999999999999999999999996442
Q ss_pred CcccchhhhhhcccccccccchhcCCCcC-CCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhh
Q 020641 243 PRGQQSLVTWATPRLSEDKVKQCVDPKLK-GEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQP 309 (323)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~ 309 (323)
.... .......... .......+.++.+++.+||+.+|++||+..++.+.|+.
T Consensus 221 ~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 221 PEEL---------------FGQVISDDIEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred HHHH---------------HHHHHhcccCCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 2110 0000000000 00112345679999999999999999997666666655
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=271.74 Aligned_cols=239 Identities=20% Similarity=0.341 Sum_probs=181.5
Q ss_pred ccCCCCCCccceecccee------------eeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccce
Q 020641 22 RLDKGPEDDLYLKKRVKM------------RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVEL 89 (323)
Q Consensus 22 ~lg~G~~~~V~~~~~~~~------------~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~ 89 (323)
+||+|+||.||+++.... ...+++|.... ........+.+|+.+++.++||||+++
T Consensus 2 ~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~------------~~~~~~~~~~~~~~~l~~l~hp~iv~~ 69 (262)
T cd05077 2 HLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDP------------SHRDISLAFFETASMMRQVSHKHIVLL 69 (262)
T ss_pred ccccCCcceEeeeecccCCCccccccchhhceeEEEeecCh------------hhhhHHHHHHHHHHHHHhCCCCCEeeE
Confidence 689999999999975422 12344443221 112233567888999999999999999
Q ss_pred eeEEEeCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEE
Q 020641 90 LGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLL 169 (323)
Q Consensus 90 ~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili 169 (323)
++++......+++|||+.+++|..++..... .+++..+..++.|++.|+.|||++ +++|+||||+||++
T Consensus 70 ~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~--------~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill 138 (262)
T cd05077 70 YGVCVRDVENIMVEEFVEFGPLDLFMHRKSD--------VLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILL 138 (262)
T ss_pred EEEEecCCCCEEEEecccCCCHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEE
Confidence 9999988889999999999999988865432 188889999999999999999999 99999999999999
Q ss_pred ccCCe-------EEEeeccccCCCCccccccccccccCccccCCCcccc-CCCCCcccchHHHHHHHHHHH-hCCCCCCC
Q 020641 170 FEDFK-------AKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAM-TGQLTQKSDVYSFGVVLLELL-TGRKPVDH 240 (323)
Q Consensus 170 ~~~~~-------~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-~~~~~~~~Di~slG~~l~~l~-~g~~pf~~ 240 (323)
+.++. ++++|||++...... ....++..|+|||.+. +..++.++||||||+++|+|+ .|..||..
T Consensus 139 ~~~~~~~~~~~~~~l~d~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~ 212 (262)
T cd05077 139 AREGIDGECGPFIKLSDPGIPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKD 212 (262)
T ss_pred ecCCccCCCCceeEeCCCCCCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence 87654 899999988654321 2234678899999876 466889999999999999998 58888764
Q ss_pred CCCcccchhhhhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHH
Q 020641 241 TMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKAL 307 (323)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l 307 (323)
........ ....... .....+..+.+++.+||+.||++||++.+|++.+
T Consensus 213 ~~~~~~~~----------------~~~~~~~--~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 213 KTLAEKER----------------FYEGQCM--LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred cchhHHHH----------------HHhcCcc--CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 32211100 0000000 1112245789999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=275.99 Aligned_cols=257 Identities=21% Similarity=0.335 Sum_probs=201.5
Q ss_pred CccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeC
Q 020641 17 PGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEG 96 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 96 (323)
+..+.+||+|++|.||++.+..+++.+++|..... .....+.+.+|+.+++.++|+||+++++++..+
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~------------~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~ 88 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLR------------KQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVG 88 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEecc------------chhHHHHHHHHHHHHHHcCCCChheEEEEEEcC
Confidence 44567999999999999999888888888854211 112235678899999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEE
Q 020641 97 NLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAK 176 (323)
Q Consensus 97 ~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~ 176 (323)
+..++++||+.+++|.+++.... ++...+..++.|++.|+.+||+. |++|+||+|+||+++.++.++
T Consensus 89 ~~~~~v~e~~~~~~L~~~~~~~~----------~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~ 155 (285)
T cd06648 89 DELWVVMEFLEGGALTDIVTHTR----------MNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVK 155 (285)
T ss_pred CeEEEEEeccCCCCHHHHHHhCC----------CCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEE
Confidence 99999999999999999987632 88889999999999999999999 999999999999999999999
Q ss_pred EeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhccc
Q 020641 177 IADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPR 256 (323)
Q Consensus 177 l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 256 (323)
|+|||.+........ ......|+..|+|||.+.+..++.++|+||||+++|+|++|+.||.............
T Consensus 156 l~d~g~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~----- 228 (285)
T cd06648 156 LSDFGFCAQVSKEVP--RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIR----- 228 (285)
T ss_pred EcccccchhhccCCc--ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHH-----
Confidence 999998765433221 1122347889999999988888999999999999999999999996543211100000
Q ss_pred ccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhhcCCCC
Q 020641 257 LSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSPPP 316 (323)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~~~~~~ 316 (323)
....+.. ..+...+..+.+++.+||+.+|++|||+.++++ ..++....+
T Consensus 229 -------~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~--~~~~~~~~~ 277 (285)
T cd06648 229 -------DNLPPKL--KNLHKVSPRLRSFLDRMLVRDPAQRATAAELLN--HPFLAKAGP 277 (285)
T ss_pred -------hcCCCCC--cccccCCHHHHHHHHHHcccChhhCcCHHHHcc--CcccccCCC
Confidence 0000010 112224567999999999999999999999997 455555444
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=276.78 Aligned_cols=255 Identities=22% Similarity=0.314 Sum_probs=201.7
Q ss_pred ccCCCCCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCccccee
Q 020641 11 GAHAPSPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELL 90 (323)
Q Consensus 11 ~~~~~~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~ 90 (323)
|.....|....+||.|+||.||++.+..++..+++|..... .....+.+.+|+.+++.++||||++++
T Consensus 15 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~------------~~~~~~~~~~e~~~l~~l~hp~i~~~~ 82 (293)
T cd06647 15 GDPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQ------------QQPKKELIINEILVMRENKHPNIVNYL 82 (293)
T ss_pred cCchhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccc------------cchHHHHHHHHHHHHhhcCCCCeeehh
Confidence 34445666777999999999999998888888888865321 111236678899999999999999999
Q ss_pred eEEEeCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEc
Q 020641 91 GYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLF 170 (323)
Q Consensus 91 ~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~ 170 (323)
+.+..++..|+|+||+.+++|.+++.+.. +++..+..++.|++.|+.+||+. |++|+||+|+||+++
T Consensus 83 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~----------l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~ 149 (293)
T cd06647 83 DSYLVGDELWVVMEYLAGGSLTDVVTETC----------MDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLG 149 (293)
T ss_pred heeeeCCcEEEEEecCCCCcHHHHHhhcC----------CCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEc
Confidence 99999999999999999999999997543 78889999999999999999999 999999999999999
Q ss_pred cCCeEEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhh
Q 020641 171 EDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLV 250 (323)
Q Consensus 171 ~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~ 250 (323)
.++.++|+|||++........ ......+++.|++||.+.+..++.++|+||||+++|++++|+.||............
T Consensus 150 ~~~~~kL~dfg~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~ 227 (293)
T cd06647 150 MDGSVKLTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI 227 (293)
T ss_pred CCCCEEEccCcceeccccccc--ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeeh
Confidence 999999999998765433221 122335788899999998888899999999999999999999999754321110000
Q ss_pred hhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHH
Q 020641 251 TWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKA 306 (323)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~ 306 (323)
. .........+...+..+.+++.+||..+|++||++.+++..
T Consensus 228 --~------------~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 228 --A------------TNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred --h------------cCCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 00000111233445679999999999999999999999973
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=271.96 Aligned_cols=249 Identities=21% Similarity=0.283 Sum_probs=197.9
Q ss_pred ccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeCCeE
Q 020641 20 FVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLR 99 (323)
Q Consensus 20 ~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 99 (323)
-..||.|++|.||++.+..+++.+++|......... ...+..+.+.+|+++++.++|+||+++++++..+...
T Consensus 5 ~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~-------~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~ 77 (258)
T cd06632 5 GELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQ-------TGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNL 77 (258)
T ss_pred cceeeecCCceEEEEEEcCCCcEEEEEEEEEccccc-------cchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeE
Confidence 356899999999999999888899998664321111 1223346788999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEEEee
Q 020641 100 VLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIAD 179 (323)
Q Consensus 100 ~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~l~D 179 (323)
++++||+.+++|.+++..... +++..+..++.|++.|+.+||+. |++|+||+|+||+++.++.++|+|
T Consensus 78 ~lv~e~~~~~~L~~~~~~~~~---------~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d 145 (258)
T cd06632 78 YIFLELVPGGSLAKLLKKYGS---------FPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLAD 145 (258)
T ss_pred EEEEEecCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcc
Confidence 999999999999999976432 78889999999999999999999 999999999999999999999999
Q ss_pred ccccCCCCccccccccccccCccccCCCccccCCC-CCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhccccc
Q 020641 180 FNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQ-LTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLS 258 (323)
Q Consensus 180 fg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 258 (323)
||.+....... ......++..|++||.+.... ++.++|+||||+++|+|++|..||......... ....
T Consensus 146 ~~~~~~~~~~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~--~~~~----- 215 (258)
T cd06632 146 FGMAKQVVEFS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAV--FKIG----- 215 (258)
T ss_pred Cccceeccccc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHH--HHHH-----
Confidence 99887654322 123345788899999887666 889999999999999999999999754321110 0000
Q ss_pred ccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 259 EDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
........+...+..+.+++.+||+.+|.+|||+.+++.
T Consensus 216 --------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 216 --------RSKELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred --------hcccCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 000111223345677999999999999999999999985
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=274.23 Aligned_cols=254 Identities=23% Similarity=0.328 Sum_probs=197.3
Q ss_pred CCCCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcC-CCCcccceeeE
Q 020641 14 APSPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRL-KHENLVELLGY 92 (323)
Q Consensus 14 ~~~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~ 92 (323)
...|.....||.|++|.||+|.+..+++.+++|+.... ....+.+.+|+++++++ +|+||++++++
T Consensus 5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~-------------~~~~~~~~~e~~~l~~~~~h~~i~~~~~~ 71 (275)
T cd06608 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDII-------------EDEEEEIKEEYNILRKYSNHPNIATFYGA 71 (275)
T ss_pred hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecC-------------chhHHHHHHHHHHHHHhcCCCChheEEEE
Confidence 35667778999999999999999988888888865422 11236788999999999 79999999999
Q ss_pred EEeCC------eEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCC
Q 020641 93 CVEGN------LRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSN 166 (323)
Q Consensus 93 ~~~~~------~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~n 166 (323)
+.... ..++||||+.+++|.+++....... ..+++..+..++.|++.||.|||+. |++|+||+|+|
T Consensus 72 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~-----~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~n 143 (275)
T cd06608 72 FIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKG-----KRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQN 143 (275)
T ss_pred EEecCCCCcceEEEEEEEcCCCCcHHHHHHHHhhcC-----CCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHH
Confidence 97644 4899999999999999986543111 1288999999999999999999999 99999999999
Q ss_pred EEEccCCeEEEeeccccCCCCccccccccccccCccccCCCccccC-----CCCCcccchHHHHHHHHHHHhCCCCCCCC
Q 020641 167 VLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT-----GQLTQKSDVYSFGVVLLELLTGRKPVDHT 241 (323)
Q Consensus 167 ili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 241 (323)
|+++.++.++|+|||.+......... .....++..|+|||.+.. ..++.++||||||+++|+|++|..||...
T Consensus 144 i~~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 221 (275)
T cd06608 144 ILLTKNAEVKLVDFGVSAQLDSTLGR--RNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDM 221 (275)
T ss_pred EEEccCCeEEECCCccceecccchhh--hcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCcccc
Confidence 99999999999999998755432221 223447889999998753 34678899999999999999999999644
Q ss_pred CCcccchhhhhhcccccccccchhcCC-CcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 242 MPRGQQSLVTWATPRLSEDKVKQCVDP-KLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
...... .+.... ......+...+..+.+++.+||..||++|||+.++++
T Consensus 222 ~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 222 HPMRAL---------------FKIPRNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred chHHHH---------------HHhhccCCCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 221110 011100 0011222345678999999999999999999999986
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=291.40 Aligned_cols=247 Identities=24% Similarity=0.307 Sum_probs=202.3
Q ss_pred ccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeCCeEEE
Q 020641 22 RLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVL 101 (323)
Q Consensus 22 ~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 101 (323)
-||+|.||+||.+++..+....|+|-+.. ...++.+-...|+.+.++++|.||++++|.+.+++.+-+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpe------------kdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kI 649 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPE------------KDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKI 649 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeeccc------------ccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEE
Confidence 68999999999999999999999884432 224445778899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEcc-CCeEEEeec
Q 020641 102 AYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFE-DFKAKIADF 180 (323)
Q Consensus 102 v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~-~~~~~l~Df 180 (323)
.||..+||||.++++..=+. . .-.+.++--+.+||++||.|||.+ .|+|||||-+|+|++. .|.+||+||
T Consensus 650 FMEqVPGGSLSsLLrskWGP----l--KDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDF 720 (1226)
T KOG4279|consen 650 FMEQVPGGSLSSLLRSKWGP----L--KDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDF 720 (1226)
T ss_pred EeecCCCCcHHHHHHhccCC----C--ccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEeccc
Confidence 99999999999999754221 0 036778889999999999999999 9999999999999964 688999999
Q ss_pred cccCCCCccccccccccccCccccCCCccccC--CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhccccc
Q 020641 181 NLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT--GQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLS 258 (323)
Q Consensus 181 g~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 258 (323)
|-+...... .....+..||.-|+|||++.. .+|+.++|||||||++.||.||++||..........
T Consensus 721 GTsKRLAgi--nP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAM---------- 788 (1226)
T KOG4279|consen 721 GTSKRLAGI--NPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAM---------- 788 (1226)
T ss_pred ccchhhccC--CccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhh----------
Confidence 988765432 233456679999999999864 468899999999999999999999997654322211
Q ss_pred ccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 259 EDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
.++=.-....+.|.+.+.+.+.||.+|+..+|.+||++.++++
T Consensus 789 ----FkVGmyKvHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 789 ----FKVGMYKVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred ----hhhcceecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 1111112234567888999999999999999999999999986
|
|
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=271.76 Aligned_cols=258 Identities=26% Similarity=0.308 Sum_probs=200.8
Q ss_pred CCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEe
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVE 95 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 95 (323)
.|.....||.|++|+||++....++..+++|+...... ......+.+|++.++.++|+||+++++.+..
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-----------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 70 (267)
T cd06610 2 DYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKC-----------QTSVDELRKEVQAMSQCNHPNVVKYYTSFVV 70 (267)
T ss_pred cceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCc-----------chHHHHHHHHHHHHHhcCCCCEEEEEEEEee
Confidence 35566789999999999999988888888886642211 1134678899999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeE
Q 020641 96 GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKA 175 (323)
Q Consensus 96 ~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~ 175 (323)
.+..++++|++.+++|.+++...... ..+++..+..++.|++.|+.+||+. |++|+||+|+||++++++.+
T Consensus 71 ~~~~~iv~e~~~~~~l~~~~~~~~~~------~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~ 141 (267)
T cd06610 71 GDELWLVMPYLSGGSLLDIMKSSYPR------GGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSV 141 (267)
T ss_pred CCEEEEEEeccCCCcHHHHHHHhccc------CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCE
Confidence 99999999999999999999764320 1288999999999999999999999 99999999999999999999
Q ss_pred EEeeccccCCCCcccccc--ccccccCccccCCCccccCC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhh
Q 020641 176 KIADFNLSNQAPDMAARL--HSTRVLGTFGYHAPEYAMTG-QLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTW 252 (323)
Q Consensus 176 ~l~Dfg~~~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 252 (323)
+|+|||++.......... ......++..|+|||.+... .++.++|+||||+++++|++|+.||.......... ..
T Consensus 142 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~--~~ 219 (267)
T cd06610 142 KIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLM--LT 219 (267)
T ss_pred EEcccchHHHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHH--HH
Confidence 999999886554332211 12233478899999988766 78899999999999999999999997553321110 00
Q ss_pred hcccccccccchhcCCCcCCC-CCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 253 ATPRLSEDKVKQCVDPKLKGE-YPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
... ..+..... .....+..+.+++.+||..||++|||+.+|++
T Consensus 220 ~~~----------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 220 LQN----------DPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred hcC----------CCCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 000 00011111 11345678999999999999999999999986
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=286.14 Aligned_cols=261 Identities=25% Similarity=0.325 Sum_probs=211.1
Q ss_pred ccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeCCeE
Q 020641 20 FVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLR 99 (323)
Q Consensus 20 ~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 99 (323)
..|||+|-||.|-++.-.. ...||+|..... ..++.+.+|.+|+++|.+|+||||+.++++|..++.+
T Consensus 543 ~ekiGeGqFGEVhLCeveg-~lkVAVK~Lr~~-----------a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePi 610 (807)
T KOG1094|consen 543 KEKIGEGQFGEVHLCEVEG-PLKVAVKILRPD-----------ATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPL 610 (807)
T ss_pred hhhhcCcccceeEEEEecC-ceEEEEeecCcc-----------cchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCch
Confidence 3499999999999998765 567777755432 2233368899999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEEEee
Q 020641 100 VLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIAD 179 (323)
Q Consensus 100 ~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~l~D 179 (323)
++|+||+++|+|.+++.+..... +.......++.||+.|++||.+. +++|||+.++|+|++.++++||+|
T Consensus 611 cmI~EYmEnGDLnqFl~aheapt-------~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiad 680 (807)
T KOG1094|consen 611 CMITEYMENGDLNQFLSAHELPT-------AETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIAD 680 (807)
T ss_pred HHHHHHHhcCcHHHHHHhccCcc-------cccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecC
Confidence 99999999999999998875321 34445667999999999999999 999999999999999999999999
Q ss_pred ccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHh--CCCCCCCCCCcccchhhhhhcccc
Q 020641 180 FNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT--GRKPVDHTMPRGQQSLVTWATPRL 257 (323)
Q Consensus 180 fg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~--g~~pf~~~~~~~~~~~~~~~~~~~ 257 (323)
||+++..-.+.......+..-+.+|+|+|.+...+++.++|+|+||+++||+++ .+.||........-.... ...
T Consensus 681 fgmsR~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~---~~~ 757 (807)
T KOG1094|consen 681 FGMSRNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAG---EFF 757 (807)
T ss_pred cccccccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhh---hhc
Confidence 999997766666666666667889999999999999999999999999999976 888987554322111000 000
Q ss_pred cccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhh
Q 020641 258 SEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLL 311 (323)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~ 311 (323)
... .+......|..++..++++|.+||+++-.+|||++++...|++..
T Consensus 758 ~~~------~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~~ 805 (807)
T KOG1094|consen 758 RDQ------GRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQEDA 805 (807)
T ss_pred CCC------CcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHhc
Confidence 000 111122456778889999999999999999999999999998764
|
|
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=273.22 Aligned_cols=248 Identities=21% Similarity=0.327 Sum_probs=195.7
Q ss_pred CccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCC---CCcccceeeEE
Q 020641 17 PGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLK---HENLVELLGYC 93 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~ 93 (323)
|....+||.|+||.||++.+..+++.+++|...... .......+.+|+.+++.++ |+|++++++++
T Consensus 3 y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~-----------~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~ 71 (277)
T cd06917 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT-----------PDDDVSDIQREVALLSQLRQSQPPNITKYYGSY 71 (277)
T ss_pred hhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC-----------CchhHHHHHHHHHHHHHhccCCCCCeeeEeeee
Confidence 455678999999999999999999999998654221 1223356778888888886 99999999999
Q ss_pred EeCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCC
Q 020641 94 VEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDF 173 (323)
Q Consensus 94 ~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~ 173 (323)
..+...+++|||+.+++|.+++.... +++..+..++.|++.|+.+||+. |++|+||+|+||+++.++
T Consensus 72 ~~~~~~~lv~e~~~~~~L~~~~~~~~----------l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~ 138 (277)
T cd06917 72 LKGPRLWIIMEYAEGGSVRTLMKAGP----------IAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTG 138 (277)
T ss_pred eeCCEEEEEEecCCCCcHHHHHHccC----------CCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCC
Confidence 99999999999999999999986542 88999999999999999999999 999999999999999999
Q ss_pred eEEEeeccccCCCCccccccccccccCccccCCCccccC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhh
Q 020641 174 KAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT-GQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTW 252 (323)
Q Consensus 174 ~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 252 (323)
.++|+|||.+........ ......|+..|+|||.+.+ ..++.++|+||||+++|+|++|..||............
T Consensus 139 ~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~-- 214 (277)
T cd06917 139 NVKLCDFGVAALLNQNSS--KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLI-- 214 (277)
T ss_pred CEEEccCCceeecCCCcc--ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhcc--
Confidence 999999999876544321 1223357889999998764 45688999999999999999999999754321110000
Q ss_pred hcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 253 ATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
.....+.+. ....+.++.+++.+||+.||++||++.++++
T Consensus 215 ----------~~~~~~~~~---~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 215 ----------PKSKPPRLE---DNGYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred ----------ccCCCCCCC---cccCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 000000110 1124567999999999999999999999987
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=275.76 Aligned_cols=265 Identities=20% Similarity=0.258 Sum_probs=195.2
Q ss_pred CCCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEE
Q 020641 15 PSPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCV 94 (323)
Q Consensus 15 ~~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 94 (323)
..|+...+||.|++|.||++++..+++.+++|....... ......+.+|+++++.++|+||+++++++.
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~-----------~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 73 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHE-----------EGAPFTAIREASLLKDLKHANIVTLHDIIH 73 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccc-----------cCCchhHHHHHHHHhhCCCcceeeEEEEEe
Confidence 346667799999999999999998889999986643211 112244678999999999999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCe
Q 020641 95 EGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFK 174 (323)
Q Consensus 95 ~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~ 174 (323)
.....++||||+.+ +|.+++...... +++..+..++.|+++||.|||+. |++|+||+|+||+++.++.
T Consensus 74 ~~~~~~lv~e~~~~-~L~~~~~~~~~~--------~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~ 141 (291)
T cd07844 74 TKKTLTLVFEYLDT-DLKQYMDDCGGG--------LSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGE 141 (291)
T ss_pred cCCeEEEEEecCCC-CHHHHHHhCCCC--------CCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCC
Confidence 99999999999985 999988754322 88999999999999999999999 9999999999999999999
Q ss_pred EEEeeccccCCCCccccccccccccCccccCCCccccC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhh
Q 020641 175 AKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT-GQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWA 253 (323)
Q Consensus 175 ~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 253 (323)
++|+|||++........ ......++..|+|||.+.+ ..++.++||||+|+++|+|++|..||.............+.
T Consensus 142 ~kl~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~ 219 (291)
T cd07844 142 LKLADFGLARAKSVPSK--TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFR 219 (291)
T ss_pred EEECccccccccCCCCc--cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHH
Confidence 99999998865432111 1122235788999998875 45788999999999999999999999755422111110000
Q ss_pred c-ccccccccchhc--------------CCCcCCCCCHHH--HHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 254 T-PRLSEDKVKQCV--------------DPKLKGEYPPKG--VAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 254 ~-~~~~~~~~~~~~--------------~~~~~~~~~~~~--~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
. ............ ...+. ...... ...+.+++.+||+.+|++|||+.++++
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 220 VLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLI-NHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred hcCCCChhhhhhhhhccccccccccccCChhHH-HhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 0 000000000000 00000 000011 257889999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=277.04 Aligned_cols=278 Identities=21% Similarity=0.232 Sum_probs=201.8
Q ss_pred CCCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEE
Q 020641 15 PSPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCV 94 (323)
Q Consensus 15 ~~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 94 (323)
..|....+||.|+||.||++.+..+++.+++|....+. ........+.+|+.++++++|+||+++++++.
T Consensus 7 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~----------~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 76 (309)
T cd07845 7 TEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDN----------ERDGIPISSLREITLLLNLRHPNIVELKEVVV 76 (309)
T ss_pred cceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEecc----------CCCCCcchhhHHHHHHHhCCCCCCcceEEEEe
Confidence 45667778999999999999999999999998654321 11222344567999999999999999999987
Q ss_pred eC--CeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccC
Q 020641 95 EG--NLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFED 172 (323)
Q Consensus 95 ~~--~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~ 172 (323)
.. +..++||||+.+ +|.+++..... .+++..+..++.|++.||.|||+. |++|+||+|+||+++.+
T Consensus 77 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~--------~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~ 144 (309)
T cd07845 77 GKHLDSIFLVMEYCEQ-DLASLLDNMPT--------PFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDK 144 (309)
T ss_pred cCCCCeEEEEEecCCC-CHHHHHHhccc--------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCC
Confidence 55 468999999975 89888875432 289999999999999999999999 99999999999999999
Q ss_pred CeEEEeeccccCCCCccccccccccccCccccCCCccccC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhh
Q 020641 173 FKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT-GQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVT 251 (323)
Q Consensus 173 ~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~ 251 (323)
+.++|+|||.+......... .....++..|+|||.+.+ ..++.++|+||||+++|+|++|..||.............
T Consensus 145 ~~~kL~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~ 222 (309)
T cd07845 145 GCLKIADFGLARTYGLPAKP--MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLII 222 (309)
T ss_pred CCEEECccceeeecCCccCC--CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 99999999998765433211 122235778999998865 457899999999999999999999997654322211111
Q ss_pred hhcccccccccch--------hc--CCCcCC---CCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhhcCCCCCC
Q 020641 252 WATPRLSEDKVKQ--------CV--DPKLKG---EYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSPPPAA 318 (323)
Q Consensus 252 ~~~~~~~~~~~~~--------~~--~~~~~~---~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~~~~~~~~ 318 (323)
............. .. ...... ......+..+.++|.+||+.||++|||++|+++ ...+...+.|.
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~--h~~f~~~~~~~ 300 (309)
T cd07845 223 QLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE--SSYFKEKPLPC 300 (309)
T ss_pred HhcCCCChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc--ChhhccCCCCC
Confidence 0000000000000 00 000000 000113567889999999999999999999997 56665555443
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=276.38 Aligned_cols=265 Identities=17% Similarity=0.205 Sum_probs=196.5
Q ss_pred CccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeC
Q 020641 17 PGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEG 96 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 96 (323)
|..+.+||.|++|.||+|++..+++.+++|...... ........+.+|++++++++|+||+++++++.++
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~----------~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 71 (284)
T cd07860 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDT----------ETEGVPSTAIREISLLKELNHPNIVKLLDVIHTE 71 (284)
T ss_pred ceeeeeecCCCceEEEEEEECCCCCEEEEEEccccc----------cccccchHHHHHHHHHHhcCCCCCcchhhhcccC
Confidence 566778999999999999999999999988554221 1122336788999999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEE
Q 020641 97 NLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAK 176 (323)
Q Consensus 97 ~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~ 176 (323)
...++||||+. ++|.+++...... .+++..+..++.|++.|+.|||+. +++|+||+|+||+++.++.++
T Consensus 72 ~~~~~v~e~~~-~~l~~~~~~~~~~-------~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~ 140 (284)
T cd07860 72 NKLYLVFEFLH-QDLKKFMDASPLS-------GIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIK 140 (284)
T ss_pred CcEEEEeeccc-cCHHHHHHhCCCC-------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEE
Confidence 99999999996 5899988654322 288999999999999999999999 999999999999999999999
Q ss_pred EeeccccCCCCccccccccccccCccccCCCccccCCC-CCcccchHHHHHHHHHHHhCCCCCCCCCCcccchh-hhhhc
Q 020641 177 IADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQ-LTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSL-VTWAT 254 (323)
Q Consensus 177 l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~-~~~~~ 254 (323)
|+|||++........ ......++..|+|||.+.+.. ++.++|+||||+++|+|++|+.||........... .....
T Consensus 141 l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~ 218 (284)
T cd07860 141 LADFGLARAFGVPVR--TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLG 218 (284)
T ss_pred EeeccchhhcccCcc--ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhC
Confidence 999999865432211 112234678899999887644 58899999999999999999999975543211110 00000
Q ss_pred cccc------------ccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 255 PRLS------------EDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 255 ~~~~------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
.... ......+..... .......+..+.+++.+||+.||.+|||+.++++
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 219 TPDEVVWPGVTSLPDYKPSFPKWARQDF-SKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred CCChhhhhhhhHHHHHHhhcccccccCH-HHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 0000 000000000000 0011223467889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=274.83 Aligned_cols=260 Identities=21% Similarity=0.280 Sum_probs=196.9
Q ss_pred cccCCCCCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcC-CCCcccc
Q 020641 10 LGAHAPSPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRL-KHENLVE 88 (323)
Q Consensus 10 ~~~~~~~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~ 88 (323)
++.....++....||+|+||.||++.+..+++.+++|+.... ......+.+|+.+++.+ +|+||++
T Consensus 13 ~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~-------------~~~~~~~~~e~~~l~~l~~h~~i~~ 79 (286)
T cd06638 13 FPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPI-------------HDIDEEIEAEYNILKALSDHPNVVK 79 (286)
T ss_pred CCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccc-------------cchHHHHHHHHHHHHHHhcCCCeee
Confidence 344556777778999999999999999999999998854311 11225677899999998 7999999
Q ss_pred eeeEEE-----eCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCC
Q 020641 89 LLGYCV-----EGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIR 163 (323)
Q Consensus 89 ~~~~~~-----~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dik 163 (323)
+++++. .+...++||||+++++|.+++...... ...+++..+..++.|++.|+.|||+. +++|+|||
T Consensus 80 ~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk 151 (286)
T cd06638 80 FYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKR-----GERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVK 151 (286)
T ss_pred eeeeeeecccCCCCeEEEEEeecCCCCHHHHHHHhhcc-----CccccHHHHHHHHHHHHHHHHHHHhC---CccccCCC
Confidence 999874 345689999999999999987643211 11288889999999999999999999 99999999
Q ss_pred CCCEEEccCCeEEEeeccccCCCCccccccccccccCccccCCCccccC-----CCCCcccchHHHHHHHHHHHhCCCCC
Q 020641 164 SSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT-----GQLTQKSDVYSFGVVLLELLTGRKPV 238 (323)
Q Consensus 164 p~nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~Di~slG~~l~~l~~g~~pf 238 (323)
|+||+++.++.++|+|||.+........ ......|+..|+|||.+.. ..++.++||||||+++|+|++|+.||
T Consensus 152 p~nili~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~ 229 (286)
T cd06638 152 GNNILLTTEGGVKLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPL 229 (286)
T ss_pred HHhEEECCCCCEEEccCCceeecccCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCC
Confidence 9999999999999999999875533211 1223358899999998753 44788999999999999999999999
Q ss_pred CCCCCcccchhhhhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHH
Q 020641 239 DHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKA 306 (323)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~ 306 (323)
.......... ... ....+. ...+...+..+.+++.+||+.||++|||+.|+++.
T Consensus 230 ~~~~~~~~~~--~~~----------~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 230 ADLHPMRALF--KIP----------RNPPPT--LHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred CCCchhHHHh--hcc----------ccCCCc--ccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 7543211100 000 000000 01122234579999999999999999999999874
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=273.45 Aligned_cols=264 Identities=23% Similarity=0.289 Sum_probs=200.7
Q ss_pred CCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEe
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVE 95 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 95 (323)
+++...+||.|++|.||++.+..+++.+++|...... .......+.+|++++++++|+||+++++++..
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~-----------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 70 (287)
T cd06621 2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDP-----------NPDLQKQILRELEINKSCKSPYIVKYYGAFLD 70 (287)
T ss_pred ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCC-----------chHHHHHHHHHHHHHHhCCCCCeeeeeeEEEc
Confidence 4566779999999999999999999999998654221 11234678899999999999999999998864
Q ss_pred C--CeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCC
Q 020641 96 G--NLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDF 173 (323)
Q Consensus 96 ~--~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~ 173 (323)
. +..++||||+.+++|.+++...... ...++...+..++.|++.||.|||+. |++|+||+|+||+++.++
T Consensus 71 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~-----~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~ 142 (287)
T cd06621 71 ESSSSIGIAMEYCEGGSLDSIYKKVKKR-----GGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKG 142 (287)
T ss_pred cCCCeEEEEEEecCCCCHHHHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCC
Confidence 3 4689999999999999987543211 11278889999999999999999999 999999999999999999
Q ss_pred eEEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccc--chhhh
Q 020641 174 KAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQ--QSLVT 251 (323)
Q Consensus 174 ~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~--~~~~~ 251 (323)
.++|+|||++........ ....++..|+|||.+.+..++.++|+||||+++|+|++|..||........ .....
T Consensus 143 ~~~l~dfg~~~~~~~~~~----~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~ 218 (287)
T cd06621 143 QVKLCDFGVSGELVNSLA----GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLS 218 (287)
T ss_pred eEEEeecccccccccccc----ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHH
Confidence 999999999865433211 123467889999999888899999999999999999999999975532110 01111
Q ss_pred hhcccccccccchhcCCCcCCCC--CHHHHHHHHHHHHHccCCCCCCCCChHHHHH--HHhhhh
Q 020641 252 WATPRLSEDKVKQCVDPKLKGEY--PPKGVAKLAAVAALCVQYEAEFRPNMSIVVK--ALQPLL 311 (323)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~cl~~~P~~Rps~~evl~--~l~~~~ 311 (323)
+.... . .+.+.... ....++.+.+++.+||+.+|.+|||+.|+++ ++.+..
T Consensus 219 ~~~~~-~--------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~ 273 (287)
T cd06621 219 YIVNM-P--------NPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQM 273 (287)
T ss_pred HHhcC-C--------chhhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCccccccc
Confidence 11100 0 00010011 1234678999999999999999999999998 444433
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=278.26 Aligned_cols=272 Identities=18% Similarity=0.217 Sum_probs=198.3
Q ss_pred CccccccCCCCCCccceeccce--eeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEE
Q 020641 17 PGYFVRLDKGPEDDLYLKKRVK--MRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCV 94 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~~~~--~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 94 (323)
|....+||+|++|.||++++.. +++.+|+|....... ........+.+|+.+++.++||||+++++++.
T Consensus 2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~---------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 72 (316)
T cd07842 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKE---------QYTGISQSACREIALLRELKHENVVSLVEVFL 72 (316)
T ss_pred ceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccc---------cccCccHHHHHHHHHHHhcCCCCccceEEEEe
Confidence 5566789999999999999998 788999997764321 22334466788999999999999999999999
Q ss_pred eC--CeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEcc-
Q 020641 95 EG--NLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFE- 171 (323)
Q Consensus 95 ~~--~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~- 171 (323)
.. ...++||||+.+ +|.+++........ ..++...++.++.|++.||.|||+. +++|+||||+||+++.
T Consensus 73 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~ 144 (316)
T cd07842 73 EHADKSVYLLFDYAEH-DLWQIIKFHRQAKR----VSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGE 144 (316)
T ss_pred CCCCceEEEEEeCCCc-CHHHHHHhhccCCC----cCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCC
Confidence 88 789999999976 78877754332111 1388999999999999999999999 9999999999999999
Q ss_pred ---CCeEEEeeccccCCCCcccc-ccccccccCccccCCCccccC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCccc
Q 020641 172 ---DFKAKIADFNLSNQAPDMAA-RLHSTRVLGTFGYHAPEYAMT-GQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQ 246 (323)
Q Consensus 172 ---~~~~~l~Dfg~~~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~ 246 (323)
++.++|+|||++........ ........++..|+|||.+.+ ..++.++||||||+++++|++|..||........
T Consensus 145 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~ 224 (316)
T cd07842 145 GPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIK 224 (316)
T ss_pred CCccceEEECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCccccc
Confidence 89999999999876543322 111223347888999998766 4578999999999999999999999976544320
Q ss_pred ch------hhhhhccccc---c---------cccchhcCCCcCCCCC---------H--HHHHHHHHHHHHccCCCCCCC
Q 020641 247 QS------LVTWATPRLS---E---------DKVKQCVDPKLKGEYP---------P--KGVAKLAAVAALCVQYEAEFR 297 (323)
Q Consensus 247 ~~------~~~~~~~~~~---~---------~~~~~~~~~~~~~~~~---------~--~~~~~l~~li~~cl~~~P~~R 297 (323)
.. .......... . .......+.......+ . ..+..+.+++.+||+.||++|
T Consensus 225 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R 304 (316)
T cd07842 225 KSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKR 304 (316)
T ss_pred ccchhHHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccC
Confidence 00 0000000000 0 0000000000000011 0 334579999999999999999
Q ss_pred CChHHHHH
Q 020641 298 PNMSIVVK 305 (323)
Q Consensus 298 ps~~evl~ 305 (323)
||+.|+++
T Consensus 305 ps~~eil~ 312 (316)
T cd07842 305 ITAEEALE 312 (316)
T ss_pred cCHHHHhc
Confidence 99999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=275.65 Aligned_cols=266 Identities=18% Similarity=0.233 Sum_probs=198.6
Q ss_pred CCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEe
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVE 95 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 95 (323)
.|....+||.|+||.||+|++..+++.+++|....... .......+.+|+.++++++|+||+++++++..
T Consensus 6 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~----------~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~ 75 (293)
T cd07843 6 EYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKE----------KEGFPITSLREINILLKLQHPNIVTVKEVVVG 75 (293)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccc----------cccchhhHHHHHHHHHhcCCCCEEEEEEEEEe
Confidence 56667799999999999999998888888886542211 12233567789999999999999999999887
Q ss_pred C--CeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCC
Q 020641 96 G--NLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDF 173 (323)
Q Consensus 96 ~--~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~ 173 (323)
. ...++|+||+.+ +|.+++..... .+++..+..++.|++.||.|||+. |++|+||+|+||+++.++
T Consensus 76 ~~~~~~~lv~e~~~~-~L~~~~~~~~~--------~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~ 143 (293)
T cd07843 76 SNLDKIYMVMEYVEH-DLKSLMETMKQ--------PFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRG 143 (293)
T ss_pred cCCCcEEEEehhcCc-CHHHHHHhccC--------CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCC
Confidence 7 889999999985 99998875432 289999999999999999999999 999999999999999999
Q ss_pred eEEEeeccccCCCCccccccccccccCccccCCCccccCC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhh
Q 020641 174 KAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG-QLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTW 252 (323)
Q Consensus 174 ~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 252 (323)
.++|+|||++........ ......+++.|+|||.+.+. .++.++|+||||+++|+|++|..||..............
T Consensus 144 ~~~l~d~g~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~ 221 (293)
T cd07843 144 ILKICDFGLAREYGSPLK--PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFK 221 (293)
T ss_pred cEEEeecCceeeccCCcc--ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence 999999998876554321 11233467889999988754 468899999999999999999999976543221111100
Q ss_pred hccc--------------ccccccchhcCCCcCCCCCHH-HHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 253 ATPR--------------LSEDKVKQCVDPKLKGEYPPK-GVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 253 ~~~~--------------~~~~~~~~~~~~~~~~~~~~~-~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
.... .............+....+.. .+..+.+++.+||+.+|++|||+.|+++
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 222 LLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred HhCCCchHHHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 0000 000000000011111122222 4677999999999999999999999986
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=274.48 Aligned_cols=253 Identities=23% Similarity=0.249 Sum_probs=190.4
Q ss_pred CccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHH-HhcCCCCcccceeeEEEe
Q 020641 17 PGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSV-VSRLKHENLVELLGYCVE 95 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~-l~~l~h~~i~~~~~~~~~ 95 (323)
+.....||.|+||.||++.+..+++.+|+|....... ......+..|+.. ++..+|+||+++++++..
T Consensus 3 ~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-----------~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~ 71 (283)
T cd06617 3 LEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVN-----------SQEQKRLLMDLDISMRSVDCPYTVTFYGALFR 71 (283)
T ss_pred ceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCC-----------cHHHHHHHHHHHHHHHHcCCCCeeeeeEEEec
Confidence 4566789999999999999999999999996643211 1112344455554 555699999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeE
Q 020641 96 GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKA 175 (323)
Q Consensus 96 ~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~ 175 (323)
++..+++|||+++ +|.+++....... ..+++..++.++.|++.|+.|||+++ +++|+||||+||+++.++.+
T Consensus 72 ~~~~~lv~e~~~~-~l~~~l~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~ 143 (283)
T cd06617 72 EGDVWICMEVMDT-SLDKFYKKVYDKG-----LTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQV 143 (283)
T ss_pred CCcEEEEhhhhcc-cHHHHHHHhccCC-----CCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCE
Confidence 9999999999974 8888876532211 13899999999999999999999843 89999999999999999999
Q ss_pred EEeeccccCCCCccccccccccccCccccCCCccccC----CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhh
Q 020641 176 KIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT----GQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVT 251 (323)
Q Consensus 176 ~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~----~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~ 251 (323)
+|+|||.+....... ......++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||........
T Consensus 144 kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~----- 215 (283)
T cd06617 144 KLCDFGISGYLVDSV---AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQ----- 215 (283)
T ss_pred EEeeccccccccccc---ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHH-----
Confidence 999999987653321 1122347888999998764 4568899999999999999999999964321111
Q ss_pred hhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 252 WATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
.+...+............+.++.+++.+||..+|++|||+.++++
T Consensus 216 ---------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 216 ---------QLKQVVEEPSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred ---------HHHHHHhcCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 111111111111111234667999999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=269.15 Aligned_cols=254 Identities=21% Similarity=0.270 Sum_probs=199.2
Q ss_pred CccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeC
Q 020641 17 PGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEG 96 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 96 (323)
|....+||+|++|.||++.+..+++.+++|........ ......+.+|+++++.++|+||+++++++...
T Consensus 2 y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~----------~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~ 71 (264)
T cd06626 2 WQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND----------PKTIKEIADEMKVLELLKHPNLVKYYGVEVHR 71 (264)
T ss_pred ceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc----------hHHHHHHHHHHHHHHhCCCCChhheeeeEecC
Confidence 45667899999999999999988899999876433111 23447789999999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEE
Q 020641 97 NLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAK 176 (323)
Q Consensus 97 ~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~ 176 (323)
+..++|+||+.+++|.+++..... +++..+..++.|++.|+.+||+. |++|+||+|+||+++.++.++
T Consensus 72 ~~~~lv~e~~~~~~L~~~~~~~~~---------~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~k 139 (264)
T cd06626 72 EKVYIFMEYCSGGTLEELLEHGRI---------LDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIK 139 (264)
T ss_pred CEEEEEEecCCCCcHHHHHhhcCC---------CChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEE
Confidence 999999999999999999976432 77888999999999999999999 999999999999999999999
Q ss_pred EeeccccCCCCccccccc--cccccCccccCCCccccCCC---CCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhh
Q 020641 177 IADFNLSNQAPDMAARLH--STRVLGTFGYHAPEYAMTGQ---LTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVT 251 (323)
Q Consensus 177 l~Dfg~~~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~---~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~ 251 (323)
|+|||++........... .....++..|+|||.+.+.. .+.++||||||+++|++++|..||.......... .
T Consensus 140 l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~--~ 217 (264)
T cd06626 140 LGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIM--F 217 (264)
T ss_pred EcccccccccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHH--H
Confidence 999999876644322111 11234688999999987665 7889999999999999999999997543211100 0
Q ss_pred hhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 252 WATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
.... ............+..+.+++.+||+.+|.+|||+.+++.
T Consensus 218 ~~~~-----------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 218 HVGA-----------GHKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred HHhc-----------CCCCCCCcccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0000 000000111223667899999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=274.95 Aligned_cols=249 Identities=23% Similarity=0.285 Sum_probs=194.8
Q ss_pred CCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEe
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVE 95 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 95 (323)
.|.....||.|+||.||++++..+++.+++|+....... .....+.+.+|+++++.++|+||+++++++..
T Consensus 16 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~---------~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~ 86 (307)
T cd06607 16 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQ---------SNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLR 86 (307)
T ss_pred hhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccC---------cHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEe
Confidence 356667899999999999999988999998866422111 11123567889999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeE
Q 020641 96 GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKA 175 (323)
Q Consensus 96 ~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~ 175 (323)
.+..++|+||+.+ ++.+++..... .+++..+..++.|++.|+.|||+. |++|+||+|+||+++.++.+
T Consensus 87 ~~~~~lv~e~~~g-~l~~~~~~~~~--------~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~ 154 (307)
T cd06607 87 EHTAWLVMEYCLG-SASDILEVHKK--------PLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTV 154 (307)
T ss_pred CCeEEEEHHhhCC-CHHHHHHHccc--------CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCE
Confidence 9999999999975 78777754322 288999999999999999999999 99999999999999999999
Q ss_pred EEeeccccCCCCccccccccccccCccccCCCcccc---CCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhh
Q 020641 176 KIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAM---TGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTW 252 (323)
Q Consensus 176 ~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 252 (323)
+|+|||++...... ....++..|+|||.+. ...++.++||||||+++|+|++|..||.............
T Consensus 155 kL~dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~- 227 (307)
T cd06607 155 KLADFGSASLVSPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA- 227 (307)
T ss_pred EEeecCcceecCCC------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHh-
Confidence 99999988654321 2234778899999874 3567889999999999999999999996543211110000
Q ss_pred hcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHH
Q 020641 253 ATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKA 306 (323)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~ 306 (323)
...........++..+.+++.+||+.+|++|||+.+|+..
T Consensus 228 --------------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 228 --------------QNDSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred --------------cCCCCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 0000111123456789999999999999999999999873
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=273.38 Aligned_cols=272 Identities=20% Similarity=0.306 Sum_probs=207.6
Q ss_pred CCCccccccCCCCC--ccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcC
Q 020641 4 DYHPRALGAHAPSP--GYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRL 81 (323)
Q Consensus 4 ~~~~~~~~~~~~~~--~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l 81 (323)
+|||..+|....+. .+++|||.|.|+|||+|.|.+++++||+|+.. +.+.+.+....|+++|+++
T Consensus 65 GYHpV~IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvK-------------SAqhYtEaAlDEIklL~~v 131 (590)
T KOG1290|consen 65 GYHPVRIGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVK-------------SAQHYTEAALDEIKLLQQV 131 (590)
T ss_pred CCceeeccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEe-------------hhhHHHHHHHHHHHHHHHH
Confidence 79999999998744 44459999999999999999999999999664 4466778889999999888
Q ss_pred -CC-------CcccceeeEEE----eCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHh
Q 020641 82 -KH-------ENLVELLGYCV----EGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYL 149 (323)
Q Consensus 82 -~h-------~~i~~~~~~~~----~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~l 149 (323)
.+ .+||+++++|. .+.+.+||+|++.. +|..+|.....+. ++...+++|++|++.||.||
T Consensus 132 ~~~Dp~~~~~~~VV~LlD~FkhsGpNG~HVCMVfEvLGd-nLLklI~~s~YrG-------lpl~~VK~I~~qvL~GLdYL 203 (590)
T KOG1290|consen 132 REGDPNDPGKKCVVQLLDHFKHSGPNGQHVCMVFEVLGD-NLLKLIKYSNYRG-------LPLSCVKEICRQVLTGLDYL 203 (590)
T ss_pred HhcCCCCCCCceeeeeeccceecCCCCcEEEEEehhhhh-HHHHHHHHhCCCC-------CcHHHHHHHHHHHHHHHHHH
Confidence 32 37999999997 45689999999965 9999998887665 99999999999999999999
Q ss_pred hcCCCCCceeCCCCCCCEEEccC---------------------------------------------------------
Q 020641 150 HEKVQPSIIHRDIRSSNVLLFED--------------------------------------------------------- 172 (323)
Q Consensus 150 h~~~~~~i~h~dikp~nili~~~--------------------------------------------------------- 172 (323)
|..| ||+|-||||+|||+..+
T Consensus 204 H~ec--gIIHTDlKPENvLl~~~e~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~ 281 (590)
T KOG1290|consen 204 HREC--GIIHTDLKPENVLLCSTEIDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQA 281 (590)
T ss_pred HHhc--CccccCCCcceeeeeccccchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhh
Confidence 9999 99999999999999400
Q ss_pred --------------------------------------------------------------------------------
Q 020641 173 -------------------------------------------------------------------------------- 172 (323)
Q Consensus 173 -------------------------------------------------------------------------------- 172 (323)
T Consensus 282 ~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~ 361 (590)
T KOG1290|consen 282 KKLEASLAGLEGIEEEPNQESYNNEPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPS 361 (590)
T ss_pred hhhhhhhcccccccccccccccccccCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccc
Confidence
Q ss_pred -----------------------------CeEEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHH
Q 020641 173 -----------------------------FKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYS 223 (323)
Q Consensus 173 -----------------------------~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~s 223 (323)
-++||.|||-|+-..... +..+.|.-|+|||++.+..|+..+||||
T Consensus 362 ~~~~~s~~s~~~~~~n~~v~p~~~~~~~di~vKIaDlGNACW~~khF-----T~DIQTRQYRapEVllGsgY~~~ADiWS 436 (590)
T KOG1290|consen 362 DGSLSSPSSPGTIASNPLVNPDIPLPECDIRVKIADLGNACWVHKHF-----TEDIQTRQYRAPEVLLGSGYSTSADIWS 436 (590)
T ss_pred cccccCcCCccccccccccCCCCCCCccceeEEEeeccchhhhhhhh-----chhhhhhhccCcceeecCCCCCchhHHH
Confidence 014555555554332221 2223577899999999999999999999
Q ss_pred HHHHHHHHHhCCCCCCCCCCcc----cchhhhhhc------------cccc------cccc-----------chhcCCCc
Q 020641 224 FGVVLLELLTGRKPVDHTMPRG----QQSLVTWAT------------PRLS------EDKV-----------KQCVDPKL 270 (323)
Q Consensus 224 lG~~l~~l~~g~~pf~~~~~~~----~~~~~~~~~------------~~~~------~~~~-----------~~~~~~~~ 270 (323)
++|++|||+||.+.|+...... ++.....+. .+.+ ...+ .+++..
T Consensus 437 ~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~e-- 514 (590)
T KOG1290|consen 437 TACMAFELATGDYLFEPHSGENYSRDEDHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIE-- 514 (590)
T ss_pred HHHHHHHhhcCceeecCCCCCCCCccHHHHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHH--
Confidence 9999999999999997554321 111111000 0000 0000 000000
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 271 KGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 271 ~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
.-.++.+...++.+|+.-||+.+|++||||.++++
T Consensus 515 KY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~cl~ 549 (590)
T KOG1290|consen 515 KYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQCLK 549 (590)
T ss_pred HhCCCHHHHHHHHHHHHHHHhcCccccccHHHHhc
Confidence 12455677889999999999999999999999996
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=268.25 Aligned_cols=253 Identities=21% Similarity=0.269 Sum_probs=204.1
Q ss_pred CccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeC
Q 020641 17 PGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEG 96 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 96 (323)
+.....||+|++|.||.+.+..+++.+++|+....... ....+.+.+|++.+++++|+||+++++.+...
T Consensus 2 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~----------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (260)
T cd06606 2 WTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS----------EEELEALEREIRILSSLQHPNIVRYYGSERDE 71 (260)
T ss_pred ceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccc----------hHHHHHHHHHHHHHHHcCCCCEeeEEEEEecC
Confidence 34456799999999999999988999998866533211 23347788999999999999999999999988
Q ss_pred --CeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCe
Q 020641 97 --NLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFK 174 (323)
Q Consensus 97 --~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~ 174 (323)
...++++||+.+++|.+++..... +++..+..++.|++.++.|||+. |++|+||+|+||+++.++.
T Consensus 72 ~~~~~~lv~e~~~~~~L~~~~~~~~~---------~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~ 139 (260)
T cd06606 72 EKNTLNIFLEYVSGGSLSSLLKKFGK---------LPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGV 139 (260)
T ss_pred CCCeEEEEEEecCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCC
Confidence 889999999999999999976541 89999999999999999999999 9999999999999999999
Q ss_pred EEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhc
Q 020641 175 AKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWAT 254 (323)
Q Consensus 175 ~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~ 254 (323)
++|+|||.+................++..|++||...+...+.++|+||||+++++|++|..||........
T Consensus 140 ~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-------- 211 (260)
T cd06606 140 VKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMA-------- 211 (260)
T ss_pred EEEcccccEEecccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHH--------
Confidence 999999998766554321112334578899999999888889999999999999999999999976541100
Q ss_pred ccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 255 PRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
..............+...+..+.+++.+||..||++||++.+++.
T Consensus 212 ------~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 212 ------ALYKIGSSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred ------HHHhccccCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 001111111122334445678999999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=269.43 Aligned_cols=251 Identities=21% Similarity=0.285 Sum_probs=202.6
Q ss_pred CccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeC
Q 020641 17 PGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEG 96 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 96 (323)
++....||.|++|.||+|++..+++.+++|....... ......+.+|++.++.++|+|++++++++..+
T Consensus 3 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~-----------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (264)
T cd06623 3 LERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGD-----------EEFRKQLLRELKTLRSCESPYVVKCYGAFYKE 71 (264)
T ss_pred ceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcc-----------hHHHHHHHHHHHHHHhcCCCCeeeEEEEEccC
Confidence 4566789999999999999999999999886543211 12347788999999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCCCceeCCCCCCCEEEccCCeE
Q 020641 97 NLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHE-KVQPSIIHRDIRSSNVLLFEDFKA 175 (323)
Q Consensus 97 ~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~-~~~~~i~h~dikp~nili~~~~~~ 175 (323)
+..++|+||+.+++|.+++.... .++...+..++.|++.|+.+||+ . +++|+||+|+||+++.++.+
T Consensus 72 ~~~~lv~e~~~~~~L~~~l~~~~---------~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~ 139 (264)
T cd06623 72 GEISIVLEYMDGGSLADLLKKVG---------KIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEV 139 (264)
T ss_pred CeEEEEEEecCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCE
Confidence 99999999999999999997652 28999999999999999999999 9 99999999999999999999
Q ss_pred EEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhcc
Q 020641 176 KIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATP 255 (323)
Q Consensus 176 ~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~ 255 (323)
+|+|||.+......... .....++..|+|||.+.+..++.++|+||||+++|+|++|..||.............
T Consensus 140 ~l~df~~~~~~~~~~~~--~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~---- 213 (264)
T cd06623 140 KIADFGISKVLENTLDQ--CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQ---- 213 (264)
T ss_pred EEccCccceecccCCCc--ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHH----
Confidence 99999998765432221 123346888999999988888999999999999999999999997654211111111
Q ss_pred cccccccchhcCCCcCCCCCHH-HHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 256 RLSEDKVKQCVDPKLKGEYPPK-GVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
... .......+.. .+..+.+++.+||+.+|++|||+.++++
T Consensus 214 --------~~~-~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~ 255 (264)
T cd06623 214 --------AIC-DGPPPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQ 255 (264)
T ss_pred --------HHh-cCCCCCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 111 1111122233 5678999999999999999999999997
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=274.91 Aligned_cols=255 Identities=24% Similarity=0.295 Sum_probs=198.0
Q ss_pred CccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeC
Q 020641 17 PGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEG 96 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 96 (323)
+....+||+|+||.||++++..++..+++|........ .......+.+|+++++.++|+|++++++++..+
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~---------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 97 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQ---------SNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLRE 97 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCC---------chHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeC
Confidence 44555899999999999999999999999865432111 112235678899999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEE
Q 020641 97 NLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAK 176 (323)
Q Consensus 97 ~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~ 176 (323)
...++||||+.+ +|.+.+..... .+++..+..++.|++.|+.|||+. |++|+||+|+||+++.++.++
T Consensus 98 ~~~~lv~e~~~g-~l~~~~~~~~~--------~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~k 165 (317)
T cd06635 98 HTAWLVMEYCLG-SASDLLEVHKK--------PLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVK 165 (317)
T ss_pred CeEEEEEeCCCC-CHHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEE
Confidence 999999999975 88887754332 288999999999999999999999 999999999999999999999
Q ss_pred EeeccccCCCCccccccccccccCccccCCCcccc---CCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhh
Q 020641 177 IADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAM---TGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWA 253 (323)
Q Consensus 177 l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 253 (323)
|+|||++...... ....++..|+|||.+. ...++.++|+||||+++|+|++|..||.........
T Consensus 166 l~dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~------ 233 (317)
T cd06635 166 LADFGSASIASPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL------ 233 (317)
T ss_pred EecCCCccccCCc------ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHH------
Confidence 9999987654321 2334788899999874 356788999999999999999999998654221111
Q ss_pred cccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhhcC
Q 020641 254 TPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKS 313 (323)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~~~ 313 (323)
..+.............+..+.+++.+||+.+|.+||++.++++.+-.+...
T Consensus 234 ---------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~ 284 (317)
T cd06635 234 ---------YHIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRER 284 (317)
T ss_pred ---------HHHHhccCCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccC
Confidence 111111111112234556799999999999999999999999865544433
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=270.13 Aligned_cols=247 Identities=20% Similarity=0.237 Sum_probs=188.7
Q ss_pred cccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHH-hcCCCCcccceeeEEEeCCeE
Q 020641 21 VRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVV-SRLKHENLVELLGYCVEGNLR 99 (323)
Q Consensus 21 ~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l-~~l~h~~i~~~~~~~~~~~~~ 99 (323)
..||.|++|.||+|.+..+++.+++|...+..... ......+..|..++ ...+|+|++++++.+..++..
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~---------~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~ 72 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIA---------KNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYL 72 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhH---------HHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeE
Confidence 46899999999999999999999998664321111 01112234444444 444899999999999999999
Q ss_pred EEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEEEee
Q 020641 100 VLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIAD 179 (323)
Q Consensus 100 ~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~l~D 179 (323)
++|+||+.+++|.+++..... ++...+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|
T Consensus 73 ~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~d 140 (260)
T cd05611 73 YLVMEYLNGGDCASLIKTLGG---------LPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTD 140 (260)
T ss_pred EEEEeccCCCCHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEee
Confidence 999999999999999976432 88899999999999999999999 999999999999999999999999
Q ss_pred ccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccccc
Q 020641 180 FNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSE 259 (323)
Q Consensus 180 fg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 259 (323)
||++..... .....++..|+|||.+.+..++.++|+||||+++|+|++|..||............. ..
T Consensus 141 fg~~~~~~~------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~--~~---- 208 (260)
T cd05611 141 FGLSRNGLE------NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNIL--SR---- 208 (260)
T ss_pred cccceeccc------cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH--hc----
Confidence 998765432 123347888999999988888999999999999999999999997543211100000 00
Q ss_pred cccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHH
Q 020641 260 DKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKAL 307 (323)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l 307 (323)
............+..+.+++.+||+.+|++|||+.++.+.|
T Consensus 209 -------~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l 249 (260)
T cd05611 209 -------RINWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIK 249 (260)
T ss_pred -------ccCCCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHH
Confidence 00001112224567799999999999999999876555544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-38 Score=272.15 Aligned_cols=261 Identities=23% Similarity=0.307 Sum_probs=199.1
Q ss_pred cccccCCCCCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcC-CCCcc
Q 020641 8 RALGAHAPSPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRL-KHENL 86 (323)
Q Consensus 8 ~~~~~~~~~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i 86 (323)
..++.....|....+||.|+||.||++.+..+++.+++|+.... ......+.+|+.+++++ +|+|+
T Consensus 15 ~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~-------------~~~~~~~~~e~~~l~~l~~h~ni 81 (291)
T cd06639 15 ESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPI-------------SDVDEEIEAEYNILQSLPNHPNV 81 (291)
T ss_pred ccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccc-------------ccHHHHHHHHHHHHHHhcCCCCe
Confidence 44556566677778999999999999999999999998865421 12235667889999988 89999
Q ss_pred cceeeEEEeC-----CeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCC
Q 020641 87 VELLGYCVEG-----NLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRD 161 (323)
Q Consensus 87 ~~~~~~~~~~-----~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~d 161 (323)
+++++++... ...++|+||+.+++|.+++...... ...+++..++.++.|++.|+.+||+. |++|+|
T Consensus 82 ~~~~~~~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~-----~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~d 153 (291)
T cd06639 82 VKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLIC-----GQRLDEAMISYILYGALLGLQHLHNN---RIIHRD 153 (291)
T ss_pred EEEEEEEEeccccCCCeeEEEEEECCCCcHHHHHHHhhhc-----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccC
Confidence 9999998754 3589999999999999988642211 11288999999999999999999999 999999
Q ss_pred CCCCCEEEccCCeEEEeeccccCCCCccccccccccccCccccCCCccccCC-----CCCcccchHHHHHHHHHHHhCCC
Q 020641 162 IRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG-----QLTQKSDVYSFGVVLLELLTGRK 236 (323)
Q Consensus 162 ikp~nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-----~~~~~~Di~slG~~l~~l~~g~~ 236 (323)
|||+||+++.++.++|+|||++......... .....|+..|+|||.+... .++.++|+||||+++|+|++|+.
T Consensus 154 lkp~nili~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~ 231 (291)
T cd06639 154 VKGNNILLTTEGGVKLVDFGVSAQLTSTRLR--RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDP 231 (291)
T ss_pred CCHHHEEEcCCCCEEEeecccchhccccccc--ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCC
Confidence 9999999999999999999998765432211 1233478889999987543 36789999999999999999999
Q ss_pred CCCCCCCcccchhhhhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 237 PVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 237 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
||......... ..+... ..+. ...+...+..+.+++.+||+.+|++|||+.|+++
T Consensus 232 p~~~~~~~~~~--~~~~~~----------~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 232 PLFDMHPVKTL--FKIPRN----------PPPT--LLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred CCCCCcHHHHH--HHHhcC----------CCCC--CCcccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 99754321110 000000 0000 0112334557999999999999999999999986
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=293.88 Aligned_cols=281 Identities=15% Similarity=0.139 Sum_probs=187.4
Q ss_pred CCccccccCCCCCCccceeccceeee-eeeeccccccc-----cCccccccccCCCCCchHHHHHHHHHhcCCCCcccce
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRVKMRR-WLCCTCQVEES-----YPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVEL 89 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~~~~~-~~~~k~~~~~~-----~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~ 89 (323)
.|..+.+||+|+||+||++....... ..+.|...... ......+...........+.+|+.++++++|+||+++
T Consensus 149 ~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l 228 (501)
T PHA03210 149 HFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILKI 228 (501)
T ss_pred ccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcCcE
Confidence 46666799999999999987543322 11111100000 0000011111222334567899999999999999999
Q ss_pred eeEEEeCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEE
Q 020641 90 LGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLL 169 (323)
Q Consensus 90 ~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili 169 (323)
++++...+..|++++++.+ +|.+++........ .......+..++.|++.||.|||+. ||+||||||+|||+
T Consensus 229 ~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~----~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NILl 300 (501)
T PHA03210 229 EEILRSEANTYMITQKYDF-DLYSFMYDEAFDWK----DRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFL 300 (501)
T ss_pred eEEEEECCeeEEEEecccc-CHHHHHhhcccccc----ccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEE
Confidence 9999999999999999965 78887754432110 1144567888999999999999999 99999999999999
Q ss_pred ccCCeEEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCC-CCCCCCcccch
Q 020641 170 FEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP-VDHTMPRGQQS 248 (323)
Q Consensus 170 ~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p-f~~~~~~~~~~ 248 (323)
+.++.++|+|||++......... ......|+..|+|||++.+..++.++|||||||++|+|++|..+ |..........
T Consensus 301 ~~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~ 379 (501)
T PHA03210 301 NCDGKIVLGDFGTAMPFEKEREA-FDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQ 379 (501)
T ss_pred CCCCCEEEEeCCCceecCccccc-ccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHH
Confidence 99999999999999765432221 12234589999999999999999999999999999999998764 43222111111
Q ss_pred hhhhhc------ccccc--cccchhcCCCcCC----CC-----CHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 249 LVTWAT------PRLSE--DKVKQCVDPKLKG----EY-----PPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 249 ~~~~~~------~~~~~--~~~~~~~~~~~~~----~~-----~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
...... ...+. ..+...++..... .. ....+.++.+++.+||+.||.+|||+.|+++
T Consensus 380 ~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~ 453 (501)
T PHA03210 380 LLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA 453 (501)
T ss_pred HHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence 111000 00000 0011111100000 00 0112346788899999999999999999986
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=269.16 Aligned_cols=251 Identities=24% Similarity=0.342 Sum_probs=201.8
Q ss_pred CccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeC
Q 020641 17 PGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEG 96 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 96 (323)
|....+||.|++|.||++++..+++.+++|........ ......+.+|++++++++|+||+++++++...
T Consensus 2 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~----------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (256)
T cd08530 2 FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMS----------QKEREDAVNEIRILASVNHPNIISYKEAFLDG 71 (256)
T ss_pred ceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhcc----------HHHHHHHHHHHHHHHhCCCCCchhhhhhhccC
Confidence 45667899999999999999989888888865432211 12235667899999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEE
Q 020641 97 NLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAK 176 (323)
Q Consensus 97 ~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~ 176 (323)
...++|+||+.+++|.+++.+.... ...+++..++.++.|++.|+.+||+. |++|+||+|+||+++.++.++
T Consensus 72 ~~~~~v~e~~~~~~L~~~~~~~~~~-----~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~k 143 (256)
T cd08530 72 NKLCIVMEYAPFGDLSKAISKRKKK-----RKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVK 143 (256)
T ss_pred CEEEEEehhcCCCCHHHHHHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEE
Confidence 9999999999999999998663211 12388899999999999999999999 999999999999999999999
Q ss_pred EeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhccc
Q 020641 177 IADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPR 256 (323)
Q Consensus 177 l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 256 (323)
|+|||++....... .....++..|++||.+.+..++.++|+||||+++++|++|+.||........
T Consensus 144 l~d~g~~~~~~~~~----~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~---------- 209 (256)
T cd08530 144 IGDLGISKVLKKNM----AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDL---------- 209 (256)
T ss_pred EeeccchhhhccCC----cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH----------
Confidence 99999987665431 1223478899999999888889999999999999999999999975532111
Q ss_pred ccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 257 LSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
...+........+...+.++.+++.+||+.+|++|||+.++++
T Consensus 210 ------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 210 ------RYKVQRGKYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred ------HHHHhcCCCCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 1111111112233456678999999999999999999999986
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=275.95 Aligned_cols=272 Identities=17% Similarity=0.260 Sum_probs=196.2
Q ss_pred cCCCCCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceee
Q 020641 12 AHAPSPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLG 91 (323)
Q Consensus 12 ~~~~~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~ 91 (323)
.....|....+||.|+||.||++.+..+++.+++|...... ........+.+|++++++++||||+++++
T Consensus 9 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~----------~~~~~~~~~~~e~~~l~~l~h~~iv~~~~ 78 (310)
T cd07865 9 DEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMEN----------EKEGFPITALREIKILQLLKHENVVNLIE 78 (310)
T ss_pred chhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccC----------CcCCchhHHHHHHHHHHhCCCCCccceEE
Confidence 33445677779999999999999999999999998664321 11223345678999999999999999999
Q ss_pred EEEeCC--------eEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCC
Q 020641 92 YCVEGN--------LRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIR 163 (323)
Q Consensus 92 ~~~~~~--------~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dik 163 (323)
++.... ..++||||+.+ +|.+++...... +++..+..++.|++.|+.|||+. |++|+||+
T Consensus 79 ~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~--------~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~ 146 (310)
T cd07865 79 ICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVK--------FTLSEIKKVMKMLLNGLYYIHRN---KILHRDMK 146 (310)
T ss_pred EEecccccccCCCceEEEEEcCCCc-CHHHHHHhcccC--------CCHHHHHHHHHHHHHHHHHHHHC---CeeccCCC
Confidence 987543 45999999975 888888654321 89999999999999999999999 99999999
Q ss_pred CCCEEEccCCeEEEeeccccCCCCccccc--cccccccCccccCCCccccCC-CCCcccchHHHHHHHHHHHhCCCCCCC
Q 020641 164 SSNVLLFEDFKAKIADFNLSNQAPDMAAR--LHSTRVLGTFGYHAPEYAMTG-QLTQKSDVYSFGVVLLELLTGRKPVDH 240 (323)
Q Consensus 164 p~nili~~~~~~~l~Dfg~~~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~ 240 (323)
|+||+++.++.++|+|||.+......... .......++..|+|||.+.+. .++.++|+||||+++|+|++|..||..
T Consensus 147 p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~ 226 (310)
T cd07865 147 AANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQG 226 (310)
T ss_pred HHHEEECCCCcEEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCC
Confidence 99999999999999999998765432211 111223467889999987654 368899999999999999999999976
Q ss_pred CCCcccchhhhhhcccccccccchhc-----C-CCcCCCC---------CHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 241 TMPRGQQSLVTWATPRLSEDKVKQCV-----D-PKLKGEY---------PPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~-----~-~~~~~~~---------~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
.................+........ + ....... +...+..+.+++.+||..||++|||+.++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 227 NTEQHQLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred CCHHHHHHHHHHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 54322211111111111111000000 0 0000000 0012346789999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=287.92 Aligned_cols=246 Identities=23% Similarity=0.327 Sum_probs=206.9
Q ss_pred ccCCCCCCccceecccee---eeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeCCe
Q 020641 22 RLDKGPEDDLYLKKRVKM---RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNL 98 (323)
Q Consensus 22 ~lg~G~~~~V~~~~~~~~---~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 98 (323)
+||+|.||.||.+.+... ..-||+||+...... ....+|.+|+.+|.+|+|+|++++|+++.+ ..
T Consensus 117 ~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~-----------~~mddflrEas~M~~L~H~hliRLyGvVl~-qp 184 (1039)
T KOG0199|consen 117 LLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLN-----------AIMDDFLREASHMLKLQHPHLIRLYGVVLD-QP 184 (1039)
T ss_pred HhcCcceeeEeeccccCCCCcEEeEEEEeccCCccc-----------hhHHHHHHHHHHHHhccCcceeEEeeeecc-ch
Confidence 789999999999998863 234888877533211 145899999999999999999999999998 66
Q ss_pred EEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEEEe
Q 020641 99 RVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIA 178 (323)
Q Consensus 99 ~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~l~ 178 (323)
..+|||.+..|||.+.+.+.... .|.....-.++.||+.|+.||..+ +++|||+..+|+++...-.+||+
T Consensus 185 ~mMV~ELaplGSLldrLrka~~~-------~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~ 254 (1039)
T KOG0199|consen 185 AMMVFELAPLGSLLDRLRKAKKA-------ILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKIC 254 (1039)
T ss_pred hhHHhhhcccchHHHHHhhcccc-------ceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeee
Confidence 78999999999999999883322 288888899999999999999999 99999999999999998899999
Q ss_pred eccccCCCCccccccccc-cccCccccCCCccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhccc
Q 020641 179 DFNLSNQAPDMAARLHST-RVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPR 256 (323)
Q Consensus 179 Dfg~~~~~~~~~~~~~~~-~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~ 256 (323)
|||+.+.+.......... ...-...|+|||.+....++.++|+|++|+++||||+ |+.||.+..
T Consensus 255 DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~-------------- 320 (1039)
T KOG0199|consen 255 DFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCR-------------- 320 (1039)
T ss_pred cccceeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCC--------------
Confidence 999998776543332222 2224668999999999999999999999999999998 999997553
Q ss_pred ccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 257 LSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
...+.+.+|..-+-..+..|+++++++++.||..+|++|||+.+|.+
T Consensus 321 --g~qIL~~iD~~erLpRPk~csedIY~imk~cWah~paDRptFsair~ 367 (1039)
T KOG0199|consen 321 --GIQILKNIDAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRE 367 (1039)
T ss_pred --HHHHHHhccccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHH
Confidence 34455566666667788999999999999999999999999999974
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=277.54 Aligned_cols=263 Identities=19% Similarity=0.257 Sum_probs=192.7
Q ss_pred cccCCC--CCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeCCe
Q 020641 21 VRLDKG--PEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNL 98 (323)
Q Consensus 21 ~~lg~G--~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 98 (323)
..||.| +||+||++++..+++.+|+|+....... ....+.+.+|+.+++.++|+||+++++++..+..
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~----------~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~ 73 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCT----------EEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSW 73 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCC----------HHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCc
Confidence 356666 8899999999999999999976532111 1123677889999999999999999999999999
Q ss_pred EEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEEEe
Q 020641 99 RVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIA 178 (323)
Q Consensus 99 ~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~l~ 178 (323)
.++|+||+.+++|.+++...... .+++..+..++.|++.||.|||+. |++|+||||+||+++.++.++++
T Consensus 74 ~~~v~e~~~~~~l~~~l~~~~~~-------~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~ 143 (328)
T cd08226 74 LWVISPFMAYGSANSLLKTYFPE-------GMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLS 143 (328)
T ss_pred eEEEEecccCCCHHHHHHhhccc-------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEe
Confidence 99999999999999998765322 188889999999999999999999 99999999999999999999999
Q ss_pred eccccCCCCcccccc-----ccccccCccccCCCccccC--CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhh
Q 020641 179 DFNLSNQAPDMAARL-----HSTRVLGTFGYHAPEYAMT--GQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVT 251 (323)
Q Consensus 179 Dfg~~~~~~~~~~~~-----~~~~~~g~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~ 251 (323)
||+.+.......... ......++..|+|||.+.+ ..++.++|||||||++|+|++|..||......... ..
T Consensus 144 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~--~~ 221 (328)
T cd08226 144 GLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQML--LQ 221 (328)
T ss_pred chHHHhhhhccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHH--HH
Confidence 997543221111000 0011124567999999876 34788999999999999999999999755321110 00
Q ss_pred hhcc-c----------------------cc----ccc-----cchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCC
Q 020641 252 WATP-R----------------------LS----EDK-----VKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPN 299 (323)
Q Consensus 252 ~~~~-~----------------------~~----~~~-----~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps 299 (323)
.... . .. ... .................+..+.+|+.+||+.||++|||
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt 301 (328)
T cd08226 222 KLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPS 301 (328)
T ss_pred HhcCCCCCCccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCC
Confidence 0000 0 00 000 00011111222233456788999999999999999999
Q ss_pred hHHHHH
Q 020641 300 MSIVVK 305 (323)
Q Consensus 300 ~~evl~ 305 (323)
+.|+++
T Consensus 302 a~e~l~ 307 (328)
T cd08226 302 ASSLLS 307 (328)
T ss_pred HHHHhh
Confidence 999974
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-38 Score=271.86 Aligned_cols=266 Identities=17% Similarity=0.194 Sum_probs=194.7
Q ss_pred CCCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEE
Q 020641 15 PSPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCV 94 (323)
Q Consensus 15 ~~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 94 (323)
.+|.....||+|+||.||++.+..+++.+++|....+. .......+.+|+.+++.++|+||+++++++.
T Consensus 5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~-----------~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~ 73 (291)
T cd07870 5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKT-----------EEGVPFTAIREASLLKGLKHANIVLLHDIIH 73 (291)
T ss_pred ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccC-----------cCCCcHHHHHHHHHHHhcCCCCEeEEEEEEe
Confidence 45666779999999999999999988889998664321 1222346678999999999999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCe
Q 020641 95 EGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFK 174 (323)
Q Consensus 95 ~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~ 174 (323)
.+...++|+||+. +++.+++...... +.+..+..++.|++.||.|||+. |++|+||||+||+++.++.
T Consensus 74 ~~~~~~lv~e~~~-~~l~~~~~~~~~~--------~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~ 141 (291)
T cd07870 74 TKETLTFVFEYMH-TDLAQYMIQHPGG--------LHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGE 141 (291)
T ss_pred cCCeEEEEEeccc-CCHHHHHHhCCCC--------CCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCc
Confidence 9999999999996 5888777544321 77788889999999999999999 9999999999999999999
Q ss_pred EEEeeccccCCCCccccccccccccCccccCCCccccCC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhh
Q 020641 175 AKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG-QLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWA 253 (323)
Q Consensus 175 ~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 253 (323)
++|+|||++......... .....++..|+|||.+.+. .++.++|+||||+++|+|++|..||.............+.
T Consensus 142 ~~l~Dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~ 219 (291)
T cd07870 142 LKLADFGLARAKSIPSQT--YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWT 219 (291)
T ss_pred EEEeccccccccCCCCCC--CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHH
Confidence 999999998754332211 1223468899999988753 5788999999999999999999999755432111111111
Q ss_pred cccccccc-------cchhcCCCcCCCC---------CHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 254 TPRLSEDK-------VKQCVDPKLKGEY---------PPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 254 ~~~~~~~~-------~~~~~~~~~~~~~---------~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
....+... ............. ....+..+.+++.+|+..||.+|||+.|++.
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 220 VLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred HcCCCChhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 00000000 0000000000000 0012457889999999999999999999875
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=270.77 Aligned_cols=247 Identities=20% Similarity=0.274 Sum_probs=189.8
Q ss_pred cCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeCCeEEEE
Q 020641 23 LDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLA 102 (323)
Q Consensus 23 lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 102 (323)
||+|+||.||++.+..+++.+|+|+..++........ .........+..++...|++|+.+++.+......++|
T Consensus 2 ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v 75 (278)
T cd05606 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGE------TLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFI 75 (278)
T ss_pred cccCCCeEEEEEEEecCCCEEEEEEeeccccccchhH------HHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEE
Confidence 7999999999999999999999998765432211110 0011112233445556899999999999999999999
Q ss_pred EeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEEEeeccc
Q 020641 103 YEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNL 182 (323)
Q Consensus 103 ~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~l~Dfg~ 182 (323)
|||+.+++|.+++.... .+++..+..++.|++.|+.|||+. +++|+||+|+||+++.++.++|+|||+
T Consensus 76 ~e~~~g~~L~~~l~~~~---------~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~ 143 (278)
T cd05606 76 LDLMNGGDLHYHLSQHG---------VFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGL 143 (278)
T ss_pred EecCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcC
Confidence 99999999999886543 289999999999999999999999 999999999999999999999999999
Q ss_pred cCCCCccccccccccccCccccCCCccccC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccccccc
Q 020641 183 SNQAPDMAARLHSTRVLGTFGYHAPEYAMT-GQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDK 261 (323)
Q Consensus 183 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 261 (323)
+....... .....|+..|+|||.+.+ ..++.++||||+|+++|+|++|..||........... ...
T Consensus 144 ~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~-~~~-------- 210 (278)
T cd05606 144 ACDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI-DRM-------- 210 (278)
T ss_pred ccccCccC----CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHH-HHH--------
Confidence 87553321 123358899999999874 3678999999999999999999999976532211110 000
Q ss_pred cchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCC-----ChHHHHH
Q 020641 262 VKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRP-----NMSIVVK 305 (323)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-----s~~evl~ 305 (323)
. .......+...+..+.+++.+||..+|.+|| ++.++++
T Consensus 211 ----~-~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 211 ----T-LTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred ----h-hccCCCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 0 0011122334467899999999999999999 9999986
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=268.49 Aligned_cols=251 Identities=22% Similarity=0.326 Sum_probs=198.4
Q ss_pred CccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeC
Q 020641 17 PGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEG 96 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 96 (323)
|.....||.|+||.||++.+..++..+++|........ ....+.+.+|+.+++.++|+||+++++.+..+
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~----------~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~ 71 (257)
T cd08225 2 YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMP----------VKEKEASKKEVILLAKMKHPNIVTFFASFQEN 71 (257)
T ss_pred ceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhcc----------chhhHHHHHHHHHHHhCCCCChhhhhheeccC
Confidence 44556899999999999999999988888865432111 11235678899999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCC-eE
Q 020641 97 NLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDF-KA 175 (323)
Q Consensus 97 ~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~-~~ 175 (323)
...++|+||+.+++|.+++.+.... .+++..+..++.|++.|+.|||+. +++|+||+|+||++++++ .+
T Consensus 72 ~~~~lv~e~~~~~~L~~~~~~~~~~-------~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~ 141 (257)
T cd08225 72 GRLFIVMEYCDGGDLMKRINRQRGV-------LFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVA 141 (257)
T ss_pred CeEEEEEecCCCCcHHHHHHhccCC-------CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeE
Confidence 9999999999999999999764322 278999999999999999999999 999999999999998885 46
Q ss_pred EEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhcc
Q 020641 176 KIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATP 255 (323)
Q Consensus 176 ~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~ 255 (323)
+|+|||.+......... .....|++.|+|||...+..++.++|+||||++++++++|..||........
T Consensus 142 ~l~d~~~~~~~~~~~~~--~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--------- 210 (257)
T cd08225 142 KLGDFGIARQLNDSMEL--AYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQL--------- 210 (257)
T ss_pred EecccccchhccCCccc--ccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHH---------
Confidence 99999988765432211 1223478899999998888889999999999999999999999964432111
Q ss_pred cccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 256 RLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
..+..... ........+..+.+++.+||..+|++|||+.|+++
T Consensus 211 ------~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 211 ------VLKICQGY-FAPISPNFSRDLRSLISQLFKVSPRDRPSITSILK 253 (257)
T ss_pred ------HHHHhccc-CCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 00111111 11122334567999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=272.39 Aligned_cols=265 Identities=18% Similarity=0.210 Sum_probs=197.2
Q ss_pred CccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeC
Q 020641 17 PGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEG 96 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 96 (323)
|....+||.|++|.||++.+..+++.+++|....+.. .......+.+|+++++.++|+|++++++++..+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~----------~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~ 70 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETE----------DEGVPSTAIREISLLKELNHPNIVRLLDVVHSE 70 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccc----------cccchhHHHHHHHHHHhcCCCCccCHhheeccC
Confidence 3556789999999999999998999999986643211 122335678899999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEE
Q 020641 97 NLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAK 176 (323)
Q Consensus 97 ~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~ 176 (323)
...++++||+. ++|.+++...... .+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++
T Consensus 71 ~~~~iv~e~~~-~~l~~~~~~~~~~-------~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~ 139 (283)
T cd07835 71 NKLYLVFEFLD-LDLKKYMDSSPLT-------GLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALK 139 (283)
T ss_pred CeEEEEEeccC-cCHHHHHhhCCCC-------CCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEE
Confidence 99999999996 5899998765421 288999999999999999999999 999999999999999999999
Q ss_pred EeeccccCCCCccccccccccccCccccCCCccccCC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhcc
Q 020641 177 IADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG-QLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATP 255 (323)
Q Consensus 177 l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~ 255 (323)
|+|||.+......... .....++..|+|||.+.+. .++.++|+||||+++|+|++|+.||.................
T Consensus 140 l~df~~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~ 217 (283)
T cd07835 140 LADFGLARAFGVPVRT--YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLG 217 (283)
T ss_pred EeecccccccCCCccc--cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence 9999998755332111 1222457889999987654 468899999999999999999999976543211111000000
Q ss_pred ccccc-------------ccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 256 RLSED-------------KVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 256 ~~~~~-------------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
..... ......... ........+..+.+++.+||+.+|.+|||++|+++
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 218 TPDEDVWPGVTSLPDYKPTFPKWARQD-LSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred CCChHHhhhhhhchhhhhhcccccccc-hhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 00000 000000000 01112234467999999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=272.65 Aligned_cols=265 Identities=18% Similarity=0.217 Sum_probs=199.4
Q ss_pred CccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeC
Q 020641 17 PGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEG 96 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 96 (323)
|.....||.|++|.||++.+..+++.+++|........ ......+.+|++++++++|+||+++++++..+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~----------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 70 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFES----------EGIPKTALREIKLLKELNHPNIIKLLDVFRHK 70 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEecccccc----------chhHHHHHHHHHHHHHhcCCCcchHHHhhccC
Confidence 34566899999999999999989998888855432111 12346788899999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEE
Q 020641 97 NLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAK 176 (323)
Q Consensus 97 ~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~ 176 (323)
...++|+||+.+ +|.+++..... .+++..+..++.|++.|+.+||+. +++|+||+|+||+++.++.++
T Consensus 71 ~~~~~v~e~~~~-~l~~~l~~~~~--------~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~ 138 (283)
T cd05118 71 GDLYLVFEFMDT-DLYKLIKDRQR--------GLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLK 138 (283)
T ss_pred CCEEEEEeccCC-CHHHHHHhhcc--------cCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEE
Confidence 999999999976 88888866432 188999999999999999999999 999999999999999999999
Q ss_pred EeeccccCCCCccccccccccccCccccCCCccccCC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhcc
Q 020641 177 IADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG-QLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATP 255 (323)
Q Consensus 177 l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~ 255 (323)
|+|||.+........ ......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||...+.............
T Consensus 139 l~df~~~~~~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~ 216 (283)
T cd05118 139 LADFGLARSFGSPVR--PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLG 216 (283)
T ss_pred EeeeeeeEecCCCcc--cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcC
Confidence 999999876644321 11223467889999988766 788999999999999999999999976543221111110000
Q ss_pred cccccccchhcC---------CCc----CCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 256 RLSEDKVKQCVD---------PKL----KGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 256 ~~~~~~~~~~~~---------~~~----~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
...........+ +.. ........+..+.+++.+||+.||.+||++.+++.
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 217 TPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred CCchHhcccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 000000000000 000 01112345678999999999999999999999986
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=272.41 Aligned_cols=269 Identities=16% Similarity=0.179 Sum_probs=194.7
Q ss_pred CccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcC-CCCcccceeeEEEe
Q 020641 17 PGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRL-KHENLVELLGYCVE 95 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~ 95 (323)
|.....||.|+||.||++.+..+++.+++|...... ........+.+|+.+++++ .|+||+++++++..
T Consensus 3 y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~----------~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~ 72 (295)
T cd07837 3 YEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEM----------DEEGIPPTALREISLLQMLSESIYIVRLLDVEHV 72 (295)
T ss_pred ceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhc----------cccCCchHHHHHHHHHHHccCCCCccceeeeEee
Confidence 455668999999999999999999999998654321 1123346678899999999 56999999999887
Q ss_pred CCe-----EEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEc
Q 020641 96 GNL-----RVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLF 170 (323)
Q Consensus 96 ~~~-----~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~ 170 (323)
... .|+||||+.+ +|.+++...... ....+++..+..++.|++.||.|||+. |++|+||+|+||+++
T Consensus 73 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~----~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~ 144 (295)
T cd07837 73 EEKNGKPSLYLVFEYLDS-DLKKFMDSNGRG----PGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVD 144 (295)
T ss_pred cCCCCCceEEEEeeccCc-CHHHHHHHhccc----CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEe
Confidence 655 7999999986 898888654321 112389999999999999999999999 999999999999999
Q ss_pred c-CCeEEEeeccccCCCCccccccccccccCccccCCCccccC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccch
Q 020641 171 E-DFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT-GQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQS 248 (323)
Q Consensus 171 ~-~~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~ 248 (323)
. ++.++|+|||.+......... .....+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||..........
T Consensus 145 ~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~ 222 (295)
T cd07837 145 KQKGLLKIADLGLGRAFSIPVKS--YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLL 222 (295)
T ss_pred cCCCeEEEeecccceecCCCccc--cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 8 889999999988754332111 122236788999998765 457899999999999999999999997654322111
Q ss_pred hhhhhcccccccccchhcC-------CC----cCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 249 LVTWATPRLSEDKVKQCVD-------PK----LKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~-------~~----~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
................... +. .........+..+.++|.+||..||.+|||+.|++.
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 223 HIFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred HHHHHhCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 1100000000000000000 00 000111235677999999999999999999999875
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=270.73 Aligned_cols=248 Identities=22% Similarity=0.288 Sum_probs=195.9
Q ss_pred cCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeCCeEEEE
Q 020641 23 LDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLA 102 (323)
Q Consensus 23 lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 102 (323)
||.|+||.||++++..+++.+++|....... ......+.+.+|++++++++|+||+++++.+..+...+++
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~---------~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 71 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADM---------IRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLV 71 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhh---------hhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEE
Confidence 6899999999999999899999996653321 1123346788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEEEeeccc
Q 020641 103 YEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNL 182 (323)
Q Consensus 103 ~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~l~Dfg~ 182 (323)
+||+.+++|.+++.+... +++..+..++.|++.||.+||+. |++|+||+|+||+++.++.++|+|||+
T Consensus 72 ~e~~~~~~L~~~l~~~~~---------~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~ 139 (265)
T cd05579 72 MEYLPGGDLASLLENVGS---------LDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGL 139 (265)
T ss_pred EecCCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEeccc
Confidence 999999999999976431 88999999999999999999999 999999999999999999999999998
Q ss_pred cCCCCcccc------ccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhccc
Q 020641 183 SNQAPDMAA------RLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPR 256 (323)
Q Consensus 183 ~~~~~~~~~------~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 256 (323)
+........ ........++..|++||.......+.++|+||||+++|++++|..||.........
T Consensus 140 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~--------- 210 (265)
T cd05579 140 SKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIF--------- 210 (265)
T ss_pred chhcccCcccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHH---------
Confidence 865433211 11223344778899999998888889999999999999999999999754321110
Q ss_pred ccccccchhcCCCcCCCCCHH--HHHHHHHHHHHccCCCCCCCCChHHHHHHHh
Q 020641 257 LSEDKVKQCVDPKLKGEYPPK--GVAKLAAVAALCVQYEAEFRPNMSIVVKALQ 308 (323)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~--~~~~l~~li~~cl~~~P~~Rps~~evl~~l~ 308 (323)
........ ..+.. .+..+.+++.+||+.+|.+|||+.++.+.|+
T Consensus 211 ------~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 211 ------QNILNGKI--EWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred ------HHHhcCCc--CCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 00000000 11111 3677999999999999999999955555544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=270.28 Aligned_cols=251 Identities=22% Similarity=0.308 Sum_probs=200.4
Q ss_pred CCCCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEE
Q 020641 14 APSPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYC 93 (323)
Q Consensus 14 ~~~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 93 (323)
...++....||+|++|.||++.+..++..+++|+...... ....+.+|++.++.++|+|++++++.+
T Consensus 18 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-------------~~~~~~~e~~~l~~l~~~~i~~~~~~~ 84 (286)
T cd06614 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-------------NKELIINEILIMKDCKHPNIVDYYDSY 84 (286)
T ss_pred cccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-------------hHHHHHHHHHHHHHCCCCCeeEEEEEE
Confidence 3455666699999999999999998888888886642110 246678899999999999999999999
Q ss_pred EeCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCC
Q 020641 94 VEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDF 173 (323)
Q Consensus 94 ~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~ 173 (323)
......++++||+.+++|.+++..... .+++..+..++.|++.|+.+||+. |++|+||+|+||+++.++
T Consensus 85 ~~~~~~~lv~e~~~~~~L~~~l~~~~~--------~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~ 153 (286)
T cd06614 85 LVGDELWVVMEYMDGGSLTDIITQNFV--------RMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDG 153 (286)
T ss_pred EECCEEEEEEeccCCCcHHHHHHHhcc--------CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCC
Confidence 999999999999999999999987541 289999999999999999999999 999999999999999999
Q ss_pred eEEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhh
Q 020641 174 KAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWA 253 (323)
Q Consensus 174 ~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 253 (323)
.++|+|||.+........ ......++..|++||.+.+..++.++|+||||+++|+|++|..||...........
T Consensus 154 ~~~l~d~~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~---- 227 (286)
T cd06614 154 SVKLADFGFAAQLTKEKS--KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFL---- 227 (286)
T ss_pred CEEECccchhhhhccchh--hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHH----
Confidence 999999998765433221 11223467889999999888889999999999999999999999975432111100
Q ss_pred cccccccccchhcCCCc-CCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 254 TPRLSEDKVKQCVDPKL-KGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 254 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
...... ........+..+.+++.+||+.+|..|||+.++++
T Consensus 228 -----------~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 228 -----------ITTKGIPPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred -----------HHhcCCCCCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 000000 01112225667999999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=284.47 Aligned_cols=268 Identities=22% Similarity=0.288 Sum_probs=208.0
Q ss_pred ccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeC-----
Q 020641 22 RLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEG----- 96 (323)
Q Consensus 22 ~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----- 96 (323)
+||+||||.||+.++..+|+.+|+|...+.. ....++...+|+++|++++|+|||+.+++-++.
T Consensus 20 ~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~-----------~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~ 88 (732)
T KOG4250|consen 20 RLGKGAFGNVYRGRNKETGRLVAVKTFNKES-----------SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLV 88 (732)
T ss_pred hhcCCccceeeeecccccccchhHHhhhhhc-----------ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcc
Confidence 8999999999999999999999999765432 234457889999999999999999999876543
Q ss_pred -CeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEcc----
Q 020641 97 -NLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFE---- 171 (323)
Q Consensus 97 -~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~---- 171 (323)
....++||||.+|||...+++..... .+++..++.++..+..|+.|||+. ||+||||||.||++-.
T Consensus 89 ~~~~vlvmEyC~gGsL~~~L~~PEN~~------GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedg 159 (732)
T KOG4250|consen 89 TRLPVLVMEYCSGGSLRKVLNSPENAY------GLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDG 159 (732)
T ss_pred cccceEEEeecCCCcHHHHhcCccccc------CCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCC
Confidence 35689999999999999998765433 399999999999999999999999 9999999999999943
Q ss_pred CCeEEEeeccccCCCCccccccccccccCccccCCCccccC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhh
Q 020641 172 DFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT-GQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLV 250 (323)
Q Consensus 172 ~~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~ 250 (323)
....||+|||.|+...... ......||+.|++||++.. ..|+...|.|||||++|+.+||..||..........-+
T Consensus 160 q~IyKLtDfG~Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~ 236 (732)
T KOG4250|consen 160 QSIYKLTDFGAARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEI 236 (732)
T ss_pred ceEEeeecccccccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchh
Confidence 3356999999999887654 3455679999999999984 78899999999999999999999999766544322212
Q ss_pred hhhcccccccccchhcCCCc------------CCCCCHHHHHHHHHHHHHccCCCCCCCC--ChHHHHHHHhhhhc
Q 020641 251 TWATPRLSEDKVKQCVDPKL------------KGEYPPKGVAKLAAVAALCVQYEAEFRP--NMSIVVKALQPLLK 312 (323)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~l~~li~~cl~~~P~~Rp--s~~evl~~l~~~~~ 312 (323)
.|....-....+.....+.. ...........+-..+..+|..+|++|- ...+....+++++.
T Consensus 237 ~~~~~tkkp~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~ 312 (732)
T KOG4250|consen 237 MWHIITKKPSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILN 312 (732)
T ss_pred hhhhhccCCCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHh
Confidence 22111111111111111111 1223344456777888889999999998 88889888888874
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=280.66 Aligned_cols=272 Identities=19% Similarity=0.230 Sum_probs=198.3
Q ss_pred CCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEe
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVE 95 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 95 (323)
.|....+||+|+||.||++.+..+++.+++|..... ........+.+|+.++++++|+||+++++++..
T Consensus 6 ~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~-----------~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 74 (336)
T cd07849 6 RYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPF-----------EHQTFCQRTLREIKILRRFKHENIIGILDIIRP 74 (336)
T ss_pred ceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEeccc-----------ccchhHHHHHHHHHHHHhCCCCCcCchhheeec
Confidence 456667899999999999999999999999865321 112234667889999999999999999998764
Q ss_pred C-----CeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEc
Q 020641 96 G-----NLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLF 170 (323)
Q Consensus 96 ~-----~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~ 170 (323)
. ...++++||+.+ +|.+.+.... +++..+..++.|++.||.+||+. |++|+||||+||+++
T Consensus 75 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~~----------l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~ 140 (336)
T cd07849 75 PSFESFNDVYIVQELMET-DLYKLIKTQH----------LSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLN 140 (336)
T ss_pred ccccccceEEEEehhccc-CHHHHHhcCC----------CCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEC
Confidence 4 357999999975 8888886543 89999999999999999999999 999999999999999
Q ss_pred cCCeEEEeeccccCCCCcccccc-ccccccCccccCCCccccC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccch
Q 020641 171 EDFKAKIADFNLSNQAPDMAARL-HSTRVLGTFGYHAPEYAMT-GQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQS 248 (323)
Q Consensus 171 ~~~~~~l~Dfg~~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~ 248 (323)
.++.++|+|||++.......... ......|+..|+|||.+.+ ..++.++||||||+++|+|++|+.||...+......
T Consensus 141 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~ 220 (336)
T cd07849 141 TNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLN 220 (336)
T ss_pred CCCCEEECcccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 99999999999987654322111 1123457889999998654 467899999999999999999999997543211100
Q ss_pred hhhhhcccccccccchhcCCCc---------CCC-----CCHHHHHHHHHHHHHccCCCCCCCCChHHHHHH--Hhhhhc
Q 020641 249 LVTWATPRLSEDKVKQCVDPKL---------KGE-----YPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKA--LQPLLK 312 (323)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~---------~~~-----~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~--l~~~~~ 312 (323)
...........+.......... ... .....+.++.+++.+||+.+|++|||+.|+++. +.....
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~ 300 (336)
T cd07849 221 LILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHD 300 (336)
T ss_pred HHHHHcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCC
Confidence 0000000000011111000000 000 011235679999999999999999999999985 655553
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=266.55 Aligned_cols=255 Identities=20% Similarity=0.238 Sum_probs=198.8
Q ss_pred CCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEe
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVE 95 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 95 (323)
.|.....||+|+||.||++.+..+++.+++|......... ........+.+|++++++++|+||+++++.+.+
T Consensus 3 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~-------~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~ 75 (264)
T cd06653 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQ-------ETSKEVNALECEIQLLKNLRHDRIVQYYGCLRD 75 (264)
T ss_pred ceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccc-------hhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEc
Confidence 3455568999999999999999999999998653221000 111223578899999999999999999999876
Q ss_pred C--CeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCC
Q 020641 96 G--NLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDF 173 (323)
Q Consensus 96 ~--~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~ 173 (323)
. ...++++||+.+++|.+++..... +++..+..++.|++.|+.|||+. |++|+||+|+||+++.++
T Consensus 76 ~~~~~~~~v~e~~~~~~L~~~~~~~~~---------l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~ 143 (264)
T cd06653 76 PEEKKLSIFVEYMPGGSIKDQLKAYGA---------LTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAG 143 (264)
T ss_pred CCCCEEEEEEEeCCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCC
Confidence 4 468899999999999999875432 78889999999999999999999 999999999999999999
Q ss_pred eEEEeeccccCCCCccccc-cccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhh
Q 020641 174 KAKIADFNLSNQAPDMAAR-LHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTW 252 (323)
Q Consensus 174 ~~~l~Dfg~~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 252 (323)
.++|+|||.+......... .......++..|+|||.+.+..++.++|+||||+++|+|++|..||.......
T Consensus 144 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------- 216 (264)
T cd06653 144 NVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMA------- 216 (264)
T ss_pred CEEECccccccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHH-------
Confidence 9999999998765432111 11123447889999999988888999999999999999999999997543211
Q ss_pred hcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 253 ATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
...+..........+...++.+.+++.+||. +|..|||+.+++.
T Consensus 217 --------~~~~~~~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 217 --------AIFKIATQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred --------HHHHHHcCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 1111111112233455667789999999999 5799999998875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=268.58 Aligned_cols=261 Identities=20% Similarity=0.259 Sum_probs=190.8
Q ss_pred ccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcC-CCCcccceeeEEEeC
Q 020641 18 GYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRL-KHENLVELLGYCVEG 96 (323)
Q Consensus 18 ~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~ 96 (323)
.+..+||+|+||.||++++..+++.+++|........ .......+|+..++++ +|+|++++++++.++
T Consensus 2 ~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~-----------~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 70 (282)
T cd07831 2 KILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKS-----------LEQVNNLREIQALRRLSPHPNILRLIEVLFDR 70 (282)
T ss_pred ceEeeccccccceEEEEEEcCCCcEEEEEEehhccCC-----------chhhhHHHHHHHHhhcCCCCCccceEEEEecC
Confidence 4566899999999999999999999999866432111 1112335688888888 599999999999987
Q ss_pred --CeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCe
Q 020641 97 --NLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFK 174 (323)
Q Consensus 97 --~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~ 174 (323)
+..++|+||+.+ +|.+.+..... .+++..+..++.|++.||.+||+. |++|+||+|+||+++. +.
T Consensus 71 ~~~~~~lv~e~~~~-~l~~~l~~~~~--------~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~ 137 (282)
T cd07831 71 KTGRLALVFELMDM-NLYELIKGRKR--------PLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DI 137 (282)
T ss_pred CCCcEEEEEecCCc-cHHHHHHhccC--------CCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CC
Confidence 889999999975 88888865432 289999999999999999999999 9999999999999999 99
Q ss_pred EEEeeccccCCCCccccccccccccCccccCCCccccC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhh
Q 020641 175 AKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT-GQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWA 253 (323)
Q Consensus 175 ~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 253 (323)
++|+|||.+......... ....++..|+|||.+.. ..++.++|+|||||++|+|++|..||...+...........
T Consensus 138 ~kl~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~ 214 (282)
T cd07831 138 LKLADFGSCRGIYSKPPY---TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDV 214 (282)
T ss_pred eEEEecccccccccCCCc---CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHH
Confidence 999999998765432221 22346888999997654 45688999999999999999999999765432111000000
Q ss_pred cccccc--------cccchhcCCCcC----CCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 254 TPRLSE--------DKVKQCVDPKLK----GEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 254 ~~~~~~--------~~~~~~~~~~~~----~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
...... ........+... .......+..+.+++.+||+.+|++|||+.++++
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 215 LGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred cCCCCHHHHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 000000 000000000000 0011234678999999999999999999999986
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-38 Score=271.50 Aligned_cols=258 Identities=21% Similarity=0.332 Sum_probs=200.4
Q ss_pred CCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEe
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVE 95 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 95 (323)
.+..+.+||+|+||.||++....++..+++|..... .......+.+|+.+++.++|+|++++++.+..
T Consensus 21 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~------------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 88 (292)
T cd06657 21 YLDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLR------------KQQRRELLFNEVVIMRDYQHENVVEMYNSYLV 88 (292)
T ss_pred HhhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEeccc------------chhHHHHHHHHHHHHHhcCCcchhheeeEEEe
Confidence 334456899999999999999999999998854211 11224568889999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeE
Q 020641 96 GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKA 175 (323)
Q Consensus 96 ~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~ 175 (323)
++..+++|||+.+++|.+++.... +++..+..++.|++.++.+||+. |++|+||+|+||+++.++.+
T Consensus 89 ~~~~~lv~e~~~~~~L~~~~~~~~----------~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~ 155 (292)
T cd06657 89 GDELWVVMEFLEGGALTDIVTHTR----------MNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRV 155 (292)
T ss_pred CCEEEEEEecCCCCcHHHHHhcCC----------CCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCE
Confidence 999999999999999999875432 78889999999999999999999 99999999999999999999
Q ss_pred EEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhcc
Q 020641 176 KIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATP 255 (323)
Q Consensus 176 ~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~ 255 (323)
+|+|||.+........ ......++..|++||.+.+..++.++|+||+|+++|+|++|..||............ .
T Consensus 156 ~l~dfg~~~~~~~~~~--~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~---~- 229 (292)
T cd06657 156 KLSDFGFCAQVSKEVP--RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI---R- 229 (292)
T ss_pred EEcccccceecccccc--cccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---H-
Confidence 9999998765433211 112344788999999988888899999999999999999999999754321110000 0
Q ss_pred cccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhhcCCCC
Q 020641 256 RLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSPPP 316 (323)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~~~~~~ 316 (323)
..+..... .....+..+.+++.+||..+|.+||++.++++ ..++....+
T Consensus 230 --------~~~~~~~~--~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~--~~~~~~~~~ 278 (292)
T cd06657 230 --------DNLPPKLK--NLHKVSPSLKGFLDRLLVRDPAQRATAAELLK--HPFLAKAGP 278 (292)
T ss_pred --------hhCCcccC--CcccCCHHHHHHHHHHHhCCcccCcCHHHHhc--ChHHhccCC
Confidence 00001100 11223556899999999999999999999998 455444443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=265.76 Aligned_cols=253 Identities=22% Similarity=0.311 Sum_probs=202.3
Q ss_pred CccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeC
Q 020641 17 PGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEG 96 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 96 (323)
|.....||.|++|.||++.+..++..+++|....... .......+.+|+++++.++|+|++++++.+...
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~----------~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~ 71 (258)
T cd08215 2 YEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNM----------SEKEREDALNEVKILKKLNHPNIIKYYESFEEK 71 (258)
T ss_pred ceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccC----------ChHHHHHHHHHHHHHHhcCCCChhheEEEEecC
Confidence 4556689999999999999998888888886643221 123346678899999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEE
Q 020641 97 NLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAK 176 (323)
Q Consensus 97 ~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~ 176 (323)
...++|+||+++++|.+++..... ....+++..+..++.+++.|+.+||+. |++|+||+|+||+++.++.++
T Consensus 72 ~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~ 143 (258)
T cd08215 72 GKLCIVMEYADGGDLSQKIKKQKK-----EGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVK 143 (258)
T ss_pred CEEEEEEEecCCCcHHHHHHHhhc-----cCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEE
Confidence 999999999999999999976531 111389999999999999999999999 999999999999999999999
Q ss_pred EeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhccc
Q 020641 177 IADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPR 256 (323)
Q Consensus 177 l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 256 (323)
|+|||.+........ ......|++.|+|||...+..++.++|+||+|+++++|++|..||........ .
T Consensus 144 l~d~~~~~~~~~~~~--~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~---~------ 212 (258)
T cd08215 144 LGDFGISKVLSSTVD--LAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLEL---A------ 212 (258)
T ss_pred ECCccceeecccCcc--eecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHH---H------
Confidence 999999876544321 12234578889999998888889999999999999999999999965431100 0
Q ss_pred ccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 257 LSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
.... .......+...+..+.+++.+||..+|++|||+.++++
T Consensus 213 ------~~~~-~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 213 ------LKIL-KGQYPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred ------HHHh-cCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 0000 01111223355678999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=309.86 Aligned_cols=259 Identities=24% Similarity=0.442 Sum_probs=203.1
Q ss_pred cccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeCCeEE
Q 020641 21 VRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRV 100 (323)
Q Consensus 21 ~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 100 (323)
..||+|+||.||++++..+++.+|+|..... . .....|++.+++++||||+++++++.+....+
T Consensus 696 ~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~-------------~---~~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~ 759 (968)
T PLN00113 696 NVISRGKKGASYKGKSIKNGMQFVVKEINDV-------------N---SIPSSEIADMGKLQHPNIVKLIGLCRSEKGAY 759 (968)
T ss_pred cEEccCCCeeEEEEEECCCCcEEEEEEccCC-------------c---cccHHHHHHHhhCCCCCcceEEEEEEcCCCCE
Confidence 3689999999999999888888888854311 0 11234578899999999999999999999999
Q ss_pred EEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEEEeec
Q 020641 101 LAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADF 180 (323)
Q Consensus 101 lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~l~Df 180 (323)
+||||+++|+|.+++.. +++..+..++.|++.|+.|||..+..+++||||||+||+++.++..++. +
T Consensus 760 lv~Ey~~~g~L~~~l~~------------l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~ 826 (968)
T PLN00113 760 LIHEYIEGKNLSEVLRN------------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-L 826 (968)
T ss_pred EEEeCCCCCcHHHHHhc------------CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-e
Confidence 99999999999999953 7889999999999999999995444499999999999999998877765 5
Q ss_pred cccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhccccccc
Q 020641 181 NLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSED 260 (323)
Q Consensus 181 g~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 260 (323)
+....... .....+++.|+|||.+.+..++.++||||||+++|||++|+.||...... ......|........
T Consensus 827 ~~~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~~ 899 (968)
T PLN00113 827 SLPGLLCT------DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGV-HGSIVEWARYCYSDC 899 (968)
T ss_pred cccccccc------CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCC-CCcHHHHHHHhcCcc
Confidence 54432211 11224788999999999889999999999999999999999999643322 222334443333333
Q ss_pred ccchhcCCCcCC--CCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhhcCCC
Q 020641 261 KVKQCVDPKLKG--EYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSPP 315 (323)
Q Consensus 261 ~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~~~~~ 315 (323)
....++++.+.. ..+.....++.+++.+||+.||++|||+.|+++.|+++.+..+
T Consensus 900 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~~ 956 (968)
T PLN00113 900 HLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSSS 956 (968)
T ss_pred chhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhcccc
Confidence 444555555533 2345566788999999999999999999999999999987544
|
|
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=263.73 Aligned_cols=249 Identities=26% Similarity=0.381 Sum_probs=199.8
Q ss_pred CccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeC
Q 020641 17 PGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEG 96 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 96 (323)
|....+||.|++|.||++.+..+++.+++|....... .....+.+|++.++.++|+|++++++++...
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~------------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 69 (253)
T cd05122 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK------------EKKEKIINEIQILKKCKHPNIVKYYGSYLKK 69 (253)
T ss_pred ceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch------------hHHHHHHHHHHHHHhCCCCCEeEEEEEEecC
Confidence 4556789999999999999998888888886653211 2346788999999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEE
Q 020641 97 NLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAK 176 (323)
Q Consensus 97 ~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~ 176 (323)
...++++||+.+++|.+++..... .+++..+..++.|++.++.+||.. |++|+||+|+||+++.++.++
T Consensus 70 ~~~~l~~e~~~~~~L~~~~~~~~~--------~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~ 138 (253)
T cd05122 70 DELWIVMEFCSGGSLKDLLKSTNQ--------TLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVK 138 (253)
T ss_pred CeEEEEEecCCCCcHHHHHhhcCC--------CCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEE
Confidence 999999999999999999976531 289999999999999999999999 999999999999999999999
Q ss_pred EeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhccc
Q 020641 177 IADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPR 256 (323)
Q Consensus 177 l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 256 (323)
|+|||.+........ .....++..|++||.+.+..++.++|+||||+++++|++|..||............ ...
T Consensus 139 l~d~~~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~---~~~ 212 (253)
T cd05122 139 LIDFGLSAQLSDTKA---RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKI---ATN 212 (253)
T ss_pred Eeecccccccccccc---ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHH---Hhc
Confidence 999999876654321 23345788999999998888899999999999999999999999754321110000 000
Q ss_pred ccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 257 LSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
. .+. .......+..+.+++.+||+.||++|||+.++++
T Consensus 213 ~---------~~~--~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 213 G---------PPG--LRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred C---------CCC--cCcccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0 000 0111123567999999999999999999999986
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-39 Score=262.69 Aligned_cols=273 Identities=18% Similarity=0.224 Sum_probs=200.1
Q ss_pred CCCccccccCCCCCCccceeccceeee----eeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCccccee
Q 020641 15 PSPGYFVRLDKGPEDDLYLKKRVKMRR----WLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELL 90 (323)
Q Consensus 15 ~~~~~~~~lg~G~~~~V~~~~~~~~~~----~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~ 90 (323)
..|+.+.+||+|.||.||+|...+++- .+|+|.+..+ +..........+|+.+++.++|+|++.+.
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~----------kd~tGiS~SAcREiaL~REl~h~nvi~Lv 93 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGE----------KDGTGISMSACREIALLRELKHPNVISLV 93 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhcc----------CCCCCcCHHHHHHHHHHHHhcCCcchhHH
Confidence 456666689999999999997776543 4566544322 11334456778999999999999999999
Q ss_pred eEEEe-CCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEE
Q 020641 91 GYCVE-GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLL 169 (323)
Q Consensus 91 ~~~~~-~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili 169 (323)
.++.. +...++++||.++ +|+..|+-...... ..++...+..+++||++|++|||++ =++|||+||.||++
T Consensus 94 ~Vfl~~d~~v~l~fdYAEh-DL~~II~fHr~~~~----~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlv 165 (438)
T KOG0666|consen 94 KVFLSHDKKVWLLFDYAEH-DLWHIIKFHRASKA----KQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILV 165 (438)
T ss_pred HHHhccCceEEEEehhhhh-hHHHHHHHhccchh----ccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEE
Confidence 99887 7789999999998 99999976554332 2388999999999999999999999 79999999999999
Q ss_pred ccC----CeEEEeeccccCCCCcccccc-ccccccCccccCCCccccCC-CCCcccchHHHHHHHHHHHhCCCCCCCCCC
Q 020641 170 FED----FKAKIADFNLSNQAPDMAARL-HSTRVLGTFGYHAPEYAMTG-QLTQKSDVYSFGVVLLELLTGRKPVDHTMP 243 (323)
Q Consensus 170 ~~~----~~~~l~Dfg~~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 243 (323)
..+ |.|||+|||+++.+.+.-... ......-|.+|+|||++.|. .|+++.|||++||++.||++-++.|.+...
T Consensus 166 mgdgperG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~ 245 (438)
T KOG0666|consen 166 MGDGPERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREE 245 (438)
T ss_pred eccCCccCeeEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhh
Confidence 887 999999999999887765444 33344579999999999875 589999999999999999999999976543
Q ss_pred cccch---------hhhhhcccccccccchhcC--------CCcCCC-CCH-----------HHHHHHHHHHHHccCCCC
Q 020641 244 RGQQS---------LVTWATPRLSEDKVKQCVD--------PKLKGE-YPP-----------KGVAKLAAVAALCVQYEA 294 (323)
Q Consensus 244 ~~~~~---------~~~~~~~~~~~~~~~~~~~--------~~~~~~-~~~-----------~~~~~l~~li~~cl~~~P 294 (323)
..... .+...-.....+..+.+.. ...+.. +.. .-++.-.+|+..+|.+||
T Consensus 246 k~~~~~Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP 325 (438)
T KOG0666|consen 246 KIKTKNPFQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDP 325 (438)
T ss_pred hcccCCCchHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCc
Confidence 22111 0000000111111110000 000000 000 002237789999999999
Q ss_pred CCCCChHHHHH
Q 020641 295 EFRPNMSIVVK 305 (323)
Q Consensus 295 ~~Rps~~evl~ 305 (323)
.+|.|+++.++
T Consensus 326 ~kRIta~qAle 336 (438)
T KOG0666|consen 326 IKRITAEQALE 336 (438)
T ss_pred hhhccHHHHhc
Confidence 99999999887
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=278.86 Aligned_cols=271 Identities=19% Similarity=0.246 Sum_probs=198.8
Q ss_pred CCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEe
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVE 95 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 95 (323)
.|.....||.|+||.||++++..+++.+++|....... .......+.+|+.+++.++|+||+++++++..
T Consensus 6 ~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~----------~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~ 75 (337)
T cd07858 6 KYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFD----------NRIDAKRTLREIKLLRHLDHENVIAIKDIMPP 75 (337)
T ss_pred ceeEEEEeccCCCeEEEEEEecCCCCeEEEEEeccccc----------ccchhHHHHHHHHHHHhcCCCCccchHHheec
Confidence 45666789999999999999999999999996543211 11223556789999999999999999998864
Q ss_pred C-----CeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEc
Q 020641 96 G-----NLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLF 170 (323)
Q Consensus 96 ~-----~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~ 170 (323)
. ...++++||+. ++|.+++..... +++..+..++.|++.|+.|||+. +++|+||||+||+++
T Consensus 76 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~---------l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~ 142 (337)
T cd07858 76 PHREAFNDVYIVYELMD-TDLHQIIRSSQT---------LSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLN 142 (337)
T ss_pred ccccccCcEEEEEeCCC-CCHHHHHhcCCC---------CCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEc
Confidence 4 34799999996 589999875432 88999999999999999999999 999999999999999
Q ss_pred cCCeEEEeeccccCCCCccccccccccccCccccCCCccccC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchh
Q 020641 171 EDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT-GQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSL 249 (323)
Q Consensus 171 ~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~ 249 (323)
.++.++|+|||++........ ......++..|+|||.+.. ..++.++|+||||+++|+|++|+.||...+.......
T Consensus 143 ~~~~~kL~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~ 220 (337)
T cd07858 143 ANCDLKICDFGLARTTSEKGD--FMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKL 220 (337)
T ss_pred CCCCEEECcCccccccCCCcc--cccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHH
Confidence 999999999999876543221 1223347888999998764 4688999999999999999999999975532111110
Q ss_pred hhhhccc--------ccccccchhcCC---CcC---CCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHH--Hhhhh
Q 020641 250 VTWATPR--------LSEDKVKQCVDP---KLK---GEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKA--LQPLL 311 (323)
Q Consensus 250 ~~~~~~~--------~~~~~~~~~~~~---~~~---~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~--l~~~~ 311 (323)
....... .........+.. ... .......+..+.+++.+||+.+|++|||+.++++. +..+.
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~ 298 (337)
T cd07858 221 ITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLH 298 (337)
T ss_pred HHHHhCCCChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhc
Confidence 1000000 000001111000 000 01112356779999999999999999999999975 55543
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-39 Score=258.30 Aligned_cols=248 Identities=21% Similarity=0.283 Sum_probs=193.9
Q ss_pred cccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcC-CCCcccceeeEEEeCC
Q 020641 19 YFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRL-KHENLVELLGYCVEGN 97 (323)
Q Consensus 19 ~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~ 97 (323)
.+.-||.|..|.||++....++...|+|..... ..++..+++...+.++... +.|.|++.+++|..+.
T Consensus 96 ~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt-----------~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~ 164 (391)
T KOG0983|consen 96 NLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRT-----------GNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNT 164 (391)
T ss_pred hHHhhcCCCccceEEEEEcccceEEEEEeeccc-----------CCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCc
Confidence 344789999999999999999999999855422 2233335666677777666 6899999999999999
Q ss_pred eEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEEE
Q 020641 98 LRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKI 177 (323)
Q Consensus 98 ~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~l 177 (323)
..++.||.|.. .+..++++-.+ ++++..+-++...+++||.||-.+. ||+|||+||+|||+|..|++||
T Consensus 165 dV~IcMelMs~-C~ekLlkrik~--------piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKl 233 (391)
T KOG0983|consen 165 DVFICMELMST-CAEKLLKRIKG--------PIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKL 233 (391)
T ss_pred hHHHHHHHHHH-HHHHHHHHhcC--------CchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEe
Confidence 99999998865 67777665443 2888888899999999999998764 9999999999999999999999
Q ss_pred eeccccCCCCccccccccccccCccccCCCcccc---CCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhc
Q 020641 178 ADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAM---TGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWAT 254 (323)
Q Consensus 178 ~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~ 254 (323)
||||++..+..... .+...|-+.|+|||.+. ...|+.++||||||++++||.||+.||..-...
T Consensus 234 CDFGIsGrlvdSkA---htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~td---------- 300 (391)
T KOG0983|consen 234 CDFGISGRLVDSKA---HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTD---------- 300 (391)
T ss_pred ecccccceeecccc---cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCcc----------
Confidence 99999876655333 34556899999999885 346889999999999999999999999864321
Q ss_pred ccccccccchhcCCCcCC-CCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 255 PRLSEDKVKQCVDPKLKG-EYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
.+.+.++++..... ......++++.+|+..||++|+.+||...++++
T Consensus 301 ----Fe~ltkvln~ePP~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~ 348 (391)
T KOG0983|consen 301 ----FEVLTKVLNEEPPLLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLE 348 (391)
T ss_pred ----HHHHHHHHhcCCCCCCcccCcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence 12222233211110 111126788999999999999999999999886
|
|
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=268.42 Aligned_cols=266 Identities=20% Similarity=0.251 Sum_probs=197.8
Q ss_pred CccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeC
Q 020641 17 PGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEG 96 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 96 (323)
|+...+||.|++|.||++++..+++.+++|+..... .......+.+|++++++++|+||+++++.+...
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~-----------~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 70 (284)
T cd07836 2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDA-----------EEGTPSTAIREISLMKELKHENIVRLHDVIHTE 70 (284)
T ss_pred ceEeeeeccCCceEEEEEEECCCCeEEEEEEecccc-----------cccchHHHHHHHHHHHhhcCCCEeeeeeeEeeC
Confidence 566779999999999999999999999998664321 112235667899999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEE
Q 020641 97 NLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAK 176 (323)
Q Consensus 97 ~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~ 176 (323)
+..++||||+.+ +|.+++...... ..+++..+..++.|++.|+.|||+. |++|+||+|+||++++++.++
T Consensus 71 ~~~~lv~e~~~~-~l~~~~~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~ 140 (284)
T cd07836 71 NKLMLVFEYMDK-DLKKYMDTHGVR------GALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELK 140 (284)
T ss_pred CcEEEEEecCCc-cHHHHHHhcCCC------CCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEE
Confidence 999999999986 899888654321 1289999999999999999999999 999999999999999999999
Q ss_pred EeeccccCCCCccccccccccccCccccCCCccccCC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhcc
Q 020641 177 IADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG-QLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATP 255 (323)
Q Consensus 177 l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~ 255 (323)
|+|||++........ ......++..|++||.+.+. .++.++|+||||+++|+|++|..||.................
T Consensus 141 l~d~g~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~ 218 (284)
T cd07836 141 LADFGLARAFGIPVN--TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMG 218 (284)
T ss_pred EeecchhhhhcCCcc--ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhC
Confidence 999999865432211 11223467889999987654 468899999999999999999999976543221111110000
Q ss_pred cccccccchhcC-CCcC-----------CCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 256 RLSEDKVKQCVD-PKLK-----------GEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 256 ~~~~~~~~~~~~-~~~~-----------~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
.........+.. +... ....+..+..+.+++.+||+.||.+||++.++++
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 219 TPTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred CCChhhHHHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 000000000000 0000 0111234567899999999999999999999985
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=270.24 Aligned_cols=265 Identities=18% Similarity=0.251 Sum_probs=197.3
Q ss_pred ccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeC-
Q 020641 18 GYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEG- 96 (323)
Q Consensus 18 ~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~- 96 (323)
....+||.|++|.||++++..+++.+++|...... ........+.+|+++++.++|+|++++++++...
T Consensus 2 ~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~----------~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 71 (287)
T cd07840 2 EKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN----------EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKG 71 (287)
T ss_pred eeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc----------ccccchHHHHHHHHHHHhccCCCeeeheeeEecCC
Confidence 45568999999999999999989999998766432 1123346788899999999999999999999988
Q ss_pred -CeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeE
Q 020641 97 -NLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKA 175 (323)
Q Consensus 97 -~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~ 175 (323)
...++|+||+.+ +|.+++..... .+++..++.++.|++.|+.+||+. |++|+||+|+||++++++.+
T Consensus 72 ~~~~~lv~e~~~~-~l~~~~~~~~~--------~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~ 139 (287)
T cd07840 72 KGSIYMVFEYMDH-DLTGLLDSPEV--------KFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVL 139 (287)
T ss_pred CCcEEEEeccccc-cHHHHHhccCC--------CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCE
Confidence 789999999985 89998865532 288999999999999999999999 99999999999999999999
Q ss_pred EEeeccccCCCCccccccccccccCccccCCCccccC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhc
Q 020641 176 KIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT-GQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWAT 254 (323)
Q Consensus 176 ~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~ 254 (323)
+|+|||++......... ......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||................
T Consensus 140 ~l~d~g~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~ 218 (287)
T cd07840 140 KLADFGLARPYTKRNSA-DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELC 218 (287)
T ss_pred EEccccceeeccCCCcc-cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Confidence 99999998766543211 1122346778999997765 457889999999999999999999997654322111111000
Q ss_pred ccccccccchh--------cC------CCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 255 PRLSEDKVKQC--------VD------PKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 255 ~~~~~~~~~~~--------~~------~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
........... .. ..+.......++..+.+++.+||+.+|.+|||+.++++
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 219 GSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred CCCchhhccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 00000000000 00 00000011113667999999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=270.35 Aligned_cols=245 Identities=23% Similarity=0.316 Sum_probs=191.3
Q ss_pred cccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeCCe
Q 020641 19 YFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNL 98 (323)
Q Consensus 19 ~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 98 (323)
.+.+||+|+||.||++++..+++.+++|........ .......+.+|+++++.++|+|++++++++.+...
T Consensus 25 ~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~---------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 95 (313)
T cd06633 25 GLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQ---------TNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHT 95 (313)
T ss_pred cceeeccCCCeEEEEEEECCCCcEEEEEEEeccccC---------chHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCE
Confidence 345799999999999999999999998866432111 11123567889999999999999999999999999
Q ss_pred EEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEEEe
Q 020641 99 RVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIA 178 (323)
Q Consensus 99 ~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~l~ 178 (323)
.|+||||+.+ ++.+++..... .+++..+..++.|++.++.|||+. |++|+||+|+||+++.++.++|+
T Consensus 96 ~~lv~e~~~~-~l~~~l~~~~~--------~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~ 163 (313)
T cd06633 96 AWLVMEYCLG-SASDLLEVHKK--------PLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLA 163 (313)
T ss_pred EEEEEecCCC-CHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEe
Confidence 9999999975 88888754332 288899999999999999999999 99999999999999999999999
Q ss_pred eccccCCCCccccccccccccCccccCCCcccc---CCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhcc
Q 020641 179 DFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAM---TGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATP 255 (323)
Q Consensus 179 Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~ 255 (323)
|||.+..... .....|+..|+|||.+. ...++.++|+||||+++|+|++|..||.............
T Consensus 164 dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~---- 233 (313)
T cd06633 164 DFGSASKSSP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA---- 233 (313)
T ss_pred ecCCCcccCC------CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH----
Confidence 9998754321 12345788899999874 3567889999999999999999999987553211111000
Q ss_pred cccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 256 RLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
............+..+.+++.+||+.+|.+||++.+++.
T Consensus 234 -----------~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~ 272 (313)
T cd06633 234 -----------QNDSPTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLR 272 (313)
T ss_pred -----------hcCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000001112233456999999999999999999999996
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-38 Score=276.36 Aligned_cols=273 Identities=19% Similarity=0.217 Sum_probs=203.9
Q ss_pred CccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeC
Q 020641 17 PGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEG 96 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 96 (323)
|....+||.|++|.||++++..+++.+++|....... .....+.+.+|+++++.++|+||+++++++...
T Consensus 2 y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----------~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (330)
T cd07834 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFD----------DLIDAKRILREIKLLRHLRHENIIGLLDILRPP 71 (330)
T ss_pred ceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccc----------cchhhhhHHHHHHHHHhcCCcchhhhhhhhccc
Confidence 4566789999999999999998899999986653211 123346788999999999999999999998877
Q ss_pred C-----eEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEcc
Q 020641 97 N-----LRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFE 171 (323)
Q Consensus 97 ~-----~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~ 171 (323)
. ..|++|+|+.+ +|.+++.... .+++..+..++.|++.||.+||+. |++|+||||+||+++.
T Consensus 72 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~---------~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~ 138 (330)
T cd07834 72 SPEDFNDVYIVTELMET-DLHKVIKSPQ---------PLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNS 138 (330)
T ss_pred CcccccceEEEecchhh-hHHHHHhCCC---------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcC
Confidence 5 78999999985 8999987643 189999999999999999999999 9999999999999999
Q ss_pred CCeEEEeeccccCCCCccccc-cccccccCccccCCCccccCC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchh
Q 020641 172 DFKAKIADFNLSNQAPDMAAR-LHSTRVLGTFGYHAPEYAMTG-QLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSL 249 (323)
Q Consensus 172 ~~~~~l~Dfg~~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~ 249 (323)
++.++|+|||.+......... .......++..|+|||.+.+. .++.++|+||||+++|+|++|..||...........
T Consensus 139 ~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~ 218 (330)
T cd07834 139 NCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNL 218 (330)
T ss_pred CCCEEEcccCceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHH
Confidence 999999999998765543210 112233478889999999877 788999999999999999999999976653221111
Q ss_pred hhhhccccc--------ccccchhcCC-CcC-----CCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH--HHhhhhc
Q 020641 250 VTWATPRLS--------EDKVKQCVDP-KLK-----GEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK--ALQPLLK 312 (323)
Q Consensus 250 ~~~~~~~~~--------~~~~~~~~~~-~~~-----~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~--~l~~~~~ 312 (323)
+........ .......+.. ... .......+..+.+++.+||+.+|.+|||+.+++. +++++..
T Consensus 219 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~ 297 (330)
T cd07834 219 IVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHD 297 (330)
T ss_pred HHHhcCCCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcc
Confidence 110000000 0001111110 000 0011224677999999999999999999999998 3555443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=269.64 Aligned_cols=270 Identities=16% Similarity=0.126 Sum_probs=185.8
Q ss_pred CCccccccCCCCCCccceecccee---eeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeE
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRVKM---RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGY 92 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~~~---~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 92 (323)
.|....+||+|+||.||++....+ +..+++|+........ ..+..............++..+..++|+|++++++.
T Consensus 13 ~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~-~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 91 (294)
T PHA02882 13 EWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETI-VMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC 91 (294)
T ss_pred ceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCch-hhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence 455556899999999999998877 5666666432211100 000000001111223344555677799999999987
Q ss_pred EEeCC----eEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEE
Q 020641 93 CVEGN----LRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVL 168 (323)
Q Consensus 93 ~~~~~----~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nil 168 (323)
+.... ..+++++++.. ++.+.+..... .++..+..++.|++.|+.|||+. +++||||||+||+
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~---------~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nil 158 (294)
T PHA02882 92 GSFKRCRMYYRFILLEKLVE-NTKEIFKRIKC---------KNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIM 158 (294)
T ss_pred eeEecCCceEEEEEEehhcc-CHHHHHHhhcc---------CCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEE
Confidence 66543 34677887754 77777654321 56778899999999999999999 9999999999999
Q ss_pred EccCCeEEEeeccccCCCCccccc-----cccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCC
Q 020641 169 LFEDFKAKIADFNLSNQAPDMAAR-----LHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMP 243 (323)
Q Consensus 169 i~~~~~~~l~Dfg~~~~~~~~~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 243 (323)
++.++.++|+|||+++........ .......||+.|+|||.+.+..++.++|||||||++|+|++|..||.....
T Consensus 159 l~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~ 238 (294)
T PHA02882 159 VDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGH 238 (294)
T ss_pred EcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCcccc
Confidence 999999999999998765321111 111223589999999999999999999999999999999999999986632
Q ss_pred cccchhhhhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHh
Q 020641 244 RGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQ 308 (323)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~ 308 (323)
......... .+.......... ....++..+.+++..||+.+|++||++.++++.|+
T Consensus 239 ~~~~~~~~~------~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 239 NGNLIHAAK------CDFIKRLHEGKI---KIKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred chHHHHHhH------HHHHHHhhhhhh---ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 211110000 000011111111 11233577999999999999999999999998763
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=278.02 Aligned_cols=268 Identities=19% Similarity=0.251 Sum_probs=197.0
Q ss_pred CCCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEE
Q 020641 15 PSPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCV 94 (323)
Q Consensus 15 ~~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 94 (323)
..|+....||.|++|.||++.+..+++.+++|....... .......+.+|+.++++++|+||+++++++.
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~----------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 74 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFD----------VPTLAKRTLRELKILRHFKHDNIIAIRDILR 74 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccc----------cccchHHHHHHHHHHHhcCCCCccCHHHhcc
Confidence 345566689999999999999999999999986643211 1223466778999999999999999999876
Q ss_pred e----CCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEc
Q 020641 95 E----GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLF 170 (323)
Q Consensus 95 ~----~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~ 170 (323)
. ....++|+||+. ++|.+++..... +++..+..++.|++.||.|||+. |++|+||||+||+++
T Consensus 75 ~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~---------~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~ 141 (334)
T cd07855 75 PPGADFKDVYVVMDLME-SDLHHIIHSDQP---------LTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVN 141 (334)
T ss_pred ccCCCCceEEEEEehhh-hhHHHHhccCCC---------CCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEc
Confidence 3 346799999996 489999865432 88999999999999999999999 999999999999999
Q ss_pred cCCeEEEeeccccCCCCccccc--cccccccCccccCCCccccC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccc
Q 020641 171 EDFKAKIADFNLSNQAPDMAAR--LHSTRVLGTFGYHAPEYAMT-GQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQ 247 (323)
Q Consensus 171 ~~~~~~l~Dfg~~~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~ 247 (323)
.++.++|+|||++......... .......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||.........
T Consensus 142 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~ 221 (334)
T cd07855 142 EDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQL 221 (334)
T ss_pred CCCcEEecccccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHH
Confidence 9999999999998655432211 11123357889999998765 45789999999999999999999999755432111
Q ss_pred hhhhhhccccc--------ccccchhcCC-CcCCCC-----CHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 248 SLVTWATPRLS--------EDKVKQCVDP-KLKGEY-----PPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 248 ~~~~~~~~~~~--------~~~~~~~~~~-~~~~~~-----~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
..........+ ...+....+. ...... ....+..+.+++.+||+.+|++|||+.+++.
T Consensus 222 ~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 293 (334)
T cd07855 222 KLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ 293 (334)
T ss_pred HHHHHHhCCChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 11100000000 0001111100 000111 1234678999999999999999999999887
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=269.07 Aligned_cols=267 Identities=15% Similarity=0.193 Sum_probs=194.8
Q ss_pred CCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEe
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVE 95 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 95 (323)
.|....+||.|++|+||++++..+++.+++|...... ........+.+|++++++++|+||+++++++..
T Consensus 3 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~----------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 72 (294)
T PLN00009 3 QYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQ----------EDEGVPSTAIREISLLKEMQHGNIVRLQDVVHS 72 (294)
T ss_pred ceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhcc----------ccccchHHHHHHHHHHHhccCCCEeeEEEEEec
Confidence 3566679999999999999999899888988654321 112233667889999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEcc-CCe
Q 020641 96 GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFE-DFK 174 (323)
Q Consensus 96 ~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~-~~~ 174 (323)
+...++||||+.+ +|.+++...... .+++..+..++.||+.||.|||++ +++|+||+|+||+++. ++.
T Consensus 73 ~~~~~lv~e~~~~-~l~~~~~~~~~~-------~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~ 141 (294)
T PLN00009 73 EKRLYLVFEYLDL-DLKKHMDSSPDF-------AKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNA 141 (294)
T ss_pred CCeEEEEEecccc-cHHHHHHhCCCC-------CcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCE
Confidence 9999999999965 888888654322 167788889999999999999999 9999999999999985 567
Q ss_pred EEEeeccccCCCCccccccccccccCccccCCCccccC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhh
Q 020641 175 AKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT-GQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWA 253 (323)
Q Consensus 175 ~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 253 (323)
++|+|||++........ ......+++.|+|||.+.+ ..++.++||||||+++|+|++|..||...............
T Consensus 142 ~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~ 219 (294)
T PLN00009 142 LKLADFGLARAFGIPVR--TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRI 219 (294)
T ss_pred EEEcccccccccCCCcc--ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 99999999865433211 1122346788999998765 45788999999999999999999999765332111110000
Q ss_pred cccccccc------cchhc--CCCcCC----CCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 254 TPRLSEDK------VKQCV--DPKLKG----EYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 254 ~~~~~~~~------~~~~~--~~~~~~----~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
........ +.... .+.... ......+..+.+++.+||+.+|++||++.++++
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 220 LGTPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred hCCCChhhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00000000 00000 000000 011234567899999999999999999999987
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-38 Score=271.80 Aligned_cols=256 Identities=23% Similarity=0.233 Sum_probs=191.5
Q ss_pred CccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcC-CCCcccceeeEEEe
Q 020641 17 PGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRL-KHENLVELLGYCVE 95 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~ 95 (323)
+.....||+|+||.||++.+..+++.+++|........ .....+.+|+.++.++ +|+||+++++++..
T Consensus 6 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~-----------~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~ 74 (288)
T cd06616 6 LKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE-----------KEQKRLLMDLDVVMRSSDCPYIVKFYGALFR 74 (288)
T ss_pred hHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh-----------HHHHHHHHHHHHHHHhcCCCCEeeeeeEEec
Confidence 34556899999999999999999999999865532111 2235678899999999 59999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCCCceeCCCCCCCEEEccCCe
Q 020641 96 GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHE-KVQPSIIHRDIRSSNVLLFEDFK 174 (323)
Q Consensus 96 ~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~-~~~~~i~h~dikp~nili~~~~~ 174 (323)
+...+++|||+.. ++.++........ ...+++..+..++.|++.|+.|||+ . +++|+||||+||+++.++.
T Consensus 75 ~~~~~~~~e~~~~-~l~~l~~~~~~~~----~~~l~~~~~~~i~~~i~~~l~~lh~~~---~i~H~dlkp~Nil~~~~~~ 146 (288)
T cd06616 75 EGDCWICMELMDI-SLDKFYKYVYEVL----KSVIPEEILGKIAVATVKALNYLKEEL---KIIHRDVKPSNILLDRNGN 146 (288)
T ss_pred CCcEEEEEecccC-CHHHHHHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhhcC---CeeccCCCHHHEEEccCCc
Confidence 9899999999865 6665442210000 0128899999999999999999996 5 8999999999999999999
Q ss_pred EEEeeccccCCCCccccccccccccCccccCCCccccCC---CCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhh
Q 020641 175 AKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG---QLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVT 251 (323)
Q Consensus 175 ~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~---~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~ 251 (323)
++|+|||++........ .....|+..|+|||.+.+. .++.++||||||+++|+|++|+.||...... ..
T Consensus 147 ~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-----~~ 218 (288)
T cd06616 147 IKLCDFGISGQLVDSIA---KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSV-----FD 218 (288)
T ss_pred EEEeecchhHHhccCCc---cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchH-----HH
Confidence 99999999865433221 1223478889999998765 6889999999999999999999999754310 00
Q ss_pred hhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 252 WATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
....... ...+.+........+..+.+++.+||+.+|++|||+.+|++
T Consensus 219 ~~~~~~~------~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~ 266 (288)
T cd06616 219 QLTQVVK------GDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLE 266 (288)
T ss_pred HHhhhcC------CCCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0000000 00011111222345677999999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=275.19 Aligned_cols=267 Identities=21% Similarity=0.285 Sum_probs=195.2
Q ss_pred CCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcC-CCCcccceeeEEE
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRL-KHENLVELLGYCV 94 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~ 94 (323)
.|....+||.|+||.||++.+..+++.+++|....... .......+.+|+.+++++ +|+||+++++++.
T Consensus 8 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~----------~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~ 77 (337)
T cd07852 8 KYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFR----------NATDAQRTFREIMFLQELGDHPNIVKLLNVIK 77 (337)
T ss_pred HHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccC----------cchhhhhhhHHHHHHHHhcCCCCccceeeeec
Confidence 35556689999999999999998888888886643211 111224567899999999 9999999999886
Q ss_pred eC--CeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccC
Q 020641 95 EG--NLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFED 172 (323)
Q Consensus 95 ~~--~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~ 172 (323)
.. ...++||||+.+ +|.+++.... +++..+..++.|++.||.|||+. |++|+||+|+||+++.+
T Consensus 78 ~~~~~~~~lv~e~~~~-~L~~~~~~~~----------~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~ 143 (337)
T cd07852 78 AENDKDIYLVFEYMET-DLHAVIRANI----------LEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSD 143 (337)
T ss_pred cCCCceEEEEeccccc-CHHHHHhcCC----------CCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCC
Confidence 53 468999999975 9999987642 78889999999999999999999 99999999999999999
Q ss_pred CeEEEeeccccCCCCccccc---cccccccCccccCCCccccC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccch
Q 020641 173 FKAKIADFNLSNQAPDMAAR---LHSTRVLGTFGYHAPEYAMT-GQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQS 248 (323)
Q Consensus 173 ~~~~l~Dfg~~~~~~~~~~~---~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~ 248 (323)
+.++|+|||++......... .......|+..|+|||.+.+ ..++.++|+||||+++|+|++|+.||..........
T Consensus 144 ~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~ 223 (337)
T cd07852 144 CRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLE 223 (337)
T ss_pred CcEEEeeccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence 99999999998765433221 12223457889999998764 457889999999999999999999997554322111
Q ss_pred hhhhhcccccccccc--------hhcC----CCcC--CCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHH
Q 020641 249 LVTWATPRLSEDKVK--------QCVD----PKLK--GEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKA 306 (323)
Q Consensus 249 ~~~~~~~~~~~~~~~--------~~~~----~~~~--~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~ 306 (323)
.............+. ..++ .... .......+..+.+++.+||+.||++|||+.++++.
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 224 KIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHHhCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 110000000000000 0000 0000 01112246789999999999999999999999973
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=269.63 Aligned_cols=262 Identities=19% Similarity=0.228 Sum_probs=193.1
Q ss_pred ccCCC--CCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeCCeE
Q 020641 22 RLDKG--PEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLR 99 (323)
Q Consensus 22 ~lg~G--~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 99 (323)
.||+| +++.||+++...+++.+|+|...... ........+.+|+++++.++|+||+++++++......
T Consensus 5 ~i~~~~~~~~~v~~~~~~~~~~~~avK~~~~~~----------~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~ 74 (314)
T cd08216 5 LIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDS----------CSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSEL 74 (314)
T ss_pred hhhHhhcCCceEEEEEecCCCCEEEEEEEeccc----------cchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeE
Confidence 34443 66778888888899999998765321 1122346789999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEEEee
Q 020641 100 VLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIAD 179 (323)
Q Consensus 100 ~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~l~D 179 (323)
+++|||+.+++|.+++....... +++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|
T Consensus 75 ~~~~e~~~~~~l~~~l~~~~~~~-------~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d 144 (314)
T cd08216 75 YVVSPLMAYGSCEDLLKTHFPEG-------LPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSG 144 (314)
T ss_pred EEEEeccCCCCHHHHHHHhcccC-------CCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEec
Confidence 99999999999999997653322 78889999999999999999999 999999999999999999999999
Q ss_pred ccccCCCCcccc-----ccccccccCccccCCCccccC--CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhh
Q 020641 180 FNLSNQAPDMAA-----RLHSTRVLGTFGYHAPEYAMT--GQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTW 252 (323)
Q Consensus 180 fg~~~~~~~~~~-----~~~~~~~~g~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 252 (323)
||.+........ ........++..|+|||.+.+ ..++.++|+||||+++|+|++|..||......... ...
T Consensus 145 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~--~~~ 222 (314)
T cd08216 145 LRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQML--LEK 222 (314)
T ss_pred CccceeeccccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHH--HHH
Confidence 998764432211 111122346778999998865 35788999999999999999999999754322110 000
Q ss_pred hcccc----ccc-------ccch----hc----CCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 253 ATPRL----SED-------KVKQ----CV----DPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 253 ~~~~~----~~~-------~~~~----~~----~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
..... ... .... .. ............+.++.+++.+||..||++|||+.++++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 294 (314)
T cd08216 223 VRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN 294 (314)
T ss_pred HhccCccccccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence 00000 000 0000 00 000111223445678999999999999999999999987
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=255.81 Aligned_cols=243 Identities=16% Similarity=0.195 Sum_probs=199.2
Q ss_pred ccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcC-CCCcccceeeEEEeC----
Q 020641 22 RLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRL-KHENLVELLGYCVEG---- 96 (323)
Q Consensus 22 ~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~---- 96 (323)
.||-|-.|.|-.+....+++.+|+|+..- ....++|+++.-+. .|+|||.++++|+..
T Consensus 69 vLG~GinGkV~~C~~k~T~ekfALKvL~D-----------------s~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~r 131 (400)
T KOG0604|consen 69 VLGAGINGKVVQCVHKRTQEKFALKVLLD-----------------SPKARREVELHWMASGHPHIVSIIDVYENSYQGR 131 (400)
T ss_pred hhccccCCceEEEEeccchhhhHHHHHhc-----------------CHHHHhHhhhhhhhcCCCceEEeehhhhhhccCc
Confidence 78999999999999999999999997652 25567888887666 899999999998743
Q ss_pred CeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEcc---CC
Q 020641 97 NLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFE---DF 173 (323)
Q Consensus 97 ~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~---~~ 173 (323)
..+.+|||+++||.|++.++.+.... +++..+..++.||+.|+.|||+. +|.||||||+|+|++. |-
T Consensus 132 kcLLiVmE~meGGeLfsriq~~g~~a-------fTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na 201 (400)
T KOG0604|consen 132 KCLLIVMECMEGGELFSRIQDRGDQA-------FTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNA 201 (400)
T ss_pred eeeEeeeecccchHHHHHHHHccccc-------chHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCc
Confidence 46789999999999999999887654 99999999999999999999999 9999999999999965 45
Q ss_pred eEEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhh
Q 020641 174 KAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWA 253 (323)
Q Consensus 174 ~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 253 (323)
.+||+|||.|....... .....+-|+.|.|||++-...|+...|+||+|+++|-|++|.+||.+......
T Consensus 202 ~lKLtDfGFAK~t~~~~---~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~ai------- 271 (400)
T KOG0604|consen 202 PLKLTDFGFAKETQEPG---DLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI------- 271 (400)
T ss_pred ceEecccccccccCCCc---cccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccC-------
Confidence 68999999998765322 22445579999999999888999999999999999999999999987765322
Q ss_pred cccccccccchhcCCCcCCCCC--HHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 254 TPRLSEDKVKQCVDPKLKGEYP--PKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
+.+.-..+....+....+ ...++..+++|+.+|+.+|.+|.|++++++
T Consensus 272 ----spgMk~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~ 321 (400)
T KOG0604|consen 272 ----SPGMKRRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD 321 (400)
T ss_pred ----ChhHHhHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence 222222222222221111 345788999999999999999999999987
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=264.54 Aligned_cols=242 Identities=19% Similarity=0.227 Sum_probs=187.3
Q ss_pred CCccccc--cCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcC-CCCcccceeeE
Q 020641 16 SPGYFVR--LDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRL-KHENLVELLGY 92 (323)
Q Consensus 16 ~~~~~~~--lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~ 92 (323)
.+.++.+ ||+|+||.||++.+..+++.+++|....+.... .|......+ +|+||+++++.
T Consensus 15 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-----------------~e~~~~~~~~~h~~iv~~~~~ 77 (267)
T PHA03390 15 NCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-----------------IEPMVHQLMKDNPNFIKLYYS 77 (267)
T ss_pred hhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-----------------hhHHHHHHhhcCCCEEEEEEE
Confidence 3344444 599999999999999999999988765321110 012222222 79999999999
Q ss_pred EEeCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccC
Q 020641 93 CVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFED 172 (323)
Q Consensus 93 ~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~ 172 (323)
+...+..++||||+.+++|.+++..... +++..+..++.|+++|+.+||+. |++|+||+|+||+++.+
T Consensus 78 ~~~~~~~~iv~e~~~~~~L~~~l~~~~~---------l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~ 145 (267)
T PHA03390 78 VTTLKGHVLIMDYIKDGDLFDLLKKEGK---------LSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRA 145 (267)
T ss_pred EecCCeeEEEEEcCCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCC
Confidence 9999999999999999999999976531 89999999999999999999999 99999999999999999
Q ss_pred C-eEEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhh
Q 020641 173 F-KAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVT 251 (323)
Q Consensus 173 ~-~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~ 251 (323)
+ .++|+|||.+...... ....++..|+|||.+.+..++.++|+||||+++|+|++|..||.......... .
T Consensus 146 ~~~~~l~dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~--~ 217 (267)
T PHA03390 146 KDRIYLCDYGLCKIIGTP------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDL--E 217 (267)
T ss_pred CCeEEEecCccceecCCC------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhH--H
Confidence 8 9999999988654321 22347889999999988889999999999999999999999997443221100 0
Q ss_pred hhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCC-hHHHHH
Q 020641 252 WATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPN-MSIVVK 305 (323)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps-~~evl~ 305 (323)
.+..... .........+..+.+++.+||+.+|.+||+ ++++++
T Consensus 218 ---------~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 218 ---------SLLKRQQ--KKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred ---------HHHHhhc--ccCCcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 0000010 011222356678999999999999999995 688875
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=262.77 Aligned_cols=249 Identities=24% Similarity=0.339 Sum_probs=201.2
Q ss_pred CccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeC
Q 020641 17 PGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEG 96 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 96 (323)
|....+||.|++|.||++++..+++.+++|........ +.....+.+|++++++++|+|++++++++..+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~----------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (254)
T cd06627 2 YQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIK----------EEALKSIMQEIDLLKNLKHPNIVKYIGSIETS 71 (254)
T ss_pred ceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccC----------HHHHHHHHHHHHHHHhCCCCCccEEEEEEEeC
Confidence 34556899999999999999988888888866533211 22346789999999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEE
Q 020641 97 NLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAK 176 (323)
Q Consensus 97 ~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~ 176 (323)
+..++++||+.+++|.+++..... +++..+..++.|++.++.+||+. |++|+||+|+||+++.++.++
T Consensus 72 ~~~~~v~e~~~~~~L~~~~~~~~~---------l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~ 139 (254)
T cd06627 72 DSLYIILEYAENGSLRQIIKKFGP---------FPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVK 139 (254)
T ss_pred CEEEEEEecCCCCcHHHHHHhccC---------CCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEE
Confidence 999999999999999999976532 89999999999999999999999 999999999999999999999
Q ss_pred EeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhccc
Q 020641 177 IADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPR 256 (323)
Q Consensus 177 l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 256 (323)
|+|||.+......... .....++..|+|||...+..++.++|+||+|+++|+|++|..||......... +..
T Consensus 140 l~d~~~~~~~~~~~~~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~----~~~-- 211 (254)
T cd06627 140 LADFGVATKLNDVSKD--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAAL----FRI-- 211 (254)
T ss_pred EeccccceecCCCccc--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHH----HHH--
Confidence 9999998766543221 22334788899999988777889999999999999999999999754321110 000
Q ss_pred ccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 257 LSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
. .......+...+..+.+++.+||..+|++|||+.+++.
T Consensus 212 ---------~-~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 212 ---------V-QDDHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred ---------h-ccCCCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 0 01111223344678999999999999999999999875
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=270.39 Aligned_cols=250 Identities=22% Similarity=0.298 Sum_probs=193.4
Q ss_pred CccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeC
Q 020641 17 PGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEG 96 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 96 (323)
+....+||.|++|.||++++..++..+++|........ ......++.+|+++++.++|+|++++++++...
T Consensus 17 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~---------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 87 (308)
T cd06634 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQ---------SNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE 87 (308)
T ss_pred HHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEeccccc---------ChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcC
Confidence 44456899999999999999988888888855421111 112235677899999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEE
Q 020641 97 NLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAK 176 (323)
Q Consensus 97 ~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~ 176 (323)
...++|+||+. +++.+.+..... .+++..+..++.|++.|+.|||+. +++|+||+|+||+++.++.++
T Consensus 88 ~~~~lv~e~~~-~~l~~~~~~~~~--------~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~k 155 (308)
T cd06634 88 HTAWLVMEYCL-GSASDLLEVHKK--------PLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVK 155 (308)
T ss_pred CeeEEEEEccC-CCHHHHHHHcCC--------CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEE
Confidence 99999999997 488887754322 178889999999999999999999 999999999999999999999
Q ss_pred EeeccccCCCCccccccccccccCccccCCCcccc---CCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhh
Q 020641 177 IADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAM---TGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWA 253 (323)
Q Consensus 177 l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 253 (323)
|+|||++..... .....++..|+|||.+. ...++.++||||||+++|+|++|..||..........
T Consensus 156 l~dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~----- 224 (308)
T cd06634 156 LGDFGSASIMAP------ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY----- 224 (308)
T ss_pred ECCcccceeecC------cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHH-----
Confidence 999998765432 12334788999999874 3457889999999999999999999986542211110
Q ss_pred cccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHh
Q 020641 254 TPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQ 308 (323)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~ 308 (323)
...............+..+.+++.+||..+|++||++.++++.-.
T Consensus 225 ----------~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~ 269 (308)
T cd06634 225 ----------HIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF 269 (308)
T ss_pred ----------HHhhcCCCCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcc
Confidence 011111111112345667999999999999999999999997533
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=276.66 Aligned_cols=265 Identities=18% Similarity=0.229 Sum_probs=192.0
Q ss_pred CCCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEE
Q 020641 15 PSPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCV 94 (323)
Q Consensus 15 ~~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 94 (323)
..|.....||.|+||.||++.+..+++.+++|....+. ....+.+.+|+++++.++|+||+++++++.
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~------------~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~ 72 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTD------------PQSVKHALREIKIIRRLDHDNIVKVYEVLG 72 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCC------------CchHHHHHHHHHHHHhcCCCcchhhHhhhc
Confidence 45666779999999999999999999999988654321 123366788999999999999999998765
Q ss_pred eC--------------CeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeC
Q 020641 95 EG--------------NLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHR 160 (323)
Q Consensus 95 ~~--------------~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~ 160 (323)
.. ...++|+||+.+ +|.+++.... +++..+..++.|++.|+.|||+. |++|+
T Consensus 73 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~~----------l~~~~~~~~~~qi~~aL~~LH~~---givH~ 138 (342)
T cd07854 73 PSGSDLTEDVGSLTELNSVYIVQEYMET-DLANVLEQGP----------LSEEHARLFMYQLLRGLKYIHSA---NVLHR 138 (342)
T ss_pred ccccccccccccccccceEEEEeecccc-cHHHHHHcCC----------CCHHHHHHHHHHHHHHHHHHHhC---CcccC
Confidence 43 357899999975 9998886432 88999999999999999999999 99999
Q ss_pred CCCCCCEEEcc-CCeEEEeeccccCCCCcccccc-ccccccCccccCCCccccC-CCCCcccchHHHHHHHHHHHhCCCC
Q 020641 161 DIRSSNVLLFE-DFKAKIADFNLSNQAPDMAARL-HSTRVLGTFGYHAPEYAMT-GQLTQKSDVYSFGVVLLELLTGRKP 237 (323)
Q Consensus 161 dikp~nili~~-~~~~~l~Dfg~~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p 237 (323)
||||+||+++. ++.++|+|||.+.......... ......++..|+|||.+.+ ..++.++|||||||++|+|++|+.|
T Consensus 139 dikp~Nili~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~p 218 (342)
T cd07854 139 DLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPL 218 (342)
T ss_pred CCCHHHEEEcCCCceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCC
Confidence 99999999974 5678999999987553321111 1122346888999997654 5678899999999999999999999
Q ss_pred CCCCCCcccchhhhhhcccccccccc-------hhcC-CCcCCC-----CCHHHHHHHHHHHHHccCCCCCCCCChHHHH
Q 020641 238 VDHTMPRGQQSLVTWATPRLSEDKVK-------QCVD-PKLKGE-----YPPKGVAKLAAVAALCVQYEAEFRPNMSIVV 304 (323)
Q Consensus 238 f~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~-~~~~~~-----~~~~~~~~l~~li~~cl~~~P~~Rps~~evl 304 (323)
|................+........ .... ...... .....+.++.+++.+||+.||.+|||+.+++
T Consensus 219 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell 298 (342)
T cd07854 219 FAGAHELEQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEAL 298 (342)
T ss_pred CCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHh
Confidence 97554322111111000000000000 0000 000000 1113456789999999999999999999998
Q ss_pred H
Q 020641 305 K 305 (323)
Q Consensus 305 ~ 305 (323)
.
T Consensus 299 ~ 299 (342)
T cd07854 299 M 299 (342)
T ss_pred C
Confidence 5
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=268.97 Aligned_cols=266 Identities=18% Similarity=0.227 Sum_probs=194.3
Q ss_pred CCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEe
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVE 95 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 95 (323)
.|+...+||.|+||.||++.+..+++.+++|...... ........+.+|+++++.++||||+++++++.+
T Consensus 8 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~----------~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~ 77 (302)
T cd07864 8 KFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDN----------EKEGFPITAIREIKILRQLNHRNIVNLKEIVTD 77 (302)
T ss_pred hhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecc----------cccCchHHHHHHHHHHHhCCCCCeeeeeheecC
Confidence 4556668999999999999999988888888654221 112234567889999999999999999998876
Q ss_pred CC----------eEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCC
Q 020641 96 GN----------LRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSS 165 (323)
Q Consensus 96 ~~----------~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~ 165 (323)
.. ..++|+||+.+ ++.+.+..... .+++..+..++.|++.||.|||+. |++|+||+|+
T Consensus 78 ~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~ 145 (302)
T cd07864 78 KQDALDFKKDKGAFYLVFEYMDH-DLMGLLESGLV--------HFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCS 145 (302)
T ss_pred cchhhhccccCCcEEEEEcccCc-cHHHHHhcCCC--------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHH
Confidence 54 78999999986 78777765422 289999999999999999999999 9999999999
Q ss_pred CEEEccCCeEEEeeccccCCCCccccccccccccCccccCCCccccC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCc
Q 020641 166 NVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT-GQLTQKSDVYSFGVVLLELLTGRKPVDHTMPR 244 (323)
Q Consensus 166 nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 244 (323)
||++++++.++|+|||.+......... ......++..|+|||.+.+ ..++.++||||||+++++|++|+.||......
T Consensus 146 nili~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~ 224 (302)
T cd07864 146 NILLNNKGQIKLADFGLARLYNSEESR-PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQEL 224 (302)
T ss_pred HEEECCCCcEEeCcccccccccCCccc-ccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH
Confidence 999999999999999998765433211 1122235778999998764 35688999999999999999999999755432
Q ss_pred ccchhhhhhcccccccccchhcC--------------CCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 245 GQQSLVTWATPRLSEDKVKQCVD--------------PKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~--------------~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
..................+...+ ...+ ......+..+.+++.+||+.+|.+|||+.++++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 225 AQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLR-EEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred HHHHHHHHHhCCCChhhcccccccccccccccccccccchh-hhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 11111111000000000000000 0000 011123567999999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=269.01 Aligned_cols=252 Identities=21% Similarity=0.272 Sum_probs=201.4
Q ss_pred CCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCC-CCcccceeeEEE
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLK-HENLVELLGYCV 94 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~ 94 (323)
.|.....||.|++|.||++++..+++.+++|+..+..... ......+.+|.+++++++ |+||+++++++.
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~---------~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~ 72 (280)
T cd05581 2 DFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIK---------EKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQ 72 (280)
T ss_pred CceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccc---------hHHHHHHHHHHHHHHhcccCCCchhHHHHhc
Confidence 3556668999999999999999999999999775432211 112356788999999997 999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCe
Q 020641 95 EGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFK 174 (323)
Q Consensus 95 ~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~ 174 (323)
..+..+++||++.+++|.+++..... +++..+..++.|++.|+.+||+. |++|+||+|+||+++.++.
T Consensus 73 ~~~~~~lv~e~~~~~~L~~~l~~~~~---------l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~ 140 (280)
T cd05581 73 DEENLYFVLEYAPNGELLQYIRKYGS---------LDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMH 140 (280)
T ss_pred CCceEEEEEcCCCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCC
Confidence 99999999999999999999976542 89999999999999999999999 9999999999999999999
Q ss_pred EEEeeccccCCCCccccc------------------cccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCC
Q 020641 175 AKIADFNLSNQAPDMAAR------------------LHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRK 236 (323)
Q Consensus 175 ~~l~Dfg~~~~~~~~~~~------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~ 236 (323)
++|+|||++......... .......++..|+|||...+..++.++|+||||++++++++|..
T Consensus 141 ~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~ 220 (280)
T cd05581 141 IKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKP 220 (280)
T ss_pred EEecCCccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCC
Confidence 999999998755432211 11223346788999999888888999999999999999999999
Q ss_pred CCCCCCCcccchhhhhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCCh----HHHHH
Q 020641 237 PVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNM----SIVVK 305 (323)
Q Consensus 237 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~----~evl~ 305 (323)
||........ ..... ......+...+..+.+++.+||+.+|.+|||+ +++++
T Consensus 221 p~~~~~~~~~---------------~~~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 221 PFRGSNEYLT---------------FQKIL--KLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred CCCCccHHHH---------------HHHHH--hcCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 9975532110 00000 11122334446779999999999999999999 77664
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=262.05 Aligned_cols=240 Identities=22% Similarity=0.249 Sum_probs=193.6
Q ss_pred cCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeCCeEEEE
Q 020641 23 LDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLA 102 (323)
Q Consensus 23 lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 102 (323)
||.|++|.||++.+..+++.+++|......... ......+..|+.+++.++|+||+++++.+..+...+++
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~---------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 71 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIK---------RKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLV 71 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcc---------hHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEE
Confidence 699999999999998888889988665432111 12345788899999999999999999999999999999
Q ss_pred EeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEEEeeccc
Q 020641 103 YEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNL 182 (323)
Q Consensus 103 ~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~l~Dfg~ 182 (323)
|||+.+++|.+++..... +++..+..++.|++.|+.+||+. +++|+||+|+||+++.++.++|+|||+
T Consensus 72 ~e~~~~~~L~~~l~~~~~---------l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~ 139 (250)
T cd05123 72 LEYAPGGELFSHLSKEGR---------FSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGL 139 (250)
T ss_pred EecCCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCc
Confidence 999999999999976532 88999999999999999999999 999999999999999999999999999
Q ss_pred cCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhccccccccc
Q 020641 183 SNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKV 262 (323)
Q Consensus 183 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 262 (323)
+....... .......++..|++||...+...+.++|+||||+++|++++|..||........ .
T Consensus 140 ~~~~~~~~--~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~---------------~ 202 (250)
T cd05123 140 AKELSSEG--SRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEI---------------Y 202 (250)
T ss_pred ceecccCC--CcccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHH---------------H
Confidence 87654322 112334478889999999888889999999999999999999999975532110 0
Q ss_pred chhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHH
Q 020641 263 KQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSI 302 (323)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~e 302 (323)
..... .....+...+..+.+++.+||..||++|||+.+
T Consensus 203 ~~~~~--~~~~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 203 EKILK--DPLRFPEFLSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred HHHhc--CCCCCCCCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence 11111 111233334677999999999999999999943
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=305.71 Aligned_cols=248 Identities=24% Similarity=0.292 Sum_probs=200.6
Q ss_pred ccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeCCeEEE
Q 020641 22 RLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVL 101 (323)
Q Consensus 22 ~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 101 (323)
++|.|-||.||.|.+..+|...|.|-+...... ......+.+|+.++..++|||+++++++-.+....++
T Consensus 1242 ~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~----------~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~I 1311 (1509)
T KOG4645|consen 1242 FIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD----------HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYI 1311 (1509)
T ss_pred ccCCcceeeeEEeecCCccchhhhhhhhcCccc----------cccCcchHHHHHHHHhccCccccccCceeecHHHHHH
Confidence 799999999999999999999998844432221 2233667899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEEEeecc
Q 020641 102 AYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFN 181 (323)
Q Consensus 102 v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~l~Dfg 181 (323)
.||||.+|+|.+++..... ..+.-...+..|++.|+.|||+. |||||||||.||+++.+|-+|++|||
T Consensus 1312 FMEyC~~GsLa~ll~~gri---------~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFG 1379 (1509)
T KOG4645|consen 1312 FMEYCEGGSLASLLEHGRI---------EDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFG 1379 (1509)
T ss_pred HHHHhccCcHHHHHHhcch---------hhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeeccc
Confidence 9999999999999977653 56666778899999999999999 99999999999999999999999999
Q ss_pred ccCCCCcccc--ccccccccCccccCCCccccCCC---CCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhccc
Q 020641 182 LSNQAPDMAA--RLHSTRVLGTFGYHAPEYAMTGQ---LTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPR 256 (323)
Q Consensus 182 ~~~~~~~~~~--~~~~~~~~g~~~y~aPE~~~~~~---~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 256 (323)
.|....+... ........||+.|+|||++.+.. -.-++|||||||++.||+||+.||...+.. |..
T Consensus 1380 sa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne-------~aI-- 1450 (1509)
T KOG4645|consen 1380 SAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE-------WAI-- 1450 (1509)
T ss_pred ceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch-------hHH--
Confidence 9987655421 11223455999999999997543 456899999999999999999999865431 111
Q ss_pred ccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHH
Q 020641 257 LSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKA 306 (323)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~ 306 (323)
.-.+-.+-....|...+.+-++|+.+||..||++|.++.|+++.
T Consensus 1451 ------My~V~~gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1451 ------MYHVAAGHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred ------HhHHhccCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 01111111234566688899999999999999999999988873
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-38 Score=277.16 Aligned_cols=252 Identities=21% Similarity=0.240 Sum_probs=210.1
Q ss_pred cCCCCCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceee
Q 020641 12 AHAPSPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLG 91 (323)
Q Consensus 12 ~~~~~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~ 91 (323)
.+...|....+||+|.|+.|.++++..++..||+|.+.+...... ....+.+|+++|..++||||++++.
T Consensus 53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~----------~~~k~~rev~imk~l~HPnIvkl~~ 122 (596)
T KOG0586|consen 53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPS----------KRQKLGREVDIMKSLNHPNIVKLFS 122 (596)
T ss_pred ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChH----------HHHHHHHHHHHHHhcCCcceeeeee
Confidence 444566666799999999999999999999999998876543332 2245789999999999999999999
Q ss_pred EEEeCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEcc
Q 020641 92 YCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFE 171 (323)
Q Consensus 92 ~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~ 171 (323)
+......+|+||||+.+|.+++++.+... ..+..+..++.|+..|+.|||++ +|+|||||.+|++++.
T Consensus 123 v~~t~~~lylV~eya~~ge~~~yl~~~gr---------~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~ 190 (596)
T KOG0586|consen 123 VIETEATLYLVMEYASGGELFDYLVKHGR---------MKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDE 190 (596)
T ss_pred eeeecceeEEEEEeccCchhHHHHHhccc---------chhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhccccc
Confidence 99999999999999999999999988764 66688999999999999999999 9999999999999999
Q ss_pred CCeEEEeeccccCCCCccccccccccccCccccCCCccccCCCC-CcccchHHHHHHHHHHHhCCCCCCCCCCcccchhh
Q 020641 172 DFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQL-TQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLV 250 (323)
Q Consensus 172 ~~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~ 250 (323)
+-+++|+|||++..+..... ....+|++.|.|||++.+..+ ++..|+||+|+++|-|+.|..||++.....-..
T Consensus 191 ~mnikIaDfgfS~~~~~~~~---lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~-- 265 (596)
T KOG0586|consen 191 NMNIKIADFGFSTFFDYGLM---LQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRP-- 265 (596)
T ss_pred ccceeeeccccceeeccccc---ccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccc--
Confidence 99999999999988764433 355679999999999999887 589999999999999999999998664322111
Q ss_pred hhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 251 TWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
..+...+ ..+.-.+.+..++|+++|-.+|.+|++.+++.+
T Consensus 266 -------------rvl~gk~--rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~ 305 (596)
T KOG0586|consen 266 -------------RVLRGKY--RIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMK 305 (596)
T ss_pred -------------hheeeee--cccceeechhHHHHHHhhccCccccCCHHHhhh
Confidence 1111111 223344567889999999999999999999875
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=271.41 Aligned_cols=278 Identities=20% Similarity=0.205 Sum_probs=198.2
Q ss_pred ccCCCCCCccceeccceeeeeeeeccccccccCcccccc--ccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeCCeE
Q 020641 22 RLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENER--LKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLR 99 (323)
Q Consensus 22 ~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~--~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 99 (323)
.||.|+||.||++.+..+++.+++|............+. ..........+.+|++++++++|+||+++++++......
T Consensus 16 ~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 95 (335)
T PTZ00024 16 HLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEGDFI 95 (335)
T ss_pred cccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecCCcE
Confidence 599999999999999999999999976543322211100 011112234678999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEEEee
Q 020641 100 VLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIAD 179 (323)
Q Consensus 100 ~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~l~D 179 (323)
+++|||+.+ +|.+++..... +++..+..++.|++.|+.+||+. |++|+||+|+||+++.++.++|+|
T Consensus 96 ~lv~e~~~~-~l~~~l~~~~~---------~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~~kl~d 162 (335)
T PTZ00024 96 NLVMDIMAS-DLKKVVDRKIR---------LTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICKIAD 162 (335)
T ss_pred EEEEecccc-CHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCCEEECC
Confidence 999999974 99999865432 88999999999999999999999 999999999999999999999999
Q ss_pred ccccCCCCccc------------cccccccccCccccCCCccccCC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCccc
Q 020641 180 FNLSNQAPDMA------------ARLHSTRVLGTFGYHAPEYAMTG-QLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQ 246 (323)
Q Consensus 180 fg~~~~~~~~~------------~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~ 246 (323)
||.+....... .........++..|+|||.+.+. .++.++|+||||+++|+|++|..||........
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~ 242 (335)
T PTZ00024 163 FGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQ 242 (335)
T ss_pred ccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 99986554111 01111222357789999988764 468899999999999999999999986653221
Q ss_pred chhhhhhcccccccccchhc--------C---CCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhhcCC
Q 020641 247 QSLVTWATPRLSEDKVKQCV--------D---PKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSP 314 (323)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~--------~---~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~~~~ 314 (323)
...+................ . +..........+..+.+++.+||+.+|++|||+.|++. ..+....
T Consensus 243 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~--~~~~~~~ 319 (335)
T PTZ00024 243 LGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK--HEYFKSD 319 (335)
T ss_pred HHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc--CcccCCC
Confidence 11110000000000000000 0 00000011223567899999999999999999999997 4444433
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=263.35 Aligned_cols=264 Identities=20% Similarity=0.260 Sum_probs=192.8
Q ss_pred ccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcC---CCCcccceeeEEE
Q 020641 18 GYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRL---KHENLVELLGYCV 94 (323)
Q Consensus 18 ~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~ 94 (323)
.....||.|+||.||++++..+++.+++|....... .......+.+|+.+++++ +|+|++++++++.
T Consensus 2 ~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~----------~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~ 71 (287)
T cd07838 2 EELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLS----------EEGIPLSTLREIALLKQLESFEHPNIVRLLDVCH 71 (287)
T ss_pred eEEEEecccCceEEEEEEECCCCCEEEEEEeccccc----------cchhhhhHHHHHHHHHHhhccCCCCcceEEEEEe
Confidence 456689999999999999998888899987653211 111223455666666554 6999999999998
Q ss_pred eCCe-----EEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEE
Q 020641 95 EGNL-----RVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLL 169 (323)
Q Consensus 95 ~~~~-----~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili 169 (323)
.... .+++|||+.+ +|.+++...... .+++..+..++.|++.||.+||+. +++|+||+|+||++
T Consensus 72 ~~~~~~~~~~~l~~e~~~~-~l~~~l~~~~~~-------~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili 140 (287)
T cd07838 72 GPRTDRELKLTLVFEHVDQ-DLATYLSKCPKP-------GLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILV 140 (287)
T ss_pred eccCCCCceeEEEehhccc-CHHHHHHHccCC-------CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEE
Confidence 7766 8999999975 899988664322 288999999999999999999999 99999999999999
Q ss_pred ccCCeEEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchh
Q 020641 170 FEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSL 249 (323)
Q Consensus 170 ~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~ 249 (323)
+.++.++|+|||.+........ .....++..|+|||.+.+..++.++|+||||+++|+|++|..||...........
T Consensus 141 ~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~ 217 (287)
T cd07838 141 TSDGQVKIADFGLARIYSFEMA---LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDK 217 (287)
T ss_pred ccCCCEEEeccCcceeccCCcc---cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHH
Confidence 9999999999999876543321 1223467889999999888899999999999999999999999976543221111
Q ss_pred hhhhccccccccc-------chhcCCCcC---CCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 250 VTWATPRLSEDKV-------KQCVDPKLK---GEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 250 ~~~~~~~~~~~~~-------~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
............. ......... .......+..+.+++.+||+.||.+||++.+++.
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 218 IFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred HHHHcCCCChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 1000000000000 000000000 1111244578899999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=269.31 Aligned_cols=269 Identities=21% Similarity=0.274 Sum_probs=193.0
Q ss_pred CCCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEE
Q 020641 15 PSPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCV 94 (323)
Q Consensus 15 ~~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 94 (323)
..|....+||.|++|.||++.+..+++.+++|...... ........+.+|+++++.++|+||+++++++.
T Consensus 8 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~----------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 77 (311)
T cd07866 8 RDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHN----------EKDGFPITALREIKILKKLKHPNVVPLIDMAV 77 (311)
T ss_pred ccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEecc----------CCCCcchhHHHHHHHHHhcCCCCccchhhhee
Confidence 34566668999999999999999999888888665332 11222345678999999999999999999875
Q ss_pred eCC--------eEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCC
Q 020641 95 EGN--------LRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSN 166 (323)
Q Consensus 95 ~~~--------~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~n 166 (323)
... ..++|++|+.+ ++.+.+..... .+++..+..++.|+++||.|||+. |++|+||||+|
T Consensus 78 ~~~~~~~~~~~~~~lv~~~~~~-~l~~~~~~~~~--------~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~n 145 (311)
T cd07866 78 ERPDKSKRKRGSVYMVTPYMDH-DLSGLLENPSV--------KLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAAN 145 (311)
T ss_pred cccccccccCceEEEEEecCCc-CHHHHHhcccc--------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHH
Confidence 433 46999999976 78777765332 289999999999999999999999 99999999999
Q ss_pred EEEccCCeEEEeeccccCCCCccccccc---------cccccCccccCCCccccCC-CCCcccchHHHHHHHHHHHhCCC
Q 020641 167 VLLFEDFKAKIADFNLSNQAPDMAARLH---------STRVLGTFGYHAPEYAMTG-QLTQKSDVYSFGVVLLELLTGRK 236 (323)
Q Consensus 167 ili~~~~~~~l~Dfg~~~~~~~~~~~~~---------~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~ 236 (323)
|++++++.++|+|||++........... .....+++.|+|||.+.+. .++.++||||||+++|+|++|+.
T Consensus 146 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~ 225 (311)
T cd07866 146 ILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRP 225 (311)
T ss_pred EEECCCCCEEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCC
Confidence 9999999999999999875543221111 1123467889999987653 57889999999999999999999
Q ss_pred CCCCCCCcccchhhhhhccccccc------ccchhcCCCcCCCCC-------HHHHHHHHHHHHHccCCCCCCCCChHHH
Q 020641 237 PVDHTMPRGQQSLVTWATPRLSED------KVKQCVDPKLKGEYP-------PKGVAKLAAVAALCVQYEAEFRPNMSIV 303 (323)
Q Consensus 237 pf~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~-------~~~~~~l~~li~~cl~~~P~~Rps~~ev 303 (323)
||...................... .+....+.......+ ......+.+++.+||+.||.+|||+.|+
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~el 305 (311)
T cd07866 226 ILQGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDA 305 (311)
T ss_pred CCCCCCHHHHHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHH
Confidence 997654432211111100000000 000000000000000 1223578999999999999999999998
Q ss_pred HH
Q 020641 304 VK 305 (323)
Q Consensus 304 l~ 305 (323)
+.
T Consensus 306 l~ 307 (311)
T cd07866 306 LE 307 (311)
T ss_pred hc
Confidence 75
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=264.61 Aligned_cols=255 Identities=20% Similarity=0.244 Sum_probs=194.7
Q ss_pred CccccccCCCCCCccceeccc---eeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcC-CCCcccceeeE
Q 020641 17 PGYFVRLDKGPEDDLYLKKRV---KMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRL-KHENLVELLGY 92 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~~~---~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~ 92 (323)
|....+||.|+||.||+|++. .+++.+++|+...... .......+.+.+|+.+++++ +|+||+++++.
T Consensus 2 y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~--------~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~ 73 (290)
T cd05613 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATI--------VQKAKTTEHTRTERQVLEHIRQSPFLVTLHYA 73 (290)
T ss_pred ceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhh--------hhcchHHHHHHHHHHHHHhcccCCChhceeeE
Confidence 456678999999999999885 3678888887643211 11122346678899999999 69999999999
Q ss_pred EEeCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccC
Q 020641 93 CVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFED 172 (323)
Q Consensus 93 ~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~ 172 (323)
+..+...++|+||+.+++|.+++..... +++..+..++.|++.||.+||+. |++|+||+|+||+++.+
T Consensus 74 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~---------l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~ 141 (290)
T cd05613 74 FQTDTKLHLILDYINGGELFTHLSQRER---------FKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSN 141 (290)
T ss_pred eecCCeEEEEEecCCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCC
Confidence 9999999999999999999999976432 78889999999999999999999 99999999999999999
Q ss_pred CeEEEeeccccCCCCccccccccccccCccccCCCccccCC--CCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhh
Q 020641 173 FKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG--QLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLV 250 (323)
Q Consensus 173 ~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~ 250 (323)
+.++|+|||++......... ......|+..|+|||.+.+. .++.++||||||+++|+|++|..||............
T Consensus 142 ~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~ 220 (290)
T cd05613 142 GHVVLTDFGLSKEFHEDEVE-RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEI 220 (290)
T ss_pred CCEEEeeCccceeccccccc-ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHH
Confidence 99999999998765332111 11233478899999988653 4678999999999999999999999643221111100
Q ss_pred hhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCC-----ChHHHHH
Q 020641 251 TWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRP-----NMSIVVK 305 (323)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-----s~~evl~ 305 (323)
...+... ....+...+..+.+++.+||+.||++|| +++++++
T Consensus 221 ------------~~~~~~~-~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 221 ------------SRRILKS-EPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred ------------HHHhhcc-CCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 0000000 1122344567799999999999999997 6777766
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=252.87 Aligned_cols=278 Identities=18% Similarity=0.295 Sum_probs=208.3
Q ss_pred CCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEe
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVE 95 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 95 (323)
.|+..-++|+|.||.||+|+..++++.|++|...-+ ++.+.+.....+|+.+|+.+.|+|++.+++.|..
T Consensus 18 ~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlme----------neKeGfpitalreikiL~~lkHenv~nliEic~t 87 (376)
T KOG0669|consen 18 KYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLME----------NEKEGFPITALREIKILQLLKHENVVNLIEICRT 87 (376)
T ss_pred HHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHh----------ccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhh
Confidence 344555899999999999999999998887755422 3346677888999999999999999999988752
Q ss_pred --------CCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCE
Q 020641 96 --------GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNV 167 (323)
Q Consensus 96 --------~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~ni 167 (323)
...+|+||++|++ +|.-++.+...+ ++..++.+++.++.+||.|+|.. .|+|||+|+.|+
T Consensus 88 k~Tp~~r~r~t~ylVf~~ceh-DLaGlLsn~~vr--------~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNv 155 (376)
T KOG0669|consen 88 KATPTNRDRATFYLVFDFCEH-DLAGLLSNRKVR--------FSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANV 155 (376)
T ss_pred ccCCcccccceeeeeHHHhhh-hHHHHhcCcccc--------ccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhE
Confidence 2358999999998 999999876544 99999999999999999999999 999999999999
Q ss_pred EEccCCeEEEeeccccCCCCcccccc--ccccccCccccCCCccccC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCc
Q 020641 168 LLFEDFKAKIADFNLSNQAPDMAARL--HSTRVLGTFGYHAPEYAMT-GQLTQKSDVYSFGVVLLELLTGRKPVDHTMPR 244 (323)
Q Consensus 168 li~~~~~~~l~Dfg~~~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 244 (323)
||+.++.++|+|||+++.+....+.. ......-|.+|++||.+.| ..+++..|||+.||++.+|+|+.+.|.+....
T Consensus 156 LIt~dgilklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteq 235 (376)
T KOG0669|consen 156 LITKDGILKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQ 235 (376)
T ss_pred EEcCCceEEeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHH
Confidence 99999999999999996554322211 1122235899999999986 56899999999999999999999999877655
Q ss_pred ccchhhhhhcccccc--------cccchhcCCC--cCCCC--------CHHHHHHHHHHHHHccCCCCCCCCChHHHHHH
Q 020641 245 GQQSLVTWATPRLSE--------DKVKQCVDPK--LKGEY--------PPKGVAKLAAVAALCVQYEAEFRPNMSIVVKA 306 (323)
Q Consensus 245 ~~~~~~~~~~~~~~~--------~~~~~~~~~~--~~~~~--------~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~ 306 (323)
.....+...-..... -.+.+.++.. ..+.. +-.-.++..+++..+|..||.+|+.+.++++
T Consensus 236 qql~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~aln- 314 (376)
T KOG0669|consen 236 QQLHLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALN- 314 (376)
T ss_pred HHHHHHHHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhc-
Confidence 443333221111111 1222222111 10000 0001236778999999999999999999987
Q ss_pred HhhhhcCCCCC
Q 020641 307 LQPLLKSPPPA 317 (323)
Q Consensus 307 l~~~~~~~~~~ 317 (323)
...+...|.|
T Consensus 315 -h~~F~kdp~p 324 (376)
T KOG0669|consen 315 -HDFFWKDPMP 324 (376)
T ss_pred -hhhhhcCCcc
Confidence 4555554444
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-37 Score=269.69 Aligned_cols=264 Identities=19% Similarity=0.233 Sum_probs=195.7
Q ss_pred CCCCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEE
Q 020641 14 APSPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYC 93 (323)
Q Consensus 14 ~~~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 93 (323)
...|.....||.|+||.||++.+..+++.+++|...+.. ......+.+.+|+++++.++||||+++++++
T Consensus 9 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~----------~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~ 78 (328)
T cd07856 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPF----------STPVLAKRTYRELKLLKHLRHENIISLSDIF 78 (328)
T ss_pred ccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccc----------cccchhHHHHHHHHHHHhcCCCCeeeEeeeE
Confidence 345667779999999999999999999999998664321 1122346678899999999999999999988
Q ss_pred Ee-CCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccC
Q 020641 94 VE-GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFED 172 (323)
Q Consensus 94 ~~-~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~ 172 (323)
.. ....++++||+. ++|.++++... ++...+..++.|+++||.+||+. |++|+||+|+||+++.+
T Consensus 79 ~~~~~~~~lv~e~~~-~~L~~~~~~~~----------~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~ 144 (328)
T cd07856 79 ISPLEDIYFVTELLG-TDLHRLLTSRP----------LEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINEN 144 (328)
T ss_pred ecCCCcEEEEeehhc-cCHHHHHhcCC----------CCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCC
Confidence 75 557899999985 58998886532 77888889999999999999999 99999999999999999
Q ss_pred CeEEEeeccccCCCCccccccccccccCccccCCCccccC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhh
Q 020641 173 FKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT-GQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVT 251 (323)
Q Consensus 173 ~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~ 251 (323)
+.++|+|||.+...... .....++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||.............
T Consensus 145 ~~~~l~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~ 219 (328)
T cd07856 145 CDLKICDFGLARIQDPQ-----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIIT 219 (328)
T ss_pred CCEEeCccccccccCCC-----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 99999999998754321 122346788999998765 568899999999999999999999997654321111111
Q ss_pred hhcccccc--------cccchhcCC-CcCCCCC-----HHHHHHHHHHHHHccCCCCCCCCChHHHHHH
Q 020641 252 WATPRLSE--------DKVKQCVDP-KLKGEYP-----PKGVAKLAAVAALCVQYEAEFRPNMSIVVKA 306 (323)
Q Consensus 252 ~~~~~~~~--------~~~~~~~~~-~~~~~~~-----~~~~~~l~~li~~cl~~~P~~Rps~~evl~~ 306 (323)
........ ......+.. ......+ ...+..+.+++.+||+.+|++|||+.+++..
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 220 DLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred HHhCCCCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000000 000000000 0001111 1235789999999999999999999999873
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=234.72 Aligned_cols=265 Identities=18% Similarity=0.257 Sum_probs=209.7
Q ss_pred CccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeC
Q 020641 17 PGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEG 96 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 96 (323)
|.-+.|||+|.||+||++++..+.+.+|+|..... ...+.......+|+-+++.+.|.||++++++...+
T Consensus 4 ydkmekigegtygtvfkarn~~t~eivalkrvrld----------dddegvpssalreicllkelkhknivrl~dvlhsd 73 (292)
T KOG0662|consen 4 YDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLD----------DDDEGVPSSALREICLLKELKHKNIVRLHDVLHSD 73 (292)
T ss_pred hHHHHhhcCCcceeeEecccCCccceEEEEEEecc----------CCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccC
Confidence 45567999999999999999999999999855432 22234456778999999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEE
Q 020641 97 NLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAK 176 (323)
Q Consensus 97 ~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~ 176 (323)
+...+|+|||.. +|..+...-.+. +....+..++.|++.|+.++|+. ++.|||+||.|.+|+.||++|
T Consensus 74 kkltlvfe~cdq-dlkkyfdslng~--------~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelk 141 (292)
T KOG0662|consen 74 KKLTLVFEFCDQ-DLKKYFDSLNGD--------LDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELK 141 (292)
T ss_pred ceeEEeHHHhhH-HHHHHHHhcCCc--------CCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEE
Confidence 999999999976 999998766554 88889999999999999999999 999999999999999999999
Q ss_pred EeeccccCCCCccccccccccccCccccCCCccccCCC-CCcccchHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhc
Q 020641 177 IADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQ-LTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWAT 254 (323)
Q Consensus 177 l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~ 254 (323)
|.|||+++-+...... .+...-|.+|++|.++.+.. |+...|+||.||++.|+.. |.+.|.+.+...+...+.+.-
T Consensus 142 ladfglarafgipvrc--ysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~l 219 (292)
T KOG0662|consen 142 LADFGLARAFGIPVRC--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLL 219 (292)
T ss_pred ecccchhhhcCCceEe--eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHh
Confidence 9999999877654332 23344689999999998765 7889999999999999987 777787776555555555554
Q ss_pred ccccccccchhcC-CCc--CCCCC---------HHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 255 PRLSEDKVKQCVD-PKL--KGEYP---------PKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 255 ~~~~~~~~~~~~~-~~~--~~~~~---------~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
.....+..+.+.. +.. -..++ +.....=++++...|..+|.+|+++++.++
T Consensus 220 g~p~ed~wps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 220 GTPTEDQWPSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred CCCccccCCccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 4444444433321 111 11111 122334578888889999999999998765
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=272.70 Aligned_cols=267 Identities=19% Similarity=0.264 Sum_probs=194.5
Q ss_pred CCCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEE
Q 020641 15 PSPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCV 94 (323)
Q Consensus 15 ~~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 94 (323)
..|.....||.|+||.||+|.+..+++.+++|...... ........+.+|+.+++.++|+||+++++++.
T Consensus 15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~----------~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~ 84 (342)
T cd07879 15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPF----------QSEIFAKRAYRELTLLKHMQHENVIGLLDVFT 84 (342)
T ss_pred cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCcc----------ccccchhHHHHHHHHHHhcCCCCccchhheec
Confidence 45566679999999999999999889999998654321 11223456788999999999999999999987
Q ss_pred eC------CeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEE
Q 020641 95 EG------NLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVL 168 (323)
Q Consensus 95 ~~------~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nil 168 (323)
.. ..+++|+||+.. +|.++.... +++..+..++.|++.|+.|||+. |++|+||+|+||+
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~-----------~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIl 149 (342)
T cd07879 85 SAVSGDEFQDFYLVMPYMQT-DLQKIMGHP-----------LSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLA 149 (342)
T ss_pred ccccCCCCceEEEEeccccc-CHHHHHcCC-----------CCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEE
Confidence 54 346999999975 787765321 88899999999999999999999 9999999999999
Q ss_pred EccCCeEEEeeccccCCCCccccccccccccCccccCCCccccC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccc
Q 020641 169 LFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT-GQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQ 247 (323)
Q Consensus 169 i~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~ 247 (323)
++.++.++|+|||++...... .....++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||.........
T Consensus 150 l~~~~~~kL~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~ 224 (342)
T cd07879 150 VNEDCELKILDFGLARHADAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQL 224 (342)
T ss_pred ECCCCCEEEeeCCCCcCCCCC-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 999999999999998754321 122346788999998865 45788999999999999999999999765321111
Q ss_pred hhhhhhccccccccc---------chhcC--CCc-CCC---CCHHHHHHHHHHHHHccCCCCCCCCChHHHHH--HHhhh
Q 020641 248 SLVTWATPRLSEDKV---------KQCVD--PKL-KGE---YPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK--ALQPL 310 (323)
Q Consensus 248 ~~~~~~~~~~~~~~~---------~~~~~--~~~-~~~---~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~--~l~~~ 310 (323)
........ ...... ..... +.. +.. .....+..+.+++.+||+.||.+|||+.+++. +++.+
T Consensus 225 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~ 303 (342)
T cd07879 225 TQILKVTG-VPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSF 303 (342)
T ss_pred HHHHHhcC-CCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhc
Confidence 10000000 000000 00000 000 000 00123456889999999999999999999994 46655
Q ss_pred hc
Q 020641 311 LK 312 (323)
Q Consensus 311 ~~ 312 (323)
..
T Consensus 304 ~~ 305 (342)
T cd07879 304 RD 305 (342)
T ss_pred cc
Confidence 43
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=262.33 Aligned_cols=263 Identities=22% Similarity=0.271 Sum_probs=198.4
Q ss_pred ccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeCC
Q 020641 18 GYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGN 97 (323)
Q Consensus 18 ~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 97 (323)
....+||.|++|.||+++...+++.+++|...... ......+.+.+|+.++++++|+|++++++++....
T Consensus 2 ~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~----------~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~ 71 (282)
T cd07829 2 EKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDN----------EEEGIPSTALREISLLKELKHPNIVKLLDVIHTER 71 (282)
T ss_pred eeehcccccCcceEEEeeecCCCcEEEEEEecccc----------ccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCC
Confidence 34567999999999999999999999998765432 12334467788999999999999999999999999
Q ss_pred eEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEEE
Q 020641 98 LRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKI 177 (323)
Q Consensus 98 ~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~l 177 (323)
..++|+||+.+ +|.+++..... .+++..+..++.|++.||.+||+. |++|+||+|+||+++.++.++|
T Consensus 72 ~~~~v~e~~~~-~l~~~i~~~~~--------~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l 139 (282)
T cd07829 72 KLYLVFEYCDM-DLKKYLDKRPG--------PLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKL 139 (282)
T ss_pred ceEEEecCcCc-CHHHHHHhhcc--------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEE
Confidence 99999999985 99999976531 189999999999999999999999 9999999999999999999999
Q ss_pred eeccccCCCCccccccccccccCccccCCCccccCC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhccc
Q 020641 178 ADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG-QLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPR 256 (323)
Q Consensus 178 ~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 256 (323)
+|||.+......... .....++..|+|||.+.+. .++.++|+||||++++++++|..||..................
T Consensus 140 ~d~g~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 217 (282)
T cd07829 140 ADFGLARAFGIPLRT--YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGT 217 (282)
T ss_pred ecCCcccccCCCccc--cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCC
Confidence 999998765443221 1223356789999988766 7788999999999999999999999765422111000000000
Q ss_pred c-------------cccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 257 L-------------SEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 257 ~-------------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
. .......+..... ....+..+..+.+++.+||..||++||++.+++.
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 218 PTEESWPGVTKLPDYKPTFPKFPPKDL-EKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred CcHHHHHhhcccccccccccccCccch-HHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 0 0000011100000 0111123567999999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=264.53 Aligned_cols=260 Identities=20% Similarity=0.225 Sum_probs=197.3
Q ss_pred CccccccCCCCCCccceeccc---eeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcC-CCCcccceeeE
Q 020641 17 PGYFVRLDKGPEDDLYLKKRV---KMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRL-KHENLVELLGY 92 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~~~---~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~ 92 (323)
+.....||+|++|.||++++. .+++.+++|+..+... .......+.+.+|+.+++++ +|+||+++++.
T Consensus 2 ~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~--------~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~ 73 (288)
T cd05583 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATI--------VQKAKTAEHTRTERQVLEAVRRCPFLVTLHYA 73 (288)
T ss_pred ceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHH--------HhhhhHHHHHHHHHHHHHhccCCcchhhhhee
Confidence 445568999999999998864 3556788876543211 11122346678899999999 69999999999
Q ss_pred EEeCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccC
Q 020641 93 CVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFED 172 (323)
Q Consensus 93 ~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~ 172 (323)
+..+...++||||+.+++|.+++..... +++..+..++.|++.+|.+||+. +++|+||+|+||+++.+
T Consensus 74 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~---------~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~ 141 (288)
T cd05583 74 FQTDTKLHLILDYVNGGELFTHLYQREH---------FTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSE 141 (288)
T ss_pred eecCCEEEEEEecCCCCcHHHHHhhcCC---------cCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCC
Confidence 9999999999999999999999865432 88889999999999999999999 99999999999999999
Q ss_pred CeEEEeeccccCCCCccccccccccccCccccCCCccccCCC--CCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhh
Q 020641 173 FKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQ--LTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLV 250 (323)
Q Consensus 173 ~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~--~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~ 250 (323)
+.++|+|||++......... ......|+..|+|||.+.+.. .+.++|+||||+++|+|++|..||............
T Consensus 142 ~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~ 220 (288)
T cd05583 142 GHVVLTDFGLSKEFLAEEEE-RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEI 220 (288)
T ss_pred CCEEEEECcccccccccccc-ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHH
Confidence 99999999998765432211 112234788999999887654 678999999999999999999999643221111000
Q ss_pred hhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhh
Q 020641 251 TWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPL 310 (323)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~ 310 (323)
. ...... ....+...+..+.+++.+||+.||++|||+.++.+.|+..
T Consensus 221 ~-----------~~~~~~--~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~ 267 (288)
T cd05583 221 S-----------RRILKS--KPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHP 267 (288)
T ss_pred H-----------HHHHcc--CCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence 0 000000 1122334556799999999999999999998887776654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=262.53 Aligned_cols=262 Identities=21% Similarity=0.296 Sum_probs=193.5
Q ss_pred ccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCC-CCcccceeeEEEeC
Q 020641 18 GYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLK-HENLVELLGYCVEG 96 (323)
Q Consensus 18 ~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~ 96 (323)
....+||.|++|+||+++...+++.+++|....+... .......+|+..+++++ |+|++++++.+..+
T Consensus 2 ~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~-----------~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 70 (283)
T cd07830 2 KVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS-----------WEECMNLREVKSLRKLNEHPNIVKLKEVFREN 70 (283)
T ss_pred eeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc-----------hhHHHHHHHHHHHHhccCCCCchhHHHHhhcC
Confidence 4556899999999999999988998999865432211 11123456888999997 99999999999999
Q ss_pred CeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEE
Q 020641 97 NLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAK 176 (323)
Q Consensus 97 ~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~ 176 (323)
...++||||+ +++|.+++...... .+++..+..++.|++.++.|||+. |++|+||+|+||+++.++.++
T Consensus 71 ~~~~lv~e~~-~~~l~~~~~~~~~~-------~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~ 139 (283)
T cd07830 71 DELYFVFEYM-EGNLYQLMKDRKGK-------PFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVK 139 (283)
T ss_pred CcEEEEEecC-CCCHHHHHHhcccc-------cCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEE
Confidence 9999999999 67999988765421 289999999999999999999999 999999999999999999999
Q ss_pred EeeccccCCCCccccccccccccCccccCCCcccc-CCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhh----
Q 020641 177 IADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAM-TGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVT---- 251 (323)
Q Consensus 177 l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~---- 251 (323)
|+|||.+........ .....++..|+|||.+. ...++.++|+||||+++++|++|+.||.............
T Consensus 140 l~d~~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~ 216 (283)
T cd07830 140 IADFGLAREIRSRPP---YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLG 216 (283)
T ss_pred EeecccceeccCCCC---cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcC
Confidence 999999875543221 12234688899999875 4557889999999999999999999997654322111110
Q ss_pred ------hhccccccccc----chhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 252 ------WATPRLSEDKV----KQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 252 ------~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
|.......... ........ .......+..+.+++.+||+.+|++|||++|++.
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 217 TPTKQDWPEGYKLASKLGFRFPQFAPTSL-HQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred CCChhhhhhHhhhhccccccccccccccH-HHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 00000000000 00000000 0001112467999999999999999999999976
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-37 Score=260.93 Aligned_cols=255 Identities=22% Similarity=0.240 Sum_probs=192.8
Q ss_pred CccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeC
Q 020641 17 PGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEG 96 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 96 (323)
|....+||+|+||.||++++...+...++|+....... .........+..|+.+++.++||||+++++.+...
T Consensus 2 y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 74 (260)
T cd08222 2 YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVG-------ELNPNETVQANQEAQLLSKLDHPAIVKFHASFLER 74 (260)
T ss_pred ceeeeeecCCCCceEEEEEecCCCCcceEEEecccccc-------ccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcC
Confidence 45567899999999999998877655544433211110 01122234566789999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEE
Q 020641 97 NLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAK 176 (323)
Q Consensus 97 ~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~ 176 (323)
...++|+||+.+++|.+++...... ...+++..++.++.|++.|+.+||+. |++|+||+|+||+++. +.++
T Consensus 75 ~~~~lv~e~~~~~~l~~~~~~~~~~-----~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~ 145 (260)
T cd08222 75 DAFCIITEYCEGRDLDCKLEELKHT-----GKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLK 145 (260)
T ss_pred CceEEEEEeCCCCCHHHHHHHHhhc-----ccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEe
Confidence 9999999999999999988642211 11289999999999999999999999 9999999999999975 5699
Q ss_pred EeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhccc
Q 020641 177 IADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPR 256 (323)
Q Consensus 177 l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 256 (323)
|+|||.+........ ......+++.|+|||.+.+..++.++|+||||+++|+|++|..||........
T Consensus 146 l~d~g~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~---------- 213 (260)
T cd08222 146 IGDFGVSRLLMGSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSV---------- 213 (260)
T ss_pred ecccCceeecCCCcc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHH----------
Confidence 999998865533221 12233478889999998888888999999999999999999999964321100
Q ss_pred ccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 257 LSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
..... .......+...+..+.+++.+||+.+|++||++.++++
T Consensus 214 -----~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 214 -----VLRIV-EGPTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred -----HHHHH-cCCCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 00010 11112234556678999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=274.23 Aligned_cols=271 Identities=20% Similarity=0.224 Sum_probs=198.9
Q ss_pred ccCCCCCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCccccee
Q 020641 11 GAHAPSPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELL 90 (323)
Q Consensus 11 ~~~~~~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~ 90 (323)
..-..+|.....||.|++|.||++++..+++.+++|...... ......+.+.+|+.+++.++|+|+++++
T Consensus 11 ~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~----------~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 80 (343)
T cd07851 11 WEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPF----------QSAIHAKRTYRELRLLKHMDHENVIGLL 80 (343)
T ss_pred ecccCceEEEEEeccCCceEEEEEEECCCCcEEEEEeccccc----------chhhHHHHHHHHHHHHHhccCCCHHHHH
Confidence 334456777789999999999999999999999998654211 1122335667899999999999999999
Q ss_pred eEEEeCCe------EEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCC
Q 020641 91 GYCVEGNL------RVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRS 164 (323)
Q Consensus 91 ~~~~~~~~------~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp 164 (323)
+++..... .++|+||+. ++|.+++.... +++..+..++.|++.|+.+||+. |++|+||+|
T Consensus 81 ~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~----------l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp 146 (343)
T cd07851 81 DVFTPASSLEDFQDVYLVTHLMG-ADLNNIVKCQK----------LSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKP 146 (343)
T ss_pred HHhhccccccccccEEEEEecCC-CCHHHHHhcCC----------CCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCH
Confidence 88765544 899999984 59999987532 89999999999999999999999 999999999
Q ss_pred CCEEEccCCeEEEeeccccCCCCccccccccccccCccccCCCccccC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCC
Q 020641 165 SNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT-GQLTQKSDVYSFGVVLLELLTGRKPVDHTMP 243 (323)
Q Consensus 165 ~nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 243 (323)
+||+++.++.++|+|||++...... .....++..|+|||.+.+ ..++.++||||||+++|++++|+.||.....
T Consensus 147 ~Nill~~~~~~kL~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~ 221 (343)
T cd07851 147 SNIAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDH 221 (343)
T ss_pred HHeEECCCCCEEEcccccccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh
Confidence 9999999999999999998765432 123346888999998765 3678899999999999999999999975543
Q ss_pred cccchhhhhhccc--------ccccccchh---cCCCcCCC---CCHHHHHHHHHHHHHccCCCCCCCCChHHHHH--HH
Q 020641 244 RGQQSLVTWATPR--------LSEDKVKQC---VDPKLKGE---YPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK--AL 307 (323)
Q Consensus 244 ~~~~~~~~~~~~~--------~~~~~~~~~---~~~~~~~~---~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~--~l 307 (323)
............. ......... +....+.. .....+..+.+++.+||+.+|++|||+.+|++ ++
T Consensus 222 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~ 301 (343)
T cd07851 222 IDQLKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYL 301 (343)
T ss_pred HHHHHHHHHhcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCc
Confidence 2111110000000 000000000 00000000 01123568999999999999999999999987 34
Q ss_pred hhh
Q 020641 308 QPL 310 (323)
Q Consensus 308 ~~~ 310 (323)
++.
T Consensus 302 ~~~ 304 (343)
T cd07851 302 AEY 304 (343)
T ss_pred ccc
Confidence 443
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=264.73 Aligned_cols=251 Identities=21% Similarity=0.297 Sum_probs=189.5
Q ss_pred CCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcC-CCCcccceeeEEE
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRL-KHENLVELLGYCV 94 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~ 94 (323)
.+....+||.|++|.||++++..+++.+++|....... ......+..|+.++... +|+||+++++++.
T Consensus 16 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~-----------~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~ 84 (296)
T cd06618 16 DLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGN-----------KEENKRILMDLDVVLKSHDCPYIVKCYGYFI 84 (296)
T ss_pred hheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCC-----------hHHHHHHHHHHHHHHhccCCCchHhhheeee
Confidence 44566699999999999999999899999987643211 11123455566666666 6999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCCCceeCCCCCCCEEEccCC
Q 020641 95 EGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHE-KVQPSIIHRDIRSSNVLLFEDF 173 (323)
Q Consensus 95 ~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~-~~~~~i~h~dikp~nili~~~~ 173 (323)
.....+++|||+.+ ++.+++..... .+++..+..++.|++.|+.|||+ . |++|+||+|+||+++.++
T Consensus 85 ~~~~~~~v~e~~~~-~l~~l~~~~~~--------~l~~~~~~~i~~~i~~~l~~lH~~~---~i~H~dl~p~nill~~~~ 152 (296)
T cd06618 85 TDSDVFICMELMST-CLDKLLKRIQG--------PIPEDILGKMTVAIVKALHYLKEKH---GVIHRDVKPSNILLDASG 152 (296)
T ss_pred cCCeEEEEeeccCc-CHHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHhhC---CEecCCCcHHHEEEcCCC
Confidence 99999999999865 78887765332 28889999999999999999996 6 999999999999999999
Q ss_pred eEEEeeccccCCCCccccccccccccCccccCCCccccCCC----CCcccchHHHHHHHHHHHhCCCCCCCCCCcccchh
Q 020641 174 KAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQ----LTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSL 249 (323)
Q Consensus 174 ~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~----~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~ 249 (323)
.++|+|||++......... ....++..|+|||.+.+.. ++.++|+||||+++|+|++|+.||....... ..
T Consensus 153 ~~kL~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-~~- 227 (296)
T cd06618 153 NVKLCDFGISGRLVDSKAK---TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEF-EV- 227 (296)
T ss_pred CEEECccccchhccCCCcc---cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHH-HH-
Confidence 9999999998765432211 2223678899999887543 7889999999999999999999996432110 00
Q ss_pred hhhhcccccccccchhcCCCc-CCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHH
Q 020641 250 VTWATPRLSEDKVKQCVDPKL-KGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKA 306 (323)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~ 306 (323)
+...+.... ........+..+.+++.+||+.||++|||+.++++.
T Consensus 228 ------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 228 ------------LTKILQEEPPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred ------------HHHHhcCCCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 001111100 001111345679999999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-37 Score=271.66 Aligned_cols=265 Identities=21% Similarity=0.222 Sum_probs=193.4
Q ss_pred cCCCCCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceee
Q 020641 12 AHAPSPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLG 91 (323)
Q Consensus 12 ~~~~~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~ 91 (323)
.-...|.....||+|+||.||++.+..+++.+++|....... .....+.+.+|+.++++++|+||+++++
T Consensus 14 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~----------~~~~~~~~~~Ei~~l~~l~h~~iv~~~~ 83 (345)
T cd07877 14 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ----------SIIHAKRTYRELRLLKHMKHENVIGLLD 83 (345)
T ss_pred hccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcch----------hhHHHHHHHHHHHHHHHcCCCcccceee
Confidence 344567777789999999999999999999999986643210 1112356778999999999999999999
Q ss_pred EEEeC------CeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCC
Q 020641 92 YCVEG------NLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSS 165 (323)
Q Consensus 92 ~~~~~------~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~ 165 (323)
++... ...+++++++ +++|.+++.... +++..+..++.|++.|+.|||+. |++|+||||+
T Consensus 84 ~~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~~~----------l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~ 149 (345)
T cd07877 84 VFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK----------LTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPS 149 (345)
T ss_pred eeeecccccccccEEEEehhc-ccCHHHHHhcCC----------CCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChH
Confidence 88643 3467888877 669998886532 88999999999999999999999 9999999999
Q ss_pred CEEEccCCeEEEeeccccCCCCccccccccccccCccccCCCccccC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCc
Q 020641 166 NVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT-GQLTQKSDVYSFGVVLLELLTGRKPVDHTMPR 244 (323)
Q Consensus 166 nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 244 (323)
||+++.++.++|+|||++...... .....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||......
T Consensus 150 NIll~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~ 224 (345)
T cd07877 150 NLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI 224 (345)
T ss_pred HEEEcCCCCEEEeccccccccccc-----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 999999999999999998754321 123347888999998766 46788999999999999999999999654322
Q ss_pred ccchhhhhhccccccccc--------chh---cCCCcCC---CCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 245 GQQSLVTWATPRLSEDKV--------KQC---VDPKLKG---EYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~--------~~~---~~~~~~~---~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
.................. ... +...... ......+..+.+++.+||+.||.+|||+.++++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 299 (345)
T cd07877 225 DQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 299 (345)
T ss_pred HHHHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhc
Confidence 111100000000000000 000 0000000 000123567899999999999999999999987
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=292.77 Aligned_cols=254 Identities=22% Similarity=0.282 Sum_probs=188.3
Q ss_pred CCCCCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeE
Q 020641 13 HAPSPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGY 92 (323)
Q Consensus 13 ~~~~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 92 (323)
-...++.+..||+||||.||+|++.-+|+.+|+|.+.... .......+.+|+.++.+|+||||++++..
T Consensus 477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~-----------s~~~~skI~rEVk~LArLnHpNVVRYysA 545 (1351)
T KOG1035|consen 477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA-----------SDKLYSKILREVKLLARLNHPNVVRYYSA 545 (1351)
T ss_pred HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch-----------HHHHHHHHHHHHHHHhhcCCcceeeeehh
Confidence 4455566668999999999999999999999999776432 12223667899999999999999998874
Q ss_pred EEe-----------------------------------------------------------------------------
Q 020641 93 CVE----------------------------------------------------------------------------- 95 (323)
Q Consensus 93 ~~~----------------------------------------------------------------------------- 95 (323)
+.+
T Consensus 546 WVEs~~~~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~de 625 (1351)
T KOG1035|consen 546 WVESTAELTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDE 625 (1351)
T ss_pred hhccCCccccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccc
Confidence 310
Q ss_pred -C-----------------------------------------CeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHH
Q 020641 96 -G-----------------------------------------NLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWM 133 (323)
Q Consensus 96 -~-----------------------------------------~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~ 133 (323)
+ ...|+-||||+..++.+++.++... -...
T Consensus 626 dg~~~S~tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~--------~~~d 697 (1351)
T KOG1035|consen 626 DGRNLSNTSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN--------SQRD 697 (1351)
T ss_pred cccccccccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc--------hhhH
Confidence 0 1247889999986777777665421 1367
Q ss_pred HHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEEEeeccccCCCC----------------cccccccccc
Q 020641 134 TRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAP----------------DMAARLHSTR 197 (323)
Q Consensus 134 ~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~l~Dfg~~~~~~----------------~~~~~~~~~~ 197 (323)
..|+++++|++||.|+|++ |++||||||.||+++.+..|||+|||+|+... .+......+.
T Consensus 698 ~~wrLFreIlEGLaYIH~~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts 774 (1351)
T KOG1035|consen 698 EAWRLFREILEGLAYIHDQ---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTS 774 (1351)
T ss_pred HHHHHHHHHHHHHHHHHhC---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCccccc
Confidence 8899999999999999999 99999999999999999999999999997721 0111123345
Q ss_pred ccCccccCCCccccCC---CCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccccccccchhcCCCcC--C
Q 020641 198 VLGTFGYHAPEYAMTG---QLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLK--G 272 (323)
Q Consensus 198 ~~g~~~y~aPE~~~~~---~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~ 272 (323)
..||.-|.|||++.+. .|+.|+|+||||+++|||+ +||........ . +..+-+..+. .
T Consensus 775 ~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~---yPF~TsMERa~--i------------L~~LR~g~iP~~~ 837 (1351)
T KOG1035|consen 775 QVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEML---YPFGTSMERAS--I------------LTNLRKGSIPEPA 837 (1351)
T ss_pred ccceeeeecHHHhcccccccccchhhhHHHHHHHHHHh---ccCCchHHHHH--H------------HHhcccCCCCCCc
Confidence 5699999999999754 4999999999999999998 46753321110 0 0011111111 1
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 273 EYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 273 ~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
.+.......-..+|.+|++.||.+||||.|+|.
T Consensus 838 ~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 838 DFFDPEHPEEASLIRWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred ccccccchHHHHHHHHHhcCCCccCCCHHHHhh
Confidence 112233345678999999999999999999987
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-37 Score=271.03 Aligned_cols=267 Identities=21% Similarity=0.256 Sum_probs=196.4
Q ss_pred CCCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEE
Q 020641 15 PSPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCV 94 (323)
Q Consensus 15 ~~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 94 (323)
..|.....||.|+||.||++.+..++..+++|...... ........+.+|+.+++.++|+||+++++++.
T Consensus 15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 84 (343)
T cd07880 15 DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPF----------QSELFAKRAYRELRLLKHMKHENVIGLLDVFT 84 (343)
T ss_pred cceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccc----------cchHHHHHHHHHHHHHHhcCCCCccceeeeec
Confidence 34667779999999999999999999999998654211 11223456789999999999999999999887
Q ss_pred eCC------eEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEE
Q 020641 95 EGN------LRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVL 168 (323)
Q Consensus 95 ~~~------~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nil 168 (323)
... ..++|++|+ +++|.+++.... +++..+..++.|++.|+.|||+. |++|+||+|+||+
T Consensus 85 ~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~----------l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nil 150 (343)
T cd07880 85 PDLSLDRFHDFYLVMPFM-GTDLGKLMKHEK----------LSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLA 150 (343)
T ss_pred CCccccccceEEEEEecC-CCCHHHHHhcCC----------CCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEE
Confidence 543 458999998 569998886432 88999999999999999999999 9999999999999
Q ss_pred EccCCeEEEeeccccCCCCccccccccccccCccccCCCccccC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccc
Q 020641 169 LFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT-GQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQ 247 (323)
Q Consensus 169 i~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~ 247 (323)
++.++.++|+|||++....... ....+++.|+|||.+.+ ..++.++|+||||+++|++++|..||.........
T Consensus 151 l~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~ 225 (343)
T cd07880 151 VNEDCELKILDFGLARQTDSEM-----TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQL 225 (343)
T ss_pred EcCCCCEEEeecccccccccCc-----cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 9999999999999987653311 22346888999998875 45788999999999999999999999755432111
Q ss_pred hhhhhhcccccc--------cccchhcC--CCcC----CCCCHHHHHHHHHHHHHccCCCCCCCCChHHHH--HHHhhh
Q 020641 248 SLVTWATPRLSE--------DKVKQCVD--PKLK----GEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVV--KALQPL 310 (323)
Q Consensus 248 ~~~~~~~~~~~~--------~~~~~~~~--~~~~----~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl--~~l~~~ 310 (323)
............ ........ +... .......+..+.+++.+||+.||.+|||+.+++ .+++..
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~ 304 (343)
T cd07880 226 MEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEF 304 (343)
T ss_pred HHHHHhcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhh
Confidence 110000000000 00000000 0000 011123455789999999999999999999999 445444
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-38 Score=267.69 Aligned_cols=249 Identities=19% Similarity=0.232 Sum_probs=206.0
Q ss_pred CccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeC
Q 020641 17 PGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEG 96 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 96 (323)
+..+..||+||||.|+.++-..+|+-+|.|+..++.......+ ....+|-.+|++++.+-||.+-..|+..
T Consensus 187 F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge---------~maLnEk~iL~kV~s~FiVslaYAfeTk 257 (591)
T KOG0986|consen 187 FRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGE---------TMALNEKQILEKVSSPFIVSLAYAFETK 257 (591)
T ss_pred eeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhh---------HHhhHHHHHHHHhccCcEEEEeeeecCC
Confidence 4455689999999999999999999999998887655443332 3346788899999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEE
Q 020641 97 NLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAK 176 (323)
Q Consensus 97 ~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~ 176 (323)
+.+++|+..|.||+|.-.+...... .+++..+.-++.+|+.||.+||+. +|++||+||+|||+|+.|+++
T Consensus 258 d~LClVLtlMNGGDLkfHiyn~g~~-------gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvR 327 (591)
T KOG0986|consen 258 DALCLVLTLMNGGDLKFHIYNHGNP-------GFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVR 327 (591)
T ss_pred CceEEEEEeecCCceeEEeeccCCC-------CCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeE
Confidence 9999999999999999988765532 299999999999999999999999 999999999999999999999
Q ss_pred EeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhccc
Q 020641 177 IADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPR 256 (323)
Q Consensus 177 l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 256 (323)
|+|+|+|..+...... ....||.+|||||++.+..|+...|-|||||++|+|+.|+.||........
T Consensus 328 ISDLGLAvei~~g~~~---~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk---------- 394 (591)
T KOG0986|consen 328 ISDLGLAVEIPEGKPI---RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVK---------- 394 (591)
T ss_pred eeccceEEecCCCCcc---ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhh----------
Confidence 9999999988765543 233699999999999999999999999999999999999999965432211
Q ss_pred ccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCCh
Q 020641 257 LSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNM 300 (323)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~ 300 (323)
.+++...+... ...++...+++.+++++..|.+||.+|.-.
T Consensus 395 --~eEvdrr~~~~-~~ey~~kFS~eakslc~~LL~Kdp~~RLGc 435 (591)
T KOG0986|consen 395 --REEVDRRTLED-PEEYSDKFSEEAKSLCEGLLTKDPEKRLGC 435 (591)
T ss_pred --HHHHHHHHhcc-hhhcccccCHHHHHHHHHHHccCHHHhccC
Confidence 11222211111 134567788899999999999999999743
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=260.24 Aligned_cols=274 Identities=21% Similarity=0.270 Sum_probs=207.3
Q ss_pred CCCCccccccCCCCCcccc--ccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhc
Q 020641 3 YDYHPRALGAHAPSPGYFV--RLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSR 80 (323)
Q Consensus 3 ~~~~~~~~~~~~~~~~~~~--~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~ 80 (323)
||+..+.+.......+... .+|+|.||.||.++. .|+.||+|++.. .......+|.++.+.
T Consensus 197 SGSGlplLVQRTiarqI~L~e~IGkGRyGEVwrG~w--rGe~VAVKiF~s---------------rdE~SWfrEtEIYqT 259 (513)
T KOG2052|consen 197 SGSGLPLLVQRTIARQIVLQEIIGKGRFGEVWRGRW--RGEDVAVKIFSS---------------RDERSWFRETEIYQT 259 (513)
T ss_pred CCCCchhHhHHhhhheeEEEEEecCccccceeeccc--cCCceEEEEecc---------------cchhhhhhHHHHHHH
Confidence 5666777777776665443 889999999999998 566789887762 223556788888876
Q ss_pred C--CCCcccceeeEEEeCC----eEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcC--
Q 020641 81 L--KHENLVELLGYCVEGN----LRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEK-- 152 (323)
Q Consensus 81 l--~h~~i~~~~~~~~~~~----~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~-- 152 (323)
. +|+||+.+++.-..++ .+|||++|.+.|||+|+++++. ++.....+++..++.||++||..
T Consensus 260 vmLRHENILgFIaaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r~t----------v~~~~ml~LalS~AsGLaHLH~eI~ 329 (513)
T KOG2052|consen 260 VMLRHENILGFIAADNKDNGSWTQLWLVTDYHEHGSLYDYLNRNT----------VTTEGMLKLALSIASGLAHLHMEIV 329 (513)
T ss_pred HHhccchhhhhhhccccCCCceEEEEEeeecccCCcHHHHHhhcc----------CCHHHHHHHHHHHhhhHHHHHHHHh
Confidence 5 9999999998766543 5799999999999999999865 99999999999999999999964
Q ss_pred ---CCCCceeCCCCCCCEEEccCCeEEEeeccccCCCCcccc--ccccccccCccccCCCccccCC------CCCcccch
Q 020641 153 ---VQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAA--RLHSTRVLGTFGYHAPEYAMTG------QLTQKSDV 221 (323)
Q Consensus 153 ---~~~~i~h~dikp~nili~~~~~~~l~Dfg~~~~~~~~~~--~~~~~~~~g~~~y~aPE~~~~~------~~~~~~Di 221 (323)
.++.|.|||||..|||+.+++.+.|+|+|+|........ ........||.+|+|||++... ..-..+||
T Consensus 330 GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADI 409 (513)
T KOG2052|consen 330 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADI 409 (513)
T ss_pred cCCCCchhhccccccccEEEccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHH
Confidence 378899999999999999999999999999965544322 1223344599999999988532 22347999
Q ss_pred HHHHHHHHHHHhC----------CCCCCCCCCcccchhhhhhcccccccccchhc-CCCcCCCCC-----HHHHHHHHHH
Q 020641 222 YSFGVVLLELLTG----------RKPVDHTMPRGQQSLVTWATPRLSEDKVKQCV-DPKLKGEYP-----PKGVAKLAAV 285 (323)
Q Consensus 222 ~slG~~l~~l~~g----------~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~-----~~~~~~l~~l 285 (323)
||||.++||+... +.||.+.-+. -.+.+++.+++ ...++...| .+....+.++
T Consensus 410 YafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~-----------DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~kl 478 (513)
T KOG2052|consen 410 YAFGLVLWEIARRCESGGIVEEYQLPYYDVVPS-----------DPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKL 478 (513)
T ss_pred HHHHHHHHHHHHHhhcCCEehhhcCCcccCCCC-----------CCCHHHHhcceeecccCCCCCcccccCHHHHHHHHH
Confidence 9999999999872 2455433221 11122222222 222222222 3455688999
Q ss_pred HHHccCCCCCCCCChHHHHHHHhhhhcCC
Q 020641 286 AALCVQYEAEFRPNMSIVVKALQPLLKSP 314 (323)
Q Consensus 286 i~~cl~~~P~~Rps~~evl~~l~~~~~~~ 314 (323)
|+.||..||.-|.|+--|-+.|.++.+.+
T Consensus 479 MkeCW~~Np~aRltALriKKtl~~l~~~~ 507 (513)
T KOG2052|consen 479 MKECWYANPAARLTALRIKKTLAKLSNSD 507 (513)
T ss_pred HHHhhcCCchhhhHHHHHHHHHHHHhcCh
Confidence 99999999999999999999999998643
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=267.83 Aligned_cols=266 Identities=18% Similarity=0.204 Sum_probs=190.4
Q ss_pred CccccccCCCCCCccceecccee--eeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcC-CCCcccceeeEE
Q 020641 17 PGYFVRLDKGPEDDLYLKKRVKM--RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRL-KHENLVELLGYC 93 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~~~~~--~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~ 93 (323)
|.....||.|+||.||++.+..+ +..+++|...... ......+.+.+|+++++++ +|+||+++++.+
T Consensus 2 y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~----------~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 71 (332)
T cd07857 2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVF----------SKKILAKRALRELKLLRHFRGHKNITCLYDMD 71 (332)
T ss_pred ceEEEEccccCCeEEEEEEeCCCCcCceEEEEEecccc----------ccchhHHHHHHHHHHHHHhcCCCChheeeeee
Confidence 45556899999999999999887 8888888654221 1122345678899999999 699999999875
Q ss_pred EeC----CeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEE
Q 020641 94 VEG----NLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLL 169 (323)
Q Consensus 94 ~~~----~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili 169 (323)
... ...+++++|+. ++|.+++..... +++..+..++.|++.||.|||+. |++|+||||+||++
T Consensus 72 ~~~~~~~~~~~~~~e~~~-~~L~~~l~~~~~---------~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili 138 (332)
T cd07857 72 IVFPGNFNELYLYEELME-ADLHQIIRSGQP---------LTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLV 138 (332)
T ss_pred eeccccCCcEEEEEeccc-CCHHHHHhcCCC---------CCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEE
Confidence 432 45788899886 489999865432 88999999999999999999999 99999999999999
Q ss_pred ccCCeEEEeeccccCCCCccccc--cccccccCccccCCCccccC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCccc
Q 020641 170 FEDFKAKIADFNLSNQAPDMAAR--LHSTRVLGTFGYHAPEYAMT-GQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQ 246 (323)
Q Consensus 170 ~~~~~~~l~Dfg~~~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~ 246 (323)
+.++.++|+|||.+......... .......|+..|+|||.+.+ ..++.++|+||+|+++|++++|..||........
T Consensus 139 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~ 218 (332)
T cd07857 139 NADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQ 218 (332)
T ss_pred cCCCCEEeCcCCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHH
Confidence 99999999999998755432211 11123457889999998765 4678999999999999999999999975432110
Q ss_pred chhhhhhcccccccccchhcC-----------CCcC---CCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 247 QSLVTWATPRLSEDKVKQCVD-----------PKLK---GEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~-----------~~~~---~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
...............+..+.. .... .......+..+.+++.+||+.||.+|||+.+++.
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 219 LNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred HHHHHHHhCCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 000000000000000000000 0000 0011123567999999999999999999999975
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=252.63 Aligned_cols=255 Identities=20% Similarity=0.280 Sum_probs=199.8
Q ss_pred ccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcC-CCCcccceeeEEEeCCeEE
Q 020641 22 RLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRL-KHENLVELLGYCVEGNLRV 100 (323)
Q Consensus 22 ~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~ 100 (323)
.||+|+++.|--+.++.++..+|+|++.+. .-..+.++.+|++++.++ .|+||++++++|+++..+|
T Consensus 85 ~LGeGAyasVqtcv~i~t~~EYAVKiidKq------------~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FY 152 (463)
T KOG0607|consen 85 LLGEGAYASVQTCVSIQTGKEYAVKIIDKQ------------PGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFY 152 (463)
T ss_pred HhcCccceeeeeeeeeccchhhhhhhhhcC------------CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEE
Confidence 679999999999999999999999977643 233457889999999999 8999999999999999999
Q ss_pred EEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCC---eEEE
Q 020641 101 LAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDF---KAKI 177 (323)
Q Consensus 101 lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~---~~~l 177 (323)
+|||-+.||+|...|..+.. +++..+..+...|+.||.+||++ ||.|||+||+|||-.+-. -+||
T Consensus 153 LVfEKm~GGplLshI~~~~~---------F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKi 220 (463)
T KOG0607|consen 153 LVFEKMRGGPLLSHIQKRKH---------FNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKI 220 (463)
T ss_pred EEEecccCchHHHHHHHhhh---------ccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceee
Confidence 99999999999999987764 99999999999999999999999 999999999999997654 3799
Q ss_pred eeccccCCCCccc-----cccccccccCccccCCCcccc-----CCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccc
Q 020641 178 ADFNLSNQAPDMA-----ARLHSTRVLGTFGYHAPEYAM-----TGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQ 247 (323)
Q Consensus 178 ~Dfg~~~~~~~~~-----~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~ 247 (323)
|||.++....... .........|+..|||||+.. ...|+.+.|.||||+++|-|+.|..||.+..+.+-
T Consensus 221 CDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dC- 299 (463)
T KOG0607|consen 221 CDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADC- 299 (463)
T ss_pred eccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcC-
Confidence 9998875432211 111223455888999999773 24578999999999999999999999988766332
Q ss_pred hhhhhhccccc---ccccchhcCCCcCCCCCH----HHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 248 SLVTWATPRLS---EDKVKQCVDPKLKGEYPP----KGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 248 ~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~----~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
.|.....= ...+.+-+..+. -++|. ..+.+..+++...|..++.+|.++.+++.
T Consensus 300 ---GWdrGe~Cr~CQ~~LFesIQEGk-YeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 300 ---GWDRGEVCRVCQNKLFESIQEGK-YEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred ---CccCCCccHHHHHHHHHHHhccC-CcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 11111000 001111111111 12232 34678889999999999999999999887
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=253.47 Aligned_cols=220 Identities=20% Similarity=0.192 Sum_probs=176.0
Q ss_pred CCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeCCeEEEEEee
Q 020641 26 GPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEF 105 (323)
Q Consensus 26 G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 105 (323)
|.+|.||+|++..+++.+++|.+.+.. .+..+...+....||||+++++++......+++|||
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----------------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~ 66 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----------------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQH 66 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----------------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEec
Confidence 899999999999999999998665321 122333444445799999999999999999999999
Q ss_pred cCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEEEeeccccCC
Q 020641 106 ATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQ 185 (323)
Q Consensus 106 ~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~l~Dfg~~~~ 185 (323)
+.+++|.+++..... +++..+..++.|++.|+.|||+. |++|+||||+||+++.++.++++|||.+..
T Consensus 67 ~~~~~L~~~l~~~~~---------l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~ 134 (237)
T cd05576 67 AEGGKLWSHISKFLN---------IPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSE 134 (237)
T ss_pred CCCCCHHHHHHHhcC---------CCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhc
Confidence 999999999866432 88999999999999999999999 999999999999999999999999998755
Q ss_pred CCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccccccccchh
Q 020641 186 APDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQC 265 (323)
Q Consensus 186 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (323)
..... ....++..|+|||...+..++.++|+||+|+++|+|++|..||.......
T Consensus 135 ~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~-------------------- 189 (237)
T cd05576 135 VEDSC-----DGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI-------------------- 189 (237)
T ss_pred ccccc-----ccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc--------------------
Confidence 43321 12235677999999888888999999999999999999998875321100
Q ss_pred cCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCCh
Q 020641 266 VDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNM 300 (323)
Q Consensus 266 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~ 300 (323)
........+...+..+.+++.+||+.||++||++
T Consensus 190 -~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~ 223 (237)
T cd05576 190 -NTHTTLNIPEWVSEEARSLLQQLLQFNPTERLGA 223 (237)
T ss_pred -ccccccCCcccCCHHHHHHHHHHccCCHHHhcCC
Confidence 0000011233345679999999999999999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=268.67 Aligned_cols=243 Identities=18% Similarity=0.248 Sum_probs=197.4
Q ss_pred CCCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcC-CCCcccceeeEE
Q 020641 15 PSPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRL-KHENLVELLGYC 93 (323)
Q Consensus 15 ~~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~ 93 (323)
.+|+.-..+|.|+|+.|-.+.+..+++..+.|++.+. ..+..+|+.++... +|+||++..+++
T Consensus 322 ~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~----------------~~~~~~e~~~~~~~~~h~niv~~~~v~ 385 (612)
T KOG0603|consen 322 ESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR----------------ADDNQDEIPISLLVRDHPNIVKSHDVY 385 (612)
T ss_pred hhhccccccCCCCccceeeeeccccccchhheecccc----------------ccccccccchhhhhcCCCcceeeccee
Confidence 4555666899999999999999999998888877643 12234556566555 899999999999
Q ss_pred EeCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEE-ccC
Q 020641 94 VEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLL-FED 172 (323)
Q Consensus 94 ~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili-~~~ 172 (323)
.++...|+|||.+.|+-+.+.+..... .. ..+..|+.+|+.++.|||.+ |++|||+||+|||+ ++.
T Consensus 386 ~~~~~~~~v~e~l~g~ell~ri~~~~~---------~~-~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~ 452 (612)
T KOG0603|consen 386 EDGKEIYLVMELLDGGELLRRIRSKPE---------FC-SEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSA 452 (612)
T ss_pred cCCceeeeeehhccccHHHHHHHhcch---------hH-HHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCC
Confidence 999999999999999888888766542 33 67788999999999999999 99999999999999 588
Q ss_pred CeEEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhh
Q 020641 173 FKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTW 252 (323)
Q Consensus 173 ~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 252 (323)
++++|+|||.+...+.. ....+-|..|.|||++....+++++|+||||++||+|++|+.||......
T Consensus 453 g~lrltyFG~a~~~~~~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~-------- 519 (612)
T KOG0603|consen 453 GHLRLTYFGFWSELERS-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG-------- 519 (612)
T ss_pred CcEEEEEechhhhCchh-----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch--------
Confidence 99999999999887654 22334588899999999999999999999999999999999999755432
Q ss_pred hcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhh
Q 020641 253 ATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLL 311 (323)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~ 311 (323)
..+...+. ........+...++|+.+||+.||.+||++.++.. ..++
T Consensus 520 -------~ei~~~i~---~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~--h~w~ 566 (612)
T KOG0603|consen 520 -------IEIHTRIQ---MPKFSECVSDEAKDLLQQLLQVDPALRLGADEIGA--HPWF 566 (612)
T ss_pred -------HHHHHhhc---CCccccccCHHHHHHHHHhccCChhhCcChhhhcc--Ccch
Confidence 11111111 12223566788999999999999999999999987 4555
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=255.61 Aligned_cols=272 Identities=26% Similarity=0.354 Sum_probs=205.1
Q ss_pred ccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhc--CCCCcccceeeEEEe
Q 020641 18 GYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSR--LKHENLVELLGYCVE 95 (323)
Q Consensus 18 ~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~--l~h~~i~~~~~~~~~ 95 (323)
+.+..+|+|.||.||+|+... +.||+|++... ..+.+..|-++.+. +.|+||+++++.-..
T Consensus 213 ~l~eli~~Grfg~V~KaqL~~--~~VAVKifp~~---------------~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr 275 (534)
T KOG3653|consen 213 QLLELIGRGRFGCVWKAQLDN--RLVAVKIFPEQ---------------EKQSFQNEKNIYSLPGMKHENILQFIGAEKR 275 (534)
T ss_pred hhHHHhhcCccceeehhhccC--ceeEEEecCHH---------------HHHHHHhHHHHHhccCccchhHHHhhchhcc
Confidence 344478999999999999855 89999977632 23556666666554 489999999998775
Q ss_pred CC----eEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCC------CCCceeCCCCCC
Q 020641 96 GN----LRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKV------QPSIIHRDIRSS 165 (323)
Q Consensus 96 ~~----~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~------~~~i~h~dikp~ 165 (323)
+. .++||++|.+.|+|.++++.+. ++|....+++..++.||+|||+.. +++|+|||||..
T Consensus 276 ~t~~~~eywLVt~fh~kGsL~dyL~~nt----------isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSk 345 (534)
T KOG3653|consen 276 GTADRMEYWLVTEFHPKGSLCDYLKANT----------ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSK 345 (534)
T ss_pred CCccccceeEEeeeccCCcHHHHHHhcc----------ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCcccccccccc
Confidence 55 7899999999999999999886 999999999999999999999753 778999999999
Q ss_pred CEEEccCCeEEEeeccccCCCCccccccccccccCccccCCCccccCCC------CCcccchHHHHHHHHHHHhCCCCCC
Q 020641 166 NVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQ------LTQKSDVYSFGVVLLELLTGRKPVD 239 (323)
Q Consensus 166 nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~------~~~~~Di~slG~~l~~l~~g~~pf~ 239 (323)
|||+.+++++.|+|||+|..+.........-...||.+|||||++.+.- .-.+.||||+|.++|||++...-+.
T Consensus 346 NVLvK~DlTccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~ 425 (534)
T KOG3653|consen 346 NVLVKNDLTCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDAD 425 (534)
T ss_pred ceEEccCCcEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhccccc
Confidence 9999999999999999998776444333333456999999999986531 1247899999999999999665543
Q ss_pred C-CCCcccchhhhhhcccccccccchhc-CCCcCCCCCH-----HHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhhc
Q 020641 240 H-TMPRGQQSLVTWATPRLSEDKVKQCV-DPKLKGEYPP-----KGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLK 312 (323)
Q Consensus 240 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~-----~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~~ 312 (323)
. .-.......-.....+..-+++++.+ ....+...+. ....-|.+.+..||..||+.|.|+.=+.+++..+..
T Consensus 426 ~~~vp~Yqlpfe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~ 505 (534)
T KOG3653|consen 426 PGPVPEYQLPFEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMM 505 (534)
T ss_pred CCCCCcccCchhHHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhc
Confidence 2 11111111122333344444444333 2222333333 224679999999999999999999999999999887
Q ss_pred CCCC
Q 020641 313 SPPP 316 (323)
Q Consensus 313 ~~~~ 316 (323)
..+.
T Consensus 506 ~~~~ 509 (534)
T KOG3653|consen 506 LWED 509 (534)
T ss_pred cCCc
Confidence 6653
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-37 Score=256.87 Aligned_cols=262 Identities=14% Similarity=0.178 Sum_probs=199.9
Q ss_pred CCCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcC-CC-C----cccc
Q 020641 15 PSPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRL-KH-E----NLVE 88 (323)
Q Consensus 15 ~~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h-~----~i~~ 88 (323)
..|..+.+||+|.||.|-.+-+..++..+|+|++.. -..+++..+-|+++++++ .+ | -++.
T Consensus 89 ~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~-------------V~kYreAa~iEi~vLqki~~~DP~g~~rcv~ 155 (415)
T KOG0671|consen 89 NRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKN-------------VDKYREAALIEIEVLQKINESDPNGKFRCVQ 155 (415)
T ss_pred cceehhhhhcCCcccceEEEeecCCCceehHHHHHH-------------HHHHhhHHHHHHHHHHHHHhcCCCCceEEEe
Confidence 445556689999999999999999999999996641 233446667788999888 33 2 4667
Q ss_pred eeeEEEeCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEE
Q 020641 89 LLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVL 168 (323)
Q Consensus 89 ~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nil 168 (323)
+.++|...++.++|+|.+. -|+++++.++.... ++..++..+.+|+++++++||+. +++|-|+||+|||
T Consensus 156 m~~wFdyrghiCivfellG-~S~~dFlk~N~y~~-------fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENIL 224 (415)
T KOG0671|consen 156 MRDWFDYRGHICIVFELLG-LSTFDFLKENNYIP-------FPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENIL 224 (415)
T ss_pred eehhhhccCceEEEEeccC-hhHHHHhccCCccc-------cchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEE
Confidence 7788999999999999884 49999999887654 99999999999999999999999 9999999999999
Q ss_pred Ecc--------------------CCeEEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHH
Q 020641 169 LFE--------------------DFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVL 228 (323)
Q Consensus 169 i~~--------------------~~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l 228 (323)
+.+ +..++++|||.|+...... .....|..|+|||++.+-+++...||||+||+|
T Consensus 225 fvss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h-----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL 299 (415)
T KOG0671|consen 225 FVSSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH-----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCIL 299 (415)
T ss_pred EeccceEEEeccCCccceeccCCCcceEEEecCCcceeccCc-----ceeeeccccCCchheeccCcCCccCceeeeeEE
Confidence 942 3458999999998765443 334468889999999999999999999999999
Q ss_pred HHHHhCCCCCCCCCCcccchhhhhhcccccccccchh-------------cCCCc----------------CCCCCHHHH
Q 020641 229 LELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQC-------------VDPKL----------------KGEYPPKGV 279 (323)
Q Consensus 229 ~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~-------------~~~~~----------------~~~~~~~~~ 279 (323)
+|+.+|...|...+..+..-..+.+....+...+.+. -+... .........
T Consensus 300 ~ElytG~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~ 379 (415)
T KOG0671|consen 300 VELYTGETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEH 379 (415)
T ss_pred EEeeccceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHH
Confidence 9999999999877643322111111111111111111 00000 011223445
Q ss_pred HHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 280 AKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 280 ~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
.+|.+|+++||.+||.+|+|+.|++.
T Consensus 380 ~~LfDLl~~mL~fDP~~RiTl~EAL~ 405 (415)
T KOG0671|consen 380 VQLFDLLRRMLEFDPARRITLREALS 405 (415)
T ss_pred hHHHHHHHHHHccCccccccHHHHhc
Confidence 68999999999999999999999986
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=276.00 Aligned_cols=260 Identities=22% Similarity=0.325 Sum_probs=219.1
Q ss_pred ccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeCCeEEE
Q 020641 22 RLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVL 101 (323)
Q Consensus 22 ~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 101 (323)
.||.|+||+||++.....++-+-+++..+..... ......+.+.+|+-.|.+++|||++++++++..+. .-|
T Consensus 703 vLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~-------t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~ql 774 (1177)
T KOG1025|consen 703 VLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEF-------TSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQL 774 (1177)
T ss_pred eeccccceeEEeeeEecCCceecceeEEEEeecc-------CCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHH
Confidence 7899999999999998877665554444332221 22223477899999999999999999999999876 788
Q ss_pred EEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEEEeecc
Q 020641 102 AYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFN 181 (323)
Q Consensus 102 v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~l~Dfg 181 (323)
|++|++.|+|.|+++..... +-....+.|+.||++|+.|||.+ +++||||-.+|+|+..-..+|+.|||
T Consensus 775 vtq~mP~G~LlDyvr~hr~~--------igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfg 843 (1177)
T KOG1025|consen 775 VTQLMPLGCLLDYVREHRDN--------IGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFG 843 (1177)
T ss_pred HHHhcccchHHHHHHHhhcc--------ccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecc
Confidence 99999999999999876543 88889999999999999999999 99999999999999999999999999
Q ss_pred ccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhccccccc
Q 020641 182 LSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPRLSED 260 (323)
Q Consensus 182 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 260 (323)
++................-.+.|+|-|.+....++.++||||||+++||++| |..|+++. +.+
T Consensus 844 la~ll~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi----------------~~~ 907 (1177)
T KOG1025|consen 844 LAKLLAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGI----------------PAE 907 (1177)
T ss_pred hhhccCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCC----------------CHH
Confidence 9987765554444443344667999999999999999999999999999998 99999755 345
Q ss_pred ccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhhcCCCC
Q 020641 261 KVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSPPP 316 (323)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~~~~~~ 316 (323)
++...++...+-.-|+-++.+++-++.+||..|++.||+++++.+++.++.++++.
T Consensus 908 eI~dlle~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ardpqr 963 (1177)
T KOG1025|consen 908 EIPDLLEKGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARDPQR 963 (1177)
T ss_pred HhhHHHhccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcCcce
Confidence 66666766667777888999999999999999999999999999999999988753
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=278.20 Aligned_cols=262 Identities=24% Similarity=0.333 Sum_probs=211.0
Q ss_pred ccCCCCCCccceecccee-------eeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcC-CCCcccceeeEE
Q 020641 22 RLDKGPEDDLYLKKRVKM-------RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRL-KHENLVELLGYC 93 (323)
Q Consensus 22 ~lg~G~~~~V~~~~~~~~-------~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~ 93 (323)
.||.|.||.||.+.-... ...+|+|..... ......+.+..|+++|+.+ .|+||+.+++++
T Consensus 303 ~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~-----------~~~~~~~~~~~El~~m~~~g~H~niv~llG~~ 371 (609)
T KOG0200|consen 303 YLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKEN-----------ASSSEKKDLMSELNVLKELGKHPNIVNLLGAC 371 (609)
T ss_pred eeecccccceEeEEEeecccccccceEEEEEEecccc-----------cCcHHHHHHHHHHHHHHHhcCCcchhhheeee
Confidence 899999999998875532 334555533211 1123357889999999999 899999999999
Q ss_pred EeCCeEEEEEeecCCCCHHHHhccCC-CCCCCCCC------CCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCC
Q 020641 94 VEGNLRVLAYEFATMGSLHDILHGRK-GVQGAQPG------PVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSN 166 (323)
Q Consensus 94 ~~~~~~~lv~e~~~~~sL~~~~~~~~-~~~~~~~~------~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~n 166 (323)
......++|+||+..|+|.++++... .......+ ..++......+++||+.|+.||++. .++|||+-.+|
T Consensus 372 t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAaRN 448 (609)
T KOG0200|consen 372 TQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAARN 448 (609)
T ss_pred ccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---Cccchhhhhhh
Confidence 99889999999999999999998776 11111111 2489999999999999999999999 99999999999
Q ss_pred EEEccCCeEEEeeccccCCCCcccccccc-ccccCccccCCCccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCc
Q 020641 167 VLLFEDFKAKIADFNLSNQAPDMAARLHS-TRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPR 244 (323)
Q Consensus 167 ili~~~~~~~l~Dfg~~~~~~~~~~~~~~-~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~ 244 (323)
||++.+..+||+|||+++...+....... +...-+..|+|||.+....++.++||||+|+++|||++ |..||.+..
T Consensus 449 VLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~-- 526 (609)
T KOG0200|consen 449 VLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP-- 526 (609)
T ss_pred EEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCC--
Confidence 99999999999999999865543333211 11112456999999999999999999999999999998 999996421
Q ss_pred ccchhhhhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhhc
Q 020641 245 GQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLK 312 (323)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~~ 312 (323)
....+.+.+..+.+...|..++.+++++|+.||+.+|++||++.++.++|...+.
T Consensus 527 -------------~~~~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~ 581 (609)
T KOG0200|consen 527 -------------PTEELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQ 581 (609)
T ss_pred -------------cHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHH
Confidence 1234455677777888888899999999999999999999999999999999653
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=250.56 Aligned_cols=244 Identities=19% Similarity=0.202 Sum_probs=202.9
Q ss_pred CCCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEE
Q 020641 15 PSPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCV 94 (323)
Q Consensus 15 ~~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 94 (323)
..+.++..||+|.||.|-+++...+++++|+|++.++.+-.. +.......|-++|+.++||.+..+-..|.
T Consensus 168 ~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiak---------dEVAHTlTE~RVL~~~~HPFLt~LKYsFQ 238 (516)
T KOG0690|consen 168 EDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAK---------DEVAHTLTENRVLQNCRHPFLTSLKYSFQ 238 (516)
T ss_pred chhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeeh---------HHhhhhhhHHHHHHhccCcHHHHhhhhhc
Confidence 456677789999999999999999999999998876543222 22244566888999999999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCe
Q 020641 95 EGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFK 174 (323)
Q Consensus 95 ~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~ 174 (323)
..+.+|+||||..||.|+-.+++... +++....-+-..|+.||.|||++ +|+.||+|.+|.+++.+|.
T Consensus 239 t~drlCFVMeyanGGeLf~HLsrer~---------FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGH 306 (516)
T KOG0690|consen 239 TQDRLCFVMEYANGGELFFHLSRERV---------FSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGH 306 (516)
T ss_pred cCceEEEEEEEccCceEeeehhhhhc---------ccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCc
Confidence 99999999999999999998877553 88888889999999999999999 9999999999999999999
Q ss_pred EEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhc
Q 020641 175 AKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWAT 254 (323)
Q Consensus 175 ~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~ 254 (323)
+||.|||+...... ........+|||.|+|||++....|+.+.|-|.+|+++|||++|+.||...+...
T Consensus 307 IKitDFGLCKE~I~--~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~k--------- 375 (516)
T KOG0690|consen 307 IKITDFGLCKEEIK--YGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEK--------- 375 (516)
T ss_pred eEeeecccchhccc--ccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhH---------
Confidence 99999999875433 2233467789999999999999999999999999999999999999997554322
Q ss_pred ccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCC
Q 020641 255 PRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRP 298 (323)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp 298 (323)
+.+++.-. ...+|...+++...|+...|.+||.+|.
T Consensus 376 -------LFeLIl~e-d~kFPr~ls~eAktLLsGLL~kdP~kRL 411 (516)
T KOG0690|consen 376 -------LFELILME-DLKFPRTLSPEAKTLLSGLLKKDPKKRL 411 (516)
T ss_pred -------HHHHHHhh-hccCCccCCHHHHHHHHHHhhcChHhhc
Confidence 22211100 1235666777899999999999999996
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=281.57 Aligned_cols=149 Identities=22% Similarity=0.280 Sum_probs=129.9
Q ss_pred CCCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEE
Q 020641 15 PSPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCV 94 (323)
Q Consensus 15 ~~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 94 (323)
.+|....+||+|+||.||++.+..+++.+|+|++...... .......+..|+.++..++|+||+++++++.
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~---------~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~ 74 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMI---------NKNMVHQVQAERDALALSKSPFIVHLYYSLQ 74 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhcc---------CHHHHHHHHHHHHHHHhcCCCCcCeEEEEEE
Confidence 4566777999999999999999999999999976543211 1122366788999999999999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCe
Q 020641 95 EGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFK 174 (323)
Q Consensus 95 ~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~ 174 (323)
.....|+||||+.+++|.+++..... +++..++.++.||+.||.|||.. +|+|+||||+|||++.++.
T Consensus 75 ~~~~~~lVmEy~~g~~L~~li~~~~~---------l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~ 142 (669)
T cd05610 75 SANNVYLVMEYLIGGDVKSLLHIYGY---------FDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGH 142 (669)
T ss_pred ECCEEEEEEeCCCCCCHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCC
Confidence 99999999999999999999975432 78889999999999999999999 9999999999999999999
Q ss_pred EEEeeccccC
Q 020641 175 AKIADFNLSN 184 (323)
Q Consensus 175 ~~l~Dfg~~~ 184 (323)
++|+|||++.
T Consensus 143 vkL~DFGls~ 152 (669)
T cd05610 143 IKLTDFGLSK 152 (669)
T ss_pred EEEEeCCCCc
Confidence 9999999874
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=267.34 Aligned_cols=254 Identities=24% Similarity=0.348 Sum_probs=209.8
Q ss_pred cCCCCCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcC-CCCccccee
Q 020641 12 AHAPSPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRL-KHENLVELL 90 (323)
Q Consensus 12 ~~~~~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~ 90 (323)
....-.+++.-+|.|.+|.||++++.++++.+|+|+..-. .+..+++..|.++++.. .|||++.++
T Consensus 16 dp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~-------------~d~deEiE~eynil~~~~~hpnv~~fy 82 (953)
T KOG0587|consen 16 DPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPT-------------EDEEEEIELEYNMLKKYSHHPNVATFY 82 (953)
T ss_pred CCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCC-------------ccccHHHHHHHHHHHhccCCCCcceEE
Confidence 3445567777899999999999999999999999976522 33446677888999888 899999999
Q ss_pred eEEE-----eCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCC
Q 020641 91 GYCV-----EGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSS 165 (323)
Q Consensus 91 ~~~~-----~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~ 165 (323)
++|. .++.+|||||||.+||..|+++...... +.+..+..+++.++.|+.+||+. .++|||||-.
T Consensus 83 g~~~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~r-------l~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~ 152 (953)
T KOG0587|consen 83 GAFIKKDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNR-------LKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQ 152 (953)
T ss_pred EEEEEecCCCCCeEEEEeeccCCccHHHHHhhhcccc-------hhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCc
Confidence 9987 3567899999999999999998876432 99999999999999999999999 9999999999
Q ss_pred CEEEccCCeEEEeeccccCCCCccccccccccccCccccCCCccccC-----CCCCcccchHHHHHHHHHHHhCCCCCCC
Q 020641 166 NVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT-----GQLTQKSDVYSFGVVLLELLTGRKPVDH 240 (323)
Q Consensus 166 nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~Di~slG~~l~~l~~g~~pf~~ 240 (323)
|||++.++.|||+|||++.+...... ......||+.|+|||++.. ..|+.++|+||||++..||.-|.+|+.+
T Consensus 153 NiLLT~e~~VKLvDFGvSaQldsT~g--rRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~D 230 (953)
T KOG0587|consen 153 NVLLTENAEVKLVDFGVSAQLDSTVG--RRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCD 230 (953)
T ss_pred eEEEeccCcEEEeeeeeeeeeecccc--cccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccC
Confidence 99999999999999999987765332 2345579999999999864 3467899999999999999999999976
Q ss_pred CCCcccchhhhhhcccccccccchhc-CCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 241 TMPRGQQSLVTWATPRLSEDKVKQCV-DPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
..+.... ..+. +|......+..+++++-++|..||.+|-+.||+..++++
T Consensus 231 mHPmraL---------------F~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 231 MHPMRAL---------------FLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred cchhhhh---------------ccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 6542221 1111 222223346788899999999999999999999999886
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=254.28 Aligned_cols=258 Identities=22% Similarity=0.316 Sum_probs=200.2
Q ss_pred ccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEe-CCeEE
Q 020641 22 RLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVE-GNLRV 100 (323)
Q Consensus 22 ~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 100 (323)
.||.|||+.||+|.+..-.+++|+|+.....-=. ....+++.+...+|.++.+.|+||.||+++++|.- .+.+|
T Consensus 470 LLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~Wr-----dEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsFC 544 (775)
T KOG1151|consen 470 LLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWR-----DEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSFC 544 (775)
T ss_pred HhccccHHHHHHhcccchhheeeEeeehhccchh-----hHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccce
Confidence 7899999999999999999999999765332111 12235667888899999999999999999999974 45789
Q ss_pred EEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEcc---CCeEEE
Q 020641 101 LAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFE---DFKAKI 177 (323)
Q Consensus 101 lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~---~~~~~l 177 (323)
-|+|||+|-+|.-+++.... ++++.+..|+.||+.||.||... ++.|+|-|+||.|||+-+ -|.+||
T Consensus 545 TVLEYceGNDLDFYLKQhkl---------mSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKI 614 (775)
T KOG1151|consen 545 TVLEYCEGNDLDFYLKQHKL---------MSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKI 614 (775)
T ss_pred eeeeecCCCchhHHHHhhhh---------hhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEe
Confidence 99999999999888876653 99999999999999999999986 668999999999999954 478999
Q ss_pred eeccccCCCCccccccc-----cccccCccccCCCccccC----CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccch
Q 020641 178 ADFNLSNQAPDMAARLH-----STRVLGTFGYHAPEYAMT----GQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQS 248 (323)
Q Consensus 178 ~Dfg~~~~~~~~~~~~~-----~~~~~g~~~y~aPE~~~~----~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~ 248 (323)
.|||++..+........ .+...||.+|++||.+.- ..++.+.||||+|+++|..+.|+.||........-.
T Consensus 615 TDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdIL 694 (775)
T KOG1151|consen 615 TDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDIL 694 (775)
T ss_pred eecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHH
Confidence 99999988765443321 234559999999998853 357889999999999999999999997554321110
Q ss_pred hhhhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 249 LVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
. .+ .+.+ -..+....-+..+.+..+||++||.+.-++|....++..
T Consensus 695 --q-eN------TIlk--AtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 695 --Q-EN------TILK--ATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred --h-hh------chhc--ceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence 0 00 0000 011112233455678999999999999999987777653
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-36 Score=259.58 Aligned_cols=245 Identities=20% Similarity=0.220 Sum_probs=200.2
Q ss_pred ccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeCCeEEE
Q 020641 22 RLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVL 101 (323)
Q Consensus 22 ~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 101 (323)
-||.|-||+||-+++.++|+.||+|++.+..+..+.. ...++|+.+|+.+.||.|+.+...|+.....++
T Consensus 571 vLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqe----------sqlR~EVaILq~l~HPGiV~le~M~ET~ervFV 640 (888)
T KOG4236|consen 571 VLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQE----------SQLRNEVAILQNLHHPGIVNLECMFETPERVFV 640 (888)
T ss_pred hccCCcceeeecceecccCceeeeeeeecccCCCchH----------HHHHHHHHHHHhcCCCCeeEEEEeecCCceEEE
Confidence 6899999999999999999999999998765554332 678999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccC---CeEEEe
Q 020641 102 AYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFED---FKAKIA 178 (323)
Q Consensus 102 v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~---~~~~l~ 178 (323)
|||-+.| ++.+.+-...... +++....-++.||+.||.|||-+ +|+|+|+||+|||+.+. .++|||
T Consensus 641 VMEKl~G-DMLEMILSsEkgR-------L~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlC 709 (888)
T KOG4236|consen 641 VMEKLHG-DMLEMILSSEKGR-------LPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLC 709 (888)
T ss_pred Eehhhcc-hHHHHHHHhhccc-------chHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeec
Confidence 9999965 7777765443322 88888889999999999999999 99999999999999664 579999
Q ss_pred eccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhccccc
Q 020641 179 DFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLS 258 (323)
Q Consensus 179 Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 258 (323)
|||.|+.+...... ....|||.|+|||++....|...-|+||+|+++|.-+.|..||....+...+.. .+.-.++
T Consensus 710 DFGfARiIgEksFR---rsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQ--NAaFMyP 784 (888)
T KOG4236|consen 710 DFGFARIIGEKSFR---RSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQ--NAAFMYP 784 (888)
T ss_pred cccceeecchhhhh---hhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHHhh--ccccccC
Confidence 99999988765433 456699999999999999999999999999999999999999986654333211 1111111
Q ss_pred ccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 259 EDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
...=.+.+....+||...|+..-.+|.|....+.
T Consensus 785 -------------p~PW~eis~~AidlIn~LLqVkm~kRysvdk~ls 818 (888)
T KOG4236|consen 785 -------------PNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLS 818 (888)
T ss_pred -------------CCchhhcCHHHHHHHHHHHHHHHHHhcchHhhcc
Confidence 1111344567889999999999999998877654
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=277.84 Aligned_cols=254 Identities=18% Similarity=0.180 Sum_probs=203.5
Q ss_pred CCCCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEE
Q 020641 14 APSPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYC 93 (323)
Q Consensus 14 ~~~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 93 (323)
+..|..+.-||+|+||.|.+++...+++.+|.|++.+-. .........|..|=.+|...+.+=|+.++..|
T Consensus 74 ~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~e---------MlKr~~tA~F~EERDimv~~ns~Wiv~LhyAF 144 (1317)
T KOG0612|consen 74 AEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWE---------MLKRAETACFREERDIMVFGNSEWIVQLHYAF 144 (1317)
T ss_pred HHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHH---------HhhchhHHHHHHHhHHHHcCCcHHHHHHHHHh
Confidence 455677778999999999999999999999999776422 12223346678888888888899999999999
Q ss_pred EeCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCC
Q 020641 94 VEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDF 173 (323)
Q Consensus 94 ~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~ 173 (323)
.+.+.+|+||||+.||+|..++.+... +++..+.-++..|+-||.-+|+. |+|||||||+|||+|..|
T Consensus 145 QD~~~LYlVMdY~pGGDlltLlSk~~~---------~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~G 212 (1317)
T KOG0612|consen 145 QDERYLYLVMDYMPGGDLLTLLSKFDR---------LPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSG 212 (1317)
T ss_pred cCccceEEEEecccCchHHHHHhhcCC---------ChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccC
Confidence 999999999999999999999988762 99999999999999999999999 999999999999999999
Q ss_pred eEEEeeccccCCCCccccccccccccCccccCCCcccc----C-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccch
Q 020641 174 KAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAM----T-GQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQS 248 (323)
Q Consensus 174 ~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~----~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~ 248 (323)
.++|+|||..-.+...+ ........|||.|+|||++. + ..|+...|.||+|+++|||+.|..||........+
T Consensus 213 HikLADFGsClkm~~dG-~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY- 290 (1317)
T KOG0612|consen 213 HIKLADFGSCLKMDADG-TVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETY- 290 (1317)
T ss_pred cEeeccchhHHhcCCCC-cEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHH-
Confidence 99999999876655322 22344556999999999885 3 56889999999999999999999999755332221
Q ss_pred hhhhhcccccccccchhcCCCcCCCCC--HHHHHHHHHHHHHccCCCCCCCCC---hHHHHH
Q 020641 249 LVTWATPRLSEDKVKQCVDPKLKGEYP--PKGVAKLAAVAALCVQYEAEFRPN---MSIVVK 305 (323)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~~P~~Rps---~~evl~ 305 (323)
.++++-.-.-.+| .+.+....+||.+.+. +|+.|.. ++++-.
T Consensus 291 --------------~KIm~hk~~l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~ 337 (1317)
T KOG0612|consen 291 --------------GKIMNHKESLSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKN 337 (1317)
T ss_pred --------------HHHhchhhhcCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHh
Confidence 1222211111222 4577889999998776 7889987 777753
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=240.31 Aligned_cols=238 Identities=27% Similarity=0.336 Sum_probs=191.1
Q ss_pred CCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeCCeEEEEEeec
Q 020641 27 PEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFA 106 (323)
Q Consensus 27 ~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 106 (323)
+||.||++++..+++.+++|+........ ..+.+.+|++.+++++|+|++++++.+......++++||+
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-----------~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 69 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKK-----------KRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYC 69 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEeccccccc-----------HHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCC
Confidence 58999999999888888888665322111 0478899999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEEEeeccccCCC
Q 020641 107 TMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQA 186 (323)
Q Consensus 107 ~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~l~Dfg~~~~~ 186 (323)
.+++|.+++..... ++...+..++.+++.++.+||+. +++|+||+|+||+++.++.++|+|||.+...
T Consensus 70 ~~~~L~~~~~~~~~---------~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~ 137 (244)
T smart00220 70 DGGDLFDLLKKRGR---------LSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQL 137 (244)
T ss_pred CCCCHHHHHHhccC---------CCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeee
Confidence 99999999976432 78889999999999999999999 9999999999999999999999999998766
Q ss_pred CccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccccccccchhc
Q 020641 187 PDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCV 266 (323)
Q Consensus 187 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (323)
.... ......++..|++||...+..++.++|+||||++++++++|..||...... ....+.+
T Consensus 138 ~~~~---~~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~---------------~~~~~~~ 199 (244)
T smart00220 138 DPGG---LLTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQL---------------LELFKKI 199 (244)
T ss_pred cccc---ccccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH---------------HHHHHHH
Confidence 5432 123344788899999998888899999999999999999999999753111 0111111
Q ss_pred CCCcCCCCCH--HHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 267 DPKLKGEYPP--KGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 267 ~~~~~~~~~~--~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
.......... ..+..+.+++.+||..+|++||++.++++
T Consensus 200 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 200 GKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred hccCCCCccccccCCHHHHHHHHHHccCCchhccCHHHHhh
Confidence 1111111011 15567999999999999999999999987
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=247.89 Aligned_cols=244 Identities=22% Similarity=0.236 Sum_probs=201.0
Q ss_pred CCCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcC-CCCcccceeeEE
Q 020641 15 PSPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRL-KHENLVELLGYC 93 (323)
Q Consensus 15 ~~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~ 93 (323)
..+.++.-||+|+||.|.++....+.+.+|+|++.+..+-. .+..+-.+.|-++|... +.|-+++++..|
T Consensus 349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQ---------dDDvectm~EKrvLAL~~kppFL~qlHScF 419 (683)
T KOG0696|consen 349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQ---------DDDVECTMVEKRVLALPGKPPFLVQLHSCF 419 (683)
T ss_pred cccceEEEeccCccceeeeecccCcchhhhhhhhccceeee---------cCcccceehhhhheecCCCCchHHHHHHHh
Confidence 34455557999999999999999999999999877554222 22334456677777766 788999999999
Q ss_pred EeCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCC
Q 020641 94 VEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDF 173 (323)
Q Consensus 94 ~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~ 173 (323)
..-+.+|+||||+.||+|-..++.-.. +.+..+.-++..|+-||-+||++ ||+.||+|.+||+++.+|
T Consensus 420 QTmDRLyFVMEyvnGGDLMyhiQQ~Gk---------FKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eG 487 (683)
T KOG0696|consen 420 QTMDRLYFVMEYVNGGDLMYHIQQVGK---------FKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEG 487 (683)
T ss_pred hhhhheeeEEEEecCchhhhHHHHhcc---------cCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCC
Confidence 999999999999999999999876554 77788899999999999999999 999999999999999999
Q ss_pred eEEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhh
Q 020641 174 KAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWA 253 (323)
Q Consensus 174 ~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 253 (323)
.+||.|||+...-.. ......+.+|||.|+|||++...+|+.+.|-||+|++||||+.|+.||++.+...
T Consensus 488 HiKi~DFGmcKEni~--~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~e-------- 557 (683)
T KOG0696|consen 488 HIKIADFGMCKENIF--DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE-------- 557 (683)
T ss_pred ceEeeeccccccccc--CCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHH--------
Confidence 999999999875432 3334566789999999999999999999999999999999999999998765321
Q ss_pred cccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCC
Q 020641 254 TPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRP 298 (323)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp 298 (323)
..+.+.+.. ..+|...+.+..++++..|.++|.+|.
T Consensus 558 -------lF~aI~ehn--vsyPKslSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 558 -------LFQAIMEHN--VSYPKSLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred -------HHHHHHHcc--CcCcccccHHHHHHHHHHhhcCCcccc
Confidence 112222222 246777788899999999999999995
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=257.30 Aligned_cols=242 Identities=20% Similarity=0.222 Sum_probs=204.9
Q ss_pred cccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeCCe
Q 020641 19 YFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNL 98 (323)
Q Consensus 19 ~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 98 (323)
.+..||-||||.|-+++.......+|+|++.+..+-.. ...+.+..|-++|..++.|.|+++|..|.+++.
T Consensus 424 ~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdt---------kQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~ky 494 (732)
T KOG0614|consen 424 RIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDT---------KQQEHVFSERNIMMECRSDFIVRLYRTFRDSKY 494 (732)
T ss_pred hhhhcccCccceEEEEEecccchHHHHHHHhHhhccch---------hHHHHHHhHHHHHHhcCchHHHHHHHHhccchh
Confidence 34478999999999999988887788888775533222 223667888999999999999999999999999
Q ss_pred EEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEEEe
Q 020641 99 RVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIA 178 (323)
Q Consensus 99 ~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~l~ 178 (323)
.|++||-|-||.|+..++++.. +...++.-++.-+++|+.|||++ ||++||+||+|.+++.+|-+||.
T Consensus 495 vYmLmEaClGGElWTiLrdRg~---------Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLV 562 (732)
T KOG0614|consen 495 VYMLMEACLGGELWTILRDRGS---------FDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLV 562 (732)
T ss_pred hhhhHHhhcCchhhhhhhhcCC---------cccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEe
Confidence 9999999999999999988764 88888899999999999999999 99999999999999999999999
Q ss_pred eccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhccccc
Q 020641 179 DFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLS 258 (323)
Q Consensus 179 Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 258 (323)
|||.|.....+... .+.+|||.|.|||++....-+.+.|.||||+++|||++|.+||.+.+.......+-....
T Consensus 563 DFGFAKki~~g~KT---wTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid--- 636 (732)
T KOG0614|consen 563 DFGFAKKIGSGRKT---WTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGID--- 636 (732)
T ss_pred ehhhHHHhccCCce---eeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhh---
Confidence 99999987765543 567799999999999999999999999999999999999999998876444332221111
Q ss_pred ccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCC
Q 020641 259 EDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPN 299 (323)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps 299 (323)
....|...+....++|++..+.+|.+|..
T Consensus 637 ------------~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 637 ------------KIEFPRRITKTATDLIKKLCRDNPTERLG 665 (732)
T ss_pred ------------hhhcccccchhHHHHHHHHHhcCcHhhhc
Confidence 23456666777889999999999999975
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=239.18 Aligned_cols=254 Identities=20% Similarity=0.194 Sum_probs=187.8
Q ss_pred ccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcC-CCCcccceeeEEEeCCeEE
Q 020641 22 RLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRL-KHENLVELLGYCVEGNLRV 100 (323)
Q Consensus 22 ~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~ 100 (323)
.||.|+||+|++-.+..+++..|+|.+..... +...+++..|.++..+- +.|||+++++.+...+..|
T Consensus 71 ~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~-----------~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcW 139 (361)
T KOG1006|consen 71 EIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI-----------EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCW 139 (361)
T ss_pred HhcCCcchhhhhhhcCccCcEEEEEEeeeccc-----------hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCcee
Confidence 78999999999999999999999985542211 11235666777765554 8999999999999888999
Q ss_pred EEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEEEeec
Q 020641 101 LAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADF 180 (323)
Q Consensus 101 lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~l~Df 180 (323)
+.||.|+- ||..+-+.--..+.. .+++...-.+..-.+.||.||-+.. .|+||||||+|||++..|.+|||||
T Consensus 140 iCMELMd~-SlDklYk~vy~vq~~----~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDF 212 (361)
T KOG1006|consen 140 ICMELMDI-SLDKLYKRVYSVQKS----RIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDF 212 (361)
T ss_pred eeHHHHhh-hHHHHHHHHHHHHhc----cCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecc
Confidence 99999975 776665432111111 1788777888888899999998764 8999999999999999999999999
Q ss_pred cccCCCCccccccccccccCccccCCCcccc--CCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhccccc
Q 020641 181 NLSNQAPDMAARLHSTRVLGTFGYHAPEYAM--TGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLS 258 (323)
Q Consensus 181 g~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~--~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 258 (323)
|+.....+.. ..+...|-..|+|||.+. +.+|+.++|+||||++++|+.||+.|+...+..-++. .. ..
T Consensus 213 GIcGqLv~Si---AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql-~~-Vv---- 283 (361)
T KOG1006|consen 213 GICGQLVDSI---AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQL-CQ-VV---- 283 (361)
T ss_pred cchHhHHHHH---HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHH-HH-HH----
Confidence 9987655432 234445788999999885 3468999999999999999999999997554321111 00 00
Q ss_pred ccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHH
Q 020641 259 EDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKA 306 (323)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~ 306 (323)
....+.+.. .......+..+..+|.-||.+|-.+||++.++.++
T Consensus 284 ~gdpp~l~~----~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 284 IGDPPILLF----DKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred cCCCCeecC----cccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 000011111 01112356679999999999999999999998763
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=257.30 Aligned_cols=274 Identities=15% Similarity=0.118 Sum_probs=168.0
Q ss_pred CCCccccccCCCCCCccceecccee----eeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCccccee
Q 020641 15 PSPGYFVRLDKGPEDDLYLKKRVKM----RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELL 90 (323)
Q Consensus 15 ~~~~~~~~lg~G~~~~V~~~~~~~~----~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~ 90 (323)
..|....+||+|+||.||++.+..+ +..+++|...... ..+.... +.++...+.++..++
T Consensus 132 ~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~--------------~~e~~~~--e~l~~~~~~~~~~~~ 195 (566)
T PLN03225 132 DDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYG--------------AVEIWMN--ERVRRACPNSCADFV 195 (566)
T ss_pred CCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccc--------------hhHHHHH--HHHHhhchhhHHHHH
Confidence 3455556899999999999999988 7788887542110 0011111 112222222222222
Q ss_pred eE------EEeCCeEEEEEeecCCCCHHHHhccCCCCC-----------CCCCCCCCCHHHHHHHHHHHHHHHHHhhcCC
Q 020641 91 GY------CVEGNLRVLAYEFATMGSLHDILHGRKGVQ-----------GAQPGPVLDWMTRVRIAVDAARGLEYLHEKV 153 (323)
Q Consensus 91 ~~------~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~ 153 (323)
.. ...+...++|+||+.+++|.+++....... ............+..++.|++.||.|||+.
T Consensus 196 ~~~~~~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~- 274 (566)
T PLN03225 196 YGFLEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST- 274 (566)
T ss_pred HhhhcccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC-
Confidence 21 234567899999999999999997543110 000011123345678999999999999999
Q ss_pred CCCceeCCCCCCCEEEcc-CCeEEEeeccccCCCCccccccccccccCccccCCCccccCC-------------------
Q 020641 154 QPSIIHRDIRSSNVLLFE-DFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG------------------- 213 (323)
Q Consensus 154 ~~~i~h~dikp~nili~~-~~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~------------------- 213 (323)
+|+||||||+|||++. ++.+||+|||++......... ......+++.|+|||.+...
T Consensus 275 --gIiHRDLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~-~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l 351 (566)
T PLN03225 275 --GIVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINY-IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVL 351 (566)
T ss_pred --CEEeCcCCHHHEEEeCCCCcEEEEeCCCcccccccccc-CCcccccCCCccChHHhhccCCCCCCccccccccccchh
Confidence 9999999999999986 579999999999765433222 12334578999999965322
Q ss_pred ---CCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccccccccchhcCCCcCC------CCCHHHHHHHHH
Q 020641 214 ---QLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKG------EYPPKGVAKLAA 284 (323)
Q Consensus 214 ---~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~l~~ 284 (323)
.++.++|||||||++|+|+++..++....... .................+.+.... ...........+
T Consensus 352 ~~~~~~~k~DVwSlGviL~el~~~~~~~~~~~~~~---~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~d 428 (566)
T PLN03225 352 WQLNLPDRFDIYSAGLIFLQMAFPNLRSDSNLIQF---NRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWE 428 (566)
T ss_pred ccccCCCCcccHHHHHHHHHHHhCcCCCchHHHHH---HHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHH
Confidence 23446699999999999999776654221000 000000000000111111111000 000111234568
Q ss_pred HHHHccCCCCCCCCChHHHHHHHhhhhcC
Q 020641 285 VAALCVQYEAEFRPNMSIVVKALQPLLKS 313 (323)
Q Consensus 285 li~~cl~~~P~~Rps~~evl~~l~~~~~~ 313 (323)
|+.+||+.||.+|||+.++++ ...+..
T Consensus 429 Li~~mL~~dP~kR~ta~e~L~--Hpff~~ 455 (566)
T PLN03225 429 LLKSMMRFKGRQRISAKAALA--HPYFDR 455 (566)
T ss_pred HHHHHccCCcccCCCHHHHhC--CcCcCC
Confidence 999999999999999999998 344443
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=242.93 Aligned_cols=210 Identities=21% Similarity=0.238 Sum_probs=176.6
Q ss_pred CccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeC
Q 020641 17 PGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEG 96 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 96 (323)
+..+..||-|+||.|-+|.-+.++..+|.|.+.++.. ..++....++.|=.+|..-+.+=||+++..|.+.
T Consensus 631 Fvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDV---------l~rnQvaHVKAERDILAEADn~WVVrLyySFQDk 701 (1034)
T KOG0608|consen 631 FVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADV---------LMRNQVAHVKAERDILAEADNEWVVRLYYSFQDK 701 (1034)
T ss_pred eEEEeeecccccceeEEEeecchhhHHHHhhhHHHHH---------HhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccC
Confidence 3445578999999999999999999999987765432 2233446677888899988999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEE
Q 020641 97 NLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAK 176 (323)
Q Consensus 97 ~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~ 176 (323)
+.+|+||+|+.||++-.++.+..- |.+..+.-++..+.+||.+.|+. |++||||||+|||||.+|.+|
T Consensus 702 dnLYFVMdYIPGGDmMSLLIrmgI---------FeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIK 769 (1034)
T KOG0608|consen 702 DNLYFVMDYIPGGDMMSLLIRMGI---------FEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIK 769 (1034)
T ss_pred CceEEEEeccCCccHHHHHHHhcc---------CHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCcee
Confidence 999999999999999999876652 88899999999999999999999 999999999999999999999
Q ss_pred EeeccccCCCCccccccc----------------------------------------cccccCccccCCCccccCCCCC
Q 020641 177 IADFNLSNQAPDMAARLH----------------------------------------STRVLGTFGYHAPEYAMTGQLT 216 (323)
Q Consensus 177 l~Dfg~~~~~~~~~~~~~----------------------------------------~~~~~g~~~y~aPE~~~~~~~~ 216 (323)
|.|||+.+-+.+...... .-...||+.|+|||++....++
T Consensus 770 LTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~ 849 (1034)
T KOG0608|consen 770 LTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYT 849 (1034)
T ss_pred eeeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCcc
Confidence 999999754432211100 0023489999999999999999
Q ss_pred cccchHHHHHHHHHHHhCCCCCCCCCCcccc
Q 020641 217 QKSDVYSFGVVLLELLTGRKPVDHTMPRGQQ 247 (323)
Q Consensus 217 ~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~ 247 (323)
...|.||.|++||+|+.|+.||........+
T Consensus 850 q~cdwws~gvil~em~~g~~pf~~~tp~~tq 880 (1034)
T KOG0608|consen 850 QLCDWWSVGVILYEMLVGQPPFLADTPGETQ 880 (1034)
T ss_pred ccchhhHhhHHHHHHhhCCCCccCCCCCcce
Confidence 9999999999999999999999877654444
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-32 Score=216.86 Aligned_cols=254 Identities=13% Similarity=0.184 Sum_probs=191.5
Q ss_pred CCCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcC-CCCcccceeeEE
Q 020641 15 PSPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRL-KHENLVELLGYC 93 (323)
Q Consensus 15 ~~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~ 93 (323)
..|+.+.|+|.|-++.||-+.+..+++.+.+|+.... -.+.+++|+.+|+.+ .||||+++++++
T Consensus 38 ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---------------kkkKIkREikIL~nL~gg~NIi~L~DiV 102 (338)
T KOG0668|consen 38 DDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---------------KKKKIKREIKILQNLRGGPNIIKLLDIV 102 (338)
T ss_pred chHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---------------HHHHHHHHHHHHHhccCCCCeeehhhhh
Confidence 4567778999999999999999999998888855421 126689999999999 599999999999
Q ss_pred EeC--CeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEcc
Q 020641 94 VEG--NLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFE 171 (323)
Q Consensus 94 ~~~--~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~ 171 (323)
.++ ....+|+||..+.+...+... ++...+..++.++++||.|||+. ||.|||+||.|++|+.
T Consensus 103 ~Dp~SktpaLiFE~v~n~Dfk~ly~t------------l~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh 167 (338)
T KOG0668|consen 103 KDPESKTPSLIFEYVNNTDFKQLYPT------------LTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDH 167 (338)
T ss_pred cCccccCchhHhhhhccccHHHHhhh------------hchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeech
Confidence 865 467899999999887776643 88889999999999999999999 9999999999999986
Q ss_pred C-CeEEEeeccccCCCCccccccccccccCccccCCCccccC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccch-
Q 020641 172 D-FKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT-GQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQS- 248 (323)
Q Consensus 172 ~-~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~- 248 (323)
. -.++|+|+|+|.....+..... ...+.-|--||++.. ..|+..-|+|||||++..|++.+.||..-.....+.
T Consensus 168 ~~rkLrlIDWGLAEFYHp~~eYnV---RVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLV 244 (338)
T KOG0668|consen 168 ELRKLRLIDWGLAEFYHPGKEYNV---RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV 244 (338)
T ss_pred hhceeeeeecchHhhcCCCceeee---eeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHH
Confidence 5 5699999999987755433211 123455788998875 457889999999999999999999986443322221
Q ss_pred hhhhh------------------------cccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHH
Q 020641 249 LVTWA------------------------TPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVV 304 (323)
Q Consensus 249 ~~~~~------------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl 304 (323)
.+... -...........+.++.+.-. +++..+++...|.+|.++|+|+.|..
T Consensus 245 kIakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~----~peaiDlldklLrYDHqeRlTakEam 320 (338)
T KOG0668|consen 245 KIAKVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLV----SPEAIDLLDKLLRYDHQERLTAKEAM 320 (338)
T ss_pred HHHHHhChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccC----ChHHHHHHHHHHhhccccccchHHHh
Confidence 11100 000111111222222222222 35688999999999999999999987
Q ss_pred H
Q 020641 305 K 305 (323)
Q Consensus 305 ~ 305 (323)
+
T Consensus 321 ~ 321 (338)
T KOG0668|consen 321 A 321 (338)
T ss_pred c
Confidence 5
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.6e-34 Score=232.31 Aligned_cols=262 Identities=21% Similarity=0.253 Sum_probs=194.9
Q ss_pred cccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeCC---
Q 020641 21 VRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGN--- 97 (323)
Q Consensus 21 ~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--- 97 (323)
+-||-|+||.||.+.|..+++.++.|....-.-. + ...+++-+|+.+|..++|.|++..++...-.+
T Consensus 59 RPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~------L----~s~krvFre~kmLcfFkHdNVLSaLDILQPph~df 128 (449)
T KOG0664|consen 59 RPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQN------L----ASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSF 128 (449)
T ss_pred CcccccceeEEEeccCCCCccchhHhhcchHHHH------H----HHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchH
Confidence 3689999999999999999999988855421111 1 11367789999999999999999998876554
Q ss_pred --eEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeE
Q 020641 98 --LRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKA 175 (323)
Q Consensus 98 --~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~ 175 (323)
..|+++|.+.. +|...+-.... ++...++-.++||+.|+.|||+. +|+||||||.|.|+++|-.+
T Consensus 129 FqEiYV~TELmQS-DLHKIIVSPQ~---------Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvL 195 (449)
T KOG0664|consen 129 FQELYVLTELMQS-DLHKIIVSPQA---------LTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCIL 195 (449)
T ss_pred HHHHHHHHHHHHh-hhhheeccCCC---------CCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceE
Confidence 34788898875 89888866543 88889999999999999999999 99999999999999999999
Q ss_pred EEeeccccCCCCccccccccccccCccccCCCccccCC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhc
Q 020641 176 KIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG-QLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWAT 254 (323)
Q Consensus 176 ~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~ 254 (323)
||||||+++..... .........-|..|+|||++.|. .|+.+.||||+||++.||+..+..|...........+...-
T Consensus 196 KICDFGLARvee~d-~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLL 274 (449)
T KOG0664|consen 196 KICDFGLARTWDQR-DRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLL 274 (449)
T ss_pred Eecccccccccchh-hhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHh
Confidence 99999999865432 23334444467789999999875 58999999999999999999999998776544443333322
Q ss_pred ccccccccch--------hcCCCcC---------CCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHH
Q 020641 255 PRLSEDKVKQ--------CVDPKLK---------GEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKA 306 (323)
Q Consensus 255 ~~~~~~~~~~--------~~~~~~~---------~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~ 306 (323)
...+.+...- ++....+ ...+.....+-..++..++..||+.|.+..+.+..
T Consensus 275 GTPs~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~ 343 (449)
T KOG0664|consen 275 GTPSQEAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQH 343 (449)
T ss_pred CCCcHHHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccc
Confidence 2222222111 1111111 01112223456678888999999999998887653
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.9e-33 Score=244.05 Aligned_cols=205 Identities=20% Similarity=0.259 Sum_probs=172.6
Q ss_pred CCCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCC---CCcccceee
Q 020641 15 PSPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLK---HENLVELLG 91 (323)
Q Consensus 15 ~~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~~ 91 (323)
..|..+..||.|+||.||+|.++..+..|.+|.+.++..-..-=.+.. --..+-.|+.+|..++ |+||+++++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDr----kLGtVp~EIqIla~l~~~sH~NIlKlLd 636 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDR----KLGTVPSEIQILATLNKHSHENILKLLD 636 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhccc----ccCccchhHHHHHHhhhcCccchhhhhh
Confidence 457777799999999999999999999999998877653332111100 0122346788888886 999999999
Q ss_pred EEEeCCeEEEEEeec-CCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEc
Q 020641 92 YCVEGNLRVLAYEFA-TMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLF 170 (323)
Q Consensus 92 ~~~~~~~~~lv~e~~-~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~ 170 (323)
+|++++.+|++||.. ++.+|++++..... +++..+..+++|++.|+++||++ ||+|||||-+|+.++
T Consensus 637 fFEddd~yyl~te~hg~gIDLFd~IE~kp~---------m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd 704 (772)
T KOG1152|consen 637 FFEDDDYYYLETEVHGEGIDLFDFIEFKPR---------MDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVD 704 (772)
T ss_pred eeecCCeeEEEecCCCCCcchhhhhhccCc---------cchHHHHHHHHHHHhcccccccc---CceecccccccEEEe
Confidence 999999999999986 56799999976653 99999999999999999999999 999999999999999
Q ss_pred cCCeEEEeeccccCCCCccccccccccccCccccCCCccccCCCC-CcccchHHHHHHHHHHHhCCCCCC
Q 020641 171 EDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQL-TQKSDVYSFGVVLLELLTGRKPVD 239 (323)
Q Consensus 171 ~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~pf~ 239 (323)
.+|-+||+|||.+....++. .....||..|.|||++.|..| +..-|||++|+++|-++..+.||.
T Consensus 705 ~~g~~klidfgsaa~~ksgp----fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 705 SNGFVKLIDFGSAAYTKSGP----FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred cCCeEEEeeccchhhhcCCC----cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 99999999999997765543 245569999999999999887 567899999999999999999984
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.8e-32 Score=225.09 Aligned_cols=252 Identities=18% Similarity=0.209 Sum_probs=197.6
Q ss_pred CCCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcC-CCCcccceeeEE
Q 020641 15 PSPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRL-KHENLVELLGYC 93 (323)
Q Consensus 15 ~~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~ 93 (323)
..+..+.-||.|+|+.|.+++..++.+.+|+|++.++.....+ ..+-.+.|-.+..+. +||.++-+..+|
T Consensus 250 ~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~ndde---------didwvqtek~vfe~asn~pflvglhscf 320 (593)
T KOG0695|consen 250 QDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDE---------DIDWVQTEKHVFEQASNNPFLVGLHSCF 320 (593)
T ss_pred ccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcc---------cchhHHhhHHHHHhccCCCeEEehhhhh
Confidence 3445555789999999999999999999999988766544432 223445555556555 899999999999
Q ss_pred EeCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCC
Q 020641 94 VEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDF 173 (323)
Q Consensus 94 ~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~ 173 (323)
.....+++|.||..||+|--.++++.. ++++.+.-+...|+-||.|||+. ||+.||+|.+|+|++..|
T Consensus 321 qtesrlffvieyv~ggdlmfhmqrqrk---------lpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeg 388 (593)
T KOG0695|consen 321 QTESRLFFVIEYVNGGDLMFHMQRQRK---------LPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEG 388 (593)
T ss_pred cccceEEEEEEEecCcceeeehhhhhc---------CcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCC
Confidence 999999999999999999877766553 99999999999999999999999 999999999999999999
Q ss_pred eEEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhh
Q 020641 174 KAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWA 253 (323)
Q Consensus 174 ~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 253 (323)
.+||.|+|+........ ...++.+|||.|.|||++.+..|+...|-|+||++++||+.|+.||+.....+....
T Consensus 389 hikltdygmcke~l~~g--d~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~n---- 462 (593)
T KOG0695|consen 389 HIKLTDYGMCKEGLGPG--DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMN---- 462 (593)
T ss_pred ceeecccchhhcCCCCC--cccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccc----
Confidence 99999999987654332 335677899999999999999999999999999999999999999974432111110
Q ss_pred cccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCC
Q 020641 254 TPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRP 298 (323)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp 298 (323)
...-..+-+++..++ .|...+-....+++.-|++||.+|.
T Consensus 463 ---tedylfqvilekqir--iprslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 463 ---TEDYLFQVILEKQIR--IPRSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred ---hhHHHHHHHhhhccc--ccceeehhhHHHHHHhhcCCcHHhc
Confidence 001111222333332 3344444566788888999999985
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.7e-33 Score=241.08 Aligned_cols=274 Identities=19% Similarity=0.178 Sum_probs=199.1
Q ss_pred CCccccccCCCC-CccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCC
Q 020641 5 YHPRALGAHAPS-PGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKH 83 (323)
Q Consensus 5 ~~~~~~~~~~~~-~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h 83 (323)
|-...+|+..-+ |.++-..|+|-|++|..|.+...+..||+|++.... .-.+.-..|+++|++|+.
T Consensus 421 YYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE-------------~M~KtGl~EleiLkKL~~ 487 (752)
T KOG0670|consen 421 YYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE-------------VMHKTGLKELEILKKLND 487 (752)
T ss_pred eEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch-------------HHhhhhhHHHHHHHHhhc
Confidence 334445544433 344447899999999999999999999999776321 112334679999999842
Q ss_pred ------CcccceeeEEEeCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCc
Q 020641 84 ------ENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSI 157 (323)
Q Consensus 84 ------~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i 157 (323)
-|++.++.+|...+++|||+|.+.- +|.+++++....- .+....+..+++|+.-||..|-+- |+
T Consensus 488 AD~Edk~Hclrl~r~F~hknHLClVFE~Lsl-NLRevLKKyG~nv------GL~ikaVRsYaqQLflALklLK~c---~v 557 (752)
T KOG0670|consen 488 ADPEDKFHCLRLFRHFKHKNHLCLVFEPLSL-NLREVLKKYGRNV------GLHIKAVRSYAQQLFLALKLLKKC---GV 557 (752)
T ss_pred cCchhhhHHHHHHHHhhhcceeEEEehhhhc-hHHHHHHHhCccc------ceeehHHHHHHHHHHHHHHHHHhc---Ce
Confidence 3899999999999999999998865 9999998765332 277788999999999999999998 99
Q ss_pred eeCCCCCCCEEEccC-CeEEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCC
Q 020641 158 IHRDIRSSNVLLFED-FKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRK 236 (323)
Q Consensus 158 ~h~dikp~nili~~~-~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~ 236 (323)
+|.||||+|||++.+ ..+||||||.|........ ....-+..|.|||++.|..|+...|+||+||+||||.||+.
T Consensus 558 lHaDIKPDNiLVNE~k~iLKLCDfGSA~~~~enei----tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkI 633 (752)
T KOG0670|consen 558 LHADIKPDNILVNESKNILKLCDFGSASFASENEI----TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKI 633 (752)
T ss_pred eecccCccceEeccCcceeeeccCccccccccccc----cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccce
Confidence 999999999999875 5679999999876543221 11113457999999999999999999999999999999999
Q ss_pred CCCCCCCcccchhhhhhccccccccc--------------------------------chhcCC------CcC--CCCC-
Q 020641 237 PVDHTMPRGQQSLVTWATPRLSEDKV--------------------------------KQCVDP------KLK--GEYP- 275 (323)
Q Consensus 237 pf~~~~~~~~~~~~~~~~~~~~~~~~--------------------------------~~~~~~------~~~--~~~~- 275 (323)
.|.+...-....+.......++...+ ...+.| .+. ..++
T Consensus 634 lFpG~TNN~MLrl~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~d 713 (752)
T KOG0670|consen 634 LFPGRTNNQMLRLFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPD 713 (752)
T ss_pred ecCCCCcHHHHHHHHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCc
Confidence 99766432111111111111111111 111111 011 1122
Q ss_pred --HHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 276 --PKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 276 --~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
.....+|.+|+..||..||++|.|..+.|.
T Consensus 714 eq~~~~~~~rdLLdkml~LdP~KRit~nqAL~ 745 (752)
T KOG0670|consen 714 EQPKIVQQLRDLLDKMLILDPEKRITVNQALK 745 (752)
T ss_pred hhHHHHHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 233568999999999999999999998875
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-32 Score=212.48 Aligned_cols=203 Identities=24% Similarity=0.257 Sum_probs=164.4
Q ss_pred cccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcC-CCCcccceeeEEEeCC
Q 020641 19 YFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRL-KHENLVELLGYCVEGN 97 (323)
Q Consensus 19 ~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~ 97 (323)
.+..||+|++|.|-+.++..++...|.|-+... ...+...+..+++.+..+. ..|.++.+++......
T Consensus 50 ~i~elGrGayG~vekmrh~~sg~imAvKri~~t-----------vn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~reg 118 (282)
T KOG0984|consen 50 GIEELGRGAYGVVEKMRHIQSGTIMAVKRIRAT-----------VNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREG 118 (282)
T ss_pred hhhhhcCCccchhhheeeccCCeEEEEeeehhh-----------cChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccc
Confidence 345899999999999999999999998855322 1123335566778877766 8999999999999899
Q ss_pred eEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEEE
Q 020641 98 LRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKI 177 (323)
Q Consensus 98 ~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~l 177 (323)
..|+.||.++. ||..+-+.-..+ +..+++.-+-+++..+..|+.|||++. .++|||+||.|||++..|++|+
T Consensus 119 dvwIcME~M~t-Sldkfy~~v~~~-----g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKi 190 (282)
T KOG0984|consen 119 DVWICMELMDT-SLDKFYRKVLKK-----GGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKI 190 (282)
T ss_pred cEEEeHHHhhh-hHHHHHHHHHhc-----CCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEE
Confidence 99999999976 887776543221 113888899999999999999999976 9999999999999999999999
Q ss_pred eeccccCCCCccccccccccccCccccCCCcccc----CCCCCcccchHHHHHHHHHHHhCCCCCCCCCC
Q 020641 178 ADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAM----TGQLTQKSDVYSFGVVLLELLTGRKPVDHTMP 243 (323)
Q Consensus 178 ~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~----~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 243 (323)
||||.+-.+.+.-. .+-..|...|+|||.+. ...|+.++||||||++++||.++++||+....
T Consensus 191 CDFGIsG~L~dSiA---kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~t 257 (282)
T KOG0984|consen 191 CDFGISGYLVDSIA---KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGT 257 (282)
T ss_pred cccccceeehhhhH---HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCC
Confidence 99999876655322 22234777899999874 34789999999999999999999999975543
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=225.56 Aligned_cols=263 Identities=21% Similarity=0.266 Sum_probs=200.5
Q ss_pred ccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeC-CeEE
Q 020641 22 RLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEG-NLRV 100 (323)
Q Consensus 22 ~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~ 100 (323)
.+-+|.||.||.+....-..+.-.+-...+. .+...++-....+..|--++....|||+..+.+++.+. ...+
T Consensus 291 llqEGtFGri~~gI~~eEdt~n~~q~v~vKT------vk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~ 364 (563)
T KOG1024|consen 291 LLQEGTFGRIYRGIWREEDTYNDCQEVLVKT------VKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATPF 364 (563)
T ss_pred hhhcCchhheeeeeecccCCcchHHHHHHHH------HHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcce
Confidence 4578999999998554322221111111000 01112222335566777778888999999999987754 5678
Q ss_pred EEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEEEeec
Q 020641 101 LAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADF 180 (323)
Q Consensus 101 lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~l~Df 180 (323)
+++.+..-|+|..++.-..... ......++..+..-++.|++.|+.|||+. |++|.||..+|.+|++..++||+|=
T Consensus 365 V~y~~~~~gNLK~FL~~Cr~~~-~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd~LqVkltDs 440 (563)
T KOG1024|consen 365 VLYPATGVGNLKSFLQICRGDD-PSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDDQLQVKLTDS 440 (563)
T ss_pred EEEeccCcchHHHHHHHhccCC-CccccchhHHHHHHHHHHHHHHHHHHHhc---CcccchhhhhcceehhheeEEeccc
Confidence 8999999899999998333211 11112377778889999999999999999 9999999999999999999999999
Q ss_pred cccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccccc
Q 020641 181 NLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPRLSE 259 (323)
Q Consensus 181 g~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~ 259 (323)
.+++..-....+.-......+..|++||.+....|+.++|+||||+++|||+| |+.|+...+ .
T Consensus 441 aLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeID----------------P 504 (563)
T KOG1024|consen 441 ALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEID----------------P 504 (563)
T ss_pred hhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccC----------------H
Confidence 99987765555544444445678999999999999999999999999999998 999997553 3
Q ss_pred cccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhh
Q 020641 260 DKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPL 310 (323)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~ 310 (323)
.++...+..+.+-.-|..++++|..+|.-||...|++|||++++..-|.+.
T Consensus 505 fEm~~ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF 555 (563)
T KOG1024|consen 505 FEMEHYLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEF 555 (563)
T ss_pred HHHHHHHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHH
Confidence 445555566666677888999999999999999999999999998877664
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-32 Score=245.84 Aligned_cols=253 Identities=23% Similarity=0.325 Sum_probs=202.5
Q ss_pred CCCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEE
Q 020641 15 PSPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCV 94 (323)
Q Consensus 15 ~~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 94 (323)
..|+.+-++|.|.+|+||+|+++.+++.+|+|++..+ ......-+++|+-+++.++|+||+.+++.+.
T Consensus 15 ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLe------------p~dd~~~iqqei~~~~dc~h~nivay~gsyl 82 (829)
T KOG0576|consen 15 DDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLE------------PGDDFSGIQQEIGMLRDCRHPNIVAYFGSYL 82 (829)
T ss_pred cchhheeeecCCcccchhhhcccccCchhhheeeecc------------CCccccccccceeeeecCCCcChHHHHhhhh
Confidence 4566667999999999999999999999999866532 2233355678899999999999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCe
Q 020641 95 EGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFK 174 (323)
Q Consensus 95 ~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~ 174 (323)
.....|+.||||.+|+|.+.-.-... +++.++..+++..+.|++|||++ |-+|||||-.||++++.|.
T Consensus 83 r~dklwicMEycgggslQdiy~~Tgp---------lselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gD 150 (829)
T KOG0576|consen 83 RRDKLWICMEYCGGGSLQDIYHVTGP---------LSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGD 150 (829)
T ss_pred hhcCcEEEEEecCCCcccceeeeccc---------chhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCc
Confidence 99999999999999999998766543 89999999999999999999999 9999999999999999999
Q ss_pred EEEeeccccCCCCccccccccccccCccccCCCcccc---CCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhh
Q 020641 175 AKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAM---TGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVT 251 (323)
Q Consensus 175 ~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~ 251 (323)
+++.|||.+..+...-.. .....||+-|+|||+.. ...|...+|||++|++..|+-.-+.|...........+..
T Consensus 151 vklaDfgvsaqitati~K--rksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmT 228 (829)
T KOG0576|consen 151 VKLADFGVSAQITATIAK--RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMT 228 (829)
T ss_pred eeecccCchhhhhhhhhh--hhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhh
Confidence 999999998776543322 24457999999999774 5678899999999999999988777765443322111111
Q ss_pred hhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 252 WATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
... .++ ....-...+.+.+.+|++.||.++|++|||++-++.
T Consensus 229 kS~-----------~qp-p~lkDk~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 229 KSG-----------FQP-PTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred ccC-----------CCC-CcccCCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 000 000 011223456678999999999999999999998765
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-32 Score=222.81 Aligned_cols=261 Identities=18% Similarity=0.184 Sum_probs=195.5
Q ss_pred CCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEe
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVE 95 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 95 (323)
.|....-+|.|.. .|-.|.|.-.++.+++|...... . .....++..+|..++..+.|+||++++.+|.-
T Consensus 18 Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf-~---------n~~~akra~rel~l~~~v~~~nii~l~n~ftP 86 (369)
T KOG0665|consen 18 RYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPF-Q---------NQTHAKRAYRELKLMKCVNHKNIISLLNVFTP 86 (369)
T ss_pred eeeeecccCCCCc-eEEecchhhccCceehhhhcCcc-c---------cCccchhhhhhhhhhhhhcccceeeeeeccCc
Confidence 4445556788887 88899999999999988665441 1 13334667889999999999999999999874
Q ss_pred CC------eEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEE
Q 020641 96 GN------LRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLL 169 (323)
Q Consensus 96 ~~------~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili 169 (323)
.. ..|+|||++.. +|.+.+... +.-.++..++.|++.|+.|||+. ||+|||+||+||++
T Consensus 87 ~~~l~~~~e~y~v~e~m~~-nl~~vi~~e-----------lDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv 151 (369)
T KOG0665|consen 87 QKTLEEFQEVYLVMELMDA-NLCQVILME-----------LDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVV 151 (369)
T ss_pred cccHHHHHhHHHHHHhhhh-HHHHHHHHh-----------cchHHHHHHHHHHHHHHHHHHhc---ceeecccCccccee
Confidence 43 56999999976 999998743 66678999999999999999999 99999999999999
Q ss_pred ccCCeEEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchh
Q 020641 170 FEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSL 249 (323)
Q Consensus 170 ~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~ 249 (323)
..+..+|+.|||+|+..... ...+....+..|+|||++.+.++.+..||||+||++.||++|...|.+.....+--.
T Consensus 152 ~~~~~lKi~dfg~ar~e~~~---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~k 228 (369)
T KOG0665|consen 152 NSDCTLKILDFGLARTEDTD---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNK 228 (369)
T ss_pred cchhheeeccchhhcccCcc---cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHH
Confidence 99999999999999765432 234555678889999999999999999999999999999999999976543221111
Q ss_pred hhh----------------------hcccccccccchhc-CCCcC--CCCCHHHHHHHHHHHHHccCCCCCCCCChHHHH
Q 020641 250 VTW----------------------ATPRLSEDKVKQCV-DPKLK--GEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVV 304 (323)
Q Consensus 250 ~~~----------------------~~~~~~~~~~~~~~-~~~~~--~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl 304 (323)
+.. ..+.+......+.+ |.... .+.+.-....+++++.+||-.||++|.|++++|
T Consensus 229 i~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL 308 (369)
T KOG0665|consen 229 IIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDAL 308 (369)
T ss_pred HHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHh
Confidence 100 00000000000110 00000 111223356788999999999999999999999
Q ss_pred H
Q 020641 305 K 305 (323)
Q Consensus 305 ~ 305 (323)
.
T Consensus 309 ~ 309 (369)
T KOG0665|consen 309 R 309 (369)
T ss_pred c
Confidence 7
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-31 Score=240.75 Aligned_cols=282 Identities=17% Similarity=0.152 Sum_probs=176.5
Q ss_pred CCccccccCCCCCCccceeccce----------------eeeeeeeccccccccCc--cccccccCCCCCchHHHHHHHH
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRVK----------------MRRWLCCTCQVEESYPS--HENERLKSPKNYPDDEKQLVSV 77 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~~----------------~~~~~~~k~~~~~~~~~--~~~~~~~~~~~~~~~~~~e~~~ 77 (323)
.+....+||+|+||.||++.... .++.+++|......... ...+.........+....|+.+
T Consensus 146 ~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~~ 225 (507)
T PLN03224 146 DFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAYM 225 (507)
T ss_pred CceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHHH
Confidence 45555699999999999986532 33456666543211000 0000000111223344556667
Q ss_pred HhcCCCCcc-----cceeeEEEe--------CCeEEEEEeecCCCCHHHHhccCCCCC---------------CCCCCCC
Q 020641 78 VSRLKHENL-----VELLGYCVE--------GNLRVLAYEFATMGSLHDILHGRKGVQ---------------GAQPGPV 129 (323)
Q Consensus 78 l~~l~h~~i-----~~~~~~~~~--------~~~~~lv~e~~~~~sL~~~~~~~~~~~---------------~~~~~~~ 129 (323)
+.+++|.++ ++++++|.. ....++|+||+.+++|.+++....... .......
T Consensus 226 l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~ 305 (507)
T PLN03224 226 CAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDK 305 (507)
T ss_pred HHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccccc
Confidence 777755543 566666653 245799999999999999987532110 0011123
Q ss_pred CCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEEEeeccccCCCCccccccccccccCccccCCCcc
Q 020641 130 LDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEY 209 (323)
Q Consensus 130 ~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~ 209 (323)
+++..+..++.|++.++.|||+. +++||||||+||+++.++.++|+|||++......... ......+++.|+|||.
T Consensus 306 ~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~g~~tp~Y~aPE~ 381 (507)
T PLN03224 306 RDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINF-NPLYGMLDPRYSPPEE 381 (507)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCcc-CccccCCCcceeChhh
Confidence 56778899999999999999999 9999999999999999999999999998654332111 1112234789999998
Q ss_pred ccCCCC----------------------CcccchHHHHHHHHHHHhCCC-CCCCCCCcccchhhhhhcccccccccchhc
Q 020641 210 AMTGQL----------------------TQKSDVYSFGVVLLELLTGRK-PVDHTMPRGQQSLVTWATPRLSEDKVKQCV 266 (323)
Q Consensus 210 ~~~~~~----------------------~~~~Di~slG~~l~~l~~g~~-pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (323)
+..... ..+.|+||+||++++|++|.. ||............ + ...........
T Consensus 382 l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~-~---~~~~~~~r~~~ 457 (507)
T PLN03224 382 LVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQ-Y---DNDLNRWRMYK 457 (507)
T ss_pred hcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhh-c---cchHHHHHhhc
Confidence 754321 124699999999999999875 76533211110000 0 00000000111
Q ss_pred CCCcCCCCCHHHHHHHHHHHHHccCCCC---CCCCChHHHHH
Q 020641 267 DPKLKGEYPPKGVAKLAAVAALCVQYEA---EFRPNMSIVVK 305 (323)
Q Consensus 267 ~~~~~~~~~~~~~~~l~~li~~cl~~~P---~~Rps~~evl~ 305 (323)
............+....+++.+||..+| .+|+|+.|+++
T Consensus 458 ~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~ 499 (507)
T PLN03224 458 GQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS 499 (507)
T ss_pred ccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence 1111112233456789999999999876 68999999986
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=213.68 Aligned_cols=212 Identities=31% Similarity=0.471 Sum_probs=181.1
Q ss_pred cCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeCCeEEEE
Q 020641 23 LDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLA 102 (323)
Q Consensus 23 lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 102 (323)
||.|++|.||++....+++.+++|+........ ....+.+|++.++.++|++++++++++......+++
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~-----------~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~ 69 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS-----------LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLV 69 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh-----------HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEE
Confidence 689999999999998888888888665332111 346789999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEcc-CCeEEEeecc
Q 020641 103 YEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFE-DFKAKIADFN 181 (323)
Q Consensus 103 ~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~-~~~~~l~Dfg 181 (323)
+|++.+++|.+++..... .++...+..++.+++.++.+||+. |++|+||+|.||+++. ++.++|+|||
T Consensus 70 ~e~~~~~~l~~~~~~~~~--------~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~ 138 (215)
T cd00180 70 MEYCEGGSLKDLLKENEG--------KLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFG 138 (215)
T ss_pred EecCCCCcHHHHHHhccC--------CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCC
Confidence 999998999999976521 188899999999999999999999 9999999999999999 8999999999
Q ss_pred ccCCCCccccccccccccCccccCCCccccCC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhccccccc
Q 020641 182 LSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG-QLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSED 260 (323)
Q Consensus 182 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 260 (323)
.+........ ......+...|.+||..... ..+.++|+|++|++++++
T Consensus 139 ~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l----------------------------- 187 (215)
T cd00180 139 LSKLLTSDKS--LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----------------------------- 187 (215)
T ss_pred ceEEccCCcc--hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH-----------------------------
Confidence 9876544321 12223467889999988776 778899999999999999
Q ss_pred ccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHH
Q 020641 261 KVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKA 306 (323)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~ 306 (323)
..+.+++.+|++.||.+||++.++++.
T Consensus 188 -------------------~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 -------------------PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred -------------------HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 358899999999999999999999875
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7e-32 Score=246.75 Aligned_cols=242 Identities=21% Similarity=0.330 Sum_probs=181.1
Q ss_pred ccCCCCCCc-cceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcC-CCCcccceeeEEEeCCeE
Q 020641 22 RLDKGPEDD-LYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRL-KHENLVELLGYCVEGNLR 99 (323)
Q Consensus 22 ~lg~G~~~~-V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~ 99 (323)
-+|.|+-|+ ||++.- .+|.||+|.+. .+......+|+..|+.. +||||+++++.-.+....
T Consensus 516 ilG~Gs~Gt~Vf~G~y--e~R~VAVKrll---------------~e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~ 578 (903)
T KOG1027|consen 516 ILGYGSNGTVVFRGVY--EGREVAVKRLL---------------EEFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFL 578 (903)
T ss_pred HcccCCCCcEEEEEee--CCceehHHHHh---------------hHhHHHHHHHHHHHHhccCCCceEEEEeeccCCceE
Confidence 568888875 454443 56678877443 33345678999999998 899999999999999999
Q ss_pred EEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEcc-----CCe
Q 020641 100 VLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFE-----DFK 174 (323)
Q Consensus 100 ~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~-----~~~ 174 (323)
|+..|.|.. +|.+++.... .. ... ......+.++.|+++|+++||+. +|+|||+||.||||+. ..+
T Consensus 579 YIalELC~~-sL~dlie~~~-~d-~~~---~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~r 649 (903)
T KOG1027|consen 579 YIALELCAC-SLQDLIESSG-LD-VEM---QSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLR 649 (903)
T ss_pred EEEehHhhh-hHHHHHhccc-cc-hhh---cccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCccee
Confidence 999999986 9999998741 10 110 11145678999999999999998 9999999999999976 257
Q ss_pred EEEeeccccCCCCccccc-cccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccchhhhh
Q 020641 175 AKIADFNLSNQAPDMAAR-LHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTW 252 (323)
Q Consensus 175 ~~l~Dfg~~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~ 252 (323)
++|+|||++......... .......||.+|+|||++.....+.+.||||+||++|+.++ |.+||...-.+...
T Consensus 650 a~iSDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~N----- 724 (903)
T KOG1027|consen 650 AKISDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQAN----- 724 (903)
T ss_pred EEecccccccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhh-----
Confidence 899999999877654332 22445569999999999998888889999999999999999 59999755322110
Q ss_pred hcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 253 ATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
.......+..+ ....++ +..+||.+|++.+|..||++.+|+.
T Consensus 725 --Il~~~~~L~~L-------~~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 725 --ILTGNYTLVHL-------EPLPDC--EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred --hhcCccceeee-------ccCchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 00011111110 111112 7889999999999999999999974
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=222.81 Aligned_cols=261 Identities=20% Similarity=0.279 Sum_probs=191.9
Q ss_pred CCccccccCCCCCCccceeccce---eeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcC-CCCcccceee
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRVK---MRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRL-KHENLVELLG 91 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~~---~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~ 91 (323)
.+..+.++|.|.|++||++.+.. .++++|+|-+.. .....++..|+++|..+ .+.||+++.+
T Consensus 37 ~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~--------------ts~p~ri~~El~~L~~~gG~~ni~~~~~ 102 (418)
T KOG1167|consen 37 AYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYR--------------TSSPSRILNELEMLYRLGGSDNIIKLNG 102 (418)
T ss_pred hhhhhccccccchhhhhhhhHhhhccccceEeeeeccc--------------ccCchHHHHHHHHHHHhccchhhhcchh
Confidence 34455599999999999999998 788898884431 23346789999999999 8999999999
Q ss_pred EEEeCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEcc
Q 020641 92 YCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFE 171 (323)
Q Consensus 92 ~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~ 171 (323)
++..++...+|+||+++....++... ++...+..+++.++.||.++|++ ||+||||||.|++++.
T Consensus 103 ~~rnnd~v~ivlp~~~H~~f~~l~~~------------l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~ 167 (418)
T KOG1167|consen 103 CFRNNDQVAIVLPYFEHDRFRDLYRS------------LSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNR 167 (418)
T ss_pred hhccCCeeEEEecccCccCHHHHHhc------------CCHHHHHHHHHHHHHHhhhhhcc---CccccCCCcccccccc
Confidence 99999999999999999999999876 88889999999999999999999 9999999999999986
Q ss_pred C-CeEEEeeccccCCCCcc-------c-------c---------------------c-------cccccccCccccCCCc
Q 020641 172 D-FKAKIADFNLSNQAPDM-------A-------A---------------------R-------LHSTRVLGTFGYHAPE 208 (323)
Q Consensus 172 ~-~~~~l~Dfg~~~~~~~~-------~-------~---------------------~-------~~~~~~~g~~~y~aPE 208 (323)
. +.-.|+|||+|...... . . . ...-...||++|+|||
T Consensus 168 ~t~rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPE 247 (418)
T KOG1167|consen 168 RTQRGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPE 247 (418)
T ss_pred ccCCceEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchH
Confidence 4 67899999998511000 0 0 0 0000123899999999
Q ss_pred cccC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccch-------------hhhhhccc--ccc-------------
Q 020641 209 YAMT-GQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQS-------------LVTWATPR--LSE------------- 259 (323)
Q Consensus 209 ~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~-------------~~~~~~~~--~~~------------- 259 (323)
++.. ...+.++||||.|+++..++++.+||.......... ........ +..
T Consensus 248 vL~k~~~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~ 327 (418)
T KOG1167|consen 248 VLFRCPRQTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVN 327 (418)
T ss_pred HHhhccCcCCccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhc
Confidence 8875 456889999999999999999999986443211100 00000000 000
Q ss_pred -ccc-chhcCCC----cC-CCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 260 -DKV-KQCVDPK----LK-GEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 260 -~~~-~~~~~~~----~~-~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
+.+ .+.+.+. .. .......+..+++++.+||..||.+|.|+++.|.
T Consensus 328 f~s~~~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALk 380 (418)
T KOG1167|consen 328 FETLHIESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALK 380 (418)
T ss_pred hhccChhhcccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhc
Confidence 000 0000000 00 0111222457999999999999999999999875
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-29 Score=203.60 Aligned_cols=241 Identities=18% Similarity=0.273 Sum_probs=178.4
Q ss_pred ccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcC-CCCcccceeeE-EEe
Q 020641 18 GYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRL-KHENLVELLGY-CVE 95 (323)
Q Consensus 18 ~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~-~~~ 95 (323)
.....||+|-||.+-+|.+.+++..+++|..... ..-..+|.+|...--.| .|.||+.-+++ |+.
T Consensus 27 ~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-------------~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt 93 (378)
T KOG1345|consen 27 TINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-------------QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQT 93 (378)
T ss_pred hHHHHhcccceeeEEeeeccCCceEEEeeccCcc-------------hhhHHHHHHHhccceeeccchhhhHHHHHHhhc
Confidence 3344789999999999999999999999866533 22236778887765556 79999988765 667
Q ss_pred CCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEc--cCC
Q 020641 96 GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLF--EDF 173 (323)
Q Consensus 96 ~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~--~~~ 173 (323)
.+.+++++||++.|+|.+-+.... +-+....+++.|+++||.|||++ +++|||||.+||||- +..
T Consensus 94 ~d~YvF~qE~aP~gdL~snv~~~G----------igE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~ 160 (378)
T KOG1345|consen 94 SDAYVFVQEFAPRGDLRSNVEAAG----------IGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFY 160 (378)
T ss_pred CceEEEeeccCccchhhhhcCccc----------ccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCcc
Confidence 778899999999999999987754 77888899999999999999999 999999999999994 335
Q ss_pred eEEEeeccccCCCCccccccccccccCccccCCCccccC-----CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccch
Q 020641 174 KAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT-----GQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQS 248 (323)
Q Consensus 174 ~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~ 248 (323)
++||||||..+..+..... ...+..|.+||+... ....+.+|+|.||+++|++++|+.||........ .
T Consensus 161 rvKlcDFG~t~k~g~tV~~-----~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~-~ 234 (378)
T KOG1345|consen 161 RVKLCDFGLTRKVGTTVKY-----LEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDK-P 234 (378)
T ss_pred EEEeeecccccccCceehh-----hhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCc-h
Confidence 8999999998766543322 223667999997642 2346789999999999999999999983322222 1
Q ss_pred hhhhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCC
Q 020641 249 LVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRP 298 (323)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp 298 (323)
-..| ..|..+... .+ .......++.+..+.++-|..+|++|=
T Consensus 235 Y~~~--~~w~~rk~~-----~~-P~~F~~fs~~a~r~Fkk~lt~~~~drc 276 (378)
T KOG1345|consen 235 YWEW--EQWLKRKNP-----AL-PKKFNPFSEKALRLFKKSLTPRFKDRC 276 (378)
T ss_pred HHHH--HHHhcccCc-----cC-chhhcccCHHHHHHHHHhcCCcccccc
Confidence 1111 111111111 11 111223355688888999999999993
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-28 Score=202.66 Aligned_cols=199 Identities=28% Similarity=0.357 Sum_probs=167.7
Q ss_pred cccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeCCe
Q 020641 19 YFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNL 98 (323)
Q Consensus 19 ~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 98 (323)
....||.|++|.||++....+++.+++|........ ...+.+.+|++.++.++|+|++++++++.....
T Consensus 3 ~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-----------~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~ 71 (225)
T smart00221 3 LGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE-----------KQREEFLREIRILKKLKHPNIVKLYGVFEDPEP 71 (225)
T ss_pred eeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch-----------HHHHHHHHHHHHHHhCCCCChhhheeeeecCCc
Confidence 345789999999999999988888888876543211 234788899999999999999999999999899
Q ss_pred EEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEEEe
Q 020641 99 RVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIA 178 (323)
Q Consensus 99 ~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~l~ 178 (323)
.++++|++.+++|.+++...... +++..+..++.+++.++.+||+. +++|+||+|.||+++.++.++|+
T Consensus 72 ~~~v~e~~~~~~L~~~~~~~~~~--------~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~ 140 (225)
T smart00221 72 LYLVMEYCEGGDLFDYLRKKGGK--------LSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLA 140 (225)
T ss_pred eEEEEeccCCCCHHHHHHhcccC--------CCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEe
Confidence 99999999999999999765421 67889999999999999999999 99999999999999999999999
Q ss_pred eccccCCCCccccccccccccCccccCCCccc-cCCCCCcccchHHHHHHHHHHHhCCCCCCC
Q 020641 179 DFNLSNQAPDMAARLHSTRVLGTFGYHAPEYA-MTGQLTQKSDVYSFGVVLLELLTGRKPVDH 240 (323)
Q Consensus 179 Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~-~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 240 (323)
|||.+......... ......++..|++||.. ....++.++|+|+||+++++|++|+.||..
T Consensus 141 d~g~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 141 DFGLARFIHRDLAA-LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred eCceeeEecCcccc-cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 99988766543200 11233467789999988 666778899999999999999999999965
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=8e-29 Score=242.19 Aligned_cols=197 Identities=19% Similarity=0.229 Sum_probs=137.4
Q ss_pred hcCCC-CcccceeeEEE-------eCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhh
Q 020641 79 SRLKH-ENLVELLGYCV-------EGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLH 150 (323)
Q Consensus 79 ~~l~h-~~i~~~~~~~~-------~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh 150 (323)
+.++| +||+.+++.|. .....+.++|++. ++|.+++..... .++...++.++.||+.||.|||
T Consensus 27 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~-~~L~~~l~~~~~--------~~~~~~~~~i~~qi~~al~~lH 97 (793)
T PLN00181 27 KSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECED-VSLRQWLDNPDR--------SVDAFECFHVFRQIVEIVNAAH 97 (793)
T ss_pred chhhHHHHHHHhhcccCCccccccccchhhhhhccCC-ccHHHHHhcccc--------cccHHHHHHHHHHHHHHHHHHH
Confidence 44566 68888888772 3345677788775 599999975322 2899999999999999999999
Q ss_pred cCCCCCceeCCCCCCCEEEccCCe-------------------EEEeeccccCCCCcccc--------------cccccc
Q 020641 151 EKVQPSIIHRDIRSSNVLLFEDFK-------------------AKIADFNLSNQAPDMAA--------------RLHSTR 197 (323)
Q Consensus 151 ~~~~~~i~h~dikp~nili~~~~~-------------------~~l~Dfg~~~~~~~~~~--------------~~~~~~ 197 (323)
++ ||+||||||+|||++..+. ++++|||+++....... ......
T Consensus 98 ~~---gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (793)
T PLN00181 98 SQ---GIVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQIL 174 (793)
T ss_pred hC---CeeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccc
Confidence 99 9999999999999965444 45555555543211000 000011
Q ss_pred ccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccccccccchhcCCCcCCCCCHH
Q 020641 198 VLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPK 277 (323)
Q Consensus 198 ~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (323)
..||+.|+|||++.+..++.++|||||||++|||++|..|+...... ...... ..+.+. ...
T Consensus 175 ~~gt~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~~----~~~~~~---------~~~~~~-----~~~ 236 (793)
T PLN00181 175 AMEMSWYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSRT----MSSLRH---------RVLPPQ-----ILL 236 (793)
T ss_pred cCCCcceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHHH----HHHHHH---------hhcChh-----hhh
Confidence 34788899999999999999999999999999999988886532110 000000 000000 011
Q ss_pred HHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 278 GVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 278 ~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
.......++.+||+.+|.+|||+.|+++
T Consensus 237 ~~~~~~~~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 237 NWPKEASFCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred cCHHHHHHHHHhCCCChhhCcChHHHhh
Confidence 1234668899999999999999999986
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.5e-28 Score=193.59 Aligned_cols=169 Identities=22% Similarity=0.199 Sum_probs=126.6
Q ss_pred CCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEEEeeccccCCCCc
Q 020641 109 GSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPD 188 (323)
Q Consensus 109 ~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~l~Dfg~~~~~~~ 188 (323)
|||.+++...... +++..++.++.|++.||.|||+. + ||+||+++.++.+++ ||++.....
T Consensus 1 GsL~~~l~~~~~~--------l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~ 61 (176)
T smart00750 1 VSLADILEVRGRP--------LNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTP 61 (176)
T ss_pred CcHHHHHHHhCCC--------CCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecc
Confidence 6899999764322 99999999999999999999999 7 999999999999999 998865433
Q ss_pred cccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccccccccchhcCC
Q 020641 189 MAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDP 268 (323)
Q Consensus 189 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (323)
. ...|++.|+|||++.+..++.++|||||||++|+|++|+.||.......... ...... ... ..+
T Consensus 62 ~-------~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~-~~~~~~-~~~------~~~ 126 (176)
T smart00750 62 E-------QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAIL-EILLNG-MPA------DDP 126 (176)
T ss_pred c-------cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHH-HHHHHH-hcc------CCc
Confidence 2 1247899999999999999999999999999999999999996543211110 000000 000 000
Q ss_pred CcCCCCCHHHHH--HHHHHHHHccCCCCCCCCChHHHHHHHhhhhc
Q 020641 269 KLKGEYPPKGVA--KLAAVAALCVQYEAEFRPNMSIVVKALQPLLK 312 (323)
Q Consensus 269 ~~~~~~~~~~~~--~l~~li~~cl~~~P~~Rps~~evl~~l~~~~~ 312 (323)
. ....+..... .+.+++.+||..+|.+|||+.++++.+..+..
T Consensus 127 ~-~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~ 171 (176)
T smart00750 127 R-DRSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFA 171 (176)
T ss_pred c-ccccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHH
Confidence 0 0011223333 69999999999999999999999998876653
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-25 Score=197.43 Aligned_cols=266 Identities=19% Similarity=0.209 Sum_probs=195.7
Q ss_pred CCccccccCCCCCCccceeccceee-eeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCC----CCccccee
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRVKMR-RWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLK----HENLVELL 90 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~~~~-~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~----h~~i~~~~ 90 (323)
.+....+||+|+||.||++.+...+ ..+|+|+..... ......+..|..++..+. ..++..++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~------------~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~ 86 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKEL------------GSKPSVLKIEIQVLKKLEKKNGPSHFPKLL 86 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecc------------cCCCccchhHHHHHHHHhhhcCCCCCCEEE
Confidence 5667779999999999999998875 567777554321 111124567778877775 36888999
Q ss_pred eEE-EeCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEE
Q 020641 91 GYC-VEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLL 169 (323)
Q Consensus 91 ~~~-~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili 169 (323)
+.+ ......++||+.+ |.+|.++........ ++..++..++.|++.+|.++|+. |++||||||+|+++
T Consensus 87 ~~G~~~~~~~~iVM~l~-G~sL~dl~~~~~~~~-------fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~ 155 (322)
T KOG1164|consen 87 DHGRSTEDFNFIVMSLL-GPSLEDLRKRNPPGR-------FSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVV 155 (322)
T ss_pred EeccCCCceeEEEEecc-CccHHHHHHhCCCCC-------cCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeee
Confidence 988 4677789999977 569999986665222 99999999999999999999999 99999999999999
Q ss_pred ccC-----CeEEEeeccccC--CCCcccc-----ccc-cccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCC
Q 020641 170 FED-----FKAKIADFNLSN--QAPDMAA-----RLH-STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRK 236 (323)
Q Consensus 170 ~~~-----~~~~l~Dfg~~~--~~~~~~~-----~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~ 236 (323)
... ..+.|+|||+++ ....... ... .....||..|.++....+...+.+.|+||++.++.+++.|..
T Consensus 156 g~~~~~~~~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~L 235 (322)
T KOG1164|consen 156 GQSSRSEVRTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSL 235 (322)
T ss_pred cCCCCcccceEEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCC
Confidence 765 469999999998 3222111 111 223459999999999999999999999999999999999999
Q ss_pred CCCCCCCcccchhhhhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhhcCCCC
Q 020641 237 PVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSPPP 316 (323)
Q Consensus 237 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~~~~~~ 316 (323)
||................ ............+..+.++...+-..+..++|....+.+.|++.......
T Consensus 236 PW~~~~~~~~~~~~~~~~------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~~~ 303 (322)
T KOG1164|consen 236 PWEALEMTDLKSKFEKDP------------RKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSEGS 303 (322)
T ss_pred CCccccccchHHHHHHHh------------hhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhcCC
Confidence 996554322211111000 00000002223345577777777778999999999999999988876533
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.3e-25 Score=183.49 Aligned_cols=260 Identities=17% Similarity=0.199 Sum_probs=201.5
Q ss_pred cccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcC-CCCcccceeeEEEeCCeE
Q 020641 21 VRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRL-KHENLVELLGYCVEGNLR 99 (323)
Q Consensus 21 ~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~ 99 (323)
.|||.|+||.+++.++.-+++.||+|+...+ ...-+.+.|.+..+.| ..++|..++-+..++..-
T Consensus 34 kKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk--------------S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~N 99 (449)
T KOG1165|consen 34 KKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK--------------SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYN 99 (449)
T ss_pred cccccCcceeeecccccccCceEEEEecccc--------------CCcchHHHHHHHHHHHcCCCCCCceeeeccccchh
Confidence 3999999999999999999999999966533 2335667888888888 779999999999999888
Q ss_pred EEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEcc-----CCe
Q 020641 100 VLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFE-----DFK 174 (323)
Q Consensus 100 ~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~-----~~~ 174 (323)
.||+|.+ |.||.|+..=...+ ++.+++.-++.|++.-+.++|++ .++.|||||+|+||.. ...
T Consensus 100 iLVidLL-GPSLEDLFD~CgR~--------FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~ 167 (449)
T KOG1165|consen 100 ILVIDLL-GPSLEDLFDLCGRR--------FSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANV 167 (449)
T ss_pred hhhhhhh-CcCHHHHHHHhcCc--------ccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCce
Confidence 9999987 55888887644433 99999999999999999999999 9999999999999953 346
Q ss_pred EEEeeccccCCCCccccccc-----cccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchh
Q 020641 175 AKIADFNLSNQAPDMAARLH-----STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSL 249 (323)
Q Consensus 175 ~~l~Dfg~~~~~~~~~~~~~-----~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~ 249 (323)
+.++|||+|....+.....+ .....||..||+-....+...+.+.|+-|||-++++++.|..||.+.........
T Consensus 168 IhiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~k 247 (449)
T KOG1165|consen 168 IHIIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEK 247 (449)
T ss_pred EEEEeccchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHH
Confidence 89999999998876544332 2234599999999999999999999999999999999999999998765433322
Q ss_pred hhhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhhcCCC
Q 020641 250 VTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSPP 315 (323)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~~~~~ 315 (323)
.+.+..+-..-.+. ......+.++..-+.-.-+.+-.+-|..+-+...+++++....
T Consensus 248 YeKIGe~Kr~T~i~---------~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~g 304 (449)
T KOG1165|consen 248 YEKIGETKRSTPIE---------VLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRLG 304 (449)
T ss_pred HHHhccccccCCHH---------HHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhcC
Confidence 22221111110111 1122345566666666666677888999999988888876543
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.4e-26 Score=216.15 Aligned_cols=256 Identities=18% Similarity=0.195 Sum_probs=192.1
Q ss_pred ccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeCCeEEE
Q 020641 22 RLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVL 101 (323)
Q Consensus 22 ~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 101 (323)
.+|.|++|.|+.+...........|....+ .. .......+...+..|+-+-..+.|+|++..+..+.+.....-
T Consensus 325 ~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~-~~-----~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~ 398 (601)
T KOG0590|consen 325 VLGSGAYGSVRIAKRRSDLKSFPEKEFRVR-VK-----PTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQ 398 (601)
T ss_pred eeeecccCceEEEEecCCCccchhhhhhcc-cC-----CcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchh
Confidence 679999998888877766654444432211 00 122222333336677777888999999988887777666666
Q ss_pred EEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEEEeecc
Q 020641 102 AYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFN 181 (323)
Q Consensus 102 v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~l~Dfg 181 (323)
.||||++ +|+.++..... +....+-.++.|++.|+.|+|.. |+.|||+|++|++++.++.+||+|||
T Consensus 399 ~mE~~~~-Dlf~~~~~~~~---------~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg 465 (601)
T KOG0590|consen 399 SMEYCPY-DLFSLVMSNGK---------LTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFG 465 (601)
T ss_pred hhhcccH-HHHHHHhcccc---------cchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecC
Confidence 6999999 99999988622 77889999999999999999999 99999999999999999999999999
Q ss_pred ccCCCCccccc--cccccccCccccCCCccccCCCCCc-ccchHHHHHHHHHHHhCCCCCCCCCCcccch-hhhhhcccc
Q 020641 182 LSNQAPDMAAR--LHSTRVLGTFGYHAPEYAMTGQLTQ-KSDVYSFGVVLLELLTGRKPVDHTMPRGQQS-LVTWATPRL 257 (323)
Q Consensus 182 ~~~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~-~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~-~~~~~~~~~ 257 (323)
.+......... .......|+..|+|||.+.+..|++ ..||||.|++++.|.+|+.||........+. ......+..
T Consensus 466 ~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~ 545 (601)
T KOG0590|consen 466 AASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRN 545 (601)
T ss_pred cceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccc
Confidence 98766554443 4556677999999999999999986 6899999999999999999998665443321 000000000
Q ss_pred cccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 258 SEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
...-........+..-+.+|.+||+.||.+|.|+++|++
T Consensus 546 ---------~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 546 ---------IFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred ---------cccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 000001122455677899999999999999999999987
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.1e-25 Score=177.67 Aligned_cols=261 Identities=18% Similarity=0.190 Sum_probs=189.9
Q ss_pred CCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCC-CCcccceeeEEE
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLK-HENLVELLGYCV 94 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~ 94 (323)
.|..+.|||.|+||++|++....++..||+|+...+.- .....-|.++.+.++ ...|..+..+..
T Consensus 16 ky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~--------------hpqL~yEskvY~iL~~g~GiP~i~~y~~ 81 (341)
T KOG1163|consen 16 KYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK--------------HPQLLYESKVYRILQGGVGIPHIRHYGT 81 (341)
T ss_pred ceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC--------------CcchhHHHHHHHHhccCCCCchhhhhcc
Confidence 45667799999999999999999999999996653321 133455667777774 467777888888
Q ss_pred eCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEcc---
Q 020641 95 EGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFE--- 171 (323)
Q Consensus 95 ~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~--- 171 (323)
+...-.+||+.. |.||.++.+-.... ++.++++-++-|++.-+.|+|.+ +.+||||||+|+|..-
T Consensus 82 e~~ynvlVMdLL-GPsLEdLfnfC~R~--------ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh 149 (341)
T KOG1163|consen 82 EKDYNVLVMDLL-GPSLEDLFNFCSRR--------FTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRH 149 (341)
T ss_pred ccccceeeeecc-CccHHHHHHHHhhh--------hhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccc
Confidence 888889999987 56999988765543 99999999999999999999999 9999999999999964
Q ss_pred CCeEEEeeccccCCCCcccccc-----ccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccc
Q 020641 172 DFKAKIADFNLSNQAPDMAARL-----HSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQ 246 (323)
Q Consensus 172 ~~~~~l~Dfg~~~~~~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~ 246 (323)
..++.|+|||+|....+..... ......||..|.+-....+...+.+.|+-|+|.++.++..|..||.+......
T Consensus 150 ~~kl~LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk 229 (341)
T KOG1163|consen 150 CNKLYLIDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATK 229 (341)
T ss_pred cceEEEEeccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhH
Confidence 3679999999998765433322 23345589999998888888888999999999999999999999998765443
Q ss_pred chhhhhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhh
Q 020641 247 QSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLL 311 (323)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~ 311 (323)
....+.+...- -...........|.++.-.+.-|-..--++-|...-+.+.+.-+.
T Consensus 230 ~QKyEkI~EkK---------~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLf 285 (341)
T KOG1163|consen 230 KQKYEKISEKK---------MSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILF 285 (341)
T ss_pred HHHHHHHHHhh---------cCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHH
Confidence 33222211111 000000111222344666666666666666666665555554443
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.2e-22 Score=178.55 Aligned_cols=264 Identities=23% Similarity=0.315 Sum_probs=192.1
Q ss_pred CccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCC-cccceeeEEEe
Q 020641 17 PGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHE-NLVELLGYCVE 95 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~-~i~~~~~~~~~ 95 (323)
+.....||.|+|+.||++.+. ..+++|.......... .....+.+|..+++.+.|+ +++++.+.+..
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~---------~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~ 69 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKS---------KEVERFLREIQILASLNHPPNIVKLYDFFQD 69 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccch---------hHHHHHHHHHHHHHHccCCcceeeEEEEEec
Confidence 445668999999999999998 4445554432221111 2457788999999999877 79999999987
Q ss_pred CCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCC-e
Q 020641 96 GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDF-K 174 (323)
Q Consensus 96 ~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~-~ 174 (323)
....+++++++.++++.+++...... ..+.......++.|++.++.++|.. +++|||+||+||+++..+ .
T Consensus 70 ~~~~~~~~~~~~~~~l~~~~~~~~~~------~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~ 140 (384)
T COG0515 70 EGSLYLVMEYVDGGSLEDLLKKIGRK------GPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRV 140 (384)
T ss_pred CCEEEEEEecCCCCcHHHHHHhcccc------cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCe
Confidence 77789999999999999777655321 1288889999999999999999999 999999999999999988 7
Q ss_pred EEEeeccccCCCCcccccc----ccccccCccccCCCccccC---CCCCcccchHHHHHHHHHHHhCCCCCCCCCCc-cc
Q 020641 175 AKIADFNLSNQAPDMAARL----HSTRVLGTFGYHAPEYAMT---GQLTQKSDVYSFGVVLLELLTGRKPVDHTMPR-GQ 246 (323)
Q Consensus 175 ~~l~Dfg~~~~~~~~~~~~----~~~~~~g~~~y~aPE~~~~---~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-~~ 246 (323)
++++|||.+.......... ......|+..|++||.+.+ .......|+||+|++++++++|..||...... ..
T Consensus 141 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~ 220 (384)
T COG0515 141 VKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSAT 220 (384)
T ss_pred EEEeccCcceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccH
Confidence 9999999987554433221 2345568999999999987 57788999999999999999999997655431 00
Q ss_pred chhhhhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHH
Q 020641 247 QSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKA 306 (323)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~ 306 (323)
............. .................+.+++..|+..+|..|.+..+....
T Consensus 221 ~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 221 SQTLKIILELPTP-----SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred HHHHHHHHhcCCc-----ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 0000000000000 000000000002223578899999999999999988877764
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.4e-23 Score=183.04 Aligned_cols=169 Identities=17% Similarity=0.023 Sum_probs=123.4
Q ss_pred CCCccccccCCCCCCccceeccce-eeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEE
Q 020641 15 PSPGYFVRLDKGPEDDLYLKKRVK-MRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYC 93 (323)
Q Consensus 15 ~~~~~~~~lg~G~~~~V~~~~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 93 (323)
.+|.....||+|+||.||+|.+.. +++.+|+|........ . ........+.+|++++++++|+|++..+..
T Consensus 18 ~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~-~------~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~- 89 (365)
T PRK09188 18 ARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPW-W------SKPLARHLAAREIRALKTVRGIGVVPQLLA- 89 (365)
T ss_pred CCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccc-c------ccHHHHHHHHHHHHHHHhccCCCCCcEEEE-
Confidence 456666789999999999998876 6777788755321100 0 011224668999999999999999863322
Q ss_pred EeCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCC-CCCCEEEccC
Q 020641 94 VEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDI-RSSNVLLFED 172 (323)
Q Consensus 94 ~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di-kp~nili~~~ 172 (323)
....|+||||+.|++|... .. .. ...++.|++.+|.+||+. ||+|||| ||+||+++.+
T Consensus 90 --~~~~~LVmE~~~G~~L~~~-~~------------~~---~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~ 148 (365)
T PRK09188 90 --TGKDGLVRGWTEGVPLHLA-RP------------HG---DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPD 148 (365)
T ss_pred --cCCcEEEEEccCCCCHHHh-Cc------------cc---hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCC
Confidence 2357999999999999632 11 11 136788999999999999 9999999 9999999999
Q ss_pred CeEEEeeccccCCCCccccccc------cccccCccccCCCccccC
Q 020641 173 FKAKIADFNLSNQAPDMAARLH------STRVLGTFGYHAPEYAMT 212 (323)
Q Consensus 173 ~~~~l~Dfg~~~~~~~~~~~~~------~~~~~g~~~y~aPE~~~~ 212 (323)
++++|+|||++........... .....++..|.|||.+..
T Consensus 149 ~~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 149 GEAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred CCEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 9999999999986654321111 123346778999998853
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.7e-24 Score=173.00 Aligned_cols=251 Identities=22% Similarity=0.339 Sum_probs=190.7
Q ss_pred CccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeC
Q 020641 17 PGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEG 96 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 96 (323)
...+.||.+...|..|+.+...+.- +.|+..... -......+|..|.-.|+-+.||||+.+++.|..+
T Consensus 192 lnl~tkl~e~hsgelwrgrwqgndi--vakil~vr~----------~t~risrdfneefp~lrifshpnilpvlgacnsp 259 (448)
T KOG0195|consen 192 LNLITKLAESHSGELWRGRWQGNDI--VAKILNVRE----------VTARISRDFNEEFPALRIFSHPNILPVLGACNSP 259 (448)
T ss_pred hhhhhhhccCCCcccccccccCcch--hhhhhhhhh----------cchhhcchhhhhCcceeeecCCchhhhhhhccCC
Confidence 3445589999999999999866542 233332211 1123346778888889999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEE
Q 020641 97 NLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAK 176 (323)
Q Consensus 97 ~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~ 176 (323)
....+|..|++.|||++.+...... .....++.+.+.+++.|++|||+.. +-|.---++...++++++.+.+
T Consensus 260 pnlv~isq~mp~gslynvlhe~t~v-------vvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmidedltar 331 (448)
T KOG0195|consen 260 PNLVIISQYMPFGSLYNVLHEQTSV-------VVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTAR 331 (448)
T ss_pred CCceEeeeeccchHHHHHHhcCccE-------EEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhh
Confidence 9999999999999999999876543 3677789999999999999999973 2233445788899999987776
Q ss_pred Ee--eccccCCCCccccccccccccCccccCCCccccCCCCC---cccchHHHHHHHHHHHhCCCCCCCCCCcccchhhh
Q 020641 177 IA--DFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLT---QKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVT 251 (323)
Q Consensus 177 l~--Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~---~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~ 251 (323)
|. |--.+. ........|.|++||.+...+-+ .++|+|||++++|||.|.+.||.........
T Consensus 332 ismad~kfsf---------qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecg---- 398 (448)
T KOG0195|consen 332 ISMADTKFSF---------QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECG---- 398 (448)
T ss_pred eecccceeee---------eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhh----
Confidence 64 211111 11112247889999998766543 4799999999999999999999866543222
Q ss_pred hhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhh
Q 020641 252 WATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLL 311 (323)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~ 311 (323)
.++.-.+++...|+..+..+.+++.-|++.||.+||.+..|+-.|+++.
T Consensus 399 -----------mkialeglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 399 -----------MKIALEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred -----------hhhhhccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 2334455666778888899999999999999999999999999888764
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=8e-24 Score=199.31 Aligned_cols=254 Identities=19% Similarity=0.178 Sum_probs=180.1
Q ss_pred CccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeC
Q 020641 17 PGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEG 96 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 96 (323)
+.+..-||.+.|=.|.++++..+- +.+|++.+..-.. ..+.+.+++.. ++ ...+++||++++..+....
T Consensus 25 ~~~~~~LGstRFlKv~r~k~~eG~--vVvKVFvk~~p~~-------sL~~~~qrL~~-ik-~~l~~~pn~lPfqk~~~t~ 93 (1431)
T KOG1240|consen 25 CHYVENLGSTRFLKVARAKDREGL--VVVKVFVKQDPTI-------SLRPFKQRLEE-IK-FALMKAPNCLPFQKVLVTD 93 (1431)
T ss_pred eeeecccCchhhhhhhhccCCCce--EEEEEEeccCCCC-------CchHHHHHHHH-HH-HHhhcCCcccchHHHHHhh
Confidence 455668999999999999987665 6777776543221 11222233332 33 4455999999999888888
Q ss_pred CeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEE
Q 020641 97 NLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAK 176 (323)
Q Consensus 97 ~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~ 176 (323)
+..|+|-+|..+ +|.|.+.-+.- +...+.+.++.|+++|+.-+|+. ||+|||||.+|||++.=+.+.
T Consensus 94 kAAylvRqyvkh-nLyDRlSTRPF---------L~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~ 160 (1431)
T KOG1240|consen 94 KAAYLVRQYVKH-NLYDRLSTRPF---------LVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLY 160 (1431)
T ss_pred HHHHHHHHHHhh-hhhhhhccchH---------HHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhh
Confidence 888999999988 99999976653 78888999999999999999999 999999999999999999999
Q ss_pred EeeccccCCC--C--ccc-cccccccccCccccCCCccccCC----------C-CCcccchHHHHHHHHHHHh-CCCCCC
Q 020641 177 IADFNLSNQA--P--DMA-ARLHSTRVLGTFGYHAPEYAMTG----------Q-LTQKSDVYSFGVVLLELLT-GRKPVD 239 (323)
Q Consensus 177 l~Dfg~~~~~--~--~~~-~~~~~~~~~g~~~y~aPE~~~~~----------~-~~~~~Di~slG~~l~~l~~-g~~pf~ 239 (323)
|.||..-+.. + +.. ......+...-..|+|||.+... . .+++-||||+||++.||++ |.+||.
T Consensus 161 LtDFAsFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~ 240 (1431)
T KOG1240|consen 161 LTDFASFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFT 240 (1431)
T ss_pred hhcccccCCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCccc
Confidence 9999875322 1 111 11111112234469999977431 1 4678899999999999998 788885
Q ss_pred CCCCcccchhhhhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhh
Q 020641 240 HTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPL 310 (323)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~ 310 (323)
-.. ............+.+.+.++ ...+++++..|++.||.+|.|+++.|+.-+.+
T Consensus 241 LSQ-----L~aYr~~~~~~~e~~Le~Ie-----------d~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~ 295 (1431)
T KOG1240|consen 241 LSQ-----LLAYRSGNADDPEQLLEKIE-----------DVSLRNLILSMIQRDPSKRLSAEDYLQKYRGL 295 (1431)
T ss_pred HHH-----HHhHhccCccCHHHHHHhCc-----------CccHHHHHHHHHccCchhccCHHHHHHhhhcc
Confidence 221 11111111111222222222 12589999999999999999999999874443
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.87 E-value=9.1e-22 Score=159.33 Aligned_cols=152 Identities=14% Similarity=0.088 Sum_probs=109.3
Q ss_pred cccCCCCCCccceeccceeeeeeeeccccccccCcccc-------cccc---CCCC----CchHHHHHHHHHhcCCCCcc
Q 020641 21 VRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHEN-------ERLK---SPKN----YPDDEKQLVSVVSRLKHENL 86 (323)
Q Consensus 21 ~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~-------~~~~---~~~~----~~~~~~~e~~~l~~l~h~~i 86 (323)
..||+|++|.||+|.+. +++.+|+|+........... .... .... .......|++.+.++.++++
T Consensus 3 ~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 3 GCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 46999999999999997 88999999887543221110 0000 0000 01223458899999988777
Q ss_pred cceeeEEEeCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHh-hcCCCCCceeCCCCCC
Q 020641 87 VELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYL-HEKVQPSIIHRDIRSS 165 (323)
Q Consensus 87 ~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~l-h~~~~~~i~h~dikp~ 165 (323)
......... ..++||||+.++++........ .++...+..++.|++.+|.++ |+. |++||||||+
T Consensus 82 ~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~~~---------~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~ 147 (190)
T cd05147 82 PCPEPILLK--SHVLVMEFIGDDGWAAPRLKDA---------PLSESKARELYLQVIQIMRILYQDC---RLVHADLSEY 147 (190)
T ss_pred CCCcEEEec--CCEEEEEEeCCCCCcchhhhcC---------CCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHH
Confidence 544333222 2389999999877765533222 188889999999999999999 799 9999999999
Q ss_pred CEEEccCCeEEEeeccccCCCCc
Q 020641 166 NVLLFEDFKAKIADFNLSNQAPD 188 (323)
Q Consensus 166 nili~~~~~~~l~Dfg~~~~~~~ 188 (323)
||+++ ++.++|+|||++....+
T Consensus 148 NIli~-~~~v~LiDFG~a~~~~~ 169 (190)
T cd05147 148 NLLYH-DGKLYIIDVSQSVEHDH 169 (190)
T ss_pred HEEEE-CCcEEEEEccccccCCC
Confidence 99998 47899999999875433
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.9e-21 Score=174.20 Aligned_cols=218 Identities=27% Similarity=0.407 Sum_probs=163.5
Q ss_pred HhcCCCCcccceeeEEEeCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCc
Q 020641 78 VSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSI 157 (323)
Q Consensus 78 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i 157 (323)
|+.+.|.|+.++++.+.++...+.|.+||..|+|.|.+.....+ +++.....+++.+++|+.|+|.. .|
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~--------~d~~F~~s~~rdi~~Gl~ylh~s---~i 69 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIK--------LDYFFILSFIRDISKGLAYLHNS---PI 69 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccC--------ccHHHHHHHHHHHHHHHHHHhcC---cc
Confidence 35679999999999999999999999999999999999875433 88889999999999999999998 55
Q ss_pred -eeCCCCCCCEEEccCCeEEEeeccccCCCCccccccccccccCccccCCCccccCCC-------CCcccchHHHHHHHH
Q 020641 158 -IHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQ-------LTQKSDVYSFGVVLL 229 (323)
Q Consensus 158 -~h~dikp~nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-------~~~~~Di~slG~~l~ 229 (323)
.|+.++..|.+++.+..+||.|||+.................-...|.|||++.... .+.++||||+|++++
T Consensus 70 ~~hg~l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ 149 (484)
T KOG1023|consen 70 GYHGALKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMY 149 (484)
T ss_pred eeeeeeccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHH
Confidence 999999999999999999999999987664311111111111345699999887531 366799999999999
Q ss_pred HHHhCCCCCCCCCCcccc-hhhhhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHh
Q 020641 230 ELLTGRKPVDHTMPRGQQ-SLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQ 308 (323)
Q Consensus 230 ~l~~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~ 308 (323)
|+++.+.||......... ..+..... ...+...|.+... .+..+.+..++..||..+|.+||+++.|-..++
T Consensus 150 ei~~r~~~~~~~~~~~~~~eii~~~~~-----~~~~~~rP~i~~~--~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~ 222 (484)
T KOG1023|consen 150 EILFRSGPFDLRNLVEDPDEIILRVKK-----GGSNPFRPSIELL--NELPPELLLLVARCWEEIPEKRPSIEQIRSKLL 222 (484)
T ss_pred HHHhccCccccccccCChHHHHHHHHh-----cCCCCcCcchhhh--hhcchHHHHHHHHhcccChhhCccHHHHHhhhh
Confidence 999999999865432221 11111110 0011111111111 144457999999999999999999999999988
Q ss_pred hhhcC
Q 020641 309 PLLKS 313 (323)
Q Consensus 309 ~~~~~ 313 (323)
.+...
T Consensus 223 ~~~~~ 227 (484)
T KOG1023|consen 223 TINKG 227 (484)
T ss_pred hhccc
Confidence 87653
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.1e-22 Score=169.97 Aligned_cols=232 Identities=19% Similarity=0.217 Sum_probs=145.5
Q ss_pred ccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCC----------CCcccceee
Q 020641 22 RLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLK----------HENLVELLG 91 (323)
Q Consensus 22 ~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~----------h~~i~~~~~ 91 (323)
.||.|+++.||.+.+..+++.+++|+....... .....+.+++|.-....+. |-.++..++
T Consensus 19 ~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~---------~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d 89 (288)
T PF14531_consen 19 IIGKGGFSIVFEVTDVETGEEFAVKVFLLPADA---------SANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLD 89 (288)
T ss_dssp EEEEETTEEEEEEEETTTTEEEEEEEEEESSTT---------HTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SE
T ss_pred ccccCCceEEEEEEEccCCceEEEEEEeccccc---------chHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeE
Confidence 689999999999999999999999987755411 1122355555554444432 223444444
Q ss_pred EEEe---------C---Ce-----EEEEEeecCCCCHHHHhcc---CCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhc
Q 020641 92 YCVE---------G---NL-----RVLAYEFATMGSLHDILHG---RKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHE 151 (323)
Q Consensus 92 ~~~~---------~---~~-----~~lv~e~~~~~sL~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~ 151 (323)
.... . +. .+++|+-+.+ +|.+++.. .... ...+.......+..|+++.+++||.
T Consensus 90 ~~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~-dL~~~~~~l~~~~~~-----~~~l~~~arl~lT~Q~I~lvA~Lh~ 163 (288)
T PF14531_consen 90 LLRIPGKPPFFERGPGQSIYWVLNRFLLMPRAQG-DLQDLVEALFSRAQT-----HSPLAFAARLSLTVQMIRLVANLHS 163 (288)
T ss_dssp EEEETTS-SEEEECETTEEEEEESEEEEEE--SE-EHHHHHHHHHHHTTT-----SHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEEcCCCcceecCCCCccceeehhhhccchhhh-cHHHHHHHHhhcccc-----cchhHHHHHHHHHHHHHHHHHHHhh
Confidence 4331 1 12 2667776654 88888642 2111 0013333345667899999999999
Q ss_pred CCCCCceeCCCCCCCEEEccCCeEEEeeccccCCCCccccccccccccCccccCCCccccC--------CCCCcccchHH
Q 020641 152 KVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT--------GQLTQKSDVYS 223 (323)
Q Consensus 152 ~~~~~i~h~dikp~nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--------~~~~~~~Di~s 223 (323)
. |++|+||+|+|++++.+|.++|+||+........... ...+..|.+||.... -.++.+.|.|+
T Consensus 164 ~---GlVHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~-----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~ 235 (288)
T PF14531_consen 164 Y---GLVHGDIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC-----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQ 235 (288)
T ss_dssp T---TEEEST-SGGGEEE-TTS-EEE--GGGEEETTEEEEG-----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHH
T ss_pred c---ceEecccceeeEEEcCCCCEEEcChHHHeecCceeec-----cCCCcccCChhhhhhhcccCcccceeeeccCHHH
Confidence 9 9999999999999999999999999887655443221 123567899996643 24678899999
Q ss_pred HHHHHHHHHhCCCCCCCCCCcccchhhhhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCC
Q 020641 224 FGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFR 297 (323)
Q Consensus 224 lG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~R 297 (323)
||+++|.|.++..||........... .. ..+. +.++.++.||..+|+.||.+|
T Consensus 236 LG~~ly~lWC~~lPf~~~~~~~~~~~-------------------~f-~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 236 LGITLYSLWCGRLPFGLSSPEADPEW-------------------DF-SRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHHHHHHHHHSS-STCCCGGGSTSGG-------------------GG-TTSS----HHHHHHHHHHT-SSGGGS
T ss_pred HHHHHHHHHHccCCCCCCCccccccc-------------------cc-hhcC-CcCHHHHHHHHHHccCCcccC
Confidence 99999999999999975533211110 11 2233 778889999999999999988
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.6e-22 Score=163.07 Aligned_cols=175 Identities=13% Similarity=0.131 Sum_probs=126.4
Q ss_pred ccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeC-
Q 020641 18 GYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEG- 96 (323)
Q Consensus 18 ~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~- 96 (323)
.....||+|+||.||++.+ ++..+++|+...+....... ...-...+.+.+|+..+.++.|++|..+.+++...
T Consensus 34 ~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~---~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~ 108 (232)
T PRK10359 34 KTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERF---LKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAE 108 (232)
T ss_pred EEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHH---HHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecc
Confidence 4445789999999999766 35568888775443222111 00001123468899999999999999999886633
Q ss_pred -------CeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEE
Q 020641 97 -------NLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLL 169 (323)
Q Consensus 97 -------~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili 169 (323)
...+++|||++|.+|.++.. ++. ..+.+++.++..+|.. |++|+|++|.||++
T Consensus 109 ~~~~~~~~~~~lvmEyi~G~tL~~~~~-------------~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili 168 (232)
T PRK10359 109 RKTLRYAHTYIMLIEYIEGVELNDMPE-------------ISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIV 168 (232)
T ss_pred cccccccCCeEEEEEEECCccHHHhhh-------------ccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEE
Confidence 35789999999999988732 332 3466999999999999 99999999999999
Q ss_pred ccCCeEEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHH
Q 020641 170 FEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELL 232 (323)
Q Consensus 170 ~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~ 232 (323)
+.++ ++|+|||........... . .......+..++|+||||+++..+.
T Consensus 169 ~~~g-i~liDfg~~~~~~e~~a~---d-----------~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 169 SKNG-LRIIDLSGKRCTAQRKAK---D-----------RIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred eCCC-EEEEECCCcccccchhhH---H-----------HHHHHhHhcccccccceeEeehHHH
Confidence 9988 999999987654321110 0 0233445667899999999987664
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=6e-21 Score=162.59 Aligned_cols=198 Identities=19% Similarity=0.215 Sum_probs=144.6
Q ss_pred CCCcccceeeEEE---------------------------eCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHH
Q 020641 82 KHENLVELLGYCV---------------------------EGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 134 (323)
Q Consensus 82 ~h~~i~~~~~~~~---------------------------~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~ 134 (323)
+||||+.+..+|. .+...|+||.-+.. +|..++..+. .+...
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~----------~s~r~ 342 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH----------RSYRT 342 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC----------CchHH
Confidence 6999999998774 23467999998876 9999997765 67778
Q ss_pred HHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEc--c--CCeEEEeeccccCCCCcccc----ccccccccCccccCC
Q 020641 135 RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLF--E--DFKAKIADFNLSNQAPDMAA----RLHSTRVLGTFGYHA 206 (323)
Q Consensus 135 ~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~--~--~~~~~l~Dfg~~~~~~~~~~----~~~~~~~~g~~~y~a 206 (323)
..-++.|+++|+.|||++ |+.|||+|.+|||+. + -..+++.|||+..-..+..- ........|+...+|
T Consensus 343 ~~~~laQlLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmA 419 (598)
T KOG4158|consen 343 GRVILAQLLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMA 419 (598)
T ss_pred HHHHHHHHHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecc
Confidence 889999999999999999 999999999999993 2 35689999998643333211 112223347788999
Q ss_pred CccccCCC------CCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccccccccchhcCCCcCCCCCHHHHH
Q 020641 207 PEYAMTGQ------LTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVA 280 (323)
Q Consensus 207 PE~~~~~~------~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (323)
||+....+ --.++|.|+.|.+.||++....||..... .. +.....++ ......+..++.
T Consensus 420 PEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGe-m~----------L~~r~Yqe----~qLPalp~~vpp 484 (598)
T KOG4158|consen 420 PEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGE-ML----------LDTRTYQE----SQLPALPSRVPP 484 (598)
T ss_pred hhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccch-he----------echhhhhh----hhCCCCcccCCh
Confidence 99875321 13589999999999999999999975211 01 11111111 111234566777
Q ss_pred HHHHHHHHccCCCCCCCCChHHHHHHHh
Q 020641 281 KLAAVAALCVQYEAEFRPNMSIVVKALQ 308 (323)
Q Consensus 281 ~l~~li~~cl~~~P~~Rps~~evl~~l~ 308 (323)
.+++++...|+.||.+|+|..=..+.|+
T Consensus 485 ~~rqlV~~lL~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 485 VARQLVFDLLKRDPSKRVSPNIAANVLN 512 (598)
T ss_pred HHHHHHHHHhcCCccccCCccHHHhHHH
Confidence 8999999999999999998765554443
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.9e-21 Score=185.86 Aligned_cols=240 Identities=18% Similarity=0.180 Sum_probs=173.2
Q ss_pred ccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCC---CCcccceeeEEEeCCe
Q 020641 22 RLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLK---HENLVELLGYCVEGNL 98 (323)
Q Consensus 22 ~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~ 98 (323)
-||.|+||+||.|...+ ++.+|+|+......=+.. +. .+++.+|+ -+.|.++...+...+.
T Consensus 705 e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfY-------------I~--~q~~~RLk~~~~~~~~~~~~a~~~~~~ 768 (974)
T KOG1166|consen 705 EIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFY-------------IC--LQVMERLKPQMLPSIMHISSAHVFQNA 768 (974)
T ss_pred eeccccceEEEEeecCC-CcEEEEEeecCCCceeee-------------eh--HHHHHhhchhhhcchHHHHHHHccCCc
Confidence 67999999999999998 899999865432211111 11 22233333 3456667777777888
Q ss_pred EEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEcc-------
Q 020641 99 RVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFE------- 171 (323)
Q Consensus 99 ~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~------- 171 (323)
.++|++|...|||.++++.... .++..+.-+..|++..|.+||.. +|+|+||||+|+++..
T Consensus 769 S~lv~ey~~~Gtlld~~N~~~~---------m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~ 836 (974)
T KOG1166|consen 769 SVLVSEYSPYGTLLDLINTNKV---------MDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSD 836 (974)
T ss_pred ceeeeeccccccHHHhhccCCC---------CCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCc
Confidence 8999999999999999984432 88889999999999999999999 9999999999999943
Q ss_pred CCeEEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhh
Q 020641 172 DFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVT 251 (323)
Q Consensus 172 ~~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~ 251 (323)
+..++|+|||.+-.+.-...........+|-.+-++|+..|+.|+..+|.|+|+.+++.|++|++.= .
T Consensus 837 ~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q------------~ 904 (974)
T KOG1166|consen 837 SKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYME------------V 904 (974)
T ss_pred ccceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH------------h
Confidence 4568999999987654333333334455788999999999999999999999999999999998752 0
Q ss_pred hhcccccccc-cchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhhc
Q 020641 252 WATPRLSEDK-VKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLK 312 (323)
Q Consensus 252 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~~ 312 (323)
+....|.... +...+. -+-+.+|+..+|+.|=..=|.+.++...|+.++.
T Consensus 905 ~~g~~~~~~~~~~Ry~~-----------~~~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~~ 955 (974)
T KOG1166|consen 905 KNGSSWMVKTNFPRYWK-----------RDMWNKFFDLLLNPDCDTLPNLQELRTELEEVLA 955 (974)
T ss_pred cCCcceeccccchhhhh-----------HHHHHHHHHHHhCcCcccchhHHHHHHHHHHHHH
Confidence 0001110000 111111 1236678888888333333778888877776653
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.84 E-value=9.5e-21 Score=153.87 Aligned_cols=151 Identities=15% Similarity=0.136 Sum_probs=110.4
Q ss_pred cccCCCCCCccceeccceeeeeeeeccccccccCcccccc-------ccCC---CC----CchHHHHHHHHHhcCCCCcc
Q 020641 21 VRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENER-------LKSP---KN----YPDDEKQLVSVVSRLKHENL 86 (323)
Q Consensus 21 ~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~-------~~~~---~~----~~~~~~~e~~~l~~l~h~~i 86 (323)
..||+|++|.||+|.+. +++.+|+|+............. .... .. .......|.+.+.++.|+++
T Consensus 3 ~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 3 GCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred ceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 36899999999999987 8999999988765321111000 0000 00 01234578899999989887
Q ss_pred cceeeEEEeCCeEEEEEeecCCCCHHHH-hccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCCCceeCCCCC
Q 020641 87 VELLGYCVEGNLRVLAYEFATMGSLHDI-LHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHE-KVQPSIIHRDIRS 164 (323)
Q Consensus 87 ~~~~~~~~~~~~~~lv~e~~~~~sL~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~-~~~~~i~h~dikp 164 (323)
.....+.... .++||||+.++++... +.... ++...+..++.|++.++.++|. . |++|+||||
T Consensus 82 ~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~~~----------~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP 146 (190)
T cd05145 82 PVPEPILLKK--NVLVMEFIGDDGSPAPRLKDVP----------LEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSE 146 (190)
T ss_pred CCceEEEecC--CEEEEEEecCCCchhhhhhhcc----------CCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCCh
Confidence 5544443332 4899999998755433 32221 6778899999999999999999 9 999999999
Q ss_pred CCEEEccCCeEEEeeccccCCCCc
Q 020641 165 SNVLLFEDFKAKIADFNLSNQAPD 188 (323)
Q Consensus 165 ~nili~~~~~~~l~Dfg~~~~~~~ 188 (323)
+||+++ ++.++|+|||++.....
T Consensus 147 ~NIll~-~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 147 YNILYH-DGKPYIIDVSQAVELDH 169 (190)
T ss_pred hhEEEE-CCCEEEEEcccceecCC
Confidence 999999 78999999999876543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.7e-21 Score=172.78 Aligned_cols=234 Identities=24% Similarity=0.270 Sum_probs=182.6
Q ss_pred cCCCCCCccceeccce---eeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcC-CCCcccceeeEEEeCCe
Q 020641 23 LDKGPEDDLYLKKRVK---MRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRL-KHENLVELLGYCVEGNL 98 (323)
Q Consensus 23 lg~G~~~~V~~~~~~~---~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~ 98 (323)
+|+|.||.|+++.-.. .+..++.|+..+......... ..+.|-.++..+ +||.++++...+.....
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~----------~t~~er~il~~~~~~~f~v~lhyafqt~~k 71 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT----------HTKQERIILAFVHNTPFLVKLHYAFQTDGK 71 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhccccccccccccc----------ccccHHHHHhhccCCCceeeeeeeeccccc
Confidence 7899999999887654 344566665544332222211 345566667777 59999999999999999
Q ss_pred EEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEEEe
Q 020641 99 RVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIA 178 (323)
Q Consensus 99 ~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~l~ 178 (323)
.++++++..+|.|...+..... +.......+...++-++.++|+. +++++|+|++||+++.+|.+++.
T Consensus 72 l~l~ld~~rgg~lft~l~~~~~---------f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~t 139 (612)
T KOG0603|consen 72 LYLILDFLRGGDLFTRLSKEVM---------FDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLT 139 (612)
T ss_pred hhHhhhhcccchhhhccccCCc---------hHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccC
Confidence 9999999999999988877654 77778888899999999999999 99999999999999999999999
Q ss_pred eccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhccccc
Q 020641 179 DFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLS 258 (323)
Q Consensus 179 Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 258 (323)
|||+++........ +||..|+|||++. ....++|-||||++.++|++|..||..
T Consensus 140 dfglske~v~~~~~------cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~------------------ 193 (612)
T KOG0603|consen 140 DFGLSKEAVKEKIA------CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG------------------ 193 (612)
T ss_pred CchhhhHhHhhhhc------ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch------------------
Confidence 99999876544332 6899999999987 567789999999999999999999974
Q ss_pred ccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCCh--HHHHHHH
Q 020641 259 EDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNM--SIVVKAL 307 (323)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~--~evl~~l 307 (323)
+....++. .....|...+.....++..++..+|..|.-. ..+.+..
T Consensus 194 -~~~~~Il~--~~~~~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik 241 (612)
T KOG0603|consen 194 -DTMKRILK--AELEMPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIK 241 (612)
T ss_pred -HHHHHHhh--hccCCchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHh
Confidence 11111111 1234577788889999999999999999744 4444443
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=7.1e-20 Score=147.11 Aligned_cols=184 Identities=15% Similarity=0.076 Sum_probs=130.8
Q ss_pred ccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCC-----chHHHHHHHHHhcC-CCCcccceeeEE
Q 020641 20 FVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNY-----PDDEKQLVSVVSRL-KHENLVELLGYC 93 (323)
Q Consensus 20 ~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~-----~~~~~~e~~~l~~l-~h~~i~~~~~~~ 93 (323)
...|+.|+||+|+++.. .++.+..+... ....+ ...+.+|+++|+++ .|+++.+++++
T Consensus 7 ~~~l~~~~f~~v~~~~~--~~~k~~~~~l~-------------~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~- 70 (218)
T PRK12274 7 NEPLKSDTFGRILLVRG--GERKFVRRDLS-------------AAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW- 70 (218)
T ss_pred ceeecCCCcceEEEeec--CCceeeecccc-------------cchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE-
Confidence 34799999999998877 33333322111 11111 12578999999999 56889999886
Q ss_pred EeCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCC-CCCCEEEccC
Q 020641 94 VEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDI-RSSNVLLFED 172 (323)
Q Consensus 94 ~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di-kp~nili~~~ 172 (323)
+..+++|+|+.|.+|.+.... ....++.|++.++.++|+. |++|+|| ||.||+++.+
T Consensus 71 ---~~~~lvmeyI~G~~L~~~~~~----------------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~ 128 (218)
T PRK12274 71 ---DGRHLDRSYLAGAAMYQRPPR----------------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQED 128 (218)
T ss_pred ---cCEEEEEeeecCccHHhhhhh----------------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCC
Confidence 346999999999888654311 1135778999999999999 9999999 7999999999
Q ss_pred CeEEEeeccccCCCCccccc---cc--------cccccCccccCCCccccCC-CCC-cccchHHHHHHHHHHHhCCCCCC
Q 020641 173 FKAKIADFNLSNQAPDMAAR---LH--------STRVLGTFGYHAPEYAMTG-QLT-QKSDVYSFGVVLLELLTGRKPVD 239 (323)
Q Consensus 173 ~~~~l~Dfg~~~~~~~~~~~---~~--------~~~~~g~~~y~aPE~~~~~-~~~-~~~Di~slG~~l~~l~~g~~pf~ 239 (323)
+.++|+|||++......... .. ......++.+++|+...-. ..+ .+.+-++.|+.+|.++|+..++-
T Consensus 129 g~i~LIDFG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~ 208 (218)
T PRK12274 129 GSPAVIDFQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHW 208 (218)
T ss_pred CCEEEEECCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcc
Confidence 99999999999855433211 00 0011256777888744321 223 46788899999999999988875
Q ss_pred CC
Q 020641 240 HT 241 (323)
Q Consensus 240 ~~ 241 (323)
+.
T Consensus 209 ~~ 210 (218)
T PRK12274 209 ED 210 (218)
T ss_pred cc
Confidence 44
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.6e-19 Score=146.39 Aligned_cols=133 Identities=12% Similarity=0.149 Sum_probs=100.3
Q ss_pred cccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcC-----CCCcccceeeEEEe
Q 020641 21 VRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRL-----KHENLVELLGYCVE 95 (323)
Q Consensus 21 ~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~ 95 (323)
..||+|+||.||. +..+... ++|+..... ....+.+.+|+.+++.+ +||||+++++++.+
T Consensus 8 ~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~------------~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et 72 (210)
T PRK10345 8 SPLGTGRHRKCYA--HPEDAQR-CIKIVYHRG------------DGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVET 72 (210)
T ss_pred ceecCCCceEEEE--CCCCcCe-EEEEEeccc------------cchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEe
Confidence 4699999999996 4445444 466443211 11236789999999999 57999999999998
Q ss_pred CC---e-EEEEEee--cCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHH-HHhhcCCCCCceeCCCCCCCEE
Q 020641 96 GN---L-RVLAYEF--ATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGL-EYLHEKVQPSIIHRDIRSSNVL 168 (323)
Q Consensus 96 ~~---~-~~lv~e~--~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l-~~lh~~~~~~i~h~dikp~nil 168 (323)
+. . +.+|+|| +.+++|.+++++.. +++. ..++.+++.++ .|||+. +|+||||||+||+
T Consensus 73 ~~g~g~v~~~I~e~~G~~~~tL~~~l~~~~----------~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NIL 137 (210)
T PRK10345 73 DCGTGYVYDVIADFDGKPSITLTEFAEQCR----------YEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNIL 137 (210)
T ss_pred CCCCeEEEEEEecCCCCcchhHHHHHHccc----------ccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEE
Confidence 74 2 3478999 44789999996632 4444 35678888777 999999 9999999999999
Q ss_pred Ecc----CCeEEEeecccc
Q 020641 169 LFE----DFKAKIADFNLS 183 (323)
Q Consensus 169 i~~----~~~~~l~Dfg~~ 183 (323)
++. +.+++|+|++.+
T Consensus 138 l~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 138 CQRISESEVIPVVCDNIGE 156 (210)
T ss_pred EeccCCCCCcEEEEECCCC
Confidence 974 347999995433
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.78 E-value=7.8e-19 Score=146.97 Aligned_cols=156 Identities=15% Similarity=0.071 Sum_probs=110.9
Q ss_pred CCCccccccCCCCCCccceec-cceeeeeeeeccccccccCccccccccC-------CC-C----CchHHHHHHHHHhcC
Q 020641 15 PSPGYFVRLDKGPEDDLYLKK-RVKMRRWLCCTCQVEESYPSHENERLKS-------PK-N----YPDDEKQLVSVVSRL 81 (323)
Q Consensus 15 ~~~~~~~~lg~G~~~~V~~~~-~~~~~~~~~~k~~~~~~~~~~~~~~~~~-------~~-~----~~~~~~~e~~~l~~l 81 (323)
..+.....||+|++|.||+|. +..+++.+|+|+................ .. . ....+.+|+..+.++
T Consensus 28 ~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L 107 (237)
T smart00090 28 ILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRL 107 (237)
T ss_pred chHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 345556689999999999998 7778999999987654322111100000 00 0 112356899999988
Q ss_pred CCCc--ccceeeEEEeCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC-ce
Q 020641 82 KHEN--LVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPS-II 158 (323)
Q Consensus 82 ~h~~--i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~-i~ 158 (323)
.+.+ +.++++ .. ..++||||+.+.+|......... .....+..++.|++.++.+||+. | ++
T Consensus 108 ~~~~i~~p~~~~---~~-~~~lV~E~~~g~~L~~~~~~~~~---------~~~~~~~~i~~qi~~~l~~LH~~---g~ii 171 (237)
T smart00090 108 YEAGVPVPKPIA---WR-RNVLVMEFIGGDGLPAPRLKDVE---------PEEEEEFELYDDILEEMRKLYKE---GELV 171 (237)
T ss_pred HhcCCCCCeeeE---ec-CceEEEEEecCCcccccccccCC---------cchHHHHHHHHHHHHHHHHHHhc---CCEE
Confidence 6532 333443 22 35899999999888765432211 55556789999999999999999 9 99
Q ss_pred eCCCCCCCEEEccCCeEEEeeccccCCCC
Q 020641 159 HRDIRSSNVLLFEDFKAKIADFNLSNQAP 187 (323)
Q Consensus 159 h~dikp~nili~~~~~~~l~Dfg~~~~~~ 187 (323)
|+||||+||+++ +++++|+|||.+....
T Consensus 172 H~Dikp~NIli~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 172 HGDLSEYNILVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred eCCCChhhEEEE-CCCEEEEEChhhhccC
Confidence 999999999999 8899999999876543
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.77 E-value=5.8e-19 Score=166.56 Aligned_cols=214 Identities=20% Similarity=0.263 Sum_probs=145.7
Q ss_pred ccccCCCCCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccc
Q 020641 9 ALGAHAPSPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVE 88 (323)
Q Consensus 9 ~~~~~~~~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~ 88 (323)
...+...++..+..+..|++|.||++++..+++.++.|+..... +.+- ++.....|.++
T Consensus 77 ~~~p~e~df~~IklisngAygavylvrh~~trqrfa~kiNkq~l------------------ilRn--ilt~a~npfvv- 135 (1205)
T KOG0606|consen 77 RRAPSESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQNL------------------ILRN--ILTFAGNPFVV- 135 (1205)
T ss_pred ccCCCccccceeEeeccCCCCceeeeeccccccchhhcccccch------------------hhhc--cccccCCccee-
Confidence 34566778888889999999999999999888877765322110 0000 11211222222
Q ss_pred eeeEEEeCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEE
Q 020641 89 LLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVL 168 (323)
Q Consensus 89 ~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nil 168 (323)
|+=...++.... ++. +++.++.|+|+. ||+|||+||+|.+
T Consensus 136 --------------------gDc~tllk~~g~---------lPv--------dmvla~Eylh~y---givhrdlkpdnll 175 (1205)
T KOG0606|consen 136 --------------------GDCATLLKNIGP---------LPV--------DMVLAVEYLHSY---GIVHRDLKPDNLL 175 (1205)
T ss_pred --------------------chhhhhcccCCC---------Ccc--------hhhHHhHhhccC---CeecCCCCCCcce
Confidence 233333333221 222 227899999999 9999999999999
Q ss_pred EccCCeEEEeeccccCCCCcc------------cc-ccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCC
Q 020641 169 LFEDFKAKIADFNLSNQAPDM------------AA-RLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGR 235 (323)
Q Consensus 169 i~~~~~~~l~Dfg~~~~~~~~------------~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~ 235 (323)
|+.-|.+|+.|||++...... .. .......+||+.|+|||++....|+...|.|++|+++|+++.|+
T Consensus 176 IT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgc 255 (1205)
T KOG0606|consen 176 ITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGC 255 (1205)
T ss_pred eeecccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheee
Confidence 999999999999987433210 11 11123456999999999999999999999999999999999999
Q ss_pred CCCCCCCCcccchhhhhhcccccccccchhcCCCcCC-CCCHHHHHHHHHHHHHccCCCCCCCC
Q 020641 236 KPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKG-EYPPKGVAKLAAVAALCVQYEAEFRP 298 (323)
Q Consensus 236 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~~P~~Rp 298 (323)
.||.+...+.-. .+.+.-.+.. +-....+.+.++++.++|+.+|..|-
T Consensus 256 vpffGdtpeelf---------------g~visd~i~wpE~dea~p~Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 256 VPFFGDTPEELF---------------GQVISDDIEWPEEDEALPPEAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred eeccCCCHHHHH---------------hhhhhhhccccccCcCCCHHHHHHHHHHHHhChHhhc
Confidence 999877432211 1111111110 11233456799999999999999995
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.76 E-value=3.4e-19 Score=157.29 Aligned_cols=170 Identities=26% Similarity=0.367 Sum_probs=127.3
Q ss_pred eEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEEE
Q 020641 98 LRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKI 177 (323)
Q Consensus 98 ~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~l 177 (323)
..|+.|++|...+|.+++.++... ...++.....++.|++.++.| + +.+|+|+||.||++..+..++|
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~------e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kI 397 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTG------EERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKI 397 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcc------cccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhh
Confidence 468999999999999999754322 126777889999999999999 7 9999999999999999999999
Q ss_pred eeccccCCCCccc----cccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccchhhhh
Q 020641 178 ADFNLSNQAPDMA----ARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTW 252 (323)
Q Consensus 178 ~Dfg~~~~~~~~~----~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~ 252 (323)
.|||+.+...... .....+...||..|++||.+.+..|+.+.||||||++|+|++. =..+|+....
T Consensus 398 gDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~t--------- 468 (516)
T KOG1033|consen 398 GDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERIAT--------- 468 (516)
T ss_pred hhhhheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHHHh---------
Confidence 9999988766544 2223344569999999999999999999999999999999986 2333321100
Q ss_pred hcccccccccchhcCCCcCCCCCHHH---HHHHHHHHHHccCCCCCCCCChH
Q 020641 253 ATPRLSEDKVKQCVDPKLKGEYPPKG---VAKLAAVAALCVQYEAEFRPNMS 301 (323)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~l~~li~~cl~~~P~~Rps~~ 301 (323)
..++. + +..|+.. -+.=+.|+.+++...|.+||++.
T Consensus 469 ------~~d~r---~----g~ip~~~~~d~p~e~~ll~~lls~~p~~RP~~~ 507 (516)
T KOG1033|consen 469 ------LTDIR---D----GIIPPEFLQDYPEEYTLLQQLLSPSPEERPSAI 507 (516)
T ss_pred ------hhhhh---c----CCCChHHhhcCcHHHHHHHHhcCCCcccCchHH
Confidence 00000 0 1111111 12346799999999999999443
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.75 E-value=6.5e-18 Score=139.78 Aligned_cols=142 Identities=19% Similarity=0.311 Sum_probs=110.2
Q ss_pred cccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeCCeEE
Q 020641 21 VRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRV 100 (323)
Q Consensus 21 ~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 100 (323)
..||+|++|.||++.. .+..+++|....+........ .......+.+|++++..+.|+++.....++......+
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~----~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~ 75 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELD----ERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFI 75 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHH----HHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCE
Confidence 4689999999999987 445566664432221111100 0011245778999999999999888777777777889
Q ss_pred EEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEEEeec
Q 020641 101 LAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADF 180 (323)
Q Consensus 101 lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~l~Df 180 (323)
++|||++|++|.+++... .. ....++.+++.++.++|.. |++|+|++|.||+++ ++.++++||
T Consensus 76 lv~e~~~G~~L~~~~~~~------------~~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf 138 (211)
T PRK14879 76 IVMEYIEGEPLKDLINSN------------GM-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDF 138 (211)
T ss_pred EEEEEeCCcCHHHHHHhc------------cH-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEEC
Confidence 999999999999998642 22 7789999999999999999 999999999999999 788999999
Q ss_pred cccCC
Q 020641 181 NLSNQ 185 (323)
Q Consensus 181 g~~~~ 185 (323)
|.+..
T Consensus 139 ~~a~~ 143 (211)
T PRK14879 139 GLAEF 143 (211)
T ss_pred CcccC
Confidence 98754
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.72 E-value=1.5e-17 Score=136.40 Aligned_cols=137 Identities=21% Similarity=0.314 Sum_probs=103.8
Q ss_pred cCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeCCeEEEE
Q 020641 23 LDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLA 102 (323)
Q Consensus 23 lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 102 (323)
||+|++|.||++.. .+..+++|............. ......++.+|+++++.++|+++.....++......++|
T Consensus 2 ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~----~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv 75 (199)
T TIGR03724 2 IAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELD----ERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIV 75 (199)
T ss_pred CCCCceEEEEEeec--CCccEEEEEecCCcCcCchHH----HHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEE
Confidence 79999999999984 445666665443221111100 000125567899999999888766655556666677999
Q ss_pred EeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEEEeeccc
Q 020641 103 YEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNL 182 (323)
Q Consensus 103 ~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~l~Dfg~ 182 (323)
|||++|++|.+++.... . .++.+++.++.++|+. |++|+|++|.||+++ ++.++++|||+
T Consensus 76 ~e~~~g~~l~~~~~~~~----------~------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~ 135 (199)
T TIGR03724 76 MEYIEGKPLKDVIEEGN----------D------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGL 135 (199)
T ss_pred EEEECCccHHHHHhhcH----------H------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCC
Confidence 99999999999875421 1 7899999999999999 999999999999999 78999999998
Q ss_pred cCC
Q 020641 183 SNQ 185 (323)
Q Consensus 183 ~~~ 185 (323)
+..
T Consensus 136 a~~ 138 (199)
T TIGR03724 136 GKY 138 (199)
T ss_pred CcC
Confidence 754
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.72 E-value=1.2e-18 Score=163.12 Aligned_cols=257 Identities=20% Similarity=0.180 Sum_probs=192.2
Q ss_pred CCCCccccccCCCCCCccceeccceeeee-eeeccccccccCccccccccCCCCCchHHHHHHHHHhcCC-CCcccceee
Q 020641 14 APSPGYFVRLDKGPEDDLYLKKRVKMRRW-LCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLK-HENLVELLG 91 (323)
Q Consensus 14 ~~~~~~~~~lg~G~~~~V~~~~~~~~~~~-~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~ 91 (323)
...+..+.-||+|+|+.|-++.+...... ++.|.+.... ...........|..+-..+. |.|++.+++
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~----------~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~ 88 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP----------KSEDSSEHIDTETDIQKKLSKHSNTVHMIE 88 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCC----------CccchhhhcCccccccccccccccccccCC
Confidence 45667777899999999999998765543 3333222111 22333344555666666664 999999999
Q ss_pred EEEeCCeEEEEEeecCCCCHHHHhc-cCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhh-cCCCCCceeCCCCCCCEEE
Q 020641 92 YCVEGNLRVLAYEFATMGSLHDILH-GRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLH-EKVQPSIIHRDIRSSNVLL 169 (323)
Q Consensus 92 ~~~~~~~~~lv~e~~~~~sL~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh-~~~~~~i~h~dikp~nili 169 (323)
........++++++..++++.+-+. ..... .+...+..++.|+..++.|+| .. ++.|+||||+|.++
T Consensus 89 ~~~~~~~~~~~~~~s~g~~~f~~i~~~~~~~--------~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l 157 (601)
T KOG0590|consen 89 PSSSPRSYLLSLSYSDGGSLFSKISHPDSTG--------TSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLL 157 (601)
T ss_pred ccCCCcccccccCcccccccccccccCCccC--------CCCcchhhhhhhhccCccccCccc---ccccCCCCCccchh
Confidence 9999999999999999999999884 33211 556677899999999999999 88 99999999999999
Q ss_pred ccCC-eEEEeeccccCCCCc-cccccccccccC-ccccCCCccccCCC-CCcccchHHHHHHHHHHHhCCCCCCCCCCcc
Q 020641 170 FEDF-KAKIADFNLSNQAPD-MAARLHSTRVLG-TFGYHAPEYAMTGQ-LTQKSDVYSFGVVLLELLTGRKPVDHTMPRG 245 (323)
Q Consensus 170 ~~~~-~~~l~Dfg~~~~~~~-~~~~~~~~~~~g-~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 245 (323)
+.++ .+++.|||+|+.... ...........| ++.|.|||...+.. ..+..|+||.|+++..+++|..|+.......
T Consensus 158 ~~s~~~l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~ 237 (601)
T KOG0590|consen 158 DESGSALKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKD 237 (601)
T ss_pred ccCCCcccCCCchhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccc
Confidence 9999 999999999988776 333333444557 99999999988754 4678999999999999999999998665433
Q ss_pred cchhhhhhcccccccccchhcCCCc--CCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 246 QQSLVTWATPRLSEDKVKQCVDPKL--KGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
... ..+.+... .............+++..++..+|..|.+.+++-.
T Consensus 238 ~~~--------------~~~~~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 238 GRY--------------SSWKSNKGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred ccc--------------eeecccccccccCccccCChhhhhcccccccCCchhccccccccc
Confidence 211 11111111 11222344556888999999999999999888754
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.69 E-value=8.3e-17 Score=150.91 Aligned_cols=138 Identities=18% Similarity=0.271 Sum_probs=105.5
Q ss_pred cccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeCCeEE
Q 020641 21 VRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRV 100 (323)
Q Consensus 21 ~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 100 (323)
..||+|+||+||++....... ++|....+....... ......+++.+|+++++.++|++++.+..++......+
T Consensus 339 ~~iG~G~~g~Vy~~~~~~~~~--v~k~~~~~~~~~~~~----~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~ 412 (535)
T PRK09605 339 HLIGKGAEADIKKGEYLGRDA--VIKERVPKGYRHPEL----DERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKT 412 (535)
T ss_pred ceeccCCcEEEEEEeecCccc--eeEEEecccccchhH----HHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCE
Confidence 478999999999987654432 222222111111100 01112356789999999999999988877777777789
Q ss_pred EEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEEEeec
Q 020641 101 LAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADF 180 (323)
Q Consensus 101 lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~l~Df 180 (323)
+||||+++++|.+++. ....++.+++.++.+||+. |++||||||+||++ .++.++|+||
T Consensus 413 lv~E~~~g~~L~~~l~-----------------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDF 471 (535)
T PRK09605 413 IVMEYIGGKDLKDVLE-----------------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDF 471 (535)
T ss_pred EEEEecCCCcHHHHHH-----------------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeC
Confidence 9999999999999874 2357899999999999999 99999999999999 6779999999
Q ss_pred cccCC
Q 020641 181 NLSNQ 185 (323)
Q Consensus 181 g~~~~ 185 (323)
|++..
T Consensus 472 Gla~~ 476 (535)
T PRK09605 472 GLGKY 476 (535)
T ss_pred ccccc
Confidence 98865
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.67 E-value=2.1e-16 Score=129.39 Aligned_cols=148 Identities=14% Similarity=0.056 Sum_probs=105.2
Q ss_pred CccccccCCCCCCccceeccceeeeeeeeccccccccCcccccc----------ccCCCCCchHHHHHHHHHhcCCCCc-
Q 020641 17 PGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENER----------LKSPKNYPDDEKQLVSVVSRLKHEN- 85 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~----------~~~~~~~~~~~~~e~~~l~~l~h~~- 85 (323)
+.....||.|+||.||.+... +++.+++|+............. .............|+..+..+.+++
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 344457999999999999874 7888999976543211000000 0000111234677888888887764
Q ss_pred -ccceeeEEEeCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCC
Q 020641 86 -LVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRS 164 (323)
Q Consensus 86 -i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp 164 (323)
+..+++ ....++||||+.+++|.+.... .....++.+++.++.++|.. |++|+||+|
T Consensus 96 ~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~---------------~~~~~~~~~i~~~l~~lh~~---gi~H~Dl~p 153 (198)
T cd05144 96 PVPKPID----WNRHAVVMEYIDGVELYRVRVL---------------EDPEEVLDEILEEIVKAYKH---GIIHGDLSE 153 (198)
T ss_pred CCCceee----cCCceEEEEEeCCcchhhcccc---------------ccHHHHHHHHHHHHHHHHHC---CCCcCCCCc
Confidence 444433 2345899999999998765421 23457889999999999999 999999999
Q ss_pred CCEEEccCCeEEEeeccccCCCC
Q 020641 165 SNVLLFEDFKAKIADFNLSNQAP 187 (323)
Q Consensus 165 ~nili~~~~~~~l~Dfg~~~~~~ 187 (323)
.||+++.++.++|+|||.+....
T Consensus 154 ~Nill~~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 154 FNILVDDDEKIYIIDWPQMVSTD 176 (198)
T ss_pred ccEEEcCCCcEEEEECCccccCC
Confidence 99999999999999999986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.66 E-value=6.1e-16 Score=129.79 Aligned_cols=146 Identities=12% Similarity=0.033 Sum_probs=102.9
Q ss_pred ccC-CCCCCccceeccceeeeeeeeccccccccCccc-cccccCCCCCchHHHHHHHHHhcCCCCcc--cceeeEEEeC-
Q 020641 22 RLD-KGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHE-NERLKSPKNYPDDEKQLVSVVSRLKHENL--VELLGYCVEG- 96 (323)
Q Consensus 22 ~lg-~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~-~~~~~~~~~~~~~~~~e~~~l~~l~h~~i--~~~~~~~~~~- 96 (323)
.|| .||.|+||.++.. +..+++|.+.....-... ............++.+|++++..++|+++ +.++++....
T Consensus 38 ~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 38 VVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred eeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 477 8999999999875 444555555322110000 00011112234678899999999988775 6666664432
Q ss_pred C---eEEEEEeecCC-CCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccC
Q 020641 97 N---LRVLAYEFATM-GSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFED 172 (323)
Q Consensus 97 ~---~~~lv~e~~~~-~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~ 172 (323)
. ..++|||+++| .+|.+++.... ++.. .+.+++.++.+||+. ||+|+||||.|||++.+
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~~~----------l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~ 178 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQEAP----------LSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPD 178 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhcCC----------CCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCC
Confidence 2 23599999997 69999886532 4432 367899999999999 99999999999999998
Q ss_pred CeEEEeeccccCCC
Q 020641 173 FKAKIADFNLSNQA 186 (323)
Q Consensus 173 ~~~~l~Dfg~~~~~ 186 (323)
+.++|+|||.+...
T Consensus 179 ~~v~LIDfg~~~~~ 192 (239)
T PRK01723 179 GKFWLIDFDRGELR 192 (239)
T ss_pred CCEEEEECCCcccC
Confidence 89999999987653
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.60 E-value=3.5e-15 Score=120.95 Aligned_cols=148 Identities=16% Similarity=0.105 Sum_probs=96.7
Q ss_pred cccCCCCCCccceeccceeeeeeeeccccccccCcccccccc--------CC----CCCchHHHHHHHHHhcCCCC--cc
Q 020641 21 VRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLK--------SP----KNYPDDEKQLVSVVSRLKHE--NL 86 (323)
Q Consensus 21 ~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~--------~~----~~~~~~~~~e~~~l~~l~h~--~i 86 (323)
..||+|+||.||+|.+. +++.+++|+............... .. .........|.+.+..+.+. .+
T Consensus 3 ~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 3 GPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred cccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 36899999999999987 788899997654322111110000 00 00011123555556555333 24
Q ss_pred cceeeEEEeCCeEEEEEeecCCCCHHHH-hccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCCCceeCCCCC
Q 020641 87 VELLGYCVEGNLRVLAYEFATMGSLHDI-LHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHE-KVQPSIIHRDIRS 164 (323)
Q Consensus 87 ~~~~~~~~~~~~~~lv~e~~~~~sL~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~-~~~~~i~h~dikp 164 (323)
.++++. ...+++|||+.++++... +.... .. ..+..++.+++.++.++|. . |++|+||||
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~----------~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p 143 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR----------LL-EDPEELYDQILELMRKLYREA---GLVHGDLSE 143 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh----------hc-ccHHHHHHHHHHHHHHHhhcc---CcCcCCCCh
Confidence 444432 235899999998543211 11110 11 4677899999999999999 8 999999999
Q ss_pred CCEEEccCCeEEEeeccccCCCCc
Q 020641 165 SNVLLFEDFKAKIADFNLSNQAPD 188 (323)
Q Consensus 165 ~nili~~~~~~~l~Dfg~~~~~~~ 188 (323)
+||+++ ++.++++|||.+.....
T Consensus 144 ~Nili~-~~~~~liDfg~a~~~~~ 166 (187)
T cd05119 144 YNILVD-DGKVYIIDVPQAVEIDH 166 (187)
T ss_pred hhEEEE-CCcEEEEECcccccccC
Confidence 999999 88999999999865443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.58 E-value=1.7e-15 Score=126.59 Aligned_cols=208 Identities=20% Similarity=0.292 Sum_probs=143.5
Q ss_pred HHHHHHHHhcCCCCcccceeeEEEeCC-----eEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHH
Q 020641 71 EKQLVSVVSRLKHENLVELLGYCVEGN-----LRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARG 145 (323)
Q Consensus 71 ~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 145 (323)
....+..+-++.|.|+++++.++.+.+ ...+++||+..|++..++++....+. .+....-.+|+.||+.|
T Consensus 114 ~~~vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~-----a~~~~~wkkw~tqIlsa 188 (458)
T KOG1266|consen 114 RRAVFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQK-----ALFQKAWKKWCTQILSA 188 (458)
T ss_pred HHHHHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhh-----hhhHHHHHHHHHHHHhh
Confidence 334445556668999999998886543 46899999999999999988765432 27777788999999999
Q ss_pred HHHhhcCCCCCceeCCCCCCCEEEccCCeEEEeeccccCCCC---ccccccccccccCccccCCCccccCCCCCcccchH
Q 020641 146 LEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAP---DMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVY 222 (323)
Q Consensus 146 l~~lh~~~~~~i~h~dikp~nili~~~~~~~l~Dfg~~~~~~---~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~ 222 (323)
|.|||+. ++-++|+++.-+.|++..++-+++. .+...... +...........+.++|.+||.=.....+..+|||
T Consensus 189 l~yLhs~-~PpiihgnlTc~tifiq~ngLIkig-~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy 266 (458)
T KOG1266|consen 189 LSYLHSC-DPPIIHGNLTCDTIFIQHNGLIKIG-SVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIY 266 (458)
T ss_pred hhhhhcc-CCccccCCcchhheeecCCceEEec-ccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhh
Confidence 9999994 7789999999999999988888774 22211111 11111122334467889999976666667799999
Q ss_pred HHHHHHHHHHhCCCCCCCCCCccc-chhhhhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChH
Q 020641 223 SFGVVLLELLTGRKPVDHTMPRGQ-QSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMS 301 (323)
Q Consensus 223 slG~~l~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ 301 (323)
+||....+|..+...-........ +..+. .+...++. ..-+.++..|++-.|..||++.
T Consensus 267 ~fgmcAlemailEiq~tnseS~~~~ee~ia---------~~i~~len-----------~lqr~~i~kcl~~eP~~rp~ar 326 (458)
T KOG1266|consen 267 KFGMCALEMAILEIQSTNSESKVEVEENIA---------NVIIGLEN-----------GLQRGSITKCLEGEPNGRPDAR 326 (458)
T ss_pred hhhHHHHHHHHheeccCCCcceeehhhhhh---------hheeeccC-----------ccccCcCcccccCCCCCCcchh
Confidence 999999999887654322211100 00000 00001111 1234688999999999999999
Q ss_pred HHHH
Q 020641 302 IVVK 305 (323)
Q Consensus 302 evl~ 305 (323)
+++.
T Consensus 327 ~llf 330 (458)
T KOG1266|consen 327 LLLF 330 (458)
T ss_pred hhhc
Confidence 8764
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.57 E-value=2.2e-14 Score=111.72 Aligned_cols=134 Identities=17% Similarity=0.175 Sum_probs=105.8
Q ss_pred ccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCC--CcccceeeEEEeCC
Q 020641 20 FVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKH--ENLVELLGYCVEGN 97 (323)
Q Consensus 20 ~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~ 97 (323)
..+||.|.++.||++.... ..+++|+..... . ...+.+|+..++.+++ .++.+++.+....+
T Consensus 3 ~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~-------------~-~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~ 66 (155)
T cd05120 3 IKLLKGGLTNRVYLLGTKD--EDYVLKINPSRE-------------K-GADREREVAILQLLARKGLPVPKVLASGESDG 66 (155)
T ss_pred ceecccccccceEEEEecC--CeEEEEecCCCC-------------c-hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCC
Confidence 3578999999999999855 456666443210 0 3567889999999865 58889988888878
Q ss_pred eEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEEE
Q 020641 98 LRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKI 177 (323)
Q Consensus 98 ~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~l 177 (323)
..++++||+.++++..+ +......++.+++.++..+|.....+++|+|++|+||++++.+.+++
T Consensus 67 ~~~~v~e~~~g~~~~~~----------------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l 130 (155)
T cd05120 67 WSYLLMEWIEGETLDEV----------------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGI 130 (155)
T ss_pred ccEEEEEecCCeecccC----------------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEE
Confidence 89999999988777544 22355678889999999999853237999999999999999899999
Q ss_pred eeccccCC
Q 020641 178 ADFNLSNQ 185 (323)
Q Consensus 178 ~Dfg~~~~ 185 (323)
+|||.+..
T Consensus 131 ~Df~~~~~ 138 (155)
T cd05120 131 IDWEYAGY 138 (155)
T ss_pred EecccccC
Confidence 99998764
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.53 E-value=2.5e-14 Score=128.93 Aligned_cols=245 Identities=20% Similarity=0.218 Sum_probs=176.5
Q ss_pred ccCC--CCCCccceecc--ceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcC-CCCcccceeeEEEeC
Q 020641 22 RLDK--GPEDDLYLKKR--VKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRL-KHENLVELLGYCVEG 96 (323)
Q Consensus 22 ~lg~--G~~~~V~~~~~--~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~ 96 (323)
.+|. |.+|.||.+.. ..++..+|+|......-... ...+=.+++.....+ .|+|.++.+..+...
T Consensus 121 ~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~----------~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~ 190 (524)
T KOG0601|consen 121 RTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPL----------DSKRKLREFLSHHKIDSHENPVRDSPAWEGS 190 (524)
T ss_pred ccccCCCCCceeecccCCcccCCcccccccccCCCCCcc----------ccccccchhhcccccCccccccccCcccccC
Confidence 7899 99999999998 66777777764332221111 112234566666666 799999988999999
Q ss_pred CeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHH----HHHHhhcCCCCCceeCCCCCCCEEEccC
Q 020641 97 NLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAAR----GLEYLHEKVQPSIIHRDIRSSNVLLFED 172 (323)
Q Consensus 97 ~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~----~l~~lh~~~~~~i~h~dikp~nili~~~ 172 (323)
+..++-+|.|. .+|.++....... ++...++..+.+... |+.++|.. +++|.|+||+||+...+
T Consensus 191 ~~lfiqtE~~~-~sl~~~~~~~~~~--------~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~ 258 (524)
T KOG0601|consen 191 GILFIQTELCG-ESLQSYCHTPCNF--------LPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSD 258 (524)
T ss_pred Ccceeeecccc-chhHHhhhccccc--------CCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccc
Confidence 99999999997 4888888766543 666777788888888 99999999 99999999999999999
Q ss_pred -CeEEEeeccccCCCCccccccc---cccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccch
Q 020641 173 -FKAKIADFNLSNQAPDMAARLH---STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQS 248 (323)
Q Consensus 173 -~~~~l~Dfg~~~~~~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~ 248 (323)
..++++|||+...+........ .....|...|++||+.. .-++...|+|++|.++.+..++..++.....
T Consensus 259 ~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~----- 332 (524)
T KOG0601|consen 259 WTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKN----- 332 (524)
T ss_pred cceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCC-----
Confidence 8899999999877654432111 12225788899999664 5668899999999999999988776542200
Q ss_pred hhhhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 249 LVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
..|. .+..+. +..++....+..+...+.+|+..+|..|++.+.+.+
T Consensus 333 ------~~W~--~~r~~~---ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 333 ------SSWS--QLRQGY---IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred ------CCcc--cccccc---CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 0010 001100 112222333456777999999999999999887765
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.50 E-value=5.1e-13 Score=121.86 Aligned_cols=149 Identities=19% Similarity=0.267 Sum_probs=118.0
Q ss_pred CCchHHHHHHHHHhcCCCCcccceeeEEEeCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHH
Q 020641 66 NYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARG 145 (323)
Q Consensus 66 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 145 (323)
.......+.++.|+.++||||+++++.++.....|+|+|-+. .|..+++. +....+..-+.||+.|
T Consensus 51 ~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~------------l~~~~v~~Gl~qIl~A 116 (690)
T KOG1243|consen 51 EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE------------LGKEEVCLGLFQILAA 116 (690)
T ss_pred hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH------------hHHHHHHHHHHHHHHH
Confidence 344667888999999999999999999999999999999884 68888876 4556777789999999
Q ss_pred HHHhhcCCCCCceeCCCCCCCEEEccCCeEEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHH
Q 020641 146 LEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFG 225 (323)
Q Consensus 146 l~~lh~~~~~~i~h~dikp~nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG 225 (323)
|.|||..| +++|++|..+.++++..|.++|++|..+........ .......-..|..|+.+.... ...|.|.||
T Consensus 117 L~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s~--~s~D~~~Lg 190 (690)
T KOG1243|consen 117 LSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPSE--WSIDSWGLG 190 (690)
T ss_pred HHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCccc--cchhhhhHH
Confidence 99999766 999999999999999999999999998765543221 011111223466676543322 467999999
Q ss_pred HHHHHHHhC
Q 020641 226 VVLLELLTG 234 (323)
Q Consensus 226 ~~l~~l~~g 234 (323)
|++++++.|
T Consensus 191 ~li~el~ng 199 (690)
T KOG1243|consen 191 CLIEELFNG 199 (690)
T ss_pred HHHHHHhCc
Confidence 999999998
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.40 E-value=1.9e-11 Score=106.26 Aligned_cols=266 Identities=18% Similarity=0.176 Sum_probs=166.0
Q ss_pred ccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcC-CCCcccceeeEE------E
Q 020641 22 RLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRL-KHENLVELLGYC------V 94 (323)
Q Consensus 22 ~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~------~ 94 (323)
-||+|+.+.+|-.-...+. +.|++.+..... -.+.+..|... .||-+..-+.+= -
T Consensus 18 ~LgqGgea~ly~l~e~~d~---VAKIYh~Pppa~---------------~aqk~a~la~~p~~p~~~~rvaWPqa~L~G~ 79 (637)
T COG4248 18 PLGQGGEADLYTLGEVRDQ---VAKIYHAPPPAA---------------QAQKVAELAATPDAPLLNYRVAWPQATLHGG 79 (637)
T ss_pred cccCCccceeeecchhhch---hheeecCCCchH---------------HHHHHHHhccCCCCcchhhhhcccHHHhhCC
Confidence 6899999999966655442 335454332221 12334445444 666444312211 1
Q ss_pred -eCCeEEEEEeecCCC-CHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccC
Q 020641 95 -EGNLRVLAYEFATMG-SLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFED 172 (323)
Q Consensus 95 -~~~~~~lv~e~~~~~-sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~ 172 (323)
.+...-++|+...+. .+.++.+..... +.-+...|....+..+.++.+.+.||.. |.+-+|++++|+|++++
T Consensus 80 ~~~~~iGflmP~v~g~~pI~~~y~p~tRR---qs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~ 153 (637)
T COG4248 80 RRGKVIGFLMPKVSGKEPIHMIYSPATRR---QSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDD 153 (637)
T ss_pred CccceeEEecccCCCccchhhhcCchhhc---ccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecC
Confidence 223356777777553 455555443332 3334589999999999999999999999 99999999999999999
Q ss_pred CeEEEeeccccCCCCccccccccccccCccccCCCcccc-----CCCCCcccchHHHHHHHHHHHhC-CCCCCCCCCccc
Q 020641 173 FKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAM-----TGQLTQKSDVYSFGVVLLELLTG-RKPVDHTMPRGQ 246 (323)
Q Consensus 173 ~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Di~slG~~l~~l~~g-~~pf~~~~~~~~ 246 (323)
+.+.|+|-..-..-.++. ......|.+.|.+||... +...+...|.|.||+++|+++.| .+||.+......
T Consensus 154 ~~V~LVdsDsfqi~~ng~---~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ 230 (637)
T COG4248 154 SKVVLVDSDSFQINANGT---LHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISD 230 (637)
T ss_pred ceEEEEcccceeeccCCc---eEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCC
Confidence 999999865433322221 223445888999999664 44567889999999999999985 999976532111
Q ss_pred c---hhhhhhcccccccc-cchhcCCCcCCCCCHHHHHHHHHHHHHccCC--CCCCCCChHHHHHHHhhhhcCC
Q 020641 247 Q---SLVTWATPRLSEDK-VKQCVDPKLKGEYPPKGVAKLAAVAALCVQY--EAEFRPNMSIVVKALQPLLKSP 314 (323)
Q Consensus 247 ~---~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~--~P~~Rps~~evl~~l~~~~~~~ 314 (323)
. .-..+....+.... ...-..+......-...+..+..+..+|+.. ++.-|||++..+..|..+-.+.
T Consensus 231 ap~p~E~~Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L 304 (637)
T COG4248 231 APNPLETDIAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQL 304 (637)
T ss_pred CCCcchhhhhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhh
Confidence 0 00001111110000 0000011111111234467899999999984 4678999999999888776443
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.39 E-value=2.6e-12 Score=103.37 Aligned_cols=148 Identities=16% Similarity=0.105 Sum_probs=101.0
Q ss_pred ccCCCCCCccceeccce------eeeeeeeccccccccCccccc-------ccc---CCCCCchHHH----HHHHHHhcC
Q 020641 22 RLDKGPEDDLYLKKRVK------MRRWLCCTCQVEESYPSHENE-------RLK---SPKNYPDDEK----QLVSVVSRL 81 (323)
Q Consensus 22 ~lg~G~~~~V~~~~~~~------~~~~~~~k~~~~~~~~~~~~~-------~~~---~~~~~~~~~~----~e~~~l~~l 81 (323)
.||.|-.+.||.|.... .+..+|+|++......-.... +.. ........+. +|++.|+++
T Consensus 4 ~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~rl 83 (197)
T cd05146 4 CISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKRM 83 (197)
T ss_pred ccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 47899999999998654 346789997764432111100 100 1123344555 899999988
Q ss_pred CC--CcccceeeEEEeCCeEEEEEeecCCCCHHH-HhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHh-hcCCCCCc
Q 020641 82 KH--ENLVELLGYCVEGNLRVLAYEFATMGSLHD-ILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYL-HEKVQPSI 157 (323)
Q Consensus 82 ~h--~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~l-h~~~~~~i 157 (323)
.. -++..++++ ...++||||+.+..+.. .+++.. ++......+..+++.++..+ |+. |+
T Consensus 84 ~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~----------~~~~~~~~i~~~i~~~l~~l~H~~---gl 146 (197)
T cd05146 84 QKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAK----------LNDEEMKNAYYQVLSMMKQLYKEC---NL 146 (197)
T ss_pred HHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccc----------cCHHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence 43 456666654 45689999997643321 222211 44456677889999999998 888 99
Q ss_pred eeCCCCCCCEEEccCCeEEEeeccccCCCC
Q 020641 158 IHRDIRSSNVLLFEDFKAKIADFNLSNQAP 187 (323)
Q Consensus 158 ~h~dikp~nili~~~~~~~l~Dfg~~~~~~ 187 (323)
+|+|+++.||++++ +.++++|||.+....
T Consensus 147 VHGDLs~~NIL~~~-~~v~iIDF~qav~~~ 175 (197)
T cd05146 147 VHADLSEYNMLWHD-GKVWFIDVSQSVEPT 175 (197)
T ss_pred ecCCCCHHHEEEEC-CcEEEEECCCceeCC
Confidence 99999999999974 689999999886554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.32 E-value=4.6e-12 Score=115.43 Aligned_cols=152 Identities=18% Similarity=0.169 Sum_probs=95.6
Q ss_pred ccCCCCCCccceeccceeeeeeeeccccccccCccccc-------------cccCCC---------CCch------HHHH
Q 020641 22 RLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENE-------------RLKSPK---------NYPD------DEKQ 73 (323)
Q Consensus 22 ~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~-------------~~~~~~---------~~~~------~~~~ 73 (323)
.||.|++|.||+|+. .+|+.||+|+............ ...... ++.. ++.+
T Consensus 124 plasaSigQVh~A~l-~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 124 PLAAASIAQVHRARL-VDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred ceeeeehhheEEEEe-cCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 699999999999986 4678899998754321111000 000000 0011 2344
Q ss_pred HHHHHhcC----CCCcccceeeEE-EeCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHH-HHH
Q 020641 74 LVSVVSRL----KHENLVELLGYC-VEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAAR-GLE 147 (323)
Q Consensus 74 e~~~l~~l----~h~~i~~~~~~~-~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~-~l~ 147 (323)
|...+.++ ++.+-+.+-.++ ...+..++||||++|++|.++....... .. ...++.+++. .+.
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~--------~~---~~~ia~~~~~~~l~ 271 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAG--------LD---RKALAENLARSFLN 271 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcC--------CC---HHHHHHHHHHHHHH
Confidence 45444443 232222322222 2234569999999999998876532111 21 2345555555 467
Q ss_pred HhhcCCCCCceeCCCCCCCEEEccCCeEEEeeccccCCCCc
Q 020641 148 YLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPD 188 (323)
Q Consensus 148 ~lh~~~~~~i~h~dikp~nili~~~~~~~l~Dfg~~~~~~~ 188 (323)
.+|.. |++|+|++|.||+++.+++++++|||++.....
T Consensus 272 ql~~~---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 272 QVLRD---GFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred HHHhC---CceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 88998 999999999999999999999999999876653
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.32 E-value=9e-12 Score=97.05 Aligned_cols=138 Identities=19% Similarity=0.279 Sum_probs=105.6
Q ss_pred ccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeCCeEEE
Q 020641 22 RLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVL 101 (323)
Q Consensus 22 ~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 101 (323)
.+++|+-+.+|.+.... ..+.+|.-..+.+...+... +-...+..+|++++.++.--.|....-+..+.....+
T Consensus 3 ~i~~GAEa~i~~~~~~g--~~av~K~Ri~K~YR~p~LD~----klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I 76 (204)
T COG3642 3 LIKQGAEAIIYLTDFLG--LPAVVKERIPKRYRHPELDE----KLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLI 76 (204)
T ss_pred hhhCCcceeEEeeeccC--cceEEEeecCcccCChHHHH----HHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEE
Confidence 46889999999885532 22556655555555433221 1123667889999999877777777777777888899
Q ss_pred EEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEEEeecc
Q 020641 102 AYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFN 181 (323)
Q Consensus 102 v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~l~Dfg 181 (323)
+|||.+|..|.+.+... ...++..+-.-+.-||.. ||+|+|+.++||+++... +.++|||
T Consensus 77 ~me~I~G~~lkd~l~~~----------------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfG 136 (204)
T COG3642 77 VMEYIEGELLKDALEEA----------------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFG 136 (204)
T ss_pred EEEEeCChhHHHHHHhc----------------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECC
Confidence 99999998999898664 136788888999999999 999999999999998774 9999999
Q ss_pred ccCC
Q 020641 182 LSNQ 185 (323)
Q Consensus 182 ~~~~ 185 (323)
++..
T Consensus 137 Lg~~ 140 (204)
T COG3642 137 LGEF 140 (204)
T ss_pred cccc
Confidence 9864
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.30 E-value=1.7e-11 Score=97.62 Aligned_cols=128 Identities=16% Similarity=0.103 Sum_probs=90.1
Q ss_pred ccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCccc-ceeeEEEeCCe
Q 020641 20 FVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLV-ELLGYCVEGNL 98 (323)
Q Consensus 20 ~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~-~~~~~~~~~~~ 98 (323)
+..|+.|.++.||++... ++.+++|+...... ....+..|+..++.+.+.+++ +++.+.. ..
T Consensus 3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~-------------~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~ 65 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE-------------LLINRENEAENSKLAAEAGIGPKLYYFDP--ET 65 (170)
T ss_pred eeecCCcccCceEEEEEC--CeEEEEEeCCCCcc-------------cccCHHHHHHHHHHHHHhCCCCceEEEeC--CC
Confidence 346889999999998864 45567775432210 112356788888887544444 4544432 33
Q ss_pred EEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC-----ceeCCCCCCCEEEccCC
Q 020641 99 RVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPS-----IIHRDIRSSNVLLFEDF 173 (323)
Q Consensus 99 ~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~-----i~h~dikp~nili~~~~ 173 (323)
.++||||++|.++.+. . . .....+.+++.++..||.. + ++|+|++|.||+++ ++
T Consensus 66 ~~lv~e~i~G~~l~~~--~------------~---~~~~~~~~l~~~l~~LH~~---~~~~~~~~HgD~~~~Nil~~-~~ 124 (170)
T cd05151 66 GVLITEFIEGSELLTE--D------------F---SDPENLEKIAKLLKKLHSS---PLPDLVPCHNDLLPGNFLLD-DG 124 (170)
T ss_pred CeEEEEecCCCccccc--c------------c---cCHHHHHHHHHHHHHHhCC---CCCCceeecCCCCcCcEEEE-CC
Confidence 5899999999877543 0 1 1124567899999999998 6 49999999999999 66
Q ss_pred eEEEeeccccCC
Q 020641 174 KAKIADFNLSNQ 185 (323)
Q Consensus 174 ~~~l~Dfg~~~~ 185 (323)
.++++||+.+..
T Consensus 125 ~~~liDf~~a~~ 136 (170)
T cd05151 125 RLWLIDWEYAGM 136 (170)
T ss_pred eEEEEecccccC
Confidence 899999998653
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.23 E-value=1.2e-11 Score=114.13 Aligned_cols=155 Identities=12% Similarity=0.068 Sum_probs=92.4
Q ss_pred cccCCCCCCccceeccceeeeeeeeccccccccCccc-------------------cccc---cCCCCCchH------HH
Q 020641 21 VRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHE-------------------NERL---KSPKNYPDD------EK 72 (323)
Q Consensus 21 ~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~-------------------~~~~---~~~~~~~~~------~~ 72 (323)
..||.|++|.||.|+...+|+.||+|+.......... .... ...+++.+. +.
T Consensus 125 ~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~ 204 (537)
T PRK04750 125 KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDLM 204 (537)
T ss_pred hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHH
Confidence 4799999999999999888999999988754311100 0000 000011222 23
Q ss_pred HHHHHHhcC----CCCcccceeeEEE-eCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHH
Q 020641 73 QLVSVVSRL----KHENLVELLGYCV-EGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLE 147 (323)
Q Consensus 73 ~e~~~l~~l----~h~~i~~~~~~~~-~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 147 (323)
+|...+.++ .+.+.+.+-.++. ..+..++||||+.|+++.++-.-.... .....+....+..++.|++
T Consensus 205 ~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g---~d~~~la~~~v~~~~~Qif---- 277 (537)
T PRK04750 205 REAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAG---TDMKLLAERGVEVFFTQVF---- 277 (537)
T ss_pred HHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcC---CCHHHHHHHHHHHHHHHHH----
Confidence 333333332 2333333333332 244568999999999998753211100 0000133333444455543
Q ss_pred HhhcCCCCCceeCCCCCCCEEEccCC----eEEEeeccccCCCCc
Q 020641 148 YLHEKVQPSIIHRDIRSSNVLLFEDF----KAKIADFNLSNQAPD 188 (323)
Q Consensus 148 ~lh~~~~~~i~h~dikp~nili~~~~----~~~l~Dfg~~~~~~~ 188 (323)
.. |++|+|+||.||+++.++ +++++|||++.....
T Consensus 278 ---~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 278 ---RD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred ---hC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 46 999999999999999888 999999999876654
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.22 E-value=1.7e-11 Score=110.83 Aligned_cols=248 Identities=16% Similarity=0.111 Sum_probs=164.0
Q ss_pred CCCccccccCCCCCCccceeccc-eeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcC-CCCcccceeeE
Q 020641 15 PSPGYFVRLDKGPEDDLYLKKRV-KMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRL-KHENLVELLGY 92 (323)
Q Consensus 15 ~~~~~~~~lg~G~~~~V~~~~~~-~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~ 92 (323)
..+..+.+||.|.|+.|+.+.-. .++..++.|-..+........ ..-..|+-+...+ .|.+++.....
T Consensus 265 ~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~d----------i~sl~ev~l~~~l~~~~~~~g~~~~ 334 (524)
T KOG0601|consen 265 TDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASD----------IFSLGEVILEAILGSHLPSVGKNSS 334 (524)
T ss_pred CCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhh----------hcchhhhhHhhHhhcccccCCCCCC
Confidence 45567779999999999976633 345555555333222111110 1112445555555 68888887777
Q ss_pred EEeCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccC
Q 020641 93 CVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFED 172 (323)
Q Consensus 93 ~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~ 172 (323)
+......|+=.|||+++++...+.-... +.....+.+..|++.++.++|+. .++|+|++|.||++..+
T Consensus 335 W~~~r~~~ip~e~~~~~s~~l~~~~~~~---------~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~ 402 (524)
T KOG0601|consen 335 WSQLRQGYIPLEFCEGGSSSLRSVTSQM---------LDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISND 402 (524)
T ss_pred ccccccccCchhhhcCcchhhhhHHHHh---------cCcchhhhhHHHHHhccccccch---hhhcccccccceeeccc
Confidence 7766677788999999887766622111 77778899999999999999999 99999999999999886
Q ss_pred -CeEEEeeccccCCCCccccccccccccCcccc-CCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhh
Q 020641 173 -FKAKIADFNLSNQAPDMAARLHSTRVLGTFGY-HAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLV 250 (323)
Q Consensus 173 -~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y-~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~ 250 (323)
+..++.|||+++.+.-.. ......+..| .++.......+..+.|++|||..+.+.+++...-....
T Consensus 403 ~~~~~~~~~~~~t~~~~~~----~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~-------- 470 (524)
T KOG0601|consen 403 GFFSKLGDFGCWTRLAFSS----GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV-------- 470 (524)
T ss_pred hhhhhccccccccccceec----ccccccccccccchhhccccccccccccccccccccccccCcccCcccc--------
Confidence 778999999886522111 1111123334 35666666778899999999999999998765322110
Q ss_pred hhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHh
Q 020641 251 TWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQ 308 (323)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~ 308 (323)
....+ ..+. .........++..+.+.++..++.-||++.++.....
T Consensus 471 ----------~~~~i-~~~~-~p~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~ 516 (524)
T KOG0601|consen 471 ----------QSLTI-RSGD-TPNLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSE 516 (524)
T ss_pred ----------cceee-eccc-ccCCCchHHhhhhhhhhhcCCccccchhhhhhcccch
Confidence 00000 0000 0111222367888999999999999999988765443
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.21 E-value=6.7e-11 Score=91.91 Aligned_cols=151 Identities=17% Similarity=0.136 Sum_probs=110.3
Q ss_pred cccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeCCe
Q 020641 19 YFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNL 98 (323)
Q Consensus 19 ~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 98 (323)
-+..+-+|+.+.|+.+.. .++.+.+|.-..+.+..-.. ..+-...+..+|.+.+.++.--.|.-..-++.+.+.
T Consensus 11 ~l~likQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~L----D~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~ 84 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF--SGEAAIIKERFSKRYRHPAL----DQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYG 84 (229)
T ss_pred cceeeeccceeeEeeecc--CCceeEEeecccccccchHH----HHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCC
Confidence 344578899998887776 55555666555444433221 112234678899999999876677777777777777
Q ss_pred EEEEEeecCC-CCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCC---e
Q 020641 99 RVLAYEFATM-GSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDF---K 174 (323)
Q Consensus 99 ~~lv~e~~~~-~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~---~ 174 (323)
..++|||.+| .++.+++....... ........++.++-..+.-||.. +++|+|+..+||++...+ .
T Consensus 85 ~~i~ME~~~g~~~vk~~i~~~~~~~-------~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~ 154 (229)
T KOG3087|consen 85 GQIYMEFIDGASTVKDFILSTMEDE-------SEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQIT 154 (229)
T ss_pred CeEEEEeccchhHHHHHHHHHccCc-------ccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCc
Confidence 8999999976 58888887665432 22233378999999999999999 999999999999996543 3
Q ss_pred EEEeeccccCC
Q 020641 175 AKIADFNLSNQ 185 (323)
Q Consensus 175 ~~l~Dfg~~~~ 185 (323)
+.++|||++..
T Consensus 155 ~~lIdfgls~~ 165 (229)
T KOG3087|consen 155 PILIDFGLSSV 165 (229)
T ss_pred eEEEeecchhc
Confidence 58999998754
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.16 E-value=1.2e-09 Score=97.40 Aligned_cols=224 Identities=13% Similarity=0.101 Sum_probs=157.3
Q ss_pred CCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEE----eCCeEEEE
Q 020641 27 PEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCV----EGNLRVLA 102 (323)
Q Consensus 27 ~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~----~~~~~~lv 102 (323)
.-.+.|++....+|..+++|.++.... .........++.++++.|.|++++.+++. .+..+++|
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~------------~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~Slvlv 355 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRD------------QSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLV 355 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccc------------cCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEE
Confidence 447889999999999999886643221 22234466788999999999999999887 34567999
Q ss_pred EeecCC-CCHHHHhccCCCCC------CCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeE
Q 020641 103 YEFATM-GSLHDILHGRKGVQ------GAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKA 175 (323)
Q Consensus 103 ~e~~~~-~sL~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~ 175 (323)
++|+++ ++|.++--...... ....+...++..+|.++.|+..||.++|+. |+..+-+.+.+|+++.+.++
T Consensus 356 YDYyP~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RI 432 (655)
T KOG3741|consen 356 YDYYPSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRI 432 (655)
T ss_pred EecCCCCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceE
Confidence 999875 58888775544322 011223478889999999999999999999 99999999999999999999
Q ss_pred EEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhcc
Q 020641 176 KIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATP 255 (323)
Q Consensus 176 ~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~ 255 (323)
+|..+|......... . +.+. -..+-|.-.||.++..|.+|...-...+
T Consensus 433 riS~C~i~Dvl~~d~--------------~--~~le---~~Qq~D~~~lG~ll~aLAt~~~ns~~~d------------- 480 (655)
T KOG3741|consen 433 RISGCGIMDVLQEDP--------------T--EPLE---SQQQNDLRDLGLLLLALATGTENSNRTD------------- 480 (655)
T ss_pred EEecccceeeecCCC--------------C--cchh---HHhhhhHHHHHHHHHHHhhccccccccc-------------
Confidence 999888654432211 0 1011 1236799999999999999864321110
Q ss_pred cccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHH
Q 020641 256 RLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKAL 307 (323)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l 307 (323)
..++.- ........+.++++++.-....++++ -++.+++..+
T Consensus 481 -----~~~~s~----~~~I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~~ 522 (655)
T KOG3741|consen 481 -----STQSSH----LTRITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPMI 522 (655)
T ss_pred -----chHHHH----HHHhhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHHH
Confidence 001000 01123455677888998888888887 5777776543
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.06 E-value=1.7e-10 Score=110.25 Aligned_cols=247 Identities=18% Similarity=0.167 Sum_probs=160.3
Q ss_pred cccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeCCe
Q 020641 19 YFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNL 98 (323)
Q Consensus 19 ~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 98 (323)
...-+-.|+++.++.++-..++-..+.++..+...-. ....+....+-.++-...+|-++...-.+.-...
T Consensus 808 i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~---------~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP 878 (1205)
T KOG0606|consen 808 ITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIR---------TNDYESIRSKSNILITPRSPAVVRSFPSFPCRSP 878 (1205)
T ss_pred ecccccCCCCcccccCCccccccccchhhhccchhhc---------cccccccCCccCccccCCCCceecccCCCCCCCC
Confidence 3336677999999999988887555544332211000 0000111111111111133433333333344567
Q ss_pred EEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEEEe
Q 020641 99 RVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIA 178 (323)
Q Consensus 99 ~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~l~ 178 (323)
.+++++|..+++|...+..-.. .+..-+.-.+..+..+..+||.. .+.|+|++|.|.++..++...+.
T Consensus 879 ~~L~~~~~~~~~~~Skl~~~~~---------~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~ 946 (1205)
T KOG0606|consen 879 LPLVGHYLNGGDLPSKLHNSGC---------LSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLT 946 (1205)
T ss_pred cchhhHHhccCCchhhhhcCCC---------cccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccC
Confidence 7999999999999999876542 33444455666788899999998 89999999999999999999999
Q ss_pred eccccCCCCcc---------------------------cc--ccccccccCccccCCCccccCCCCCcccchHHHHHHHH
Q 020641 179 DFNLSNQAPDM---------------------------AA--RLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLL 229 (323)
Q Consensus 179 Dfg~~~~~~~~---------------------------~~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~ 229 (323)
||+........ .. ........+|+.|.+||...+..-...+|.|++|++++
T Consensus 947 ~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~ 1026 (1205)
T KOG0606|consen 947 DFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLF 1026 (1205)
T ss_pred ccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhh
Confidence 99732111100 00 00112334899999999999999999999999999999
Q ss_pred HHHhCCCCCCCCCCcccchhhhhhcccccccccchhcCCCcCC-CCCHHHHHHHHHHHHHccCCCCCCCCChH
Q 020641 230 ELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKG-EYPPKGVAKLAAVAALCVQYEAEFRPNMS 301 (323)
Q Consensus 230 ~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~~P~~Rps~~ 301 (323)
+.++|..||.....+.... .++.....+ ..+...+....+++...+..+|.+|..+.
T Consensus 1027 e~l~g~pp~na~tpq~~f~---------------ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1027 EVLTGIPPFNAETPQQIFE---------------NILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred hhhcCCCCCCCcchhhhhh---------------ccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 9999999998665433221 111111111 22344556788899999999999997765
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.04 E-value=2e-09 Score=89.42 Aligned_cols=143 Identities=22% Similarity=0.215 Sum_probs=98.9
Q ss_pred cccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCC--cccceeeEEEeCC-
Q 020641 21 VRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHE--NLVELLGYCVEGN- 97 (323)
Q Consensus 21 ~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~--~i~~~~~~~~~~~- 97 (323)
+.|+.|.++.||++.... ++.+++|+...... ......+.+|+++++.+.+. .+.+++.+.....
T Consensus 4 ~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~-----------~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~ 71 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGAL-----------LPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSV 71 (223)
T ss_pred eecCCCccceEEEEEecC-CcceEEEeCCCccc-----------CcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCc
Confidence 568999999999998644 35566664432210 01335678899999988553 4566777766532
Q ss_pred --eEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCC----------------------
Q 020641 98 --LRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKV---------------------- 153 (323)
Q Consensus 98 --~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~---------------------- 153 (323)
..++||||+.|.++.+.+.... ++......++.+++..+..||+..
T Consensus 72 ~~~~~~v~e~i~G~~l~~~~~~~~----------~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~ 141 (223)
T cd05154 72 LGTPFYVMERVDGRVLRDRLLRPE----------LSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVAR 141 (223)
T ss_pred cCCceEEEEEeCCEecCCCCCCCC----------CCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHH
Confidence 5689999999988877653111 555556666666666666666421
Q ss_pred -------------------------------CCCceeCCCCCCCEEEcc--CCeEEEeeccccCC
Q 020641 154 -------------------------------QPSIIHRDIRSSNVLLFE--DFKAKIADFNLSNQ 185 (323)
Q Consensus 154 -------------------------------~~~i~h~dikp~nili~~--~~~~~l~Dfg~~~~ 185 (323)
...++|+|+++.||+++. ++.+.++||+.+..
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 142 WRRQYDASRTDEPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHhhcccccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 236799999999999998 56789999997754
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.98 E-value=2.3e-10 Score=105.21 Aligned_cols=157 Identities=18% Similarity=0.262 Sum_probs=109.2
Q ss_pred HHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEEEeeccccCCCCccccccccc-------cccCccccCC
Q 020641 134 TRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHST-------RVLGTFGYHA 206 (323)
Q Consensus 134 ~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~-------~~~g~~~y~a 206 (323)
....-+.+.+.|+.++|... +++|++|.|++|.++.++.+||+.|+............... -......|.|
T Consensus 100 ~~f~nl~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~a 177 (700)
T KOG2137|consen 100 DGFANLGNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLA 177 (700)
T ss_pred HhhhhhhcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCccccc
Confidence 34444555669999999875 99999999999999999999999999875544422111100 0113457999
Q ss_pred CccccCCCCCcccchHHHHHHHHHHH-hCCCCCCCCCCcccchhhhhhcccccccccchhcCCCcCCCCCHHHHHHHHHH
Q 020641 207 PEYAMTGQLTQKSDVYSFGVVLLELL-TGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAV 285 (323)
Q Consensus 207 PE~~~~~~~~~~~Di~slG~~l~~l~-~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 285 (323)
||.+.....+.++|+||+|+++|.+. .|+..+........... ....+..-...+..+.+.++++-
T Consensus 178 pE~~~~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~-------------~~~~~~~~~~~~s~~~p~el~~~ 244 (700)
T KOG2137|consen 178 PEYLLGTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSF-------------SRNLLNAGAFGYSNNLPSELRES 244 (700)
T ss_pred chhhccccccccccceeeeeEEEEEecCCcchhhccCCcchhhh-------------hhcccccccccccccCcHHHHHH
Confidence 99998877789999999999999999 46655544322111111 11111111223446677889999
Q ss_pred HHHccCCCCCCCCChHHHHH
Q 020641 286 AALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 286 i~~cl~~~P~~Rps~~evl~ 305 (323)
+.+++..++..||++.++..
T Consensus 245 l~k~l~~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 245 LKKLLNGDSAVRPTLDLLLS 264 (700)
T ss_pred HHHHhcCCcccCcchhhhhc
Confidence 99999999999997776643
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.98 E-value=3e-09 Score=85.38 Aligned_cols=100 Identities=19% Similarity=0.224 Sum_probs=66.3
Q ss_pred hHHHHHHHHHhcCCCC--cccceeeEEEeCCeEEEEEeecC--CCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHH
Q 020641 69 DDEKQLVSVVSRLKHE--NLVELLGYCVEGNLRVLAYEFAT--MGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAAR 144 (323)
Q Consensus 69 ~~~~~e~~~l~~l~h~--~i~~~~~~~~~~~~~~lv~e~~~--~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 144 (323)
....+|++.|.++... ++.+++++ . ..++||||+. |..+..+.... ++......++.+++.
T Consensus 53 ~~~~~E~~~L~~l~~~Gv~vP~p~~~--~--~~~ivME~I~~~G~~~~~l~~~~-----------~~~~~~~~~~~~il~ 117 (188)
T PF01163_consen 53 EWAKKEFRNLKRLYEAGVPVPKPYDY--N--RNVIVMEYIGEDGVPLPRLKDVD-----------LSPEEPKELLEEILE 117 (188)
T ss_dssp HHHHHHHHHHHHCCCTT-SS--EEEE--E--TTEEEEE--EETTEEGGCHHHCG-----------GGGSTHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHCCccCCcEEEE--e--CCEEEEEecCCCccchhhHHhcc-----------ccchhHHHHHHHHHH
Confidence 3466899999999665 45666644 2 2379999998 65555544332 222345677788888
Q ss_pred HHHH-hhcCCCCCceeCCCCCCCEEEccCCeEEEeeccccCCCC
Q 020641 145 GLEY-LHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAP 187 (323)
Q Consensus 145 ~l~~-lh~~~~~~i~h~dikp~nili~~~~~~~l~Dfg~~~~~~ 187 (323)
.+.. +|+. |++|+|+++.||+++.+ .+.++|||.+....
T Consensus 118 ~~~~~~~~~---givHGDLs~~NIlv~~~-~~~iIDf~qav~~~ 157 (188)
T PF01163_consen 118 EIIKMLHKA---GIVHGDLSEYNILVDDG-KVYIIDFGQAVDSS 157 (188)
T ss_dssp HHHHHHHCT---TEEESS-STTSEEEETT-CEEE--GTTEEETT
T ss_pred HHHHHHHhc---CceecCCChhhEEeecc-eEEEEecCcceecC
Confidence 5555 5788 99999999999999988 99999999876543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.93 E-value=8e-09 Score=87.82 Aligned_cols=105 Identities=17% Similarity=0.121 Sum_probs=80.5
Q ss_pred HHHHHHHHHhcCCCCccc--ceeeEEEe-----CCeEEEEEeecCCC-CHHHHhccCCCCCCCCCCCCCCHHHHHHHHHH
Q 020641 70 DEKQLVSVVSRLKHENLV--ELLGYCVE-----GNLRVLAYEFATMG-SLHDILHGRKGVQGAQPGPVLDWMTRVRIAVD 141 (323)
Q Consensus 70 ~~~~e~~~l~~l~h~~i~--~~~~~~~~-----~~~~~lv~e~~~~~-sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 141 (323)
...+|+..+..|...+|. .++.+... ....++|||++++. +|.+++...... .........++.+
T Consensus 74 ~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~~sL~~~~~~~~~~-------~~~~~~~~~ll~~ 146 (268)
T PRK15123 74 GADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITEDLAPTISLEDYCADWATN-------PPDPRLKRMLIKR 146 (268)
T ss_pred HHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEeeCCCCccHHHHHHhhccc-------CCCHHHHHHHHHH
Confidence 477888888877444443 44555543 23578999999875 899998543211 1455677799999
Q ss_pred HHHHHHHhhcCCCCCceeCCCCCCCEEEcc-------CCeEEEeeccccC
Q 020641 142 AARGLEYLHEKVQPSIIHRDIRSSNVLLFE-------DFKAKIADFNLSN 184 (323)
Q Consensus 142 i~~~l~~lh~~~~~~i~h~dikp~nili~~-------~~~~~l~Dfg~~~ 184 (323)
++..+..||.. |++|+|+++.|||++. +..+.++||+.+.
T Consensus 147 la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 147 VATMVRDMHAA---GINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ 193 (268)
T ss_pred HHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence 99999999999 9999999999999975 4689999999774
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.89 E-value=3.1e-08 Score=81.40 Aligned_cols=105 Identities=24% Similarity=0.227 Sum_probs=82.3
Q ss_pred hHHHHHHHHHhcCCCC--cccceeeEEEeC----CeEEEEEeecCC-CCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHH
Q 020641 69 DDEKQLVSVVSRLKHE--NLVELLGYCVEG----NLRVLAYEFATM-GSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVD 141 (323)
Q Consensus 69 ~~~~~e~~~l~~l~h~--~i~~~~~~~~~~----~~~~lv~e~~~~-~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 141 (323)
....+|+..+..|... .+.+++++.... ...++|+|++++ .+|.+++..... .+......++.+
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~---------~~~~~~~~ll~~ 126 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ---------LDPSQRRELLRA 126 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc---------cchhhHHHHHHH
Confidence 4677788877777333 345667766653 245899999987 489999876332 445567789999
Q ss_pred HHHHHHHhhcCCCCCceeCCCCCCCEEEccCC---eEEEeeccccCC
Q 020641 142 AARGLEYLHEKVQPSIIHRDIRSSNVLLFEDF---KAKIADFNLSNQ 185 (323)
Q Consensus 142 i~~~l~~lh~~~~~~i~h~dikp~nili~~~~---~~~l~Dfg~~~~ 185 (323)
++..+.-||.. |++|+|+++.|||++.+. .+.++||+.+..
T Consensus 127 l~~~i~~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 127 LARLIAKLHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHHHHHHHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 99999999999 999999999999999887 899999997654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.86 E-value=8e-09 Score=85.58 Aligned_cols=142 Identities=15% Similarity=0.143 Sum_probs=96.7
Q ss_pred ccCCCCCCccceeccceeeeeeeeccccccccCccccc--------cccCC--CCCchHHHHHHHHHhcCCCC--cccce
Q 020641 22 RLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENE--------RLKSP--KNYPDDEKQLVSVVSRLKHE--NLVEL 89 (323)
Q Consensus 22 ~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~--------~~~~~--~~~~~~~~~e~~~l~~l~h~--~i~~~ 89 (323)
+||-|--|+||.+.+. .+..+++|+.......-...+ ....+ ...+....+|.+.|+++... .+.+.
T Consensus 98 ~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~VP~P 176 (304)
T COG0478 98 KIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKVPKP 176 (304)
T ss_pred ccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCCCCc
Confidence 7899999999999987 455677775443321111100 00111 01123356789999988544 77777
Q ss_pred eeEEEeCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEE
Q 020641 90 LGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLL 169 (323)
Q Consensus 90 ~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili 169 (323)
++ .+...+|||+.+|-.|.... +.......++..|+.-+..+-.. |++|+|+++-||++
T Consensus 177 ~~----~nRHaVvMe~ieG~eL~~~r--------------~~~en~~~il~~il~~~~~~~~~---GiVHGDlSefNIlV 235 (304)
T COG0478 177 IA----WNRHAVVMEYIEGVELYRLR--------------LDVENPDEILDKILEEVRKAYRR---GIVHGDLSEFNILV 235 (304)
T ss_pred cc----cccceeeeehcccceeeccc--------------CcccCHHHHHHHHHHHHHHHHHc---CccccCCchheEEE
Confidence 65 34568999999987666554 22334456666777776666677 99999999999999
Q ss_pred ccCCeEEEeeccccCC
Q 020641 170 FEDFKAKIADFNLSNQ 185 (323)
Q Consensus 170 ~~~~~~~l~Dfg~~~~ 185 (323)
+++|.++++||-.+..
T Consensus 236 ~~dg~~~vIDwPQ~v~ 251 (304)
T COG0478 236 TEDGDIVVIDWPQAVP 251 (304)
T ss_pred ecCCCEEEEeCccccc
Confidence 9999999999976544
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.78 E-value=1.5e-07 Score=76.13 Aligned_cols=143 Identities=12% Similarity=0.021 Sum_probs=96.6
Q ss_pred CCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCC--cccceeeEEEe-----C
Q 020641 24 DKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHE--NLVELLGYCVE-----G 96 (323)
Q Consensus 24 g~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~--~i~~~~~~~~~-----~ 96 (323)
|.||.|.|+....... .++ +|-... ........ ..-..-|.+|+..++++... .+.+++ ++.. .
T Consensus 27 ~rgG~SgV~r~~~~g~-~~y-lKrq~n-----hl~~s~r~-P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~ 97 (216)
T PRK09902 27 RRNGMSGVQCVERNGK-KLY-VKRMTH-----HLFHSVRY-PFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGE 97 (216)
T ss_pred CCCCcceEEEEEeCCc-EEE-EEeccC-----cccccccC-CCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCc
Confidence 5589999998764333 233 332211 11111111 22446788999998888432 355555 3321 1
Q ss_pred CeEEEEEeecCC-CCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCe-
Q 020641 97 NLRVLAYEFATM-GSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFK- 174 (323)
Q Consensus 97 ~~~~lv~e~~~~-~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~- 174 (323)
...+||+|-+.+ .+|.+++....... .+......++.+++..+.-||.. |+.|+|+.+.||+++.++.
T Consensus 98 ~rA~LVTe~L~g~~~L~~~l~~~~~~~-------~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~ 167 (216)
T PRK09902 98 WRALLVTEDMAGFISIADWYAQHAVSP-------YSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKA 167 (216)
T ss_pred eEEEEEEEeCCCCccHHHHHhcCCcCC-------cchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCe
Confidence 246899997753 58999886543221 56667789999999999999999 9999999999999986666
Q ss_pred -EEEeeccccCC
Q 020641 175 -AKIADFNLSNQ 185 (323)
Q Consensus 175 -~~l~Dfg~~~~ 185 (323)
+.++||..++.
T Consensus 168 ~v~lIDlEk~r~ 179 (216)
T PRK09902 168 EAGFLDLEKSRR 179 (216)
T ss_pred eEEEEEhhccch
Confidence 99999986643
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.68 E-value=1.3e-08 Score=93.03 Aligned_cols=200 Identities=18% Similarity=0.189 Sum_probs=150.7
Q ss_pred CCCCccccccCCCCCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCC
Q 020641 3 YDYHPRALGAHAPSPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLK 82 (323)
Q Consensus 3 ~~~~~~~~~~~~~~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~ 82 (323)
|+|-|+++....--+..|--+++|+.+.+++.+...++-.. .+++... ....-++++|.+++
T Consensus 230 S~~qpp~lkDk~kws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~-----------------l~~rl~~eLLdK~n 291 (829)
T KOG0576|consen 230 SGFQPPTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT-----------------LSRRLAIELLDKVN 291 (829)
T ss_pred cCCCCCcccCCccchHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc-----------------hhhHHHHHHHHHcc
Confidence 68899999999999999999999999999999988776543 3322211 34466889999999
Q ss_pred CCc-ccceeeEEEeCCeEEEEEeecCCC-CHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeC
Q 020641 83 HEN-LVELLGYCVEGNLRVLAYEFATMG-SLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHR 160 (323)
Q Consensus 83 h~~-i~~~~~~~~~~~~~~lv~e~~~~~-sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~ 160 (323)
||| .+..++.++.....++.++++.++ +....+....- .+.......+++.-+.+++++|+. .-+|+
T Consensus 292 ~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~~~~~~~se~--------~~~~~~~~~~~r~et~~l~~l~~~---~~~~~ 360 (829)
T KOG0576|consen 292 NPNPVVRYLEDYDGEDYLWIPMRICSTGRSSALEMTVSEI--------ALEQYQFAYPLRKETRPLAELHSS---YKVHR 360 (829)
T ss_pred CCCCcccccccCCcccccchhhhhhcCCccccccCChhhH--------hhhhhhhhhhhhhhcccccccccc---cccCc
Confidence 999 667777777777889999999876 33333222111 134445556777788899999987 66788
Q ss_pred CCCCCCEEEccCCeEEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCC
Q 020641 161 DIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVD 239 (323)
Q Consensus 161 dikp~nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~ 239 (323)
| ||+.++ +..++.||+....+.... ......+++.++|||......+..+.|.|++|.-..++.-|.+|-.
T Consensus 361 d----~~l~s~-~~~~~~~~~v~~~L~~~~---~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~ 431 (829)
T KOG0576|consen 361 D----NILGSE-EEVKLLDFAVPPQLTRTM---KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS 431 (829)
T ss_pred c----cccccc-cccccccccCCcccCccc---ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence 7 666655 688999999987776543 2344568999999999999999999999999988778877777754
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.40 E-value=7.3e-06 Score=68.27 Aligned_cols=73 Identities=11% Similarity=0.070 Sum_probs=49.6
Q ss_pred ccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCc--ccceeeEEEeCC
Q 020641 20 FVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHEN--LVELLGYCVEGN 97 (323)
Q Consensus 20 ~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~--i~~~~~~~~~~~ 97 (323)
...||.|..+.||+.. .++ +++|.... ........+|.++++.+..-+ +.+++++...++
T Consensus 6 ~~~i~~G~t~~~y~~~---~~~-~VlR~~~~--------------~~~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~ 67 (226)
T TIGR02172 6 WTQTGEGGNGESYTHK---TGK-WMLKLYNP--------------GFDKETIKREFDASRKVFSLGIPTPHPFDLVEDGG 67 (226)
T ss_pred heeecCCCCcceeEec---CCC-EEEEeCCC--------------CCCHHHHHHHHHHHHHHHHcCCCCCceEEEEecCC
Confidence 3578999999999742 233 34443321 112245688999998884333 567888888888
Q ss_pred eEEEEEeecCCCC
Q 020641 98 LRVLAYEFATMGS 110 (323)
Q Consensus 98 ~~~lv~e~~~~~s 110 (323)
...+||++++|.+
T Consensus 68 ~~glv~e~i~G~~ 80 (226)
T TIGR02172 68 RLGLIYELIVGKR 80 (226)
T ss_pred eeeeeeeecCCcc
Confidence 8899999999863
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.38 E-value=1.5e-06 Score=70.62 Aligned_cols=68 Identities=24% Similarity=0.286 Sum_probs=53.4
Q ss_pred CeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEE
Q 020641 97 NLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAK 176 (323)
Q Consensus 97 ~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~ 176 (323)
...+++|||++|..|.+... ++. .+...+.+++.-+|+. |+.|+|.+|.|++++++ .++
T Consensus 116 ~~~~ll~EYIeG~~l~d~~~-------------i~e----~~~~ki~~~ikqlH~~---G~~HGD~hpgNFlv~~~-~i~ 174 (229)
T PF06176_consen 116 SSYVLLMEYIEGVELNDIED-------------IDE----DLAEKIVEAIKQLHKH---GFYHGDPHPGNFLVSNN-GIR 174 (229)
T ss_pred eEEEEEEEEecCeecccchh-------------cCH----HHHHHHHHHHHHHHHc---CCccCCCCcCcEEEECC-cEE
Confidence 35578999999988877642 222 2445677789999999 99999999999999865 599
Q ss_pred EeeccccCC
Q 020641 177 IADFNLSNQ 185 (323)
Q Consensus 177 l~Dfg~~~~ 185 (323)
++||+....
T Consensus 175 iID~~~k~~ 183 (229)
T PF06176_consen 175 IIDTQGKRM 183 (229)
T ss_pred EEECccccc
Confidence 999986543
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.36 E-value=3e-06 Score=69.77 Aligned_cols=154 Identities=15% Similarity=0.186 Sum_probs=96.9
Q ss_pred CccccccCCCCCCccceeccceeeeeeeeccccccccCccc-------cccccCCCCCchH-----HHHHHHHHhcCC--
Q 020641 17 PGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHE-------NERLKSPKNYPDD-----EKQLVSVVSRLK-- 82 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~-------~~~~~~~~~~~~~-----~~~e~~~l~~l~-- 82 (323)
.++..-|+.|-.+.||+|.. ..++.+|+|++......-.. ..++......... ...|+.-|+++.
T Consensus 50 ~~~~g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eA 128 (268)
T COG1718 50 TELVGCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEA 128 (268)
T ss_pred eeeEeeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHc
Confidence 34445788999999999887 45677888877654432221 1122222222222 224666666663
Q ss_pred CCcccceeeEEEeCCeEEEEEeecCCC-CHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCC
Q 020641 83 HENLVELLGYCVEGNLRVLAYEFATMG-SLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRD 161 (323)
Q Consensus 83 h~~i~~~~~~~~~~~~~~lv~e~~~~~-sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~d 161 (323)
+=.+.+.+.+. ...+||||+... .-.=.+++. .+....+..+..++++.+.-|-..+ +++|+|
T Consensus 129 GVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~LkDv----------~~e~~e~~~~~~~~v~~~~~l~~~a--~LVHgD 192 (268)
T COG1718 129 GVRVPEPIAFR----NNVLVMEFIGDDGLPAPRLKDV----------PLELEEAEGLYEDVVEYMRRLYKEA--GLVHGD 192 (268)
T ss_pred CCCCCCceeec----CCeEEEEeccCCCCCCCCcccC----------CcCchhHHHHHHHHHHHHHHHHHhc--Cccccc
Confidence 33444454433 247999998652 111111111 1333357778888888888888732 999999
Q ss_pred CCCCCEEEccCCeEEEeeccccCCCCc
Q 020641 162 IRSSNVLLFEDFKAKIADFNLSNQAPD 188 (323)
Q Consensus 162 ikp~nili~~~~~~~l~Dfg~~~~~~~ 188 (323)
++.-|||+. .+.+.++|++.|....+
T Consensus 193 LSEyNiL~~-~~~p~iID~~QaV~~~h 218 (268)
T COG1718 193 LSEYNILVH-DGEPYIIDVSQAVTIDH 218 (268)
T ss_pred chhhheEEE-CCeEEEEECccccccCC
Confidence 999999999 77999999998876543
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.21 E-value=8.5e-05 Score=59.89 Aligned_cols=105 Identities=23% Similarity=0.221 Sum_probs=79.6
Q ss_pred HHHHHHHhcCCC-CcccceeeEEEeCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhh
Q 020641 72 KQLVSVVSRLKH-ENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLH 150 (323)
Q Consensus 72 ~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh 150 (323)
..|.-+++.+++ +++.+++|+|- .++++||...+++......- . .....+|..+.+++.++++.+.+++
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l--~----~~~~~~w~~R~~iA~~lL~~l~~l~ 76 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPL--S----QFLQSPWEQRAKIALQLLELLEELD 76 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCcccccccccc--c----cccccCHHHHHHHHHHHHHHHHHHh
Confidence 347777888854 69999999983 36788999876664320000 0 0001789999999999999999999
Q ss_pred cCCCCCceeCCCCCCCEEEccCCeEEEeeccccCCC
Q 020641 151 EKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQA 186 (323)
Q Consensus 151 ~~~~~~i~h~dikp~nili~~~~~~~l~Dfg~~~~~ 186 (323)
......+...|++++|+.++++++++++|.+.+...
T Consensus 77 ~~~~~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 77 HGPLGFFYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred cCCCCcEEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 854446888999999999999999999999876443
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.21 E-value=2.8e-05 Score=63.00 Aligned_cols=138 Identities=17% Similarity=0.192 Sum_probs=90.6
Q ss_pred ccCCCCCCccceeccceeeeeeeeccccccccCccc----cccccCCCCCchHHHHHHHHHhcCC------CCcccceee
Q 020641 22 RLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHE----NERLKSPKNYPDDEKQLVSVVSRLK------HENLVELLG 91 (323)
Q Consensus 22 ~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~----~~~~~~~~~~~~~~~~e~~~l~~l~------h~~i~~~~~ 91 (323)
.||.|+.-.||.-.+..+ .|+|+.......... ............+..+|+.....+. +.+|.+++|
T Consensus 8 ~i~~G~~R~cy~HP~dp~---~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G 84 (199)
T PF10707_consen 8 LIAQGGERDCYQHPDDPN---LCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYG 84 (199)
T ss_pred ccccCCCceEEECCCCCC---eEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeE
Confidence 589999999997766555 466766544411000 0000011122355556666554444 889999999
Q ss_pred EEEeCCeEEEEEeecCC------CCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCC
Q 020641 92 YCVEGNLRVLAYEFATM------GSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSS 165 (323)
Q Consensus 92 ~~~~~~~~~lv~e~~~~------~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~ 165 (323)
+.+++....+|+|-..+ .+|.+++.... ++. .+...+-+-..+|-.. +|+.+|++|.
T Consensus 85 ~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~----------~~~----~~~~~L~~f~~~l~~~---~Iv~~dl~~~ 147 (199)
T PF10707_consen 85 FVETNLGLGLVVELIRDADGNISPTLEDYLKEGG----------LTE----ELRQALDEFKRYLLDH---HIVIRDLNPH 147 (199)
T ss_pred EEecCCceEEEEEEEECCCCCcCccHHHHHHcCC----------ccH----HHHHHHHHHHHHHHHc---CCeecCCCcc
Confidence 99999989999997632 37889986553 444 3344444556677777 9999999999
Q ss_pred CEEEccCC----eEEEee
Q 020641 166 NVLLFEDF----KAKIAD 179 (323)
Q Consensus 166 nili~~~~----~~~l~D 179 (323)
||++..+. .++|+|
T Consensus 148 NIv~~~~~~~~~~lvlID 165 (199)
T PF10707_consen 148 NIVVQRRDSGEFRLVLID 165 (199)
T ss_pred cEEEEecCCCceEEEEEe
Confidence 99995432 577777
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.13 E-value=4e-05 Score=64.69 Aligned_cols=77 Identities=10% Similarity=0.036 Sum_probs=48.8
Q ss_pred cccCCCCC-CccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcC-CCCcccceeeEEEeCCe
Q 020641 21 VRLDKGPE-DDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRL-KHENLVELLGYCVEGNL 98 (323)
Q Consensus 21 ~~lg~G~~-~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~ 98 (323)
.+|..|.. +.||.+.... ..+.+|..... . .....+|+++++.+ ++--+.+++++...++.
T Consensus 4 ~~~~~g~~~~~v~~~~~~~--~~~~vk~~~~~--------------~-~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~ 66 (244)
T cd05150 4 ERVTEGQSGATVYRLDGKN--PGLYLKIAPSG--------------P-TYELEREAERLRWLAGKLPVPEVIDYGSDDGR 66 (244)
T ss_pred eecCCCCCcCeEEEEcCCC--CcEEEEecCCC--------------c-ccchHHHHHHHHHHHhcCCCCeEEEEEecCCc
Confidence 34555555 7889887643 33444433211 0 23456788887777 44445677777776667
Q ss_pred EEEEEeecCCCCHHHH
Q 020641 99 RVLAYEFATMGSLHDI 114 (323)
Q Consensus 99 ~~lv~e~~~~~sL~~~ 114 (323)
.++||++.+|.++...
T Consensus 67 ~~lv~e~i~G~~l~~~ 82 (244)
T cd05150 67 AWLLTSAVPGVPAAAL 82 (244)
T ss_pred cEEEEEeeCCccHhHh
Confidence 8999999998777644
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.10 E-value=6.7e-06 Score=76.02 Aligned_cols=152 Identities=16% Similarity=0.123 Sum_probs=88.3
Q ss_pred ccCCCCCCccceeccceeeeeeeeccccccccCccc------------cccccC----------CCCCchH------HHH
Q 020641 22 RLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHE------------NERLKS----------PKNYPDD------EKQ 73 (323)
Q Consensus 22 ~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~------------~~~~~~----------~~~~~~~------~~~ 73 (323)
-++.++-|.|+.|+... |+.||+|+.......... .+.... -+++.+. +.+
T Consensus 132 PiAsASIaQVH~A~L~s-G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 132 PIASASIAQVHRAVLKS-GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred chhhhhHhhheeEEecC-CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 56789999999999876 889999977654322110 000000 0011111 222
Q ss_pred HHHHHhcC-----CCCcccceeeEEEeCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHH-HH
Q 020641 74 LVSVVSRL-----KHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARG-LE 147 (323)
Q Consensus 74 e~~~l~~l-----~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~-l~ 147 (323)
|...+.++ +.+++.-.-=+.+..+.-.++|||++|..+.+...-.... ++.+.+ +..++.+ +.
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g--------~d~k~i---a~~~~~~f~~ 279 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAG--------IDRKEL---AELLVRAFLR 279 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcC--------CCHHHH---HHHHHHHHHH
Confidence 33323222 2333332222223345568999999999888885322221 443322 2222222 22
Q ss_pred HhhcCCCCCceeCCCCCCCEEEccCCeEEEeeccccCCCCc
Q 020641 148 YLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPD 188 (323)
Q Consensus 148 ~lh~~~~~~i~h~dikp~nili~~~~~~~l~Dfg~~~~~~~ 188 (323)
.+-.. |+.|.|.+|.||+++.++++.+.|||+......
T Consensus 280 q~~~d---gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 280 QLLRD---GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred HHHhc---CccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 22334 999999999999999999999999999876654
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.09 E-value=2.2e-05 Score=61.33 Aligned_cols=127 Identities=16% Similarity=0.156 Sum_probs=89.3
Q ss_pred ccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeCCeEEE
Q 020641 22 RLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVL 101 (323)
Q Consensus 22 ~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 101 (323)
-|++|.+|.||++..... .+++|+.. .+.-+..+..|.++|..+.-.++.+=+-.+... ++
T Consensus 29 ~L~KG~~s~Vyl~~~~~~--~~a~Kvrr--------------~ds~r~~l~kEakiLeil~g~~~~p~vy~yg~~---~i 89 (201)
T COG2112 29 ELAKGTTSVVYLGEWRGG--EVALKVRR--------------RDSPRRNLEKEAKILEILAGEGVTPEVYFYGED---FI 89 (201)
T ss_pred hhhcccccEEEEeeccCc--eEEEEEec--------------CCcchhhHHHHHHHHHHhhhcCCCceEEEechh---hh
Confidence 689999999999887543 56666443 233446678899999988777776533333322 34
Q ss_pred EEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCC-CCCCEEEccCCeEEEeec
Q 020641 102 AYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDI-RSSNVLLFEDFKAKIADF 180 (323)
Q Consensus 102 v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di-kp~nili~~~~~~~l~Df 180 (323)
.|||..|-+|.+...... .+-+..+++...-|-.. ||-|+.| .|...++.+.+.+.|+||
T Consensus 90 ~me~i~G~~L~~~~~~~~----------------rk~l~~vlE~a~~LD~~---GI~H~El~~~~k~vlv~~~~~~iIDF 150 (201)
T COG2112 90 RMEYIDGRPLGKLEIGGD----------------RKHLLRVLEKAYKLDRL---GIEHGELSRPWKNVLVNDRDVYIIDF 150 (201)
T ss_pred hhhhhcCcchhhhhhccc----------------HHHHHHHHHHHHHHHHh---ccchhhhcCCceeEEecCCcEEEEEc
Confidence 499999988877764311 24455566777777778 9999999 566666666669999999
Q ss_pred cccCCC
Q 020641 181 NLSNQA 186 (323)
Q Consensus 181 g~~~~~ 186 (323)
..|+..
T Consensus 151 d~At~k 156 (201)
T COG2112 151 DSATFK 156 (201)
T ss_pred cchhhc
Confidence 998744
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.97 E-value=2e-05 Score=72.76 Aligned_cols=151 Identities=12% Similarity=0.019 Sum_probs=86.3
Q ss_pred ccCCCCCCccceeccceeeeeeeeccccccccCcccc-------------cccc------CCCCCch------HHHHHHH
Q 020641 22 RLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHEN-------------ERLK------SPKNYPD------DEKQLVS 76 (323)
Q Consensus 22 ~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~-------------~~~~------~~~~~~~------~~~~e~~ 76 (323)
-||..+.|.|+.|+... |+.||+|+........... +... ..++..+ +|.+|.+
T Consensus 168 piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 168 PIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred hhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 67889999999999887 8889999876554222100 0000 0000011 1222222
Q ss_pred HH----hcCCCCc------ccceeeEEEeCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHH
Q 020641 77 VV----SRLKHEN------LVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGL 146 (323)
Q Consensus 77 ~l----~~l~h~~------i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l 146 (323)
-. +.+.|-+ |.+++..+. ....|+|||++|..+.|.-.-.... ++...+..-+.+...-.
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~s--t~RVLtME~~~G~~i~Dl~~i~~~g--------i~~~~i~~~l~~~~~~q 316 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWDLS--TKRVLTMEYVDGIKINDLDAIDKRG--------ISPHDILNKLVEAYLEQ 316 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhhcC--cceEEEEEecCCccCCCHHHHHHcC--------CCHHHHHHHHHHHHHHH
Confidence 22 2223444 444443332 3458999999997665553222111 55544333333322222
Q ss_pred HHhhcCCCCCceeCCCCCCCEEEcc----CCeEEEeeccccCCCCc
Q 020641 147 EYLHEKVQPSIIHRDIRSSNVLLFE----DFKAKIADFNLSNQAPD 188 (323)
Q Consensus 147 ~~lh~~~~~~i~h~dikp~nili~~----~~~~~l~Dfg~~~~~~~ 188 (323)
+-.. |.+|+|-+|.||++.. ++.+.+.|||+......
T Consensus 317 --If~~---GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 317 --IFKT---GFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred --HHhc---CCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 2233 9999999999999984 67899999999876554
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.96 E-value=5.7e-05 Score=74.40 Aligned_cols=193 Identities=20% Similarity=0.227 Sum_probs=131.8
Q ss_pred HHHHHHhcCCCCcccceeeEEEeCCeE----EEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHH
Q 020641 73 QLVSVVSRLKHENLVELLGYCVEGNLR----VLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEY 148 (323)
Q Consensus 73 ~e~~~l~~l~h~~i~~~~~~~~~~~~~----~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 148 (323)
-|++.+....|+|+..++.+....... .+..+++...++.+.+..-.. ++..+...+..++.+|+.+
T Consensus 231 ~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~---------i~~~~~r~~~~~~~~GL~~ 301 (1351)
T KOG1035|consen 231 IELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGS---------IPLETLRILHQKLLEGLAY 301 (1351)
T ss_pred HHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccc---------cCHHHHHHHHHHHhhhHHH
Confidence 355566777999999998887654332 344567777777777765442 8888999999999999999
Q ss_pred hhcCCCCCceeCCCCCC---CEEEccCCeEEEe--eccccCCCCccccccccccccCccccCCCccccCCCCCc--ccch
Q 020641 149 LHEKVQPSIIHRDIRSS---NVLLFEDFKAKIA--DFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQ--KSDV 221 (323)
Q Consensus 149 lh~~~~~~i~h~dikp~---nili~~~~~~~l~--Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~--~~Di 221 (323)
+|+. .+.|.-+... +...+..+.+.+. ||+.+....+.... .....+..+.++|......... ..|+
T Consensus 302 ~h~~---~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~---~~~~~~~~~~~~e~~~~~~~~~~r~~dL 375 (1351)
T KOG1035|consen 302 LHSL---SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS---FSDLLAEIRNADEDLKENTAKKSRLTDL 375 (1351)
T ss_pred HHHh---ccceeEEecccccccccCccceeecchhhhcccccCCCcccc---hhhcCccccccccccccccchhhhhhHH
Confidence 9998 7766655554 4445556666666 88887766543322 2222455678888776555544 4799
Q ss_pred HHHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChH
Q 020641 222 YSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMS 301 (323)
Q Consensus 222 ~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ 301 (323)
|.+|.....+..|..+-.... .....++ ......+.+...+|+..++++|+++.
T Consensus 376 ~~lgll~~~~~~~~~i~~~~~------------------~~~~~l~--------~~~~~~~~d~~~~~~~~~~~~Rl~~~ 429 (1351)
T KOG1035|consen 376 WCLGLLLLQLSQGEDISEKSA------------------VPVSLLD--------VLSTSELLDALPKCLDEDSEERLSAL 429 (1351)
T ss_pred HHHHHHHhhhhhcCccccccc------------------chhhhhc--------cccchhhhhhhhhhcchhhhhccchh
Confidence 999999999998765532110 0111111 11111577889999999999999999
Q ss_pred HHHHH
Q 020641 302 IVVKA 306 (323)
Q Consensus 302 evl~~ 306 (323)
+++..
T Consensus 430 ~ll~~ 434 (1351)
T KOG1035|consen 430 ELLTH 434 (1351)
T ss_pred hhhhc
Confidence 99874
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=97.90 E-value=3.7e-05 Score=64.18 Aligned_cols=78 Identities=14% Similarity=0.190 Sum_probs=49.6
Q ss_pred ccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCC--cccceeeEEE---
Q 020641 20 FVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHE--NLVELLGYCV--- 94 (323)
Q Consensus 20 ~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~--~i~~~~~~~~--- 94 (323)
+..|+.|..+.||.+.... +++ ++|+.... .....+.+|..+++.+... .+..++....
T Consensus 2 i~~l~~G~~n~~~~v~~~~-~~~-vlK~~~~~--------------~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~ 65 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-GRY-VLKFYRPP--------------DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDE 65 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-SEE-EEEEESSH--------------HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETE
T ss_pred CccCCCCCeeeEEEEEECC-cEE-EEEEeCCC--------------CCHHHHHHHHHHHHHHHhcCCCCceEEeeccccc
Confidence 3468889999999999877 544 44432211 1235667788888777322 3556666443
Q ss_pred eCCeEEEEEeecCCCCHHH
Q 020641 95 EGNLRVLAYEFATMGSLHD 113 (323)
Q Consensus 95 ~~~~~~lv~e~~~~~sL~~ 113 (323)
.....+++|++++|.++..
T Consensus 66 ~~~~~~~~~~~i~g~~~~~ 84 (239)
T PF01636_consen 66 FNGFPYLLMEYIPGRPLDD 84 (239)
T ss_dssp ETSEEEEEEEEESSEEHHH
T ss_pred ccccceEEEEEeccccccc
Confidence 2335689999999887777
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.90 E-value=0.00015 Score=72.01 Aligned_cols=82 Identities=9% Similarity=0.108 Sum_probs=51.8
Q ss_pred cccccCCCCCCccceeccceee--eeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCC-CCcc--cceeeEE
Q 020641 19 YFVRLDKGPEDDLYLKKRVKMR--RWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLK-HENL--VELLGYC 93 (323)
Q Consensus 19 ~~~~lg~G~~~~V~~~~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i--~~~~~~~ 93 (323)
.+.+|+.|.+..+|++.....+ ..+++|...... .......+.+|+++++.+. |.++ .+++.++
T Consensus 42 ~v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~-----------~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~ 110 (822)
T PLN02876 42 KVSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGK-----------LLQSAHAVEREYQVLRALGEHTDVPVPKVYCLC 110 (822)
T ss_pred eEEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCc-----------cCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEe
Confidence 4568899999999998754432 122333221100 0011246788999999884 6665 6777777
Q ss_pred EeC---CeEEEEEeecCCCCH
Q 020641 94 VEG---NLRVLAYEFATMGSL 111 (323)
Q Consensus 94 ~~~---~~~~lv~e~~~~~sL 111 (323)
.+. +..|+||||++|..+
T Consensus 111 ~d~~v~G~~flVME~v~G~~~ 131 (822)
T PLN02876 111 TDASVIGTAFYIMEYLEGRIF 131 (822)
T ss_pred cCCCcCCCceEEEEecCCccc
Confidence 654 357899999987543
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.82 E-value=0.00016 Score=58.37 Aligned_cols=136 Identities=25% Similarity=0.348 Sum_probs=90.8
Q ss_pred CCCccccccCCCCC-CccceeccceeeeeeeeccccccccC----------ccccccccCCCCCchHHHHHHHHHhcCC-
Q 020641 15 PSPGYFVRLDKGPE-DDLYLKKRVKMRRWLCCTCQVEESYP----------SHENERLKSPKNYPDDEKQLVSVVSRLK- 82 (323)
Q Consensus 15 ~~~~~~~~lg~G~~-~~V~~~~~~~~~~~~~~k~~~~~~~~----------~~~~~~~~~~~~~~~~~~~e~~~l~~l~- 82 (323)
...++++.||.|.- |.||+++. .++.+|+|+...-.+. .... .+.+...+..-|.+|.+...+++
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I--~g~~YALKlf~~~~~~~~~~~~~~~~~~~~-~~~~~~~y~~PF~~ECRAfgRLke 113 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI--DGRIYALKLFRFWDYTEPDYTRERFAGHET-SLSTPAHYADPFNCECRAFGRLKE 113 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE--CCeEEEEEEeeccccCCCcccccccccccc-ccchhhhhcChHHHHHHhhHHHHh
Confidence 56677789999999 99999887 5568999982211111 1111 22333456778999999887773
Q ss_pred --CCcc--cceeeEEEeC------------------CeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHH
Q 020641 83 --HENL--VELLGYCVEG------------------NLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAV 140 (323)
Q Consensus 83 --h~~i--~~~~~~~~~~------------------~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 140 (323)
+.++ ++++++..-. ....+|.||..... . ++ ..-+.
T Consensus 114 ~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~--------~----------~~----~~~~~ 171 (207)
T PF13095_consen 114 AGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP--------P----------LQ----IRDIP 171 (207)
T ss_pred ccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc--------c----------cc----hhHHH
Confidence 4455 8888877422 12245666554422 0 22 24456
Q ss_pred HHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEEEeecccc
Q 020641 141 DAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLS 183 (323)
Q Consensus 141 ~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~l~Dfg~~ 183 (323)
+|..-+..+|+. ||+-+|+++.|.. .-+|+|||.+
T Consensus 172 ~~~~dl~~~~k~---gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 172 QMLRDLKILHKL---GIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHHHHHHHHHC---CeeeccCcccccc-----CCEEEecccC
Confidence 677788899999 9999999999987 3578899864
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.76 E-value=0.00032 Score=58.76 Aligned_cols=29 Identities=24% Similarity=0.421 Sum_probs=26.0
Q ss_pred CceeCCCCCCCEEEcc-CCeEEEeeccccC
Q 020641 156 SIIHRDIRSSNVLLFE-DFKAKIADFNLSN 184 (323)
Q Consensus 156 ~i~h~dikp~nili~~-~~~~~l~Dfg~~~ 184 (323)
+++|+|+.+.||++++ ++.+.++||..+.
T Consensus 171 ~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~ 200 (235)
T cd05157 171 VFCHNDLLSGNIIYNEEKNSVKFIDYEYAG 200 (235)
T ss_pred EEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence 7999999999999998 5789999998764
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.75 E-value=0.00028 Score=59.24 Aligned_cols=31 Identities=23% Similarity=0.380 Sum_probs=26.1
Q ss_pred CCceeCCCCCCCEEEccCCeEEEeeccccCC
Q 020641 155 PSIIHRDIRSSNVLLFEDFKAKIADFNLSNQ 185 (323)
Q Consensus 155 ~~i~h~dikp~nili~~~~~~~l~Dfg~~~~ 185 (323)
.+++|+|+.+.|++++.+...-++||+.+..
T Consensus 164 ~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~ 194 (235)
T cd05155 164 PVWFHGDLAPGNLLVQDGRLSAVIDFGCLGV 194 (235)
T ss_pred ceEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence 3699999999999998776667999997644
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.70 E-value=0.00037 Score=59.28 Aligned_cols=29 Identities=17% Similarity=0.363 Sum_probs=25.6
Q ss_pred CceeCCCCCCCEEEccCCeEEEeeccccCC
Q 020641 156 SIIHRDIRSSNVLLFEDFKAKIADFNLSNQ 185 (323)
Q Consensus 156 ~i~h~dikp~nili~~~~~~~l~Dfg~~~~ 185 (323)
.++|+|+.|.||+++.++ +.++||+.+..
T Consensus 147 ~l~H~Dl~~~Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 147 APLHMDVHAYNLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred eeecCCCCcCcEEEeCCC-CEEEeccccCc
Confidence 689999999999999876 78999997754
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.42 E-value=0.0022 Score=55.75 Aligned_cols=75 Identities=15% Similarity=0.021 Sum_probs=50.0
Q ss_pred cccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcC-CC--CcccceeeEEEeC-
Q 020641 21 VRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRL-KH--ENLVELLGYCVEG- 96 (323)
Q Consensus 21 ~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h--~~i~~~~~~~~~~- 96 (323)
..||.|..+.||....... + +.+|+.. . ......+..|.+.++.+ ++ -.+.++++++..+
T Consensus 20 ~~i~~G~~~~vy~~~~~~~-~-~~~k~~~-~-------------~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~ 83 (297)
T PRK10593 20 ECISEQPYAALWALYDSQG-N-PMPLMAR-S-------------FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQ 83 (297)
T ss_pred eecCCccceeEEEEEcCCC-C-EEEEEec-c-------------cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCC
Confidence 4789999999999865443 2 2333221 0 01125678888888877 33 3577888877543
Q ss_pred --CeEEEEEeecCCCCH
Q 020641 97 --NLRVLAYEFATMGSL 111 (323)
Q Consensus 97 --~~~~lv~e~~~~~sL 111 (323)
+..++|||++++.++
T Consensus 84 ~~g~~~LVmE~i~G~~~ 100 (297)
T PRK10593 84 SPGPDVLLLERLRGVSV 100 (297)
T ss_pred cCCCeEEEEeccCCEec
Confidence 568999999988654
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.33 E-value=0.0013 Score=57.63 Aligned_cols=151 Identities=17% Similarity=0.157 Sum_probs=96.7
Q ss_pred ccCCCCCCccceeccceeeeeeeeccccccccCcccccccc---------CCCCCc-hH----HHHHHHHHhcCCCCccc
Q 020641 22 RLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLK---------SPKNYP-DD----EKQLVSVVSRLKHENLV 87 (323)
Q Consensus 22 ~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~---------~~~~~~-~~----~~~e~~~l~~l~h~~i~ 87 (323)
-|..|--+.||.|....+.. +|+|++....+.-....+.. ..+.+. +. ...|++-|.++....|.
T Consensus 151 CiSTGKEANVYHat~~dG~~-~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGIP 229 (520)
T KOG2270|consen 151 CISTGKEANVYHATEEDGSE-FAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGIP 229 (520)
T ss_pred ccccCccceeEeeecCCCce-EEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCCC
Confidence 46778999999998877666 88887765553322211111 111111 11 12466667777665554
Q ss_pred ceeeEEEeCCeEEEEEeecCCC-CHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCC
Q 020641 88 ELLGYCVEGNLRVLAYEFATMG-SLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSN 166 (323)
Q Consensus 88 ~~~~~~~~~~~~~lv~e~~~~~-sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~n 166 (323)
-.--..... ..|||+|+... -..-.+++. .++...+..+-.+++.-+.-|.+.| +++|.||+--|
T Consensus 230 ~PePIlLk~--hVLVM~FlGrdgw~aPkLKd~----------~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN 295 (520)
T KOG2270|consen 230 CPEPILLKN--HVLVMEFLGRDGWAAPKLKDA----------SLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFN 295 (520)
T ss_pred CCCceeeec--ceEeeeeccCCCCcCcccccc----------cCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhh
Confidence 332222222 37899998531 111112221 2777788888888999999998888 99999999999
Q ss_pred EEEccCCeEEEeeccccCCCCc
Q 020641 167 VLLFEDFKAKIADFNLSNQAPD 188 (323)
Q Consensus 167 ili~~~~~~~l~Dfg~~~~~~~ 188 (323)
+|+.+ |.++++|-+.+.....
T Consensus 296 ~Lyhd-G~lyiIDVSQSVE~DH 316 (520)
T KOG2270|consen 296 LLYHD-GKLYIIDVSQSVEHDH 316 (520)
T ss_pred heEEC-CEEEEEEccccccCCC
Confidence 99965 5899999988765543
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.22 E-value=0.0024 Score=55.74 Aligned_cols=32 Identities=25% Similarity=0.436 Sum_probs=27.4
Q ss_pred CCCceeCCCCCCCEEEccC----CeEEEeeccccCC
Q 020641 154 QPSIIHRDIRSSNVLLFED----FKAKIADFNLSNQ 185 (323)
Q Consensus 154 ~~~i~h~dikp~nili~~~----~~~~l~Dfg~~~~ 185 (323)
...++|+|+.+.||+++.+ +.+.++||..+..
T Consensus 178 ~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~ 213 (302)
T cd05156 178 PVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY 213 (302)
T ss_pred CceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence 4478999999999999984 7899999997643
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.13 E-value=0.0033 Score=54.70 Aligned_cols=31 Identities=29% Similarity=0.400 Sum_probs=27.0
Q ss_pred CCceeCCCCCCCEEEccCCeEEEeeccccCC
Q 020641 155 PSIIHRDIRSSNVLLFEDFKAKIADFNLSNQ 185 (323)
Q Consensus 155 ~~i~h~dikp~nili~~~~~~~l~Dfg~~~~ 185 (323)
.+++|+|+.|.|+++++++.+.|+||+.+..
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred CcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 3799999999999999987778999987654
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.86 E-value=0.012 Score=53.12 Aligned_cols=83 Identities=10% Similarity=-0.027 Sum_probs=50.0
Q ss_pred ccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcC-C--CCcccceeeEEEeC
Q 020641 20 FVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRL-K--HENLVELLGYCVEG 96 (323)
Q Consensus 20 ~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~--h~~i~~~~~~~~~~ 96 (323)
...||.|-+..||++.+..+++.+.+|..... .... ...-.-..++...|.+.|+.+ . ..++.+++.+ +.
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~-~r~~----g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~ 103 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPY-VRVV----GESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DE 103 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcc-cccc----cccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CC
Confidence 45789999999999998765445666643211 0000 000011235677788888776 2 2456666665 33
Q ss_pred CeEEEEEeecCCC
Q 020641 97 NLRVLAYEFATMG 109 (323)
Q Consensus 97 ~~~~lv~e~~~~~ 109 (323)
...++|||++++.
T Consensus 104 ~~~~lVME~L~~~ 116 (401)
T PRK09550 104 ELAVTVMEDLSDH 116 (401)
T ss_pred CCCEEEEecCCCc
Confidence 4578999998763
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.30 E-value=0.03 Score=49.87 Aligned_cols=29 Identities=21% Similarity=0.430 Sum_probs=25.5
Q ss_pred CceeCCCCCCCEEEcc-CCeEEEeeccccC
Q 020641 156 SIIHRDIRSSNVLLFE-DFKAKIADFNLSN 184 (323)
Q Consensus 156 ~i~h~dikp~nili~~-~~~~~l~Dfg~~~ 184 (323)
.++|+|+++.||++++ ++.+.++||..+.
T Consensus 201 ~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 201 GFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred eEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 6899999999999986 4689999998764
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.29 E-value=0.054 Score=47.30 Aligned_cols=34 Identities=21% Similarity=0.430 Sum_probs=29.4
Q ss_pred CCCceeCCCCCCCEEEccCCeEEEeeccccCCCC
Q 020641 154 QPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAP 187 (323)
Q Consensus 154 ~~~i~h~dikp~nili~~~~~~~l~Dfg~~~~~~ 187 (323)
...++|+|+++.|++++...-+-++||+++....
T Consensus 197 ~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGD 230 (321)
T COG3173 197 PPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGD 230 (321)
T ss_pred CceeeeCCcccCCEEEeCCCeeEEEeccccccCC
Confidence 3468999999999999999889999999886543
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.24 E-value=0.0041 Score=53.73 Aligned_cols=139 Identities=15% Similarity=0.149 Sum_probs=85.6
Q ss_pred ccCCCCCCccceeccceeeeeeeeccccccccCcccc--cc----ccCCCCCc----hHHHHHHHHHhcC-CC-Ccccce
Q 020641 22 RLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHEN--ER----LKSPKNYP----DDEKQLVSVVSRL-KH-ENLVEL 89 (323)
Q Consensus 22 ~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~--~~----~~~~~~~~----~~~~~e~~~l~~l-~h-~~i~~~ 89 (323)
+||-|--+.||.+-+... +..++|+.......-... ++ ....-.|. -...+|+..|+.+ .| --+.+.
T Consensus 99 qIGVGKESDIY~v~d~~G-~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfpVPkp 177 (465)
T KOG2268|consen 99 QIGVGKESDIYVVADEEG-NPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFPVPKP 177 (465)
T ss_pred ccccccccceEEEecCCC-CchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCCCCCc
Confidence 788899999998887644 344555332221110000 00 00001121 1234677777776 33 234445
Q ss_pred eeEEEeCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEE
Q 020641 90 LGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLL 169 (323)
Q Consensus 90 ~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili 169 (323)
++ .+..++|||+..+..|.....-. ....+...+..-|--|-+. |++|+|.+-=||++
T Consensus 178 iD----~~RH~Vvmelv~g~Pl~~v~~v~---------------d~~~ly~~lm~~Iv~la~~---GlIHgDFNEFNimv 235 (465)
T KOG2268|consen 178 ID----HNRHCVVMELVDGYPLRQVRHVE---------------DPPTLYDDLMGLIVRLANH---GLIHGDFNEFNIMV 235 (465)
T ss_pred cc----ccceeeHHHhhcccceeeeeecC---------------ChHHHHHHHHHHHHHHHHc---CceecccchheeEE
Confidence 44 34568999999988886664321 2224555555666777788 99999999999999
Q ss_pred ccCCeEEEeecccc
Q 020641 170 FEDFKAKIADFNLS 183 (323)
Q Consensus 170 ~~~~~~~l~Dfg~~ 183 (323)
++++.++++||-..
T Consensus 236 ~dd~~i~vIDFPQm 249 (465)
T KOG2268|consen 236 KDDDKIVVIDFPQM 249 (465)
T ss_pred ecCCCEEEeechHh
Confidence 99999999999643
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.12 E-value=0.037 Score=49.00 Aligned_cols=30 Identities=30% Similarity=0.402 Sum_probs=25.5
Q ss_pred CceeCCCCCCCEEEcc-CCeEEEeeccccCC
Q 020641 156 SIIHRDIRSSNVLLFE-DFKAKIADFNLSNQ 185 (323)
Q Consensus 156 ~i~h~dikp~nili~~-~~~~~l~Dfg~~~~ 185 (323)
-++|+|+.+.||++++ ++.++++||+.|..
T Consensus 183 v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 183 VFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred EEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 3799999999999975 46899999997643
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=96.01 E-value=0.00029 Score=71.58 Aligned_cols=158 Identities=11% Similarity=-0.008 Sum_probs=108.2
Q ss_pred HHHHHhcCCCCcccceeeEEE--eCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhc
Q 020641 74 LVSVVSRLKHENLVELLGYCV--EGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHE 151 (323)
Q Consensus 74 e~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~ 151 (323)
|...++...|+++.....-.. +....|..++++.+|.+++.+.+....... +...-+.....+......-+|.
T Consensus 1279 e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~-----ld~~~v~~~~kvsvl~~~~~ls 1353 (2724)
T KOG1826|consen 1279 ERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPD-----LDRSPVHLRHKVSVLNRNVILS 1353 (2724)
T ss_pred hhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCc-----chhchHHHHHHHHHhccchhhh
Confidence 333445557777766544333 233458889999999999999766533211 3333333444444555555555
Q ss_pred CC--CCCceeCCCCCCCEEEccCCeEEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHH
Q 020641 152 KV--QPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLL 229 (323)
Q Consensus 152 ~~--~~~i~h~dikp~nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~ 229 (323)
.. ..--+|+++++.|.+|..+.++++.++|+.+...... ...+...+++.|++|++...-.++.++|+|..|+.+|
T Consensus 1354 ~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~--sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly 1431 (2724)
T KOG1826|consen 1354 LTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVL--SFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLY 1431 (2724)
T ss_pred cccCCccchhhhhhhhccceecCCcccccccccccccCchH--hhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHH
Confidence 43 2235799999999999999999999999998433221 1223344677888888877778888899999999999
Q ss_pred HHHhCCCCC
Q 020641 230 ELLTGRKPV 238 (323)
Q Consensus 230 ~l~~g~~pf 238 (323)
..--|..+|
T Consensus 1432 ~rs~~n~~f 1440 (2724)
T KOG1826|consen 1432 LRSDGNAYF 1440 (2724)
T ss_pred HHhcccHHH
Confidence 988887776
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.93 E-value=0.0099 Score=54.48 Aligned_cols=50 Identities=26% Similarity=0.317 Sum_probs=39.0
Q ss_pred hHHHHHHHHHhcCCCCcccceeeEEEeC-CeEEEEEeecCCCCHHHHhccCC
Q 020641 69 DDEKQLVSVVSRLKHENLVELLGYCVEG-NLRVLAYEFATMGSLHDILHGRK 119 (323)
Q Consensus 69 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~sL~~~~~~~~ 119 (323)
..+......++.+.|+|....+++-... ....+|+|++.. ||.+....+.
T Consensus 27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~~~-Sled~~~~~~ 77 (725)
T KOG1093|consen 27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHYTM-SLEDILKTGN 77 (725)
T ss_pred HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhhcc-chHHHHHhcc
Confidence 4455667788999999999998877633 357889999965 9999987664
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=95.92 E-value=0.03 Score=48.38 Aligned_cols=75 Identities=12% Similarity=0.066 Sum_probs=41.9
Q ss_pred ccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcC---CCCcccceeeEEE
Q 020641 18 GYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRL---KHENLVELLGYCV 94 (323)
Q Consensus 18 ~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~ 94 (323)
..+..++.|....+|.+.. +++.+.+|+.. ......+..|.+-|+.+ ..-.+.+++.+..
T Consensus 20 ~~~~~v~GG~i~~a~~~~~--~~~~~FvK~~~---------------~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~ 82 (288)
T PF03881_consen 20 TSIEPVSGGDINEAYRLDT--DGGSYFVKVNS---------------ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGE 82 (288)
T ss_dssp -EEEEE--SSSSEEEEEET--TS-EEEEEEEE---------------GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE
T ss_pred eeeEecCCCChhheEEEEC--CCccEEEEecC---------------hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEe
Confidence 3445788888899998883 33344455332 11224566677766666 3456778999988
Q ss_pred eCCeEEEEEeecCCC
Q 020641 95 EGNLRVLAYEFATMG 109 (323)
Q Consensus 95 ~~~~~~lv~e~~~~~ 109 (323)
..+..++|+||++.+
T Consensus 83 ~~~~~fLlle~l~~~ 97 (288)
T PF03881_consen 83 YDDDAFLLLEFLEMG 97 (288)
T ss_dssp -SSCCEEEEE-----
T ss_pred ecCCceEEEEeecCC
Confidence 877789999998765
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=95.29 E-value=0.069 Score=43.84 Aligned_cols=121 Identities=15% Similarity=0.059 Sum_probs=72.8
Q ss_pred hHHHHHHHHHhcCCCCcccceeeEEEeCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHH
Q 020641 69 DDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEY 148 (323)
Q Consensus 69 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 148 (323)
.-+..+.+++.++ -.|+++..- .+..+-+|.|.|-.... . .. .++..=++++.-
T Consensus 103 ~~y~nky~v~Arm--hGilrL~ND--n~~~yGvIlE~Cy~~~i------------------~---~~-N~i~agi~~L~~ 156 (308)
T PF07387_consen 103 ALYFNKYRVFARM--HGILRLKND--NNYKYGVILERCYKIKI------------------N---FS-NFITAGIKDLMD 156 (308)
T ss_pred hhhhhhhhHHHHh--hheeEeecC--CCceeEEEEeeccCccc------------------c---hh-HHHHHhHHHHHH
Confidence 4456677777743 346666532 45567889998854211 0 00 111111456777
Q ss_pred hhcCCCCCceeCCCCCCCEEEccCCeEEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHH
Q 020641 149 LHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVL 228 (323)
Q Consensus 149 lh~~~~~~i~h~dikp~nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l 228 (323)
.|+. +.+.+|+|..|+||+-++.|.+||.|-+.... +. ..|.-- .....+.++.+-+|-..+
T Consensus 157 fH~~-~~~~lHGD~np~NiM~D~~G~lKlVDP~~Ll~--~~------------V~~vN~---~Y~~lT~~aE~~~fv~s~ 218 (308)
T PF07387_consen 157 FHSE-NQHCLHGDCNPDNIMCDKFGYLKLVDPVCLLE--NQ------------VNMVNI---EYESLTQEAEVKVFVKSC 218 (308)
T ss_pred hhcc-CCCeecCCCChhheeecCCCCEEecChhhhhh--he------------eeEEee---eccccChHHHHHHHHHHH
Confidence 8853 44899999999999999999999999775421 11 111111 123345666776766666
Q ss_pred HHHHh
Q 020641 229 LELLT 233 (323)
Q Consensus 229 ~~l~~ 233 (323)
+++..
T Consensus 219 l~~v~ 223 (308)
T PF07387_consen 219 LKLVE 223 (308)
T ss_pred HHHHH
Confidence 66665
|
The function of this family is unknown. |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=95.10 E-value=0.34 Score=43.87 Aligned_cols=88 Identities=7% Similarity=-0.039 Sum_probs=49.7
Q ss_pred cccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCC---CCcccceeeEEEe
Q 020641 19 YFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLK---HENLVELLGYCVE 95 (323)
Q Consensus 19 ~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~ 95 (323)
....||.|-.-.||++.+. .+. +.+|.......... ..-.....+...|.+.|+.+. ...+.+++.++.+
T Consensus 36 ~~~eiggGn~N~VyrV~~~-~~s-vVVKqa~p~~r~vg-----a~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded 108 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVSS-SGS-FVIKQALPYIRCIG-----ESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRT 108 (418)
T ss_pred eEEEcCCCceeeEEEEEcC-Ccc-EEEEeCCccccCCC-----ccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCC
Confidence 4557899999999999873 333 45553331111000 000012344555566666552 3477788887774
Q ss_pred CCeEEEEEeecCC--CCHHHHh
Q 020641 96 GNLRVLAYEFATM--GSLHDIL 115 (323)
Q Consensus 96 ~~~~~lv~e~~~~--~sL~~~~ 115 (323)
. .+++||++++ ..+.+.+
T Consensus 109 ~--~vlvME~L~~~~~ilr~~L 128 (418)
T PLN02756 109 M--ALIGMRYLEPPHIILRKGL 128 (418)
T ss_pred C--CEEEEeecCCcceehhhhh
Confidence 3 5788999976 2344444
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.03 E-value=0.2 Score=45.17 Aligned_cols=28 Identities=25% Similarity=0.393 Sum_probs=23.8
Q ss_pred CceeCCCCCCCEEEccCCeEEEeeccccC
Q 020641 156 SIIHRDIRSSNVLLFEDFKAKIADFNLSN 184 (323)
Q Consensus 156 ~i~h~dikp~nili~~~~~~~l~Dfg~~~ 184 (323)
..+|.|+.+.||+.++ ..++++||..|.
T Consensus 228 VfCHNDL~~gNIL~~~-~~l~lID~EYA~ 255 (383)
T PTZ00384 228 LFCHNDLFFTNILDFN-QGIYFIDFDFAG 255 (383)
T ss_pred eeeeccCCcccEEecC-CCEEEEEecccc
Confidence 7899999999999765 469999998764
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=94.80 E-value=0.12 Score=45.78 Aligned_cols=53 Identities=21% Similarity=0.244 Sum_probs=46.1
Q ss_pred CCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEEEeeccccCC
Q 020641 130 LDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQ 185 (323)
Q Consensus 130 ~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~l~Dfg~~~~ 185 (323)
..+.++..++++.+..++-+.++- ..-|||+..+||+|+ +|++-|+||-+++.
T Consensus 318 ~~~~e~lsff~s~~sil~~lekkf--~fehrnlt~~niLId-~GnvtLIDfklsRl 370 (488)
T COG5072 318 DRSEEELSFFWSCISILDILEKKF--PFEHRNLTLDNILID-EGNVTLIDFKLSRL 370 (488)
T ss_pred ccHHHHHHHHHHHHHHHhhhhhcC--Ccccccccccceeee-cCceEEEEeeeeec
Confidence 567788899999888888887653 788999999999999 99999999999873
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=94.67 E-value=0.43 Score=42.47 Aligned_cols=29 Identities=21% Similarity=0.452 Sum_probs=24.6
Q ss_pred CceeCCCCCCCEEEccCCeEEEeeccccCC
Q 020641 156 SIIHRDIRSSNVLLFEDFKAKIADFNLSNQ 185 (323)
Q Consensus 156 ~i~h~dikp~nili~~~~~~~l~Dfg~~~~ 185 (323)
.++|+|+.+.||+++.+ .++++|+..+..
T Consensus 193 ~llHGDl~~gNi~~~~~-~~~~iD~e~~~~ 221 (370)
T TIGR01767 193 TLLHGDLHSGSIFVSEH-ETKVIDPEFAFY 221 (370)
T ss_pred eeeeccCCcccEEEcCC-CCEEEcCccccc
Confidence 79999999999999776 477999986644
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PHA00451 protein kinase | Back alignment and domain information |
|---|
Probab=94.50 E-value=0.066 Score=44.62 Aligned_cols=130 Identities=11% Similarity=0.049 Sum_probs=72.3
Q ss_pred ccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcC--CCCcccceeeEEEeCC
Q 020641 20 FVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRL--KHENLVELLGYCVEGN 97 (323)
Q Consensus 20 ~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l--~h~~i~~~~~~~~~~~ 97 (323)
|..||.|.|+..|.-.-..++. +|+-.++.-.. . -.....++ ..+.|..++.+-....
T Consensus 70 F~~LGNGHFSAAy~H~lLPgrV---IKVGFKKEDSG-------------A----AYtAFCRM~QGR~GIPnVY~VaRHaG 129 (362)
T PHA00451 70 FNLLGNGHFSAAYSHELLPGRV---IKVGFKKEDSG-------------A----AYTAFCRMHQGRAGIPNVYHVARHAG 129 (362)
T ss_pred HHHhcCcchhhHhhcccCCCee---EEecccccccc-------------H----HHHHHHHHhcCCCCCccHHHHHHhcC
Confidence 4689999999999877666643 33222221111 1 12223333 5788888888877778
Q ss_pred eEEEEEeecCCC------------CHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCC
Q 020641 98 LRVLAYEFATMG------------SLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSS 165 (323)
Q Consensus 98 ~~~lv~e~~~~~------------sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~ 165 (323)
.+.+|++++... .+..++.+........ ...+. ..+..+..| ...- . ||..-|....
T Consensus 130 CYTVVLD~L~~C~r~~nd~h~~ya~~a~~~~e~~~d~~~~--~~~~~-~FIETCk~I----RkFF-~---GIASFDmHSG 198 (362)
T PHA00451 130 CYTVVLDYLNPCYRESNDVHHHYAAAAYIIIECCSDAAEE--YPGSQ-EFIETCKMI----RKFF-Y---GIASFDMHSG 198 (362)
T ss_pred ceEEehhhccccccccchHHHHHHHHHHHHHhccCCHHhc--cCCch-hHHHHHHHH----HHHH-h---hhhcccccCC
Confidence 888888876431 1222232222111000 00111 111222211 1111 1 7778899999
Q ss_pred CEEEccCCeEEEeec
Q 020641 166 NVLLFEDFKAKIADF 180 (323)
Q Consensus 166 nili~~~~~~~l~Df 180 (323)
||+++.++..+|+|-
T Consensus 199 NiMf~~~g~p~ITDP 213 (362)
T PHA00451 199 NIMFDQDGVPYITDP 213 (362)
T ss_pred ceeeCCCCCeEecCC
Confidence 999999999999984
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=94.43 E-value=0.075 Score=46.48 Aligned_cols=31 Identities=29% Similarity=0.406 Sum_probs=27.1
Q ss_pred CCceeCCCCCCCEEEccCCeEEEeeccccCC
Q 020641 155 PSIIHRDIRSSNVLLFEDFKAKIADFNLSNQ 185 (323)
Q Consensus 155 ~~i~h~dikp~nili~~~~~~~l~Dfg~~~~ 185 (323)
.+++|+|+++.|++++.++.+.++||+.+..
T Consensus 187 ~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~ 217 (307)
T TIGR00938 187 RGVIHADLFPDNVLFDGDSVKGVIDFYFACT 217 (307)
T ss_pred CccCCCCCCcCcEEEECCceEEEeecccccC
Confidence 3899999999999999987778999997643
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PRK10271 thiK thiamine kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.15 E-value=0.052 Score=43.51 Aligned_cols=30 Identities=13% Similarity=0.325 Sum_probs=26.1
Q ss_pred CceeCCCCCCCEEEccCCeEEEeeccccCCC
Q 020641 156 SIIHRDIRSSNVLLFEDFKAKIADFNLSNQA 186 (323)
Q Consensus 156 ~i~h~dikp~nili~~~~~~~l~Dfg~~~~~ 186 (323)
..+|+|+.|.|+++++++ ++++||+.+...
T Consensus 78 ~p~H~D~~~~N~~~~~~~-~~lIDwe~a~~g 107 (188)
T PRK10271 78 APLHMDVHAGNLVHSASG-LRLIDWEYAGDG 107 (188)
T ss_pred eeecCCCCCccEEEECCC-EEEEeCCcccCC
Confidence 579999999999998877 889999987653
|
|
| >COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism] | Back alignment and domain information |
|---|
Probab=93.90 E-value=0.13 Score=44.04 Aligned_cols=49 Identities=18% Similarity=0.236 Sum_probs=36.1
Q ss_pred HHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEEEeeccccCCC
Q 020641 137 RIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQA 186 (323)
Q Consensus 137 ~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~l~Dfg~~~~~ 186 (323)
+.+..+-..+.-.+.. ..-++|+|+.|+|++.++.+.++|+||..|...
T Consensus 136 ~~~~~l~~~l~~~~~~-~~v~cH~Dl~~~N~l~t~~~~l~LIDWEyAg~~ 184 (269)
T COG0510 136 KKLKELRRALEEVPKD-DLVPCHNDLNPGNLLLTDKGGLFLIDWEYAGLN 184 (269)
T ss_pred HHHHHHHHHhhhcCCC-ceeeecCCCCccceEEcCCCcEEEEecccCCCc
Confidence 3444555555555543 125899999999999999999999999877543
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=93.78 E-value=0.053 Score=47.67 Aligned_cols=31 Identities=29% Similarity=0.399 Sum_probs=26.3
Q ss_pred CCceeCCCCCCCEEEccCCeEEEeeccccCC
Q 020641 155 PSIIHRDIRSSNVLLFEDFKAKIADFNLSNQ 185 (323)
Q Consensus 155 ~~i~h~dikp~nili~~~~~~~l~Dfg~~~~ 185 (323)
.+++|+|+.|.||+++.+...-++||+.+..
T Consensus 187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 187 RGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred cccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 3899999999999999765568999997654
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=93.77 E-value=0.15 Score=44.52 Aligned_cols=29 Identities=24% Similarity=0.408 Sum_probs=25.1
Q ss_pred CCceeCCCCCCCEEEccCCeEEEeeccccC
Q 020641 155 PSIIHRDIRSSNVLLFEDFKAKIADFNLSN 184 (323)
Q Consensus 155 ~~i~h~dikp~nili~~~~~~~l~Dfg~~~ 184 (323)
.+++|+|+.+.|++++. +.+.++||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 38999999999999988 578999998553
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=93.40 E-value=0.41 Score=43.09 Aligned_cols=62 Identities=16% Similarity=0.089 Sum_probs=42.7
Q ss_pred EEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccC
Q 020641 99 RVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFED 172 (323)
Q Consensus 99 ~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~ 172 (323)
..++=+|..|.++..+++... .++....+++.-..+|+.-+---. +.+|.|++|.||++.-+
T Consensus 320 ~vl~E~~~~Gl~v~~~v~~~~----------~pe~l~kkva~lg~~AllkMl~vD--NFvHaDlHPGNVlirf~ 381 (565)
T KOG1236|consen 320 LVLVETYERGLSVLRFVKWKS----------QPEALVKKVAKLGVNALLKMLIVD--NFVHADLHPGNVLIRFN 381 (565)
T ss_pred ceeeeeccccccHHhhhhccc----------ChHHHHHHHHHHHHHHHHHHHHhh--cceecccCCCcEEEEec
Confidence 356666778889998887654 444555566665666654443322 89999999999999543
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=92.89 E-value=0.13 Score=42.22 Aligned_cols=29 Identities=28% Similarity=0.526 Sum_probs=20.8
Q ss_pred CceeCCCCCCCEEE-ccCCeEEEeeccccC
Q 020641 156 SIIHRDIRSSNVLL-FEDFKAKIADFNLSN 184 (323)
Q Consensus 156 ~i~h~dikp~nili-~~~~~~~l~Dfg~~~ 184 (323)
.++|+|+.+.||++ +.++.++++||..+.
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~ 173 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAG 173 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-E
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHh
Confidence 68999999999999 888999999998763
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >smart00587 CHK ZnF_C4 abd HLH domain containing kinases domain | Back alignment and domain information |
|---|
Probab=91.89 E-value=0.5 Score=38.33 Aligned_cols=30 Identities=27% Similarity=0.424 Sum_probs=25.2
Q ss_pred CceeCCCCCCCEEEccCC-----eEEEeeccccCC
Q 020641 156 SIIHRDIRSSNVLLFEDF-----KAKIADFNLSNQ 185 (323)
Q Consensus 156 ~i~h~dikp~nili~~~~-----~~~l~Dfg~~~~ 185 (323)
.++|+|+.+.|+++..++ .+.++||..+..
T Consensus 121 vl~HgD~~~~N~~~~~~~~~~~~~~~liDfq~~~~ 155 (196)
T smart00587 121 VLNHGDLWANNIMFKYDDEGKPEDVALIDFQLSHY 155 (196)
T ss_pred EEeeCCCCccceeeccCCCCCccceEEEecccCCc
Confidence 789999999999997543 689999997643
|
subfamily of choline kinases |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=91.49 E-value=0.33 Score=42.47 Aligned_cols=32 Identities=16% Similarity=0.218 Sum_probs=28.4
Q ss_pred CCCceeCCCCCCCEEEccCCeEEEeeccccCC
Q 020641 154 QPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQ 185 (323)
Q Consensus 154 ~~~i~h~dikp~nili~~~~~~~l~Dfg~~~~ 185 (323)
..+++|+|+.++|++++.++.+.++||..+..
T Consensus 195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 195 RTVLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred ceeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 44899999999999999998999999987754
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly | Back alignment and domain information |
|---|
Probab=91.43 E-value=0.24 Score=43.46 Aligned_cols=53 Identities=23% Similarity=0.323 Sum_probs=32.9
Q ss_pred HHHHHHHHHHHHHHhhc-CCCCCceeCCCCCCCEEEccCC------------------eEEEeeccccCCCC
Q 020641 135 RVRIAVDAARGLEYLHE-KVQPSIIHRDIRSSNVLLFEDF------------------KAKIADFNLSNQAP 187 (323)
Q Consensus 135 ~~~~~~~i~~~l~~lh~-~~~~~i~h~dikp~nili~~~~------------------~~~l~Dfg~~~~~~ 187 (323)
++-+..|++--.--+-. .|..+.+|.||||+|||+-++. .++|.||..+....
T Consensus 277 vkfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~~~~vF~Epi~~~LnDFDfSqv~~ 348 (434)
T PF05445_consen 277 VKFIFLQIALLYIKIYELPCCTNFLHVDLKPDNILIFDSKEPIRIKFGNRNYVFKEPIRCCLNDFDFSQVAN 348 (434)
T ss_pred HHHHHHHHHHHHeeeecCCCcceeeecccCcCcEEEecCCCceEEEECCeEEEecccceeeecccCHHHhcc
Confidence 34455666443322322 2345799999999999995432 36777887775443
|
; GO: 0004672 protein kinase activity, 0005524 ATP binding |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=90.67 E-value=0.24 Score=42.59 Aligned_cols=30 Identities=20% Similarity=0.468 Sum_probs=25.4
Q ss_pred CceeCCCCCCCEEEccCCe-EEEeeccccCC
Q 020641 156 SIIHRDIRSSNVLLFEDFK-AKIADFNLSNQ 185 (323)
Q Consensus 156 ~i~h~dikp~nili~~~~~-~~l~Dfg~~~~ 185 (323)
.++|+|+++.||+++++++ .-|+||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 6899999999999997555 56999998754
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 323 | ||||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 8e-38 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 1e-37 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-36 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 1e-35 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-32 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-32 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-32 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 3e-32 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 3e-23 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 7e-23 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-20 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-18 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 1e-18 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 5e-18 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 6e-18 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-17 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-17 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 3e-17 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 4e-17 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 5e-17 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 5e-17 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 5e-17 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 6e-17 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 6e-17 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 6e-17 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 7e-17 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 7e-17 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 8e-17 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 8e-17 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 8e-17 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 9e-17 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-16 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 1e-16 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-16 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-16 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 1e-16 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 1e-16 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 1e-16 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 1e-16 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-16 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 1e-16 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-16 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-16 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-16 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-16 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-16 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-16 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-16 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-16 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 3e-16 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 3e-16 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 3e-16 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-16 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-16 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 3e-16 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 4e-16 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 5e-16 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 5e-16 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 5e-16 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 6e-16 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 7e-16 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 7e-16 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 8e-16 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-15 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-15 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 3e-15 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-15 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 4e-15 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 4e-15 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 4e-15 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 5e-15 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-15 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-15 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 7e-15 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 9e-15 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-14 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 1e-14 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-14 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-14 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-14 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-14 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 3e-14 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 3e-14 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 3e-14 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 3e-14 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 3e-14 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 3e-14 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 3e-14 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 3e-14 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-14 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 4e-14 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 4e-14 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 4e-14 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 4e-14 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 5e-14 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 5e-14 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 5e-14 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 6e-14 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 6e-14 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 8e-14 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 8e-14 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 9e-14 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 9e-14 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 9e-14 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 9e-14 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 9e-14 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 9e-14 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 1e-13 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-13 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 1e-13 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 1e-13 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-13 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 1e-13 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 1e-13 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-13 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-13 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 1e-13 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 1e-13 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-13 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-13 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-13 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-13 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-13 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-13 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 2e-13 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-13 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-13 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-13 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-13 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-13 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-13 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-13 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-13 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-13 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-13 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-13 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-13 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-13 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-13 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-13 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-13 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-13 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-13 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-13 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 3e-13 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 3e-13 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 3e-13 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-13 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 3e-13 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 3e-13 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 3e-13 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 4e-13 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 4e-13 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-13 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 6e-13 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 7e-13 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 8e-13 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 9e-13 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 9e-13 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 9e-13 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-12 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-12 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 1e-12 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-12 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 1e-12 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-12 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-12 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 1e-12 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-12 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-12 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-12 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-12 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 1e-12 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 1e-12 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 1e-12 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-12 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 1e-12 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-12 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-12 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-12 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-12 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 1e-12 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-12 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-12 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 1e-12 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-12 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-12 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 1e-12 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-12 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-12 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-12 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-12 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-12 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-12 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-12 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-12 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-12 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-12 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 2e-12 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-12 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-12 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-12 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-12 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 3e-12 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 3e-12 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-12 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-12 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 3e-12 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 3e-12 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 3e-12 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 3e-12 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 4e-12 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 4e-12 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 4e-12 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-12 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 4e-12 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 4e-12 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 4e-12 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 4e-12 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 4e-12 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-12 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 4e-12 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 5e-12 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 5e-12 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 5e-12 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 5e-12 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 5e-12 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 5e-12 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 5e-12 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 6e-12 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 6e-12 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 6e-12 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 6e-12 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 6e-12 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 6e-12 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 6e-12 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 6e-12 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 6e-12 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 6e-12 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 6e-12 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 6e-12 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 6e-12 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 6e-12 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 6e-12 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 6e-12 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 6e-12 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 7e-12 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 7e-12 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 7e-12 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 7e-12 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 7e-12 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 8e-12 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 8e-12 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 8e-12 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 8e-12 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-12 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 9e-12 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 1e-11 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 1e-11 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 1e-11 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 1e-11 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 1e-11 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 1e-11 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-11 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 1e-11 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 1e-11 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 1e-11 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-11 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 2e-11 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-11 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 2e-11 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-11 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-11 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-11 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-11 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-11 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 2e-11 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 2e-11 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 2e-11 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 2e-11 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 2e-11 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-11 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 3e-11 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 3e-11 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 3e-11 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 3e-11 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 3e-11 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 3e-11 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 3e-11 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 3e-11 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 3e-11 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 3e-11 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 4e-11 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 4e-11 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 4e-11 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 4e-11 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 4e-11 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 5e-11 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 5e-11 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 5e-11 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 5e-11 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 6e-11 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 6e-11 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 7e-11 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 8e-11 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 9e-11 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 9e-11 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 1e-10 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 1e-10 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 1e-10 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-10 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-10 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-10 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 1e-10 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 1e-10 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 1e-10 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-10 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-10 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-10 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 1e-10 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 1e-10 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-10 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 1e-10 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 1e-10 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-10 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-10 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-10 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-10 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-10 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-10 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 2e-10 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-10 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 2e-10 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-10 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 2e-10 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 2e-10 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 2e-10 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 2e-10 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-10 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-10 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-10 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 3e-10 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 3e-10 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-10 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-10 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 3e-10 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 3e-10 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 3e-10 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 3e-10 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 3e-10 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 3e-10 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-10 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 4e-10 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 4e-10 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-10 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 4e-10 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 4e-10 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 4e-10 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-10 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 4e-10 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 4e-10 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 4e-10 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 4e-10 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 4e-10 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-10 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 5e-10 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 5e-10 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 5e-10 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 5e-10 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 6e-10 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 6e-10 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 6e-10 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 6e-10 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 6e-10 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 6e-10 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-10 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 7e-10 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 7e-10 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 7e-10 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 8e-10 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 8e-10 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 8e-10 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 8e-10 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 8e-10 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 9e-10 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 9e-10 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 9e-10 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 9e-10 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 9e-10 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 9e-10 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 9e-10 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 9e-10 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 9e-10 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 9e-10 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 9e-10 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 9e-10 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 9e-10 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 9e-10 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 1e-09 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-09 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-09 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 1e-09 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 1e-09 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 1e-09 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-09 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 1e-09 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 1e-09 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 1e-09 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 1e-09 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-09 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-09 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-09 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 1e-09 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-09 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-09 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 1e-09 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-09 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-09 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 1e-09 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 1e-09 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 1e-09 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 1e-09 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 1e-09 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 1e-09 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 1e-09 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 1e-09 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 1e-09 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-09 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 1e-09 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 1e-09 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 1e-09 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 1e-09 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 1e-09 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 1e-09 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 1e-09 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 1e-09 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 1e-09 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 1e-09 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 1e-09 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 1e-09 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 1e-09 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 1e-09 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 1e-09 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-09 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-09 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-09 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-09 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-09 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-09 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-09 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-09 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 2e-09 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-09 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-09 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-09 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 2e-09 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 2e-09 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-09 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-09 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-09 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-09 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-09 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-09 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-09 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-09 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-09 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 2e-09 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-09 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-09 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-09 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-09 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-09 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-09 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-09 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-09 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-09 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-09 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-09 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-09 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 2e-09 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-09 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-09 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-09 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 2e-09 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-09 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-09 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 2e-09 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 3e-09 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 3e-09 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-09 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-09 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 3e-09 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 3e-09 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 3e-09 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 3e-09 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 3e-09 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 3e-09 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 3e-09 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-09 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 3e-09 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-09 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 3e-09 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 3e-09 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-09 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 4e-09 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 4e-09 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 4e-09 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 4e-09 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 4e-09 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-09 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 4e-09 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 4e-09 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 4e-09 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-09 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 4e-09 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-09 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-09 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 4e-09 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-09 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 5e-09 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 5e-09 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 5e-09 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 5e-09 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 5e-09 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 5e-09 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 5e-09 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 5e-09 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 5e-09 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 5e-09 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 5e-09 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 5e-09 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 5e-09 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 5e-09 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 5e-09 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 5e-09 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 5e-09 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 5e-09 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 6e-09 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-09 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 6e-09 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 6e-09 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 6e-09 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 6e-09 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 6e-09 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 6e-09 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 6e-09 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 6e-09 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 6e-09 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 7e-09 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 7e-09 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 7e-09 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 7e-09 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 7e-09 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 7e-09 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 7e-09 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 8e-09 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 8e-09 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 8e-09 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 8e-09 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 9e-09 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 9e-09 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 9e-09 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-08 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-08 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 1e-08 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 1e-08 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 1e-08 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 1e-08 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-08 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-08 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 1e-08 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-08 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-08 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-08 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-08 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 2e-08 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-08 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-08 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-08 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-08 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-08 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-08 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 2e-08 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 2e-08 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-08 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-08 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-08 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-08 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-08 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-08 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-08 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-08 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-08 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-08 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-08 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-08 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-08 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-08 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-08 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-08 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-08 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-08 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-08 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-08 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-08 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 3e-08 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 3e-08 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-08 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 3e-08 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 3e-08 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 3e-08 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-08 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 4e-08 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 5e-08 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 5e-08 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 5e-08 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 5e-08 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 5e-08 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 6e-08 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-08 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 6e-08 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 6e-08 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-08 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 7e-08 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 7e-08 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 7e-08 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 8e-08 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 8e-08 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 8e-08 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 9e-08 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 9e-08 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 9e-08 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 9e-08 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 1e-07 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-07 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 1e-07 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 1e-07 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-07 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-07 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 1e-07 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-07 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-07 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 2e-07 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-07 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-07 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 2e-07 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-07 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-07 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-07 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-07 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-07 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-07 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 3e-07 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 3e-07 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-07 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 3e-07 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 3e-07 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 3e-07 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 3e-07 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 3e-07 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 3e-07 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 3e-07 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 3e-07 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 3e-07 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 3e-07 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 3e-07 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 4e-07 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 4e-07 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 4e-07 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 4e-07 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 4e-07 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 4e-07 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 4e-07 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 5e-07 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 6e-07 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 6e-07 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 6e-07 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 7e-07 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 7e-07 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 7e-07 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 7e-07 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 8e-07 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 9e-07 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 9e-07 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 9e-07 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 9e-07 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 9e-07 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-06 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-06 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 1e-06 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 1e-06 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-06 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-06 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-06 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-06 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-06 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-06 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-06 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-06 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 2e-06 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-06 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-06 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-06 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-06 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-06 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-06 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-06 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-06 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 3e-06 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-06 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 3e-06 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 3e-06 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-06 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-06 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 3e-06 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 3e-06 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 3e-06 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 3e-06 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-06 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-06 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 3e-06 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 4e-06 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 4e-06 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 4e-06 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 4e-06 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-06 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 5e-06 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 5e-06 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 5e-06 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 5e-06 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 5e-06 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 5e-06 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 5e-06 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 5e-06 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 5e-06 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 5e-06 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 5e-06 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 5e-06 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 5e-06 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 6e-06 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 6e-06 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 6e-06 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 6e-06 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 6e-06 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 6e-06 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 6e-06 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 6e-06 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 6e-06 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 6e-06 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 6e-06 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 7e-06 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 7e-06 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 7e-06 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 8e-06 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 8e-06 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 9e-06 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 9e-06 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 9e-06 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 9e-06 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 9e-06 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 1e-05 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-05 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-05 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 1e-05 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-05 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 1e-05 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 1e-05 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 1e-05 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 1e-05 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 1e-05 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-05 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 1e-05 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 1e-05 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 1e-05 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 1e-05 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-05 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 1e-05 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 1e-05 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 1e-05 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-05 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-05 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-05 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-05 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 1e-05 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 1e-05 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-05 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-05 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-05 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-05 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-05 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-05 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 2e-05 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-05 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-05 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-05 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-05 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 2e-05 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 2e-05 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-05 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 2e-05 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 2e-05 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-05 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-05 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-05 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-05 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-05 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-05 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-05 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-05 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-05 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-05 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-05 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-05 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 3e-05 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 3e-05 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 3e-05 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-05 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 3e-05 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 3e-05 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 3e-05 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 3e-05 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 3e-05 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 3e-05 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 3e-05 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-05 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 3e-05 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 3e-05 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 3e-05 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-05 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 3e-05 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 3e-05 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 3e-05 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-05 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 3e-05 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-05 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 3e-05 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 3e-05 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 3e-05 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 4e-05 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 4e-05 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 4e-05 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 4e-05 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 4e-05 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 4e-05 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 5e-05 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 5e-05 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 5e-05 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 5e-05 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 5e-05 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 6e-05 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 6e-05 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 7e-05 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 8e-05 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 8e-05 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 8e-05 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 9e-05 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 9e-05 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 1e-04 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 1e-04 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 1e-04 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 1e-04 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 1e-04 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 1e-04 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 2e-04 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-04 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 2e-04 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-04 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 2e-04 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 3e-04 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 3e-04 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 3e-04 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-04 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 3e-04 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 3e-04 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 3e-04 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 3e-04 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 4e-04 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 4e-04 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 7e-04 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 7e-04 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 9e-04 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 9e-04 |
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 341 bits (876), Expect = e-117
Identities = 92/239 (38%), Positives = 137/239 (57%), Gaps = 10/239 (4%)
Query: 75 VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 134
+ +S +H +LV L+G+C E N +L Y++ G+L L+G P + W
Sbjct: 86 IETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDL-----PTMSMSWEQ 140
Query: 135 RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 194
R+ I + AARGL YLH +IIHRD++S N+LL E+F KI DF +S + ++ + H
Sbjct: 141 RLEICIGAARGLHYLHT---RAIIHRDVKSINILLDENFVPKITDFGISKKGTELD-QTH 196
Query: 195 -STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWA 253
ST V GT GY PEY + G+LT+KSDVYSFGVVL E+L R + ++PR +L WA
Sbjct: 197 LSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWA 256
Query: 254 TPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLK 312
+ +++Q VDP L + P+ + K A C+ +E RP+M V+ L+ L+
Sbjct: 257 VESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALR 315
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 335 bits (862), Expect = e-115
Identities = 94/236 (39%), Positives = 133/236 (56%), Gaps = 10/236 (4%)
Query: 75 VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 134
V ++S H NL+ L G+C+ R+L Y + GS+ L R Q P LDW
Sbjct: 78 VEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQ-----PPLDWPK 132
Query: 135 RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 194
R RIA+ +ARGL YLH+ P IIHRD++++N+LL E+F+A + DF L+ H
Sbjct: 133 RQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT--H 190
Query: 195 -STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQS--LVT 251
+T V GT G+ APEY TG+ ++K+DV+ +GV+LLEL+TG++ D L+
Sbjct: 191 VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLD 250
Query: 252 WATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKAL 307
W L E K++ VD L+G Y + V +L VA LC Q RP MS VV+ L
Sbjct: 251 WVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML 306
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 333 bits (857), Expect = e-115
Identities = 91/240 (37%), Positives = 136/240 (56%), Gaps = 14/240 (5%)
Query: 75 VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 134
+ V+++ +HENLVELLG+ +G+ L Y + GSL D L G P L W
Sbjct: 81 IKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDG------TPPLSWHM 134
Query: 135 RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 194
R +IA AA G+ +LHE IHRDI+S+N+LL E F AKI+DF L+ + A +
Sbjct: 135 RCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVM 191
Query: 195 STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWAT 254
++R++GT Y APE + G++T KSD+YSFGVVLLE++TG VD R Q L+
Sbjct: 192 TSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVDEH--REPQLLLDIKE 248
Query: 255 PRLSEDK-VKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKS 313
E+K ++ +D K+ + V + +VA+ C+ + RP++ V + LQ + S
Sbjct: 249 EIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS 307
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 222 bits (567), Expect = 5e-71
Identities = 69/261 (26%), Positives = 105/261 (40%), Gaps = 32/261 (12%)
Query: 75 VSVVSRLKHENLVELLGYCVEGNLRV----LAYEFATMGSLHDILHGRKGVQGAQPGPVL 130
V + +KHEN+++ +G G L F GSL D L V+
Sbjct: 69 VYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN----------VV 118
Query: 131 DWMTRVRIAVDAARGLEYLHEKVQ-------PSIIHRDIRSSNVLLFEDFKAKIADFNLS 183
W IA ARGL YLHE + P+I HRDI+S NVLL + A IADF L+
Sbjct: 119 SWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLA 178
Query: 184 NQAPDMAARLHSTRVLGTFGYHAPEYAMTG-----QLTQKSDVYSFGVVLLELLTGRKPV 238
+ + + +GT Y APE + D+Y+ G+VL EL +
Sbjct: 179 LKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAA 238
Query: 239 DHTMPRGQQSLVTWATPRLSEDKVKQCV-----DPKLKGEYPP-KGVAKLAAVAALCVQY 292
D + S + +++ V P L+ + G+A L C +
Sbjct: 239 DGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDH 298
Query: 293 EAEFRPNMSIVVKALQPLLKS 313
+AE R + V + + + +
Sbjct: 299 DAEARLSAGCVGERITQMQRL 319
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 175 bits (445), Expect = 6e-53
Identities = 67/244 (27%), Positives = 111/244 (45%), Gaps = 28/244 (11%)
Query: 75 VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 134
+ +SR+ H N+V+L G C+ V+ E+A GSL+++LHG + P P
Sbjct: 52 LRQLSRVNHPNIVKLYGACLNPVCLVM--EYAEGGSLYNVLHGAE------PLPYYTAAH 103
Query: 135 RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFK-AKIADFNLSNQAPDMAARL 193
+ + ++G+ YLH ++IHRD++ N+LL KI DF +
Sbjct: 104 AMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT----- 158
Query: 194 HSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWA 253
H T G+ + APE ++K DV+S+G++L E++T RKP D + + WA
Sbjct: 159 HMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFR--IMWA 216
Query: 254 TPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKS 313
V P L P + ++ C + RP+M +VK + L++
Sbjct: 217 --------VHNGTRPPLIKNLPK----PIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRY 264
Query: 314 PPPA 317
P A
Sbjct: 265 FPGA 268
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 174 bits (444), Expect = 8e-53
Identities = 73/260 (28%), Positives = 121/260 (46%), Gaps = 27/260 (10%)
Query: 60 RLKSPKNYPDDEKQL---VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILH 116
L + + + V+++ RL+H N+V +G + + E+ + GSL+ +LH
Sbjct: 67 ILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLH 126
Query: 117 GRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAK 176
LD R+ +A D A+G+ YLH + P I+HR+++S N+L+ + + K
Sbjct: 127 KSG------AREQLDERRRLSMAYDVAKGMNYLHNR-NPPIVHRNLKSPNLLVDKKYTVK 179
Query: 177 IADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRK 236
+ DF LS S GT + APE +KSDVYSFGV+L EL T ++
Sbjct: 180 VCDFGLSRLKASTFLSSKSAA--GTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQ 237
Query: 237 PVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEF 296
P + + Q V A +C ++ P ++AA+ C E
Sbjct: 238 PWGN-LNPAQ---VVAAV-------GFKCKRLEIPRNLNP----QVAAIIEGCWTNEPWK 282
Query: 297 RPNMSIVVKALQPLLKSPPP 316
RP+ + ++ L+PL+KS P
Sbjct: 283 RPSFATIMDLLRPLIKSAVP 302
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 169 bits (429), Expect = 3e-50
Identities = 61/284 (21%), Positives = 100/284 (35%), Gaps = 49/284 (17%)
Query: 75 VSVVSRLKHENLVELLGYCVEGNLRV-----LAYEFATMGSLHDILHGRKGVQGAQPGPV 129
+ V ++H+N+ + L E+ GSL L
Sbjct: 58 IYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT---------- 107
Query: 130 LDWMTRVRIAVDAARGLEYLHEKV------QPSIIHRDIRSSNVLLFEDFKAKIADFNLS 183
DW++ R+A RGL YLH ++ +P+I HRD+ S NVL+ D I+DF LS
Sbjct: 108 SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLS 167
Query: 184 ------NQAPDMAARLHSTRVLGTFGYHAPEYAM-------TGQLTQKSDVYSFGVVLLE 230
+ +GT Y APE ++ D+Y+ G++ E
Sbjct: 168 MRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWE 227
Query: 231 LLTGRKPVDH--TMPRGQQSLVTWATPRLSEDKVKQCVD-----PKLKGEYP--PKGVAK 281
+ + ++P Q + T + + ++ V PK + V
Sbjct: 228 IFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRS 287
Query: 282 LAAVAALCVQYEAEFRPNMSIVVKALQPLL------KSPPPAAP 319
L C +AE R + + L+ KS P A
Sbjct: 288 LKETIEDCWDQDAEARLTAQXAEERMAELMMIWERNKSVSPTAH 331
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 3e-50
Identities = 65/259 (25%), Positives = 117/259 (45%), Gaps = 29/259 (11%)
Query: 60 RLKSPKNYPDDEKQL---VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILH 116
L P + V V+ + +H N++ +GY L ++ ++ SL+ LH
Sbjct: 53 MLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQLAIVT-QWCEGSSLYHHLH 111
Query: 117 GRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAK 176
+ + + IA ARG++YLH K SIIHRD++S+N+ L ED K
Sbjct: 112 ASE--------TKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVK 160
Query: 177 IADFNLSNQAPDMAARLHSTRVLGTFGYHAPE---YAMTGQLTQKSDVYSFGVVLLELLT 233
I DF L+ + + ++ G+ + APE + + +SDVY+FG+VL EL+T
Sbjct: 161 IGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMT 220
Query: 234 GRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYE 293
G+ P + R Q + R K++ P ++ + A C++ +
Sbjct: 221 GQLPYSNINNRDQ---IIEMVGR----GSLSPDLSKVRSNCPK----RMKRLMAECLKKK 269
Query: 294 AEFRPNMSIVVKALQPLLK 312
+ RP+ ++ ++ L +
Sbjct: 270 RDERPSFPRILAEIEELAR 288
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 3e-49
Identities = 71/244 (29%), Positives = 113/244 (46%), Gaps = 38/244 (15%)
Query: 75 VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 134
V ++S L H N+V+L G V+ EF G L+ L + + W
Sbjct: 74 VFIMSNLNHPNIVKLYGLMHNPPRMVM--EFVPCGDLYHRLLDKAHP--------IKWSV 123
Query: 135 RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFE-----DFKAKIADFNLSNQAPDM 189
++R+ +D A G+EY+ + P I+HRD+RS N+ L AK+ADF LS Q+
Sbjct: 124 KLRLMLDIALGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHS 182
Query: 190 AARLHSTRVLGTFGYHAPEYAMTGQL---TQKSDVYSFGVVLLELLTGRKPVDHTMPRGQ 246
+ +LG F + APE + + T+K+D YSF ++L +LTG P D G+
Sbjct: 183 -----VSGLLGNFQWMAPE-TIGAEEESYTEKADTYSFAMILYTILTGEGPFDE-YSYGK 235
Query: 247 QSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKA 306
+ ++ + P + + PP +L V LC + + RP+ S +VK
Sbjct: 236 IKFINMI--------REEGLRPTIPEDCPP----RLRNVIELCWSGDPKKRPHFSYIVKE 283
Query: 307 LQPL 310
L L
Sbjct: 284 LSEL 287
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 7e-49
Identities = 62/276 (22%), Positives = 104/276 (37%), Gaps = 41/276 (14%)
Query: 61 LKSPKNYPDDEKQL----VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILH 116
+K + ++ ++ V V+ L+H N+++ +G + E+ G+L I+
Sbjct: 40 MKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIK 99
Query: 117 GRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAK 176
W RV A D A G+ YLH +IIHRD+ S N L+ E+
Sbjct: 100 SMDSQ--------YPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVV 148
Query: 177 IADFNLS------------NQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSF 224
+ADF L+ ++ R V+G + APE +K DV+SF
Sbjct: 149 VADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSF 208
Query: 225 GVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAA 284
G+VL E++ +PR + V+ +D PP
Sbjct: 209 GIVLCEIIGRVNADPDYLPRTMDFGL----------NVRGFLDRYCPPNCPP----SFFP 254
Query: 285 VAALCVQYEAEFRPNMSIVVKALQPLLKSPPPAAPV 320
+ C + E RP+ + L+ L P+
Sbjct: 255 ITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGHLPL 290
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 4e-48
Identities = 54/269 (20%), Positives = 96/269 (35%), Gaps = 44/269 (16%)
Query: 60 RLKSPKNYPDDEKQL---VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILH 116
+ ++ D K V + +HEN+V +G C+ + +L+ ++
Sbjct: 62 LIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVR 121
Query: 117 GRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAK 176
K VLD +IA + +G+ YLH I+H+D++S NV ++ K
Sbjct: 122 DAK--------IVLDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSKNVFY-DNGKVV 169
Query: 177 IADFNLS---NQAPDMAARLHSTRVLGTFGYHAPEYAMTGQL---------TQKSDVYSF 224
I DF L G + APE ++ SDV++
Sbjct: 170 ITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFAL 229
Query: 225 GVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGV-AKLA 283
G + EL P P + W + +K G+ +++
Sbjct: 230 GTIWYELHAREWPFKT-QPAEA---IIWQ------------MGTGMKPNLSQIGMGKEIS 273
Query: 284 AVAALCVQYEAEFRPNMSIVVKALQPLLK 312
+ C +E E RP + ++ L+ L K
Sbjct: 274 DILLFCWAFEQEERPTFTKLMDMLEKLPK 302
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 5e-48
Identities = 52/244 (21%), Positives = 93/244 (38%), Gaps = 37/244 (15%)
Query: 75 VSVVSRLKHENLVELLGYCVEGNLRVLAY--EFATMGSLHDILHGRKGVQGAQPGPVLDW 132
+ H N++ +LG C + GSL+++LH V+D
Sbjct: 58 CPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTN-------FVVDQ 110
Query: 133 MTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAAR 192
V+ A+D ARG+ +LH +P I + S +V++ ED A+I+ D+
Sbjct: 111 SQAVKFALDMARGMAFLHTL-EPLIPRHALNSRSVMIDEDMTARISMA-------DVKFS 162
Query: 193 LHSTRVLGTFGYHAPEYAMTGQ----LTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQS 248
S + + APE A+ + + +D++SF V+L EL+T P
Sbjct: 163 FQSPGRMYAPAWVAPE-ALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGM 221
Query: 249 LVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQ 308
V R PP ++ + +C+ + RP ++V L+
Sbjct: 222 KVALEGLRP---------------TIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILE 266
Query: 309 PLLK 312
+
Sbjct: 267 KMQD 270
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 2e-46
Identities = 52/262 (19%), Positives = 100/262 (38%), Gaps = 34/262 (12%)
Query: 75 VSVVSRLKHENLVELLGYCVEGNLRVLAY----EFATMGSLHDILHGRKGVQGAQPGPVL 130
+ ++HEN++ + ++G ++ GSL+D L L
Sbjct: 82 IYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTT----------L 131
Query: 131 DWMTRVRIAVDAARGLEYLHEKV-----QPSIIHRDIRSSNVLLFEDFKAKIADFNLS-- 183
D + +++A + GL +LH ++ +P+I HRD++S N+L+ ++ IAD L+
Sbjct: 132 DAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVK 191
Query: 184 NQAPDMAARLHSTRVLGTFGYHAPE------YAMTGQLTQKSDVYSFGVVLLELLTGRKP 237
+ + +GT Y PE Q +D+YSFG++L E+ R
Sbjct: 192 FISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVAR-RCV 250
Query: 238 VDHTMPRGQQSLVTWATPRLSEDKVKQCVD-----PKLKGEYPPKGV-AKLAAVAALCVQ 291
+ Q S + +++ V P + ++ + C
Sbjct: 251 SGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWA 310
Query: 292 YEAEFRPNMSIVVKALQPLLKS 313
+ R V K L + +S
Sbjct: 311 HNPASRLTALRVKKTLAKMSES 332
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 3e-46
Identities = 63/244 (25%), Positives = 102/244 (41%), Gaps = 37/244 (15%)
Query: 75 VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 134
+ + LKH N++ L G C++ L EFA G L+ +L G++ +
Sbjct: 57 AKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKR----------IPPDI 106
Query: 135 RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFK--------AKIADFNLSNQA 186
V AV ARG+ YLH++ IIHRD++SSN+L+ + + KI DF L+
Sbjct: 107 LVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR-- 164
Query: 187 PDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQ 246
R G + + APE ++ SDV+S+GV+L ELLTG P +
Sbjct: 165 --EWHRTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRG-IDGLA 221
Query: 247 QSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKA 306
V + + + P A + C + RP+ + ++
Sbjct: 222 ---VAYG-------VAMNKLALPIPSTCPE----PFAKLMEDCWNPDPHSRPSFTNILDQ 267
Query: 307 LQPL 310
L +
Sbjct: 268 LTTI 271
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 6e-45
Identities = 56/262 (21%), Positives = 106/262 (40%), Gaps = 40/262 (15%)
Query: 75 VSVVSRLKHENLVELLGYCVEGNLRVLAY----EFATMGSLHDILHGRKGVQGAQPGPVL 130
+ L+HEN++ + + + MGSL+D L L
Sbjct: 53 LYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT----------L 102
Query: 131 DWMTRVRIAVDAARGLEYLHEKV-----QPSIIHRDIRSSNVLLFEDFKAKIADFNLS-- 183
D ++ +RI + A GL +LH ++ +P+I HRD++S N+L+ ++ + IAD L+
Sbjct: 103 DTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVM 162
Query: 184 -NQAPDMAARLHSTRVLGTFGYHAPE------YAMTGQLTQKSDVYSFGVVLLELLTGRK 236
+Q+ + ++ RV GT Y APE ++ D+++FG+VL E+ R
Sbjct: 163 HSQSTNQLDVGNNPRV-GTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVAR-RM 220
Query: 237 PVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPP--------KGVAKLAAVAAL 288
+ + + S + +++ V + + P + LA +
Sbjct: 221 VSNGIVEDYKPPFYDVVPNDPSFEDMRKVV--CVDQQRPNIPNRWFSDPTLTSLAKLMKE 278
Query: 289 CVQYEAEFRPNMSIVVKALQPL 310
C R + K L +
Sbjct: 279 CWYQNPSARLTALRIKKTLTKI 300
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 7e-44
Identities = 54/266 (20%), Positives = 103/266 (38%), Gaps = 42/266 (15%)
Query: 75 VSVVSRLKHENLVELLGYCVEGNLRVLAY----EFATMGSLHDILHGRKGVQGAQPGPVL 130
+ L+HEN++ + + N ++ GSL D L+ +
Sbjct: 87 IYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT----------V 136
Query: 131 DWMTRVRIAVDAARGLEYLHEKVQ-----PSIIHRDIRSSNVLLFEDFKAKIADFNLS-- 183
+++A+ A GL +LH ++ P+I HRD++S N+L+ ++ IAD L+
Sbjct: 137 TVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 196
Query: 184 -NQAPDMAARLHSTRVLGTFGYHAPEYAMTGQL-------TQKSDVYSFGVVLLELLTGR 235
+ A D + RV GT Y APE + + +++D+Y+ G+V E+ R
Sbjct: 197 HDSATDTIDIAPNHRV-GTKRYMAPE-VLDDSINMKHFESFKRADIYAMGLVFWEIAR-R 253
Query: 236 KPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPP--------KGVAKLAAVAA 287
+ Q S +++++ V + P + + +A +
Sbjct: 254 CSIGGIHEDYQLPYYDLVPSDPSVEEMRKVV--CEQKLRPNIPNRWQSCEALRVMAKIMR 311
Query: 288 LCVQYEAEFRPNMSIVVKALQPLLKS 313
C R + K L L +
Sbjct: 312 ECWYANGAARLTALRIKKTLSQLSQQ 337
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 5e-33
Identities = 64/256 (25%), Positives = 98/256 (38%), Gaps = 60/256 (23%)
Query: 76 SVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTR 135
++ + H N+V L+G C + + E G L G L T
Sbjct: 164 RILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTE--------GARLRVKTL 215
Query: 136 VRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHS 195
+++ DAA G+EYL K IHRD+ + N L+ E KI+DF +S
Sbjct: 216 LQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMS------------ 260
Query: 196 TRVLGTFGYH-------------APEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHT 241
R Y APE G+ + +SDV+SFG++L E + G P
Sbjct: 261 -REEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPY--- 316
Query: 242 MPRGQQSLVTWATPRLSEDKVKQCVDPKLKGE--YPPKGV-AKLAAVAALCVQYEAEFRP 298
P LS + ++ V+ KG P+ + + C YE RP
Sbjct: 317 -------------PNLSNQQTREFVE---KGGRLPCPELCPDAVFRLMEQCWAYEPGQRP 360
Query: 299 NMSIVVKALQPLLKSP 314
+ S + + LQ + K
Sbjct: 361 SFSTIYQELQSIRKRH 376
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 4e-29
Identities = 70/247 (28%), Positives = 107/247 (43%), Gaps = 45/247 (18%)
Query: 76 SVVSRLKHENLVELLGYCVEGNLRV-LAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 134
SV+++L+H NLV+LLG VE + + E+ GSL D L R VL
Sbjct: 238 SVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR-------SVLGGDC 290
Query: 135 RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAAR-L 193
++ ++D +EYL + +HRD+ + NVL+ ED AK++DF L +
Sbjct: 291 LLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGL--------TKEA 339
Query: 194 HSTRVLGTFGYH--APEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLV 250
ST+ G APE + + KSDV+SFG++L E+ + GR P
Sbjct: 340 SSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPY------------ 387
Query: 251 TWATPRLSEDKVKQCVDPKLKGE--YPPKGV-AKLAAVAALCVQYEAEFRPNMSIVVKAL 307
PR+ V V+ KG P G + V C +A RP + + L
Sbjct: 388 ----PRIPLKDVVPRVE---KGYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQL 440
Query: 308 QPLLKSP 314
+ +
Sbjct: 441 EHIRTHE 447
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 7e-29
Identities = 60/242 (24%), Positives = 104/242 (42%), Gaps = 32/242 (13%)
Query: 76 SVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTR 135
+V+ +KH NLV+LLG C + EF T G+L D L + +
Sbjct: 268 AVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-------QEVSAVVL 320
Query: 136 VRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHS 195
+ +A + +EYL +K + IHR++ + N L+ E+ K+ADF LS ++
Sbjct: 321 LYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTG---DTYT 374
Query: 196 TRVLGTFGYH--APEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTW 252
F APE + + KSDV++FGV+L E+ T G P
Sbjct: 375 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY-------------- 420
Query: 253 ATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLK 312
P + +V + ++ + E P K+ + C Q+ RP+ + + +A + + +
Sbjct: 421 --PGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 478
Query: 313 SP 314
Sbjct: 479 ES 480
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-28
Identities = 73/260 (28%), Positives = 110/260 (42%), Gaps = 35/260 (13%)
Query: 61 LKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKG 120
LK P+ Q V+ +L+HE LV+L E + ++ E+ + GSL D L G G
Sbjct: 216 LKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVT-EYMSKGSLLDFLKGETG 274
Query: 121 VQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADF 180
L V +A A G+ Y+ + +HRD+R++N+L+ E+ K+ADF
Sbjct: 275 -------KYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADF 324
Query: 181 NLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVD 239
L+ D + APE A+ G+ T KSDV+SFG++L EL T GR P
Sbjct: 325 GLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY- 382
Query: 240 HTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGE--YPPKGV-AKLAAVAALCVQYEAEF 296
P + +V V+ +G P L + C + E E
Sbjct: 383 ---------------PGMVNREVLDQVE---RGYRMPCPPECPESLHDLMCQCWRKEPEE 424
Query: 297 RPNMSIVVKALQPLLKSPPP 316
RP + L+ S P
Sbjct: 425 RPTFEYLQAFLEDYFTSTEP 444
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 7e-28
Identities = 55/247 (22%), Positives = 98/247 (39%), Gaps = 26/247 (10%)
Query: 78 VSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVR 137
S+L H+N+V ++ E + L E+ +L + + GP L T +
Sbjct: 65 SSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESH--------GP-LSVDTAIN 115
Query: 138 IAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTR 197
G+++ H+ I+HRDI+ N+L+ + KI DF ++ +A + +
Sbjct: 116 FTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIA-KALSETSLTQTNH 171
Query: 198 VLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRL 257
VLGT Y +PE A + +D+YS G+VL E+L G P + V+ A +
Sbjct: 172 VLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETA------VSIAIKHI 225
Query: 258 SEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRP-NMSIVVKALQPLLKSPPP 316
+ P + + L+ V + + R + + L +L
Sbjct: 226 QDSV------PNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENRA 279
Query: 317 AAPVSET 323
V E
Sbjct: 280 NEDVYEL 286
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 9e-28
Identities = 60/255 (23%), Positives = 102/255 (40%), Gaps = 59/255 (23%)
Query: 76 SVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTR 135
V+ +L H LV+L G C+E L EF G L D L ++G+ T
Sbjct: 55 EVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGL--------FAAETL 106
Query: 136 VRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHS 195
+ + +D G+ YL E +IHRD+ + N L+ E+ K++DF ++
Sbjct: 107 LGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMT------------ 151
Query: 196 TRVLGTFGYH------------APEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTM 242
R + Y +PE + + KSDV+SFGV++ E+ + G+ P
Sbjct: 152 -RFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPY---- 206
Query: 243 PRGQQSLVTWATPRLSEDKVKQCVDPKLKGE--YPPKGV-AKLAAVAALCVQYEAEFRPN 299
S +V + + G Y P+ + + C + E RP
Sbjct: 207 ------------ENRSNSEVVEDIS---TGFRLYKPRLASTHVYQIMNHCWRERPEDRPA 251
Query: 300 MSIVVKALQPLLKSP 314
S +++ L + +S
Sbjct: 252 FSRLLRQLAEIAESG 266
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 1e-27
Identities = 73/260 (28%), Positives = 110/260 (42%), Gaps = 35/260 (13%)
Query: 61 LKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKG 120
LK P+ Q V+ +L+HE LV+L E + ++ E+ + GSL D L G G
Sbjct: 299 LKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVT-EYMSKGSLLDFLKGETG 357
Query: 121 VQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADF 180
L V +A A G+ Y+ + +HRD+R++N+L+ E+ K+ADF
Sbjct: 358 -------KYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADF 407
Query: 181 NLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVD 239
L+ D + APE A+ G+ T KSDV+SFG++L EL T GR P
Sbjct: 408 GLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY- 465
Query: 240 HTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGE--YPPKGV-AKLAAVAALCVQYEAEF 296
P + +V V+ +G P L + C + E E
Sbjct: 466 ---------------PGMVNREVLDQVE---RGYRMPCPPECPESLHDLMCQCWRKEPEE 507
Query: 297 RPNMSIVVKALQPLLKSPPP 316
RP + L+ S P
Sbjct: 508 RPTFEYLQAFLEDYFTSTEP 527
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 3e-27
Identities = 65/265 (24%), Positives = 110/265 (41%), Gaps = 59/265 (22%)
Query: 75 VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGR-------KGVQGAQPG 127
+++ L+HE++V+ G C +G+ ++ +E+ G L+ L Q Q
Sbjct: 68 AELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAK 127
Query: 128 PVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAP 187
L + IA A G+ YL + +HRD+ + N L+ + KI DF +S
Sbjct: 128 GELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMS---- 180
Query: 188 DMAARLHSTRVLGTFGYH-------------APEYAMTGQLTQKSDVYSFGVVLLELLT- 233
R + + Y+ PE M + T +SDV+SFGV+L E+ T
Sbjct: 181 ---------RDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTY 231
Query: 234 GRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEY--PPKGV-AKLAAVAALCV 290
G++P +LS +V +C+ +G P+ ++ V C
Sbjct: 232 GKQPW----------------FQLSNTEVIECIT---QGRVLERPRVCPKEVYDVMLGCW 272
Query: 291 QYEAEFRPNMSIVVKALQPLLKSPP 315
Q E + R N+ + K L L K+ P
Sbjct: 273 QREPQQRLNIKEIYKILHALGKATP 297
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 3e-27
Identities = 64/254 (25%), Positives = 105/254 (41%), Gaps = 29/254 (11%)
Query: 75 VSVVSRLKHENLVELLGYCVEGNLRVLAY---EFATMGSLHDILHGRKGVQGAQPGPVLD 131
+ ++ L HE++++ G C + L E+ +GSL D L +
Sbjct: 84 IDILRTLYHEHIIKYKGCCEDAGAASL-QLVMEYVPLGSLRDYLPRHS----------IG 132
Query: 132 WMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAA 191
+ A G+ YLH + IHRD+ + NVLL D KI DF L+ P+
Sbjct: 133 LAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHE 189
Query: 192 --RLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQS 248
R+ F Y APE + SDV+SFGV L ELLT +
Sbjct: 190 YYRVREDGDSPVFWY-APECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELI 248
Query: 249 LVTWATPRLSEDKVKQCVDPKLKGEY---PPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305
+ +++ ++ + ++ +GE P K A++ + C + EA FRP ++
Sbjct: 249 GIAQ--GQMTVLRLTELLE---RGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP 303
Query: 306 ALQPLLKSPPPAAP 319
L+ + + AP
Sbjct: 304 ILKTVHEKYQGQAP 317
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 6e-27
Identities = 43/183 (23%), Positives = 70/183 (38%), Gaps = 27/183 (14%)
Query: 65 KNYPDDEKQL---VSVVSRLKHENLVELLGYCVEGNLR----VLAYEFATMGSLHDIL-- 115
K + ++ ++ L+H N+V VL E T G+L L
Sbjct: 63 KLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKR 122
Query: 116 HGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLL-FEDFK 174
+ +GL++LH + P IIHRD++ N+ +
Sbjct: 123 FKV-----------MKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGS 170
Query: 175 AKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTG 234
KI D L+ A+ V+GT + APE + + DVY+FG+ +LE+ T
Sbjct: 171 VKIGDLGLATLKRASFAK----AVIGTPEFMAPEM-YEEKYDESVDVYAFGMCMLEMATS 225
Query: 235 RKP 237
P
Sbjct: 226 EYP 228
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 7e-27
Identities = 58/282 (20%), Positives = 104/282 (36%), Gaps = 54/282 (19%)
Query: 66 NYPDDEKQLVS---VVSRLKHENLVELLGYCVEGNLRVLAY---EFATMGSLHDILHGRK 119
+ PD ++ ++ L + +V+ G + L E+ G L D L +
Sbjct: 63 SGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL-RLVMEYLPSGCLRDFLQRHR 121
Query: 120 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIAD 179
LD + + +G+EYL + +HRD+ + N+L+ + KIAD
Sbjct: 122 --------ARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIAD 170
Query: 180 FNLSNQAPDMAARLHSTRVLGTFG--YH------------APEYAMTGQLTQKSDVYSFG 225
F L+ ++L Y APE +++SDV+SFG
Sbjct: 171 FGLA-------------KLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFG 217
Query: 226 VVLLELLT-GRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKG---EYPPKGVAK 281
VVL EL T K + ++ + ++ + ++ +G PP A+
Sbjct: 218 VVLYELFTYCDKS--CSPSAEFLRMMGCERDVPALSRLLELLE---EGQRLPAPPACPAE 272
Query: 282 LAAVAALCVQYEAEFRPNMSIVVKALQPLLKSPPPAAPVSET 323
+ + LC + RP+ S + L L + T
Sbjct: 273 VHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGCETHAFT 314
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 1e-26
Identities = 42/176 (23%), Positives = 75/176 (42%), Gaps = 39/176 (22%)
Query: 76 SVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTR 135
V++ + + ++ LLG C+ ++++ + G L D + K +
Sbjct: 69 YVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDN--------IGSQYL 119
Query: 136 VRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHS 195
+ V A+G+ YL ++ ++HRD+ + NVL+ KI DF L+
Sbjct: 120 LNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLA------------ 164
Query: 196 TRVLGTFGYH-------------APEYAMTGQLTQKSDVYSFGVVLLELLT-GRKP 237
++LG A E + T +SDV+S+GV + EL+T G KP
Sbjct: 165 -KLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 1e-26
Identities = 61/247 (24%), Positives = 105/247 (42%), Gaps = 39/247 (15%)
Query: 76 SVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTR 135
+V+ L+H+ LV+L + + ++ EF GSL D L +G
Sbjct: 235 NVMKTLQHDKLVKLHAVVTKEPIYIIT-EFMAKGSLLDFLKSDEG-------SKQPLPKL 286
Query: 136 VRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHS 195
+ + A G+ ++ ++ + IHRD+R++N+L+ KIADF L+ D ++
Sbjct: 287 IDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNE---YT 340
Query: 196 TRVLGTFGYH--APEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTW 252
R F APE G T KSDV+SFG++L+E++T GR P
Sbjct: 341 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPY-------------- 386
Query: 253 ATPRLSEDKVKQCVDPKLKGE--YPPKGV-AKLAAVAALCVQYEAEFRPNMSIVVKALQP 309
P +S +V + ++ +G P+ +L + C + E RP + L
Sbjct: 387 --PGMSNPEVIRALE---RGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 441
Query: 310 LLKSPPP 316
+
Sbjct: 442 FYTATES 448
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-26
Identities = 62/259 (23%), Positives = 95/259 (36%), Gaps = 61/259 (23%)
Query: 76 SVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTR 135
S++ + H N++ L G G L ++ E+ GSL L G M
Sbjct: 102 SIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQ--------FTIMQL 153
Query: 136 VRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHS 195
V + G+ YL + +HRD+ + NVL+ + K++DF LS
Sbjct: 154 VGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLS------------ 198
Query: 196 TRVLG--TFGYH------------APEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDH 240
RVL + APE + SDV+SFGVV+ E+L G +P
Sbjct: 199 -RVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPY-- 255
Query: 241 TMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGE--YPPKG-VAKLAAVAALCVQYEAEFR 297
++ V V+ +G P G L + C + R
Sbjct: 256 --------------WNMTNRDVISSVE---EGYRLPAPMGCPHALHQLMLDCWHKDRAQR 298
Query: 298 PNMSIVVKALQPLLKSPPP 316
P S +V L L++SP
Sbjct: 299 PRFSQIVSVLDALIRSPES 317
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-26
Identities = 56/257 (21%), Positives = 105/257 (40%), Gaps = 43/257 (16%)
Query: 76 SVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTR 135
++ + H N++ L G + ++ E+ G+L L + G +
Sbjct: 98 GIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGE--------FSVLQL 149
Query: 136 VRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHS 195
V + A G++YL + +HRD+ + N+L+ + K++DF LS D ++
Sbjct: 150 VGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYT 206
Query: 196 TR-----VLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSL 249
T + T APE + T SDV+SFG+V+ E++T G +P
Sbjct: 207 TSGGKIPIRWT----APEAISYRKFTSASDVWSFGIVMWEVMTYGERPY----------- 251
Query: 250 VTWATPRLSEDKVKQCVDPKLKGE--YPPKGV-AKLAAVAALCVQYEAEFRPNMSIVVKA 306
LS +V + ++ G P + + + C Q E RP + +V
Sbjct: 252 -----WELSNHEVMKAIN---DGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSI 303
Query: 307 LQPLLKSPPPAAPVSET 323
L L+++P +++
Sbjct: 304 LDKLIRAPDSLKTLADF 320
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-26
Identities = 53/272 (19%), Positives = 102/272 (37%), Gaps = 44/272 (16%)
Query: 65 KNYPDDEKQL----VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKG 120
E++ V+V++ +KH N+V+ E + ++ G L ++ +KG
Sbjct: 60 SRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKG 119
Query: 121 VQGAQPGP---VLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKI 177
+LDW ++ L+++H++ I+HRDI+S N+ L +D ++
Sbjct: 120 ----VLFQEDQILDWFVQI------CLALKHVHDR---KILHRDIKSQNIFLTKDGTVQL 166
Query: 178 ADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 237
DF ++ + +GT Y +PE KSD+++ G VL EL T +
Sbjct: 167 GDFGIARVLNSTVELARA--CIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHA 224
Query: 238 VDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFR 297
+ ++LV K+ P + Y L ++ + + R
Sbjct: 225 FEA---GSMKNLVL---------KIISGSFPPVSLHYSY----DLRSLVSQLFKRNPRDR 268
Query: 298 P------NMSIVVKALQPLLKSPPPAAPVSET 323
P + K ++ L A
Sbjct: 269 PSVNSILEKGFIAKRIEKFLSPQLIAEEFCLK 300
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 3e-26
Identities = 47/177 (26%), Positives = 73/177 (41%), Gaps = 31/177 (17%)
Query: 76 SVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQP-GPVLDWMT 134
SV+ ++V LLG +G ++ E T G L L + P
Sbjct: 80 SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSK 139
Query: 135 RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 194
+++A + A G+ YL+ +HRD+ + N ++ EDF KI DF ++
Sbjct: 140 MIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMT----------- 185
Query: 195 STRVLGTFGYH-------------APEYAMTGQLTQKSDVYSFGVVLLELLT-GRKP 237
R + Y+ +PE G T SDV+SFGVVL E+ T +P
Sbjct: 186 --RDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP 240
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 3e-26
Identities = 62/252 (24%), Positives = 105/252 (41%), Gaps = 52/252 (20%)
Query: 76 SVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTR 135
+V+ +KH NLV+LLG C + EF T G+L D L + +
Sbjct: 61 AVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-------QEVSAVVL 113
Query: 136 VRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHS 195
+ +A + +EYL +K + IHRD+ + N L+ E+ K+ADF LS
Sbjct: 114 LYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLS------------ 158
Query: 196 TRVLGTFGYH------------APEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTM 242
R++ Y APE + + KSDV++FGV+L E+ T G P
Sbjct: 159 -RLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY---- 213
Query: 243 PRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSI 302
P + +V + ++ + E P K+ + C Q+ RP+ +
Sbjct: 214 ------------PGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAE 261
Query: 303 VVKALQPLLKSP 314
+ +A + + +
Sbjct: 262 IHQAFETMFQES 273
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 3e-26
Identities = 50/253 (19%), Positives = 92/253 (36%), Gaps = 59/253 (23%)
Query: 76 SVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTR 135
+ +L H LV+ G C + + E+ + G L + L G L+
Sbjct: 55 QTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSH--------GKGLEPSQL 106
Query: 136 VRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHS 195
+ + D G+ +L IHRD+ + N L+ D K++DF ++
Sbjct: 107 LEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMT------------ 151
Query: 196 TRVLGTFGYH------------APEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTM 242
R + Y APE + + KSDV++FG+++ E+ + G+ P
Sbjct: 152 -RYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPY---- 206
Query: 243 PRGQQSLVTWATPRLSEDKVKQCVDPKLKGE--YPPKGV-AKLAAVAALCVQYEAEFRPN 299
+ +V V +G Y P + + C E RP
Sbjct: 207 ------------DLYTNSEVVLKVS---QGHRLYRPHLASDTIYQIMYSCWHELPEKRPT 251
Query: 300 MSIVVKALQPLLK 312
++ +++PL +
Sbjct: 252 FQQLLSSIEPLRE 264
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 3e-26
Identities = 70/247 (28%), Positives = 108/247 (43%), Gaps = 45/247 (18%)
Query: 76 SVVSRLKHENLVELLGYCVEGNLRV-LAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 134
SV+++L+H NLV+LLG VE + + E+ GSL D L R VL
Sbjct: 66 SVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR-------SVLGGDC 118
Query: 135 RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAAR-L 193
++ ++D +EYL + +HRD+ + NVL+ ED AK++DF L +
Sbjct: 119 LLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGL--------TKEA 167
Query: 194 HSTRVLGTFGYH--APEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLV 250
ST+ G APE + + KSDV+SFG++L E+ + GR P
Sbjct: 168 SSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPY------------ 215
Query: 251 TWATPRLSEDKVKQCVDPKLKGE--YPPKGV-AKLAAVAALCVQYEAEFRPNMSIVVKAL 307
PR+ V V+ KG P G + V C +A RP+ + + L
Sbjct: 216 ----PRIPLKDVVPRVE---KGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQL 268
Query: 308 QPLLKSP 314
+ +
Sbjct: 269 EHIKTHE 275
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 3e-26
Identities = 52/245 (21%), Positives = 97/245 (39%), Gaps = 39/245 (15%)
Query: 76 SVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTR 135
V+ L HE LV+L G C + + E+ G L + L +
Sbjct: 71 KVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR--------FQTQQL 122
Query: 136 VRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHS 195
+ + D +EYL K +HRD+ + N L+ + K++DF LS + ++
Sbjct: 123 LEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSR---YVLDDEYT 176
Query: 196 TRVLGTFGYH--APEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTW 252
+ V F PE M + + KSD+++FGV++ E+ + G+ P
Sbjct: 177 SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPY-------------- 222
Query: 253 ATPRLSEDKVKQCVDPKLKGE--YPPKGV-AKLAAVAALCVQYEAEFRPNMSIVVKALQP 309
R + + + + +G Y P K+ + C +A+ RP I++ +
Sbjct: 223 --ERFTNSETAEHIA---QGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD 277
Query: 310 LLKSP 314
++
Sbjct: 278 VMDEE 282
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 5e-26
Identities = 48/165 (29%), Positives = 75/165 (45%), Gaps = 17/165 (10%)
Query: 78 VSRLKHENLVELLGY-CVEGNLRVLAY---EFATMGSLHDILHGRKGVQGAQPGPVLDWM 133
+ L H +V + E L Y E+ +L DI+H GP +
Sbjct: 66 AAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE--------GP-MTPK 116
Query: 134 TRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARL 193
+ + DA + L + H+ IIHRD++ +N+++ K+ DF ++ D +
Sbjct: 117 RAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSV 173
Query: 194 HST-RVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 237
T V+GT Y +PE A + +SDVYS G VL E+LTG P
Sbjct: 174 TQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 5e-26
Identities = 54/248 (21%), Positives = 96/248 (38%), Gaps = 24/248 (9%)
Query: 75 VSVVSRLKHENLVELLGYCVEGNLRVLAY---EFATMGSLHDILHGRKGVQGAQPGPVLD 131
+ ++ L+H+N+V+ G C R L E+ GSL D L K +D
Sbjct: 62 IEILKSLQHDNIVKYKGVCYSAGRRNL-KLIMEYLPYGSLRDYLQKHKER--------ID 112
Query: 132 WMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPD--M 189
+ ++ +G+EYL K IHRD+ + N+L+ + + KI DF L+ P
Sbjct: 113 HIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKE 169
Query: 190 AARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSL 249
++ F Y APE + + SDV+SFGVVL EL T + + +
Sbjct: 170 FFKVKEPGESPIFWY-APESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMI 228
Query: 250 VTWATPRLSEDKVKQCVDPKLKG---EYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKA 306
++ + + + P ++ + C RP+ +
Sbjct: 229 GNDKQGQMIVFHLIELLK---NNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALR 285
Query: 307 LQPLLKSP 314
+ + +
Sbjct: 286 VDQIRDNM 293
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 6e-26
Identities = 58/248 (23%), Positives = 101/248 (40%), Gaps = 43/248 (17%)
Query: 76 SVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTR 135
S++ + H N++ L G + ++ E+ GSL L +
Sbjct: 98 SIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ--------FTVIQL 149
Query: 136 VRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHS 195
V + A G++YL + +HRD+ + N+L+ + K++DF L D ++
Sbjct: 150 VGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYT 206
Query: 196 TR-----VLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSL 249
TR + T +PE + T SDV+S+G+VL E+++ G +P
Sbjct: 207 TRGGKIPIRWT----SPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY----------- 251
Query: 250 VTWATPRLSEDKVKQCVDPKLKGE--YPPKG-VAKLAAVAALCVQYEAEFRPNMSIVVKA 306
+S V + VD +G PP A L + C Q + RP +V
Sbjct: 252 -----WEMSNQDVIKAVD---EGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSI 303
Query: 307 LQPLLKSP 314
L L+++P
Sbjct: 304 LDKLIRNP 311
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 1e-25
Identities = 54/260 (20%), Positives = 92/260 (35%), Gaps = 60/260 (23%)
Query: 76 SVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTR 135
++ L H ++V+L+G E ++ E G L L K L +T
Sbjct: 65 VIMKNLDHPHIVKLIGIIEEEPTWIIM-ELYPYGELGHYLERNKNS--------LKVLTL 115
Query: 136 VRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHS 195
V ++ + + YL + +HRDI N+L+ K+ DF LS
Sbjct: 116 VLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLS------------ 160
Query: 196 TRVLGTFGYH------------APEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTM 242
R + Y+ +PE + T SDV+ F V + E+L+ G++P
Sbjct: 161 -RYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPF---- 215
Query: 243 PRGQQSLVTWATPRLSEDKVKQCVDPKLKGE--YPPKGV-AKLAAVAALCVQYEAEFRPN 299
L V ++ KG+ P L + C Y+ RP
Sbjct: 216 ------------FWLENKDVIGVLE---KGDRLPKPDLCPPVLYTLMTRCWDYDPSDRPR 260
Query: 300 MSIVVKALQPLLKSPPPAAP 319
+ +V +L + + A
Sbjct: 261 FTELVCSLSDVYQMEKDIAM 280
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-25
Identities = 54/247 (21%), Positives = 95/247 (38%), Gaps = 24/247 (9%)
Query: 75 VSVVSRLKHENLVELLGYCVEGNLRVLAY---EFATMGSLHDILHGRKGVQGAQPGPVLD 131
+ ++ L+H+N+V+ G C R L E+ GSL D L K +D
Sbjct: 93 IEILKSLQHDNIVKYKGVCYSAGRRNL-KLIMEYLPYGSLRDYLQKHKER--------ID 143
Query: 132 WMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPD--M 189
+ ++ +G+EYL K IHRD+ + N+L+ + + KI DF L+ P
Sbjct: 144 HIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKE 200
Query: 190 AARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSL 249
++ F Y APE + + SDV+SFGVVL EL T + + +
Sbjct: 201 YYKVKEPGESPIFWY-APESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMI 259
Query: 250 VTWATPRLSEDKVKQCVDPKLKG---EYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKA 306
++ + + + P ++ + C RP+ +
Sbjct: 260 GNDKQGQMIVFHLIELLK---NNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALR 316
Query: 307 LQPLLKS 313
+ +
Sbjct: 317 VDQIRDQ 323
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 1e-25
Identities = 56/286 (19%), Positives = 106/286 (37%), Gaps = 58/286 (20%)
Query: 61 LKSPKNYPDDEKQLVS---VVSRLKHENLVELLGYCVEGNLRVLAY------EFATMGSL 111
LK+ D ++ + + H ++ +L+G + + F G L
Sbjct: 59 LKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDL 118
Query: 112 HDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFE 171
H L + + P+ VR VD A G+EYL + + IHRD+ + N +L E
Sbjct: 119 HAFLLASRIGENPFNLPLQT---LVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAE 172
Query: 172 DFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYH-------------APEYAMTGQLTQK 218
D +ADF LS R + + Y+ A E T
Sbjct: 173 DMTVCVADFGLS-------------RKIYSGDYYRQGCASKLPVKWLALESLADNLYTVH 219
Query: 219 SDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPK 277
SDV++FGV + E++T G+ P + ++ + + + PP+
Sbjct: 220 SDVWAFGVTMWEIMTRGQTPY----------------AGIENAEIYNYLIGGNRLKQPPE 263
Query: 278 GVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSPPPAAPVSET 323
+ ++ + C + + RP+ + + L+ +L + +
Sbjct: 264 CMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQDP 309
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 2e-25
Identities = 46/184 (25%), Positives = 78/184 (42%), Gaps = 37/184 (20%)
Query: 75 VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGR-------KGVQGAQPG 127
+ +RL+H N+V LLG + + + + + G LH+ L R
Sbjct: 63 AMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVK 122
Query: 128 PVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAP 187
L+ V + A G+EYL ++H+D+ + NVL+++ KI+D L
Sbjct: 123 SALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLF---- 175
Query: 188 DMAARLHSTRVLGTFGYH-------------APEYAMTGQLTQKSDVYSFGVVLLELLT- 233
R + Y+ APE M G+ + SD++S+GVVL E+ +
Sbjct: 176 ---------REVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSY 226
Query: 234 GRKP 237
G +P
Sbjct: 227 GLQP 230
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 2e-25
Identities = 56/190 (29%), Positives = 76/190 (40%), Gaps = 40/190 (21%)
Query: 63 SPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQ 122
S DD + V+ + L H NL+ L G + ++++ E A +GSL D L +G
Sbjct: 60 SQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMKMVT-ELAPLGSLLDRLRKHQGH- 117
Query: 123 GAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNL 182
T R AV A G+ YL K IHRD+ + N+LL KI DF L
Sbjct: 118 -------FLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGL 167
Query: 183 SNQAPDMAARLHSTRVLGTFG--YH------------APEYAMTGQLTQKSDVYSFGVVL 228
R L Y APE T + SD + FGV L
Sbjct: 168 M-------------RALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTL 214
Query: 229 LELLT-GRKP 237
E+ T G++P
Sbjct: 215 WEMFTYGQEP 224
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 2e-25
Identities = 57/258 (22%), Positives = 102/258 (39%), Gaps = 51/258 (19%)
Query: 76 SVVSRLKHENLVELLGYCVEGNLRVLAY---EFATMGSLHDILHGRKGVQGAQPGPVLDW 132
++ L HEN+V+ G C E + EF GSL + L K ++
Sbjct: 75 EILRNLYHENIVKYKGICTEDGGNGI-KLIMEFLPSGSLKEYLPKNKNK--------INL 125
Query: 133 MTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAAR 192
+++ AV +G++YL + +HRD+ + NVL+ + + KI DF L+
Sbjct: 126 KQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLT--------- 173
Query: 193 LHSTRVL--GTFGYH------------APEYAMTGQLTQKSDVYSFGVVLLELLT-GRKP 237
+ + Y APE M + SDV+SFGV L ELLT
Sbjct: 174 ----KAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSD 229
Query: 238 VDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKG---EYPPKGVAKLAAVAALCVQYEA 294
+ T +++ ++ + +G PP ++ + C +++
Sbjct: 230 SSPMALFLKMIGPTH--GQMTVTRLVNTLK---EGKRLPCPPNCPDEVYQLMRKCWEFQP 284
Query: 295 EFRPNMSIVVKALQPLLK 312
R + +++ + LLK
Sbjct: 285 SNRTSFQNLIEGFEALLK 302
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 3e-25
Identities = 63/247 (25%), Positives = 109/247 (44%), Gaps = 39/247 (15%)
Query: 76 SVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTR 135
+++ +L+H+ LV L + + ++ E+ GSL D L G++ L
Sbjct: 60 NLMKQLQHQRLVRLYAVVTQEPIYIIT-EYMENGSLVDFLKTPSGIK-------LTINKL 111
Query: 136 VRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHS 195
+ +A A G+ ++ E+ + IHRD+R++N+L+ + KIADF L+ D ++
Sbjct: 112 LDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE---YT 165
Query: 196 TRVLGTFGYH--APEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTW 252
R F APE G T KSDV+SFG++L E++T GR P
Sbjct: 166 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPY-------------- 211
Query: 253 ATPRLSEDKVKQCVDPKLKGE--YPPKGV-AKLAAVAALCVQYEAEFRPNMSIVVKALQP 309
P ++ +V Q ++ +G P +L + LC + E RP + L+
Sbjct: 212 --PGMTNPEVIQNLE---RGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLED 266
Query: 310 LLKSPPP 316
+
Sbjct: 267 FFTATEG 273
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 4e-25
Identities = 42/176 (23%), Positives = 75/176 (42%), Gaps = 39/176 (22%)
Query: 76 SVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTR 135
V++ + + ++ LLG C+ ++++ + G L D + K +
Sbjct: 69 YVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDN--------IGSQYL 119
Query: 136 VRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHS 195
+ V A+G+ YL ++ ++HRD+ + NVL+ KI DF L+
Sbjct: 120 LNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLA------------ 164
Query: 196 TRVLGTFGYH-------------APEYAMTGQLTQKSDVYSFGVVLLELLT-GRKP 237
++LG A E + T +SDV+S+GV + EL+T G KP
Sbjct: 165 -KLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 4e-25
Identities = 61/262 (23%), Positives = 105/262 (40%), Gaps = 62/262 (23%)
Query: 75 VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 134
++ +L + +V L+G C L ++ E A G LH L G++ +
Sbjct: 61 AQIMHQLDNPYIVRLIGVCQAEALMLVM-EMAGGGPLHKFLVGKREE--------IPVSN 111
Query: 135 RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 194
+ + G++YL EK + +HRD+ + NVLL AKI+DF LS
Sbjct: 112 VAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLS----------- 157
Query: 195 STRVLGT--FGYH------------APEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVD 239
+ LG Y APE + + +SDV+S+GV + E L+ G+KP
Sbjct: 158 --KALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPY- 214
Query: 240 HTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGE--YPPKGV-AKLAAVAALCVQYEAEF 296
++ +V ++ +G+ P +L A+ + C Y+ E
Sbjct: 215 ---------------KKMKGPEVMAFIE---QGKRMECPPECPPELYALMSDCWIYKWED 256
Query: 297 RPNMSIVVKALQPLLKSPPPAA 318
RP+ V + ++ S
Sbjct: 257 RPDFLTVEQRMRACYYSLASKV 278
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 4e-25
Identities = 62/260 (23%), Positives = 100/260 (38%), Gaps = 57/260 (21%)
Query: 75 VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 134
++S+ H+N+V +G ++ R + E G L L + L +
Sbjct: 84 ALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPS--QPSSLAMLD 141
Query: 135 RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLF---EDFKAKIADFNLSNQAPDMAA 191
+ +A D A G +YL E IHRDI + N LL AKI DF ++
Sbjct: 142 LLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMA-------- 190
Query: 192 RLHSTRVLGTFGYH-------------APEYAMTGQLTQKSDVYSFGVVLLELLT-GRKP 237
R + Y+ PE M G T K+D +SFGV+L E+ + G P
Sbjct: 191 -----RDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 245
Query: 238 VDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKG---EYPPKGVAKLAAVAALCVQYEA 294
P S +V + V G + P + + C Q++
Sbjct: 246 Y----------------PSKSNQEVLEFVT---SGGRMDPPKNCPGPVYRIMTQCWQHQP 286
Query: 295 EFRPNMSIVVKALQPLLKSP 314
E RPN +I+++ ++ + P
Sbjct: 287 EDRPNFAIILERIEYCTQDP 306
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 4e-25
Identities = 46/176 (26%), Positives = 79/176 (44%), Gaps = 39/176 (22%)
Query: 76 SVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTR 135
+ L H ++V LLG C +L+++ ++ +GSL D + +G G Q
Sbjct: 67 LAIGSLDHAHIVRLLGLCPGSSLQLVT-QYLPLGSLLDHVRQHRGALGPQ--------LL 117
Query: 136 VRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHS 195
+ V A+G+ YL E ++HR++ + NVLL + ++ADF ++
Sbjct: 118 LNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVA------------ 162
Query: 196 TRVLGTFGYH-------------APEYAMTGQLTQKSDVYSFGVVLLELLT-GRKP 237
+L A E G+ T +SDV+S+GV + EL+T G +P
Sbjct: 163 -DLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEP 217
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 5e-25
Identities = 48/199 (24%), Positives = 82/199 (41%), Gaps = 41/199 (20%)
Query: 61 LKSPKNYPDDEKQLVS---VVSRLKHENLVELLGYCVEGNLRVLAY-----EFATMGSLH 112
+K + + ++ +S + H N++ LLG C+E + + + F G LH
Sbjct: 70 MKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLH 129
Query: 113 DILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFED 172
L + + T ++ VD A G+EYL + + +HRD+ + N +L +D
Sbjct: 130 TYLLYSRL---ETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDD 183
Query: 173 FKAKIADFNLSNQAPDMAARLHSTRVLGTFGYH-------------APEYAMTGQLTQKS 219
+ADF LS + + + Y+ A E T KS
Sbjct: 184 MTVCVADFGLS-------------KKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKS 230
Query: 220 DVYSFGVVLLELLT-GRKP 237
DV++FGV + E+ T G P
Sbjct: 231 DVWAFGVTMWEIATRGMTP 249
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 7e-25
Identities = 61/265 (23%), Positives = 105/265 (39%), Gaps = 58/265 (21%)
Query: 75 VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 134
+++ L+H+++V G C EG ++ +E+ G L+ L G
Sbjct: 94 AELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPG 153
Query: 135 R------VRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPD 188
+ +A A G+ YL +HRD+ + N L+ + KI DF +S
Sbjct: 154 PLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGLVVKIGDFGMS----- 205
Query: 189 MAARLHSTRVLGTFGYH-------------APEYAMTGQLTQKSDVYSFGVVLLELLT-G 234
R + + Y+ PE + + T +SDV+SFGVVL E+ T G
Sbjct: 206 --------RDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYG 257
Query: 235 RKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEY--PPKGV-AKLAAVAALCVQ 291
++P +LS + C+ +G P+ ++ A+ C Q
Sbjct: 258 KQPW----------------YQLSNTEAIDCIT---QGRELERPRACPPEVYAIMRGCWQ 298
Query: 292 YEAEFRPNMSIVVKALQPLLKSPPP 316
E + R ++ V LQ L ++PP
Sbjct: 299 REPQQRHSIKDVHARLQALAQAPPV 323
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 1e-24
Identities = 55/257 (21%), Positives = 97/257 (37%), Gaps = 63/257 (24%)
Query: 76 SVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTR 135
S++S+L H++LV G CV G+ +L EF GSL L K ++ + +
Sbjct: 64 SMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKN--------CINILWK 115
Query: 136 VRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFK--------AKIADFNLSNQAP 187
+ +A A + +L E ++IH ++ + N+LL + K++D +S
Sbjct: 116 LEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGIS---- 168
Query: 188 DMAARLHSTRVLGTFGYH-------APEYAMTGQL-TQKSDVYSFGVVLLELLT-GRKPV 238
+ PE + +D +SFG L E+ + G KP+
Sbjct: 169 ---------ITVLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPL 219
Query: 239 DHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGE--YPPKGVAKLAAVAALCVQYEAEF 296
L + Q + PK A+LA + C+ YE +
Sbjct: 220 ----------------SALDSQRKLQFYE---DRHQLPAPKA-AELANLINNCMDYEPDH 259
Query: 297 RPNMSIVVKALQPLLKS 313
RP+ +++ L L
Sbjct: 260 RPSFRAIIRDLNSLFTP 276
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 1e-24
Identities = 52/177 (29%), Positives = 78/177 (44%), Gaps = 37/177 (20%)
Query: 82 KHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQ-------GAQPGPVLDWMT 134
KH+N++ LLG C + + E+A+ G+L + L R+ P + +
Sbjct: 99 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 135 RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 194
V ARG+EYL + IHRD+ + NVL+ E+ KIADF L+
Sbjct: 159 LVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLA----------- 204
Query: 195 STRVLGTFGYH-------------APEYAMTGQLTQKSDVYSFGVVLLELLT-GRKP 237
R + Y+ APE T +SDV+SFGV++ E+ T G P
Sbjct: 205 --RDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 1e-24
Identities = 38/160 (23%), Positives = 59/160 (36%), Gaps = 13/160 (8%)
Query: 78 VSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVR 137
RL+ ++V + + + L +L + GP L V
Sbjct: 88 AGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQ--------GP-LAPPRAVA 138
Query: 138 IAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTR 197
I L+ H HRD++ N+L+ D A + DF ++ A
Sbjct: 139 IVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIA-SATTDEKLTQLGN 194
Query: 198 VLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 237
+GT Y APE T ++D+Y+ VL E LTG P
Sbjct: 195 TVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPP 234
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 1e-24
Identities = 48/175 (27%), Positives = 72/175 (41%), Gaps = 38/175 (21%)
Query: 76 SVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTR 135
+ + H ++V+L+G E + ++ E T+G L L RK LD +
Sbjct: 68 LTMRQFDHPHIVKLIGVITENPVWIIM-ELCTLGELRSFLQVRKYS--------LDLASL 118
Query: 136 VRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHS 195
+ A + L YL K +HRDI + NVL+ + K+ DF LS
Sbjct: 119 ILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLS------------ 163
Query: 196 TRVLGTFGYH------------APEYAMTGQLTQKSDVYSFGVVLLELLT-GRKP 237
R + Y+ APE + T SDV+ FGV + E+L G KP
Sbjct: 164 -RYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP 217
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 2e-24
Identities = 55/273 (20%), Positives = 99/273 (36%), Gaps = 55/273 (20%)
Query: 75 VSVVSRLKHENLVELLGYCVEGN---------LRVLAY---EFATMGSLHDILHGRKGVQ 122
V +++L+H +V +E N +V Y + +L D ++GR ++
Sbjct: 54 VKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIE 113
Query: 123 GAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNL 182
+ L ++ A +E+LH K ++HRD++ SN+ D K+ DF L
Sbjct: 114 ERERSVCLHIFLQI------AEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGL 164
Query: 183 S-----------NQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLEL 231
P A H+ +V GT Y +PE + K D++S G++L EL
Sbjct: 165 VTAMDQDEEEQTVLTPMPAYARHTGQV-GTKLYMSPEQIHGNSYSHKVDIFSLGLILFEL 223
Query: 232 LTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQ 291
L P M R + V+ P L + P + +
Sbjct: 224 LY---PFSTQMERVRTL-----------TDVRNLKFPPLFTQKYP----CEYVMVQDMLS 265
Query: 292 YEAEFRPNMSIVVKALQPLLKS--PPPAAPVSE 322
RP +++ + + P + +
Sbjct: 266 PSPMERPEAINIIE--NAVFEDLDFPGKTVLRQ 296
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 2e-24
Identities = 61/243 (25%), Positives = 94/243 (38%), Gaps = 36/243 (14%)
Query: 76 SVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTR 135
+ + H ++V+L+G E + ++ E T+G L L RK LD +
Sbjct: 443 LTMRQFDHPHIVKLIGVITENPVWIIM-ELCTLGELRSFLQVRK--------FSLDLASL 493
Query: 136 VRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHS 195
+ A + L YL K +HRDI + NVL+ + K+ DF LS D S
Sbjct: 494 ILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKAS 550
Query: 196 TRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWAT 254
L APE + T SDV+ FGV + E+L G KP
Sbjct: 551 KGKLPIKWM-APESINFRRFTSASDVWMFGVCMWEILMHGVKPF---------------- 593
Query: 255 PRLSEDKVKQCVDPKLKGEY---PPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLL 311
+ + V ++ GE PP L ++ C Y+ RP + + L +L
Sbjct: 594 QGVKNNDVIGRIE---NGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 650
Query: 312 KSP 314
+
Sbjct: 651 EEE 653
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 3e-24
Identities = 43/188 (22%), Positives = 78/188 (41%), Gaps = 35/188 (18%)
Query: 69 DDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAY----------------EFATMGSLH 112
+ ++ V +++L H N+V G + EF G+L
Sbjct: 49 EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLE 108
Query: 113 DILHGRKGVQGAQPGP---VLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLL 169
+ R+G + L+ ++ +G++Y+H K +I+RD++ SN+ L
Sbjct: 109 QWIEKRRG----EKLDKVLALELFEQI------TKGVDYIHSK---KLINRDLKPSNIFL 155
Query: 170 FEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLL 229
+ + KI DF L + R TR GT Y +PE + ++ D+Y+ G++L
Sbjct: 156 VDTKQVKIGDFGLVTSLKNDGKR---TRSKGTLRYMSPEQISSQDYGKEVDLYALGLILA 212
Query: 230 ELLTGRKP 237
ELL
Sbjct: 213 ELLHVCDT 220
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 3e-24
Identities = 63/260 (24%), Positives = 101/260 (38%), Gaps = 57/260 (21%)
Query: 75 VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 134
++S+ H+N+V +G ++ R + E G L L + L +
Sbjct: 125 ALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRP--RPSQPSSLAMLD 182
Query: 135 RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLF---EDFKAKIADFNLSNQAPDMAA 191
+ +A D A G +YL E IHRDI + N LL AKI DF ++
Sbjct: 183 LLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMA-------- 231
Query: 192 RLHSTRVLGTFGYH-------------APEYAMTGQLTQKSDVYSFGVVLLELLT-GRKP 237
R + GY+ PE M G T K+D +SFGV+L E+ + G P
Sbjct: 232 -----RDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 286
Query: 238 VDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKG---EYPPKGVAKLAAVAALCVQYEA 294
P S +V + V G + P + + C Q++
Sbjct: 287 Y----------------PSKSNQEVLEFVT---SGGRMDPPKNCPGPVYRIMTQCWQHQP 327
Query: 295 EFRPNMSIVVKALQPLLKSP 314
E RPN +I+++ ++ + P
Sbjct: 328 EDRPNFAIILERIEYCTQDP 347
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 3e-24
Identities = 65/254 (25%), Positives = 100/254 (39%), Gaps = 53/254 (20%)
Query: 82 KHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQ-------PGPVLDWMT 134
KH+N++ LLG C + + E+A+ G+L + L R+ P L
Sbjct: 133 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 192
Query: 135 RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 194
V A ARG+EYL K IHRD+ + NVL+ ED KIADF L+
Sbjct: 193 LVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLA----------- 238
Query: 195 STRVLGTFGYH-------------APEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDH 240
R + Y+ APE T +SDV+SFGV+L E+ T G P
Sbjct: 239 --RDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP--- 293
Query: 241 TMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNM 300
P + +++ + + + + P +L + C RP
Sbjct: 294 -------------YPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTF 340
Query: 301 SIVVKALQPLLKSP 314
+V+ L ++
Sbjct: 341 KQLVEDLDRIVALT 354
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 3e-24
Identities = 46/177 (25%), Positives = 78/177 (44%), Gaps = 41/177 (23%)
Query: 76 SVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTR 135
+V+ +L + +V ++G C + ++ E A +G L+ L + V+
Sbjct: 70 NVMQQLDNPYIVRMIGICEAESWMLVM-EMAELGPLNKYLQQNRHVKDKN---------I 119
Query: 136 VRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHS 195
+ + + G++YL E + +HRD+ + NVLL AKI+DF LS
Sbjct: 120 IELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLS------------ 164
Query: 196 TRVLGTFG--YH------------APEYAMTGQLTQKSDVYSFGVVLLELLT-GRKP 237
+ L Y APE + + KSDV+SFGV++ E + G+KP
Sbjct: 165 -KALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 220
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 3e-24
Identities = 52/231 (22%), Positives = 96/231 (41%), Gaps = 31/231 (13%)
Query: 75 VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGP---VLD 131
+ ++ +L H N+++ +E N + E A G L ++ K + + P V
Sbjct: 83 IDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFK--KQKRLIPERTVWK 140
Query: 132 WMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAA 191
+ ++ LE++H + ++HRDI+ +NV + K+ D L
Sbjct: 141 YFVQL------CSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 191
Query: 192 RLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVT 251
HS ++GT Y +PE KSD++S G +L E+ + P + SL
Sbjct: 192 AAHS--LVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPF-YGDKMNLYSLCK 248
Query: 252 WATPRLSEDKVKQCVDPKL-KGEYPPKGVAKLAAVAALCVQYEAEFRPNMS 301
K++QC P L Y +L + +C+ + E RP+++
Sbjct: 249 ---------KIEQCDYPPLPSDHYSE----ELRQLVNMCINPDPEKRPDVT 286
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 3e-24
Identities = 52/177 (29%), Positives = 78/177 (44%), Gaps = 37/177 (20%)
Query: 82 KHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQ-------PGPVLDWMT 134
KH+N++ LLG C + + E+A+ G+L + L R+ P + +
Sbjct: 145 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 204
Query: 135 RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 194
V ARG+EYL + IHRD+ + NVL+ E+ KIADF L+
Sbjct: 205 LVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLA----------- 250
Query: 195 STRVLGTFGYH-------------APEYAMTGQLTQKSDVYSFGVVLLELLT-GRKP 237
R + Y+ APE T +SDV+SFGV++ E+ T G P
Sbjct: 251 --RDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 305
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 4e-24
Identities = 55/238 (23%), Positives = 94/238 (39%), Gaps = 41/238 (17%)
Query: 75 VSVVSRLKHENLVELLGYCVEGNLRVLAY---EFATMGSLHDILHGRKGVQGAQPGP--- 128
V+++ LKH N+V ++ L Y E+ G L ++ KG + Q
Sbjct: 56 VNLLRELKHPNIVRYYDRIIDRTNTTL-YIVMEYCEGGDLASVI--TKGTKERQYLDEEF 112
Query: 129 VLDWMTRVRIAVDAARGLEYLHEK--VQPSIIHRDIRSSNVLLFEDFKAKIADFNLS--- 183
VL MT++ L+ H + +++HRD++ +NV L K+ DF L+
Sbjct: 113 VLRVMTQL------TLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL 166
Query: 184 NQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMP 243
N A T V GT Y +PE +KSD++S G +L EL P
Sbjct: 167 NHDTSFA----KTFV-GTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTA--- 218
Query: 244 RGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMS 301
Q+ L K+++ ++ Y +L + + + RP++
Sbjct: 219 FSQKELA---------GKIREGKFRRIPYRYSD----ELNEIITRMLNLKDYHRPSVE 263
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 6e-24
Identities = 47/174 (27%), Positives = 72/174 (41%), Gaps = 31/174 (17%)
Query: 76 SVVSRLKHENLVELLGYCVEGNLRVLA-YEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 134
++ H N++ LLG C+ L + G L + +
Sbjct: 78 IIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNET--------HNPTVKD 129
Query: 135 RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAAR-L 193
+ + A+G++YL K +HRD+ + N +L E F K+ADF L+ R +
Sbjct: 130 LIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLA--------RDM 178
Query: 194 HST---RVLGTFGYH------APEYAMTGQLTQKSDVYSFGVVLLELLT-GRKP 237
+ V G A E T + T KSDV+SFGV+L EL+T G P
Sbjct: 179 YDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 232
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 6e-24
Identities = 49/179 (27%), Positives = 73/179 (40%), Gaps = 41/179 (22%)
Query: 76 SVVSRLKHENLVELLGYCVEGN-LRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 134
++ L H N++ L+G + L + + G L + P
Sbjct: 74 LLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIR--------SPQRNPTVKD 125
Query: 135 RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 194
+ + ARG+EYL E+ +HRD+ + N +L E F K+ADF L+
Sbjct: 126 LISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLA----------- 171
Query: 195 STRVLGTFGYH---------------APEYAMTGQLTQKSDVYSFGVVLLELLT-GRKP 237
R + Y+ A E T + T KSDV+SFGV+L ELLT G P
Sbjct: 172 --RDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPP 228
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 9e-24
Identities = 61/278 (21%), Positives = 104/278 (37%), Gaps = 67/278 (24%)
Query: 75 VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK--------------- 119
++++ + N+V+LLG C G L +E+ G L++ L
Sbjct: 101 AALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTR 160
Query: 120 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIAD 179
+ P L ++ IA A G+ YL E+ +HRD+ + N L+ E+ KIAD
Sbjct: 161 ARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIAD 217
Query: 180 FNLSNQAPDMAARLHSTRVLGTFGYH-------------APEYAMTGQLTQKSDVYSFGV 226
F LS R + + Y+ PE + T +SDV+++GV
Sbjct: 218 FGLS-------------RNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGV 264
Query: 227 VLLELLT-GRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKG---EYPPKGVAKL 282
VL E+ + G +P ++ ++V V G P +L
Sbjct: 265 VLWEIFSYGLQPY----------------YGMAHEEVIYYVR---DGNILACPENCPLEL 305
Query: 283 AAVAALCVQYEAEFRPNMSIVVKALQPLLKSPPPAAPV 320
+ LC RP+ + + LQ + + V
Sbjct: 306 YNLMRLCWSKLPADRPSFCSIHRILQRMCERAEGTVGV 343
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 1e-23
Identities = 39/193 (20%), Positives = 82/193 (42%), Gaps = 13/193 (6%)
Query: 49 VEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRV-LAYEFAT 107
++ + N S K+ DD K + +++ +K+E + G + V + YE+
Sbjct: 68 EKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGI-ITNYDEVYIIYEYME 126
Query: 108 MGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNV 167
S+ + + + + I Y+H + +I HRD++ SN+
Sbjct: 127 NDSILKFDEYFFVLDKNYTCFIPIQVIK-CIIKSVLNSFSYIHN--EKNICHRDVKPSNI 183
Query: 168 LLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLT---QKSDVYSF 224
L+ ++ + K++DF S D ++ +R GT+ + PE + + + K D++S
Sbjct: 184 LMDKNGRVKLSDFGESEYMVD--KKIKGSR--GTYEFMPPE-FFSNESSYNGAKVDIWSL 238
Query: 225 GVVLLELLTGRKP 237
G+ L + P
Sbjct: 239 GICLYVMFYNVVP 251
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 98.3 bits (245), Expect = 1e-23
Identities = 46/174 (26%), Positives = 72/174 (41%), Gaps = 16/174 (9%)
Query: 68 PDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPG 127
+ + + L +V L G EG + E GSL ++ ++ G P
Sbjct: 94 EVFRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLI--KQM--GCLPE 149
Query: 128 PVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFED-FKAKIADFNLSNQ- 185
+ A GLEYLH + I+H D+++ NVLL D +A + DF +
Sbjct: 150 DRALYYLG-----QALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCL 201
Query: 186 APDMAARLHSTR--VLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 237
PD + T + GT + APE M K D++S ++L +L G P
Sbjct: 202 QPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHP 255
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 100 bits (249), Expect = 1e-23
Identities = 60/259 (23%), Positives = 105/259 (40%), Gaps = 62/259 (23%)
Query: 76 SVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTR 135
++ +L + +V L+G C L ++ E A G LH L G++ +
Sbjct: 388 QIMHQLDNPYIVRLIGVCQAEALMLVM-EMAGGGPLHKFLVGKREE--------IPVSNV 438
Query: 136 VRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHS 195
+ + G++YL EK + +HR++ + NVLL AKI+DF LS
Sbjct: 439 AELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLS------------ 483
Query: 196 TRVLGT--FGYH------------APEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDH 240
+ LG Y APE + + +SDV+S+GV + E L+ G+KP
Sbjct: 484 -KALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPY-- 540
Query: 241 TMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGE--YPPKGV-AKLAAVAALCVQYEAEFR 297
++ +V ++ +G+ P +L A+ + C Y+ E R
Sbjct: 541 --------------KKMKGPEVMAFIE---QGKRMECPPECPPELYALMSDCWIYKWEDR 583
Query: 298 PNMSIVVKALQPLLKSPPP 316
P+ V + ++ S
Sbjct: 584 PDFLTVEQRMRACYYSLAS 602
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 1e-23
Identities = 55/169 (32%), Positives = 79/169 (46%), Gaps = 24/169 (14%)
Query: 82 KHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQ-------PGPVLDWMT 134
H N++ LLG C LA E+A G+L D L + ++ L
Sbjct: 84 HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 143
Query: 135 RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 194
+ A D ARG++YL +K IHRD+ + N+L+ E++ AKIADF LS R
Sbjct: 144 LLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLS--------RGQ 192
Query: 195 STRVLGTFG-----YHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKP 237
V T G + A E T SDV+S+GV+L E+++ G P
Sbjct: 193 EVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 241
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 2e-23
Identities = 47/176 (26%), Positives = 75/176 (42%), Gaps = 19/176 (10%)
Query: 75 VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 134
+++ LKH+N+V+ LG E + E GSL +L + G P +
Sbjct: 70 IALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWG-----PLKDNEQTI 124
Query: 135 RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLL-FEDFKAKIADFNLSNQAPDMAARL 193
GL+YLH+ I+HRDI+ NVL+ KI+DF S + +
Sbjct: 125 GF-YTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCT 180
Query: 194 HSTRVLGTFGYHAPE---YAMTGQLTQKSDVYSFGVVLLELLTGRKP---VDHTMP 243
+ GT Y APE G + +D++S G ++E+ TG+ P +
Sbjct: 181 ET--FTGTLQYMAPEIIDKGPRG-YGKAADIWSLGCTIIEMATGKPPFYELGEPQA 233
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 2e-23
Identities = 47/178 (26%), Positives = 70/178 (39%), Gaps = 38/178 (21%)
Query: 82 KHENLVELLGYC-VEGNLRVLAYEFATMGSLHDILHGRKGVQGAQ-------PGPVLDWM 133
H N+V LLG C G ++ EF G+L L ++ L
Sbjct: 89 HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLE 148
Query: 134 TRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARL 193
+ + A+G+E+L + IHRD+ + N+LL E KI DF L+
Sbjct: 149 HLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLA---------- 195
Query: 194 HSTRVLGTFGYH-------------APEYAMTGQLTQKSDVYSFGVVLLELLT-GRKP 237
R + + APE T +SDV+SFGV+L E+ + G P
Sbjct: 196 ---RDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 3e-23
Identities = 49/174 (28%), Positives = 73/174 (41%), Gaps = 33/174 (18%)
Query: 82 KHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQP-----GPVLDWMTRV 136
+HEN+V LLG C G ++ E+ G L + L + V P +
Sbjct: 108 QHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLL 167
Query: 137 RIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHST 196
+ A+G+ +L K + IHRD+ + NVLL AKI DF L AR
Sbjct: 168 HFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNGHVAKIGDFGL--------ARD--- 213
Query: 197 RVLGTFGYH------------APEYAMTGQLTQKSDVYSFGVVLLELLT-GRKP 237
++ Y APE T +SDV+S+G++L E+ + G P
Sbjct: 214 -IMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP 266
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 97.6 bits (243), Expect = 3e-23
Identities = 50/222 (22%), Positives = 92/222 (41%), Gaps = 20/222 (9%)
Query: 68 PDDEKQLV---SVVSRLKHENLVELLG-YCVEGNLRVLAYEFATMGSLHDILHGRKGVQG 123
P Q++ V+ +V G + +G + + E GSL +L +
Sbjct: 72 PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEI-SICMEHMDGGSLDQVLKKAGRI-- 128
Query: 124 AQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLS 183
P +L ++++ +GL YL EK + I+HRD++ SN+L+ + K+ DF +S
Sbjct: 129 --PEQIL-----GKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVS 179
Query: 184 NQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMP 243
Q D A + V GT Y +PE + +SD++S G+ L+E+ GR P+
Sbjct: 180 GQLIDSMAN---SFV-GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDA 235
Query: 244 RGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAV 285
+ + + + + + P A+
Sbjct: 236 KELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAI 277
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 4e-23
Identities = 45/179 (25%), Positives = 69/179 (38%), Gaps = 39/179 (21%)
Query: 82 KHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQ---------PGPVLDW 132
H N+V LLG C G ++ E+ G L + L ++ LD
Sbjct: 85 NHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDL 144
Query: 133 MTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAAR 192
+ + A+G+ +L K + IHRD+ + N+LL KI DF L+
Sbjct: 145 EDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLA--------- 192
Query: 193 LHSTRVLGTFGYH-------------APEYAMTGQLTQKSDVYSFGVVLLELLT-GRKP 237
R + + APE T +SDV+S+G+ L EL + G P
Sbjct: 193 ----RDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP 247
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 6e-23
Identities = 57/225 (25%), Positives = 92/225 (40%), Gaps = 37/225 (16%)
Query: 68 PDDEKQLVS----VVSRLKHENLVELLG-YCVEGNLRVLAYEFATM-GSLHDILHGRKGV 121
++K+L+ + + V G EG++ + E M SL
Sbjct: 46 SQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDV-WICMEL--MDTSLDKFYKQVIDK 102
Query: 122 QGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFN 181
P +L +IAV + LE+LH K+ +IHRD++ SNVL+ + K+ DF
Sbjct: 103 GQTIPEDIL-----GKIAVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFG 155
Query: 182 LSNQAPDMAARLHSTRVLGTFGYHAPE----YAMTGQLTQKSDVYSFGVVLLELLTGRKP 237
+S D A+ G Y APE + KSD++S G+ ++EL R P
Sbjct: 156 ISGYLVDDVAK---DIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFP 212
Query: 238 ---VDHTMPRGQQSLVTWATPRLSEDK--------VKQCV--DPK 269
+ +Q +V +P+L DK QC+ + K
Sbjct: 213 YDSWGTPFQQLKQ-VVEEPSPQLPADKFSAEFVDFTSQCLKKNSK 256
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 8e-23
Identities = 50/265 (18%), Positives = 96/265 (36%), Gaps = 43/265 (16%)
Query: 75 VSVVSRLKHENLVELLGYCVEGNLRVLAY----EFATMGSLHDILHGRKGVQGAQPGPVL 130
+ H N++ L+ YC+ F G+L + + K G L
Sbjct: 77 ADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLK-----DKGNFL 131
Query: 131 DWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMA 190
+ + + RGLE +H HRD++ +N+LL ++ + + D NQA
Sbjct: 132 TEDQILWLLLGICRGLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHV 188
Query: 191 ARLHSTRVL-------GTFGYHAPE------YAMTGQLTQKSDVYSFGVVLLELLTGRKP 237
L T Y APE + + + +++DV+S G VL ++ G P
Sbjct: 189 EGSRQALTLQDWAAQRCTISYRAPELFSVQSHCV---IDERTDVWSLGCVLYAMMFGEGP 245
Query: 238 VDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFR 297
D +G + V+ + + L + + + R
Sbjct: 246 YDMVFQKGDSVAL----------AVQNQLSIPQSPRHSS----ALWQLLNSMMTVDPHQR 291
Query: 298 PNMSIVVKALQPLLKSPPPAAPVSE 322
P++ +++ L+ L+ P P ++
Sbjct: 292 PHIPLLLSQLE-ALQPPAPGQHTTQ 315
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 8e-23
Identities = 57/218 (26%), Positives = 97/218 (44%), Gaps = 33/218 (15%)
Query: 68 PDDEKQLVSVVSRLKHENLVELLG-YCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQP 126
+ + +S++ + ++V+ G Y +L ++ E+ GS+ DI+ R
Sbjct: 68 LQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVM-EYCGAGSVSDIIRLRNKT----- 121
Query: 127 GPVLDWMTRVRIAV---DAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLS 183
+T IA +GLEYLH IHRDI++ N+LL + AK+ADF ++
Sbjct: 122 ------LTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVA 172
Query: 184 NQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMP 243
Q D A+ ++ V+GT + APE +D++S G+ +E+ G+ P P
Sbjct: 173 GQLTDTMAKRNT--VIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHP 230
Query: 244 -RGQQSLVTWATPRLSEDK---------VKQC--VDPK 269
R + T P + + VKQC P+
Sbjct: 231 MRAIFMIPTNPPPTFRKPELWSDNFTDFVKQCLVKSPE 268
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 96.4 bits (240), Expect = 9e-23
Identities = 44/179 (24%), Positives = 70/179 (39%), Gaps = 41/179 (22%)
Query: 76 SVVSRLKHENLVELLGYCVEGNLRVL-AYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 134
++ H N++ LLG C+ L + G L + +
Sbjct: 142 IIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNET--------HNPTVKD 193
Query: 135 RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 194
+ + A+G+++L K +HRD+ + N +L E F K+ADF L+
Sbjct: 194 LIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLA----------- 239
Query: 195 STRVLGTFGYH---------------APEYAMTGQLTQKSDVYSFGVVLLELLT-GRKP 237
R + + A E T + T KSDV+SFGV+L EL+T G P
Sbjct: 240 --RDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 296
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 1e-22
Identities = 48/191 (25%), Positives = 79/191 (41%), Gaps = 45/191 (23%)
Query: 76 SVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQ---------- 125
+V+ ++ H ++++L G C + +L E+A GSL L + V
Sbjct: 78 NVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSS 137
Query: 126 -----PGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADF 180
L + A ++G++YL E ++HRD+ + N+L+ E K KI+DF
Sbjct: 138 SLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRDLAARNILVAEGRKMKISDF 194
Query: 181 NLSNQAPDMAARLHSTRVLGTFGYH-------------APEYAMTGQLTQKSDVYSFGVV 227
LS R + + A E T +SDV+SFGV+
Sbjct: 195 GLS-------------RDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVL 241
Query: 228 LLELLT-GRKP 237
L E++T G P
Sbjct: 242 LWEIVTLGGNP 252
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 3e-22
Identities = 58/222 (26%), Positives = 95/222 (42%), Gaps = 39/222 (17%)
Query: 68 PDDEKQL----VSVVSRLKHENLVELLG-YCVEGNLRVLAYEFATMGSLHDILHGRKGVQ 122
+K+L + V+ K+ N+V L Y V L V+ E+ GSL D++
Sbjct: 57 QQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM-EYLAGGSLTDVVTETC--- 112
Query: 123 GAQPGPVLDWMTRVRIAV---DAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIAD 179
M +IA + + LE+LH +IHRDI+S N+LL D K+ D
Sbjct: 113 ----------MDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTD 159
Query: 180 FNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVD 239
F Q ++ + ++GT + APE K D++S G++ +E++ G P
Sbjct: 160 FGFCAQITPEQSKRST--MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYL 217
Query: 240 HTMP-RGQQSLVTWATPRLSE---------DKVKQC--VDPK 269
+ P R + T TP L D + +C +D +
Sbjct: 218 NENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDVE 259
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 7e-22
Identities = 54/171 (31%), Positives = 77/171 (45%), Gaps = 21/171 (12%)
Query: 71 EKQL---VSVVSRLKHENLVELLGYCVEGNLRV-LAYEFATMGSLHDILHGRKGVQGAQP 126
E QL V + S L+H N++ L GY RV L E+A +G+++ L +
Sbjct: 53 EHQLRREVEIQSHLRHPNILRLYGY-FHDATRVYLILEYAPLGTVYREL--------QKL 103
Query: 127 GPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQA 186
+ T + A L Y H K +IHRDI+ N+LL + KIADF S A
Sbjct: 104 SKFDEQRTA-TYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHA 159
Query: 187 PDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 237
P + + GT Y PE +K D++S GV+ E L G+ P
Sbjct: 160 PS---SRRTD-LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 206
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 7e-22
Identities = 50/184 (27%), Positives = 77/184 (41%), Gaps = 44/184 (23%)
Query: 82 KHENLVELLGYCVEGNLRVLAYEFATMGSLHDIL--------------HGRKGVQGAQPG 127
HEN+V LLG C L +E+ G L + L +K ++ +
Sbjct: 107 SHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDL 166
Query: 128 PVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAP 187
VL + + A A+G+E+L K S +HRD+ + NVL+ KI DF L+
Sbjct: 167 NVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLA---- 219
Query: 188 DMAARLHSTRVLGTFGYH-------------APEYAMTGQLTQKSDVYSFGVVLLELLT- 233
R + + + APE G T KSDV+S+G++L E+ +
Sbjct: 220 ---------RDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSL 270
Query: 234 GRKP 237
G P
Sbjct: 271 GVNP 274
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 91.8 bits (229), Expect = 9e-22
Identities = 50/174 (28%), Positives = 76/174 (43%), Gaps = 18/174 (10%)
Query: 68 PDDEKQL---VSVVSRLKHENLVELLGYCVEGNLRV-LAYEFATMGSLHDILHGRKGVQG 123
+++ V + +LKH +++EL Y E + V L E G ++ L
Sbjct: 52 AGMVQRVQNEVKIHCQLKHPSILELYNY-FEDSNYVYLVLEMCHNGEMNRYLK------- 103
Query: 124 AQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLS 183
+ P + R G+ YLH I+HRD+ SN+LL + KIADF L+
Sbjct: 104 NRVKPFSENEAR-HFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLA 159
Query: 184 NQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 237
Q + ++ GT Y +PE A +SDV+S G + LL GR P
Sbjct: 160 TQLKMPHEKHYTL--CGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPP 211
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 92.3 bits (229), Expect = 1e-21
Identities = 45/204 (22%), Positives = 78/204 (38%), Gaps = 22/204 (10%)
Query: 44 CCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAY 103
Q E ++E P + P + R+ + +G + +V Y
Sbjct: 78 PEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLY 137
Query: 104 ---EFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHR 160
+ +L D ++ R ++ + G L ++ A +E+LH K ++HR
Sbjct: 138 IQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQI------AEAVEFLHSK---GLMHR 188
Query: 161 DIRSSNVLLFEDFKAKIADFNLS----------NQAPDMAARLHSTRVLGTFGYHAPEYA 210
D++ SN+ D K+ DF L M A T +GT Y +PE
Sbjct: 189 DLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQI 248
Query: 211 MTGQLTQKSDVYSFGVVLLELLTG 234
+ K D++S G++L ELL
Sbjct: 249 HGNNYSHKVDIFSLGLILFELLYS 272
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 4e-21
Identities = 58/223 (26%), Positives = 103/223 (46%), Gaps = 33/223 (14%)
Query: 61 LKSPKNYPDDEKQLVSVVSRLKHENLVELLG-YCVEGNLRVLAYEFATMGSLHDILHGRK 119
L+ ++ +D +Q ++V+S+ + + G Y + L ++ E+ GS D+L
Sbjct: 57 LEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIM-EYLGGGSALDLL---- 111
Query: 120 GVQGAQPGPVLDWMTRVRIAV---DAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAK 176
+PGP + +IA + +GL+YLH + IHRDI+++NVLL E + K
Sbjct: 112 -----EPGP----LDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVK 159
Query: 177 IADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRK 236
+ADF ++ Q D + ++ +GT + APE K+D++S G+ +EL G
Sbjct: 160 LADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEP 217
Query: 237 PVDHTMP-RGQQSLVTWATPRLSE-------DKVKQC--VDPK 269
P P + + P L + V+ C +P
Sbjct: 218 PHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPS 260
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 4e-21
Identities = 53/227 (23%), Positives = 94/227 (41%), Gaps = 42/227 (18%)
Query: 68 PDDEKQL----VSVVSRLKHENLVELLG-YCVEGNLRVLAYEFATMGSLHDILHGRKGVQ 122
++E + + +++ H +V+LLG Y +G L ++ EF G++ I+
Sbjct: 56 SEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMI-EFCPGGAVDAIMLELDRG- 113
Query: 123 GAQPGPVLDWMTRVRIAV---DAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIAD 179
+T +I V L +LH K IIHRD+++ NVL+ + ++AD
Sbjct: 114 ----------LTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLAD 160
Query: 180 FNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQ-----KSDVYSFGVVLLELLTG 234
F +S + + S +GT + APE M + K+D++S G+ L+E+
Sbjct: 161 FGVSAKNLKTLQKRDS--FIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQI 218
Query: 235 RKPVDHTMP-RGQQSLVTWATPRLSE---------DKVKQC--VDPK 269
P P R + P L D +K +P+
Sbjct: 219 EPPHHELNPMRVLLKIAKSDPPTLLTPSKWSVEFRDFLKIALDKNPE 265
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 91.6 bits (227), Expect = 4e-21
Identities = 31/178 (17%), Positives = 55/178 (30%), Gaps = 18/178 (10%)
Query: 71 EKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVL 130
QL+ + ++ + N VL E + G+L + ++ K P V+
Sbjct: 114 GTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYK----NTPEKVM 169
Query: 131 DWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKA-----------KIAD 179
+ A+ +E +H+ IIH DI+ N +L F + D
Sbjct: 170 PQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALID 226
Query: 180 FNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 237
S T T G+ E + D + + +L G
Sbjct: 227 LGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYM 284
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 6e-21
Identities = 61/210 (29%), Positives = 91/210 (43%), Gaps = 26/210 (12%)
Query: 68 PDDEKQLV---SVVSRL-KHENLVELLG-YCVEGNLRVLAYEFATM-GSLHDILHGRKGV 121
++KQL+ VV R +V+ G EG+ + E M S V
Sbjct: 61 EKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDC-WICMEL--MSTSFDKFYKYVYSV 117
Query: 122 QGAQ-PGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADF 180
P +L +I + + L +L E ++ IIHRDI+ SN+LL K+ DF
Sbjct: 118 LDDVIPEEIL-----GKITLATVKALNHLKENLK--IIHRDIKPSNILLDRSGNIKLCDF 170
Query: 181 NLSNQAPDMAARLHSTRVLGTFGYHAPE----YAMTGQLTQKSDVYSFGVVLLELLTGRK 236
+S Q D A+ TR G Y APE A +SDV+S G+ L EL TGR
Sbjct: 171 GISGQLVDSIAK---TRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRF 227
Query: 237 PVD--HTMPRGQQSLVTWATPRLSEDKVKQ 264
P +++ +V P+LS + ++
Sbjct: 228 PYPKWNSVFDQLTQVVKGDPPQLSNSEERE 257
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 92.2 bits (229), Expect = 6e-21
Identities = 31/176 (17%), Positives = 64/176 (36%), Gaps = 29/176 (16%)
Query: 78 VSRLKHENLVELLGYCVEGNLRVLAYEFATM-----GSLHDILHGRKGVQGAQPGPVLDW 132
++ + H ++V++ + + + M SL + L
Sbjct: 133 LAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK-----------LPV 181
Query: 133 MTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAAR 192
+ ++ L YLH +++ D++ N++L E+ + K+ D +R
Sbjct: 182 AEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGA-------VSR 230
Query: 193 LHST-RVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQ 247
++S + GT G+ APE T +D+Y+ G L L + G
Sbjct: 231 INSFGYLYGTPGFQAPEIV-RTGPTVATDIYTVGRTLAALTLDLPTRNGRYVDGLP 285
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 8e-21
Identities = 55/222 (24%), Positives = 96/222 (43%), Gaps = 39/222 (17%)
Query: 68 PDDEKQL----VSVVSRLKHENLVELLG-YCVEGNLRVLAYEFATMGSLHDILHGRKGVQ 122
++L V ++ +H N+VE+ Y V L VL EF G+L DI+ +
Sbjct: 82 KQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLM-EFLQGGALTDIVSQVR--- 137
Query: 123 GAQPGPVLDWMTRVRIAV---DAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIAD 179
+ +IA + L YLH + +IHRDI+S ++LL D + K++D
Sbjct: 138 ----------LNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILLTLDGRVKLSD 184
Query: 180 FNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVD 239
F Q + S ++GT + APE + D++S G++++E++ G P
Sbjct: 185 FGFCAQISKDVPKRKS--LVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYF 242
Query: 240 HTMP-RGQQSLVTWATPRLSE---------DKVKQC--VDPK 269
P + + L P+L D +++ DP+
Sbjct: 243 SDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERMLVRDPQ 284
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 91.0 bits (226), Expect = 1e-20
Identities = 35/165 (21%), Positives = 64/165 (38%), Gaps = 21/165 (12%)
Query: 82 KHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVD 141
+H N++ + + +A E +L + + Q + + +
Sbjct: 76 EHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYV--------EQKDFAHLGLEPITLLQQ 126
Query: 142 AARGLEYLHEKVQPSIIHRDIRSSNVLLFE-----DFKAKIADFNLSNQ-APDMAARLHS 195
GL +LH +I+HRD++ N+L+ KA I+DF L + A +
Sbjct: 127 TTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRR 183
Query: 196 TRVLGTFGYHAPEY---AMTGQLTQKSDVYSFGVVLLELLTGRKP 237
+ V GT G+ APE T D++S G V +++
Sbjct: 184 SGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSH 228
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 2e-20
Identities = 59/226 (26%), Positives = 97/226 (42%), Gaps = 40/226 (17%)
Query: 68 PDDEKQLV---SVVSRL-KHENLVELLG-YCVEGNLRVLAYEFATMG-SLHDILHGRKGV 121
++ K+++ VV + +V+ G + ++ +A E MG + K +
Sbjct: 64 KEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDV-FIAMEL--MGTCAEKLK---KRM 117
Query: 122 QGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFN 181
QG P +L ++ V + L YL EK +IHRD++ SN+LL E + K+ DF
Sbjct: 118 QGPIPERIL-----GKMTVAIVKALYYLKEKHG--VIHRDVKPSNILLDERGQIKLCDFG 170
Query: 182 LSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQ-----KSDVYSFGVVLLELLTGRK 236
+S + D A+ R G Y APE T+ ++DV+S G+ L+EL TG+
Sbjct: 171 ISGRLVDDKAK---DRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQF 227
Query: 237 PVD--HTMPRGQQSLVTWATPRLSEDK---------VKQCV--DPK 269
P T ++ P L VK C+ D +
Sbjct: 228 PYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHR 273
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 2e-20
Identities = 55/211 (26%), Positives = 92/211 (43%), Gaps = 17/211 (8%)
Query: 69 DDEKQLVSVVSRLKHENLVELLG-YCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPG 127
D+ + + +S+ H N+V + V+ L ++ + + GS+ DI+ + G
Sbjct: 58 DELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVM-KLLSGGSVLDIIKHIVAKGEHKSG 116
Query: 128 PVLDWMTRVRIAV---DAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSN 184
+ IA + GLEYLH+ IHRD+++ N+LL ED +IADF +S
Sbjct: 117 V----LDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSA 169
Query: 185 Q-APDMAARLHSTR--VLGTFGYHAPEYAMTGQL-TQKSDVYSFGVVLLELLTGRKPVDH 240
A + R +GT + APE + K+D++SFG+ +EL TG P
Sbjct: 170 FLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHK 229
Query: 241 TMP-RGQQSLVTWATPRLSEDKVKQCVDPKL 270
P + + P L + + K
Sbjct: 230 YPPMKVLMLTLQNDPPSLETGVQDKEMLKKY 260
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 2e-20
Identities = 42/182 (23%), Positives = 66/182 (36%), Gaps = 20/182 (10%)
Query: 60 RLKSPKNYPDDEKQLVSVVSRL----KHENLVELLGYCVEGNLRVLAYEFATMGSLHDIL 115
R SP P D + ++ V +H V L EG + L E SL
Sbjct: 89 RSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELCG-PSLQQHC 147
Query: 116 HGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKA 175
G L D L +LH + ++H D++ +N+ L +
Sbjct: 148 E--------AWGASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRC 196
Query: 176 KIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGR 235
K+ DF L + A + G Y APE + G +DV+S G+ +LE+
Sbjct: 197 KLGDFGLLVELGTAGAG--EVQE-GDPRYMAPE-LLQGSYGTAADVFSLGLTILEVACNM 252
Query: 236 KP 237
+
Sbjct: 253 EL 254
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 88.0 bits (219), Expect = 2e-20
Identities = 51/171 (29%), Positives = 74/171 (43%), Gaps = 21/171 (12%)
Query: 71 EKQL---VSVVSRLKHENLVELLGYCVEGNLRV-LAYEFATMGSLHDILHGRKGVQGAQP 126
E QL + + S L+H N++ + Y R+ L EFA G L+ L +
Sbjct: 58 EHQLRREIEIQSHLRHPNILRMYNY-FHDRKRIYLMLEFAPRGELYKEL--------QKH 108
Query: 127 GPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQA 186
G + + + A L Y HE+ +IHRDI+ N+L+ + KIADF S A
Sbjct: 109 GRFDEQRSA-TFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHA 164
Query: 187 PDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 237
P R + GT Y PE +K D++ GV+ E L G P
Sbjct: 165 PS--LRRRTM--CGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPP 211
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 89.6 bits (222), Expect = 2e-20
Identities = 35/187 (18%), Positives = 61/187 (32%), Gaps = 25/187 (13%)
Query: 62 KSPKNYPDDEKQLVSVVSRLKHENLVELLG-YCVEGNLRVLAYEFATMGSLHDILHGRKG 120
+ + V H N+V + + L V+ F GS D++
Sbjct: 64 ACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVV-TSFMAYGSAKDLICTHF- 121
Query: 121 VQGAQPGPVLDWMTRVRIAV---DAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKI 177
M + IA + L+Y+H +HR +++S++L+ D K +
Sbjct: 122 -----MDG----MNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYL 169
Query: 178 ADFNLSNQAPDMAARLHSTRVL-----GTFGYHAPEYAMTGQL--TQKSDVYSFGVVLLE 230
+ + R + +PE KSD+YS G+ E
Sbjct: 170 SGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACE 229
Query: 231 LLTGRKP 237
L G P
Sbjct: 230 LANGHVP 236
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 4e-20
Identities = 35/179 (19%), Positives = 68/179 (37%), Gaps = 27/179 (15%)
Query: 75 VSVVSRLKHENL--VELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDW 132
++ +++L+ + + L Y + + E L+ L +K +D
Sbjct: 77 IAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGN-IDLNSWLKKKKS---------IDP 126
Query: 133 MTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAAR 192
R + + +H+ I+H D++ +N L D K+ DF ++NQ
Sbjct: 127 WERKSYWKNMLEAVHTIHQH---GIVHSDLKPAN-FLIVDGMLKLIDFGIANQMQPDTTS 182
Query: 193 LHSTRVLGTFGYHAPE-----------YAMTGQLTQKSDVYSFGVVLLELLTGRKPVDH 240
+ +GT Y PE +++ KSDV+S G +L + G+ P
Sbjct: 183 VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ 241
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 5e-20
Identities = 35/179 (19%), Positives = 69/179 (38%), Gaps = 27/179 (15%)
Query: 75 VSVVSRLKH--ENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDW 132
++ +++L+ + ++ L Y + + E L+ L +K +D
Sbjct: 58 IAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGN-IDLNSWLKKKKS---------IDP 107
Query: 133 MTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAAR 192
R + + +H+ I+H D++ +N L D K+ DF ++NQ
Sbjct: 108 WERKSYWKNMLEAVHTIHQH---GIVHSDLKPAN-FLIVDGMLKLIDFGIANQMQPDTTS 163
Query: 193 LHSTRVLGTFGYHAPE-----------YAMTGQLTQKSDVYSFGVVLLELLTGRKPVDH 240
+ +GT Y PE +++ KSDV+S G +L + G+ P
Sbjct: 164 VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ 222
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 2e-19
Identities = 43/186 (23%), Positives = 70/186 (37%), Gaps = 37/186 (19%)
Query: 75 VSVVSRLKHENLVELLGYCVEGNLRVLAY-------------EFATMGSLHDILHGRKGV 121
V +++ L H+ +V +E V E+ G+L+D++H
Sbjct: 53 VMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLN 112
Query: 122 QGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFN 181
Q Q ++ L Y+H + IIHRD++ N+ + E KI DF
Sbjct: 113 Q--QRDEYWRLFRQI------LEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFG 161
Query: 182 LSNQAPDMAARLHS------------TRVLGTFGYHAPE-YAMTGQLTQKSDVYSFGVVL 228
L+ L T +GT Y A E TG +K D+YS G++
Sbjct: 162 LAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIF 221
Query: 229 LELLTG 234
E++
Sbjct: 222 FEMIYP 227
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 87.4 bits (216), Expect = 2e-19
Identities = 21/193 (10%), Positives = 57/193 (29%), Gaps = 18/193 (9%)
Query: 77 VVSRLKHENLVELLG----YCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDW 132
+V + + ++ + V + + + + ++L + L
Sbjct: 156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKS-----LVH 210
Query: 133 MTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAAR 192
R+++ + R L LH ++H +R +++L + + F +A
Sbjct: 211 HARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHL-VRDGASAV 266
Query: 193 LHSTRVLGTFGYHAPE-----YAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQ 247
R A +T D ++ G+ + + P G
Sbjct: 267 SPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGS 326
Query: 248 SLVTWATPRLSED 260
+ + + +
Sbjct: 327 EWIFRSCKNIPQP 339
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 87.2 bits (216), Expect = 2e-19
Identities = 34/179 (18%), Positives = 67/179 (37%), Gaps = 27/179 (15%)
Query: 75 VSVVSRLKHENL--VELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDW 132
++ +++L+ + + L Y + + E L+ L +K +D
Sbjct: 105 IAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGN-IDLNSWLKKKKS---------IDP 154
Query: 133 MTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAAR 192
R + + +H+ I+H D++ +N L D K+ DF ++NQ
Sbjct: 155 WERKSYWKNMLEAVHTIHQH---GIVHSDLKPAN-FLIVDGMLKLIDFGIANQMQPDTTS 210
Query: 193 LHSTRVLGTFGYHAPE-----------YAMTGQLTQKSDVYSFGVVLLELLTGRKPVDH 240
+ +G Y PE +++ KSDV+S G +L + G+ P
Sbjct: 211 VVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ 269
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 87.0 bits (215), Expect = 4e-19
Identities = 47/188 (25%), Positives = 76/188 (40%), Gaps = 24/188 (12%)
Query: 65 KNYPDDEKQL---VSVVSRLKHENLVELL------GYCVEGNLRVLAYEFATMGSLHDIL 115
+ P + ++ + ++ +L H N+V +L +LA E+ G L L
Sbjct: 50 ELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYL 109
Query: 116 HGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKA 175
+ + G L + D + L YLHE IIHRD++ N++L +
Sbjct: 110 NQFENCCG------LKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQR 160
Query: 176 ---KIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELL 232
KI D + + L + V GT Y APE + T D +SFG + E +
Sbjct: 161 LIHKIIDLGYAKELDQ--GELCTEFV-GTLQYLAPELLEQKKYTVTVDYWSFGTLAFECI 217
Query: 233 TGRKPVDH 240
TG +P
Sbjct: 218 TGFRPFLP 225
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 4e-19
Identities = 56/227 (24%), Positives = 95/227 (41%), Gaps = 41/227 (18%)
Query: 69 DDEKQLVSVVSRL-KHENLVELLGYCVEGNLRVLAY------EFATMGSLHDILHGRKGV 121
++ KQ ++++ + H N+ G ++ N + EF GS+ D++ KG
Sbjct: 65 EEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKG- 123
Query: 122 QGAQPGPVLDWMTRVRIAV---DAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIA 178
+ IA + RGL +LH+ +IHRDI+ NVLL E+ + K+
Sbjct: 124 -----NT----LKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLV 171
Query: 179 DFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQ-----KSDVYSFGVVLLELLT 233
DF +S Q R ++ +GT + APE + KSD++S G+ +E+
Sbjct: 172 DFGVSAQLDRTVGRRNT--FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAE 229
Query: 234 GRKPVDHTMP-RGQQSLVTWATPRLSEDK--------VKQC--VDPK 269
G P+ P R + PRL K ++ C +
Sbjct: 230 GAPPLCDMHPMRALFLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHS 276
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 5e-19
Identities = 47/174 (27%), Positives = 72/174 (41%), Gaps = 32/174 (18%)
Query: 75 VSVVSRLKHENLVELLGYCVEGNLRV-LAYEFATMGSLHDILHGRKGVQGAQPGPVLDWM 133
+S+ L H+++V G+ E N V + E SL ++ RK
Sbjct: 66 ISIHRSLAHQHVVGFHGF-FEDNDFVFVVLELCRRRSLLELHKRRK-------------- 110
Query: 134 TRVRIAVDAAR--------GLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQ 185
+ AR G +YLH +IHRD++ N+ L ED + KI DF L+ +
Sbjct: 111 ---ALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATK 164
Query: 186 APDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVD 239
R GT Y APE + + DV+S G ++ LL G+ P +
Sbjct: 165 VEYDGERKKVL--CGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE 216
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 1e-18
Identities = 48/182 (26%), Positives = 75/182 (41%), Gaps = 35/182 (19%)
Query: 68 PDDEKQL---VSVVSRLKHENLVELLGYCVEGNLRV-LAYEFATMGSLHDILHGRKGVQG 123
P +++ +S+ L H+++V G+ E N V + E SL ++ RK
Sbjct: 82 PHQREKMSMEISIHRSLAHQHVVGFHGF-FEDNDFVFVVLELCRRRSLLELHKRRK---- 136
Query: 124 AQPGPVLDWMTRVRIAVDAAR--------GLEYLHEKVQPSIIHRDIRSSNVLLFEDFKA 175
+ AR G +YLH +IHRD++ N+ L ED +
Sbjct: 137 -------------ALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEV 180
Query: 176 KIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGR 235
KI DF L+ + R GT Y APE + + DV+S G ++ LL G+
Sbjct: 181 KIGDFGLATKVEYDGERKKVL--CGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGK 238
Query: 236 KP 237
P
Sbjct: 239 PP 240
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 2e-18
Identities = 57/220 (25%), Positives = 93/220 (42%), Gaps = 33/220 (15%)
Query: 36 RVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVE 95
+ K+ R + P+ + Q ++++ +L H N+V+L V
Sbjct: 48 KKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKL--VEV- 104
Query: 96 GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAAR--------GLE 147
+ L+ + GPV++ T ++ D AR G+E
Sbjct: 105 -------LDDPNEDHLYMVFELVNQ------GPVMEVPTLKPLSEDQARFYFQDLIKGIE 151
Query: 148 YLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAP 207
YLH + IIHRDI+ SN+L+ ED KIADF +SN+ A L +T GT + AP
Sbjct: 152 YLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTV--GTPAFMAP 206
Query: 208 EYAMTGQLT---QKSDVYSFGVVLLELLTGRKP-VDHTMP 243
E + + DV++ GV L + G+ P +D +
Sbjct: 207 ESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIM 246
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 2e-18
Identities = 55/228 (24%), Positives = 89/228 (39%), Gaps = 52/228 (22%)
Query: 68 PDDEKQL----VSVVSRLKHENLVELLG-YCVEGNLRVLAYEFATM----GSLHDILHGR 118
+++ Q V + +L+H N ++ G Y E ++ M GS D+L
Sbjct: 94 SNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV------MEYCLGSASDLLEVH 147
Query: 119 KGVQGAQPGPVLDWMTRVRIAV---DAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKA 175
K + V IA A +GL YLH ++IHRD+++ N+LL E
Sbjct: 148 KKP-----------LQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLV 193
Query: 176 KIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQ---KSDVYSFGVVLLELL 232
K+ DF ++ MA +GT + APE + Q K DV+S G+ +EL
Sbjct: 194 KLGDFGSASI---MAPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELA 247
Query: 233 TGRKPVDHTMP-RGQQSLVTWATPRLSEDK--------VKQC--VDPK 269
+ P+ + + +P L V C P+
Sbjct: 248 ERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQ 295
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 82.9 bits (205), Expect = 3e-18
Identities = 45/203 (22%), Positives = 73/203 (35%), Gaps = 30/203 (14%)
Query: 65 KNYPDDEKQL---VSVVSRLKHENLVELLGYCVEGNLR--VLAYEFATMGSLHDILHGRK 119
++ V+ +L H+N+V+L E R VL EF GSL+ +L
Sbjct: 45 ISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPS 104
Query: 120 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLF----EDFKA 175
G L + V G+ +L E I+HR+I+ N++
Sbjct: 105 NAYGLPESEFLIVLRDV------VGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVY 155
Query: 176 KIADFNLSNQAPDMAARLHSTRVLGTFGYHAPE--------YAMTGQLTQKSDVYSFGVV 227
K+ DF + + D + S + GT Y P+ + D++S GV
Sbjct: 156 KLTDFGAARELED-DEQFVS--LYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVT 212
Query: 228 LLELLTGRKP-VDHTMPRGQQSL 249
TG P PR + +
Sbjct: 213 FYHAATGSLPFRPFEGPRRNKEV 235
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 83.1 bits (205), Expect = 4e-18
Identities = 23/201 (11%), Positives = 62/201 (30%), Gaps = 29/201 (14%)
Query: 75 VSVVSRLKHENLVELLGYCVEGNL--RVLAYEFA--TMGSLHDILHGRKGVQGAQPGPVL 130
+V + + ++ + + + R Y + + ++L + L
Sbjct: 149 FDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKS-----L 203
Query: 131 DWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMA 190
R+++ + R L LH ++H +R +++L + + F +
Sbjct: 204 VHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG--- 257
Query: 191 ARLHSTRVLGTFGYHAPEYAMT-----------GQLTQKSDVYSFGVVLLELLTGRKPVD 239
+ G+ PE +T D ++ G+V+ + P+
Sbjct: 258 ---ARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPIT 314
Query: 240 HTMPRGQQSLVTWATPRLSED 260
G + + + +
Sbjct: 315 KDAALGGSEWIFRSCKNIPQP 335
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 81.6 bits (201), Expect = 1e-17
Identities = 20/152 (13%), Positives = 39/152 (25%), Gaps = 13/152 (8%)
Query: 99 RVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSII 158
+L A+ L L G + + R L K ++
Sbjct: 163 YLLLMPAAS-VDLEL-LFSTLDFVYVFRGD-EGILALHILTAQLIRLAANLQSK---GLV 216
Query: 159 HRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAM--TGQLT 216
H N+ + D + + D + + Y E+ T T
Sbjct: 217 HGHFTPDNLFIMPDGRLMLGDVSALWKVGTR-----GPASSVPVTYAPREFLNASTATFT 271
Query: 217 QKSDVYSFGVVLLELLTGRKPVDHTMPRGQQS 248
+ + G+ + + P P + S
Sbjct: 272 HALNAWQLGLSIYRVWCLFLPFGLVTPGIKGS 303
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 82.1 bits (203), Expect = 1e-17
Identities = 37/179 (20%), Positives = 68/179 (37%), Gaps = 28/179 (15%)
Query: 81 LKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAV 140
H N++ +A E +L D++ + + + + +
Sbjct: 66 DDHPNVIRYYCSETTDRFLYIALELCN-LNLQDLVESKN--VSDENLKLQKEYNPISLLR 122
Query: 141 DAARGLEYLHEKVQPSIIHRDIRSSNVLL-------------FEDFKAKIADFNLSNQ-- 185
A G+ +LH IIHRD++ N+L+ E+ + I+DF L +
Sbjct: 123 QIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLD 179
Query: 186 APDMAARLHSTRVLGTFGYHAPE-------YAMTGQLTQKSDVYSFGVVLLELLTGRKP 237
+ + R + GT G+ APE +LT+ D++S G V +L+ K
Sbjct: 180 SGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKH 238
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 81.8 bits (202), Expect = 1e-17
Identities = 45/203 (22%), Positives = 74/203 (36%), Gaps = 30/203 (14%)
Query: 65 KNYPDDEKQL---VSVVSRLKHENLVELLGYCVEGNLR--VLAYEFATMGSLHDILHGRK 119
++ V+ +L H+N+V+L E R VL EF GSL+ +L
Sbjct: 45 ISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPS 104
Query: 120 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLF----EDFKA 175
G L + + D G+ +L E I+HR+I+ N++
Sbjct: 105 NAYG------LPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVY 155
Query: 176 KIADFNLSNQAPDMAARLHSTRVLGTFGYHAPE--------YAMTGQLTQKSDVYSFGVV 227
K+ DF + + D + S + GT Y P+ + D++S GV
Sbjct: 156 KLTDFGAARELED-DEQFVS--LYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVT 212
Query: 228 LLELLTGRKP-VDHTMPRGQQSL 249
TG P PR + +
Sbjct: 213 FYHAATGSLPFRPFEGPRRNKEV 235
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 2e-17
Identities = 38/203 (18%), Positives = 67/203 (33%), Gaps = 40/203 (19%)
Query: 60 RLKSPKNYPDDEKQL---VSVVSRL-KHENLVELLGYCVEGNLRVLAYEFATMGSLHDIL 115
R K P DE+ V + L +H ++V E + ++ E+ GSL D +
Sbjct: 43 RSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAI 102
Query: 116 HGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFED--- 172
+ L + + RGL Y+H S++H DI+ SN+ +
Sbjct: 103 SENYRIMSYFKEAEL-----KDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIP 154
Query: 173 ----------------FKAKIADFNLSNQAPDMAARLHSTRVL-GTFGYHAPE-YAMTGQ 214
KI D R+ S +V G + A E
Sbjct: 155 NAASEEGDEDDWASNKVMFKIGDLGH-------VTRISSPQVEEGDSRFLANEVLQENYT 207
Query: 215 LTQKSDVYSFGVVLLELLTGRKP 237
K+D+++ + ++
Sbjct: 208 HLPKADIFALALTVVCAAGAEPL 230
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 80.6 bits (199), Expect = 2e-17
Identities = 39/190 (20%), Positives = 66/190 (34%), Gaps = 28/190 (14%)
Query: 69 DDEKQLVSVVSRLK-HENLVELLGYCV-------EGNLRVLAYEFATMGSLHDILHGRKG 120
Q V + +L H N+V+ G L G L + L +
Sbjct: 70 RAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMES 129
Query: 121 VQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADF 180
VL R ++++H + +P IIHRD++ N+LL K+ DF
Sbjct: 130 RGPLSCDTVLKIFY------QTCRAVQHMHRQ-KPPIIHRDLKVENLLLSNQGTIKLCDF 182
Query: 181 NLSNQA---PDMAARLHSTRVL-------GTFGYHAPE---YAMTGQLTQKSDVYSFGVV 227
+ PD + ++ T Y PE + +K D+++ G +
Sbjct: 183 GSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCI 242
Query: 228 LLELLTGRKP 237
L L + P
Sbjct: 243 LYLLCFRQHP 252
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 4e-15
Identities = 53/184 (28%), Positives = 78/184 (42%), Gaps = 26/184 (14%)
Query: 62 KSPKNYPDDEKQL---VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHD--ILH 116
K D++ L V ++ +L H N+++L + + L E T G L D I
Sbjct: 61 KRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISR 120
Query: 117 GRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLF---EDF 173
R A RI G+ Y+H+ I+HRD++ N+LL +D
Sbjct: 121 KRFSEVDAA-----------RIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDA 166
Query: 174 KAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT 233
+I DF LS +GT Y APE + G +K DV+S GV+L LL+
Sbjct: 167 NIRIIDFGLSTHFEASKKM---KDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLS 222
Query: 234 GRKP 237
G P
Sbjct: 223 GCPP 226
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 5e-15
Identities = 51/188 (27%), Positives = 77/188 (40%), Gaps = 26/188 (13%)
Query: 58 NERLKSPKNYPDDEKQL---VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHD- 113
KN +++ +S++ L H N+++L + L EF G L +
Sbjct: 77 GRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQ 136
Query: 114 -ILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLF-- 170
I + A I G+ YLH+ +I+HRDI+ N+LL
Sbjct: 137 IINRHKFDECDAA-----------NIMKQILSGICYLHKH---NIVHRDIKPENILLENK 182
Query: 171 -EDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLL 229
KI DF LS+ +L LGT Y APE + + +K DV+S GV++
Sbjct: 183 NSLLNIKIVDFGLSSFFSK-DYKLRD--RLGTAYYIAPE-VLKKKYNEKCDVWSCGVIMY 238
Query: 230 ELLTGRKP 237
LL G P
Sbjct: 239 ILLCGYPP 246
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 2e-14
Identities = 50/168 (29%), Positives = 72/168 (42%), Gaps = 23/168 (13%)
Query: 75 VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHD--ILHGRKGVQGAQPGPVLDW 132
V+V+ L H N+++L + + L E G L D I + A
Sbjct: 87 VAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAA------- 139
Query: 133 MTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLF---EDFKAKIADFNLSNQAPDM 189
I G+ YLH+ +I+HRD++ N+LL +D KI DF LS +
Sbjct: 140 ----VIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ 192
Query: 190 AARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 237
LGT Y APE + + +K DV+S GV+L LL G P
Sbjct: 193 KKM---KERLGTAYYIAPE-VLRKKYDEKCDVWSIGVILFILLAGYPP 236
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 71.5 bits (175), Expect = 3e-14
Identities = 33/113 (29%), Positives = 50/113 (44%), Gaps = 4/113 (3%)
Query: 126 PGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQ 185
L + + A+G+E+L + IHRD+ + N+LL E KI DF L+
Sbjct: 186 YKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARD 242
Query: 186 APDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKP 237
+ + APE T +SDV+SFGV+L E+ + G P
Sbjct: 243 IYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 295
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 71.0 bits (174), Expect = 4e-14
Identities = 47/216 (21%), Positives = 69/216 (31%), Gaps = 43/216 (19%)
Query: 62 KSPKNYPDDEKQL---VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGR 118
K + P D +++ V ++ +L H N+ L + L E G L D L+
Sbjct: 63 KIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVF 122
Query: 119 KGVQGAQPGPVLDWMTRVRIAV------------------------DAAR-------GLE 147
+ + + L
Sbjct: 123 IDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALH 182
Query: 148 YLHEKVQPSIIHRDIRSSNVLLF--EDFKAKIADFNLSN--QAPDMAARLHSTRVLGTFG 203
YLH + I HRDI+ N L + F+ K+ DF LS + T GT
Sbjct: 183 YLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPY 239
Query: 204 YHAPE--YAMTGQLTQKSDVYSFGVVLLELLTGRKP 237
+ APE K D +S GV+L LL G P
Sbjct: 240 FVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVP 275
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 69.4 bits (170), Expect = 1e-13
Identities = 35/242 (14%), Positives = 62/242 (25%), Gaps = 53/242 (21%)
Query: 78 VSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVR 137
+SR+ + +L ++ E+ GSL ++ GA +R
Sbjct: 85 LSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVADTSPSPVGA-----------IR 133
Query: 138 IAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTR 197
A + H + S V + D
Sbjct: 134 AMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVV--------------------- 169
Query: 198 VLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRL 257
L + D+ G L LL R P+ R S + A
Sbjct: 170 -LAYPATMPDA-------NPQDDIRGIGASLYALLVNRWPLPEAGVR---SGLAPAERDT 218
Query: 258 SEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSPPPA 317
+ P + +++AVAA VQ + R +++ Q +
Sbjct: 219 AG-------QPIEPADIDRDIPFQISAVAARSVQGDGGIRSASTLLNLMQQATAVADRTE 271
Query: 318 AP 319
Sbjct: 272 VL 273
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 1e-13
Identities = 35/124 (28%), Positives = 54/124 (43%), Gaps = 17/124 (13%)
Query: 129 VLDWMTRVRIAVDAAR--------GLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADF 180
+LD + R V A GLEYLH + I+H+DI+ N+LL KI+
Sbjct: 97 MLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISAL 153
Query: 181 NLSNQAPDMAA--RLHSTRVLGTFGYHAPEYAMTGQL--TQKSDVYSFGVVLLELLTGRK 236
++ AA +++ G+ + PE A K D++S GV L + TG
Sbjct: 154 GVAEALHPFAADDTCRTSQ--GSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLY 211
Query: 237 PVDH 240
P +
Sbjct: 212 PFEG 215
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 2e-13
Identities = 33/102 (32%), Positives = 49/102 (48%), Gaps = 10/102 (9%)
Query: 145 GLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGY 204
++Y H+K I+HRD+++ N+LL D KIADF SN+ G Y
Sbjct: 126 AVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTV--GGKLDAFC-GAPPY 179
Query: 205 HAPEYAMTGQL--TQKSDVYSFGVVLLELLTGRKP-VDHTMP 243
APE G+ + DV+S GV+L L++G P +
Sbjct: 180 AAPE-LFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLK 220
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 2e-13
Identities = 44/171 (25%), Positives = 68/171 (39%), Gaps = 26/171 (15%)
Query: 75 VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHD--ILHGRKGVQGAQPGPVLDW 132
+ ++ +L H ++++ + + + E G L D + + R +
Sbjct: 191 IEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCK------- 242
Query: 133 MTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLF---EDFKAKIADFNLSNQAPDM 189
++YLHE IIHRD++ NVLL ED KI DF S +
Sbjct: 243 ----LYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET 295
Query: 190 AARLHSTRVLGTFGYHAPE---YAMTGQLTQKSDVYSFGVVLLELLTGRKP 237
+ L T GT Y APE T + D +S GV+L L+G P
Sbjct: 296 S--LMRTLC-GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 343
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 4e-13
Identities = 50/193 (25%), Positives = 74/193 (38%), Gaps = 47/193 (24%)
Query: 62 KSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGV 121
KSP + ++V+ ++KHEN+V L L + + G L D
Sbjct: 44 KSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFD-------- 95
Query: 122 QGAQPGPVLDWMTRVRIA-------VDAAR-------GLEYLHEKVQPSIIHRDIRSSNV 167
RI DA+ ++YLHE I+HRD++ N+
Sbjct: 96 ---------------RILERGVYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENL 137
Query: 168 LLF---EDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSF 224
L E+ K I DF LS + + + GT GY APE ++ D +S
Sbjct: 138 LYLTPEENSKIMITDFGLSKMEQN--GIMST--ACGTPGYVAPEVLAQKPYSKAVDCWSI 193
Query: 225 GVVLLELLTGRKP 237
GV+ LL G P
Sbjct: 194 GVITYILLCGYPP 206
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 67.2 bits (165), Expect = 4e-13
Identities = 51/180 (28%), Positives = 75/180 (41%), Gaps = 41/180 (22%)
Query: 75 VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 134
+ + L HEN+V+ G+ EGN++ L E+ + G L D +
Sbjct: 56 ICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI-----------------EP 98
Query: 135 RVRIAVDAAR--------GLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQA 186
+ + A+ G+ YLH I HRDI+ N+LL E KI+DF L+
Sbjct: 99 DIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVF 155
Query: 187 PD-MAARLHSTRVLGTFGYHAPE------YAMTGQLTQKSDVYSFGVVLLELLTGRKPVD 239
RL + GT Y APE + + DV+S G+VL +L G P D
Sbjct: 156 RYNNRERLLNKMC-GTLPYVAPELLKRREFH--A---EPVDVWSCGIVLTAMLAGELPWD 209
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 7e-13
Identities = 50/168 (29%), Positives = 76/168 (45%), Gaps = 23/168 (13%)
Query: 75 VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHD--ILHGRKGVQGAQPGPVLDW 132
V ++ +L H N+++L + + + E T G L D I R A
Sbjct: 72 VELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAA------- 124
Query: 133 MTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLF---EDFKAKIADFNLSNQAPDM 189
RI G+ Y+H+ +I+HRD++ N+LL +D KI DF LS
Sbjct: 125 ----RIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ- 176
Query: 190 AARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 237
++ +GT Y APE + G +K DV+S GV+L LL+G P
Sbjct: 177 NTKMKD--RIGTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSGTPP 221
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 1e-12
Identities = 51/180 (28%), Positives = 75/180 (41%), Gaps = 41/180 (22%)
Query: 75 VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 134
+ + L HEN+V+ G+ EGN++ L E+ + G L D +
Sbjct: 56 ICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI-----------------EP 98
Query: 135 RVRIAVDAAR--------GLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQA 186
+ + A+ G+ YLH I HRDI+ N+LL E KI+DF L+
Sbjct: 99 DIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVF 155
Query: 187 PD-MAARLHSTRVLGTFGYHAPE------YAMTGQLTQKSDVYSFGVVLLELLTGRKPVD 239
RL + GT Y APE + + DV+S G+VL +L G P D
Sbjct: 156 RYNNRERLLNKMC-GTLPYVAPELLKRREFH--A---EPVDVWSCGIVLTAMLAGELPWD 209
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 2e-12
Identities = 28/92 (30%), Positives = 45/92 (48%), Gaps = 6/92 (6%)
Query: 144 RGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFG 203
G+++LH IIHRD++ SN+++ D KI DF L A T + T
Sbjct: 138 CGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL---ARTAGTSFMMTPYVVTRY 191
Query: 204 YHAPEYAMTGQLTQKSDVYSFGVVLLELLTGR 235
Y APE + + D++S G ++ E++ G
Sbjct: 192 YRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 2e-12
Identities = 35/96 (36%), Positives = 48/96 (50%), Gaps = 9/96 (9%)
Query: 145 GLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGY 204
L+YL + IIHRD++ N+LL E I DFN++ P +T + GT Y
Sbjct: 127 ALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR--ETQITT-MAGTKPY 180
Query: 205 HAPE--YAMTGQLTQKS-DVYSFGVVLLELLTGRKP 237
APE + G + D +S GV ELL GR+P
Sbjct: 181 MAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 4e-12
Identities = 31/97 (31%), Positives = 46/97 (47%), Gaps = 9/97 (9%)
Query: 145 GLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGY 204
+ YL K IIHRDI+ N+++ EDF K+ DF + +L T GT Y
Sbjct: 142 AVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLER--GKLFYTFC-GTIEY 195
Query: 205 HAPEYAMTGQLTQ--KSDVYSFGVVLLELLTGRKPVD 239
APE + G + + +++S GV L L+ P
Sbjct: 196 CAPE-VLMGNPYRGPELEMWSLGVTLYTLVFEENPFC 231
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 5e-12
Identities = 46/195 (23%), Positives = 77/195 (39%), Gaps = 51/195 (26%)
Query: 64 PKNYPDDEKQL---VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKG 120
YP D+ + +S++++L H L+ L + VL EF + G L D
Sbjct: 85 NTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFD------- 137
Query: 121 VQGAQPGPVLDWMTRVRIA--------VDAAR-------GLEYLHEKVQPSIIHRDIRSS 165
RIA + GL+++HE SI+H DI+
Sbjct: 138 ----------------RIAAEDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPE 178
Query: 166 NVLLF--EDFKAKIADFNLSNQA-PDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVY 222
N++ + KI DF L+ + PD ++ T + APE + +D++
Sbjct: 179 NIMCETKKASSVKIIDFGLATKLNPDEIVKV----TTATAEFAAPEIVDREPVGFYTDMW 234
Query: 223 SFGVVLLELLTGRKP 237
+ GV+ LL+G P
Sbjct: 235 AIGVLGYVLLSGLSP 249
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 6e-12
Identities = 51/186 (27%), Positives = 68/186 (36%), Gaps = 46/186 (24%)
Query: 69 DDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGP 128
+ + V+ RL H N+++L L E T G L D
Sbjct: 93 KIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFD--------------- 137
Query: 129 VLDWMTRVRIA-------VDAAR-------GLEYLHEKVQPSIIHRDIRSSNVLLF---E 171
RI DAA + YLHE I+HRD++ N+L
Sbjct: 138 --------RIVEKGYYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAP 186
Query: 172 DFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLEL 231
D KIADF LS L T GT GY APE + D++S G++ L
Sbjct: 187 DAPLKIADFGLSKIVEH--QVLMKTVC-GTPGYCAPEILRGCAYGPEVDMWSVGIITYIL 243
Query: 232 LTGRKP 237
L G +P
Sbjct: 244 LCGFEP 249
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 7e-12
Identities = 38/97 (39%), Positives = 54/97 (55%), Gaps = 9/97 (9%)
Query: 145 GLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGY 204
+EY H I+HRD++ N+LL ++ KIADF LSN D L ++ G+ Y
Sbjct: 120 AIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTD-GNFLKTS--CGSPNY 173
Query: 205 HAPEYAMTGQLTQ--KSDVYSFGVVLLELLTGRKPVD 239
APE + G+L + DV+S G+VL +L GR P D
Sbjct: 174 AAPE-VINGKLYAGPEVDVWSCGIVLYVMLVGRLPFD 209
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 65.3 bits (159), Expect = 7e-12
Identities = 31/94 (32%), Positives = 47/94 (50%), Gaps = 8/94 (8%)
Query: 145 GLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGY 204
GLE++H + +++RD++ +N+LL E +I+D L+ V GT GY
Sbjct: 304 GLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH---ASV-GTHGY 356
Query: 205 HAPEYAMTGQLTQKS-DVYSFGVVLLELLTGRKP 237
APE G S D +S G +L +LL G P
Sbjct: 357 MAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 7e-12
Identities = 46/173 (26%), Positives = 71/173 (41%), Gaps = 19/173 (10%)
Query: 75 VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVL---D 131
S+ LKH ++VELL + + +EF L + V+ A G V
Sbjct: 77 ASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEI-----VKRADAGFVYSEAV 131
Query: 132 WMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLF---EDFKAKIADFNLSNQAPD 188
+R ++A L Y H+ +IIHRD++ VLL K+ F ++ Q +
Sbjct: 132 ASHYMRQILEA---LRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGE 185
Query: 189 MAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHT 241
+GT + APE + DV+ GV+L LL+G P T
Sbjct: 186 SGLVAGG--RVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGT 236
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 64.9 bits (158), Expect = 7e-12
Identities = 43/183 (23%), Positives = 77/183 (42%), Gaps = 27/183 (14%)
Query: 64 PKNYPDDEKQL---VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKG 120
+ D++ + + +S L+H LV L + N V+ YEF + G L + +
Sbjct: 191 MTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHN 250
Query: 121 VQGAQPGPVLDWMTRVRIAVDAAR----GLEYLHEKVQPSIIHRDIRSSNVLLF--EDFK 174
M+ AV+ R GL ++HE + +H D++ N++ +
Sbjct: 251 K-----------MSE-DEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNE 295
Query: 175 AKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTG 234
K+ DF L+ + + GT + APE A + +D++S GV+ LL+G
Sbjct: 296 LKLIDFGLTAH---LDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSG 352
Query: 235 RKP 237
P
Sbjct: 353 LSP 355
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 8e-12
Identities = 38/119 (31%), Positives = 51/119 (42%), Gaps = 27/119 (22%)
Query: 137 RIAVDAAR--------GLEYLHEKVQPSIIHRDIRSSNVLLFEDFKA--KIADFNLSNQA 186
R + D AR G+ Y H I HRD++ N LL KI DF S +
Sbjct: 112 RFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSS 168
Query: 187 PDMAARLHSTRVLGTFGYHAPE------YAMTGQLTQKSDVYSFGVVLLELLTGRKPVD 239
++ ST +GT Y APE Y G+ +DV+S GV L +L G P +
Sbjct: 169 VL-HSQPKST--VGTPAYIAPEVLLRQEYD--GK---IADVWSCGVTLYVMLVGAYPFE 219
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 9e-12
Identities = 40/195 (20%), Positives = 69/195 (35%), Gaps = 47/195 (24%)
Query: 62 KSPKNYPDDE--KQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK 119
+ D + ++ + LKH N+V L E L ++ T G L +
Sbjct: 46 TKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFE------ 99
Query: 120 GVQGAQPGPVLDWMTRVRIA-------VDAAR-------GLEYLHEKVQPSIIHRDIRSS 165
I DA+ + + H+ ++HR+++
Sbjct: 100 -----------------DIVAREYYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPE 139
Query: 166 NVLLF---EDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVY 222
N+LL + K+ADF L+ + GT GY +PE + D++
Sbjct: 140 NLLLASKLKGAAVKLADFGLAIEVEGEQQAWFG--FAGTPGYLSPEVLRKDPYGKPVDLW 197
Query: 223 SFGVVLLELLTGRKP 237
+ GV+L LL G P
Sbjct: 198 ACGVILYILLVGYPP 212
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 9e-12
Identities = 32/94 (34%), Positives = 50/94 (53%), Gaps = 11/94 (11%)
Query: 144 RGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLS-NQAPDMAARLHSTRVLGTF 202
+GL Y+H IIHRD++ N+ + ED + KI DF L+ +M T + T
Sbjct: 139 KGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQADSEM------TGYVVTR 189
Query: 203 GYHAPEYAMTGQL-TQKSDVYSFGVVLLELLTGR 235
Y APE + TQ D++S G ++ E++TG+
Sbjct: 190 WYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 1e-11
Identities = 30/94 (31%), Positives = 52/94 (55%), Gaps = 11/94 (11%)
Query: 144 RGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLS-NQAPDMAARLHSTRVLGTF 202
+GL+Y+H ++HRD++ N+ + ED + KI DF L+ + +M T + T
Sbjct: 137 KGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHADAEM------TGYVVTR 187
Query: 203 GYHAPEYAMTGQL-TQKSDVYSFGVVLLELLTGR 235
Y APE ++ Q D++S G ++ E+LTG+
Sbjct: 188 WYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 1e-11
Identities = 36/93 (38%), Positives = 50/93 (53%), Gaps = 9/93 (9%)
Query: 144 RGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFG 203
RGL+Y+H IIHRD++ SN+ + ED + KI DF L+ D +TR
Sbjct: 143 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATRW----- 194
Query: 204 YHAPEYAMTGQL-TQKSDVYSFGVVLLELLTGR 235
Y APE + Q D++S G ++ ELLTGR
Sbjct: 195 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 1e-11
Identities = 30/92 (32%), Positives = 48/92 (52%), Gaps = 3/92 (3%)
Query: 146 LEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYH 205
LEYLH K IIHRD++ N+LL ED +I DF + + + + +GT Y
Sbjct: 143 LEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYV 199
Query: 206 APEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 237
+PE + SD+++ G ++ +L+ G P
Sbjct: 200 SPELLTEKSACKSSDLWALGCIIYQLVAGLPP 231
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 63.0 bits (154), Expect = 1e-11
Identities = 38/166 (22%), Positives = 64/166 (38%), Gaps = 15/166 (9%)
Query: 75 VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 134
+ V+ L H N++++ + + + E G L + + + L
Sbjct: 71 IEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGK-----ALSEGY 125
Query: 135 RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLF---EDFKAKIADFNLSNQAPDMAA 191
+ L Y H + ++H+D++ N+L KI DF L+
Sbjct: 126 VAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKS--D 180
Query: 192 RLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 237
+ GT Y APE +T K D++S GVV+ LLTG P
Sbjct: 181 EHSTNAA-GTALYMAPE-VFKRDVTFKCDIWSAGVVMYFLLTGCLP 224
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 63.0 bits (154), Expect = 1e-11
Identities = 41/182 (22%), Positives = 74/182 (40%), Gaps = 26/182 (14%)
Query: 64 PKNYPDDEKQL---VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHD--ILHGR 118
PK + +D + + ++ L H N++ L + L E T G L + +
Sbjct: 43 PKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRV 102
Query: 119 KGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLF---EDFKA 175
A ++ + A + Y H+ ++ HRD++ N L D
Sbjct: 103 FRESDAA--------RIMKDVLSA---VAYCHKL---NVAHRDLKPENFLFLTDSPDSPL 148
Query: 176 KIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGR 235
K+ DF L+ + ++ T+V GT Y +P+ + G + D +S GV++ LL G
Sbjct: 149 KLIDFGLAARFKP--GKMMRTKV-GTPYYVSPQ-VLEGLYGPECDEWSAGVMMYVLLCGY 204
Query: 236 KP 237
P
Sbjct: 205 PP 206
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 63.7 bits (155), Expect = 2e-11
Identities = 27/92 (29%), Positives = 46/92 (50%), Gaps = 6/92 (6%)
Query: 144 RGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFG 203
G+++LH IIHRD++ SN+++ D KI DF L+ A T + T
Sbjct: 175 CGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---SFMMTPYVVTRY 228
Query: 204 YHAPEYAMTGQLTQKSDVYSFGVVLLELLTGR 235
Y APE + + D++S G ++ E++ +
Sbjct: 229 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 62.6 bits (153), Expect = 2e-11
Identities = 43/201 (21%), Positives = 76/201 (37%), Gaps = 55/201 (27%)
Query: 60 RLKSPKNYPDDE--KQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHG 117
RL S + E ++ V+++ ++H N++ L VL E + G L D
Sbjct: 42 RLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFD---- 97
Query: 118 RKGVQGAQPGPVLDWMTRVRIA-------VDAAR-------GLEYLHEKVQPSIIHRDIR 163
+A +A + G+ YLH K I H D++
Sbjct: 98 -------------------FLAEKESLTEDEATQFLKQILDGVHYLHSK---RIAHFDLK 135
Query: 164 SSNVLL----FEDFKAKIADFNLS---NQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLT 216
N++L + + K+ DF ++ + + GT + APE L
Sbjct: 136 PENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF------KNIFGTPEFVAPEIVNYEPLG 189
Query: 217 QKSDVYSFGVVLLELLTGRKP 237
++D++S GV+ LL+G P
Sbjct: 190 LEADMWSIGVITYILLSGASP 210
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 62.6 bits (153), Expect = 2e-11
Identities = 50/179 (27%), Positives = 78/179 (43%), Gaps = 42/179 (23%)
Query: 75 VSVVSRLKHENLVELLGYCVEGNLR--VLAYEFATMGSLHDIL--HGRKGVQGAQPGPVL 130
+ + +H ++++L Y V + E+ + G L D + HGR
Sbjct: 62 IQNLKLFRHPHIIKL--YQVISTPTDFFMVMEYVSGGELFDYICKHGR------------ 107
Query: 131 DWMTRVRIAVDAAR--------GLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNL 182
+ AR ++Y H ++HRD++ NVLL AKIADF L
Sbjct: 108 -------VEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGL 157
Query: 183 SNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQ--KSDVYSFGVVLLELLTGRKPVD 239
SN D L ++ G+ Y APE ++G+L + D++S GV+L LL G P D
Sbjct: 158 SNMMSD-GEFLRTS--CGSPNYAAPE-VISGRLYAGPEVDIWSCGVILYALLCGTLPFD 212
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 2e-11
Identities = 30/93 (32%), Positives = 50/93 (53%), Gaps = 5/93 (5%)
Query: 145 GLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGY 204
GLE+LH++ +II+RD++ NVLL +D +I+D L+ + + GT G+
Sbjct: 301 GLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTK-GYA-GTPGF 355
Query: 205 HAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 237
APE + + D ++ GV L E++ R P
Sbjct: 356 MAPELLLGEEYDFSVDYFALGVTLYEMIAARGP 388
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 2e-11
Identities = 37/99 (37%), Positives = 46/99 (46%), Gaps = 12/99 (12%)
Query: 145 GLEYLHEKVQPSIIHRDIRSSNVLLF---EDFKAKIADFNLSNQAPDMAARLHSTRVLGT 201
++YLHE IIHRD++ NVLL ED KI DF S + L T GT
Sbjct: 126 AVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET--SLMRTLC-GT 179
Query: 202 FGYHAPE---YAMTGQLTQKSDVYSFGVVLLELLTGRKP 237
Y APE T + D +S GV+L L+G P
Sbjct: 180 PTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 218
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 63.0 bits (154), Expect = 2e-11
Identities = 36/181 (19%), Positives = 66/181 (36%), Gaps = 48/181 (26%)
Query: 75 VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 134
+S+++ +H N++ L V+ +EF + + +
Sbjct: 52 ISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFE--------------------- 90
Query: 135 RVRIA--------VDAAR-------GLEYLHEKVQPSIIHRDIRSSNVLLF--EDFKAKI 177
RI + L++LH +I H DIR N++ KI
Sbjct: 91 --RINTSAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKI 145
Query: 178 ADFNLSNQ-APDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRK 236
+F + Q P RL + Y+APE ++ +D++S G ++ LL+G
Sbjct: 146 IEFGQARQLKPGDNFRL----LFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGIN 201
Query: 237 P 237
P
Sbjct: 202 P 202
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 2e-11
Identities = 30/102 (29%), Positives = 45/102 (44%), Gaps = 12/102 (11%)
Query: 145 GLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGY 204
+ LH+ +I+HRD++ N+LL +D K+ DF S Q GT Y
Sbjct: 136 VICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDP--GEKLREVC-GTPSY 189
Query: 205 HAPE------YAMTGQLTQKSDVYSFGVVLLELLTGRKPVDH 240
APE ++ D++S GV++ LL G P H
Sbjct: 190 LAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH 231
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 3e-11
Identities = 29/93 (31%), Positives = 45/93 (48%), Gaps = 7/93 (7%)
Query: 144 RGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFG 203
GL LHE ++HRD+ N+LL ++ I DFNL+ + A + T +
Sbjct: 145 LGLHVLHEA---GVVHRDLHPGNILLADNNDITICDFNLARED---TADANKTHYVTHRW 198
Query: 204 YHAPEYAMT-GQLTQKSDVYSFGVVLLELLTGR 235
Y APE M T+ D++S G V+ E+ +
Sbjct: 199 YRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 3e-11
Identities = 24/98 (24%), Positives = 43/98 (43%), Gaps = 9/98 (9%)
Query: 145 GLEYLHEKVQPSIIHRDIRSSNVLL-FEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFG 203
+++ H + ++HRDI+ N+L+ AK+ DF D GT
Sbjct: 151 AIQHCHSR---GVVHRDIKDENILIDLRRGCAKLIDFGSGALLHD--EPYTDF--DGTRV 203
Query: 204 YHAPEYAMTGQLT-QKSDVYSFGVVLLELLTGRKPVDH 240
Y PE+ Q + V+S G++L +++ G P +
Sbjct: 204 YSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFER 241
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 3e-11
Identities = 23/98 (23%), Positives = 46/98 (46%), Gaps = 9/98 (9%)
Query: 145 GLEYLHEKVQPSIIHRDIRSSNVLL-FEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFG 203
+ + H ++HRDI+ N+L+ + K+ DF D +++ GT
Sbjct: 161 AVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALLKD---TVYTDFD-GTRV 213
Query: 204 YHAPEYAMTGQLT-QKSDVYSFGVVLLELLTGRKPVDH 240
Y PE+ + + + V+S G++L +++ G P +H
Sbjct: 214 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 251
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 3e-11
Identities = 44/201 (21%), Positives = 73/201 (36%), Gaps = 55/201 (27%)
Query: 60 RLKSPKNYPDDE--KQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHG 117
R KS + E ++ VS++ ++H N++ L +L E G L D
Sbjct: 48 RTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFD---- 103
Query: 118 RKGVQGAQPGPVLDWMTRVRIA-------VDAAR-------GLEYLHEKVQPSIIHRDIR 163
+A +A G+ YLH I H D++
Sbjct: 104 -------------------FLAEKESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLK 141
Query: 164 SSNVLL----FEDFKAKIADFNLS---NQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLT 216
N++L + KI DF L+ + + + GT + APE L
Sbjct: 142 PENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF------KNIFGTPEFVAPEIVNYEPLG 195
Query: 217 QKSDVYSFGVVLLELLTGRKP 237
++D++S GV+ LL+G P
Sbjct: 196 LEADMWSIGVITYILLSGASP 216
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 3e-11
Identities = 33/94 (35%), Positives = 51/94 (54%), Gaps = 5/94 (5%)
Query: 144 RGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLS-NQAPDMAARLHSTRVLGTF 202
RGL+Y+H +++HRD++ SN+LL KI DF L+ PD T + T
Sbjct: 139 RGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 195
Query: 203 GYHAPEYAMTGQL-TQKSDVYSFGVVLLELLTGR 235
Y APE + + T+ D++S G +L E+L+ R
Sbjct: 196 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 62.5 bits (152), Expect = 5e-11
Identities = 31/93 (33%), Positives = 50/93 (53%), Gaps = 6/93 (6%)
Query: 145 GLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGY 204
GLE LH + I++RD++ N+LL + +I+D L+ P+ + RV GT GY
Sbjct: 298 GLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPE--GQTIKGRV-GTVGY 351
Query: 205 HAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 237
APE + T D ++ G +L E++ G+ P
Sbjct: 352 MAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 384
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 6e-11
Identities = 41/180 (22%), Positives = 68/180 (37%), Gaps = 46/180 (25%)
Query: 75 VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 134
+ +L+H N+V L E + L ++ T G L +
Sbjct: 79 ARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFE--------------------- 117
Query: 135 RVRIA-------VDAAR-------GLEYLHEKVQPSIIHRDIRSSNVLLF---EDFKAKI 177
I DA+ + Y H I+HR+++ N+LL + K+
Sbjct: 118 --DIVAREFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKL 172
Query: 178 ADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 237
ADF L+ + D + GT GY +PE ++ D+++ GV+L LL G P
Sbjct: 173 ADFGLAIEVND--SEAWHGFA-GTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 229
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 6e-11
Identities = 48/174 (27%), Positives = 75/174 (43%), Gaps = 23/174 (13%)
Query: 69 DDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHD--ILHGRKGVQGAQP 126
+ V ++ +L H N+++L + + + E T G L D I R A
Sbjct: 66 STILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAA- 124
Query: 127 GPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLF---EDFKAKIADFNLS 183
++ + Y+H+ +I+HRD++ N+LL +D KI DF LS
Sbjct: 125 -------RIIKQVFSG---ITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLS 171
Query: 184 NQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 237
R+ GT Y APE + G +K DV+S GV+L LL+G P
Sbjct: 172 TCFQQ--NTKMKDRI-GTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSGTPP 221
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 7e-11
Identities = 42/201 (20%), Positives = 73/201 (36%), Gaps = 55/201 (27%)
Query: 60 RLKSPKNYPDDE--KQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHG 117
+ ++ + E ++ VS++ ++ H N++ L VL E + G L D
Sbjct: 49 QSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFD---- 104
Query: 118 RKGVQGAQPGPVLDWMTRVRIA-------VDAAR-------GLEYLHEKVQPSIIHRDIR 163
+A +A G+ YLH K I H D++
Sbjct: 105 -------------------FLAQKESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLK 142
Query: 164 SSNVLL----FEDFKAKIADFNLS---NQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLT 216
N++L K+ DF L+ + + GT + APE L
Sbjct: 143 PENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF------KNIFGTPEFVAPEIVNYEPLG 196
Query: 217 QKSDVYSFGVVLLELLTGRKP 237
++D++S GV+ LL+G P
Sbjct: 197 LEADMWSIGVITYILLSGASP 217
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 8e-11
Identities = 29/101 (28%), Positives = 47/101 (46%), Gaps = 12/101 (11%)
Query: 144 RGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFG 203
R ++ LH ++IHRD++ SN+L+ + K+ DF L+ + AA +
Sbjct: 123 RAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGM 179
Query: 204 --------YHAPEYAMTGQL-TQKSDVYSFGVVLLELLTGR 235
Y APE +T ++ DV+S G +L EL R
Sbjct: 180 VEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 60.7 bits (148), Expect = 9e-11
Identities = 42/198 (21%), Positives = 76/198 (38%), Gaps = 49/198 (24%)
Query: 60 RLKSPKNYPDDE--KQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHG 117
+ ++ + E ++ VS++ ++ H N++ L VL E + G L D
Sbjct: 49 QSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFD---- 104
Query: 118 RKGVQGAQPGPVLDWMTRVRIA-------VDAAR-------GLEYLHEKVQPSIIHRDIR 163
+A +A G+ YLH K I H D++
Sbjct: 105 -------------------FLAQKESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLK 142
Query: 164 SSNVLLF----EDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKS 219
N++L K+ DF L+++ + + + GT + APE L ++
Sbjct: 143 PENIMLLDKNIPIPHIKLIDFGLAHE---IEDGVEFKNIFGTPEFVAPEIVNYEPLGLEA 199
Query: 220 DVYSFGVVLLELLTGRKP 237
D++S GV+ LL+G P
Sbjct: 200 DMWSIGVITYILLSGASP 217
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 61.3 bits (149), Expect = 1e-10
Identities = 38/97 (39%), Positives = 54/97 (55%), Gaps = 9/97 (9%)
Query: 145 GLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGY 204
G++Y H ++HRD++ NVLL AKIADF LSN D L ++ G+ Y
Sbjct: 128 GVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD-GEFLRTS--CGSPNY 181
Query: 205 HAPEYAMTGQLTQ--KSDVYSFGVVLLELLTGRKPVD 239
APE ++G+L + D++S GV+L LL G P D
Sbjct: 182 AAPE-VISGRLYAGPEVDIWSSGVILYALLCGTLPFD 217
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 61.0 bits (148), Expect = 1e-10
Identities = 42/177 (23%), Positives = 68/177 (38%), Gaps = 40/177 (22%)
Query: 81 LKHENLVELLGYCVEGNLR--VLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRI 138
LKH N++ L + R L +++A L I+ + + + L +
Sbjct: 75 LKHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSL 133
Query: 139 AVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKA----KIADFNLSNQAPDMAARL- 193
G+ YLH ++HRD++ +N+L+ + KIAD ARL
Sbjct: 134 LYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGF--------ARLF 182
Query: 194 --------HSTRVLGTFGYHAPE-------YAMTGQLTQKSDVYSFGVVLLELLTGR 235
V+ TF Y APE Y T+ D+++ G + ELLT
Sbjct: 183 NSPLKPLADLDPVVVTFWYRAPELLLGARHY------TKAIDIWAIGCIFAELLTSE 233
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 1e-10
Identities = 29/93 (31%), Positives = 48/93 (51%), Gaps = 4/93 (4%)
Query: 145 GLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGY 204
L+YLH + ++++RD++ N++L +D KI DF L + A + + GT Y
Sbjct: 260 ALDYLHSEK--NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT--FCGTPEY 315
Query: 205 HAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 237
APE + D + GVV+ E++ GR P
Sbjct: 316 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 348
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 59.9 bits (146), Expect = 2e-10
Identities = 41/180 (22%), Positives = 68/180 (37%), Gaps = 46/180 (25%)
Query: 75 VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 134
+ +L+H N+V L E + L ++ T G L +
Sbjct: 56 ARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFE--------------------- 94
Query: 135 RVRIA-------VDAAR-------GLEYLHEKVQPSIIHRDIRSSNVLLF---EDFKAKI 177
I DA+ + Y H I+HR+++ N+LL + K+
Sbjct: 95 --DIVAREFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKL 149
Query: 178 ADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 237
ADF L+ + D + GT GY +PE ++ D+++ GV+L LL G P
Sbjct: 150 ADFGLAIEVND--SEAWHGFA-GTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 206
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 2e-10
Identities = 29/95 (30%), Positives = 53/95 (55%), Gaps = 6/95 (6%)
Query: 144 RGLEYLHEKVQPSIIHRDIRSSNVLL-FEDFKAKIADFNLS-NQAPDMAARLHSTRVLGT 201
RGL+Y+H +++HRD++ +N+ + ED KI DF L+ P + + H + L T
Sbjct: 131 RGLKYIHSA---NVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVT 187
Query: 202 FGYHAPEYAMTGQL-TQKSDVYSFGVVLLELLTGR 235
Y +P ++ T+ D+++ G + E+LTG+
Sbjct: 188 KWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 2e-10
Identities = 45/198 (22%), Positives = 76/198 (38%), Gaps = 57/198 (28%)
Query: 64 PKNYPDDEKQL---VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKG 120
D++++ +SV+++L H NL++L N VL E+ G L D
Sbjct: 123 KTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFD------- 175
Query: 121 VQGAQPGPVLDWMTRVRIA--------VDAAR-------GLEYLHEKVQPSIIHRDIRSS 165
RI +D G+ ++H+ I+H D++
Sbjct: 176 ----------------RIIDESYNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPE 216
Query: 166 NVLLF--EDFKAKIADFNLSNQAPDMAARLHSTRVL----GTFGYHAPEYAMTGQLTQKS 219
N+L + + KI DF L+ R L GT + APE ++ +
Sbjct: 217 NILCVNRDAKQIKIIDFGLA-------RRYKPREKLKVNFGTPEFLAPEVVNYDFVSFPT 269
Query: 220 DVYSFGVVLLELLTGRKP 237
D++S GV+ LL+G P
Sbjct: 270 DMWSVGVIAYMLLSGLSP 287
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 3e-10
Identities = 27/99 (27%), Positives = 46/99 (46%), Gaps = 12/99 (12%)
Query: 145 GLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGY 204
+ +LH +I+HRD++ N+LL ++ + +++DF S GT GY
Sbjct: 212 AVSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFSCHLEP--GEKLRELC-GTPGY 265
Query: 205 HAPE------YAMTGQLTQKSDVYSFGVVLLELLTGRKP 237
APE ++ D+++ GV+L LL G P
Sbjct: 266 LAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPP 304
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 59.1 bits (144), Expect = 3e-10
Identities = 36/93 (38%), Positives = 53/93 (56%), Gaps = 5/93 (5%)
Query: 145 GLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGY 204
L++LH II+RD++ N+LL E+ K+ DF LS ++ D + +S GT Y
Sbjct: 138 ALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVEY 192
Query: 205 HAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 237
APE TQ +D +SFGV++ E+LTG P
Sbjct: 193 MAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLP 225
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 58.7 bits (143), Expect = 5e-10
Identities = 29/93 (31%), Positives = 46/93 (49%), Gaps = 5/93 (5%)
Query: 145 GLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGY 204
L +LH+K II+RD++ N++L K+ DF L ++ H+ GT Y
Sbjct: 133 ALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHT--FCGTIEY 187
Query: 205 HAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 237
APE M + D +S G ++ ++LTG P
Sbjct: 188 MAPEILMRSGHNRAVDWWSLGALMYDMLTGAPP 220
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 57.6 bits (140), Expect = 1e-09
Identities = 31/93 (33%), Positives = 47/93 (50%), Gaps = 5/93 (5%)
Query: 145 GLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGY 204
LEYLH + +++RDI+ N++L +D KI DF L + A + + GT Y
Sbjct: 117 ALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGTPEY 171
Query: 205 HAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 237
APE + D + GVV+ E++ GR P
Sbjct: 172 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 57.1 bits (139), Expect = 1e-09
Identities = 38/166 (22%), Positives = 71/166 (42%), Gaps = 19/166 (11%)
Query: 75 VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 134
+ ++ LKH+N+V L L +EF L G P V ++
Sbjct: 52 ICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNG--DLDPEIVKSFLF 108
Query: 135 RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSN--QAPDMAAR 192
++ +GL + H + +++HRD++ N+L+ + + K+A+F L+ P R
Sbjct: 109 QL------LKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV---R 156
Query: 193 LHSTRVLGTFGYHAPEYAM-TGQLTQKSDVYSFGVVLLELLTGRKP 237
+S V+ T Y P+ + D++S G + EL +P
Sbjct: 157 CYSAEVV-TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP 201
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 2e-09
Identities = 26/107 (24%), Positives = 49/107 (45%), Gaps = 15/107 (14%)
Query: 141 DAAR-------GLEYLHEKVQPSIIHRDIRSSNVLLF---EDFKAKIADFNLSNQAPDMA 190
+A+ + ++H+ ++HRD++ N+L ++ + KI DF + P
Sbjct: 107 EASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN 163
Query: 191 ARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 237
L + T Y APE + D++S GV+L +L+G+ P
Sbjct: 164 QPLKT--PCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVP 208
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 57.5 bits (139), Expect = 2e-09
Identities = 25/98 (25%), Positives = 44/98 (44%), Gaps = 9/98 (9%)
Query: 145 GLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGY 204
++ +H+ +HRDI+ N+L+ + ++ADF + + S V GT Y
Sbjct: 187 AIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV-GTPDY 242
Query: 205 HAPEYAMTGQLTQKS-----DVYSFGVVLLELLTGRKP 237
+PE + + D +S GV + E+L G P
Sbjct: 243 ISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 2e-09
Identities = 23/100 (23%), Positives = 39/100 (39%), Gaps = 11/100 (11%)
Query: 145 GLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGY 204
++ +H +HRDI+ N+LL ++ADF + + S +GT Y
Sbjct: 174 AIDSVHRL---GYVHRDIKPDNILLDRCGHIRLADFGSCLKL-RADGTVRSLVAVGTPDY 229
Query: 205 HAPEYAMTGQLTQKSDVY-------SFGVVLLELLTGRKP 237
+PE + Y + GV E+ G+ P
Sbjct: 230 LSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 2e-09
Identities = 34/123 (27%), Positives = 52/123 (42%), Gaps = 16/123 (13%)
Query: 127 GPVLDWMTRVRIAVDAAR--------GLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIA 178
G +++ M+ + AR L+ +H IHRD++ N+LL + K+A
Sbjct: 154 GDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLA 210
Query: 179 DFNLSNQAPDMAARLHSTRVLGTFGYHAPE----YAMTGQLTQKSDVYSFGVVLLELLTG 234
DF + T V GT Y +PE G ++ D +S GV L E+L G
Sbjct: 211 DFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 269
Query: 235 RKP 237
P
Sbjct: 270 DTP 272
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 2e-09
Identities = 39/196 (19%), Positives = 70/196 (35%), Gaps = 58/196 (29%)
Query: 68 PDDEKQL---VSVVSRLKH-ENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQG 123
D ++ ++V+ K ++ L + +L E+A G +
Sbjct: 69 QDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFS---------- 118
Query: 124 AQPGPVLDWMTRVRIA---------VDAAR-------GLEYLHEKVQPSIIHRDIRSSNV 167
D R G+ YLH+ +I+H D++ N+
Sbjct: 119 -------------LCLPELAEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNI 162
Query: 168 LL---FEDFKAKIADFNLS---NQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDV 221
LL + KI DF +S A ++ ++GT Y APE +T +D+
Sbjct: 163 LLSSIYPLGDIKIVDFGMSRKIGHACEL------REIMGTPEYLAPEILNYDPITTATDM 216
Query: 222 YSFGVVLLELLTGRKP 237
++ G++ LLT P
Sbjct: 217 WNIGIIAYMLLTHTSP 232
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 3e-09
Identities = 24/99 (24%), Positives = 50/99 (50%), Gaps = 14/99 (14%)
Query: 144 RGLEYLHEKVQPSIIHRDIRSSNVLL-FEDFKAKIADFNLS---NQAPDMAARLHSTRVL 199
+ L+Y H I+HRD++ NV++ E K ++ D+ L+ + + R+ ++R
Sbjct: 141 KALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRV-ASRY- 195
Query: 200 GTFGYHAPEYAMTGQLTQKS-DVYSFGVVLLELLTGRKP 237
+ PE + Q+ S D++S G +L ++ ++P
Sbjct: 196 ----FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP 230
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 3e-09
Identities = 30/94 (31%), Positives = 48/94 (51%), Gaps = 7/94 (7%)
Query: 145 GLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGY 204
L YLHE+ II+RD++ NVLL + K+ D+ + + + GT Y
Sbjct: 122 ALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST--FCGTPNY 176
Query: 205 HAPEYAMTGQLTQKS-DVYSFGVVLLELLTGRKP 237
APE + G+ S D ++ GV++ E++ GR P
Sbjct: 177 IAPE-ILRGEDYGFSVDWWALGVLMFEMMAGRSP 209
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 4e-09
Identities = 44/170 (25%), Positives = 77/170 (45%), Gaps = 26/170 (15%)
Query: 75 VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATM--GSLHDILHGRKGVQGAQPGPVLDW 132
+S++ LKHEN+V L N L +EF D +G + V +
Sbjct: 54 ISLMKELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYF 113
Query: 133 MTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAAR 192
++ +GL + HE I+HRD++ N+L+ + + K+ DF L+ +A +
Sbjct: 114 QWQL------LQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLA-RAFGIPVN 163
Query: 193 LHSTRVLGTFGYHAPE-------YAMTGQLTQKSDVYSFGVVLLELLTGR 235
S+ V+ T Y AP+ Y + D++S G +L E++TG+
Sbjct: 164 TFSSEVV-TLWYRAPDVLMGSRTY------STSIDIWSCGCILAEMITGK 206
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 4e-09
Identities = 34/93 (36%), Positives = 53/93 (56%), Gaps = 5/93 (5%)
Query: 145 GLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGY 204
GL++LH K I++RD++ N+LL +D KIADF + + A+ ++ GT Y
Sbjct: 130 GLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT--FCGTPDY 184
Query: 205 HAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 237
APE + + D +SFGV+L E+L G+ P
Sbjct: 185 IAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP 217
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 4e-09
Identities = 27/93 (29%), Positives = 42/93 (45%), Gaps = 5/93 (5%)
Query: 145 GLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGY 204
L YLH +I++RD++ N+LL + DF L + ++ ++ GT Y
Sbjct: 151 ALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKE--NIEHNSTTSTFCGTPEY 205
Query: 205 HAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 237
APE + D + G VL E+L G P
Sbjct: 206 LAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPP 238
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 55.7 bits (135), Expect = 5e-09
Identities = 31/94 (32%), Positives = 49/94 (52%), Gaps = 7/94 (7%)
Query: 145 GLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGY 204
L +LH+K II+RD++ NVLL + K+ADF + + + + + GT Y
Sbjct: 136 ALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKE--GICNGVTTATFCGTPDY 190
Query: 205 HAPEYAMTGQLTQKS-DVYSFGVVLLELLTGRKP 237
APE + L + D ++ GV+L E+L G P
Sbjct: 191 IAPE-ILQEMLYGPAVDWWAMGVLLYEMLCGHAP 223
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 56.2 bits (135), Expect = 5e-09
Identities = 31/93 (33%), Positives = 49/93 (52%), Gaps = 5/93 (5%)
Query: 145 GLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGY 204
GL +L K II+RD++ NV+L + KIADF + + ++ + + GT Y
Sbjct: 454 GLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKE--NIWDGVTTKTFCGTPDY 508
Query: 205 HAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 237
APE + D ++FGV+L E+L G+ P
Sbjct: 509 IAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP 541
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 6e-09
Identities = 33/96 (34%), Positives = 47/96 (48%), Gaps = 8/96 (8%)
Query: 145 GLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVL-GTFG 203
LE+LH+ II+RDI+ N+LL + + DF LS + +A GT
Sbjct: 171 ALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKE--FVADETERAYDFCGTIE 225
Query: 204 YHAPEYAMTGQL--TQKSDVYSFGVVLLELLTGRKP 237
Y AP+ G + D +S GV++ ELLTG P
Sbjct: 226 YMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 261
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 55.3 bits (134), Expect = 6e-09
Identities = 44/163 (26%), Positives = 79/163 (48%), Gaps = 17/163 (10%)
Query: 75 VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 134
+S++ L H N+V L+ L +EF L +L K G Q + ++
Sbjct: 70 ISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKT--GLQDSQIKIYLY 126
Query: 135 RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 194
++ RG+ + H+ I+HRD++ N+L+ D K+ADF L+ +A + R +
Sbjct: 127 QL------LRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLA-RAFGIPVRSY 176
Query: 195 STRVLGTFGYHAPEYAMTGQLTQKS--DVYSFGVVLLELLTGR 235
+ V+ T Y AP+ M G + D++S G + E++TG+
Sbjct: 177 THEVV-TLWYRAPDVLM-GSKKYSTSVDIWSIGCIFAEMITGK 217
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 9e-09
Identities = 30/94 (31%), Positives = 48/94 (51%), Gaps = 7/94 (7%)
Query: 145 GLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGY 204
L YLHE+ II+RD++ NVLL + K+ D+ + + + GT Y
Sbjct: 165 ALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST--FCGTPNY 219
Query: 205 HAPEYAMTGQLTQKS-DVYSFGVVLLELLTGRKP 237
APE + G+ S D ++ GV++ E++ GR P
Sbjct: 220 IAPE-ILRGEDYGFSVDWWALGVLMFEMMAGRSP 252
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 54.9 bits (133), Expect = 1e-08
Identities = 31/93 (33%), Positives = 46/93 (49%), Gaps = 5/93 (5%)
Query: 145 GLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGY 204
GL +L K II+RD++ NV+L + KIADF + + + GT Y
Sbjct: 133 GLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT--FCGTPDY 187
Query: 205 HAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 237
APE + D ++FGV+L E+L G+ P
Sbjct: 188 IAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP 220
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 54.1 bits (131), Expect = 1e-08
Identities = 40/168 (23%), Positives = 78/168 (46%), Gaps = 27/168 (16%)
Query: 75 VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 134
+S++ LKH N+V+L VL +E L +L +G G + ++
Sbjct: 51 ISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEG--GLESVTAKSFLL 107
Query: 135 RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 194
++ G+ Y H++ ++HRD++ N+L+ + + KIADF L+ +A + R +
Sbjct: 108 QL------LNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLA-RAFGIPVRKY 157
Query: 195 STRVLGTFGYHAPE-------YAMTGQLTQKSDVYSFGVVLLELLTGR 235
+ ++ T Y AP+ Y + D++S G + E++ G
Sbjct: 158 THEIV-TLWYRAPDVLMGSKKY------STTIDIWSVGCIFAEMVNGT 198
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 54.8 bits (132), Expect = 1e-08
Identities = 27/115 (23%), Positives = 43/115 (37%), Gaps = 24/115 (20%)
Query: 144 RGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFG 203
G ++HE IIHRD++ +N LL +D K+ DF L+ +
Sbjct: 140 LGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEE 196
Query: 204 --------------------YHAPEYAMTGQL-TQKSDVYSFGVVLLELLTGRKP 237
Y APE + + T+ D++S G + ELL +
Sbjct: 197 PGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQS 251
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 2e-08
Identities = 46/242 (19%), Positives = 83/242 (34%), Gaps = 60/242 (24%)
Query: 62 KSPKNYPDDEKQLVSVVSRLK-HENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKG 120
K P + + V ++ + + H N++EL+ + E + L +E GS+
Sbjct: 48 KQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILS------- 100
Query: 121 VQGAQPGPVLDWMTRVRIA-------VDAAR-------GLEYLHEKVQPSIIHRDIRSSN 166
I ++A+ L++LH K I HRD++ N
Sbjct: 101 ----------------HIHKRRHFNELEASVVVQDVASALDFLHNK---GIAHRDLKPEN 141
Query: 167 VLLF---EDFKAKIADFNLS------NQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQ 217
+L + KI DF+L ++ T G+ Y APE
Sbjct: 142 ILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPC-GSAEYMAPEVVEAFSEEA 200
Query: 218 KS-----DVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKG 272
D++S GV+L LL+G P ++ + + + +G
Sbjct: 201 SIYDKRCDLWSLGVILYILLSGYPPFVGR-CGSDCGWDRGEACPACQNMLFESI---QEG 256
Query: 273 EY 274
+Y
Sbjct: 257 KY 258
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 2e-08
Identities = 26/98 (26%), Positives = 43/98 (43%), Gaps = 10/98 (10%)
Query: 143 ARGLEYLHEKVQPSIIHRDIRSSNVLLF---EDFKAKIADFNLSNQAPDMAARLHSTRVL 199
+++LH +I HRD++ N+L +D K+ DF + + T
Sbjct: 138 GTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQ---NALQTPC- 190
Query: 200 GTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 237
T Y APE + + D++S GV++ LL G P
Sbjct: 191 YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPP 228
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 2e-08
Identities = 28/112 (25%), Positives = 50/112 (44%), Gaps = 23/112 (20%)
Query: 144 RGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFG 203
+ ++YLH ++HRD++ SN+LL + K+ADF LS ++ ++ +
Sbjct: 120 KVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINEN 176
Query: 204 -------------------YHAPEYAMTGQL-TQKSDVYSFGVVLLELLTGR 235
Y APE + T+ D++S G +L E+L G+
Sbjct: 177 TENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 53.4 bits (129), Expect = 3e-08
Identities = 40/162 (24%), Positives = 73/162 (45%), Gaps = 15/162 (9%)
Query: 75 VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 134
VS++ LKH N+V L L +E+ L L V ++
Sbjct: 51 VSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGN--IINMHNVKLFLF 107
Query: 135 RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 194
++ RGL Y H + ++HRD++ N+L+ E + K+ADF L+ +A + + +
Sbjct: 108 QL------LRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLA-RAKSIPTKTY 157
Query: 195 STRVLGTFGYHAPEYAM-TGQLTQKSDVYSFGVVLLELLTGR 235
V+ T Y P+ + + + + D++ G + E+ TGR
Sbjct: 158 DNEVV-TLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGR 198
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 53.0 bits (128), Expect = 4e-08
Identities = 42/167 (25%), Positives = 66/167 (39%), Gaps = 29/167 (17%)
Query: 79 SRLKHENLVELLGYCVEGNLRV-----LAYEFATMGSLHDILHGRKGVQGAQPGPVLDWM 133
+H N+V L+ C L +E D+ + P P L
Sbjct: 69 EAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVD----QDL----RTYLDKAPPPGLPAE 120
Query: 134 TRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARL 193
T + RGL++LH I+HRD++ N+L+ K+ADF L AR+
Sbjct: 121 TIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGL--------ARI 169
Query: 194 HS-----TRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGR 235
+S T V+ T Y APE + D++S G + E+ +
Sbjct: 170 YSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 5e-08
Identities = 26/96 (27%), Positives = 43/96 (44%), Gaps = 12/96 (12%)
Query: 144 RGLEYLHEKVQPSIIHRDIRSSNVLLF-EDFKAKIADFNLSNQAPDMAARLH--STRVLG 200
R + ++H I HRDI+ N+L+ +D K+ DF + + + +R
Sbjct: 152 RAVGFIHSL---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRF-- 206
Query: 201 TFGYHAPEYAMTGQL-TQKSDVYSFGVVLLELLTGR 235
Y APE + T D++S G V EL+ G+
Sbjct: 207 ---YRAPELMLGATEYTPSIDLWSIGCVFGELILGK 239
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 6e-08
Identities = 24/93 (25%), Positives = 43/93 (46%), Gaps = 10/93 (10%)
Query: 146 LEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVL-GTFGY 204
EYLH +I+RD++ N+L+ + ++ DF + + T L GT
Sbjct: 154 FEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR------TWTLCGTPEA 204
Query: 205 HAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 237
APE ++ + D ++ GV++ E+ G P
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 51.8 bits (125), Expect = 8e-08
Identities = 40/167 (23%), Positives = 65/167 (38%), Gaps = 29/167 (17%)
Query: 79 SRLKHENLVELLGYCVEGNLR-----VLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWM 133
+H N+V L C L +E D+ P P +
Sbjct: 69 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD----QDL----TTYLDKVPEPGVPTE 120
Query: 134 TRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARL 193
T + RGL++LH ++HRD++ N+L+ + K+ADF L AR+
Sbjct: 121 TIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGL--------ARI 169
Query: 194 HS-----TRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGR 235
+S T V+ T Y APE + D++S G + E+ +
Sbjct: 170 YSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 9e-08
Identities = 42/183 (22%), Positives = 75/183 (40%), Gaps = 45/183 (24%)
Query: 75 VSVVSRLKHENLVELLGYCVEGNLRV--------LAYEFATMGSLHDILHGRKGVQGAQP 126
+ ++ LKHEN+V L+ C L ++F HD+ G+
Sbjct: 67 IKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCE----HDL----AGL----- 113
Query: 127 GPVLDWMTRVRIAVDAA----------RGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAK 176
++ V + + GL Y+H I+HRD++++NVL+ D K
Sbjct: 114 ------LSNVLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLK 164
Query: 177 IADFNLS---NQAPDMAARLHSTRVLGTFGYHAPEYAM-TGQLTQKSDVYSFGVVLLELL 232
+ADF L+ + A + ++ RV+ T Y PE + D++ G ++ E+
Sbjct: 165 LADFGLARAFSLAKNSQPNRYTNRVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMW 223
Query: 233 TGR 235
T
Sbjct: 224 TRS 226
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 1e-07
Identities = 29/111 (26%), Positives = 50/111 (45%), Gaps = 9/111 (8%)
Query: 143 ARGLEYLHEKVQPSIIHRDIRSSNVLLF---EDFKA-KIADFNLSNQAPDMAARLHSTRV 198
+ +EYLH + ++HRD++ SN+L + ++ +I DF + Q L T
Sbjct: 126 TKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLM-TPC 181
Query: 199 LGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSL 249
T + APE D++S GV+L +LTG P + + +
Sbjct: 182 -YTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEI 231
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 1e-07
Identities = 26/96 (27%), Positives = 41/96 (42%), Gaps = 10/96 (10%)
Query: 144 RGLEYLHEKVQPSIIHRDIRSSNVLL-FEDFKAKIADFNLSNQAPDMAARLH--STRVLG 200
R + LH ++ HRDI+ NVL+ D K+ DF + + + +R
Sbjct: 140 RSIGCLHLPSV-NVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRY-- 196
Query: 201 TFGYHAPEYAMTGQL-TQKSDVYSFGVVLLELLTGR 235
Y APE Q T D++S G + E++ G
Sbjct: 197 ---YRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 1e-07
Identities = 42/164 (25%), Positives = 74/164 (45%), Gaps = 19/164 (11%)
Query: 75 VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 134
+ ++ +L+HENLV LL C + L +EF ++ D L G V ++
Sbjct: 75 IKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFP--NGLDYQVVQKYLF 131
Query: 135 RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLS--NQAPDMAAR 192
++ G+ + H +IIHRDI+ N+L+ + K+ DF + AP
Sbjct: 132 QI------INGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG---E 179
Query: 193 LHSTRVLGTFGYHAPEYAM-TGQLTQKSDVYSFGVVLLELLTGR 235
++ V T Y APE + + + DV++ G ++ E+ G
Sbjct: 180 VYDDEVA-TRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGE 222
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 2e-07
Identities = 33/104 (31%), Positives = 41/104 (39%), Gaps = 28/104 (26%)
Query: 144 RGLEYLHEKVQPSIIHRDIRSSNVLLFED-FKAKIADFNLSNQAPDMAARLHS------- 195
R L Y+H I HRDI+ N+LL D K+ DF A+
Sbjct: 167 RSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGS--------AKQLVRGEPNVS 215
Query: 196 ---TRVLGTFGYHAPEYAMTGQL-TQKSDVYSFGVVLLELLTGR 235
+R Y APE T DV+S G VL ELL G+
Sbjct: 216 YICSRY-----YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 50.6 bits (122), Expect = 2e-07
Identities = 36/94 (38%), Positives = 50/94 (53%), Gaps = 10/94 (10%)
Query: 145 GLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVL-GTFG 203
LEYLH K II+RD++ N+LL ++ KI DF + PD+ T L GT
Sbjct: 118 ALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV------TYTLCGTPD 168
Query: 204 YHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 237
Y APE T + D +SFG+++ E+L G P
Sbjct: 169 YIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTP 202
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 50.3 bits (121), Expect = 3e-07
Identities = 44/168 (26%), Positives = 73/168 (43%), Gaps = 27/168 (16%)
Query: 75 VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 134
+ ++ L H N++ LL + L ++F L I+ P + +M
Sbjct: 63 IKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNS--LVLTPSHIKAYML 119
Query: 135 RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 194
+GLEYLH+ I+HRD++ +N+LL E+ K+ADF L+ R +
Sbjct: 120 MT------LQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGS-PNRAY 169
Query: 195 STRVLGTFGYHAPE-------YAMTGQLTQKSDVYSFGVVLLELLTGR 235
+ +V+ T Y APE Y D+++ G +L ELL
Sbjct: 170 THQVV-TRWYRAPELLFGARMY------GVGVDMWAVGCILAELLLRV 210
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 50.3 bits (121), Expect = 3e-07
Identities = 36/170 (21%), Positives = 68/170 (40%), Gaps = 27/170 (15%)
Query: 75 VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 134
VS++ L+H N++EL + L +E+A L + V + ++
Sbjct: 84 VSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVS---MRVIKSFLY 139
Query: 135 RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKA-----KIADFNL--SNQAP 187
++ G+ + H + +HRD++ N+LL + KI DF L + P
Sbjct: 140 QL------INGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIP 190
Query: 188 DMAARLHSTRVLGTFGYHAPEYAMTGQLTQKS--DVYSFGVVLLELLTGR 235
R + ++ T Y PE + G + D++S + E+L
Sbjct: 191 I---RQFTHEII-TLWYRPPEILL-GSRHYSTSVDIWSIACIWAEMLMKT 235
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 4e-07
Identities = 28/96 (29%), Positives = 40/96 (41%), Gaps = 12/96 (12%)
Query: 144 RGLEYLHEKVQPSIIHRDIRSSNVLLFED-FKAKIADFNLSNQAPDMAARLH--STRVLG 200
R L Y+H I HRDI+ N+LL K+ DF + + +R
Sbjct: 152 RSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRY-- 206
Query: 201 TFGYHAPEYAMTGQL-TQKSDVYSFGVVLLELLTGR 235
Y APE T D++S G V+ EL+ G+
Sbjct: 207 ---YRAPELIFGATNYTTNIDIWSTGCVMAELMQGQ 239
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 4e-07
Identities = 26/98 (26%), Positives = 43/98 (43%), Gaps = 9/98 (9%)
Query: 143 ARGLEYLHEKVQPSIIHRDIRSSNVLL---FEDFKAKIADFNLSNQAPDMAARLHSTRVL 199
++YLH +I HRD++ N+L + K+ DF + + +T
Sbjct: 171 GEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS--HNSLTTPC- 224
Query: 200 GTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 237
T Y APE + + D++S GV++ LL G P
Sbjct: 225 YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 262
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 49.5 bits (119), Expect = 5e-07
Identities = 40/168 (23%), Positives = 69/168 (41%), Gaps = 27/168 (16%)
Query: 75 VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 134
+ ++ +LKH NLV LL L +E+ LH++ ++GV V
Sbjct: 53 IRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVP---EHLVKSITW 109
Query: 135 RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 194
+ + + + H+ + IHRD++ N+L+ + K+ DF ARL
Sbjct: 110 QT------LQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGF--------ARLL 152
Query: 195 S------TRVLGTFGYHAPEYAMTGQLTQKS-DVYSFGVVLLELLTGR 235
+ + T Y +PE + DV++ G V ELL+G
Sbjct: 153 TGPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGV 200
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 6e-07
Identities = 27/97 (27%), Positives = 43/97 (44%), Gaps = 13/97 (13%)
Query: 145 GLEYLHEKVQPSIIHRDIRSSNVLLFE------DFKAKIADFNLSNQAPDMAARLHSTRV 198
GL+Y+H + IIH DI+ NVL+ + KIAD + + TR
Sbjct: 143 GLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTRE 200
Query: 199 LGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGR 235
Y +PE + +D++S ++ EL+TG
Sbjct: 201 -----YRSPEVLLGAPWGCGADIWSTACLIFELITGD 232
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 48.7 bits (115), Expect = 2e-06
Identities = 47/310 (15%), Positives = 95/310 (30%), Gaps = 76/310 (24%)
Query: 42 WLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVS--VVSRLKHENLVELLGYCVEGNLR 99
+L + E+ PS ++ ++ Q+ + VSRL+ LR
Sbjct: 93 FLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYL-----------KLR 141
Query: 100 VLAYEFATMGSLHDILHGRKG---------------VQGAQPGPVLDWMT--RVRIAVDA 142
E ++ ++ G G VQ + W+
Sbjct: 142 QALLELRPAKNV--LIDGVLGSGKTWVALDVCLSYKVQCKMDFKIF-WLNLKNCNSPETV 198
Query: 143 ARGLEYLHEKVQPSIIHRDIRSSNV-LLFEDFKAKIADFNLSNQAPDMAARL------HS 195
L+ L ++ P+ R SSN+ L +A++ S + L +
Sbjct: 199 LEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENC---LLVLLNVQN 255
Query: 196 TRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATP 255
+ F +T T+ V F L T +DH +L TP
Sbjct: 256 AKAWNAFNLSCK-ILLT---TRFKQVTDF---LSAATTTHISLDHH----SMTL----TP 300
Query: 256 RLSEDKVKQCVDPKLKGEYPPKGVA----KLAAVAALC------------VQYEAEFRPN 299
+ + + +D + + + P + + +L+ +A V + +
Sbjct: 301 DEVKSLLLKYLDCRPQ-DLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCD-KLTTI 358
Query: 300 MSIVVKALQP 309
+ + L+P
Sbjct: 359 IESSLNVLEP 368
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 48.3 bits (115), Expect = 2e-06
Identities = 28/129 (21%), Positives = 49/129 (37%), Gaps = 29/129 (22%)
Query: 144 RGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLS---NQAPDMAARLHSTRVLG 200
G++Y+H I+HRD++ +N L+ +D K+ DF L+ + + ++L +
Sbjct: 167 VGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPRED 223
Query: 201 TFG----------------------YHAPEYAMTGQL-TQKSDVYSFGVVLLELLTGRKP 237
Y APE + + T+ DV+S G + ELL K
Sbjct: 224 DMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKE 283
Query: 238 VDHTMPRGQ 246
Sbjct: 284 NVAYHADRG 292
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 2e-05
Identities = 42/180 (23%), Positives = 68/180 (37%), Gaps = 42/180 (23%)
Query: 65 KNYPDDEKQLVSVVSRLKHEN---LV-ELLGYCVEGNLRVLAYEFATMGSLHDIL--HGR 118
K+ + + +V + N LV E+L Y +L+D+L
Sbjct: 109 KHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSY-----------------NLYDLLRNTNF 151
Query: 119 KGVQGAQPGPVLDWMTRVR-IAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKA-- 175
+GV + R A L +L + SIIH D++ N+LL ++
Sbjct: 152 RGVS----------LNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAI 200
Query: 176 KIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGR 235
KI DF S Q + F Y +PE + D++S G +L+E+ TG
Sbjct: 201 KIVDFGSSCQLGQR----IYQYIQSRF-YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 2e-05
Identities = 31/113 (27%), Positives = 49/113 (43%), Gaps = 13/113 (11%)
Query: 134 TRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAK---IADFNLSNQAPDMA 190
T + +A +EY+H K + IHRD++ N L+ K I DF L+ + D
Sbjct: 106 TVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 162
Query: 191 ARLH-----STRVLGTFGYHAPEYAMTG-QLTQKSDVYSFGVVLLELLTGRKP 237
H + + GT Y A G + +++ D+ S G VL+ G P
Sbjct: 163 THQHIPYRENKNLTGTARY-ASINTHLGIEQSRRDDLESLGYVLMYFNLGSLP 214
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 2e-05
Identities = 32/106 (30%), Positives = 49/106 (46%), Gaps = 11/106 (10%)
Query: 133 MTRVR-IAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKA--KIADFNLSNQAPDM 189
+ VR A + L+ LH+ IIH D++ N+LL + ++ K+ DF S
Sbjct: 199 LPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQR 255
Query: 190 AARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGR 235
+R F Y APE + + D++S G +L ELLTG
Sbjct: 256 VYTYIQSR----F-YRAPEVILGARYGMPIDMWSLGCILAELLTGY 296
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 4e-05
Identities = 25/115 (21%), Positives = 44/115 (38%), Gaps = 15/115 (13%)
Query: 134 TRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAK-----IADFNLSNQAPD 188
T A ++ +HEK S+++RDI+ N L+ + DF + D
Sbjct: 107 TVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRD 163
Query: 189 MAARLH-----STRVLGTFGYHAPEYAMTG-QLTQKSDVYSFGVVLLELLTGRKP 237
+ H + GT Y G + +++ D+ + G V + L G P
Sbjct: 164 PVTKQHIPYREKKNLSGTARY-MSINTHLGREQSRRDDLEALGHVFMYFLRGSLP 217
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 41.1 bits (97), Expect = 2e-04
Identities = 24/107 (22%), Positives = 40/107 (37%), Gaps = 37/107 (34%)
Query: 141 DAAR-------GLEYLHEKVQPSIIHRDIRSSNVLL---FEDFKAKIADFNLSNQAPDMA 190
+A+ ++YLH +I HRD++ N+L + K+ DF A +
Sbjct: 118 EASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGF---AKE-- 169
Query: 191 ARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 237
G Y + D++S GV++ LL G P
Sbjct: 170 -------TTGE-KY-----------DKSCDMWSLGVIMYILLCGYPP 197
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 41.0 bits (96), Expect = 3e-04
Identities = 36/190 (18%), Positives = 56/190 (29%), Gaps = 64/190 (33%)
Query: 95 EGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQ 154
G + +E L + P P + + + + +GL+YLH K +
Sbjct: 116 NGTHICMVFEVLGH-HLLKWIIKSNY--QGLPLPCVKKIIQQVL-----QGLDYLHTKCR 167
Query: 155 PSIIHRDIRSSNVLL--------------------------------------------- 169
IIH DI+ N+LL
Sbjct: 168 --IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPL 225
Query: 170 ----FEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFG 225
E K KIAD + H T + T Y + E + +D++S
Sbjct: 226 EPKNAEKLKVKIADLGNACWVHK-----HFTEDIQTRQYRSLEVLIGSGYNTPADIWSTA 280
Query: 226 VVLLELLTGR 235
+ EL TG
Sbjct: 281 CMAFELATGD 290
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 40.8 bits (95), Expect = 4e-04
Identities = 32/113 (28%), Positives = 52/113 (46%), Gaps = 13/113 (11%)
Query: 134 TRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAK---IADFNLSNQAPDMA 190
T + +A +E++H K S +HRDI+ N L+ +A I DF L+ + D +
Sbjct: 104 TVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160
Query: 191 ARLH-----STRVLGTFGYHAPEYAMTG-QLTQKSDVYSFGVVLLELLTGRKP 237
H + + GT Y A G + +++ D+ S G VL+ L G P
Sbjct: 161 THQHIPYRENKNLTGTARY-ASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 40.1 bits (94), Expect = 7e-04
Identities = 27/115 (23%), Positives = 49/115 (42%), Gaps = 15/115 (13%)
Query: 134 TRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAK-----IADFNLSNQAPD 188
T + IA+ +EY+H K ++I+RD++ N L+ I DF L+ + D
Sbjct: 106 TVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYID 162
Query: 189 MAARLH-----STRVLGTFGYHAPEYAMTG-QLTQKSDVYSFGVVLLELLTGRKP 237
+ H + GT Y G + +++ D+ + G + + L G P
Sbjct: 163 PETKKHIPYREHKSLTGTARY-MSINTHLGKEQSRRDDLEALGHMFMYFLRGSLP 216
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 39.7 bits (93), Expect = 7e-04
Identities = 29/112 (25%), Positives = 50/112 (44%), Gaps = 12/112 (10%)
Query: 134 TRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKI--ADFNLSNQAPDMAA 191
T +++ + LEY+HE +H DI+++N+LL ++ AD+ LS +
Sbjct: 152 TVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGN 208
Query: 192 RLH----STRVL-GTFGYHAPEYAMTG-QLTQKSDVYSFGVVLLELLTGRKP 237
+ GT + A G L+++SDV G +L L G+ P
Sbjct: 209 HKQYQENPRKGHNGTIEF-TSLDAHKGVALSRRSDVEILGYCMLRWLCGKLP 259
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 323 | |||
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.97 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.93 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.88 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.79 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.68 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.37 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.16 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.09 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.81 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.52 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.5 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.25 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.03 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.99 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.92 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.9 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.87 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.68 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.5 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.21 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.18 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.96 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.64 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 96.61 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.59 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.42 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.28 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.22 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 92.08 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 91.92 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 90.86 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 90.7 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 86.37 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 83.98 |
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-58 Score=403.35 Aligned_cols=252 Identities=19% Similarity=0.272 Sum_probs=203.6
Q ss_pred CCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEe
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVE 95 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 95 (323)
.|+.+.+||+|+||.||+|++..+++.+|+|++.+..... ...+.+.+|++++++++||||+++++++.+
T Consensus 25 ~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~----------~~~~~~~~E~~il~~l~HpnIV~~~~~~~~ 94 (350)
T 4b9d_A 25 KYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSS----------KEREESRREVAVLANMKHPNIVQYRESFEE 94 (350)
T ss_dssp CEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCH----------HHHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred ceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCH----------HHHHHHHHHHHHHHHCCCCCCCcEEEEEEE
Confidence 4566669999999999999999999999999876543222 123678999999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeE
Q 020641 96 GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKA 175 (323)
Q Consensus 96 ~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~ 175 (323)
++..|+|||||+||+|.+++...... .+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+
T Consensus 95 ~~~~yiVmEy~~gg~L~~~i~~~~~~-------~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~v 164 (350)
T 4b9d_A 95 NGSLYIVMDYCEGGDLFKRINAQKGV-------LFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTV 164 (350)
T ss_dssp TTEEEEEEECCTTCBHHHHHHHTTTC-------CCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCE
T ss_pred CCEEEEEEeCCCCCcHHHHHHHcCCC-------CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCE
Confidence 99999999999999999999765432 278999999999999999999999 99999999999999999999
Q ss_pred EEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhcc
Q 020641 176 KIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATP 255 (323)
Q Consensus 176 ~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~ 255 (323)
||+|||+|+........ .....||+.|+|||++.+..|+.++|||||||++|+|++|+.||...+.....
T Consensus 165 Kl~DFGla~~~~~~~~~--~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~-------- 234 (350)
T 4b9d_A 165 QLGDFGIARVLNSTVEL--ARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLV-------- 234 (350)
T ss_dssp EECSTTEESCCCHHHHH--HHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH--------
T ss_pred EEcccccceeecCCccc--ccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHH--------
Confidence 99999999877543221 23346999999999999999999999999999999999999999765422111
Q ss_pred cccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 256 RLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
.+++.... ...+...+.++.+||.+||+.||++|||+.|+++
T Consensus 235 -------~~i~~~~~-~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 235 -------LKIISGSF-PPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp -------HHHHHTCC-CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -------HHHHcCCC-CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11111111 1223455678999999999999999999999986
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-58 Score=401.07 Aligned_cols=259 Identities=20% Similarity=0.316 Sum_probs=212.7
Q ss_pred CCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEe
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVE 95 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 95 (323)
.|+.+.+||+|+||.||+|++..+++.+|+|++.... ....+.+.+|+++|++++||||+++++++.+
T Consensus 75 ~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~------------~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~ 142 (346)
T 4fih_A 75 YLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRK------------QQRRELLFNEVVIMRDYQHENVVEMYNSYLV 142 (346)
T ss_dssp TEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGG------------CSSGGGGHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred hcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCc------------hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEE
Confidence 3677779999999999999999999999999775331 1223567899999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeE
Q 020641 96 GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKA 175 (323)
Q Consensus 96 ~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~ 175 (323)
++..|+|||||+||+|.+++.... +++..+..++.||+.||.|||++ ||+||||||+|||++.++.+
T Consensus 143 ~~~~~ivmEy~~gg~L~~~l~~~~----------l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~v 209 (346)
T 4fih_A 143 GDELWVVMEFLEGGALTDIVTHTR----------MNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRV 209 (346)
T ss_dssp TTEEEEEECCCTTEEHHHHHHHSC----------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCE
T ss_pred CCEEEEEEeCCCCCcHHHHHHcCC----------CCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCE
Confidence 999999999999999999997643 99999999999999999999999 99999999999999999999
Q ss_pred EEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhcc
Q 020641 176 KIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATP 255 (323)
Q Consensus 176 ~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~ 255 (323)
||+|||++........ ......||+.|+|||++.+..|+.++|||||||++|+|++|+.||...........+.
T Consensus 210 Kl~DFGla~~~~~~~~--~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~---- 283 (346)
T 4fih_A 210 KLSDFGFCAQVSKEVP--RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIR---- 283 (346)
T ss_dssp EECCCTTCEECCSSSC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH----
T ss_pred EEecCcCceecCCCCC--cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHH----
Confidence 9999999986644322 2345679999999999999999999999999999999999999997653321111110
Q ss_pred cccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhhcCCCCC
Q 020641 256 RLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSPPPA 317 (323)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~~~~~~~ 317 (323)
....+ ........+.++.+||.+||..||++|||+.|+++ ..+++...+|
T Consensus 284 --------~~~~~--~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~--Hp~~~~~~~p 333 (346)
T 4fih_A 284 --------DNLPP--RLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK--HPFLAKAGPP 333 (346)
T ss_dssp --------HSSCC--CCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT--CGGGGGCCCG
T ss_pred --------cCCCC--CCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc--CHhhcCCCCC
Confidence 00000 11223456678999999999999999999999988 4455444443
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-58 Score=400.06 Aligned_cols=265 Identities=24% Similarity=0.368 Sum_probs=205.6
Q ss_pred cccCCCCCCccceeccc-----eeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEe
Q 020641 21 VRLDKGPEDDLYLKKRV-----KMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVE 95 (323)
Q Consensus 21 ~~lg~G~~~~V~~~~~~-----~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 95 (323)
.+||+|+||.||+|+.. .+++.||+|++... .....+.|.+|+++|++++||||++++++|.+
T Consensus 47 ~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~------------~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~ 114 (329)
T 4aoj_A 47 WELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA------------SESARQDFQREAELLTMLQHQHIVRFFGVCTE 114 (329)
T ss_dssp EEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC------------SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred EEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC------------CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE
Confidence 37999999999999754 46888999976421 11223678999999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHhccCCCCCC------CCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEE
Q 020641 96 GNLRVLAYEFATMGSLHDILHGRKGVQG------AQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLL 169 (323)
Q Consensus 96 ~~~~~lv~e~~~~~sL~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili 169 (323)
++..++|||||++|+|.+++........ ......+++..+..++.|++.||.|||++ +|+||||||+|||+
T Consensus 115 ~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl 191 (329)
T 4aoj_A 115 GRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLV 191 (329)
T ss_dssp SSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEE
T ss_pred CCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEE
Confidence 9999999999999999999976542210 01122499999999999999999999999 99999999999999
Q ss_pred ccCCeEEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccch
Q 020641 170 FEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQS 248 (323)
Q Consensus 170 ~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~ 248 (323)
+.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||+| |+.||.......
T Consensus 192 ~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~--- 268 (329)
T 4aoj_A 192 GQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTE--- 268 (329)
T ss_dssp ETTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHH---
T ss_pred CCCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHH---
Confidence 9999999999999987654443333445568999999999999999999999999999999998 999997553211
Q ss_pred hhhhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhhcCCCC
Q 020641 249 LVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSPPP 316 (323)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~~~~~~ 316 (323)
+...+....+...+..+++++.+|+.+||+.||++|||+.||++.|+.+.+.+|.
T Consensus 269 -------------~~~~i~~g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~pp~ 323 (329)
T 4aoj_A 269 -------------AIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPPV 323 (329)
T ss_dssp -------------HHHHHHHTCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHSCC-
T ss_pred -------------HHHHHHcCCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhCCcc
Confidence 1111111222344566778899999999999999999999999999999987664
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-58 Score=397.83 Aligned_cols=270 Identities=24% Similarity=0.381 Sum_probs=213.5
Q ss_pred ccccccCCCCCCccceeccc-----eeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeE
Q 020641 18 GYFVRLDKGPEDDLYLKKRV-----KMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGY 92 (323)
Q Consensus 18 ~~~~~lg~G~~~~V~~~~~~-----~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 92 (323)
....+||+|+||+||+|+.. .+++.||+|.+... .....+.+.+|+++|++++||||++++++
T Consensus 16 ~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~------------~~~~~~~f~~E~~il~~l~HpnIV~l~g~ 83 (299)
T 4asz_A 16 VLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA------------SDNARKDFHREAELLTNLQHEHIVKFYGV 83 (299)
T ss_dssp EEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC------------CHHHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred EEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC------------ChHHHHHHHHHHHHHHhCCCCCCccEEEE
Confidence 33458999999999999864 46788999866421 11224678999999999999999999999
Q ss_pred EEeCCeEEEEEeecCCCCHHHHhccCCC----CCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEE
Q 020641 93 CVEGNLRVLAYEFATMGSLHDILHGRKG----VQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVL 168 (323)
Q Consensus 93 ~~~~~~~~lv~e~~~~~sL~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nil 168 (323)
+.+++..++|||||++|+|.+++..... .........+++..+..++.|++.|+.|||++ +|+||||||+|||
T Consensus 84 ~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NIL 160 (299)
T 4asz_A 84 CVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCL 160 (299)
T ss_dssp ECSSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEE
T ss_pred EeeCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEE
Confidence 9999999999999999999999976431 00011122399999999999999999999999 9999999999999
Q ss_pred EccCCeEEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccc
Q 020641 169 LFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQ 247 (323)
Q Consensus 169 i~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~ 247 (323)
++.++.+||+|||+|+...............||+.|+|||.+.+..++.++|||||||++|||+| |+.||......
T Consensus 161 l~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~--- 237 (299)
T 4asz_A 161 VGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN--- 237 (299)
T ss_dssp ECGGGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH---
T ss_pred ECCCCcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH---
Confidence 99999999999999976544333333344458999999999999999999999999999999998 99999765321
Q ss_pred hhhhhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhhcCCCCCC
Q 020641 248 SLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSPPPAA 318 (323)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~~~~~~~~ 318 (323)
.+...+........+..++.++.+|+.+||+.||++|||+.||.+.|+++.+..|...
T Consensus 238 -------------~~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~~p~~l 295 (299)
T 4asz_A 238 -------------EVIECITQGRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKASPVYL 295 (299)
T ss_dssp -------------HHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCCCS
T ss_pred -------------HHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcCCccc
Confidence 1111121222234456677889999999999999999999999999999988766543
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-57 Score=394.22 Aligned_cols=264 Identities=21% Similarity=0.308 Sum_probs=214.2
Q ss_pred ccccccCCCCCCccceeccc-----eeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeE
Q 020641 18 GYFVRLDKGPEDDLYLKKRV-----KMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGY 92 (323)
Q Consensus 18 ~~~~~lg~G~~~~V~~~~~~-----~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 92 (323)
.+..+||+|+||+||+++.. .+++.||+|.+... ......+.|.+|+.++++++||||++++++
T Consensus 29 ~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~-----------~~~~~~~~f~~E~~il~~l~HpNIV~l~g~ 97 (308)
T 4gt4_A 29 RFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDK-----------AEGPLREEFRHEAMLRARLQHPNVVCLLGV 97 (308)
T ss_dssp EEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC------------CCC-CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred eEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcc-----------cChHHHHHHHHHHHHHHhCCCCCCCCcceE
Confidence 44558999999999999853 46778999876422 123345789999999999999999999999
Q ss_pred EEeCCeEEEEEeecCCCCHHHHhccCCCCCC-------CCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCC
Q 020641 93 CVEGNLRVLAYEFATMGSLHDILHGRKGVQG-------AQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSS 165 (323)
Q Consensus 93 ~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~ 165 (323)
+.+++..++|||||++|+|.+++........ ......+++..+..++.|++.|+.|||++ +|+||||||+
T Consensus 98 ~~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~ 174 (308)
T 4gt4_A 98 VTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATR 174 (308)
T ss_dssp ECSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGG
T ss_pred EEECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCcccc
Confidence 9999999999999999999999975432111 01123489999999999999999999999 9999999999
Q ss_pred CEEEccCCeEEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCc
Q 020641 166 NVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPR 244 (323)
Q Consensus 166 nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~ 244 (323)
|||+++++.+||+|||+++...............||+.|+|||.+.+..++.++|||||||++|||+| |..||.+....
T Consensus 175 NILl~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~ 254 (308)
T 4gt4_A 175 NVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ 254 (308)
T ss_dssp GEEECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHH
T ss_pred ceEECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999999987655444334455668999999999999999999999999999999998 89999765321
Q ss_pred ccchhhhhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhh
Q 020641 245 GQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLL 311 (323)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~ 311 (323)
.+...+....+...+..++..+.+|+.+||+.||++|||+.||++.|+.+.
T Consensus 255 ----------------~~~~~i~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~ 305 (308)
T 4gt4_A 255 ----------------DVVEMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWG 305 (308)
T ss_dssp ----------------HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred ----------------HHHHHHHcCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhcc
Confidence 122222223334456677888999999999999999999999999998764
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-56 Score=387.98 Aligned_cols=260 Identities=25% Similarity=0.367 Sum_probs=198.8
Q ss_pred cccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeCCe
Q 020641 19 YFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNL 98 (323)
Q Consensus 19 ~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 98 (323)
...+||+|+||+||+++... .+|+|++.... ......+.|.+|++++++++||||+++++++.++ .
T Consensus 40 l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~----------~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~-~ 105 (307)
T 3omv_A 40 LSTRIGSGSFGTVYKGKWHG---DVAVKILKVVD----------PTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKD-N 105 (307)
T ss_dssp EEEECCCCSSSEEEEEESSS---EEEEEECCCSS----------CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS-S
T ss_pred EeeEEeeCCCcEEEEEEECC---cEEEEEEEecC----------CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEECC-e
Confidence 44589999999999998654 36777553211 1112246789999999999999999999988654 5
Q ss_pred EEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEEEe
Q 020641 99 RVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIA 178 (323)
Q Consensus 99 ~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~l~ 178 (323)
.++|||||++|+|.+++...... +++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+
T Consensus 106 ~~iVmEy~~gGsL~~~l~~~~~~--------l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~ 174 (307)
T 3omv_A 106 LAIVTQWCEGSSLYKHLHVQETK--------FQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIG 174 (307)
T ss_dssp CEEEEECCSSCBHHHHHHTSCCC--------CCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEEC
T ss_pred EEEEEEcCCCCCHHHHHhhcCCC--------CCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEe
Confidence 79999999999999999765432 99999999999999999999999 99999999999999999999999
Q ss_pred eccccCCCCccccccccccccCccccCCCccccC---CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhcc
Q 020641 179 DFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT---GQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATP 255 (323)
Q Consensus 179 Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~---~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~ 255 (323)
|||+|+...............||+.|+|||++.+ ..++.++|||||||++|||+||+.||.......... .....
T Consensus 175 DFGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~--~~~~~ 252 (307)
T 3omv_A 175 DFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQII--FMVGR 252 (307)
T ss_dssp CCSSCBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHH--HHHHT
T ss_pred eccCceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHH--HHHhc
Confidence 9999987654433333445679999999999864 358999999999999999999999997654321111 00000
Q ss_pred cccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhhcCC
Q 020641 256 RLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSP 314 (323)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~~~~ 314 (323)
.. ..+. ....+..++..+.+|+.+||+.||++|||+.||++.|+.+....
T Consensus 253 ~~--------~~p~-~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~l 302 (307)
T 3omv_A 253 GY--------ASPD-LSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSL 302 (307)
T ss_dssp TC--------CCCC-STTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTC
T ss_pred CC--------CCCC-cccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccC
Confidence 00 0111 11234556778999999999999999999999999998876544
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-57 Score=394.74 Aligned_cols=251 Identities=22% Similarity=0.204 Sum_probs=204.9
Q ss_pred ccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeCCeE
Q 020641 20 FVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLR 99 (323)
Q Consensus 20 ~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 99 (323)
..+||+|+||.||+|++..+++.+|+|++..+. ...+|+.++++++||||+++++++.+++..
T Consensus 63 ~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~-----------------~~~~E~~il~~l~HpnIV~l~~~~~~~~~~ 125 (336)
T 4g3f_A 63 QPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV-----------------FRVEELVACAGLSSPRIVPLYGAVREGPWV 125 (336)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEETTT-----------------CCTHHHHTTTTCCCTTBCCEEEEEEETTEE
T ss_pred CcEeccCCCeEEEEEEECCCCCEEEEEEECHHH-----------------hHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 347999999999999999999999999775321 113689999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCC-eEEEe
Q 020641 100 VLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDF-KAKIA 178 (323)
Q Consensus 100 ~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~-~~~l~ 178 (323)
|+|||||+||+|.++++.... +++..+..++.|++.||.|||++ ||+||||||+|||++.++ .+||+
T Consensus 126 ~ivmEy~~gg~L~~~l~~~~~---------l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~ 193 (336)
T 4g3f_A 126 NIFMELLEGGSLGQLIKQMGC---------LPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALC 193 (336)
T ss_dssp EEEECCCTTCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEEC
T ss_pred EEEEeccCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEe
Confidence 999999999999999976542 99999999999999999999999 999999999999999987 69999
Q ss_pred eccccCCCCccccc---cccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhcc
Q 020641 179 DFNLSNQAPDMAAR---LHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATP 255 (323)
Q Consensus 179 Dfg~~~~~~~~~~~---~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~ 255 (323)
|||+|+........ .......||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+....
T Consensus 194 DFGla~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~- 272 (336)
T 4g3f_A 194 DFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEP- 272 (336)
T ss_dssp CCTTCEEC------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSC-
T ss_pred eCCCCeEccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCC-
Confidence 99999766432211 12233569999999999999999999999999999999999999997654322211111100
Q ss_pred cccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhhcC
Q 020641 256 RLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKS 313 (323)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~~~ 313 (323)
.+ ....+..++..+.++|.+||+.||.+|||+.|+++.|..++..
T Consensus 273 -~~------------~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~ 317 (336)
T 4g3f_A 273 -PP------------IREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQE 317 (336)
T ss_dssp -CG------------GGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -CC------------chhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhh
Confidence 00 0123445677899999999999999999999999998887754
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-58 Score=395.36 Aligned_cols=250 Identities=20% Similarity=0.257 Sum_probs=210.0
Q ss_pred CccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeC
Q 020641 17 PGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEG 96 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 96 (323)
|+....||+|+||+||+|++..+++.+|+|++.+..... ....+.+.+|++++++++||||+++++++.+.
T Consensus 34 y~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~---------~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~ 104 (311)
T 4aw0_A 34 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIK---------ENKVPYVTRERDVMSRLDHPFFVKLYFTFQDD 104 (311)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHH---------TTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCC---------HHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC
Confidence 566669999999999999999999999999886543211 22347789999999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEE
Q 020641 97 NLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAK 176 (323)
Q Consensus 97 ~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~ 176 (323)
+..|+|||||.||+|.+++.+... +++..+..++.||+.||.|||++ ||+||||||+|||++.++.+|
T Consensus 105 ~~~yivmEy~~gG~L~~~i~~~~~---------l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vK 172 (311)
T 4aw0_A 105 EKLYFGLSYAKNGELLKYIRKIGS---------FDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQ 172 (311)
T ss_dssp SEEEEEECCCTTEEHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEE
T ss_pred CEEEEEEecCCCCCHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEE
Confidence 999999999999999999976542 99999999999999999999999 999999999999999999999
Q ss_pred EeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhccc
Q 020641 177 IADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPR 256 (323)
Q Consensus 177 l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 256 (323)
|+|||+|...............+||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.....
T Consensus 173 l~DFGla~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~--------- 243 (311)
T 4aw0_A 173 ITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIF--------- 243 (311)
T ss_dssp ECCCTTCEECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---------
T ss_pred EEEcCCceecCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH---------
Confidence 99999998765443333445567999999999999999999999999999999999999999765321111
Q ss_pred ccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHH
Q 020641 257 LSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVV 304 (323)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl 304 (323)
.+++... ...+...+.++.+||.+||..||++|||++|++
T Consensus 244 ------~~i~~~~--~~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 244 ------AKIIKLE--YDFPEKFFPKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp ------HHHHHTC--CCCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred ------HHHHcCC--CCCCcccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence 1111111 123344567799999999999999999999863
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-56 Score=401.39 Aligned_cols=259 Identities=20% Similarity=0.316 Sum_probs=212.5
Q ss_pred CCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEe
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVE 95 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 95 (323)
.|..+.+||+|+||.||+|++..+++.+|+|++.... ....+.+.+|+.+|++++||||++++++|.+
T Consensus 152 ~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~------------~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~ 219 (423)
T 4fie_A 152 YLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRK------------QQRRELLFNEVVIMRDYQHENVVEMYNSYLV 219 (423)
T ss_dssp TEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTT------------CSSGGGHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred hcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccc------------hhHHHHHHHHHHHHHhCCCCCCCceEEEEEE
Confidence 4677779999999999999999999999999775321 2234678999999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeE
Q 020641 96 GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKA 175 (323)
Q Consensus 96 ~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~ 175 (323)
++.+|+|||||+||+|.+++.... +++..+..++.||+.||.|||++ ||+||||||+|||++.++.+
T Consensus 220 ~~~~~iVmEy~~gG~L~~~i~~~~----------l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~v 286 (423)
T 4fie_A 220 GDELWVVMEFLEGGALTDIVTHTR----------MNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRV 286 (423)
T ss_dssp TTEEEEEEECCTTEEHHHHHHHSC----------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCE
T ss_pred CCEEEEEEeCCCCCcHHHHHhccC----------CCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCE
Confidence 999999999999999999997643 99999999999999999999999 99999999999999999999
Q ss_pred EEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhcc
Q 020641 176 KIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATP 255 (323)
Q Consensus 176 ~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~ 255 (323)
||+|||++........ ......||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.........+.
T Consensus 287 Kl~DFGla~~~~~~~~--~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~---- 360 (423)
T 4fie_A 287 KLSDFGFCAQVSKEVP--RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIR---- 360 (423)
T ss_dssp EECCCTTCEECCSSCC--CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH----
T ss_pred EEecCccceECCCCCc--cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHH----
Confidence 9999999976644322 2245579999999999999999999999999999999999999997553321111110
Q ss_pred cccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhhcCCCCC
Q 020641 256 RLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSPPPA 317 (323)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~~~~~~~ 317 (323)
....+. .......+.++.+||.+||..||++|||+.|+++ ..+++...+|
T Consensus 361 --------~~~~~~--~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~--Hp~~~~~~~p 410 (423)
T 4fie_A 361 --------DNLPPR--LKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK--HPFLAKAGPP 410 (423)
T ss_dssp --------HSCCCC--CSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT--CGGGGGCCCG
T ss_pred --------cCCCCC--CcccccCCHHHHHHHHHHcCCChhHCcCHHHHhc--CHHhcCCCCC
Confidence 000011 1122345678999999999999999999999998 4444444333
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-56 Score=381.45 Aligned_cols=249 Identities=20% Similarity=0.233 Sum_probs=193.8
Q ss_pred CCCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEE
Q 020641 15 PSPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCV 94 (323)
Q Consensus 15 ~~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 94 (323)
..|+...+||+|+||.||+|++..+++.+|+|++.+.... .......+.+|++++++++||||+++++++.
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~---------~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~ 83 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLA---------KSDMQGRIEREISYLRLLRHPHIIKLYDVIK 83 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC---------------CHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcC---------CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEE
Confidence 3577777999999999999999999999999987654322 1234577899999999999999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCe
Q 020641 95 EGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFK 174 (323)
Q Consensus 95 ~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~ 174 (323)
+.+..|+||||+ +|+|.+++..... +++..+..++.||+.||.|||++ ||+||||||+|||++.++.
T Consensus 84 ~~~~~~ivmEy~-~g~L~~~l~~~~~---------l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~ 150 (275)
T 3hyh_A 84 SKDEIIMVIEYA-GNELFDYIVQRDK---------MSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLN 150 (275)
T ss_dssp CSSEEEEEEECC-CEEHHHHHHHSCS---------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCC
T ss_pred ECCEEEEEEeCC-CCCHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCC
Confidence 999999999999 5699999976542 99999999999999999999999 9999999999999999999
Q ss_pred EEEeeccccCCCCccccccccccccCccccCCCccccCCCC-CcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhh
Q 020641 175 AKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQL-TQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWA 253 (323)
Q Consensus 175 ~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 253 (323)
+||+|||+|+....... .....||+.|+|||++.+..+ +.++|||||||++|+|++|+.||...........+
T Consensus 151 vkl~DFGla~~~~~~~~---~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i--- 224 (275)
T 3hyh_A 151 VKIADFGLSNIMTDGNF---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNI--- 224 (275)
T ss_dssp EEECCSSCC------------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH---
T ss_pred EEEeecCCCeecCCCCc---cCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHH---
Confidence 99999999976544322 234569999999999998876 57999999999999999999999754321111101
Q ss_pred cccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 254 TPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
.+.. ...+...++++.+|+.+||+.||++|||+.|+++
T Consensus 225 ------------~~~~--~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 225 ------------SNGV--YTLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp ------------HHTC--CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred ------------HcCC--CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 1100 1223445677999999999999999999999998
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-56 Score=382.38 Aligned_cols=243 Identities=20% Similarity=0.319 Sum_probs=196.0
Q ss_pred cccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEe----C
Q 020641 21 VRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVE----G 96 (323)
Q Consensus 21 ~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~ 96 (323)
.+||+|+||+||+|.+..+++.+|+|.+....... ...+.+.+|++++++++||||+++++++.+ .
T Consensus 32 ~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~----------~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~ 101 (290)
T 3fpq_A 32 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTK----------SERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGK 101 (290)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCH----------HHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTE
T ss_pred eEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCH----------HHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCC
Confidence 37999999999999999999999999776443222 123678999999999999999999999875 3
Q ss_pred CeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC--ceeCCCCCCCEEEcc-CC
Q 020641 97 NLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPS--IIHRDIRSSNVLLFE-DF 173 (323)
Q Consensus 97 ~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~--i~h~dikp~nili~~-~~ 173 (323)
...|+|||||++|+|.+++.+... +++..+..++.||+.||.|||++ | |+||||||+|||++. ++
T Consensus 102 ~~~~lvmEy~~gg~L~~~l~~~~~---------l~~~~~~~~~~qi~~aL~ylH~~---~~~IiHRDlKp~NILl~~~~g 169 (290)
T 3fpq_A 102 KCIVLVTELMTSGTLKTYLKRFKV---------MKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTG 169 (290)
T ss_dssp EEEEEEEECCCSCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHTS---SSCCCCCCCCGGGEEESSTTS
T ss_pred cEEEEEEeCCCCCCHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHC---CCCEEecccChhheeEECCCC
Confidence 457999999999999999976542 89999999999999999999999 8 999999999999975 78
Q ss_pred eEEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhh
Q 020641 174 KAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWA 253 (323)
Q Consensus 174 ~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 253 (323)
.+||+|||+|+..... ......||+.|+|||++.+ .++.++|||||||++|+|+||+.||........ ..
T Consensus 170 ~vKl~DFGla~~~~~~----~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~--~~--- 239 (290)
T 3fpq_A 170 SVKIGDLGLATLKRAS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ--IY--- 239 (290)
T ss_dssp CEEECCTTGGGGCCTT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH--HH---
T ss_pred CEEEEeCcCCEeCCCC----ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHH--HH---
Confidence 9999999999754332 2234569999999998865 699999999999999999999999975432111 00
Q ss_pred cccccccccchhcCCCc-CCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 254 TPRLSEDKVKQCVDPKL-KGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 254 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
..+.... ....+...++++.+||.+||+.||++|||+.|+++
T Consensus 240 ----------~~i~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 240 ----------RRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp ----------HHHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ----------HHHHcCCCCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1111000 01112233457999999999999999999999987
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-56 Score=382.04 Aligned_cols=249 Identities=21% Similarity=0.250 Sum_probs=197.8
Q ss_pred CCccccccCCCCCCccceeccc---eeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeE
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRV---KMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGY 92 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~---~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 92 (323)
.|+....||+|+||+||+|++. .+++.+|+|++.+....... ...+.+|++++++++||||++++++
T Consensus 25 ~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~----------~~~~~~E~~il~~l~HpnIv~l~~~ 94 (304)
T 3ubd_A 25 QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRD----------RVRTKMERDILVEVNHPFIVKLHYA 94 (304)
T ss_dssp GEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEE----------CC------CCCCCCCCTTEECEEEE
T ss_pred ccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHH----------HHHHHHHHHHHHHCCCCCCCeEEEE
Confidence 3677779999999999999874 46788999987654322211 2356789999999999999999999
Q ss_pred EEeCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccC
Q 020641 93 CVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFED 172 (323)
Q Consensus 93 ~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~ 172 (323)
+.+++..|+|||||+||+|.+++.+... +++..+..++.|++.||.|||++ ||+||||||+|||++.+
T Consensus 95 ~~~~~~~~ivmEy~~gg~L~~~l~~~~~---------l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~ 162 (304)
T 3ubd_A 95 FQTEGKLYLILDFLRGGDLFTRLSKEVM---------FTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEE 162 (304)
T ss_dssp EEETTEEEEEECCCTTCEEHHHHHHHCC---------CCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTT
T ss_pred EEECCEEEEEEEcCCCCCHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCC
Confidence 9999999999999999999999976543 99999999999999999999999 99999999999999999
Q ss_pred CeEEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhh
Q 020641 173 FKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTW 252 (323)
Q Consensus 173 ~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 252 (323)
+.+||+|||+|+....... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+......
T Consensus 163 g~vKl~DFGla~~~~~~~~--~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~---- 236 (304)
T 3ubd_A 163 GHIKLTDFGLSKESIDHEK--KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMT---- 236 (304)
T ss_dssp SCEEEESSEEEEC-----C--CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH----
T ss_pred CCEEecccccceeccCCCc--cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHH----
Confidence 9999999999976543222 2244569999999999999999999999999999999999999997654321111
Q ss_pred hcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCCh-----HHHHH
Q 020641 253 ATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNM-----SIVVK 305 (323)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~-----~evl~ 305 (323)
.+.... ...+...++++.+||.+||+.||++|||+ +|+++
T Consensus 237 -----------~i~~~~--~~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 237 -----------MILKAK--LGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp -----------HHHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred -----------HHHcCC--CCCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence 111111 12344566789999999999999999984 67775
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-55 Score=386.95 Aligned_cols=268 Identities=22% Similarity=0.299 Sum_probs=211.5
Q ss_pred ccccccCCCCCCccceecccee-----eeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCC-Ccccceee
Q 020641 18 GYFVRLDKGPEDDLYLKKRVKM-----RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKH-ENLVELLG 91 (323)
Q Consensus 18 ~~~~~lg~G~~~~V~~~~~~~~-----~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~ 91 (323)
+...+||+|+||.||+|....+ .+.+|+|...... .....+.+.+|+++|.+++| |||+++++
T Consensus 67 ~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~-----------~~~~~~~~~~E~~il~~l~hhpnIV~l~g 135 (353)
T 4ase_A 67 KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-----------THSEHRALMSELKILIHIGHHLNVVNLLG 135 (353)
T ss_dssp EEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC-----------CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred EEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc-----------ChHHHHHHHHHHHHHHHcCCCCcEEEEEE
Confidence 3445899999999999987654 3567777553211 01123568899999999955 99999999
Q ss_pred EEEeC-CeEEEEEeecCCCCHHHHhccCCCCC-------CCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCC
Q 020641 92 YCVEG-NLRVLAYEFATMGSLHDILHGRKGVQ-------GAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIR 163 (323)
Q Consensus 92 ~~~~~-~~~~lv~e~~~~~sL~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dik 163 (323)
+|... +..++|||||++|+|.++++...... .......+++..+..++.||+.|+.|||++ +|+|||||
T Consensus 136 ~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRDLK 212 (353)
T 4ase_A 136 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLA 212 (353)
T ss_dssp EECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCS
T ss_pred EEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCccC
Confidence 99764 56899999999999999997643210 111223489999999999999999999999 99999999
Q ss_pred CCCEEEccCCeEEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCC
Q 020641 164 SSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTM 242 (323)
Q Consensus 164 p~nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~ 242 (323)
|+|||++.++.+||+|||+|+...............||+.|+|||++.+..++.++|||||||++|||+| |+.||.+..
T Consensus 213 ~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~ 292 (353)
T 4ase_A 213 ARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 292 (353)
T ss_dssp GGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred ccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCC
Confidence 9999999999999999999987655443333445568999999999999999999999999999999998 999997653
Q ss_pred CcccchhhhhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhhcCC
Q 020641 243 PRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSP 314 (323)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~~~~ 314 (323)
.. ..+...+....+...+..+++++.+++.+||+.||++|||+.||++.|++++++.
T Consensus 293 ~~---------------~~~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~~ 349 (353)
T 4ase_A 293 ID---------------EEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 349 (353)
T ss_dssp CS---------------HHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred HH---------------HHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHHh
Confidence 21 1122222233334455667788999999999999999999999999999998643
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-53 Score=368.17 Aligned_cols=269 Identities=20% Similarity=0.256 Sum_probs=196.3
Q ss_pred ccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeCC--
Q 020641 20 FVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGN-- 97 (323)
Q Consensus 20 ~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-- 97 (323)
-.+||+|+||+||+|+. +++.||+|++.... . .......|+..+.+++||||+++++++.+++
T Consensus 8 ~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~-----~--------~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~ 72 (303)
T 3hmm_A 8 QESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE-----E--------RSWFREAEIYQTVMLRHENILGFIAADNKDNGT 72 (303)
T ss_dssp EEEEEECSSSEEEEEEE--TTEEEEEEEECGGG-----H--------HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSS
T ss_pred EEEEeeCCCeEEEEEEE--CCEEEEEEEECccc-----h--------hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCC
Confidence 34899999999999986 57889999764321 0 0112234566667789999999999998654
Q ss_pred --eEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCC-----CCCceeCCCCCCCEEEc
Q 020641 98 --LRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKV-----QPSIIHRDIRSSNVLLF 170 (323)
Q Consensus 98 --~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~-----~~~i~h~dikp~nili~ 170 (323)
..|+||||+++|+|.++++... +++..+..++.|++.||.|||+++ ..+|+||||||+|||++
T Consensus 73 ~~~~~lV~Ey~~~gsL~~~l~~~~----------l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~ 142 (303)
T 3hmm_A 73 WTQLWLVSDYHEHGSLFDYLNRYT----------VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK 142 (303)
T ss_dssp SEEEEEEEECCTTCBHHHHHHHCC----------BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEEC
T ss_pred ceEEEEEecCCCCCcHHHHHHhCC----------CCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEEC
Confidence 5799999999999999997653 899999999999999999999752 33899999999999999
Q ss_pred cCCeEEEeeccccCCCCccccc--cccccccCccccCCCccccCC------CCCcccchHHHHHHHHHHHhCCCCCCCCC
Q 020641 171 EDFKAKIADFNLSNQAPDMAAR--LHSTRVLGTFGYHAPEYAMTG------QLTQKSDVYSFGVVLLELLTGRKPVDHTM 242 (323)
Q Consensus 171 ~~~~~~l~Dfg~~~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~------~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 242 (323)
.++.+||+|||+++........ .......||+.|+|||++.+. .++.++|||||||++|||+||..||....
T Consensus 143 ~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~ 222 (303)
T 3hmm_A 143 KNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHE 222 (303)
T ss_dssp TTSCEEECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCC
T ss_pred CCCCEEEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccc
Confidence 9999999999998754432221 122334699999999998754 36779999999999999999998876443
Q ss_pred Ccccchhhhhhcccccccccc-hhcCCCcCCCCC-----HHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhhcCC
Q 020641 243 PRGQQSLVTWATPRLSEDKVK-QCVDPKLKGEYP-----PKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSP 314 (323)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~-----~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~~~~ 314 (323)
....... ...........+. ...+...+...+ .+.+..+.+|+.+||+.||++|||+.||++.|+++.++.
T Consensus 223 ~~~~p~~-~~~~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~~ 299 (303)
T 3hmm_A 223 DYQLPYY-DLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 299 (303)
T ss_dssp CCCCTTT-TTSCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred cccccch-hcccccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHHc
Confidence 2211110 0000000111111 122233332322 345678999999999999999999999999999998764
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-53 Score=366.33 Aligned_cols=251 Identities=20% Similarity=0.254 Sum_probs=186.8
Q ss_pred CccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeC
Q 020641 17 PGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEG 96 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 96 (323)
|+.+..||+|+||.||+|++..+++.+|+|.+.... .....+.+.+|++++++++||||+++++++.+.
T Consensus 7 y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-----------~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~ 75 (299)
T 4g31_A 7 FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-----------RELAREKVMREVKALAKLEHPGIVRYFNAWLEK 75 (299)
T ss_dssp EEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS-----------SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEE
T ss_pred CEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC-----------CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEec
Confidence 556678999999999999999999999999765321 111236788999999999999999999998754
Q ss_pred C------------eEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCC
Q 020641 97 N------------LRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRS 164 (323)
Q Consensus 97 ~------------~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp 164 (323)
+ ..|+|||||.+|+|.+++....... ...+..++.++.||+.||.|||++ ||+||||||
T Consensus 76 ~~~~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~------~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp 146 (299)
T 4g31_A 76 NTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIE------ERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKP 146 (299)
T ss_dssp C----------CEEEEEEEECCCSCCHHHHHHTCCSGG------GSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCG
T ss_pred CccccccccCCCcEEEEEEecCCCCcHHHHHHhcCCCC------hhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcH
Confidence 4 3699999999999999997654211 155667889999999999999999 999999999
Q ss_pred CCEEEccCCeEEEeeccccCCCCccccc----------cccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhC
Q 020641 165 SNVLLFEDFKAKIADFNLSNQAPDMAAR----------LHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTG 234 (323)
Q Consensus 165 ~nili~~~~~~~l~Dfg~~~~~~~~~~~----------~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g 234 (323)
+|||++.++.+||+|||+|+........ .......||+.|+|||++.+..++.++|||||||++|+|++
T Consensus 147 ~NILl~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~- 225 (299)
T 4g31_A 147 SNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY- 225 (299)
T ss_dssp GGEEECTTCCEEECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS-
T ss_pred HHeEECCCCcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc-
Confidence 9999999999999999999876543211 11233469999999999999999999999999999999996
Q ss_pred CCCCCCCCCcccchhhhhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 235 RKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 235 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
||...... ... +....+... .......++.+.+|+.+||+.||++|||+.|+++
T Consensus 226 --Pf~~~~~~--~~~------------~~~~~~~~~-p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 226 --PFSTQMER--VRT------------LTDVRNLKF-PPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp --CCSSHHHH--HHH------------HHHHHTTCC-CHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --CCCCccHH--HHH------------HHHHhcCCC-CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 77532110 000 000001000 0111233456788999999999999999999998
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-51 Score=370.08 Aligned_cols=266 Identities=18% Similarity=0.248 Sum_probs=201.7
Q ss_pred CccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEe-
Q 020641 17 PGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVE- 95 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~- 95 (323)
|+...+||+|+||.||+|.+..+++.+|+|++.+.... ....+.+.+|+++|+.++||||+++++++..
T Consensus 56 Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~----------~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~ 125 (398)
T 4b99_A 56 YEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDV----------VTNAKRTLRELKILKHFKHDNIIAIKDILRPT 125 (398)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSS----------HHHHHHHHHHHHHHHHCCCTTBCCEEEECCCS
T ss_pred eEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccc----------hHHHHHHHHHHHHHHhcCCCCcceEeeeeecc
Confidence 66667999999999999999999999999977533211 1123567899999999999999999998764
Q ss_pred -----CCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEc
Q 020641 96 -----GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLF 170 (323)
Q Consensus 96 -----~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~ 170 (323)
.+..|+|||||. |+|.+++..... +++..+..++.||+.||.|||++ ||+||||||+|||++
T Consensus 126 ~~~~~~~~~~ivmE~~~-g~L~~~i~~~~~---------l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~ 192 (398)
T 4b99_A 126 VPYGEFKSVYVVLDLME-SDLHQIIHSSQP---------LTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVN 192 (398)
T ss_dssp SCTTTCCCEEEEEECCS-EEHHHHHTSSSC---------CCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEEC
T ss_pred cccccCCEEEEEEeCCC-CCHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccC
Confidence 357899999996 589999976542 99999999999999999999999 999999999999999
Q ss_pred cCCeEEEeeccccCCCCccc--cccccccccCccccCCCccccCC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCcccc
Q 020641 171 EDFKAKIADFNLSNQAPDMA--ARLHSTRVLGTFGYHAPEYAMTG-QLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQ 247 (323)
Q Consensus 171 ~~~~~~l~Dfg~~~~~~~~~--~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~ 247 (323)
.++.+||+|||+++...... .........||+.|+|||++.+. .++.++||||+||++|+|++|+.||.+.+.....
T Consensus 193 ~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l 272 (398)
T 4b99_A 193 ENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQL 272 (398)
T ss_dssp TTCCEEECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHH
T ss_pred CCCCEEEeecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHH
Confidence 99999999999998764322 12223456799999999998875 4689999999999999999999999876543222
Q ss_pred hhhhhhccccccccc--------chhcCCCc-CCCCC-----HHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 248 SLVTWATPRLSEDKV--------KQCVDPKL-KGEYP-----PKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 248 ~~~~~~~~~~~~~~~--------~~~~~~~~-~~~~~-----~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
..+............ ...+.... ....+ ...+.++.+||.+||..||.+|||+.|+++
T Consensus 273 ~~I~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 344 (398)
T 4b99_A 273 QLIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR 344 (398)
T ss_dssp HHHHHHHCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HHHHHhcCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 222111111111100 00000000 00011 123567899999999999999999999997
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-50 Score=356.18 Aligned_cols=262 Identities=19% Similarity=0.223 Sum_probs=195.8
Q ss_pred CCCccccccCCCCCCccceeccc---eeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcC-CCCccccee
Q 020641 15 PSPGYFVRLDKGPEDDLYLKKRV---KMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRL-KHENLVELL 90 (323)
Q Consensus 15 ~~~~~~~~lg~G~~~~V~~~~~~---~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~ 90 (323)
..|+...+||+|+||+||+|++. .+++.+|+|.+... ....++.+|+++++.+ +||||++++
T Consensus 21 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~--------------~~~~~~~~E~~~l~~~~~h~nIv~l~ 86 (361)
T 4f9c_A 21 NVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT--------------SHPIRIAAELQCLTVAGGQDNVMGVK 86 (361)
T ss_dssp GTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT--------------SCHHHHHHHHHHHHHTCSBTTBCCCS
T ss_pred CcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc--------------cCHHHHHHHHHHHHHhcCCCCCceEE
Confidence 34777779999999999999864 46888999865421 2235678999999998 799999999
Q ss_pred eEEEeCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEc
Q 020641 91 GYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLF 170 (323)
Q Consensus 91 ~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~ 170 (323)
+++.+.+..|+||||+++|+|.++++. +++..+..++.||+.||.|||++ ||+||||||+|||++
T Consensus 87 ~~~~~~~~~~lvmE~~~g~~L~~~~~~------------l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~ 151 (361)
T 4f9c_A 87 YCFRKNDHVVIAMPYLEHESFLDILNS------------LSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYN 151 (361)
T ss_dssp EEEEETTEEEEEEECCCCCCHHHHHTT------------CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEE
T ss_pred EEEEECCEEEEEEeCCCcccHHHHHcC------------CCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEe
Confidence 999999999999999999999999942 89999999999999999999999 999999999999998
Q ss_pred cC-CeEEEeeccccCCCCcccc--------------------------ccccccccCccccCCCccccCC-CCCcccchH
Q 020641 171 ED-FKAKIADFNLSNQAPDMAA--------------------------RLHSTRVLGTFGYHAPEYAMTG-QLTQKSDVY 222 (323)
Q Consensus 171 ~~-~~~~l~Dfg~~~~~~~~~~--------------------------~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~ 222 (323)
.+ +.+||+|||+|+....... ........||+.|+|||++.+. .++.++|||
T Consensus 152 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiW 231 (361)
T 4f9c_A 152 RRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMW 231 (361)
T ss_dssp TTTTEEEECCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHH
T ss_pred CCCCeEEECcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchh
Confidence 77 7999999999965432211 0112234699999999999875 589999999
Q ss_pred HHHHHHHHHHhCCCCCCCCCCcccchh-hhh----------h---------cccccccccchhcC---------CC----
Q 020641 223 SFGVVLLELLTGRKPVDHTMPRGQQSL-VTW----------A---------TPRLSEDKVKQCVD---------PK---- 269 (323)
Q Consensus 223 slG~~l~~l~~g~~pf~~~~~~~~~~~-~~~----------~---------~~~~~~~~~~~~~~---------~~---- 269 (323)
|+||++|+|++|+.||........+.. +.. . ....+........+ +.
T Consensus 232 SlG~il~ell~G~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~ 311 (361)
T 4f9c_A 232 SAGVIFLSLLSGRYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSD 311 (361)
T ss_dssp HHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC------------
T ss_pred hhHHHHHHHHHCCCCCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccc
Confidence 999999999999999965443211110 000 0 00000000000000 00
Q ss_pred -----cCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 270 -----LKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 270 -----~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
.........++++.+|+.+||..||++|||++|+++
T Consensus 312 ~~~~~~~~~~~~~is~~a~DLl~~lL~~dP~~R~ta~eaL~ 352 (361)
T 4f9c_A 312 IQGHATNLEGWNEVPDEAYDLLDKLLDLNPASRITAEEALL 352 (361)
T ss_dssp ----------CTTCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred cccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 000111234567899999999999999999999986
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-50 Score=375.80 Aligned_cols=255 Identities=18% Similarity=0.235 Sum_probs=204.6
Q ss_pred CCCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEE
Q 020641 15 PSPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCV 94 (323)
Q Consensus 15 ~~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 94 (323)
..|.....||+|+||.||+|++..+++.+|+|++.+........ .......+.++.+++.++||||++++++|.
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~------~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~ 262 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQG------ETLALNERIMLSLVSTGDCPFIVCMSYAFH 262 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTC------HHHHHHHHHHHHHHSSSCCTTBCCEEEEEE
T ss_pred HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhh------HHHHHHHHHHHHHHhhCCCCCEeEEEEEEE
Confidence 34667779999999999999999999999999887554322111 111233345577888889999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCe
Q 020641 95 EGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFK 174 (323)
Q Consensus 95 ~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~ 174 (323)
+.+.+|+||||+.||+|.+++..... +++..+..++.||+.||.|||++ ||+||||||+|||++.+|.
T Consensus 263 ~~~~lylVmEy~~GGdL~~~l~~~~~---------l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~ 330 (689)
T 3v5w_A 263 TPDKLSFILDLMNGGDLHYHLSQHGV---------FSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGH 330 (689)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHHCC---------CCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSC
T ss_pred ECCEEEEEEecCCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCC
Confidence 99999999999999999999976542 99999999999999999999999 9999999999999999999
Q ss_pred EEEeeccccCCCCccccccccccccCccccCCCcccc-CCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhh
Q 020641 175 AKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAM-TGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWA 253 (323)
Q Consensus 175 ~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 253 (323)
+||+|||+|....... ....+||+.|+|||++. +..|+.++|+|||||++|+|++|..||.............
T Consensus 331 vKL~DFGlA~~~~~~~----~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~-- 404 (689)
T 3v5w_A 331 VRISDLGLACDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR-- 404 (689)
T ss_dssp EEECCCTTCEECSSCC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHH--
T ss_pred EEecccceeeecCCCC----CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH--
Confidence 9999999997654422 23457999999999986 4679999999999999999999999997543322111111
Q ss_pred cccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCC-----hHHHHH
Q 020641 254 TPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPN-----MSIVVK 305 (323)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps-----~~evl~ 305 (323)
..... ....+...+.++.+||.+||..||.+|++ ++||++
T Consensus 405 ----------~i~~~--~~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 405 ----------MTLTM--AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp ----------HHHHC--CCCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred ----------hhcCC--CCCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 11111 11234556778999999999999999998 678765
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-48 Score=341.96 Aligned_cols=286 Identities=33% Similarity=0.528 Sum_probs=232.6
Q ss_pred cccCCCCCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccce
Q 020641 10 LGAHAPSPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVEL 89 (323)
Q Consensus 10 ~~~~~~~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~ 89 (323)
+......|.....||+|+||.||++++. +++.+++|..... .....+.+.+|+++++.++||||+++
T Consensus 34 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~------------~~~~~~~~~~E~~~l~~l~h~~iv~~ 100 (321)
T 2qkw_B 34 LEEATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPE------------SSQGIEEFETEIETLSFCRHPHLVSL 100 (321)
T ss_dssp CCCCCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSC------------CSSHHHHHHHHHHGGGSCCCTTBCCE
T ss_pred HHHHHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEeccc------------ChHHHHHHHHHHHHHHhCCCCCEeeE
Confidence 3344456667778999999999999964 5777888854321 12234678899999999999999999
Q ss_pred eeEEEeCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEE
Q 020641 90 LGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLL 169 (323)
Q Consensus 90 ~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili 169 (323)
++++...+..++||||+.+++|.+++...... ...+++..++.++.|++.||.|||+. |++|+||||+||++
T Consensus 101 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-----~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~ 172 (321)
T 2qkw_B 101 IGFCDERNEMILIYKYMENGNLKRHLYGSDLP-----TMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILL 172 (321)
T ss_dssp EEECCCTTCCEEEEECCTTCBTGGGSSSSCCC-----SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEE
T ss_pred EEEEcCCCeEEEEEEcCCCCcHHHHHhccCCC-----ccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEE
Confidence 99999999999999999999999999765321 12389999999999999999999999 99999999999999
Q ss_pred ccCCeEEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchh
Q 020641 170 FEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSL 249 (323)
Q Consensus 170 ~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~ 249 (323)
+.++.++|+|||++................|++.|+|||.+.+..++.++||||||+++|+|++|+.||...........
T Consensus 173 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~ 252 (321)
T 2qkw_B 173 DENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNL 252 (321)
T ss_dssp CTTCCEEECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCH
T ss_pred CCCCCEEEeecccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHH
Confidence 99999999999998754433222223344589999999999888899999999999999999999999987655444444
Q ss_pred hhhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhhcCCCC
Q 020641 250 VTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSPPP 316 (323)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~~~~~~ 316 (323)
..|.........+...+++......+...+..+.+++.+||+.||++|||+.|+++.|+.+++...+
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~~~~ 319 (321)
T 2qkw_B 253 AEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQES 319 (321)
T ss_dssp HHHTHHHHTTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSCC
T ss_pred HHHhhhccccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhcccC
Confidence 4444333344455566677777777889999999999999999999999999999999999876543
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-50 Score=374.94 Aligned_cols=250 Identities=17% Similarity=0.193 Sum_probs=204.5
Q ss_pred CccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeC
Q 020641 17 PGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEG 96 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 96 (323)
|+...+||+|+||.||+|.+..+++.+|+|++.... ....+.+.+|+++|+.++||||++++++|.+.
T Consensus 159 Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~------------~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~ 226 (573)
T 3uto_A 159 YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH------------ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDD 226 (573)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS------------HHHHHHHHHHHHHHHHTCCTTBCCEEEEEECS
T ss_pred cEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc------------hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence 555668999999999999999999999999765321 11135678999999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccC--Ce
Q 020641 97 NLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFED--FK 174 (323)
Q Consensus 97 ~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~--~~ 174 (323)
+..|+|||||.||+|.+++...... +++..+..++.||+.||.|||++ ||+||||||+|||++.+ +.
T Consensus 227 ~~~~iv~E~~~gg~L~~~i~~~~~~--------l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~ 295 (573)
T 3uto_A 227 NEMVMIYEFMSGGELFEKVADEHNK--------MSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNE 295 (573)
T ss_dssp SEEEEEEECCCCCBHHHHHTCTTSC--------EEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCC
T ss_pred CEEEEEEeecCCCcHHHHHHHhCCC--------CCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCC
Confidence 9999999999999999999654332 99999999999999999999999 99999999999999854 89
Q ss_pred EEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhc
Q 020641 175 AKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWAT 254 (323)
Q Consensus 175 ~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~ 254 (323)
+||+|||++........ .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.........+....
T Consensus 296 vKl~DFG~a~~~~~~~~---~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~ 372 (573)
T 3uto_A 296 LKLIDFGLTAHLDPKQS---VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCD 372 (573)
T ss_dssp EEECCCSSCEECCTTSE---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTC
T ss_pred EEEeeccceeEccCCCc---eeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCC
Confidence 99999999987654322 233469999999999999999999999999999999999999997654322111111110
Q ss_pred ccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 255 PRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
. ..........+.++.+||.+||..||.+|||+.|+++
T Consensus 373 ~-------------~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 373 W-------------NMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp C-------------CCCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred C-------------CCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 0011112334667999999999999999999999998
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-49 Score=342.03 Aligned_cols=268 Identities=27% Similarity=0.381 Sum_probs=199.9
Q ss_pred CccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeC
Q 020641 17 PGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEG 96 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 96 (323)
+....+||+|+||+||++++ +++.+|+|+........ ...+.+.+|++++++++||||+++++++...
T Consensus 39 y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~----------~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 106 (309)
T 3p86_A 39 LNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHA----------ERVNEFLREVAIMKRLRHPNIVLFMGAVTQP 106 (309)
T ss_dssp EEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSH----------HHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred ceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCH----------HHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC
Confidence 44455899999999999976 46678888765332111 1135688999999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC--ceeCCCCCCCEEEccCCe
Q 020641 97 NLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPS--IIHRDIRSSNVLLFEDFK 174 (323)
Q Consensus 97 ~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~--i~h~dikp~nili~~~~~ 174 (323)
...++||||+.+++|.+++...... ..+++..++.++.|++.||.|||+. | ++||||||+||+++.++.
T Consensus 107 ~~~~lv~e~~~~~~L~~~l~~~~~~------~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~ 177 (309)
T 3p86_A 107 PNLSIVTEYLSRGSLYRLLHKSGAR------EQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYT 177 (309)
T ss_dssp TCCEEEEECCTTCBHHHHHHSTTHH------HHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCC
T ss_pred CceEEEEecCCCCcHHHHHhhcCCC------CCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCc
Confidence 9999999999999999999764311 1288899999999999999999999 9 999999999999999999
Q ss_pred EEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhc
Q 020641 175 AKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWAT 254 (323)
Q Consensus 175 ~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~ 254 (323)
++|+|||++........ ......||+.|+|||.+.+..++.++||||||+++|+|++|..||..........
T Consensus 178 ~kL~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~------ 249 (309)
T 3p86_A 178 VKVCDFGLSRLKASTFL--SSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVA------ 249 (309)
T ss_dssp EEECCCC-------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHH------
T ss_pred EEECCCCCCcccccccc--ccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH------
Confidence 99999999875443221 1233458999999999999999999999999999999999999997553211111
Q ss_pred ccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhhcCCCCCCCCCC
Q 020641 255 PRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSPPPAAPVSE 322 (323)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~~~~~~~~~~~~ 322 (323)
...........+...+..+.+++.+||+.||.+|||+.++++.|+.+++...||+++++
T Consensus 250 ---------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p~~~~~~ 308 (309)
T 3p86_A 250 ---------AVGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPPPNRSD 308 (309)
T ss_dssp ---------HHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC----------
T ss_pred ---------HHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCCCCCccc
Confidence 00001112233455667899999999999999999999999999999998888877654
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-47 Score=332.47 Aligned_cols=254 Identities=22% Similarity=0.305 Sum_probs=208.8
Q ss_pred ccCCCCCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCccccee
Q 020641 11 GAHAPSPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELL 90 (323)
Q Consensus 11 ~~~~~~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~ 90 (323)
|.....|....+||+|+||+||+|.+..+++.+|+|...... ....+.+.+|+.+++.++||||++++
T Consensus 16 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------------~~~~~~~~~E~~~l~~l~hp~iv~~~ 83 (297)
T 3fxz_A 16 GDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ------------QPKKELIINEILVMRENKNPNIVNYL 83 (297)
T ss_dssp SCGGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGG------------CSCHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CChhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeeccc------------ccHHHHHHHHHHHHhcCCCCCCCeEe
Confidence 334456777779999999999999999999999999765321 12246688999999999999999999
Q ss_pred eEEEeCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEc
Q 020641 91 GYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLF 170 (323)
Q Consensus 91 ~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~ 170 (323)
+++..++..++||||+.+++|.+++.... +++..+..++.|++.||.|||+. |++|+||||+||+++
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~----------~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~ 150 (297)
T 3fxz_A 84 DSYLVGDELWVVMEYLAGGSLTDVVTETC----------MDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLG 150 (297)
T ss_dssp EEEEETTEEEEEEECCTTCBHHHHHHHSC----------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEC
T ss_pred EEEEECCEEEEEEECCCCCCHHHHHhhcC----------CCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEC
Confidence 99999999999999999999999997653 88999999999999999999999 999999999999999
Q ss_pred cCCeEEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhh
Q 020641 171 EDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLV 250 (323)
Q Consensus 171 ~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~ 250 (323)
.++.++|+|||++........ ......||+.|+|||.+.+..++.++||||||+++|+|++|..||............
T Consensus 151 ~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~ 228 (297)
T 3fxz_A 151 MDGSVKLTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI 228 (297)
T ss_dssp TTCCEEECCCTTCEECCSTTC--CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH
T ss_pred CCCCEEEeeCCCceecCCccc--ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 999999999999876543222 223456899999999999999999999999999999999999999755332111111
Q ss_pred hhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 251 TWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
.. ........+...+..+.+++.+||+.||.+|||+.|+++
T Consensus 229 ~~--------------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 229 AT--------------NGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp HH--------------HCSCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred Hh--------------CCCCCCCCccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 00 000111224456678999999999999999999999987
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-48 Score=336.96 Aligned_cols=262 Identities=24% Similarity=0.309 Sum_probs=209.4
Q ss_pred CccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeC
Q 020641 17 PGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEG 96 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 96 (323)
+....+||+|+||+||++.+..+++.+++|..... .....+.+.+|++++++++||||+++++++.++
T Consensus 12 ~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~------------~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 79 (310)
T 3s95_A 12 LIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF------------DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKD 79 (310)
T ss_dssp EEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC------------CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET
T ss_pred eeccceecCCCCEEEEEEEECCCCcEEEEEEeccC------------CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecC
Confidence 44555899999999999999999999999865321 122346788999999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEE
Q 020641 97 NLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAK 176 (323)
Q Consensus 97 ~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~ 176 (323)
+..++||||+.+++|.+++...... +++..+..++.|++.||.|||+. |++|+||||+||+++.++.++
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~~~--------~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~k 148 (310)
T 3s95_A 80 KRLNFITEYIKGGTLRGIIKSMDSQ--------YPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVV 148 (310)
T ss_dssp TEEEEEEECCTTCBHHHHHHHCCTT--------SCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEE
T ss_pred CeeEEEEEecCCCcHHHHHHhccCC--------CCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEE
Confidence 9999999999999999999864332 89999999999999999999999 999999999999999999999
Q ss_pred EeeccccCCCCcccccc------------ccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCc
Q 020641 177 IADFNLSNQAPDMAARL------------HSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPR 244 (323)
Q Consensus 177 l~Dfg~~~~~~~~~~~~------------~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 244 (323)
|+|||++.......... ......||+.|+|||.+.+..++.++||||||+++|+|++|..||......
T Consensus 149 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~ 228 (310)
T 3s95_A 149 VADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPR 228 (310)
T ss_dssp ECCCTTCEECC--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCB
T ss_pred EeecccceecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhh
Confidence 99999997654332211 111345899999999999999999999999999999999999998754332
Q ss_pred ccchhhhhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhhcCCC
Q 020641 245 GQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSPP 315 (323)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~~~~~ 315 (323)
..... ......... ..+..++..+.+++.+||+.||++|||+.++++.|+.+.....
T Consensus 229 ~~~~~----------~~~~~~~~~----~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~ 285 (310)
T 3s95_A 229 TMDFG----------LNVRGFLDR----YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLA 285 (310)
T ss_dssp CTTSS----------BCHHHHHHH----TCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred HHHHh----------hhhhccccc----cCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhcc
Confidence 21110 001111111 1123344569999999999999999999999999999875543
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-47 Score=335.70 Aligned_cols=249 Identities=22% Similarity=0.259 Sum_probs=205.4
Q ss_pred CCCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEE
Q 020641 15 PSPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCV 94 (323)
Q Consensus 15 ~~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 94 (323)
..|.....||+|+||.||+|.+..+++.+|+|++....... ...+.+.+|+++++.++||||+++++++.
T Consensus 15 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~----------~~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 84 (328)
T 3fe3_A 15 GNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNP----------TSLQKLFREVRIMKILNHPNIVKLFEVIE 84 (328)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCH----------HHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred CCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCH----------HHHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence 34666679999999999999999999999999876443221 12356789999999999999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCe
Q 020641 95 EGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFK 174 (323)
Q Consensus 95 ~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~ 174 (323)
..+..|+||||+.+++|.+++..... +++..+..++.|++.||.|||+. |++||||||+||+++.++.
T Consensus 85 ~~~~~~lv~e~~~~~~L~~~l~~~~~---------l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~ 152 (328)
T 3fe3_A 85 TEKTLYLIMEYASGGEVFDYLVAHGR---------MKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMN 152 (328)
T ss_dssp CSSEEEEEECCCTTCBHHHHHHHHCC---------CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSC
T ss_pred ECCEEEEEEECCCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCC
Confidence 99999999999999999999976542 89999999999999999999999 9999999999999999999
Q ss_pred EEEeeccccCCCCccccccccccccCccccCCCccccCCCCC-cccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhh
Q 020641 175 AKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLT-QKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWA 253 (323)
Q Consensus 175 ~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~-~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 253 (323)
++|+|||++........ .....||+.|+|||.+.+..++ .++|||||||++|+|++|..||...........+
T Consensus 153 ~kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i--- 226 (328)
T 3fe3_A 153 IKIADFGFSNEFTVGGK---LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERV--- 226 (328)
T ss_dssp EEECSTTCCGGGSSSCG---GGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH---
T ss_pred EEEeeccCceecCCCCc---cccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHH---
Confidence 99999999875543322 2345689999999999888775 7999999999999999999999765422111111
Q ss_pred cccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 254 TPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
.... ...+...+.++.+++.+||..||.+|||++|+++
T Consensus 227 ------------~~~~--~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 264 (328)
T 3fe3_A 227 ------------LRGK--YRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMK 264 (328)
T ss_dssp ------------HHCC--CCCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred ------------HhCC--CCCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 1111 1223345667999999999999999999999987
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-47 Score=339.40 Aligned_cols=265 Identities=24% Similarity=0.353 Sum_probs=210.0
Q ss_pred ccccccCCCCCCccceeccc-------eeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcC-CCCcccce
Q 020641 18 GYFVRLDKGPEDDLYLKKRV-------KMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRL-KHENLVEL 89 (323)
Q Consensus 18 ~~~~~lg~G~~~~V~~~~~~-------~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~ 89 (323)
.....||+|+||.||+|++. .++..+|+|+..... .....+.+.+|+.+++.+ +||||+++
T Consensus 84 ~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~-----------~~~~~~~~~~E~~~l~~l~~hpnIv~~ 152 (370)
T 2psq_A 84 TLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-----------TEKDLSDLVSEMEMMKMIGKHKNIINL 152 (370)
T ss_dssp EEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC-----------BHHHHHHHHHHHHHHHHSCCCTTBCCE
T ss_pred EeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc-----------CHHHHHHHHHHHHHHHHhcCCCCEeeE
Confidence 34448999999999999864 356678888664321 011235688999999999 89999999
Q ss_pred eeEEEeCCeEEEEEeecCCCCHHHHhccCCCCC-------CCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCC
Q 020641 90 LGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQ-------GAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDI 162 (323)
Q Consensus 90 ~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di 162 (323)
++++...+..|+||||+.+|+|.+++....... ...+...+++..++.++.||+.||.|||+. ||+||||
T Consensus 153 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDl 229 (370)
T 2psq_A 153 LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDL 229 (370)
T ss_dssp EEEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCC
T ss_pred EEEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---Ceecccc
Confidence 999999999999999999999999997654210 001122388999999999999999999999 9999999
Q ss_pred CCCCEEEccCCeEEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCC
Q 020641 163 RSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHT 241 (323)
Q Consensus 163 kp~nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~ 241 (323)
||+||+++.++.+||+|||++................+++.|+|||.+.+..++.++||||||+++|+|++ |..||...
T Consensus 230 kp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~ 309 (370)
T 2psq_A 230 AARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI 309 (370)
T ss_dssp CGGGEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred chhhEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCC
Confidence 99999999999999999999976554333223334457889999999999999999999999999999999 99999754
Q ss_pred CCcccchhhhhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhhc
Q 020641 242 MPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLK 312 (323)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~~ 312 (323)
... .+...+........+..++.++.+++.+||+.||.+|||+.|+++.|++++.
T Consensus 310 ~~~----------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~ 364 (370)
T 2psq_A 310 PVE----------------ELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 364 (370)
T ss_dssp CGG----------------GHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CHH----------------HHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 321 1111222222233445667789999999999999999999999999999875
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=337.41 Aligned_cols=265 Identities=23% Similarity=0.334 Sum_probs=208.2
Q ss_pred ccccccCCCCCCccceeccceeee---eeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEE
Q 020641 18 GYFVRLDKGPEDDLYLKKRVKMRR---WLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCV 94 (323)
Q Consensus 18 ~~~~~lg~G~~~~V~~~~~~~~~~---~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 94 (323)
.....||+|+||.||++.+..+++ .+|+|+..... .....+.+.+|+.++++++||||+++++++.
T Consensus 52 ~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~-----------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 120 (325)
T 3kul_A 52 HIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY-----------TERQRRDFLSEASIMGQFDHPNIIRLEGVVT 120 (325)
T ss_dssp EEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC-----------CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred EEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC-----------CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence 334589999999999999875544 48888664221 1112367889999999999999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCe
Q 020641 95 EGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFK 174 (323)
Q Consensus 95 ~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~ 174 (323)
.++..++||||+.+++|.+++...... +++..++.++.|++.||.|||+. ||+|+||||+||+++.++.
T Consensus 121 ~~~~~~lv~e~~~~~~L~~~l~~~~~~--------~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~ 189 (325)
T 3kul_A 121 RGRLAMIVTEYMENGSLDTFLRTHDGQ--------FTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLV 189 (325)
T ss_dssp GGGCCEEEEECCTTCBHHHHHHTTTTC--------SCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCC
T ss_pred eCCccEEEeeCCCCCcHHHHHHhcccC--------CCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCC
Confidence 999999999999999999999755332 89999999999999999999999 9999999999999999999
Q ss_pred EEEeeccccCCCCccccc-cccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccchhhhh
Q 020641 175 AKIADFNLSNQAPDMAAR-LHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTW 252 (323)
Q Consensus 175 ~~l~Dfg~~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~ 252 (323)
++|+|||++......... .......+|+.|+|||.+.+..++.++||||||+++|+|++ |..||......
T Consensus 190 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~-------- 261 (325)
T 3kul_A 190 CKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNR-------- 261 (325)
T ss_dssp EEECCCSSCEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHH--------
T ss_pred EEECCCCcccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHH--------
Confidence 999999999765443221 11222335778999999998889999999999999999999 99999754321
Q ss_pred hcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhhcCCCCCCCC
Q 020641 253 ATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSPPPAAPV 320 (323)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~~~~~~~~~~ 320 (323)
.+...+........+..++..+.+++.+||+.||.+|||+.+|++.|+.+++.+....+.
T Consensus 262 --------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~~~~~~ 321 (325)
T 3kul_A 262 --------DVISSVEEGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPESLRAT 321 (325)
T ss_dssp --------HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC-----
T ss_pred --------HHHHHHHcCCCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCccccccc
Confidence 111112222223344556778999999999999999999999999999999887765543
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=330.24 Aligned_cols=282 Identities=35% Similarity=0.531 Sum_probs=228.3
Q ss_pred cCCCCCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceee
Q 020641 12 AHAPSPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLG 91 (323)
Q Consensus 12 ~~~~~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~ 91 (323)
.....|.....||+|+||.||++++. +++.+|+|....... ......+.+|+++++.++||||+++++
T Consensus 27 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-----------~~~~~~~~~e~~~l~~l~h~~iv~~~~ 94 (326)
T 3uim_A 27 VASDNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERT-----------QGGELQFQTEVEMISMAVHRNLLRLRG 94 (326)
T ss_dssp TTTTSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC----------------CCCHHHHHHHGGGTCCCTTBCCCCE
T ss_pred HHhhccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccC-----------chHHHHHHHHHHHHHhccCCCccceEE
Confidence 34456677779999999999999854 577888886653211 122246899999999999999999999
Q ss_pred EEEeCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEcc
Q 020641 92 YCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFE 171 (323)
Q Consensus 92 ~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~ 171 (323)
++...+..++||||+.+++|.+++....... ..+++..+..++.|++.||.|||+.+..|++|+||||+||+++.
T Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~ 169 (326)
T 3uim_A 95 FCMTPTERLLVYPYMANGSVASCLRERPESQ-----PPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDE 169 (326)
T ss_dssp EECCSSCCEEEEECCTTCBHHHHHHCCSTTC-----CCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECT
T ss_pred EEecCCceEEEEEeccCCCHHHHHHhccccC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECC
Confidence 9999999999999999999999998754321 23899999999999999999999987778999999999999999
Q ss_pred CCeEEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCC--Ccccchh
Q 020641 172 DFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTM--PRGQQSL 249 (323)
Q Consensus 172 ~~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~--~~~~~~~ 249 (323)
++.++|+|||++......... ......||+.|+|||.+.+..++.++||||||+++|+|++|..||.... .......
T Consensus 170 ~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~ 248 (326)
T 3uim_A 170 EFEAVVGDFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVML 248 (326)
T ss_dssp TCCEEECCCSSCEECCSSSSC-EECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBH
T ss_pred CCCEEeccCccccccCccccc-ccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhH
Confidence 999999999999765432221 2233458999999999988889999999999999999999999996321 1122233
Q ss_pred hhhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhh
Q 020641 250 VTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLL 311 (323)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~ 311 (323)
..+..............+.......+...+..+.+++.+||+.||.+|||+.||++.|++..
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~ 310 (326)
T 3uim_A 249 LDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDG 310 (326)
T ss_dssp HHHHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSS
T ss_pred HHHHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcc
Confidence 44555555556666777777777888999999999999999999999999999999998654
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-47 Score=336.41 Aligned_cols=265 Identities=21% Similarity=0.302 Sum_probs=207.1
Q ss_pred CCCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEE
Q 020641 15 PSPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCV 94 (323)
Q Consensus 15 ~~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 94 (323)
..|....+||+|+||.||+|.+..+++.+++|+..+..... ........+.+|+.++++++||||+++++++.
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~-------~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 85 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDK-------SGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP 85 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCT-------TSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEecccc-------ccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc
Confidence 34556668999999999999999888875555444332111 11223356678999999999999999999987
Q ss_pred eCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCe
Q 020641 95 EGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFK 174 (323)
Q Consensus 95 ~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~ 174 (323)
. ...++||||+.+|+|.+++...... +++..+..++.|++.||.|||+. |++||||||+||+++.++.
T Consensus 86 ~-~~~~~v~e~~~~~~L~~~l~~~~~~--------~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~ 153 (325)
T 3kex_A 86 G-SSLQLVTQYLPLGSLLDHVRQHRGA--------LGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQ 153 (325)
T ss_dssp B-SSEEEEEECCTTCBSHHHHHSSGGG--------SCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSC
T ss_pred C-CccEEEEEeCCCCCHHHHHHHcccc--------CCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCe
Confidence 4 4578999999999999999765322 88889999999999999999999 9999999999999999999
Q ss_pred EEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhh
Q 020641 175 AKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWA 253 (323)
Q Consensus 175 ~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~ 253 (323)
++|+|||++................++..|+|||.+.+..++.++||||||+++|+|++ |..||........
T Consensus 154 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~------- 226 (325)
T 3kex_A 154 VQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEV------- 226 (325)
T ss_dssp EEECSCSGGGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHH-------
T ss_pred EEECCCCcccccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHH-------
Confidence 99999999987654443333344557889999999998899999999999999999999 9999976543211
Q ss_pred cccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhhcCC
Q 020641 254 TPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSP 314 (323)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~~~~ 314 (323)
...+........+..++..+.+++.+||+.||.+|||+.++++.|+++...+
T Consensus 227 ---------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~~ 278 (325)
T 3kex_A 227 ---------PDLLEKGERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARDP 278 (325)
T ss_dssp ---------HHHHHTTCBCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTSH
T ss_pred ---------HHHHHcCCCCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence 1111111122233344556899999999999999999999999999987643
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-47 Score=329.69 Aligned_cols=271 Identities=20% Similarity=0.289 Sum_probs=212.0
Q ss_pred CCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEe
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVE 95 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 95 (323)
.|....+||+|+||.||++++..+++.+|+|........ .....+.+.+|+.++++++||||+++++++..
T Consensus 12 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---------~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~ 82 (294)
T 4eqm_A 12 RYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPRE---------KEETLKRFEREVHNSSQLSHQNIVSMIDVDEE 82 (294)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSC---------CHHHHHHHHHHHHHHTTCCBTTBCCEEEEEEC
T ss_pred cEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccc---------cHHHHHHHHHHHHHHhcCCCCCCceEEEeeee
Confidence 356667999999999999999999999999976532211 11223678899999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeE
Q 020641 96 GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKA 175 (323)
Q Consensus 96 ~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~ 175 (323)
++..++||||+.+++|.+++..... +++..+..++.|++.||.|||+. |++|+||||+||+++.++.+
T Consensus 83 ~~~~~lv~e~~~g~~L~~~l~~~~~---------~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~ 150 (294)
T 4eqm_A 83 DDCYYLVMEYIEGPTLSEYIESHGP---------LSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTL 150 (294)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHHCS---------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCE
T ss_pred CCeEEEEEeCCCCCCHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCE
Confidence 9999999999999999999976542 89999999999999999999999 99999999999999999999
Q ss_pred EEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhcc
Q 020641 176 KIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATP 255 (323)
Q Consensus 176 ~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~ 255 (323)
+|+|||++......... ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||......... ......
T Consensus 151 kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~--~~~~~~ 227 (294)
T 4eqm_A 151 KIFDFGIAKALSETSLT-QTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIA--IKHIQD 227 (294)
T ss_dssp EECCCSSSTTC--------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHH--HHHHSS
T ss_pred EEEeCCCcccccccccc-ccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHH--HHHhhc
Confidence 99999999866443221 123345899999999999999999999999999999999999999755321110 000000
Q ss_pred cccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCC-ChHHHHHHHhhhhcCCCCCCCC
Q 020641 256 RLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRP-NMSIVVKALQPLLKSPPPAAPV 320 (323)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-s~~evl~~l~~~~~~~~~~~~~ 320 (323)
.. +..........+..+.+++.+||+.||.+|| +++++.+.|+.++.........
T Consensus 228 ~~----------~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~~~~~~ 283 (294)
T 4eqm_A 228 SV----------PNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENRANEDV 283 (294)
T ss_dssp CC----------CCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSSTTCCC
T ss_pred cC----------CCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhccCCcch
Confidence 00 0000112234456799999999999999998 9999999999998776655443
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-47 Score=334.20 Aligned_cols=265 Identities=20% Similarity=0.314 Sum_probs=208.1
Q ss_pred CCCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEE
Q 020641 15 PSPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCV 94 (323)
Q Consensus 15 ~~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 94 (323)
..|....+||+|+||.||+|.+..+++.+++|+..+.... .......+.+.+|+.++++++||||+++++++.
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~-------~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 87 (327)
T 3lzb_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELRE-------ATSPKANKEILDEAYVMASVDNPHVCRLLGICL 87 (327)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECC-------CSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEE
T ss_pred hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecc-------ccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEe
Confidence 3456666999999999999999988888777655543321 122344578899999999999999999999998
Q ss_pred eCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCe
Q 020641 95 EGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFK 174 (323)
Q Consensus 95 ~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~ 174 (323)
.+. .++|++|+.+++|.+++...... +++..++.++.|++.||.|||+. |++|+||||+||+++.++.
T Consensus 88 ~~~-~~~v~~~~~~g~L~~~l~~~~~~--------~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~ 155 (327)
T 3lzb_A 88 TST-VQLITQLMPFGCLLDYVREHKDN--------IGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQH 155 (327)
T ss_dssp SSS-EEEEECCCSSCBHHHHHHHTTTC--------CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTE
T ss_pred cCC-ceEEEEecCCCcHHHHHHhcCCC--------CCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCC
Confidence 765 78899999999999999765432 89999999999999999999999 9999999999999999999
Q ss_pred EEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhh
Q 020641 175 AKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWA 253 (323)
Q Consensus 175 ~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~ 253 (323)
++|+|||++................+++.|+|||.+.+..++.++||||||+++|+|++ |..||.......
T Consensus 156 ~kL~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~-------- 227 (327)
T 3lzb_A 156 VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-------- 227 (327)
T ss_dssp EEECCTTC----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--------
T ss_pred EEEccCcceeEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH--------
Confidence 99999999987654443333344456888999999999999999999999999999999 999997653321
Q ss_pred cccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhhcCC
Q 020641 254 TPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSP 314 (323)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~~~~ 314 (323)
+...+........+...+..+.+++.+||+.||.+|||+.|+++.|+++...+
T Consensus 228 --------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 280 (327)
T 3lzb_A 228 --------ISSILEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDP 280 (327)
T ss_dssp --------HHHHHHTTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTSH
T ss_pred --------HHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhCc
Confidence 22222222233344556678999999999999999999999999999998654
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-47 Score=336.32 Aligned_cols=262 Identities=20% Similarity=0.313 Sum_probs=204.3
Q ss_pred CccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeC
Q 020641 17 PGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEG 96 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 96 (323)
|....+||+|+||+||+|++..+++.+++|+..+..... ......+.+.+|+.++++++||||+++++++..+
T Consensus 17 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~-------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 89 (327)
T 3poz_A 17 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-------TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS 89 (327)
T ss_dssp EEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC--------------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS
T ss_pred cccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccc-------cCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC
Confidence 455568999999999999998888877555444332111 1233457889999999999999999999999876
Q ss_pred CeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEE
Q 020641 97 NLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAK 176 (323)
Q Consensus 97 ~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~ 176 (323)
. .++|++|+.+|+|.+++...... +++..++.++.|++.||.|||+. |++||||||+||+++.++.++
T Consensus 90 ~-~~~v~e~~~~g~L~~~l~~~~~~--------~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~k 157 (327)
T 3poz_A 90 T-VQLITQLMPFGCLLDYVREHKDN--------IGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVK 157 (327)
T ss_dssp S-EEEEEECCTTCBHHHHHHHSTTS--------CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEE
T ss_pred C-eEEEEEecCCCcHHHHHHhcCCC--------CCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEE
Confidence 5 68899999999999999765432 89999999999999999999999 999999999999999999999
Q ss_pred EeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcc
Q 020641 177 IADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATP 255 (323)
Q Consensus 177 l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~ 255 (323)
|+|||++................+|+.|+|||.+.+..++.++||||||+++|+|++ |..||......
T Consensus 158 l~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~----------- 226 (327)
T 3poz_A 158 ITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS----------- 226 (327)
T ss_dssp ECCTTHHHHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG-----------
T ss_pred EccCcceeEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHH-----------
Confidence 999999875543333323333446889999999999999999999999999999999 99999755332
Q ss_pred cccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhhcC
Q 020641 256 RLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKS 313 (323)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~~~ 313 (323)
.+...+........+..++..+.+++.+||+.||.+|||+.++++.|+.+...
T Consensus 227 -----~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~ 279 (327)
T 3poz_A 227 -----EISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp -----GHHHHHHTTCCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred -----HHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence 12222222223334555677899999999999999999999999999998754
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-48 Score=333.61 Aligned_cols=276 Identities=20% Similarity=0.272 Sum_probs=207.2
Q ss_pred CCccccccCCCCCCccceec----cceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceee
Q 020641 16 SPGYFVRLDKGPEDDLYLKK----RVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLG 91 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~----~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~ 91 (323)
.+....+||+|+||+||+++ +..+++.+|+|+.... .....+.+.+|++++++++||||+++++
T Consensus 11 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~------------~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 78 (295)
T 3ugc_A 11 HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS------------TEEHLRDFEREIEILKSLQHDNIVKYKG 78 (295)
T ss_dssp GEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC------------CHHHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred HhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC------------CHHHHHHHHHHHHHHHhCCCCCEeeEEE
Confidence 34555699999999999998 6778899999966421 1122356889999999999999999999
Q ss_pred EEEeC--CeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEE
Q 020641 92 YCVEG--NLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLL 169 (323)
Q Consensus 92 ~~~~~--~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili 169 (323)
++... ...++||||+.+++|.+++...... +++..+..++.|++.||.|||+. |++|+||||+||++
T Consensus 79 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~--------~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~ 147 (295)
T 3ugc_A 79 VCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER--------IDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILV 147 (295)
T ss_dssp EECHHHHTSCEEEEECCTTCBHHHHHHHCGGG--------CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEE
T ss_pred EEecCCCCceEEEEEeCCCCCHHHHHHhcccc--------cCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEE
Confidence 98643 5589999999999999999765432 88999999999999999999999 99999999999999
Q ss_pred ccCCeEEEeeccccCCCCccccc-cccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccch
Q 020641 170 FEDFKAKIADFNLSNQAPDMAAR-LHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQS 248 (323)
Q Consensus 170 ~~~~~~~l~Dfg~~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~ 248 (323)
+.++.++|+|||++......... .......++..|+|||.+.+..++.++||||||+++|+|++|..||..........
T Consensus 148 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~ 227 (295)
T 3ugc_A 148 ENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRM 227 (295)
T ss_dssp EETTEEEECCCCSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHH
T ss_pred cCCCeEEEccCcccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhh
Confidence 99999999999999876543221 11223346778999999999999999999999999999999999986432110000
Q ss_pred hhhhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhhcCC
Q 020641 249 LVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSP 314 (323)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~~~~ 314 (323)
.................+........+..++..+.+++.+||+.||++|||+.|+++.|+++.+..
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l 293 (295)
T 3ugc_A 228 IGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM 293 (295)
T ss_dssp HCTTCCTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred hcCccccchhHHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhc
Confidence 000000000001112222233334455667788999999999999999999999999999998654
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-47 Score=344.52 Aligned_cols=258 Identities=24% Similarity=0.342 Sum_probs=209.2
Q ss_pred ccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeCC
Q 020641 18 GYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGN 97 (323)
Q Consensus 18 ~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 97 (323)
....+||+|+||.||++++..+++.+|+|...... .......+.+|++++++++||||+++++++....
T Consensus 117 ~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-----------~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 185 (377)
T 3cbl_A 117 VLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETL-----------PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQ 185 (377)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTS-----------CHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred EEeeEeccCCCCeEEEEEEecCCeEEEEEEccccC-----------CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCC
Confidence 34458999999999999999899999999664221 0111245778999999999999999999999998
Q ss_pred eEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEEE
Q 020641 98 LRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKI 177 (323)
Q Consensus 98 ~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~l 177 (323)
..++||||+.+|+|.+++...... +++..+..++.|++.||.|||++ |++||||||+||+++.++.+||
T Consensus 186 ~~~lv~e~~~~g~L~~~l~~~~~~--------~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl 254 (377)
T 3cbl_A 186 PIYIVMELVQGGDFLTFLRTEGAR--------LRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKI 254 (377)
T ss_dssp SCEEEEECCTTCBHHHHHHHHGGG--------CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEE
T ss_pred CcEEEEEcCCCCCHHHHHHhcCCC--------CCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEE
Confidence 999999999999999999764322 88999999999999999999999 9999999999999999999999
Q ss_pred eeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhccc
Q 020641 178 ADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPR 256 (323)
Q Consensus 178 ~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~ 256 (323)
+|||++................++..|+|||.+.+..++.++||||||+++|+|++ |..||......
T Consensus 255 ~DfG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~------------ 322 (377)
T 3cbl_A 255 SDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQ------------ 322 (377)
T ss_dssp CCGGGCEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHH------------
T ss_pred CcCCCceecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH------------
Confidence 99999876543322221222235678999999988889999999999999999998 99999754321
Q ss_pred ccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhhcC
Q 020641 257 LSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKS 313 (323)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~~~ 313 (323)
.+...+....+...+..++..+.+++.+||+.||++|||+.+|++.|+++.+.
T Consensus 323 ----~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~ 375 (377)
T 3cbl_A 323 ----QTREFVEKGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375 (377)
T ss_dssp ----HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----HHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence 11222222223344555677899999999999999999999999999998754
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=321.69 Aligned_cols=256 Identities=24% Similarity=0.371 Sum_probs=207.6
Q ss_pred CCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEe
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVE 95 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 95 (323)
.+....+||+|+||.||++.+.. ++.+|+|+.... ....+.+.+|++++++++||||+++++++.+
T Consensus 11 ~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~-------------~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 76 (269)
T 4hcu_A 11 ELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIREG-------------AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 76 (269)
T ss_dssp GEEEEEEEEECSSCEEEEEEETT-TEEEEEEEECTT-------------SBCHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred hceeeheecCCCccEEEEEEecC-CCeEEEEEeccc-------------ccCHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 45566699999999999999875 445777755422 1123668999999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeE
Q 020641 96 GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKA 175 (323)
Q Consensus 96 ~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~ 175 (323)
.+..++||||+.+++|.+++...... +++..++.++.|++.|+.|||+. |++|+||||+||+++.++.+
T Consensus 77 ~~~~~lv~e~~~~~~L~~~l~~~~~~--------~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~ 145 (269)
T 4hcu_A 77 QAPICLVFEFMEHGCLSDYLRTQRGL--------FAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVI 145 (269)
T ss_dssp SSSEEEEEECCTTCBHHHHHHTTTTC--------CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCE
T ss_pred CCceEEEEEeCCCCcHHHHHHhcCcc--------cCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCE
Confidence 99999999999999999999765432 89999999999999999999999 99999999999999999999
Q ss_pred EEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhc
Q 020641 176 KIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWAT 254 (323)
Q Consensus 176 ~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~ 254 (323)
+|+|||++......... ......+++.|+|||.+.+..++.++||||||+++|+|++ |..||.......
T Consensus 146 kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~--------- 215 (269)
T 4hcu_A 146 KVSDFGMTRFVLDDQYT-SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE--------- 215 (269)
T ss_dssp EECCTTGGGGBCCHHHH-STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---------
T ss_pred Eeccccccccccccccc-cccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHH---------
Confidence 99999999765443222 2233346788999999998899999999999999999999 999997543211
Q ss_pred ccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhhcC
Q 020641 255 PRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKS 313 (323)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~~~ 313 (323)
....+........+...+..+.+++.+||+.||.+|||+.++++.|+++.++
T Consensus 216 -------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~ 267 (269)
T 4hcu_A 216 -------VVEDISTGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 267 (269)
T ss_dssp -------HHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred -------HHHHHhcCccCCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence 1111111122233344567799999999999999999999999999998764
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-47 Score=332.09 Aligned_cols=254 Identities=24% Similarity=0.270 Sum_probs=204.7
Q ss_pred CCCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEE
Q 020641 15 PSPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCV 94 (323)
Q Consensus 15 ~~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 94 (323)
..|....+||+|+||.||+|.+..+++.+|+|++..+.. ....+.+.+|+.+++.++||||+++++++.
T Consensus 7 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----------~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~ 75 (323)
T 3tki_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-----------VDCPENIKKEICINKMLNHENVVKFYGHRR 75 (323)
T ss_dssp TCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC------------------CHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred hhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccc-----------cchHHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence 456677799999999999999999999999997643211 122356789999999999999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCe
Q 020641 95 EGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFK 174 (323)
Q Consensus 95 ~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~ 174 (323)
+++..++||||+.+++|.+++..... +++..+..++.|++.||.|||+. |++|+||||+||+++.++.
T Consensus 76 ~~~~~~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~ 143 (323)
T 3tki_A 76 EGNIQYLFLEYCSGGELFDRIEPDIG---------MPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDN 143 (323)
T ss_dssp CSSEEEEEEECCTTEEGGGGSBTTTB---------CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCC
T ss_pred cCCeEEEEEEcCCCCcHHHHHhhcCC---------CCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCC
Confidence 99999999999999999999976532 89999999999999999999999 9999999999999999999
Q ss_pred EEEeeccccCCCCccccccccccccCccccCCCccccCCCC-CcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhh
Q 020641 175 AKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQL-TQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWA 253 (323)
Q Consensus 175 ~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 253 (323)
++|+|||++................||+.|+|||++.+..+ +.++||||||+++|+|++|..||.......... .
T Consensus 144 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~-~--- 219 (323)
T 3tki_A 144 LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY-S--- 219 (323)
T ss_dssp EEECCCTTCEECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHH-H---
T ss_pred EEEEEeeccceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHH-H---
Confidence 99999999976544333333345568999999999987775 778999999999999999999997654321111 1
Q ss_pred cccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 254 TPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
.+.............+..+.+|+.+||+.||.+|||+.|+++
T Consensus 220 ----------~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~ 261 (323)
T 3tki_A 220 ----------DWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (323)
T ss_dssp ----------HHHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ----------HHhcccccCCccccCCHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 111111111122345677899999999999999999999987
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-47 Score=332.19 Aligned_cols=274 Identities=25% Similarity=0.315 Sum_probs=206.5
Q ss_pred CCCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEE
Q 020641 15 PSPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCV 94 (323)
Q Consensus 15 ~~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 94 (323)
..|....+||+|+||+||++++. ++.+|+|++.... ........|+.++++++||||+++++++.
T Consensus 24 ~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~-------------~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 88 (322)
T 3soc_A 24 MPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQD-------------KQSWQNEYEVYSLPGMKHENILQFIGAEK 88 (322)
T ss_dssp EEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGG-------------HHHHHHHHHHHTSTTCCCTTBCCEEEEEE
T ss_pred hhchhhheecccCceEEEEEEEC--CCEEEEEEeecCc-------------hHHHHHHHHHHHHhcCCCCCchhhcceec
Confidence 34555568999999999999875 6788988764221 11234456888899999999999999998
Q ss_pred eCC----eEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCC-------CCCceeCCCC
Q 020641 95 EGN----LRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKV-------QPSIIHRDIR 163 (323)
Q Consensus 95 ~~~----~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~-------~~~i~h~dik 163 (323)
... ..++||||+.+|+|.+++.... +++..++.++.|++.||.|||+.+ +.|++|+|||
T Consensus 89 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlk 158 (322)
T 3soc_A 89 RGTSVDVDLWLITAFHEKGSLSDFLKANV----------VSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIK 158 (322)
T ss_dssp EECSSSEEEEEEEECCTTCBHHHHHHHCC----------BCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCS
T ss_pred cCCCCCceEEEEEecCCCCCHHHHHHhcC----------CCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCC
Confidence 754 4799999999999999997653 899999999999999999999752 2389999999
Q ss_pred CCCEEEccCCeEEEeeccccCCCCccccccccccccCccccCCCccccCC-----CCCcccchHHHHHHHHHHHhCCCCC
Q 020641 164 SSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG-----QLTQKSDVYSFGVVLLELLTGRKPV 238 (323)
Q Consensus 164 p~nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-----~~~~~~Di~slG~~l~~l~~g~~pf 238 (323)
|+||+++.++.+||+|||++................||+.|+|||++.+. .++.++||||||+++|+|++|+.||
T Consensus 159 p~Nill~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf 238 (322)
T 3soc_A 159 SKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAA 238 (322)
T ss_dssp GGGEEECTTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTS
T ss_pred hHhEEECCCCeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCC
Confidence 99999999999999999999765443333233345689999999998763 4566889999999999999999999
Q ss_pred CCCCCcccchhhhhhcccccccccchhc-CCCcCCCC-----CHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhhc
Q 020641 239 DHTMPRGQQSLVTWATPRLSEDKVKQCV-DPKLKGEY-----PPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLK 312 (323)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~-----~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~~ 312 (323)
.......................+...+ ........ ....+..+.+++.+||+.||++|||+.||++.|+++.+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~ 318 (322)
T 3soc_A 239 DGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQR 318 (322)
T ss_dssp SSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCcchhccchhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 8665433322222211111222222111 11111111 22456779999999999999999999999999999875
Q ss_pred C
Q 020641 313 S 313 (323)
Q Consensus 313 ~ 313 (323)
.
T Consensus 319 ~ 319 (322)
T 3soc_A 319 L 319 (322)
T ss_dssp H
T ss_pred H
Confidence 3
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-47 Score=339.62 Aligned_cols=266 Identities=23% Similarity=0.318 Sum_probs=207.2
Q ss_pred CccccccCCCCCCccceec-----cceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceee
Q 020641 17 PGYFVRLDKGPEDDLYLKK-----RVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLG 91 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~-----~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~ 91 (323)
+....+||+|+||.||+|+ +..+++.+|+|.+.... .......+.+|+.++++++||||+++++
T Consensus 73 ~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~-----------~~~~~~~~~~E~~~l~~l~hpnIv~~~~ 141 (367)
T 3l9p_A 73 ITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC-----------SEQDELDFLMEALIISKFNHQNIVRCIG 141 (367)
T ss_dssp EEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSC-----------CHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred eEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEeccccc-----------ChhhHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 3445589999999999999 55677889998664211 1112346788999999999999999999
Q ss_pred EEEeCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEcc
Q 020641 92 YCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFE 171 (323)
Q Consensus 92 ~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~ 171 (323)
++......++||||+.+|+|.+++........ ....+++..++.++.|++.||.|||++ ||+||||||+||+++.
T Consensus 142 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~ 216 (367)
T 3l9p_A 142 VSLQSLPRFILLELMAGGDLKSFLRETRPRPS--QPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTC 216 (367)
T ss_dssp EECSSSSCEEEEECCTTEEHHHHHHHHSCCSS--SCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESC
T ss_pred EEecCCCCEEEEEeCCCCCHHHHHHhhccccC--ccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEec
Confidence 99999999999999999999999976543211 112389999999999999999999999 9999999999999995
Q ss_pred CC---eEEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccc
Q 020641 172 DF---KAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQ 247 (323)
Q Consensus 172 ~~---~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~ 247 (323)
++ .++|+|||++................||+.|+|||.+.+..++.++|||||||++|+|++ |..||......
T Consensus 217 ~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~--- 293 (367)
T 3l9p_A 217 PGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ--- 293 (367)
T ss_dssp SSTTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---
T ss_pred CCCCceEEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH---
Confidence 54 599999999865433222222333457889999999998899999999999999999998 99999755321
Q ss_pred hhhhhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhhcCC
Q 020641 248 SLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSP 314 (323)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~~~~ 314 (323)
.+...+........+..++..+.+++.+||+.||.+|||+.+|++.|+.+...+
T Consensus 294 -------------~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~ 347 (367)
T 3l9p_A 294 -------------EVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP 347 (367)
T ss_dssp -------------HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred -------------HHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhCh
Confidence 111122222222334455677999999999999999999999999999887543
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=330.33 Aligned_cols=270 Identities=20% Similarity=0.247 Sum_probs=195.7
Q ss_pred CCccccccCCCCCCccceeccceeee---eeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeE
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRVKMRR---WLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGY 92 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~~~~~---~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 92 (323)
.|.....||+|+||.||+|.+..++. .+|+|+....... ....+.+.+|++++++++||||++++++
T Consensus 24 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~----------~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 93 (323)
T 3qup_A 24 QFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIA----------SSDIEEFLREAACMKEFDHPHVAKLVGV 93 (323)
T ss_dssp -CEEEEEEEEETTEEEEEEEC-------CEEEEEEC----------------CHHHHHHHHHHHHHTTCCCTTBCCCCEE
T ss_pred HeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccC----------HHHHHHHHHHHHHHHHCCCCceehhhce
Confidence 35555689999999999999988775 6888866533211 1224678899999999999999999999
Q ss_pred EEeCCeE------EEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCC
Q 020641 93 CVEGNLR------VLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSN 166 (323)
Q Consensus 93 ~~~~~~~------~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~n 166 (323)
+...... ++||||+.+++|.+++....... ....+++..++.++.|++.||.|||+. |++|+||||+|
T Consensus 94 ~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~---~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~N 167 (323)
T 3qup_A 94 SLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGE---NPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARN 167 (323)
T ss_dssp EECC-------CEEEEEECCTTCBHHHHHHHHHC------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGG
T ss_pred eeccccccCCCccEEEEEeccCCcHHHHHHhhhccc---cccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcce
Confidence 9877655 99999999999999996543211 111289999999999999999999999 99999999999
Q ss_pred EEEccCCeEEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcc
Q 020641 167 VLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRG 245 (323)
Q Consensus 167 ili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~ 245 (323)
|+++.++.++|+|||++................+++.|+|||.+.+..++.++||||||+++|+|++ |..||.......
T Consensus 168 Ili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~ 247 (323)
T 3qup_A 168 CMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE 247 (323)
T ss_dssp EEECTTSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG
T ss_pred EEEcCCCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHH
Confidence 9999999999999999976654433333333446788999999999899999999999999999999 999997654321
Q ss_pred cchhhhhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhhcCCCCC
Q 020641 246 QQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSPPPA 317 (323)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~~~~~~~ 317 (323)
. ...+........+...+..+.+++.+||+.||++|||+.++++.|++++..+...
T Consensus 248 ~----------------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~ 303 (323)
T 3qup_A 248 I----------------YNYLIGGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVL 303 (323)
T ss_dssp H----------------HHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC----
T ss_pred H----------------HHHHhcCCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhc
Confidence 1 1111111122334455678999999999999999999999999999999766443
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-46 Score=332.97 Aligned_cols=256 Identities=19% Similarity=0.228 Sum_probs=205.3
Q ss_pred CCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEe
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVE 95 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 95 (323)
.|.....||+|+||.||+|.+..+++.+|+|++.+....... .....+.+.+|+.++++++||||+++++++.+
T Consensus 13 ~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~------~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~ 86 (361)
T 2yab_A 13 FYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASR------RGVCREEIEREVSILRQVLHPNIITLHDVYEN 86 (361)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCS------SSBCHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred ceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEcccccccc------chhHHHHHHHHHHHHHhCCCcCCCcEEEEEEe
Confidence 355666999999999999999999999999987654322211 12234778999999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCC--
Q 020641 96 GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDF-- 173 (323)
Q Consensus 96 ~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~-- 173 (323)
....++||||+.+|+|.+++..... +++..+..++.||+.||.|||+. |++|+||||+||+++.++
T Consensus 87 ~~~~~lv~e~~~gg~L~~~l~~~~~---------l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~ 154 (361)
T 2yab_A 87 RTDVVLILELVSGGELFDFLAQKES---------LSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIP 154 (361)
T ss_dssp SSEEEEEEECCCSCBHHHHHTTCSC---------CBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSS
T ss_pred CCEEEEEEEcCCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCC
Confidence 9999999999999999999976432 89999999999999999999999 999999999999998876
Q ss_pred --eEEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhh
Q 020641 174 --KAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVT 251 (323)
Q Consensus 174 --~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~ 251 (323)
.++|+|||++........ .....||+.|+|||++.+..++.++||||||+++|+|++|..||...........+.
T Consensus 155 ~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~ 231 (361)
T 2yab_A 155 IPHIKLIDFGLAHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANIT 231 (361)
T ss_dssp SCCEEECCCSSCEECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHH
T ss_pred ccCEEEEecCCceEcCCCCc---cccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 799999999976544221 234468999999999998899999999999999999999999997653221111110
Q ss_pred hhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 252 WATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
... .. .........+..+.+||.+||..||.+|||+.|+++
T Consensus 232 ~~~--~~-----------~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 232 AVS--YD-----------FDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp TTC--CC-----------CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hcC--CC-----------CCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 000 00 000001233567999999999999999999999986
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=318.67 Aligned_cols=259 Identities=28% Similarity=0.415 Sum_probs=205.3
Q ss_pred CCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEe
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVE 95 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 95 (323)
.|.....||+|+||.||++++..+++.+|+|............. ....+.+.+|+.++++++||||+++++++.+
T Consensus 20 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~-----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 94 (287)
T 4f0f_A 20 EIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEM-----IEKFQEFQREVFIMSNLNHPNIVKLYGLMHN 94 (287)
T ss_dssp TEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHH-----HCCSHHHHHHHHHHTTCCCTTBCCEEEEETT
T ss_pred cceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhH-----HHHHHHHHHHHHHHHhCCCCCchhhheeecC
Confidence 44555689999999999999999999999997754332211110 1223678999999999999999999999876
Q ss_pred CCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC--ceeCCCCCCCEEEccCC
Q 020641 96 GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPS--IIHRDIRSSNVLLFEDF 173 (323)
Q Consensus 96 ~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~--i~h~dikp~nili~~~~ 173 (323)
.. ++||||+.+++|.+++...... +++..++.++.|++.|+.|||+. | ++|+||||+||+++.++
T Consensus 95 ~~--~lv~e~~~~~~L~~~l~~~~~~--------~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~ 161 (287)
T 4f0f_A 95 PP--RMVMEFVPCGDLYHRLLDKAHP--------IKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLD 161 (287)
T ss_dssp TT--EEEEECCTTCBHHHHHHCTTSC--------CCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCC
T ss_pred CC--eEEEEecCCCCHHHHHhcccCC--------ccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccC
Confidence 65 7999999999999988665432 89999999999999999999999 9 99999999999998877
Q ss_pred e-----EEEeeccccCCCCccccccccccccCccccCCCcccc--CCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccc
Q 020641 174 K-----AKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAM--TGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQ 246 (323)
Q Consensus 174 ~-----~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~--~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~ 246 (323)
. ++|+|||++...... .....|++.|+|||.+. ...++.++||||||+++|+|++|+.||........
T Consensus 162 ~~~~~~~kl~Dfg~~~~~~~~-----~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~ 236 (287)
T 4f0f_A 162 ENAPVCAKVADFGLSQQSVHS-----VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKI 236 (287)
T ss_dssp TTCSCCEEECCCTTCBCCSSC-----EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHH
T ss_pred CCCceeEEeCCCCcccccccc-----ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHH
Confidence 6 999999998754432 23345899999999884 45578899999999999999999999975543211
Q ss_pred chhhhhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhh
Q 020641 247 QSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPL 310 (323)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~ 310 (323)
... ............+...+..+.+++.+||+.||.+|||+.|+++.|+++
T Consensus 237 ~~~-------------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 237 KFI-------------NMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp HHH-------------HHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred HHH-------------HHHhccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 111 111112222334455677899999999999999999999999999874
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-46 Score=328.17 Aligned_cols=250 Identities=21% Similarity=0.232 Sum_probs=205.8
Q ss_pred CCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEe
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVE 95 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 95 (323)
.|.....||+|+||.||+|++..+++.+|+|++.+.... .......+.+|..+++.++||||+++++++..
T Consensus 6 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~---------~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~ 76 (337)
T 1o6l_A 6 DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVII---------AKDEVAHTVTESRVLQNTRHPFLTALKYAFQT 76 (337)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH---------HTTCHHHHHHHHHHHHSCCCTTBCCEEEEEEC
T ss_pred HeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhh---------hhhHHHHHHHHHHHHHhCCCCcCcceEEEEEe
Confidence 456667899999999999999999999999987643211 12334678899999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeE
Q 020641 96 GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKA 175 (323)
Q Consensus 96 ~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~ 175 (323)
.+..|+||||+.+|+|.+++..... +++..+..++.||+.||.|||++ ||+||||||+||+++.++.+
T Consensus 77 ~~~~~lv~E~~~gg~L~~~l~~~~~---------~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~v 144 (337)
T 1o6l_A 77 HDRLCFVMEYANGGELFFHLSRERV---------FTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHI 144 (337)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHSC---------CCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCE
T ss_pred CCEEEEEEeCCCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCE
Confidence 9999999999999999999976542 89999999999999999999999 99999999999999999999
Q ss_pred EEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhcc
Q 020641 176 KIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATP 255 (323)
Q Consensus 176 ~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~ 255 (323)
+|+|||++........ ......||+.|+|||++.+..++.++|+||||+++|+|++|..||..........
T Consensus 145 kL~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~------- 215 (337)
T 1o6l_A 145 KITDFGLCKEGISDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFE------- 215 (337)
T ss_dssp EECCCTTCBCSCCTTC--CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH-------
T ss_pred EEeeccchhhcccCCC--cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHH-------
Confidence 9999999875432211 2234568999999999999999999999999999999999999997543211110
Q ss_pred cccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCC-----ChHHHHH
Q 020641 256 RLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRP-----NMSIVVK 305 (323)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-----s~~evl~ 305 (323)
.+.... ...+...+..+.++|.+||+.||.+|| ++.|+++
T Consensus 216 --------~i~~~~--~~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~ 260 (337)
T 1o6l_A 216 --------LILMEE--IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp --------HHHHCC--CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred --------HHHcCC--CCCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence 111111 123344567899999999999999999 8999976
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=330.10 Aligned_cols=249 Identities=22% Similarity=0.247 Sum_probs=204.5
Q ss_pred CCCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEE
Q 020641 15 PSPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCV 94 (323)
Q Consensus 15 ~~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 94 (323)
..|.....||+|+||.||+|.+..+++.+|+|++...... .......+.+|+.+++.++||||+++++++.
T Consensus 9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~---------~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 79 (336)
T 3h4j_B 9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLK---------KSDMHMRVEREISYLKLLRHPHIIKLYDVIT 79 (336)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHH---------HTTCSHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHcc---------chhHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence 3456667999999999999999999999999977543211 1233467899999999999999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCe
Q 020641 95 EGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFK 174 (323)
Q Consensus 95 ~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~ 174 (323)
..+..++||||+ +|+|.+++..... +++..+..++.|++.||.|||+. |++||||||+||+++.++.
T Consensus 80 ~~~~~~lv~E~~-~g~l~~~l~~~~~---------l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~ 146 (336)
T 3h4j_B 80 TPTDIVMVIEYA-GGELFDYIVEKKR---------MTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLN 146 (336)
T ss_dssp CSSEEEEEECCC-CEEHHHHHHHHCS---------CCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCC
T ss_pred eCCEEEEEEECC-CCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCC
Confidence 999999999999 5699998876542 89999999999999999999999 9999999999999999999
Q ss_pred EEEeeccccCCCCccccccccccccCccccCCCccccCCCC-CcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhh
Q 020641 175 AKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQL-TQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWA 253 (323)
Q Consensus 175 ~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 253 (323)
++|+|||++........ .....||+.|+|||++.+..+ +.++||||||+++|+|++|..||.........
T Consensus 147 ~kl~DFG~s~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~------ 217 (336)
T 3h4j_B 147 VKIADFGLSNIMTDGNF---LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLF------ 217 (336)
T ss_dssp EEECCSSCTBTTTTSBT---TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCB------
T ss_pred EEEEEeccceeccCCcc---cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHH------
Confidence 99999999976654322 234468999999999988776 68999999999999999999999754321111
Q ss_pred cccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 254 TPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
+.+... ....+...+..+.+++.+||+.||.+|||+.|+++
T Consensus 218 ----------~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 258 (336)
T 3h4j_B 218 ----------KKVNSC-VYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRR 258 (336)
T ss_dssp ----------CCCCSS-CCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred ----------HHHHcC-CCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 111100 11234445677999999999999999999999987
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-46 Score=326.93 Aligned_cols=267 Identities=22% Similarity=0.306 Sum_probs=210.9
Q ss_pred CccccccCCCCCCccceeccc-----eeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceee
Q 020641 17 PGYFVRLDKGPEDDLYLKKRV-----KMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLG 91 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~~~-----~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~ 91 (323)
|.....||.|+||.||+|.+. .+++.+|+|+..... .....+.+.+|++++++++||||+++++
T Consensus 25 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-----------~~~~~~~~~~E~~~l~~l~hp~iv~~~~ 93 (314)
T 2ivs_A 25 LVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA-----------SPSELRDLLSEFNVLKQVNHPHVIKLYG 93 (314)
T ss_dssp EEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC-----------CHHHHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred eeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC-----------CHHHHHHHHHHHHHHhhCCCCceeeEEE
Confidence 344458999999999999874 455788888664221 1112366889999999999999999999
Q ss_pred EEEeCCeEEEEEeecCCCCHHHHhccCCCCCC---------------CCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 020641 92 YCVEGNLRVLAYEFATMGSLHDILHGRKGVQG---------------AQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPS 156 (323)
Q Consensus 92 ~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~ 156 (323)
++...+..++||||+.+++|.+++........ ......+++..++.++.|++.||.|||+. |
T Consensus 94 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ 170 (314)
T 2ivs_A 94 ACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---K 170 (314)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---T
T ss_pred EEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---C
Confidence 99999999999999999999999976542100 00112388999999999999999999999 9
Q ss_pred ceeCCCCCCCEEEccCCeEEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHh-CC
Q 020641 157 IIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GR 235 (323)
Q Consensus 157 i~h~dikp~nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~ 235 (323)
++|+||||+||+++.++.++|+|||++................+++.|+|||.+.+..++.++||||||+++|+|++ |.
T Consensus 171 ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~ 250 (314)
T 2ivs_A 171 LVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGG 250 (314)
T ss_dssp EECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSC
T ss_pred CcccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCC
Confidence 99999999999999999999999999876544333333344457888999999988889999999999999999999 99
Q ss_pred CCCCCCCCcccchhhhhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhhcC
Q 020641 236 KPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKS 313 (323)
Q Consensus 236 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~~~ 313 (323)
.||....... +...+........+...+..+.+++.+||+.||.+|||+.++++.|++++..
T Consensus 251 ~p~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 312 (314)
T 2ivs_A 251 NPYPGIPPER----------------LFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK 312 (314)
T ss_dssp CSSTTCCGGG----------------HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CCCCCCCHHH----------------HHHHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence 9997554321 1111222222233445667899999999999999999999999999998764
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=335.69 Aligned_cols=260 Identities=21% Similarity=0.305 Sum_probs=198.1
Q ss_pred CccccccCCCCCCccceeccc---eeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEE
Q 020641 17 PGYFVRLDKGPEDDLYLKKRV---KMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYC 93 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~~~---~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 93 (323)
+.....||+|+||.||++++. .++..+|+|...... .....+.+.+|+.++++++||||+++++++
T Consensus 47 ~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~-----------~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 115 (373)
T 2qol_A 47 ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY-----------TEKQRRDFLGEASIMGQFDHPNIIRLEGVV 115 (373)
T ss_dssp CCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC-----------CHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred ceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc-----------CHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 444558999999999999887 567778888664221 111236788999999999999999999999
Q ss_pred EeCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCC
Q 020641 94 VEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDF 173 (323)
Q Consensus 94 ~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~ 173 (323)
...+..++||||+.+++|.+++...... +++..++.++.|++.||.|||+. |++||||||+||+++.++
T Consensus 116 ~~~~~~~lv~e~~~~~sL~~~l~~~~~~--------~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~ 184 (373)
T 2qol_A 116 TKSKPVMIVTEYMENGSLDSFLRKHDAQ--------FTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNL 184 (373)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHTTTTC--------SCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTC
T ss_pred eeCCceEEEEeCCCCCcHHHHHHhCCCC--------CCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCC
Confidence 9999999999999999999999765322 89999999999999999999999 999999999999999999
Q ss_pred eEEEeeccccCCCCcccccc-ccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccchhhh
Q 020641 174 KAKIADFNLSNQAPDMAARL-HSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVT 251 (323)
Q Consensus 174 ~~~l~Dfg~~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~ 251 (323)
.++|+|||++.......... ......++..|+|||.+.+..++.++||||||+++|+|++ |+.||......
T Consensus 185 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~------- 257 (373)
T 2qol_A 185 VCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ------- 257 (373)
T ss_dssp CEEECCC----------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHH-------
T ss_pred CEEECcCccccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHH-------
Confidence 99999999997665432111 1122235678999999998899999999999999999998 99999754321
Q ss_pred hhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhhcCC
Q 020641 252 WATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSP 314 (323)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~~~~ 314 (323)
.+...+....+...+..++..+.+++.+||+.||.+|||+.+|++.|++++..+
T Consensus 258 ---------~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~ 311 (373)
T 2qol_A 258 ---------DVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP 311 (373)
T ss_dssp ---------HHHHHHHTTEECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCG
T ss_pred ---------HHHHHHHcCCCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCc
Confidence 111122222223334456678999999999999999999999999999998654
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-46 Score=321.07 Aligned_cols=255 Identities=22% Similarity=0.321 Sum_probs=203.8
Q ss_pred CccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeC
Q 020641 17 PGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEG 96 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 96 (323)
|....+||+|+||.||++++. +++.+++|+.... ....+.+.+|++++++++|+||+++++++...
T Consensus 26 y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-------------~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 91 (283)
T 3gen_A 26 LTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEG-------------SMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ 91 (283)
T ss_dssp EEEEEECC---CEEEEEEEET-TTEEEEEEEECTT-------------SBCHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred HHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCC-------------CCCHHHHHHHHHHHhcCCCCCEeeEEEEEecC
Confidence 344558999999999999776 4556777765422 11236688999999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEE
Q 020641 97 NLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAK 176 (323)
Q Consensus 97 ~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~ 176 (323)
+..++||||+.+++|.+++...... +++..++.++.|++.||.|||+. |++|+||||+||+++.++.++
T Consensus 92 ~~~~lv~e~~~~~~L~~~l~~~~~~--------~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~k 160 (283)
T 3gen_A 92 RPIFIITEYMANGCLLNYLREMRHR--------FQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVK 160 (283)
T ss_dssp SSEEEEECCCTTCBHHHHHHCGGGC--------CCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEE
T ss_pred CCeEEEEeccCCCcHHHHHHHhccC--------CCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEE
Confidence 9999999999999999999764322 89999999999999999999999 999999999999999999999
Q ss_pred EeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcc
Q 020641 177 IADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATP 255 (323)
Q Consensus 177 l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~ 255 (323)
|+|||++......... ......+++.|+|||.+.+..++.++||||||+++|+|++ |..||........
T Consensus 161 l~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~--------- 230 (283)
T 3gen_A 161 VSDFGLSRYVLDDEYT-SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSET--------- 230 (283)
T ss_dssp ECSTTGGGGBCCHHHH-STTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH---------
T ss_pred Eccccccccccccccc-cccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHH---------
Confidence 9999999765443222 2233346788999999998899999999999999999998 9999975543211
Q ss_pred cccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhhcC
Q 020641 256 RLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKS 313 (323)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~~~ 313 (323)
...+........+...+..+.+++.+||+.||.+|||+.++++.|++++++
T Consensus 231 -------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~ 281 (283)
T 3gen_A 231 -------AEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE 281 (283)
T ss_dssp -------HHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -------HHHHhcccCCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence 111111122233344456799999999999999999999999999998864
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-46 Score=331.78 Aligned_cols=271 Identities=23% Similarity=0.328 Sum_probs=209.5
Q ss_pred CCccccccCCCCCCccceeccc-----eeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCccccee
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRV-----KMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELL 90 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~-----~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~ 90 (323)
.|.....||+|+||.||++++. .+++.+|+|+..... .....+.+.+|+.++++++||||++++
T Consensus 48 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-----------~~~~~~~~~~E~~~l~~l~hp~iv~~~ 116 (343)
T 1luf_A 48 NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-----------SADMQADFQREAALMAEFDNPNIVKLL 116 (343)
T ss_dssp GCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-----------CHHHHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred HCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc-----------CHHHHHHHHHHHHHHHhCCCCCEEEEE
Confidence 4555668999999999999987 456889998765321 112236788999999999999999999
Q ss_pred eEEEeCCeEEEEEeecCCCCHHHHhccCCCCCC---------------CCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCC
Q 020641 91 GYCVEGNLRVLAYEFATMGSLHDILHGRKGVQG---------------AQPGPVLDWMTRVRIAVDAARGLEYLHEKVQP 155 (323)
Q Consensus 91 ~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~ 155 (323)
+++..++..++||||+.+++|.+++........ ......+++..++.++.|++.||.|||+.
T Consensus 117 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~--- 193 (343)
T 1luf_A 117 GVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER--- 193 (343)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---
T ss_pred EEEccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---
Confidence 999999999999999999999999976432110 00112489999999999999999999999
Q ss_pred CceeCCCCCCCEEEccCCeEEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHh-C
Q 020641 156 SIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-G 234 (323)
Q Consensus 156 ~i~h~dikp~nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g 234 (323)
|++|+||||+||+++.++.++|+|||++................+++.|+|||.+.+..++.++||||||+++|+|++ |
T Consensus 194 ~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g 273 (343)
T 1luf_A 194 KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYG 273 (343)
T ss_dssp TCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTT
T ss_pred CeecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcC
Confidence 999999999999999999999999999865543332222334457889999999998889999999999999999999 9
Q ss_pred CCCCCCCCCcccchhhhhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhhcCC
Q 020641 235 RKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSP 314 (323)
Q Consensus 235 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~~~~ 314 (323)
..||........ ...+........+..++..+.+++.+||+.||.+|||+.++++.|+++.+..
T Consensus 274 ~~p~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~ 337 (343)
T 1luf_A 274 LQPYYGMAHEEV----------------IYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERA 337 (343)
T ss_dssp CCTTTTSCHHHH----------------HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC--
T ss_pred CCcCCCCChHHH----------------HHHHhCCCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhh
Confidence 999975432111 1111111112234455678999999999999999999999999999998765
Q ss_pred CC
Q 020641 315 PP 316 (323)
Q Consensus 315 ~~ 316 (323)
..
T Consensus 338 ~~ 339 (343)
T 1luf_A 338 EG 339 (343)
T ss_dssp --
T ss_pred hh
Confidence 43
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-46 Score=337.66 Aligned_cols=252 Identities=17% Similarity=0.175 Sum_probs=202.2
Q ss_pred CccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeC
Q 020641 17 PGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEG 96 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 96 (323)
|....+||+|+||.||+|.+..+++.+|+|++..+.... ...+.+.+|+.+++.++||||+++++++.+.
T Consensus 13 Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~----------~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~ 82 (444)
T 3soa_A 13 YQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSA----------RDHQKLEREARICRLLKHPNIVRLHDSISEE 82 (444)
T ss_dssp EEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHH----------HHHHHHHHHHHHHHHCCBTTBCCEEEEEECS
T ss_pred eEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCH----------HHHHHHHHHHHHHHhCCCcCCCeEEEEEEEC
Confidence 455668999999999999999999999999776443211 1235678999999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEc---cCC
Q 020641 97 NLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLF---EDF 173 (323)
Q Consensus 97 ~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~---~~~ 173 (323)
+..++||||+.+|+|.+.+..... +++..+..++.||+.||.|||++ ||+||||||+||+++ .++
T Consensus 83 ~~~~lv~E~~~gg~L~~~i~~~~~---------~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~ 150 (444)
T 3soa_A 83 GHHYLIFDLVTGGELFEDIVAREY---------YSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGA 150 (444)
T ss_dssp SEEEEEECCCBCCBHHHHHHHCSC---------CCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTC
T ss_pred CEEEEEEEeCCCCCHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCC
Confidence 999999999999999999976543 89999999999999999999999 999999999999998 457
Q ss_pred eEEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhh
Q 020641 174 KAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWA 253 (323)
Q Consensus 174 ~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 253 (323)
.++|+|||++........ ......||+.|+|||++.+..++.++||||||+++|+|++|..||...........+...
T Consensus 151 ~vkL~DFG~a~~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~ 228 (444)
T 3soa_A 151 AVKLADFGLAIEVEGEQQ--AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAG 228 (444)
T ss_dssp CEEECCCSSCBCCCTTCC--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHT
T ss_pred cEEEccCceeEEecCCCc--eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhC
Confidence 899999999976654322 123456899999999999889999999999999999999999999755321111111100
Q ss_pred cccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 254 TPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
.. ..........+..+.+++.+||+.||.+|||+.|+++
T Consensus 229 ~~-------------~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 229 AY-------------DFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp CC-------------CCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CC-------------CCCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 00 0001111244667999999999999999999999987
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=329.41 Aligned_cols=252 Identities=17% Similarity=0.193 Sum_probs=193.9
Q ss_pred CCCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEE
Q 020641 15 PSPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCV 94 (323)
Q Consensus 15 ~~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 94 (323)
..|....+||+|+||.||++++..+++.+|+|++... ....+.+.+|+.+++.++||||+++++++.
T Consensus 20 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-------------~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 86 (361)
T 3uc3_A 20 DRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERG-------------AAIDENVQREIINHRSLRHPNIVRFKEVIL 86 (361)
T ss_dssp TTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESS-------------TTSCHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred CcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecC-------------ccccHHHHHHHHHHHhCCCCCCCcEEEEEe
Confidence 4566667999999999999999999999999976422 223367889999999999999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCe
Q 020641 95 EGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFK 174 (323)
Q Consensus 95 ~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~ 174 (323)
.....++||||+.+|+|.+++..... +++..+..++.|++.||.|||+. |++||||||+||+++.++.
T Consensus 87 ~~~~~~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~ 154 (361)
T 3uc3_A 87 TPTHLAIIMEYASGGELYERICNAGR---------FSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPA 154 (361)
T ss_dssp CSSEEEEEEECCCSCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSS
T ss_pred eCCEEEEEEEeCCCCCHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCC
Confidence 99999999999999999999976442 89999999999999999999999 9999999999999987765
Q ss_pred --EEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcc-cchHHHHHHHHHHHhCCCCCCCCCCcccchhhh
Q 020641 175 --AKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQK-SDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVT 251 (323)
Q Consensus 175 --~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~-~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~ 251 (323)
++|+|||++........ .....||+.|+|||.+.+..++.+ +||||||+++|+|++|+.||............
T Consensus 155 ~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~- 230 (361)
T 3uc3_A 155 PRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKT- 230 (361)
T ss_dssp CCEEECCCCCC------------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHH-
T ss_pred ceEEEeecCccccccccCC---CCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHH-
Confidence 99999999874332221 233458999999999988777655 89999999999999999999765432221111
Q ss_pred hhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 252 WATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
+................+..+.+||.+||+.||.+|||+.|+++
T Consensus 231 ----------~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~ 274 (361)
T 3uc3_A 231 ----------IQRILSVKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKT 274 (361)
T ss_dssp ----------HHHHHTTCCCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred ----------HHHHhcCCCCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHh
Confidence 11111111111112234567999999999999999999999987
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=319.29 Aligned_cols=275 Identities=16% Similarity=0.217 Sum_probs=205.0
Q ss_pred CCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEe
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVE 95 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 95 (323)
.|....+||+|+||+||+|++..+++.+|+|+..... ........+.+|+.++++++||||+++++++.+
T Consensus 3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 72 (292)
T 3o0g_A 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD----------DDEGVPSSALREICLLKELKHKNIVRLHDVLHS 72 (292)
T ss_dssp SEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSC----------SSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred CceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccC----------CcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEe
Confidence 3566779999999999999999999999999775332 112234678899999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeE
Q 020641 96 GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKA 175 (323)
Q Consensus 96 ~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~ 175 (323)
++..++||||+.+ ++.+.+...... +++..+..++.|++.||.|||+. |++|+||||+||+++.++.+
T Consensus 73 ~~~~~lv~e~~~~-~l~~~~~~~~~~--------l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~ 140 (292)
T 3o0g_A 73 DKKLTLVFEFCDQ-DLKKYFDSCNGD--------LDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGEL 140 (292)
T ss_dssp TTEEEEEEECCSE-EHHHHHHHTTTC--------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCE
T ss_pred CCEEEEEEecCCC-CHHHHHHhCCCC--------CCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCE
Confidence 9999999999986 676666543322 99999999999999999999999 99999999999999999999
Q ss_pred EEeeccccCCCCccccccccccccCccccCCCccccCCC-CCcccchHHHHHHHHHHHhCCCCCCCCCCcccch-hhhhh
Q 020641 176 KIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQ-LTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQS-LVTWA 253 (323)
Q Consensus 176 ~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~-~~~~~ 253 (323)
+|+|||++........ ......||+.|+|||.+.+.. ++.++||||||+++|+|++|..||.......... .....
T Consensus 141 kl~Dfg~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~ 218 (292)
T 3o0g_A 141 KLANFGLARAFGIPVR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRL 218 (292)
T ss_dssp EECCCTTCEECCSCCS--CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHH
T ss_pred EEeecccceecCCccc--cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHH
Confidence 9999999976543221 223345899999999987765 7999999999999999999888864433221111 00000
Q ss_pred cccccccccchhc------------CCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhhcCCCC
Q 020641 254 TPRLSEDKVKQCV------------DPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSPPP 316 (323)
Q Consensus 254 ~~~~~~~~~~~~~------------~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~~~~~~ 316 (323)
............. ............+..+.+|+.+||+.||++|||+.|+++ ...++...|
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~--hp~f~~~~p 291 (292)
T 3o0g_A 219 LGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ--HPYFSDFCP 291 (292)
T ss_dssp HCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT--SGGGTTC--
T ss_pred hCCCChhhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc--CcccccCCC
Confidence 0000000000000 000111222345678999999999999999999999998 555554443
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-46 Score=334.40 Aligned_cols=269 Identities=25% Similarity=0.341 Sum_probs=212.9
Q ss_pred ccccccCCCCCCccceeccce-------eeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcC-CCCcccce
Q 020641 18 GYFVRLDKGPEDDLYLKKRVK-------MRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRL-KHENLVEL 89 (323)
Q Consensus 18 ~~~~~lg~G~~~~V~~~~~~~-------~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~ 89 (323)
....+||+|+||.||+|++.. .+..+|+|+..... .......+.+|+++++++ +||||+++
T Consensus 72 ~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~-----------~~~~~~~~~~E~~~l~~l~~hpnIv~~ 140 (382)
T 3tt0_A 72 VLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-----------TEKDLSDLISEMEMMKMIGKHKNIINL 140 (382)
T ss_dssp EEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTC-----------CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred EeeeEEecCCCeEEEEEEEccccccccccceEEEEEeecccc-----------CHHHHHHHHHHHHHHHHhcCCchhhhh
Confidence 333489999999999998653 34568888654221 111236688999999999 99999999
Q ss_pred eeEEEeCCeEEEEEeecCCCCHHHHhccCCCCC-------CCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCC
Q 020641 90 LGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQ-------GAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDI 162 (323)
Q Consensus 90 ~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di 162 (323)
++++...+..++||||+.+|+|.+++....... .......+++..++.++.|++.||.|||+. |++||||
T Consensus 141 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dl 217 (382)
T 3tt0_A 141 LGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDL 217 (382)
T ss_dssp EEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCC
T ss_pred eeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCC
Confidence 999999999999999999999999998654211 111223499999999999999999999999 9999999
Q ss_pred CCCCEEEccCCeEEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCC
Q 020641 163 RSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHT 241 (323)
Q Consensus 163 kp~nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~ 241 (323)
||+||+++.++.++|+|||++................+++.|+|||.+.+..++.++||||||+++|+|++ |..||...
T Consensus 218 kp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~ 297 (382)
T 3tt0_A 218 AARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV 297 (382)
T ss_dssp CGGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred CcceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999999987655433333344457889999999999999999999999999999999 99999755
Q ss_pred CCcccchhhhhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhhcCCCC
Q 020641 242 MPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSPPP 316 (323)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~~~~~~ 316 (323)
... .+.+.+........+..++.++.+++.+||+.||++|||+.||++.|++++.....
T Consensus 298 ~~~----------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~ 356 (382)
T 3tt0_A 298 PVE----------------ELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSN 356 (382)
T ss_dssp CHH----------------HHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCS
T ss_pred CHH----------------HHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhc
Confidence 321 11122222222333445667899999999999999999999999999999865543
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-46 Score=344.91 Aligned_cols=256 Identities=25% Similarity=0.349 Sum_probs=213.1
Q ss_pred cccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeCCe
Q 020641 19 YFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNL 98 (323)
Q Consensus 19 ~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 98 (323)
...+||+|+||.||++.+..+++.+|+|..... ....+.+.+|+.++++++||||+++++++.....
T Consensus 224 ~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-------------~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 290 (495)
T 1opk_A 224 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-------------TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP 290 (495)
T ss_dssp EEEESGGGTTSSEEEEEEGGGTEEEEEEECCSS-------------SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred eeeEecCCCCeEEEEEEEcCCCeEEEEEEecCc-------------ccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCc
Confidence 344899999999999999998999999966421 1234778999999999999999999999999999
Q ss_pred EEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEEEe
Q 020641 99 RVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIA 178 (323)
Q Consensus 99 ~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~l~ 178 (323)
.++||||+.+|+|.+++....... +++..++.++.|++.||.|||++ ||+||||||+|||++.++.+||+
T Consensus 291 ~~lv~E~~~~g~L~~~l~~~~~~~-------~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~ 360 (495)
T 1opk_A 291 FYIITEFMTYGNLLDYLRECNRQE-------VSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVA 360 (495)
T ss_dssp CEEEEECCTTCBHHHHHHHSCTTT-------SCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEEC
T ss_pred EEEEEEccCCCCHHHHHHhcCcCC-------CCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEe
Confidence 999999999999999997643322 88999999999999999999999 99999999999999999999999
Q ss_pred eccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccc
Q 020641 179 DFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPRL 257 (323)
Q Consensus 179 Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~ 257 (323)
|||++......... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||......
T Consensus 361 DFG~a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~------------- 426 (495)
T 1opk_A 361 DFGLSRLMTGDTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS------------- 426 (495)
T ss_dssp CTTCEECCTTCCEE-CCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG-------------
T ss_pred ecccceeccCCcee-ecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHH-------------
Confidence 99999866432221 1223346778999999988889999999999999999999 99999755321
Q ss_pred cccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhhcCC
Q 020641 258 SEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSP 314 (323)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~~~~ 314 (323)
.+.+.+....+...+..++..+.+||.+||+.||.+|||+.+|++.|+.+....
T Consensus 427 ---~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~~~ 480 (495)
T 1opk_A 427 ---QVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 480 (495)
T ss_dssp ---GHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCSSS
T ss_pred ---HHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHhcc
Confidence 122223333344455667788999999999999999999999999999987654
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-46 Score=329.97 Aligned_cols=269 Identities=22% Similarity=0.320 Sum_probs=208.9
Q ss_pred ccccccCCCCCCccceecc-----ceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcC-CCCcccceee
Q 020641 18 GYFVRLDKGPEDDLYLKKR-----VKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRL-KHENLVELLG 91 (323)
Q Consensus 18 ~~~~~lg~G~~~~V~~~~~-----~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~ 91 (323)
.....||+|+||.||+|.+ ..+++.+|+|+..... .....+.+.+|+.+++++ +||||+++++
T Consensus 48 ~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-----------~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 116 (344)
T 1rjb_A 48 EFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-----------DSSEREALMSELKMMTQLGSHENIVNLLG 116 (344)
T ss_dssp EEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-----------------CHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred eeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc-----------CHHHHHHHHHHHHHHHhhcCCCCeeeEEE
Confidence 4445899999999999997 3467788888765321 123347889999999999 9999999999
Q ss_pred EEEeCCeEEEEEeecCCCCHHHHhccCCCCCC--------------CCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCc
Q 020641 92 YCVEGNLRVLAYEFATMGSLHDILHGRKGVQG--------------AQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSI 157 (323)
Q Consensus 92 ~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i 157 (323)
++...+..++||||+.+|+|.+++........ ......+++..++.++.|++.||.|||+. |+
T Consensus 117 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i 193 (344)
T 1rjb_A 117 ACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SC 193 (344)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred EEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---Cc
Confidence 99999999999999999999999976543210 00112378999999999999999999999 99
Q ss_pred eeCCCCCCCEEEccCCeEEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHh-CCC
Q 020641 158 IHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRK 236 (323)
Q Consensus 158 ~h~dikp~nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~ 236 (323)
+|+||||+||+++.++.++|+|||++................+++.|+|||.+.+..++.++||||||+++|+|++ |..
T Consensus 194 vH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~ 273 (344)
T 1rjb_A 194 VHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVN 273 (344)
T ss_dssp EETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCC
T ss_pred ccCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCC
Confidence 9999999999999999999999999986654333223334457888999999988899999999999999999998 999
Q ss_pred CCCCCCCcccchhhhhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhhcCCC
Q 020641 237 PVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSPP 315 (323)
Q Consensus 237 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~~~~~ 315 (323)
||........ ....+........+...+..+.+++.+||+.||.+|||+.++++.|+.++...+
T Consensus 274 p~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~ 337 (344)
T 1rjb_A 274 PYPGIPVDAN---------------FYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAE 337 (344)
T ss_dssp SSTTCCCSHH---------------HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC----
T ss_pred CcccCCcHHH---------------HHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHHH
Confidence 9976543211 111122222223344556789999999999999999999999999999987654
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=330.57 Aligned_cols=251 Identities=21% Similarity=0.262 Sum_probs=204.4
Q ss_pred CccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeC
Q 020641 17 PGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEG 96 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 96 (323)
|.....||+|+||.||+|.+..+++.+|+|++.+.... .......+.+|+.+++.++||||+++++++.+.
T Consensus 17 y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~---------~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 87 (384)
T 4fr4_A 17 FEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCV---------ERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDE 87 (384)
T ss_dssp EEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHH---------HTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred eEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcc---------cHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC
Confidence 45556899999999999999999999999977643211 123346788999999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEE
Q 020641 97 NLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAK 176 (323)
Q Consensus 97 ~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~ 176 (323)
...|+||||+.+|+|.+++..... +++..+..++.||+.||.|||+. ||+||||||+||+++.++.++
T Consensus 88 ~~~~lv~e~~~gg~L~~~l~~~~~---------l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vk 155 (384)
T 4fr4_A 88 EDMFMVVDLLLGGDLRYHLQQNVH---------FKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVH 155 (384)
T ss_dssp SEEEEEECCCTTEEHHHHHHTTCC---------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEE
T ss_pred CEEEEEEecCCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEE
Confidence 999999999999999999976532 89999999999999999999999 999999999999999999999
Q ss_pred EeeccccCCCCccccccccccccCccccCCCccccC---CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhh
Q 020641 177 IADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT---GQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWA 253 (323)
Q Consensus 177 l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~---~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 253 (323)
|+|||++....... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||...............
T Consensus 156 L~DFG~a~~~~~~~---~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~ 232 (384)
T 4fr4_A 156 ITDFNIAAMLPRET---QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTF 232 (384)
T ss_dssp ECCCTTCEECCTTC---CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHH
T ss_pred EeccceeeeccCCC---ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHH
Confidence 99999997654322 2244569999999999863 45889999999999999999999999755432221111111
Q ss_pred cccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCC-hHHHHH
Q 020641 254 TPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPN-MSIVVK 305 (323)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps-~~evl~ 305 (323)
. . .....+...+..+.++|.+||+.||.+||+ ++++++
T Consensus 233 ~------------~--~~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 233 E------------T--TVVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp H------------H--CCCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred h------------h--cccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 0 0 012234455678999999999999999998 777765
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=334.33 Aligned_cols=269 Identities=22% Similarity=0.292 Sum_probs=211.0
Q ss_pred CCccccccCCCCCCccceec-----cceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcC-CCCcccce
Q 020641 16 SPGYFVRLDKGPEDDLYLKK-----RVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRL-KHENLVEL 89 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~-----~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~ 89 (323)
.|....+||+|+||.||+++ +..+++.+|+|+..... .....+.+.+|+++++++ +||||+++
T Consensus 23 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-----------~~~~~~~~~~E~~~l~~l~~hpniv~~ 91 (359)
T 3vhe_A 23 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-----------THSEHRALMSELKILIHIGHHLNVVNL 91 (359)
T ss_dssp GEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-----------CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC-----------CHHHHHHHHHHHHHHHhhcCCcceeee
Confidence 44555689999999999998 66778899999764321 011135688999999999 89999999
Q ss_pred eeEEEeCC-eEEEEEeecCCCCHHHHhccCCCCCC---------------------------------------------
Q 020641 90 LGYCVEGN-LRVLAYEFATMGSLHDILHGRKGVQG--------------------------------------------- 123 (323)
Q Consensus 90 ~~~~~~~~-~~~lv~e~~~~~sL~~~~~~~~~~~~--------------------------------------------- 123 (323)
++++...+ ..++||||+.+|+|.+++........
T Consensus 92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (359)
T 3vhe_A 92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171 (359)
T ss_dssp EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence 99998765 48999999999999999976542100
Q ss_pred ------------CCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEEEeeccccCCCCcccc
Q 020641 124 ------------AQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAA 191 (323)
Q Consensus 124 ------------~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~l~Dfg~~~~~~~~~~ 191 (323)
......+++..++.++.|++.||.|||+. |++|+||||+||+++.++.++|+|||++........
T Consensus 172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 248 (359)
T 3vhe_A 172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 248 (359)
T ss_dssp ------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT
T ss_pred ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeeccccc
Confidence 00122388999999999999999999999 999999999999999999999999999986654433
Q ss_pred ccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccccccccchhcCCCc
Q 020641 192 RLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKL 270 (323)
Q Consensus 192 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (323)
........||+.|+|||++.+..++.++||||||+++|+|++ |..||........ +...+....
T Consensus 249 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~---------------~~~~~~~~~ 313 (359)
T 3vhe_A 249 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE---------------FCRRLKEGT 313 (359)
T ss_dssp CEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH---------------HHHHHHHTC
T ss_pred chhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHH---------------HHHHHHcCC
Confidence 333444557889999999999999999999999999999998 9999976543211 111111112
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhhcC
Q 020641 271 KGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKS 313 (323)
Q Consensus 271 ~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~~~ 313 (323)
....+...+..+.+++.+||+.||.+|||+.|+++.|+.++++
T Consensus 314 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 356 (359)
T 3vhe_A 314 RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 356 (359)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHH
Confidence 2233444567799999999999999999999999999998754
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-46 Score=325.81 Aligned_cols=255 Identities=19% Similarity=0.214 Sum_probs=203.8
Q ss_pred CccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeC
Q 020641 17 PGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEG 96 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 96 (323)
|.....||+|+||.||+|.+..+++.+|+|++......... .....+.+.+|+.++++++||||+++++++...
T Consensus 13 y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~------~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 86 (326)
T 2y0a_A 13 YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSR------RGVSREDIEREVSILKEIQHPNVITLHEVYENK 86 (326)
T ss_dssp EEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCS------SSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred eEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEcccccccc------chhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeC
Confidence 44555899999999999999999999999977654322211 112347789999999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCC---
Q 020641 97 NLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDF--- 173 (323)
Q Consensus 97 ~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~--- 173 (323)
...++||||+.+++|.+++..... +++..+..++.|++.||.|||+. |++|+||||+||+++.++
T Consensus 87 ~~~~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~ 154 (326)
T 2y0a_A 87 TDVILILELVAGGELFDFLAEKES---------LTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPK 154 (326)
T ss_dssp SEEEEEEECCCSCBHHHHHTTSSC---------CBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSS
T ss_pred CEEEEEEEcCCCCCHHHHHHhcCC---------cCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCC
Confidence 999999999999999999975432 89999999999999999999999 999999999999998887
Q ss_pred -eEEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhh
Q 020641 174 -KAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTW 252 (323)
Q Consensus 174 -~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 252 (323)
.++|+|||++........ .....||+.|+|||++.+..++.++||||||+++|+|++|..||..............
T Consensus 155 ~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~ 231 (326)
T 2y0a_A 155 PRIKIIDFGLAHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSA 231 (326)
T ss_dssp CCEEECCCTTCEECCTTSC---CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHH
T ss_pred CCEEEEECCCCeECCCCCc---cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHh
Confidence 899999999876543221 2334589999999999988999999999999999999999999975532211111110
Q ss_pred hcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 253 ATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
... ..........+..+.+++.+||+.||.+|||+.|+++
T Consensus 232 ~~~-------------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 232 VNY-------------EFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp TCC-------------CCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred cCC-------------CcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 000 0000001233567999999999999999999999997
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-46 Score=321.88 Aligned_cols=260 Identities=22% Similarity=0.240 Sum_probs=195.8
Q ss_pred CCccccccCCCCCCccceeccceeeeeeeeccccccccCccccc--------------cccCCCCCchHHHHHHHHHhcC
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENE--------------RLKSPKNYPDDEKQLVSVVSRL 81 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~--------------~~~~~~~~~~~~~~e~~~l~~l 81 (323)
.|....+||+|+||.||+|++..+++.+|+|+............ .........+.+.+|+++++++
T Consensus 14 ~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 93 (298)
T 2zv2_A 14 QYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKL 93 (298)
T ss_dssp TEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHTC
T ss_pred ceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHhC
Confidence 45666699999999999999999999999998865543221100 0001122346789999999999
Q ss_pred CCCcccceeeEEEe--CCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCcee
Q 020641 82 KHENLVELLGYCVE--GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIH 159 (323)
Q Consensus 82 ~h~~i~~~~~~~~~--~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h 159 (323)
+||||+++++++.. ....++||||+.+++|.+++... .+++..+..++.|++.||.|||+. |++|
T Consensus 94 ~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~----------~~~~~~~~~~~~qi~~~l~~lH~~---~ivH 160 (298)
T 2zv2_A 94 DHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLK----------PLSEDQARFYFQDLIKGIEYLHYQ---KIIH 160 (298)
T ss_dssp CCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCSS----------CCCHHHHHHHHHHHHHHHHHHHHT---TEEC
T ss_pred CCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhcC----------CCCHHHHHHHHHHHHHHHHHHHHC---Ceec
Confidence 99999999999986 56889999999999998865432 289999999999999999999999 9999
Q ss_pred CCCCCCCEEEccCCeEEEeeccccCCCCccccccccccccCccccCCCccccCCC---CCcccchHHHHHHHHHHHhCCC
Q 020641 160 RDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQ---LTQKSDVYSFGVVLLELLTGRK 236 (323)
Q Consensus 160 ~dikp~nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~---~~~~~Di~slG~~l~~l~~g~~ 236 (323)
+||||+||+++.++.++|+|||++......... .....||+.|+|||.+.+.. ++.++||||||+++|+|++|..
T Consensus 161 ~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~ 238 (298)
T 2zv2_A 161 RDIKPSNLLVGEDGHIKIADFGVSNEFKGSDAL--LSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQC 238 (298)
T ss_dssp CCCCGGGEEECTTSCEEECCCTTCEECSSSSCE--ECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSC
T ss_pred cCCCHHHEEECCCCCEEEecCCCcccccccccc--ccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCC
Confidence 999999999999999999999998765432211 23346899999999987655 3778999999999999999999
Q ss_pred CCCCCCCcccchhhhhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 237 PVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 237 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
||.......... .+.............+..+.+++.+||+.||++|||+.|+++
T Consensus 239 pf~~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 239 PFMDERIMCLHS---------------KIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp SSCCSSHHHHHH---------------HHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred CCCCccHHHHHH---------------HHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 997543211100 000011111112334567999999999999999999999975
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-46 Score=321.99 Aligned_cols=258 Identities=25% Similarity=0.342 Sum_probs=213.0
Q ss_pred CCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEe
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVE 95 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 95 (323)
.+....+||+|+||.||++.+..+++.+++|..... ....+.+.+|++++++++||||+++++++..
T Consensus 14 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------------~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 80 (288)
T 3kfa_A 14 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-------------TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 80 (288)
T ss_dssp GEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-------------STHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred ceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-------------HHHHHHHHHHHHHHHhCCCCCEeeEEEEEcc
Confidence 345556899999999999999999999999866421 2224678899999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeE
Q 020641 96 GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKA 175 (323)
Q Consensus 96 ~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~ 175 (323)
.+..++||||+.+++|.+++....... +++..++.++.|++.||.|||+. |++|+||||+||+++.++.+
T Consensus 81 ~~~~~~v~e~~~~~~L~~~~~~~~~~~-------~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~ 150 (288)
T 3kfa_A 81 EPPFYIITEFMTYGNLLDYLRECNRQE-------VSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLV 150 (288)
T ss_dssp SSSEEEEEECCTTEEHHHHHHHCCTTT-------SCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCE
T ss_pred CCCEEEEEEcCCCCcHHHHHHhcccCC-------ccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCE
Confidence 999999999999999999997654332 89999999999999999999999 99999999999999999999
Q ss_pred EEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhc
Q 020641 176 KIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWAT 254 (323)
Q Consensus 176 ~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~ 254 (323)
+|+|||++......... ......+++.|+|||.+.+..++.++||||||+++|+|++ |..||.......
T Consensus 151 ~l~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~--------- 220 (288)
T 3kfa_A 151 KVADFGLSRLMTGDTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ--------- 220 (288)
T ss_dssp EECCCCGGGTSCSSSSE-EETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---------
T ss_pred EEccCccceeccCCccc-cccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---------
Confidence 99999999766533221 1223346788999999998899999999999999999999 999997553221
Q ss_pred ccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhhcC
Q 020641 255 PRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKS 313 (323)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~~~ 313 (323)
..+.+........+...+..+.+++.+||+.||.+|||+.++++.|+.+...
T Consensus 221 -------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~ 272 (288)
T 3kfa_A 221 -------VYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 272 (288)
T ss_dssp -------HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -------HHHHHhccCCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHh
Confidence 1122222223334455667899999999999999999999999999998754
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=318.92 Aligned_cols=268 Identities=14% Similarity=0.136 Sum_probs=212.1
Q ss_pred CCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcC-CCCcccceeeEEE
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRL-KHENLVELLGYCV 94 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~ 94 (323)
.|.....||+|+||.||++.+..+++.+|+|+.... .....+.+|+.+++.+ +|+|++++++++.
T Consensus 11 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--------------~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~ 76 (298)
T 1csn_A 11 HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR--------------SDAPQLRDEYRTYKLLAGCTGIPNVYYFGQ 76 (298)
T ss_dssp TEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECC--------------TTSCCHHHHHHHHHHTTTCTTCCCEEEEEE
T ss_pred ceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccC--------------CccHHHHHHHHHHHHHhcCCCCCeEEeecC
Confidence 356666899999999999999999999999965421 1234578899999999 8999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCe
Q 020641 95 EGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFK 174 (323)
Q Consensus 95 ~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~ 174 (323)
.+...++||||+ +++|.+++...... +++..+..++.|++.||.|||+. |++|+||||+||+++.++.
T Consensus 77 ~~~~~~lv~e~~-~~~L~~~l~~~~~~--------~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~ 144 (298)
T 1csn_A 77 EGLHNVLVIDLL-GPSLEDLLDLCGRK--------FSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNS 144 (298)
T ss_dssp ETTEEEEEEECC-CCBHHHHHHHTTTC--------CCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSS
T ss_pred CCceeEEEEEec-CCCHHHHHHHhccC--------CCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCC
Confidence 999999999999 88999999865322 89999999999999999999999 9999999999999987765
Q ss_pred -----EEEeeccccCCCCccccc-----cccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCc
Q 020641 175 -----AKIADFNLSNQAPDMAAR-----LHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPR 244 (323)
Q Consensus 175 -----~~l~Dfg~~~~~~~~~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 244 (323)
++|+|||++......... .......||+.|+|||.+.+..++.++||||||+++|+|++|+.||......
T Consensus 145 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 224 (298)
T 1csn_A 145 KNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAA 224 (298)
T ss_dssp TTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSC
T ss_pred CCCCeEEEEECccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhcc
Confidence 999999999765443221 1123455899999999999989999999999999999999999999875433
Q ss_pred ccchhhhhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhhcCCCCCC
Q 020641 245 GQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSPPPAA 318 (323)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~~~~~~~~ 318 (323)
................... ......+..+.+++.+||+.||++|||+.+|++.|+++.+......
T Consensus 225 ~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~~~ 289 (298)
T 1csn_A 225 TNKQKYERIGEKKQSTPLR---------ELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTE 289 (298)
T ss_dssp CHHHHHHHHHHHHHHSCHH---------HHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCS
T ss_pred ccHHHHHHHHhhccCccHH---------HHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCCCC
Confidence 2221111110000000000 0112345679999999999999999999999999999997665443
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-46 Score=324.24 Aligned_cols=272 Identities=24% Similarity=0.330 Sum_probs=209.6
Q ss_pred ccccccCCCCCCccceec----cceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEE
Q 020641 18 GYFVRLDKGPEDDLYLKK----RVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYC 93 (323)
Q Consensus 18 ~~~~~lg~G~~~~V~~~~----~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 93 (323)
....+||+|+||.||+|+ +..+++.+|+|+..... .......+.+|+++++.++|+||+++++++
T Consensus 24 ~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-----------~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 92 (302)
T 4e5w_A 24 KRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-----------GGNHIADLKKEIEILRNLYHENIVKYKGIC 92 (302)
T ss_dssp EEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC----------------CCHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred hhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc-----------cchhHHHHHHHHHHHHhCCCCCeeeeeeEE
Confidence 444589999999999998 67889999999765321 123447789999999999999999999999
Q ss_pred EeC--CeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEcc
Q 020641 94 VEG--NLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFE 171 (323)
Q Consensus 94 ~~~--~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~ 171 (323)
... +..++||||+.+++|.+++...... +++..++.++.|++.||.|||+. |++|+||||+||+++.
T Consensus 93 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~--------~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~ 161 (302)
T 4e5w_A 93 TEDGGNGIKLIMEFLPSGSLKEYLPKNKNK--------INLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVES 161 (302)
T ss_dssp EC---CCEEEEEECCTTCBHHHHHHHHTTT--------CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEE
T ss_pred ecCCCceEEEEEEeCCCCcHHHHHHhcccc--------CCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcC
Confidence 876 6689999999999999999654432 89999999999999999999999 9999999999999999
Q ss_pred CCeEEEeeccccCCCCccccc-cccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhh
Q 020641 172 DFKAKIADFNLSNQAPDMAAR-LHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLV 250 (323)
Q Consensus 172 ~~~~~l~Dfg~~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~ 250 (323)
++.++|+|||++......... .......|+..|+|||.+.+..++.++||||||+++|+|++|..|+...........
T Consensus 162 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~- 240 (302)
T 4e5w_A 162 EHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMI- 240 (302)
T ss_dssp TTEEEECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHH-
T ss_pred CCCEEECcccccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhcc-
Confidence 999999999998765543221 223344578889999999988899999999999999999999998643211000000
Q ss_pred hhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhhc
Q 020641 251 TWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLK 312 (323)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~~ 312 (323)
...........+...+........+...+..+.+++.+||+.||.+|||+.++++.|+.+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll~ 302 (302)
T 4e5w_A 241 GPTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALLK 302 (302)
T ss_dssp CSCCGGGHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred CCcccccCHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhC
Confidence 00000011112222223333344556667889999999999999999999999999999874
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-46 Score=325.98 Aligned_cols=270 Identities=20% Similarity=0.295 Sum_probs=213.0
Q ss_pred CccccccCCCCCCccceecc-----ceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcC-CCCccccee
Q 020641 17 PGYFVRLDKGPEDDLYLKKR-----VKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRL-KHENLVELL 90 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~~-----~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~ 90 (323)
|.....||+|+||.||++++ ..+++.+++|+...... ....+.+.+|+.+++++ +||||++++
T Consensus 25 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~-----------~~~~~~~~~E~~~l~~l~~h~~i~~~~ 93 (313)
T 1t46_A 25 LSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH-----------LTEREALMSELKVLSYLGNHMNIVNLL 93 (313)
T ss_dssp EEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC-----------HHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred hhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchh-----------HHHHHHHHHHHHHHhhcccCCCeeeEE
Confidence 44445899999999999984 45788899986653210 11236788999999999 999999999
Q ss_pred eEEEeCCeEEEEEeecCCCCHHHHhccCCCCCC---------CCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCC
Q 020641 91 GYCVEGNLRVLAYEFATMGSLHDILHGRKGVQG---------AQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRD 161 (323)
Q Consensus 91 ~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~d 161 (323)
+++..++..++||||+.+++|.+++........ ......+++..++.++.|++.||.|||+. |++|+|
T Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~d 170 (313)
T 1t46_A 94 GACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRD 170 (313)
T ss_dssp EEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSC
T ss_pred EEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCC
Confidence 999999999999999999999999976542100 01112389999999999999999999999 999999
Q ss_pred CCCCCEEEccCCeEEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHh-CCCCCCC
Q 020641 162 IRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDH 240 (323)
Q Consensus 162 ikp~nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~ 240 (323)
|||+||+++.++.++|+|||++................+++.|+|||.+.+..++.++||||||+++|+|++ |..||..
T Consensus 171 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~ 250 (313)
T 1t46_A 171 LAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPG 250 (313)
T ss_dssp CSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred CccceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCc
Confidence 999999999999999999999987665443333344457888999999988899999999999999999998 9999976
Q ss_pred CCCcccchhhhhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhhcCCC
Q 020641 241 TMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSPP 315 (323)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~~~~~ 315 (323)
...... ....+........+...+..+.+++.+||+.||.+|||+.|+++.|+++++..+
T Consensus 251 ~~~~~~---------------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 310 (313)
T 1t46_A 251 MPVDSK---------------FYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISEST 310 (313)
T ss_dssp CCSSHH---------------HHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTC
T ss_pred ccchhH---------------HHHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHhh
Confidence 543211 111111112222334456789999999999999999999999999999987543
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=323.57 Aligned_cols=263 Identities=15% Similarity=0.182 Sum_probs=207.7
Q ss_pred CCCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcC-CCCcccceeeEE
Q 020641 15 PSPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRL-KHENLVELLGYC 93 (323)
Q Consensus 15 ~~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~ 93 (323)
..|....+||.|+||.||++++..+++.+|+|+.... ...+.+.+|+++++.+ +|+||+++++++
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--------------~~~~~~~~E~~~l~~l~~h~~i~~~~~~~ 74 (330)
T 2izr_A 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMK--------------SRAPQLHLEYRFYKQLGSGDGIPQVYYFG 74 (330)
T ss_dssp TTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETT--------------CSSCCHHHHHHHHHHHCSCTTSCCEEEEE
T ss_pred CCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccc--------------cchHHHHHHHHHHHHhhCCCCCCEEEEEE
Confidence 3466667999999999999999999999999976422 1124578999999999 999999999999
Q ss_pred EeCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCC
Q 020641 94 VEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDF 173 (323)
Q Consensus 94 ~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~ 173 (323)
..++..++||||+ +++|.+++..... .+++..+..++.|++.||.|||+. |++||||||+||+++.++
T Consensus 75 ~~~~~~~lv~e~~-~~~L~~~~~~~~~--------~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~ 142 (330)
T 2izr_A 75 PCGKYNAMVLELL-GPSLEDLFDLCDR--------TFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPG 142 (330)
T ss_dssp EETTEEEEEEECC-CCBHHHHHHHTTT--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGG
T ss_pred ecCCccEEEEEeC-CCCHHHHHHHcCC--------CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCC
Confidence 9999999999999 8899999986432 299999999999999999999999 999999999999999888
Q ss_pred e-----EEEeeccccCCCCcccccc-----ccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCC
Q 020641 174 K-----AKIADFNLSNQAPDMAARL-----HSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMP 243 (323)
Q Consensus 174 ~-----~~l~Dfg~~~~~~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 243 (323)
. ++|+|||++.......... ......||+.|+|||.+.+..++.++||||||+++|+|++|..||.....
T Consensus 143 ~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~ 222 (330)
T 2izr_A 143 NKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKA 222 (330)
T ss_dssp GTCTTSEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC
T ss_pred CCCCceEEEEEcccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCcccccc
Confidence 7 9999999997654322211 12345689999999999999999999999999999999999999986543
Q ss_pred cccchhhhhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhhcC
Q 020641 244 RGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKS 313 (323)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~~~ 313 (323)
................ .... ......+ .+.+++.+||+.||.+||++.+|.+.|+++.+.
T Consensus 223 ~~~~~~~~~i~~~~~~-~~~~--------~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~ 282 (330)
T 2izr_A 223 DTLKERYQKIGDTKRA-TPIE--------VLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDR 282 (330)
T ss_dssp SSHHHHHHHHHHHHHH-SCHH--------HHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred ccHHHHHHHHHhhhcc-CCHH--------HHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHH
Confidence 2221111110000000 0000 0011123 799999999999999999999999999988754
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-46 Score=317.81 Aligned_cols=256 Identities=21% Similarity=0.277 Sum_probs=205.6
Q ss_pred CCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEe
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVE 95 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 95 (323)
.+....+||+|+||.||++++.. +..+|+|+.... ....+.+.+|++++++++||||+++++++..
T Consensus 9 ~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~-------------~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 74 (268)
T 3sxs_A 9 EITLLKELGSGQFGVVKLGKWKG-QYDVAVKMIKEG-------------SMSEDEFFQEAQTMMKLSHPKLVKFYGVCSK 74 (268)
T ss_dssp GEEEEEEEEEETTEEEEEEEETT-TEEEEEEEECBT-------------TBCHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred heeeeeeeccCCCceEEEEEecC-ceeEEEEEeccC-------------CCcHHHHHHHHHHHHhCCCCCEeeEEEEEcc
Confidence 34556689999999999997764 555777765422 1123668899999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeE
Q 020641 96 GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKA 175 (323)
Q Consensus 96 ~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~ 175 (323)
.+..++||||+++++|.+++...... +++..++.++.|++.||.|||+. |++|+||||+||+++.++.+
T Consensus 75 ~~~~~lv~e~~~~~~L~~~l~~~~~~--------~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~ 143 (268)
T 3sxs_A 75 EYPIYIVTEYISNGCLLNYLRSHGKG--------LEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCV 143 (268)
T ss_dssp SSSEEEEEECCTTCBHHHHHHHHGGG--------CCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCE
T ss_pred CCceEEEEEccCCCcHHHHHHHcCCC--------CCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCE
Confidence 99999999999999999999765322 89999999999999999999999 99999999999999999999
Q ss_pred EEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhc
Q 020641 176 KIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWAT 254 (323)
Q Consensus 176 ~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~ 254 (323)
+|+|||++.......... .....+++.|+|||.+.+..++.++||||||+++|+|++ |..||...........
T Consensus 144 ~l~Dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~----- 217 (268)
T 3sxs_A 144 KVSDFGMTRYVLDDQYVS-SVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLK----- 217 (268)
T ss_dssp EECCTTCEEECCTTCEEE-CCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHH-----
T ss_pred EEccCccceecchhhhhc-ccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHH-----
Confidence 999999987654432221 223346778999999988889999999999999999999 9999975543211111
Q ss_pred ccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhhcC
Q 020641 255 PRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKS 313 (323)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~~~ 313 (323)
+........+...+..+.+++.+||+.||.+|||+.++++.|+.+.+.
T Consensus 218 -----------~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (268)
T 3sxs_A 218 -----------VSQGHRLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK 265 (268)
T ss_dssp -----------HHTTCCCCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred -----------HHcCCCCCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence 111111222333456799999999999999999999999999998764
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=323.25 Aligned_cols=247 Identities=20% Similarity=0.288 Sum_probs=205.3
Q ss_pred CCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEe
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVE 95 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 95 (323)
.|.....||+|+||.||+|++..+++.+|+|+..+..... ....+.+.+|..+++.++||||+++++++.+
T Consensus 7 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~---------~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~ 77 (318)
T 1fot_A 7 DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVR---------LKQVEHTNDERLMLSIVTHPFIIRMWGTFQD 77 (318)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHH---------TTCHHHHHHHHHHHHSCCBTTBCCEEEEEEC
T ss_pred HcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhh---------hhHHHHHHHHHHHHhhCCCCCCceEeEEEEe
Confidence 4566679999999999999999999999999876432111 1234677899999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeE
Q 020641 96 GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKA 175 (323)
Q Consensus 96 ~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~ 175 (323)
....|+||||+.+|+|.+++..... +++..+..++.|++.||.|||+. |++||||||+||+++.++.+
T Consensus 78 ~~~~~lv~e~~~gg~L~~~l~~~~~---------~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~ 145 (318)
T 1fot_A 78 AQQIFMIMDYIEGGELFSLLRKSQR---------FPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHI 145 (318)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHTSS---------CCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCE
T ss_pred CCEEEEEEeCCCCCCHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCE
Confidence 9999999999999999999976542 89999999999999999999999 99999999999999999999
Q ss_pred EEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhcc
Q 020641 176 KIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATP 255 (323)
Q Consensus 176 ~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~ 255 (323)
+|+|||++...... .....||+.|+|||++.+..++.++|+||||+++|+|++|..||.........
T Consensus 146 kL~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~-------- 212 (318)
T 1fot_A 146 KITDFGFAKYVPDV-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTY-------- 212 (318)
T ss_dssp EECCCSSCEECSSC-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHH--------
T ss_pred EEeecCcceecCCc-----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHH--------
Confidence 99999998765432 23446899999999999999999999999999999999999999755321111
Q ss_pred cccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCC-----ChHHHHH
Q 020641 256 RLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRP-----NMSIVVK 305 (323)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-----s~~evl~ 305 (323)
..++... ...+...+.++.+++.+||..||.+|| +++|+++
T Consensus 213 -------~~i~~~~--~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 213 -------EKILNAE--LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp -------HHHHHCC--CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred -------HHHHhCC--CCCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 1111111 122344567799999999999999999 8999984
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=331.05 Aligned_cols=254 Identities=19% Similarity=0.219 Sum_probs=200.4
Q ss_pred CCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcC-CCCcccceeeEEE
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRL-KHENLVELLGYCV 94 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~ 94 (323)
.|.....||+|+||.||+|++..+++.+|+|++.+..... ......+..|..++.++ +||||+++++++.
T Consensus 53 ~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~---------~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~ 123 (396)
T 4dc2_A 53 DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVND---------DEDIDWVQTEKHVFEQASNHPFLVGLHSCFQ 123 (396)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC-------------CCHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred HcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccC---------HHHHHHHHHHHHHHHhcCCCCCcCeeEEEEE
Confidence 3556668999999999999999999999999876543222 22346678899998877 8999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCe
Q 020641 95 EGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFK 174 (323)
Q Consensus 95 ~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~ 174 (323)
+.+..|+||||+.+|+|.+++..... +++..+..++.||+.||.|||+. ||+||||||+|||++.++.
T Consensus 124 ~~~~~~lV~E~~~gg~L~~~l~~~~~---------l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ 191 (396)
T 4dc2_A 124 TESRLFFVIEYVNGGDLMFHMQRQRK---------LPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGH 191 (396)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSC
T ss_pred ECCEEEEEEEcCCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCC
Confidence 99999999999999999999976542 99999999999999999999999 9999999999999999999
Q ss_pred EEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhc
Q 020641 175 AKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWAT 254 (323)
Q Consensus 175 ~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~ 254 (323)
++|+|||++....... .......||+.|+|||++.+..++.++|+|||||++|+|++|+.||...........
T Consensus 192 ikL~DFGla~~~~~~~--~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~----- 264 (396)
T 4dc2_A 192 IKLTDYGMCKEGLRPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ----- 264 (396)
T ss_dssp EEECCCTTCBCCCCTT--CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC-----------
T ss_pred EEEeecceeeecccCC--CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccch-----
Confidence 9999999997533222 123445699999999999999999999999999999999999999975432111000
Q ss_pred ccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCCh
Q 020641 255 PRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNM 300 (323)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~ 300 (323)
.........+.... ...+...+..+.+||.+||+.||.+||++
T Consensus 265 -~~~~~~~~~i~~~~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 265 -NTEDYLFQVILEKQ--IRIPRSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp -CCHHHHHHHHHHCC--CCCCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred -hhHHHHHHHHhccc--cCCCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 00000001111111 12344566789999999999999999996
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-46 Score=324.94 Aligned_cols=248 Identities=16% Similarity=0.128 Sum_probs=201.8
Q ss_pred CCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEe
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVE 95 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 95 (323)
.|....+||+|+||.||++.+..+++.+++|+.... ......+.+|+.+++.++||||+++++++.+
T Consensus 6 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-------------~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~ 72 (321)
T 1tki_A 6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-------------GTDQVLVKKEISILNIARHRNILHLHESFES 72 (321)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-------------THHHHHHHHHHHHHHHSCCTTBCCEEEEEEE
T ss_pred ceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC-------------cccHHHHHHHHHHHHhCCCCCCCeEeEEEec
Confidence 455666899999999999999999999999866421 1123567899999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEcc--CC
Q 020641 96 GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFE--DF 173 (323)
Q Consensus 96 ~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~--~~ 173 (323)
.+..++||||+.+++|.+++...... +++..+..++.|++.||.|||+. |++|+||||+||+++. ++
T Consensus 73 ~~~~~lv~e~~~g~~L~~~l~~~~~~--------~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~ 141 (321)
T 1tki_A 73 MEELVMIFEFISGLDIFERINTSAFE--------LNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSS 141 (321)
T ss_dssp TTEEEEEECCCCCCBHHHHHTSSSCC--------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCC
T ss_pred CCEEEEEEEeCCCCCHHHHHHhcCCC--------CCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCC
Confidence 99999999999999999999765322 89999999999999999999999 9999999999999987 78
Q ss_pred eEEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhh
Q 020641 174 KAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWA 253 (323)
Q Consensus 174 ~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 253 (323)
.++|+|||++........ .....|++.|+|||++.+..++.++||||||+++|+|++|..||..........
T Consensus 142 ~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~----- 213 (321)
T 1tki_A 142 TIKIIEFGQARQLKPGDN---FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIE----- 213 (321)
T ss_dssp CEEECCCTTCEECCTTCE---EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH-----
T ss_pred CEEEEECCCCeECCCCCc---cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHH-----
Confidence 999999999976643322 223458999999999988888999999999999999999999997653221111
Q ss_pred cccccccccchhcCCCcCCC--CCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 254 TPRLSEDKVKQCVDPKLKGE--YPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
.+........ .....+.++.+++.+||..||.+|||+.|+++
T Consensus 214 ----------~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 257 (321)
T 1tki_A 214 ----------NIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp ----------HHHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ----------HHHcCCCCCChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1111110000 01134567999999999999999999999998
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=320.84 Aligned_cols=277 Identities=17% Similarity=0.194 Sum_probs=201.2
Q ss_pred CCCccccccCCC-CCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCC
Q 020641 4 DYHPRALGAHAP-SPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLK 82 (323)
Q Consensus 4 ~~~~~~~~~~~~-~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~ 82 (323)
.+++...+.+.. .|....+||+|+||+||+|++.. ++.+|+|...... ........+.+|++++++++
T Consensus 9 ~~~~~~~~q~l~~~y~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~----------~~~~~~~~~~~E~~~l~~l~ 77 (311)
T 3niz_A 9 SGRENLYFQGLMEKYQKLEKVGEGTYGVVYKAKDSQ-GRIVALKRIRLDA----------EDEGIPSTAIREISLLKELH 77 (311)
T ss_dssp ------CEECSSCEEEEEEEEEECSSCEEEEEEETT-SCEEEEEEEC----------------CHHHHHHHHHHHHHHCC
T ss_pred ccccceeecchHhhhHhhhhccCCCCeEEEEEEECC-CCEEEEEEEeccc----------ccchhhHHHHHHHHHHHHcC
Confidence 344455555543 34555699999999999999854 7788888664321 11223467889999999999
Q ss_pred CCcccceeeEEEeCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCC
Q 020641 83 HENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDI 162 (323)
Q Consensus 83 h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di 162 (323)
||||+++++++.+.+..++||||+.+ +|.+++...... +++..+..++.|++.||.|||+. |++||||
T Consensus 78 hp~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~--------~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Di 145 (311)
T 3niz_A 78 HPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTG--------LQDSQIKIYLYQLLRGVAHCHQH---RILHRDL 145 (311)
T ss_dssp CTTBCCEEEEECCSSCEEEEEECCSE-EHHHHHHTCTTC--------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCC
T ss_pred CCCEeeeeeEEccCCEEEEEEcCCCC-CHHHHHHhccCC--------CCHHHHHHHHHHHHHHHHHHHHC---CcccCCC
Confidence 99999999999999999999999986 888888765432 89999999999999999999999 9999999
Q ss_pred CCCCEEEccCCeEEEeeccccCCCCccccccccccccCccccCCCccccC-CCCCcccchHHHHHHHHHHHhCCCCCCCC
Q 020641 163 RSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT-GQLTQKSDVYSFGVVLLELLTGRKPVDHT 241 (323)
Q Consensus 163 kp~nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 241 (323)
||+||+++.++.++|+|||++........ ......||+.|+|||.+.+ ..++.++||||||+++|+|++|+.||...
T Consensus 146 kp~NIl~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~ 223 (311)
T 3niz_A 146 KPQNLLINSDGALKLADFGLARAFGIPVR--SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGV 223 (311)
T ss_dssp CGGGEEECTTCCEEECCCTTCEETTSCCC-----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred chHhEEECCCCCEEEccCcCceecCCCcc--cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCC
Confidence 99999999999999999999976543221 1233457999999999876 56799999999999999999999999866
Q ss_pred CCcccchhhhhhccccccccc------chhcCCCcC--CC-----CCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 242 MPRGQQSLVTWATPRLSEDKV------KQCVDPKLK--GE-----YPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~--~~-----~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
..................... ..+...... .. .....+.++.+|+.+||+.||.+|||+.|+++
T Consensus 224 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 224 TDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp STTTHHHHHHHHHCCCCTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred ChHHHHHHHHHHHCCCChHHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 543322211111100001000 000000000 00 11223467899999999999999999999998
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=329.07 Aligned_cols=251 Identities=18% Similarity=0.198 Sum_probs=202.1
Q ss_pred CccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeC
Q 020641 17 PGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEG 96 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 96 (323)
|.....||+|+||.||+|.+..+++.+|+|++....... ...+.+.+|+.+++.++||||+++++++.+.
T Consensus 31 y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~----------~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~ 100 (362)
T 2bdw_A 31 YDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSA----------RDFQKLEREARICRKLQHPNIVRLHDSIQEE 100 (362)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCH----------HHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred eEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCH----------HHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC
Confidence 455568999999999999999999999999776443221 1235678999999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccC---C
Q 020641 97 NLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFED---F 173 (323)
Q Consensus 97 ~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~---~ 173 (323)
+..++||||+.+++|.+++..... +++..+..++.||+.||.|||+. ||+|+||||+||+++.+ +
T Consensus 101 ~~~~lv~e~~~gg~L~~~l~~~~~---------~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~ 168 (362)
T 2bdw_A 101 SFHYLVFDLVTGGELFEDIVAREF---------YSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGA 168 (362)
T ss_dssp SEEEEEECCCCSCBHHHHHTTCSC---------CCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTC
T ss_pred CEEEEEEecCCCCCHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCC
Confidence 999999999999999999976532 89999999999999999999999 99999999999999765 4
Q ss_pred eEEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhh
Q 020641 174 KAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWA 253 (323)
Q Consensus 174 ~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 253 (323)
.++|+|||++........ .....||+.|+|||++.+..++.++|||||||++|+|++|..||...........+...
T Consensus 169 ~~kl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~ 245 (362)
T 2bdw_A 169 AVKLADFGLAIEVNDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG 245 (362)
T ss_dssp CEEECCCTTCBCCTTCCS---CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT
T ss_pred CEEEeecCcceEecCCcc---cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhC
Confidence 599999999977653322 23456899999999999889999999999999999999999999755321111100000
Q ss_pred cccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 254 TPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
... .........+..+.+++.+||+.||.+|||+.|+++
T Consensus 246 ~~~-------------~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 284 (362)
T 2bdw_A 246 AYD-------------YPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK 284 (362)
T ss_dssp CCC-------------CCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred CCC-------------CCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 000 000111344677999999999999999999999986
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-45 Score=321.17 Aligned_cols=247 Identities=21% Similarity=0.295 Sum_probs=202.0
Q ss_pred ccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeCC
Q 020641 18 GYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGN 97 (323)
Q Consensus 18 ~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 97 (323)
....+||+|+||.||+|++..+++.+|+|+.... .....+.+.+|+.+++.++|+||+++++++...+
T Consensus 48 ~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~------------~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (321)
T 2c30_A 48 DSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLR------------KQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGE 115 (321)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEEEETT------------TCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETT
T ss_pred hccEEeccCCCeEEEEEEECCCCcEEEEEEEecc------------chhHHHHHHHHHHHHHhCCCCCcceEEEEEEECC
Confidence 3445899999999999999999999999976422 1233467889999999999999999999999999
Q ss_pred eEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEEE
Q 020641 98 LRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKI 177 (323)
Q Consensus 98 ~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~l 177 (323)
..++||||+.+++|.+++.... +++..+..++.|++.||.|||+. |++|+||||+||+++.++.++|
T Consensus 116 ~~~lv~e~~~~~~L~~~l~~~~----------l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl 182 (321)
T 2c30_A 116 ELWVLMEFLQGGALTDIVSQVR----------LNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILLTLDGRVKL 182 (321)
T ss_dssp EEEEEECCCCSCBHHHHHTTCC----------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEE
T ss_pred EEEEEEecCCCCCHHHHHHhcC----------CCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCcEEE
Confidence 9999999999999999987542 89999999999999999999999 9999999999999999999999
Q ss_pred eeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccc
Q 020641 178 ADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRL 257 (323)
Q Consensus 178 ~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 257 (323)
+|||++........ ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||......... ...
T Consensus 183 ~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~---~~~---- 253 (321)
T 2c30_A 183 SDFGFCAQISKDVP--KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAM---KRL---- 253 (321)
T ss_dssp CCCTTCEECCSSSC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH---HHH----
T ss_pred eeeeeeeecccCcc--ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHH----
Confidence 99999876543221 123446899999999999889999999999999999999999999754321110 000
Q ss_pred cccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 258 SEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
.....+. .......+..+.+++.+||+.||++|||+.|+++
T Consensus 254 -----~~~~~~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 294 (321)
T 2c30_A 254 -----RDSPPPK--LKNSHKVSPVLRDFLERMLVRDPQERATAQELLD 294 (321)
T ss_dssp -----HHSSCCC--CTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred -----hcCCCCC--cCccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0000000 1112344567999999999999999999999987
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-46 Score=326.62 Aligned_cols=273 Identities=22% Similarity=0.288 Sum_probs=203.1
Q ss_pred CCCCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEE
Q 020641 14 APSPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYC 93 (323)
Q Consensus 14 ~~~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 93 (323)
...|.....||+|+||.||+|++..+++.+|+|++....... ......+.+|+.++++++||||+++++++
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---------~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 81 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARD---------PSFYLRFRREAQNAAALNHPAIVAVYDTG 81 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTS---------HHHHHHHHHHHTTCCCCCCTTBCCEEEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCC---------HHHHHHHHHHHHHHHcCCCCCcceEEEee
Confidence 445667779999999999999999999999999775432111 12235688999999999999999999998
Q ss_pred EeCC----eEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEE
Q 020641 94 VEGN----LRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLL 169 (323)
Q Consensus 94 ~~~~----~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili 169 (323)
.... ..++||||+++++|.+++..... +++..++.++.|++.||.|||++ |++|+||||+||++
T Consensus 82 ~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~---------~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~ 149 (311)
T 3ork_A 82 EAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---------MTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMI 149 (311)
T ss_dssp EEEETTEEEEEEEEECCCEEEHHHHHHHHCS---------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEE
T ss_pred eccCCCCcccEEEEecCCCCCHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEE
Confidence 7654 34999999999999999976532 89999999999999999999999 99999999999999
Q ss_pred ccCCeEEEeeccccCCCCccccc-cccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccch
Q 020641 170 FEDFKAKIADFNLSNQAPDMAAR-LHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQS 248 (323)
Q Consensus 170 ~~~~~~~l~Dfg~~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~ 248 (323)
+.++.++|+|||++......... .......|++.|+|||.+.+..++.++||||||+++|+|++|+.||..........
T Consensus 150 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~ 229 (311)
T 3ork_A 150 SATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAY 229 (311)
T ss_dssp ETTSCEEECCCSCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred cCCCCEEEeeccCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence 99999999999999765443221 12233458999999999999999999999999999999999999997553211110
Q ss_pred hhhhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCC-hHHHHHHHhhhhcCCCCCCCC
Q 020641 249 LVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPN-MSIVVKALQPLLKSPPPAAPV 320 (323)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps-~~evl~~l~~~~~~~~~~~~~ 320 (323)
......... . .......+.++.+++.+||+.||++||+ ++++...+.++....++.+|.
T Consensus 230 --~~~~~~~~~---~--------~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~~~~~~~~ 289 (311)
T 3ork_A 230 --QHVREDPIP---P--------SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNGEPPEAPK 289 (311)
T ss_dssp --HHHHCCCCC---H--------HHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHTTCCCSSCC
T ss_pred --HHhcCCCCC---c--------ccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhcCCCCCCCc
Confidence 000000000 0 0001224567999999999999999995 555667777777666655544
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=316.62 Aligned_cols=254 Identities=26% Similarity=0.391 Sum_probs=194.8
Q ss_pred CCCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEE
Q 020641 15 PSPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCV 94 (323)
Q Consensus 15 ~~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 94 (323)
..+....+||+|+||.||++.+. ++.+++|+...... .......+.+.+|+++++.++||||+++++++.
T Consensus 7 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~--------~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 76 (271)
T 3dtc_A 7 AELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPD--------EDISQTIENVRQEAKLFAMLKHPNIIALRGVCL 76 (271)
T ss_dssp TSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC------------------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred hheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCc--------ccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEe
Confidence 34566669999999999999975 66788886653211 111234577899999999999999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC---ceeCCCCCCCEEEcc
Q 020641 95 EGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPS---IIHRDIRSSNVLLFE 171 (323)
Q Consensus 95 ~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~---i~h~dikp~nili~~ 171 (323)
.++..++||||+.+++|.+++.... +++..++.++.|++.|+.|||+. | ++|+||||+||+++.
T Consensus 77 ~~~~~~lv~e~~~~~~L~~~~~~~~----------~~~~~~~~i~~~l~~~l~~lH~~---~~~~i~H~dikp~Nil~~~ 143 (271)
T 3dtc_A 77 KEPNLCLVMEFARGGPLNRVLSGKR----------IPPDILVNWAVQIARGMNYLHDE---AIVPIIHRDLKSSNILILQ 143 (271)
T ss_dssp CC--CEEEEECCTTEEHHHHHTSSC----------CCHHHHHHHHHHHHHHHHHHHHS---SSSCCCCSCCSGGGEEESS
T ss_pred cCCceEEEEEcCCCCCHHHHhhcCC----------CCHHHHHHHHHHHHHHHHHHHhC---CCCceeecCCchHHEEEec
Confidence 9999999999999999999996442 89999999999999999999999 8 899999999999986
Q ss_pred --------CCeEEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCC
Q 020641 172 --------DFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMP 243 (323)
Q Consensus 172 --------~~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 243 (323)
++.++|+|||++........ ....|++.|+|||.+.+..++.++||||||+++|+|++|+.||.....
T Consensus 144 ~~~~~~~~~~~~kl~Dfg~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~ 219 (271)
T 3dtc_A 144 KVENGDLSNKILKITDFGLAREWHRTTK----MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDG 219 (271)
T ss_dssp CCSSSCCSSCCEEECCCCC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCH
T ss_pred ccccccccCcceEEccCCcccccccccc----cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 67899999999976543322 233589999999999988899999999999999999999999975532
Q ss_pred cccchhhhhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhh
Q 020641 244 RGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPL 310 (323)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~ 310 (323)
... .............+...+..+.+++.+||+.||.+|||+.|+++.|+++
T Consensus 220 ~~~---------------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 220 LAV---------------AYGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp HHH---------------HHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred HHH---------------HHhhhcCCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 111 1111112222233455567899999999999999999999999999864
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=338.73 Aligned_cols=262 Identities=29% Similarity=0.413 Sum_probs=206.2
Q ss_pred cccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeCCe
Q 020641 19 YFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNL 98 (323)
Q Consensus 19 ~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 98 (323)
...+||+|+||.||++.+..+. .+|+|..... ....+.+.+|++++++++||||+++++++.. +.
T Consensus 188 ~~~~lG~G~fg~Vy~~~~~~~~-~vavK~~~~~-------------~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~ 252 (452)
T 1fmk_A 188 LEVKLGQGCFGEVWMGTWNGTT-RVAIKTLKPG-------------TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EP 252 (452)
T ss_dssp EEEEEEECSSCEEEEEEETTTE-EEEEEECCTT-------------SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred eeeeecCCCCeEEEEEEECCCc-eEEEEEeccC-------------CCCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-Cc
Confidence 3448999999999999987654 4777755422 1123678999999999999999999999876 56
Q ss_pred EEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEEEe
Q 020641 99 RVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIA 178 (323)
Q Consensus 99 ~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~l~ 178 (323)
.++||||+.+|+|.+++...... .+++..+..++.|++.||.|||++ |++||||||+||+++.++.+||+
T Consensus 253 ~~iv~e~~~~gsL~~~l~~~~~~-------~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~ 322 (452)
T 1fmk_A 253 IYIVTEYMSKGSLLDFLKGETGK-------YLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVA 322 (452)
T ss_dssp CEEEECCCTTCBHHHHHSHHHHT-------TCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEEC
T ss_pred eEEEehhhcCCCHHHHHHhcCCC-------CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEEC
Confidence 89999999999999999754222 288999999999999999999999 99999999999999999999999
Q ss_pred eccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccc
Q 020641 179 DFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPRL 257 (323)
Q Consensus 179 Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~ 257 (323)
|||++......... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||......
T Consensus 323 DfG~a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~------------- 388 (452)
T 1fmk_A 323 DFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR------------- 388 (452)
T ss_dssp CCCTTC---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-------------
T ss_pred CCccceecCCCcee-cccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHH-------------
Confidence 99999865432211 1222346788999999988899999999999999999999 99999754321
Q ss_pred cccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhhcCCCCCCCCCC
Q 020641 258 SEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSPPPAAPVSE 322 (323)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~~~~~~~~~~~~ 322 (323)
.+...+....+...+..++..+.++|.+||+.||++|||+.+|++.|+++.....+.....+
T Consensus 389 ---~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~~~~~~~~ 450 (452)
T 1fmk_A 389 ---EVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPGE 450 (452)
T ss_dssp ---HHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCCCCCCSC
T ss_pred ---HHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCCccccccc
Confidence 11112222223344556678899999999999999999999999999999988877655544
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=317.77 Aligned_cols=273 Identities=19% Similarity=0.204 Sum_probs=210.3
Q ss_pred CccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeC
Q 020641 17 PGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEG 96 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 96 (323)
|.....||+|+||+||+|.+..+++.+|+|++..... ....+.+.+|++++++++||||+++++++...
T Consensus 11 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 79 (319)
T 4euu_A 11 WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF-----------LRPVDVQMREFEVLKKLNHKNIVKLFAIEEET 79 (319)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG-----------GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECT
T ss_pred EEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccc-----------cchHHHHHHHHHHHHhcCCCCcceEEEEeecC
Confidence 4555589999999999999999999999997653211 12246678999999999999999999999876
Q ss_pred C--eEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEE----c
Q 020641 97 N--LRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLL----F 170 (323)
Q Consensus 97 ~--~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili----~ 170 (323)
. ..++||||+.+++|.+++....... .+++..++.++.|++.||.|||+. |++|+||||+||++ +
T Consensus 80 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~------~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~ 150 (319)
T 4euu_A 80 TTRHKVLIMEFCPCGSLYTVLEEPSNAY------GLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGED 150 (319)
T ss_dssp TTCCEEEEEECCTTCBHHHHHHSGGGTT------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTT
T ss_pred CCceEEEEEeCCCCCCHHHHHHHhcccc------CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCC
Confidence 5 7799999999999999998654221 289999999999999999999999 99999999999999 7
Q ss_pred cCCeEEEeeccccCCCCccccccccccccCccccCCCcccc--------CCCCCcccchHHHHHHHHHHHhCCCCCCCCC
Q 020641 171 EDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAM--------TGQLTQKSDVYSFGVVLLELLTGRKPVDHTM 242 (323)
Q Consensus 171 ~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~--------~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 242 (323)
.++.++|+|||++........ .....||+.|+|||++. +..++.++||||||+++|+|++|..||....
T Consensus 151 ~~~~~kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 227 (319)
T 4euu_A 151 GQSVYKLTDFGAARELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFE 227 (319)
T ss_dssp SCEEEEECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTT
T ss_pred CCceEEEccCCCceecCCCCc---eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 788899999999976544322 23345899999999886 5678899999999999999999999997544
Q ss_pred Ccccch-hhhhhcccccccc---cc-------hhc-CCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhh
Q 020641 243 PRGQQS-LVTWATPRLSEDK---VK-------QCV-DPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPL 310 (323)
Q Consensus 243 ~~~~~~-~~~~~~~~~~~~~---~~-------~~~-~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~ 310 (323)
...... .........+... +. .+. ............+..+.+++.+||+.||++|||+.|+++...+.
T Consensus 228 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~ 307 (319)
T 4euu_A 228 GPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (319)
T ss_dssp CGGGCHHHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred ccchhHHHHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence 322211 1110000000000 00 000 01112245678889999999999999999999999999988776
Q ss_pred hc
Q 020641 311 LK 312 (323)
Q Consensus 311 ~~ 312 (323)
.-
T Consensus 308 ~~ 309 (319)
T 4euu_A 308 LH 309 (319)
T ss_dssp TC
T ss_pred hh
Confidence 53
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-45 Score=317.15 Aligned_cols=261 Identities=25% Similarity=0.392 Sum_probs=190.7
Q ss_pred CccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeC
Q 020641 17 PGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEG 96 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 96 (323)
+....+||+|+||+||++++... +++|+...... .....+.+.+|+.++++++|+||+++++++ ..
T Consensus 26 y~~~~~lG~G~~g~Vy~~~~~~~---vavK~~~~~~~----------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~ 91 (289)
T 3og7_A 26 ITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAP----------TPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TA 91 (289)
T ss_dssp CEEEEEEEECSSEEEEEEESSSE---EEEEEESCSSC----------CHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CS
T ss_pred eeeeeEecCCCCeEEEEEEEcCc---eEEEEEeccCC----------CHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cC
Confidence 44455899999999999987553 67775542211 112236788999999999999999999965 45
Q ss_pred CeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEE
Q 020641 97 NLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAK 176 (323)
Q Consensus 97 ~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~ 176 (323)
...++||||+.+++|.+++...... +++..++.++.|++.||.|||+. |++|+||||+||+++.++.++
T Consensus 92 ~~~~lv~e~~~~~~L~~~l~~~~~~--------~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~k 160 (289)
T 3og7_A 92 PQLAIVTQWCEGSSLYHHLHASETK--------FEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVK 160 (289)
T ss_dssp SSCEEEEECCCEEEHHHHHTTC-----------CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEE
T ss_pred CccEEEEEecCCCcHHHHHhhccCC--------CCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEE
Confidence 5679999999999999999654332 89999999999999999999999 999999999999999999999
Q ss_pred EeeccccCCCCccccccccccccCccccCCCcccc---CCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhh
Q 020641 177 IADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAM---TGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWA 253 (323)
Q Consensus 177 l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 253 (323)
|+|||++................|++.|+|||.+. +..++.++||||||+++|+|++|+.||......... ....
T Consensus 161 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~--~~~~ 238 (289)
T 3og7_A 161 IGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI--IEMV 238 (289)
T ss_dssp ECCCC------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHH--HHHH
T ss_pred EccceeccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHH--HHHh
Confidence 99999987654433333334456899999999886 566788999999999999999999999765432111 1100
Q ss_pred cccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhhcC
Q 020641 254 TPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKS 313 (323)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~~~ 313 (323)
.... ..+. .......++..+.+++.+||+.||.+|||+.++++.|+++.++
T Consensus 239 ~~~~--------~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~e 289 (289)
T 3og7_A 239 GRGS--------LSPD-LSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELARE 289 (289)
T ss_dssp HHTS--------CCCC-TTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTCC
T ss_pred cccc--------cCcc-hhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhhC
Confidence 0000 0000 1112334567899999999999999999999999999998763
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=315.70 Aligned_cols=255 Identities=20% Similarity=0.315 Sum_probs=204.2
Q ss_pred CCCCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEE
Q 020641 14 APSPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYC 93 (323)
Q Consensus 14 ~~~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 93 (323)
...|....+||+|+||.||++++. ++.+++|+....... ....+.+.+|+.++++++||||+++++++
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~----------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 76 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWS----------TRKSRDFNEECPRLRIFSHPNVLPVLGAC 76 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCC----------HHHHHHHHHHGGGGCCCSCTTEECEEEEE
T ss_pred HHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccC----------HHHHHHHHHHHHHHHhcCCCchhheEEEE
Confidence 345666679999999999999985 666888866533111 11235688999999999999999999999
Q ss_pred EeC--CeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC--ceeCCCCCCCEEE
Q 020641 94 VEG--NLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPS--IIHRDIRSSNVLL 169 (323)
Q Consensus 94 ~~~--~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~--i~h~dikp~nili 169 (323)
... ...++||||+.+++|.+++...... .+++..++.++.|++.||.|||+. | ++|+||||+||++
T Consensus 77 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-------~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~ 146 (271)
T 3kmu_A 77 QSPPAPHPTLITHWMPYGSLYNVLHEGTNF-------VVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMI 146 (271)
T ss_dssp CTTTSSSCEEEEECCTTCBHHHHHHSCSSC-------CCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEE
T ss_pred ccCCCCCeEeeecccCCCcHHHHHhhcccC-------CCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEE
Confidence 877 7789999999999999999875432 289999999999999999999999 9 9999999999999
Q ss_pred ccCCeEEEeeccccCCCCccccccccccccCccccCCCccccCCCCCc---ccchHHHHHHHHHHHhCCCCCCCCCCccc
Q 020641 170 FEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQ---KSDVYSFGVVLLELLTGRKPVDHTMPRGQ 246 (323)
Q Consensus 170 ~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~---~~Di~slG~~l~~l~~g~~pf~~~~~~~~ 246 (323)
+.++.++++|||.+..... ....||+.|+|||.+.+..++. ++||||||+++|+|++|+.||........
T Consensus 147 ~~~~~~~l~~~~~~~~~~~-------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~ 219 (271)
T 3kmu_A 147 DEDMTARISMADVKFSFQS-------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEI 219 (271)
T ss_dssp CTTSCEEEEGGGSCCTTSC-------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHH
T ss_pred cCCcceeEEeccceeeecc-------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHH
Confidence 9999999999988754322 2234789999999998765544 79999999999999999999975532111
Q ss_pred chhhhhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhhc
Q 020641 247 QSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLK 312 (323)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~~ 312 (323)
.............+...+..+.+++.+||+.||++|||+.++++.|+++.+
T Consensus 220 ---------------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 220 ---------------GMKVALEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp ---------------HHHHHHSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred ---------------HHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 111111222233445566789999999999999999999999999998865
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-46 Score=330.38 Aligned_cols=251 Identities=19% Similarity=0.227 Sum_probs=202.0
Q ss_pred CCCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcC-CCCcccceeeEE
Q 020641 15 PSPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRL-KHENLVELLGYC 93 (323)
Q Consensus 15 ~~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~ 93 (323)
..|.....||+|+||.||+|++..+++.+|+|++.+..... ....+.+.+|..+++.+ +||||+++++++
T Consensus 23 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~---------~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~ 93 (353)
T 3txo_A 23 DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQ---------DDDVECTMTEKRILSLARNHPFLTQLFCCF 93 (353)
T ss_dssp CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHH---------HTTHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred hheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcc---------hhHHHHHHHHHHHHHhccCCCceeeEEEEE
Confidence 34566679999999999999999999999999876432111 12346678899999988 799999999999
Q ss_pred EeCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCC
Q 020641 94 VEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDF 173 (323)
Q Consensus 94 ~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~ 173 (323)
.+.+..|+||||+.+|+|.+++..... +++..+..++.||+.||.|||+. ||+||||||+|||++.++
T Consensus 94 ~~~~~~~lv~E~~~gg~L~~~l~~~~~---------~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g 161 (353)
T 3txo_A 94 QTPDRLFFVMEFVNGGDLMFHIQKSRR---------FDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEG 161 (353)
T ss_dssp ECSSEEEEEEECCCSCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTS
T ss_pred EeCCEEEEEEeCCCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCC
Confidence 999999999999999999999976542 89999999999999999999999 999999999999999999
Q ss_pred eEEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhh
Q 020641 174 KAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWA 253 (323)
Q Consensus 174 ~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 253 (323)
.++|+|||++........ ......||+.|+|||++.+..++.++|||||||++|+|++|..||.........
T Consensus 162 ~ikL~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~------ 233 (353)
T 3txo_A 162 HCKLADFGMCKEGICNGV--TTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLF------ 233 (353)
T ss_dssp CEEECCCTTCBCSCC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH------
T ss_pred CEEEccccceeecccCCc--cccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHH------
Confidence 999999999875432221 223456899999999998888999999999999999999999999765432111
Q ss_pred cccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCCh------HHHHH
Q 020641 254 TPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNM------SIVVK 305 (323)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~------~evl~ 305 (323)
..+.... ...+...+..+.+++.+||+.||.+||++ .|+++
T Consensus 234 ---------~~i~~~~--~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 234 ---------EAILNDE--VVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp ---------HHHHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred ---------HHHHcCC--CCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 1111111 12234456779999999999999999998 77765
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=317.71 Aligned_cols=274 Identities=20% Similarity=0.250 Sum_probs=195.8
Q ss_pred CCCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEE
Q 020641 15 PSPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCV 94 (323)
Q Consensus 15 ~~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 94 (323)
..|....+||+|+||.||+|.+..+++.+|+|+..... .......+.+|++++++++||||+++++++.
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----------~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 73 (317)
T 2pmi_A 5 SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDS-----------EEGTPSTAIREISLMKELKHENIVRLYDVIH 73 (317)
T ss_dssp --------------CEEEEEECSSSCCEEEEEEEECCS-----------TTCSCHHHHHHHHHHTTCCBTTBCCEEEEEC
T ss_pred cceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccc-----------ccccHHHHHHHHHHHHhcCCCCcceEEEEEE
Confidence 35677779999999999999999999999999764321 2233467889999999999999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCe
Q 020641 95 EGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFK 174 (323)
Q Consensus 95 ~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~ 174 (323)
.++..++||||+.+ +|.+++....... ....+++..+..++.|++.||.|||+. |++|+||||+||+++.++.
T Consensus 74 ~~~~~~lv~e~~~~-~L~~~l~~~~~~~---~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~ 146 (317)
T 2pmi_A 74 TENKLTLVFEFMDN-DLKKYMDSRTVGN---TPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQ 146 (317)
T ss_dssp CTTEEEEEEECCCC-BHHHHHHHHHSSS---CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCC
T ss_pred ECCeEEEEEEecCC-CHHHHHHhccccc---cccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCC
Confidence 99999999999985 9999986543211 111288999999999999999999999 9999999999999999999
Q ss_pred EEEeeccccCCCCccccccccccccCccccCCCccccCC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhh
Q 020641 175 AKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG-QLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWA 253 (323)
Q Consensus 175 ~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 253 (323)
++|+|||++........ ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||...........+...
T Consensus 147 ~kl~Dfg~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~ 224 (317)
T 2pmi_A 147 LKLGDFGLARAFGIPVN--TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDI 224 (317)
T ss_dssp EEECCCSSCEETTSCCC--CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred EEECcCccceecCCCcc--cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Confidence 99999999876543221 12334589999999998764 6899999999999999999999999865432211111100
Q ss_pred cccccc---------------------cccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH--HHhhh
Q 020641 254 TPRLSE---------------------DKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK--ALQPL 310 (323)
Q Consensus 254 ~~~~~~---------------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~--~l~~~ 310 (323)
...... ..+.+.+.+. .....+..+.+|+.+||+.||++|||+.|+++ ++.+.
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 300 (317)
T 2pmi_A 225 MGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPH----TKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEY 300 (317)
T ss_dssp HCSCCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGG----CSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGG
T ss_pred hCCCChhHhhhhhhhhhcccccccccchhHHHhhccc----ccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcc
Confidence 000000 0000111111 11134567999999999999999999999997 34444
Q ss_pred hc
Q 020641 311 LK 312 (323)
Q Consensus 311 ~~ 312 (323)
..
T Consensus 301 ~~ 302 (317)
T 2pmi_A 301 YH 302 (317)
T ss_dssp CC
T ss_pred cc
Confidence 43
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=317.24 Aligned_cols=258 Identities=23% Similarity=0.294 Sum_probs=194.0
Q ss_pred CCccccccCCCCCCccceecccee---eeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeE
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRVKM---RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGY 92 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~~~---~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 92 (323)
.|.....||+|+||.||++.+..+ +..+++|..... ......+.+.+|+.++++++||||++++++
T Consensus 16 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~-----------~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 84 (281)
T 1mp8_A 16 RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC-----------TSDSVREKFLQEALTMRQFDHPHIVKLIGV 84 (281)
T ss_dssp GEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT-----------TSHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred HeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEecccc-----------CCHHHHHHHHHHHHHHHhCCCCccceEEEE
Confidence 344455899999999999998654 445777754321 111223678899999999999999999999
Q ss_pred EEeCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccC
Q 020641 93 CVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFED 172 (323)
Q Consensus 93 ~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~ 172 (323)
+. .+..++||||+.+++|.+++...... +++..++.++.|++.||.|||+. |++|+||||+||+++.+
T Consensus 85 ~~-~~~~~lv~e~~~~~~L~~~l~~~~~~--------~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~ 152 (281)
T 1mp8_A 85 IT-ENPVWIIMELCTLGELRSFLQVRKYS--------LDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSN 152 (281)
T ss_dssp EC-SSSCEEEEECCTTEEHHHHHHHTTTT--------SCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEET
T ss_pred Ec-cCccEEEEecCCCCCHHHHHHhcCCC--------CCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCC
Confidence 85 45679999999999999999765322 89999999999999999999999 99999999999999999
Q ss_pred CeEEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccchhhh
Q 020641 173 FKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVT 251 (323)
Q Consensus 173 ~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~ 251 (323)
+.++|+|||++......... ......+++.|+|||.+.+..++.++||||||+++|+|++ |..||.........
T Consensus 153 ~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~---- 227 (281)
T 1mp8_A 153 DCVKLGDFGLSRYMEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI---- 227 (281)
T ss_dssp TEEEECC--------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH----
T ss_pred CCEEECccccccccCccccc-ccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHH----
Confidence 99999999999766543221 1223346788999999988899999999999999999997 99999765432111
Q ss_pred hhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhhcC
Q 020641 252 WATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKS 313 (323)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~~~ 313 (323)
..+........+...+..+.+++.+||+.||.+|||+.|+++.|+++++.
T Consensus 228 ------------~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 277 (281)
T 1mp8_A 228 ------------GRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 277 (281)
T ss_dssp ------------HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ------------HHHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 11111111223445667899999999999999999999999999998753
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=314.96 Aligned_cols=270 Identities=33% Similarity=0.495 Sum_probs=210.4
Q ss_pred cccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeCCeEE
Q 020641 21 VRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRV 100 (323)
Q Consensus 21 ~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 100 (323)
.+||+|+||.||++.+ +++.+++|+...... .......+.+.+|+.++++++||||+++++++...+..+
T Consensus 37 ~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~--------~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 106 (307)
T 2nru_A 37 NKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVD--------ITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLC 106 (307)
T ss_dssp CEEEECSSEEEEEEES--SSCEEEEEEECCCTT--------SCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred CccccCCCeEEEEEEE--CCceEEEEEEecccC--------cchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceE
Confidence 5799999999999987 466778876543211 112334577899999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEEEeec
Q 020641 101 LAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADF 180 (323)
Q Consensus 101 lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~l~Df 180 (323)
+||||+.+++|.+++...... ..+++..+..++.|++.||.|||+. |++|+||||+||+++.++.++|+||
T Consensus 107 lv~e~~~~~~L~~~l~~~~~~------~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Df 177 (307)
T 2nru_A 107 LVYVYMPNGSLLDRLSCLDGT------PPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDF 177 (307)
T ss_dssp EEEECCTTCBHHHHHHTGGGC------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCC
T ss_pred EEEEecCCCcHHHHHHhccCC------CCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEcCCCcEEEeec
Confidence 999999999999999754321 1289999999999999999999999 9999999999999999999999999
Q ss_pred cccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhccccccc
Q 020641 181 NLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSED 260 (323)
Q Consensus 181 g~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 260 (323)
|++................|++.|+|||.+.+ .++.++||||||+++|+|++|..||................ .....
T Consensus 178 g~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~ 255 (307)
T 2nru_A 178 GLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEI-EDEEK 255 (307)
T ss_dssp TTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHH-HTTSC
T ss_pred ccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHh-hhhhh
Confidence 99876544333222344568999999998765 57899999999999999999999998654322211111000 00112
Q ss_pred ccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhhc
Q 020641 261 KVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLK 312 (323)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~~ 312 (323)
.+...+++.. ...+...+..+.+++.+||+.||.+|||+.++++.|+++..
T Consensus 256 ~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 256 TIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306 (307)
T ss_dssp CHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred hhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence 2333344333 34567788999999999999999999999999999998854
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-46 Score=327.72 Aligned_cols=276 Identities=24% Similarity=0.319 Sum_probs=210.5
Q ss_pred cccccCCCCCCccce----eccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEE
Q 020641 19 YFVRLDKGPEDDLYL----KKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCV 94 (323)
Q Consensus 19 ~~~~lg~G~~~~V~~----~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 94 (323)
...+||+|+||+||+ +.+..+++.+|+|+..... .....+.+.+|++++++++||||+++++++.
T Consensus 35 ~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-----------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 103 (318)
T 3lxp_A 35 KIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA-----------GPQHRSGWKQEIDILRTLYHEHIIKYKGCCE 103 (318)
T ss_dssp EEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTC-----------CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred hhheecCCCCeEEEEEEEccCCCCCCcEEEEEEecccc-----------ChHHHHHHHHHHHHHHhCCCcchhhEEEEEe
Confidence 335899999999955 4566788999999765321 1122366889999999999999999999998
Q ss_pred eC--CeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccC
Q 020641 95 EG--NLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFED 172 (323)
Q Consensus 95 ~~--~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~ 172 (323)
.. ...++||||+.+++|.+++.... +++..++.++.|++.||.+||+. |++|+||||+||+++.+
T Consensus 104 ~~~~~~~~lv~e~~~~~~L~~~l~~~~----------~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~ 170 (318)
T 3lxp_A 104 DAGAASLQLVMEYVPLGSLRDYLPRHS----------IGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDND 170 (318)
T ss_dssp ETTTTEEEEEECCCTTCBHHHHGGGSC----------CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTT
T ss_pred cCCCceEEEEEecccCCcHHHHHhhCC----------CCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCC
Confidence 74 67899999999999999997654 88999999999999999999999 99999999999999999
Q ss_pred CeEEEeeccccCCCCccccc-cccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhh
Q 020641 173 FKAKIADFNLSNQAPDMAAR-LHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVT 251 (323)
Q Consensus 173 ~~~~l~Dfg~~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~ 251 (323)
+.++|+|||++......... .......++..|+|||.+.+..++.++||||||+++|+|++|..||......... ...
T Consensus 171 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~-~~~ 249 (318)
T 3lxp_A 171 RLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLE-LIG 249 (318)
T ss_dssp CCEEECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHH-HHC
T ss_pred CCEEECCccccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhh-hhc
Confidence 99999999999766543221 1223344788899999999888999999999999999999999998643211000 000
Q ss_pred hhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhhcCCCCCCC
Q 020641 252 WATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSPPPAAP 319 (323)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~~~~~~~~~ 319 (323)
+.........+.+.+........+..++..+.+++.+||+.||.+|||+.|+++.|+.+.+....++|
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~~~p 317 (318)
T 3lxp_A 250 IAQGQMTVLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQGQAP 317 (318)
T ss_dssp SCCHHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHC---
T ss_pred ccccchhHHHHHHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhccCCC
Confidence 00001111122333333444445566778899999999999999999999999999999877666555
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=316.08 Aligned_cols=270 Identities=20% Similarity=0.237 Sum_probs=202.8
Q ss_pred CCCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcC---CCCcccceee
Q 020641 15 PSPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRL---KHENLVELLG 91 (323)
Q Consensus 15 ~~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~~i~~~~~ 91 (323)
..|....+||+|+||+||+|++..+++.+|+|+........ ........+.+|+.+++.+ +||||+++++
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-------~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~ 81 (308)
T 3g33_A 9 SRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGG-------GGGGLPISTVREVALLRRLEAFEHPNVVRLMD 81 (308)
T ss_dssp -CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCT-------TSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEE
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccc-------cccccchhHHHHHHHHHHHhhcCCCCeEEeee
Confidence 45667779999999999999999999999999775432211 1223345667777777666 4999999999
Q ss_pred EEEeCC-----eEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCC
Q 020641 92 YCVEGN-----LRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSN 166 (323)
Q Consensus 92 ~~~~~~-----~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~n 166 (323)
++.... ..++||||+.+ +|.+++....... +++..+..++.|++.||.|||+. |++|+||||+|
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~~~~~-------~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~N 150 (308)
T 3g33_A 82 VCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPG-------LPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPEN 150 (308)
T ss_dssp EEEECCSSSEEEEEEEEECCCC-BHHHHHHTCCTTC-------SCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTT
T ss_pred eeeccCCCCceeEEEEehhhhc-CHHHHHhhccCCC-------CCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHH
Confidence 998765 57999999975 9999998765332 89999999999999999999999 99999999999
Q ss_pred EEEccCCeEEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccc
Q 020641 167 VLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQ 246 (323)
Q Consensus 167 ili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~ 246 (323)
|+++.++.++|+|||++........ .....||+.|+|||.+.+..++.++||||||+++|+|++|+.||........
T Consensus 151 il~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~ 227 (308)
T 3g33_A 151 ILVTSGGTVKLADFGLARIYSYQMA---LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQ 227 (308)
T ss_dssp EEECTTSCEEECSCSCTTTSTTCCC---SGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHH
T ss_pred EEEcCCCCEEEeeCccccccCCCcc---cCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 9999999999999999976543222 2334589999999999999999999999999999999999999976543222
Q ss_pred chhhhhhcccccccccchhcC---CCcC--C-----CCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 247 QSLVTWATPRLSEDKVKQCVD---PKLK--G-----EYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~---~~~~--~-----~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
...+................. .... . ......+..+.+++.+||+.||++|||+.|+++
T Consensus 228 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 228 LGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp HHHHHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 111111111111111100000 0000 0 011234567999999999999999999999987
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-45 Score=325.35 Aligned_cols=248 Identities=16% Similarity=0.170 Sum_probs=205.4
Q ss_pred CCCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEE
Q 020641 15 PSPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCV 94 (323)
Q Consensus 15 ~~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 94 (323)
..|.....||+|+||.||+|++..+++.+|+|++.+.... .....+.+.+|+.+++.++||||+++++++.
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~---------~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 111 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVV---------KLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 111 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH---------HTTCHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhc---------cHHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence 3456666999999999999999999999999987543211 1223467889999999999999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCe
Q 020641 95 EGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFK 174 (323)
Q Consensus 95 ~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~ 174 (323)
+....|+||||+.+|+|.+++..... +++..+..++.||+.||.|||+. ||+||||||+||+++.++.
T Consensus 112 ~~~~~~lv~e~~~gg~L~~~l~~~~~---------~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~ 179 (350)
T 1rdq_E 112 DNSNLYMVMEYVAGGEMFSHLRRIGR---------FSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGY 179 (350)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHHCC---------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSC
T ss_pred cCCEEEEEEcCCCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCC
Confidence 99999999999999999999976532 89999999999999999999999 9999999999999999999
Q ss_pred EEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhc
Q 020641 175 AKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWAT 254 (323)
Q Consensus 175 ~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~ 254 (323)
++|+|||++...... .....||+.|+|||++.+..++.++|+||||+++|+|++|..||.........
T Consensus 180 ~kL~DFg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~------- 247 (350)
T 1rdq_E 180 IQVTDFGFAKRVKGR-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIY------- 247 (350)
T ss_dssp EEECCCTTCEECSSC-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-------
T ss_pred EEEcccccceeccCC-----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHH-------
Confidence 999999998765432 23346899999999999999999999999999999999999999755321111
Q ss_pred ccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCC-----hHHHHH
Q 020641 255 PRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPN-----MSIVVK 305 (323)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps-----~~evl~ 305 (323)
..+.... ...+...+..+.++|.+||+.||.+||+ ++||++
T Consensus 248 --------~~i~~~~--~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 248 --------EKIVSGK--VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp --------HHHHHCC--CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred --------HHHHcCC--CCCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 1111111 1223445677999999999999999998 888875
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-45 Score=325.83 Aligned_cols=256 Identities=21% Similarity=0.228 Sum_probs=201.2
Q ss_pred CccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeC
Q 020641 17 PGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEG 96 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 96 (323)
|.....||+|+||.||+|.+..+++.+|+|++....... ......+.+.+|+.+++.++||||+++++++...
T Consensus 26 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-------~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 98 (351)
T 3c0i_A 26 YELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTS-------SPGLSTEDLKREASICHMLKHPHIVELLETYSSD 98 (351)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHT-------SSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred eEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccc-------cccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeC
Confidence 444558999999999999999999999999775432211 1122347789999999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCe--
Q 020641 97 NLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFK-- 174 (323)
Q Consensus 97 ~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~-- 174 (323)
+..|+||||+.+++|.+.+...... ...+++..+..++.||+.||.|||++ |++||||||+||+++.++.
T Consensus 99 ~~~~lv~e~~~g~~L~~~l~~~~~~-----~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~ 170 (351)
T 3c0i_A 99 GMLYMVFEFMDGADLCFEIVKRADA-----GFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSA 170 (351)
T ss_dssp TEEEEEEECCSSCBHHHHHHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTC
T ss_pred CEEEEEEeCCCCCCHHHHHHHhccc-----CCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCC
Confidence 9999999999999999888654211 11288999999999999999999999 9999999999999987654
Q ss_pred -EEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhh
Q 020641 175 -AKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWA 253 (323)
Q Consensus 175 -~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 253 (323)
++|+|||++........ ......||+.|+|||++.+..++.++|||||||++|+|++|..||..... ....
T Consensus 171 ~vkl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~----~~~~-- 242 (351)
T 3c0i_A 171 PVKLGGFGVAIQLGESGL--VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE----RLFE-- 242 (351)
T ss_dssp CEEECCCTTCEECCTTSC--BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH----HHHH--
T ss_pred cEEEecCcceeEecCCCe--eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH----HHHH--
Confidence 99999999976544221 12344689999999999988999999999999999999999999975321 0000
Q ss_pred cccccccccchhcCCCcCCC--CCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 254 TPRLSEDKVKQCVDPKLKGE--YPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
.+........ .....+..+.+++.+||+.||++|||+.|+++
T Consensus 243 ----------~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 243 ----------GIIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp ----------HHHHTCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ----------HHHcCCCCCCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0000000000 00123567999999999999999999999986
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-45 Score=329.13 Aligned_cols=271 Identities=15% Similarity=0.199 Sum_probs=204.1
Q ss_pred CCCCCccccccCCC--CCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCccccee
Q 020641 13 HAPSPGYFVRLDKG--PEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELL 90 (323)
Q Consensus 13 ~~~~~~~~~~lg~G--~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~ 90 (323)
....|+...+||+| +||.||+|++..+++.+|+|++....... ...+.+.+|+.+++.++||||++++
T Consensus 23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~----------~~~~~~~~E~~~l~~l~h~niv~~~ 92 (389)
T 3gni_B 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSN----------EMVTFLQGELHVSKLFNHPNIVPYR 92 (389)
T ss_dssp CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCH----------HHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccCh----------HHHHHHHHHHHHHHhCCCCCCCcEe
Confidence 33456666799999 99999999999999999999876442221 2236778899999999999999999
Q ss_pred eEEEeCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEc
Q 020641 91 GYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLF 170 (323)
Q Consensus 91 ~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~ 170 (323)
+++...+..++||||+.+++|.+++....... +++..+..++.||+.||.|||+. ||+||||||+||+++
T Consensus 93 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~-------~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~ 162 (389)
T 3gni_B 93 ATFIADNELWVVTSFMAYGSAKDLICTHFMDG-------MNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILIS 162 (389)
T ss_dssp EEEEETTEEEEEEECCTTCBHHHHHHHTCTTC-------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEC
T ss_pred EEEEECCEEEEEEEccCCCCHHHHHhhhcccC-------CCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEc
Confidence 99999999999999999999999997653322 89999999999999999999999 999999999999999
Q ss_pred cCCeEEEeeccccCCCCccccc-----cccccccCccccCCCccccC--CCCCcccchHHHHHHHHHHHhCCCCCCCCCC
Q 020641 171 EDFKAKIADFNLSNQAPDMAAR-----LHSTRVLGTFGYHAPEYAMT--GQLTQKSDVYSFGVVLLELLTGRKPVDHTMP 243 (323)
Q Consensus 171 ~~~~~~l~Dfg~~~~~~~~~~~-----~~~~~~~g~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 243 (323)
.++.++|+|||.+......... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.....
T Consensus 163 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~ 242 (389)
T 3gni_B 163 VDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPA 242 (389)
T ss_dssp TTCCEEECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCS
T ss_pred CCCCEEEcccccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCH
Confidence 9999999999987654322111 11122358899999999987 5789999999999999999999999976543
Q ss_pred cccchhhhhhccccc---------ccc-------------cchhcC---------CCcCCCCCHHHHHHHHHHHHHccCC
Q 020641 244 RGQQSLVTWATPRLS---------EDK-------------VKQCVD---------PKLKGEYPPKGVAKLAAVAALCVQY 292 (323)
Q Consensus 244 ~~~~~~~~~~~~~~~---------~~~-------------~~~~~~---------~~~~~~~~~~~~~~l~~li~~cl~~ 292 (323)
....... ...... ... ....+. .......+...+..+.+|+.+||+.
T Consensus 243 ~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~ 320 (389)
T 3gni_B 243 TQMLLEK--LNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQR 320 (389)
T ss_dssp TTHHHHC----------------------------------------------------------CCHHHHHHHHHHTCS
T ss_pred HHHHHHH--hcCCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhc
Confidence 2211100 000000 000 000000 0000112334567899999999999
Q ss_pred CCCCCCChHHHHH
Q 020641 293 EAEFRPNMSIVVK 305 (323)
Q Consensus 293 ~P~~Rps~~evl~ 305 (323)
||.+|||+.|+++
T Consensus 321 dP~~Rpta~ell~ 333 (389)
T 3gni_B 321 NPDARPSASTLLN 333 (389)
T ss_dssp CTTTSCCHHHHTT
T ss_pred CcccCCCHHHHhc
Confidence 9999999999985
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-45 Score=318.93 Aligned_cols=266 Identities=22% Similarity=0.268 Sum_probs=197.2
Q ss_pred ccccccCCCCCCccceeccce---eeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEE
Q 020641 18 GYFVRLDKGPEDDLYLKKRVK---MRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCV 94 (323)
Q Consensus 18 ~~~~~lg~G~~~~V~~~~~~~---~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 94 (323)
.....||+|+||.||+|.+.. +++.+|+|........ ....+.+.+|+.++++++||||+++++++.
T Consensus 37 ~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~----------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 106 (313)
T 3brb_A 37 ILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSS----------QREIEEFLSEAACMKDFSHPNVIRLLGVCI 106 (313)
T ss_dssp EEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCC----------HHHHHHHHHHHHHHHTCCCTTBCCCCEEEE
T ss_pred eeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccc----------hhHHHHHHHHHHHHhcCCCCCeeeeeEEEe
Confidence 334479999999999997765 5668888866533211 112356889999999999999999999998
Q ss_pred eCC-----eEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEE
Q 020641 95 EGN-----LRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLL 169 (323)
Q Consensus 95 ~~~-----~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili 169 (323)
... ..++||||+.+++|.+++....... ....+++..++.++.|++.||.|||+. |++|+||||+||++
T Consensus 107 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli 180 (313)
T 3brb_A 107 EMSSQGIPKPMVILPFMKYGDLHTYLLYSRLET---GPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCML 180 (313)
T ss_dssp C-------CEEEEEECCTTCBHHHHHHHTTBTT---SCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEE
T ss_pred eccccCCcccEEEEecccCCCHHHHHHHhhhhc---CCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEE
Confidence 655 3499999999999999985432111 112389999999999999999999999 99999999999999
Q ss_pred ccCCeEEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccch
Q 020641 170 FEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQS 248 (323)
Q Consensus 170 ~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~ 248 (323)
+.++.++|+|||++................+++.|+|||.+.+..++.++||||||+++|+|++ |..||.........
T Consensus 181 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~- 259 (313)
T 3brb_A 181 RDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMY- 259 (313)
T ss_dssp CTTSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH-
T ss_pred cCCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHH-
Confidence 9999999999999976654332222333447889999999999899999999999999999999 89999755432111
Q ss_pred hhhhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhhcCCC
Q 020641 249 LVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSPP 315 (323)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~~~~~ 315 (323)
..+........+...+..+.+++.+||+.||.+|||+.++++.|+++++..|
T Consensus 260 ---------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~lp 311 (313)
T 3brb_A 260 ---------------DYLLHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLP 311 (313)
T ss_dssp ---------------HHHHTTCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred ---------------HHHHcCCCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence 1111111122334556789999999999999999999999999999987655
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-45 Score=318.92 Aligned_cols=273 Identities=18% Similarity=0.189 Sum_probs=202.1
Q ss_pred cccCCCCCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccce
Q 020641 10 LGAHAPSPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVEL 89 (323)
Q Consensus 10 ~~~~~~~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~ 89 (323)
.|.....|.....||+|+||.||++.+..+++.+++|+........ ....+.+.+|+.++++++||||+++
T Consensus 29 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~---------~~~~~~~~~e~~~l~~l~hp~iv~~ 99 (309)
T 2h34_A 29 EGTQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSD---------PVFRTRMQREARTAGRLQEPHVVPI 99 (309)
T ss_dssp -----CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGS---------HHHHHHHHHHHHHHTTCCCTTBCCE
T ss_pred CCcEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccC---------HHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 3444455667779999999999999999999999999775432111 1223678899999999999999999
Q ss_pred eeEEEeCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEE
Q 020641 90 LGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLL 169 (323)
Q Consensus 90 ~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili 169 (323)
++++...+..++||||+.+++|.+++..... +++..++.++.|++.||.|||+. |++|+||||+||++
T Consensus 100 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~ 167 (309)
T 2h34_A 100 HDFGEIDGQLYVDMRLINGVDLAAMLRRQGP---------LAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILV 167 (309)
T ss_dssp EEEEEETTEEEEEEECCCCEEHHHHHHHHCS---------CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEE
T ss_pred EEEEeeCCeEEEEEEecCCCCHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEE
Confidence 9999999999999999999999999976532 89999999999999999999999 99999999999999
Q ss_pred ccCCeEEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchh
Q 020641 170 FEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSL 249 (323)
Q Consensus 170 ~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~ 249 (323)
+.++.++|+|||++......... ......|++.|+|||.+.+..++.++||||||+++|+|++|..||....... .
T Consensus 168 ~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~ 243 (309)
T 2h34_A 168 SADDFAYLVDFGIASATTDEKLT-QLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSV---M 243 (309)
T ss_dssp CTTSCEEECSCCC-----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHH---H
T ss_pred cCCCCEEEecCccCccccccccc-cccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHH---H
Confidence 99999999999998765443211 1223458999999999998889999999999999999999999997543210 0
Q ss_pred hhhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCC-ChHHHHHHHhhhhcCCCCCC
Q 020641 250 VTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRP-NMSIVVKALQPLLKSPPPAA 318 (323)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-s~~evl~~l~~~~~~~~~~~ 318 (323)
......... .....+...+..+.+++.+||+.||++|| |++++++.|++++.......
T Consensus 244 ~~~~~~~~~-----------~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~~~~ 302 (309)
T 2h34_A 244 GAHINQAIP-----------RPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATADQDR 302 (309)
T ss_dssp HHHHHSCCC-----------CGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC------
T ss_pred HHHhccCCC-----------CccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhcccc
Confidence 000000000 00112234456799999999999999999 99999999999987765543
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-45 Score=322.79 Aligned_cols=259 Identities=19% Similarity=0.214 Sum_probs=203.7
Q ss_pred CCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcC-CCCcccceeeEEE
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRL-KHENLVELLGYCV 94 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~ 94 (323)
.|.....||+|+||.||+|++..+++.+|+|++.+...... .....+.+|..+++++ +||||+++++++.
T Consensus 10 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~---------~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~ 80 (345)
T 3a8x_A 10 DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDD---------EDIDWVQTEKHVFEQASNHPFLVGLHSCFQ 80 (345)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSH---------HHHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred heEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcch---------HHHHHHHHHHHHHHhcCCCCccCeEEEEEE
Confidence 45666799999999999999999999999998765432221 1235678899999888 8999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCe
Q 020641 95 EGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFK 174 (323)
Q Consensus 95 ~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~ 174 (323)
+.+..|+||||+.+|+|.+++..... +++..++.++.||+.||.|||+. ||+||||||+||+++.++.
T Consensus 81 ~~~~~~lv~e~~~gg~L~~~l~~~~~---------l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~ 148 (345)
T 3a8x_A 81 TESRLFFVIEYVNGGDLMFHMQRQRK---------LPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGH 148 (345)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSC
T ss_pred eCCEEEEEEeCCCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCC
Confidence 99999999999999999999976532 89999999999999999999999 9999999999999999999
Q ss_pred EEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhc
Q 020641 175 AKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWAT 254 (323)
Q Consensus 175 ~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~ 254 (323)
++|+|||++........ ......||+.|+|||++.+..++.++|+|||||++|+|++|..||............
T Consensus 149 ~kL~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~---- 222 (345)
T 3a8x_A 149 IKLTDYGMCKEGLRPGD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQN---- 222 (345)
T ss_dssp EEECCGGGCBCSCCTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-----------
T ss_pred EEEEeccccccccCCCC--cccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccc----
Confidence 99999999975432221 234456899999999999999999999999999999999999999753221110000
Q ss_pred ccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCCh------HHHHH
Q 020641 255 PRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNM------SIVVK 305 (323)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~------~evl~ 305 (323)
........+.... ...+...+..+.+++.+||+.||.+||++ .|+++
T Consensus 223 --~~~~~~~~i~~~~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~ 275 (345)
T 3a8x_A 223 --TEDYLFQVILEKQ--IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG 275 (345)
T ss_dssp --CHHHHHHHHHHCC--CCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHT
T ss_pred --cHHHHHHHHHcCC--CCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhc
Confidence 0000001111111 12344566789999999999999999996 56654
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=326.48 Aligned_cols=252 Identities=21% Similarity=0.222 Sum_probs=204.2
Q ss_pred CCCCCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcC-CCCcccceee
Q 020641 13 HAPSPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRL-KHENLVELLG 91 (323)
Q Consensus 13 ~~~~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~ 91 (323)
....|.....||+|+||.||+|++..+++.+|+|+..+.... .......+..|..++..+ +||||+++++
T Consensus 15 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~---------~~~~~~~~~~E~~il~~~~~hp~iv~l~~ 85 (345)
T 1xjd_A 15 KIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVL---------MDDDVECTMVEKRVLSLAWEHPFLTHMFC 85 (345)
T ss_dssp -CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHH---------HTTCHHHHHHHHHHHHHHTTCTTBCCEEE
T ss_pred ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhh---------hhhhHHHHHHHHHHHHhcCCCCCCCcEEE
Confidence 334566667999999999999999999999999977643211 122346678888888877 9999999999
Q ss_pred EEEeCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEcc
Q 020641 92 YCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFE 171 (323)
Q Consensus 92 ~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~ 171 (323)
++.+.+..|+||||+.+|+|.+++..... +++..+..++.||+.||.|||+. ||+||||||+||+++.
T Consensus 86 ~~~~~~~~~lv~E~~~gg~L~~~l~~~~~---------~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~ 153 (345)
T 1xjd_A 86 TFQTKENLFFVMEYLNGGDLMYHIQSCHK---------FDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDK 153 (345)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECT
T ss_pred EEEeCCEEEEEEeCCCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECC
Confidence 99999999999999999999999976432 89999999999999999999999 9999999999999999
Q ss_pred CCeEEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhh
Q 020641 172 DFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVT 251 (323)
Q Consensus 172 ~~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~ 251 (323)
++.++|+|||++........ ......||+.|+|||++.+..++.++|+||||+++|+|++|..||...........+
T Consensus 154 ~g~vkL~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i- 230 (345)
T 1xjd_A 154 DGHIKIADFGMCKENMLGDA--KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSI- 230 (345)
T ss_dssp TSCEEECCCTTCBCCCCTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH-
T ss_pred CCCEEEeEChhhhhcccCCC--cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHH-
Confidence 99999999999875432221 224456899999999999999999999999999999999999999755321111111
Q ss_pred hhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChH-HHH
Q 020641 252 WATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMS-IVV 304 (323)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~-evl 304 (323)
... ....+...+..+.+++.+||..||.+||++. +|+
T Consensus 231 --------------~~~--~~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 231 --------------RMD--NPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp --------------HHC--CCCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred --------------HhC--CCCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 000 0122334567799999999999999999997 665
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-45 Score=316.90 Aligned_cols=260 Identities=21% Similarity=0.270 Sum_probs=203.5
Q ss_pred cccCCCCCCccceeccceee---eeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeCC
Q 020641 21 VRLDKGPEDDLYLKKRVKMR---RWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGN 97 (323)
Q Consensus 21 ~~lg~G~~~~V~~~~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 97 (323)
.+||+|+||+||+|.+..++ ..+++|..... ......+.+.+|+.++++++||||+++++++...+
T Consensus 27 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~-----------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 95 (298)
T 3pls_A 27 RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI-----------TEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPE 95 (298)
T ss_dssp EEEEEETTEEEEEEEEECSSSCEEEEEEEEETTC-----------CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSS
T ss_pred ceeccCCCceEEEEEEecCCCceeeeeeeecccc-----------ccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCC
Confidence 57999999999999865543 36777755321 11112367889999999999999999999998766
Q ss_pred eE-EEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEE
Q 020641 98 LR-VLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAK 176 (323)
Q Consensus 98 ~~-~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~ 176 (323)
.. ++||||+.+++|.+++...... +++..++.++.|++.||.|||+. |++|+||||+||+++.++.++
T Consensus 96 ~~~~~v~e~~~~~~L~~~~~~~~~~--------~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~k 164 (298)
T 3pls_A 96 GLPHVLLPYMCHGDLLQFIRSPQRN--------PTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVK 164 (298)
T ss_dssp SCCEEEECCCTTCBHHHHHHCTTCC--------CBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEE
T ss_pred CCcEEEEecccCCCHHHHHhccccC--------CCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEE
Confidence 54 9999999999999999764332 88999999999999999999999 999999999999999999999
Q ss_pred EeeccccCCCCcccc--ccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhc
Q 020641 177 IADFNLSNQAPDMAA--RLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWAT 254 (323)
Q Consensus 177 l~Dfg~~~~~~~~~~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~ 254 (323)
|+|||++........ ........+++.|+|||.+.+..++.++||||||+++|+|++|..|+......
T Consensus 165 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~---------- 234 (298)
T 3pls_A 165 VADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDP---------- 234 (298)
T ss_dssp ECCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCG----------
T ss_pred eCcCCCcccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCH----------
Confidence 999999986654322 12223345788999999999999999999999999999999966554332211
Q ss_pred ccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhhcCCCCC
Q 020641 255 PRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSPPPA 317 (323)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~~~~~~~ 317 (323)
......+........+...+..+.+++.+||+.||.+|||+.++++.|++++++....
T Consensus 235 -----~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~~ 292 (298)
T 3pls_A 235 -----FDLTHFLAQGRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLGD 292 (298)
T ss_dssp -----GGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCSC
T ss_pred -----HHHHHHhhcCCCCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhcc
Confidence 1111111112222334445678999999999999999999999999999998766543
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-45 Score=317.05 Aligned_cols=258 Identities=24% Similarity=0.338 Sum_probs=203.8
Q ss_pred Ccccc-ccCCCCCCcccee--ccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEE
Q 020641 17 PGYFV-RLDKGPEDDLYLK--KRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYC 93 (323)
Q Consensus 17 ~~~~~-~lg~G~~~~V~~~--~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 93 (323)
+.... .||+|+||.||++ ....+++.+++|+..... ......+.+.+|+++++.++||||+++++++
T Consensus 18 y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~----------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 87 (291)
T 1xbb_A 18 LTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA----------NDPALKDELLAEANVMQQLDNPYIVRMIGIC 87 (291)
T ss_dssp EEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC---------------CHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred hhhccCccccccCeeeEeeeecCCCceeeEEEEeecccc----------cCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 34444 7999999999999 445677889998765321 1122246788999999999999999999999
Q ss_pred EeCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCC
Q 020641 94 VEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDF 173 (323)
Q Consensus 94 ~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~ 173 (323)
..+..++||||+.+++|.+++..... +++..++.++.|++.||.|||+. |++|+||||+||+++.++
T Consensus 88 -~~~~~~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~ 154 (291)
T 1xbb_A 88 -EAESWMLVMEMAELGPLNKYLQQNRH---------VKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQH 154 (291)
T ss_dssp -ESSSEEEEEECCTTEEHHHHHHHCTT---------CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETT
T ss_pred -CCCCcEEEEEeCCCCCHHHHHHhCcC---------CCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCC
Confidence 55678999999999999999976532 88999999999999999999999 999999999999999999
Q ss_pred eEEEeeccccCCCCccccc-cccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccchhhh
Q 020641 174 KAKIADFNLSNQAPDMAAR-LHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVT 251 (323)
Q Consensus 174 ~~~l~Dfg~~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~ 251 (323)
.++|+|||++......... .......+++.|+|||.+.+..++.++||||||+++|+|++ |..||.......
T Consensus 155 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~------ 228 (291)
T 1xbb_A 155 YAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE------ 228 (291)
T ss_dssp EEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH------
T ss_pred cEEEccCCcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHH------
Confidence 9999999998765432221 11222336788999999988888999999999999999999 999997653211
Q ss_pred hhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhhcC
Q 020641 252 WATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKS 313 (323)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~~~ 313 (323)
+...+........+...+..+.+++.+||+.||.+|||+.++++.|+++...
T Consensus 229 ----------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~ 280 (291)
T 1xbb_A 229 ----------VTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 280 (291)
T ss_dssp ----------HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred ----------HHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 1111111122233455677899999999999999999999999999998743
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=311.35 Aligned_cols=252 Identities=25% Similarity=0.292 Sum_probs=203.7
Q ss_pred CccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeC
Q 020641 17 PGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEG 96 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 96 (323)
|.....||+|+||.||+|.+..+++.+++|+...... ....+.+.+|+.+++.++|+||+++++++.++
T Consensus 9 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 77 (276)
T 2yex_A 9 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-----------VDCPENIKKEICINKMLNHENVVKFYGHRREG 77 (276)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGC-----------TTHHHHHHHHHHHHHTCCCTTBCCEEEEEEET
T ss_pred eEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccc-----------hhhhHHHHHHHHHHHhcCCCCceeeeeEEEcC
Confidence 4556689999999999999999999999997653321 12346788999999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEE
Q 020641 97 NLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAK 176 (323)
Q Consensus 97 ~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~ 176 (323)
+..++||||+.+++|.+++..... +++..+..++.|++.||.|||+. |++|+||||+||+++.++.++
T Consensus 78 ~~~~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~k 145 (276)
T 2yex_A 78 NIQYLFLEYCSGGELFDRIEPDIG---------MPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLK 145 (276)
T ss_dssp TEEEEEEECCTTEEGGGGSBTTTB---------CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEE
T ss_pred CEEEEEEEecCCCcHHHHHhhccC---------CCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEE
Confidence 999999999999999999875432 89999999999999999999999 999999999999999999999
Q ss_pred EeeccccCCCCccccccccccccCccccCCCccccCCCC-CcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhcc
Q 020641 177 IADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQL-TQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATP 255 (323)
Q Consensus 177 l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~ 255 (323)
|+|||.+................|++.|+|||.+.+..+ +.++||||||+++|+|++|..||.......... ..+.
T Consensus 146 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~-~~~~-- 222 (276)
T 2yex_A 146 ISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY-SDWK-- 222 (276)
T ss_dssp ECCCTTCEECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHH-HHHH--
T ss_pred EeeCCCccccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHH-HHhh--
Confidence 999999876543332222344568999999999987665 678999999999999999999997654321111 1111
Q ss_pred cccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 256 RLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
............+..+.+++.+||+.||.+|||+.|+++
T Consensus 223 -----------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 223 -----------EKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp -----------TTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -----------hcccccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 111111112345667999999999999999999999987
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-45 Score=320.36 Aligned_cols=266 Identities=21% Similarity=0.292 Sum_probs=206.9
Q ss_pred CccccccCCCCCCccceeccc-----eeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceee
Q 020641 17 PGYFVRLDKGPEDDLYLKKRV-----KMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLG 91 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~~~-----~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~ 91 (323)
|.....||+|+||.||+|.+. .+++.+++|...... .......+.+|+.+++.++|+||+++++
T Consensus 27 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~-----------~~~~~~~~~~E~~~l~~l~h~~i~~~~~ 95 (322)
T 1p4o_A 27 ITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-----------SMRERIEFLNEASVMKEFNCHHVVRLLG 95 (322)
T ss_dssp EEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS-----------CHHHHHHHHHHHHHGGGCCCTTBCCEEE
T ss_pred eeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc-----------CHHHHHHHHHHHHHHHhcCCCCEeeeEE
Confidence 444558999999999999887 467788888664221 0112356789999999999999999999
Q ss_pred EEEeCCeEEEEEeecCCCCHHHHhccCCCCC-CCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEc
Q 020641 92 YCVEGNLRVLAYEFATMGSLHDILHGRKGVQ-GAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLF 170 (323)
Q Consensus 92 ~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~ 170 (323)
++..++..++||||+.+++|.+++....... .......+++..++.++.|++.||.|||++ |++|+||||+||+++
T Consensus 96 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli~ 172 (322)
T 1p4o_A 96 VVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVA 172 (322)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEEC
T ss_pred EEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEEc
Confidence 9999999999999999999999997532100 000001278999999999999999999999 999999999999999
Q ss_pred cCCeEEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccchh
Q 020641 171 EDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSL 249 (323)
Q Consensus 171 ~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~ 249 (323)
.++.++|+|||++................+++.|+|||.+.+..++.++||||||+++|+|++ |..||........
T Consensus 173 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~--- 249 (322)
T 1p4o_A 173 EDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV--- 249 (322)
T ss_dssp TTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHH---
T ss_pred CCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHH---
Confidence 999999999999876544333223334456889999999988889999999999999999999 8999975432111
Q ss_pred hhhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhhc
Q 020641 250 VTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLK 312 (323)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~~ 312 (323)
...+........+...+..+.+++.+||+.||.+|||+.|+++.|+++..
T Consensus 250 -------------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 250 -------------LRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp -------------HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred -------------HHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 11111111112334556779999999999999999999999999998754
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-45 Score=319.01 Aligned_cols=258 Identities=21% Similarity=0.262 Sum_probs=193.4
Q ss_pred ccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcC-CCCcccceeeEEEeCCeEE
Q 020641 22 RLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRL-KHENLVELLGYCVEGNLRV 100 (323)
Q Consensus 22 ~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~ 100 (323)
.||+|+||.||+|.+..+++.+|+|++... .......+.+|++++.++ +||||+++++++.+.+..+
T Consensus 20 ~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------------~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~ 87 (316)
T 2ac3_A 20 VLGEGAHARVQTCINLITSQEYAVKIIEKQ------------PGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFY 87 (316)
T ss_dssp CCCCCSSEEEEEEECSSSCCEEEEEEEECC------------SSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred eecCCceEEEEEEEEcCCCcEEEEEEEeeC------------cchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEE
Confidence 689999999999999999999999976432 123457788999999886 8999999999999999999
Q ss_pred EEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCe---EEE
Q 020641 101 LAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFK---AKI 177 (323)
Q Consensus 101 lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~---~~l 177 (323)
+||||+.+++|.+++..... +++..+..++.|++.||.|||+. |++|+||||+||+++.++. ++|
T Consensus 88 lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl 155 (316)
T 2ac3_A 88 LVFEKMRGGSILSHIHKRRH---------FNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKI 155 (316)
T ss_dssp EEEECCTTCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEE
T ss_pred EEEEcCCCCcHHHHHhccCC---------CCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEE
Confidence 99999999999999976532 89999999999999999999999 9999999999999988766 999
Q ss_pred eeccccCCCCcccc-----ccccccccCccccCCCccccC-----CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccc
Q 020641 178 ADFNLSNQAPDMAA-----RLHSTRVLGTFGYHAPEYAMT-----GQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQ 247 (323)
Q Consensus 178 ~Dfg~~~~~~~~~~-----~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~ 247 (323)
+|||++........ ........||+.|+|||++.+ ..++.++||||||+++|+|++|..||.........
T Consensus 156 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~ 235 (316)
T 2ac3_A 156 CDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCG 235 (316)
T ss_dssp CCTTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSC
T ss_pred EEccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccccccccc
Confidence 99999876542211 111223448999999998865 45788999999999999999999999865432211
Q ss_pred hhhhhhcccccccccchhcCCCcCCCCCH----HHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 248 SLVTWATPRLSEDKVKQCVDPKLKGEYPP----KGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
.................+..... ..+. ..+..+.+++.+||+.||.+|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~i~~~~~--~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 236 WDRGEACPACQNMLFESIQEGKY--EFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp C----CCHHHHHHHHHHHHHCCC--CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ccccccchhHHHHHHHHHhccCc--ccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 00000000000000001111111 1121 24567999999999999999999999998
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-45 Score=312.95 Aligned_cols=256 Identities=24% Similarity=0.354 Sum_probs=206.3
Q ss_pred CCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEe
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVE 95 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 95 (323)
.+.....||+|+||.||++.+. +++.+++|...... ...+.+.+|++++++++||||+++++++..
T Consensus 9 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~-------------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 74 (267)
T 3t9t_A 9 ELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGA-------------MSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 74 (267)
T ss_dssp GEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTT-------------BCHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred heeeeeEecCCCceeEEEEEec-CCCeEEEEEccccC-------------CCHHHHHHHHHHHHhCCCCCEeeEEEEEcc
Confidence 3455668999999999999986 44567777654221 123678999999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeE
Q 020641 96 GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKA 175 (323)
Q Consensus 96 ~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~ 175 (323)
.+..++||||+.+++|.+++...... +++..++.++.|++.||.+||+. |++|+||||+||+++.++.+
T Consensus 75 ~~~~~lv~e~~~~~~L~~~~~~~~~~--------~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~ 143 (267)
T 3t9t_A 75 QAPICLVTEFMEHGCLSDYLRTQRGL--------FAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVI 143 (267)
T ss_dssp SSSCEEEECCCTTCBHHHHHHHTTTC--------CCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCE
T ss_pred CCCeEEEEeCCCCCcHHHHHhhCccc--------CCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCE
Confidence 99999999999999999999765332 88999999999999999999999 99999999999999999999
Q ss_pred EEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhc
Q 020641 176 KIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWAT 254 (323)
Q Consensus 176 ~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~ 254 (323)
+|+|||++......... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||........
T Consensus 144 kl~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~-------- 214 (267)
T 3t9t_A 144 KVSDFGMTRFVLDDQYT-SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV-------- 214 (267)
T ss_dssp EECCTTGGGGBCCHHHH-STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH--------
T ss_pred EEccccccccccccccc-ccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHH--------
Confidence 99999998765433221 2233346788999999988889999999999999999999 8999975432111
Q ss_pred ccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhhcC
Q 020641 255 PRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKS 313 (323)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~~~ 313 (323)
...+........+...+..+.+++.+||+.||.+|||+.++++.|+++.++
T Consensus 215 --------~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (267)
T 3t9t_A 215 --------VEDISTGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 265 (267)
T ss_dssp --------HHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred --------HHHHhcCCcCCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 111111111222334567799999999999999999999999999998764
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=337.30 Aligned_cols=257 Identities=23% Similarity=0.345 Sum_probs=206.5
Q ss_pred ccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeCC
Q 020641 18 GYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGN 97 (323)
Q Consensus 18 ~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 97 (323)
....+||+|+||.||++.+.. +..+|+|..... ....+.+.+|++++++++||||+++++++. ..
T Consensus 191 ~~~~~lG~G~fg~V~~~~~~~-~~~vavK~~~~~-------------~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~ 255 (454)
T 1qcf_A 191 KLEKKLGAGQFGEVWMATYNK-HTKVAVKTMKPG-------------SMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KE 255 (454)
T ss_dssp EEEEEEECCSSEEEEEEEETT-TEEEEEEEECTT-------------SBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SS
T ss_pred EEEEEcccCCceEEEEEEECC-ccEEEEEEecCC-------------CccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CC
Confidence 334489999999999998864 455788765421 123478899999999999999999999987 55
Q ss_pred eEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEEE
Q 020641 98 LRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKI 177 (323)
Q Consensus 98 ~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~l 177 (323)
..++||||+.+|+|.+++....... +++..+..++.|++.||.|||++ |++||||||+|||++.++.+||
T Consensus 256 ~~~lv~e~~~~g~L~~~l~~~~~~~-------~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl 325 (454)
T 1qcf_A 256 PIYIITEFMAKGSLLDFLKSDEGSK-------QPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKI 325 (454)
T ss_dssp SCEEEECCCTTCBHHHHHHSHHHHT-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEE
T ss_pred ccEEEEeecCCCcHHHHHHhccCCC-------CCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEE
Confidence 6899999999999999997643211 88889999999999999999999 9999999999999999999999
Q ss_pred eeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhccc
Q 020641 178 ADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPR 256 (323)
Q Consensus 178 ~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~ 256 (323)
+|||++......... ......++..|+|||.+.+..++.++||||||+++|+|++ |+.||......
T Consensus 326 ~DFG~a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~------------ 392 (454)
T 1qcf_A 326 ADFGLARVIEDNEYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP------------ 392 (454)
T ss_dssp CSTTGGGGBCCHHHH-TTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH------------
T ss_pred eeCCCceEcCCCcee-ccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHH------------
Confidence 999999865433221 1223346778999999988889999999999999999999 99999754321
Q ss_pred ccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhhcCCCC
Q 020641 257 LSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSPPP 316 (323)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~~~~~~ 316 (323)
.+...+....+...+..++..+.++|.+||+.||++|||+.+|++.|+++.....+
T Consensus 393 ----~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~~~ 448 (454)
T 1qcf_A 393 ----EVIRALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTATES 448 (454)
T ss_dssp ----HHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSSCC
T ss_pred ----HHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhcccc
Confidence 11111222223334556677899999999999999999999999999999876554
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-45 Score=332.77 Aligned_cols=249 Identities=28% Similarity=0.393 Sum_probs=203.9
Q ss_pred ccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeCC
Q 020641 18 GYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGN 97 (323)
Q Consensus 18 ~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 97 (323)
....+||+|+||.||++... ++.+|+|+.... ...+.+.+|++++++++||||+++++++....
T Consensus 196 ~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~--------------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 259 (450)
T 1k9a_A 196 KLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND--------------ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEK 259 (450)
T ss_dssp EEEEEEEECSSEEEEEEEET--TEEEEEEEESSC--------------TTSHHHHHHHHHHHTCCCTTBCCEEEEEECTT
T ss_pred EEEeeecCcCCeeEEEEEec--CCeEEEEEeCCc--------------hHHHHHHHHHHHHHhccCCCEEEEEEEEEcCC
Confidence 44458999999999999875 567888865421 13478899999999999999999999987765
Q ss_pred -eEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEE
Q 020641 98 -LRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAK 176 (323)
Q Consensus 98 -~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~ 176 (323)
..++||||+.+|+|.+++...... .++...+..++.|++.||.|||++ |++||||||+||+++.++.+|
T Consensus 260 ~~~~iv~e~~~~g~L~~~l~~~~~~-------~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~k 329 (450)
T 1k9a_A 260 GGLYIVTEYMAKGSLVDYLRSRGRS-------VLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAK 329 (450)
T ss_dssp SCEEEEEECCTTCBHHHHHHHHCTT-------TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEE
T ss_pred CceEEEEEecCCCcHHHHHHhcCCC-------CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEE
Confidence 789999999999999999865432 278899999999999999999999 999999999999999999999
Q ss_pred EeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcc
Q 020641 177 IADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATP 255 (323)
Q Consensus 177 l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~ 255 (323)
|+|||++....... ....++..|+|||.+.+..++.++||||||+++|+|++ |..||.......
T Consensus 330 l~DfG~a~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~---------- 394 (450)
T 1k9a_A 330 VSDFGLTKEASSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---------- 394 (450)
T ss_dssp ECCCTTCEECC-----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT----------
T ss_pred EeeCCCcccccccc-----cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH----------
Confidence 99999987543221 12246788999999999999999999999999999998 999997553221
Q ss_pred cccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhhcC
Q 020641 256 RLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKS 313 (323)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~~~ 313 (323)
+...+....+...+..++..+.++|.+||+.||.+|||+.++++.|+++...
T Consensus 395 ------~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 395 ------VVPRVEKGYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp ------HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred ------HHHHHHcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence 1122222233345566778899999999999999999999999999998754
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-45 Score=321.48 Aligned_cols=256 Identities=19% Similarity=0.227 Sum_probs=204.5
Q ss_pred CCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEe
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVE 95 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 95 (323)
.|.....||.|+||.||+|.+..+++.+|+|++......... .....+.+.+|+.++++++||||+++++++..
T Consensus 13 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 86 (321)
T 2a2a_A 13 FYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASR------RGVSREEIEREVSILRQVLHHNVITLHDVYEN 86 (321)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCS------SSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred cEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccc------cchhHHHHHHHHHHHHhCCCCCcceEEEEEec
Confidence 355666899999999999999999999999977654322211 12235778999999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCC--
Q 020641 96 GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDF-- 173 (323)
Q Consensus 96 ~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~-- 173 (323)
....++||||+.+++|.+++..... +++..++.++.|++.||.|||+. |++|+||||+||+++.++
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~ 154 (321)
T 2a2a_A 87 RTDVVLILELVSGGELFDFLAQKES---------LSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIP 154 (321)
T ss_dssp SSEEEEEECCCCSCBHHHHHHTCSC---------EEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSS
T ss_pred CCEEEEEEEcCCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCC
Confidence 9999999999999999999976432 89999999999999999999999 999999999999999887
Q ss_pred --eEEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhh
Q 020641 174 --KAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVT 251 (323)
Q Consensus 174 --~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~ 251 (323)
.++|+|||++........ .....|++.|+|||.+.+..++.++||||||+++|+|++|..||.............
T Consensus 155 ~~~~kl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~ 231 (321)
T 2a2a_A 155 IPHIKLIDFGLAHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANIT 231 (321)
T ss_dssp SCCEEECCCTTCEECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHH
T ss_pred cCCEEEccCccceecCcccc---ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH
Confidence 799999999876544221 233458999999999998899999999999999999999999997543211110000
Q ss_pred hhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 252 WATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
.... ..........+..+.+++.+||+.||.+|||+.|+++
T Consensus 232 --~~~~-----------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 232 --SVSY-----------DFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp --TTCC-----------CCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred --hccc-----------ccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 0000 0000001223467999999999999999999999987
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=331.90 Aligned_cols=248 Identities=21% Similarity=0.235 Sum_probs=203.9
Q ss_pred CccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeC
Q 020641 17 PGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEG 96 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 96 (323)
|.....||+|+||.||+|++..+++.+|+|++...... .......+.+|+.+++.++||||+++++++...
T Consensus 18 Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~---------~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~ 88 (476)
T 2y94_A 18 YILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIR---------SLDVVGKIRREIQNLKLFRHPHIIKLYQVISTP 88 (476)
T ss_dssp EEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHH---------HTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred EEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhcc---------CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC
Confidence 44555899999999999999999999999987643211 123346789999999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEE
Q 020641 97 NLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAK 176 (323)
Q Consensus 97 ~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~ 176 (323)
+..++||||+.+++|.+++..... +++..+..++.||+.||.|||+. |++||||||+||+++.++.++
T Consensus 89 ~~~~lv~E~~~gg~L~~~l~~~~~---------l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vk 156 (476)
T 2y94_A 89 SDIFMVMEYVSGGELFDYICKNGR---------LDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAK 156 (476)
T ss_dssp SEEEEEEECCSSEEHHHHTTSSSS---------CCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEE
T ss_pred CEEEEEEeCCCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeE
Confidence 999999999999999999976432 89999999999999999999999 999999999999999999999
Q ss_pred EeeccccCCCCccccccccccccCccccCCCccccCCCC-CcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhcc
Q 020641 177 IADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQL-TQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATP 255 (323)
Q Consensus 177 l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~ 255 (323)
|+|||++....... ......||+.|+|||++.+..+ +.++||||||+++|+|++|..||.........
T Consensus 157 L~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~-------- 225 (476)
T 2y94_A 157 IADFGLSNMMSDGE---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLF-------- 225 (476)
T ss_dssp ECCCSSCEECCTTC---CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHH--------
T ss_pred EEeccchhhccccc---cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHH--------
Confidence 99999987654322 1234468999999999988766 68999999999999999999999755331111
Q ss_pred cccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 256 RLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
..+.+.. ...+...+..+.+++.+||+.||.+|||+.|+++
T Consensus 226 -------~~i~~~~--~~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 226 -------KKICDGI--FYTPQYLNPSVISLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp -------HHHHTTC--CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred -------HHHhcCC--cCCCccCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence 1111111 1123334567999999999999999999999997
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-46 Score=326.78 Aligned_cols=276 Identities=21% Similarity=0.263 Sum_probs=210.5
Q ss_pred CCccccccCCCCCCccceec----cceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceee
Q 020641 16 SPGYFVRLDKGPEDDLYLKK----RVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLG 91 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~----~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~ 91 (323)
.|....+||+|+||.||+++ +..+++.+++|.+... .....+.+.+|++++++++|+||+++++
T Consensus 24 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~------------~~~~~~~~~~E~~~l~~l~h~~i~~~~~ 91 (327)
T 3lxl_A 24 HLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS------------GPDQQRDFQREIQILKALHSDFIVKYRG 91 (327)
T ss_dssp GEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC------------CHHHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred hhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC------------CHHHHHHHHHHHHHHHhcCCCceeEEEE
Confidence 34555599999999999998 6778899999866422 1112356889999999999999999999
Q ss_pred EEE--eCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEE
Q 020641 92 YCV--EGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLL 169 (323)
Q Consensus 92 ~~~--~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili 169 (323)
++. .....++||||+.+++|.+++...... +++..++.++.|++.||.|||+. |++|+||||+||++
T Consensus 92 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~--------~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~ 160 (327)
T 3lxl_A 92 VSYGPGRQSLRLVMEYLPSGCLRDFLQRHRAR--------LDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILV 160 (327)
T ss_dssp EEECSSSCEEEEEEECCTTCBHHHHHHHHGGG--------CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEE
T ss_pred EEecCCCceEEEEEeecCCCCHHHHHHhcccC--------CCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEE
Confidence 887 456789999999999999999764322 89999999999999999999999 99999999999999
Q ss_pred ccCCeEEEeeccccCCCCccccc-cccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccch
Q 020641 170 FEDFKAKIADFNLSNQAPDMAAR-LHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQS 248 (323)
Q Consensus 170 ~~~~~~~l~Dfg~~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~ 248 (323)
+.++.++|+|||++......... .......++..|+|||.+.+..++.++||||||+++|+|++|..||..........
T Consensus 161 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~ 240 (327)
T 3lxl_A 161 ESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRM 240 (327)
T ss_dssp EETTEEEECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHH
T ss_pred CCCCCEEEcccccceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhh
Confidence 99999999999999765433221 12233447888999999988889999999999999999999999986432110000
Q ss_pred hhhhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhhcCCC
Q 020641 249 LVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSPP 315 (323)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~~~~~ 315 (323)
............+...+........+..++..+.+++.+||+.||.+|||+.|+++.|+.+.....
T Consensus 241 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~ 306 (327)
T 3lxl_A 241 -MGCERDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSR 306 (327)
T ss_dssp -CC----CCHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC-----
T ss_pred -cccccccccHHHHHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence 000000001112223333334444566677889999999999999999999999999999975443
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-45 Score=328.44 Aligned_cols=251 Identities=19% Similarity=0.165 Sum_probs=202.0
Q ss_pred CCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEe
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVE 95 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 95 (323)
.|.....||+|+||.||+|.+..+++.+|+|+..... ......+.+|+++++.++||||+++++++.+
T Consensus 52 ~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~------------~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~ 119 (387)
T 1kob_A 52 YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY------------PLDKYTVKNEISIMNQLHHPKLINLHDAFED 119 (387)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS------------HHHHHHHHHHHHHHTTCCSTTBCCEEEEEEC
T ss_pred ceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc------------hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEe
Confidence 3555568999999999999999999999999765321 0112467899999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEcc--CC
Q 020641 96 GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFE--DF 173 (323)
Q Consensus 96 ~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~--~~ 173 (323)
....++||||+.+++|.+++...... +++..+..++.||+.||.|||+. |++||||||+||+++. ++
T Consensus 120 ~~~~~lv~E~~~gg~L~~~l~~~~~~--------l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~ 188 (387)
T 1kob_A 120 KYEMVLILEFLSGGELFDRIAAEDYK--------MSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKAS 188 (387)
T ss_dssp SSEEEEEEECCCCCBHHHHTTCTTCC--------BCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCC
T ss_pred CCEEEEEEEcCCCCcHHHHHHhhcCC--------CCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCC
Confidence 99999999999999999999765322 89999999999999999999999 9999999999999974 47
Q ss_pred eEEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhh
Q 020641 174 KAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWA 253 (323)
Q Consensus 174 ~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 253 (323)
.++|+|||++........ .....||+.|+|||++.+..++.++|||||||++|+|++|..||.............
T Consensus 189 ~vkL~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~-- 263 (387)
T 1kob_A 189 SVKIIDFGLATKLNPDEI---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVK-- 263 (387)
T ss_dssp CEEECCCTTCEECCTTSC---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHH--
T ss_pred ceEEEecccceecCCCcc---eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHH--
Confidence 799999999976543221 123358999999999999899999999999999999999999997653211111000
Q ss_pred cccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 254 TPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
.. ............+..+.++|.+||+.||.+|||+.|+++
T Consensus 264 ~~-----------~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 304 (387)
T 1kob_A 264 RC-----------DWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 304 (387)
T ss_dssp HC-----------CCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred hC-----------CCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 00 000111122345667999999999999999999999997
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-45 Score=317.81 Aligned_cols=271 Identities=17% Similarity=0.200 Sum_probs=199.1
Q ss_pred CccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeC
Q 020641 17 PGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEG 96 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 96 (323)
|....+||+|+||.||++.+..+++.+|+|.+....... ......+.+|+.++++++|+||+++++++...
T Consensus 34 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~---------~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 104 (310)
T 2wqm_A 34 FRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMD---------AKARADCIKEIDLLKQLNHPNVIKYYASFIED 104 (310)
T ss_dssp EEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCC---------HHHHHHHHHHHHHHHTCCCTTBCCEEEEEEET
T ss_pred eEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccC---------HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcC
Confidence 455558999999999999999999999999765321111 12236688999999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEE
Q 020641 97 NLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAK 176 (323)
Q Consensus 97 ~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~ 176 (323)
+..++||||+.+++|.+++...... ...++...++.++.|++.||.|||+. |++|+||||+||+++.++.++
T Consensus 105 ~~~~lv~e~~~~~~L~~~l~~~~~~-----~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~k 176 (310)
T 2wqm_A 105 NELNIVLELADAGDLSRMIKHFKKQ-----KRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVK 176 (310)
T ss_dssp TEEEEEEECCCSCBHHHHHHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEE
T ss_pred CcEEEEEecCCCCCHHHHHHHhccc-----ccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEE
Confidence 9999999999999999998652211 01288999999999999999999999 999999999999999999999
Q ss_pred EeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhccc
Q 020641 177 IADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPR 256 (323)
Q Consensus 177 l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 256 (323)
|+|||++......... .....|++.|+|||.+.+..++.++||||||+++|+|++|..||.............
T Consensus 177 l~Dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~----- 249 (310)
T 2wqm_A 177 LGDLGLGRFFSSKTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKK----- 249 (310)
T ss_dssp ECCC--------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHH-----
T ss_pred EEeccceeeecCCCcc--ccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHH-----
Confidence 9999998765432211 223458899999999998899999999999999999999999997543211110000
Q ss_pred ccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhhcCCCCCCC
Q 020641 257 LSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSPPPAAP 319 (323)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~~~~~~~~~ 319 (323)
..............+..+.+++.+||+.||.+|||+.++++.|+++.....+|+.
T Consensus 250 --------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~~~~ 304 (310)
T 2wqm_A 250 --------IEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASSLE 304 (310)
T ss_dssp --------HHTTCSCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC----
T ss_pred --------hhcccCCCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhhhhh
Confidence 0000111111234566799999999999999999999999999999876666554
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-45 Score=316.63 Aligned_cols=268 Identities=22% Similarity=0.284 Sum_probs=204.1
Q ss_pred cccCCCCCccccccCCCCCCccceeccceee---eeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcc
Q 020641 10 LGAHAPSPGYFVRLDKGPEDDLYLKKRVKMR---RWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENL 86 (323)
Q Consensus 10 ~~~~~~~~~~~~~lg~G~~~~V~~~~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i 86 (323)
+++....+....+||+|+||.||++.+..++ ..+++|..... ......+.+.+|+.++++++||||
T Consensus 20 i~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~-----------~~~~~~~~~~~E~~~l~~l~h~~i 88 (298)
T 3f66_A 20 IGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-----------TDIGEVSQFLTEGIIMKDFSHPNV 88 (298)
T ss_dssp CCGGGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTC-----------CSHHHHHHHHHHHHHHHTCCCTTB
T ss_pred cCccceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccC-----------CCHHHHHHHHHHHHHHHhCCCCCE
Confidence 3444455566679999999999999875443 34666644321 111123668899999999999999
Q ss_pred cceeeEEE-eCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCC
Q 020641 87 VELLGYCV-EGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSS 165 (323)
Q Consensus 87 ~~~~~~~~-~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~ 165 (323)
+++++++. ..+..++||||+.+++|.+++...... +++..++.++.|++.||.|||+. |++|+||||+
T Consensus 89 v~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~--------~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~ 157 (298)
T 3f66_A 89 LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN--------PTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAAR 157 (298)
T ss_dssp CCCCEEECCSSSCCEEEEECCTTCBHHHHHHCTTCC--------CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGG
T ss_pred eeeeeEEEcCCCceEEEEeCCCCCCHHHHHHhcccC--------CCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchh
Confidence 99999864 456789999999999999999764432 88999999999999999999999 9999999999
Q ss_pred CEEEccCCeEEEeeccccCCCCccccc--cccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCC
Q 020641 166 NVLLFEDFKAKIADFNLSNQAPDMAAR--LHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTM 242 (323)
Q Consensus 166 nili~~~~~~~l~Dfg~~~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~ 242 (323)
||+++.++.++|+|||++......... .......+++.|+|||.+.+..++.++||||||+++|+|++ |..||....
T Consensus 158 Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~ 237 (298)
T 3f66_A 158 NCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN 237 (298)
T ss_dssp GEEECTTCCEEECSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSC
T ss_pred eEEECCCCCEEECcccccccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCC
Confidence 999999999999999999876543321 12233447788999999998899999999999999999999 566665443
Q ss_pred CcccchhhhhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhhcCCC
Q 020641 243 PRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSPP 315 (323)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~~~~~ 315 (323)
...... .+........+...+..+.+++.+||+.||.+|||+.|+++.|+++.+...
T Consensus 238 ~~~~~~----------------~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~ 294 (298)
T 3f66_A 238 TFDITV----------------YLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 294 (298)
T ss_dssp TTTHHH----------------HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSC
T ss_pred HHHHHH----------------HHhcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhc
Confidence 221111 111111122233455679999999999999999999999999999987654
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-45 Score=315.12 Aligned_cols=259 Identities=24% Similarity=0.344 Sum_probs=206.2
Q ss_pred ccCCCCCCccceeccc--eeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeCCeE
Q 020641 22 RLDKGPEDDLYLKKRV--KMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLR 99 (323)
Q Consensus 22 ~lg~G~~~~V~~~~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 99 (323)
.||+|+||.||++.+. .+++.+++|+..... .....+.+.+|++++++++||||+++++++. .+..
T Consensus 17 ~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~-----------~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~ 84 (287)
T 1u59_A 17 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-----------EKADTEEMMREAQIMHQLDNPYIVRLIGVCQ-AEAL 84 (287)
T ss_dssp EEECCTTEEEEEEEEC---CCEEEEEEEECSSC-----------CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSE
T ss_pred cccccCceeEEEeEeccCCCcceEEEEecCCcc-----------chhHHHHHHHHHHHHHhCCCCCEeEEEEEec-CCCc
Confidence 7999999999999754 467778888665321 1122467889999999999999999999994 5568
Q ss_pred EEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEEEee
Q 020641 100 VLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIAD 179 (323)
Q Consensus 100 ~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~l~D 179 (323)
++||||+.+++|.+++..... .+++..+..++.|++.||.+||+. |++|+||||+||+++.++.++|+|
T Consensus 85 ~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~D 153 (287)
T 1u59_A 85 MLVMEMAGGGPLHKFLVGKRE--------EIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISD 153 (287)
T ss_dssp EEEEECCTTEEHHHHHTTCTT--------TSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECC
T ss_pred EEEEEeCCCCCHHHHHHhCCc--------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECc
Confidence 999999999999999965432 289999999999999999999999 999999999999999999999999
Q ss_pred ccccCCCCccccc-cccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccc
Q 020641 180 FNLSNQAPDMAAR-LHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPRL 257 (323)
Q Consensus 180 fg~~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~ 257 (323)
||++......... .......+++.|+|||.+.+..++.++||||||+++|+|++ |..||.......
T Consensus 154 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~------------ 221 (287)
T 1u59_A 154 FGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE------------ 221 (287)
T ss_dssp CTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH------------
T ss_pred ccceeeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH------------
Confidence 9998765432221 11223346889999999988889999999999999999998 999997554311
Q ss_pred cccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhhcCCCCCCC
Q 020641 258 SEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSPPPAAP 319 (323)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~~~~~~~~~ 319 (323)
+...+........+...+..+.+++.+||+.||.+|||+.++++.|+.+..+...+..
T Consensus 222 ----~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~~~ 279 (287)
T 1u59_A 222 ----VMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVE 279 (287)
T ss_dssp ----HHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTTCS
T ss_pred ----HHHHHhcCCcCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCccc
Confidence 1111111112234455677899999999999999999999999999999876555443
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-45 Score=321.27 Aligned_cols=259 Identities=21% Similarity=0.310 Sum_probs=199.2
Q ss_pred cccccCCCCCCccceeccceee----eeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEE
Q 020641 19 YFVRLDKGPEDDLYLKKRVKMR----RWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCV 94 (323)
Q Consensus 19 ~~~~lg~G~~~~V~~~~~~~~~----~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 94 (323)
....||+|+||.||++.+..++ ..+++|...... .......+.+|+.+++.++||||+++++++.
T Consensus 48 ~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~-----------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 116 (333)
T 1mqb_A 48 RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-----------TEKQRVDFLGEAGIMGQFSHHNIIRLEGVIS 116 (333)
T ss_dssp EEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-----------CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred cccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC-----------CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEe
Confidence 3457999999999999887653 357777654221 1112356789999999999999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCe
Q 020641 95 EGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFK 174 (323)
Q Consensus 95 ~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~ 174 (323)
..+..++||||+.+++|.+++...... +++..++.++.|++.||.|||+. |++|+||||+||+++.++.
T Consensus 117 ~~~~~~lv~e~~~~~~L~~~l~~~~~~--------~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~ 185 (333)
T 1mqb_A 117 KYKPMMIITEYMENGALDKFLREKDGE--------FSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLV 185 (333)
T ss_dssp SSSSEEEEEECCTTEEHHHHHHHTTTC--------SCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCC
T ss_pred cCCCcEEEEeCCCCCcHHHHHHhCCCC--------CCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCc
Confidence 999999999999999999999764322 89999999999999999999999 9999999999999999999
Q ss_pred EEEeeccccCCCCccccc-cccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccchhhhh
Q 020641 175 AKIADFNLSNQAPDMAAR-LHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTW 252 (323)
Q Consensus 175 ~~l~Dfg~~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~ 252 (323)
++|+|||++......... .......+++.|+|||.+.+..++.++||||||+++|+|++ |..||.......
T Consensus 186 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~------- 258 (333)
T 1mqb_A 186 CKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE------- 258 (333)
T ss_dssp EEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-------
T ss_pred EEECCCCcchhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHH-------
Confidence 999999999766433211 11222335778999999998899999999999999999998 999996543211
Q ss_pred hcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhhcCCC
Q 020641 253 ATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSPP 315 (323)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~~~~~ 315 (323)
+...+........+...+..+.+++.+||+.||.+|||+.++++.|++++..+.
T Consensus 259 ---------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~ 312 (333)
T 1mqb_A 259 ---------VMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPD 312 (333)
T ss_dssp ---------HHHHHHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGG
T ss_pred ---------HHHHHHCCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcch
Confidence 111111111223344566789999999999999999999999999999886544
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-45 Score=313.59 Aligned_cols=263 Identities=22% Similarity=0.314 Sum_probs=212.7
Q ss_pred CCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEe
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVE 95 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 95 (323)
.|.....||.|+||.||++++..+++.+++|+....... .......+.+|+++++.++|+||+++++++..
T Consensus 15 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~---------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 85 (284)
T 2vgo_A 15 DFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLE---------KEGVEHQLRREIEIQSHLRHPNILRMYNYFHD 85 (284)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHH---------HTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred hceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccc---------hHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEc
Confidence 455566899999999999999999999999977543211 12234678899999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeE
Q 020641 96 GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKA 175 (323)
Q Consensus 96 ~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~ 175 (323)
.+..++||||+.+++|.+++..... +++..+..++.|++.|+.|||+. |++|+||||+||+++.++.+
T Consensus 86 ~~~~~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~ 153 (284)
T 2vgo_A 86 RKRIYLMLEFAPRGELYKELQKHGR---------FDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGEL 153 (284)
T ss_dssp SSEEEEEECCCTTEEHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCE
T ss_pred CCEEEEEEEeCCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCE
Confidence 9999999999999999999976542 88999999999999999999999 99999999999999999999
Q ss_pred EEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhcc
Q 020641 176 KIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATP 255 (323)
Q Consensus 176 ~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~ 255 (323)
+|+|||++....... .....|++.|+|||.+.+..++.++||||||+++|+|++|..||..........
T Consensus 154 kl~Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~------- 222 (284)
T 2vgo_A 154 KIADFGWSVHAPSLR----RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHR------- 222 (284)
T ss_dssp EECCCTTCEECSSSC----BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH-------
T ss_pred EEecccccccCcccc----cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHH-------
Confidence 999999886544321 233458999999999999889999999999999999999999997553211111
Q ss_pred cccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH--HHhhhhcCCCCCCCC
Q 020641 256 RLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK--ALQPLLKSPPPAAPV 320 (323)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~--~l~~~~~~~~~~~~~ 320 (323)
.+... ....+...+..+.+++.+||+.||.+|||+.++++ +++...+...||+..
T Consensus 223 --------~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~~~~~~p~~~~ 279 (284)
T 2vgo_A 223 --------RIVNV--DLKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANSRRVLPPVYQ 279 (284)
T ss_dssp --------HHHTT--CCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHHCCCCCCCCC-
T ss_pred --------HHhcc--ccCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhhccccCCCccc
Confidence 11111 11223445667999999999999999999999997 666666555555443
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-45 Score=323.43 Aligned_cols=268 Identities=24% Similarity=0.341 Sum_probs=208.0
Q ss_pred CccccccCCCCCCccceeccc-------eeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcC-CCCcccc
Q 020641 17 PGYFVRLDKGPEDDLYLKKRV-------KMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRL-KHENLVE 88 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~~~-------~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~ 88 (323)
|.....||+|+||.||+|++. .+++.+|+|+..... .......+.+|+++++++ +||||++
T Consensus 37 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~-----------~~~~~~~~~~E~~~l~~l~~hp~iv~ 105 (334)
T 2pvf_A 37 LTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-----------TEKDLSDLVSEMEMMKMIGKHKNIIN 105 (334)
T ss_dssp EEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC-----------CHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred eEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC-----------cHHHHHHHHHHHHHHHHhhcCCCEee
Confidence 344458999999999999876 456778888664321 111235688999999999 9999999
Q ss_pred eeeEEEeCCeEEEEEeecCCCCHHHHhccCCCCCCC-------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCC
Q 020641 89 LLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGA-------QPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRD 161 (323)
Q Consensus 89 ~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~d 161 (323)
+++++...+..++||||+.+++|.+++......... .....+++..++.++.|++.||.|||+. |++|+|
T Consensus 106 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~D 182 (334)
T 2pvf_A 106 LLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRD 182 (334)
T ss_dssp EEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSC
T ss_pred EEEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCC
Confidence 999999999999999999999999999865421100 0112388999999999999999999999 999999
Q ss_pred CCCCCEEEccCCeEEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHh-CCCCCCC
Q 020641 162 IRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDH 240 (323)
Q Consensus 162 ikp~nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~ 240 (323)
|||+||+++.++.++|+|||++................+++.|+|||.+.+..++.++||||||+++|+|++ |..||..
T Consensus 183 lkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~ 262 (334)
T 2pvf_A 183 LAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG 262 (334)
T ss_dssp CSGGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred CccceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCc
Confidence 999999999999999999999976654333223334457888999999988889999999999999999999 9999975
Q ss_pred CCCcccchhhhhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhhcCC
Q 020641 241 TMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSP 314 (323)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~~~~ 314 (323)
..... +...+........+..++..+.+++.+||+.||.+|||+.|+++.|++++...
T Consensus 263 ~~~~~----------------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~ 320 (334)
T 2pvf_A 263 IPVEE----------------LFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT 320 (334)
T ss_dssp CCHHH----------------HHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CCHHH----------------HHHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence 53211 11111111112234455677999999999999999999999999999998543
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-45 Score=322.37 Aligned_cols=251 Identities=20% Similarity=0.210 Sum_probs=205.3
Q ss_pred CCCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcC-CCCcccceeeEE
Q 020641 15 PSPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRL-KHENLVELLGYC 93 (323)
Q Consensus 15 ~~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~ 93 (323)
..|.....||+|+||.||+|++..+++.+|+|+..+.... .....+.+..|..++..+ +||||+++++++
T Consensus 20 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~---------~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~ 90 (353)
T 2i0e_A 20 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVI---------QDDDVECTMVEKRVLALPGKPPFLTQLHSCF 90 (353)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHH---------HTTCHHHHHHHHHHHTCTTCCTTBCCEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh---------cchHHHHHHHHHHHHHhcCCCCEEeeEEEEE
Confidence 4566777999999999999999999999999987643211 123346778899999988 899999999999
Q ss_pred EeCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCC
Q 020641 94 VEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDF 173 (323)
Q Consensus 94 ~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~ 173 (323)
.+.+..|+||||+.+|+|.+++..... +++..++.++.||+.||.|||+. ||+||||||+||+++.++
T Consensus 91 ~~~~~~~lv~E~~~gg~L~~~l~~~~~---------~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g 158 (353)
T 2i0e_A 91 QTMDRLYFVMEYVNGGDLMYHIQQVGR---------FKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEG 158 (353)
T ss_dssp ECSSEEEEEEECCCSCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTS
T ss_pred EcCCEEEEEEeCCCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCC
Confidence 999999999999999999999976432 89999999999999999999999 999999999999999999
Q ss_pred eEEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhh
Q 020641 174 KAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWA 253 (323)
Q Consensus 174 ~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 253 (323)
.++|+|||++........ ......||+.|+|||++.+..++.++|+||||+++|+|++|+.||........
T Consensus 159 ~vkL~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~------- 229 (353)
T 2i0e_A 159 HIKIADFGMCKENIWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL------- 229 (353)
T ss_dssp CEEECCCTTCBCCCCTTC--CBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-------
T ss_pred cEEEEeCCcccccccCCc--ccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHH-------
Confidence 999999999876432211 23345699999999999999999999999999999999999999975432111
Q ss_pred cccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCC-----hHHHHH
Q 020641 254 TPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPN-----MSIVVK 305 (323)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps-----~~evl~ 305 (323)
...+.... ...+...+..+.+++.+||+.||.+||+ +.+|++
T Consensus 230 --------~~~i~~~~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 230 --------FQSIMEHN--VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp --------HHHHHHCC--CCCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred --------HHHHHhCC--CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 11111111 1233456678999999999999999995 577765
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=318.52 Aligned_cols=268 Identities=25% Similarity=0.323 Sum_probs=207.6
Q ss_pred CCccccccCCCCCCccceeccceeeeee--eeccccccccCccccccccCCCCCchHHHHHHHHHhcC-CCCcccceeeE
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRVKMRRWL--CCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRL-KHENLVELLGY 92 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~~~~~~~--~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~ 92 (323)
.|.....||+|+||.||+|++..+++.+ ++|..... ......+.+.+|+++++++ +||||++++++
T Consensus 26 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~-----------~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 94 (327)
T 1fvr_A 26 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-----------ASKDDHRDFAGELEVLCKLGHHPNIINLLGA 94 (327)
T ss_dssp GCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-----------------CHHHHHHHHHTTCCCCTTBCCEEEE
T ss_pred HccceeeeecCCCceEEEEEEccCCcccceeeeeeccc-----------cchHHHHHHHHHHHHHHhccCCCchhhhcee
Confidence 4455568999999999999999887755 66644311 1123346789999999999 99999999999
Q ss_pred EEeCCeEEEEEeecCCCCHHHHhccCCCCCC-------CCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCC
Q 020641 93 CVEGNLRVLAYEFATMGSLHDILHGRKGVQG-------AQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSS 165 (323)
Q Consensus 93 ~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~ 165 (323)
+...+..++||||+.+++|.+++........ ......+++..++.++.|++.||.|||+. |++|+||||+
T Consensus 95 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~ 171 (327)
T 1fvr_A 95 CEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAAR 171 (327)
T ss_dssp EEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGG
T ss_pred eeeCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccc
Confidence 9999999999999999999999976530000 00011289999999999999999999999 9999999999
Q ss_pred CEEEccCCeEEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCc
Q 020641 166 NVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPR 244 (323)
Q Consensus 166 nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~ 244 (323)
||+++.++.++|+|||++........ .....+++.|+|||.+.+..++.++||||||+++|+|++ |..||......
T Consensus 172 NIl~~~~~~~kL~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~ 248 (327)
T 1fvr_A 172 NILVGENYVAKIADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA 248 (327)
T ss_dssp GEEECGGGCEEECCTTCEESSCEECC---C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH
T ss_pred eEEEcCCCeEEEcccCcCcccccccc---ccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHH
Confidence 99999999999999999875433221 122346788999999988888999999999999999998 99999755321
Q ss_pred ccchhhhhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhhcCCCC
Q 020641 245 GQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSPPP 316 (323)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~~~~~~ 316 (323)
. +...+........+...+..+.+++.+||+.||.+|||+.++++.|++++.....
T Consensus 249 ~----------------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~ 304 (327)
T 1fvr_A 249 E----------------LYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKT 304 (327)
T ss_dssp H----------------HHHHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSSC
T ss_pred H----------------HHHHhhcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhcC
Confidence 1 1111111122233445667899999999999999999999999999999876544
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=319.70 Aligned_cols=248 Identities=21% Similarity=0.222 Sum_probs=202.0
Q ss_pred CCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEe
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVE 95 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 95 (323)
.|....+||+|+||.||+|.+..+++.+|+|++........... .......+.+|+.++++++||||+++++++.+
T Consensus 25 ~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~----~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~ 100 (335)
T 3dls_A 25 KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWI----EDPKLGKVTLEIAILSRVEHANIIKVLDIFEN 100 (335)
T ss_dssp HEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEE----EETTTEEEEHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred ceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhccccccc----chHHHHHHHHHHHHHHhCCCCCEeeEEEEEee
Confidence 34556689999999999999999999999998765443222110 01123566789999999999999999999999
Q ss_pred CCeEEEEEeecCCC-CHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCe
Q 020641 96 GNLRVLAYEFATMG-SLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFK 174 (323)
Q Consensus 96 ~~~~~lv~e~~~~~-sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~ 174 (323)
.+..++||||+.+| +|.+++..... +++..+..++.|++.||.|||+. |++|+||||+||+++.++.
T Consensus 101 ~~~~~lv~e~~~~g~~l~~~~~~~~~---------l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~ 168 (335)
T 3dls_A 101 QGFFQLVMEKHGSGLDLFAFIDRHPR---------LDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFT 168 (335)
T ss_dssp SSEEEEEEECCTTSCBHHHHHHTCCC---------CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSC
T ss_pred CCEEEEEEEeCCCCccHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCc
Confidence 99999999999766 99999976542 89999999999999999999999 9999999999999999999
Q ss_pred EEEeeccccCCCCccccccccccccCccccCCCccccCCCC-CcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhh
Q 020641 175 AKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQL-TQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWA 253 (323)
Q Consensus 175 ~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 253 (323)
++|+|||++........ .....||+.|+|||.+.+..+ +.++||||||+++|+|++|..||......
T Consensus 169 ~kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--------- 236 (335)
T 3dls_A 169 IKLIDFGSAAYLERGKL---FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET--------- 236 (335)
T ss_dssp EEECCCTTCEECCTTCC---BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG---------
T ss_pred EEEeecccceECCCCCc---eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH---------
Confidence 99999999876544322 233458999999999988877 78999999999999999999999642110
Q ss_pred cccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 254 TPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
.... ...+...+..+.+++.+||+.||++|||+.++++
T Consensus 237 ------------~~~~--~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~ 274 (335)
T 3dls_A 237 ------------VEAA--IHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVT 274 (335)
T ss_dssp ------------TTTC--CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------------Hhhc--cCCCcccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0000 0112234567999999999999999999999998
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-45 Score=322.34 Aligned_cols=252 Identities=19% Similarity=0.324 Sum_probs=194.5
Q ss_pred CCCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCC--CcccceeeE
Q 020641 15 PSPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKH--ENLVELLGY 92 (323)
Q Consensus 15 ~~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h--~~i~~~~~~ 92 (323)
..|....+||+|+||.||++.+. +++.+|+|+....... ....+.+.+|+.+++.++| +||++++++
T Consensus 9 ~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----------~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~ 77 (343)
T 3dbq_A 9 RIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEAD----------NQTLDSYRNEIAYLNKLQQHSDKIIRLYDY 77 (343)
T ss_dssp CEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTTCC----------HHHHHHHHHHHHHHHHHTTTCTTBCCEEEE
T ss_pred CEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeeccccc----------hHHHHHHHHHHHHHHhhhhcCCceEEEeee
Confidence 34666779999999999999885 5777888866533211 1123667899999999976 999999999
Q ss_pred EEeCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccC
Q 020641 93 CVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFED 172 (323)
Q Consensus 93 ~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~ 172 (323)
+..+...++||| +.+++|.+++..... +++..+..++.|++.||.|||+. ||+||||||+||+++ +
T Consensus 78 ~~~~~~~~lv~e-~~~~~L~~~l~~~~~---------~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~ 143 (343)
T 3dbq_A 78 EITDQYIYMVME-CGNIDLNSWLKKKKS---------IDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-D 143 (343)
T ss_dssp EECSSEEEEEEC-CCSEEHHHHHHHSCC---------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-T
T ss_pred EeeCCEEEEEEe-CCCCCHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-C
Confidence 999999999999 456799999986542 89999999999999999999999 999999999999997 5
Q ss_pred CeEEEeeccccCCCCccccccccccccCccccCCCccccC-----------CCCCcccchHHHHHHHHHHHhCCCCCCCC
Q 020641 173 FKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT-----------GQLTQKSDVYSFGVVLLELLTGRKPVDHT 241 (323)
Q Consensus 173 ~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-----------~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 241 (323)
+.++|+|||++................||+.|+|||.+.+ ..++.++||||||+++|+|++|+.||...
T Consensus 144 ~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 223 (343)
T 3dbq_A 144 GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI 223 (343)
T ss_dssp TEEEECCCSSSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred CcEEEeecccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhh
Confidence 7899999999987654433333344568999999998864 56788999999999999999999999754
Q ss_pred CCcccchhhhhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 242 MPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
.... ......+++......+...+..+.+++.+||+.||.+|||+.|+++
T Consensus 224 ~~~~--------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~ 273 (343)
T 3dbq_A 224 INQI--------------SKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 273 (343)
T ss_dssp CSHH--------------HHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhHH--------------HHHHHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHh
Confidence 3211 1122223333333444445567999999999999999999999987
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=325.97 Aligned_cols=269 Identities=22% Similarity=0.328 Sum_probs=207.9
Q ss_pred CCccccccCCCCCCccceeccceeee-----eeeeccccccccCccccccccCCCCCchHHHHHHHHHhcC-CCCcccce
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRVKMRR-----WLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRL-KHENLVEL 89 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~~~~~-----~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~ 89 (323)
.+.....||.|+||.||++.+..+++ .+++|...... .....+.+.+|+.+++++ +||||+++
T Consensus 47 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-----------~~~~~~~~~~E~~~l~~l~~h~~iv~~ 115 (333)
T 2i1m_A 47 NLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA-----------HADEKEALMSELKIMSHLGQHENIVNL 115 (333)
T ss_dssp SEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC-----------CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred HceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc-----------ChHHHHHHHHHHHHHHhhcCCCCeeeE
Confidence 34445589999999999999877665 56666543211 111236688999999999 89999999
Q ss_pred eeEEEeCCeEEEEEeecCCCCHHHHhccCCCCCC-----CCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCC
Q 020641 90 LGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQG-----AQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRS 164 (323)
Q Consensus 90 ~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp 164 (323)
++++..++..++||||+.+|+|.+++........ ......+++..++.++.|++.||.|||+. |++|+||||
T Consensus 116 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp 192 (333)
T 2i1m_A 116 LGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAA 192 (333)
T ss_dssp EEEECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSG
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCccc
Confidence 9999999999999999999999999975421000 00012378999999999999999999999 999999999
Q ss_pred CCEEEccCCeEEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCC
Q 020641 165 SNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMP 243 (323)
Q Consensus 165 ~nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~ 243 (323)
+||+++.++.++|+|||++................+++.|+|||.+.+..++.++||||||+++|+|++ |..||.....
T Consensus 193 ~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 272 (333)
T 2i1m_A 193 RNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILV 272 (333)
T ss_dssp GGCEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCS
T ss_pred ceEEECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccch
Confidence 999999999999999999986544333222334446788999999988889999999999999999998 9999975533
Q ss_pred cccchhhhhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhhcC
Q 020641 244 RGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKS 313 (323)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~~~ 313 (323)
... ....+........+...+..+.+++.+||+.||.+|||+.||++.|+++...
T Consensus 273 ~~~---------------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~ 327 (333)
T 2i1m_A 273 NSK---------------FYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQE 327 (333)
T ss_dssp SHH---------------HHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hHH---------------HHHHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHh
Confidence 211 1111111122223334466799999999999999999999999999988753
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-45 Score=319.88 Aligned_cols=245 Identities=18% Similarity=0.193 Sum_probs=188.3
Q ss_pred CccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcC-CCCcccceeeEEEe
Q 020641 17 PGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRL-KHENLVELLGYCVE 95 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~ 95 (323)
|....+||+|+||+||+|++..+++.+|+|+......... .......|+..+..+ +|+||+++++++.+
T Consensus 59 y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~----------~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~ 128 (311)
T 3p1a_A 59 FQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPK----------DRARKLAEVGSHEKVGQHPCCVRLEQAWEE 128 (311)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHH----------HHHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred eeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChH----------HHHHHHHHHHHHHHhcCCCcEEEEEEEEEe
Confidence 4445589999999999999999999999996543211111 113344455555444 99999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeE
Q 020641 96 GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKA 175 (323)
Q Consensus 96 ~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~ 175 (323)
++..++||||+ +++|.+++...... +++..++.++.|++.||.|||+. ||+|+||||+||+++.++.+
T Consensus 129 ~~~~~lv~e~~-~~~L~~~~~~~~~~--------l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~ 196 (311)
T 3p1a_A 129 GGILYLQTELC-GPSLQQHCEAWGAS--------LPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRC 196 (311)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHHCSC--------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCE
T ss_pred CCEEEEEEecc-CCCHHHHHHhcCCC--------CCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCE
Confidence 99999999999 55999998765432 99999999999999999999999 99999999999999999999
Q ss_pred EEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhcc
Q 020641 176 KIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATP 255 (323)
Q Consensus 176 ~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~ 255 (323)
+|+|||++........ .....||+.|+|||++.+ .++.++||||||+++|+|++|..|+.....
T Consensus 197 kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~------------ 260 (311)
T 3p1a_A 197 KLGDFGLLVELGTAGA---GEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG------------ 260 (311)
T ss_dssp EECCCTTCEECC---------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH------------
T ss_pred EEccceeeeecccCCC---CcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH------------
Confidence 9999999876543322 233458999999998876 789999999999999999999776643211
Q ss_pred cccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 256 RLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
...+.........+...+..+.+++.+||+.||++|||+.|+++
T Consensus 261 ------~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 261 ------WQQLRQGYLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp ------HHHHTTTCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ------HHHHhccCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 00010100000111234567999999999999999999999997
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-45 Score=315.84 Aligned_cols=256 Identities=22% Similarity=0.361 Sum_probs=198.1
Q ss_pred CccccccCCCCCCccceeccceee-------eeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccce
Q 020641 17 PGYFVRLDKGPEDDLYLKKRVKMR-------RWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVEL 89 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~~~~~~-------~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~ 89 (323)
|....+||+|+||+||++.+..++ +.+++|..... .....+.+.+|++++++++||||+++
T Consensus 10 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~------------~~~~~~~~~~E~~~l~~l~h~~iv~~ 77 (289)
T 4fvq_A 10 LIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKA------------HRNYSESFFEAASMMSKLSHKHLVLN 77 (289)
T ss_dssp EEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGG------------GGGGHHHHHHHHHHHHTSCCTTBCCE
T ss_pred eeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccc------------cHHHHHHHHHHHHHHHhCCCCCEeEE
Confidence 455568999999999999998877 35777755321 12234678999999999999999999
Q ss_pred eeEEEeCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEE
Q 020641 90 LGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLL 169 (323)
Q Consensus 90 ~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili 169 (323)
++++..++..++||||+.+++|.+++...... +++..+..++.|++.||.|||+. |++|+||||+||++
T Consensus 78 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~--------~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll 146 (289)
T 4fvq_A 78 YGVCVCGDENILVQEFVKFGSLDTYLKKNKNC--------INILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILL 146 (289)
T ss_dssp EEEECCTTCCEEEEECCTTCBHHHHHHHTGGG--------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEE
T ss_pred EEEEEeCCCCEEEEECCCCCCHHHHHHhCCCC--------CCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEE
Confidence 99999999999999999999999999765432 88999999999999999999999 99999999999999
Q ss_pred ccCCe--------EEEeeccccCCCCccccccccccccCccccCCCccccC-CCCCcccchHHHHHHHHHHHhCCCCCCC
Q 020641 170 FEDFK--------AKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT-GQLTQKSDVYSFGVVLLELLTGRKPVDH 240 (323)
Q Consensus 170 ~~~~~--------~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~ 240 (323)
+.++. ++|+|||++....... ...|++.|+|||.+.+ ..++.++||||||+++|+|++|..|+..
T Consensus 147 ~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~ 220 (289)
T 4fvq_A 147 IREEDRKTGNPPFIKLSDPGISITVLPKD------ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLS 220 (289)
T ss_dssp EECCBGGGTBCCEEEECCCCSCTTTSCHH------HHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred ecCCcccccccceeeeccCcccccccCcc------ccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCcc
Confidence 98877 9999999987654322 2236888999999987 6789999999999999999995554432
Q ss_pred CCCcccchhhhhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhhcCCCCCC
Q 020641 241 TMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSPPPAA 318 (323)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~~~~~~~~ 318 (323)
............. ....+...+..+.+++.+||+.||.+|||+.++++.|++++....++.
T Consensus 221 ~~~~~~~~~~~~~-----------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~~~~~ 281 (289)
T 4fvq_A 221 ALDSQRKLQFYED-----------------RHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDLVPR 281 (289)
T ss_dssp TSCHHHHHHHHHT-----------------TCCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-------
T ss_pred ccchHHHHHHhhc-----------------cCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCCCC
Confidence 2211110000000 011112224468999999999999999999999999999997555443
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-45 Score=313.11 Aligned_cols=248 Identities=24% Similarity=0.346 Sum_probs=201.9
Q ss_pred CCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEe
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVE 95 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 95 (323)
.|....+||.|+||.||++.+..+++.+++|+........ ......+.+|+.++++++||||+++++++.+
T Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 80 (279)
T 3fdn_A 10 DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEK---------AGVEHQLRREVEIQSHLRHPNILRLYGYFHD 80 (279)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHH---------HTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred cEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccch---------hhHHHHHHHHHHHHHcCCCCCCcchhheEec
Confidence 3555668999999999999999999999999775432211 2234678899999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeE
Q 020641 96 GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKA 175 (323)
Q Consensus 96 ~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~ 175 (323)
....++||||+.+++|.+++..... +++..+..++.|++.||.|||+. |++|+||||+||+++.++.+
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~---------~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~ 148 (279)
T 3fdn_A 81 ATRVYLILEYAPLGTVYRELQKLSK---------FDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGEL 148 (279)
T ss_dssp SSEEEEEECCCTTEEHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCE
T ss_pred CCEEEEEEecCCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCE
Confidence 9999999999999999999976532 89999999999999999999999 99999999999999999999
Q ss_pred EEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhcc
Q 020641 176 KIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATP 255 (323)
Q Consensus 176 ~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~ 255 (323)
+|+|||++....... .....|++.|+|||.+.+..++.++||||||+++|+|++|..||..............
T Consensus 149 ~l~Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--- 221 (279)
T 3fdn_A 149 KIADFGWSVHAPSSR----RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR--- 221 (279)
T ss_dssp EECSCCEESCC------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH---
T ss_pred EEEeccccccCCccc----ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHh---
Confidence 999999986554322 1334589999999999988899999999999999999999999975432211111100
Q ss_pred cccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 256 RLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
.....+...+..+.+++.+||+.||.+|||+.|+++
T Consensus 222 --------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 257 (279)
T 3fdn_A 222 --------------VEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 257 (279)
T ss_dssp --------------TCCCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred --------------CCCCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 011223345667999999999999999999999997
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-45 Score=317.68 Aligned_cols=266 Identities=17% Similarity=0.202 Sum_probs=198.3
Q ss_pred CCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEe
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVE 95 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 95 (323)
.|....+||+|+||+||+|.+..+++.+|+|....... .....+.+.+|++++++++||||+++++++..
T Consensus 4 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----------~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 73 (311)
T 4agu_A 4 KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESED----------DPVIKKIALREIRMLKQLKHPNLVNLLEVFRR 73 (311)
T ss_dssp CEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-----------HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred cceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeecccc----------chHHHHHHHHHHHHHHhCCCCCccchhheeec
Confidence 35666799999999999999999999999996643211 11123567889999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeE
Q 020641 96 GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKA 175 (323)
Q Consensus 96 ~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~ 175 (323)
.+..++||||+.+++|.+++..... +++..+..++.|++.||.|||+. |++|+||||+||+++.++.+
T Consensus 74 ~~~~~lv~e~~~~~~l~~~~~~~~~---------~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~ 141 (311)
T 4agu_A 74 KRRLHLVFEYCDHTVLHELDRYQRG---------VPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVI 141 (311)
T ss_dssp TTEEEEEEECCSEEHHHHHHHTSSC---------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCE
T ss_pred CCeEEEEEEeCCCchHHHHHhhhcC---------CCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCE
Confidence 9999999999999999998875532 89999999999999999999999 99999999999999999999
Q ss_pred EEeeccccCCCCccccccccccccCccccCCCccccC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhc
Q 020641 176 KIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT-GQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWAT 254 (323)
Q Consensus 176 ~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~ 254 (323)
+|+|||++......... .....|++.|+|||.+.+ ..++.++||||||+++|+|++|..||................
T Consensus 142 kl~Dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~ 219 (311)
T 4agu_A 142 KLCDFGFARLLTGPSDY--YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTL 219 (311)
T ss_dssp EECCCTTCEECC--------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred EEeeCCCchhccCcccc--cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence 99999999765432221 233458999999999876 567999999999999999999999997665432211111110
Q ss_pred cccccc--------cc-chhcCCCcCCCC-----CHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 255 PRLSED--------KV-KQCVDPKLKGEY-----PPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 255 ~~~~~~--------~~-~~~~~~~~~~~~-----~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
...... .. .....+...... ....+..+.+++.+||+.||.+|||++|+++
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 284 (311)
T 4agu_A 220 GDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH 284 (311)
T ss_dssp CSCCHHHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred cccccccccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 000000 00 000000000000 0234567999999999999999999999986
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-45 Score=327.31 Aligned_cols=283 Identities=15% Similarity=0.146 Sum_probs=205.1
Q ss_pred CCccccccCCCCCCccceecccee-----eeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCccccee
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRVKM-----RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELL 90 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~~~-----~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~ 90 (323)
.|....+||+|+||.||+|.+..+ ++.+|+|+.......... +...........+..++..++.++|+||++++
T Consensus 36 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~-e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~ 114 (364)
T 3op5_A 36 AWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFT-ELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYW 114 (364)
T ss_dssp EEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHH-HHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEE
T ss_pred eEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHH-HHHHHHhhhhhHHHHHHHHHhhccCCCCCeEE
Confidence 455566999999999999988765 467888866533210000 00000011123455667778888999999999
Q ss_pred eEEEeC----CeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCC
Q 020641 91 GYCVEG----NLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSN 166 (323)
Q Consensus 91 ~~~~~~----~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~n 166 (323)
+++... ...++||||+ +++|.+++...... +++..++.++.|++.||.|||+. ||+||||||+|
T Consensus 115 ~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~--------l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~N 182 (364)
T 3op5_A 115 GSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKR--------FSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASN 182 (364)
T ss_dssp EEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSC--------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGG
T ss_pred eeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCC--------CCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHH
Confidence 998764 4579999999 88999999765322 99999999999999999999999 99999999999
Q ss_pred EEEc--cCCeEEEeeccccCCCCccccccc-----cccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCC
Q 020641 167 VLLF--EDFKAKIADFNLSNQAPDMAARLH-----STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVD 239 (323)
Q Consensus 167 ili~--~~~~~~l~Dfg~~~~~~~~~~~~~-----~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~ 239 (323)
|+++ .++.++|+|||++........... .....||+.|+|||.+.+..++.++||||||+++|+|++|+.||.
T Consensus 183 ill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~ 262 (364)
T 3op5_A 183 LLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWE 262 (364)
T ss_dssp EEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTG
T ss_pred EEEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence 9999 889999999999976554322211 123348999999999999999999999999999999999999997
Q ss_pred CCCCcccchhhhhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhhcCCCCC
Q 020641 240 HTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSPPPA 317 (323)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~~~~~~~ 317 (323)
......... ....... ...+...+++.+. ....+..+.+++..||+.||.+|||+.+|++.|+++++.....
T Consensus 263 ~~~~~~~~~--~~~~~~~-~~~~~~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~ 334 (364)
T 3op5_A 263 DNLKDPKYV--RDSKIRY-RENIASLMDKCFP---AANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSK 334 (364)
T ss_dssp GGTTCHHHH--HHHHHHH-HHCHHHHHHHHSC---TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred ccccCHHHH--HHHHHHh-hhhHHHHHHHhcc---cccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCC
Confidence 543221111 0000000 0111122211111 1233567999999999999999999999999999998765443
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-45 Score=314.27 Aligned_cols=265 Identities=18% Similarity=0.245 Sum_probs=197.1
Q ss_pred CCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEe
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVE 95 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 95 (323)
.|....+||+|+||+||+|++ .+++.+|+|...... ........+.+|++++++++||||+++++++..
T Consensus 3 ~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~----------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 71 (288)
T 1ob3_A 3 KYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEK----------EDEGIPSTTIREISILKELKHSNIVKLYDVIHT 71 (288)
T ss_dssp SEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSS----------GGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEEC
T ss_pred cchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccc----------cccccchhHHHHHHHHHhcCCCCEeeeeeEEcc
Confidence 356677999999999999998 567778888664321 112334778899999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeE
Q 020641 96 GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKA 175 (323)
Q Consensus 96 ~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~ 175 (323)
.+..++||||+.+ +|.+++...... +++..+..++.|++.||.|||+. |++|+||||+||+++.++.+
T Consensus 72 ~~~~~lv~e~~~~-~l~~~~~~~~~~--------~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~ 139 (288)
T 1ob3_A 72 KKRLVLVFEHLDQ-DLKKLLDVCEGG--------LESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGEL 139 (288)
T ss_dssp SSCEEEEEECCSE-EHHHHHHTSTTC--------CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCE
T ss_pred CCeEEEEEEecCC-CHHHHHHhcccC--------CCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCE
Confidence 9999999999986 999999765332 88999999999999999999999 99999999999999999999
Q ss_pred EEeeccccCCCCccccccccccccCccccCCCccccCC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhc
Q 020641 176 KIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG-QLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWAT 254 (323)
Q Consensus 176 ~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~ 254 (323)
+|+|||++........ ......||+.|+|||.+.+. .++.++||||||+++|+|++|..||................
T Consensus 140 kl~Dfg~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 217 (288)
T 1ob3_A 140 KIADFGLARAFGIPVR--KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRIL 217 (288)
T ss_dssp EECCTTHHHHHCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred EEeECccccccCcccc--ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHH
Confidence 9999999865432211 12234579999999998764 58999999999999999999999997654322111111000
Q ss_pred c-----cccccccchhcCCCcC-------CCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 255 P-----RLSEDKVKQCVDPKLK-------GEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 255 ~-----~~~~~~~~~~~~~~~~-------~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
. .++........++... .......+..+.+++.+||+.||++|||+.|+++
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 218 GTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp CCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCCChhhchhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0 0000000000111110 0112234677999999999999999999999986
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-45 Score=313.40 Aligned_cols=263 Identities=20% Similarity=0.257 Sum_probs=203.6
Q ss_pred cccCCCCCccccccCCCCCCccceeccce---eeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcc
Q 020641 10 LGAHAPSPGYFVRLDKGPEDDLYLKKRVK---MRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENL 86 (323)
Q Consensus 10 ~~~~~~~~~~~~~lg~G~~~~V~~~~~~~---~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i 86 (323)
.+-....+.....||+|+||.||++.+.. ++..+++|...... .....+.+.+|+.+++.++||||
T Consensus 7 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~-----------~~~~~~~~~~E~~~l~~l~h~~i 75 (281)
T 3cc6_A 7 YGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC-----------TLDNKEKFMSEAVIMKNLDHPHI 75 (281)
T ss_dssp CSCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS-----------CHHHHHHHHHHHHHHHHHCCTTB
T ss_pred ceecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc-----------CchHHHHHHHHHHHHHhCCCCCc
Confidence 33334455566689999999999998543 45568888664321 11123678899999999999999
Q ss_pred cceeeEEEeCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCC
Q 020641 87 VELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSN 166 (323)
Q Consensus 87 ~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~n 166 (323)
+++++++..+ ..++||||+.+++|.+++...... +++..+..++.|++.||.|||+. |++|+||||+|
T Consensus 76 ~~~~~~~~~~-~~~~v~e~~~~~~L~~~l~~~~~~--------~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~N 143 (281)
T 3cc6_A 76 VKLIGIIEEE-PTWIIMELYPYGELGHYLERNKNS--------LKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRN 143 (281)
T ss_dssp CCEEEEECSS-SCEEEEECCTTCBHHHHHHHHTTT--------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGG
T ss_pred ceEEEEEcCC-CCEEEEecCCCCCHHHHHHhcccc--------CCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccce
Confidence 9999998755 468999999999999999765432 88999999999999999999999 99999999999
Q ss_pred EEEccCCeEEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcc
Q 020641 167 VLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRG 245 (323)
Q Consensus 167 ili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~ 245 (323)
|+++.++.++|+|||++......... ......+++.|+|||.+.+..++.++||||||+++|+|++ |+.||.......
T Consensus 144 il~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~ 222 (281)
T 3cc6_A 144 ILVASPECVKLGDFGLSRYIEDEDYY-KASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD 222 (281)
T ss_dssp EEEEETTEEEECCCCGGGCC----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGG
T ss_pred EEECCCCcEEeCccCCCccccccccc-ccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHH
Confidence 99999999999999998766543221 1223346788999999988889999999999999999998 999997543321
Q ss_pred cchhhhhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhhc
Q 020641 246 QQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLK 312 (323)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~~ 312 (323)
... .+........+...+..+.+++.+||+.||.+|||+.|+++.|+++..
T Consensus 223 ~~~----------------~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 273 (281)
T 3cc6_A 223 VIG----------------VLEKGDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQ 273 (281)
T ss_dssp HHH----------------HHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHH----------------HHhcCCCCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHH
Confidence 111 111111122234456779999999999999999999999999998865
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-45 Score=320.56 Aligned_cols=248 Identities=17% Similarity=0.194 Sum_probs=179.5
Q ss_pred cccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCC-CCcccceeeEEEeCCeE
Q 020641 21 VRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLK-HENLVELLGYCVEGNLR 99 (323)
Q Consensus 21 ~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~ 99 (323)
..||+|+||.||++.+..+++.+|+|++.+. ......+|+.+++.+. ||||+++++++.+....
T Consensus 17 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---------------~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~ 81 (325)
T 3kn6_A 17 KPLGEGSFSICRKCVHKKSNQAFAVKIISKR---------------MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHT 81 (325)
T ss_dssp CCSEEETTEEEEEEEETTTCCEEEEEEEEGG---------------GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEChh---------------hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEE
Confidence 3699999999999999999999999976432 2356778999999995 99999999999999999
Q ss_pred EEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCC---eEE
Q 020641 100 VLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDF---KAK 176 (323)
Q Consensus 100 ~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~---~~~ 176 (323)
++||||+.+++|.+++..... +++..+..++.|++.||.|||+. |++||||||+||+++.++ .++
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~k 149 (325)
T 3kn6_A 82 FLVMELLNGGELFERIKKKKH---------FSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIK 149 (325)
T ss_dssp EEEECCCCSCBHHHHHHHCSC---------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEE
T ss_pred EEEEEccCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEE
Confidence 999999999999999977542 89999999999999999999999 999999999999997765 899
Q ss_pred EeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhccc
Q 020641 177 IADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPR 256 (323)
Q Consensus 177 l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 256 (323)
|+|||++........ ......||+.|+|||.+.+..++.++||||||+++|+|++|..||.............
T Consensus 150 l~Dfg~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~----- 222 (325)
T 3kn6_A 150 IIDFGFARLKPPDNQ--PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAV----- 222 (325)
T ss_dssp ECCCTTCEECCC------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHH-----
T ss_pred EeccccceecCCCCC--cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHH-----
Confidence 999999875543222 1233457999999999999999999999999999999999999997654321110000
Q ss_pred ccccccchhcCCCcCCC--CCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 257 LSEDKVKQCVDPKLKGE--YPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 257 ~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
.....+........ .....+..+.+++.+||+.||.+|||+.|+++
T Consensus 223 ---~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 270 (325)
T 3kn6_A 223 ---EIMKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY 270 (325)
T ss_dssp ---HHHHHHTTTCCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred ---HHHHHHHcCCCCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence 00111111111000 01234678999999999999999999999985
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=315.21 Aligned_cols=254 Identities=21% Similarity=0.298 Sum_probs=193.8
Q ss_pred CCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhc--CCCCcccceeeEE
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSR--LKHENLVELLGYC 93 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~--l~h~~i~~~~~~~ 93 (323)
.|....+||+|+||+||++++ +++.+|+|+.... ....+..|.+++.. ++||||+++++++
T Consensus 9 ~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---------------~~~~~~~e~~~~~~~~l~h~niv~~~~~~ 71 (301)
T 3q4u_A 9 DITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSR---------------DEKSWFRETELYNTVMLRHENILGFIASD 71 (301)
T ss_dssp GCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGG---------------GHHHHHHHHHHHHHTCCCCTTBCCEEEEE
T ss_pred cEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccc---------------cchhhHHHHHHHHHhhccCcCeeeEEEee
Confidence 455666999999999999987 5778898866421 12445566666655 7999999999986
Q ss_pred EeC----CeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhh--------cCCCCCceeCC
Q 020641 94 VEG----NLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLH--------EKVQPSIIHRD 161 (323)
Q Consensus 94 ~~~----~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh--------~~~~~~i~h~d 161 (323)
... ...++||||+.+|+|.++++... +++..++.++.|++.||.||| +. |++|||
T Consensus 72 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~D 138 (301)
T 3q4u_A 72 MTSRHSSTQLWLITHYHEMGSLYDYLQLTT----------LDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRD 138 (301)
T ss_dssp EEEETTEEEEEEEECCCTTCBHHHHHTTCC----------BCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSC
T ss_pred ccccCCCceeEEehhhccCCCHHHHHhhcc----------cCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCC
Confidence 543 45799999999999999996542 999999999999999999999 88 999999
Q ss_pred CCCCCEEEccCCeEEEeeccccCCCCccccc--cccccccCccccCCCccccCC------CCCcccchHHHHHHHHHHHh
Q 020641 162 IRSSNVLLFEDFKAKIADFNLSNQAPDMAAR--LHSTRVLGTFGYHAPEYAMTG------QLTQKSDVYSFGVVLLELLT 233 (323)
Q Consensus 162 ikp~nili~~~~~~~l~Dfg~~~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~------~~~~~~Di~slG~~l~~l~~ 233 (323)
|||+||+++.++.++|+|||++......... .......||+.|+|||.+.+. .++.++||||||+++|+|++
T Consensus 139 lkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~t 218 (301)
T 3q4u_A 139 LKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVAR 218 (301)
T ss_dssp CCGGGEEECTTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHT
T ss_pred CChHhEEEcCCCCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHh
Confidence 9999999999999999999998644332211 112334689999999998766 44579999999999999999
Q ss_pred C----------CCCCCCCCCcccchhhhhhcccccccccchhc-CCCcCCC-----CCHHHHHHHHHHHHHccCCCCCCC
Q 020641 234 G----------RKPVDHTMPRGQQSLVTWATPRLSEDKVKQCV-DPKLKGE-----YPPKGVAKLAAVAALCVQYEAEFR 297 (323)
Q Consensus 234 g----------~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~-----~~~~~~~~l~~li~~cl~~~P~~R 297 (323)
| ..||........... ...... ....... .+...+..+.+++.+||+.||++|
T Consensus 219 g~~~~~~~~~~~~pf~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R 287 (301)
T 3q4u_A 219 RMVSNGIVEDYKPPFYDVVPNDPSFE-----------DMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSAR 287 (301)
T ss_dssp TBCBTTBCCCCCCTTTTTSCSSCCHH-----------HHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGS
T ss_pred hhcCccccccccccccccCCCCcchh-----------hhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhC
Confidence 9 777764432211110 000000 0011111 223567889999999999999999
Q ss_pred CChHHHHHHHhhh
Q 020641 298 PNMSIVVKALQPL 310 (323)
Q Consensus 298 ps~~evl~~l~~~ 310 (323)
||+.+|++.|+++
T Consensus 288 ps~~~i~~~L~~i 300 (301)
T 3q4u_A 288 LTALRIKKTLTKI 300 (301)
T ss_dssp CCHHHHHHHHHHH
T ss_pred CCHHHHHHHHhcc
Confidence 9999999999875
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=327.11 Aligned_cols=243 Identities=16% Similarity=0.171 Sum_probs=188.6
Q ss_pred ccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcC-CCCcccceeeEEEe----C
Q 020641 22 RLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRL-KHENLVELLGYCVE----G 96 (323)
Q Consensus 22 ~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~----~ 96 (323)
.||.|+||.||++.+..+++.+|+|++.. ...+.+|+.++.++ +|+||+++++++.. .
T Consensus 69 ~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-----------------~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~ 131 (400)
T 1nxk_A 69 VLGLGINGKVLQIFNKRTQEKFALKMLQD-----------------CPKARREVELHWRASQCPHIVRIVDVYENLYAGR 131 (400)
T ss_dssp EEEEETTEEEEEEEETTTCCEEEEEEEEC-----------------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred eeeeccCeEEEEEEECCCCCEEEEEEeCc-----------------chhHHHHHHHHHHhcCCCCcceEeEEEeecccCC
Confidence 68999999999999999999999997631 14567888887544 99999999999875 5
Q ss_pred CeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEcc---CC
Q 020641 97 NLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFE---DF 173 (323)
Q Consensus 97 ~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~---~~ 173 (323)
...|+||||+.+|+|.+++...... .+++..+..++.||+.||.|||+. ||+||||||+||+++. ++
T Consensus 132 ~~~~lv~E~~~gg~L~~~l~~~~~~-------~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~ 201 (400)
T 1nxk_A 132 KCLLIVMECLDGGELFSRIQDRGDQ-------AFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNA 201 (400)
T ss_dssp EEEEEEEECCCSEEHHHHHHCC----------CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTC
T ss_pred cEEEEEEEeCCCCcHHHHHHHhCCC-------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCc
Confidence 5789999999999999999865432 289999999999999999999999 9999999999999987 78
Q ss_pred eEEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhh
Q 020641 174 KAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWA 253 (323)
Q Consensus 174 ~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 253 (323)
.+||+|||++........ .....||+.|+|||++.+..++.++|||||||++|+|++|..||...........
T Consensus 202 ~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~---- 274 (400)
T 1nxk_A 202 ILKLTDFGFAKETTSHNS---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG---- 274 (400)
T ss_dssp CEEECCCTTCEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCS----
T ss_pred cEEEEecccccccCCCCc---cccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHH----
Confidence 999999999876543221 2344589999999999999999999999999999999999999976543221100
Q ss_pred cccccccccchhcCCCc--CCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 254 TPRLSEDKVKQCVDPKL--KGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 254 ~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
....+..... ........+.++.+||.+||+.||.+|||+.|+++
T Consensus 275 -------~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 321 (400)
T 1nxk_A 275 -------MKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 321 (400)
T ss_dssp -------HHHHHHHTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -------HHHHHHcCcccCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0000000000 01111345677999999999999999999999997
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-45 Score=312.38 Aligned_cols=258 Identities=23% Similarity=0.298 Sum_probs=189.6
Q ss_pred ccccCCCCCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccc
Q 020641 9 ALGAHAPSPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVE 88 (323)
Q Consensus 9 ~~~~~~~~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~ 88 (323)
.+|.....|.....||+|+||.||++++..+++.+++|+....... .....+.+.+|+.++++++||||++
T Consensus 5 ~~g~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---------~~~~~~~~~~e~~~l~~l~h~~i~~ 75 (278)
T 3cok_A 5 CIGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMY---------KAGMVQRVQNEVKIHCQLKHPSILE 75 (278)
T ss_dssp HHCSSGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH---------HTTCHHHHHHHHHHHTTBCCTTBCC
T ss_pred ccccccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhh---------hhhHHHHHHHHHHHHHhCCCCCeEe
Confidence 3455556677777999999999999999999999999977543211 1233477899999999999999999
Q ss_pred eeeEEEeCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEE
Q 020641 89 LLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVL 168 (323)
Q Consensus 89 ~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nil 168 (323)
+++++...+..++||||+.+++|.+++...... +++..++.++.|++.||.|||+. |++|+||||+||+
T Consensus 76 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~--------~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil 144 (278)
T 3cok_A 76 LYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKP--------FSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLL 144 (278)
T ss_dssp EEEEEECSSEEEEEEECCTTEEHHHHHHTCSSC--------CCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEE
T ss_pred EEEEEccCCeEEEEEecCCCCcHHHHHhhccCC--------CCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEE
Confidence 999999999999999999999999999765322 89999999999999999999999 9999999999999
Q ss_pred EccCCeEEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccch
Q 020641 169 LFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQS 248 (323)
Q Consensus 169 i~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~ 248 (323)
++.++.++|+|||++......... .....|++.|+|||.+.+..++.++||||||+++|+|++|+.||.........
T Consensus 145 i~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~- 221 (278)
T 3cok_A 145 LTRNMNIKIADFGLATQLKMPHEK--HYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTL- 221 (278)
T ss_dssp ECTTCCEEECCCTTCEECC------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC----
T ss_pred EcCCCCEEEEeecceeeccCCCCc--ceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHH-
Confidence 999999999999998765432211 12345899999999998888899999999999999999999999754322110
Q ss_pred hhhhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 249 LVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
....... ...+...+..+.+++.+||+.||++|||+.++++
T Consensus 222 --------------~~~~~~~--~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 222 --------------NKVVLAD--YEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp ----------------CCSSC--CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred --------------HHHhhcc--cCCccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 0011111 1223345667999999999999999999999987
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=331.94 Aligned_cols=253 Identities=16% Similarity=0.166 Sum_probs=204.4
Q ss_pred CCCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEE
Q 020641 15 PSPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCV 94 (323)
Q Consensus 15 ~~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 94 (323)
..|.....||+|+||.||+|++..+++.+|+|++.+.... .......+.+|..+++.++||||+++++++.
T Consensus 69 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~---------~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~ 139 (410)
T 3v8s_A 69 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMI---------KRSDSAFFWEERDIMAFANSPWVVQLFYAFQ 139 (410)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH---------HTCCCSTHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred cccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhh---------hhHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence 4566667999999999999999999999999987643211 1223356889999999999999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCe
Q 020641 95 EGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFK 174 (323)
Q Consensus 95 ~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~ 174 (323)
+....|+||||+.+|+|.+++.... +++..+..++.||+.||.|||+. ||+||||||+||+++.++.
T Consensus 140 ~~~~~~lV~E~~~gg~L~~~l~~~~----------~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ 206 (410)
T 3v8s_A 140 DDRYLYMVMEYMPGGDLVNLMSNYD----------VPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGH 206 (410)
T ss_dssp CSSEEEEEECCCTTEEHHHHHHHCC----------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSC
T ss_pred ECCEEEEEEeCCCCCcHHHHHHcCC----------CCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCC
Confidence 9999999999999999999997643 89999999999999999999999 9999999999999999999
Q ss_pred EEEeeccccCCCCccccccccccccCccccCCCccccCCC----CCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhh
Q 020641 175 AKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQ----LTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLV 250 (323)
Q Consensus 175 ~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~----~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~ 250 (323)
++|+|||++........ .......||+.|+|||++.+.. ++.++||||||+++|+|++|+.||..........
T Consensus 207 ikL~DFG~a~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~-- 283 (410)
T 3v8s_A 207 LKLADFGTCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYS-- 283 (410)
T ss_dssp EEECCCTTCEECCTTSE-EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH--
T ss_pred EEEeccceeEeeccCCc-ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHH--
Confidence 99999999976543321 1223456999999999997665 7889999999999999999999997554321111
Q ss_pred hhhcccccccccchhcCCC--cCCCCCHHHHHHHHHHHHHccCCCCCC--CCChHHHHH
Q 020641 251 TWATPRLSEDKVKQCVDPK--LKGEYPPKGVAKLAAVAALCVQYEAEF--RPNMSIVVK 305 (323)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~cl~~~P~~--Rps~~evl~ 305 (323)
+++... .........+..+.+||.+||..+|.. ||+++||++
T Consensus 284 -------------~i~~~~~~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~ 329 (410)
T 3v8s_A 284 -------------KIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKR 329 (410)
T ss_dssp -------------HHHTHHHHCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHT
T ss_pred -------------HHHhccccccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhc
Confidence 111100 011111234567999999999999988 999999997
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=311.74 Aligned_cols=252 Identities=18% Similarity=0.204 Sum_probs=203.1
Q ss_pred CCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEe
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVE 95 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 95 (323)
.|....+||.|+||.||+|.+..+++.+++|+........ ...+.+.+|+.++++++||||+++++++..
T Consensus 7 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 76 (284)
T 3kk8_A 7 NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSA----------RDFQKLEREARICRKLQHPNIVRLHDSIQE 76 (284)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCH----------HHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred hhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCH----------HHHHHHHHHHHHHHHcCCCCcCeEEEEEEc
Confidence 4556669999999999999999999999999776443221 123567899999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCe-
Q 020641 96 GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFK- 174 (323)
Q Consensus 96 ~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~- 174 (323)
++..++||||+.+++|.+.+..... +++..+..++.|++.|+.|||+. |++|+||||+||+++.++.
T Consensus 77 ~~~~~~v~e~~~~~~l~~~~~~~~~---------~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~ 144 (284)
T 3kk8_A 77 ESFHYLVFDLVTGGELFEDIVAREF---------YSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKG 144 (284)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTT
T ss_pred CCEEEEEEecCCCCCHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCC
Confidence 9999999999999999998876542 89999999999999999999999 9999999999999986655
Q ss_pred --EEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhh
Q 020641 175 --AKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTW 252 (323)
Q Consensus 175 --~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 252 (323)
++|+|||++........ .....|++.|+|||.+.+..++.++||||||+++|+|++|..||..............
T Consensus 145 ~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 221 (284)
T 3kk8_A 145 AAVKLADFGLAIEVNDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKA 221 (284)
T ss_dssp CCEEECCCTTCEECCSSCB---CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred CcEEEeeceeeEEcccCcc---ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHh
Confidence 99999999876543322 2334589999999999999999999999999999999999999975532211111110
Q ss_pred hcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 253 ATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
.... .........+..+.+++.+||+.||.+|||+.|+++
T Consensus 222 ~~~~-------------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 222 GAYD-------------YPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp TCCC-------------CCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred cccc-------------CCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 0000 001112344567999999999999999999999987
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-44 Score=339.92 Aligned_cols=253 Identities=25% Similarity=0.354 Sum_probs=202.5
Q ss_pred ccCCCCCCccceeccc--eeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeCCeE
Q 020641 22 RLDKGPEDDLYLKKRV--KMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLR 99 (323)
Q Consensus 22 ~lg~G~~~~V~~~~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 99 (323)
+||+|+||.||++... .++..+|+|+.... ......+.+.+|++++++++||||+++++++.. +..
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~-----------~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~ 410 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG-----------TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EAL 410 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCC-----------CSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSE
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCC-----------CChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCe
Confidence 6899999999999765 45667888866432 122345788999999999999999999999976 458
Q ss_pred EEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEEEee
Q 020641 100 VLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIAD 179 (323)
Q Consensus 100 ~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~l~D 179 (323)
++||||+.+|+|.+++...... +++..+..++.|++.||.|||++ ||+||||||+|||++.++.+||+|
T Consensus 411 ~lv~E~~~~g~L~~~l~~~~~~--------l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~D 479 (613)
T 2ozo_A 411 MLVMEMAGGGPLHKFLVGKREE--------IPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISD 479 (613)
T ss_dssp EEEEECCTTCBHHHHHTTCTTT--------SCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC
T ss_pred EEEEEeCCCCcHHHHHhhccCC--------CCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEee
Confidence 9999999999999999754322 89999999999999999999999 999999999999999999999999
Q ss_pred ccccCCCCccccc-cccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccc
Q 020641 180 FNLSNQAPDMAAR-LHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPRL 257 (323)
Q Consensus 180 fg~~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~ 257 (323)
||++......... .......+++.|+|||.+.+..++.++||||||+++|+|++ |+.||......
T Consensus 480 FGla~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~------------- 546 (613)
T 2ozo_A 480 FGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP------------- 546 (613)
T ss_dssp CSTTTTCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSH-------------
T ss_pred ccCcccccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHH-------------
Confidence 9999876433221 11122235678999999998899999999999999999998 99999765432
Q ss_pred cccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhhcC
Q 020641 258 SEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKS 313 (323)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~~~ 313 (323)
.+...+....+...+..++..+.++|.+||+.||++|||+.+|++.|+.+...
T Consensus 547 ---~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~ 599 (613)
T 2ozo_A 547 ---EVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 599 (613)
T ss_dssp ---HHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred ---HHHHHHHcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence 12222222333445566778899999999999999999999999999998643
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=321.33 Aligned_cols=246 Identities=22% Similarity=0.302 Sum_probs=197.4
Q ss_pred ccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeCC
Q 020641 18 GYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGN 97 (323)
Q Consensus 18 ~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 97 (323)
....+||+|+||+||+|++..+++.+|+|+........ ....+.+.+|++++++++||||+++++++...+
T Consensus 57 ~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~---------~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 127 (348)
T 1u5q_A 57 SDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQS---------NEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREH 127 (348)
T ss_dssp EEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCH---------HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred eeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccc---------hHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC
Confidence 34458999999999999999999999999765322111 112356789999999999999999999999999
Q ss_pred eEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEEE
Q 020641 98 LRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKI 177 (323)
Q Consensus 98 ~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~l 177 (323)
..++||||+.+ +|.+++..... .+++..+..++.|++.||.|||+. |++|+||||+||+++.++.++|
T Consensus 128 ~~~lv~e~~~g-~l~~~l~~~~~--------~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL 195 (348)
T 1u5q_A 128 TAWLVMEYCLG-SASDLLEVHKK--------PLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKL 195 (348)
T ss_dssp EEEEEEECCSE-EHHHHHHHHTS--------CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEE
T ss_pred eEEEEEecCCC-CHHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEE
Confidence 99999999984 88888864432 289999999999999999999999 9999999999999999999999
Q ss_pred eeccccCCCCccccccccccccCccccCCCcccc---CCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhc
Q 020641 178 ADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAM---TGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWAT 254 (323)
Q Consensus 178 ~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~ 254 (323)
+|||++...... ....||+.|+|||++. ...++.++||||||+++|+|++|+.||..........
T Consensus 196 ~DfG~a~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~------ 263 (348)
T 1u5q_A 196 GDFGSASIMAPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY------ 263 (348)
T ss_dssp CCCTTCBSSSSB------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH------
T ss_pred eeccCceecCCC------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH------
Confidence 999998765432 2345899999999884 5678999999999999999999999997553211110
Q ss_pred ccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 255 PRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
...........+...+..+.+++.+||+.||++|||+.++++
T Consensus 264 ---------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 305 (348)
T 1u5q_A 264 ---------HIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 305 (348)
T ss_dssp ---------HHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ---------HHHhcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence 011111111122344567999999999999999999999987
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-44 Score=316.75 Aligned_cols=279 Identities=17% Similarity=0.239 Sum_probs=206.6
Q ss_pred CCCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEE
Q 020641 15 PSPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCV 94 (323)
Q Consensus 15 ~~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 94 (323)
..|....+||+|+||.||+|.+..+++.+|+|++.... ........+.+|+.+++.++||||+++++++.
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 86 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMEN----------EKEGFPITALREIKILQLLKHENVVNLIEICR 86 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSS----------CSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEeccc----------ccccchHHHHHHHHHHHhccCCCcccHhheee
Confidence 34566669999999999999999999999999765332 12334467889999999999999999999998
Q ss_pred e--------CCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCC
Q 020641 95 E--------GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSN 166 (323)
Q Consensus 95 ~--------~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~n 166 (323)
. .+..++||||+.+ +|.+.+...... +++..+..++.|++.||.|||+. |++|+||||+|
T Consensus 87 ~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~--------~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~N 154 (351)
T 3mi9_A 87 TKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVK--------FTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAAN 154 (351)
T ss_dssp EC--------CEEEEEEECCSE-EHHHHHHCTTSC--------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGG
T ss_pred ccccccccCCceEEEEEeccCC-CHHHHHhhccCC--------CCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHH
Confidence 7 4468999999986 888887665432 89999999999999999999999 99999999999
Q ss_pred EEEccCCeEEEeeccccCCCCcccc--ccccccccCccccCCCccccC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCC
Q 020641 167 VLLFEDFKAKIADFNLSNQAPDMAA--RLHSTRVLGTFGYHAPEYAMT-GQLTQKSDVYSFGVVLLELLTGRKPVDHTMP 243 (323)
Q Consensus 167 ili~~~~~~~l~Dfg~~~~~~~~~~--~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 243 (323)
|+++.++.++|+|||++........ ........||+.|+|||++.+ ..++.++||||||+++|+|++|..||.....
T Consensus 155 Il~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~ 234 (351)
T 3mi9_A 155 VLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTE 234 (351)
T ss_dssp EEECTTSCEEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred EEEcCCCCEEEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCCh
Confidence 9999999999999999875542211 112233458999999998876 4579999999999999999999999986643
Q ss_pred cccchhhhhhcccccccccch--------hcCCCcCCCCC--HH-----HHHHHHHHHHHccCCCCCCCCChHHHHHHHh
Q 020641 244 RGQQSLVTWATPRLSEDKVKQ--------CVDPKLKGEYP--PK-----GVAKLAAVAALCVQYEAEFRPNMSIVVKALQ 308 (323)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~--~~-----~~~~l~~li~~cl~~~P~~Rps~~evl~~l~ 308 (323)
......+.............. .+......... .. .+..+.+|+.+||+.||++|||+.|+++ .
T Consensus 235 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~--h 312 (351)
T 3mi9_A 235 QHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN--H 312 (351)
T ss_dssp HHHHHHHHHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT--S
T ss_pred HHHHHHHHHHhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC--C
Confidence 322211111111111111110 00000000000 01 1356889999999999999999999998 5
Q ss_pred hhhcCCCCC
Q 020641 309 PLLKSPPPA 317 (323)
Q Consensus 309 ~~~~~~~~~ 317 (323)
..+...+.|
T Consensus 313 p~f~~~~~~ 321 (351)
T 3mi9_A 313 DFFWSDPMP 321 (351)
T ss_dssp GGGGSSSCC
T ss_pred CCcCCCCCc
Confidence 666555444
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-45 Score=327.45 Aligned_cols=267 Identities=19% Similarity=0.262 Sum_probs=190.8
Q ss_pred CCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCC-CCcccceeeEEE
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLK-HENLVELLGYCV 94 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~ 94 (323)
.|....+||.|+||.||+|.+..+++.+|+|.+...... ......+.+|+.+++.+. |+||+++++++.
T Consensus 10 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~----------~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~ 79 (388)
T 3oz6_A 10 KYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQN----------STDAQRTFREIMILTELSGHENIVNLLNVLR 79 (388)
T ss_dssp TEEEEEC-------CEEEEEETTTCCEEEEEEECC--CC----------HHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred ceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccC----------hHHHHHHHHHHHHHHhccCCCCCCeeeeEEe
Confidence 456667999999999999999999999999976432111 112356778999999995 999999999998
Q ss_pred eCC--eEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccC
Q 020641 95 EGN--LRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFED 172 (323)
Q Consensus 95 ~~~--~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~ 172 (323)
..+ ..|+||||+.+ +|.+++.... ++...+..++.|++.||.|||+. ||+||||||+||+++.+
T Consensus 80 ~~~~~~~~lv~e~~~~-~L~~~~~~~~----------~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~ 145 (388)
T 3oz6_A 80 ADNDRDVYLVFDYMET-DLHAVIRANI----------LEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAE 145 (388)
T ss_dssp CTTSSCEEEEEECCSE-EHHHHHHHTC----------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTT
T ss_pred cCCCCEEEEEecccCc-CHHHHHHcCC----------CCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCC
Confidence 554 68999999985 9999997643 88999999999999999999999 99999999999999999
Q ss_pred CeEEEeeccccCCCCccc-------------------cccccccccCccccCCCccccC-CCCCcccchHHHHHHHHHHH
Q 020641 173 FKAKIADFNLSNQAPDMA-------------------ARLHSTRVLGTFGYHAPEYAMT-GQLTQKSDVYSFGVVLLELL 232 (323)
Q Consensus 173 ~~~~l~Dfg~~~~~~~~~-------------------~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~ 232 (323)
+.++|+|||+++...... .........||+.|+|||++.+ ..++.++|||||||++|+|+
T Consensus 146 ~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell 225 (388)
T 3oz6_A 146 CHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEIL 225 (388)
T ss_dssp CCEEECCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHH
T ss_pred CCEEecCCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHH
Confidence 999999999987543210 1111233468999999999876 67899999999999999999
Q ss_pred hCCCCCCCCCCcccchhhhhhcccccccccchhcC------------------CCcCC------------CCCHHHHHHH
Q 020641 233 TGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVD------------------PKLKG------------EYPPKGVAKL 282 (323)
Q Consensus 233 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------------~~~~~------------~~~~~~~~~l 282 (323)
+|+.||.+.........+...........+..... ..... ......+.++
T Consensus 226 ~g~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (388)
T 3oz6_A 226 CGKPIFPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEA 305 (388)
T ss_dssp HSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHH
T ss_pred hCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHH
Confidence 99999986653222111111100000000000000 00000 0011335679
Q ss_pred HHHHHHccCCCCCCCCChHHHHHH
Q 020641 283 AAVAALCVQYEAEFRPNMSIVVKA 306 (323)
Q Consensus 283 ~~li~~cl~~~P~~Rps~~evl~~ 306 (323)
.+|+.+||..||++|||+.|+++.
T Consensus 306 ~dll~~~L~~dP~~R~t~~e~l~H 329 (388)
T 3oz6_A 306 LDLLDKLLQFNPNKRISANDALKH 329 (388)
T ss_dssp HHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred HHHHHHhhccCcccCCCHHHHhCC
Confidence 999999999999999999999874
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-45 Score=333.90 Aligned_cols=249 Identities=20% Similarity=0.236 Sum_probs=196.0
Q ss_pred CccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeC
Q 020641 17 PGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEG 96 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 96 (323)
|....+||+|+||.||+|++..+++.+|+|++...... .......+.+|+.+++.++||||+++++++...
T Consensus 150 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---------~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~ 220 (446)
T 4ejn_A 150 FEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIV---------AKDEVAHTLTENRVLQNSRHPFLTALKYSFQTH 220 (446)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC----------------------CCCCCSCTTSCCEEEEEEET
T ss_pred cEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhh---------hhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeC
Confidence 45556899999999999999999999999987643221 122335567899999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCCCceeCCCCCCCEEEccCCeE
Q 020641 97 NLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHE-KVQPSIIHRDIRSSNVLLFEDFKA 175 (323)
Q Consensus 97 ~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~-~~~~~i~h~dikp~nili~~~~~~ 175 (323)
+..++||||+.+++|.+++..... +++..+..++.|++.||.|||+ . ||+||||||+|||++.++.+
T Consensus 221 ~~~~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~ 288 (446)
T 4ejn_A 221 DRLCFVMEYANGGELFFHLSRERV---------FSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHI 288 (446)
T ss_dssp TEEEEEECCCSSCBHHHHHHHHSC---------CCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCE
T ss_pred CEEEEEEeeCCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCE
Confidence 999999999999999999976542 8999999999999999999998 8 99999999999999999999
Q ss_pred EEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhcc
Q 020641 176 KIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATP 255 (323)
Q Consensus 176 ~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~ 255 (323)
+|+|||++........ ......||+.|+|||++.+..++.++||||||+++|+|++|+.||...........+
T Consensus 289 kl~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i----- 361 (446)
T 4ejn_A 289 KITDFGLCKEGIKDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI----- 361 (446)
T ss_dssp EECCCCCCCTTCC-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH-----
T ss_pred EEccCCCceeccCCCc--ccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHH-----
Confidence 9999999976433222 223456999999999999999999999999999999999999999755321111111
Q ss_pred cccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCC-----ChHHHHH
Q 020641 256 RLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRP-----NMSIVVK 305 (323)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-----s~~evl~ 305 (323)
.... ...+...+..+.++|.+||+.||.+|| |+.|+++
T Consensus 362 ----------~~~~--~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 362 ----------LMEE--IRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp ----------HHCC--CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred ----------HhCC--CCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 1111 122344567799999999999999999 9999986
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=321.13 Aligned_cols=246 Identities=20% Similarity=0.228 Sum_probs=187.6
Q ss_pred CccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeC
Q 020641 17 PGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEG 96 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 96 (323)
|....+||+|+||.||+|++..+++.+|+|+..... ..+.+.+|++++++++||||+++++++...
T Consensus 55 y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--------------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 120 (349)
T 2w4o_A 55 FEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--------------DKKIVRTEIGVLLRLSHPNIIKLKEIFETP 120 (349)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------------------CHHHHHCCCTTBCCEEEEEECS
T ss_pred EEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--------------hHHHHHHHHHHHHhCCCCCCcceeeeEecC
Confidence 444558999999999999999999999999765321 124567899999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEcc---CC
Q 020641 97 NLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFE---DF 173 (323)
Q Consensus 97 ~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~---~~ 173 (323)
...++||||+.+++|.+++..... +++..+..++.|++.||.|||+. |++|+||||+||+++. ++
T Consensus 121 ~~~~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~ 188 (349)
T 2w4o_A 121 TEISLVLELVTGGELFDRIVEKGY---------YSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDA 188 (349)
T ss_dssp SEEEEEECCCCSCBHHHHHTTCSS---------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTC
T ss_pred CeEEEEEEeCCCCCHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCC
Confidence 999999999999999999976532 89999999999999999999999 9999999999999975 88
Q ss_pred eEEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhh
Q 020641 174 KAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWA 253 (323)
Q Consensus 174 ~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 253 (323)
.++|+|||++........ .....||+.|+|||.+.+..++.++|||||||++|+|++|..||........ ..
T Consensus 189 ~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--~~--- 260 (349)
T 2w4o_A 189 PLKIADFGLSKIVEHQVL---MKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQF--MF--- 260 (349)
T ss_dssp CEEECCCC-------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHH--HH---
T ss_pred CEEEccCccccccCcccc---cccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHH--HH---
Confidence 999999999876543221 2334589999999999998999999999999999999999999975433211 00
Q ss_pred cccccccccchhcCCCc--CCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 254 TPRLSEDKVKQCVDPKL--KGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 254 ~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
..+..... ........+..+.+++.+||+.||++|||+.|+++
T Consensus 261 ---------~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 261 ---------RRILNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp ---------HHHHTTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ---------HHHHhCCCccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 01111100 11122345667999999999999999999999997
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=325.34 Aligned_cols=250 Identities=19% Similarity=0.332 Sum_probs=194.5
Q ss_pred CccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCC--CCcccceeeEEE
Q 020641 17 PGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLK--HENLVELLGYCV 94 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~ 94 (323)
|....+||+|+||.||++.+.. ++.+|+|++...... ....+.+.+|+.+++.++ |+||+++++++.
T Consensus 58 y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~----------~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~ 126 (390)
T 2zmd_A 58 YSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEAD----------NQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI 126 (390)
T ss_dssp EEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCC----------HHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred eEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEeccccc----------HHHHHHHHHHHHHHHHcccCCCeEEEEEEEEe
Confidence 5566699999999999999876 788899876543211 112367889999999995 599999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCe
Q 020641 95 EGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFK 174 (323)
Q Consensus 95 ~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~ 174 (323)
..+..++||| +.+++|.+++..... +++..+..++.||+.||.|||+. ||+||||||+|||++ ++.
T Consensus 127 ~~~~~~lv~E-~~~~~L~~~l~~~~~---------~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~ 192 (390)
T 2zmd_A 127 TDQYIYMVME-CGNIDLNSWLKKKKS---------IDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGM 192 (390)
T ss_dssp CSSEEEEEEE-CCSEEHHHHHHHCSS---------CCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSC
T ss_pred cCCEEEEEEe-cCCCCHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCe
Confidence 9999999999 567799999976542 88889999999999999999999 999999999999995 579
Q ss_pred EEEeeccccCCCCccccccccccccCccccCCCccccC-----------CCCCcccchHHHHHHHHHHHhCCCCCCCCCC
Q 020641 175 AKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT-----------GQLTQKSDVYSFGVVLLELLTGRKPVDHTMP 243 (323)
Q Consensus 175 ~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-----------~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 243 (323)
+||+|||++................||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.....
T Consensus 193 ~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~ 272 (390)
T 2zmd_A 193 LKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN 272 (390)
T ss_dssp EEECCCSSSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCC
T ss_pred EEEEecCccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhH
Confidence 99999999987654433333344569999999998865 3678899999999999999999999975432
Q ss_pred cccchhhhhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 244 RGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
.. ..+...+++......+...+..+.+++.+||+.||.+|||+.|+++
T Consensus 273 ~~--------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 320 (390)
T 2zmd_A 273 QI--------------SKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 320 (390)
T ss_dssp HH--------------HHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HH--------------HHHHHHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhh
Confidence 11 1122222333323333334567999999999999999999999986
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=318.86 Aligned_cols=281 Identities=19% Similarity=0.186 Sum_probs=202.8
Q ss_pred cccCCCCCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccce
Q 020641 10 LGAHAPSPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVEL 89 (323)
Q Consensus 10 ~~~~~~~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~ 89 (323)
++.....|.....||+|+||.||++.+..+++.+|+|++....... ........+.+|+++++.++||||+++
T Consensus 5 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-------~~~~~~~~~~~E~~~l~~l~h~~iv~~ 77 (346)
T 1ua2_A 5 VKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSE-------AKDGINRTALREIKLLQELSHPNIIGL 77 (346)
T ss_dssp --------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC-------------------CTHHHHHHHHHHHCCCTTBCCE
T ss_pred hHHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcch-------hhhhhhHHHHHHHHHHhhCCCCCCCeE
Confidence 4445566777789999999999999999999999999775432111 112234678899999999999999999
Q ss_pred eeEEEeCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEE
Q 020641 90 LGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLL 169 (323)
Q Consensus 90 ~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili 169 (323)
++++...+..++||||+.+ +|.+++...... +++..+..++.|++.||.|||+. |++|+||||+||++
T Consensus 78 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~--------~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~ 145 (346)
T 1ua2_A 78 LDAFGHKSNISLVFDFMET-DLEVIIKDNSLV--------LTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLL 145 (346)
T ss_dssp EEEECCTTCCEEEEECCSE-EHHHHHTTCCSS--------CCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEE
T ss_pred EEEEeeCCceEEEEEcCCC-CHHHHHHhcCcC--------CCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEE
Confidence 9999999999999999986 899998765422 78889999999999999999999 99999999999999
Q ss_pred ccCCeEEEeeccccCCCCccccccccccccCccccCCCccccCC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCcccch
Q 020641 170 FEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG-QLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQS 248 (323)
Q Consensus 170 ~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~ 248 (323)
+.++.++|+|||++........ ......||+.|+|||.+.+. .++.++||||||+++|+|++|..||..........
T Consensus 146 ~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~ 223 (346)
T 1ua2_A 146 DENGVLKLADFGLAKSFGSPNR--AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLT 223 (346)
T ss_dssp CTTCCEEECCCGGGSTTTSCCC--CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred cCCCCEEEEecccceeccCCcc--cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHH
Confidence 9999999999999987643221 22344589999999998764 47899999999999999999999997654322111
Q ss_pred hhhhhccccccccc------chhcCCCcCCCCC-----HHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhhcC
Q 020641 249 LVTWATPRLSEDKV------KQCVDPKLKGEYP-----PKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKS 313 (323)
Q Consensus 249 ~~~~~~~~~~~~~~------~~~~~~~~~~~~~-----~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~~~ 313 (323)
.+............ ...+........+ ...+..+.+++.+||+.||.+|||+.|+++ ...+..
T Consensus 224 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~--h~~f~~ 297 (346)
T 1ua2_A 224 RIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK--MKYFSN 297 (346)
T ss_dssp HHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT--SGGGTS
T ss_pred HHHHHcCCCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhc--Chhhhc
Confidence 11110000000000 0111000000111 234578999999999999999999999998 444443
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=311.72 Aligned_cols=269 Identities=16% Similarity=0.219 Sum_probs=206.1
Q ss_pred CCCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEE-
Q 020641 15 PSPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYC- 93 (323)
Q Consensus 15 ~~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~- 93 (323)
..|.....||+|+||.||++++..+++.+|+|+.... .....+.+|+.+++.++|++++..+..+
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--------------~~~~~~~~e~~~l~~l~~~~~i~~~~~~~ 74 (296)
T 4hgt_A 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVK--------------TKHPQLHIESKIYKMMQGGVGIPTIRWCG 74 (296)
T ss_dssp --CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----------------CCCHHHHHHHHHHHTTSTTCCCEEEEE
T ss_pred CceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccc--------------ccchHHHHHHHHHHHhcCCCCCCeeeeec
Confidence 3466667999999999999999999999999964321 1224578899999999887777666554
Q ss_pred EeCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEE---c
Q 020641 94 VEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLL---F 170 (323)
Q Consensus 94 ~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili---~ 170 (323)
..+...++||||+ +++|.+++...... +++..+..++.|++.||.|||+. |++|+||||+||++ +
T Consensus 75 ~~~~~~~lv~e~~-~~~L~~~~~~~~~~--------~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~ 142 (296)
T 4hgt_A 75 AEGDYNVMVMELL-GPSLEDLFNFCSRK--------FSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGK 142 (296)
T ss_dssp EETTEEEEEEECC-CCBHHHHHHHTTSC--------CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGG
T ss_pred CCCCceEEEEEcc-CCCHHHHHHHhcCC--------CCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccC
Confidence 6778889999999 88999999754322 89999999999999999999999 99999999999999 7
Q ss_pred cCCeEEEeeccccCCCCccccc-----cccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcc
Q 020641 171 EDFKAKIADFNLSNQAPDMAAR-----LHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRG 245 (323)
Q Consensus 171 ~~~~~~l~Dfg~~~~~~~~~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 245 (323)
.++.++|+|||++......... .......|++.|+|||.+.+..++.++||||||+++|+|++|+.||.......
T Consensus 143 ~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~ 222 (296)
T 4hgt_A 143 KGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAAT 222 (296)
T ss_dssp GTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSS
T ss_pred CCCeEEEecCccceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhh
Confidence 8899999999999765443221 12234568999999999999999999999999999999999999998654432
Q ss_pred cchhhhhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhhcCCCCCC
Q 020641 246 QQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSPPPAA 318 (323)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~~~~~~~~ 318 (323)
................. .......+..+.+++.+||+.||++|||+.+|++.|+++..+...+.
T Consensus 223 ~~~~~~~~~~~~~~~~~---------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~~~ 286 (296)
T 4hgt_A 223 KRQKYERISEKKMSTPI---------EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSY 286 (296)
T ss_dssp SSSHHHHHHHHHHHSCH---------HHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTCCT
T ss_pred hhhhhhhhhcccccchh---------hhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCCCc
Confidence 22211110000000000 00012235679999999999999999999999999999997665443
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-45 Score=324.29 Aligned_cols=276 Identities=18% Similarity=0.156 Sum_probs=198.9
Q ss_pred CccccccCCCCCCccceeccce---eeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEE
Q 020641 17 PGYFVRLDKGPEDDLYLKKRVK---MRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYC 93 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~~~~---~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 93 (323)
|.....||+|+||.||+|.+.. ++..+++|+.......... +...........+.+|+..++.++|+||+++++++
T Consensus 39 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~-e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~~ 117 (345)
T 2v62_A 39 WVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFS-ELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSG 117 (345)
T ss_dssp EEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHH-HHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEEE
T ss_pred EEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHH-HHHHHHHHhhhHHHHHHHhhccccccCcceeeccc
Confidence 4455599999999999999987 7888888876643211000 00000011235577888999999999999999999
Q ss_pred Ee----CCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEE
Q 020641 94 VE----GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLL 169 (323)
Q Consensus 94 ~~----~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili 169 (323)
.. ....++||||+ +++|.+++..... +++..++.++.|++.||.|||+. |++||||||+||++
T Consensus 118 ~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~---------~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll 184 (345)
T 2v62_A 118 LTEFKGRSYRFMVMERL-GIDLQKISGQNGT---------FKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLL 184 (345)
T ss_dssp EEESSSCEEEEEEEECE-EEEHHHHCBGGGB---------CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEE
T ss_pred ccccCCCcEEEEEEecc-CCCHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEE
Confidence 88 77899999999 8899999986542 89999999999999999999999 99999999999999
Q ss_pred ccCC--eEEEeeccccCCCCcccccc-----ccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCC
Q 020641 170 FEDF--KAKIADFNLSNQAPDMAARL-----HSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTM 242 (323)
Q Consensus 170 ~~~~--~~~l~Dfg~~~~~~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 242 (323)
+.++ .++|+|||++.......... ......|++.|+|||.+.+..++.++||||||+++|+|++|+.||....
T Consensus 185 ~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~ 264 (345)
T 2v62_A 185 GYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNL 264 (345)
T ss_dssp ESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGT
T ss_pred ccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccc
Confidence 9887 99999999997654332111 1133458999999999999889999999999999999999999996432
Q ss_pred CcccchhhhhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhhc
Q 020641 243 PRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLK 312 (323)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~~ 312 (323)
......... ..... ......+... ......+..+.+++.+||+.||++|||+.+|++.|+++..
T Consensus 265 ~~~~~~~~~--~~~~~-~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 328 (345)
T 2v62_A 265 KDPVAVQTA--KTNLL-DELPQSVLKW---APSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI 328 (345)
T ss_dssp TCHHHHHHH--HHHHH-HTTTHHHHHH---SCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred cccHHHHHH--HHhhc-ccccHHHHhh---ccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence 211111000 00000 0000000000 0011345679999999999999999999999999998765
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-45 Score=324.48 Aligned_cols=247 Identities=18% Similarity=0.184 Sum_probs=192.4
Q ss_pred CCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHH-HhcCCCCcccceeeEEE
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSV-VSRLKHENLVELLGYCV 94 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~-l~~l~h~~i~~~~~~~~ 94 (323)
.|.....||+|+||.||+|++..+++.+|+|++.+...... .....+..|..+ ++.++||||+++++++.
T Consensus 39 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~---------~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~ 109 (373)
T 2r5t_A 39 DFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKK---------KEEKHIMSERNVLLKNVKHPFLVGLHFSFQ 109 (373)
T ss_dssp GEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC----------------------CCBCCCCCTTBCCEEEEEE
T ss_pred heEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhh---------HHHHHHHHHHHHHHHhCCCCCCCCEEEEEE
Confidence 35556699999999999999999999999998865433221 122345556665 46679999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCe
Q 020641 95 EGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFK 174 (323)
Q Consensus 95 ~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~ 174 (323)
+.+..|+||||+.+|+|.+++..... +++..+..++.||+.||.|||++ ||+||||||+||+++.++.
T Consensus 110 ~~~~~~lv~E~~~gg~L~~~l~~~~~---------~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ 177 (373)
T 2r5t_A 110 TADKLYFVLDYINGGELFYHLQRERC---------FLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGH 177 (373)
T ss_dssp CSSEEEEEEECCCSCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSC
T ss_pred eCCEEEEEEeCCCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCC
Confidence 99999999999999999999976542 88999999999999999999999 9999999999999999999
Q ss_pred EEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhc
Q 020641 175 AKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWAT 254 (323)
Q Consensus 175 ~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~ 254 (323)
++|+|||++....... .......||+.|+|||++.+..++.++|+|||||++|+|++|..||........
T Consensus 178 ikL~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~-------- 247 (373)
T 2r5t_A 178 IVLTDFGLCKENIEHN--STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEM-------- 247 (373)
T ss_dssp EEECCCCBCGGGBCCC--CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHH--------
T ss_pred EEEeeCccccccccCC--CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHH--------
Confidence 9999999987532211 123445699999999999999999999999999999999999999975432111
Q ss_pred ccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHH
Q 020641 255 PRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSI 302 (323)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~e 302 (323)
...++... ...+...+..+.++|.+||+.||.+||++.+
T Consensus 248 -------~~~i~~~~--~~~~~~~~~~~~~li~~lL~~dp~~R~~~~~ 286 (373)
T 2r5t_A 248 -------YDNILNKP--LQLKPNITNSARHLLEGLLQKDRTKRLGAKD 286 (373)
T ss_dssp -------HHHHHHSC--CCCCSSSCHHHHHHHHHHTCSSGGGSTTTTT
T ss_pred -------HHHHHhcc--cCCCCCCCHHHHHHHHHHcccCHHhCCCCCC
Confidence 11111111 1123345667999999999999999999853
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=324.52 Aligned_cols=274 Identities=19% Similarity=0.203 Sum_probs=211.4
Q ss_pred CccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeC
Q 020641 17 PGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEG 96 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 96 (323)
|....+||+|+||+||+|.+..+++.+|+|++..... ....+.+.+|++++++++||||+++++++...
T Consensus 11 y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-----------~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 79 (396)
T 4eut_A 11 WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF-----------LRPVDVQMREFEVLKKLNHKNIVKLFAIEEET 79 (396)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG-----------GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECT
T ss_pred eEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccc-----------cchHHHHHHHHHHHHhcCCCCCCeEEEeeccC
Confidence 4455589999999999999999999999997753211 12246678999999999999999999999876
Q ss_pred C--eEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEE----c
Q 020641 97 N--LRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLL----F 170 (323)
Q Consensus 97 ~--~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili----~ 170 (323)
. ..++||||+.+++|.+++....... .+++..++.++.|++.||.|||+. ||+||||||+||++ +
T Consensus 80 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~------~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~ 150 (396)
T 4eut_A 80 TTRHKVLIMEFCPCGSLYTVLEEPSNAY------GLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGED 150 (396)
T ss_dssp TTCCEEEEECCCTTEEHHHHTTSGGGTT------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTT
T ss_pred CCCeeEEEEecCCCCCHHHHHHhhhccc------CCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCC
Confidence 5 7799999999999999997653211 288999999999999999999999 99999999999999 7
Q ss_pred cCCeEEEeeccccCCCCccccccccccccCccccCCCccccC--------CCCCcccchHHHHHHHHHHHhCCCCCCCCC
Q 020641 171 EDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT--------GQLTQKSDVYSFGVVLLELLTGRKPVDHTM 242 (323)
Q Consensus 171 ~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--------~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 242 (323)
.++.++|+|||++........ .....||+.|+|||++.+ ..++.++||||||+++|+|++|+.||....
T Consensus 151 ~~~~~kL~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~ 227 (396)
T 4eut_A 151 GQSVYKLTDFGAARELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFE 227 (396)
T ss_dssp SCEEEEECCGGGCEECCCGGG---SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTT
T ss_pred CceeEEEecCCCceEccCCCc---cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 788899999999976654332 233458999999998864 456789999999999999999999997544
Q ss_pred Ccccch-hhhhhcccccccc---cch-------hc-CCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhh
Q 020641 243 PRGQQS-LVTWATPRLSEDK---VKQ-------CV-DPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPL 310 (323)
Q Consensus 243 ~~~~~~-~~~~~~~~~~~~~---~~~-------~~-~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~ 310 (323)
...... .........+... +.. +. ............+..+.+++.+||+.||++|||+.++++.++++
T Consensus 228 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~i 307 (396)
T 4eut_A 228 GPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (396)
T ss_dssp CTTTCHHHHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred cccchHHHHHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHH
Confidence 322111 1110000000000 000 00 00112234578889999999999999999999999999999999
Q ss_pred hcC
Q 020641 311 LKS 313 (323)
Q Consensus 311 ~~~ 313 (323)
++.
T Consensus 308 l~~ 310 (396)
T 4eut_A 308 LHR 310 (396)
T ss_dssp HTC
T ss_pred hhc
Confidence 875
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=323.10 Aligned_cols=260 Identities=22% Similarity=0.290 Sum_probs=194.5
Q ss_pred ccccccCCCCCCccceecccee---eeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEE
Q 020641 18 GYFVRLDKGPEDDLYLKKRVKM---RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCV 94 (323)
Q Consensus 18 ~~~~~lg~G~~~~V~~~~~~~~---~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 94 (323)
.....||+|+||.||++.+..+ ...+++|..... ......+.+.+|+.++++++||||+++++++.
T Consensus 92 ~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~-----------~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~ 160 (373)
T 3c1x_A 92 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-----------TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICL 160 (373)
T ss_dssp EEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSC-----------SCSHHHHHHHHHHTTSTTCCCTTBCCCCEEEC
T ss_pred ecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCC-----------CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEE
Confidence 3445899999999999987543 345777754321 11222467889999999999999999999875
Q ss_pred e-CCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCC
Q 020641 95 E-GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDF 173 (323)
Q Consensus 95 ~-~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~ 173 (323)
. .+..++||||+.+++|.+++...... +++..++.++.|++.||.|||+. |++||||||+||+++.++
T Consensus 161 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~--------~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~ 229 (373)
T 3c1x_A 161 RSEGSPLVVLPYMKHGDLRNFIRNETHN--------PTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKF 229 (373)
T ss_dssp CCSSCCEEEEECCTTCBHHHHHHCTTCC--------CBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTC
T ss_pred cCCCCeEEEEECCCCCCHHHHHhhcccC--------CCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCC
Confidence 4 45789999999999999999765432 88899999999999999999999 999999999999999999
Q ss_pred eEEEeeccccCCCCccccc--cccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccchhh
Q 020641 174 KAKIADFNLSNQAPDMAAR--LHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLV 250 (323)
Q Consensus 174 ~~~l~Dfg~~~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~ 250 (323)
.+||+|||++......... .......+++.|+|||.+.+..++.++||||||+++|+|++ |..||............
T Consensus 230 ~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~ 309 (373)
T 3c1x_A 230 TVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL 309 (373)
T ss_dssp CEEECCC---------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHH
T ss_pred CEEEeeccccccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHH
Confidence 9999999999765432211 11223346788999999998999999999999999999999 77788655332211111
Q ss_pred hhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhhcCCC
Q 020641 251 TWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSPP 315 (323)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~~~~~ 315 (323)
........+..++..+.+++.+||+.||++|||+.|+++.|+.+.....
T Consensus 310 ----------------~~~~~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~ 358 (373)
T 3c1x_A 310 ----------------LQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 358 (373)
T ss_dssp ----------------HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred ----------------HcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcc
Confidence 1111122234456779999999999999999999999999999987654
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-45 Score=318.91 Aligned_cols=269 Identities=22% Similarity=0.285 Sum_probs=208.6
Q ss_pred CCccccccCCCCCCccceecc-----ceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcC-CCCcccce
Q 020641 16 SPGYFVRLDKGPEDDLYLKKR-----VKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRL-KHENLVEL 89 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~-----~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~ 89 (323)
.|.....||.|+||.||+|++ ..+++.+++|+...... ......+.+|+.+++++ +||||+++
T Consensus 28 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-----------~~~~~~~~~E~~~l~~l~~hp~iv~~ 96 (316)
T 2xir_A 28 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT-----------HSEHRALMSELKILIHIGHHLNVVNL 96 (316)
T ss_dssp GEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC-----------HHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred heeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCC-----------cHHHHHHHHHHHHHHhcccCCCeeeE
Confidence 344555899999999999984 45778899987653210 11225678999999999 79999999
Q ss_pred eeEEEeCC-eEEEEEeecCCCCHHHHhccCCCCCC-------CCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCC
Q 020641 90 LGYCVEGN-LRVLAYEFATMGSLHDILHGRKGVQG-------AQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRD 161 (323)
Q Consensus 90 ~~~~~~~~-~~~lv~e~~~~~sL~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~d 161 (323)
++++...+ ..++||||+.+++|.+++........ ......+++..++.++.|++.||.|||+. |++|+|
T Consensus 97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~d 173 (316)
T 2xir_A 97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRD 173 (316)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCSC
T ss_pred EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---Cccccc
Confidence 99988754 58999999999999999976543100 00112378999999999999999999999 999999
Q ss_pred CCCCCEEEccCCeEEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHh-CCCCCCC
Q 020641 162 IRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDH 240 (323)
Q Consensus 162 ikp~nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~ 240 (323)
|||+||+++.++.++|+|||++................+++.|+|||.+.+..++.++||||||+++|+|++ |..||..
T Consensus 174 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~ 253 (316)
T 2xir_A 174 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 253 (316)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred CccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcc
Confidence 999999999999999999999986654333333334457889999999998899999999999999999998 9999975
Q ss_pred CCCcccchhhhhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhhcC
Q 020641 241 TMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKS 313 (323)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~~~ 313 (323)
...... +...+........+...+..+.+++.+||+.||.+|||+.|+++.|+.+++.
T Consensus 254 ~~~~~~---------------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 311 (316)
T 2xir_A 254 VKIDEE---------------FCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 311 (316)
T ss_dssp CCCSHH---------------HHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cchhHH---------------HHHHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhh
Confidence 532211 1111111111223344566799999999999999999999999999998754
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-45 Score=321.73 Aligned_cols=273 Identities=20% Similarity=0.253 Sum_probs=199.6
Q ss_pred CCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEe
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVE 95 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 95 (323)
.|....+||+|+||+||+|++..+++.+|+|+....... .....+.+|++++++++||||+++++++..
T Consensus 3 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 71 (324)
T 3mtl_A 3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEE-----------GAPCTAIREVSLLKDLKHANIVTLHDIIHT 71 (324)
T ss_dssp SEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC-----------------CCCCCCCHHHHSCCCCTTBCCEEEEEEC
T ss_pred ceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEeccccc-----------ccchhHHHHHHHHHhcCCCCCCeeeeEEee
Confidence 356667999999999999999999999999976532211 111223468999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeE
Q 020641 96 GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKA 175 (323)
Q Consensus 96 ~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~ 175 (323)
.+..++||||+.+ +|.+++...... +++..+..++.|++.||.|||+. |++|+||||+||+++.++.+
T Consensus 72 ~~~~~lv~e~~~~-~l~~~~~~~~~~--------~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~ 139 (324)
T 3mtl_A 72 EKSLTLVFEYLDK-DLKQYLDDCGNI--------INMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGEL 139 (324)
T ss_dssp SSCEEEEEECCSE-EHHHHHHHTTTC--------CCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCE
T ss_pred CCEEEEEeccccc-CHHHHHHhcCCC--------CCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCE
Confidence 9999999999985 999998765432 88999999999999999999999 99999999999999999999
Q ss_pred EEeeccccCCCCccccccccccccCccccCCCccccC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhc
Q 020641 176 KIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT-GQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWAT 254 (323)
Q Consensus 176 ~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~ 254 (323)
+|+|||++........ ......||+.|+|||.+.+ ..++.++||||||+++|+|++|+.||................
T Consensus 140 kl~Dfg~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~ 217 (324)
T 3mtl_A 140 KLADFGLARAKSIPTK--TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRIL 217 (324)
T ss_dssp EECSSSEEECC--------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred EEccCcccccccCCcc--ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence 9999999875543222 1233457999999999876 567999999999999999999999998664332211111111
Q ss_pred ccccccccchhcC---------CCcCC----CCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH--HHhhhhcC
Q 020641 255 PRLSEDKVKQCVD---------PKLKG----EYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK--ALQPLLKS 313 (323)
Q Consensus 255 ~~~~~~~~~~~~~---------~~~~~----~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~--~l~~~~~~ 313 (323)
............. +.... ......+..+.+|+.+||+.||.+|||+.|+++ ++.++.+.
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~ 291 (324)
T 3mtl_A 218 GTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGER 291 (324)
T ss_dssp CCCCTTTSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCST
T ss_pred CCCChHhchhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcccc
Confidence 1111111111100 00000 011234567899999999999999999999988 55555443
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-44 Score=308.44 Aligned_cols=253 Identities=18% Similarity=0.187 Sum_probs=203.6
Q ss_pred CccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeC
Q 020641 17 PGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEG 96 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 96 (323)
|....+||+|+||.||++.+..++..+++|...... ....+.+.+|++++++++||||+++++++.++
T Consensus 11 y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~------------~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 78 (277)
T 3f3z_A 11 YTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYF------------VEDVDRFKQEIEIMKSLDHPNIIRLYETFEDN 78 (277)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGG------------CSCHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred EEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhc------------cchHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 445568999999999999999999988888665321 12246789999999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEE---ccCC
Q 020641 97 NLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLL---FEDF 173 (323)
Q Consensus 97 ~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili---~~~~ 173 (323)
...++||||+.+++|.+++..... +++..+..++.|++.|+.|||+. |++|+||||+||++ +.++
T Consensus 79 ~~~~lv~e~~~~~~L~~~~~~~~~---------~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~ 146 (277)
T 3f3z_A 79 TDIYLVMELCTGGELFERVVHKRV---------FRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDS 146 (277)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHCS---------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTC
T ss_pred CeEEEEEeccCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCC
Confidence 999999999999999999876542 89999999999999999999999 99999999999999 7889
Q ss_pred eEEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhh
Q 020641 174 KAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWA 253 (323)
Q Consensus 174 ~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 253 (323)
.++|+|||++........ .....|++.|+|||.+.+. ++.++||||||+++|+|++|..||.............
T Consensus 147 ~~~l~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~-- 220 (277)
T 3f3z_A 147 PLKLIDFGLAARFKPGKM---MRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIR-- 220 (277)
T ss_dssp CEEECCCTTCEECCTTSC---BCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--
T ss_pred cEEEEecccceeccCccc---hhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHH--
Confidence 999999999876543221 2334589999999987654 8999999999999999999999997653221111111
Q ss_pred cccccccccchhcCCCcCCCCCH----HHHHHHHHHHHHccCCCCCCCCChHHHHH--HHhhhhcCC
Q 020641 254 TPRLSEDKVKQCVDPKLKGEYPP----KGVAKLAAVAALCVQYEAEFRPNMSIVVK--ALQPLLKSP 314 (323)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~----~~~~~l~~li~~cl~~~P~~Rps~~evl~--~l~~~~~~~ 314 (323)
... ...+. ..+..+.+++.+||+.||.+|||+.++++ ++++..+..
T Consensus 221 -------------~~~--~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~~~~ 272 (277)
T 3f3z_A 221 -------------EGT--FTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQLSSS 272 (277)
T ss_dssp -------------HCC--CCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHHHHCCS
T ss_pred -------------hCC--CCCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcccccc
Confidence 000 01111 24567999999999999999999999986 555555443
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=318.52 Aligned_cols=251 Identities=17% Similarity=0.210 Sum_probs=194.6
Q ss_pred CccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeC
Q 020641 17 PGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEG 96 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 96 (323)
|.....||+|+||.||+|++..+++.+|+|++.... .....+.+.+|+.++++++||||+++++++.+.
T Consensus 8 y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-----------~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 76 (332)
T 3qd2_B 8 FEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-----------RELAREKVMREVKALAKLEHPGIVRYFNAWLET 76 (332)
T ss_dssp EEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS-----------TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEEC
T ss_pred CceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC-----------chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEe
Confidence 455668999999999999999999999999775321 122347789999999999999999999998654
Q ss_pred C---------------------------------------------------------eEEEEEeecCCCCHHHHhccCC
Q 020641 97 N---------------------------------------------------------LRVLAYEFATMGSLHDILHGRK 119 (323)
Q Consensus 97 ~---------------------------------------------------------~~~lv~e~~~~~sL~~~~~~~~ 119 (323)
. ..++||||+.+++|.+++....
T Consensus 77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~ 156 (332)
T 3qd2_B 77 PPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRC 156 (332)
T ss_dssp CSCHHHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCC
T ss_pred ccchhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhccc
Confidence 3 2799999999999999998754
Q ss_pred CCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEEEeeccccCCCCccccc-------
Q 020641 120 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAAR------- 192 (323)
Q Consensus 120 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~l~Dfg~~~~~~~~~~~------- 192 (323)
... ...+..++.++.|++.||.|||+. |++||||||+||+++.++.++|+|||++.........
T Consensus 157 ~~~------~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~ 227 (332)
T 3qd2_B 157 SLE------DREHGVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 227 (332)
T ss_dssp SGG------GSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC----------
T ss_pred Ccc------chhhHHHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccc
Confidence 321 256667899999999999999999 9999999999999999999999999998766543211
Q ss_pred ---cccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccccccccchhcCCC
Q 020641 193 ---LHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPK 269 (323)
Q Consensus 193 ---~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (323)
.......||+.|+|||.+.+..++.++||||||+++|+|++|..|+.... ... ..... .
T Consensus 228 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~-----~~~------------~~~~~-~ 289 (332)
T 3qd2_B 228 PAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERV-----RII------------TDVRN-L 289 (332)
T ss_dssp ----CCCSCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHH-----HHH------------HHHHT-T
T ss_pred cccccccccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHH-----HHH------------HHhhc-c
Confidence 11233458999999999999999999999999999999999876642110 000 00000 0
Q ss_pred cCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 270 LKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 270 ~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
.........+..+.+++.+||+.||.+|||+.|+++
T Consensus 290 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 290 KFPLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIE 325 (332)
T ss_dssp CCCHHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHH
T ss_pred CCCcccccCChhHHHHHHHHccCCCCcCCCHHHHhh
Confidence 001112344567899999999999999999999997
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=322.19 Aligned_cols=245 Identities=21% Similarity=0.224 Sum_probs=193.2
Q ss_pred ccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeCCeEEE
Q 020641 22 RLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVL 101 (323)
Q Consensus 22 ~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 101 (323)
.||+|+||.||+|.+..+++.+|+|++..... ...+.+.+|++++++++||||+++++++...+..++
T Consensus 96 ~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~------------~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 163 (373)
T 2x4f_A 96 ILGGGRFGQVHKCEETATGLKLAAKIIKTRGM------------KDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVL 163 (373)
T ss_dssp ECC-----CEEEEEETTTCCEEEEEEEECCSH------------HHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred EEecCcCEEEEEEEEcCCCcEEEEEEEccccc------------ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEE
Confidence 59999999999999999999999997653211 123678899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEE--ccCCeEEEee
Q 020641 102 AYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLL--FEDFKAKIAD 179 (323)
Q Consensus 102 v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili--~~~~~~~l~D 179 (323)
||||+++++|.+++...... +++..+..++.|++.||.|||+. ||+||||||+||++ +.++.++|+|
T Consensus 164 v~E~~~~~~L~~~l~~~~~~--------l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~D 232 (373)
T 2x4f_A 164 VMEYVDGGELFDRIIDESYN--------LTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIID 232 (373)
T ss_dssp EEECCTTCEEHHHHHHTGGG--------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECC
T ss_pred EEeCCCCCcHHHHHHhcCCC--------CCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEe
Confidence 99999999999988654322 88999999999999999999999 99999999999999 5678999999
Q ss_pred ccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccccc
Q 020641 180 FNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSE 259 (323)
Q Consensus 180 fg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 259 (323)
||++........ .....||+.|+|||++.+..++.++|||||||++|+|++|..||...........+ ....+.
T Consensus 233 FG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i--~~~~~~- 306 (373)
T 2x4f_A 233 FGLARRYKPREK---LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNI--LACRWD- 306 (373)
T ss_dssp CSSCEECCTTCB---CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH--HHTCCC-
T ss_pred CCCceecCCccc---cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--HhccCC-
Confidence 999976543322 22345899999999998888999999999999999999999999765432111111 110000
Q ss_pred cccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 260 DKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
.........+..+.+|+.+||+.||.+|||+.|+++
T Consensus 307 ----------~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 307 ----------LEDEEFQDISEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp ----------SCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ----------CChhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000111234567999999999999999999999997
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=317.64 Aligned_cols=251 Identities=20% Similarity=0.238 Sum_probs=192.9
Q ss_pred CCccccccCCCCCCccceeccc---eeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeE
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRV---KMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGY 92 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~---~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 92 (323)
.|.....||+|+||.||+|++. .+++.+|+|++.+..... .......+.+|+.+++.++||||++++++
T Consensus 18 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~--------~~~~~~~~~~E~~~l~~l~hp~iv~~~~~ 89 (327)
T 3a62_A 18 CFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVR--------NAKDTAHTKAERNILEEVKHPFIVDLIYA 89 (327)
T ss_dssp GEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC----------------------HHHHHHHCCCTTBCCEEEE
T ss_pred HeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhh--------hhhHHHHHHHHHHHHHhCCCCCccceeEE
Confidence 3555668999999999999885 678889999776432211 11223557789999999999999999999
Q ss_pred EEeCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccC
Q 020641 93 CVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFED 172 (323)
Q Consensus 93 ~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~ 172 (323)
+...+..|+||||+.+++|.+++..... +++..+..++.|++.||.|||+. |++||||||+||+++.+
T Consensus 90 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~ 157 (327)
T 3a62_A 90 FQTGGKLYLILEYLSGGELFMQLEREGI---------FMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQ 157 (327)
T ss_dssp EECSSCEEEEEECCTTEEHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTT
T ss_pred EEcCCEEEEEEeCCCCCcHHHHHHhCCC---------CCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCC
Confidence 9999999999999999999999976542 88999999999999999999999 99999999999999999
Q ss_pred CeEEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhh
Q 020641 173 FKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTW 252 (323)
Q Consensus 173 ~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 252 (323)
+.++|+|||++........ ......||+.|+|||++.+..++.++||||||+++|+|++|..||.........
T Consensus 158 ~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~----- 230 (327)
T 3a62_A 158 GHVKLTDFGLCKESIHDGT--VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTI----- 230 (327)
T ss_dssp SCEEECCCSCC------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH-----
T ss_pred CcEEEEeCCcccccccCCc--cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHH-----
Confidence 9999999999875433221 123446899999999999888999999999999999999999999755321111
Q ss_pred hcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCC-----ChHHHHH
Q 020641 253 ATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRP-----NMSIVVK 305 (323)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-----s~~evl~ 305 (323)
..+.... ...+...+..+.+++.+||+.||.+|| ++.|+++
T Consensus 231 ----------~~i~~~~--~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 231 ----------DKILKCK--LNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp ----------HHHHHTC--CCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred ----------HHHHhCC--CCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 1111111 122344567799999999999999999 7778876
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-45 Score=339.60 Aligned_cols=259 Identities=29% Similarity=0.415 Sum_probs=208.8
Q ss_pred cccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeCCe
Q 020641 19 YFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNL 98 (323)
Q Consensus 19 ~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 98 (323)
...+||+|+||.||++.+..+. .+|+|++... ....+.+.+|++++++++|+||+++++++.+ ..
T Consensus 271 ~~~~lG~G~fg~Vy~~~~~~~~-~vavK~~~~~-------------~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~ 335 (535)
T 2h8h_A 271 LEVKLGQGCFGEVWMGTWNGTT-RVAIKTLKPG-------------TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EP 335 (535)
T ss_dssp EEEEEEECSSEEEEEEEETTTE-EEEEEEECTT-------------SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred hheecccCCCeEEEEEEECCCc-eEEEEEeCCC-------------CCCHHHHHHHHHHHHhCCCCCEeeEEEEEee-cc
Confidence 3448999999999999987654 4777755421 1124678999999999999999999999876 56
Q ss_pred EEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEEEe
Q 020641 99 RVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIA 178 (323)
Q Consensus 99 ~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~l~ 178 (323)
.++||||+.+|+|.+++...... .+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+
T Consensus 336 ~~lv~e~~~~gsL~~~l~~~~~~-------~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~ 405 (535)
T 2h8h_A 336 IYIVTEYMSKGSLLDFLKGETGK-------YLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVA 405 (535)
T ss_dssp CEEEECCCTTEEHHHHHSHHHHT-------TCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEEC
T ss_pred ceEeeehhcCCcHHHHHhhcCCC-------CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEc
Confidence 89999999999999999754222 288999999999999999999999 99999999999999999999999
Q ss_pred eccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccc
Q 020641 179 DFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPRL 257 (323)
Q Consensus 179 Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~ 257 (323)
|||++......... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||......
T Consensus 406 DFG~a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~------------- 471 (535)
T 2h8h_A 406 DFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR------------- 471 (535)
T ss_dssp CTTSTTTCCCHHHH-TTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHH-------------
T ss_pred ccccceecCCCcee-cccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-------------
Confidence 99999876543221 1223346788999999988899999999999999999999 99999754321
Q ss_pred cccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhhcCCCCCCC
Q 020641 258 SEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSPPPAAP 319 (323)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~~~~~~~~~ 319 (323)
.+...+....+...+..++..+.+||.+||+.||++|||+.+|++.|+++.....+...
T Consensus 472 ---~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~~~~~ 530 (535)
T 2h8h_A 472 ---EVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQ 530 (535)
T ss_dssp ---HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCCSCSSC
T ss_pred ---HHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhccCcccC
Confidence 11112222223334556677899999999999999999999999999999987766543
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-45 Score=322.65 Aligned_cols=273 Identities=20% Similarity=0.279 Sum_probs=206.9
Q ss_pred CccccccCCCCCCccceec----cceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeE
Q 020641 17 PGYFVRLDKGPEDDLYLKK----RVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGY 92 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~----~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 92 (323)
+....+||+|+||.||+++ +..+++.+++|+.... .....+.+.+|++++++++|+||++++++
T Consensus 43 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~------------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 110 (326)
T 2w1i_A 43 LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS------------TEEHLRDFEREIEILKSLQHDNIVKYKGV 110 (326)
T ss_dssp EEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC------------CSHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC------------CHHHHHHHHHHHHHHHhCCCCCeeeEEEE
Confidence 3445589999999999998 5678889999866421 12223678899999999999999999998
Q ss_pred EEeCC--eEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEc
Q 020641 93 CVEGN--LRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLF 170 (323)
Q Consensus 93 ~~~~~--~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~ 170 (323)
+.... ..++||||+.+++|.+++...... +++..++.++.|++.||.+||+. |++|+||||+||+++
T Consensus 111 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~--------~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~ 179 (326)
T 2w1i_A 111 CYSAGRRNLKLIMEYLPYGSLRDYLQKHKER--------IDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVE 179 (326)
T ss_dssp ECC----CCEEEECCCTTCBHHHHHHHSTTS--------SCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEE
T ss_pred EEecCCCceEEEEECCCCCCHHHHHHhcccC--------CCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEc
Confidence 87543 679999999999999999765432 89999999999999999999999 999999999999999
Q ss_pred cCCeEEEeeccccCCCCccccc-cccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchh
Q 020641 171 EDFKAKIADFNLSNQAPDMAAR-LHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSL 249 (323)
Q Consensus 171 ~~~~~~l~Dfg~~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~ 249 (323)
.++.++|+|||++......... .......++..|+|||.+.+..++.++||||||+++|+|++|..||...........
T Consensus 180 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~ 259 (326)
T 2w1i_A 180 NENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMI 259 (326)
T ss_dssp ETTEEEECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHH
T ss_pred CCCcEEEecCcchhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhh
Confidence 9999999999999766443221 112233467789999999888889999999999999999999999863311000000
Q ss_pred hhhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhhc
Q 020641 250 VTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLK 312 (323)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~~ 312 (323)
............+.+.+........+..++..+.+++.+||+.||.+|||+.||++.|+++..
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~ 322 (326)
T 2w1i_A 260 GNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 322 (326)
T ss_dssp CTTCCTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ccccchhhhHHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 000000000011122222222333455667789999999999999999999999999998864
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=319.10 Aligned_cols=267 Identities=23% Similarity=0.319 Sum_probs=202.6
Q ss_pred CCccccccCCCCCCccceec-----cceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCccccee
Q 020641 16 SPGYFVRLDKGPEDDLYLKK-----RVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELL 90 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~-----~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~ 90 (323)
.|.....||.|+||.||+++ +..+++.+|+|.+.... .......+.+|+.++++++||||++++
T Consensus 31 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-----------~~~~~~~~~~E~~~l~~l~h~~iv~~~ 99 (327)
T 2yfx_A 31 NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC-----------SEQDELDFLMEALIISKFNHQNIVRCI 99 (327)
T ss_dssp GCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSC-----------CHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred heEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecccc-----------chhhHHHHHHHHHHHhhCCCCCCCeEE
Confidence 45566699999999999999 55677789998664211 111235678899999999999999999
Q ss_pred eEEEeCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEc
Q 020641 91 GYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLF 170 (323)
Q Consensus 91 ~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~ 170 (323)
+++......++||||+.+++|.+++....... .....+++..++.++.|++.||.|||+. |++|+||||+||+++
T Consensus 100 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~--~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~ 174 (327)
T 2yfx_A 100 GVSLQSLPRFILMELMAGGDLKSFLRETRPRP--SQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLT 174 (327)
T ss_dssp EEECSSSSCEEEEECCTTEEHHHHHHHTSCCS--SSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEES
T ss_pred EEEcCCCCcEEEEecCCCCcHHHHHHhhcccc--cccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEe
Confidence 99999999999999999999999998764321 1112388999999999999999999999 999999999999998
Q ss_pred c---CCeEEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCccc
Q 020641 171 E---DFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQ 246 (323)
Q Consensus 171 ~---~~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~ 246 (323)
. +..++|+|||++................+++.|+|||.+.+..++.++||||||+++|+|++ |..||.......
T Consensus 175 ~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~- 253 (327)
T 2yfx_A 175 CPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE- 253 (327)
T ss_dssp CSSTTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH-
T ss_pred cCCCcceEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHH-
Confidence 4 45699999999864332222222233457889999999988889999999999999999998 999997543211
Q ss_pred chhhhhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhhcCC
Q 020641 247 QSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSP 314 (323)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~~~~ 314 (323)
+...+........+..++..+.+++.+||+.||.+|||+.++++.|+.+...+
T Consensus 254 ---------------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~ 306 (327)
T 2yfx_A 254 ---------------VLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP 306 (327)
T ss_dssp ---------------HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred ---------------HHHHHhcCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCH
Confidence 11111111112233455678999999999999999999999999999887544
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-44 Score=333.26 Aligned_cols=263 Identities=22% Similarity=0.257 Sum_probs=201.0
Q ss_pred CCCCccccccCCCCCCccceeccceeeeeeeeccccccccCccc-cccccCCCCCchHHHHHHHHHhcCCCCcccceeeE
Q 020641 14 APSPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHE-NERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGY 92 (323)
Q Consensus 14 ~~~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~-~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 92 (323)
...|....+||+|+||+||+|++..+++.+|+|++.+....... ...........+.+.+|+.++++++||||++++++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 114 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 34566667999999999999999999999999988755433211 11112223456788999999999999999999999
Q ss_pred EEeCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccC
Q 020641 93 CVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFED 172 (323)
Q Consensus 93 ~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~ 172 (323)
+.+....++||||+.+|+|.+++..... +++..+..++.||+.||.|||+. ||+||||||+||+++.+
T Consensus 115 ~~~~~~~~lv~e~~~gg~L~~~l~~~~~---------~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~ 182 (504)
T 3q5i_A 115 FEDKKYFYLVTEFYEGGELFEQIINRHK---------FDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENK 182 (504)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHHSC---------CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESST
T ss_pred EEcCCEEEEEEecCCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecC
Confidence 9999999999999999999999976542 89999999999999999999999 99999999999999877
Q ss_pred C---eEEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchh
Q 020641 173 F---KAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSL 249 (323)
Q Consensus 173 ~---~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~ 249 (323)
+ .++|+|||++........ .....||+.|+|||++. ..++.++||||||+++|+|++|..||...........
T Consensus 183 ~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~ 258 (504)
T 3q5i_A 183 NSLLNIKIVDFGLSSFFSKDYK---LRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKK 258 (504)
T ss_dssp TCCSSEEECCCTTCEECCTTSC---BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred CCCccEEEEECCCCEEcCCCCc---cccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 5 699999999976544321 23445899999999876 4689999999999999999999999976543211111
Q ss_pred hhhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 250 VTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
+......... ......+..+.+++.+||+.||.+|||+.|+++
T Consensus 259 i~~~~~~~~~-------------~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~ 301 (504)
T 3q5i_A 259 VEKGKYYFDF-------------NDWKNISDEAKELIKLMLTYDYNKRCTAEEALN 301 (504)
T ss_dssp HHHCCCCCCH-------------HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHcCCCCCCc-------------cccCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 1100000000 000123567999999999999999999999986
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-45 Score=312.97 Aligned_cols=259 Identities=25% Similarity=0.356 Sum_probs=204.4
Q ss_pred CCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEe
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVE 95 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 95 (323)
.+....+||+|+||.||++.+. +++.+++|..... ....+.+.+|++++++++||||+++++++..
T Consensus 14 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-------------~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 79 (279)
T 1qpc_A 14 TLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQG-------------SMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 79 (279)
T ss_dssp GEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTT-------------SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred hhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCC-------------cccHHHHHHHHHHHHhCCCcCcceEEEEEcC
Confidence 4556669999999999999875 4456777755421 1234678999999999999999999999875
Q ss_pred CCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeE
Q 020641 96 GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKA 175 (323)
Q Consensus 96 ~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~ 175 (323)
+ ..++||||+.+++|.+++...... .+++..+..++.|++.||.|||+. |++|+||||+||+++.++.+
T Consensus 80 ~-~~~~v~e~~~~~~L~~~l~~~~~~-------~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~ 148 (279)
T 1qpc_A 80 E-PIYIITEYMENGSLVDFLKTPSGI-------KLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSC 148 (279)
T ss_dssp S-SCEEEEECCTTCBHHHHTTSHHHH-------TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCE
T ss_pred C-CcEEEEecCCCCCHHHHHhcCCCC-------CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCE
Confidence 4 579999999999999999754321 188999999999999999999999 99999999999999999999
Q ss_pred EEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhc
Q 020641 176 KIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWAT 254 (323)
Q Consensus 176 ~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~ 254 (323)
+|+|||++......... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||.......
T Consensus 149 kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--------- 218 (279)
T 1qpc_A 149 KIADFGLARLIEDNEYT-AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE--------- 218 (279)
T ss_dssp EECCCTTCEECSSSCEE-CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH---------
T ss_pred EECCCcccccccCcccc-cccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHH---------
Confidence 99999998765433221 1223346788999999988888999999999999999999 999997543211
Q ss_pred ccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhhcCCCC
Q 020641 255 PRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSPPP 316 (323)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~~~~~~ 316 (323)
....+........+...+..+.+++.+||+.||++|||+.++++.|+++......
T Consensus 219 -------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~ 273 (279)
T 1qpc_A 219 -------VIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEG 273 (279)
T ss_dssp -------HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC--
T ss_pred -------HHHHHhcccCCCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhccC
Confidence 1111111112223345567899999999999999999999999999999866443
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=321.02 Aligned_cols=264 Identities=20% Similarity=0.152 Sum_probs=198.3
Q ss_pred CccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeC
Q 020641 17 PGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEG 96 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 96 (323)
|....+||+|+||.||+|.+..+++.+|+|+........ ......+.+.+|++++++++||||+++++++.+.
T Consensus 28 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-------~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 100 (345)
T 3hko_A 28 YHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQ-------INPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE 100 (345)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC----------CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred eeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcc-------cCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence 444558999999999999999999999999776442211 1123347789999999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHhccCCCCCC-------------------------------CCCCCCCCHHHHHHHHHHHHHH
Q 020641 97 NLRVLAYEFATMGSLHDILHGRKGVQG-------------------------------AQPGPVLDWMTRVRIAVDAARG 145 (323)
Q Consensus 97 ~~~~lv~e~~~~~sL~~~~~~~~~~~~-------------------------------~~~~~~~~~~~~~~~~~~i~~~ 145 (323)
+..++||||+.+|+|.+++........ ......+++..++.++.|++.|
T Consensus 101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~ 180 (345)
T 3hko_A 101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180 (345)
T ss_dssp SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence 999999999999999999963211000 0001124677888999999999
Q ss_pred HHHhhcCCCCCceeCCCCCCCEEEccCC--eEEEeeccccCCCCccc--cccccccccCccccCCCccccC--CCCCccc
Q 020641 146 LEYLHEKVQPSIIHRDIRSSNVLLFEDF--KAKIADFNLSNQAPDMA--ARLHSTRVLGTFGYHAPEYAMT--GQLTQKS 219 (323)
Q Consensus 146 l~~lh~~~~~~i~h~dikp~nili~~~~--~~~l~Dfg~~~~~~~~~--~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~ 219 (323)
|.|||+. |++|+||||+||+++.++ .++|+|||++....... .........|++.|+|||.+.+ ..++.++
T Consensus 181 l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 257 (345)
T 3hko_A 181 LHYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC 257 (345)
T ss_dssp HHHHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHH
T ss_pred HHHHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHH
Confidence 9999999 999999999999998776 89999999987543211 1112234458999999999865 6788999
Q ss_pred chHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccccccccchhcCCCcCC--CCCHHHHHHHHHHHHHccCCCCCCC
Q 020641 220 DVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKG--EYPPKGVAKLAAVAALCVQYEAEFR 297 (323)
Q Consensus 220 Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~~P~~R 297 (323)
||||||+++|+|++|+.||.......... ..+...... ......+..+.+++.+||+.||.+|
T Consensus 258 DiwslG~il~el~~g~~pf~~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 322 (345)
T 3hko_A 258 DAWSAGVLLHLLLMGAVPFPGVNDADTIS---------------QVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDER 322 (345)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCSSHHHHHH---------------HHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTS
T ss_pred HHHHHHHHHHHHHHCCCCCCCCChHHHHH---------------HHHhcccccCCcccccCCHHHHHHHHHHcCCChhHC
Confidence 99999999999999999997654321111 111111111 1112346779999999999999999
Q ss_pred CChHHHHH
Q 020641 298 PNMSIVVK 305 (323)
Q Consensus 298 ps~~evl~ 305 (323)
||+.|+++
T Consensus 323 ps~~~~l~ 330 (345)
T 3hko_A 323 FDAMRALQ 330 (345)
T ss_dssp CCHHHHHH
T ss_pred CCHHHHhc
Confidence 99999987
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=323.19 Aligned_cols=261 Identities=18% Similarity=0.259 Sum_probs=199.4
Q ss_pred CCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCC-----CCccccee
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLK-----HENLVELL 90 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-----h~~i~~~~ 90 (323)
.|....+||+|+||.||+|++..+++.+|+|+.... .........|+.+++.+. |+||++++
T Consensus 36 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-------------~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~ 102 (360)
T 3llt_A 36 AFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-------------KKYTRSAKIEADILKKIQNDDINNNNIVKYH 102 (360)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-------------HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEE
T ss_pred EEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-------------hhhhhhhHHHHHHHHHhcccCCCCCCeeccc
Confidence 456666999999999999999999999999976421 112355677888888886 99999999
Q ss_pred eEEEeCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEc
Q 020641 91 GYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLF 170 (323)
Q Consensus 91 ~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~ 170 (323)
+++...+..++||||+ +++|.+++....... +++..+..++.||+.||.|||+. ||+||||||+||+++
T Consensus 103 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~-------~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~ 171 (360)
T 3llt_A 103 GKFMYYDHMCLIFEPL-GPSLYEIITRNNYNG-------FHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLD 171 (360)
T ss_dssp EEEEETTEEEEEECCC-CCBHHHHHHHTTTCC-------CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEES
T ss_pred ceeeECCeeEEEEcCC-CCCHHHHHHhcCCCC-------CCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEc
Confidence 9999999999999999 789999998765332 88999999999999999999999 999999999999997
Q ss_pred c-------------------------CCeEEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHH
Q 020641 171 E-------------------------DFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFG 225 (323)
Q Consensus 171 ~-------------------------~~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG 225 (323)
. ++.++|+|||++...... .....||+.|+|||++.+..++.++||||||
T Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG 246 (360)
T 3llt_A 172 DPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY-----HGSIINTRQYRAPEVILNLGWDVSSDMWSFG 246 (360)
T ss_dssp CTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC-----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHH
T ss_pred cccccccccchhcccccccccccccCCCCEEEEeccCceecCCC-----CcCccCcccccCcHHHcCCCCCCccchHHHH
Confidence 5 788999999998754332 2344589999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCCCcccchhhhhhcccccccccchhc--------C-CCcCCCC--------------------CH
Q 020641 226 VVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCV--------D-PKLKGEY--------------------PP 276 (323)
Q Consensus 226 ~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~-~~~~~~~--------------------~~ 276 (323)
|++|+|++|+.||...................+........ + ....... ..
T Consensus 247 ~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~ 326 (360)
T 3llt_A 247 CVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKI 326 (360)
T ss_dssp HHHHHHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHH
T ss_pred HHHHHHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhccccccc
Confidence 99999999999997654322211111111111111000000 0 0000000 00
Q ss_pred HHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 277 KGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 277 ~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
..+..+.+|+.+||+.||++|||+.|+++
T Consensus 327 ~~~~~l~~li~~~L~~dP~~Rpta~elL~ 355 (360)
T 3llt_A 327 IKHELFCDFLYSILQIDPTLRPSPAELLK 355 (360)
T ss_dssp CCCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred chHHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 11257889999999999999999999985
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-44 Score=309.42 Aligned_cols=269 Identities=16% Similarity=0.220 Sum_probs=207.9
Q ss_pred CCCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEE-
Q 020641 15 PSPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYC- 93 (323)
Q Consensus 15 ~~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~- 93 (323)
..|.....||+|+||.||++++..+++.+|+|+.... .....+.+|+.+++.++|++++..+..+
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--------------~~~~~~~~e~~~l~~l~~~~~i~~~~~~~ 74 (296)
T 3uzp_A 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVK--------------TKHPQLHIESKIYKMMQGGVGIPTIRWCG 74 (296)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESC--------------SSCCHHHHHHHHHHHHTTSTTCCCEEEEE
T ss_pred cEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCC--------------cchhHHHHHHHHHHHhhcCCCCCcccccc
Confidence 3456667999999999999999999999999965422 1224688999999999887766655554
Q ss_pred EeCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEE---c
Q 020641 94 VEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLL---F 170 (323)
Q Consensus 94 ~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili---~ 170 (323)
..+...++||||+ +++|.+++...... +++..+..++.|++.||.|||+. |++|+||||+||++ +
T Consensus 75 ~~~~~~~lv~e~~-~~~L~~~~~~~~~~--------~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~ 142 (296)
T 3uzp_A 75 AEGDYNVMVMELL-GPSLEDLFNFCSRK--------FSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGK 142 (296)
T ss_dssp EETTEEEEEEECC-CCBHHHHHHHTTTC--------CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGG
T ss_pred CCCCceEEEEEec-CCCHHHHHHhhccC--------CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCC
Confidence 6677889999999 78999999744322 89999999999999999999999 99999999999999 4
Q ss_pred cCCeEEEeeccccCCCCcccccc-----ccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcc
Q 020641 171 EDFKAKIADFNLSNQAPDMAARL-----HSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRG 245 (323)
Q Consensus 171 ~~~~~~l~Dfg~~~~~~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 245 (323)
.++.++|+|||++.......... ......|++.|+|||.+.+..++.++||||||+++|+|++|+.||.......
T Consensus 143 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~ 222 (296)
T 3uzp_A 143 KGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAAT 222 (296)
T ss_dssp GTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSS
T ss_pred CCCeEEEeeCCCcccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchh
Confidence 88899999999987654432211 1234458999999999999899999999999999999999999998654322
Q ss_pred cchhhhhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhhcCCCCCC
Q 020641 246 QQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSPPPAA 318 (323)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~~~~~~~~ 318 (323)
................. .......+..+.+++.+||+.||.+|||+.+|++.|+++......+.
T Consensus 223 ~~~~~~~~~~~~~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~~ 286 (296)
T 3uzp_A 223 KRQKYERISEKKMSTPI---------EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSY 286 (296)
T ss_dssp SSSHHHHHHHHHHHSCH---------HHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTCCS
T ss_pred hhhhhhhhcccccCCch---------HHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCCcc
Confidence 21111110000000000 00012335679999999999999999999999999999997766554
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=342.21 Aligned_cols=252 Identities=24% Similarity=0.344 Sum_probs=202.1
Q ss_pred ccCCCCCCccceec--cceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeCCeE
Q 020641 22 RLDKGPEDDLYLKK--RVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLR 99 (323)
Q Consensus 22 ~lg~G~~~~V~~~~--~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 99 (323)
+||+|+||.||++. ...+++.+|+|+...... .....+.+.+|++++++++||||+++++++... ..
T Consensus 376 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~----------~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~-~~ 444 (635)
T 4fl3_A 376 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN----------DPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SW 444 (635)
T ss_dssp EEEECSSEEEEEEEEECSSCEEEEEEEEECGGGG----------CGGGHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SE
T ss_pred EeccCCCEEEEEEEEcCCCcceEEEEEEeccccC----------CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CE
Confidence 69999999999994 456778899997653311 122347789999999999999999999999754 57
Q ss_pred EEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEEEee
Q 020641 100 VLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIAD 179 (323)
Q Consensus 100 ~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~l~D 179 (323)
++||||+.+|+|.+++..... +++..+..++.||+.||.|||++ ||+||||||+|||++.++.+||+|
T Consensus 445 ~lv~E~~~~g~L~~~l~~~~~---------l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~D 512 (635)
T 4fl3_A 445 MLVMEMAELGPLNKYLQQNRH---------VKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISD 512 (635)
T ss_dssp EEEEECCTTEEHHHHHHHCTT---------CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC
T ss_pred EEEEEccCCCCHHHHHhhCCC---------CCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEE
Confidence 899999999999999976432 89999999999999999999999 999999999999999999999999
Q ss_pred ccccCCCCcccc-ccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccc
Q 020641 180 FNLSNQAPDMAA-RLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPRL 257 (323)
Q Consensus 180 fg~~~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~ 257 (323)
||++........ ........+++.|+|||++.+..++.++||||||+++|+|++ |+.||.....
T Consensus 513 FGla~~~~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~-------------- 578 (635)
T 4fl3_A 513 FGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG-------------- 578 (635)
T ss_dssp TTHHHHTTC-------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH--------------
T ss_pred cCCccccccCccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH--------------
Confidence 999875543221 111222346788999999999899999999999999999998 9999975532
Q ss_pred cccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhhc
Q 020641 258 SEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLK 312 (323)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~~ 312 (323)
..+...+........+..++..+.++|.+||+.||++|||+.+|++.|+++..
T Consensus 579 --~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~ 631 (635)
T 4fl3_A 579 --SEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 631 (635)
T ss_dssp --HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred --HHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 12222233333344556677889999999999999999999999999998864
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-44 Score=329.74 Aligned_cols=262 Identities=16% Similarity=0.149 Sum_probs=194.9
Q ss_pred CCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEe
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVE 95 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 95 (323)
.|....+||+|+||.||+|.+..+++.+|+|++...... ....+.+.+|+.+++.++||||+++++++..
T Consensus 63 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~----------~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 132 (464)
T 3ttj_A 63 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQN----------QTHAKRAYRELVLMKCVNHKNIISLLNVFTP 132 (464)
T ss_dssp TEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGS----------HHHHHHHHHHHHHHHHCCCTTBCCCSEEECS
T ss_pred CeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccC----------hHHHHHHHHHHHHHHhCCCCCCCcEEEEEcc
Confidence 455666899999999999999999999999977543211 1223667899999999999999999999965
Q ss_pred C------CeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEE
Q 020641 96 G------NLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLL 169 (323)
Q Consensus 96 ~------~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili 169 (323)
. ...|+||||+.+ +|.+.+... +++..+..++.||+.||.|||+. ||+||||||+||++
T Consensus 133 ~~~~~~~~~~~lv~E~~~~-~l~~~~~~~-----------l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll 197 (464)
T 3ttj_A 133 QKTLEEFQDVYLVMELMDA-NLCQVIQME-----------LDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVV 197 (464)
T ss_dssp CCSTTTCCEEEEEEECCSE-EHHHHHTSC-----------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEE
T ss_pred CCccccCCeEEEEEeCCCC-CHHHHHhhc-----------CCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEE
Confidence 4 467999999986 677777542 88999999999999999999999 99999999999999
Q ss_pred ccCCeEEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchh
Q 020641 170 FEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSL 249 (323)
Q Consensus 170 ~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~ 249 (323)
+.++.+||+|||++....... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......
T Consensus 198 ~~~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~ 274 (464)
T 3ttj_A 198 KSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNK 274 (464)
T ss_dssp CTTSCEEECCCCCC-----CC---CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred eCCCCEEEEEEEeeeecCCCc---ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 999999999999997654321 22345689999999999999999999999999999999999999986643221111
Q ss_pred hhhhccc----------------------ccccccchhcCCCcCCC---CCHHHHHHHHHHHHHccCCCCCCCCChHHHH
Q 020641 250 VTWATPR----------------------LSEDKVKQCVDPKLKGE---YPPKGVAKLAAVAALCVQYEAEFRPNMSIVV 304 (323)
Q Consensus 250 ~~~~~~~----------------------~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~~P~~Rps~~evl 304 (323)
+...... ................. .....+.++.+|+.+||..||++|||+.|++
T Consensus 275 i~~~lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L 354 (464)
T 3ttj_A 275 VIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDAL 354 (464)
T ss_dssp HHHHHCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred HHHhcCCCCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHh
Confidence 1000000 00000011110000000 0112267899999999999999999999999
Q ss_pred H
Q 020641 305 K 305 (323)
Q Consensus 305 ~ 305 (323)
+
T Consensus 355 ~ 355 (464)
T 3ttj_A 355 Q 355 (464)
T ss_dssp T
T ss_pred c
Confidence 7
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=310.54 Aligned_cols=252 Identities=23% Similarity=0.310 Sum_probs=201.3
Q ss_pred CccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEe-
Q 020641 17 PGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVE- 95 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~- 95 (323)
|.....||+|+||.||++.+..+++.+++|..... .+.+.+|++++++++||||+++++++..
T Consensus 13 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----------------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 76 (284)
T 2a19_B 13 FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYN----------------NEKAEREVKALAKLDHVNIVHYNGCWDGF 76 (284)
T ss_dssp EEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECC----------------SGGGHHHHHHHHHCCCTTBCCEEEEEEEE
T ss_pred cceeeeeccCCceEEEEEEEcCCCeEEEEEEeccc----------------cHHHHHHHHHHHhCCCCCEEEEeeeEecc
Confidence 44556899999999999999989999999866422 1456789999999999999999998864
Q ss_pred ---------------CCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeC
Q 020641 96 ---------------GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHR 160 (323)
Q Consensus 96 ---------------~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~ 160 (323)
....++||||+.+++|.+++...... .+++..++.++.|++.||.|||+. |++|+
T Consensus 77 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-------~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~ 146 (284)
T 2a19_B 77 DYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGE-------KLDKVLALELFEQITKGVDYIHSK---KLINR 146 (284)
T ss_dssp EEC---------CCEEEEEEEEECCCCSCBHHHHHHHGGGS-------CCCHHHHHHHHHHHHHHHHHHHHT---TEECS
T ss_pred ccCcccccccccccCcceEEEEEeccCCCCHHHHHhhccCC-------CCCHHHHHHHHHHHHHHHHHHHhC---Ceeec
Confidence 34579999999999999999754322 289999999999999999999999 99999
Q ss_pred CCCCCCEEEccCCeEEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCC
Q 020641 161 DIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDH 240 (323)
Q Consensus 161 dikp~nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 240 (323)
||||+||+++.++.++|+|||++........ .....|++.|+|||.+.+..++.++||||||+++|+|++|..||..
T Consensus 147 dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~ 223 (284)
T 2a19_B 147 DLKPSNIFLVDTKQVKIGDFGLVTSLKNDGK---RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFE 223 (284)
T ss_dssp CCSGGGEEEEETTEEEECCCTTCEESSCCSC---CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHH
T ss_pred cCCHHHEEEcCCCCEEECcchhheecccccc---ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchh
Confidence 9999999999999999999999876544321 2334589999999999988899999999999999999999988742
Q ss_pred CCCcccchhhhhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhhcCCCCCC
Q 020641 241 TMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSPPPAA 318 (323)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~~~~~~~~ 318 (323)
... . ....... ..+...+..+.+++.+||+.||.+|||+.|+++.|+.+.+.+....
T Consensus 224 ~~~-----~------------~~~~~~~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~~~~ 280 (284)
T 2a19_B 224 TSK-----F------------FTDLRDG----IISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNE 280 (284)
T ss_dssp HHH-----H------------HHHHHTT----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC------
T ss_pred HHH-----H------------HHHhhcc----cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCCccc
Confidence 100 0 0001111 1123345669999999999999999999999999999987766543
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-45 Score=330.98 Aligned_cols=257 Identities=15% Similarity=0.130 Sum_probs=203.1
Q ss_pred CCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEe
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVE 95 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 95 (323)
.|....+||+|+||.||++++..+++.+|+|++.+..... ......+.+|..++..++||||+++++++.+
T Consensus 75 ~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~---------~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~ 145 (437)
T 4aw2_A 75 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLK---------RAETACFREERDVLVNGDSKWITTLHYAFQD 145 (437)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHH---------TTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred heEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhh---------HHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence 4556668999999999999999999999999876432111 1223557899999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeE
Q 020641 96 GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKA 175 (323)
Q Consensus 96 ~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~ 175 (323)
.+..|+||||+.+|+|.+++...... +++..+..++.|++.||.|||+. ||+||||||+|||++.++.+
T Consensus 146 ~~~~~lV~Ey~~gg~L~~~l~~~~~~--------l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~v 214 (437)
T 4aw2_A 146 DNNLYLVMDYYVGGDLLTLLSKFEDR--------LPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHI 214 (437)
T ss_dssp SSEEEEEECCCTTCBHHHHHHTTTTC--------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCE
T ss_pred CCEEEEEEecCCCCcHHHHHHHccCC--------CCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCE
Confidence 99999999999999999999764322 99999999999999999999999 99999999999999999999
Q ss_pred EEeeccccCCCCccccccccccccCccccCCCcccc-----CCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhh
Q 020641 176 KIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAM-----TGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLV 250 (323)
Q Consensus 176 ~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~ 250 (323)
||+|||++......... ......||+.|+|||++. ...++.++|||||||++|+|++|+.||...........+
T Consensus 215 kL~DFGla~~~~~~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i 293 (437)
T 4aw2_A 215 RLADFGSCLKLMEDGTV-QSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI 293 (437)
T ss_dssp EECCCTTCEECCTTSCE-ECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH
T ss_pred EEcchhhhhhcccCCCc-ccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhh
Confidence 99999998655432221 223356999999999986 456899999999999999999999999765432211111
Q ss_pred hhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCC--CCChHHHHH
Q 020641 251 TWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEF--RPNMSIVVK 305 (323)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~--Rps~~evl~ 305 (323)
....... .-+ ......+.++.+||.+||..+|+. ||+++|+++
T Consensus 294 ~~~~~~~--------~~p----~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~ 338 (437)
T 4aw2_A 294 MNHKERF--------QFP----TQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKK 338 (437)
T ss_dssp HTHHHHC--------CCC----SSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred hhccccc--------cCC----cccccCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence 0000000 000 111234667999999999988888 999999987
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-45 Score=319.17 Aligned_cols=267 Identities=21% Similarity=0.326 Sum_probs=203.1
Q ss_pred CCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEe
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVE 95 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 95 (323)
.|....+||+|+||.||++++..+++.+|+|++... .....+.+.+|+++++.++||||+++++++..
T Consensus 30 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 97 (317)
T 2buj_A 30 HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH------------EQQDREEAQREADMHRLFNHPNILRLVAYCLR 97 (317)
T ss_dssp EEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES------------SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEE
T ss_pred EEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC------------CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEe
Confidence 455666999999999999999999999999976431 11223678899999999999999999999873
Q ss_pred ----CCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEcc
Q 020641 96 ----GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFE 171 (323)
Q Consensus 96 ----~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~ 171 (323)
....++||||+.+++|.+++...... ...+++..++.++.|++.||.|||+. |++|+||||+||+++.
T Consensus 98 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-----~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~ 169 (317)
T 2buj_A 98 ERGAKHEAWLLLPFFKRGTLWNEIERLKDK-----GNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGD 169 (317)
T ss_dssp EETTEEEEEEEEECCTTCBHHHHHHHHHTT-----TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECT
T ss_pred ccCCCceeEEEEEeCCCCcHHHHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcC
Confidence 34779999999999999999763211 11289999999999999999999999 9999999999999999
Q ss_pred CCeEEEeeccccCCCCcccccc-------ccccccCccccCCCccccCCC---CCcccchHHHHHHHHHHHhCCCCCCCC
Q 020641 172 DFKAKIADFNLSNQAPDMAARL-------HSTRVLGTFGYHAPEYAMTGQ---LTQKSDVYSFGVVLLELLTGRKPVDHT 241 (323)
Q Consensus 172 ~~~~~l~Dfg~~~~~~~~~~~~-------~~~~~~g~~~y~aPE~~~~~~---~~~~~Di~slG~~l~~l~~g~~pf~~~ 241 (323)
++.++|+|||++.......... ......|++.|+|||.+.+.. ++.++||||||+++|+|++|+.||...
T Consensus 170 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 249 (317)
T 2buj_A 170 EGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMV 249 (317)
T ss_dssp TSCEEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHH
T ss_pred CCCEEEEecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhh
Confidence 9999999999886554221110 011234789999999987554 688999999999999999999999532
Q ss_pred CCcccchhhhhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhhcCCCC
Q 020641 242 MPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSPPP 316 (323)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~~~~~~ 316 (323)
...... ....+............+..+.+++.+||+.||.+|||+.++++.|+.+....+.
T Consensus 250 ~~~~~~--------------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~ 310 (317)
T 2buj_A 250 FQKGDS--------------VALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAPG 310 (317)
T ss_dssp HHTTSC--------------HHHHHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCCCC
T ss_pred hcccch--------------hhHHhhccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCCCC
Confidence 111100 0011111111222334567799999999999999999999999999988654444
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-44 Score=310.16 Aligned_cols=252 Identities=21% Similarity=0.238 Sum_probs=195.2
Q ss_pred CccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeC
Q 020641 17 PGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEG 96 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 96 (323)
|....+||+|+||.||+|.+..+++.+++|+..... .....+.+.+|++++++++||||+++++++.+.
T Consensus 24 y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-----------~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 92 (285)
T 3is5_A 24 FIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDR-----------SQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDY 92 (285)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGG-----------CCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred eeecceeccCCCeEEEEEEEccCCceEEEEEeeccc-----------cchhHHHHHHHHHHHHhCCCchHHhHHHheecC
Confidence 455569999999999999999999999998765432 122347789999999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEE---ccCC
Q 020641 97 NLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLL---FEDF 173 (323)
Q Consensus 97 ~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili---~~~~ 173 (323)
...++||||+.+++|.+++...... ...+++..+..++.|++.||.|||+. |++|+||||+||++ +.++
T Consensus 93 ~~~~lv~e~~~~~~L~~~l~~~~~~-----~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~ 164 (285)
T 3is5_A 93 HNMYIVMETCEGGELLERIVSAQAR-----GKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHS 164 (285)
T ss_dssp SEEEEEECCCSCCBHHHHHHHHHHH-----TCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTC
T ss_pred CeEEEEEEeCCCCcHHHHHHhhhhc-----ccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCC
Confidence 9999999999999999998643210 01289999999999999999999999 99999999999999 4567
Q ss_pred eEEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhh
Q 020641 174 KAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWA 253 (323)
Q Consensus 174 ~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 253 (323)
.++|+|||++........ .....|++.|+|||.+. ..++.++||||||+++|+|++|+.||...............
T Consensus 165 ~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~ 240 (285)
T 3is5_A 165 PIKIIDFGLAELFKSDEH---STNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYK 240 (285)
T ss_dssp CEEECCCCCCCC-------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC
T ss_pred CEEEEeeecceecCCccc---CcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccC
Confidence 899999999976544322 23345899999999875 56889999999999999999999999765432111111111
Q ss_pred cccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 254 TPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
.. ... ......++.+.+++.+||+.||.+|||+.|+++
T Consensus 241 ~~-------------~~~-~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 241 EP-------------NYA-VECRPLTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp CC-------------CCC-C--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred Cc-------------ccc-cccCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 10 000 001123467899999999999999999999986
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=318.00 Aligned_cols=265 Identities=17% Similarity=0.190 Sum_probs=192.6
Q ss_pred CCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEe
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVE 95 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 95 (323)
.|....+||+|+||+||+|.+..+++.+|+|++.... ......+.+.+|+.++++++||||+++++++..
T Consensus 35 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 104 (329)
T 3gbz_A 35 RYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEH----------EEEGVPGTAIREVSLLKELQHRNIIELKSVIHH 104 (329)
T ss_dssp GEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC------------------CHHHHHHGGGCCCTTBCCEEEEEEE
T ss_pred hEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccc----------cccccchhHHHHHHHHHHcCCCCcceEEEEEec
Confidence 3455569999999999999999999999999775332 112233556789999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEc-----
Q 020641 96 GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLF----- 170 (323)
Q Consensus 96 ~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~----- 170 (323)
.+..++||||+.+ +|.+++..... +++..+..++.|++.||.|||+. ||+|+||||+||+++
T Consensus 105 ~~~~~lv~e~~~~-~L~~~~~~~~~---------~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~ 171 (329)
T 3gbz_A 105 NHRLHLIFEYAEN-DLKKYMDKNPD---------VSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDAS 171 (329)
T ss_dssp TTEEEEEEECCSE-EHHHHHHHCTT---------CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC----
T ss_pred CCEEEEEEecCCC-CHHHHHhhcCC---------CCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCC
Confidence 9999999999985 99999976543 89999999999999999999999 999999999999994
Q ss_pred cCCeEEEeeccccCCCCccccccccccccCccccCCCccccCC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchh
Q 020641 171 EDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG-QLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSL 249 (323)
Q Consensus 171 ~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~ 249 (323)
.++.++|+|||++........ ......||+.|+|||++.+. .++.++||||||+++|+|++|..||...........
T Consensus 172 ~~~~~kl~Dfg~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~ 249 (329)
T 3gbz_A 172 ETPVLKIGDFGLARAFGIPIR--QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFK 249 (329)
T ss_dssp -CCEEEECCTTHHHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred ccceEEECcCCCccccCCccc--ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHH
Confidence 555699999999865432211 12334579999999998874 479999999999999999999999976543221111
Q ss_pred hhhhccccccccc------chhcC--CCcCC-----CCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 250 VTWATPRLSEDKV------KQCVD--PKLKG-----EYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 250 ~~~~~~~~~~~~~------~~~~~--~~~~~-----~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
............. ..+.. +.... ..+...+.++.+|+.+||+.||.+|||+.|+++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 250 IFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp HHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHhCCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 1110000000000 00000 00000 011124567999999999999999999999987
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=312.32 Aligned_cols=262 Identities=21% Similarity=0.325 Sum_probs=197.8
Q ss_pred CCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcC--CCCcccceeeEE
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRL--KHENLVELLGYC 93 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l--~h~~i~~~~~~~ 93 (323)
.|....+||+|+||.||++++. ++.+|+|++... .......|.+++..+ +|+||+++++++
T Consensus 38 ~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~---------------~~~~~~~e~~~~~~~~~~h~~i~~~~~~~ 100 (337)
T 3mdy_A 38 QIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTT---------------EEASWFRETEIYQTVLMRHENILGFIAAD 100 (337)
T ss_dssp HCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGG---------------GHHHHHHHHHHHTSTTCCCTTBCCEEEEE
T ss_pred ceEEEeEeecCCCeEEEEEEEC--CceEEEEEEecc---------------ccchhhhHHHHHHHHhhcCCCeeeEEEEE
Confidence 4556669999999999999875 778888866321 113345566666554 999999999999
Q ss_pred EeC----CeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCC-----CCCceeCCCCC
Q 020641 94 VEG----NLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKV-----QPSIIHRDIRS 164 (323)
Q Consensus 94 ~~~----~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~-----~~~i~h~dikp 164 (323)
... ...++||||+.+|+|.+++.... +++..++.++.|++.||.|||+.+ ..|++||||||
T Consensus 101 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp 170 (337)
T 3mdy_A 101 IKGTGSWTQLYLITDYHENGSLYDYLKSTT----------LDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKS 170 (337)
T ss_dssp EESCGGGCEEEEEECCCTTCBHHHHHHHCC----------BCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCG
T ss_pred ccCCCCCCceEEEEeccCCCcHHHHhhccC----------CCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccch
Confidence 887 78899999999999999997653 899999999999999999999652 23899999999
Q ss_pred CCEEEccCCeEEEeeccccCCCCcccccc--ccccccCccccCCCccccCCCCCcc------cchHHHHHHHHHHHhC--
Q 020641 165 SNVLLFEDFKAKIADFNLSNQAPDMAARL--HSTRVLGTFGYHAPEYAMTGQLTQK------SDVYSFGVVLLELLTG-- 234 (323)
Q Consensus 165 ~nili~~~~~~~l~Dfg~~~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~------~Di~slG~~l~~l~~g-- 234 (323)
+||+++.++.++|+|||++.......... ......||+.|+|||.+.+...+.. +||||||+++|+|++|
T Consensus 171 ~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~ 250 (337)
T 3mdy_A 171 KNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCV 250 (337)
T ss_dssp GGEEECTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBC
T ss_pred HHEEECCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccC
Confidence 99999999999999999986554332221 1223468999999999987766554 9999999999999999
Q ss_pred --------CCCCCCCCCcccchhhhhhcccccccccchh-cCCCcCCCCC-----HHHHHHHHHHHHHccCCCCCCCCCh
Q 020641 235 --------RKPVDHTMPRGQQSLVTWATPRLSEDKVKQC-VDPKLKGEYP-----PKGVAKLAAVAALCVQYEAEFRPNM 300 (323)
Q Consensus 235 --------~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~-----~~~~~~l~~li~~cl~~~P~~Rps~ 300 (323)
..||.......... ...... .........+ ..++..+.+++.+||+.||.+|||+
T Consensus 251 ~~~~~~~~~~p~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~ 319 (337)
T 3mdy_A 251 SGGIVEEYQLPYHDLVPSDPSY-----------EDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTA 319 (337)
T ss_dssp BTTBCCCCCCTTTTTSCSSCCH-----------HHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCH
T ss_pred cccccccccccHhhhcCCCCch-----------hhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCH
Confidence 55554332211110 001111 1111112222 3678899999999999999999999
Q ss_pred HHHHHHHhhhhcCCC
Q 020641 301 SIVVKALQPLLKSPP 315 (323)
Q Consensus 301 ~evl~~l~~~~~~~~ 315 (323)
.+|++.|+++.++..
T Consensus 320 ~ell~~L~~l~~~~~ 334 (337)
T 3mdy_A 320 LRVKKTLAKMSESQD 334 (337)
T ss_dssp HHHHHHHHHHHHTTT
T ss_pred HHHHHHHHHHHhhcc
Confidence 999999999998765
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=311.41 Aligned_cols=263 Identities=24% Similarity=0.294 Sum_probs=196.1
Q ss_pred CCccccccCCCCCCccceeccce---eeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeE
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRVK---MRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGY 92 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~~---~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 92 (323)
.|....+||+|+||+||++++.. ....+++|+....... .....+.+.+|++++++++||||++++++
T Consensus 19 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~---------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 89 (291)
T 1u46_A 19 DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLS---------QPEAMDDFIREVNAMHSLDHRNLIRLYGV 89 (291)
T ss_dssp GEEEEEECC----CCCEEEEEECTTSCEEEEEEEC-----------------CHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred HeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccC---------CHHHHHHHHHHHHHHHhCCCCCcccEEEE
Confidence 35555699999999999998543 2345788866533211 12234678899999999999999999999
Q ss_pred EEeCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccC
Q 020641 93 CVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFED 172 (323)
Q Consensus 93 ~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~ 172 (323)
+..+. .++|+||+.+++|.+++...... +++..+..++.|++.||.+||+. |++|+||||+||+++.+
T Consensus 90 ~~~~~-~~~v~e~~~~~~L~~~l~~~~~~--------~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~ 157 (291)
T 1u46_A 90 VLTPP-MKMVTELAPLGSLLDRLRKHQGH--------FLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATR 157 (291)
T ss_dssp ECSSS-CEEEEECCTTCBHHHHHHHHGGG--------SCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEET
T ss_pred EccCC-ceeeEecccCCCHHHHHHhccCC--------cCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCC
Confidence 98765 78999999999999999764322 88999999999999999999999 99999999999999999
Q ss_pred CeEEEeeccccCCCCccccc-cccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccchhh
Q 020641 173 FKAKIADFNLSNQAPDMAAR-LHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLV 250 (323)
Q Consensus 173 ~~~~l~Dfg~~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~ 250 (323)
+.++|+|||++......... .......++..|+|||.+.+..++.++||||||+++|+|++ |..||........
T Consensus 158 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~---- 233 (291)
T 1u46_A 158 DLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI---- 233 (291)
T ss_dssp TEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH----
T ss_pred CCEEEccccccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHH----
Confidence 99999999998765433221 11223346778999999988888999999999999999999 9999975532111
Q ss_pred hhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhhcCC
Q 020641 251 TWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSP 314 (323)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~~~~ 314 (323)
.............+...+..+.+++.+||+.||.+|||+.++++.|+++....
T Consensus 234 -----------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 286 (291)
T 1u46_A 234 -----------LHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTD 286 (291)
T ss_dssp -----------HHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred -----------HHHHHccCCCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCccc
Confidence 11111111112233455678999999999999999999999999999887544
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-44 Score=311.48 Aligned_cols=247 Identities=24% Similarity=0.338 Sum_probs=203.4
Q ss_pred CccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeC
Q 020641 17 PGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEG 96 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 96 (323)
|....+||+|+||.||++.+..+++.+++|+..... .....+.+.+|+.+++.++|+||+++++++...
T Consensus 24 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 92 (303)
T 3a7i_A 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE-----------AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKD 92 (303)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTT-----------CSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred HHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccc-----------cHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC
Confidence 455568999999999999999999999999765331 123357789999999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEE
Q 020641 97 NLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAK 176 (323)
Q Consensus 97 ~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~ 176 (323)
...++||||+.+++|.+++.... +++..+..++.|++.||.+||+. |++|+||||+||+++.++.++
T Consensus 93 ~~~~lv~e~~~~~~L~~~~~~~~----------~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~k 159 (303)
T 3a7i_A 93 TKLWIIMEYLGGGSALDLLEPGP----------LDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVK 159 (303)
T ss_dssp TEEEEEEECCTTEEHHHHHTTSC----------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEE
T ss_pred CeEEEEEEeCCCCcHHHHHhcCC----------CCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEE
Confidence 99999999999999999997532 89999999999999999999999 999999999999999999999
Q ss_pred EeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhccc
Q 020641 177 IADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPR 256 (323)
Q Consensus 177 l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 256 (323)
|+|||++........ ......|++.|+|||.+.+..++.++||||||+++|+|++|..||...........
T Consensus 160 l~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~------- 230 (303)
T 3a7i_A 160 LADFGVAGQLTDTQI--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFL------- 230 (303)
T ss_dssp ECCCTTCEECBTTBC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH-------
T ss_pred EeecccceecCcccc--ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHH-------
Confidence 999999876543221 12344589999999999988999999999999999999999999975432111100
Q ss_pred ccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 257 LSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
+........+...+..+.+++.+||+.||.+|||+.++++
T Consensus 231 ---------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 270 (303)
T 3a7i_A 231 ---------IPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLK 270 (303)
T ss_dssp ---------HHHSCCCCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred ---------hhcCCCCCCccccCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 0001111223344567999999999999999999999987
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-44 Score=323.19 Aligned_cols=254 Identities=19% Similarity=0.229 Sum_probs=191.4
Q ss_pred CccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeC
Q 020641 17 PGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEG 96 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 96 (323)
|....+||+|+||.||+|.+..+++.+|+|++.++........ .......+.+|+.++++++||||+++++++..
T Consensus 137 y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~----~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~- 211 (419)
T 3i6u_A 137 YIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAR----EADPALNVETEIEILKKLNHPCIIKIKNFFDA- 211 (419)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC------------CCHHHHHHHHHHCCCTTBCCCCEEEES-
T ss_pred EEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccc----cchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-
Confidence 4455589999999999999999999999998876543322211 12233568899999999999999999999864
Q ss_pred CeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCC---
Q 020641 97 NLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDF--- 173 (323)
Q Consensus 97 ~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~--- 173 (323)
...++||||+.+++|.+++..... +++..+..++.|++.||.|||+. |++||||||+||+++.++
T Consensus 212 ~~~~lv~e~~~~g~L~~~l~~~~~---------~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~ 279 (419)
T 3i6u_A 212 EDYYIVLELMEGGELFDKVVGNKR---------LKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDC 279 (419)
T ss_dssp SEEEEEEECCTTCBGGGGTSSSCC---------CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSC
T ss_pred CceEEEEEcCCCCcHHHHHhccCC---------CCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcc
Confidence 457999999999999999876542 89999999999999999999999 999999999999997654
Q ss_pred eEEEeeccccCCCCccccccccccccCccccCCCccccC---CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhh
Q 020641 174 KAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT---GQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLV 250 (323)
Q Consensus 174 ~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~---~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~ 250 (323)
.++|+|||++....... ......||+.|+|||.+.+ ..++.++||||||+++|+|++|..||..........
T Consensus 280 ~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~-- 354 (419)
T 3i6u_A 280 LIKITDFGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLK-- 354 (419)
T ss_dssp CEEECCSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHH--
T ss_pred eEEEeecccceecCCCc---cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHH--
Confidence 59999999998765432 1234568999999998863 567889999999999999999999997543321111
Q ss_pred hhhcccccccccchhcCCCcCCCCC---HHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 251 TWATPRLSEDKVKQCVDPKLKGEYP---PKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
..+........+ ...+..+.+++.+||+.||.+|||+.|+++
T Consensus 355 -------------~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 355 -------------DQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp -------------HHHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred -------------HHHhcCCCCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 000000000001 123567999999999999999999999987
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-44 Score=330.25 Aligned_cols=250 Identities=22% Similarity=0.244 Sum_probs=199.9
Q ss_pred CccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeC
Q 020641 17 PGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEG 96 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 96 (323)
|....+||+|+||+||+|++..+++.+|+|++.+.... ......+.+|++++++++||||+++++++...
T Consensus 24 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----------~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 93 (486)
T 3mwu_A 24 YNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAK----------NKDTSTILREVELLKKLDHPNIMKLFEILEDS 93 (486)
T ss_dssp EEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHB----------CSCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred eEEeEEEeecCCEEEEEEEECCCCCEEEEEEEeccccc----------chHHHHHHHHHHHHHhCCCCCcCeEEEEEEcC
Confidence 44555999999999999999999999999977543211 22346788999999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEc---cCC
Q 020641 97 NLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLF---EDF 173 (323)
Q Consensus 97 ~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~---~~~ 173 (323)
...++||||+.+++|.+.+..... +++..+..++.|++.||.|||+. ||+||||||+||+++ .++
T Consensus 94 ~~~~lv~e~~~~~~L~~~~~~~~~---------~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~ 161 (486)
T 3mwu_A 94 SSFYIVGELYTGGELFDEIIKRKR---------FSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDC 161 (486)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTC
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCC
Confidence 999999999999999999876542 89999999999999999999999 999999999999995 456
Q ss_pred eEEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhh
Q 020641 174 KAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWA 253 (323)
Q Consensus 174 ~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 253 (323)
.++|+|||++........ .....||+.|+|||++.+ .++.++|||||||++|+|++|..||...........+...
T Consensus 162 ~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~ 237 (486)
T 3mwu_A 162 DIKIIDFGLSTCFQQNTK---MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETG 237 (486)
T ss_dssp CEEECSCSCTTTBCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT
T ss_pred CEEEEECCcCeECCCCCc---cCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC
Confidence 799999999976543322 233458999999998876 5899999999999999999999999765332111111100
Q ss_pred cccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 254 TPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
... .........+..+.++|.+||+.||.+|||+.++++
T Consensus 238 ~~~-------------~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~ 276 (486)
T 3mwu_A 238 KYA-------------FDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (486)
T ss_dssp CCC-------------SCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred CCC-------------CCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 000 000111344677999999999999999999999998
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=319.32 Aligned_cols=267 Identities=20% Similarity=0.271 Sum_probs=198.3
Q ss_pred CCCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEE
Q 020641 15 PSPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCV 94 (323)
Q Consensus 15 ~~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 94 (323)
..|.....||+|+||.||++++..+++.+|+|+...... .....+.+.+|+.++++++||||+++++++.
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 94 (331)
T 4aaa_A 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDD----------DKMVKKIAMREIKLLKQLRHENLVNLLEVCK 94 (331)
T ss_dssp GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSS----------CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCC----------chHHHHHHHHHHHHHhhCCCCCEeeEEEEee
Confidence 344555599999999999999999999999997643211 1112355778999999999999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCe
Q 020641 95 EGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFK 174 (323)
Q Consensus 95 ~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~ 174 (323)
..+..++||||+.+++|.++...... +++..+..++.|++.||.|||+. |++|+||||+||+++.++.
T Consensus 95 ~~~~~~lv~e~~~~~~l~~~~~~~~~---------~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~ 162 (331)
T 4aaa_A 95 KKKRWYLVFEFVDHTILDDLELFPNG---------LDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGV 162 (331)
T ss_dssp ETTEEEEEEECCSEEHHHHHHHSTTC---------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSC
T ss_pred cCCEEEEEEecCCcchHHHHHhhccC---------CCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCc
Confidence 99999999999999888888765432 89999999999999999999999 9999999999999999999
Q ss_pred EEEeeccccCCCCccccccccccccCccccCCCccccCC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhh
Q 020641 175 AKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG-QLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWA 253 (323)
Q Consensus 175 ~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 253 (323)
++|+|||++........ ......|++.|+|||.+.+. .++.++||||||+++|+|++|+.||...............
T Consensus 163 ~kl~Dfg~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~ 240 (331)
T 4aaa_A 163 VKLCDFGFARTLAAPGE--VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMC 240 (331)
T ss_dssp EEECCCTTC--------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred EEEEeCCCceeecCCcc--ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHH
Confidence 99999999976543222 12334589999999998765 6889999999999999999999999766432211111100
Q ss_pred cccccc---------cccchhcCCCcCCCC-----CHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 254 TPRLSE---------DKVKQCVDPKLKGEY-----PPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 254 ~~~~~~---------~~~~~~~~~~~~~~~-----~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
...... ........+...... ....+..+.+|+.+||+.||.+|||+.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 241 LGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp HCSCCHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred hCCCChhhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 000000 000000111111111 1234678999999999999999999999886
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-44 Score=320.36 Aligned_cols=262 Identities=20% Similarity=0.236 Sum_probs=194.8
Q ss_pred CCCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEE
Q 020641 15 PSPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCV 94 (323)
Q Consensus 15 ~~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 94 (323)
..|.....||+|+||.||+|.+..+++.+|+|....... .....+.+.+|+++++.++||||+++++++.
T Consensus 25 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~----------~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 94 (367)
T 1cm8_A 25 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQ----------SELFAKRAYRELRLLKHMRHENVIGLLDVFT 94 (367)
T ss_dssp SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTS----------SHHHHHHHHHHHHHHHHCCBTTBCCCSEEEC
T ss_pred ceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCcccc----------CHHHHHHHHHHHHHHHhCCCcCCCCceeeEe
Confidence 345666689999999999999999999999997643211 1122367789999999999999999999998
Q ss_pred eCC------eEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEE
Q 020641 95 EGN------LRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVL 168 (323)
Q Consensus 95 ~~~------~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nil 168 (323)
... ..|+||||+ +++|.+++.... +++..+..++.|++.||.|||+. |++||||||+||+
T Consensus 95 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~----------l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIl 160 (367)
T 1cm8_A 95 PDETLDDFTDFYLVMPFM-GTDLGKLMKHEK----------LGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLA 160 (367)
T ss_dssp SCSSTTTCCCCEEEEECC-SEEHHHHHHHCC----------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEE
T ss_pred cCCccccCceEEEEEecC-CCCHHHHHhcCC----------CCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEE
Confidence 653 469999999 679999997642 89999999999999999999999 9999999999999
Q ss_pred EccCCeEEEeeccccCCCCccccccccccccCccccCCCccccC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccc
Q 020641 169 LFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT-GQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQ 247 (323)
Q Consensus 169 i~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~ 247 (323)
++.++.++|+|||++...... .....+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.......
T Consensus 161 l~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l 235 (367)
T 1cm8_A 161 VNEDCELKILDFGLARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQL 235 (367)
T ss_dssp ECTTCCEEECCCTTCEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred EcCCCCEEEEeeecccccccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 999999999999998765432 234458999999999877 67899999999999999999999999866432211
Q ss_pred hhhhhhccccccccc--------chhcC--CCc----CCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 248 SLVTWATPRLSEDKV--------KQCVD--PKL----KGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 248 ~~~~~~~~~~~~~~~--------~~~~~--~~~----~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
..+.......+.... ...+. +.. ........+..+.+|+.+||..||.+|||+.|+++
T Consensus 236 ~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~ 307 (367)
T 1cm8_A 236 KEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 307 (367)
T ss_dssp HHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHHhcCCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence 111110000000000 00000 000 00112344677999999999999999999999998
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-44 Score=310.20 Aligned_cols=249 Identities=20% Similarity=0.262 Sum_probs=203.5
Q ss_pred CccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeC
Q 020641 17 PGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEG 96 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 96 (323)
|.....||+|+||.||++.+..+++.+++|+........ ....+.+.+|+.+++.++|+||+++++++...
T Consensus 17 y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~---------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 87 (294)
T 2rku_A 17 YVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLK---------PHQREKMSMEISIHRSLAHQHVVGFHGFFEDN 87 (294)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCS---------HHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred eEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccC---------HHHHHHHHHHHHHHHhCCCCCEeeeeeeeccC
Confidence 344458999999999999999999999999776433221 12236778899999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEE
Q 020641 97 NLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAK 176 (323)
Q Consensus 97 ~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~ 176 (323)
+..++||||+.+++|.+++..... +++..+..++.|++.|+.|||+. |++|+||||+||+++.++.++
T Consensus 88 ~~~~lv~e~~~~~~L~~~~~~~~~---------~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~k 155 (294)
T 2rku_A 88 DFVFVVLELCRRRSLLELHKRRKA---------LTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVK 155 (294)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHCS---------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEE
T ss_pred CEEEEEEecCCCCCHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEE
Confidence 999999999999999999876532 89999999999999999999999 999999999999999999999
Q ss_pred EeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhccc
Q 020641 177 IADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPR 256 (323)
Q Consensus 177 l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 256 (323)
|+|||++........ ......|++.|+|||.+.+..++.++||||||+++|+|++|..||...........
T Consensus 156 l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~------- 226 (294)
T 2rku_A 156 IGDFGLATKVEYDGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLR------- 226 (294)
T ss_dssp ECCCTTCEECCSTTC--CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH-------
T ss_pred EEeccCceecccCcc--ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-------
Confidence 999999876543221 12334589999999999988899999999999999999999999975532211110
Q ss_pred ccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 257 LSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
..... ...+...+..+.+++.+||+.||++|||+.|+++
T Consensus 227 --------~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 265 (294)
T 2rku_A 227 --------IKKNE--YSIPKHINPVAASLIQKMLQTDPTARPTINELLN 265 (294)
T ss_dssp --------HHTTC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred --------Hhhcc--CCCccccCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence 00100 1123345567999999999999999999999997
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-44 Score=316.50 Aligned_cols=249 Identities=20% Similarity=0.270 Sum_probs=203.4
Q ss_pred CccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeC
Q 020641 17 PGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEG 96 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 96 (323)
|.....||+|+||.||++.+..+++.+++|+........ ....+.+.+|+.+++.++|+||+++++++.+.
T Consensus 43 y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~---------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 113 (335)
T 2owb_A 43 YVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLK---------PHQREKMSMEISIHRSLAHQHVVGFHGFFEDN 113 (335)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCS---------HHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred eEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcC---------HHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence 334458999999999999999999999999776443221 12236788999999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEE
Q 020641 97 NLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAK 176 (323)
Q Consensus 97 ~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~ 176 (323)
+..++||||+.+++|.+++..... +++..++.++.|++.||.|||+. |++|+||||+||+++.++.++
T Consensus 114 ~~~~lv~e~~~~~~L~~~~~~~~~---------l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~k 181 (335)
T 2owb_A 114 DFVFVVLELCRRRSLLELHKRRKA---------LTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVK 181 (335)
T ss_dssp SEEEEEECCCTTCBHHHHHHHHCS---------CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEE
T ss_pred CeEEEEEecCCCCCHHHHHhccCC---------CCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEE
Confidence 999999999999999999876532 89999999999999999999999 999999999999999999999
Q ss_pred EeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhccc
Q 020641 177 IADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPR 256 (323)
Q Consensus 177 l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 256 (323)
|+|||++........ ......|++.|+|||.+.+..++.++||||||+++|+|++|..||.............
T Consensus 182 l~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~----- 254 (335)
T 2owb_A 182 IGDFGLATKVEYDGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIK----- 254 (335)
T ss_dssp ECCCTTCEECCSTTC--CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH-----
T ss_pred EeeccCceecccCcc--cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHh-----
Confidence 999999876543221 1233458999999999998889999999999999999999999997553211111000
Q ss_pred ccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 257 LSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
... ...+...+..+.+++.+||+.||++|||+.|+++
T Consensus 255 ----------~~~--~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 291 (335)
T 2owb_A 255 ----------KNE--YSIPKHINPVAASLIQKMLQTDPTARPTINELLN 291 (335)
T ss_dssp ----------HTC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred ----------cCC--CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000 1123344567999999999999999999999997
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-44 Score=311.62 Aligned_cols=252 Identities=25% Similarity=0.370 Sum_probs=193.8
Q ss_pred CccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeC
Q 020641 17 PGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEG 96 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 96 (323)
+.....||+|+||.||+++.. ++.+++|.... ....+.+.+|++++++++||||+++++++.+
T Consensus 10 ~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~--------------~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~- 72 (307)
T 2eva_A 10 IEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIES--------------ESERKAFIVELRQLSRVNHPNIVKLYGACLN- 72 (307)
T ss_dssp EEEEEEEECCSSSEEEEEEET--TEEEEEEECSS--------------TTHHHHHHHHHHHHHHCCCTTBCCEEEBCTT-
T ss_pred eeeeeEeecCCCceEEEEEEC--CeeEEEEEecC--------------hhHHHHHHHHHHHHhcCCCCCcCeEEEEEcC-
Confidence 445568999999999999874 56678775531 1234678899999999999999999998874
Q ss_pred CeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhc---CCCCCceeCCCCCCCEEEccCC
Q 020641 97 NLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHE---KVQPSIIHRDIRSSNVLLFEDF 173 (323)
Q Consensus 97 ~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~---~~~~~i~h~dikp~nili~~~~ 173 (323)
..++||||+.+++|.+++...... ..++...++.++.|++.||.|||+ + |++|+||||+||+++.++
T Consensus 73 -~~~lv~e~~~~~~L~~~l~~~~~~------~~~~~~~~~~~~~qi~~~l~~LH~~~~~---~ivH~dlkp~NIll~~~~ 142 (307)
T 2eva_A 73 -PVCLVMEYAEGGSLYNVLHGAEPL------PYYTAAHAMSWCLQCSQGVAYLHSMQPK---ALIHRDLKPPNLLLVAGG 142 (307)
T ss_dssp -TTEEEEECCTTCBHHHHHHCSSSE------ECCCHHHHHHHHHHHHHHHHHHHTCSSS---CCCCCCCSGGGEEEETTT
T ss_pred -CcEEEEEcCCCCCHHHHHhccCCC------CccCHHHHHHHHHHHHHHHHHHHhCCCC---CeecCCCChhHEEEeCCC
Confidence 378999999999999999765421 127888999999999999999999 7 999999999999999887
Q ss_pred e-EEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhh
Q 020641 174 K-AKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTW 252 (323)
Q Consensus 174 ~-~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 252 (323)
. ++|+|||++....... ....|++.|+|||.+.+..++.++||||||+++|+|++|+.||.......... .+
T Consensus 143 ~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~--~~ 215 (307)
T 2eva_A 143 TVLKICDFGTACDIQTHM-----TNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRI--MW 215 (307)
T ss_dssp TEEEECCCCC-----------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHH--HH
T ss_pred CEEEEccccccccccccc-----ccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHH--HH
Confidence 6 7999999987554321 22348999999999999899999999999999999999999997543321111 00
Q ss_pred hcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhhcCC
Q 020641 253 ATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSP 314 (323)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~~~~ 314 (323)
. .............+..+.+++.+||+.||.+|||+.++++.|+.+....
T Consensus 216 ~------------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 265 (307)
T 2eva_A 216 A------------VHNGTRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYF 265 (307)
T ss_dssp H------------HHTTCCCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGC
T ss_pred H------------HhcCCCCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhc
Confidence 0 0011111223345567999999999999999999999999999987544
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-44 Score=308.40 Aligned_cols=247 Identities=19% Similarity=0.292 Sum_probs=195.1
Q ss_pred ccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEe--
Q 020641 18 GYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVE-- 95 (323)
Q Consensus 18 ~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-- 95 (323)
....+||+|+||.||+|.+..+++.+++|......... ...+.+.+|+.++++++||||+++++++..
T Consensus 29 ~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~----------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 98 (290)
T 1t4h_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTK----------SERQRFKEEAEMLKGLQHPNIVRFYDSWESTV 98 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCH----------HHHHHHHHHHHHHTTCCCTTBCCEEEEEEEES
T ss_pred EeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCH----------HHHHHHHHHHHHHHhCCCCCeeeeeeeecccc
Confidence 33347999999999999999999999998765432221 123678899999999999999999999875
Q ss_pred --CCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC--ceeCCCCCCCEEEc-
Q 020641 96 --GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPS--IIHRDIRSSNVLLF- 170 (323)
Q Consensus 96 --~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~--i~h~dikp~nili~- 170 (323)
....++||||+.+++|.+++..... +++..++.++.|++.||.|||+. | ++|+||||+||+++
T Consensus 99 ~~~~~~~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~ 166 (290)
T 1t4h_A 99 KGKKCIVLVTELMTSGTLKTYLKRFKV---------MKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITG 166 (290)
T ss_dssp SSCEEEEEEEECCCSCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESS
T ss_pred CCCceEEEEEEecCCCCHHHHHHHccC---------CCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEEC
Confidence 3568999999999999999976432 88999999999999999999999 8 99999999999997
Q ss_pred cCCeEEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhh
Q 020641 171 EDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLV 250 (323)
Q Consensus 171 ~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~ 250 (323)
.++.++|+|||++....... .....|++.|+|||.+. ..++.++||||||+++|+|++|..||..........
T Consensus 167 ~~~~~kl~Dfg~~~~~~~~~----~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~-- 239 (290)
T 1t4h_A 167 PTGSVKIGDLGLATLKRASF----AKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIY-- 239 (290)
T ss_dssp TTSCEEECCTTGGGGCCTTS----BEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHH--
T ss_pred CCCCEEEeeCCCcccccccc----cccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHH--
Confidence 78999999999986544322 12345899999999876 458999999999999999999999997543211110
Q ss_pred hhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 251 TWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
.... ........+...+..+.+++.+||+.||.+|||+.|+++
T Consensus 240 ~~~~------------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 240 RRVT------------SGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp HHHT------------TTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHh------------ccCCccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 0000 000000112223457999999999999999999999987
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=329.21 Aligned_cols=250 Identities=22% Similarity=0.250 Sum_probs=196.4
Q ss_pred CccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeC
Q 020641 17 PGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEG 96 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 96 (323)
|....+||+|+||+||+|++..+++.+|+|++.+.... ......+.+|+.+++.++||||+++++++...
T Consensus 39 y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~----------~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 108 (494)
T 3lij_A 39 YQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVS----------TSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDK 108 (494)
T ss_dssp EEEEEEEECC---EEEEEEETTTCCEEEEEEEEC---------------CTTHHHHHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred eEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccC----------chHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC
Confidence 55566899999999999999999999999977643211 22346789999999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccC---C
Q 020641 97 NLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFED---F 173 (323)
Q Consensus 97 ~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~---~ 173 (323)
...++||||+.+|+|.+.+..... +++..+..++.|++.||.|||+. ||+||||||+||+++.+ +
T Consensus 109 ~~~~lv~e~~~~g~L~~~~~~~~~---------~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~ 176 (494)
T 3lij_A 109 RNYYLVMECYKGGELFDEIIHRMK---------FNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDA 176 (494)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTC
T ss_pred CEEEEEEecCCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCC
Confidence 999999999999999998876542 89999999999999999999999 99999999999999764 4
Q ss_pred eEEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhh
Q 020641 174 KAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWA 253 (323)
Q Consensus 174 ~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 253 (323)
.++|+|||++........ .....||+.|+|||++. ..++.++|||||||++|+|++|..||...........+...
T Consensus 177 ~~kl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~ 252 (494)
T 3lij_A 177 LIKIVDFGLSAVFENQKK---MKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKG 252 (494)
T ss_dssp CEEECCCTTCEECBTTBC---BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT
T ss_pred cEEEEECCCCeECCCCcc---ccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC
Confidence 599999999876554322 23445899999999876 56899999999999999999999999765432111111111
Q ss_pred cccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 254 TPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
..... .......+..+.+++.+||+.||.+|||+.|+++
T Consensus 253 ~~~~~-------------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 253 KYTFD-------------SPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp CCCCC-------------SGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCCCC-------------chhcccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence 00000 0001234567999999999999999999999985
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=320.04 Aligned_cols=269 Identities=16% Similarity=0.184 Sum_probs=204.6
Q ss_pred CCCccccccCCCCCCccceecccee--------eeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcc
Q 020641 15 PSPGYFVRLDKGPEDDLYLKKRVKM--------RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENL 86 (323)
Q Consensus 15 ~~~~~~~~lg~G~~~~V~~~~~~~~--------~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i 86 (323)
..|.....||.|+||.||+|++..+ ++.+|+|+.... +.+.+|++++++++||||
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----------------~~~~~E~~~l~~l~h~ni 104 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----------------GRLFNEQNFFQRAAKPLQ 104 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----------------STHHHHHHHHHHHCCHHH
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----------------chHHHHHHHHHHhcccch
Confidence 3455556999999999999999884 788888865422 467899999999999999
Q ss_pred cc---------------eeeEEEe-CCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhh
Q 020641 87 VE---------------LLGYCVE-GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLH 150 (323)
Q Consensus 87 ~~---------------~~~~~~~-~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh 150 (323)
++ +++++.. +...++||||+ +++|.+++...... .+++..++.++.|++.||.|||
T Consensus 105 v~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~-------~l~~~~~~~i~~qi~~~L~~LH 176 (352)
T 2jii_A 105 VNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKH-------VLSERSVLQVACRLLDALEFLH 176 (352)
T ss_dssp HHHHHHHTTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGG-------CCCHHHHHHHHHHHHHHHHHHH
T ss_pred hhhhhhhccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcC-------CCCHHHHHHHHHHHHHHHHHHH
Confidence 88 5667766 67889999999 88999999865221 2999999999999999999999
Q ss_pred cCCCCCceeCCCCCCCEEEccCC--eEEEeeccccCCCCcccccc-----ccccccCccccCCCccccCCCCCcccchHH
Q 020641 151 EKVQPSIIHRDIRSSNVLLFEDF--KAKIADFNLSNQAPDMAARL-----HSTRVLGTFGYHAPEYAMTGQLTQKSDVYS 223 (323)
Q Consensus 151 ~~~~~~i~h~dikp~nili~~~~--~~~l~Dfg~~~~~~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~Di~s 223 (323)
++ |++|+||||+||+++.++ .++|+|||++.......... ......|++.|+|||.+.+..++.++||||
T Consensus 177 ~~---~ivH~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s 253 (352)
T 2jii_A 177 EN---EYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQS 253 (352)
T ss_dssp HT---TCBCSCCCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHH
T ss_pred hC---CccCCCCCHHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHH
Confidence 99 999999999999999998 89999999997765433211 112336899999999999989999999999
Q ss_pred HHHHHHHHHhCCCCCCCCCCcccchhhhhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHH
Q 020641 224 FGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIV 303 (323)
Q Consensus 224 lG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev 303 (323)
||+++|+|++|+.||................ .. .......... ......+..+.+++.+||+.||.+|||+.+|
T Consensus 254 lG~il~el~~g~~pf~~~~~~~~~~~~~~~~--~~-~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l 327 (352)
T 2jii_A 254 LGYCMLKWLYGFLPWTNCLPNTEDIMKQKQK--FV-DKPGPFVGPC---GHWIRPSETLQKYLKVVMALTYEEKPPYAML 327 (352)
T ss_dssp HHHHHHHHHHSCCTTGGGTTCHHHHHHHHHH--HH-HSCCCEECTT---SCEECCCHHHHHHHHHHHTCCTTCCCCHHHH
T ss_pred HHHHHHHHHhCCCCcccCCcCHHHHHHHHHh--cc-CChhhhhhhc---cccCCCcHHHHHHHHHHHhCChhhCCCHHHH
Confidence 9999999999999997553211111000000 00 0000000000 0011235679999999999999999999999
Q ss_pred HHHHhhhhcCCCCC
Q 020641 304 VKALQPLLKSPPPA 317 (323)
Q Consensus 304 l~~l~~~~~~~~~~ 317 (323)
++.|+++++.....
T Consensus 328 ~~~L~~~~~~~~~~ 341 (352)
T 2jii_A 328 RNNLEALLQDLRVS 341 (352)
T ss_dssp HHHHHHHHHHTTCC
T ss_pred HHHHHHHHHhcCCC
Confidence 99999999765543
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=335.02 Aligned_cols=254 Identities=18% Similarity=0.228 Sum_probs=206.3
Q ss_pred CccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeC
Q 020641 17 PGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEG 96 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 96 (323)
+.....||+|+||.||+|++..+++.+|+|++.+..... ......+.+|+++++.++||||+++++++.+.
T Consensus 186 f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~---------~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~ 256 (576)
T 2acx_A 186 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKK---------RKGEAMALNEKQILEKVNSRFVVSLAYAYETK 256 (576)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHH---------TTCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred eEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhh---------hHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeC
Confidence 455568999999999999999999999999876432211 22346678999999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEE
Q 020641 97 NLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAK 176 (323)
Q Consensus 97 ~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~ 176 (323)
+..|+||||+.+|+|.+++....... +++..+..++.||+.||.|||+. ||+||||||+||+++.++.++
T Consensus 257 ~~l~lVmEy~~gg~L~~~l~~~~~~~-------l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vK 326 (576)
T 2acx_A 257 DALCLVLTLMNGGDLKFHIYHMGQAG-------FPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIR 326 (576)
T ss_dssp SEEEEEECCCCSCBHHHHHHSSSSCC-------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEE
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCCCC-------CCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeE
Confidence 99999999999999999997654322 89999999999999999999999 999999999999999999999
Q ss_pred EeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhccc
Q 020641 177 IADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPR 256 (323)
Q Consensus 177 l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 256 (323)
|+|||++........ .....||+.|+|||++.+..++.++|||||||++|+|++|..||.............
T Consensus 327 L~DFGla~~~~~~~~---~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~----- 398 (576)
T 2acx_A 327 ISDLGLAVHVPEGQT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVE----- 398 (576)
T ss_dssp ECCCTTCEECCTTCC---EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHH-----
T ss_pred EEecccceecccCcc---ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHH-----
Confidence 999999976543221 233468999999999998889999999999999999999999998654322111111
Q ss_pred ccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCC-----ChHHHHH
Q 020641 257 LSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRP-----NMSIVVK 305 (323)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-----s~~evl~ 305 (323)
..+.. .....+...+.++.+||.+||+.||.+|| ++.||++
T Consensus 399 -------~~i~~-~~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 399 -------RLVKE-VPEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp -------HHHHH-CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred -------HHhhc-ccccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 00000 01123345567899999999999999999 7888875
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=309.35 Aligned_cols=254 Identities=19% Similarity=0.206 Sum_probs=198.2
Q ss_pred CCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEE-
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCV- 94 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~- 94 (323)
.|.....||+|+||.||++.+..+++.+++|+........ .......+.+|+.+++.++|+||+++++++.
T Consensus 6 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~--------~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 77 (305)
T 2wtk_C 6 KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRR--------IPNGEANVKKEIQLLRRLRHKNVIQLVDVLYN 77 (305)
T ss_dssp CBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHH--------STTHHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred ceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccc--------cchhHHHHHHHHHHHHhcCCCCeeEEEEEEEc
Confidence 4566679999999999999999999999999776432211 1223467899999999999999999999984
Q ss_pred -eCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCC
Q 020641 95 -EGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDF 173 (323)
Q Consensus 95 -~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~ 173 (323)
+....++||||+.++ |.+++...... .+++..+..++.|++.||.|||+. |++|+||||+||+++.++
T Consensus 78 ~~~~~~~lv~e~~~~~-l~~~~~~~~~~-------~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~ 146 (305)
T 2wtk_C 78 EEKQKMYMVMEYCVCG-MQEMLDSVPEK-------RFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGG 146 (305)
T ss_dssp C---CEEEEEECCSEE-HHHHHHHSTTC-------SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTC
T ss_pred CCCCeEEEEehhccCC-HHHHHHhCccc-------ccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCC
Confidence 455789999999875 77777654332 289999999999999999999999 999999999999999999
Q ss_pred eEEEeeccccCCCCccccccccccccCccccCCCccccCCCC--CcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhh
Q 020641 174 KAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQL--TQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVT 251 (323)
Q Consensus 174 ~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~--~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~ 251 (323)
.++|+|||++................|++.|+|||.+.+... +.++||||||+++|+|++|..||.............
T Consensus 147 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~ 226 (305)
T 2wtk_C 147 TLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIG 226 (305)
T ss_dssp CEEECCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred cEEeeccccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHh
Confidence 999999999876543222222334458999999998876443 779999999999999999999997543211100000
Q ss_pred hhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 252 WATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
.. ....+...+..+.+++.+||+.||.+|||+.|+++
T Consensus 227 ---------------~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 263 (305)
T 2wtk_C 227 ---------------KG--SYAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQ 263 (305)
T ss_dssp ---------------HC--CCCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred ---------------cC--CCCCCCccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 00 01223345667999999999999999999999996
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-44 Score=312.35 Aligned_cols=283 Identities=23% Similarity=0.251 Sum_probs=185.8
Q ss_pred CCCCCCccccccCCCCCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhc
Q 020641 1 MDYDYHPRALGAHAPSPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSR 80 (323)
Q Consensus 1 ~~~~~~~~~~~~~~~~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~ 80 (323)
|+.+.......-....|.....||.|+||.||++.+..+++.+++|....... ....+.+.+|+.++++
T Consensus 1 m~~~s~~~p~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----------~~~~~~~~~e~~~l~~ 69 (303)
T 2vwi_A 1 MSEDSSALPWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC-----------QTSMDELLKEIQAMSQ 69 (303)
T ss_dssp ------------CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC---------------------------CCCC
T ss_pred CCCcccccccccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc-----------chhHHHHHHHHHHHhh
Confidence 34443333333444566777799999999999999999999999997653321 1223567889999999
Q ss_pred CCCCcccceeeEEEeCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeC
Q 020641 81 LKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHR 160 (323)
Q Consensus 81 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~ 160 (323)
++||||+++++++...+..++||||+.+++|.+++....... ......+++..++.++.|++.||.|||+. |++|+
T Consensus 70 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~-~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~ 145 (303)
T 2vwi_A 70 CHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKG-EHKSGVLDESTIATILREVLEGLEYLHKN---GQIHR 145 (303)
T ss_dssp CCCTTBCCEEEEEESSSCEEEEEECCTTCBHHHHHHHHHHTT-TTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCC
T ss_pred cCCCCEeeEEEEEeecCCcEEEehhccCCchHHHHHHHhhcc-ccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCC
Confidence 999999999999999999999999999999999997421110 00112389999999999999999999999 99999
Q ss_pred CCCCCCEEEccCCeEEEeeccccCCCCcccc---ccccccccCccccCCCccccC-CCCCcccchHHHHHHHHHHHhCCC
Q 020641 161 DIRSSNVLLFEDFKAKIADFNLSNQAPDMAA---RLHSTRVLGTFGYHAPEYAMT-GQLTQKSDVYSFGVVLLELLTGRK 236 (323)
Q Consensus 161 dikp~nili~~~~~~~l~Dfg~~~~~~~~~~---~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~ 236 (323)
||||+||+++.++.++|+|||++........ ........|++.|+|||.+.+ ..++.++||||||+++|+|++|..
T Consensus 146 dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~ 225 (303)
T 2vwi_A 146 DVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAA 225 (303)
T ss_dssp CCSGGGEEECTTCCEEECCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred CCChhhEEEcCCCCEEEEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCC
Confidence 9999999999999999999999865433211 111223458999999998865 568899999999999999999999
Q ss_pred CCCCCCCcccchhhhhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 237 PVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 237 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
||............. ............+ .......+..+.+++.+||+.||.+|||+.++++
T Consensus 226 pf~~~~~~~~~~~~~---~~~~~~~~~~~~~----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 226 PYHKYPPMKVLMLTL---QNDPPSLETGVQD----KEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp TTTTSCGGGHHHHHH---TSSCCCTTC---------CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred CCccCchhhHHHHHh---ccCCCcccccccc----chhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 997654322111000 0000000000001 1122234567999999999999999999999987
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-44 Score=309.58 Aligned_cols=248 Identities=20% Similarity=0.260 Sum_probs=199.5
Q ss_pred CccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeC
Q 020641 17 PGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEG 96 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 96 (323)
|.....||+|+||.||++++..+++.+++|++.... ....+.+.+|+.+++.++||||+++++++...
T Consensus 11 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 78 (304)
T 2jam_A 11 FIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSP------------AFRDSSLENEIAVLKKIKHENIVTLEDIYEST 78 (304)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------------------HHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred ceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccc------------ccchHHHHHHHHHHHhCCCCCeeehhhhcccC
Confidence 445568999999999999999999999999775321 11235688999999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEE---ccCC
Q 020641 97 NLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLL---FEDF 173 (323)
Q Consensus 97 ~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili---~~~~ 173 (323)
...++||||+.+++|.+++..... +++..+..++.|++.||.|||+. |++|+||||+||++ +.++
T Consensus 79 ~~~~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~ 146 (304)
T 2jam_A 79 THYYLVMQLVSGGELFDRILERGV---------YTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENS 146 (304)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHSC---------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTC
T ss_pred CEEEEEEEcCCCccHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCC
Confidence 999999999999999999876542 88999999999999999999999 99999999999999 7788
Q ss_pred eEEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhh
Q 020641 174 KAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWA 253 (323)
Q Consensus 174 ~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 253 (323)
.++|+|||++....... .....|++.|+|||.+.+..++.++||||||+++|+|++|..||.............
T Consensus 147 ~~kl~Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~-- 220 (304)
T 2jam_A 147 KIMITDFGLSKMEQNGI----MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIK-- 220 (304)
T ss_dssp CEEBCSCSTTCCCCCBT----THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH--
T ss_pred CEEEccCCcceecCCCc----cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH--
Confidence 99999999987654321 122348999999999998899999999999999999999999997543211100000
Q ss_pred cccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 254 TPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
... ...........+..+.+++.+||+.||.+|||+.|+++
T Consensus 221 ~~~-----------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (304)
T 2jam_A 221 EGY-----------YEFESPFWDDISESAKDFICHLLEKDPNERYTCEKALS 261 (304)
T ss_dssp HCC-----------CCCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred cCC-----------CCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 000 00111222345677999999999999999999999987
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-44 Score=315.33 Aligned_cols=248 Identities=17% Similarity=0.199 Sum_probs=198.6
Q ss_pred ccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcC-CCCcccceeeEEEeCCeEE
Q 020641 22 RLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRL-KHENLVELLGYCVEGNLRV 100 (323)
Q Consensus 22 ~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~ 100 (323)
.||+|+||.||++.+..+++.+|+|++..... .......+.+|+.+++.+ .||||+++++++......+
T Consensus 36 ~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~----------~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~ 105 (327)
T 3lm5_A 36 ELGRGKFAVVRQCISKSTGQEYAAKFLKKRRR----------GQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEII 105 (327)
T ss_dssp EEEEETTEEEEEEEETTTCCEEEEEEEESEET----------TEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred eeCCCCCeEEEEEEECCCCCEEEEEEEehhhc----------chHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEE
Confidence 69999999999999999999999997764321 122346788999999999 6799999999999999999
Q ss_pred EEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEcc---CCeEEE
Q 020641 101 LAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFE---DFKAKI 177 (323)
Q Consensus 101 lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~---~~~~~l 177 (323)
+||||+.+++|.+++...... .+++..++.++.|++.||.|||+. |++|+||||+||+++. ++.++|
T Consensus 106 lv~e~~~~~~L~~~~~~~~~~-------~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~~~~kL 175 (327)
T 3lm5_A 106 LILEYAAGGEIFSLCLPELAE-------MVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIKI 175 (327)
T ss_dssp EEEECCTTEEGGGGGSSCC-C-------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTBCCEEE
T ss_pred EEEEecCCCcHHHHHHHhccc-------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCCCcEEE
Confidence 999999999999998654322 289999999999999999999999 9999999999999987 789999
Q ss_pred eeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccc
Q 020641 178 ADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRL 257 (323)
Q Consensus 178 ~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 257 (323)
+|||++........ .....|++.|+|||.+.+..++.++||||||+++|+|++|..||...............
T Consensus 176 ~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~---- 248 (327)
T 3lm5_A 176 VDFGMSRKIGHACE---LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQV---- 248 (327)
T ss_dssp CCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT----
T ss_pred eeCccccccCCccc---cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhc----
Confidence 99999976543322 23345899999999999999999999999999999999999999765432111111111
Q ss_pred cccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 258 SEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
............+..+.+++.+||+.||.+|||+.++++
T Consensus 249 ---------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~ 287 (327)
T 3lm5_A 249 ---------NVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLS 287 (327)
T ss_dssp ---------CCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred ---------ccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence 111112223345677999999999999999999999987
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-44 Score=308.17 Aligned_cols=263 Identities=17% Similarity=0.232 Sum_probs=205.3
Q ss_pred CccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeC
Q 020641 17 PGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEG 96 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 96 (323)
|....+||+|+||.||++.+..+++.+++|++......... .....+.+.+|+.++++++||||+++++++...
T Consensus 7 y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~------~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 80 (283)
T 3bhy_A 7 YEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSR------RGVSREEIEREVNILREIRHPNIITLHDIFENK 80 (283)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCS------SSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccc------cchHHHHHHHHHHHHHhCCCCCeeehhheecCC
Confidence 45566899999999999999999999999977654332211 122357789999999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCC---
Q 020641 97 NLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDF--- 173 (323)
Q Consensus 97 ~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~--- 173 (323)
...++||||+.+++|.+++..... +++..+..++.|++.||.+||+. |++|+||||+||+++.++
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~ 148 (283)
T 3bhy_A 81 TDVVLILELVSGGELFDFLAEKES---------LTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPN 148 (283)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSS
T ss_pred CeEEEEEeecCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCC
Confidence 999999999999999999976432 89999999999999999999999 999999999999998876
Q ss_pred -eEEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhh
Q 020641 174 -KAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTW 252 (323)
Q Consensus 174 -~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 252 (323)
.++|+|||++........ .....|++.|+|||.+.+..++.++||||||+++|+|++|..||..............
T Consensus 149 ~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~ 225 (283)
T 3bhy_A 149 PRIKLIDFGIAHKIEAGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISA 225 (283)
T ss_dssp CCEEECCCTTCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHT
T ss_pred CceEEEecccceeccCCCc---ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHh
Confidence 899999999876543222 1234589999999999988899999999999999999999999976532111110000
Q ss_pred hcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH--HHhhhhcC
Q 020641 253 ATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK--ALQPLLKS 313 (323)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~--~l~~~~~~ 313 (323)
.. ...........+..+.+++.+||+.||.+|||+.|+++ +++.+...
T Consensus 226 ~~-------------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~ 275 (283)
T 3bhy_A 226 VN-------------YDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRR 275 (283)
T ss_dssp TC-------------CCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHHC
T ss_pred cc-------------cCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHHH
Confidence 00 00000001223567999999999999999999999997 56655443
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=318.17 Aligned_cols=249 Identities=18% Similarity=0.235 Sum_probs=196.5
Q ss_pred CccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcC-CCCcccceeeEEEe
Q 020641 17 PGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRL-KHENLVELLGYCVE 95 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~ 95 (323)
|.....||+|+||.||+|.+..+++.+|+|++.+.. ....+|++++.++ +||||+++++++.+
T Consensus 24 y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~----------------~~~~~E~~~l~~~~~hp~iv~~~~~~~~ 87 (342)
T 2qr7_A 24 YEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSK----------------RDPTEEIEILLRYGQHPNIITLKDVYDD 87 (342)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTT----------------CCCHHHHHHHHHHTTSTTBCCEEEEEEC
T ss_pred EEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEccc----------------CChHHHHHHHHHhcCCCCcCeEEEEEEc
Confidence 455568999999999999999999999999775321 1235677888777 89999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccC---
Q 020641 96 GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFED--- 172 (323)
Q Consensus 96 ~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~--- 172 (323)
+...|+||||+.+|+|.+++..... +++..+..++.|++.||.|||+. |++||||||+||++..+
T Consensus 88 ~~~~~lv~E~~~gg~L~~~i~~~~~---------~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~ 155 (342)
T 2qr7_A 88 GKYVYVVTELMKGGELLDKILRQKF---------FSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGN 155 (342)
T ss_dssp SSEEEEEECCCCSCBHHHHHHTCTT---------CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCS
T ss_pred CCEEEEEEeCCCCCcHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCC
Confidence 9999999999999999999976542 89999999999999999999999 99999999999998543
Q ss_pred -CeEEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhh
Q 020641 173 -FKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVT 251 (323)
Q Consensus 173 -~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~ 251 (323)
+.++|+|||++........ ......||+.|+|||++.+..++.++||||||+++|+|++|..||.............
T Consensus 156 ~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~ 233 (342)
T 2qr7_A 156 PESIRICDFGFAKQLRAENG--LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILA 233 (342)
T ss_dssp GGGEEECCCTTCEECBCTTC--CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHH
T ss_pred cCeEEEEECCCcccCcCCCC--ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHH
Confidence 3599999999876543221 1234468999999999988788999999999999999999999997543221111111
Q ss_pred hhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 252 WATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
..... ............+..+.+|+.+||..||++|||+.++++
T Consensus 234 ~i~~~----------~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 234 RIGSG----------KFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp HHHHC----------CCCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred HHccC----------CcccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 10000 001111222345678999999999999999999999986
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-44 Score=306.31 Aligned_cols=263 Identities=19% Similarity=0.219 Sum_probs=202.2
Q ss_pred CCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEe
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVE 95 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 95 (323)
.|....+||+|+||.||++++..+++.+++|+...... ......+.+.+|+.+++.++||||+++++++..
T Consensus 12 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 82 (276)
T 2h6d_A 12 HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKI---------RSLDVVGKIKREIQNLKLFRHPHIIKLYQVIST 82 (276)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHH---------HHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred cEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccc---------cchhHHHHHHHHHHHHhcCCCCCEeEEEEEEec
Confidence 34555689999999999999999999999997754321 112345778999999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeE
Q 020641 96 GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKA 175 (323)
Q Consensus 96 ~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~ 175 (323)
.+..++||||+.+++|.+++..... +++..+..++.|++.||.+||+. |++|+||||+||+++.++.+
T Consensus 83 ~~~~~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~ 150 (276)
T 2h6d_A 83 PTDFFMVMEYVSGGELFDYICKHGR---------VEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNA 150 (276)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHHCS---------CCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCE
T ss_pred CCeEEEEEeccCCCcHHHHHhccCC---------CCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCE
Confidence 9999999999999999999976532 88999999999999999999999 99999999999999999999
Q ss_pred EEeeccccCCCCccccccccccccCccccCCCccccCCCC-CcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhc
Q 020641 176 KIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQL-TQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWAT 254 (323)
Q Consensus 176 ~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~ 254 (323)
+|+|||++........ .....|++.|+|||.+.+..+ +.++||||||+++|+|++|..||.............
T Consensus 151 ~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~--- 224 (276)
T 2h6d_A 151 KIADFGLSNMMSDGEF---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIR--- 224 (276)
T ss_dssp EECCCCGGGCCCC----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH---
T ss_pred EEeecccccccCCCcc---eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhh---
Confidence 9999999876654322 123357899999999987765 689999999999999999999997543211100000
Q ss_pred ccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhhcCCCCCCCCC
Q 020641 255 PRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSPPPAAPVS 321 (323)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~~~~~~~~~~~ 321 (323)
. . ....+...+..+.+++.+||+.||.+|||+.|+++ ...++...++...|
T Consensus 225 ------------~-~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~--h~~~~~~~~~~~~p 275 (276)
T 2h6d_A 225 ------------G-G-VFYIPEYLNRSVATLLMHMLQVDPLKRATIKDIRE--HEWFKQDLPSYLFP 275 (276)
T ss_dssp ------------H-C-CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH--SHHHHTTCCGGGCC
T ss_pred ------------c-C-cccCchhcCHHHHHHHHHHccCChhhCCCHHHHHh--ChhhccCchhccCC
Confidence 0 0 01123334567999999999999999999999998 45555554444333
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-45 Score=312.53 Aligned_cols=258 Identities=18% Similarity=0.213 Sum_probs=201.7
Q ss_pred CCCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEE
Q 020641 15 PSPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCV 94 (323)
Q Consensus 15 ~~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 94 (323)
..|.....||+|+||.||++.+..+++.+++|........ ....+.+.+|+.++++++||||+++++++.
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 75 (279)
T 2w5a_A 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMT----------EAEKQMLVSEVNLLRELKHPNIVRYYDRII 75 (279)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCC----------HHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred hheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCC----------HHHHHHHHHHHHHHHhcCCCCCCeEEEEEe
Confidence 3566677999999999999999999999999977543221 112367889999999999999999999885
Q ss_pred e--CCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC-----ceeCCCCCCCE
Q 020641 95 E--GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPS-----IIHRDIRSSNV 167 (323)
Q Consensus 95 ~--~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~-----i~h~dikp~ni 167 (323)
. ....++||||+.+++|.+++...... ...+++..++.++.|++.||.|||+. | ++|+||||+||
T Consensus 76 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-----~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NI 147 (279)
T 2w5a_A 76 DRTNTTLYIVMEYCEGGDLASVITKGTKE-----RQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANV 147 (279)
T ss_dssp EGGGTEEEEEEECCTTEEHHHHHHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGE
T ss_pred cCCCceEEEEEeCCCCCCHHHHHHhhccc-----CCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhE
Confidence 4 56889999999999999999754321 11288999999999999999999999 8 99999999999
Q ss_pred EEccCCeEEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccc
Q 020641 168 LLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQ 247 (323)
Q Consensus 168 li~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~ 247 (323)
+++.++.++|+|||++......... .....|++.|+|||.+.+..++.++||||||+++|+|++|..||.........
T Consensus 148 l~~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~ 225 (279)
T 2w5a_A 148 FLDGKQNVKLGDFGLARILNHDTSF--AKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELA 225 (279)
T ss_dssp EECSSSCEEECCCCHHHHC---CHH--HHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred EEcCCCCEEEecCchheeecccccc--ccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHH
Confidence 9999999999999998755432211 12234789999999999888999999999999999999999999755321110
Q ss_pred hhhhhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHh
Q 020641 248 SLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQ 308 (323)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~ 308 (323)
..+........+...+..+.+++.+||+.||.+|||+.||++.+.
T Consensus 226 ----------------~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~ 270 (279)
T 2w5a_A 226 ----------------GKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPL 270 (279)
T ss_dssp ----------------HHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred ----------------HHHhhcccccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChh
Confidence 000001111233445677999999999999999999999998554
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=317.33 Aligned_cols=263 Identities=19% Similarity=0.197 Sum_probs=188.6
Q ss_pred CCCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcC-CCCcccceeeEE
Q 020641 15 PSPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRL-KHENLVELLGYC 93 (323)
Q Consensus 15 ~~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~ 93 (323)
..|.....||+|+||.||++++..+++.+|+|.+.... ......+.+|+.+++++ +||||+++++++
T Consensus 28 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------------~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~ 95 (337)
T 3ll6_A 28 LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE------------EEKNRAIIQEVCFMKKLSGHPNIVQFCSAA 95 (337)
T ss_dssp EEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESS------------HHHHHHHHHHHHHHHHHTTSTTBCCEEEEE
T ss_pred ceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCc------------hHHHHHHHHHHHHHHHhccCCChhhccccc
Confidence 34556669999999999999999999999999764221 11235678899999999 599999999998
Q ss_pred E--------eCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC--ceeCCCC
Q 020641 94 V--------EGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPS--IIHRDIR 163 (323)
Q Consensus 94 ~--------~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~--i~h~dik 163 (323)
. .....+++|||+. |+|.+++...... ..+++..++.++.|++.||.|||+. | ++|+|||
T Consensus 96 ~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~------~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dik 165 (337)
T 3ll6_A 96 SIGKEESDTGQAEFLLLTELCK-GQLVEFLKKMESR------GPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLK 165 (337)
T ss_dssp EECTTTSTTSSEEEEEEEECCS-EEHHHHHHHHHTT------CSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCC
T ss_pred cccccccccCCceEEEEEEecC-CCHHHHHHHhhcc------CCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCC
Confidence 4 3345799999997 5999988652211 1289999999999999999999999 9 9999999
Q ss_pred CCCEEEccCCeEEEeeccccCCCCcccccc----------ccccccCccccCCCccc---cCCCCCcccchHHHHHHHHH
Q 020641 164 SSNVLLFEDFKAKIADFNLSNQAPDMAARL----------HSTRVLGTFGYHAPEYA---MTGQLTQKSDVYSFGVVLLE 230 (323)
Q Consensus 164 p~nili~~~~~~~l~Dfg~~~~~~~~~~~~----------~~~~~~g~~~y~aPE~~---~~~~~~~~~Di~slG~~l~~ 230 (323)
|+||+++.++.++|+|||++.......... ......|++.|+|||.+ .+..++.++||||||+++|+
T Consensus 166 p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~e 245 (337)
T 3ll6_A 166 VENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYL 245 (337)
T ss_dssp GGGCEECTTSCEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHH
T ss_pred cccEEECCCCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHH
Confidence 999999999999999999997665422211 11133489999999988 56678899999999999999
Q ss_pred HHhCCCCCCCCCCcccchhhhhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhh
Q 020641 231 LLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPL 310 (323)
Q Consensus 231 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~ 310 (323)
|++|..||....... .+............+..+.+++.+||+.||.+|||+.|+++.|+.+
T Consensus 246 l~~g~~p~~~~~~~~-------------------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~ 306 (337)
T 3ll6_A 246 LCFRQHPFEDGAKLR-------------------IVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEI 306 (337)
T ss_dssp HHHSSCCC-------------------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred HHhCCCCCcchhHHH-------------------hhcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 999999996432210 1111111111222334588999999999999999999999999999
Q ss_pred hcCCCCCC
Q 020641 311 LKSPPPAA 318 (323)
Q Consensus 311 ~~~~~~~~ 318 (323)
....+..+
T Consensus 307 ~~~~~~~~ 314 (337)
T 3ll6_A 307 AAARNVNP 314 (337)
T ss_dssp HHHTTCCT
T ss_pred HhccCCCC
Confidence 87655443
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=325.05 Aligned_cols=257 Identities=15% Similarity=0.102 Sum_probs=200.8
Q ss_pred CCCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEE
Q 020641 15 PSPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCV 94 (323)
Q Consensus 15 ~~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 94 (323)
..|.....||+|+||.||+|++..+++.+|+|++.+...... .....+.+|..++..++|+||+++++++.
T Consensus 61 ~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~---------~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 131 (412)
T 2vd5_A 61 DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKR---------GEVSCFREERDVLVNGDRRWITQLHFAFQ 131 (412)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHH---------GGGCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhH---------HHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence 345566689999999999999999999999998764321111 12245788999999999999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCe
Q 020641 95 EGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFK 174 (323)
Q Consensus 95 ~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~ 174 (323)
+.+..|+||||+.+|+|.+++.+.... +++..+..++.||+.||.|||+. ||+||||||+|||++.++.
T Consensus 132 ~~~~~~lVmE~~~gg~L~~~l~~~~~~--------l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~ 200 (412)
T 2vd5_A 132 DENYLYLVMEYYVGGDLLTLLSKFGER--------IPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGH 200 (412)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHHSSC--------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSC
T ss_pred eCCEEEEEEcCCCCCcHHHHHHhcCCC--------CCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCC
Confidence 999999999999999999999764322 89999999999999999999999 9999999999999999999
Q ss_pred EEEeeccccCCCCccccccccccccCccccCCCcccc-------CCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccc
Q 020641 175 AKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAM-------TGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQ 247 (323)
Q Consensus 175 ~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-------~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~ 247 (323)
+||+|||++......... ......||+.|+|||++. +..++.++|+|||||++|+|++|+.||.........
T Consensus 201 vkL~DFGla~~~~~~~~~-~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~ 279 (412)
T 2vd5_A 201 IRLADFGSCLKLRADGTV-RSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETY 279 (412)
T ss_dssp EEECCCTTCEECCTTSCE-ECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH
T ss_pred EEEeechhheeccCCCcc-ccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHH
Confidence 999999998765432211 123346999999999887 356889999999999999999999999765432111
Q ss_pred hhhhhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCC---CChHHHHH
Q 020641 248 SLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFR---PNMSIVVK 305 (323)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~R---ps~~evl~ 305 (323)
..+........ . ...+...+.++.+||.+||. +|.+| |+++|+++
T Consensus 280 ~~i~~~~~~~~--------~----p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~ 327 (412)
T 2vd5_A 280 GKIVHYKEHLS--------L----PLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT 327 (412)
T ss_dssp HHHHTHHHHCC--------C----C----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred HHHHhcccCcC--------C----CccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence 11110000000 0 01123456679999999999 99998 58999976
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-44 Score=307.21 Aligned_cols=250 Identities=28% Similarity=0.392 Sum_probs=195.9
Q ss_pred CCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEe
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVE 95 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 95 (323)
.|....+||+|+||+||++++. ++.+++|+... ....+.+.+|++++++++||||+++++++..
T Consensus 22 ~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~--------------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 85 (278)
T 1byg_A 22 ELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKN--------------DATAQAFLAEASVMTQLRHSNLVQLLGVIVE 85 (278)
T ss_dssp GEEEEEEEEECSSCEEEEEEET--TEEEEEEECCC--------------CC--HHHHHTHHHHTTCCCTTBCCEEEEECC
T ss_pred hceEEeEEecCCCceEEEEEEc--CCEEEEEEecc--------------hhHHHHHHHHHHHHHhCCCCCEeeEEEEEEc
Confidence 4555568999999999999874 66788886532 1234778999999999999999999998765
Q ss_pred C-CeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCe
Q 020641 96 G-NLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFK 174 (323)
Q Consensus 96 ~-~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~ 174 (323)
. +..++||||+.+++|.+++...... .+++..++.++.|++.|+.+||+. |++|+||||+||+++.++.
T Consensus 86 ~~~~~~lv~e~~~~~~L~~~l~~~~~~-------~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~ 155 (278)
T 1byg_A 86 EKGGLYIVTEYMAKGSLVDYLRSRGRS-------VLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNV 155 (278)
T ss_dssp C--CCEEEECCCTTEEHHHHHHHHHHH-------HCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSC
T ss_pred CCCceEEEEecCCCCCHHHHHHhcccc-------cCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCc
Confidence 4 4689999999999999999764321 178889999999999999999999 9999999999999999999
Q ss_pred EEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhh
Q 020641 175 AKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWA 253 (323)
Q Consensus 175 ~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~ 253 (323)
++|+|||++....... ....+++.|+|||.+.+..++.++||||||+++|+|++ |..||.......
T Consensus 156 ~~l~Dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~-------- 222 (278)
T 1byg_A 156 AKVSDFGLTKEASSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD-------- 222 (278)
T ss_dssp EEECCCCC-----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG--------
T ss_pred EEEeeccccccccccc-----cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH--------
Confidence 9999999987554321 22346888999999988889999999999999999998 999997543211
Q ss_pred cccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhhc
Q 020641 254 TPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLK 312 (323)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~~ 312 (323)
+...+........+...+..+.+++.+||+.||.+|||+.++++.|+.+..
T Consensus 223 --------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~ 273 (278)
T 1byg_A 223 --------VVPRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 273 (278)
T ss_dssp --------HHHHHTTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --------HHHHHhcCCCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHh
Confidence 111111222223344566789999999999999999999999999998864
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-44 Score=331.01 Aligned_cols=256 Identities=23% Similarity=0.254 Sum_probs=203.8
Q ss_pred CccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeC
Q 020641 17 PGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEG 96 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 96 (323)
|.....||+|+||.||+|++..+++.+|+|++.+.... .....+.+.+|+.++++++||||+++++++...
T Consensus 28 y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~---------~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 98 (484)
T 3nyv_A 28 YKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVK---------QKTDKESLLREVQLLKQLDHPNIMKLYEFFEDK 98 (484)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC---------BSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred eEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcc---------cchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC
Confidence 44455899999999999999999999999987543221 123357789999999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEE---ccCC
Q 020641 97 NLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLL---FEDF 173 (323)
Q Consensus 97 ~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili---~~~~ 173 (323)
+..++||||+.+++|.+++..... +++..+..++.|++.||.|||+. |++||||||+||++ +.++
T Consensus 99 ~~~~lv~e~~~~~~L~~~~~~~~~---------~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~ 166 (484)
T 3nyv_A 99 GYFYLVGEVYTGGELFDEIISRKR---------FSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDA 166 (484)
T ss_dssp SEEEEEECCCCSCBHHHHHHTCSC---------CBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTC
T ss_pred CEEEEEEecCCCCCHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCC
Confidence 999999999999999999976542 89999999999999999999999 99999999999999 5678
Q ss_pred eEEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhh
Q 020641 174 KAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWA 253 (323)
Q Consensus 174 ~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 253 (323)
.++|+|||++........ .....||+.|+|||++.+ .++.++||||||+++|+|++|..||...........+...
T Consensus 167 ~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~ 242 (484)
T 3nyv_A 167 NIRIIDFGLSTHFEASKK---MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKG 242 (484)
T ss_dssp CEEECCTTHHHHBCCCCS---HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC
T ss_pred cEEEEeeeeeEEcccccc---cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcC
Confidence 999999999865443221 223458999999998876 6899999999999999999999999765432111111100
Q ss_pred cccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH--HHhhh
Q 020641 254 TPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK--ALQPL 310 (323)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~--~l~~~ 310 (323)
... .........+..+.+++.+||+.||.+|||+.|+++ +++..
T Consensus 243 ~~~-------------~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~ 288 (484)
T 3nyv_A 243 KYT-------------FELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTY 288 (484)
T ss_dssp CCC-------------CCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHH
T ss_pred CCC-------------CCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhccc
Confidence 000 000111345678999999999999999999999996 44443
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=328.95 Aligned_cols=259 Identities=17% Similarity=0.212 Sum_probs=206.4
Q ss_pred CCCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEE
Q 020641 15 PSPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCV 94 (323)
Q Consensus 15 ~~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 94 (323)
..|.....||+|+||.||+|++..+++.+|+|++.+..... ......+.+|..++++++||||+++++++.
T Consensus 185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~---------~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~ 255 (543)
T 3c4z_A 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKK---------RKGYQGAMVEKKILAKVHSRFIVSLAYAFE 255 (543)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHH---------TTCHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhh---------hHHHHHHHHHHHHHHhcCCCCEeeEEEEEe
Confidence 34555568999999999999999999999999876432211 223467889999999999999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCe
Q 020641 95 EGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFK 174 (323)
Q Consensus 95 ~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~ 174 (323)
.....|+||||+.||+|.+++...... ...+++..+..++.||+.||.|||+. ||+||||||+||+++.++.
T Consensus 256 ~~~~l~lVmE~~~gg~L~~~l~~~~~~-----~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~ 327 (543)
T 3c4z_A 256 TKTDLCLVMTIMNGGDIRYHIYNVDED-----NPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGN 327 (543)
T ss_dssp CSSEEEEEECCCTTCBHHHHHHTSSTT-----SCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSC
T ss_pred eCCEEEEEEEeccCCCHHHHHHHhhcc-----cccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCC
Confidence 999999999999999999999764321 11389999999999999999999999 9999999999999999999
Q ss_pred EEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhc
Q 020641 175 AKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWAT 254 (323)
Q Consensus 175 ~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~ 254 (323)
++|+|||++........ ......||+.|+|||++.+..++.++|+|||||++|+|++|..||.............
T Consensus 328 vkL~DFGla~~~~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~--- 402 (543)
T 3c4z_A 328 VRISDLGLAVELKAGQT--KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELK--- 402 (543)
T ss_dssp EEECCCTTCEECCTTCC--CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHH---
T ss_pred EEEeecceeeeccCCCc--ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHH---
Confidence 99999999976543221 1233469999999999999999999999999999999999999997654321111000
Q ss_pred ccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCCh-----HHHHH
Q 020641 255 PRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNM-----SIVVK 305 (323)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~-----~evl~ 305 (323)
..+.... ...+...+..+.++|.+||+.||.+||++ .+|++
T Consensus 403 --------~~i~~~~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~ 448 (543)
T 3c4z_A 403 --------QRVLEQA--VTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT 448 (543)
T ss_dssp --------HHHHHCC--CCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred --------HHHhhcc--cCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence 0111111 12344566789999999999999999965 66664
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=314.90 Aligned_cols=256 Identities=15% Similarity=0.123 Sum_probs=200.0
Q ss_pred CccccccCCCCCCcccee-----ccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCC---CCcccc
Q 020641 17 PGYFVRLDKGPEDDLYLK-----KRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLK---HENLVE 88 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~-----~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~ 88 (323)
|....+||+|+||+||+| .+..+++.+|+|+... .....+..|.++++.+. |+||+.
T Consensus 67 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~---------------~~~~~~~~e~~~~~~l~~~~~~~iv~ 131 (365)
T 3e7e_A 67 VYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKP---------------ANPWEFYIGTQLMERLKPSMQHMFMK 131 (365)
T ss_dssp EEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESS---------------CCHHHHHHHHHHHHHSCGGGGGGBCC
T ss_pred EEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCC---------------CChhHHHHHHHHHHHhhhhhhhhhhh
Confidence 444458999999999999 5677888899986542 12356777788877775 999999
Q ss_pred eeeEEEeCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEE
Q 020641 89 LLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVL 168 (323)
Q Consensus 89 ~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nil 168 (323)
+++++...+..++||||+.+|+|.+++....... ...+++..++.++.|++.||.|||+. ||+||||||+|||
T Consensus 132 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~----~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIl 204 (365)
T 3e7e_A 132 FYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTP----EKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFI 204 (365)
T ss_dssp EEEEEECSSCEEEEECCCCSCBHHHHHHHHHTST----TCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEE
T ss_pred hheeeecCCCcEEEEeccCCCcHHHHHHHhhccc----ccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEE
Confidence 9999999999999999999999999997532111 11299999999999999999999999 9999999999999
Q ss_pred Ecc-----------CCeEEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCC
Q 020641 169 LFE-----------DFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 237 (323)
Q Consensus 169 i~~-----------~~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p 237 (323)
++. ++.++|+|||++................||+.|+|||++.+..++.++|||||||++|+|++|+.|
T Consensus 205 l~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p 284 (365)
T 3e7e_A 205 LGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYM 284 (365)
T ss_dssp ECGGGTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCC
T ss_pred ecccccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCc
Confidence 998 899999999999654322222233455699999999999999999999999999999999999999
Q ss_pred CCCCCCcccchhhhhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCC-CChHHHHHHHhhhhcCCC
Q 020641 238 VDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFR-PNMSIVVKALQPLLKSPP 315 (323)
Q Consensus 238 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~R-ps~~evl~~l~~~~~~~~ 315 (323)
|....... .. +....... ..++.+.+++..||+.+|.+| |++.++.+.|++++....
T Consensus 285 f~~~~~~~--------------~~----~~~~~~~~---~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~~ 342 (365)
T 3e7e_A 285 KVKNEGGE--------------CK----PEGLFRRL---PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHY 342 (365)
T ss_dssp CEEEETTE--------------EE----ECSCCTTC---SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred cccCCCCc--------------ee----echhcccc---CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHhh
Confidence 95332100 00 01111111 125678899999999999999 689999999998876543
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-44 Score=319.74 Aligned_cols=263 Identities=17% Similarity=0.217 Sum_probs=201.7
Q ss_pred CCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEe
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVE 95 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 95 (323)
.|....+||.|+||.||++.+..+++.+|+|+..... .....+.+.+|+.+++.++||||+++++++..
T Consensus 34 ~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~-----------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 102 (360)
T 3eqc_A 34 DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-----------KPAIRNQIIRELQVLHECNSPYIVGFYGAFYS 102 (360)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC-----------CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEE
T ss_pred cceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc-----------CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEE
Confidence 3455569999999999999999999999999775321 11223678899999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCCCceeCCCCCCCEEEccCCe
Q 020641 96 GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHE-KVQPSIIHRDIRSSNVLLFEDFK 174 (323)
Q Consensus 96 ~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~-~~~~~i~h~dikp~nili~~~~~ 174 (323)
++..++||||+.+++|.+++..... +++..+..++.|++.|+.|||+ . |++|+||||+||+++.++.
T Consensus 103 ~~~~~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~i~~~i~~~l~~lh~~~---~i~H~dlkp~Nil~~~~~~ 170 (360)
T 3eqc_A 103 DGEISICMEHMDGGSLDQVLKKAGR---------IPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGE 170 (360)
T ss_dssp TTEEEEEECCCTTCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCC
T ss_pred CCEEEEEEECCCCCCHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHhC---CEEcCCccHHHEEECCCCC
Confidence 9999999999999999999976542 8899999999999999999998 6 8999999999999999999
Q ss_pred EEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhh-
Q 020641 175 AKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWA- 253 (323)
Q Consensus 175 ~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~- 253 (323)
++|+|||++...... ......|++.|+|||.+.+..++.++||||||+++|+|++|+.||...............
T Consensus 171 ~kl~Dfg~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 246 (360)
T 3eqc_A 171 IKLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQV 246 (360)
T ss_dssp EEECCCCCCHHHHHH----C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC---
T ss_pred EEEEECCCCcccccc----cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccc
Confidence 999999988543221 123345899999999999999999999999999999999999999765432111100000
Q ss_pred ----------------------ccccccc----ccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 254 ----------------------TPRLSED----KVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 254 ----------------------~~~~~~~----~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
....... ..................+..+.+|+.+||+.||.+|||+.|+++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 324 (360)
T 3eqc_A 247 EGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 324 (360)
T ss_dssp ---------------------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred cccCCCCCCCcccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 0000000 000111111111122334667999999999999999999999986
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-43 Score=306.70 Aligned_cols=249 Identities=22% Similarity=0.307 Sum_probs=199.0
Q ss_pred CCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEe
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVE 95 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 95 (323)
.|.....||.|+||.||++.+..+++.+++|..... ...+.+.+|+.+++.++||||+++++++..
T Consensus 30 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--------------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 95 (314)
T 3com_A 30 VFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--------------SDLQEIIKEISIMQQCDSPHVVKYYGSYFK 95 (314)
T ss_dssp CEEEEEECC----CEEEEEEETTTCCEEEEEEEETT--------------SCCHHHHHHHHHHHTCCCTTBCCEEEEEEE
T ss_pred hhhhheeeccCCCeEEEEEEECCCCCEEEEEecCch--------------HHHHHHHHHHHHHHhCCCCCCccEEEEEEe
Confidence 355566999999999999999999999999966421 124678999999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeE
Q 020641 96 GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKA 175 (323)
Q Consensus 96 ~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~ 175 (323)
.+..++||||+.+++|.+++...... +++..+..++.|++.||.|||+. |++|+||||+||+++.++.+
T Consensus 96 ~~~~~lv~e~~~~~~L~~~~~~~~~~--------~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~ 164 (314)
T 3com_A 96 NTDLWIVMEYCGAGSVSDIIRLRNKT--------LTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHA 164 (314)
T ss_dssp TTEEEEEEECCTTEEHHHHHHHHTCC--------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCE
T ss_pred CCEEEEEeecCCCCCHHHHHHhcCCC--------CCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCE
Confidence 99999999999999999999743222 89999999999999999999999 99999999999999999999
Q ss_pred EEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhcc
Q 020641 176 KIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATP 255 (323)
Q Consensus 176 ~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~ 255 (323)
+|+|||++........ ......|++.|+|||.+.+..++.++||||||+++|+|++|..||.............
T Consensus 165 kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~---- 238 (314)
T 3com_A 165 KLADFGVAGQLTDTMA--KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIP---- 238 (314)
T ss_dssp EECCCTTCEECBTTBS--CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH----
T ss_pred EEeecccchhhhhhcc--ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHh----
Confidence 9999999876543221 1233458999999999998889999999999999999999999997543211110000
Q ss_pred cccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 256 RLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
. ........+...+..+.+++.+||+.||.+|||+.++++
T Consensus 239 --------~--~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 239 --------T--NPPPTFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp --------H--SCCCCCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred --------c--CCCcccCCcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 0 000011123345678999999999999999999999986
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=311.84 Aligned_cols=258 Identities=20% Similarity=0.277 Sum_probs=200.5
Q ss_pred CccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhc--CCCCcccceeeEEE
Q 020641 17 PGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSR--LKHENLVELLGYCV 94 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~--l~h~~i~~~~~~~~ 94 (323)
|.....||+|+||.||++++ +++.+|+|++... ....+.+|.+++.. ++||||+++++++.
T Consensus 44 y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~---------------~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~ 106 (342)
T 1b6c_B 44 IVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR---------------EERSWFREAEIYQTVMLRHENILGFIAADN 106 (342)
T ss_dssp CEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGG---------------GHHHHHHHHHHHHHSCCCCTTBCCEEEEEE
T ss_pred EEEEeeecCCCCcEEEEEEE--cCccEEEEEeCch---------------hHHHHHHHHHHHHHhhcCCCcEEEEEeeec
Confidence 44555899999999999987 4778888876421 12556778888877 69999999999998
Q ss_pred eCC----eEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhh--------cCCCCCceeCCC
Q 020641 95 EGN----LRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLH--------EKVQPSIIHRDI 162 (323)
Q Consensus 95 ~~~----~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh--------~~~~~~i~h~di 162 (323)
... ..++||||+.+++|.+++.... +++..++.++.|++.||.||| +. |++|+||
T Consensus 107 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dl 173 (342)
T 1b6c_B 107 KDNGTWTQLWLVSDYHEHGSLFDYLNRYT----------VTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDL 173 (342)
T ss_dssp CCCSSCCCEEEEECCCTTCBHHHHHHHCC----------BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCC
T ss_pred ccCCccceeEEEEeecCCCcHHHHHhccC----------ccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCC
Confidence 776 7899999999999999997643 899999999999999999999 88 9999999
Q ss_pred CCCCEEEccCCeEEEeeccccCCCCccccc--cccccccCccccCCCccccCCC------CCcccchHHHHHHHHHHHhC
Q 020641 163 RSSNVLLFEDFKAKIADFNLSNQAPDMAAR--LHSTRVLGTFGYHAPEYAMTGQ------LTQKSDVYSFGVVLLELLTG 234 (323)
Q Consensus 163 kp~nili~~~~~~~l~Dfg~~~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~------~~~~~Di~slG~~l~~l~~g 234 (323)
||+||+++.++.++|+|||++......... .......|++.|+|||.+.+.. ++.++||||||+++|+|++|
T Consensus 174 kp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg 253 (342)
T 1b6c_B 174 KSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARR 253 (342)
T ss_dssp SGGGEEECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CHHHEEECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhc
Confidence 999999999999999999998654332211 1223445899999999987652 33689999999999999999
Q ss_pred ----------CCCCCCCCCcccchhhhhhcccccccccc-hhcCCCcCCCC-----CHHHHHHHHHHHHHccCCCCCCCC
Q 020641 235 ----------RKPVDHTMPRGQQSLVTWATPRLSEDKVK-QCVDPKLKGEY-----PPKGVAKLAAVAALCVQYEAEFRP 298 (323)
Q Consensus 235 ----------~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~-----~~~~~~~l~~li~~cl~~~P~~Rp 298 (323)
..||.......... ..+. .......+... ....+..+.+++.+||+.||.+||
T Consensus 254 ~~~~~~~~~~~~p~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp 322 (342)
T 1b6c_B 254 CSIGGIHEDYQLPYYDLVPSDPSV-----------EEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARL 322 (342)
T ss_dssp BCBTTBCCCCCCTTTTTSCSSCCH-----------HHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSC
T ss_pred cCcCCcccccccCccccCcCcccH-----------HHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCC
Confidence 67776543211110 0000 11111112222 235678899999999999999999
Q ss_pred ChHHHHHHHhhhhcCCC
Q 020641 299 NMSIVVKALQPLLKSPP 315 (323)
Q Consensus 299 s~~evl~~l~~~~~~~~ 315 (323)
|+.+|++.|+++.+...
T Consensus 323 s~~~i~~~L~~i~~~~~ 339 (342)
T 1b6c_B 323 TALRIKKTLSQLSQQEG 339 (342)
T ss_dssp CHHHHHHHHHHHHHTTC
T ss_pred CHHHHHHHHHHHHHHhc
Confidence 99999999999987653
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=325.02 Aligned_cols=267 Identities=17% Similarity=0.190 Sum_probs=183.0
Q ss_pred CCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEe
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVE 95 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 95 (323)
.|.....||+|+||.||+|.+..+++.+|+|++...... ....+++.+|+.+++.++|+||+++++++..
T Consensus 54 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~----------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 123 (458)
T 3rp9_A 54 RYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFED----------LIDCKRILREIAILNRLNHDHVVKVLDIVIP 123 (458)
T ss_dssp TEEECCC-------CEEEEEECC--CEEEEEEECSTTSS----------HHHHHHHHHHHHHHHHCCCTTBCCEEEECCC
T ss_pred CeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcC----------HHHHHHHHHHHHHHHhCCCCCCCceEEEEec
Confidence 456666999999999999999999999999976432111 1123678899999999999999999999853
Q ss_pred C-----CeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEc
Q 020641 96 G-----NLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLF 170 (323)
Q Consensus 96 ~-----~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~ 170 (323)
. ...|+||||+. ++|.+++..... +++..+..++.||+.||.|||+. ||+||||||+|||++
T Consensus 124 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~---------l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~ 190 (458)
T 3rp9_A 124 KDVEKFDELYVVLEIAD-SDFKKLFRTPVY---------LTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVN 190 (458)
T ss_dssp SCTTTCCCEEEEECCCS-EEHHHHHHSSCC---------CCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEEC
T ss_pred CCcccCceEEEEEeccc-cchhhhcccCCC---------CCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEEC
Confidence 3 56899999986 599999976532 99999999999999999999999 999999999999999
Q ss_pred cCCeEEEeeccccCCCCccccc-------------------------cccccccCccccCCCccc-cCCCCCcccchHHH
Q 020641 171 EDFKAKIADFNLSNQAPDMAAR-------------------------LHSTRVLGTFGYHAPEYA-MTGQLTQKSDVYSF 224 (323)
Q Consensus 171 ~~~~~~l~Dfg~~~~~~~~~~~-------------------------~~~~~~~g~~~y~aPE~~-~~~~~~~~~Di~sl 224 (323)
.++.+||+|||++......... .......||+.|+|||++ .+..++.++|||||
T Consensus 191 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSl 270 (458)
T 3rp9_A 191 QDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSI 270 (458)
T ss_dssp TTCCEEECCCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHH
T ss_pred CCCCEeecccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHH
Confidence 9999999999999765422110 112334589999999976 46679999999999
Q ss_pred HHHHHHHHh-----------CCCCCCCCCCcccc-----------------h---hhhhhcccccccc--------cchh
Q 020641 225 GVVLLELLT-----------GRKPVDHTMPRGQQ-----------------S---LVTWATPRLSEDK--------VKQC 265 (323)
Q Consensus 225 G~~l~~l~~-----------g~~pf~~~~~~~~~-----------------~---~~~~~~~~~~~~~--------~~~~ 265 (323)
||++|+|++ |+.+|.+....... . .+........... ....
T Consensus 271 G~il~elltg~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~ 350 (458)
T 3rp9_A 271 GCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRY 350 (458)
T ss_dssp HHHHHHHHTTSTTTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHH
T ss_pred HHHHHHHHHhccccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHH
Confidence 999999999 56666543210000 0 0000000000000 0000
Q ss_pred cC---CCcC---CCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 266 VD---PKLK---GEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 266 ~~---~~~~---~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
+. .... .......+.++.+|+.+||..||++|||+.|+++
T Consensus 351 ~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~ 396 (458)
T 3rp9_A 351 IRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLA 396 (458)
T ss_dssp HTTSCCCCCCCGGGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHhcCCCCCCCHHHHCCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence 00 0000 0011233677999999999999999999999998
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-43 Score=313.98 Aligned_cols=263 Identities=17% Similarity=0.186 Sum_probs=192.5
Q ss_pred CCCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEE
Q 020641 15 PSPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCV 94 (323)
Q Consensus 15 ~~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 94 (323)
..|.....||+|+||.||+|.+..+++.+|+|+....... ....+.+.+|+.+++.++||||+++++++.
T Consensus 25 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----------~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 94 (371)
T 2xrw_A 25 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQN----------QTHAKRAYRELVLMKCVNHKNIIGLLNVFT 94 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSS----------HHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred hheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCC----------hHHHHHHHHHHHHHHhcCCCCccceEEeec
Confidence 4566677999999999999999999999999976532211 112356789999999999999999999998
Q ss_pred eCC------eEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEE
Q 020641 95 EGN------LRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVL 168 (323)
Q Consensus 95 ~~~------~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nil 168 (323)
... ..++||||+.+ +|.+.+... +++..+..++.|++.||.|||+. |++||||||+||+
T Consensus 95 ~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~-----------~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl 159 (371)
T 2xrw_A 95 PQKSLEEFQDVYIVMELMDA-NLCQVIQME-----------LDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIV 159 (371)
T ss_dssp SCCSTTTCCEEEEEEECCSE-EHHHHHHSC-----------CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEE
T ss_pred cccccccccceEEEEEcCCC-CHHHHHhhc-----------cCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEE
Confidence 664 78999999986 898888632 88999999999999999999999 9999999999999
Q ss_pred EccCCeEEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccch
Q 020641 169 LFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQS 248 (323)
Q Consensus 169 i~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~ 248 (323)
++.++.++|+|||++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||..........
T Consensus 160 ~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~ 236 (371)
T 2xrw_A 160 VKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWN 236 (371)
T ss_dssp ECTTSCEEECCCCC-------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred EcCCCCEEEEEeeccccccccc---ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 9999999999999997654322 1233458999999999999899999999999999999999999998654321111
Q ss_pred hhhhh----------------------cccccccccchhcCCCcCC---CCCHHHHHHHHHHHHHccCCCCCCCCChHHH
Q 020641 249 LVTWA----------------------TPRLSEDKVKQCVDPKLKG---EYPPKGVAKLAAVAALCVQYEAEFRPNMSIV 303 (323)
Q Consensus 249 ~~~~~----------------------~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev 303 (323)
.+... ................... ......+..+.+|+.+||..||.+|||+.|+
T Consensus 237 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~ 316 (371)
T 2xrw_A 237 KVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA 316 (371)
T ss_dssp HHHC-CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred HHHHHhCCCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHH
Confidence 00000 0000000000000000000 0112346789999999999999999999999
Q ss_pred HH
Q 020641 304 VK 305 (323)
Q Consensus 304 l~ 305 (323)
++
T Consensus 317 l~ 318 (371)
T 2xrw_A 317 LQ 318 (371)
T ss_dssp HH
T ss_pred hC
Confidence 87
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=310.53 Aligned_cols=256 Identities=13% Similarity=0.201 Sum_probs=197.2
Q ss_pred CccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCC-CCcccceeeEEEe
Q 020641 17 PGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLK-HENLVELLGYCVE 95 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~ 95 (323)
|....+||+|+||+||+|.+..+++.+|+|+... ...+.+.+|+.++++++ |+||+++++++..
T Consensus 38 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~---------------~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~ 102 (330)
T 3nsz_A 38 YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP---------------VKKKKIKREIKILENLRGGPNIITLADIVKD 102 (330)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS---------------CCHHHHHHHHHHHHHHTTSTTBCCEEEEEEC
T ss_pred eEEEEEecccCCeEEEEEEECCCCcEEEEEEecc---------------cchHHHHHHHHHHHHcCCCCCEEEeeeeecc
Confidence 4555699999999999999999999999996541 22367889999999995 9999999999997
Q ss_pred --CCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCC
Q 020641 96 --GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDF 173 (323)
Q Consensus 96 --~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~ 173 (323)
....++||||+.+++|.+++.. ++...+..++.|++.||.|||+. |++|+||||+||+++.++
T Consensus 103 ~~~~~~~lv~e~~~~~~l~~~~~~------------~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~ 167 (330)
T 3nsz_A 103 PVSRTPALVFEHVNNTDFKQLYQT------------LTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEH 167 (330)
T ss_dssp TTTCCEEEEEECCCCCCHHHHGGG------------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTT
T ss_pred CCCCceEEEEeccCchhHHHHHHh------------CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCC
Confidence 6678999999999999999853 88899999999999999999999 999999999999999776
Q ss_pred -eEEEeeccccCCCCccccccccccccCccccCCCccccC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhh-
Q 020641 174 -KAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT-GQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLV- 250 (323)
Q Consensus 174 -~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~- 250 (323)
.++|+|||++........ .....|+..|+|||.+.+ ..++.++||||||+++|+|++|..||............
T Consensus 168 ~~~kl~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~ 244 (330)
T 3nsz_A 168 RKLRLIDWGLAEFYHPGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRI 244 (330)
T ss_dssp TEEEECCCTTCEECCTTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHH
T ss_pred CEEEEEeCCCceEcCCCCc---cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHH
Confidence 899999999975543222 233458899999999877 66899999999999999999999999644322111100
Q ss_pred ----------hhhcc-c-ccccccchhc--------CCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 251 ----------TWATP-R-LSEDKVKQCV--------DPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 251 ----------~~~~~-~-~~~~~~~~~~--------~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
.+... . .......... ............+..+.+|+.+||+.||.+|||+.|+++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 245 AKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp HHHHCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred HHhcCCchhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00000 0 0000000000 001111222335678999999999999999999999998
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-43 Score=305.06 Aligned_cols=249 Identities=24% Similarity=0.325 Sum_probs=196.5
Q ss_pred ccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeCCeE
Q 020641 20 FVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLR 99 (323)
Q Consensus 20 ~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 99 (323)
...||+|+||.||++.+..+++.+++|..... .....+.+.+|+.+++.++||||+++++++...+..
T Consensus 27 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~------------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 94 (295)
T 2clq_A 27 RVVLGKGTYGIVYAGRDLSNQVRIAIKEIPER------------DSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFI 94 (295)
T ss_dssp BCEEEECSSSEEEEEEETTTCCEEEEEEEECC------------CC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEE
T ss_pred cEEEeecCcEEEEEEEECCCCeEEEEEEccCC------------chHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcE
Confidence 34799999999999999999999999966422 123457789999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEcc-CCeEEEe
Q 020641 100 VLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFE-DFKAKIA 178 (323)
Q Consensus 100 ~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~-~~~~~l~ 178 (323)
++||||+.+++|.+++...... ..+++..+..++.|++.||.|||+. |++|+||||+||+++. ++.++|+
T Consensus 95 ~lv~e~~~~~~L~~~l~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~ 165 (295)
T 2clq_A 95 KIFMEQVPGGSLSALLRSKWGP------LKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKIS 165 (295)
T ss_dssp EEEEECCSEEEHHHHHHHTTCC------CTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEEC
T ss_pred EEEEEeCCCCCHHHHHHhhccC------CCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEe
Confidence 9999999999999999765321 1267888999999999999999999 9999999999999987 8999999
Q ss_pred eccccCCCCccccccccccccCccccCCCccccCCC--CCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhccc
Q 020641 179 DFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQ--LTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPR 256 (323)
Q Consensus 179 Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~--~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 256 (323)
|||++........ ......|++.|+|||.+.+.. ++.++||||||+++|+|++|+.||...........
T Consensus 166 Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~------- 236 (295)
T 2clq_A 166 DFGTSKRLAGINP--CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMF------- 236 (295)
T ss_dssp CTTTCEESCC-------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHH-------
T ss_pred ecccccccCCCCC--cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHH-------
Confidence 9999876543221 123345899999999987543 78899999999999999999999964322111000
Q ss_pred ccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 257 LSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
...........+...+..+.+++.+||+.||++|||+.++++
T Consensus 237 -------~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 237 -------KVGMFKVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp -------HHHHHCCCCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred -------hhccccccccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 000001112234455678999999999999999999999986
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-43 Score=322.07 Aligned_cols=262 Identities=18% Similarity=0.235 Sum_probs=204.6
Q ss_pred CCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCC-CcccceeeEEE
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKH-ENLVELLGYCV 94 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~ 94 (323)
.|....+||+|+||.||++++..+++.+|+|+.... .....+.+|+++++.++| +++..+..++.
T Consensus 8 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~--------------~~~~~~~~E~~il~~L~~~~~i~~i~~~~~ 73 (483)
T 3sv0_A 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK--------------TKHPQLLYESKIYRILQGGTGIPNVRWFGV 73 (483)
T ss_dssp TEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETT--------------CSSCCHHHHHHHHHHTTTSTTCCCEEEEEE
T ss_pred cEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccc--------------cccHHHHHHHHHHHHhcCCCCCCeEEEEEe
Confidence 456667999999999999999999999999964422 112457889999999966 56666667777
Q ss_pred eCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEE---cc
Q 020641 95 EGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLL---FE 171 (323)
Q Consensus 95 ~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili---~~ 171 (323)
.....++||||+ +++|.+++...... +++..++.++.||+.||.|||+. ||+||||||+|||+ +.
T Consensus 74 ~~~~~~lvme~~-g~sL~~ll~~~~~~--------l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~ 141 (483)
T 3sv0_A 74 EGDYNVLVMDLL-GPSLEDLFNFCSRK--------LSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRR 141 (483)
T ss_dssp ETTEEEEEEECC-CCBHHHHHHHTTTC--------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGG
T ss_pred eCCEEEEEEECC-CCCHHHHHHhhcCC--------CCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCC
Confidence 888999999999 78999999754322 99999999999999999999999 99999999999999 68
Q ss_pred CCeEEEeeccccCCCCccccc-----cccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccc
Q 020641 172 DFKAKIADFNLSNQAPDMAAR-----LHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQ 246 (323)
Q Consensus 172 ~~~~~l~Dfg~~~~~~~~~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~ 246 (323)
++.++|+|||++......... .......||+.|+|||.+.+..++.++|||||||++|+|++|+.||........
T Consensus 142 ~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~ 221 (483)
T 3sv0_A 142 ANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK 221 (483)
T ss_dssp TTCEEECCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSH
T ss_pred CCeEEEEeCCcceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhH
Confidence 899999999999765543221 112245689999999999999999999999999999999999999987654322
Q ss_pred chhhhhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhhc
Q 020641 247 QSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLK 312 (323)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~~ 312 (323)
.................. ....++.++.+++.+||+.||++||++.+|++.|++++.
T Consensus 222 ~~~~~~i~~~~~~~~~~~---------l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~ 278 (483)
T 3sv0_A 222 KQKYEKISEKKVATSIEA---------LCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFI 278 (483)
T ss_dssp HHHHHHHHHHHHHSCHHH---------HHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred HHHHHHHhhccccccHHH---------HhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence 221111110000000000 011234679999999999999999999999999999864
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=304.89 Aligned_cols=246 Identities=15% Similarity=0.167 Sum_probs=195.0
Q ss_pred CccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcC-CCCcccceeeEEEe
Q 020641 17 PGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRL-KHENLVELLGYCVE 95 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~ 95 (323)
|.....||+|+||.||++.+..+++.+++|+....... ......+.+|+..+..+ +||||+++++++.+
T Consensus 13 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----------~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~ 82 (289)
T 1x8b_A 13 FHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAG----------SVDEQNALREVYAHAVLGQHSHVVRYFSAWAE 82 (289)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTT----------SHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEE
T ss_pred hhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccc----------cHHHHHHHHHHHHHHHhCCCCCeeeeeeeeec
Confidence 45556899999999999999999999999976533211 11235677889999998 99999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEcc----
Q 020641 96 GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFE---- 171 (323)
Q Consensus 96 ~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~---- 171 (323)
.+..++||||+.+++|.+++....... ..+++..++.++.|++.||.|||++ |++|+||||+||+++.
T Consensus 83 ~~~~~lv~e~~~~~~L~~~l~~~~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~ 154 (289)
T 1x8b_A 83 DDHMLIQNEYCNGGSLADAISENYRIM-----SYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIP 154 (289)
T ss_dssp TTEEEEEEECCTTCBHHHHHHHHHHHT-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC-----
T ss_pred CCeEEEEEEecCCCcHHHHHHhhcccc-----cCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCC
Confidence 999999999999999999997642100 1289999999999999999999999 9999999999999984
Q ss_pred ---------------CCeEEEeeccccCCCCccccccccccccCccccCCCccccCC-CCCcccchHHHHHHHHHHHhCC
Q 020641 172 ---------------DFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG-QLTQKSDVYSFGVVLLELLTGR 235 (323)
Q Consensus 172 ---------------~~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~ 235 (323)
...++|+|||.+...... ....|++.|+|||.+.+. .++.++||||||+++|+|++|.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~ 228 (289)
T 1x8b_A 155 NAASEEGDEDDWASNKVMFKIGDLGHVTRISSP------QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAE 228 (289)
T ss_dssp ---------------CCCEEECCCTTCEETTCS------CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCC
T ss_pred cccccccccccccCCceEEEEcccccccccCCc------cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCC
Confidence 447999999998765432 223489999999998765 5668999999999999999998
Q ss_pred CCCCCCCCcccchhhhhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 236 KPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 236 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
.++..... . ..+. .......+...+..+.+++.+||+.||.+|||+.|+++
T Consensus 229 ~~~~~~~~------~------------~~~~-~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 229 PLPRNGDQ------W------------HEIR-QGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp CCCSSSHH------H------------HHHH-TTCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCCcchhH------H------------HHHH-cCCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 87643211 0 0000 01112233445677999999999999999999999986
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-43 Score=335.89 Aligned_cols=250 Identities=20% Similarity=0.212 Sum_probs=205.8
Q ss_pred CCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcC-CCCcccceeeEEE
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRL-KHENLVELLGYCV 94 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~ 94 (323)
.|.....||+|+||.||+|++..+++.+|+|++.+.... .....+.+..|..++..+ .|++|+.+++++.
T Consensus 342 ~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~---------~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~ 412 (674)
T 3pfq_A 342 DFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVI---------QDDDVECTMVEKRVLALPGKPPFLTQLHSCFQ 412 (674)
T ss_dssp TEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHH---------HTTTTHHHHHHHHHHTCTTCCTTBCCEEEECB
T ss_pred ceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccc---------cHHHHHHHHHHHHHHHhccCCCeEEEEEEEEE
Confidence 345556899999999999999999999999977643211 122346788899999988 8999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCe
Q 020641 95 EGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFK 174 (323)
Q Consensus 95 ~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~ 174 (323)
+.+..|+||||+.+|+|.+++..... +++..+..++.||+.||.|||+. ||+||||||+|||++.++.
T Consensus 413 ~~~~~~lV~E~~~gg~L~~~l~~~~~---------~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ 480 (674)
T 3pfq_A 413 TMDRLYFVMEYVNGGDLMYHIQQVGR---------FKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGH 480 (674)
T ss_dssp CSSEEEEEEECCCSCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSC
T ss_pred eCCEEEEEEeCcCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCc
Confidence 99999999999999999999986542 89999999999999999999999 9999999999999999999
Q ss_pred EEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhc
Q 020641 175 AKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWAT 254 (323)
Q Consensus 175 ~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~ 254 (323)
++|+|||++........ ......||+.|+|||++.+..++.++||||||+++|+|++|..||........
T Consensus 481 ikL~DFGla~~~~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~-------- 550 (674)
T 3pfq_A 481 IKIADFGMCKENIWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL-------- 550 (674)
T ss_dssp EEECCCTTCEECCCTTC--CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--------
T ss_pred EEEeecceeeccccCCc--ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHH--------
Confidence 99999999875432221 23445699999999999999999999999999999999999999976532111
Q ss_pred ccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCCh-----HHHHH
Q 020641 255 PRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNM-----SIVVK 305 (323)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~-----~evl~ 305 (323)
...++... ...+...+.++.+||.+||+.||.+||++ +||++
T Consensus 551 -------~~~i~~~~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 551 -------FQSIMEHN--VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp -------HHHHHSSC--CCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred -------HHHHHhCC--CCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 11111211 12345567789999999999999999998 77764
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-44 Score=319.82 Aligned_cols=254 Identities=10% Similarity=0.028 Sum_probs=180.1
Q ss_pred CccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHH---HHHHhcCCCCccccee---
Q 020641 17 PGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQL---VSVVSRLKHENLVELL--- 90 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e---~~~l~~l~h~~i~~~~--- 90 (323)
|....+||+|+||.||+|.+..+++.+|+|++........ ...+.+.+| +..++. +||||++++
T Consensus 64 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~---------~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~ 133 (371)
T 3q60_A 64 LKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSR---------SELERLHEATFAAARLLG-ESPEEARDRRRL 133 (371)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHH---------HHHHHHHHHHHHHHHHHC-----------CB
T ss_pred eeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccc---------cHHHHHHHHHHHHHHhcc-cChhhhhhceeE
Confidence 5566699999999999999999999999998765432111 112456677 455555 799988755
Q ss_pred ----eEEEeC-----------------CeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHH------HHHHHHHH
Q 020641 91 ----GYCVEG-----------------NLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTR------VRIAVDAA 143 (323)
Q Consensus 91 ----~~~~~~-----------------~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~i~ 143 (323)
+++... ...++||||+. ++|.+++...... +....+ ..++.|++
T Consensus 134 ~~p~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~--------~~~~~~~~~~vk~~i~~qi~ 204 (371)
T 3q60_A 134 LLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFV--------YVFRGDEGILALHILTAQLI 204 (371)
T ss_dssp CCCCEEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHS--------CCCCHHHHHHHHHHHHHHHH
T ss_pred EeeehheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccc--------cchhhhhhhhhHHHHHHHHH
Confidence 444433 33799999999 7999999864221 333344 67779999
Q ss_pred HHHHHhhcCCCCCceeCCCCCCCEEEccCCeEEEeeccccCCCCccccccccccccCccccCCCccccC--CCCCcccch
Q 020641 144 RGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT--GQLTQKSDV 221 (323)
Q Consensus 144 ~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~Di 221 (323)
.||.|||++ ||+||||||+|||++.++.+||+|||++....... ....+++.|+|||.+.+ ..++.++||
T Consensus 205 ~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~~Di 276 (371)
T 3q60_A 205 RLAANLQSK---GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRG-----PASSVPVTYAPREFLNASTATFTHALNA 276 (371)
T ss_dssp HHHHHHHHT---TEEETTCSGGGEEECTTSCEEECCGGGEEETTCEE-----EGGGSCGGGCCHHHHTCSEEECCHHHHH
T ss_pred HHHHHHHHC---CCccCcCCHHHEEECCCCCEEEEecceeeecCCCc-----cCccCCcCCcChhhccCCCCCcCccccH
Confidence 999999999 99999999999999999999999999997654322 12346799999999987 678999999
Q ss_pred HHHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChH
Q 020641 222 YSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMS 301 (323)
Q Consensus 222 ~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ 301 (323)
||||+++|+|++|+.||.......... +.....................+..+.+++.+||+.||++|||+.
T Consensus 277 wSlG~il~elltg~~Pf~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ 348 (371)
T 3q60_A 277 WQLGLSIYRVWCLFLPFGLVTPGIKGS--------WKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPL 348 (371)
T ss_dssp HHHHHHHHHHHHSSCSTTBCCTTCTTC--------CCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHH
T ss_pred HHHHHHHHHHHhCCCCCCCcCcccccc--------hhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHH
Confidence 999999999999999998654321110 000000111111111222235567899999999999999999999
Q ss_pred HHHH
Q 020641 302 IVVK 305 (323)
Q Consensus 302 evl~ 305 (323)
++++
T Consensus 349 e~l~ 352 (371)
T 3q60_A 349 EAME 352 (371)
T ss_dssp HHTT
T ss_pred HHhc
Confidence 9975
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=317.01 Aligned_cols=262 Identities=21% Similarity=0.232 Sum_probs=182.7
Q ss_pred CCCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEE
Q 020641 15 PSPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCV 94 (323)
Q Consensus 15 ~~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 94 (323)
..|.....||+|+||.||+|.+..+++.+|+|++...... ....+.+.+|+++++.++||||+++++++.
T Consensus 29 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~----------~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~ 98 (367)
T 2fst_X 29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS----------IIHAKRTYRELRLLKHMKHENVIGLLDVFT 98 (367)
T ss_dssp TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSS----------HHHHHHHHHHHHHHHHCCCTTBCCCSEEEC
T ss_pred CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccC----------HHHHHHHHHHHHHHHhCCCCCCCcEEEEEe
Confidence 4566667999999999999999999999999976532111 112366789999999999999999999987
Q ss_pred eC------CeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEE
Q 020641 95 EG------NLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVL 168 (323)
Q Consensus 95 ~~------~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nil 168 (323)
.. ...++|+|++ +++|.+++.... +++..+..++.||+.||.|||+. |++||||||+||+
T Consensus 99 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~----------l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIl 164 (367)
T 2fst_X 99 PARSLEEFNDVYLVTHLM-GADLNNIVKCQK----------LTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLA 164 (367)
T ss_dssp SCSSGGGCCCCEEEEECC-CEECC-----CC----------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEE
T ss_pred cCCccccCCeEEEEeccc-CCCHHHHHhcCC----------CCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEE
Confidence 54 5679999999 569999886532 89999999999999999999999 9999999999999
Q ss_pred EccCCeEEEeeccccCCCCccccccccccccCccccCCCccccC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccc
Q 020641 169 LFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT-GQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQ 247 (323)
Q Consensus 169 i~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~ 247 (323)
++.++.++|+|||++...... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.......
T Consensus 165 l~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l 239 (367)
T 2fst_X 165 VNEDCELKILDFGLARHTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQL 239 (367)
T ss_dssp ECTTCCEEECC--------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred ECCCCCEEEeecccccccccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 999999999999999765432 233458999999999876 67899999999999999999999999866532221
Q ss_pred hhhhhhccccc--------ccccchhcCCCcCC-CC-----CHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 248 SLVTWATPRLS--------EDKVKQCVDPKLKG-EY-----PPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 248 ~~~~~~~~~~~--------~~~~~~~~~~~~~~-~~-----~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
..+........ .......+...... .. ....+..+.+|+.+||..||.+|||+.|+++
T Consensus 240 ~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~ 311 (367)
T 2fst_X 240 KLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 311 (367)
T ss_dssp HHHHHHHCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHHhCCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence 11111100000 00001111000000 00 1123567999999999999999999999987
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=306.47 Aligned_cols=252 Identities=20% Similarity=0.254 Sum_probs=197.3
Q ss_pred CCCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEE
Q 020641 15 PSPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCV 94 (323)
Q Consensus 15 ~~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 94 (323)
..|....+||.|+||.||++.+..+++.+++|+.... .....+.+.+|+++++.++||||+++++++.
T Consensus 19 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~------------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 86 (302)
T 2j7t_A 19 EVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETK------------SEEELEDYIVEIEILATCDHPYIVKLLGAYY 86 (302)
T ss_dssp GTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----------------CCHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred cceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCC------------CHHHHHHHHHHHHHHhcCCCCCEeeeeeeee
Confidence 3455666899999999999999999999999876432 1233477889999999999999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCe
Q 020641 95 EGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFK 174 (323)
Q Consensus 95 ~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~ 174 (323)
..+..++||||+.+++|.+++...... +++..+..++.|++.||.|||+. |++|+||||+||+++.++.
T Consensus 87 ~~~~~~lv~e~~~~~~l~~~~~~~~~~--------~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~ 155 (302)
T 2j7t_A 87 HDGKLWIMIEFCPGGAVDAIMLELDRG--------LTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGD 155 (302)
T ss_dssp CC-CEEEEEECCTTEEHHHHHHHHTSC--------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSC
T ss_pred eCCeEEEEEEeCCCCcHHHHHHhhccC--------CCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCC
Confidence 999999999999999999998754322 89999999999999999999999 9999999999999999999
Q ss_pred EEEeeccccCCCCccccccccccccCccccCCCcccc-----CCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchh
Q 020641 175 AKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAM-----TGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSL 249 (323)
Q Consensus 175 ~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~ 249 (323)
++|+|||++....... .......|++.|+|||.+. +..++.++||||||+++|+|++|..||..........
T Consensus 156 ~kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~- 232 (302)
T 2j7t_A 156 IRLADFGVSAKNLKTL--QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLL- 232 (302)
T ss_dssp EEECCCHHHHHHHHHH--HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH-
T ss_pred EEEEECCCCccccccc--cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHH-
Confidence 9999999875322111 1123345899999999883 5678899999999999999999999997654211110
Q ss_pred hhhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 250 VTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
..... .......+...+..+.+++.+||+.||.+|||+.++++
T Consensus 233 -~~~~~------------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 233 -KIAKS------------DPPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp -HHHHS------------CCCCCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred -HHhcc------------CCcccCCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 00000 00011123445677999999999999999999999986
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=309.90 Aligned_cols=263 Identities=21% Similarity=0.224 Sum_probs=192.9
Q ss_pred CCCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEE
Q 020641 15 PSPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCV 94 (323)
Q Consensus 15 ~~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 94 (323)
..+.....||+|+||.||++++.. .+++|+...... .....+.+.+|+.++++++|+||+++++++.
T Consensus 33 ~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~----------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 99 (319)
T 2y4i_B 33 EQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERD----------NEDQLKAFKREVMAYRQTRHENVVLFMGACM 99 (319)
T ss_dssp SCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSC----------CCCCCCCCCTTGGGGTTCCCTTBCCCCEEEE
T ss_pred HHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCC----------CHHHHHHHHHHHHHHhcCCCCCEeEEEEEEe
Confidence 344555689999999999998754 366665543211 1222345667889999999999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCe
Q 020641 95 EGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFK 174 (323)
Q Consensus 95 ~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~ 174 (323)
.....++||||+.+++|.+++...... +++..++.++.|++.||.|||+. |++|+||||+||+++ ++.
T Consensus 100 ~~~~~~iv~e~~~~~~L~~~l~~~~~~--------~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~ 167 (319)
T 2y4i_B 100 SPPHLAIITSLCKGRTLYSVVRDAKIV--------LDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGK 167 (319)
T ss_dssp CSSCEEEECBCCCSEEHHHHTTSSCCC--------CCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---C
T ss_pred cCCceEEEeecccCCcHHHHHHhcCCC--------CCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCC
Confidence 999999999999999999999765422 88899999999999999999999 999999999999998 679
Q ss_pred EEEeeccccCCCCcccc---ccccccccCccccCCCccccC---------CCCCcccchHHHHHHHHHHHhCCCCCCCCC
Q 020641 175 AKIADFNLSNQAPDMAA---RLHSTRVLGTFGYHAPEYAMT---------GQLTQKSDVYSFGVVLLELLTGRKPVDHTM 242 (323)
Q Consensus 175 ~~l~Dfg~~~~~~~~~~---~~~~~~~~g~~~y~aPE~~~~---------~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 242 (323)
++|+|||++........ ........|++.|+|||.+.+ ..++.++||||||+++|+|++|..||....
T Consensus 168 ~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~ 247 (319)
T 2y4i_B 168 VVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQP 247 (319)
T ss_dssp CEECCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCC
T ss_pred EEEeecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999865432111 112223348899999998864 346889999999999999999999997553
Q ss_pred CcccchhhhhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhhcCCCCC
Q 020641 243 PRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSPPPA 317 (323)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~~~~~~~ 317 (323)
......... ............+..+.+++.+||..||.+|||+.++++.|+++.+.....
T Consensus 248 ~~~~~~~~~---------------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~~ 307 (319)
T 2y4i_B 248 AEAIIWQMG---------------TGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRL 307 (319)
T ss_dssp HHHHHHHHH---------------TTCCCCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC-------
T ss_pred HHHHHHHhc---------------cCCCCCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhccC
Confidence 221110000 000001111223456999999999999999999999999999998775443
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=320.87 Aligned_cols=202 Identities=20% Similarity=0.224 Sum_probs=164.2
Q ss_pred CCCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEE
Q 020641 15 PSPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCV 94 (323)
Q Consensus 15 ~~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 94 (323)
..|.....||+|+||.||+|.+..+++.+|+|++..... .....+++.+|+.+++.++|+||+++++++.
T Consensus 26 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~----------~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~ 95 (432)
T 3n9x_A 26 DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFE----------DLIDCKRILREITILNRLKSDYIIRLYDLII 95 (432)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTT----------SHHHHHHHHHHHHHHHHCCCTTBCCEEEECC
T ss_pred CCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhc----------ChHHHHHHHHHHHHHHHcCCCCcceEEEEEe
Confidence 345555589999999999999999999999997653211 1112367889999999999999999999997
Q ss_pred eC-----CeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEE
Q 020641 95 EG-----NLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLL 169 (323)
Q Consensus 95 ~~-----~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili 169 (323)
.. ...|+||||+.+ +|.+++..... +++..+..++.||+.||.|||+. ||+||||||+|||+
T Consensus 96 ~~~~~~~~~~~lv~e~~~~-~L~~~~~~~~~---------l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl 162 (432)
T 3n9x_A 96 PDDLLKFDELYIVLEIADS-DLKKLFKTPIF---------LTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLL 162 (432)
T ss_dssp CSCTTTCCCEEEEEECCSE-EHHHHHHSSCC---------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEE
T ss_pred cCCCCcCCeEEEEEecCCc-CHHHHHhccCC---------CCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEE
Confidence 66 578999999875 99999976532 89999999999999999999999 99999999999999
Q ss_pred ccCCeEEEeeccccCCCCccccc--------------------cccccccCccccCCCccc-cCCCCCcccchHHHHHHH
Q 020641 170 FEDFKAKIADFNLSNQAPDMAAR--------------------LHSTRVLGTFGYHAPEYA-MTGQLTQKSDVYSFGVVL 228 (323)
Q Consensus 170 ~~~~~~~l~Dfg~~~~~~~~~~~--------------------~~~~~~~g~~~y~aPE~~-~~~~~~~~~Di~slG~~l 228 (323)
+.++.+||+|||++......... .......||+.|+|||++ .+..++.++|||||||++
T Consensus 163 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il 242 (432)
T 3n9x_A 163 NQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIF 242 (432)
T ss_dssp CTTCCEEECCCTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHH
T ss_pred CCCCCEEEccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHH
Confidence 99999999999999765433211 112445689999999986 456789999999999999
Q ss_pred HHHHhCCCCCC
Q 020641 229 LELLTGRKPVD 239 (323)
Q Consensus 229 ~~l~~g~~pf~ 239 (323)
|+|++|..||.
T Consensus 243 ~ell~g~~p~~ 253 (432)
T 3n9x_A 243 AELLNMLQSHI 253 (432)
T ss_dssp HHHHTTCTTTC
T ss_pred HHHHhcccccc
Confidence 99998665554
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=322.38 Aligned_cols=198 Identities=20% Similarity=0.261 Sum_probs=167.5
Q ss_pred CccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcC------CCCccccee
Q 020641 17 PGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRL------KHENLVELL 90 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l------~h~~i~~~~ 90 (323)
|.....||+|+||.||+|.+..+++.+|+|++... ......+.+|+.+++.+ +|+||++++
T Consensus 99 y~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-------------~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~ 165 (429)
T 3kvw_A 99 YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-------------KRFHRQAAEEIRILEHLRKQDKDNTMNVIHML 165 (429)
T ss_dssp EEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-------------HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEE
T ss_pred EEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-------------cchHHHHHHHHHHHHHHhhccccCCcCEEEEE
Confidence 55566999999999999999999999999976421 11124556677766655 577999999
Q ss_pred eEEEeCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEc
Q 020641 91 GYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLF 170 (323)
Q Consensus 91 ~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~ 170 (323)
+++...+..++||||+. ++|.+++....... +++..+..++.||+.||.|||+. ||+||||||+|||++
T Consensus 166 ~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~-------~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~ 234 (429)
T 3kvw_A 166 ENFTFRNHICMTFELLS-MNLYELIKKNKFQG-------FSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLK 234 (429)
T ss_dssp EEEEETTEEEEEECCCC-CBHHHHHHHTTTCC-------CCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEES
T ss_pred eecccCCeEEEEEeccC-CCHHHHHHhccCCC-------CCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEc
Confidence 99999999999999997 49999998765332 89999999999999999999999 999999999999999
Q ss_pred cCCe--EEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCC
Q 020641 171 EDFK--AKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMP 243 (323)
Q Consensus 171 ~~~~--~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 243 (323)
.++. ++|+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|..||.....
T Consensus 235 ~~~~~~vkL~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~ 304 (429)
T 3kvw_A 235 QQGRSGIKVIDFGSSCYEHQR-----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDE 304 (429)
T ss_dssp STTSCCEEECCCTTCEETTCC-----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred cCCCcceEEeecccceecCCc-----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCH
Confidence 9887 999999998654322 2334689999999999999999999999999999999999999976643
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=311.25 Aligned_cols=275 Identities=20% Similarity=0.250 Sum_probs=196.2
Q ss_pred cCCCCCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHH--HhcCCCCcccce
Q 020641 12 AHAPSPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSV--VSRLKHENLVEL 89 (323)
Q Consensus 12 ~~~~~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~--l~~l~h~~i~~~ 89 (323)
-....|....+||+|+||.||+++. +++.+|+|++.... ...+..|.++ +..++|+||+++
T Consensus 10 ~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~---------------~~~~~~e~~~~~~~~~~h~~i~~~ 72 (336)
T 3g2f_A 10 LDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFAN---------------RQNFINEKNIYRVPLMEHDNIARF 72 (336)
T ss_dssp CCTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGG---------------HHHHHHHHHHHTSTTCCCTTBCCE
T ss_pred cChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccc---------------hhhHHHHHHHHHHHhccCcchhhh
Confidence 3445566777999999999999966 67788998764221 1334444444 445799999999
Q ss_pred eeEEEe-----CCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCC------CCCce
Q 020641 90 LGYCVE-----GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKV------QPSII 158 (323)
Q Consensus 90 ~~~~~~-----~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~------~~~i~ 158 (323)
++.+.. ...+++||||+.+|+|.+++.... .++..+..++.|++.||.|||+.+ ..|++
T Consensus 73 ~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~iv 142 (336)
T 3g2f_A 73 IVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT----------SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAIS 142 (336)
T ss_dssp EEEEEEECTTSCEEEEEEECCCTTCBHHHHHHHCC----------BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEE
T ss_pred eecccccccCCCceEEEEEecCCCCcHHHHHhhcc----------cchhHHHHHHHHHHHHHHHHHhhhcccccccccee
Confidence 986542 236789999999999999997654 788899999999999999999763 23899
Q ss_pred eCCCCCCCEEEccCCeEEEeeccccCCCCccc------cccccccccCccccCCCccccC-------CCCCcccchHHHH
Q 020641 159 HRDIRSSNVLLFEDFKAKIADFNLSNQAPDMA------ARLHSTRVLGTFGYHAPEYAMT-------GQLTQKSDVYSFG 225 (323)
Q Consensus 159 h~dikp~nili~~~~~~~l~Dfg~~~~~~~~~------~~~~~~~~~g~~~y~aPE~~~~-------~~~~~~~Di~slG 225 (323)
||||||+||+++.++.++|+|||++....... .........||+.|+|||++.+ ..++.++||||||
T Consensus 143 H~Dikp~Nill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG 222 (336)
T 3g2f_A 143 HRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALG 222 (336)
T ss_dssp CSSCSGGGEEECTTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHH
T ss_pred ecccccceEEEcCCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHH
Confidence 99999999999999999999999997654321 1112223458999999999876 3456789999999
Q ss_pred HHHHHHHhCCCCCCCCCCcccch-hhh-hhcccccccccchhc-CCCcCCC------CCHHHHHHHHHHHHHccCCCCCC
Q 020641 226 VVLLELLTGRKPVDHTMPRGQQS-LVT-WATPRLSEDKVKQCV-DPKLKGE------YPPKGVAKLAAVAALCVQYEAEF 296 (323)
Q Consensus 226 ~~l~~l~~g~~pf~~~~~~~~~~-~~~-~~~~~~~~~~~~~~~-~~~~~~~------~~~~~~~~l~~li~~cl~~~P~~ 296 (323)
+++|+|++|..||.......... ... ..............+ ....+.. .....+..+.++|.+||+.||++
T Consensus 223 ~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~ 302 (336)
T 3g2f_A 223 LIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEA 302 (336)
T ss_dssp HHHHHHHTTBGGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGG
T ss_pred HHHHHHHhcCCcCCCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhh
Confidence 99999999987765433221111 000 000000011111111 1111111 12346778999999999999999
Q ss_pred CCChHHHHHHHhhhhcC
Q 020641 297 RPNMSIVVKALQPLLKS 313 (323)
Q Consensus 297 Rps~~evl~~l~~~~~~ 313 (323)
|||+.|+++.|++++..
T Consensus 303 Rps~~e~l~~L~~ll~~ 319 (336)
T 3g2f_A 303 RLTAQXAEERMAELMMI 319 (336)
T ss_dssp SCCHHHHHHHHHHHHHC
T ss_pred CcchHHHHHHHHHHHHH
Confidence 99999999999999844
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-44 Score=320.74 Aligned_cols=252 Identities=13% Similarity=0.119 Sum_probs=188.7
Q ss_pred CccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHH---HHHhcCCCCccccee---
Q 020641 17 PGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLV---SVVSRLKHENLVELL--- 90 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~---~~l~~l~h~~i~~~~--- 90 (323)
|....+||+|+||.||+|.+..+++.+|+|++...... .....+.+.+|+ +.+++++||||++++
T Consensus 75 y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~---------~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~ 145 (377)
T 3byv_A 75 LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERP---------PSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRF 145 (377)
T ss_dssp EEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-C---------CTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCB
T ss_pred EEEcceeecCCCEEEEEEEECCCCcEEEEEEEeecccc---------chHHHHHHHHHHHHHHhccccCCHHHHHHHhhh
Confidence 44456899999999999999999999999987643211 122346788999 556666899999998
Q ss_pred ----eEEEeCC-----------------eEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHh
Q 020641 91 ----GYCVEGN-----------------LRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYL 149 (323)
Q Consensus 91 ----~~~~~~~-----------------~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~l 149 (323)
+++...+ ..++||||+ +|+|.+++....... .....+++..++.++.|++.||.||
T Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~--~~~~~l~~~~~~~i~~qi~~aL~~L 222 (377)
T 3byv_A 146 IFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHS--STHKSLVHHARLQLTLQVIRLLASL 222 (377)
T ss_dssp CCCSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTT--TTTHHHHHHHHHHHHHHHHHHHHHH
T ss_pred hhhhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccc--cccccccHHHHHHHHHHHHHHHHHH
Confidence 6666553 278999999 569999997643211 0011244578889999999999999
Q ss_pred hcCCCCCceeCCCCCCCEEEccCCeEEEeeccccCCCCccccccccccccCccccCCCccccCC-----------CCCcc
Q 020641 150 HEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG-----------QLTQK 218 (323)
Q Consensus 150 h~~~~~~i~h~dikp~nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-----------~~~~~ 218 (323)
|+. ||+||||||+|||++.++.+||+|||++...... .....| +.|+|||++.+. .++.+
T Consensus 223 H~~---~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~ 293 (377)
T 3byv_A 223 HHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAR-----VVSSVS-RGFEPPELEARRATISYHRDRRTLMTFS 293 (377)
T ss_dssp HHT---TEECSCCCGGGEEECTTCCEEECCGGGCEETTCE-----EECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHH
T ss_pred HhC---CeecCCCCHHHEEEcCCCCEEEEechhheecCCc-----ccCCCC-cCccChhhhcccccccccccccccCChh
Confidence 999 9999999999999999999999999998754331 233457 899999999877 78999
Q ss_pred cchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCC
Q 020641 219 SDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRP 298 (323)
Q Consensus 219 ~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp 298 (323)
+||||||+++|+|++|+.||.......... .... . ....+..+.+++.+||+.||++||
T Consensus 294 ~DvwSlG~il~elltg~~Pf~~~~~~~~~~---------------~~~~-~-----~~~~~~~~~~li~~~L~~dp~~Rp 352 (377)
T 3byv_A 294 FDAWALGLVIYWIWCADLPITKDAALGGSE---------------WIFR-S-----CKNIPQPVRALLEGFLRYPKEDRL 352 (377)
T ss_dssp HHHHHHHHHHHHHHHSSCCC------CCSG---------------GGGS-S-----CCCCCHHHHHHHHHHTCSSGGGCC
T ss_pred hhHHHHHHHHHHHHHCCCCCcccccccchh---------------hhhh-h-----ccCCCHHHHHHHHHHcCCCchhCC
Confidence 999999999999999999997553321110 0000 0 123356799999999999999999
Q ss_pred ChHHHHH--HHhhh
Q 020641 299 NMSIVVK--ALQPL 310 (323)
Q Consensus 299 s~~evl~--~l~~~ 310 (323)
|+.|+++ +++++
T Consensus 353 t~~e~l~hp~f~~~ 366 (377)
T 3byv_A 353 LPLQAMETPEYEQL 366 (377)
T ss_dssp CHHHHHTSHHHHHH
T ss_pred CHHHHhhChHHHHH
Confidence 9999986 44443
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=314.07 Aligned_cols=257 Identities=19% Similarity=0.228 Sum_probs=199.7
Q ss_pred CCccccccCCCCCCccceeccc---eeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcC-CCCcccceee
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRV---KMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRL-KHENLVELLG 91 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~---~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~ 91 (323)
.|.....||+|+||.||++++. .+++.+|+|++........ ....+.+.+|+++++.+ .|+||+++++
T Consensus 55 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~--------~~~~~~~~~E~~~l~~l~~h~~iv~~~~ 126 (355)
T 1vzo_A 55 NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQK--------AKTTEHTRTERQVLEHIRQSPFLVTLHY 126 (355)
T ss_dssp GEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEE--------ESSGGGCCCHHHHHHHHHTCTTBCCEEE
T ss_pred ceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhh--------hhHHHHHHHHHHHHHHccCCCceeEEEE
Confidence 4455568999999999999985 4788999997754322111 11234456788889888 7999999999
Q ss_pred EEEeCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEcc
Q 020641 92 YCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFE 171 (323)
Q Consensus 92 ~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~ 171 (323)
++......++||||+.+++|.+++..... +++..+..++.|++.||.|||+. ||+||||||+||+++.
T Consensus 127 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~ 194 (355)
T 1vzo_A 127 AFQTETKLHLILDYINGGELFTHLSQRER---------FTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDS 194 (355)
T ss_dssp EEEETTEEEEEECCCCSCBHHHHHHHHSC---------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECT
T ss_pred EEeeCceEEEEeecCCCCCHHHHHHHcCC---------CCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECC
Confidence 99999999999999999999999976542 89999999999999999999999 9999999999999999
Q ss_pred CCeEEEeeccccCCCCccccccccccccCccccCCCccccC--CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchh
Q 020641 172 DFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT--GQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSL 249 (323)
Q Consensus 172 ~~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~ 249 (323)
++.++|+|||++......... ......||+.|+|||++.+ ..++.++||||||+++|+|++|..||...........
T Consensus 195 ~~~~kl~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~ 273 (355)
T 1vzo_A 195 NGHVVLTDFGLSKEFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAE 273 (355)
T ss_dssp TSCEEESCSSEEEECCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHH
T ss_pred CCcEEEeeCCCCeecccCCCC-cccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHH
Confidence 999999999999765433222 1233458999999999885 3468899999999999999999999975543222111
Q ss_pred hhhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCC-----ChHHHHHH
Q 020641 250 VTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRP-----NMSIVVKA 306 (323)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-----s~~evl~~ 306 (323)
... .... .....+...+..+.+++.+||..||.+|| |+.|+++.
T Consensus 274 ~~~-----------~~~~--~~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h 322 (355)
T 1vzo_A 274 ISR-----------RILK--SEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 322 (355)
T ss_dssp HHH-----------HHHH--CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred HHH-----------HHhc--cCCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcC
Confidence 110 0000 01223445567799999999999999999 99999874
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-43 Score=314.05 Aligned_cols=265 Identities=18% Similarity=0.206 Sum_probs=201.1
Q ss_pred CCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEe
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVE 95 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 95 (323)
.|.....||+|+||.||+|.+..+++.+|+|+.... ......+.+.+|++++++++||||+++++++..
T Consensus 28 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-----------~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 96 (364)
T 3qyz_A 28 RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPF-----------EHQTYCQRTLREIKILLRFRHENIIGINDIIRA 96 (364)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCT-----------TCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECC
T ss_pred cEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccc-----------cCcHHHHHHHHHHHHHHhcCCCCCccceeEEec
Confidence 566667999999999999999999999999966421 111223667899999999999999999999975
Q ss_pred C-----CeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEc
Q 020641 96 G-----NLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLF 170 (323)
Q Consensus 96 ~-----~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~ 170 (323)
. ...++||||+.+ +|.+++.... +++..+..++.|++.||.|||+. |++|+||||+||+++
T Consensus 97 ~~~~~~~~~~iv~e~~~~-~L~~~l~~~~----------~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~ 162 (364)
T 3qyz_A 97 PTIEQMKDVYIVQDLMET-DLYKLLKTQH----------LSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLN 162 (364)
T ss_dssp SSTTTCCCEEEEEECCSE-EHHHHHHHCC----------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEC
T ss_pred CCccccceEEEEEcccCc-CHHHHHHhCC----------CCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEEC
Confidence 5 368999999985 9999997643 89999999999999999999999 999999999999999
Q ss_pred cCCeEEEeeccccCCCCcccccc-ccccccCccccCCCccccC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccch
Q 020641 171 EDFKAKIADFNLSNQAPDMAARL-HSTRVLGTFGYHAPEYAMT-GQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQS 248 (323)
Q Consensus 171 ~~~~~~l~Dfg~~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~ 248 (323)
.++.++|+|||++.......... ......||+.|+|||.+.+ ..++.++||||||+++|+|++|+.||..........
T Consensus 163 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~ 242 (364)
T 3qyz_A 163 TTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLN 242 (364)
T ss_dssp TTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHH
T ss_pred CCCCEEEEeCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHH
Confidence 99999999999997665433221 1234468999999998654 458999999999999999999999998665433222
Q ss_pred hhhhhcccccccccchh--------cCCCc-CCCC-----CHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 249 LVTWATPRLSEDKVKQC--------VDPKL-KGEY-----PPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 249 ~~~~~~~~~~~~~~~~~--------~~~~~-~~~~-----~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
.+............... ..... .... ....+..+.+|+.+||+.||.+|||+.|+++
T Consensus 243 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 313 (364)
T 3qyz_A 243 HILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313 (364)
T ss_dssp HHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 11111111111100000 00000 0001 1233567999999999999999999999997
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=308.31 Aligned_cols=274 Identities=16% Similarity=0.188 Sum_probs=201.9
Q ss_pred CCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCC-----CCCchHHHHHHHHHhcCCCCccccee
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSP-----KNYPDDEKQLVSVVSRLKHENLVELL 90 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~ 90 (323)
.|.....||+|+||.||+|.+ +++.+|+|+................. ....+.+.+|+.++++++||||++++
T Consensus 32 ~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~ 109 (348)
T 2pml_X 32 DYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCE 109 (348)
T ss_dssp TEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCS
T ss_pred ceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEE
Confidence 456666999999999999999 88899999876554332211100000 01117889999999999999999999
Q ss_pred eEEEeCCeEEEEEeecCCCCHHHH------hccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCCCceeCCCC
Q 020641 91 GYCVEGNLRVLAYEFATMGSLHDI------LHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHE-KVQPSIIHRDIR 163 (323)
Q Consensus 91 ~~~~~~~~~~lv~e~~~~~sL~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~-~~~~~i~h~dik 163 (323)
+++.+.+..++||||+.+++|.++ +...... .+++..++.++.|++.||.|||+ . |++|+|||
T Consensus 110 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~-------~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~ 179 (348)
T 2pml_X 110 GIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTC-------FIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVK 179 (348)
T ss_dssp EEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCC-------CCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCC
T ss_pred EEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhcccc-------CCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCC
Confidence 999999999999999999999998 5442121 39999999999999999999999 9 99999999
Q ss_pred CCCEEEccCCeEEEeeccccCCCCccccccccccccCccccCCCccccCC-CCCc-ccchHHHHHHHHHHHhCCCCCCCC
Q 020641 164 SSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG-QLTQ-KSDVYSFGVVLLELLTGRKPVDHT 241 (323)
Q Consensus 164 p~nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~-~~Di~slG~~l~~l~~g~~pf~~~ 241 (323)
|+||+++.++.++|+|||.+...... ......|++.|+|||.+.+. .++. ++||||||+++|+|++|..||...
T Consensus 180 p~Nil~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 255 (348)
T 2pml_X 180 PSNILMDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLK 255 (348)
T ss_dssp GGGEEECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred hHhEEEcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 99999999999999999998765432 22344589999999999877 5666 999999999999999999999865
Q ss_pred CCcccc-hhhhhhccccccc--ccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 242 MPRGQQ-SLVTWATPRLSED--KVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 242 ~~~~~~-~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
...... ..........+.. ..................+..+.+++.+||+.||.+|||+.|+++
T Consensus 256 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 256 ISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp SCSHHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred CcHHHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 431111 0000000000000 000000000000111345678999999999999999999999987
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-43 Score=306.30 Aligned_cols=257 Identities=19% Similarity=0.231 Sum_probs=193.7
Q ss_pred CccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeC
Q 020641 17 PGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEG 96 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 96 (323)
|....+||+|+||.||+|.+..+++.+|+|++.......... ........+.+|++++++++||||+++++++...
T Consensus 12 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~----~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 12 YIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSA----READPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC-------------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred eeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhccc----ccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 555668999999999999999999999999876543321111 1122335688999999999999999999998766
Q ss_pred CeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCe--
Q 020641 97 NLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFK-- 174 (323)
Q Consensus 97 ~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~-- 174 (323)
. .++||||+.+++|.+++..... +++..++.++.|++.||.|||+. |++|+||||+||+++.++.
T Consensus 88 ~-~~lv~e~~~~~~L~~~~~~~~~---------~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~ 154 (322)
T 2ycf_A 88 D-YYIVLELMEGGELFDKVVGNKR---------LKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDC 154 (322)
T ss_dssp S-EEEEEECCTTEETHHHHSTTCC---------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSC
T ss_pred c-eEEEEecCCCCcHHHHHhccCC---------CCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCC
Confidence 5 8999999999999999975432 89999999999999999999999 9999999999999987664
Q ss_pred -EEEeeccccCCCCccccccccccccCccccCCCcccc---CCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhh
Q 020641 175 -AKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAM---TGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLV 250 (323)
Q Consensus 175 -~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~ 250 (323)
++|+|||++........ .....|++.|+|||.+. ...++.++||||||+++|+|++|..||...........
T Consensus 155 ~~kl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~- 230 (322)
T 2ycf_A 155 LIKITDFGHSKILGETSL---MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKD- 230 (322)
T ss_dssp CEEECCCTTCEECCCCHH---HHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHH-
T ss_pred eEEEccCccceecccccc---cccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHH-
Confidence 99999999876543221 12334899999999874 46678999999999999999999999975543211100
Q ss_pred hhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 251 TWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
........ .........+..+.+++.+||+.||++|||+.++++
T Consensus 231 ~~~~~~~~-----------~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 231 QITSGKYN-----------FIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp HHHHTCCC-----------CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHhCccc-----------cCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 00000000 000001123567999999999999999999999984
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-43 Score=308.38 Aligned_cols=251 Identities=24% Similarity=0.334 Sum_probs=194.0
Q ss_pred CCCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcC-CCCcccceeeEE
Q 020641 15 PSPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRL-KHENLVELLGYC 93 (323)
Q Consensus 15 ~~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~ 93 (323)
..|.....||.|+||.||++++..+++.+++|+.... ......+.+|+.+++++ +||||+++++++
T Consensus 24 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-------------~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 90 (326)
T 2x7f_A 24 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-------------GDEEEEIKQEINMLKKYSHHRNIATYYGAF 90 (326)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------------SSTTHHHHHHHHHHHHHCCSTTBCCEEEEE
T ss_pred CcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecC-------------cccHHHHHHHHHHHHhccCCCCeeeeeeEE
Confidence 4455666999999999999999999999999976421 12346788999999998 899999999999
Q ss_pred Ee------CCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCE
Q 020641 94 VE------GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNV 167 (323)
Q Consensus 94 ~~------~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~ni 167 (323)
.. ....++||||+.+++|.+++...... .++...+..++.|++.||.|||+. |++|+||||+||
T Consensus 91 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-------~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NI 160 (326)
T 2x7f_A 91 IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGN-------TLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNV 160 (326)
T ss_dssp EECC--CCCCEEEEEEECCTTEEHHHHHHHSGGG-------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGE
T ss_pred eeccCccccceEEEEEEcCCCCcHHHHHHhcccC-------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHE
Confidence 87 46789999999999999999765322 288999999999999999999999 999999999999
Q ss_pred EEccCCeEEEeeccccCCCCccccccccccccCccccCCCcccc-----CCCCCcccchHHHHHHHHHHHhCCCCCCCCC
Q 020641 168 LLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAM-----TGQLTQKSDVYSFGVVLLELLTGRKPVDHTM 242 (323)
Q Consensus 168 li~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 242 (323)
+++.++.++|+|||++........ ......|++.|+|||.+. +..++.++||||||+++|+|++|..||....
T Consensus 161 l~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 238 (326)
T 2x7f_A 161 LLTENAEVKLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH 238 (326)
T ss_dssp EECTTCCEEECCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred EEcCCCCEEEeeCcCceecCcCcc--ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCc
Confidence 999999999999999876543221 123345899999999886 4567899999999999999999999997543
Q ss_pred CcccchhhhhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 243 PRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
........ .............+..+.+++.+||..||.+|||+.++++
T Consensus 239 ~~~~~~~~---------------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 239 PMRALFLI---------------PRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp HHHHHHHH---------------HHSCCCCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HHHHHHHh---------------hcCccccCCccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 21111000 0000011112334567999999999999999999999987
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-43 Score=313.35 Aligned_cols=263 Identities=17% Similarity=0.225 Sum_probs=193.9
Q ss_pred CCCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEE
Q 020641 15 PSPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCV 94 (323)
Q Consensus 15 ~~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 94 (323)
..|....+||+|+||.||+|.+..+++.+|+|...... ....+|+++++.++|+||+++++++.
T Consensus 7 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----------------~~~~~E~~il~~l~hpnIv~l~~~~~ 70 (383)
T 3eb0_A 7 KKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP----------------RYKNRELDIMKVLDHVNIIKLVDYFY 70 (383)
T ss_dssp TTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCT----------------TSCCHHHHHHTTCCCTTBCCEEEEEE
T ss_pred ceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCc----------------chHHHHHHHHHHcCCCCccchhheee
Confidence 45666779999999999999999999999999664220 11236899999999999999999985
Q ss_pred eC--------------------------------------CeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHH
Q 020641 95 EG--------------------------------------NLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRV 136 (323)
Q Consensus 95 ~~--------------------------------------~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~ 136 (323)
.. ...++||||+.+ +|.+.+...... ...+++..+.
T Consensus 71 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~-----~~~l~~~~~~ 144 (383)
T 3eb0_A 71 TTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRS-----GRSIPMNLIS 144 (383)
T ss_dssp EC-------------------------------------CCEEEEEECCCSE-EHHHHHHHHHHT-----TCCCCHHHHH
T ss_pred ecCcccccccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhc-----CCCCCHHHHH
Confidence 43 347899999985 888777542110 0128999999
Q ss_pred HHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEc-cCCeEEEeeccccCCCCccccccccccccCccccCCCccccCC-C
Q 020641 137 RIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLF-EDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG-Q 214 (323)
Q Consensus 137 ~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~-~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~ 214 (323)
.++.||+.||.|||+. |++||||||+||+++ .++.++|+|||++........ .....|++.|+|||.+.+. .
T Consensus 145 ~i~~qi~~aL~~LH~~---gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~ 218 (383)
T 3eb0_A 145 IYIYQLFRAVGFIHSL---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP---SVAYICSRFYRAPELMLGATE 218 (383)
T ss_dssp HHHHHHHHHHHHHHTT---TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC---CCCCCCCSSCCCHHHHTTCSS
T ss_pred HHHHHHHHHHHHHHHC---cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC---CcCcccCCCccCHHHhcCCCC
Confidence 9999999999999999 999999999999997 688999999999976543222 2334579999999988765 4
Q ss_pred CCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhc------------ccccccccchhcCCCcCCCCCHHHHHHH
Q 020641 215 LTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWAT------------PRLSEDKVKQCVDPKLKGEYPPKGVAKL 282 (323)
Q Consensus 215 ~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~------------~~~~~~~~~~~~~~~~~~~~~~~~~~~l 282 (323)
++.++|||||||++|+|++|+.||...........+.... ....................+...+..+
T Consensus 219 ~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (383)
T 3eb0_A 219 YTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLA 298 (383)
T ss_dssp CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHH
T ss_pred CCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHH
Confidence 8999999999999999999999998664322211111100 0000001111111111111233456779
Q ss_pred HHHHHHccCCCCCCCCChHHHHH
Q 020641 283 AAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 283 ~~li~~cl~~~P~~Rps~~evl~ 305 (323)
.+|+.+||+.||.+|||+.|+++
T Consensus 299 ~~li~~~L~~dP~~R~t~~e~l~ 321 (383)
T 3eb0_A 299 IDLLEQILRYEPDLRINPYEAMA 321 (383)
T ss_dssp HHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HHHHHHHccCChhhCCCHHHHhc
Confidence 99999999999999999999984
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=313.54 Aligned_cols=276 Identities=18% Similarity=0.218 Sum_probs=184.4
Q ss_pred ccCCCCCCccceeccc--eeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEe--CC
Q 020641 22 RLDKGPEDDLYLKKRV--KMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVE--GN 97 (323)
Q Consensus 22 ~lg~G~~~~V~~~~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~ 97 (323)
+||+|+||+||+|++. .+++.+|+|.+.. ......+.+|+.+++.++||||+++++++.. ..
T Consensus 28 ~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~--------------~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 93 (405)
T 3rgf_A 28 KVGRGTYGHVYKAKRKDGKDDKDYALKQIEG--------------TGISMSACREIALLRELKHPNVISLQKVFLSHADR 93 (405)
T ss_dssp CCC-----EEEEEEESSSSCCCCEEEEECSS--------------SSCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTT
T ss_pred EeeecCCeEEEEEEEccCCCCeEEEEEEECC--------------CCCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCC
Confidence 7999999999999955 5788899886642 1223568899999999999999999999964 67
Q ss_pred eEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEE----ccCC
Q 020641 98 LRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLL----FEDF 173 (323)
Q Consensus 98 ~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili----~~~~ 173 (323)
..++||||+.+ +|.+++..............+++..++.++.||+.||.|||+. ||+||||||+|||+ +.++
T Consensus 94 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~ 169 (405)
T 3rgf_A 94 KVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERG 169 (405)
T ss_dssp EEEEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTT
T ss_pred eEEEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCC
Confidence 89999999975 8888886332111111111289999999999999999999999 99999999999999 6778
Q ss_pred eEEEeeccccCCCCccccc-cccccccCccccCCCccccCC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCcccc----
Q 020641 174 KAKIADFNLSNQAPDMAAR-LHSTRVLGTFGYHAPEYAMTG-QLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQ---- 247 (323)
Q Consensus 174 ~~~l~Dfg~~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~---- 247 (323)
.++|+|||++......... .......||+.|+|||++.+. .++.++|||||||++|+|++|..||.........
T Consensus 170 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~ 249 (405)
T 3rgf_A 170 RVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPY 249 (405)
T ss_dssp CEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCC
T ss_pred cEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccc
Confidence 9999999999876532211 222345689999999998874 4899999999999999999999999755431100
Q ss_pred ---hhhhh--hcccccccccch------------hcCCCcCCCC---------CHHHHHHHHHHHHHccCCCCCCCCChH
Q 020641 248 ---SLVTW--ATPRLSEDKVKQ------------CVDPKLKGEY---------PPKGVAKLAAVAALCVQYEAEFRPNMS 301 (323)
Q Consensus 248 ---~~~~~--~~~~~~~~~~~~------------~~~~~~~~~~---------~~~~~~~l~~li~~cl~~~P~~Rps~~ 301 (323)
..... ............ .......... ....+..+.+||.+||+.||.+|||+.
T Consensus 250 ~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~ 329 (405)
T 3rgf_A 250 HHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSE 329 (405)
T ss_dssp CHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHH
T ss_pred hHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHH
Confidence 00000 000000000000 0000000000 001145688999999999999999999
Q ss_pred HHHHHHhhhhcCCCCC
Q 020641 302 IVVKALQPLLKSPPPA 317 (323)
Q Consensus 302 evl~~l~~~~~~~~~~ 317 (323)
|+++ ...+...+.+
T Consensus 330 e~L~--hp~f~~~~~~ 343 (405)
T 3rgf_A 330 QAMQ--DPYFLEDPLP 343 (405)
T ss_dssp HHHT--SGGGTSSSCC
T ss_pred HHhc--ChhhccCCCC
Confidence 9998 5666554433
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-43 Score=310.98 Aligned_cols=254 Identities=17% Similarity=0.257 Sum_probs=198.4
Q ss_pred ccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcC-CCCcccceeeEEEeC
Q 020641 18 GYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRL-KHENLVELLGYCVEG 96 (323)
Q Consensus 18 ~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~ 96 (323)
.....||.|+||.||+|.+..+++.+|+|+........... ......+.+.+|+.+++++ +||||+++++++...
T Consensus 97 ~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~----~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 172 (365)
T 2y7j_A 97 DPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPE----QLEEVREATRRETHILRQVAGHPHIITLIDSYESS 172 (365)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHH----HHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBS
T ss_pred ccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHH----HHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeC
Confidence 33458999999999999999899999999775432111100 0011235678899999998 899999999999999
Q ss_pred CeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEE
Q 020641 97 NLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAK 176 (323)
Q Consensus 97 ~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~ 176 (323)
...++||||+.+++|.+++..... +++..+..++.|++.||.|||+. |++|+||||+||+++.++.++
T Consensus 173 ~~~~lv~e~~~g~~L~~~l~~~~~---------l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~ik 240 (365)
T 2y7j_A 173 SFMFLVFDLMRKGELFDYLTEKVA---------LSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIR 240 (365)
T ss_dssp SEEEEEECCCTTCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEE
T ss_pred CEEEEEEEeCCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEE
Confidence 999999999999999999976432 89999999999999999999999 999999999999999999999
Q ss_pred EeeccccCCCCccccccccccccCccccCCCccccC------CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhh
Q 020641 177 IADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT------GQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLV 250 (323)
Q Consensus 177 l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~------~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~ 250 (323)
|+|||++........ .....||+.|+|||.+.+ ..++.++||||||+++|+|++|..||...........+
T Consensus 241 l~DfG~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i 317 (365)
T 2y7j_A 241 LSDFGFSCHLEPGEK---LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMI 317 (365)
T ss_dssp ECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred EEecCcccccCCCcc---cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence 999999876543221 234568999999998853 35788999999999999999999999754321110000
Q ss_pred hhhcccccccccchhcCCCcCCCCC--HHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 251 TWATPRLSEDKVKQCVDPKLKGEYP--PKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
. ........+ ...+..+.+++.+||+.||.+|||+.|+++
T Consensus 318 ~---------------~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 318 M---------------EGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp H---------------HTCCCCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred H---------------hCCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0 000000000 123456999999999999999999999987
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=308.29 Aligned_cols=270 Identities=19% Similarity=0.201 Sum_probs=188.6
Q ss_pred CCCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEE
Q 020641 15 PSPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCV 94 (323)
Q Consensus 15 ~~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 94 (323)
..|....+||+|+||.||++++..+++.+|+|..... ......+.++++.++.++||||+++++++.
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-------------~~~~~~~~~~~~~l~~l~h~niv~~~~~~~ 89 (360)
T 3e3p_A 23 DRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQD-------------PRFRNRELQIMQDLAVLHHPNIVQLQSYFY 89 (360)
T ss_dssp TTEEEC----------CEEEEETTTCCEEEEEEEECC-------------TTCCCHHHHHHHHHHHHCCTTBCCEEEEEE
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecC-------------ccccHHHHHHHHHHHhcCCCCcccHHHhhh
Confidence 3466667999999999999999999999999966321 223356778888889899999999999987
Q ss_pred eCCe-------EEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhh--cCCCCCceeCCCCCC
Q 020641 95 EGNL-------RVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLH--EKVQPSIIHRDIRSS 165 (323)
Q Consensus 95 ~~~~-------~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh--~~~~~~i~h~dikp~ 165 (323)
.... .++||||+.+ +|.+.+...... ...++...+..++.|++.|+.||| +. |++|+||||+
T Consensus 90 ~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~-----~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~ 160 (360)
T 3e3p_A 90 TLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRR-----QVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPH 160 (360)
T ss_dssp EECSSCTTCEEEEEEEECCSC-BHHHHHHHHHTT-----TCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGG
T ss_pred ccccccccceeEEEEeecccc-cHHHHHHHHhhc-----ccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHH
Confidence 5433 7899999987 665554321110 012889999999999999999999 88 9999999999
Q ss_pred CEEEcc-CCeEEEeeccccCCCCccccccccccccCccccCCCccccCCC-CCcccchHHHHHHHHHHHhCCCCCCCCCC
Q 020641 166 NVLLFE-DFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQ-LTQKSDVYSFGVVLLELLTGRKPVDHTMP 243 (323)
Q Consensus 166 nili~~-~~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 243 (323)
||+++. ++.++|+|||++........ .....||+.|+|||.+.+.. ++.++||||||+++|+|++|+.||.....
T Consensus 161 NIll~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~ 237 (360)
T 3e3p_A 161 NVLVNEADGTLKLCDFGSAKKLSPSEP---NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNS 237 (360)
T ss_dssp GEEEETTTTEEEECCCTTCBCCCTTSC---CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred HEEEeCCCCcEEEeeCCCceecCCCCC---cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCCh
Confidence 999997 89999999999986654322 23345899999999887654 79999999999999999999999986643
Q ss_pred cccchhhhhhcccccccccchhcCC----------------CcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH--
Q 020641 244 RGQQSLVTWATPRLSEDKVKQCVDP----------------KLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK-- 305 (323)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~----------------~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~-- 305 (323)
..................+. .+.+ ..........+..+.+|+.+||+.||.+|||+.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp 316 (360)
T 3e3p_A 238 AGQLHEIVRVLGCPSREVLR-KLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHP 316 (360)
T ss_dssp HHHHHHHHHHHCCCCHHHHH-HHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSG
T ss_pred HHHHHHHHHHcCCCCHHHHH-hcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCc
Confidence 22211111110000000000 0000 0011122335678999999999999999999999997
Q ss_pred HHhhh
Q 020641 306 ALQPL 310 (323)
Q Consensus 306 ~l~~~ 310 (323)
+++++
T Consensus 317 ~f~~~ 321 (360)
T 3e3p_A 317 YFDEL 321 (360)
T ss_dssp GGGGG
T ss_pred ccccc
Confidence 34444
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-43 Score=316.11 Aligned_cols=274 Identities=19% Similarity=0.226 Sum_probs=205.0
Q ss_pred CCCccccccCCCC-CccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCC
Q 020641 4 DYHPRALGAHAPS-PGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLK 82 (323)
Q Consensus 4 ~~~~~~~~~~~~~-~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~ 82 (323)
+|+|..+|....+ |....+||+|+||.||+|++..+++.+|+|++... ....+.+.+|+.+++.++
T Consensus 25 ~~~~~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-------------~~~~~~~~~E~~~l~~l~ 91 (397)
T 1wak_A 25 GYHLVKIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-------------EHYTETALDEIRLLKSVR 91 (397)
T ss_dssp -CCSSCTTCEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-------------HHHHHHHHHHHHHHHHHH
T ss_pred CceEEehhhhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-------------CcchHHHHHHHHHHHHHh
Confidence 5667777765533 56666999999999999999999999999976421 112356788999988885
Q ss_pred --------CCcccceeeEEE----eCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhh
Q 020641 83 --------HENLVELLGYCV----EGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLH 150 (323)
Q Consensus 83 --------h~~i~~~~~~~~----~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh 150 (323)
|+||+++++++. .+...++||||+. ++|.+.+...... .+++..++.++.||+.||.|||
T Consensus 92 ~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~-------~~~~~~~~~i~~qi~~aL~~lH 163 (397)
T 1wak_A 92 NSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVLG-HHLLKWIIKSNYQ-------GLPLPCVKKIIQQVLQGLDYLH 163 (397)
T ss_dssp HSCTTCGGGGGBCCEEEEEEEEETTEEEEEEEECCCC-CBHHHHHHHTTTS-------CCCHHHHHHHHHHHHHHHHHHH
T ss_pred hcCCCCCCcceeeeeecceeecCCCCceEEEEEeccC-ccHHHHHHhcccC-------CCCHHHHHHHHHHHHHHHHHHH
Confidence 788999999987 4567899999995 4777776554322 2899999999999999999999
Q ss_pred cCCCCCceeCCCCCCCEEEccCC-------------------------------------------------eEEEeecc
Q 020641 151 EKVQPSIIHRDIRSSNVLLFEDF-------------------------------------------------KAKIADFN 181 (323)
Q Consensus 151 ~~~~~~i~h~dikp~nili~~~~-------------------------------------------------~~~l~Dfg 181 (323)
+++ ||+||||||+|||++.++ .++|+|||
T Consensus 164 ~~~--givHrDikp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG 241 (397)
T 1wak_A 164 TKC--RIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLG 241 (397)
T ss_dssp HTT--CEECCCCSGGGEEECCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGG
T ss_pred HhC--CEecCCCCHHHeeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccc
Confidence 854 899999999999998775 79999999
Q ss_pred ccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhh---h---hhcc
Q 020641 182 LSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLV---T---WATP 255 (323)
Q Consensus 182 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~---~---~~~~ 255 (323)
++...... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||............ . ....
T Consensus 242 ~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 316 (397)
T 1wak_A 242 NACWVHKH-----FTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLG 316 (397)
T ss_dssp GCEETTBC-----SCSCCSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHC
T ss_pred cccccccc-----CccCCCCCcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcC
Confidence 98765432 23345899999999999999999999999999999999999999865432211000 0 0000
Q ss_pred ccccc----------------ccchhcCCC---------cCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 256 RLSED----------------KVKQCVDPK---------LKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 256 ~~~~~----------------~~~~~~~~~---------~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
..+.. ......... .....+...+..+.+|+.+||+.||++|||+.|+++
T Consensus 317 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 317 KVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp SCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred CCChHHhhcccccccccCCccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 00000 000000000 011345677889999999999999999999999986
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=304.20 Aligned_cols=251 Identities=19% Similarity=0.328 Sum_probs=191.7
Q ss_pred CCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCC--CCcccceeeEE
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLK--HENLVELLGYC 93 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~ 93 (323)
.|....+||+|+||.||++.+.. ++.+|+|+....... ....+.+.+|++++++++ |+||+++++++
T Consensus 29 ~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~----------~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~ 97 (313)
T 3cek_A 29 IYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEAD----------NQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE 97 (313)
T ss_dssp EEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECSSCC----------HHHHHHHHHHHHHHHHHGGGCTTBCCEEEEE
T ss_pred eEEEEEEecCCCCEEEEEEEcCC-CcEEEEEEecccccc----------ccchHHHHHHHHHHHhccccCCceEEEEEEe
Confidence 34555689999999999999864 777888876533211 112367889999999996 59999999999
Q ss_pred EeCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCC
Q 020641 94 VEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDF 173 (323)
Q Consensus 94 ~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~ 173 (323)
...+..++||| +.+++|.+++..... +++..+..++.|++.||.|||+. |++|+||||+||++++ +
T Consensus 98 ~~~~~~~lv~e-~~~~~L~~~l~~~~~---------~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-~ 163 (313)
T 3cek_A 98 ITDQYIYMVME-CGNIDLNSWLKKKKS---------IDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-G 163 (313)
T ss_dssp ECSSEEEEEEC-CCSEEHHHHHHHCSS---------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET-T
T ss_pred ecCCEEEEEEe-cCCCcHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC-C
Confidence 99999999999 556799999976542 88999999999999999999999 9999999999999965 8
Q ss_pred eEEEeeccccCCCCccccccccccccCccccCCCccccC-----------CCCCcccchHHHHHHHHHHHhCCCCCCCCC
Q 020641 174 KAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT-----------GQLTQKSDVYSFGVVLLELLTGRKPVDHTM 242 (323)
Q Consensus 174 ~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-----------~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 242 (323)
.++|+|||++................|++.|+|||.+.+ ..++.++||||||+++|+|++|..||....
T Consensus 164 ~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 243 (313)
T 3cek_A 164 MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII 243 (313)
T ss_dssp EEEECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred eEEEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHH
Confidence 999999999987654333222334458999999998865 467889999999999999999999997543
Q ss_pred CcccchhhhhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 243 PRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
... ......+++......+...+..+.+++.+||+.||.+|||+.|+++
T Consensus 244 ~~~--------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 292 (313)
T 3cek_A 244 NQI--------------SKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 292 (313)
T ss_dssp SHH--------------HHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHH--------------HHHHHHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhc
Confidence 211 1112222233333334444667999999999999999999999997
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-43 Score=304.09 Aligned_cols=260 Identities=22% Similarity=0.214 Sum_probs=188.1
Q ss_pred CCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEe
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVE 95 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 95 (323)
.|....+||+|+||+||+|++..+++.+|+|......... .....+.++...++.++||||+++++++..
T Consensus 8 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----------~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~ 77 (290)
T 3fme_A 8 DLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQ----------EQKRLLMDLDISMRTVDCPFTVTFYGALFR 77 (290)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHH----------HHHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred hhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcH----------HHHHHHHHHHHHHHhCCCCeEEEEeeeeec
Confidence 4566679999999999999999999999999765321111 112334455556788899999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeE
Q 020641 96 GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKA 175 (323)
Q Consensus 96 ~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~ 175 (323)
++..++||||+.+ +|.+++...... ...+++..+..++.|++.||.|||+++ |++|+||||+||+++.++.+
T Consensus 78 ~~~~~lv~e~~~~-~l~~~l~~~~~~-----~~~~~~~~~~~i~~qi~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~~~ 149 (290)
T 3fme_A 78 EGDVWICMELMDT-SLDKFYKQVIDK-----GQTIPEDILGKIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQV 149 (290)
T ss_dssp SSSEEEEEECCSE-EHHHHHHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHHHS--CCCCCCCSGGGCEECTTCCE
T ss_pred cCCEEEEEehhcc-chHHHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCE
Confidence 9999999999985 888877542110 012999999999999999999999843 89999999999999999999
Q ss_pred EEeeccccCCCCccccccccccccCccccCCCccc----cCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhh
Q 020641 176 KIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYA----MTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVT 251 (323)
Q Consensus 176 ~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~----~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~ 251 (323)
+|+|||++........ .....|++.|+|||.+ .+..++.++||||||+++|+|++|..||.........
T Consensus 150 kl~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~---- 222 (290)
T 3fme_A 150 KMCDFGISGYLVDDVA---KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQ---- 222 (290)
T ss_dssp EBCCC------------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHH----
T ss_pred EEeecCCccccccccc---ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHH----
Confidence 9999999976544322 1233589999999986 4567889999999999999999999999754321111
Q ss_pred hhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH--HHhhh
Q 020641 252 WATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK--ALQPL 310 (323)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~--~l~~~ 310 (323)
+...+............+..+.+++.+||+.||++|||+.|+++ +++..
T Consensus 223 ----------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~ 273 (290)
T 3fme_A 223 ----------LKQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLH 273 (290)
T ss_dssp ----------HHHHHHSCCCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred ----------HHHHhccCCCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccC
Confidence 11111111111222345677999999999999999999999988 55443
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-43 Score=303.11 Aligned_cols=260 Identities=18% Similarity=0.188 Sum_probs=202.0
Q ss_pred CCCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcC-CCCcccceeeEE
Q 020641 15 PSPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRL-KHENLVELLGYC 93 (323)
Q Consensus 15 ~~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~ 93 (323)
..|.....||+|+||.||++.+..+++.+++|++........... ......+.+.+|+++++++ +||||+++++++
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~---~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (298)
T 1phk_A 17 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAE---EVQELREATLKEVDILRKVSGHPNIIQLKDTY 93 (298)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHH---HHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred hccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHH---HHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence 344555589999999999999999999999997754321111000 0011235678899999999 599999999999
Q ss_pred EeCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCC
Q 020641 94 VEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDF 173 (323)
Q Consensus 94 ~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~ 173 (323)
...+..++||||+.+++|.+++..... +++..+..++.|++.||.|||+. |++|+||+|+||+++.++
T Consensus 94 ~~~~~~~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~ 161 (298)
T 1phk_A 94 ETNTFFFLVFDLMKKGELFDYLTEKVT---------LSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDM 161 (298)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTC
T ss_pred ccCCeEEEEEeccCCCcHHHHHhccCC---------CCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCC
Confidence 999999999999999999999976532 89999999999999999999999 999999999999999999
Q ss_pred eEEEeeccccCCCCccccccccccccCccccCCCcccc------CCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccc
Q 020641 174 KAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAM------TGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQ 247 (323)
Q Consensus 174 ~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~------~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~ 247 (323)
.++|+|||++........ .....|++.|+|||.+. ...++.++||||||+++|+|++|..||.........
T Consensus 162 ~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~ 238 (298)
T 1phk_A 162 NIKLTDFGFSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLML 238 (298)
T ss_dssp CEEECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred cEEEecccchhhcCCCcc---cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHH
Confidence 999999999876543221 23345899999999875 456788999999999999999999999754321111
Q ss_pred hhhhhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 248 SLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
....... ...........+..+.+++.+||+.||.+|||+.|+++
T Consensus 239 ~~~~~~~-------------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 239 RMIMSGN-------------YQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp HHHHHTC-------------CCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HHHhcCC-------------cccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 0000000 00001112345678999999999999999999999986
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=300.06 Aligned_cols=256 Identities=22% Similarity=0.248 Sum_probs=200.8
Q ss_pred CCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEe
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVE 95 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 95 (323)
.|....+||+|+||.||+|++..+++.+++|+....... ....+.+.+|++++++++||||+++++++..
T Consensus 23 ~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~----------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 92 (287)
T 2wei_A 23 RYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAK----------NKDTSTILREVELLKKLDHPNIMKLFEILED 92 (287)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBS----------SSCHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred cceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccc----------hHHHHHHHHHHHHHHhccCCCccEEEEEEeC
Confidence 345566999999999999999999999999977543211 2334778899999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccC---
Q 020641 96 GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFED--- 172 (323)
Q Consensus 96 ~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~--- 172 (323)
.+..++|+||+.+++|.+++..... +++..++.++.|++.||.+||+. |++|+||||+||+++.+
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~ 160 (287)
T 2wei_A 93 SSSFYIVGELYTGGELFDEIIKRKR---------FSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKD 160 (287)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTT
T ss_pred CCeEEEEEEccCCCCHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCc
Confidence 9999999999999999998865432 89999999999999999999999 99999999999999764
Q ss_pred CeEEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhh
Q 020641 173 FKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTW 252 (323)
Q Consensus 173 ~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 252 (323)
+.++|+|||++........ .....|++.|+|||.+.+ .++.++||||||+++|+|++|..||.............
T Consensus 161 ~~~kL~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~- 235 (287)
T 2wei_A 161 CDIKIIDFGLSTCFQQNTK---MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVE- 235 (287)
T ss_dssp CCEEECSTTGGGTBCCCSS---CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH-
T ss_pred ccEEEeccCcceeecCCCc---cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHH-
Confidence 4699999999876543221 122347889999998865 48899999999999999999999997653221110000
Q ss_pred hcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH--HHhhh
Q 020641 253 ATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK--ALQPL 310 (323)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~--~l~~~ 310 (323)
..... .........+..+.+++.+||+.||.+|||+.|+++ ++++.
T Consensus 236 -~~~~~-----------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~ 283 (287)
T 2wei_A 236 -TGKYA-----------FDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKY 283 (287)
T ss_dssp -HCCCC-----------CCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHH
T ss_pred -cCCCC-----------CCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhcc
Confidence 00000 000001234567999999999999999999999998 45443
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=303.17 Aligned_cols=267 Identities=17% Similarity=0.243 Sum_probs=198.9
Q ss_pred CCCccccccCCCCCCccceeccc-eeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcC---CCCccccee
Q 020641 15 PSPGYFVRLDKGPEDDLYLKKRV-KMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRL---KHENLVELL 90 (323)
Q Consensus 15 ~~~~~~~~lg~G~~~~V~~~~~~-~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~~i~~~~ 90 (323)
..|.....||+|+||.||+|.+. .+++.+|+|+....... ......+.+|+.+++.+ +||||++++
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~----------~~~~~~~~~e~~~l~~l~~~~h~~i~~~~ 80 (326)
T 1blx_A 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGE----------EGMPLSTIREVAVLRHLETFEHPNVVRLF 80 (326)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCT----------TSCBCTHHHHHHHHHHHHHTCCTTBCCEE
T ss_pred hceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCccc----------ccCCchhhHHHHHHHhhhccCCCCeEeee
Confidence 44666679999999999999985 67888999977543211 12234456666666555 899999999
Q ss_pred eEEE-----eCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCC
Q 020641 91 GYCV-----EGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSS 165 (323)
Q Consensus 91 ~~~~-----~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~ 165 (323)
+++. .....++||||+. ++|.+++....... +++..+..++.|++.||.|||+. |++|+||||+
T Consensus 81 ~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~-------~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~ 149 (326)
T 1blx_A 81 DVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPG-------VPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQ 149 (326)
T ss_dssp EEEEEEECSSEEEEEEEEECCS-CBHHHHHHHSCTTC-------SCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGG
T ss_pred eeeeecccCCCceEEEEEecCC-CCHHHHHHhcccCC-------CCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHH
Confidence 9987 4567899999998 49999997654322 89999999999999999999999 9999999999
Q ss_pred CEEEccCCeEEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcc
Q 020641 166 NVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRG 245 (323)
Q Consensus 166 nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 245 (323)
||+++.++.++|+|||++....... ......|++.|+|||.+.+..++.++||||||+++|+|++|+.||.......
T Consensus 150 Nili~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~ 226 (326)
T 1blx_A 150 NILVTSSGQIKLADFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD 226 (326)
T ss_dssp GEEECTTCCEEECSCCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred HeEEcCCCCEEEecCcccccccCCC---CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHH
Confidence 9999999999999999998765432 2234458999999999998899999999999999999999999998654322
Q ss_pred cchhhhhhcccccccccch-------hc---CCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 246 QQSLVTWATPRLSEDKVKQ-------CV---DPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~-------~~---~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
....+.............. .. ............+..+.+++.+||+.||.+|||+.|+++
T Consensus 227 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 227 QLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp HHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHHHHHHcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 1111100000000000000 00 000001122345677999999999999999999999995
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=313.38 Aligned_cols=260 Identities=17% Similarity=0.200 Sum_probs=186.4
Q ss_pred CccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeC
Q 020641 17 PGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEG 96 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 96 (323)
|.....||+|+||.||+|++..+++++++| ..... ....+|+++++.++||||+++++++...
T Consensus 42 Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk-~~~~~----------------~~~~~E~~il~~l~h~niv~l~~~~~~~ 104 (394)
T 4e7w_A 42 YTNCKVIGNGSFGVVFQAKLVESDEVAIKK-VLQDK----------------RFKNRELQIMRIVKHPNVVDLKAFFYSN 104 (394)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTEEEEEEE-EECCT----------------TSCCHHHHHHHTCCCTTBCCEEEEEEEE
T ss_pred EEEeEEEeeCCCeEEEEEEECCCCeEEEEE-EecCc----------------chHHHHHHHHHhCCCCCcceEEEEEEec
Confidence 455558999999999999998888844444 32110 1113689999999999999999998654
Q ss_pred C------eEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEc
Q 020641 97 N------LRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLF 170 (323)
Q Consensus 97 ~------~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~ 170 (323)
. ..++||||+.+ ++.+.+...... ...+++..+..++.|++.||.|||+. ||+||||||+||+++
T Consensus 105 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~ 175 (394)
T 4e7w_A 105 GDKKDEVFLNLVLEYVPE-TVYRASRHYAKL-----KQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLD 175 (394)
T ss_dssp SSSSSCEEEEEEEECCSE-EHHHHHHHHHHT-----TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEE
T ss_pred CCCCCceEEEEEeeccCc-cHHHHHHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEc
Confidence 3 37899999987 454444321100 01289999999999999999999999 999999999999999
Q ss_pred -cCCeEEEeeccccCCCCccccccccccccCccccCCCccccCC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCcccch
Q 020641 171 -EDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG-QLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQS 248 (323)
Q Consensus 171 -~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~ 248 (323)
.++.++|+|||++........ .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+........
T Consensus 176 ~~~~~~kL~DFG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~ 252 (394)
T 4e7w_A 176 PPSGVLKLIDFGSAKILIAGEP---NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLV 252 (394)
T ss_dssp TTTTEEEECCCTTCEECCTTCC---CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred CCCCcEEEeeCCCcccccCCCC---CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 789999999999976543222 2334589999999998765 58999999999999999999999998765322211
Q ss_pred hhhhh------------cccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 249 LVTWA------------TPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 249 ~~~~~------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
.+... ...+.................+...+.++.+|+.+||+.||.+|||+.|+++
T Consensus 253 ~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 321 (394)
T 4e7w_A 253 EIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC 321 (394)
T ss_dssp HHHHHHCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HHHHHhCCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc
Confidence 11110 0000000000000000000112235568999999999999999999999997
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-43 Score=305.55 Aligned_cols=272 Identities=18% Similarity=0.243 Sum_probs=193.8
Q ss_pred CCCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEE
Q 020641 15 PSPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCV 94 (323)
Q Consensus 15 ~~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 94 (323)
..|.....||.|+||.||++.+..+++.+|+|.+... .....+.+.+|++++++++||||+++++++.
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 78 (320)
T 2i6l_A 11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT------------DPQSVKHALREIKIIRRLDHDNIVKVFEILG 78 (320)
T ss_dssp TTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC------------SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred CceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC------------ChHHHHHHHHHHHHHHhcCCCCeeEEEEecc
Confidence 3456666999999999999999999999999966422 1112366789999999999999999999873
Q ss_pred --------------eCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeC
Q 020641 95 --------------EGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHR 160 (323)
Q Consensus 95 --------------~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~ 160 (323)
.....++||||+. ++|.+++.... +++..++.++.|++.||.|||+. |++|+
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~----------~~~~~~~~~~~qi~~~l~~lH~~---~i~H~ 144 (320)
T 2i6l_A 79 PSGSQLTDDVGSLTELNSVYIVQEYME-TDLANVLEQGP----------LLEEHARLFMYQLLRGLKYIHSA---NVLHR 144 (320)
T ss_dssp TTSCBCCC----CCSCSEEEEEEECCS-EEHHHHHTTCC----------CCHHHHHHHHHHHHHHHHHHHHT---TCBCC
T ss_pred ccccccccccccccccCceeEEeeccC-CCHHHHhhcCC----------ccHHHHHHHHHHHHHHHHHHHhC---CEecC
Confidence 4467899999998 49999996532 88999999999999999999999 99999
Q ss_pred CCCCCCEEEc-cCCeEEEeeccccCCCCcccc-ccccccccCccccCCCccccC-CCCCcccchHHHHHHHHHHHhCCCC
Q 020641 161 DIRSSNVLLF-EDFKAKIADFNLSNQAPDMAA-RLHSTRVLGTFGYHAPEYAMT-GQLTQKSDVYSFGVVLLELLTGRKP 237 (323)
Q Consensus 161 dikp~nili~-~~~~~~l~Dfg~~~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p 237 (323)
||||+||+++ .++.++|+|||++........ ........++..|+|||.+.+ ..++.++||||||+++|+|++|+.|
T Consensus 145 dlkp~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~p 224 (320)
T 2i6l_A 145 DLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTL 224 (320)
T ss_dssp CCSGGGEEEETTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCS
T ss_pred CCCHHHEEEcCCCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCC
Confidence 9999999997 567999999999986643221 111223347889999998865 6789999999999999999999999
Q ss_pred CCCCCCcccchhhhhhcccccccccchhc-------CCCcC-CC-----CCHHHHHHHHHHHHHccCCCCCCCCChHHHH
Q 020641 238 VDHTMPRGQQSLVTWATPRLSEDKVKQCV-------DPKLK-GE-----YPPKGVAKLAAVAALCVQYEAEFRPNMSIVV 304 (323)
Q Consensus 238 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~-~~-----~~~~~~~~l~~li~~cl~~~P~~Rps~~evl 304 (323)
|.........................+.. ..... .. .....+..+.+++.+||+.||.+|||+.|++
T Consensus 225 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell 304 (320)
T 2i6l_A 225 FAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEAL 304 (320)
T ss_dssp SCCSSHHHHHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHH
T ss_pred CCCCCHHHHHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHh
Confidence 98664322111111111100000000000 00000 00 1123467799999999999999999999998
Q ss_pred HHHhhhhcCC
Q 020641 305 KALQPLLKSP 314 (323)
Q Consensus 305 ~~l~~~~~~~ 314 (323)
+ ...++..
T Consensus 305 ~--hp~~~~~ 312 (320)
T 2i6l_A 305 S--HPYMSIY 312 (320)
T ss_dssp T--SHHHHTT
T ss_pred C--Ccccccc
Confidence 8 4444433
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-42 Score=322.04 Aligned_cols=284 Identities=20% Similarity=0.202 Sum_probs=205.5
Q ss_pred CCCCccccccCCCCCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCC
Q 020641 3 YDYHPRALGAHAPSPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLK 82 (323)
Q Consensus 3 ~~~~~~~~~~~~~~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~ 82 (323)
-+++|...+.....|....+||.|+||+||++.+..+++.+|+|+..... .....+.+.+|++++++++
T Consensus 2 GG~~p~~pg~~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~-----------~~~~~~~~~~Ei~iL~~L~ 70 (676)
T 3qa8_A 2 GGRSPSLPTQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQEL-----------SPKNRERWCLEIQIMKKLN 70 (676)
T ss_dssp ---------------CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCC-----------CHHHHHHHHHHHHHHHHCC
T ss_pred CCCCCCCCCCCCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccC-----------CHHHHHHHHHHHHHHHhCC
Confidence 36788888888888888889999999999999999999999999764321 1122366889999999999
Q ss_pred CCcccceeeEEEe------CCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 020641 83 HENLVELLGYCVE------GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPS 156 (323)
Q Consensus 83 h~~i~~~~~~~~~------~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~ 156 (323)
||||+++++++.. ++..++||||+.+++|.+++...... ..+++..++.++.|++.||.|||+. |
T Consensus 71 HpnIV~l~~v~~~~~~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~------~~lse~~i~~I~~QLl~aL~yLHs~---g 141 (676)
T 3qa8_A 71 HPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENC------CGLKEGPIRTLLSDISSALRYLHEN---R 141 (676)
T ss_dssp BTTBCCEEECCTTTCCCCTTSSCCCEEECCSSCBHHHHHHSSSCT------TCCCSSHHHHHHHHHHHHHHHHHHT---T
T ss_pred CCCCCceeeeecccccccCCCeEEEEEEeCCCCCHHHHHHhcccC------CCCCHHHHHHHHHHHHHHHHHHHHC---C
Confidence 9999999998765 66779999999999999999865421 1277889999999999999999999 9
Q ss_pred ceeCCCCCCCEEEccCCe---EEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHh
Q 020641 157 IIHRDIRSSNVLLFEDFK---AKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT 233 (323)
Q Consensus 157 i~h~dikp~nili~~~~~---~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~ 233 (323)
++|+||||+||+++.++. ++|+|||++........ .....|++.|+|||.+.+..++.++||||||+++|+|++
T Consensus 142 IVHrDLKP~NILl~~~g~~~~vKL~DFG~a~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLlt 218 (676)
T 3qa8_A 142 IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGEL---CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECIT 218 (676)
T ss_dssp BCCCCCCSTTEEEECCSSSCEEEECSCCCCCBTTSCCC---CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHS
T ss_pred CccCCCCHHHeEeecCCCceeEEEcccccccccccccc---cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHH
Confidence 999999999999997654 89999999987654322 234468999999999999999999999999999999999
Q ss_pred CCCCCCCCCCcccchhhhhhcccc--------cccccchhc----CCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChH
Q 020641 234 GRKPVDHTMPRGQQSLVTWATPRL--------SEDKVKQCV----DPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMS 301 (323)
Q Consensus 234 g~~pf~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~----~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ 301 (323)
|..||....... .|..... ........+ ............+..+.+++.+||..||.+|||+.
T Consensus 219 G~~Pf~~~~~~~-----~~~~~i~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~ 293 (676)
T 3qa8_A 219 GFRPFLPNWQPV-----QWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDP 293 (676)
T ss_dssp SCSSCCSSCHHH-----HSSTTCC------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCT
T ss_pred CCCCCCcccchh-----hhhhhhhcccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHH
Confidence 999997542110 0000000 000000000 00111234566788999999999999999999998
Q ss_pred H-----HHHHHhhhhcCC
Q 020641 302 I-----VVKALQPLLKSP 314 (323)
Q Consensus 302 e-----vl~~l~~~~~~~ 314 (323)
+ .++.++++++..
T Consensus 294 elL~hp~F~~l~~iL~~k 311 (676)
T 3qa8_A 294 QNPNVGCFQALDSILSLK 311 (676)
T ss_dssp TCCCCTTHHHHHHHHCCC
T ss_pred HHhcCHHHHHHHHHHhcc
Confidence 8 667777777554
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-43 Score=312.01 Aligned_cols=260 Identities=18% Similarity=0.242 Sum_probs=194.4
Q ss_pred CCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEe
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVE 95 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 95 (323)
.|....+||.|+||.||+|.+..+++.+|+|+....... ....+.+.+|+.+++.++||||+++++++..
T Consensus 43 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~----------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 112 (371)
T 4exu_A 43 TYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQS----------EIFAKRAYRELLLLKHMQHENVIGLLDVFTP 112 (371)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSS----------HHHHHHHHHHHHHHHHCCCTTBCCCSEEECS
T ss_pred cEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccc----------hhHHHHHHHHHHHHHhcCCCCchhhhhheec
Confidence 344555899999999999999999999999976532211 1223677899999999999999999999987
Q ss_pred CCeE------EEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEE
Q 020641 96 GNLR------VLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLL 169 (323)
Q Consensus 96 ~~~~------~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili 169 (323)
.... ++||||+.+ +|.+++... +++..+..++.|++.||.|||+. |++|+||||+||++
T Consensus 113 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~~-----------~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll 177 (371)
T 4exu_A 113 ASSLRNFYDFYLVMPFMQT-DLQKIMGME-----------FSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAV 177 (371)
T ss_dssp CSSSTTCCCCEEEEECCCE-EHHHHTTSC-----------CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEE
T ss_pred cCCcccceeEEEEEccccc-cHHHHhhcC-----------CCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEE
Confidence 7654 999999985 898888432 88999999999999999999999 99999999999999
Q ss_pred ccCCeEEEeeccccCCCCccccccccccccCccccCCCccccC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccch
Q 020641 170 FEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT-GQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQS 248 (323)
Q Consensus 170 ~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~ 248 (323)
+.++.++|+|||++...... .....||+.|+|||.+.+ ..++.++||||||+++|+|++|+.||..........
T Consensus 178 ~~~~~~kL~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~ 252 (371)
T 4exu_A 178 NEDCELKILDFGLARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLT 252 (371)
T ss_dssp CTTCCEEECSTTCC-------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred CCCCCEEEEecCcccccccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence 99999999999999765432 233458999999999887 678999999999999999999999998654321111
Q ss_pred hhhhhccccc--------ccccchhc---CCCcCCC---CCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 249 LVTWATPRLS--------EDKVKQCV---DPKLKGE---YPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 249 ~~~~~~~~~~--------~~~~~~~~---~~~~~~~---~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
.......... ........ ....... .....+..+.+|+.+||+.||++|||+.|+++
T Consensus 253 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 323 (371)
T 4exu_A 253 QILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 323 (371)
T ss_dssp HHHHHHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HHHHHhCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence 1100000000 00000000 0000000 11234578999999999999999999999987
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=315.13 Aligned_cols=266 Identities=19% Similarity=0.225 Sum_probs=192.6
Q ss_pred CccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeC
Q 020641 17 PGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEG 96 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 96 (323)
|.....||+|+||.||+|++..+++.+|+|.+.... ....+|+++++.++|+||+++++++...
T Consensus 56 y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----------------~~~~~E~~il~~l~hpniv~l~~~~~~~ 119 (420)
T 1j1b_A 56 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----------------RFKNRELQIMRKLDHCNIVRLRYFFYSS 119 (420)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----------------TSCCHHHHHHHTCCCTTBCCEEEEEEEE
T ss_pred EEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----------------hhHHHHHHHHHHcCCCCccceeeEEecc
Confidence 455558999999999999999999999999664221 1123689999999999999999988542
Q ss_pred ----C--eEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEc
Q 020641 97 ----N--LRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLF 170 (323)
Q Consensus 97 ----~--~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~ 170 (323)
. ..++||||+.+ +|.+.+...... ...+++..+..++.||+.||.|||+. ||+||||||+|||++
T Consensus 120 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~ 190 (420)
T 1j1b_A 120 GEKKDEVYLNLVLDYVPE-TVYRVARHYSRA-----KQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLD 190 (420)
T ss_dssp ETTTTEEEEEEEEECCCE-EHHHHHHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEE
T ss_pred CCCCcceeEEeehhcccc-cHHHHHHHHhhc-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEe
Confidence 1 35799999986 777766432100 01289999999999999999999999 999999999999999
Q ss_pred cC-CeEEEeeccccCCCCccccccccccccCccccCCCccccCC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCcccch
Q 020641 171 ED-FKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG-QLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQS 248 (323)
Q Consensus 171 ~~-~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~ 248 (323)
.+ +.+||+|||++........ .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||..........
T Consensus 191 ~~~~~~kl~DFG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~ 267 (420)
T 1j1b_A 191 PDTAVLKLCDFGSAKQLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 267 (420)
T ss_dssp TTTTEEEECCCTTCEECCTTCC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred CCCCeEEeccchhhhhcccCCC---ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 55 6789999999976543221 2334589999999998765 68999999999999999999999998764322111
Q ss_pred hhhhhcccccccccchh-------cCCCcCC-----CCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH--HHhhh
Q 020641 249 LVTWATPRLSEDKVKQC-------VDPKLKG-----EYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK--ALQPL 310 (323)
Q Consensus 249 ~~~~~~~~~~~~~~~~~-------~~~~~~~-----~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~--~l~~~ 310 (323)
.+.........+.+... ..+.+.. ..+...+.++.+|+.+||..||.+|||+.|+++ +++.+
T Consensus 268 ~i~~~lg~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~ 343 (420)
T 1j1b_A 268 EIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 343 (420)
T ss_dssp HHHHHHCSCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred HHHHHhCCCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhccc
Confidence 11110000000111000 0011100 012334578999999999999999999999986 45444
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=330.37 Aligned_cols=255 Identities=24% Similarity=0.307 Sum_probs=199.0
Q ss_pred cccccCCCCCCccceecccee---eeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEe
Q 020641 19 YFVRLDKGPEDDLYLKKRVKM---RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVE 95 (323)
Q Consensus 19 ~~~~lg~G~~~~V~~~~~~~~---~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 95 (323)
....||+|+||.||++.+..+ +..+++|..... ......+.+.+|+.++++++||||+++++++.+
T Consensus 394 i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~-----------~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 462 (656)
T 2j0j_A 394 LGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNC-----------TSDSVREKFLQEALTMRQFDHPHIVKLIGVITE 462 (656)
T ss_dssp EEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSST-----------TCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred EeeEEeeCCCEEEEEEEEecCCCccEEEEEEEeccc-----------CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec
Confidence 344799999999999988653 455777744311 111223678899999999999999999999854
Q ss_pred CCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeE
Q 020641 96 GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKA 175 (323)
Q Consensus 96 ~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~ 175 (323)
+..++||||+.+|+|.+++...... +++..++.++.|++.||.|||+. |++||||||+||+++.++.+
T Consensus 463 -~~~~lv~E~~~~g~L~~~l~~~~~~--------l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~v 530 (656)
T 2j0j_A 463 -NPVWIIMELCTLGELRSFLQVRKFS--------LDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCV 530 (656)
T ss_dssp -SSCEEEEECCTTCBHHHHHHHTTTT--------CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEE
T ss_pred -CceEEEEEcCCCCcHHHHHHhccCC--------CCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCE
Confidence 5589999999999999999765322 88999999999999999999999 99999999999999999999
Q ss_pred EEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhc
Q 020641 176 KIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWAT 254 (323)
Q Consensus 176 ~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~ 254 (323)
+|+|||++......... ......+++.|+|||.+.+..++.++||||||+++|+|++ |..||........
T Consensus 531 kL~DFG~a~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~-------- 601 (656)
T 2j0j_A 531 KLGDFGLSRYMEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV-------- 601 (656)
T ss_dssp EECCCCCCCSCCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH--------
T ss_pred EEEecCCCeecCCCcce-eccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHH--------
Confidence 99999999876543221 1223346788999999988899999999999999999997 9999975532111
Q ss_pred ccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhhcC
Q 020641 255 PRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKS 313 (323)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~~~ 313 (323)
...+........+..++..+.+++.+||+.||.+|||+.+|++.|+++++.
T Consensus 602 --------~~~i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~ 652 (656)
T 2j0j_A 602 --------IGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 652 (656)
T ss_dssp --------HHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --------HHHHHcCCCCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence 111111112223445667899999999999999999999999999998753
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=306.20 Aligned_cols=262 Identities=15% Similarity=0.217 Sum_probs=199.4
Q ss_pred CCCccccccCCCCCCccceecc-ceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCC------ccc
Q 020641 15 PSPGYFVRLDKGPEDDLYLKKR-VKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHE------NLV 87 (323)
Q Consensus 15 ~~~~~~~~lg~G~~~~V~~~~~-~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~------~i~ 87 (323)
..|....+||+|+||.||+|.+ ..+++.+|+|+.... ....+.+.+|+.+++.++|+ +++
T Consensus 14 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-------------~~~~~~~~~e~~~l~~l~~~~~~~~~~i~ 80 (339)
T 1z57_A 14 ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-------------DRYCEAARSEIQVLEHLNTTDPNSTFRCV 80 (339)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-------------HHHHHHHHHHHHHHHHHHHHCTTCTTCBC
T ss_pred CceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-------------CchhHHHHHHHHHHHHhhhcCCCCceeeE
Confidence 3566667999999999999998 557888999976421 11235677888888877655 499
Q ss_pred ceeeEEEeCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCE
Q 020641 88 ELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNV 167 (323)
Q Consensus 88 ~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~ni 167 (323)
++++++...+..++||||+ +++|.+++....... +++..+..++.|++.||.|||+. |++|+||||+||
T Consensus 81 ~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~-------~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Ni 149 (339)
T 1z57_A 81 QMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLP-------FRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENI 149 (339)
T ss_dssp CEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCC-------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGE
T ss_pred eeecccccCCcEEEEEcCC-CCCHHHHHHhcCCCC-------CcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHE
Confidence 9999999999999999999 779999997764322 88999999999999999999999 999999999999
Q ss_pred EEcc-------------------CCeEEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHH
Q 020641 168 LLFE-------------------DFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVL 228 (323)
Q Consensus 168 li~~-------------------~~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l 228 (323)
+++. ++.++|+|||++...... .....||+.|+|||++.+..++.++||||||+++
T Consensus 150 l~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il 224 (339)
T 1z57_A 150 LFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCIL 224 (339)
T ss_dssp EESCCCEEEEEC----CEEEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHH
T ss_pred EEeccccccccCCccccccccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHH
Confidence 9987 667999999998754322 2334589999999999998999999999999999
Q ss_pred HHHHhCCCCCCCCCCcccchhhhhhcccccccccc--------------------------hhcCCC-cCCCCCHHHHHH
Q 020641 229 LELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVK--------------------------QCVDPK-LKGEYPPKGVAK 281 (323)
Q Consensus 229 ~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~-~~~~~~~~~~~~ 281 (323)
|+|++|..||...................+..... ....+. .........+..
T Consensus 225 ~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (339)
T 1z57_A 225 IEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHER 304 (339)
T ss_dssp HHHHHSSCSCCCSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHH
T ss_pred HHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHH
Confidence 99999999998654322211111111111100000 000000 001223456788
Q ss_pred HHHHHHHccCCCCCCCCChHHHHH
Q 020641 282 LAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 282 l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
+.+++.+||+.||.+|||+.|+++
T Consensus 305 l~~li~~~L~~dP~~Rpt~~ell~ 328 (339)
T 1z57_A 305 LFDLIQKMLEYDPAKRITLREALK 328 (339)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred HHHHHHHHhCcCcccccCHHHHhc
Confidence 999999999999999999999985
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=305.73 Aligned_cols=260 Identities=18% Similarity=0.248 Sum_probs=195.0
Q ss_pred CCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEe
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVE 95 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 95 (323)
.|.....||.|+||.||+|.+..+++.+|+|+...... .....+.+.+|+.+++.++||||+++++++..
T Consensus 25 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 94 (353)
T 3coi_A 25 TYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQ----------SEIFAKRAYRELLLLKHMQHENVIGLLDVFTP 94 (353)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTS----------SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECS
T ss_pred eEEEeeeEecCCCeEEEEEEECCCCCEEEEEEeccccc----------chHHHHHHHHHHHHHHhcCCCCcccHhheEec
Confidence 45566689999999999999999999999997653211 11223667899999999999999999999987
Q ss_pred CCe------EEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEE
Q 020641 96 GNL------RVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLL 169 (323)
Q Consensus 96 ~~~------~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili 169 (323)
... .++||||+.+ +|.+++... +++..+..++.|++.||.|||+. |++|+||||+||++
T Consensus 95 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~~-----------~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~ 159 (353)
T 3coi_A 95 ASSLRNFYDFYLVMPFMQT-DLQKIMGLK-----------FSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAV 159 (353)
T ss_dssp CSSGGGCCCCEEEEECCSE-EGGGTTTSC-----------CCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEE
T ss_pred ccccccceeEEEEeccccC-CHHHHhcCC-----------CCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeE
Confidence 653 4999999985 888887432 88999999999999999999999 99999999999999
Q ss_pred ccCCeEEEeeccccCCCCccccccccccccCccccCCCccccC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccch
Q 020641 170 FEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT-GQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQS 248 (323)
Q Consensus 170 ~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~ 248 (323)
+.++.++|+|||++...... .....+++.|+|||.+.+ ..++.++||||||+++|+|++|..||..........
T Consensus 160 ~~~~~~kl~Dfg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~ 234 (353)
T 3coi_A 160 NEDCELKILDFGLARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLT 234 (353)
T ss_dssp CTTCCEEECSTTCTTC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHH
T ss_pred CCCCcEEEeecccccCCCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 99999999999998765432 223457999999998876 678899999999999999999999998654321111
Q ss_pred hhhhhccc--------ccccccchh---cCCCcC---CCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 249 LVTWATPR--------LSEDKVKQC---VDPKLK---GEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 249 ~~~~~~~~--------~~~~~~~~~---~~~~~~---~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
.+...... ......... +..... .......+..+.+++.+||+.||.+|||+.++++
T Consensus 235 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 305 (353)
T 3coi_A 235 QILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 305 (353)
T ss_dssp HHHHHHCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HHHHHhCCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 10000000 000000000 000000 1122345678999999999999999999999986
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=304.35 Aligned_cols=254 Identities=16% Similarity=0.181 Sum_probs=173.1
Q ss_pred ccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEe----CC
Q 020641 22 RLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVE----GN 97 (323)
Q Consensus 22 ~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~ 97 (323)
.||.|+||.||+|.+..+++.+|+|+.... .....+....++.++|+||+++++++.. ..
T Consensus 36 ~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----------------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 99 (336)
T 3fhr_A 36 VLGLGVNGKVLECFHRRTGQKCALKLLYDS----------------PKARQEVDHHWQASGGPHIVCILDVYENMHHGKR 99 (336)
T ss_dssp EEEEETTEEEEEEEETTTCCEEEEEEEESS----------------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEecCc----------------HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCc
Confidence 389999999999999999999999976421 1222233334566699999999999876 44
Q ss_pred eEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEcc---CCe
Q 020641 98 LRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFE---DFK 174 (323)
Q Consensus 98 ~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~---~~~ 174 (323)
..++||||+.+|+|.+++...... .+++..++.++.|++.||.|||+. |++|+||||+||+++. ++.
T Consensus 100 ~~~lv~e~~~gg~L~~~l~~~~~~-------~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~ 169 (336)
T 3fhr_A 100 CLLIIMECMEGGELFSRIQERGDQ-------AFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAV 169 (336)
T ss_dssp EEEEEEECCTTEEHHHHHHTC-CC-------CCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCC
T ss_pred eEEEEEeccCCCCHHHHHHhcCCC-------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCce
Confidence 589999999999999999875432 289999999999999999999999 9999999999999976 455
Q ss_pred EEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhc
Q 020641 175 AKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWAT 254 (323)
Q Consensus 175 ~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~ 254 (323)
++|+|||++....... .....|++.|+|||.+.+..++.++||||||+++|+|++|..||.............
T Consensus 170 ~kl~Dfg~~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~--- 242 (336)
T 3fhr_A 170 LKLTDFGFAKETTQNA----LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMK--- 242 (336)
T ss_dssp EEECCCTTCEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC----------------
T ss_pred EEEeccccceeccccc----cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHH---
Confidence 9999999987554322 223457999999999988888999999999999999999999997554321100000
Q ss_pred ccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH--HHhhhhcCC
Q 020641 255 PRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK--ALQPLLKSP 314 (323)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~--~l~~~~~~~ 314 (323)
.. ................+..+.+++.+||+.||.+|||+.|+++ ++.+....+
T Consensus 243 ~~------~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~ 298 (336)
T 3fhr_A 243 RR------IRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVP 298 (336)
T ss_dssp --------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTGGGSC
T ss_pred Hh------hhccccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccccccCC
Confidence 00 0000000111112345677999999999999999999999998 555544333
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=306.38 Aligned_cols=266 Identities=18% Similarity=0.193 Sum_probs=196.9
Q ss_pred CCCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEE
Q 020641 15 PSPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCV 94 (323)
Q Consensus 15 ~~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 94 (323)
..|.....||+|+||.||++.+..+++.+|+|+.... ........+.+|+.++++++||||+++++++.
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 79 (353)
T 2b9h_A 11 SDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPF-----------DKPLFALRTLREIKILKHFKHENIITIFNIQR 79 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-----------SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECC
T ss_pred cceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeeccc-----------ccchHHHHHHHHHHHHHhCcCCCcCCeeeeec
Confidence 4456666999999999999999999999999966321 01112356779999999999999999999887
Q ss_pred eC-----CeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEE
Q 020641 95 EG-----NLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLL 169 (323)
Q Consensus 95 ~~-----~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili 169 (323)
.. ...++||||+.+ +|.+++.... +++..+..++.|++.||.|||+. |++|+||||+||++
T Consensus 80 ~~~~~~~~~~~lv~e~~~~-~L~~~~~~~~----------~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~ 145 (353)
T 2b9h_A 80 PDSFENFNEVYIIQELMQT-DLHRVISTQM----------LSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLI 145 (353)
T ss_dssp CSCSTTCCCEEEEECCCSE-EHHHHHHHCC----------CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEE
T ss_pred ccccCccceEEEEEeccCc-cHHHHHhhcC----------CCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEE
Confidence 54 678999999985 9999987642 89999999999999999999999 99999999999999
Q ss_pred ccCCeEEEeeccccCCCCcccccc--------ccccccCccccCCCccccC-CCCCcccchHHHHHHHHHHHhCCCCCCC
Q 020641 170 FEDFKAKIADFNLSNQAPDMAARL--------HSTRVLGTFGYHAPEYAMT-GQLTQKSDVYSFGVVLLELLTGRKPVDH 240 (323)
Q Consensus 170 ~~~~~~~l~Dfg~~~~~~~~~~~~--------~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~ 240 (323)
+.++.++|+|||++.......... ......||+.|+|||.+.+ ..++.++||||||+++|+|++|..||..
T Consensus 146 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 225 (353)
T 2b9h_A 146 NSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPG 225 (353)
T ss_dssp CTTCCEEECCCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cCCCcEEEEecccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCC
Confidence 999999999999987654322111 1223458999999998764 6789999999999999999999999986
Q ss_pred CCCcccchhhhhhccccc---------ccccchhcCCCcC-C-----CCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 241 TMPRGQQSLVTWATPRLS---------EDKVKQCVDPKLK-G-----EYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~-~-----~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
.................. .....+.+..... . ......+..+.+++.+||+.||.+|||+.|+++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (353)
T 2b9h_A 226 RDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305 (353)
T ss_dssp SSHHHHHHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCcHHHHHHHHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 543211111100000000 0000000000000 0 001234567999999999999999999999998
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=309.56 Aligned_cols=276 Identities=16% Similarity=0.185 Sum_probs=195.0
Q ss_pred CCCCCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeE
Q 020641 13 HAPSPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGY 92 (323)
Q Consensus 13 ~~~~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 92 (323)
-...|.....||.|+||.||++.+.. ++.+|+|............. ........+.+.+|++++++++||||++++++
T Consensus 20 ~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~-~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 97 (362)
T 3pg1_A 20 MQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVN-ILSDSFLCKRVLREIRLLNHFHHPNILGLRDI 97 (362)
T ss_dssp TTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEE-GGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEE
T ss_pred hccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhh-hhhhhhHHHHHHHHHHHHHhCCCcCccceeee
Confidence 34567777799999999999999866 77888887754433222111 11112223678999999999999999999999
Q ss_pred EEe-----CCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCE
Q 020641 93 CVE-----GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNV 167 (323)
Q Consensus 93 ~~~-----~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~ni 167 (323)
+.. ....++||||+.+ +|.+++...... +++..+..++.|++.||.|||+. |++|+||||+||
T Consensus 98 ~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~--------~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NI 165 (362)
T 3pg1_A 98 FVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIV--------ISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNI 165 (362)
T ss_dssp EEECCTTTCCEEEEEEECCSE-EHHHHHHCTTSC--------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGE
T ss_pred EEeccCCCcceEEEEEccCCC-CHHHHHHhcccC--------CCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHHE
Confidence 854 3468999999985 898888754322 89999999999999999999999 999999999999
Q ss_pred EEccCCeEEEeeccccCCCCccccccccccccCccccCCCccccC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCccc
Q 020641 168 LLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT-GQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQ 246 (323)
Q Consensus 168 li~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~ 246 (323)
+++.++.++|+|||++........ .....|++.|+|||.+.+ ..++.++||||||+++|+|++|+.||........
T Consensus 166 l~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~ 242 (362)
T 3pg1_A 166 LLADNNDITICDFNLAREDTADAN---KTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQ 242 (362)
T ss_dssp EECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred EEcCCCCEEEEecCcccccccccc---cceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHH
Confidence 999999999999999975443222 233458899999998876 6789999999999999999999999986543211
Q ss_pred chhhhhhccccc--------ccccchhcCCCcCC-------CCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 247 QSLVTWATPRLS--------EDKVKQCVDPKLKG-------EYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 247 ~~~~~~~~~~~~--------~~~~~~~~~~~~~~-------~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
............ .......+...... ......+..+.+++.+||+.||.+|||+.|+++
T Consensus 243 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 316 (362)
T 3pg1_A 243 LNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR 316 (362)
T ss_dssp HHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence 111100000000 00001111111110 011233567999999999999999999999997
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=308.13 Aligned_cols=283 Identities=18% Similarity=0.245 Sum_probs=205.9
Q ss_pred CCCccccccCC--CCCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcC
Q 020641 4 DYHPRALGAHA--PSPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRL 81 (323)
Q Consensus 4 ~~~~~~~~~~~--~~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l 81 (323)
+|+|...|... ..|....+||+|+||.||+|++..+++.+|+|+..... .....+.+|+.+++++
T Consensus 6 ~~~p~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------------~~~~~~~~e~~~l~~l 72 (373)
T 1q8y_A 6 GYHPAFKGEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-------------VYTEAAEDEIKLLQRV 72 (373)
T ss_dssp -CCCCCTTCEETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-------------HHHHHHHHHHHHHHHH
T ss_pred CceeeecCCcccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc-------------cchhhhhHHHHHHHHh
Confidence 46666666544 34566669999999999999999999999999764211 1235567888888877
Q ss_pred C-----------CCcccceeeEEEeCC----eEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHH
Q 020641 82 K-----------HENLVELLGYCVEGN----LRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGL 146 (323)
Q Consensus 82 ~-----------h~~i~~~~~~~~~~~----~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l 146 (323)
+ |+||+++++++.... ..++|||++ +++|.+++....... +++..+..++.||+.||
T Consensus 73 ~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~-------~~~~~~~~i~~qi~~aL 144 (373)
T 1q8y_A 73 NDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRG-------IPLIYVKQISKQLLLGL 144 (373)
T ss_dssp HHTCCSHHHHHHHTTBCCCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSC-------CCHHHHHHHHHHHHHHH
T ss_pred hcccccchhccccchHHHHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccC-------CcHHHHHHHHHHHHHHH
Confidence 5 899999999988654 789999999 779999997654322 88999999999999999
Q ss_pred HHhhcCCCCCceeCCCCCCCEEEc------cCCeEEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccc
Q 020641 147 EYLHEKVQPSIIHRDIRSSNVLLF------EDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSD 220 (323)
Q Consensus 147 ~~lh~~~~~~i~h~dikp~nili~------~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~D 220 (323)
.|||+++ |++|+||||+||+++ ..+.++|+|||++...... .....||+.|+|||++.+..++.++|
T Consensus 145 ~~lH~~~--~ivH~Dikp~NIll~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~D 217 (373)
T 1q8y_A 145 DYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGAD 217 (373)
T ss_dssp HHHHHTT--CEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHH
T ss_pred HHHHhcC--CEEecCCChHHeEEeccCCCcCcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHh
Confidence 9999943 899999999999995 3448999999998765432 23345899999999999999999999
Q ss_pred hHHHHHHHHHHHhCCCCCCCCCCcccc----hhhhh--hcccccc---------------cccchhcCC----------C
Q 020641 221 VYSFGVVLLELLTGRKPVDHTMPRGQQ----SLVTW--ATPRLSE---------------DKVKQCVDP----------K 269 (323)
Q Consensus 221 i~slG~~l~~l~~g~~pf~~~~~~~~~----~~~~~--~~~~~~~---------------~~~~~~~~~----------~ 269 (323)
|||||+++|+|++|..||......... ..... .....+. ......+.. .
T Consensus 218 i~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (373)
T 1q8y_A 218 IWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLT 297 (373)
T ss_dssp HHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHH
T ss_pred HHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhh
Confidence 999999999999999999865422110 00000 0000000 000000000 0
Q ss_pred cCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH--HHhhhhcCC
Q 020641 270 LKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK--ALQPLLKSP 314 (323)
Q Consensus 270 ~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~--~l~~~~~~~ 314 (323)
.....+...+..+.+||.+||+.||++|||+.|+++ ++.+.....
T Consensus 298 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~ 344 (373)
T 1q8y_A 298 EKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLGME 344 (373)
T ss_dssp HTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGGGTTCTTCT
T ss_pred hcccCCcchHHHHHHHHHHHhccCccccCCHHHHhhChhhhcccCcc
Confidence 012355778899999999999999999999999998 555554433
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=298.87 Aligned_cols=250 Identities=19% Similarity=0.287 Sum_probs=189.5
Q ss_pred CccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEe-
Q 020641 17 PGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVE- 95 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~- 95 (323)
|.....||+|+||.||+|++..+++.+++|..... ....+.+.+|+.++++++||||+++++++.+
T Consensus 8 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------------~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 74 (303)
T 1zy4_A 8 FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-------------EEKLSTILSEVMLLASLNHQYVVRYYAAWLER 74 (303)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-------------HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEC
T ss_pred chhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-------------HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhh
Confidence 45566899999999999999999999999976421 1123668899999999999999999998865
Q ss_pred ------------CCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCC
Q 020641 96 ------------GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIR 163 (323)
Q Consensus 96 ------------~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dik 163 (323)
....++||||+.+++|.+++..... .++...++.++.|++.||.|||+. |++|+|||
T Consensus 75 ~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlk 143 (303)
T 1zy4_A 75 RNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENL--------NQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLK 143 (303)
T ss_dssp CCCCC------CEEEEEEEEECCCSCBHHHHHHHSCG--------GGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCC
T ss_pred cchhhhhcccccCCceEEEEecCCCCCHHHhhhcccc--------ccchHHHHHHHHHHHHHHHHHHhC---CeecccCC
Confidence 3567999999999999999975432 278889999999999999999999 99999999
Q ss_pred CCCEEEccCCeEEEeeccccCCCCcccc------------ccccccccCccccCCCccccCC-CCCcccchHHHHHHHHH
Q 020641 164 SSNVLLFEDFKAKIADFNLSNQAPDMAA------------RLHSTRVLGTFGYHAPEYAMTG-QLTQKSDVYSFGVVLLE 230 (323)
Q Consensus 164 p~nili~~~~~~~l~Dfg~~~~~~~~~~------------~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~ 230 (323)
|+||+++.++.++|+|||++........ ........|++.|+|||.+.+. .++.++||||||+++|+
T Consensus 144 p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~ 223 (303)
T 1zy4_A 144 PMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFE 223 (303)
T ss_dssp GGGEEECTTSCEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHH
T ss_pred HHhEEEcCCCCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHH
Confidence 9999999999999999999876543211 1112334589999999998764 68899999999999999
Q ss_pred HHhCCCCCCCCCCcccchhhhhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 231 LLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 231 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
|++ ||...... ........ ..........+...+..+.+++.+||+.||.+|||+.++++
T Consensus 224 l~~---p~~~~~~~--~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 224 MIY---PFSTGMER--VNILKKLR----------SVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp HHS---CCSSHHHH--HHHHHHHH----------STTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHh---ccCCchhH--HHHHHhcc----------ccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 998 55421110 00000000 00111122334455677999999999999999999999997
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=304.40 Aligned_cols=199 Identities=22% Similarity=0.264 Sum_probs=165.6
Q ss_pred CCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcC-CCC-----cccce
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRL-KHE-----NLVEL 89 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~-----~i~~~ 89 (323)
.|....+||+|+||+||+|.+..+++.+|+|++... ......+..|+.+++.+ .|+ +|+++
T Consensus 55 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------------~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~ 121 (382)
T 2vx3_A 55 RYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-------------KAFLNQAQIEVRLLELMNKHDTEMKYYIVHL 121 (382)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-------------HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCE
T ss_pred eEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-------------HHHHHHHHHHHHHHHHHHhcccccceeEEEe
Confidence 344555899999999999999999999999976421 11234566778887777 355 48999
Q ss_pred eeEEEeCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhh--cCCCCCceeCCCCCCCE
Q 020641 90 LGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLH--EKVQPSIIHRDIRSSNV 167 (323)
Q Consensus 90 ~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh--~~~~~~i~h~dikp~ni 167 (323)
++++...+..++||||+.+ +|.+++....... +++..+..++.|++.||.||| +. ||+||||||+||
T Consensus 122 ~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~-------~~~~~~~~i~~qi~~al~~lH~~~~---~ivHrDlkp~NI 190 (382)
T 2vx3_A 122 KRHFMFRNHLCLVFEMLSY-NLYDLLRNTNFRG-------VSLNLTRKFAQQMCTALLFLATPEL---SIIHCDLKPENI 190 (382)
T ss_dssp EEEEEETTEEEEEEECCCC-BHHHHHHHTTTSC-------CCHHHHHHHHHHHHHHHHHHTSTTT---CEECCCCSGGGE
T ss_pred eeeeccCCceEEEEecCCC-CHHHHHhhcCcCC-------CCHHHHHHHHHHHHHHHHHhccCCC---CEEcCCCCcccE
Confidence 9999999999999999975 9999998764322 899999999999999999999 46 999999999999
Q ss_pred EEc--cCCeEEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCC
Q 020641 168 LLF--EDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMP 243 (323)
Q Consensus 168 li~--~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 243 (323)
+++ .++.++|+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.....
T Consensus 191 ll~~~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~ 263 (382)
T 2vx3_A 191 LLCNPKRSAIKIVDFGSSCQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANE 263 (382)
T ss_dssp EESSTTSCCEEECCCTTCEETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred EEecCCCCcEEEEeccCceecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 995 4778999999999765432 2334689999999999999999999999999999999999999986543
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=298.23 Aligned_cols=245 Identities=17% Similarity=0.211 Sum_probs=197.3
Q ss_pred CCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCC--CCcccceeeEE
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLK--HENLVELLGYC 93 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~ 93 (323)
.|.....||+|+||.||++.+..+++.+|+|++.......... ......+.+|+.++++++ |+||+++++++
T Consensus 44 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~------~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~ 117 (320)
T 3a99_A 44 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGE------LPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF 117 (320)
T ss_dssp TEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEE------CTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE
T ss_pred ceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhh------hhhhhHHHHHHHHHHhhccCCCCceEEEEEE
Confidence 3555569999999999999999999999999876544332111 112345677888998885 69999999999
Q ss_pred EeCCeEEEEEeecCC-CCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEc-c
Q 020641 94 VEGNLRVLAYEFATM-GSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLF-E 171 (323)
Q Consensus 94 ~~~~~~~lv~e~~~~-~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~-~ 171 (323)
...+..++|+|++.+ ++|.+++..... +++..++.++.|++.||.|||+. |++|+||||+||+++ .
T Consensus 118 ~~~~~~~lv~e~~~~~~~L~~~l~~~~~---------l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~ 185 (320)
T 3a99_A 118 ERPDSFVLILERPEPVQDLFDFITERGA---------LQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLN 185 (320)
T ss_dssp ECSSEEEEEEECCSSEEEHHHHHHHHCS---------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETT
T ss_pred ecCCcEEEEEEcCCCCccHHHHHhccCC---------CCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCC
Confidence 999999999999975 799999976432 89999999999999999999999 999999999999999 7
Q ss_pred CCeEEEeeccccCCCCccccccccccccCccccCCCccccCCCC-CcccchHHHHHHHHHHHhCCCCCCCCCCcccchhh
Q 020641 172 DFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQL-TQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLV 250 (323)
Q Consensus 172 ~~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~ 250 (323)
++.++|+|||++....... .....|++.|+|||.+.+..+ +.++||||||+++|+|++|+.||.....
T Consensus 186 ~~~~kL~Dfg~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~------- 254 (320)
T 3a99_A 186 RGELKLIDFGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------- 254 (320)
T ss_dssp TTEEEECCCTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-------
T ss_pred CCCEEEeeCcccccccccc----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh-------
Confidence 8999999999987654322 233458999999999887665 6789999999999999999999964311
Q ss_pred hhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 251 TWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
.... ....+...+..+.+++.+||+.||++|||+.|+++
T Consensus 255 -~~~~---------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 255 -IIRG---------------QVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp -HHHC---------------CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -hhcc---------------cccccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0000 00112234567999999999999999999999987
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=298.17 Aligned_cols=251 Identities=20% Similarity=0.238 Sum_probs=176.5
Q ss_pred CCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEe
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVE 95 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 95 (323)
.|.....||.|+||.||++.+..+++.+++|+........ .....+.++..+++.++||||+++++++..
T Consensus 26 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----------~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~ 95 (318)
T 2dyl_A 26 DLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKE----------ENKRILMDLDVVLKSHDCPYIVQCFGTFIT 95 (318)
T ss_dssp GEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHH----------HHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred cccccceeeecCCeeEEEEEEecCCeEEEEEEecccccch----------HHHHHHHHHHHHHHhcCCCceeeEEEEEec
Confidence 3444568999999999999999999999999775331111 112334455566788899999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCCCceeCCCCCCCEEEccCCe
Q 020641 96 GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHE-KVQPSIIHRDIRSSNVLLFEDFK 174 (323)
Q Consensus 96 ~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~-~~~~~i~h~dikp~nili~~~~~ 174 (323)
++..++||||+ ++.+..+...... .+++..+..++.|++.||.|||+ . |++|+||||+||+++.++.
T Consensus 96 ~~~~~lv~e~~-~~~~~~l~~~~~~--------~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~ 163 (318)
T 2dyl_A 96 NTDVFIAMELM-GTCAEKLKKRMQG--------PIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQ 163 (318)
T ss_dssp SSEEEEEECCC-SEEHHHHHHHHTS--------CCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSC
T ss_pred CCcEEEEEecc-CCcHHHHHHHhcc--------CCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCC
Confidence 99999999999 4466666543222 18999999999999999999998 7 8999999999999999999
Q ss_pred EEEeeccccCCCCccccccccccccCccccCCCcccc-----CCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchh
Q 020641 175 AKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAM-----TGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSL 249 (323)
Q Consensus 175 ~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~ 249 (323)
++|+|||++........ .....|++.|+|||.+. ...++.++||||||+++|+|++|..||.........
T Consensus 164 ~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-- 238 (318)
T 2dyl_A 164 IKLCDFGISGRLVDDKA---KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEV-- 238 (318)
T ss_dssp EEECCCTTC-----------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHH--
T ss_pred EEEEECCCchhccCCcc---ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHH--
Confidence 99999999876543222 22345899999999984 456788999999999999999999999754321110
Q ss_pred hhhhcccccccccchhcCCCc-CCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 250 VTWATPRLSEDKVKQCVDPKL-KGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
.. ....... ........+..+.+++.+||+.||.+|||+.++++
T Consensus 239 ~~------------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 239 LT------------KVLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp HH------------HHHHSCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred HH------------HHhccCCCCCCccCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 00 0000000 00111234567999999999999999999999876
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=298.51 Aligned_cols=259 Identities=22% Similarity=0.239 Sum_probs=175.5
Q ss_pred CCCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHH-HHhcCCCCcccceeeEE
Q 020641 15 PSPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVS-VVSRLKHENLVELLGYC 93 (323)
Q Consensus 15 ~~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~ 93 (323)
..+.....||+|+||.||++.+..+++.+|+|.+..... ......+..|+. +++.++||||+++++++
T Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-----------~~~~~~~~~e~~~~~~~~~h~niv~~~~~~ 90 (327)
T 3aln_A 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVD-----------EKEQKQLLMDLDVVMRSSDCPYIVQFYGAL 90 (327)
T ss_dssp CSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCC-----------HHHHHHHHHHHHHHHSSCCCTTBCCEEEEE
T ss_pred HHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccC-----------chHHHHHHHHHHHHHHcCCCCcEeeeeeEE
Confidence 345556689999999999999999999999997653211 011233445555 67777999999999999
Q ss_pred EeCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCC
Q 020641 94 VEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDF 173 (323)
Q Consensus 94 ~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~ 173 (323)
...+..++||||+.+ +|.+++....... ...+++..+..++.|++.||.|||+.. |++|+||||+||+++.++
T Consensus 91 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~--~ivH~dlkp~NIll~~~~ 163 (327)
T 3aln_A 91 FREGDCWICMELMST-SFDKFYKYVYSVL----DDVIPEEILGKITLATVKALNHLKENL--KIIHRDIKPSNILLDRSG 163 (327)
T ss_dssp ECSSEEEEEECCCSE-EHHHHHHHHHHTT----CCCCCHHHHHHHHHHHHHHHHHHHHHH--SCCCSCCCGGGEEEETTT
T ss_pred EeCCceEEEEeecCC-ChHHHHHHHHhhh----cccCcHHHHHHHHHHHHHHHHHHhccC--CEeECCCCHHHEEEcCCC
Confidence 999999999999986 8888876311000 012899999999999999999999843 899999999999999999
Q ss_pred eEEEeeccccCCCCccccccccccccCccccCCCccc----cCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchh
Q 020641 174 KAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYA----MTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSL 249 (323)
Q Consensus 174 ~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~----~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~ 249 (323)
.++|+|||++........ .....|++.|+|||.+ .+..++.++||||||+++|+|++|..||..........
T Consensus 164 ~~kl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~- 239 (327)
T 3aln_A 164 NIKLCDFGISGQLVDSIA---KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQL- 239 (327)
T ss_dssp EEEECCCSSSCC---------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC--------
T ss_pred CEEEccCCCceecccccc---cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHH-
Confidence 999999999976644322 2233589999999998 45668899999999999999999999997543211100
Q ss_pred hhhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 250 VTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
. .......+.+........+..+.+++.+||+.||.+|||+.++++
T Consensus 240 ----~------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 240 ----T------QVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp ----C------CCCCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ----H------HHhcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 0 000000111111122345567999999999999999999999865
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=301.86 Aligned_cols=272 Identities=15% Similarity=0.189 Sum_probs=200.3
Q ss_pred CCccccccCC-CCCccccccCCCCCCccceeccceee-eeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCC
Q 020641 5 YHPRALGAHA-PSPGYFVRLDKGPEDDLYLKKRVKMR-RWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLK 82 (323)
Q Consensus 5 ~~~~~~~~~~-~~~~~~~~lg~G~~~~V~~~~~~~~~-~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~ 82 (323)
+.+..+|... ..|....+||+|+||.||+|.+..++ +.+|+|+.... ....+.+.+|+.+++.++
T Consensus 8 ~~~~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-------------~~~~~~~~~E~~~l~~l~ 74 (355)
T 2eu9_A 8 HLVCRIGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-------------GKYREAARLEINVLKKIK 74 (355)
T ss_dssp CBCCCTTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-------------HHHHHHHHHHHHHHHHHH
T ss_pred CcccccCceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-------------ccchhHHHHHHHHHHHHh
Confidence 3333444433 34566669999999999999998776 78999876421 112356778888888886
Q ss_pred CCc------ccceeeEEEeCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 020641 83 HEN------LVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPS 156 (323)
Q Consensus 83 h~~------i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~ 156 (323)
|++ ++.+++++...+..++||||+. +++.+++....... +++..+..++.||+.||.|||+. |
T Consensus 75 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~-------~~~~~~~~i~~qi~~~L~~lH~~---~ 143 (355)
T 2eu9_A 75 EKDKENKFLCVLMSDWFNFHGHMCIAFELLG-KNTFEFLKENNFQP-------YPLPHVRHMAYQLCHALRFLHEN---Q 143 (355)
T ss_dssp HHCTTSCSCBCCEEEEEEETTEEEEEEECCC-CBHHHHHHHTTTCC-------CCHHHHHHHHHHHHHHHHHHHTT---T
T ss_pred hcCCCCceeEEEeeeeeeeCCeEEEEEeccC-CChHHHHHhccCCC-------CCHHHHHHHHHHHHHHHHHHHHC---C
Confidence 655 8899999999999999999994 57777776554222 89999999999999999999999 9
Q ss_pred ceeCCCCCCCEEE-------------------ccCCeEEEeeccccCCCCccccccccccccCccccCCCccccCCCCCc
Q 020641 157 IIHRDIRSSNVLL-------------------FEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQ 217 (323)
Q Consensus 157 i~h~dikp~nili-------------------~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~ 217 (323)
++|+||||+||++ +.++.++|+|||++...... .....||+.|+|||++.+..++.
T Consensus 144 ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~ 218 (355)
T 2eu9_A 144 LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPPEVILELGWAQ 218 (355)
T ss_dssp EECCCCCGGGEEESCCCEEEEECCC-CCCEEEESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHTTCCCCT
T ss_pred cccCCCCHHHEEEecccccccccccccccccccCCCcEEEeecCcccccccc-----ccCCcCCCcccCCeeeecCCCCC
Confidence 9999999999999 56789999999998754322 23346899999999999999999
Q ss_pred ccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccccccccc--------------------------hhcCC-Cc
Q 020641 218 KSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVK--------------------------QCVDP-KL 270 (323)
Q Consensus 218 ~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~-~~ 270 (323)
++||||||+++|+|++|..||...................+..... ....+ ..
T Consensus 219 ~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (355)
T 2eu9_A 219 PCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKS 298 (355)
T ss_dssp HHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGG
T ss_pred ccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccc
Confidence 9999999999999999999998654322111111111110000000 00000 00
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 271 KGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 271 ~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
........+..+.+|+.+||+.||.+|||+.|+++
T Consensus 299 ~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 333 (355)
T 2eu9_A 299 YMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALL 333 (355)
T ss_dssp GCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred cccccchhHHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 01123345678999999999999999999999985
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=287.35 Aligned_cols=234 Identities=15% Similarity=0.101 Sum_probs=184.1
Q ss_pred CCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEe
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVE 95 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 95 (323)
.|....+||+|+||.||++.+..+++.+|+|++....... ....+.+.+|+..+++++|+||+++++++..
T Consensus 32 ~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~---------~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~ 102 (286)
T 3uqc_A 32 RYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLP---------DDVLQETLSRTLRLSRIDKPGVARVLDVVHT 102 (286)
T ss_dssp TEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSC---------HHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE
T ss_pred cEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccC---------HHHHHHHHHHHHHHhcCCCCCcceeeEEEEE
Confidence 3556669999999999999999999999999776432211 1123678899999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeE
Q 020641 96 GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKA 175 (323)
Q Consensus 96 ~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~ 175 (323)
.+..|+||||+.+++|.+++... .....+..++.|++.||.|||+. |++|+||||+||+++.++.+
T Consensus 103 ~~~~~lv~e~~~g~~L~~~l~~~-----------~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~ 168 (286)
T 3uqc_A 103 RAGGLVVAEWIRGGSLQEVADTS-----------PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDV 168 (286)
T ss_dssp TTEEEEEEECCCEEEHHHHHTTC-----------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCE
T ss_pred CCcEEEEEEecCCCCHHHHHhcC-----------CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCE
Confidence 99999999999999999999542 44557889999999999999999 99999999999999999999
Q ss_pred EEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhcc
Q 020641 176 KIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATP 255 (323)
Q Consensus 176 ~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~ 255 (323)
+|++++ |++ .++.++||||||+++|+|++|+.||............
T Consensus 169 kl~~~~----------------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~----- 214 (286)
T 3uqc_A 169 VLAYPA----------------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPA----- 214 (286)
T ss_dssp EECSCC----------------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEEC-----
T ss_pred EEEecc----------------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHH-----
Confidence 997443 333 3588999999999999999999999865432111000
Q ss_pred cccccccchhcCCCcC--CCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhhcCC
Q 020641 256 RLSEDKVKQCVDPKLK--GEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSP 314 (323)
Q Consensus 256 ~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~~~~ 314 (323)
...+..... .......+..+.+++.+||+.||.+| |+.|+++.|+++....
T Consensus 215 -------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~ 267 (286)
T 3uqc_A 215 -------ERDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVA 267 (286)
T ss_dssp -------CBCTTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC--
T ss_pred -------HHHhccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccC
Confidence 000000000 01112345679999999999999999 9999999999987554
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=297.52 Aligned_cols=245 Identities=18% Similarity=0.235 Sum_probs=189.6
Q ss_pred CCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcC----CCCcccceee
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRL----KHENLVELLG 91 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l----~h~~i~~~~~ 91 (323)
.|....+||+|+||.||++++..+++.+++|++.......... ......+.+|+.+++++ +|+||+++++
T Consensus 32 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~------~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~ 105 (312)
T 2iwi_A 32 EYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSP------LSDSVTCPLEVALLWKVGAGGGHPGVIRLLD 105 (312)
T ss_dssp -CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred ceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEeccccccccc------chhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence 3556669999999999999999999999999775443221110 01123345677777776 8999999999
Q ss_pred EEEeCCeEEEEEee-cCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEc
Q 020641 92 YCVEGNLRVLAYEF-ATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLF 170 (323)
Q Consensus 92 ~~~~~~~~~lv~e~-~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~ 170 (323)
++...+..++|+|+ +.+++|.+++..... +++..++.++.|++.||.|||+. |++|+||||+||+++
T Consensus 106 ~~~~~~~~~~v~e~~~~~~~L~~~l~~~~~---------~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~ 173 (312)
T 2iwi_A 106 WFETQEGFMLVLERPLPAQDLFDYITEKGP---------LGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILID 173 (312)
T ss_dssp EC-----CEEEEECCSSEEEHHHHHHHHCS---------CCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEE
T ss_pred EEecCCeEEEEEEecCCCCCHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEe
Confidence 99999999999999 788999999976532 89999999999999999999999 999999999999999
Q ss_pred -cCCeEEEeeccccCCCCccccccccccccCccccCCCccccCCCCC-cccchHHHHHHHHHHHhCCCCCCCCCCcccch
Q 020641 171 -EDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLT-QKSDVYSFGVVLLELLTGRKPVDHTMPRGQQS 248 (323)
Q Consensus 171 -~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~-~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~ 248 (323)
.++.++|+|||++....... .....|+..|+|||.+.+..+. .++||||||+++|+|++|+.||.....
T Consensus 174 ~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~----- 244 (312)
T 2iwi_A 174 LRRGCAKLIDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE----- 244 (312)
T ss_dssp TTTTEEEECCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-----
T ss_pred CCCCeEEEEEcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH-----
Confidence 88999999999987654322 2334589999999988776664 589999999999999999999963210
Q ss_pred hhhhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 249 LVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
. ... ....+...+..+.+++.+||+.||++|||+.|+++
T Consensus 245 -~---------------~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 283 (312)
T 2iwi_A 245 -I---------------LEA--ELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILL 283 (312)
T ss_dssp -H---------------HHT--CCCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred -H---------------hhh--ccCCcccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 000 01123345567999999999999999999999998
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=303.34 Aligned_cols=248 Identities=19% Similarity=0.223 Sum_probs=181.7
Q ss_pred CCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcC-CCCcccceeeEEE
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRL-KHENLVELLGYCV 94 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~ 94 (323)
.+.....||+|+||+||. ....+++.+|+|.+..+ ......+|+.+++.+ +||||+++++++.
T Consensus 25 ~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~---------------~~~~~~~E~~~l~~l~~HpnIv~l~~~~~ 88 (432)
T 3p23_A 25 SFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPE---------------CFSFADREVQLLRESDEHPNVIRYFCTEK 88 (432)
T ss_dssp EEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTT---------------TEEECHHHHHHHHHSCCCTTBCCEEEEEE
T ss_pred EEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHH---------------HHHHHHHHHHHHHhccCCCCcCeEEEEEe
Confidence 344445899999999874 44567788898866421 113346899999999 8999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEcc---
Q 020641 95 EGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFE--- 171 (323)
Q Consensus 95 ~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~--- 171 (323)
+....|+||||+.+ +|.+++...... .....+..++.|++.||.|||+. ||+||||||+||+++.
T Consensus 89 ~~~~~~lv~E~~~g-~L~~~l~~~~~~--------~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~ 156 (432)
T 3p23_A 89 DRQFQYIAIELCAA-TLQEYVEQKDFA--------HLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNA 156 (432)
T ss_dssp ETTEEEEEEECCSE-EHHHHHHSSSCC--------CCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBT
T ss_pred cCCEEEEEEECCCC-CHHHHHHhcCCC--------ccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCC
Confidence 99999999999975 999999766432 33445678999999999999999 9999999999999953
Q ss_pred --CCeEEEeeccccCCCCcccc-ccccccccCccccCCCcccc---CCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCc
Q 020641 172 --DFKAKIADFNLSNQAPDMAA-RLHSTRVLGTFGYHAPEYAM---TGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPR 244 (323)
Q Consensus 172 --~~~~~l~Dfg~~~~~~~~~~-~~~~~~~~g~~~y~aPE~~~---~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~ 244 (323)
...++|+|||++........ ........||+.|+|||++. ...++.++|||||||++|+|++ |..||......
T Consensus 157 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~ 236 (432)
T 3p23_A 157 HGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQR 236 (432)
T ss_dssp TTBCCEEECCTTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTH
T ss_pred CCceeEEEecccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHH
Confidence 34688999999976653321 12223456899999999987 4567789999999999999999 99999644221
Q ss_pred ccchhhhhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 245 GQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
.... ...... ..........+..+.+++.+||+.||.+|||+.|+++
T Consensus 237 ~~~~----~~~~~~----------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 237 QANI----LLGACS----------LDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp HHHH----HTTCCC----------CTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHH----HhccCC----------ccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 1100 000000 0001122345667899999999999999999999984
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=303.12 Aligned_cols=250 Identities=19% Similarity=0.277 Sum_probs=181.8
Q ss_pred ccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcC-CCCcccceeeEEEeCCeEE
Q 020641 22 RLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRL-KHENLVELLGYCVEGNLRV 100 (323)
Q Consensus 22 ~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~ 100 (323)
.||+|+||+||.+ ...+++.+|+|..... ..+.+.+|+.+++.+ +||||+++++++.+.+..+
T Consensus 22 ~LG~G~~g~V~~~-~~~~g~~vAvK~~~~~---------------~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~ 85 (434)
T 2rio_A 22 ILGYGSSGTVVFQ-GSFQGRPVAVKRMLID---------------FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLY 85 (434)
T ss_dssp EEEECSTTCEEEE-EESSSSEEEEEEEEGG---------------GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEE
T ss_pred eEeeCCCeEEEEE-EEECCeEEEEEEEcHH---------------HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEE
Confidence 6999999999875 4456888999866422 124567899999876 8999999999999999999
Q ss_pred EEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccC--------
Q 020641 101 LAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFED-------- 172 (323)
Q Consensus 101 lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~-------- 172 (323)
+||||+. |+|.+++......... ....++..++.++.|++.||.|||+. ||+||||||+||+++.+
T Consensus 86 lv~E~~~-gsL~~~l~~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~ 159 (434)
T 2rio_A 86 IALELCN-LNLQDLVESKNVSDEN--LKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQ 159 (434)
T ss_dssp EEECCCS-EEHHHHHHTC--------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCT
T ss_pred EEEecCC-CCHHHHHhccCCCchh--hhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccc
Confidence 9999996 5999999765432100 00123335678999999999999999 99999999999999754
Q ss_pred -----CeEEEeeccccCCCCcccccc--ccccccCccccCCCccccC-------CCCCcccchHHHHHHHHHHHh-CCCC
Q 020641 173 -----FKAKIADFNLSNQAPDMAARL--HSTRVLGTFGYHAPEYAMT-------GQLTQKSDVYSFGVVLLELLT-GRKP 237 (323)
Q Consensus 173 -----~~~~l~Dfg~~~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~-------~~~~~~~Di~slG~~l~~l~~-g~~p 237 (323)
+.++|+|||++.......... ......||+.|+|||++.+ ..++.++|||||||++|+|++ |..|
T Consensus 160 ~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~P 239 (434)
T 2rio_A 160 TGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHP 239 (434)
T ss_dssp TCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCT
T ss_pred cCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCC
Confidence 489999999997665432211 1223468999999999865 568899999999999999999 9999
Q ss_pred CCCCCCcccchhhhhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 238 VDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 238 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
|........ ........ .+..........+.++.+++.+||+.||.+|||+.++++
T Consensus 240 f~~~~~~~~----~i~~~~~~--------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 240 FGDKYSRES----NIIRGIFS--------LDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp TCSTTTHHH----HHHHTCCC--------CCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCCchhhHH----HHhcCCCC--------cccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 975432211 00000000 011112234567889999999999999999999999985
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-40 Score=285.22 Aligned_cols=231 Identities=15% Similarity=0.214 Sum_probs=179.6
Q ss_pred ccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHH-hcCCCCcccceeeEEEe----C
Q 020641 22 RLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVV-SRLKHENLVELLGYCVE----G 96 (323)
Q Consensus 22 ~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l-~~l~h~~i~~~~~~~~~----~ 96 (323)
.||.|+||.||++.+..+++.+|+|+... .....+|+.++ +..+||||+++++++.. .
T Consensus 25 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----------------~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~ 87 (299)
T 3m2w_A 25 VLGLGINGKVLQIFNKRTQEKFALKMLQD-----------------CPKARREVELHWRASQCPHIVRIVDVYENLYAGR 87 (299)
T ss_dssp EEEEETTEEEEEEEETTTCCEEEEEEEEC-----------------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred ccccCCCeEEEEEEEcCCCcEEEEEEecc-----------------cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCC
Confidence 58999999999999999999999997631 24567888887 55599999999999987 6
Q ss_pred CeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEcc---CC
Q 020641 97 NLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFE---DF 173 (323)
Q Consensus 97 ~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~---~~ 173 (323)
...++||||+.+++|.+++....... +++..++.++.|++.||.|||+. |++|+||||+||+++. ++
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~~~~~-------~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~ 157 (299)
T 3m2w_A 88 KCLLIVMECLDGGELFSRIQDRGDQA-------FTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNA 157 (299)
T ss_dssp EEEEEEECCCCSCBHHHHHHHCTTCC-------CBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTC
T ss_pred ceEEEEEeecCCCcHHHHHHhccCCC-------CCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCC
Confidence 67899999999999999998754322 89999999999999999999999 9999999999999998 78
Q ss_pred eEEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhh
Q 020641 174 KAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWA 253 (323)
Q Consensus 174 ~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 253 (323)
.++|+|||++.... +..++.++||||||+++|+|++|..||..........
T Consensus 158 ~~kl~Dfg~a~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~----- 208 (299)
T 3m2w_A 158 ILKLTDFGFAKETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP----- 208 (299)
T ss_dssp CEEECCCTTCEECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------C-----
T ss_pred cEEEeccccccccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhH-----
Confidence 89999999875322 2346789999999999999999999997553321100
Q ss_pred cccccccccchhcCCCcCCCCC----HHHHHHHHHHHHHccCCCCCCCCChHHHHH--HHhhhhcCCCC
Q 020641 254 TPRLSEDKVKQCVDPKLKGEYP----PKGVAKLAAVAALCVQYEAEFRPNMSIVVK--ALQPLLKSPPP 316 (323)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~cl~~~P~~Rps~~evl~--~l~~~~~~~~~ 316 (323)
.......... ...+ ...+..+.+++.+||+.||.+|||+.|+++ ++.+..+.+.+
T Consensus 209 ------~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~~~~~~ 269 (299)
T 3m2w_A 209 ------GMKTRIRMGQ--YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQT 269 (299)
T ss_dssp ------CSCCSSCTTC--CSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGGGSCCC
T ss_pred ------HHHHHHhhcc--ccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccccCCCC
Confidence 0000000000 0111 234678999999999999999999999997 45555444443
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=312.16 Aligned_cols=239 Identities=17% Similarity=0.214 Sum_probs=188.4
Q ss_pred CccccccCCCCCCccceeccce-eeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEe
Q 020641 17 PGYFVRLDKGPEDDLYLKKRVK-MRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVE 95 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 95 (323)
|.....||+|+||.||++.+.. +++.+++|...... .......+.+|++++++++||||+++++++..
T Consensus 82 y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~-----------~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 150 (681)
T 2pzi_A 82 YEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG-----------DAEAQAMAMAERQFLAEVVHPSIVQIFNFVEH 150 (681)
T ss_dssp EEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSC-----------CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEE
T ss_pred eEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccC-----------CHHHHHHHHHHHHHHHhcCCCCcCeEeeeEee
Confidence 4555589999999999999976 68889998664211 11223567899999999999999999999987
Q ss_pred CCe-----EEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEc
Q 020641 96 GNL-----RVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLF 170 (323)
Q Consensus 96 ~~~-----~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~ 170 (323)
.+. .|+||||+.+++|.+++... +++..++.++.||+.||.|||++ ||+||||||+||+++
T Consensus 151 ~~~~~~~~~~lv~E~~~g~~L~~~~~~~-----------l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~ 216 (681)
T 2pzi_A 151 TDRHGDPVGYIVMEYVGGQSLKRSKGQK-----------LPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLT 216 (681)
T ss_dssp ECTTSCEEEEEEEECCCCEECC----CC-----------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEC
T ss_pred cCCCCCceeEEEEEeCCCCcHHHHHhCC-----------CCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEe
Confidence 654 79999999999999877541 89999999999999999999999 999999999999998
Q ss_pred cCCeEEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhh
Q 020641 171 EDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLV 250 (323)
Q Consensus 171 ~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~ 250 (323)
.+ .+||+|||++...... ....||+.|+|||++.+. ++.++||||||+++|+|++|..||.......
T Consensus 217 ~~-~~kl~DFG~a~~~~~~------~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~----- 283 (681)
T 2pzi_A 217 EE-QLKLIDLGAVSRINSF------GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDG----- 283 (681)
T ss_dssp SS-CEEECCCTTCEETTCC------SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSS-----
T ss_pred CC-cEEEEecccchhcccC------CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCccccccc-----
Confidence 86 8999999998765432 334589999999988754 4889999999999999999988876321100
Q ss_pred hhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCC-ChHHHHHHHhhhh
Q 020641 251 TWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRP-NMSIVVKALQPLL 311 (323)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-s~~evl~~l~~~~ 311 (323)
+. ........+..+.+++.+||+.||.+|| +++++...|..++
T Consensus 284 -----------~~-------~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 327 (681)
T 2pzi_A 284 -----------LP-------EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVL 327 (681)
T ss_dssp -----------CC-------TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred -----------cc-------ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence 00 0011123346799999999999999999 5777777777664
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=289.30 Aligned_cols=242 Identities=14% Similarity=0.111 Sum_probs=173.8
Q ss_pred cccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCC-Ccccce---------e
Q 020641 21 VRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKH-ENLVEL---------L 90 (323)
Q Consensus 21 ~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~---------~ 90 (323)
..||+|+||.||+|.+..+++.+|+|+..... .......+.+.+|+.+++.++| .|...+ .
T Consensus 84 ~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~---------~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~ 154 (413)
T 3dzo_A 84 TVLGQEDPYAYLEATDQETGESFEVHVPYFTE---------RPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPF 154 (413)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEECCSC---------C----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCC
T ss_pred cccccCCCEEEEEEEecCCCCceEEEEEecCC---------CccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccch
Confidence 37999999999999999999999999665221 1112335778999999999876 322211 1
Q ss_pred eE------------EEe-----CCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCC
Q 020641 91 GY------------CVE-----GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKV 153 (323)
Q Consensus 91 ~~------------~~~-----~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~ 153 (323)
+. +.. ....+++|+.+ +++|.+++....... .....+++..++.++.|++.||.|||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~--~~~~~l~~~~~~~i~~qi~~aL~~LH~~- 230 (413)
T 3dzo_A 155 DLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHS--STHKSLVHHARLQLTLQVIRLLASLHHY- 230 (413)
T ss_dssp EEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHT--TTSHHHHHHHHHHHHHHHHHHHHHHHHT-
T ss_pred hhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhccc--ccCCCCCHHHHHHHHHHHHHHHHHHHhC-
Confidence 11 111 12356777765 469999985210000 0011277888999999999999999999
Q ss_pred CCCceeCCCCCCCEEEccCCeEEEeeccccCCCCccccccccccccCccccCCCccc----------cCCCCCcccchHH
Q 020641 154 QPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYA----------MTGQLTQKSDVYS 223 (323)
Q Consensus 154 ~~~i~h~dikp~nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~----------~~~~~~~~~Di~s 223 (323)
||+||||||+|||++.++.+||+|||++...... .....| +.|+|||++ .+..++.++||||
T Consensus 231 --~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwS 302 (413)
T 3dzo_A 231 --GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWT 302 (413)
T ss_dssp --TEECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHH
T ss_pred --CcccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHH
Confidence 9999999999999999999999999998765433 233457 899999998 5556788999999
Q ss_pred HHHHHHHHHhCCCCCCCCCCcccchhhhhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHH
Q 020641 224 FGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIV 303 (323)
Q Consensus 224 lG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ev 303 (323)
|||++|+|++|+.||......... ...+. . ....+..+.+++.+||+.||++|||+.++
T Consensus 303 lGvil~elltg~~Pf~~~~~~~~~---------------~~~~~-~-----~~~~~~~~~~li~~~l~~dP~~Rpt~~~~ 361 (413)
T 3dzo_A 303 LGLAIYWIWCADLPNTDDAALGGS---------------EWIFR-S-----CKNIPQPVRALLEGFLRYPKEDRLLPLQA 361 (413)
T ss_dssp HHHHHHHHHHSSCCCCTTGGGSCS---------------GGGGS-S-----CCCCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred HHHHHHHHHHCCCCCCCcchhhhH---------------HHHHh-h-----cccCCHHHHHHHHHHccCChhhCcCHHHH
Confidence 999999999999999754321110 01111 0 01234679999999999999999997665
Q ss_pred H
Q 020641 304 V 304 (323)
Q Consensus 304 l 304 (323)
+
T Consensus 362 l 362 (413)
T 3dzo_A 362 M 362 (413)
T ss_dssp T
T ss_pred H
Confidence 3
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-39 Score=282.55 Aligned_cols=245 Identities=13% Similarity=0.082 Sum_probs=178.4
Q ss_pred CccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCC---------CCccc
Q 020641 17 PGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLK---------HENLV 87 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~---------h~~i~ 87 (323)
|....+||+|+||.||+|++ +++.+|+|++......... .......+.+.+|+.+++.++ |+||+
T Consensus 22 y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~----~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv 95 (336)
T 2vuw_A 22 LQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVN----GSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFI 95 (336)
T ss_dssp HHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBT----TBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBC
T ss_pred chheeeecccCceEEEEEEe--CCceEEEEEEecCCccccc----cccchhHHHHHHHHHHHHHHHHhhccccccCCchh
Confidence 45566999999999999998 6789999987654322111 012233477888999888775 55555
Q ss_pred ceee-----------------EEEe-------------CCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHH
Q 020641 88 ELLG-----------------YCVE-------------GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVR 137 (323)
Q Consensus 88 ~~~~-----------------~~~~-------------~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~ 137 (323)
++.+ ++.. ....|+||||+.+|++.+.+.+.. +++..++.
T Consensus 96 ~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~~~----------~~~~~~~~ 165 (336)
T 2vuw_A 96 GLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKL----------SSLATAKS 165 (336)
T ss_dssp CEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTTTC----------CCHHHHHH
T ss_pred hhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHhcC----------CCHHHHHH
Confidence 5554 4443 678999999999997777764422 89999999
Q ss_pred HHHHHHHHHHHhh-cCCCCCceeCCCCCCCEEEccCC--------------------eEEEeeccccCCCCccccccccc
Q 020641 138 IAVDAARGLEYLH-EKVQPSIIHRDIRSSNVLLFEDF--------------------KAKIADFNLSNQAPDMAARLHST 196 (323)
Q Consensus 138 ~~~~i~~~l~~lh-~~~~~~i~h~dikp~nili~~~~--------------------~~~l~Dfg~~~~~~~~~~~~~~~ 196 (323)
++.||+.||.||| +. ||+||||||+|||++.++ .+||+|||+++.... .
T Consensus 166 i~~qi~~aL~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-------~ 235 (336)
T 2vuw_A 166 ILHQLTASLAVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD-------G 235 (336)
T ss_dssp HHHHHHHHHHHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-------T
T ss_pred HHHHHHHHHHHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-------C
Confidence 9999999999999 89 999999999999999887 899999999975432 1
Q ss_pred cccCccccCCCccccCCCCCcccchHHHHHH-HHHHHhCCCCCCCCCCcccchhhhhhcccccccccchh--cCCCcCCC
Q 020641 197 RVLGTFGYHAPEYAMTGQLTQKSDVYSFGVV-LLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQC--VDPKLKGE 273 (323)
Q Consensus 197 ~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~-l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 273 (323)
...||+.|+|||++.+.. +.++||||||++ .++++.|..||.... |... ....+... ........
T Consensus 236 ~~~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~---------~~~~--~~~~~~~~~~~~~~~~~~ 303 (336)
T 2vuw_A 236 IVVFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVL---------WLHY--LTDKMLKQMTFKTKCNTP 303 (336)
T ss_dssp EEECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHH---------HHHH--HHHHHHHTCCCSSCCCSH
T ss_pred cEEEeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchh---------hhhH--HHHhhhhhhccCcccchh
Confidence 235899999999998766 889999998877 677788999884210 0000 00000000 00011111
Q ss_pred CCHHHHHHHHHHHHHccCCCCCCCCChHHHH
Q 020641 274 YPPKGVAKLAAVAALCVQYEAEFRPNMSIVV 304 (323)
Q Consensus 274 ~~~~~~~~l~~li~~cl~~~P~~Rps~~evl 304 (323)
.....+.++.+||.+||++| |+.|++
T Consensus 304 ~~~~~s~~~~dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 304 AMKQIKRKIQEFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHHHHHHHHHHHHHHGGGSS-----SHHHHH
T ss_pred hhhhcCHHHHHHHHHHhccC-----CHHHHH
Confidence 23467889999999999977 999988
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.5e-32 Score=255.82 Aligned_cols=200 Identities=15% Similarity=0.074 Sum_probs=137.4
Q ss_pred ccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcC-CCCcccceeeEEEeC
Q 020641 18 GYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRL-KHENLVELLGYCVEG 96 (323)
Q Consensus 18 ~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~ 96 (323)
.+...++.|+.|.+..++..-.++.+++|++.+......... ...+...+++.+|+++|+++ .|+||++++++++++
T Consensus 237 ~w~~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~--~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~ 314 (569)
T 4azs_A 237 HWQNQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTA--EESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENA 314 (569)
T ss_dssp EEECC-C--------CCEEEEECSSEEEEEEESSCSTTCSCH--HHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECS
T ss_pred hhhhccccCCcccccccccccccceeEEEEEecccccccchh--hhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEEC
Confidence 334467888889999888888999999998775533222111 11123346799999999999 899999999999999
Q ss_pred CeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEE
Q 020641 97 NLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAK 176 (323)
Q Consensus 97 ~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~ 176 (323)
+..||||||++|++|.+++.+... ++.. +++.||+.||.|+|++ ||+||||||+|||++.++.+|
T Consensus 315 ~~~yLVMEyv~G~~L~d~i~~~~~---------l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vK 379 (569)
T 4azs_A 315 QSGWLVMEKLPGRLLSDMLAAGEE---------IDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHAR 379 (569)
T ss_dssp SEEEEEEECCCSEEHHHHHHTTCC---------CCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEE
T ss_pred CEEEEEEecCCCCcHHHHHHhCCC---------CCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEE
Confidence 999999999999999999987542 5543 5899999999999999 999999999999999999999
Q ss_pred EeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCC
Q 020641 177 IADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 237 (323)
Q Consensus 177 l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p 237 (323)
|+|||+|+....... ......||+.|+|||++.+ .+..++|+||+|++++.+.++..+
T Consensus 380 L~DFGlAr~~~~~~~--~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 380 LIDFGSIVTTPQDCS--WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp ECCCTTEESCC---C--CSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred EeecccCeeCCCCCc--cccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence 999999976654322 1234569999999998875 456789999999998877665444
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=6.4e-28 Score=224.82 Aligned_cols=189 Identities=15% Similarity=0.155 Sum_probs=142.6
Q ss_pred ccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeCCeEEE
Q 020641 22 RLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVL 101 (323)
Q Consensus 22 ~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 101 (323)
.||+|+||.||++.. .++.+++|....+......... ....+++.+|++++++++||||+++..++...+..|+
T Consensus 343 ~LG~G~fg~Vy~~~~--~~~~~~~k~~~~~~~~~~~~~~----~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l 416 (540)
T 3en9_A 343 LIGKGAEADIKRDSY--LDFDVIIKERVKKGYRDERLDE----NIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRI 416 (540)
T ss_dssp -----CCEEEEEEEC--SSCEEEEEEECCCTTSCHHHHH----HHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEE
T ss_pred EEeeCCCEEEEEEEE--CCCeEEEEEEecccccchhhhh----HHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEE
Confidence 789999999999943 3445566654433322211110 1123567999999999999999966666667777899
Q ss_pred EEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEEEeecc
Q 020641 102 AYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFN 181 (323)
Q Consensus 102 v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~l~Dfg 181 (323)
||||+++++|.+++.. +..++.|++.||.|||++ ||+||||||+||+++. .+||+|||
T Consensus 417 VmE~~~ggsL~~~l~~-----------------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFG 474 (540)
T 3en9_A 417 MMSYINGKLAKDVIED-----------------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFG 474 (540)
T ss_dssp EEECCCSEEHHHHSTT-----------------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCT
T ss_pred EEECCCCCCHHHHHHH-----------------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECc
Confidence 9999999999999865 348999999999999999 9999999999999998 99999999
Q ss_pred ccCCCCcccccc-----ccccccCccccCCCccccC--CCCCcccchHHHHHHHHHHHhCCCCC
Q 020641 182 LSNQAPDMAARL-----HSTRVLGTFGYHAPEYAMT--GQLTQKSDVYSFGVVLLELLTGRKPV 238 (323)
Q Consensus 182 ~~~~~~~~~~~~-----~~~~~~g~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~l~~g~~pf 238 (323)
+++......... ......||+.|+|||++.. ..|+...|+|+..+-..+-+.++.+|
T Consensus 475 la~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 475 LGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp TCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred cCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 998776533221 1234568999999999976 56788899999999888888777665
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=2.1e-23 Score=178.91 Aligned_cols=148 Identities=11% Similarity=0.040 Sum_probs=112.1
Q ss_pred cccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCC---------CchHHHHHHHHHhcCCCCcccceee
Q 020641 21 VRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKN---------YPDDEKQLVSVVSRLKHENLVELLG 91 (323)
Q Consensus 21 ~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~---------~~~~~~~e~~~l~~l~h~~i~~~~~ 91 (323)
..||.|+||.||+|.+ .+++.+|+|+........... ....+ ....+.+|+.++++++ | +++.+
T Consensus 96 ~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~---~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~~ 168 (282)
T 1zar_A 96 KLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKV---KEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVPK 168 (282)
T ss_dssp EEEEECSSEEEEEEEE-TTTEEEEEEEECC------CC---CC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSCC
T ss_pred CEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhh---hhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcCe
Confidence 6899999999999999 888999999775432111111 00011 1356889999999998 5 66667
Q ss_pred EEEeCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEcc
Q 020641 92 YCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFE 171 (323)
Q Consensus 92 ~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~ 171 (323)
++.. +..++||||+++++|.+ +.. . ....++.|++.|+.+||+. |++||||||+||+++
T Consensus 169 ~~~~-~~~~lvmE~~~g~~L~~-l~~-------------~--~~~~i~~qi~~~l~~lH~~---giiHrDlkp~NILl~- 227 (282)
T 1zar_A 169 VYAW-EGNAVLMELIDAKELYR-VRV-------------E--NPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVS- 227 (282)
T ss_dssp EEEE-ETTEEEEECCCCEEGGG-CCC-------------S--CHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEE-
T ss_pred EEec-cceEEEEEecCCCcHHH-cch-------------h--hHHHHHHHHHHHHHHHHHC---CCEeCCCCHHHEEEE-
Confidence 6654 44599999999999998 421 1 2347999999999999999 999999999999999
Q ss_pred CCeEEEeeccccCCCCccccccccccccCccccCCCcccc
Q 020641 172 DFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAM 211 (323)
Q Consensus 172 ~~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~ 211 (323)
++.++|+|||++.. +..+.|||.+.
T Consensus 228 ~~~vkl~DFG~a~~---------------~~~~~a~e~l~ 252 (282)
T 1zar_A 228 EEGIWIIDFPQSVE---------------VGEEGWREILE 252 (282)
T ss_dssp TTEEEECCCTTCEE---------------TTSTTHHHHHH
T ss_pred CCcEEEEECCCCeE---------------CCCCCHHHHHH
Confidence 99999999998853 33467788663
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.79 E-value=7.1e-20 Score=155.02 Aligned_cols=148 Identities=15% Similarity=0.142 Sum_probs=103.9
Q ss_pred ccccccCCCCCCccceeccceeeee--eeeccccccccCcccccc-------ccCCC-----CCchHHHHHHHHHhcCCC
Q 020641 18 GYFVRLDKGPEDDLYLKKRVKMRRW--LCCTCQVEESYPSHENER-------LKSPK-----NYPDDEKQLVSVVSRLKH 83 (323)
Q Consensus 18 ~~~~~lg~G~~~~V~~~~~~~~~~~--~~~k~~~~~~~~~~~~~~-------~~~~~-----~~~~~~~~e~~~l~~l~h 83 (323)
.....||.|+||.||+|.+..+++. +|+|+............. ..... .....+.+|+..+..+.|
T Consensus 50 ~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~ 129 (258)
T 1zth_A 50 AMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAKE 129 (258)
T ss_dssp EEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHHH
T ss_pred hhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHHh
Confidence 3445899999999999999778888 999975433111000000 00000 001357889999999987
Q ss_pred Ccc--cceeeEEEeCCeEEEEEeecCC-C----CHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhh-cCCCC
Q 020641 84 ENL--VELLGYCVEGNLRVLAYEFATM-G----SLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLH-EKVQP 155 (323)
Q Consensus 84 ~~i--~~~~~~~~~~~~~~lv~e~~~~-~----sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh-~~~~~ 155 (323)
+++ ..+++. ...++||||+.+ | +|.++... .++..+..++.|++.++.+|| +.
T Consensus 130 ~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~------------~~~~~~~~i~~qi~~~l~~lH~~~--- 190 (258)
T 1zth_A 130 AGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE------------LKELDVEGIFNDVVENVKRLYQEA--- 190 (258)
T ss_dssp TTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG------------GGGSCHHHHHHHHHHHHHHHHHTS---
T ss_pred CCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc------------cChHHHHHHHHHHHHHHHHHHHHC---
Confidence 764 333332 245899999942 3 77776543 223356789999999999999 88
Q ss_pred CceeCCCCCCCEEEccCCeEEEeeccccCCC
Q 020641 156 SIIHRDIRSSNVLLFEDFKAKIADFNLSNQA 186 (323)
Q Consensus 156 ~i~h~dikp~nili~~~~~~~l~Dfg~~~~~ 186 (323)
|++||||||.|||++. .++|+|||++...
T Consensus 191 givHrDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 191 ELVHADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp CEECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred CEEeCCCCHHHEEEcC--cEEEEECcccccC
Confidence 9999999999999998 8999999998653
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.68 E-value=4.5e-18 Score=149.97 Aligned_cols=152 Identities=11% Similarity=0.022 Sum_probs=97.8
Q ss_pred CCCCccccccCCCCCCccceeccceeeeeeeeccccccccCcccccc--ccCCCCCchHH--------HHHHHHHhcCCC
Q 020641 14 APSPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENER--LKSPKNYPDDE--------KQLVSVVSRLKH 83 (323)
Q Consensus 14 ~~~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~--~~~~~~~~~~~--------~~e~~~l~~l~h 83 (323)
..-|....+||.|++|.||+|.+. +++.+|+|++..........+. .-......... ..|...|.++.+
T Consensus 94 g~iY~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~ 172 (397)
T 4gyi_A 94 KDVYSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYE 172 (397)
T ss_dssp TSCSEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred CCEEEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHh
Confidence 344666669999999999999985 5788999976543221111100 00001111111 234555555533
Q ss_pred CcccceeeEEEeCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCC
Q 020641 84 ENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIR 163 (323)
Q Consensus 84 ~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dik 163 (323)
.++... ..+... ..++||||++|++|.++... .....++.|++.+|.+||+. ||+|||||
T Consensus 173 ~gv~vp-~p~~~~-~~~LVME~i~G~~L~~l~~~---------------~~~~~l~~qll~~l~~lH~~---gIVHrDLK 232 (397)
T 4gyi_A 173 EGFPVP-EPIAQS-RHTIVMSLVDALPMRQVSSV---------------PDPASLYADLIALILRLAKH---GLIHGDFN 232 (397)
T ss_dssp TTCSCC-CEEEEE-TTEEEEECCSCEEGGGCCCC---------------SCHHHHHHHHHHHHHHHHHT---TEECSCCS
T ss_pred cCCCCC-eeeecc-CceEEEEecCCccHhhhccc---------------HHHHHHHHHHHHHHHHHHHC---CCcCCCCC
Confidence 333211 111111 23799999999888665321 13457889999999999999 99999999
Q ss_pred CCCEEEccCC----------eEEEeeccccCCC
Q 020641 164 SSNVLLFEDF----------KAKIADFNLSNQA 186 (323)
Q Consensus 164 p~nili~~~~----------~~~l~Dfg~~~~~ 186 (323)
|.|||++.++ .+.|+||+.+...
T Consensus 233 p~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 233 EFNILIREEKDAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp TTSEEEEEEECSSCTTSEEEEEEECCCTTCEET
T ss_pred HHHEEEeCCCCcccccccccceEEEEeCCcccC
Confidence 9999998876 4899999977543
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.37 E-value=9.6e-13 Score=111.29 Aligned_cols=149 Identities=11% Similarity=-0.006 Sum_probs=107.8
Q ss_pred ccccccCCCCCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcC-CCCc
Q 020641 7 PRALGAHAPSPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRL-KHEN 85 (323)
Q Consensus 7 ~~~~~~~~~~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~ 85 (323)
|+.+.....++.....++.|+.+.||++... ++.+++|....... .....+.+|+++++.+ .+..
T Consensus 6 p~~l~~~l~~~~~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~------------~~~~~~~~E~~~l~~l~~~~~ 71 (263)
T 3tm0_A 6 SPELKKLIEKYRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYK------------GTTYDVEREKDMMLWLEGKLP 71 (263)
T ss_dssp CHHHHHHHTTSEEEECCSCCSSSEEEEEECS--SCEEEEEEECGGGT------------TSTTCHHHHHHHHHHHTTTSC
T ss_pred CHHHHHHhccceeEeeccCCCCCeEEEEECC--CCcEEEEeCCcccC------------CCHHHHHHHHHHHHHHhcCCC
Confidence 3444444456666667788888999999754 45566665432110 1123578889999888 5677
Q ss_pred ccceeeEEEeCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCC------------
Q 020641 86 LVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKV------------ 153 (323)
Q Consensus 86 i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~------------ 153 (323)
+.++++++...+..|+|||+++|.+|.+.... ......++.+++.++..||+..
T Consensus 72 vP~v~~~~~~~~~~~lv~e~i~G~~l~~~~~~--------------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~ 137 (263)
T 3tm0_A 72 VPKVLHFERHDGWSNLLMSEADGVLCSEEYED--------------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDS 137 (263)
T ss_dssp CCCEEEEEEETTEEEEEEECCSSEEHHHHCCT--------------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHH
T ss_pred CCeEEEEEecCCceEEEEEecCCeehhhccCC--------------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHH
Confidence 88999999999899999999999999876321 1123477889999999999810
Q ss_pred --------------------------------------------CCCceeCCCCCCCEEEccCCeEEEeecccc
Q 020641 154 --------------------------------------------QPSIIHRDIRSSNVLLFEDFKAKIADFNLS 183 (323)
Q Consensus 154 --------------------------------------------~~~i~h~dikp~nili~~~~~~~l~Dfg~~ 183 (323)
...++|+|++|.||+++++..+.|+||+.+
T Consensus 138 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a 211 (263)
T 3tm0_A 138 RLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRS 211 (263)
T ss_dssp HHHHHHHHHHTTCSCCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTC
T ss_pred HHHHHHHHHhccccccccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhc
Confidence 026899999999999987655679999865
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.16 E-value=1.5e-10 Score=97.48 Aligned_cols=144 Identities=13% Similarity=0.045 Sum_probs=96.2
Q ss_pred ccccccCCCCCccccccC-CCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCc
Q 020641 7 PRALGAHAPSPGYFVRLD-KGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHEN 85 (323)
Q Consensus 7 ~~~~~~~~~~~~~~~~lg-~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~ 85 (323)
|..+.....++.. ..++ .|..+.||++.. .+++.+++|+.... ....+..|+.+++.+.+.+
T Consensus 12 p~~l~~~~~~~~~-~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~---------------~~~~~~~E~~~l~~l~~~~ 74 (264)
T 1nd4_A 12 PAAWVERLFGYDW-AQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSG---------------ALNELQDEAARLSWLATTG 74 (264)
T ss_dssp CGGGTTTTTTCEE-EECSCTTSSCEEEEEEC-TTSCCEEEEEECSC---------------TTSCHHHHHHHHHHHHTTT
T ss_pred CHHHHHhcCCCce-EecccCCCCceEEEEec-CCCCeEEEEeCCcc---------------cchhhhHHHHHHHHHHhCC
Confidence 4445454455444 4555 555699999965 34455666653211 1245778888888884334
Q ss_pred --ccceeeEEEeCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCC----------
Q 020641 86 --LVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKV---------- 153 (323)
Q Consensus 86 --i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~---------- 153 (323)
+.+++.+...++..++||||++|.+|. ... .. ...++.+++..+..||+..
T Consensus 75 ~~vP~~~~~~~~~~~~~~v~e~i~G~~l~--~~~------------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~ 137 (264)
T 1nd4_A 75 VPCAAVLDVVTEAGRDWLLLGEVPGQDLL--SSH------------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQA 137 (264)
T ss_dssp CCBCCEEEEEECSSCEEEEEECCSSEETT--TSC------------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCH
T ss_pred CCCCeEEEeccCCCCCEEEEEecCCcccC--cCc------------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHH
Confidence 556888888777889999999998883 211 11 1256677777777777641
Q ss_pred ---------------------------------------------CCCceeCCCCCCCEEEccCCeEEEeeccccC
Q 020641 154 ---------------------------------------------QPSIIHRDIRSSNVLLFEDFKAKIADFNLSN 184 (323)
Q Consensus 154 ---------------------------------------------~~~i~h~dikp~nili~~~~~~~l~Dfg~~~ 184 (323)
..+++|+|++|.||+++.+..+.|+||+.+.
T Consensus 138 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 138 KHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp HHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 0139999999999999877666799999753
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.09 E-value=4.2e-10 Score=99.48 Aligned_cols=146 Identities=15% Similarity=0.165 Sum_probs=101.4
Q ss_pred CCccccccCCCCCCccceeccceeeeeeeecccc--ccccCccccccccCCCCCchHHHHHHHHHhcCC--CCcccceee
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQV--EESYPSHENERLKSPKNYPDDEKQLVSVVSRLK--HENLVELLG 91 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~--~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~ 91 (323)
+...+.+|+.|.++.||++.... +. +++|... .... ......+.+|+.+++.+. +..+.+++.
T Consensus 39 ~~~~~~~l~~G~sn~~y~v~~~~-~~-~vlr~~~~p~~~~-----------~~~~~~~~~E~~~l~~L~~~~vpvP~~~~ 105 (359)
T 3dxp_A 39 GPLSVEQFKGGQSNPTFKLVTPG-QT-YVMRAKPGPKSKL-----------LPSAHAIEREYRVMDALAGTDVPVAKMYA 105 (359)
T ss_dssp CCCEEEECCC-CCSCEEEEECSS-CE-EEEECCCC---------------------CHHHHHHHHHHHTTSSSCCCCEEE
T ss_pred CCceEEEcCCcccceEEEEEECC-ce-EEEEeCCCCCCCC-----------CCcHHHHHHHHHHHHHhhcCCCCCCcEEE
Confidence 34456689999999999988653 33 3444332 1100 011246778888888885 345778888
Q ss_pred EEEeC---CeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCC---------------
Q 020641 92 YCVEG---NLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKV--------------- 153 (323)
Q Consensus 92 ~~~~~---~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~--------------- 153 (323)
++.+. +..++||||++|.++.+.... .++......++.+++..|..||+..
T Consensus 106 ~~~~~~~~g~~~~vme~v~G~~l~~~~~~-----------~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~ 174 (359)
T 3dxp_A 106 LCEDESVIGRAFYIMEFVSGRVLWDQSLP-----------GMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNY 174 (359)
T ss_dssp EECCTTTTSSCEEEEECCCCBCCCCTTCT-----------TCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCH
T ss_pred ECCCCCccCCeEEEEEecCCeecCCCccc-----------cCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCc
Confidence 88766 347999999998777542211 1677788899999999999999721
Q ss_pred ----------------------------------------CCCceeCCCCCCCEEEccCCe--EEEeeccccCC
Q 020641 154 ----------------------------------------QPSIIHRDIRSSNVLLFEDFK--AKIADFNLSNQ 185 (323)
Q Consensus 154 ----------------------------------------~~~i~h~dikp~nili~~~~~--~~l~Dfg~~~~ 185 (323)
..+++|+|+++.||+++.++. +.++||+.+..
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 175 FQRQIERWTKQYKLSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHHHHHHHHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred hHHHHHHHHHHHHhcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 137999999999999987653 68999998754
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.81 E-value=4.2e-10 Score=97.17 Aligned_cols=186 Identities=16% Similarity=0.126 Sum_probs=113.7
Q ss_pred ccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcC-CCCc--ccceeeEEEeC
Q 020641 20 FVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRL-KHEN--LVELLGYCVEG 96 (323)
Q Consensus 20 ~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~--i~~~~~~~~~~ 96 (323)
+..++.|....||++. ++ +++|+.... .....+.+|.++++.+ .+.. +..++.....+
T Consensus 25 i~~~~~G~~n~v~~v~----~~-~vlR~~~~~--------------~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~ 85 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RD-FIFKFPKHS--------------RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPS 85 (304)
T ss_dssp CCEEEECSSEEEEEST----TS-EEEEEESSH--------------HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCC
T ss_pred eEecCCCCcceEEEEC----CE-EEEEecCCc--------------chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCC
Confidence 4468899999999886 22 344432110 1235678899998877 4433 33444443333
Q ss_pred C---eEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCC--------------------
Q 020641 97 N---LRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKV-------------------- 153 (323)
Q Consensus 97 ~---~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~-------------------- 153 (323)
. ..|+||++++|.++.+..... ++......++.+++..+..||+..
T Consensus 86 ~~~~~~~~vm~~i~G~~l~~~~~~~-----------l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~ 154 (304)
T 3sg8_A 86 ETYQMSFAGFTKIKGVPLTPLLLNN-----------LPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDN 154 (304)
T ss_dssp SSCSCSCEEEECCCCEECCHHHHHT-----------SCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHH
T ss_pred CCCCcceEEEcccCCeECCcccccc-----------CCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHH
Confidence 3 348899999998887543321 666777778888888888887510
Q ss_pred -----------------------------------CCCceeCCCCCCCEEEcc--CCeEEEeeccccCCCCccccccccc
Q 020641 154 -----------------------------------QPSIIHRDIRSSNVLLFE--DFKAKIADFNLSNQAPDMAARLHST 196 (323)
Q Consensus 154 -----------------------------------~~~i~h~dikp~nili~~--~~~~~l~Dfg~~~~~~~~~~~~~~~ 196 (323)
...++|+|++|.||+++. ...+.++||+.+.............
T Consensus 155 ~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~ 234 (304)
T 3sg8_A 155 KKIKKLLSRELKGPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLM 234 (304)
T ss_dssp HHHHHHHTTTSCHHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTC
T ss_pred HHHHHHhcccCCcccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHH
Confidence 135799999999999998 5567899999875422111100000
Q ss_pred cccCccccCCCcccc----C-CC---------CCcccchHHHHHHHHHHHhCCCCC
Q 020641 197 RVLGTFGYHAPEYAM----T-GQ---------LTQKSDVYSFGVVLLELLTGRKPV 238 (323)
Q Consensus 197 ~~~g~~~y~aPE~~~----~-~~---------~~~~~Di~slG~~l~~l~~g~~pf 238 (323)
.. . .-..|+... . .. .....+.|++|.++|.+.+|..+|
T Consensus 235 ~~--~-~~~~~~~~~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 235 ED--D-EEYGMEFVSKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp CT--T-TSCCHHHHHHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred hh--c-cccCHHHHHHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 00 0 001122110 0 00 012358899999999999998776
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.50 E-value=4.1e-07 Score=76.78 Aligned_cols=136 Identities=14% Similarity=0.028 Sum_probs=93.9
Q ss_pred cccCCCCCC-ccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcC-CCCcccceeeEEEeCCe
Q 020641 21 VRLDKGPED-DLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRL-KHENLVELLGYCVEGNL 98 (323)
Q Consensus 21 ~~lg~G~~~-~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~ 98 (323)
.++..|..+ .||++.....+..+.+|..... ....+.+|...|+.+ .+--+.+++.++.+++.
T Consensus 30 ~~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---------------~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~ 94 (272)
T 4gkh_A 30 ARDNVGQSGATIYRLYGKPNAPELFLKHGKGS---------------VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDD 94 (272)
T ss_dssp EEEECSSSSCEEEEEECCTTCCCEEEEEEETH---------------HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTE
T ss_pred EEccCCCcCCeEEEEEecCCCeEEEEEECCCC---------------CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCe
Confidence 355555555 6898877766666666644311 124567888888877 44447788999999999
Q ss_pred EEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCC-------------------------
Q 020641 99 RVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKV------------------------- 153 (323)
Q Consensus 99 ~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~------------------------- 153 (323)
.++||++++|.++.+...... .....+..+++..+..||...
T Consensus 95 ~~lvme~l~G~~~~~~~~~~~-------------~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (272)
T 4gkh_A 95 AWLLTTAIPGKTAFQVLEEYP-------------DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGL 161 (272)
T ss_dssp EEEEEECCCSEEHHHHHHHCG-------------GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTC
T ss_pred EEEEEEeeCCccccccccCCH-------------HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhh
Confidence 999999999988877654321 122345566666666666420
Q ss_pred ------------------------------CCCceeCCCCCCCEEEccCCeEEEeeccccC
Q 020641 154 ------------------------------QPSIIHRDIRSSNVLLFEDFKAKIADFNLSN 184 (323)
Q Consensus 154 ------------------------------~~~i~h~dikp~nili~~~~~~~l~Dfg~~~ 184 (323)
...++|+|+.+.||+++..+.+-|+||+.+.
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 162 VDASDFDDERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp CCGGGCCGGGTTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred hhhhhccccccchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 1137899999999999987777899998764
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.25 E-value=2.3e-06 Score=73.62 Aligned_cols=136 Identities=16% Similarity=0.090 Sum_probs=85.2
Q ss_pred ccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCC---cccceeeEEE-e
Q 020641 20 FVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHE---NLVELLGYCV-E 95 (323)
Q Consensus 20 ~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~---~i~~~~~~~~-~ 95 (323)
+..++.|....||++ +++ +++|+-. . ......+.+|.++++.+.+. .+.+++.+.. .
T Consensus 24 v~~l~~G~~n~v~~v----g~~-~VlR~~~-----~---------~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~ 84 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGD-WVFRFPK-----S---------QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRS 84 (306)
T ss_dssp EEEEEECSSEEEEEE----TTT-EEEEEES-----S---------HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECT
T ss_pred eeecCCCcceeEEEE----CCE-EEEEecC-----C---------chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccC
Confidence 446778888889988 233 3344211 0 01235678999999988542 3556666664 3
Q ss_pred CCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCC----------------------
Q 020641 96 GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKV---------------------- 153 (323)
Q Consensus 96 ~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~---------------------- 153 (323)
.+..++||++++|.++.+..... ++......+..++...+..||+..
T Consensus 85 ~g~~~~v~e~i~G~~l~~~~~~~-----------l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~ 153 (306)
T 3tdw_A 85 DGNPFVGYRKVQGQILGEDGMAV-----------LPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLS 153 (306)
T ss_dssp TSCEEEEEECCCSEECHHHHHTT-----------SCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHH
T ss_pred CCceEEEEeccCCeECchhhhhh-----------CCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHH
Confidence 44578999999998887642211 334444444455555544444321
Q ss_pred -----------------------------------CCCceeCCCCCCCEEEcc---CCe-EEEeeccccCC
Q 020641 154 -----------------------------------QPSIIHRDIRSSNVLLFE---DFK-AKIADFNLSNQ 185 (323)
Q Consensus 154 -----------------------------------~~~i~h~dikp~nili~~---~~~-~~l~Dfg~~~~ 185 (323)
...++|+|+++.||+++. ++. +.|+||+.+..
T Consensus 154 ~~~~~~~~~~l~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 154 EAVEDQVFPLLDESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHTGGGSCHHHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHhcccccchhhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 125699999999999987 455 48999997643
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.99 E-value=1.3e-05 Score=70.34 Aligned_cols=85 Identities=6% Similarity=-0.039 Sum_probs=50.1
Q ss_pred cccc-CCCCCCccceeccce------eeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcC-CC--Ccccce
Q 020641 20 FVRL-DKGPEDDLYLKKRVK------MRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRL-KH--ENLVEL 89 (323)
Q Consensus 20 ~~~l-g~G~~~~V~~~~~~~------~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h--~~i~~~ 89 (323)
+..| +.|....+|++.... .++.+++|+..... ... ......+..|+.+++.+ .+ -.+.++
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~----~~~-----~~~~~~~~~E~~~l~~L~~~~~vpvP~v 95 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAE----DVP-----VFPTYRLDHQFEVIRLVGELTDVPVPRV 95 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGG----GCC-----SSSCCCHHHHHHHHHHHHHHCCSCCCCE
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCC----ccc-----cCchhHHHHHHHHHHHHhhcCCCCCCcE
Confidence 4467 888889999887541 13444555332110 000 00014567788888777 33 346677
Q ss_pred eeEEEeC---CeEEEEEeecCCCCHHH
Q 020641 90 LGYCVEG---NLRVLAYEFATMGSLHD 113 (323)
Q Consensus 90 ~~~~~~~---~~~~lv~e~~~~~sL~~ 113 (323)
+.++.++ ...++|||+++|.++.+
T Consensus 96 ~~~~~~~~~~g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 96 RWIETTGDVLGTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp EEEECSSTTTSSCEEEEECCCCBCCCB
T ss_pred EEEccCCCccCCceEEEEecCCCChhh
Confidence 7776655 34689999998866543
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.92 E-value=6.5e-05 Score=60.14 Aligned_cols=146 Identities=13% Similarity=0.062 Sum_probs=94.4
Q ss_pred CCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEEEeeccccCCCCc
Q 020641 109 GSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPD 188 (323)
Q Consensus 109 ~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~l~Dfg~~~~~~~ 188 (323)
.||.+.++..... +++.++|.++.|.+.++.-+-... .-..+=+.|..|++..+|.+.+.+ +.+.
T Consensus 33 vSL~eIL~~~~~P--------lsEEqaWALc~Qc~~~L~~~~~~~--~~~~~i~~~~~i~l~~dG~V~f~~-~~s~---- 97 (229)
T 2yle_A 33 LSLEEILRLYNQP--------INEEQAWAVCYQCCGSLRAAARRR--QPRHRVRSAAQIRVWRDGAVTLAP-AADD---- 97 (229)
T ss_dssp EEHHHHHHHHTSC--------CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCSGGGEEEETTSCEEECC-C-------
T ss_pred ccHHHHHHHcCCC--------cCHHHHHHHHHHHHHHHHhhhhcc--cCCceecCCcceEEecCCceeccc-cccc----
Confidence 4799999876543 999999999999999988873210 111233467899999999998864 1110
Q ss_pred cccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccccccccchhcCC
Q 020641 189 MAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDP 268 (323)
Q Consensus 189 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (323)
.....+.+||... ...+.+.=|||||+++|.-+--..|=+
T Consensus 98 ----------~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~e~----------------------------- 137 (229)
T 2yle_A 98 ----------AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLKEN----------------------------- 137 (229)
T ss_dssp -------------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCCTT-----------------------------
T ss_pred ----------ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCCcc-----------------------------
Confidence 0133477888653 455678899999999999885333311
Q ss_pred CcCCCCCHHHHHHHHHHHHHccCC-------------------------CCCCCCChHHHHHHHhhhhcCC
Q 020641 269 KLKGEYPPKGVAKLAAVAALCVQY-------------------------EAEFRPNMSIVVKALQPLLKSP 314 (323)
Q Consensus 269 ~~~~~~~~~~~~~l~~li~~cl~~-------------------------~P~~Rps~~evl~~l~~~~~~~ 314 (323)
.+.+.++.|-+||..|..- .+..|+|+++|++.=..=++.+
T Consensus 138 -----eE~eLS~~LE~LL~~Mt~~~~d~~~~DeG~~~~~eg~~d~~~~~~~~~~~sl~~Vi~~C~~hl~~p 203 (229)
T 2yle_A 138 -----EERELSPPLEQLIDHMANTVEADGSNDEGYEAAEEGLGDEDEKRKISAIRSYRDVMKLCAAHLPTE 203 (229)
T ss_dssp -----EEECCCHHHHHHHHHHTTCCC--------------------CCSCCCCCCSHHHHHHHHHTTSSSG
T ss_pred -----cchhhCHHHHHHHHHHHhcccccccccccccccccccccccccccccCcCCHHHHHHHHHhhccCc
Confidence 1223345677777777655 3568899999998765554433
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.90 E-value=5.3e-05 Score=67.51 Aligned_cols=84 Identities=13% Similarity=-0.010 Sum_probs=47.4
Q ss_pred cccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcC-CC-Cc-ccceeeEEEe
Q 020641 19 YFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRL-KH-EN-LVELLGYCVE 95 (323)
Q Consensus 19 ~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h-~~-i~~~~~~~~~ 95 (323)
.+..||.|..+.||++....+++.+++|...... . .. ........+++..|.++++.+ .. +. +.+++.+ +
T Consensus 34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~-r---~~-~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d 106 (397)
T 2olc_A 34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYA-K---VV-GESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--D 106 (397)
T ss_dssp EEEECCSSSSEEEEEEEC----CEEEEEEECCC------------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--E
T ss_pred EEEECCCCceEEEEEEEECCCCcEEEEEecchhh-c---cc-CCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--c
Confidence 3458999999999999766555667777543211 0 00 000012235667788888776 32 33 3345543 3
Q ss_pred CCeEEEEEeecCCC
Q 020641 96 GNLRVLAYEFATMG 109 (323)
Q Consensus 96 ~~~~~lv~e~~~~~ 109 (323)
....++|||++.+.
T Consensus 107 ~~~~~lvmE~l~g~ 120 (397)
T 2olc_A 107 TEMAVTVMEDLSHL 120 (397)
T ss_dssp TTTTEEEECCCTTS
T ss_pred CCccEEEEEeCCCc
Confidence 44568999999763
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.68 E-value=0.00052 Score=59.49 Aligned_cols=29 Identities=24% Similarity=0.352 Sum_probs=26.4
Q ss_pred CceeCCCCCCCEEEccCCeEEEeeccccC
Q 020641 156 SIIHRDIRSSNVLLFEDFKAKIADFNLSN 184 (323)
Q Consensus 156 ~i~h~dikp~nili~~~~~~~l~Dfg~~~ 184 (323)
+++|+|+++.||+++.++.+.++||+.+.
T Consensus 223 ~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 223 NLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp CEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred ceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 89999999999999888889999999653
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.50 E-value=0.00028 Score=60.59 Aligned_cols=77 Identities=13% Similarity=0.059 Sum_probs=55.4
Q ss_pred ccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcC-C--CCcccceeeEEE
Q 020641 18 GYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRL-K--HENLVELLGYCV 94 (323)
Q Consensus 18 ~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~--h~~i~~~~~~~~ 94 (323)
..+..|+.|....+|++... +..+++|+.... ....+..|.+.|+.+ . ...+.+++.+..
T Consensus 39 ~~~~~l~gG~~n~~y~v~~~--~~~~vlK~~~~~---------------~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~ 101 (312)
T 3jr1_A 39 KHKEKLYSGEMNEIWLINDE--VQTVFVKINERS---------------YRSMFRAEADQLALLAKTNSINVPLVYGIGN 101 (312)
T ss_dssp CEEEEECCSSSSEEEEEESS--SCEEEEEEEEGG---------------GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEE
T ss_pred eeeEEeCCccceeeeEEEEC--CCeEEEEeCCcc---------------cHHHHHHHHHHHHHHHhhCCCCcceEEEEee
Confidence 34568999999999999863 333445543311 135678888888877 3 356778888888
Q ss_pred eCCeEEEEEeecCCCCH
Q 020641 95 EGNLRVLAYEFATMGSL 111 (323)
Q Consensus 95 ~~~~~~lv~e~~~~~sL 111 (323)
..+..++|||++++.++
T Consensus 102 ~~g~~~lvme~l~G~~~ 118 (312)
T 3jr1_A 102 SQGHSFLLLEALNKSKN 118 (312)
T ss_dssp CSSEEEEEEECCCCCCC
T ss_pred cCCceEEEEEeccCCCC
Confidence 88889999999998654
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.21 E-value=0.0011 Score=59.35 Aligned_cols=30 Identities=23% Similarity=0.438 Sum_probs=26.6
Q ss_pred CceeCCCCCCCEEEccCCeEEEeeccccCCC
Q 020641 156 SIIHRDIRSSNVLLFEDFKAKIADFNLSNQA 186 (323)
Q Consensus 156 ~i~h~dikp~nili~~~~~~~l~Dfg~~~~~ 186 (323)
.++|+|+++.||+++.++ +.++||+.+...
T Consensus 233 ~liHGDl~~~Nil~~~~~-~~lID~e~a~~G 262 (420)
T 2pyw_A 233 ALIHGDLHTGSVMVTQDS-TQVIDPEFSFYG 262 (420)
T ss_dssp EEECSCCSGGGEEECSSC-EEECCCTTCEEE
T ss_pred eEEecCCCCCcEEEeCCC-CEEEeCcccccC
Confidence 899999999999998876 999999887543
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.18 E-value=0.0007 Score=57.76 Aligned_cols=29 Identities=24% Similarity=0.187 Sum_probs=24.7
Q ss_pred CceeCCCCCCCEEEccCCeEEEeeccccCC
Q 020641 156 SIIHRDIRSSNVLLFEDFKAKIADFNLSNQ 185 (323)
Q Consensus 156 ~i~h~dikp~nili~~~~~~~l~Dfg~~~~ 185 (323)
.++|+|+.+.||+ ..++.+.++||..+..
T Consensus 174 ~l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 174 AACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp EEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred eeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 6899999999999 5667889999987653
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.96 E-value=0.0025 Score=55.11 Aligned_cols=30 Identities=23% Similarity=0.500 Sum_probs=26.3
Q ss_pred CceeCCCCCCCEEEccC----CeEEEeeccccCC
Q 020641 156 SIIHRDIRSSNVLLFED----FKAKIADFNLSNQ 185 (323)
Q Consensus 156 ~i~h~dikp~nili~~~----~~~~l~Dfg~~~~ 185 (323)
.++|+|+.+.||+++.+ +.+.++||+.+..
T Consensus 184 ~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 184 VFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp EEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred eeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 79999999999999874 6789999997754
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.64 E-value=0.0018 Score=58.19 Aligned_cols=74 Identities=11% Similarity=0.028 Sum_probs=43.3
Q ss_pred cccccCCCCCCccceeccce-------eeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCC-CCccccee
Q 020641 19 YFVRLDKGPEDDLYLKKRVK-------MRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLK-HENLVELL 90 (323)
Q Consensus 19 ~~~~lg~G~~~~V~~~~~~~-------~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~ 90 (323)
.+.+|+.|....+|++.... .++.+.+|+.... .....+..|..+++.+. +.-..+++
T Consensus 77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--------------~~~~~li~E~~~l~~L~~~g~~P~l~ 142 (429)
T 1nw1_A 77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--------------ETESHLVAESVIFTLLSERHLGPKLY 142 (429)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--------------CCHHHHHHHHHHHHHHHHTTSSSCEE
T ss_pred EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--------------CcHHHHHHHHHHHHHHHhCCCCCcEE
Confidence 45578888889999987532 1344555543210 01134557888887773 33235566
Q ss_pred eEEEeCCeEEEEEeecCCCC
Q 020641 91 GYCVEGNLRVLAYEFATMGS 110 (323)
Q Consensus 91 ~~~~~~~~~~lv~e~~~~~s 110 (323)
+.+. + .+|++|++|.+
T Consensus 143 ~~~~--~--g~v~e~l~G~~ 158 (429)
T 1nw1_A 143 GIFS--G--GRLEEYIPSRP 158 (429)
T ss_dssp EEET--T--EEEECCCCEEE
T ss_pred EEeC--C--CEEEEEeCCcc
Confidence 5543 2 38899997633
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=96.61 E-value=0.0076 Score=50.88 Aligned_cols=75 Identities=12% Similarity=0.066 Sum_probs=45.7
Q ss_pred cccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCC-CC--cccceeeEEEe
Q 020641 19 YFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLK-HE--NLVELLGYCVE 95 (323)
Q Consensus 19 ~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~--~i~~~~~~~~~ 95 (323)
-+.++|.|..+.||++.... ++.+.+|+.... .......+..|...|+.+. .. -+.+++.+ .
T Consensus 19 ~v~~~g~G~~~~vyrv~l~D-G~~~~vK~~~~~------------~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~ 83 (288)
T 3f7w_A 19 AVAERGHSHRWHLYRVELAD-GTPLFVKALPDD------------APALDGLFRAEALGLDWLGRSFGSPVPQVAGW--D 83 (288)
T ss_dssp EEEEEEEETTEEEEEEEETT-SCEEEEEECCTT------------CCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE--E
T ss_pred EEEecCCCCCeEEEEEEECC-CCEEEEEEeCCC------------CcchhhHHHHHHHHHHHHHhhCCCCcceEEec--c
Confidence 34588999999999998654 444555543211 1112355778888888773 22 23344443 2
Q ss_pred CCeEEEEEeecCCCC
Q 020641 96 GNLRVLAYEFATMGS 110 (323)
Q Consensus 96 ~~~~~lv~e~~~~~s 110 (323)
. .++||||..++.
T Consensus 84 ~--~~lv~e~l~~~~ 96 (288)
T 3f7w_A 84 D--RTLAMEWVDERP 96 (288)
T ss_dssp T--TEEEEECCCCCC
T ss_pred C--ceEEEEeecccC
Confidence 2 378999987654
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.59 E-value=0.0069 Score=54.80 Aligned_cols=79 Identities=13% Similarity=0.040 Sum_probs=44.3
Q ss_pred CCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcc-cceeeEEE
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENL-VELLGYCV 94 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~ 94 (323)
....+.+|+.|-...+|++.....+..+.+|+.... .... -+-..|..+++.+...++ .++++.+.
T Consensus 109 ~~~~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~------------~~~~-idR~~E~~vl~~L~~~gl~P~ll~~~~ 175 (458)
T 2qg7_A 109 DSLEFQIINGGITNILIKVKDMSKQAKYLIRLYGPK------------TDEI-INREREKKISCILYNKNIAKKIYVFFT 175 (458)
T ss_dssp TTEEEEEECC--CEEEEEEEETTTTEEEEEEEECC-------------CCSC-SCHHHHHHHHHHHTTSSSBCCEEEEET
T ss_pred cCeEEEEcCCCeEeEEEEEEECCCCceEEEEECCCC------------hhhh-cCHHHHHHHHHHHHhcCCCCCEEEEeC
Confidence 334556888898999999876542344556644211 0111 112577777777744444 45666652
Q ss_pred eCCeEEEEEeecCCCCH
Q 020641 95 EGNLRVLAYEFATMGSL 111 (323)
Q Consensus 95 ~~~~~~lv~e~~~~~sL 111 (323)
+ .+|++|++|.+|
T Consensus 176 --~--G~v~e~I~G~~l 188 (458)
T 2qg7_A 176 --N--GRIEEFMDGYAL 188 (458)
T ss_dssp --T--EEEEECCCSEEC
T ss_pred --C--eEEEEeeCCccC
Confidence 3 259999987443
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.42 E-value=0.0025 Score=56.16 Aligned_cols=148 Identities=15% Similarity=0.057 Sum_probs=76.3
Q ss_pred cccccCCCCCCccceeccce-------eeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcC-CCCccccee
Q 020641 19 YFVRLDKGPEDDLYLKKRVK-------MRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRL-KHENLVELL 90 (323)
Q Consensus 19 ~~~~lg~G~~~~V~~~~~~~-------~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~ 90 (323)
.+.+|..|-...+|++.... .++.+.+|+.- . .........+|..+++.+ .+.-..+++
T Consensus 54 ~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g-~------------~~~~~~~~~rE~~vl~~L~~~gv~P~ll 120 (379)
T 3feg_A 54 RVYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYG-A------------ILQGVDSLVLESVMFAILAERSLGPQLY 120 (379)
T ss_dssp CCEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----------------CCHHHHHHHHHHHHHHHHTTSSCCEE
T ss_pred EEEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECC-C------------ccchHHHHHHHHHHHHHHHhcCCCCeEE
Confidence 45578888888999887642 22344454321 0 011235556888888777 333335566
Q ss_pred eEEEeCCeEEEEEeecCCCCHHHH--------------hccCCCCCCCCCCCCC--CHHHHHHHHHHHHH----------
Q 020641 91 GYCVEGNLRVLAYEFATMGSLHDI--------------LHGRKGVQGAQPGPVL--DWMTRVRIAVDAAR---------- 144 (323)
Q Consensus 91 ~~~~~~~~~~lv~e~~~~~sL~~~--------------~~~~~~~~~~~~~~~~--~~~~~~~~~~~i~~---------- 144 (323)
+.+.+ .+|+||++|.+|..- +.+-.... ..-.... .+..+.+++.++..
T Consensus 121 ~~~~~----g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~-~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~ 195 (379)
T 3feg_A 121 GVFPE----GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGME-MPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMN 195 (379)
T ss_dssp EEETT----EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCC-CSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCC
T ss_pred EEcCC----ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCC-CCCCCCcccHHHHHHHHHHHHHhccCcccchhh
Confidence 65543 289999987544311 00000000 0001111 23444445444322
Q ss_pred ---------HHHHhh----cC-CCCCceeCCCCCCCEEEccC----CeEEEeeccccC
Q 020641 145 ---------GLEYLH----EK-VQPSIIHRDIRSSNVLLFED----FKAKIADFNLSN 184 (323)
Q Consensus 145 ---------~l~~lh----~~-~~~~i~h~dikp~nili~~~----~~~~l~Dfg~~~ 184 (323)
.+..|. .. ....++|+|+.+.||+++.+ +.+.++||..+.
T Consensus 196 ~~~~~~l~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 196 LLEMYSLKDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHTTHHHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred hhhhHHHHHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 122221 11 12368999999999999876 689999998764
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.28 E-value=0.0043 Score=54.44 Aligned_cols=28 Identities=21% Similarity=0.466 Sum_probs=23.7
Q ss_pred CceeCCCCCCCEEEccCCeEEEeeccccC
Q 020641 156 SIIHRDIRSSNVLLFEDFKAKIADFNLSN 184 (323)
Q Consensus 156 ~i~h~dikp~nili~~~~~~~l~Dfg~~~ 184 (323)
.++|+|+++.||+++.+. +.++||+.+.
T Consensus 213 ~l~HgDl~~~Nil~~~~~-~~lID~e~a~ 240 (369)
T 3c5i_A 213 VFCHNDLQENNIINTNKC-LRLIDFEYSG 240 (369)
T ss_dssp EEECSCCCGGGEEECC-C-EEECCCTTCE
T ss_pred EEEeCCCCcccEEecCCc-EEEEEecCCC
Confidence 689999999999998654 8999998764
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.22 E-value=0.054 Score=46.37 Aligned_cols=28 Identities=21% Similarity=0.318 Sum_probs=24.4
Q ss_pred CceeCCCCCCCEEEccCCeEEEeeccccCC
Q 020641 156 SIIHRDIRSSNVLLFEDFKAKIADFNLSNQ 185 (323)
Q Consensus 156 ~i~h~dikp~nili~~~~~~~l~Dfg~~~~ 185 (323)
.++|+|+++.||+++ + .+.++||+.+..
T Consensus 196 ~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 196 LRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp EECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred eeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 689999999999999 4 899999987643
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=92.08 E-value=0.81 Score=36.44 Aligned_cols=122 Identities=7% Similarity=0.103 Sum_probs=79.1
Q ss_pred HHHHHhcCCCCcccceeeEEEeCCeEEEEEeecCC-CCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcC
Q 020641 74 LVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATM-GSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEK 152 (323)
Q Consensus 74 e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~ 152 (323)
|+.+|.. .||+.+.. .+-.+.+.+.+.++.-.. .++.. ++. .+....+.++.+|+....+++.
T Consensus 36 el~LL~~-~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-ik~------------~~~~eKlr~l~ni~~l~~~~~~- 99 (215)
T 4ann_A 36 LMYLLEQ-HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-IKS------------FTKNEKLRYLLNIKNLEEVNRT- 99 (215)
T ss_dssp GGGGGGS-CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-GGG------------SCHHHHHHHHHHGGGGGGGGGS-
T ss_pred HHHHHhc-cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-HHh------------cCHHHHHHHHHHHHHHHHHhcC-
Confidence 3444442 67888766 555566665555554332 23333 332 7788999999999888855543
Q ss_pred CCCCceeCCCCCCCEEEccCCeEEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHH
Q 020641 153 VQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELL 232 (323)
Q Consensus 153 ~~~~i~h~dikp~nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~ 232 (323)
=+|--++|+|++++.++.+++.-.|+-.. ++|. ..++..=.-..=+++..++
T Consensus 100 ----r~tf~L~P~NL~f~~~~~p~i~~RGik~~-------------------l~P~-----~~~ee~fL~qyKAliiall 151 (215)
T 4ann_A 100 ----RYTFVLAPDELFFTRDGLPIAKTRGLQNV-------------------VDPL-----PVSEAEFLTRYKALVICAF 151 (215)
T ss_dssp ----SEECCCSGGGEEECTTSCEEESCCEETTT-------------------BSCC-----CCCHHHHHHHHHHHHHHHH
T ss_pred ----ceEEEEecceEEEcCCCCEEEEEccCccC-------------------CCCC-----CCCHHHHHHHHHHHHHHHH
Confidence 46788999999999999999987775322 1121 1111122235667888999
Q ss_pred hCCCCCC
Q 020641 233 TGRKPVD 239 (323)
Q Consensus 233 ~g~~pf~ 239 (323)
++++.|.
T Consensus 152 ~~K~~Fe 158 (215)
T 4ann_A 152 NEKQSFD 158 (215)
T ss_dssp CTTCCHH
T ss_pred cCCCCHH
Confidence 9999885
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=91.92 E-value=0.054 Score=46.24 Aligned_cols=29 Identities=28% Similarity=0.490 Sum_probs=25.1
Q ss_pred CceeCCCCCCCEEEccCCeEEEeeccccC
Q 020641 156 SIIHRDIRSSNVLLFEDFKAKIADFNLSN 184 (323)
Q Consensus 156 ~i~h~dikp~nili~~~~~~~l~Dfg~~~ 184 (323)
+++|+|+++.||+++.+..+.++||+.+.
T Consensus 188 ~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 188 GVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp EEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred ccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 79999999999999887656899998653
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=90.86 E-value=0.2 Score=43.23 Aligned_cols=30 Identities=27% Similarity=0.329 Sum_probs=26.6
Q ss_pred CceeCCCCCCCEEEccCCeEEEeeccccCC
Q 020641 156 SIIHRDIRSSNVLLFEDFKAKIADFNLSNQ 185 (323)
Q Consensus 156 ~i~h~dikp~nili~~~~~~~l~Dfg~~~~ 185 (323)
.++|+|+.+.||+++.++.+.++||+.+..
T Consensus 207 ~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 207 VLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp EEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred eeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 799999999999999888899999986543
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=90.70 E-value=1.3 Score=35.41 Aligned_cols=113 Identities=9% Similarity=0.096 Sum_probs=76.1
Q ss_pred CCCcccceeeEEEeCCeEEEEEeecCCC-CHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHH-HhhcCCCCCcee
Q 020641 82 KHENLVELLGYCVEGNLRVLAYEFATMG-SLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLE-YLHEKVQPSIIH 159 (323)
Q Consensus 82 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~-sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~-~lh~~~~~~i~h 159 (323)
.||+. ....-.+.+.+.+.++.-+++ ++. .++. .+....++++.+|+.... +++ .-+|
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~-~i~~------------~~~~eKlrll~nl~~L~~~~~~-----~r~t 107 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFA-AIRK------------TTLLSRIRAAIHLVSKVKHHSA-----RRLI 107 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHH-HHHT------------SCHHHHHHHHHHHHHHHSSCCS-----SSEE
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHH-HHHh------------cCHHHHHHHHHHHHHHHHHhhh-----Ccee
Confidence 56777 445556667766666655343 444 3432 778899999999988777 554 3467
Q ss_pred CCCCCCCEEEccCCeEEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchH-HHHHHHHHHHhCCCCC
Q 020641 160 RDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVY-SFGVVLLELLTGRKPV 238 (323)
Q Consensus 160 ~dikp~nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~-slG~~l~~l~~g~~pf 238 (323)
--++|+|++++.++.+++.-.|+-.. ++|..+ + ..|.| .+=|++..++.+++.|
T Consensus 108 f~l~P~NL~f~~~~~p~i~hRGi~~~-------------------lpP~e~-----~-ee~fl~qyKali~all~~K~~F 162 (219)
T 4ano_A 108 FIVCPENLMFNRALEPFFLHVGVKES-------------------LPPDEW-----D-DERLLREVKATVLALTEGEYRF 162 (219)
T ss_dssp CCCCGGGEEECTTCCEEESCCEETTT-------------------BSSCSC-----C-HHHHHHHHHHHHHHHTTCSSCH
T ss_pred EEEeCceEEEeCCCcEEEEEcCCccc-------------------CCCCCC-----C-HHHHHHHHHHHHHHHHcCCCCH
Confidence 78999999999999999987775322 222211 1 12332 6667888888888887
Q ss_pred C
Q 020641 239 D 239 (323)
Q Consensus 239 ~ 239 (323)
.
T Consensus 163 e 163 (219)
T 4ano_A 163 D 163 (219)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=83.98 E-value=0.46 Score=41.95 Aligned_cols=30 Identities=33% Similarity=0.511 Sum_probs=24.6
Q ss_pred CceeCCCCCCCEEEc------cCCeEEEeeccccCC
Q 020641 156 SIIHRDIRSSNVLLF------EDFKAKIADFNLSNQ 185 (323)
Q Consensus 156 ~i~h~dikp~nili~------~~~~~~l~Dfg~~~~ 185 (323)
.++|+|+.+.||++. .+..+.++||..|..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 468999999999993 456799999987743
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 323 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 5e-58 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 8e-51 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-49 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-49 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 9e-48 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-47 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-46 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-46 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-46 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-46 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-46 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 6e-46 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 7e-46 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 9e-46 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-44 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-44 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-44 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-43 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-43 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 9e-43 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 3e-41 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 5e-41 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 5e-41 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 5e-41 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 5e-41 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 6e-41 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 7e-40 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-39 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 5e-39 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-38 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 8e-38 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 3e-34 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-33 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 3e-32 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 4e-32 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-31 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-31 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 8e-31 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-30 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-30 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-30 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-29 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 3e-29 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-28 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 3e-27 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 5e-27 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-26 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-26 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 3e-25 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 5e-25 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 6e-25 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 7e-25 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-24 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 4e-23 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-22 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 7e-22 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 7e-22 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-19 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-17 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-17 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-16 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-15 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 4e-07 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (473), Expect = 5e-58
Identities = 64/262 (24%), Positives = 113/262 (43%), Gaps = 29/262 (11%)
Query: 60 RLKSPKNYPDDEKQL---VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILH 116
L P + V V+ + +H N++ +GY L + ++ SL+ LH
Sbjct: 37 MLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQL-AIVTQWCEGSSLYHHLH 95
Query: 117 GRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAK 176
+ + + + IA A+G++YLH K SIIHRD++S+N+ L ED K
Sbjct: 96 IIETK--------FEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVK 144
Query: 177 IADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT---GQLTQKSDVYSFGVVLLELLT 233
I DF L+ + ++ G+ + APE + +SDVY+FG+VL EL+T
Sbjct: 145 IGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMT 204
Query: 234 GRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYE 293
G+ P + R Q V + + + + A C++ +
Sbjct: 205 GQLPYSNINNRDQI-----------IFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKK 253
Query: 294 AEFRPNMSIVVKALQPLLKSPP 315
+ RP ++ +++ L +S P
Sbjct: 254 RDERPLFPQILASIELLARSLP 275
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (424), Expect = 8e-51
Identities = 61/254 (24%), Positives = 105/254 (41%), Gaps = 27/254 (10%)
Query: 60 RLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK 119
LK PD +++ +L+H+ LV L + + + E+ GSL D L
Sbjct: 44 SLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPS 102
Query: 120 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIAD 179
G++ L + +A A G+ ++ E+ + IHRD+R++N+L+ + KIAD
Sbjct: 103 GIK-------LTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIAD 152
Query: 180 FNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVD 239
F L+ D + APE G T KSDV+SFG++L E++T +
Sbjct: 153 FGLARLIEDNEYT-AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPY 211
Query: 240 HTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPN 299
M + +V Q ++ + P +L + LC + E RP
Sbjct: 212 PGM---------------TNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPT 256
Query: 300 MSIVVKALQPLLKS 313
+ L+ +
Sbjct: 257 FDYLRSVLEDFFTA 270
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (419), Expect = 1e-49
Identities = 50/261 (19%), Positives = 101/261 (38%), Gaps = 32/261 (12%)
Query: 75 VSVVSRLKHENLVELLGYCVEGNLRV----LAYEFATMGSLHDILHGRKGVQGAQPGPVL 130
+ L+HEN++ + + N L ++ GSL D L+ +
Sbjct: 48 IYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT----------V 97
Query: 131 DWMTRVRIAVDAARGLEYLHEKV-----QPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQ 185
+++A+ A GL +LH ++ +P+I HRD++S N+L+ ++ IAD L+ +
Sbjct: 98 TVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 157
Query: 186 APDMAARLH--STRVLGTFGYHAPEYAMT------GQLTQKSDVYSFGVVLLELLTGRKP 237
+ +GT Y APE + +++D+Y+ G+V E+
Sbjct: 158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSI 217
Query: 238 ----VDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAK-LAAVAALCVQY 292
D+ +P + + + +Q + P + + + +A + C
Sbjct: 218 GGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYA 277
Query: 293 EAEFRPNMSIVVKALQPLLKS 313
R + K L L +
Sbjct: 278 NGAARLTALRIKKTLSQLSQQ 298
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (419), Expect = 1e-49
Identities = 56/266 (21%), Positives = 100/266 (37%), Gaps = 30/266 (11%)
Query: 63 SPKNYPDDEKQL---VSVVSRLK-HENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGR 118
P + + + L + V+S L H N+V LLG C G ++ E+ G L + L +
Sbjct: 62 KPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRK 121
Query: 119 KG---------VQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLL 169
+ LD + + A+G+ +L K + IHRD+ + N+LL
Sbjct: 122 RDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILL 178
Query: 170 FEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLL 229
KI DF L+ + + + + APE T +SDV+S+G+ L
Sbjct: 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLW 238
Query: 230 ELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALC 289
EL + MP + K + + + P A++ + C
Sbjct: 239 ELFSLGSSPYPGMP--------------VDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTC 284
Query: 290 VQYEAEFRPNMSIVVKALQPLLKSPP 315
+ RP +V+ ++ +
Sbjct: 285 WDADPLKRPTFKQIVQLIEKQISEST 310
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (403), Expect = 9e-48
Identities = 59/254 (23%), Positives = 105/254 (41%), Gaps = 27/254 (10%)
Query: 60 RLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK 119
++ +D + V+ +L H LV+L G C+E L +EF G L D L ++
Sbjct: 36 TIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQR 95
Query: 120 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIAD 179
G+ T + + +D G+ YL E +IHRD+ + N L+ E+ K++D
Sbjct: 96 GLF--------AAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSD 144
Query: 180 FNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVD 239
F ++ D ST + +PE + + KSDV+SFGV++ E+ + K
Sbjct: 145 FGMTRFVLDDQYT-SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPY 203
Query: 240 HTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPN 299
S +V + + + P + + C + E RP
Sbjct: 204 ENR---------------SNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPA 248
Query: 300 MSIVVKALQPLLKS 313
S +++ L + +S
Sbjct: 249 FSRLLRQLAEIAES 262
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (403), Expect = 1e-47
Identities = 51/249 (20%), Positives = 102/249 (40%), Gaps = 27/249 (10%)
Query: 75 VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 134
++ + H N++ L G + ++ E+ G+L L + G +
Sbjct: 60 AGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGE--------FSVLQ 111
Query: 135 RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 194
V + A G++YL + +HRD+ + N+L+ + K++DF LS D +
Sbjct: 112 LVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATY 168
Query: 195 ST-RVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWA 253
+T + APE + T SDV+SFG+V+ E++T + +
Sbjct: 169 TTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWEL----------- 217
Query: 254 TPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKS 313
S +V + ++ + P + + + C Q E RP + +V L L+++
Sbjct: 218 ----SNHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273
Query: 314 PPPAAPVSE 322
P +++
Sbjct: 274 PDSLKTLAD 282
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (397), Expect = 1e-46
Identities = 70/257 (27%), Positives = 109/257 (42%), Gaps = 27/257 (10%)
Query: 60 RLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK 119
LK P+ Q V+ +L+HE LV+L E + + E+ + GSL D L G
Sbjct: 48 TLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGET 106
Query: 120 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIAD 179
G L V +A A G+ Y+ + + +HRD+R++N+L+ E+ K+AD
Sbjct: 107 G-------KYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVAD 156
Query: 180 FNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVD 239
F L+ D + APE A+ G+ T KSDV+SFG++L EL T +
Sbjct: 157 FGLARLIED-NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY 215
Query: 240 HTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPN 299
P + +V V+ + PP+ L + C + E E RP
Sbjct: 216 ---------------PGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPT 260
Query: 300 MSIVVKALQPLLKSPPP 316
+ L+ S P
Sbjct: 261 FEYLQAFLEDYFTSTEP 277
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 157 bits (398), Expect = 1e-46
Identities = 53/243 (21%), Positives = 97/243 (39%), Gaps = 29/243 (11%)
Query: 75 VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 134
S++ + H N++ L G + ++ EF GSL L G +
Sbjct: 78 ASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF--------TVIQ 129
Query: 135 RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 194
V + A G++YL + +HRD+ + N+L+ + K++DF LS D +
Sbjct: 130 LVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPT 186
Query: 195 STRVLG---TFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVT 251
T LG + APE + T SDV+S+G+V+ E+++ + M
Sbjct: 187 YTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDM--------- 237
Query: 252 WATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLL 311
+ V ++ + P + L + C Q + RP +V L ++
Sbjct: 238 ------TNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMI 291
Query: 312 KSP 314
++P
Sbjct: 292 RNP 294
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (400), Expect = 1e-46
Identities = 56/267 (20%), Positives = 105/267 (39%), Gaps = 32/267 (11%)
Query: 60 RLKSPKNYPDDEKQLVSVVSRL-KHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGR 118
+ K+ + + + ++++L HEN+V LLG C L +E+ G L + L +
Sbjct: 76 KEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSK 135
Query: 119 KG--------------VQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRS 164
+ ++ + VL + + A A+G+E+L K S +HRD+ +
Sbjct: 136 REKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAA 192
Query: 165 SNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSF 224
NVL+ KI DF L+ + + + APE G T KSDV+S+
Sbjct: 193 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSY 252
Query: 225 GVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAA 284
G++L E+ + +P + + K + P ++
Sbjct: 253 GILLWEIFSLGVNPYPGIPVDAN--------------FYKLIQNGFKMDQPFYATEEIYI 298
Query: 285 VAALCVQYEAEFRPNMSIVVKALQPLL 311
+ C +++ RP+ + L L
Sbjct: 299 IMQSCWAFDSRKRPSFPNLTSFLGCQL 325
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 157 bits (397), Expect = 1e-46
Identities = 61/255 (23%), Positives = 106/255 (41%), Gaps = 26/255 (10%)
Query: 60 RLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK 119
LK ++ + +V+ +KH NLV+LLG C + EF T G+L D L
Sbjct: 49 TLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN 108
Query: 120 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIAD 179
+ + + +A + +EYL +K + IHRD+ + N L+ E+ K+AD
Sbjct: 109 R-------QEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVAD 158
Query: 180 FNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVD 239
F LS H + APE + + KSDV++FGV+L E+ T
Sbjct: 159 FGLSRLMTGDTYTAH-AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 217
Query: 240 HTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPN 299
P + +V + ++ + E P K+ + C Q+ RP+
Sbjct: 218 ---------------PGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPS 262
Query: 300 MSIVVKALQPLLKSP 314
+ + +A + + +
Sbjct: 263 FAEIHQAFETMFQES 277
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 156 bits (396), Expect = 2e-46
Identities = 57/268 (21%), Positives = 102/268 (38%), Gaps = 33/268 (12%)
Query: 60 RLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK 119
+ ++ + D ++ ++++ + N+V+LLG C G L +E+ G L++ L
Sbjct: 52 KEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMS 111
Query: 120 G---------------VQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRS 164
+ P L ++ IA A G+ YL E +HRD+ +
Sbjct: 112 PHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLAT 168
Query: 165 SNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSF 224
N L+ E+ KIADF LS + PE + T +SDV+++
Sbjct: 169 RNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAY 228
Query: 225 GVVLLELLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAA 284
GVVL E+ + + M E+ + D + P +L
Sbjct: 229 GVVLWEIFSYGLQPYYGMAH--------------EEVIYYVRDGNIL-ACPENCPLELYN 273
Query: 285 VAALCVQYEAEFRPNMSIVVKALQPLLK 312
+ LC RP+ + + LQ + +
Sbjct: 274 LMRLCWSKLPADRPSFCSIHRILQRMCE 301
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (391), Expect = 6e-46
Identities = 63/235 (26%), Positives = 103/235 (43%), Gaps = 31/235 (13%)
Query: 75 VSVVSRLKHENLVELLGYCVEGNLRV-LAYEFATMGSLHDILHGRKGVQGAQPGPVLDWM 133
SV+++L+H NLV+LLG VE + + E+ GSL D L R VL
Sbjct: 51 ASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR-------SVLGGD 103
Query: 134 TRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARL 193
++ ++D +EYL + +HRD+ + NVL+ ED AK++DF L+ +A
Sbjct: 104 CLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST---- 156
Query: 194 HSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWA 253
+ APE + + KSDV+SFG++L E+ + +
Sbjct: 157 -QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPY-------------- 201
Query: 254 TPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQ 308
PR+ V V+ K + P + V C +A RP+ + + L+
Sbjct: 202 -PRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLE 255
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (390), Expect = 7e-46
Identities = 52/249 (20%), Positives = 94/249 (37%), Gaps = 27/249 (10%)
Query: 60 RLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK 119
+K D+ + V+ L HE LV+L G C + + E+ G L + L +
Sbjct: 35 MIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMR 94
Query: 120 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIAD 179
+ + D +EYL K +HRD+ + N L+ + K++D
Sbjct: 95 HR--------FQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSD 143
Query: 180 FNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVD 239
F LS D S + PE M + + KSD+++FGV++ E+ + K
Sbjct: 144 FGLSRYVLDDEYT-SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPY 202
Query: 240 HTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPN 299
R + + + + L+ P K+ + C +A+ RP
Sbjct: 203 ---------------ERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPT 247
Query: 300 MSIVVKALQ 308
I++ +
Sbjct: 248 FKILLSNIL 256
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (394), Expect = 9e-46
Identities = 42/190 (22%), Positives = 78/190 (41%), Gaps = 15/190 (7%)
Query: 60 RLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK 119
L+ + + + V+ +V G + E GSL +L
Sbjct: 40 HLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG 99
Query: 120 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIAD 179
+ ++++ +GL YL EK I+HRD++ SN+L+ + K+ D
Sbjct: 100 R---------IPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCD 148
Query: 180 FNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVD 239
F +S Q D + +GT Y +PE + +SD++S G+ L+E+ GR P+
Sbjct: 149 FGVSGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIP 204
Query: 240 HTMPRGQQSL 249
+ + +
Sbjct: 205 PPDAKELELM 214
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (384), Expect = 1e-44
Identities = 58/240 (24%), Positives = 104/240 (43%), Gaps = 28/240 (11%)
Query: 75 VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 134
++ +L + +V L+G C L +L E A G LH L G++ +
Sbjct: 60 AQIMHQLDNPYIVRLIGVCQAEAL-MLVMEMAGGGPLHKFLVGKREE--------IPVSN 110
Query: 135 RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQA-PDMAARL 193
+ + G++YL EK + +HRD+ + NVLL AKI+DF LS D +
Sbjct: 111 VAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYT 167
Query: 194 HSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWA 253
+ ++APE + + +SDV+S+GV + E L+ +
Sbjct: 168 ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQK---------------P 212
Query: 254 TPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKS 313
++ +V ++ + E PP+ +L A+ + C Y+ E RP+ V + ++ S
Sbjct: 213 YKKMKGPEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (384), Expect = 2e-44
Identities = 46/241 (19%), Positives = 92/241 (38%), Gaps = 27/241 (11%)
Query: 75 VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 134
V++ + + ++ LLG C+ ++++ + G L D + K
Sbjct: 62 AYVMASVDNPHVCRLLGICLTSTVQLI-TQLMPFGCLLDYVREHKDNI--------GSQY 112
Query: 135 RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 194
+ V A+G+ YL ++ ++HRD+ + NVL+ KI DF L+ H
Sbjct: 113 LLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH 169
Query: 195 STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWAT 254
+ + A E + T +SDV+S+GV + EL+T +P +
Sbjct: 170 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-------- 221
Query: 255 PRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSP 314
+ ++ + PP + + C +A+ RP ++ + + P
Sbjct: 222 -------ISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 274
Query: 315 P 315
Sbjct: 275 Q 275
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (383), Expect = 2e-44
Identities = 54/242 (22%), Positives = 91/242 (37%), Gaps = 29/242 (11%)
Query: 75 VSVVSRLKHENLVELLGYCVEG-NLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWM 133
++ H N++ LLG C+ ++ + G L + +
Sbjct: 79 GIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN--------PTVK 130
Query: 134 TRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPD--MAA 191
+ + A+G+++L +HRD+ + N +L E F K+ADF L+ D +
Sbjct: 131 DLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDS 187
Query: 192 RLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVT 251
+ T + A E T + T KSDV+SFGV+L EL+T P P +
Sbjct: 188 VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP-----PYPDVNTFD 242
Query: 252 WATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLL 311
+ Q P L V C +AE RP+ S +V + +
Sbjct: 243 IT------VYLLQGRRLLQPEYCPD----PLYEVMLKCWHPKAEMRPSFSELVSRISAIF 292
Query: 312 KS 313
+
Sbjct: 293 ST 294
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 1e-43
Identities = 58/258 (22%), Positives = 104/258 (40%), Gaps = 32/258 (12%)
Query: 60 RLKSPKNYPDDEKQL---VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILH 116
LK+ N P + +L +V+ +L + +V ++G C + +L E A +G L+ L
Sbjct: 41 ILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQ 99
Query: 117 GRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAK 176
+ + + + + G++YL E + +HRD+ + NVLL AK
Sbjct: 100 QNRH---------VKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAK 147
Query: 177 IADFNLSNQ-APDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGR 235
I+DF LS D T ++APE + + KSDV+SFGV++ E +
Sbjct: 148 ISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYG 207
Query: 236 KPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAE 295
+ + +V ++ + P ++ + LC Y+ E
Sbjct: 208 QK---------------PYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVE 252
Query: 296 FRPNMSIVVKALQPLLKS 313
RP + V L+
Sbjct: 253 NRPGFAAVELRLRNYYYD 270
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (378), Expect = 1e-43
Identities = 62/260 (23%), Positives = 109/260 (41%), Gaps = 32/260 (12%)
Query: 68 PDDEKQL---VSVVSRL-KHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQ- 122
DD + + V+ +L H N++ LLG C LA E+A G+L D L + ++
Sbjct: 51 KDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLET 110
Query: 123 ------GAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAK 176
L + A D ARG++YL +K IHRD+ + N+L+ E++ AK
Sbjct: 111 DPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAK 167
Query: 177 IADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRK 236
IADF LS + T + A E T SDV+S+GV+L E+++
Sbjct: 168 IADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGG 224
Query: 237 PVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEF 296
M + ++ + + + E P ++ + C + +
Sbjct: 225 TPYCGM---------------TCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYE 269
Query: 297 RPNMSIVVKALQPLLKSPPP 316
RP+ + ++ +L +L+
Sbjct: 270 RPSFAQILVSLNRMLEERKT 289
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (369), Expect = 9e-43
Identities = 58/247 (23%), Positives = 94/247 (38%), Gaps = 36/247 (14%)
Query: 62 KSPKNYPDDEKQL---VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGR 118
K+ E QL V + S L+H N++ L GY + L E+A +G+++ L
Sbjct: 41 KAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL 100
Query: 119 KGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIA 178
D + A L Y H K +IHRDI+ N+LL + KIA
Sbjct: 101 SK---------FDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIA 148
Query: 179 DFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPV 238
DF S AP T + GT Y PE +K D++S GV+ E L G+ P
Sbjct: 149 DFGWSVHAPSS----RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF 204
Query: 239 DHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRP 298
+ + ++ + + D + + +++ RP
Sbjct: 205 EANTYQETYKRISRVEFTFPDFVTEGARD-----------------LISRLLKHNPSQRP 247
Query: 299 NMSIVVK 305
+ V++
Sbjct: 248 MLREVLE 254
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (360), Expect = 3e-41
Identities = 59/247 (23%), Positives = 94/247 (38%), Gaps = 27/247 (10%)
Query: 60 RLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK 119
+K + P++ K+ + + L HEN+V+ G+ EGN++ L E+ + G L D +
Sbjct: 39 DMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI 98
Query: 120 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIAD 179
G + R G+ YLH I HRDI+ N+LL E KI+D
Sbjct: 99 G---------MPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISD 146
Query: 180 FNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQL-TQKSDVYSFGVVLLELLTGRKPV 238
F L+ ++ GT Y APE + + DV+S G+VL +L G P
Sbjct: 147 FGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPW 206
Query: 239 DHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRP 298
D Q+ + K K + A+ + R
Sbjct: 207 DQPSDSCQE--------------YSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARI 252
Query: 299 NMSIVVK 305
+ + K
Sbjct: 253 TIPDIKK 259
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 5e-41
Identities = 44/235 (18%), Positives = 91/235 (38%), Gaps = 27/235 (11%)
Query: 75 VSVVSRLKHENLVELLGYCVE--GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDW 132
V+++ LKH N+V ++ + E+ G L ++ +G + LD
Sbjct: 54 VNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVIT-----KGTKERQYLDE 108
Query: 133 MTRVRIAVDAARGLEYLHEK--VQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMA 190
+R+ L+ H + +++HRD++ +NV L K+ DF L+
Sbjct: 109 EFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDT 168
Query: 191 ARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLV 250
+ + +GT Y +PE +KSD++S G +L EL P +
Sbjct: 169 S--FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELA--- 223
Query: 251 TWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305
K+++ ++ Y +L + + + RP++ +++
Sbjct: 224 ---------GKIREGKFRRIPYRYSD----ELNEIITRMLNLKDYHRPSVEEILE 265
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (360), Expect = 5e-41
Identities = 62/245 (25%), Positives = 102/245 (41%), Gaps = 26/245 (10%)
Query: 75 VSVVSRL-KHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKG-------VQGAQP 126
+ ++ + KH+N++ LLG C + + E+A+ G+L + L R+ P
Sbjct: 69 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNP 128
Query: 127 GPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQA 186
L V A ARG+EYL K IHRD+ + NVL+ ED KIADF L+
Sbjct: 129 EEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDI 185
Query: 187 PDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQ 246
+ +T + APE T +SDV+SFGV+L E+ T +P
Sbjct: 186 HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP--- 242
Query: 247 QSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKA 306
+++ + + + + P +L + C RP +V+
Sbjct: 243 ------------VEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 290
Query: 307 LQPLL 311
L ++
Sbjct: 291 LDRIV 295
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 5e-41
Identities = 48/254 (18%), Positives = 90/254 (35%), Gaps = 37/254 (14%)
Query: 60 RLKSPKNYPDDEKQL---VSVVSRLKHENLVELLGYCVE----GNLRVLAYEFATMGSLH 112
L+ K + ++ ++ L+H N+V VL E T G+L
Sbjct: 41 ELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLK 100
Query: 113 DILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLF-E 171
L K V+ +GL++LH + P IIHRD++ N+ +
Sbjct: 101 TYLKRFK---------VMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGP 150
Query: 172 DFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLEL 231
KI D L+ + V+GT + APE + + DVY+FG+ +LE+
Sbjct: 151 TGSVKIGDLGLATLKRAS----FAKAVIGTPEFMAPEM-YEEKYDESVDVYAFGMCMLEM 205
Query: 232 LTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQ 291
T P Q ++ + + ++ + C++
Sbjct: 206 ATSEYPYSECQNAAQI--------------YRRVTSGVKPASFDKVAIPEVKEIIEGCIR 251
Query: 292 YEAEFRPNMSIVVK 305
+ R ++ ++
Sbjct: 252 QNKDERYSIKDLLN 265
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 143 bits (361), Expect = 5e-41
Identities = 50/251 (19%), Positives = 94/251 (37%), Gaps = 38/251 (15%)
Query: 75 VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 134
V + +L+H N ++ G + + L E+ + + +K L +
Sbjct: 66 VRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP---------LQEVE 116
Query: 135 RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 194
+ A +GL YLH ++IHRD+++ N+LL E K+ DF ++
Sbjct: 117 IAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA----- 168
Query: 195 STRVLGTFGYHAPEYAMT---GQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVT 251
+GT + APE + GQ K DV+S G+ +EL + P+ +
Sbjct: 169 -NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL---- 223
Query: 252 WATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLL 311
+ Q P L+ + + C+Q + RP +++K +
Sbjct: 224 --------YHIAQNESPALQSGHWSEYFRNF---VDSCLQKIPQDRPTSEVLLK--HRFV 270
Query: 312 KSPPPAAPVSE 322
P + +
Sbjct: 271 LRERPPTVIMD 281
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (359), Expect = 6e-41
Identities = 52/245 (21%), Positives = 89/245 (36%), Gaps = 32/245 (13%)
Query: 62 KSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGV 121
+ +D + +++ H N+V+LL N + EF G++ ++ +
Sbjct: 47 TKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERP 106
Query: 122 QGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFN 181
L + L YLH+ IIHRD+++ N+L D K+ADF
Sbjct: 107 --------LTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFG 155
Query: 182 LSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQL-----TQKSDVYSFGVVLLELLTGRK 236
+S + R S +GT + APE M K+DV+S G+ L+E+
Sbjct: 156 VSAKNTRTIQRRDS--FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEP 213
Query: 237 PVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEF 296
P P K+ + P L P + + C++ +
Sbjct: 214 PHHELNPMRVL------------LKIAKSEPPTL--AQPSRWSSNFKDFLKKCLEKNVDA 259
Query: 297 RPNMS 301
R S
Sbjct: 260 RWTTS 264
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (352), Expect = 7e-40
Identities = 55/239 (23%), Positives = 98/239 (41%), Gaps = 19/239 (7%)
Query: 75 VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQP-GPVLDWM 133
SV+ ++V LLG +G ++ E T G L L + P
Sbjct: 74 ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLS 133
Query: 134 TRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARL 193
+++A + A G+ YL+ +HRD+ + N ++ EDF KI DF ++ +
Sbjct: 134 KMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR 190
Query: 194 HSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWA 253
+ L + +PE G T SDV+SFGVVL E+ T + +
Sbjct: 191 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL----------- 239
Query: 254 TPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLK 312
S ++V + V + P L + +C QY + RP+ ++ +++ ++
Sbjct: 240 ----SNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (349), Expect = 2e-39
Identities = 57/263 (21%), Positives = 97/263 (36%), Gaps = 29/263 (11%)
Query: 63 SPKNYPDDEKQLVSVVSRLK----HENLVELLGYCVE-GNLRVLAYEFATMGSLHDILHG 117
+ + L+S + L H N+V LLG C + G ++ EF G+L L
Sbjct: 52 KEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRS 111
Query: 118 RKG-------VQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLF 170
++ L + + A+G+E+L + IHRD+ + N+LL
Sbjct: 112 KRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLS 168
Query: 171 EDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLE 230
E KI DF L+ + + APE T +SDV+SFGV+L E
Sbjct: 169 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWE 228
Query: 231 LLTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCV 290
+ + + ++ + + + P ++ C
Sbjct: 229 IFSLGASPYPGVKIDEE--------------FCRRLKEGTRMRAPDYTTPEMYQTMLDCW 274
Query: 291 QYEAEFRPNMSIVVKALQPLLKS 313
E RP S +V+ L LL++
Sbjct: 275 HGEPSQRPTFSELVEHLGNLLQA 297
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (344), Expect = 5e-39
Identities = 54/253 (21%), Positives = 96/253 (37%), Gaps = 28/253 (11%)
Query: 60 RLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK 119
+ + + + Q + + H ++V+L+G E + ++ E T+G L L RK
Sbjct: 44 KNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVWII-MELCTLGELRSFLQVRK 102
Query: 120 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIAD 179
LD + + A + L YL K +HRDI + NVL+ + K+ D
Sbjct: 103 YS--------LDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGD 151
Query: 180 FNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVD 239
F LS D +++ + APE + T SDV+ FGV + E+L
Sbjct: 152 FGLSRYMEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF 210
Query: 240 HTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPN 299
+ +++ + PP L ++ C Y+ RP
Sbjct: 211 QGVKNNDVI-----------GRIENGERLPMPPNCPP----TLYSLMTKCWAYDPSRRPR 255
Query: 300 MSIVVKALQPLLK 312
+ + L +L+
Sbjct: 256 FTELKAQLSTILE 268
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (341), Expect = 2e-38
Identities = 58/235 (24%), Positives = 86/235 (36%), Gaps = 27/235 (11%)
Query: 75 VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 134
V+ + L H NL+ L G + ++ + E A +GSL D L +G T
Sbjct: 62 VNAMHSLDHRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGH--------FLLGT 112
Query: 135 RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAP-DMAARL 193
R AV A G+ YL K IHRD+ + N+LL KI DF L P + +
Sbjct: 113 LSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYV 169
Query: 194 HSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWA 253
F + APE T + SD + FGV L E+ T + + Q
Sbjct: 170 MQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI------ 223
Query: 254 TPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQ 308
+ + + P + V C ++ E RP + L
Sbjct: 224 --------LHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLL 270
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (338), Expect = 8e-38
Identities = 56/249 (22%), Positives = 97/249 (38%), Gaps = 33/249 (13%)
Query: 75 VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 134
+ V+ K+ N+V L + G+ + E+ GSL D++ D
Sbjct: 68 ILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM----------DEGQ 117
Query: 135 RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 194
+ + + LE+LH +IHRDI+S N+LL D K+ DF Q +
Sbjct: 118 IAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE--QSK 172
Query: 195 STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWAT 254
+ ++GT + APE K D++S G++ +E++ G P + P
Sbjct: 173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL------- 225
Query: 255 PRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQ-PLLKS 313
+ P+L + P K A C+ + E R + + LQ LK
Sbjct: 226 -----YLIATNGTPEL--QNPEKLSAIFRDFLNRCLDMDVEKRGSAK---ELLQHQFLKI 275
Query: 314 PPPAAPVSE 322
P + ++
Sbjct: 276 AKPLSSLTP 284
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (313), Expect = 3e-34
Identities = 42/192 (21%), Positives = 68/192 (35%), Gaps = 12/192 (6%)
Query: 76 SVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTR 135
V+SRL H V+L + +A G L + D
Sbjct: 60 DVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS---------FDETCT 110
Query: 136 VRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHS 195
+ LEYLH IIHRD++ N+LL ED +I DF + + + +
Sbjct: 111 RFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARA 167
Query: 196 TRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATP 255
+GT Y +PE + SD+++ G ++ +L+ G P +
Sbjct: 168 NSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEY 227
Query: 256 RLSEDKVKQCVD 267
E + D
Sbjct: 228 DFPEKFFPKARD 239
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 124 bits (311), Expect = 2e-33
Identities = 46/206 (22%), Positives = 78/206 (37%), Gaps = 19/206 (9%)
Query: 65 KNYPDDEKQL---VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGV 121
YP D+ + +S++++L H L+ L + VL EF + G L D +
Sbjct: 64 TPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYK 123
Query: 122 QGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLL--FEDFKAKIAD 179
+ + A GL+++HE SI+H DI+ N++ + KI D
Sbjct: 124 --------MSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIID 172
Query: 180 FNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVD 239
F L+ + +T T + APE + +D+++ GV+ LL+G P
Sbjct: 173 FGLATKLNPDEIVKVTT---ATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFA 229
Query: 240 HTMPRGQQSLVTWATPRLSEDKVKQC 265
V ED
Sbjct: 230 GEDDLETLQNVKRCDWEFDEDAFSSV 255
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 120 bits (303), Expect = 3e-32
Identities = 46/242 (19%), Positives = 84/242 (34%), Gaps = 32/242 (13%)
Query: 65 KNYPDDEKQL---VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGV 121
+ D++ + + +S L+H LV L + N V+ YEF + G L + +
Sbjct: 61 TPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK 120
Query: 122 QGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLF--EDFKAKIAD 179
+ V +GL ++HE + +H D++ N++ + K+ D
Sbjct: 121 --------MSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLID 169
Query: 180 FNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVD 239
F L+ + +T GT + APE A + +D++S GV+ LL+G P
Sbjct: 170 FGLTAHLDPKQSVKVTT---GTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFG 226
Query: 240 HTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPN 299
VK C D + + + R
Sbjct: 227 GENDDETL------------RNVKSC-DWNMDDSAFSGISEDGKDFIRKLLLADPNTRMT 273
Query: 300 MS 301
+
Sbjct: 274 IH 275
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (300), Expect = 4e-32
Identities = 38/208 (18%), Positives = 77/208 (37%), Gaps = 16/208 (7%)
Query: 60 RLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK 119
+K K+ +S+++ +H N++ L V+ +EF + + + ++
Sbjct: 37 FVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERIN--- 93
Query: 120 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLL--FEDFKAKI 177
L+ V L++LH +I H DIR N++ KI
Sbjct: 94 -----TSAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKI 145
Query: 178 ADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 237
+F + Q + + Y+APE ++ +D++S G ++ LL+G P
Sbjct: 146 IEFGQARQLKPGD---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINP 202
Query: 238 VDHTMPRGQQSLVTWATPRLSEDKVKQC 265
+ + A E+ K+
Sbjct: 203 FLAETNQQIIENIMNAEYTFDEEAFKEI 230
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (296), Expect = 1e-31
Identities = 39/241 (16%), Positives = 75/241 (31%), Gaps = 19/241 (7%)
Query: 71 EKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVL 130
E ++ + +H N+V L C + P P +
Sbjct: 57 EVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD---QDLTTYLDKVPEPGV 113
Query: 131 DWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMA 190
T + RGL++LH ++HRD++ N+L+ + K+ADF L+
Sbjct: 114 PTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM 170
Query: 191 ARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLV 250
T V+ T Y APE + D++S G + E+ + + Q +
Sbjct: 171 ---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKI 227
Query: 251 ----------TWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNM 300
W + + ++ + C+ + R +
Sbjct: 228 LDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISA 287
Query: 301 S 301
Sbjct: 288 Y 288
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 119 bits (298), Expect = 2e-31
Identities = 48/245 (19%), Positives = 92/245 (37%), Gaps = 33/245 (13%)
Query: 71 EKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVL 130
E+ ++S+VS +V + + + G LH L
Sbjct: 54 ERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFS-------- 105
Query: 131 DWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMA 190
A + GLE++H + +++RD++ +N+LL E +I+D L+
Sbjct: 106 -EADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKK- 160
Query: 191 ARLHSTRVLGTFGYHAPEYAMTGQ-LTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSL 249
+GT GY APE G +D +S G +L +LL G P + + +
Sbjct: 161 ---KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI 217
Query: 250 VTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQP 309
D++ + +L + P +L ++ +Q + R + + Q
Sbjct: 218 ----------DRMTLTMAVELPDSFSP----ELRSLLEGLLQRDVNRRL--GCLGRGAQE 261
Query: 310 LLKSP 314
+ +SP
Sbjct: 262 VKESP 266
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 115 bits (288), Expect = 8e-31
Identities = 44/234 (18%), Positives = 80/234 (34%), Gaps = 35/234 (14%)
Query: 75 VSVVSRLK-HENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWM 133
V ++ ++ H N+++L L ++ G L D L + L
Sbjct: 60 VDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT---------LSEK 110
Query: 134 TRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARL 193
+I + LH+ +I+HRD++ N+LL +D K+ DF S Q
Sbjct: 111 ETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE--- 164
Query: 194 HSTRVLGTFGYHAPEYAMTGQL------TQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQ 247
V GT Y APE ++ D++S GV++ LL G P H
Sbjct: 165 KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLML 224
Query: 248 SLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMS 301
++ + + D + + + + + + R
Sbjct: 225 RMIMSGNYQFGSPEWDDYSDT-------------VKDLVSRFLVVQPQKRYTAE 265
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (290), Expect = 1e-30
Identities = 44/210 (20%), Positives = 74/210 (35%), Gaps = 14/210 (6%)
Query: 58 NERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHG 117
+ + + + + +H L + E+ G L +
Sbjct: 37 KDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQS 96
Query: 118 RKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKI 177
D A + GL++LH K I++RD++ N+LL +D KI
Sbjct: 97 CHK---------FDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKI 144
Query: 178 ADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 237
ADF + + A+ + GT Y APE + + D +SFGV+L E+L G+ P
Sbjct: 145 ADFGMCKENMLGDAK--TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP 202
Query: 238 VDHTMPRGQQSLVTWATPRLSEDKVKQCVD 267
+ P K+ D
Sbjct: 203 FHGQDEEELFHSIRMDNPFYPRWLEKEAKD 232
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 114 bits (286), Expect = 2e-30
Identities = 53/240 (22%), Positives = 86/240 (35%), Gaps = 31/240 (12%)
Query: 75 VSVVSRLKHENLVELLGYCVE----GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVL 130
+ L H +V + G L + E+ +L DI+H +
Sbjct: 58 AQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---------M 108
Query: 131 DWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMA 190
+ + DA + L + H+ IIHRD++ +N+++ K+ DF ++ D
Sbjct: 109 TPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSG 165
Query: 191 ARLHSTR-VLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSL 249
+ T V+GT Y +PE A + +SDVYS G VL E+LTG P P
Sbjct: 166 NSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQ 225
Query: 250 VTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRP-NMSIVVKALQ 308
P + + L AV + E R + + L
Sbjct: 226 HVREDPIPPSARHEGLSAD-------------LDAVVLKALAKNPENRYQTAAEMRADLV 272
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 114 bits (287), Expect = 2e-30
Identities = 43/262 (16%), Positives = 83/262 (31%), Gaps = 30/262 (11%)
Query: 61 LKSPKNYPDDEKQLVSVVSRLKHENLVELLGYC-VEGNLRVLAYEFATMGSLHDILHGRK 119
L+ K + ++ + + +C EG+ V+ E +
Sbjct: 39 LECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSR 98
Query: 120 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFE---DFKAK 176
T + +A +EY+H K + IHRD++ N L+
Sbjct: 99 K---------FSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVY 146
Query: 177 IADFNLSNQAPD-----MAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLEL 231
I DF L+ + D + + GT Y + + + +++ D+ S G VL+
Sbjct: 147 IIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYF 206
Query: 232 LTGRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQ 291
G P ++ +K L YP + A C
Sbjct: 207 NLGSLPWQGLKAATKRQKY-----ERISEKKMSTPIEVLCKGYPS----EFATYLNFCRS 257
Query: 292 YEAEFRPNMSIVVKALQPLLKS 313
+ +P+ S + + + L
Sbjct: 258 LRFDDKPDYSYLRQLFRNLFHR 279
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 112 bits (281), Expect = 2e-29
Identities = 44/193 (22%), Positives = 76/193 (39%), Gaps = 17/193 (8%)
Query: 75 VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 134
++S + H ++ + G + + ++ G L +L +
Sbjct: 55 RLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRF---------PNPV 105
Query: 135 RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 194
A + LEYLH K II+RD++ N+LL ++ KI DF + PD+
Sbjct: 106 AKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV----- 157
Query: 195 STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWAT 254
+ + GT Y APE T + D +SFG+++ E+L G P + + A
Sbjct: 158 TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAE 217
Query: 255 PRLSEDKVKQCVD 267
R + D
Sbjct: 218 LRFPPFFNEDVKD 230
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 112 bits (280), Expect = 3e-29
Identities = 50/245 (20%), Positives = 84/245 (34%), Gaps = 34/245 (13%)
Query: 63 SPKNYPDDEKQL---VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRK 119
+ K E + ++V+ ++KH N+V L G L + + G L D + +
Sbjct: 43 AKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG 102
Query: 120 GVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLF---EDFKAK 176
R+ ++YLH+ I+HRD++ N+L + ED K
Sbjct: 103 ---------FYTERDASRLIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIM 150
Query: 177 IADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRK 236
I+DF LS + + GT GY APE ++ D +S GV+ LL G
Sbjct: 151 ISDFGLSKMEDPGSVL---STACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYP 207
Query: 237 PVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEF 296
P + A + + Y ++ + E
Sbjct: 208 PFYDENDAKLFEQILKA-------------EYEFDSPYWDDISDSAKDFIRHLMEKDPEK 254
Query: 297 RPNMS 301
R
Sbjct: 255 RFTCE 259
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 109 bits (274), Expect = 1e-28
Identities = 35/259 (13%), Positives = 75/259 (28%), Gaps = 30/259 (11%)
Query: 65 KNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGA 124
++ + L + + Y + L + SL D+L
Sbjct: 41 RSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLD-------- 92
Query: 125 QPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFK-----AKIAD 179
G T A ++ +HEK S+++RDI+ N L+ + D
Sbjct: 93 LCGRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVD 149
Query: 180 FNLSNQAPDMAARLH-----STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTG 234
F + D + H + GT Y + + + +++ D+ + G V + L G
Sbjct: 150 FGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRG 209
Query: 235 RKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEA 294
P + +++ + E +
Sbjct: 210 SLPWQGLKAATNKQKY---------ERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAF 260
Query: 295 EFRPNMSIVVKALQPLLKS 313
+ P+ + +L+
Sbjct: 261 DATPDYDYLQGLFSKVLER 279
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (267), Expect = 3e-27
Identities = 48/262 (18%), Positives = 94/262 (35%), Gaps = 33/262 (12%)
Query: 60 RLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATM----GSLHDIL 115
+ Y + + ++ R +HEN++ + + + + L+ +L
Sbjct: 42 SPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLL 101
Query: 116 HGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKA 175
+ L RGL+Y+H +++HRD++ SN+LL
Sbjct: 102 KTQH----------LSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDL 148
Query: 176 KIADFNLSNQA-PDMAARLHSTRVLGTFGYHAPEYAMTGQL-TQKSDVYSFGVVLLELLT 233
KI DF L+ A PD T + T Y APE + + T+ D++S G +L E+L+
Sbjct: 149 KICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLS 208
Query: 234 GRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKG--------------EYPPKGV 279
R Q + + S++ + ++ K + P
Sbjct: 209 NRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNAD 268
Query: 280 AKLAAVAALCVQYEAEFRPNMS 301
+K + + + R +
Sbjct: 269 SKALDLLDKMLTFNPHKRIEVE 290
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (263), Expect = 5e-27
Identities = 52/261 (19%), Positives = 91/261 (34%), Gaps = 30/261 (11%)
Query: 75 VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 134
+ ++ L H N++ LL + L ++F I L
Sbjct: 51 IKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLV---------LTPSH 101
Query: 135 RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 194
+ +GLEYLH+ I+HRD++ +N+LL E+ K+ADF L+
Sbjct: 102 IKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGS--PNRA 156
Query: 195 STRVLGTFGYHAPEYAMTGQL-TQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWA 253
T + T Y APE ++ D+++ G +L ELL + Q + +
Sbjct: 157 YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFET 216
Query: 254 TPRLSED------KVKQCVDPKLKGEYPPKGVAKLAAVAAL-----CVQYEAEFRPNMSI 302
+E+ + V K P + A L + R +
Sbjct: 217 LGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITAT- 275
Query: 303 VVKALQ-PLLKSPPPAAPVSE 322
+AL+ + P P +
Sbjct: 276 --QALKMKYFSNRPGPTPGCQ 294
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (263), Expect = 1e-26
Identities = 40/222 (18%), Positives = 75/222 (33%), Gaps = 18/222 (8%)
Query: 61 LKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLR------VLAYEFATMGSLHDI 114
+K + + + ++ +L H N+V L + + L ++
Sbjct: 50 IKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVA 109
Query: 115 LHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFED-F 173
H + Q L + R L Y+H I HRDI+ N+LL D
Sbjct: 110 RHYSRAKQT------LPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTA 160
Query: 174 KAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT 233
K+ DF + Q + + + + T DV+S G VL ELL
Sbjct: 161 VLKLCDFGSAKQLVR--GEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLL 218
Query: 234 GRKPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYP 275
G+ Q + + +++++ + ++P
Sbjct: 219 GQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFP 260
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (259), Expect = 1e-26
Identities = 46/231 (19%), Positives = 83/231 (35%), Gaps = 32/231 (13%)
Query: 75 VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 134
VS++ ++H N++ L +L E G L D L ++ L
Sbjct: 64 VSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---------LTEEE 114
Query: 135 RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFED----FKAKIADFNLSNQAPDMA 190
G+ YLH I H D++ N++L + + KI DF L+++
Sbjct: 115 ATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN 171
Query: 191 ARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLV 250
+ GT + APE L ++D++S GV+ LL+G P + + V
Sbjct: 172 ---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV 228
Query: 251 TWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMS 301
+ V+ + + EY A + + + R +
Sbjct: 229 SA-------------VNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQ 266
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 100 bits (249), Expect = 3e-25
Identities = 38/252 (15%), Positives = 83/252 (32%), Gaps = 25/252 (9%)
Query: 62 KSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGV 121
K + P + +S++ LKH N+V+L VL +E + G
Sbjct: 38 KEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGG- 96
Query: 122 QGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFN 181
L+ +T + G+ Y H++ ++HRD++ N+L+ + + KIADF
Sbjct: 97 --------LESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFG 145
Query: 182 LSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHT 241
L+ + ++ + + + + D++S G + E++ G
Sbjct: 146 LARAFGIPVRKYT-HEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGV 204
Query: 242 MPRGQQSLVTWATPRLSE------------DKVKQCVDPKLKGEYPPKGVAKLAAVAALC 289
Q + + D +P + + +
Sbjct: 205 SEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKM 264
Query: 290 VQYEAEFRPNMS 301
++ + R
Sbjct: 265 LKLDPNQRITAK 276
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (250), Expect = 5e-25
Identities = 42/203 (20%), Positives = 65/203 (32%), Gaps = 14/203 (6%)
Query: 65 KNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGA 124
K+ V+ +H L L + E+A G L L
Sbjct: 46 KDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRE------ 99
Query: 125 QPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSN 184
T R A + L +++RDI+ N++L +D KI DF L
Sbjct: 100 ------RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCK 153
Query: 185 QAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPR 244
+ A + GT Y APE + D + GVV+ E++ GR P +
Sbjct: 154 EGISDGATMK--TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE 211
Query: 245 GQQSLVTWATPRLSEDKVKQCVD 267
L+ R +
Sbjct: 212 RLFELILMEEIRFPRTLSPEAKS 234
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 99 bits (248), Expect = 6e-25
Identities = 47/271 (17%), Positives = 87/271 (32%), Gaps = 28/271 (10%)
Query: 62 KSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGV 121
+ P + +S++ L H N+V+LL N L +EF +
Sbjct: 39 TETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTG 98
Query: 122 QGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFN 181
+ +GL + H ++HRD++ N+L+ + K+ADF
Sbjct: 99 --------IPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFG 147
Query: 182 LSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHT 241
L+ +A + R ++ V+ + + D++S G + E++T R
Sbjct: 148 LA-RAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 206
Query: 242 MPRGQQSLVTWATPRLSEDKVKQCVD--------PKLKGEYPPKGVAKLAAVA----ALC 289
Q + E PK + K V L +
Sbjct: 207 SEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQM 266
Query: 290 VQYEAEFRPNMSIVVKALQ-PLLKSPPPAAP 319
+ Y+ R + AL P + P
Sbjct: 267 LHYDPNKRISAK---AALAHPFFQDVTKPVP 294
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 99.0 bits (246), Expect = 7e-25
Identities = 37/203 (18%), Positives = 72/203 (35%), Gaps = 24/203 (11%)
Query: 75 VSVVSRLK--HENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDW 132
V ++ ++ ++ LL + + VL E +G L
Sbjct: 58 VVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA--------LQE 109
Query: 133 MTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLL-FEDFKAKIADFNLSNQAPDMAA 191
+ + H ++HRDI+ N+L+ + K+ DF D
Sbjct: 110 ELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-- 164
Query: 192 RLHSTRVLGTFGYHAPEYAMTGQL-TQKSDVYSFGVVLLELLTGRKPVDHT--MPRGQQS 248
T GT Y PE+ + + + V+S G++L +++ G P +H + RGQ
Sbjct: 165 --VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVF 222
Query: 249 LVTWATPRLSEDKVKQC--VDPK 269
+ + ++ C + P
Sbjct: 223 FRQRVSSEC-QHLIRWCLALRPS 244
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 99.0 bits (246), Expect = 2e-24
Identities = 39/267 (14%), Positives = 85/267 (31%), Gaps = 29/267 (10%)
Query: 61 LKSPKNYPDDEKQLVSVVSRLKHENLVELLGYC----VEGNLRVLAYEFATMGSLHDILH 116
LK ++ P +++ + ++V ++ ++ E G L +
Sbjct: 42 LKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQ 101
Query: 117 GRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAK 176
R I ++YLH +I HRD++ N+L
Sbjct: 102 DRGD-------QAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNA 151
Query: 177 IADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRK 236
I A + + T T Y APE + + D++S GV++ LL G
Sbjct: 152 ILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYP 211
Query: 237 PVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEF 296
P + + +++ + + ++ + ++ E
Sbjct: 212 PFYSNHGLAISPGM--------KTRIRMG-QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQ 262
Query: 297 RPNMSIVVKALQ-PLLK--SPPPAAPV 320
R ++ + + P + + P P+
Sbjct: 263 RMTIT---EFMNHPWIMQSTKVPQTPL 286
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 95.3 bits (236), Expect = 4e-23
Identities = 48/277 (17%), Positives = 93/277 (33%), Gaps = 26/277 (9%)
Query: 62 KSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGV 121
+ +P + + ++ LKHEN+V L+ C + + H G+
Sbjct: 47 NEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGL 106
Query: 122 QGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFN 181
R+ GL Y+H I+HRD++++NVL+ D K+ADF
Sbjct: 107 LSNVLVK-FTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFG 162
Query: 182 LSNQ--APDMAARLHSTRVLGTFGYHAPEYAMTGQL-TQKSDVYSFGVVLLELLTGRKPV 238
L+ + T + T Y PE + + D++ G ++ E+ T +
Sbjct: 163 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIM 222
Query: 239 DHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAAL---------- 288
+ Q +L++ ++ + + +L + K L
Sbjct: 223 QGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYAL 282
Query: 289 -----CVQYEAEFRPNMSIVVKALQ-PLLKSPPPAAP 319
+ + R + AL S P +
Sbjct: 283 DLIDKLLVLDPAQRIDSD---DALNHDFFWSDPMPSD 316
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 93.7 bits (232), Expect = 2e-22
Identities = 43/215 (20%), Positives = 81/215 (37%), Gaps = 15/215 (6%)
Query: 60 RLKSPKNYPDDEKQL---VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILH 116
+L P K+ + ++ ++HEN++ LL +F +
Sbjct: 50 KLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDL 109
Query: 117 GRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAK 176
G+ L + +GL Y+H IIHRD++ N+ + ED + K
Sbjct: 110 GKLMKHEK-----LGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELK 161
Query: 177 IADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRK 236
I DF L+ QA + V+ + + TQ D++S G ++ E++TG+
Sbjct: 162 ILDFGLARQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKT 217
Query: 237 PVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLK 271
+ Q + T + V++ + K
Sbjct: 218 LFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAK 252
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 91.2 bits (225), Expect = 7e-22
Identities = 32/176 (18%), Positives = 66/176 (37%), Gaps = 13/176 (7%)
Query: 62 KSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGV 121
+ P + + ++ LKH+N+V L L +EF +
Sbjct: 39 DDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDL 98
Query: 122 QGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFN 181
+GL + H + +++HRD++ N+L+ + + K+A+F
Sbjct: 99 D---------PEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFG 146
Query: 182 LSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKP 237
L+ +A + R +S V+ + + D++S G + EL +P
Sbjct: 147 LA-RAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP 201
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 92.2 bits (228), Expect = 7e-22
Identities = 32/193 (16%), Positives = 63/193 (32%), Gaps = 17/193 (8%)
Query: 75 VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMT 134
++ + LV+L + + + E+ G + L
Sbjct: 92 KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR---------FSEPH 142
Query: 135 RVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLH 194
A EYLH +I+RD++ N+L+ + ++ DF + +
Sbjct: 143 ARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----R 194
Query: 195 STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWAT 254
+ + GT APE ++ + D ++ GV++ E+ G P P +
Sbjct: 195 TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK 254
Query: 255 PRLSEDKVKQCVD 267
R D
Sbjct: 255 VRFPSHFSSDLKD 267
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 85.7 bits (211), Expect = 1e-19
Identities = 46/216 (21%), Positives = 76/216 (35%), Gaps = 17/216 (7%)
Query: 59 ERLKSPKNYPDDEKQLVSVVSRLKHE-NLVELLGYCVEGNLRVLAYEFATMGSLHDILHG 117
+ + + V+ ++ LV L L ++ G L L
Sbjct: 63 ATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQ 122
Query: 118 RKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKI 177
R+ + LE+LH+ II+RDI+ N+LL + +
Sbjct: 123 RER---------FTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVL 170
Query: 178 ADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQ--LTQKSDVYSFGVVLLELLTGR 235
DF LS + + GT Y AP+ G + D +S GV++ ELLTG
Sbjct: 171 TDFGLSKEFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA 229
Query: 236 KPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLK 271
P + Q+ ++ + SE Q + K
Sbjct: 230 SPFTVDGEKNSQAEISRRILK-SEPPYPQEMSALAK 264
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 80.1 bits (196), Expect = 2e-17
Identities = 31/188 (16%), Positives = 70/188 (37%), Gaps = 10/188 (5%)
Query: 60 RLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDI----- 114
++ K Y + + + ++ R+ + + L++L + + +
Sbjct: 45 IVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFE 104
Query: 115 --LHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLL-FE 171
+ + + +I+ GL+Y+H + IIH DI+ NVL+
Sbjct: 105 VLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRR--CGIIHTDIKPENVLMEIV 162
Query: 172 DFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLEL 231
D + +++ H T + T Y +PE + +D++S ++ EL
Sbjct: 163 DSPENLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFEL 222
Query: 232 LTGRKPVD 239
+TG +
Sbjct: 223 ITGDFLFE 230
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 79.6 bits (195), Expect = 2e-17
Identities = 46/215 (21%), Positives = 76/215 (35%), Gaps = 15/215 (6%)
Query: 60 RLKSPKNYPDDEKQL---VSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILH 116
+L P K+ + ++ +KHEN++ LL + + L
Sbjct: 50 KLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADL 109
Query: 117 GRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAK 176
L + RGL+Y+H IIHRD++ SN+ + ED + K
Sbjct: 110 NNIVKCQK-----LTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELK 161
Query: 177 IADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRK 236
I DF L+ D + V + Q D++S G ++ ELLTGR
Sbjct: 162 ILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 217
Query: 237 PVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLK 271
T Q L+ + +K+ +
Sbjct: 218 LFPGTDHIDQLKLILRLVGTPGAELLKKISSESAR 252
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 76.0 bits (186), Expect = 2e-16
Identities = 31/188 (16%), Positives = 65/188 (34%), Gaps = 26/188 (13%)
Query: 68 PDDEKQLVSVVSRLK----HENLVELLGYCVE--GNLRVLAYEFATMGSLHDILHGRKGV 121
P +K++ + L+ N++ L + L +E +
Sbjct: 70 PVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT---- 125
Query: 122 QGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLL-FEDFKAKIADF 180
L + + L+Y H I+HRD++ NV++ E K ++ D+
Sbjct: 126 --------LTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDW 174
Query: 181 NLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQL-TQKSDVYSFGVVLLELLTGRKPVD 239
L+ + + + PE + Q+ D++S G +L ++ ++P
Sbjct: 175 GLAEFYHPGQ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFF 231
Query: 240 HTMPRGQQ 247
H Q
Sbjct: 232 HGHDNYDQ 239
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 74.6 bits (182), Expect = 1e-15
Identities = 40/200 (20%), Positives = 70/200 (35%), Gaps = 27/200 (13%)
Query: 60 RLKSPKNYPDDEKQL---VSVVSRLKHENLVELLGYCV------EGNLRVLAYEFATMGS 110
+L P K+ + ++ + H+N++ LL E L E
Sbjct: 49 KLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANL 108
Query: 111 LHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLF 170
I D + G+++LH IIHRD++ SN+++
Sbjct: 109 CQVIQMEL------------DHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVK 153
Query: 171 EDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLE 230
D KI DF L+ T + T Y APE + + D++S G ++ E
Sbjct: 154 SDCTLKILDFGLART---AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 210
Query: 231 LLTGRKPVDHTMPRGQQSLV 250
++ + Q + V
Sbjct: 211 MVRHKILFPGRDYIDQWNKV 230
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 47.5 bits (112), Expect = 4e-07
Identities = 18/126 (14%), Positives = 31/126 (24%), Gaps = 21/126 (16%)
Query: 72 KQLVSVVSRLKHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLD 131
L +R + L +L G V L+
Sbjct: 54 SVLAIRSARNEFRALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRV------------R 101
Query: 132 WMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIADFNLS-----NQA 186
+ + + I+H D+ NVL+ + I DF S
Sbjct: 102 VENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVLV-SEEGIWIIDFPQSVEVGEEGW 157
Query: 187 PDMAAR 192
++ R
Sbjct: 158 REILER 163
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 323 | |||
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.88 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.4 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.11 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.83 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.44 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 94.0 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 87.44 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.8e-57 Score=381.53 Aligned_cols=253 Identities=24% Similarity=0.265 Sum_probs=206.1
Q ss_pred CCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEe
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVE 95 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 95 (323)
.|+...+||+|+||+||+|++..+++.+|+|++..+.. .+..+.+.+|++++++++||||+++++++.+
T Consensus 6 dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~-----------~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~ 74 (271)
T d1nvra_ 6 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-----------VDCPENIKKEICINKMLNHENVVKFYGHRRE 74 (271)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC------------------CHHHHHHHHHTCCCTTBCCEEEEEEE
T ss_pred ceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-----------chHHHHHHHHHHHHHhCCCCCEeeEeeeecc
Confidence 46677799999999999999999999999997753311 1223568999999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeE
Q 020641 96 GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKA 175 (323)
Q Consensus 96 ~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~ 175 (323)
++..|+||||+++|+|.+++..... +++..+..++.|++.||.|||++ ||+||||||+|||++.++.+
T Consensus 75 ~~~~~ivmEy~~gg~L~~~l~~~~~---------l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~ 142 (271)
T d1nvra_ 75 GNIQYLFLEYCSGGELFDRIEPDIG---------MPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNL 142 (271)
T ss_dssp TTEEEEEEECCTTEEGGGGSBTTTB---------CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCE
T ss_pred CceeEEEEeccCCCcHHHHHhcCCC---------CCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCE
Confidence 9999999999999999999975432 99999999999999999999999 99999999999999999999
Q ss_pred EEeeccccCCCCccccccccccccCccccCCCccccCCCC-CcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhc
Q 020641 176 KIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQL-TQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWAT 254 (323)
Q Consensus 176 ~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~ 254 (323)
||+|||+|................||+.|+|||++.+..+ +.++|||||||++|+|++|+.||............
T Consensus 143 KL~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~---- 218 (271)
T d1nvra_ 143 KISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD---- 218 (271)
T ss_dssp EECCCTTCEECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHH----
T ss_pred EEccchhheeeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHH----
Confidence 9999999987654433333455679999999999988776 57899999999999999999999755432211111
Q ss_pred ccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 255 PRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
..............+.++.+|+.+||+.||++|||++|+++
T Consensus 219 ----------~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 219 ----------WKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp ----------HHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ----------HhcCCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 11111111222345678999999999999999999999987
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=6.1e-56 Score=380.35 Aligned_cols=259 Identities=24% Similarity=0.322 Sum_probs=214.1
Q ss_pred CccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeC
Q 020641 17 PGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEG 96 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 96 (323)
+....+||+|+||+||+|.+..+++.+|+|++... ....+++.+|++++++++||||+++++++.++
T Consensus 19 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~-------------~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~ 85 (287)
T d1opja_ 19 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-------------TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE 85 (287)
T ss_dssp EEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTT-------------CSCHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred eEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCc-------------cchHHHHHHHHHHHHhCCCCCEecCCccEeeC
Confidence 34455899999999999999999999999966421 22346789999999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEE
Q 020641 97 NLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAK 176 (323)
Q Consensus 97 ~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~ 176 (323)
+..++||||+.+|+|.+++....... +++..+..++.|++.||.|||++ ||+||||||+|||++.++.+|
T Consensus 86 ~~~~iv~E~~~~g~l~~~l~~~~~~~-------~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~K 155 (287)
T d1opja_ 86 PPFYIITEFMTYGNLLDYLRECNRQE-------VSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVK 155 (287)
T ss_dssp SSCEEEEECCTTCBHHHHHHHSCTTT-------SCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEE
T ss_pred CeeEEEeecccCcchHHHhhhccccc-------hHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEE
Confidence 99999999999999999997654332 89999999999999999999999 999999999999999999999
Q ss_pred EeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhccc
Q 020641 177 IADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPR 256 (323)
Q Consensus 177 l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 256 (323)
|+|||+++........ ......|++.|+|||.+.+..++.++|||||||++|+|++|..||.....
T Consensus 156 l~DFG~a~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~------------- 221 (287)
T d1opja_ 156 VADFGLSRLMTGDTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID------------- 221 (287)
T ss_dssp ECCCCCTTTCCSSSSE-EETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCC-------------
T ss_pred EccccceeecCCCCce-eeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcch-------------
Confidence 9999999876543222 22333478899999999999999999999999999999997777643322
Q ss_pred ccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhhcCC
Q 020641 257 LSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSP 314 (323)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~~~~ 314 (323)
...+.+.+....+...+..++.++.+|+.+||+.||++|||+.||++.|+.+.+..
T Consensus 222 --~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~~ 277 (287)
T d1opja_ 222 --LSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 277 (287)
T ss_dssp --HHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSSS
T ss_pred --HHHHHHHHhcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhC
Confidence 11222233333344455667788999999999999999999999999999987653
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-55 Score=377.29 Aligned_cols=250 Identities=22% Similarity=0.311 Sum_probs=208.5
Q ss_pred CCCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEE
Q 020641 15 PSPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCV 94 (323)
Q Consensus 15 ~~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 94 (323)
-.|+.+.+||+|+||+||+|.+..+++.+|+|++.... ....+.+.+|+.++++++||||+++++++.
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~------------~~~~~~~~~E~~il~~l~HpnIv~~~~~~~ 87 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ------------QPKKELIINEILVMRENKNPNIVNYLDSYL 87 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGG------------CSCHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEeccc------------ChHHHHHHHHHHHHHhCCCCCEeeEeEEEE
Confidence 35778889999999999999999999999999765321 122467899999999999999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCe
Q 020641 95 EGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFK 174 (323)
Q Consensus 95 ~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~ 174 (323)
+++..|+||||+.+|+|.+++.+.. +++..+..++.||+.||.|||++ ||+||||||+|||++.++.
T Consensus 88 ~~~~~~ivmEy~~gg~L~~~~~~~~----------l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~ 154 (293)
T d1yhwa1 88 VGDELWVVMEYLAGGSLTDVVTETC----------MDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGS 154 (293)
T ss_dssp ETTEEEEEEECCTTCBHHHHHHHSC----------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCC
T ss_pred ECCEEEEEEEecCCCcHHHHhhccC----------CCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCc
Confidence 9999999999999999999987653 89999999999999999999999 9999999999999999999
Q ss_pred EEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhc
Q 020641 175 AKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWAT 254 (323)
Q Consensus 175 ~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~ 254 (323)
+||+|||++........ ......||+.|+|||++.+..++.++|||||||++|+|++|+.||............. .
T Consensus 155 vkl~DFG~a~~~~~~~~--~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~--~ 230 (293)
T d1yhwa1 155 VKLTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIA--T 230 (293)
T ss_dssp EEECCCTTCEECCSTTC--CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH--H
T ss_pred Eeeccchhheeeccccc--cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHH--h
Confidence 99999999986543222 2244569999999999999999999999999999999999999997554321111000 0
Q ss_pred ccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 255 PRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
........+...+..+.+||.+||+.||.+|||+.|+++
T Consensus 231 ------------~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 231 ------------NGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp ------------HCSCCCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred ------------CCCCCCCCcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 001111233456778999999999999999999999987
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-56 Score=375.55 Aligned_cols=247 Identities=24% Similarity=0.340 Sum_probs=207.7
Q ss_pred CccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeC
Q 020641 17 PGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEG 96 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 96 (323)
|+....||+|+||+||+|++..+++.+|+|++.+..... ....+.+.+|++++++++||||+++++++.++
T Consensus 8 y~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~---------~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~ 78 (263)
T d2j4za1 8 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEK---------AGVEHQLRREVEIQSHLRHPNILRLYGYFHDA 78 (263)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHH---------TTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred eEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccC---------hHHHHHHHHHHHHHHhcCCCCCCeEEEEEEEC
Confidence 556668999999999999999999999999776432211 23457789999999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEE
Q 020641 97 NLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAK 176 (323)
Q Consensus 97 ~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~ 176 (323)
+..|+||||+.+|+|.+++..... +++..+..++.||+.||.|||++ ||+||||||+|||++.++.+|
T Consensus 79 ~~~~ivmEy~~~g~L~~~l~~~~~---------l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~k 146 (263)
T d2j4za1 79 TRVYLILEYAPLGTVYRELQKLSK---------FDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELK 146 (263)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEE
T ss_pred CEEEEEEeecCCCcHHHHHhhcCC---------CCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEe
Confidence 999999999999999999976542 89999999999999999999999 999999999999999999999
Q ss_pred EeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhccc
Q 020641 177 IADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPR 256 (323)
Q Consensus 177 l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 256 (323)
|+|||++....... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||..........
T Consensus 147 l~DFG~a~~~~~~~----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~-------- 214 (263)
T d2j4za1 147 IADFGWSVHAPSSR----RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYK-------- 214 (263)
T ss_dssp ECCCCSCSCCCCCC----CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH--------
T ss_pred ecccceeeecCCCc----ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHH--------
Confidence 99999997765432 233458999999999999999999999999999999999999997553221111
Q ss_pred ccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 257 LSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
.+.... ...+...++++.+|+.+||+.||++|||++|+++
T Consensus 215 -------~i~~~~--~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 215 -------RISRVE--FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp -------HHHTTC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -------HHHcCC--CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 111111 1233445678999999999999999999999987
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-55 Score=374.53 Aligned_cols=263 Identities=25% Similarity=0.373 Sum_probs=201.2
Q ss_pred CccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeC
Q 020641 17 PGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEG 96 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 96 (323)
+....+||+|+||+||+|+... .+|+|++..... .....+.+.+|++++++++||||+++++++.++
T Consensus 10 ~~~~~~lG~G~fg~Vy~~~~~~---~vAvK~~~~~~~----------~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~ 76 (276)
T d1uwha_ 10 ITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAP----------TPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAP 76 (276)
T ss_dssp CCCCSEEEECSSCEEEEEESSS---EEEEEECCCSSC----------CTTHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred EEEEEEEeeCCCcEEEEEEECC---EEEEEEEEcccC----------CHHHHHHHHHHHHHHHhCCCCCEeeeeEEEecc
Confidence 4555689999999999997643 378886643221 122347789999999999999999999987654
Q ss_pred CeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEE
Q 020641 97 NLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAK 176 (323)
Q Consensus 97 ~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~ 176 (323)
..++||||+++|+|.+++...... +++..+..++.|++.||.|||++ ||+||||||+|||++.++.+|
T Consensus 77 -~~~lv~Ey~~~g~L~~~l~~~~~~--------~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~K 144 (276)
T d1uwha_ 77 -QLAIVTQWCEGSSLYHHLHIIETK--------FEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVK 144 (276)
T ss_dssp -SCEEEEECCCEEEHHHHHHTSCCC--------CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEE
T ss_pred -EEEEEEecCCCCCHHHHHhhccCC--------CCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEE
Confidence 579999999999999999765432 89999999999999999999999 999999999999999999999
Q ss_pred EeeccccCCCCccccccccccccCccccCCCccccC---CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhh
Q 020641 177 IADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT---GQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWA 253 (323)
Q Consensus 177 l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~---~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 253 (323)
|+|||++................||+.|+|||++.+ ..++.++|||||||++|||+||+.||.............
T Consensus 145 l~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~-- 222 (276)
T d1uwha_ 145 IGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV-- 222 (276)
T ss_dssp ECCCCCSCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHH--
T ss_pred EccccceeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHH--
Confidence 999999987655444334455669999999999864 347889999999999999999999997654322111110
Q ss_pred cccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhhcCCC
Q 020641 254 TPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSPP 315 (323)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~~~~~ 315 (323)
..... .+. ....+..+++.+.+++.+||+.||++|||+.||++.|+.+.+..|
T Consensus 223 ~~~~~--------~p~-~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~P 275 (276)
T d1uwha_ 223 GRGYL--------SPD-LSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLP 275 (276)
T ss_dssp HHTSC--------CCC-GGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred hcCCC--------CCc-chhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcCC
Confidence 00000 000 012234456789999999999999999999999999999987654
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-56 Score=379.97 Aligned_cols=251 Identities=20% Similarity=0.257 Sum_probs=205.1
Q ss_pred CCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEe
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVE 95 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 95 (323)
.|+....||+|+||+||+|++..+++.+|+|++.+.... .....+.+.+|++++++++||||+++++++.+
T Consensus 9 dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~---------~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~ 79 (288)
T d1uu3a_ 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHII---------KENKVPYVTRERDVMSRLDHPFFVKLYFTFQD 79 (288)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH---------HTTCHHHHHHHHHHHHHCCSTTBCCEEEEEEC
T ss_pred CCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHcc---------CHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEE
Confidence 467777999999999999999999999999987643221 12334778999999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeE
Q 020641 96 GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKA 175 (323)
Q Consensus 96 ~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~ 175 (323)
.+..|+||||+.+|+|.+++..... +++..+..++.|++.||.|||+. ||+||||||+||+++.++.+
T Consensus 80 ~~~~~ivmEy~~gg~L~~~~~~~~~---------l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~v 147 (288)
T d1uu3a_ 80 DEKLYFGLSYAKNGELLKYIRKIGS---------FDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHI 147 (288)
T ss_dssp SSEEEEEECCCTTEEHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCE
T ss_pred CCEEEEEEEccCCCCHHHhhhccCC---------CCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceE
Confidence 9999999999999999999876543 99999999999999999999999 99999999999999999999
Q ss_pred EEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhcc
Q 020641 176 KIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATP 255 (323)
Q Consensus 176 ~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~ 255 (323)
+|+|||++................||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.....
T Consensus 148 kl~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~-------- 219 (288)
T d1uu3a_ 148 QITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIF-------- 219 (288)
T ss_dssp EECCCTTCEECC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH--------
T ss_pred EecccccceecccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHH--------
Confidence 999999998765444333344556999999999999999999999999999999999999999755321111
Q ss_pred cccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHH
Q 020641 256 RLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVV 304 (323)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl 304 (323)
.++.... ...+...++++.+||.+||+.||.+|||++|++
T Consensus 220 -------~~i~~~~--~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~ 259 (288)
T d1uu3a_ 220 -------QKIIKLE--YDFPEKFFPKARDLVEKLLVLDATKRLGCEEME 259 (288)
T ss_dssp -------HHHHTTC--CCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGT
T ss_pred -------HHHHcCC--CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHc
Confidence 1111111 123344567799999999999999999999863
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.6e-55 Score=377.67 Aligned_cols=259 Identities=20% Similarity=0.327 Sum_probs=199.2
Q ss_pred cccccCCCCCCccceeccceeee---eeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEe
Q 020641 19 YFVRLDKGPEDDLYLKKRVKMRR---WLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVE 95 (323)
Q Consensus 19 ~~~~lg~G~~~~V~~~~~~~~~~---~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 95 (323)
....||+|+||+||+|++..+++ .+|+|...... .....+.+.+|++++++++||||+++++++..
T Consensus 30 ~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-----------~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~ 98 (299)
T d1jpaa_ 30 IEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY-----------TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTK 98 (299)
T ss_dssp EEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC-----------CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred EeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc-----------CHHHHHHHHHHHHHHHhCCCCCCccEEEEEee
Confidence 33489999999999999876654 46666443211 11223678999999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeE
Q 020641 96 GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKA 175 (323)
Q Consensus 96 ~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~ 175 (323)
++..++||||+.+|+|.+++...... +++..+..++.|++.||.|||++ +++||||||+|||++.++.+
T Consensus 99 ~~~~~iv~Ey~~~g~L~~~~~~~~~~--------l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~ 167 (299)
T d1jpaa_ 99 STPVMIITEFMENGSLDSFLRQNDGQ--------FTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVC 167 (299)
T ss_dssp SSSCEEEEECCTTEEHHHHHHTTTTC--------SCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCE
T ss_pred CCEEEEEEEecCCCcceeeeccccCC--------CCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECCCCcE
Confidence 99999999999999999988765432 89999999999999999999999 99999999999999999999
Q ss_pred EEeeccccCCCCccccccc---cccccCccccCCCccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccchhhh
Q 020641 176 KIADFNLSNQAPDMAARLH---STRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVT 251 (323)
Q Consensus 176 ~l~Dfg~~~~~~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~ 251 (323)
||+|||+++.......... .....||+.|+|||.+.+..++.++|||||||++|||+| |+.||......
T Consensus 168 Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~------- 240 (299)
T d1jpaa_ 168 KVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ------- 240 (299)
T ss_dssp EECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-------
T ss_pred EECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHH-------
Confidence 9999999986654322211 122347889999999999999999999999999999998 89999755321
Q ss_pred hhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhhcCCC
Q 020641 252 WATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSPP 315 (323)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~~~~~ 315 (323)
.+...+....+...+..++..+.+++.+||+.||.+|||+.||++.|+++++.+.
T Consensus 241 ---------~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~p~ 295 (299)
T d1jpaa_ 241 ---------DVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNPN 295 (299)
T ss_dssp ---------HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGG
T ss_pred ---------HHHHHHHcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcChh
Confidence 1222222233344556677889999999999999999999999999999987643
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.2e-55 Score=368.84 Aligned_cols=255 Identities=24% Similarity=0.364 Sum_probs=198.1
Q ss_pred CCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEe
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVE 95 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 95 (323)
.++...+||+|+||+||+|++.. ++.+|+|.+... ....+++.+|++++++++||||+++++++..
T Consensus 6 ~~~~~~~iG~G~fg~Vy~~~~~~-~~~vAvK~i~~~-------------~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~ 71 (263)
T d1sm2a_ 6 ELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIREG-------------AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 71 (263)
T ss_dssp CEEEEEEEECCSSCCEEEEEETT-TEEEEEEECCSS-------------SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred HcEEEEEEeeCCCeEEEEEEECC-CCEEEEEEECCC-------------cCcHHHHHHHHHHHHhcCCCCcccccceecc
Confidence 45667799999999999998764 456888865321 2233678999999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeE
Q 020641 96 GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKA 175 (323)
Q Consensus 96 ~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~ 175 (323)
++..++||||+.+|+|.+++...... +++..+..++.|++.||.|||+. +|+||||||+||+++.++.+
T Consensus 72 ~~~~~lv~E~~~~g~L~~~l~~~~~~--------~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~ 140 (263)
T d1sm2a_ 72 QAPICLVFEFMEHGCLSDYLRTQRGL--------FAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVI 140 (263)
T ss_dssp SSSCEEEEECCTTCBHHHHHHTTTTC--------CCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCE
T ss_pred CCceEEEEEecCCCcHHHHhhccccC--------CCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCe
Confidence 99999999999999999998765432 88999999999999999999999 99999999999999999999
Q ss_pred EEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhC-CCCCCCCCCcccchhhhhhc
Q 020641 176 KIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTG-RKPVDHTMPRGQQSLVTWAT 254 (323)
Q Consensus 176 ~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g-~~pf~~~~~~~~~~~~~~~~ 254 (323)
||+|||+++........ ......||+.|+|||.+.+..++.++||||||+++|||+|+ ..||.....
T Consensus 141 Kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~----------- 208 (263)
T d1sm2a_ 141 KVSDFGMTRFVLDDQYT-SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN----------- 208 (263)
T ss_dssp EECSCC-------------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCH-----------
T ss_pred EecccchheeccCCCce-eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCH-----------
Confidence 99999999766543322 12234589999999999999999999999999999999995 555543321
Q ss_pred ccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhhc
Q 020641 255 PRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLK 312 (323)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~~ 312 (323)
..+.+.+....+...+..++.++.+++.+||+.||++|||++||++.|+++.+
T Consensus 209 -----~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e 261 (263)
T d1sm2a_ 209 -----SEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261 (263)
T ss_dssp -----HHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -----HHHHHHHHhcCCCCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 11111122222233445566789999999999999999999999999999875
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-55 Score=373.61 Aligned_cols=250 Identities=20% Similarity=0.266 Sum_probs=204.9
Q ss_pred CCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEe
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVE 95 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 95 (323)
.|+...+||+|+||+||+|++..+++.+|+|++.... ....+.+.+|++++++++||||+++++++.+
T Consensus 13 ~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~------------~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~ 80 (288)
T d2jfla1 13 FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS------------EEELEDYMVEIDILASCDHPNIVKLLDAFYY 80 (288)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS------------SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred CeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC------------HHHHHHHHHHHHHHHhCCCCCCCeEEEEEee
Confidence 3566779999999999999999999999999775321 1223667899999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeE
Q 020641 96 GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKA 175 (323)
Q Consensus 96 ~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~ 175 (323)
++..++||||+.+|+|.+++.+.... +++..+..++.||+.||.|||++ ||+||||||+|||++.++.+
T Consensus 81 ~~~~~lvmEy~~~g~L~~~~~~~~~~--------l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~ 149 (288)
T d2jfla1 81 ENNLWILIEFCAGGAVDAVMLELERP--------LTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDI 149 (288)
T ss_dssp TTEEEEEEECCTTEEHHHHHHHHTSC--------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCE
T ss_pred CCeEEEEEecCCCCcHHHHHHhcCCC--------CCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCE
Confidence 99999999999999999998654322 99999999999999999999999 99999999999999999999
Q ss_pred EEeeccccCCCCccccccccccccCccccCCCcccc-----CCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhh
Q 020641 176 KIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAM-----TGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLV 250 (323)
Q Consensus 176 ~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~ 250 (323)
||+|||++........ ......||+.|+|||++. +..++.++|||||||++|+|++|+.||..........
T Consensus 150 Kl~DFG~a~~~~~~~~--~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~-- 225 (288)
T d2jfla1 150 KLADFGVSAKNTRTIQ--RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLL-- 225 (288)
T ss_dssp EECCCTTCEECHHHHH--HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHH--
T ss_pred EEEechhhhccCCCcc--cccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHH--
Confidence 9999999876543322 223456999999999884 4567899999999999999999999997654322111
Q ss_pred hhhcccccccccchhcCCC-cCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 251 TWATPRLSEDKVKQCVDPK-LKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
++.... .....+...+.++.+||.+||+.||.+|||+.|+++
T Consensus 226 -------------~i~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 226 -------------KIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp -------------HHHHSCCCCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -------------HHHcCCCCCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111110 011223456778999999999999999999999987
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-55 Score=374.83 Aligned_cols=257 Identities=18% Similarity=0.225 Sum_probs=193.8
Q ss_pred CCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEe
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVE 95 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 95 (323)
.|+....||+|+||.||+|++..+++.+|+|++........ ..+.+.+|++++++++||||+++++++.+
T Consensus 5 dy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~----------~~~~~~~E~~il~~l~HpnIv~~~~~~~~ 74 (269)
T d2java1 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEA----------EKQMLVSEVNLLRELKHPNIVRYYDRIID 74 (269)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHH----------HHHHHHHHHHHTTSCCCTTBCCEEEEEEC
T ss_pred hCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHH----------HHHHHHHHHHHHHHCCCCCEeeEEEEEEe
Confidence 46777899999999999999999999999997754432211 13568899999999999999999999864
Q ss_pred --CCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCC--CCCceeCCCCCCCEEEcc
Q 020641 96 --GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKV--QPSIIHRDIRSSNVLLFE 171 (323)
Q Consensus 96 --~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~--~~~i~h~dikp~nili~~ 171 (323)
++..|+|||||++|+|.+++.+.... ...+++..++.++.|++.||.|||++. ..+|+||||||+|||++.
T Consensus 75 ~~~~~~~ivmEy~~~g~L~~~i~~~~~~-----~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~ 149 (269)
T d2java1 75 RTNTTLYIVMEYCEGGDLASVITKGTKE-----RQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDG 149 (269)
T ss_dssp ----CEEEEEECCTTEEHHHHHHHHHHH-----TCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECT
T ss_pred CCCCEEEEEEecCCCCcHHHHHHhcccc-----CCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCC
Confidence 45689999999999999998653211 012999999999999999999999971 013999999999999999
Q ss_pred CCeEEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhh
Q 020641 172 DFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVT 251 (323)
Q Consensus 172 ~~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~ 251 (323)
++.+||+|||++........ ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.........
T Consensus 150 ~~~vkl~DFG~a~~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~---- 223 (269)
T d2java1 150 KQNVKLGDFGLARILNHDTS--FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELA---- 223 (269)
T ss_dssp TSCEEECCHHHHHHC-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH----
T ss_pred CCcEEEeeccceeecccCCC--ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHH----
Confidence 99999999999976544222 123456899999999999999999999999999999999999999754321110
Q ss_pred hhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 252 WATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
..+.+.. ....+...++++.+|+.+||+.||.+|||+.|+++
T Consensus 224 -----------~~i~~~~-~~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 224 -----------GKIREGK-FRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp -----------HHHHHTC-CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -----------HHHHcCC-CCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 0111111 11234455678999999999999999999999975
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-54 Score=366.76 Aligned_cols=244 Identities=20% Similarity=0.305 Sum_probs=194.9
Q ss_pred cccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEe----C
Q 020641 21 VRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVE----G 96 (323)
Q Consensus 21 ~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~ 96 (323)
.+||+|+||+||+|.+..+++.+|+|.+....... ...+.+.+|++++++++||||+++++++.. .
T Consensus 15 ~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~----------~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 84 (270)
T d1t4ha_ 15 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTK----------SERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGK 84 (270)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCH----------HHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSC
T ss_pred eEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCH----------HHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccC
Confidence 37999999999999999999999999765443221 123678899999999999999999999875 3
Q ss_pred CeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC--ceeCCCCCCCEEEc-cCC
Q 020641 97 NLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPS--IIHRDIRSSNVLLF-EDF 173 (323)
Q Consensus 97 ~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~--i~h~dikp~nili~-~~~ 173 (323)
...|+||||+++|+|.+++.+... +++..+..++.||+.||.|||++ + |+||||||+|||++ .++
T Consensus 85 ~~~~ivmE~~~~g~L~~~l~~~~~---------~~~~~~~~~~~qi~~gl~yLH~~---~~~IiHrDiKp~NILl~~~~~ 152 (270)
T d1t4ha_ 85 KCIVLVTELMTSGTLKTYLKRFKV---------MKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTG 152 (270)
T ss_dssp EEEEEEEECCCSCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTS
T ss_pred CEEEEEEeCCCCCcHHHHHhcccc---------ccHHHHHHHHHHHHHHHHHHHHC---CCCEEeCCcChhhceeeCCCC
Confidence 467999999999999999976542 89999999999999999999999 8 99999999999996 478
Q ss_pred eEEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhh
Q 020641 174 KAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWA 253 (323)
Q Consensus 174 ~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 253 (323)
.+||+|||+++...... .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||........ .....
T Consensus 153 ~~Kl~DFGla~~~~~~~----~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~--~~~~i 225 (270)
T d1t4ha_ 153 SVKIGDLGLATLKRASF----AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ--IYRRV 225 (270)
T ss_dssp CEEECCTTGGGGCCTTS----BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH--HHHHH
T ss_pred CEEEeecCcceeccCCc----cCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHH--HHHHH
Confidence 99999999997543321 234569999999998865 599999999999999999999999975432111 01100
Q ss_pred cccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 254 TPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
. ........+...++++.+++.+||+.||++|||+.|+++
T Consensus 226 ~------------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 226 T------------SGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp T------------TTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred H------------cCCCCcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 0 000001112234557999999999999999999999987
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.8e-54 Score=374.32 Aligned_cols=247 Identities=21% Similarity=0.279 Sum_probs=201.7
Q ss_pred CccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeC
Q 020641 17 PGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEG 96 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 96 (323)
|..+.+||+|+||+||+|++..+++.+|+|++........ ...+.+.+|++++++++||||+++++++.++
T Consensus 17 y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~---------~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~ 87 (309)
T d1u5ra_ 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSN---------EKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE 87 (309)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHH---------HHHHHHHHHHHHHTTCCCTTBCCEEEEEEET
T ss_pred cEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCH---------HHHHHHHHHHHHHHHCCCCCEeeEEEEEEEC
Confidence 5566799999999999999999999999997764322221 1235688999999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEE
Q 020641 97 NLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAK 176 (323)
Q Consensus 97 ~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~ 176 (323)
+..|+|||||.+|+|..++..... +++..+..++.||+.||.|||++ ||+||||||+|||++.++.+|
T Consensus 88 ~~~~iv~E~~~~g~l~~~~~~~~~---------l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~K 155 (309)
T d1u5ra_ 88 HTAWLVMEYCLGSASDLLEVHKKP---------LQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVK 155 (309)
T ss_dssp TEEEEEEECCSEEHHHHHHHHTSC---------CCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEE
T ss_pred CEEEEEEEecCCCchHHHHHhCCC---------CCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEE
Confidence 999999999999888777655432 99999999999999999999999 999999999999999999999
Q ss_pred EeeccccCCCCccccccccccccCccccCCCccccC---CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhh
Q 020641 177 IADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT---GQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWA 253 (323)
Q Consensus 177 l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~---~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 253 (323)
|+|||++...... ....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.........
T Consensus 156 l~DFG~a~~~~~~------~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~------ 223 (309)
T d1u5ra_ 156 LGDFGSASIMAPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL------ 223 (309)
T ss_dssp ECCCTTCBSSSSB------CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH------
T ss_pred EeecccccccCCC------CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHH------
Confidence 9999999765432 33469999999999864 45889999999999999999999999755321111
Q ss_pred cccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 254 TPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
............+...++.+.+||.+||+.||.+|||+.|+++
T Consensus 224 ---------~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 224 ---------YHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp ---------HHHHHSCCCCCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ---------HHHHhCCCCCCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 1111111111122345678999999999999999999999986
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-54 Score=367.98 Aligned_cols=251 Identities=24% Similarity=0.347 Sum_probs=202.0
Q ss_pred ccCCCCCCccceeccc--eeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeCCeE
Q 020641 22 RLDKGPEDDLYLKKRV--KMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLR 99 (323)
Q Consensus 22 ~lg~G~~~~V~~~~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 99 (323)
+||+|+||+||+|... .+++.+|+|++..... .....+.+.+|++++++++||||+++++++..+ ..
T Consensus 14 ~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~----------~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~ 82 (277)
T d1xbba_ 14 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN----------DPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SW 82 (277)
T ss_dssp EEEECSSEEEEEEEEECSSSEEEEEEEEEC---------------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SE
T ss_pred CcccCCCeEEEEEEEccCCcCeEEEEEEEChhhC----------CHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CE
Confidence 6999999999999753 4567899987643211 122246789999999999999999999999754 57
Q ss_pred EEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEEEee
Q 020641 100 VLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIAD 179 (323)
Q Consensus 100 ~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~l~D 179 (323)
++||||+++|+|.+++..... +++..+..++.||+.||.|||++ +|+||||||+||+++.++.++|+|
T Consensus 83 ~lvmE~~~~g~L~~~l~~~~~---------l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~D 150 (277)
T d1xbba_ 83 MLVMEMAELGPLNKYLQQNRH---------VKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISD 150 (277)
T ss_dssp EEEEECCTTEEHHHHHHHCTT---------CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECC
T ss_pred EEEEEcCCCCcHHHHHhhccC---------CCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccc
Confidence 899999999999999976543 99999999999999999999999 999999999999999999999999
Q ss_pred ccccCCCCcccc-ccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccc
Q 020641 180 FNLSNQAPDMAA-RLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPRL 257 (323)
Q Consensus 180 fg~~~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~ 257 (323)
||+++....... ........||+.|+|||.+.+..++.++||||||+++|||++ |+.||.+....
T Consensus 151 FGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~------------- 217 (277)
T d1xbba_ 151 FGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS------------- 217 (277)
T ss_dssp CTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-------------
T ss_pred hhhhhhccccccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHH-------------
Confidence 999976543322 222334458999999999999999999999999999999998 89999765321
Q ss_pred cccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhh
Q 020641 258 SEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLL 311 (323)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~ 311 (323)
.+...+....+...+..++.++.+|+.+||+.||++|||+.+|.+.|+...
T Consensus 218 ---~~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~ 268 (277)
T d1xbba_ 218 ---EVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 268 (277)
T ss_dssp ---HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred ---HHHHHHHcCCCCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHH
Confidence 112222222333445667788999999999999999999999999888764
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4e-54 Score=372.09 Aligned_cols=250 Identities=21% Similarity=0.289 Sum_probs=191.2
Q ss_pred CccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeC
Q 020641 17 PGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEG 96 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 96 (323)
|.....||+|+||+||+|++..+++.+|+|++.++... .....+.+|++++++++||||+++++++.++
T Consensus 11 Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-----------~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~ 79 (307)
T d1a06a_ 11 YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE-----------GKEGSMENEIAVLHKIKHPNIVALDDIYESG 79 (307)
T ss_dssp EEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC---------------------CHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred eEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhh-----------hHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC
Confidence 56666899999999999999999999999987644321 1124567899999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEc---cCC
Q 020641 97 NLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLF---EDF 173 (323)
Q Consensus 97 ~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~---~~~ 173 (323)
+..|+|||||+||+|.+++..... +++..+..++.||+.||.|||++ ||+||||||+||++. .++
T Consensus 80 ~~~~lvmE~~~gg~L~~~l~~~~~---------l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~ 147 (307)
T d1a06a_ 80 GHLYLIMQLVSGGELFDRIVEKGF---------YTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDS 147 (307)
T ss_dssp SEEEEEECCCCSCBHHHHHHTCSC---------CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTC
T ss_pred CEEEEEEeccCCCcHHHhhhcccC---------CCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCc
Confidence 999999999999999999976542 99999999999999999999999 999999999999995 478
Q ss_pred eEEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhh
Q 020641 174 KAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWA 253 (323)
Q Consensus 174 ~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 253 (323)
.+||+|||++........ .....||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+...
T Consensus 148 ~vkl~DFG~a~~~~~~~~---~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~ 224 (307)
T d1a06a_ 148 KIMISDFGLSKMEDPGSV---LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKA 224 (307)
T ss_dssp CEEECCC---------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTT
T ss_pred eEEEeccceeEEccCCCe---eeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhcc
Confidence 999999999976543322 23456999999999999999999999999999999999999999755322111111000
Q ss_pred cccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 254 TPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
............++++.+|+.+||+.||++|||+.|+++
T Consensus 225 -------------~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 225 -------------EYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp -------------CCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred -------------CCCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 011111223455678999999999999999999999998
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-54 Score=377.25 Aligned_cols=268 Identities=17% Similarity=0.216 Sum_probs=206.5
Q ss_pred CCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEe
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVE 95 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 95 (323)
.|+.+.+||+|+||+||+|++..+++.+|+|++..+. .....+.+.+|+.++++++||||++++++|.+
T Consensus 7 ~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-----------~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~ 75 (322)
T d1s9ja_ 7 DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-----------KPAIRNQIIRELQVLHECNSPYIVGFYGAFYS 75 (322)
T ss_dssp GEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC-----------CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEEC
T ss_pred CCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh-----------CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE
Confidence 4566779999999999999999999999999765321 12334678999999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCCCceeCCCCCCCEEEccCCe
Q 020641 96 GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHE-KVQPSIIHRDIRSSNVLLFEDFK 174 (323)
Q Consensus 96 ~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~-~~~~~i~h~dikp~nili~~~~~ 174 (323)
.+..|+||||+.+|+|.+++.+... +++..+..++.|++.||.|||+ . ||+||||||+|||++.++.
T Consensus 76 ~~~~~iVmEy~~gg~L~~~l~~~~~---------l~~~~~~~~~~qil~aL~yLH~~~---~IiHRDiKP~NILl~~~~~ 143 (322)
T d1s9ja_ 76 DGEISICMEHMDGGSLDQVLKKAGR---------IPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGE 143 (322)
T ss_dssp SSEEEEEEECCTTEEHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCC
T ss_pred CCEEEEEEEcCCCCcHHHHHhhcCC---------CCHHHHHHHHHHHHHHHHHHHHhC---CEEccccCHHHeeECCCCC
Confidence 9999999999999999999976542 8999999999999999999996 6 8999999999999999999
Q ss_pred EEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhc
Q 020641 175 AKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWAT 254 (323)
Q Consensus 175 ~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~ 254 (323)
+||+|||+|...... ......||+.|+|||++.+..++.++||||+||++|+|++|+.||...+....+.......
T Consensus 144 vkl~DFGla~~~~~~----~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~ 219 (322)
T d1s9ja_ 144 IKLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQV 219 (322)
T ss_dssp EEECCCCCCHHHHHH----TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC----
T ss_pred EEEeeCCCccccCCC----ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHh
Confidence 999999998754322 2234569999999999999999999999999999999999999997654322111000000
Q ss_pred cc-----------------------cccccc----chhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH--
Q 020641 255 PR-----------------------LSEDKV----KQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK-- 305 (323)
Q Consensus 255 ~~-----------------------~~~~~~----~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~-- 305 (323)
.. ...... ................+.++.+|+.+||..||.+|||++|+++
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hp 299 (322)
T d1s9ja_ 220 EGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHA 299 (322)
T ss_dssp --------------------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred cCCcccCCcccccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCH
Confidence 00 000000 0000000000111224567999999999999999999999987
Q ss_pred HHhhh
Q 020641 306 ALQPL 310 (323)
Q Consensus 306 ~l~~~ 310 (323)
++++.
T Consensus 300 f~~~~ 304 (322)
T d1s9ja_ 300 FIKRS 304 (322)
T ss_dssp HHHHH
T ss_pred hhCcC
Confidence 45543
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-54 Score=366.47 Aligned_cols=252 Identities=25% Similarity=0.354 Sum_probs=203.8
Q ss_pred ccCCCCCCccceeccc--eeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeCCeE
Q 020641 22 RLDKGPEDDLYLKKRV--KMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNLR 99 (323)
Q Consensus 22 ~lg~G~~~~V~~~~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 99 (323)
+||+|+||+||+|.+. .++..||+|++.... .....+.+.+|++++++++||||+++++++..+ ..
T Consensus 16 ~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~-----------~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~-~~ 83 (285)
T d1u59a_ 16 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-----------EKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE-AL 83 (285)
T ss_dssp EEECCTTEEEEEEEEC---CCEEEEEEEECSSC-----------CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SE
T ss_pred EEecccCeEEEEEEEecCCCcEEEEEEEEChhc-----------CHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccC-eE
Confidence 6999999999999764 345578888664221 112236789999999999999999999998754 57
Q ss_pred EEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEEEee
Q 020641 100 VLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIAD 179 (323)
Q Consensus 100 ~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~l~D 179 (323)
|+||||+++|+|.+++...... +++..+..++.|++.||.|||++ |++||||||+||+++.++.+||+|
T Consensus 84 ~lvmE~~~~g~L~~~l~~~~~~--------l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~D 152 (285)
T d1u59a_ 84 MLVMEMAGGGPLHKFLVGKREE--------IPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISD 152 (285)
T ss_dssp EEEEECCTTEEHHHHHTTCTTT--------SCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECC
T ss_pred EEEEEeCCCCcHHHHhhccccC--------CCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeecc
Confidence 9999999999999998654332 99999999999999999999999 999999999999999999999999
Q ss_pred ccccCCCCcccc-ccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhcccc
Q 020641 180 FNLSNQAPDMAA-RLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWATPRL 257 (323)
Q Consensus 180 fg~~~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~ 257 (323)
||+++....... ........||+.|+|||.+.+..++.++|||||||++|||++ |+.||......
T Consensus 153 FGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~------------- 219 (285)
T d1u59a_ 153 FGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP------------- 219 (285)
T ss_dssp CTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH-------------
T ss_pred chhhhcccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHH-------------
Confidence 999976644322 222334458899999999998899999999999999999998 99999765321
Q ss_pred cccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhhc
Q 020641 258 SEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLK 312 (323)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~~ 312 (323)
.+...+....+...+..+++++.+|+.+||+.||++|||+.+|.+.|+....
T Consensus 220 ---~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~ 271 (285)
T d1u59a_ 220 ---EVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 271 (285)
T ss_dssp ---HHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---HHHHHHHcCCCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 1112222223334556677889999999999999999999999999987654
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-53 Score=359.07 Aligned_cols=253 Identities=22% Similarity=0.325 Sum_probs=209.7
Q ss_pred CCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEe
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVE 95 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 95 (323)
.+++..+||+|+||+||+++. ++++.+|+|.+.+. ....+.+.+|+.++++++||||+++++++.+
T Consensus 5 ~~~~~~~iG~G~fg~Vy~~~~-~~~~~vAvK~l~~~-------------~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~ 70 (258)
T d1k2pa_ 5 DLTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIKEG-------------SMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 70 (258)
T ss_dssp CCCCCCCCCEETTEEEEEEEE-TTTEEEEEEEEESS-------------SSCHHHHHHHHHHHHTCCCTTBCCEEEEECC
T ss_pred HCEEeEEEecCCCeEEEEEEE-CCCCEEEEEEECcC-------------cCCHHHHHHHHHHHHhcCCCceeeEEEEEee
Confidence 456777999999999999997 46777888865422 1224678999999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeE
Q 020641 96 GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKA 175 (323)
Q Consensus 96 ~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~ 175 (323)
.+..++||||+.+|+|.+++...... +++..++.++.|++.||.|||+. ||+||||||+||+++.++.+
T Consensus 71 ~~~~~iv~Ey~~~g~l~~~~~~~~~~--------~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~ 139 (258)
T d1k2pa_ 71 QRPIFIITEYMANGCLLNYLREMRHR--------FQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVV 139 (258)
T ss_dssp SSSEEEEEECCTTEEHHHHHHSGGGC--------CCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCE
T ss_pred CCceEEEEEccCCCcHHHhhhccccC--------CcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcE
Confidence 99999999999999999997665443 88999999999999999999999 99999999999999999999
Q ss_pred EEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhc
Q 020641 176 KIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWAT 254 (323)
Q Consensus 176 ~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~ 254 (323)
||+|||++......... ......||+.|+|||.+.+..++.++||||||+++|||+| |+.||.......
T Consensus 140 kl~DfG~a~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~--------- 209 (258)
T d1k2pa_ 140 KVSDFGLSRYVLDDEYT-SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE--------- 209 (258)
T ss_dssp EECCCSSCCBCSSSSCC-CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH---------
T ss_pred EECcchhheeccCCCce-eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHH---------
Confidence 99999999765543222 2334558999999999999999999999999999999998 899997654321
Q ss_pred ccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhh
Q 020641 255 PRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPL 310 (323)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~ 310 (323)
+...+....+...+...+..+.+|+.+||+.||++|||+++|++.|.++
T Consensus 210 -------~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 210 -------TAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp -------HHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred -------HHHHHHhCCCCCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 1111222223344555667899999999999999999999999998764
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-54 Score=374.01 Aligned_cols=263 Identities=22% Similarity=0.331 Sum_probs=207.8
Q ss_pred CccccccCCCCCCccceeccceeee-----eeeeccccccccCccccccccCCCCCchHHHHHHHHHhcC-CCCccccee
Q 020641 17 PGYFVRLDKGPEDDLYLKKRVKMRR-----WLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRL-KHENLVELL 90 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~~~~~~~-----~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~ 90 (323)
++....||+|+||+||+|++..+++ .+|+|..... ........+.+|+.+++++ +||||++++
T Consensus 39 ~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~-----------~~~~~~~~~~~E~~~l~~l~~HpnIv~l~ 107 (325)
T d1rjba_ 39 LEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEK-----------ADSSEREALMSELKMMTQLGSHENIVNLL 107 (325)
T ss_dssp EEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-----------------CHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred eEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccc-----------cCHHHHHHHHHHHHHHHHhcCCCcEeEEE
Confidence 3444589999999999999876543 4666644321 1223447789999999998 899999999
Q ss_pred eEEEeCCeEEEEEeecCCCCHHHHhccCCCCCC--------------CCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 020641 91 GYCVEGNLRVLAYEFATMGSLHDILHGRKGVQG--------------AQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPS 156 (323)
Q Consensus 91 ~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~ 156 (323)
+++.+.+..++|||||++|+|.+++........ ......+++..++.++.|++.||.|||++ +
T Consensus 108 ~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~ 184 (325)
T d1rjba_ 108 GACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---S 184 (325)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---T
T ss_pred EEEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---C
Confidence 999999999999999999999999976542210 11123489999999999999999999999 9
Q ss_pred ceeCCCCCCCEEEccCCeEEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHh-CC
Q 020641 157 IIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GR 235 (323)
Q Consensus 157 i~h~dikp~nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~ 235 (323)
|+||||||+||+++.++.+||+|||+|+...............||+.|+|||.+.+..++.++|||||||++|||++ |.
T Consensus 185 IiHRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~ 264 (325)
T d1rjba_ 185 CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGV 264 (325)
T ss_dssp EEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSC
T ss_pred eeeccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCC
Confidence 99999999999999999999999999987655444333445568999999999999999999999999999999997 89
Q ss_pred CCCCCCCCcccchhhhhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHh
Q 020641 236 KPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQ 308 (323)
Q Consensus 236 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~ 308 (323)
.||.+.... ..+.+.+....+...+..+++++.+||.+||+.||++|||++||++.|.
T Consensus 265 ~Pf~~~~~~---------------~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 265 NPYPGIPVD---------------ANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp CSSTTCCCS---------------HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCCCCCHH---------------HHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 999765432 1122233333344455667788999999999999999999999999985
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-54 Score=366.12 Aligned_cols=257 Identities=24% Similarity=0.348 Sum_probs=205.0
Q ss_pred CCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEe
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVE 95 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 95 (323)
.+....+||+|+||+||+|... +++.||+|.+... ....+.+.+|++++++++||||+++++++.+
T Consensus 14 ~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~-------------~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~ 79 (272)
T d1qpca_ 14 TLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQG-------------SMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 79 (272)
T ss_dssp GEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTT-------------SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred HeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccC-------------cCCHHHHHHHHHHHHhCCCCCEeEEEeeecc
Confidence 3455568999999999999975 5667888865321 2234678999999999999999999998865
Q ss_pred CCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeE
Q 020641 96 GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKA 175 (323)
Q Consensus 96 ~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~ 175 (323)
+ ..++||||+.+|+|.+++....... +++..+..++.||+.||.|||++ +|+||||||+||+++.++.+
T Consensus 80 ~-~~~iv~Ey~~~g~L~~~~~~~~~~~-------l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~ 148 (272)
T d1qpca_ 80 E-PIYIITEYMENGSLVDFLKTPSGIK-------LTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSC 148 (272)
T ss_dssp S-SCEEEEECCTTCBHHHHTTSHHHHT-------CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCE
T ss_pred C-CeEEEEEeCCCCcHHHHHhhcCCCC-------CCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccce
Confidence 4 5699999999999999886554322 89999999999999999999999 99999999999999999999
Q ss_pred EEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhcc
Q 020641 176 KIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATP 255 (323)
Q Consensus 176 ~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~ 255 (323)
||+|||+++........ ......|++.|+|||.+.+..++.++|||||||++|||+||..|+......
T Consensus 149 Kl~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~----------- 216 (272)
T d1qpca_ 149 KIADFGLARLIEDNEYT-AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN----------- 216 (272)
T ss_dssp EECCCTTCEECSSSCEE-CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH-----------
T ss_pred eeccccceEEccCCccc-cccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCH-----------
Confidence 99999999876543222 223445899999999999888999999999999999999966555432211
Q ss_pred cccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhhcC
Q 020641 256 RLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKS 313 (323)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~~~ 313 (323)
..+...+....+...+..++.++.+|+.+||+.||++|||+.||++.|+++..+
T Consensus 217 ----~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts 270 (272)
T d1qpca_ 217 ----PEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (272)
T ss_dssp ----HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----HHHHHHHHhcCCCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence 111122222233344556677899999999999999999999999999998753
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-53 Score=364.02 Aligned_cols=262 Identities=20% Similarity=0.288 Sum_probs=203.0
Q ss_pred CccccccCCCCCCccceeccceee----eeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeE
Q 020641 17 PGYFVRLDKGPEDDLYLKKRVKMR----RWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGY 92 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~~~~~~----~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 92 (323)
+.....||+|+||+||+|....++ ..+|+|...... .......+.+|++++++++||||++++++
T Consensus 9 ~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~-----------~~~~~~~~~~E~~il~~l~H~nIv~~~g~ 77 (283)
T d1mqba_ 9 VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-----------TEKQRVDFLGEAGIMGQFSHHNIIRLEGV 77 (283)
T ss_dssp EEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-----------CHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred eEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc-----------ChHHHHHHHHHHHHHHhcCCCCEeeeeEE
Confidence 344457899999999999876554 467887653221 11123568899999999999999999999
Q ss_pred EEeCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccC
Q 020641 93 CVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFED 172 (323)
Q Consensus 93 ~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~ 172 (323)
+.+....++||||+.++++.+++...... +++..+..++.|++.|+.|||+. +|+||||||+|||++.+
T Consensus 78 ~~~~~~~~~v~e~~~~~~l~~~~~~~~~~--------~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~ 146 (283)
T d1mqba_ 78 ISKYKPMMIITEYMENGALDKFLREKDGE--------FSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSN 146 (283)
T ss_dssp ECSSSSEEEEEECCTTEEHHHHHHHTTTC--------SCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTT
T ss_pred EecCCceEEEEEecccCcchhhhhccccc--------ccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCC
Confidence 99999999999999999999988765432 99999999999999999999999 99999999999999999
Q ss_pred CeEEEeeccccCCCCccccc-cccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhh
Q 020641 173 FKAKIADFNLSNQAPDMAAR-LHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVT 251 (323)
Q Consensus 173 ~~~~l~Dfg~~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~ 251 (323)
+.+||+|||+++........ .......||+.|+|||.+.+..++.++|||||||++|||+++..|+.....
T Consensus 147 ~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~-------- 218 (283)
T d1mqba_ 147 LVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS-------- 218 (283)
T ss_dssp CCEEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC--------
T ss_pred CeEEEcccchhhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCC--------
Confidence 99999999999876543222 122334589999999999999999999999999999999997666543321
Q ss_pred hhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhhcCCC
Q 020641 252 WATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSPP 315 (323)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~~~~~ 315 (323)
...+...+....+...+..++..+.+++.+||+.||++|||+.||++.|+++++.+.
T Consensus 219 -------~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~p~ 275 (283)
T d1mqba_ 219 -------NHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPD 275 (283)
T ss_dssp -------HHHHHHHHHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGG
T ss_pred -------HHHHHHHHhccCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhCcc
Confidence 112222333334445556677889999999999999999999999999999988654
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-53 Score=366.68 Aligned_cols=255 Identities=19% Similarity=0.214 Sum_probs=206.6
Q ss_pred CccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeC
Q 020641 17 PGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEG 96 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 96 (323)
|.....||+|+||.||+|++..+++.+|+|++.+....... .....+.+.+|+.++++++||||+++++++.+.
T Consensus 12 Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~------~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~ 85 (293)
T d1jksa_ 12 YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSR------RGVSREDIEREVSILKEIQHPNVITLHEVYENK 85 (293)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCS------SSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred EEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhh------hhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC
Confidence 55666899999999999999999999999987654433221 122357889999999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCC---
Q 020641 97 NLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDF--- 173 (323)
Q Consensus 97 ~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~--- 173 (323)
+..|+|||||++|+|.+++..... +++..+..++.|++.||.|||+. ||+||||||+||+++.++
T Consensus 86 ~~~~iv~E~~~gg~L~~~i~~~~~---------l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~ 153 (293)
T d1jksa_ 86 TDVILILELVAGGELFDFLAEKES---------LTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPK 153 (293)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSS
T ss_pred CEEEEEEEcCCCccccchhccccc---------cchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcc
Confidence 999999999999999999976542 99999999999999999999999 999999999999998776
Q ss_pred -eEEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhh
Q 020641 174 -KAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTW 252 (323)
Q Consensus 174 -~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 252 (323)
.+||+|||++........ .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.........+..
T Consensus 154 ~~vkl~DfG~a~~~~~~~~---~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~ 230 (293)
T d1jksa_ 154 PRIKIIDFGLAHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSA 230 (293)
T ss_dssp CCEEECCCTTCEECTTSCB---CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHT
T ss_pred cceEecchhhhhhcCCCcc---ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHh
Confidence 599999999876644322 2344589999999999999999999999999999999999999976543211111110
Q ss_pred hcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 253 ATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
... ......+...+..+.+||.+||+.||.+|||++|+++
T Consensus 231 ~~~-------------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 231 VNY-------------EFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp TCC-------------CCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred cCC-------------CCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000 0000011234567999999999999999999999997
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-53 Score=362.40 Aligned_cols=264 Identities=28% Similarity=0.383 Sum_probs=206.9
Q ss_pred ccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeCC
Q 020641 18 GYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGN 97 (323)
Q Consensus 18 ~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 97 (323)
....+||+|+||.||+|.+..+.+ +|+|++... ....+.+.+|+.++++++|+||+++++++.+ +
T Consensus 20 ~i~~~iG~G~fg~Vy~~~~~~~~~-vAiK~l~~~-------------~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~ 84 (285)
T d1fmka3 20 RLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPG-------------TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-E 84 (285)
T ss_dssp EEEEEEEECSSCEEEEEEETTTEE-EEEEECCTT-------------SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred EEeeEEeeCCCeEEEEEEECCCCE-EEEEEECcc-------------cCCHHHHHHHHHHHHhcccCCEeEEEEEEec-C
Confidence 334489999999999999877654 788865422 1223678999999999999999999999865 4
Q ss_pred eEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEEE
Q 020641 98 LRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKI 177 (323)
Q Consensus 98 ~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~l 177 (323)
..++||||+.+|+|.+++....... +++..+..++.|++.||.|||++ |++||||||+|||++.++.+||
T Consensus 85 ~~~lv~Ey~~~g~l~~~~~~~~~~~-------l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl 154 (285)
T d1fmka3 85 PIYIVTEYMSKGSLLDFLKGETGKY-------LRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKV 154 (285)
T ss_dssp SCEEEECCCTTCBHHHHHSHHHHTT-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEE
T ss_pred CeEEEEEecCCCchhhhhhhccccc-------chHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEE
Confidence 5789999999999999987643222 89999999999999999999999 9999999999999999999999
Q ss_pred eeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccc
Q 020641 178 ADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRL 257 (323)
Q Consensus 178 ~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 257 (323)
+|||+++....... .......||+.|+|||.+.+..++.++||||||+++|||++|..|+......
T Consensus 155 ~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~------------- 220 (285)
T d1fmka3 155 ADFGLARLIEDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN------------- 220 (285)
T ss_dssp CCCCTTC---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH-------------
T ss_pred cccchhhhccCCCc-eeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCH-------------
Confidence 99999976543222 2233345899999999999999999999999999999999976665433221
Q ss_pred cccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhhcCCCCCCCCCC
Q 020641 258 SEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSPPPAAPVSE 322 (323)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~~~~~~~~~~~~ 322 (323)
..+...+....+...+..++.++.+++.+||+.||++|||+++|+++|+..+....|+.++-|
T Consensus 221 --~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~p~~~p~~ 283 (285)
T d1fmka3 221 --REVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPGE 283 (285)
T ss_dssp --HHHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCCCCCCSC
T ss_pred --HHHHHHHHhcCCCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCCCCCCCCC
Confidence 111122222233345566677899999999999999999999999999999988887766544
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=2.3e-53 Score=373.72 Aligned_cols=250 Identities=19% Similarity=0.170 Sum_probs=204.7
Q ss_pred CccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeC
Q 020641 17 PGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEG 96 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 96 (323)
|+...+||+|+||.||+|.+..+++.+|+|++..... .....+.+|++++++++||||+++++++.++
T Consensus 31 Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~------------~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~ 98 (352)
T d1koba_ 31 YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP------------LDKYTVKNEISIMNQLHHPKLINLHDAFEDK 98 (352)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH------------HHHHHHHHHHHHHTTCCSTTBCCEEEEEECS
T ss_pred eEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcch------------hHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC
Confidence 5666799999999999999999999999997653211 1125678999999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEc--cCCe
Q 020641 97 NLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLF--EDFK 174 (323)
Q Consensus 97 ~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~--~~~~ 174 (323)
+..|+|||||++|+|.+++...... +++..++.++.||+.||.|||++ ||+||||||+|||++ .++.
T Consensus 99 ~~~~ivmE~~~gg~L~~~~~~~~~~--------l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~ 167 (352)
T d1koba_ 99 YEMVLILEFLSGGELFDRIAAEDYK--------MSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASS 167 (352)
T ss_dssp SEEEEEEECCCCCBHHHHTTCTTCC--------BCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCC
T ss_pred CEEEEEEEcCCCChHHHHHHhcCCC--------CCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCe
Confidence 9999999999999999988665432 99999999999999999999999 999999999999997 5689
Q ss_pred EEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhc
Q 020641 175 AKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWAT 254 (323)
Q Consensus 175 ~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~ 254 (323)
+||+|||++........ .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.........+...
T Consensus 168 vkL~DFGla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~- 243 (352)
T d1koba_ 168 VKIIDFGLATKLNPDEI---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRC- 243 (352)
T ss_dssp EEECCCTTCEECCTTSC---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHC-
T ss_pred EEEeecccceecCCCCc---eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-
Confidence 99999999977654322 23345899999999999999999999999999999999999999765432111111100
Q ss_pred ccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 255 PRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
+...........+.++.+||.+||+.||.+|||+.|+++
T Consensus 244 ------------~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 282 (352)
T d1koba_ 244 ------------DWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 282 (352)
T ss_dssp ------------CCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred ------------CCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 011111223445677999999999999999999999987
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-52 Score=366.37 Aligned_cols=250 Identities=21% Similarity=0.230 Sum_probs=209.1
Q ss_pred CCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEe
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVE 95 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 95 (323)
.|+.+..||+|+||.||+|++..+++.+|+|++.++.... ....+.+.+|+.+|++++||||+++++++.+
T Consensus 6 dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~---------~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 76 (337)
T d1o6la_ 6 DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIA---------KDEVAHTVTESRVLQNTRHPFLTALKYAFQT 76 (337)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHH---------TTCHHHHHHHHHHHHSCCCTTBCCEEEEEEC
T ss_pred hcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccC---------HHHHHHHHHHHHHHHhCCCCCEEEEEeeecc
Confidence 3667779999999999999999999999999876543211 2234778899999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeE
Q 020641 96 GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKA 175 (323)
Q Consensus 96 ~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~ 175 (323)
.+..|+||||+.+|+|.+++..... +++..++.++.||+.||.|||++ ||+||||||+|||++.+|.+
T Consensus 77 ~~~~~iv~ey~~gg~L~~~~~~~~~---------~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~v 144 (337)
T d1o6la_ 77 HDRLCFVMEYANGGELFFHLSRERV---------FTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHI 144 (337)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHSC---------CCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCE
T ss_pred ccccccceeccCCCchhhhhhcccC---------CcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCE
Confidence 9999999999999999999987653 89999999999999999999999 99999999999999999999
Q ss_pred EEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhcc
Q 020641 176 KIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATP 255 (323)
Q Consensus 176 ~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~ 255 (323)
||+|||+|+....... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+......
T Consensus 145 kl~DFG~a~~~~~~~~--~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~------- 215 (337)
T d1o6la_ 145 KITDFGLCKEGISDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFE------- 215 (337)
T ss_dssp EECCCTTCBCSCCTTC--CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH-------
T ss_pred EEeecccccccccCCc--ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHH-------
Confidence 9999999986543222 2234569999999999999999999999999999999999999998654321111
Q ss_pred cccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCC-----hHHHHH
Q 020641 256 RLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPN-----MSIVVK 305 (323)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps-----~~evl~ 305 (323)
.+.... ...+...+.++.+||.+||++||.+||+ ++|+++
T Consensus 216 --------~i~~~~--~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 216 --------LILMEE--IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp --------HHHHCC--CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred --------HHhcCC--CCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 111111 1234456677999999999999999995 888876
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=4e-53 Score=371.88 Aligned_cols=251 Identities=17% Similarity=0.192 Sum_probs=204.2
Q ss_pred CCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEe
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVE 95 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 95 (323)
.|....+||+|+||.||+|++..+++.+|+|++.... ....+.+.+|+.++++++||||+++++++.+
T Consensus 27 ~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~------------~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~ 94 (350)
T d1koaa2 27 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH------------ESDKETVRKEIQTMSVLRHPTLVNLHDAFED 94 (350)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS------------HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEE
T ss_pred CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc------------hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEE
Confidence 3566678999999999999999999999999765321 1113668899999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEcc--CC
Q 020641 96 GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFE--DF 173 (323)
Q Consensus 96 ~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~--~~ 173 (323)
.+..|+||||+.+|+|.+++.+.... +++..+..++.||+.||.|||++ |++||||||+|||++. ++
T Consensus 95 ~~~~~ivmE~~~gg~L~~~l~~~~~~--------l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~ 163 (350)
T d1koaa2 95 DNEMVMIYEFMSGGELFEKVADEHNK--------MSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSN 163 (350)
T ss_dssp TTEEEEEECCCCSCBHHHHHTCTTSC--------BCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSC
T ss_pred CCEEEEEEEcCCCCCHHHHHHhhcCC--------CCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCC
Confidence 99999999999999999999654332 99999999999999999999999 9999999999999964 57
Q ss_pred eEEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhh
Q 020641 174 KAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWA 253 (323)
Q Consensus 174 ~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 253 (323)
.+||+|||++........ .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.........+...
T Consensus 164 ~vkL~DFG~a~~~~~~~~---~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~ 240 (350)
T d1koaa2 164 ELKLIDFGLTAHLDPKQS---VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSC 240 (350)
T ss_dssp CEEECCCTTCEECCTTSC---EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT
T ss_pred eEEEeecchheecccccc---cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhC
Confidence 899999999976544322 23346899999999999999999999999999999999999999755332111111110
Q ss_pred cccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 254 TPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
.. ..........++++.+||.+||+.||.+|||+.|+++
T Consensus 241 ~~-------------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 279 (350)
T d1koaa2 241 DW-------------NMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE 279 (350)
T ss_dssp CC-------------CSCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred CC-------------CCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00 0011112345677999999999999999999999998
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-53 Score=367.67 Aligned_cols=263 Identities=20% Similarity=0.312 Sum_probs=205.8
Q ss_pred CCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEe
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVE 95 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 95 (323)
.|+.+..||+|+||+||+|.+..+++.+++|+..+..... ......+.+.+|++++++++||||+++++++.+
T Consensus 10 dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~-------~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~ 82 (317)
T d1xkka_ 10 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-------TSPKANKEILDEAYVMASVDNPHVCRLLGICLT 82 (317)
T ss_dssp TEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-----------CTHHHHHHHHHHHHHCCCTTBCCEEEEEES
T ss_pred HCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccc-------cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 4677779999999999999999888866655544332111 123345789999999999999999999999987
Q ss_pred CCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeE
Q 020641 96 GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKA 175 (323)
Q Consensus 96 ~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~ 175 (323)
++ .+++++++.+++|.+++...... +++..+..++.|++.||.|||++ ||+||||||+||+++.++.+
T Consensus 83 ~~-~~~v~e~~~~~~l~~~~~~~~~~--------~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~ 150 (317)
T d1xkka_ 83 ST-VQLITQLMPFGCLLDYVREHKDN--------IGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHV 150 (317)
T ss_dssp SS-EEEEEECCTTCBHHHHHHHTSSS--------CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEE
T ss_pred CC-eeEEEEeccCCcccccccccccC--------CCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCe
Confidence 65 57788999999999988765433 89999999999999999999999 99999999999999999999
Q ss_pred EEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhc
Q 020641 176 KIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWAT 254 (323)
Q Consensus 176 ~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~ 254 (323)
||+|||++................||+.|+|||.+.+..++.++|||||||++|||+| |..||......
T Consensus 151 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~---------- 220 (317)
T d1xkka_ 151 KITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS---------- 220 (317)
T ss_dssp EECCCSHHHHTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGG----------
T ss_pred EeeccccceecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHH----------
Confidence 9999999986654433333344558999999999999999999999999999999998 88898755321
Q ss_pred ccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhhcC
Q 020641 255 PRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKS 313 (323)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~~~ 313 (323)
.+...+....+...+..++..+.+++.+||+.||.+|||+.||++.|..+.+.
T Consensus 221 ------~~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~~ 273 (317)
T d1xkka_ 221 ------EISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 273 (317)
T ss_dssp ------GHHHHHHHTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred ------HHHHHHHcCCCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHhC
Confidence 12222222333344566778899999999999999999999999999887643
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-52 Score=360.49 Aligned_cols=266 Identities=19% Similarity=0.162 Sum_probs=198.0
Q ss_pred cccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeCCe
Q 020641 19 YFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEGNL 98 (323)
Q Consensus 19 ~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 98 (323)
.+..||+|+||+||+|++..+++.+|+|++...... .......+.+.+|+.++++++||||+++++++..++.
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-------~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~ 74 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRS-------EAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN 74 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC-------------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhh-------hhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCc
Confidence 456799999999999999999999999977543211 1122345778999999999999999999999999999
Q ss_pred EEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEEEe
Q 020641 99 RVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKIA 178 (323)
Q Consensus 99 ~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~l~ 178 (323)
.|+||||+.++++..+...... +++..+..++.||+.||.|||++ |++||||||+|||++.++.+||+
T Consensus 75 ~~ivmE~~~~~~~~~~~~~~~~---------l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~ 142 (299)
T d1ua2a_ 75 ISLVFDFMETDLEVIIKDNSLV---------LTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLA 142 (299)
T ss_dssp CEEEEECCSEEHHHHHTTCCSS---------CCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEEC
T ss_pred eeehhhhhcchHHhhhhhcccC---------CCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccc
Confidence 9999999998777666644332 88889999999999999999999 99999999999999999999999
Q ss_pred eccccCCCCccccccccccccCccccCCCccccC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhcccc
Q 020641 179 DFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT-GQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPRL 257 (323)
Q Consensus 179 Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 257 (323)
|||++......... .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||...........+.......
T Consensus 143 DFG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~ 220 (299)
T d1ua2a_ 143 DFGLAKSFGSPNRA--YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTP 220 (299)
T ss_dssp CCGGGSTTTSCCCC--CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred cCccccccCCCccc--ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCC
Confidence 99999766543222 233468999999998865 457999999999999999999999997654322211111110000
Q ss_pred cccccchhcC------CCcCCCCC-----HHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 258 SEDKVKQCVD------PKLKGEYP-----PKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 258 ~~~~~~~~~~------~~~~~~~~-----~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
.......... .......+ ...++++.+|+.+||+.||++|||++|+++
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 221 TEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp CTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred ChhhccchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 0000000000 00000111 133567999999999999999999999997
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.6e-52 Score=362.10 Aligned_cols=246 Identities=20% Similarity=0.286 Sum_probs=206.8
Q ss_pred CccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeC
Q 020641 17 PGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEG 96 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 96 (323)
|+...+||+|+||+||+|++..+++.+|+|++.+.... .....+.+.+|+.++++++||||+++++++.++
T Consensus 6 y~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~---------~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~ 76 (316)
T d1fota_ 6 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVV---------RLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDA 76 (316)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH---------HTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECS
T ss_pred eEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHcc---------CHHHHHHHHHHHHHHHhccCcChhheeeeEeeC
Confidence 56677999999999999999999999999987643221 123347789999999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEE
Q 020641 97 NLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAK 176 (323)
Q Consensus 97 ~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~ 176 (323)
+..|+||||+.||+|..++..... +++..+..++.||+.||.|||++ ||+||||||+|||++.++.+|
T Consensus 77 ~~~~ivmE~~~gg~l~~~~~~~~~---------~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vk 144 (316)
T d1fota_ 77 QQIFMIMDYIEGGELFSLLRKSQR---------FPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIK 144 (316)
T ss_dssp SEEEEEECCCCSCBHHHHHHHTSS---------CCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEE
T ss_pred CeeeeEeeecCCcccccccccccc---------ccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEE
Confidence 999999999999999999987653 88889999999999999999999 999999999999999999999
Q ss_pred EeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhccc
Q 020641 177 IADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATPR 256 (323)
Q Consensus 177 l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 256 (323)
|+|||++....... ....||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.....
T Consensus 145 L~DFG~a~~~~~~~-----~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~--------- 210 (316)
T d1fota_ 145 ITDFGFAKYVPDVT-----YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTY--------- 210 (316)
T ss_dssp ECCCSSCEECSSCB-----CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHH---------
T ss_pred EecCccceEecccc-----ccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHH---------
Confidence 99999997765422 3456999999999999999999999999999999999999999765321111
Q ss_pred ccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCC-----ChHHHHH
Q 020641 257 LSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRP-----NMSIVVK 305 (323)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-----s~~evl~ 305 (323)
..+.... ...+...+.++.+++.+||..||.+|+ |++++++
T Consensus 211 ------~~i~~~~--~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 211 ------EKILNAE--LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp ------HHHHHCC--CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred ------HHHHcCC--CCCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 1111111 123344567799999999999999996 8999986
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=4.6e-52 Score=355.19 Aligned_cols=262 Identities=22% Similarity=0.288 Sum_probs=202.1
Q ss_pred CCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEe
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVE 95 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 95 (323)
.|+....||+|+||+||+|++..+++.+|+|++.+..... ......+.+|+++++.++||||+++++++..
T Consensus 8 rY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~---------~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~ 78 (277)
T d1o6ya_ 8 RYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARD---------PSFYLRFRREAQNAAALNHPAIVAVYDTGEA 78 (277)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTC---------HHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE
T ss_pred eeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccC---------HHHHHHHHHHHHHHHhcCCCCCCcccceeee
Confidence 3667779999999999999999999999999876432221 1223678899999999999999999999886
Q ss_pred CC----eEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEcc
Q 020641 96 GN----LRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFE 171 (323)
Q Consensus 96 ~~----~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~ 171 (323)
.+ ..|+||||++|++|.+++..... +++..+..++.||+.||.|||++ ||+||||||+||+++.
T Consensus 79 ~~~~~~~~~lvmE~~~g~~L~~~~~~~~~---------l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~ 146 (277)
T d1o6ya_ 79 ETPAGPLPYIVMEYVDGVTLRDIVHTEGP---------MTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISA 146 (277)
T ss_dssp ECSSSEEEEEEEECCCEEEHHHHHHHHCS---------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEET
T ss_pred ccCCCceEEEEEECCCCCEehhhhcccCC---------CCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCc
Confidence 53 47999999999999999876543 99999999999999999999999 9999999999999999
Q ss_pred CCeEEEeeccccCCCCccc-cccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhh
Q 020641 172 DFKAKIADFNLSNQAPDMA-ARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLV 250 (323)
Q Consensus 172 ~~~~~l~Dfg~~~~~~~~~-~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~ 250 (323)
++..+++|||.+....... .........||+.|+|||++.+..++.++|||||||++|+|++|+.||............
T Consensus 147 ~~~~~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~ 226 (277)
T d1o6ya_ 147 TNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQH 226 (277)
T ss_dssp TSCEEECCCTTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred cccceeehhhhhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHH
Confidence 9999999999876543322 222234456999999999999999999999999999999999999999755332111100
Q ss_pred hhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCC-ChHHHHHHHhhhh
Q 020641 251 TWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRP-NMSIVVKALQPLL 311 (323)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-s~~evl~~l~~~~ 311 (323)
... .+..........++++.++|.+||+.||.+|| |++++++.|.++.
T Consensus 227 --~~~-----------~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 227 --VRE-----------DPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp --HHC-----------CCCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred --Hhc-----------CCCCCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 000 00000111234567799999999999999999 8999999988764
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-52 Score=353.07 Aligned_cols=258 Identities=25% Similarity=0.298 Sum_probs=197.3
Q ss_pred CccccccCCCCCCccceecccee---eeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEE
Q 020641 17 PGYFVRLDKGPEDDLYLKKRVKM---RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYC 93 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~~~~~---~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 93 (323)
++...+||+|+||+||+|+.... ...+|+|++.+..... ....+.+.+|++++++++||||+++++++
T Consensus 10 ~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~---------~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~ 80 (273)
T d1u46a_ 10 LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQ---------PEAMDDFIREVNAMHSLDHRNLIRLYGVV 80 (273)
T ss_dssp EEEEEECC----CCCEEEEEECTTSCEEEEEEEC-----------------CHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred eEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCC---------HHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 56677999999999999986432 3467888665332211 22336789999999999999999999999
Q ss_pred EeCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCC
Q 020641 94 VEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDF 173 (323)
Q Consensus 94 ~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~ 173 (323)
.++ ..++||||+.+|++.+++...... +++..+..++.|++.||.|||++ ||+||||||+||+++.++
T Consensus 81 ~~~-~~~lv~e~~~~~~l~~~~~~~~~~--------l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~ 148 (273)
T d1u46a_ 81 LTP-PMKMVTELAPLGSLLDRLRKHQGH--------FLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRD 148 (273)
T ss_dssp CSS-SCEEEEECCTTCBHHHHHHHHGGG--------SCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETT
T ss_pred eec-chheeeeeecCcchhhhhhcccCC--------CCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhcccccc
Confidence 765 568999999999999988765432 99999999999999999999999 999999999999999999
Q ss_pred eEEEeeccccCCCCccccc-cccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccchhhh
Q 020641 174 KAKIADFNLSNQAPDMAAR-LHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVT 251 (323)
Q Consensus 174 ~~~l~Dfg~~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~ 251 (323)
.+||+|||+++........ .......|+..|+|||.+.+..++.++||||||+++|||++ |..||........
T Consensus 149 ~vkl~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~----- 223 (273)
T d1u46a_ 149 LVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI----- 223 (273)
T ss_dssp EEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH-----
T ss_pred ceeeccchhhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHH-----
Confidence 9999999999876443322 22233447889999999999999999999999999999998 8999975533211
Q ss_pred hhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhh
Q 020641 252 WATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPL 310 (323)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~ 310 (323)
...+.....+...+..++..+.+++.+||+.||++|||+.||++.|.++
T Consensus 224 ----------~~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 224 ----------LHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp ----------HHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----------HHHHHhCCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 1122222233344455667899999999999999999999999999875
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=4.2e-52 Score=354.21 Aligned_cols=259 Identities=18% Similarity=0.191 Sum_probs=207.2
Q ss_pred CCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCC-CCcccceeeEEE
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLK-HENLVELLGYCV 94 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~ 94 (323)
.|+....||+|+||+||+|++..+++.+|+|++.+.......... .+...+.+.+|+.++++++ ||||+++++++.
T Consensus 4 ~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~---~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 80 (277)
T d1phka_ 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEE---VQELREATLKEVDILRKVSGHPNIIQLKDTYE 80 (277)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHH---HHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred cCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHH---HHHHHHHHHHHHHHHHHhcCCCCeEEEEeecc
Confidence 356667999999999999999999999999987765433221111 0122356889999999995 999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCe
Q 020641 95 EGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFK 174 (323)
Q Consensus 95 ~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~ 174 (323)
+++..|+||||+++|+|.+++..... +++..+..++.||+.||.|||++ ||+||||||+||+++.++.
T Consensus 81 ~~~~~~ivmE~~~~g~L~~~l~~~~~---------l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ 148 (277)
T d1phka_ 81 TNTFFFLVFDLMKKGELFDYLTEKVT---------LSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMN 148 (277)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCC
T ss_pred cCcceEEEEEcCCCchHHHHHHhcCC---------CCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCC
Confidence 99999999999999999999976542 99999999999999999999999 9999999999999999999
Q ss_pred EEEeeccccCCCCccccccccccccCccccCCCccccC------CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccch
Q 020641 175 AKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT------GQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQS 248 (323)
Q Consensus 175 ~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~------~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~ 248 (323)
+||+|||++........ .....||+.|.|||.+.+ ..++.++||||+||++|+|++|+.||..........
T Consensus 149 ~kl~DFG~a~~~~~~~~---~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~ 225 (277)
T d1phka_ 149 IKLTDFGFSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLR 225 (277)
T ss_dssp EEECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred eEEccchheeEccCCCc---eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHH
Confidence 99999999976544222 234568999999998853 356889999999999999999999998654322111
Q ss_pred hhhhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 249 LVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
.+.... ...........++++.+|+.+||+.||.+|||+.|+++
T Consensus 226 ~i~~~~-------------~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 226 MIMSGN-------------YQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp HHHHTC-------------CCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HHHhCC-------------CCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 111000 01112223456778999999999999999999999986
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.2e-51 Score=364.57 Aligned_cols=254 Identities=19% Similarity=0.240 Sum_probs=202.9
Q ss_pred CCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEe
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVE 95 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 95 (323)
.|.....||+|+||.||+|++..+++.+|+|++.+........ .........++++++.++||||+++++++.+
T Consensus 5 dy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~------~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~ 78 (364)
T d1omwa3 5 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQG------ETLALNERIMLSLVSTGDCPFIVCMSYAFHT 78 (364)
T ss_dssp TEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTC------HHHHHHHHHHHHHHSSSCCTTBCCEEEEEEC
T ss_pred hCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhH------HHHHHHHHHHHHHHhcCCCCcEEEEEEEEEE
Confidence 4566678999999999999999999999999876543222111 1111233456788888899999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeE
Q 020641 96 GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKA 175 (323)
Q Consensus 96 ~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~ 175 (323)
.+..|+||||+.+|+|.+++..... +++..+..++.||+.||.|||++ |++||||||+|||++.++.+
T Consensus 79 ~~~~~ivmE~~~gg~L~~~l~~~~~---------~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~i 146 (364)
T d1omwa3 79 PDKLSFILDLMNGGDLHYHLSQHGV---------FSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHV 146 (364)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHHCS---------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCE
T ss_pred CCEEEEEEEecCCCcHHHHHHhccc---------ccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcE
Confidence 9999999999999999999976543 88999999999999999999999 99999999999999999999
Q ss_pred EEeeccccCCCCccccccccccccCccccCCCcccc-CCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhc
Q 020641 176 KIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAM-TGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWAT 254 (323)
Q Consensus 176 ~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~ 254 (323)
||+|||+++...... .....||+.|+|||++. +..++.++|||||||++|+|++|+.||...............
T Consensus 147 Kl~DFGla~~~~~~~----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~- 221 (364)
T d1omwa3 147 RISDLGLACDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT- 221 (364)
T ss_dssp EECCCTTCEECSSSC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHS-
T ss_pred EEeeeceeeecCCCc----ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-
Confidence 999999998654432 23446999999999986 456899999999999999999999999765432221111100
Q ss_pred ccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCC-----hHHHHH
Q 020641 255 PRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPN-----MSIVVK 305 (323)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps-----~~evl~ 305 (323)
.......+...++++.+||.+||+.||.+||| ++|+++
T Consensus 222 -------------~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 222 -------------LTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp -------------SSCCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred -------------ccCCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 00111233445677999999999999999999 688875
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-51 Score=358.35 Aligned_cols=249 Identities=15% Similarity=0.163 Sum_probs=197.1
Q ss_pred CCccccc-cCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcC-CCCcccceeeEE
Q 020641 16 SPGYFVR-LDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRL-KHENLVELLGYC 93 (323)
Q Consensus 16 ~~~~~~~-lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~ 93 (323)
.|..+.+ ||+|+||.||+|++..+++.+|+|++.. ...+.+|+.++.++ +||||++++++|
T Consensus 12 ~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----------------~~~~~~E~~~~~~~~~hpnIv~l~~~~ 74 (335)
T d2ozaa1 12 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----------------CPKARREVELHWRASQCPHIVRIVDVY 74 (335)
T ss_dssp TEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----------------SHHHHHHHHHHHHHTTSTTBCCEEEEE
T ss_pred CEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-----------------cHHHHHHHHHHHHhcCCCCCCeEEEEE
Confidence 3444445 8999999999999999999999997631 25677899887655 899999999998
Q ss_pred Ee----CCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEE
Q 020641 94 VE----GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLL 169 (323)
Q Consensus 94 ~~----~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili 169 (323)
.+ ...+|+|||||.||+|.+++...... .+++..+..++.||+.||.|||++ ||+||||||+|||+
T Consensus 75 ~~~~~~~~~~~ivmEy~~gg~L~~~i~~~~~~-------~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll 144 (335)
T d2ozaa1 75 ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQ-------AFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLY 144 (335)
T ss_dssp EEEETTEEEEEEEEECCCSEEHHHHHHSCSCC-------CEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEE
T ss_pred eecccCCCEEEEEEECCCCCcHHHHHHhcCCC-------CcCHHHHHHHHHHHHHHHHHHHHc---CCcccccccccccc
Confidence 75 35689999999999999999765332 299999999999999999999999 99999999999999
Q ss_pred cc---CCeEEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccc
Q 020641 170 FE---DFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQ 246 (323)
Q Consensus 170 ~~---~~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~ 246 (323)
+. .+.+||+|||+++....... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+......
T Consensus 145 ~~~~~~~~~Kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~ 221 (335)
T d2ozaa1 145 TSKRPNAILKLTDFGFAKETTSHNS---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI 221 (335)
T ss_dssp SCSSTTCCEEECCCTTCEECCCCCC---CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--
T ss_pred ccccccccccccccceeeeccCCCc---cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHH
Confidence 75 46799999999976544322 2345699999999999999999999999999999999999999975543221
Q ss_pred chhhhhhcccccccccchhcCCCcCC--CCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 247 QSLVTWATPRLSEDKVKQCVDPKLKG--EYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
..... .......... ......++++.+||.+||+.||++|||+.|+++
T Consensus 222 ~~~~~-----------~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 222 SPGMK-----------TRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp -----------------CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHH-----------HHHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 11000 0011111111 111345678999999999999999999999988
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.1e-51 Score=362.91 Aligned_cols=247 Identities=16% Similarity=0.170 Sum_probs=206.8
Q ss_pred CCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEe
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVE 95 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 95 (323)
.|+.+.+||+|+||.||+|++..+++.+|+|++.+..... ....+.+.+|+.+++.++||||+++++++..
T Consensus 42 ~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~---------~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~ 112 (350)
T d1rdqe_ 42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVK---------LKQIEHTLNEKRILQAVNFPFLVKLEFSFKD 112 (350)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHH---------TTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred CeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccC---------HHHHHHHHHHHHHHHHcCCCcEeeccccccc
Confidence 4677779999999999999999999999999876432211 2234678999999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeE
Q 020641 96 GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKA 175 (323)
Q Consensus 96 ~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~ 175 (323)
....++||||+.+|+|.+++..... +++..+..++.||+.||.|||++ ||+||||||+|||++.++.+
T Consensus 113 ~~~~~~v~e~~~~g~l~~~l~~~~~---------l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~i 180 (350)
T d1rdqe_ 113 NSNLYMVMEYVAGGEMFSHLRRIGR---------FSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYI 180 (350)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHCC---------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCE
T ss_pred ccccccccccccccchhhhHhhcCC---------CCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCE
Confidence 9999999999999999999976543 99999999999999999999999 99999999999999999999
Q ss_pred EEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhcc
Q 020641 176 KIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATP 255 (323)
Q Consensus 176 ~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~ 255 (323)
||+|||+++...... ....||+.|+|||++.+..++.++|||||||++|+|++|+.||..........
T Consensus 181 kL~DFG~a~~~~~~~-----~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~------- 248 (350)
T d1rdqe_ 181 QVTDFGFAKRVKGRT-----WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYE------- 248 (350)
T ss_dssp EECCCTTCEECSSCB-----CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH-------
T ss_pred Eeeeceeeeeccccc-----ccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHH-------
Confidence 999999998765422 34569999999999999999999999999999999999999997553211111
Q ss_pred cccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCC-----ChHHHHH
Q 020641 256 RLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRP-----NMSIVVK 305 (323)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-----s~~evl~ 305 (323)
.+.... ...+...+.++.++|.+||..||.+|+ |++|+++
T Consensus 249 --------~i~~~~--~~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 249 --------KIVSGK--VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp --------HHHHCC--CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred --------HHhcCC--CCCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 111111 122344567799999999999999994 8999986
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-52 Score=353.21 Aligned_cols=257 Identities=23% Similarity=0.303 Sum_probs=194.7
Q ss_pred CccccccCCCCCCccceeccceee---eeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEE
Q 020641 17 PGYFVRLDKGPEDDLYLKKRVKMR---RWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYC 93 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 93 (323)
++....||+|+||.||+|.+..++ ..+|+|..... ......+.+.+|++++++++||||+++++++
T Consensus 9 ~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~-----------~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~ 77 (273)
T d1mp8a_ 9 IELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC-----------TSDSVREKFLQEALTMRQFDHPHIVKLIGVI 77 (273)
T ss_dssp EEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT-----------TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred eEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccc-----------cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 455568999999999999886543 34666543211 1122236788999999999999999999999
Q ss_pred EeCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCC
Q 020641 94 VEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDF 173 (323)
Q Consensus 94 ~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~ 173 (323)
.+ +..++||||+.+|+|.+++...... +++..+..++.||+.||.|||++ +++||||||+||+++.++
T Consensus 78 ~~-~~~~iv~E~~~~g~l~~~~~~~~~~--------l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~ 145 (273)
T d1mp8a_ 78 TE-NPVWIIMELCTLGELRSFLQVRKYS--------LDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSND 145 (273)
T ss_dssp CS-SSCEEEEECCTTEEHHHHHHHTTTT--------SCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETT
T ss_pred ec-CeEEEEEEeccCCcHHhhhhccCCC--------CCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCC
Confidence 64 5679999999999999987655432 89999999999999999999999 999999999999999999
Q ss_pred eEEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccchhhhh
Q 020641 174 KAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTW 252 (323)
Q Consensus 174 ~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~ 252 (323)
.+||+|||+++........ ......||+.|+|||.+.+..++.++|||||||++|||++ |..||........
T Consensus 146 ~~Kl~DfG~a~~~~~~~~~-~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~------ 218 (273)
T d1mp8a_ 146 CVKLGDFGLSRYMEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV------ 218 (273)
T ss_dssp EEEECC--------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH------
T ss_pred cEEEccchhheeccCCcce-eccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHH------
Confidence 9999999999865543222 2233457899999999999999999999999999999998 8999976543211
Q ss_pred hcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhhcC
Q 020641 253 ATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKS 313 (323)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~~~ 313 (323)
...+....+...+..+++.+.+||.+||+.||++|||+.||++.|+.++++
T Consensus 219 ----------~~~i~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 269 (273)
T d1mp8a_ 219 ----------IGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 269 (273)
T ss_dssp ----------HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----------HHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 111111222234556678899999999999999999999999999998753
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.7e-52 Score=357.72 Aligned_cols=267 Identities=23% Similarity=0.335 Sum_probs=209.7
Q ss_pred CCccccccCCCCCCccceeccc-----eeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCccccee
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRV-----KMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELL 90 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~-----~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~ 90 (323)
.++...+||+|+||+||+|+.. .+++.+|+|.+.... .....+++.+|++++++++||||++++
T Consensus 14 ~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-----------~~~~~~~~~~E~~il~~l~h~niv~~~ 82 (301)
T d1lufa_ 14 NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-----------SADMQADFQREAALMAEFDNPNIVKLL 82 (301)
T ss_dssp GCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-----------CHHHHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred HcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc-----------ChHHHHHHHHHHHHHHhcCCCCcccce
Confidence 3667779999999999999864 466789998654221 112246789999999999999999999
Q ss_pred eEEEeCCeEEEEEeecCCCCHHHHhccCCCCC---------------CCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCC
Q 020641 91 GYCVEGNLRVLAYEFATMGSLHDILHGRKGVQ---------------GAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQP 155 (323)
Q Consensus 91 ~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~ 155 (323)
+++...+..+++|||+.+|+|.+++....... .......+++..+..++.|++.|++|||++
T Consensus 83 ~~~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~--- 159 (301)
T d1lufa_ 83 GVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER--- 159 (301)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---
T ss_pred eeeccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---
Confidence 99999999999999999999999997543211 011123488999999999999999999999
Q ss_pred CceeCCCCCCCEEEccCCeEEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCC
Q 020641 156 SIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGR 235 (323)
Q Consensus 156 ~i~h~dikp~nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~ 235 (323)
+++||||||+|||++.++.+||+|||++................|++.|+|||.+.+..++.++|||||||++|||++|.
T Consensus 160 ~ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~ 239 (301)
T d1lufa_ 160 KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYG 239 (301)
T ss_dssp TCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTT
T ss_pred CeEeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccC
Confidence 99999999999999999999999999987554443333334456889999999999999999999999999999999985
Q ss_pred -CCCCCCCCcccchhhhhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhhc
Q 020641 236 -KPVDHTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLK 312 (323)
Q Consensus 236 -~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~~ 312 (323)
.||....... +...+........+..++.++.+|+.+||+.||++|||+.||+++|+++.+
T Consensus 240 ~~p~~~~~~~e----------------~~~~v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~~ 301 (301)
T d1lufa_ 240 LQPYYGMAHEE----------------VIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 301 (301)
T ss_dssp CCTTTTSCHHH----------------HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred CCCCCCCCHHH----------------HHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 5676543221 111111122233455666789999999999999999999999999998864
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-52 Score=349.35 Aligned_cols=249 Identities=28% Similarity=0.391 Sum_probs=197.8
Q ss_pred CccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeC
Q 020641 17 PGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEG 96 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 96 (323)
++...+||+|+||.||+|... ++.+|+|++.. +...+.+.+|++++++++||||+++++++.++
T Consensus 9 ~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~--------------~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~ 72 (262)
T d1byga_ 9 LKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKN--------------DATAQAFLAEASVMTQLRHSNLVQLLGVIVEE 72 (262)
T ss_dssp EEEEEEEEECSSCEEEEEEET--TEEEEEEECCC--------------CC--HHHHHTHHHHTTCCCTTBCCEEEEECCC
T ss_pred eEEeEEEecCCCeEEEEEEEC--CeEEEEEEECc--------------HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEec
Confidence 345568999999999999974 55688886532 12336789999999999999999999998654
Q ss_pred -CeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeE
Q 020641 97 -NLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKA 175 (323)
Q Consensus 97 -~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~ 175 (323)
+..++||||+.+|+|.+++...... .+++..++.++.|++.|+.|||+. +++||||||+||+++.++.+
T Consensus 73 ~~~~~lv~ey~~~g~L~~~l~~~~~~-------~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~ 142 (262)
T d1byga_ 73 KGGLYIVTEYMAKGSLVDYLRSRGRS-------VLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVA 142 (262)
T ss_dssp --CCEEEECCCTTEEHHHHHHHHHHH-------HCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCE
T ss_pred CCcEEEEEeccCCCCHHHHHHhcCCC-------CCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCE
Confidence 5679999999999999999654322 289999999999999999999999 99999999999999999999
Q ss_pred EEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhc
Q 020641 176 KIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHTMPRGQQSLVTWAT 254 (323)
Q Consensus 176 ~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~~~~~~~~~~~~~~ 254 (323)
+|+|||++....... ....++..|+|||.+.+..++.++||||||+++|||++ |+.||.....
T Consensus 143 kl~dfg~s~~~~~~~-----~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~----------- 206 (262)
T d1byga_ 143 KVSDFGLTKEASSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL----------- 206 (262)
T ss_dssp EECCCCC-----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG-----------
T ss_pred eecccccceecCCCC-----ccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCH-----------
Confidence 999999997654322 23347889999999998999999999999999999998 7888765432
Q ss_pred ccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhhc
Q 020641 255 PRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLK 312 (323)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~~ 312 (323)
..+...+....+...+...++.+.+++.+||+.||++|||+.+|++.|+++..
T Consensus 207 -----~~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~ 259 (262)
T d1byga_ 207 -----KDVVPRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259 (262)
T ss_dssp -----GGHHHHHTTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -----HHHHHHHHcCCCCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence 12222233334445566677889999999999999999999999999998754
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-51 Score=356.71 Aligned_cols=269 Identities=22% Similarity=0.273 Sum_probs=200.5
Q ss_pred CCccccccCCCCCCccceeccce-----eeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcC-CCCcccce
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRVK-----MRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRL-KHENLVEL 89 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~~-----~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~ 89 (323)
.++...+||+|+||.||+|.+.. +++.+|+|.+..... ....+.+.+|...+.++ .|+||+.+
T Consensus 14 ~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~-----------~~~~~~~~~e~~~l~~~~~h~~iv~~ 82 (299)
T d1ywna1 14 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT-----------HSEHRALMSELKILIHIGHHLNVVNL 82 (299)
T ss_dssp GEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----C-----------HHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred HEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccC-----------cHHHHHHHHHHHHHHhhcCCCeEEEe
Confidence 35566699999999999998654 456788886542211 11125567777777777 78999999
Q ss_pred eeEEEeC-CeEEEEEeecCCCCHHHHhccCCCCC-------CCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCC
Q 020641 90 LGYCVEG-NLRVLAYEFATMGSLHDILHGRKGVQ-------GAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRD 161 (323)
Q Consensus 90 ~~~~~~~-~~~~lv~e~~~~~sL~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~d 161 (323)
++++... ...++|||||++|+|.+++....... .......+++..+..++.|++.||.|||++ +|+|||
T Consensus 83 ~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrD 159 (299)
T d1ywna1 83 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRD 159 (299)
T ss_dssp EEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSC
T ss_pred eeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCc
Confidence 9987754 46899999999999999997543210 001122489999999999999999999999 999999
Q ss_pred CCCCCEEEccCCeEEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhC-CCCCCC
Q 020641 162 IRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTG-RKPVDH 240 (323)
Q Consensus 162 ikp~nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g-~~pf~~ 240 (323)
|||+|||++.++.+||+|||+|+...............||+.|+|||.+.+..++.++|||||||++|+|++| ..||..
T Consensus 160 lKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~ 239 (299)
T d1ywna1 160 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 239 (299)
T ss_dssp CCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred CCccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCC
Confidence 9999999999999999999999876554444444556799999999999999999999999999999999986 567764
Q ss_pred CCCcccchhhhhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhhcC
Q 020641 241 TMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKS 313 (323)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~~~ 313 (323)
..... .+...+....+...+..+++++.+++.+||+.||++|||+.||++.|++++++
T Consensus 240 ~~~~~---------------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~ 297 (299)
T d1ywna1 240 VKIDE---------------EFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 297 (299)
T ss_dssp CCCSH---------------HHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCHHH---------------HHHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 43211 11122222223344555677899999999999999999999999999998753
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-51 Score=353.70 Aligned_cols=267 Identities=25% Similarity=0.351 Sum_probs=208.3
Q ss_pred CCccccccCCCCCCccceeccceee-------eeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcC-CCCccc
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRVKMR-------RWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRL-KHENLV 87 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~~~~-------~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~ 87 (323)
.++...+||+|+||.||+|+...++ ..+|+|...+.. .......+.+|...+.++ +||||+
T Consensus 14 ~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~-----------~~~~~~~~~~e~~~l~~~~~HpnIv 82 (299)
T d1fgka_ 14 RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-----------TEKDLSDLISEMEMMKMIGKHKNII 82 (299)
T ss_dssp GEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC-----------CHHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred HeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc-----------ChHHHHHHHHHHHHHHHhcCCCeEE
Confidence 4455568999999999999876554 367887664321 112236678888888888 899999
Q ss_pred ceeeEEEeCCeEEEEEeecCCCCHHHHhccCCCCC-------CCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeC
Q 020641 88 ELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQ-------GAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHR 160 (323)
Q Consensus 88 ~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~ 160 (323)
++++++.++...++||||+.+|+|.+++....... .......+++..++.++.||+.||.|||+. +++||
T Consensus 83 ~~~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHr 159 (299)
T d1fgka_ 83 NLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHR 159 (299)
T ss_dssp CEEEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCS
T ss_pred ecccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEee
Confidence 99999999999999999999999999997654211 111223489999999999999999999999 99999
Q ss_pred CCCCCCEEEccCCeEEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHh-CCCCCC
Q 020641 161 DIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVD 239 (323)
Q Consensus 161 dikp~nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~ 239 (323)
||||+|||++.++.+||+|||++................|++.|+|||.+.+..++.++||||||+++|+|++ |..||.
T Consensus 160 DiKp~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~ 239 (299)
T d1fgka_ 160 DLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYP 239 (299)
T ss_dssp CCSGGGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred eecccceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCC
Confidence 9999999999999999999999987766554444455668999999999999999999999999999999998 788886
Q ss_pred CCCCcccchhhhhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhhc
Q 020641 240 HTMPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLK 312 (323)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~~ 312 (323)
..... .+...+....+...+...++++.+|+.+||+.||.+|||+.||++.|++++.
T Consensus 240 ~~~~~----------------~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 240 GVPVE----------------ELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp TCCHH----------------HHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCHH----------------HHHHHHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence 54321 1222222233334455567789999999999999999999999999999874
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-51 Score=355.29 Aligned_cols=247 Identities=16% Similarity=0.131 Sum_probs=201.6
Q ss_pred CccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEeC
Q 020641 17 PGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVEG 96 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 96 (323)
|.....||+|+||+||+|.+..+++.+|+|++..+. .....+.+|+++|++++||||+++++++.++
T Consensus 7 Y~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-------------~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~ 73 (321)
T d1tkia_ 7 YMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-------------TDQVLVKKEISILNIARHRNILHLHESFESM 73 (321)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-------------HHHHHHHHHHHHHHHSCCTTBCCEEEEEEET
T ss_pred eEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-------------ccHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence 556669999999999999999999999999775331 1124578999999999999999999999999
Q ss_pred CeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccC--Ce
Q 020641 97 NLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFED--FK 174 (323)
Q Consensus 97 ~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~--~~ 174 (323)
+.+|+|||||.||+|.+++...... +++..+..++.||+.||.|||++ ||+||||||+||+++.+ ..
T Consensus 74 ~~~~lvmE~~~gg~L~~~i~~~~~~--------l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ 142 (321)
T d1tkia_ 74 EELVMIFEFISGLDIFERINTSAFE--------LNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSST 142 (321)
T ss_dssp TEEEEEECCCCCCBHHHHHTSSSCC--------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCC
T ss_pred CEEEEEEecCCCCcHHHHHHhcCCC--------CCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceE
Confidence 9999999999999999999765422 89999999999999999999999 99999999999999854 58
Q ss_pred EEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhc
Q 020641 175 AKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWAT 254 (323)
Q Consensus 175 ~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~ 254 (323)
++|+|||++........ .....+++.|+|||...+..++.++|||||||++|+|++|..||..........
T Consensus 143 ikl~DFG~~~~~~~~~~---~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~------ 213 (321)
T d1tkia_ 143 IKIIEFGQARQLKPGDN---FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIE------ 213 (321)
T ss_dssp EEECCCTTCEECCTTCE---EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH------
T ss_pred EEEcccchhhccccCCc---ccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHH------
Confidence 99999999876543222 223458999999999999999999999999999999999999997654321111
Q ss_pred ccccccccchhcCCCcCC--CCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 255 PRLSEDKVKQCVDPKLKG--EYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
.+....... ......+.++.+|+.+||..||.+|||+.|+++
T Consensus 214 ---------~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 214 ---------NIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp ---------HHHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ---------HHHhCCCCCChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111111100 001124567999999999999999999999997
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-50 Score=351.34 Aligned_cols=266 Identities=24% Similarity=0.315 Sum_probs=206.4
Q ss_pred ccccccCCCCCCccceeccceeeee--eeeccccccccCccccccccCCCCCchHHHHHHHHHhcC-CCCcccceeeEEE
Q 020641 18 GYFVRLDKGPEDDLYLKKRVKMRRW--LCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRL-KHENLVELLGYCV 94 (323)
Q Consensus 18 ~~~~~lg~G~~~~V~~~~~~~~~~~--~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~ 94 (323)
+....||+|+||+||+|++..++.. +|+|.... .......+.+.+|+++++++ +||||+++++++.
T Consensus 13 ~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~-----------~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~ 81 (309)
T d1fvra_ 13 KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKE-----------YASKDDHRDFAGELEVLCKLGHHPNIINLLGACE 81 (309)
T ss_dssp EEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEEC-----------C------CHHHHHHHHHTTCCCCTTBCCEEEEEE
T ss_pred EEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECc-----------ccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEe
Confidence 4445899999999999999888765 44543321 11223346799999999999 7999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHhccCCCCC-------CCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCE
Q 020641 95 EGNLRVLAYEFATMGSLHDILHGRKGVQ-------GAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNV 167 (323)
Q Consensus 95 ~~~~~~lv~e~~~~~sL~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~ni 167 (323)
+.+..++||||+++|+|.+++....... .......+++..+..++.|++.|+.|||++ +++||||||+||
T Consensus 82 ~~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NI 158 (309)
T d1fvra_ 82 HRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNI 158 (309)
T ss_dssp ETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGE
T ss_pred cCCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceE
Confidence 9999999999999999999997642100 000112399999999999999999999999 999999999999
Q ss_pred EEccCCeEEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCC-CCCCCCCCccc
Q 020641 168 LLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGR-KPVDHTMPRGQ 246 (323)
Q Consensus 168 li~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~-~pf~~~~~~~~ 246 (323)
|++.++.+||+|||++........ .....||..|+|||.+.+..++.++||||||+++|+|++|. .||.....
T Consensus 159 L~~~~~~~kl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~--- 232 (309)
T d1fvra_ 159 LVGENYVAKIADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC--- 232 (309)
T ss_dssp EECGGGCEEECCTTCEESSCEECC---C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH---
T ss_pred EEcCCCceEEcccccccccccccc---ccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCH---
Confidence 999999999999999876543322 22345899999999999999999999999999999999965 46654422
Q ss_pred chhhhhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhhcCCCC
Q 020641 247 QSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSPPP 316 (323)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~~~~~~ 316 (323)
..+...+....+...+..+++++.+||.+||+.||++|||++||++.|++++++...
T Consensus 233 -------------~~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~~~ 289 (309)
T d1fvra_ 233 -------------AELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKT 289 (309)
T ss_dssp -------------HHHHHHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSSC
T ss_pred -------------HHHHHHHHhcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcCcC
Confidence 111122222223344556778899999999999999999999999999999976553
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-51 Score=356.32 Aligned_cols=250 Identities=21% Similarity=0.233 Sum_probs=203.6
Q ss_pred CCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHh-cCCCCcccceeeEEE
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVS-RLKHENLVELLGYCV 94 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~ 94 (323)
.|+....||+|+||+||+|++..+++.+|+|++.+..... ....+.+..|..++. .++||||+++++++.
T Consensus 3 dy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~---------~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~ 73 (320)
T d1xjda_ 3 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLM---------DDDVECTMVEKRVLSLAWEHPFLTHMFCTFQ 73 (320)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHH---------TTCHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred CeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccC---------hHHHHHHHHHHHHHHHhCCCCcEEEEEEEEc
Confidence 3566679999999999999999999999999876432211 223355667777665 679999999999999
Q ss_pred eCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCe
Q 020641 95 EGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFK 174 (323)
Q Consensus 95 ~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~ 174 (323)
+++..|+||||+.+|+|.+++..... +++..+..++.||+.||.|||++ |++||||||+|||++.++.
T Consensus 74 ~~~~~yivmEy~~~g~L~~~i~~~~~---------~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~ 141 (320)
T d1xjda_ 74 TKENLFFVMEYLNGGDLMYHIQSCHK---------FDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGH 141 (320)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHHSS---------CCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSC
T ss_pred cCCceeEEEeecCCCcHHHHhhccCC---------CCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCc
Confidence 99999999999999999999976543 88999999999999999999999 9999999999999999999
Q ss_pred EEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhc
Q 020641 175 AKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWAT 254 (323)
Q Consensus 175 ~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~ 254 (323)
+||+|||++........ ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.........+.
T Consensus 142 ~kl~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~--- 216 (320)
T d1xjda_ 142 IKIADFGMCKENMLGDA--KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIR--- 216 (320)
T ss_dssp EEECCCTTCBCCCCTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH---
T ss_pred eeccccchhhhcccccc--cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHH---
Confidence 99999999986543322 2344569999999999999999999999999999999999999997654321111111
Q ss_pred ccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChH-HHHH
Q 020641 255 PRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMS-IVVK 305 (323)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~-evl~ 305 (323)
.. ....+...+.++.+||.+||..||.+|||+. |+++
T Consensus 217 ------------~~--~~~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 217 ------------MD--NPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp ------------HC--CCCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred ------------cC--CCCCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 00 1122344567799999999999999999996 6764
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-50 Score=348.34 Aligned_cols=267 Identities=18% Similarity=0.222 Sum_probs=198.9
Q ss_pred CCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEe
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVE 95 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 95 (323)
.|..+.+||+|+||+||+|++..+++.+|+|++.... ..+...+.+.+|++++++++||||+++++++.+
T Consensus 3 ~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~----------~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~ 72 (298)
T d1gz8a_ 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDT----------ETEGVPSTAIREISLLKELNHPNIVKLLDVIHT 72 (298)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-----------------CCHHHHHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred CCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhh----------cChHHHHHHHHHHHHHHhCCCCcEEEecccccc
Confidence 4567779999999999999999999999999775331 112345788999999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeE
Q 020641 96 GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKA 175 (323)
Q Consensus 96 ~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~ 175 (323)
++..|+||||+.+ ++.+++...... .+++..+..++.|++.||.|||++ ||+||||||+||+++.++.+
T Consensus 73 ~~~~~iv~e~~~~-~~~~~~~~~~~~-------~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~ 141 (298)
T d1gz8a_ 73 ENKLYLVFEFLHQ-DLKKFMDASALT-------GIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAI 141 (298)
T ss_dssp TTEEEEEEECCSE-EHHHHHHHTTTT-------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCE
T ss_pred ccceeEEEeecCC-chhhhhhhhccc-------CCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcc
Confidence 9999999999976 555555433222 299999999999999999999999 99999999999999999999
Q ss_pred EEeeccccCCCCccccccccccccCccccCCCccccCCC-CCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhc
Q 020641 176 KIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQ-LTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWAT 254 (323)
Q Consensus 176 ~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~ 254 (323)
||+|||.+....... .......||+.|+|||.+.... ++.++|||||||++|+|++|+.||...+............
T Consensus 142 kl~DFG~a~~~~~~~--~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~ 219 (298)
T d1gz8a_ 142 KLADFGLARAFGVPV--RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTL 219 (298)
T ss_dssp EECSTTHHHHHCCCS--BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred eeccCCcceeccCCc--ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhc
Confidence 999999986543222 1223346899999999887665 4789999999999999999999997654322111110000
Q ss_pred ccccccc---cchh--cCCCcCC----C---CCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 255 PRLSEDK---VKQC--VDPKLKG----E---YPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 255 ~~~~~~~---~~~~--~~~~~~~----~---~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
....... .... ....... . .....+.++.+|+.+||..||++|||++|+++
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~ 282 (298)
T d1gz8a_ 220 GTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282 (298)
T ss_dssp CCCCTTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCCchhhccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 0000000 0000 0000000 0 01133467899999999999999999999998
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-50 Score=347.52 Aligned_cols=257 Identities=21% Similarity=0.282 Sum_probs=202.3
Q ss_pred ccCCCCCCccceeccceee---eeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEe-CC
Q 020641 22 RLDKGPEDDLYLKKRVKMR---RWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVE-GN 97 (323)
Q Consensus 22 ~lg~G~~~~V~~~~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~ 97 (323)
.||+|+||+||+|....++ ..+|+|..... ......+++.+|++++++++||||+++++++.. ++
T Consensus 34 ~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~-----------~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~ 102 (311)
T d1r0pa_ 34 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-----------TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG 102 (311)
T ss_dssp EEEEETTEEEEEEEECC----CEEEEEEEECCC-----------CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTT
T ss_pred EEeecCCeEEEEEEEECCCCEEEEEEEEEECcc-----------cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCC
Confidence 6899999999999876543 35777755311 112224678999999999999999999999876 45
Q ss_pred eEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeEEE
Q 020641 98 LRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKAKI 177 (323)
Q Consensus 98 ~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~~l 177 (323)
..++||||+.+|+|.+++...... .++..+..++.|++.||.|||+. +|+||||||+|||+++++.+||
T Consensus 103 ~~~lv~E~~~~g~l~~~~~~~~~~--------~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL 171 (311)
T d1r0pa_ 103 SPLVVLPYMKHGDLRNFIRNETHN--------PTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKV 171 (311)
T ss_dssp EEEEEEECCTTCBHHHHHHCTTCC--------CBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEE
T ss_pred ceEEEEEEeecCchhhhhcccccc--------chHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEE
Confidence 889999999999999998765443 77888999999999999999999 9999999999999999999999
Q ss_pred eeccccCCCCccccc--cccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhcc
Q 020641 178 ADFNLSNQAPDMAAR--LHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWATP 255 (323)
Q Consensus 178 ~Dfg~~~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~ 255 (323)
+|||+++........ .......||+.|+|||.+.+..++.++||||||+++|||++|..||........
T Consensus 172 ~DFG~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~--------- 242 (311)
T d1r0pa_ 172 ADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD--------- 242 (311)
T ss_dssp CSSGGGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC---------------
T ss_pred ecccchhhccccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHH---------
Confidence 999999876543221 222334589999999999999999999999999999999998888764332111
Q ss_pred cccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhhcCCC
Q 020641 256 RLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSPP 315 (323)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~~~~~ 315 (323)
+...+....+...+..+++.+.+|+.+||+.||++|||+.||++.|+.+.+.-.
T Consensus 243 ------~~~~i~~g~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~ 296 (311)
T d1r0pa_ 243 ------ITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 296 (311)
T ss_dssp ------CHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred ------HHHHHHcCCCCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhhh
Confidence 111111112223344556789999999999999999999999999999987643
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-50 Score=350.52 Aligned_cols=267 Identities=21% Similarity=0.307 Sum_probs=212.8
Q ss_pred ccccccCCCCCCccceecc-----ceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcC-CCCcccceee
Q 020641 18 GYFVRLDKGPEDDLYLKKR-----VKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRL-KHENLVELLG 91 (323)
Q Consensus 18 ~~~~~lg~G~~~~V~~~~~-----~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~ 91 (323)
+...+||+|+||.||+|+. ..+++.+|+|.+.... .......+.+|+.+++.+ +||||+++++
T Consensus 26 ~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-----------~~~~~~~~~~E~~~~~~l~~HpnIv~~~g 94 (311)
T d1t46a_ 26 SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-----------HLTEREALMSELKVLSYLGNHMNIVNLLG 94 (311)
T ss_dssp EEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-----------CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred EEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc-----------CHHHHHHHHHHHHHHHhccCCCCEEEEEE
Confidence 3344899999999999975 3567788988664321 111235688999999999 7999999999
Q ss_pred EEEeCCeEEEEEeecCCCCHHHHhccCCCCCC---------CCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCC
Q 020641 92 YCVEGNLRVLAYEFATMGSLHDILHGRKGVQG---------AQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDI 162 (323)
Q Consensus 92 ~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~di 162 (323)
++.+....++|||||++|+|.+++........ ......+++..+..++.||+.|+.|||++ +++||||
T Consensus 95 ~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDL 171 (311)
T d1t46a_ 95 ACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDL 171 (311)
T ss_dssp EECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCC
T ss_pred EEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeeccc
Confidence 99999999999999999999999976542110 11223489999999999999999999999 9999999
Q ss_pred CCCCEEEccCCeEEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHh-CCCCCCCC
Q 020641 163 RSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT-GRKPVDHT 241 (323)
Q Consensus 163 kp~nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~-g~~pf~~~ 241 (323)
||+||+++.++.++++|||.+................||+.|+|||.+.+..++.++||||||+++|+|+| |..||...
T Consensus 172 Kp~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~ 251 (311)
T d1t46a_ 172 AARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM 251 (311)
T ss_dssp SGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred ccccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999999987765544444455678999999999999999999999999999999999 55555443
Q ss_pred CCcccchhhhhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhhcC
Q 020641 242 MPRGQQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKS 313 (323)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~~~ 313 (323)
.. ...+.+.+....+...+...+..+.+||.+||+.||.+|||+.+|++.|++++++
T Consensus 252 ~~---------------~~~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~ 308 (311)
T d1t46a_ 252 PV---------------DSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (311)
T ss_dssp CS---------------SHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CH---------------HHHHHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhcc
Confidence 32 1222233333344444555677899999999999999999999999999988765
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-49 Score=344.60 Aligned_cols=265 Identities=22% Similarity=0.293 Sum_probs=208.6
Q ss_pred ccccccCCCCCCccceeccce-----eeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeE
Q 020641 18 GYFVRLDKGPEDDLYLKKRVK-----MRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGY 92 (323)
Q Consensus 18 ~~~~~lg~G~~~~V~~~~~~~-----~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 92 (323)
....+||+|+||+||+|.+.. .++.||+|...... .......+.+|++++++++||||++++++
T Consensus 23 ~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~-----------~~~~~~~~~~E~~il~~l~h~nIv~~~~~ 91 (308)
T d1p4oa_ 23 TMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-----------SMRERIEFLNEASVMKEFNCHHVVRLLGV 91 (308)
T ss_dssp EEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS-----------CHHHHHHHHHHHHHGGGCCCTTBCCEEEE
T ss_pred EEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc-----------ChHHHHHHHHHHHHHHHcCCCCEeeeeeE
Confidence 444589999999999998863 45678888654211 11112568899999999999999999999
Q ss_pred EEeCCeEEEEEeecCCCCHHHHhccCCCCC-CCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEcc
Q 020641 93 CVEGNLRVLAYEFATMGSLHDILHGRKGVQ-GAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFE 171 (323)
Q Consensus 93 ~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~ 171 (323)
+......++||||+.+|+|.+++....... .......+++..+..++.|++.||.|||++ +|+||||||+|||++.
T Consensus 92 ~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~ 168 (308)
T d1p4oa_ 92 VSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAE 168 (308)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECT
T ss_pred EecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecC
Confidence 999999999999999999999986432100 001111278899999999999999999999 9999999999999999
Q ss_pred CCeEEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhC-CCCCCCCCCcccchhh
Q 020641 172 DFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTG-RKPVDHTMPRGQQSLV 250 (323)
Q Consensus 172 ~~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g-~~pf~~~~~~~~~~~~ 250 (323)
++++||+|||++................|++.|+|||.+.+..++.++||||||+++|||++| ..||.......
T Consensus 169 ~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~----- 243 (308)
T d1p4oa_ 169 DFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ----- 243 (308)
T ss_dssp TCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHH-----
T ss_pred CceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHH-----
Confidence 999999999999877655544444555689999999999999999999999999999999997 46775443211
Q ss_pred hhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhhc
Q 020641 251 TWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLK 312 (323)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~~ 312 (323)
....+........+..++..+.+++.+||+.||.+|||+++|++.|++.++
T Consensus 244 -----------~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 244 -----------VLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp -----------HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred -----------HHHHHHhCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 111111112233445566789999999999999999999999999998765
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-49 Score=344.05 Aligned_cols=266 Identities=17% Similarity=0.224 Sum_probs=196.1
Q ss_pred CCccccccCCCCCCccceecccee-eeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhc---CCCCcccceee
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRVKM-RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSR---LKHENLVELLG 91 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~~~-~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~---l~h~~i~~~~~ 91 (323)
.|+.+.+||+|+||+||+|++..+ ++.+|+|++...... ......+.+|+.+++. ++||||+++++
T Consensus 8 ~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~----------~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~ 77 (305)
T d1blxa_ 8 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGE----------EGMPLSTIREVAVLRHLETFEHPNVVRLFD 77 (305)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCT----------TSCBCTHHHHHHHHHHHHHTCCTTBCCEEE
T ss_pred CEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhcc----------chHHHHHHHHHHHHHHHhhcCCCCcceeee
Confidence 466777999999999999999765 778999977543222 1222345566666554 48999999999
Q ss_pred EEEe-----CCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCC
Q 020641 92 YCVE-----GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSN 166 (323)
Q Consensus 92 ~~~~-----~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~n 166 (323)
++.. ....+++|||+.++++.......... +++..++.++.|++.||.|||++ ||+||||||+|
T Consensus 78 ~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~N 146 (305)
T d1blxa_ 78 VCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPG--------VPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQN 146 (305)
T ss_dssp EEEEEECSSEEEEEEEEECCSCBHHHHHHHSCTTC--------SCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGG
T ss_pred eecccccccCceEEEEEEeccCCchhhhhhccCCC--------CCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccE
Confidence 9863 24679999999986665554433322 89999999999999999999999 99999999999
Q ss_pred EEEccCCeEEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCccc
Q 020641 167 VLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQ 246 (323)
Q Consensus 167 ili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~ 246 (323)
||++.++.++|+|||.+........ .....||+.|+|||++.+..++.++||||+||++|+|++|+.||........
T Consensus 147 ILi~~~~~~kl~dfg~~~~~~~~~~---~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~ 223 (305)
T d1blxa_ 147 ILVTSSGQIKLADFGLARIYSFQMA---LTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ 223 (305)
T ss_dssp EEECTTCCEEECSCCSCCCCCGGGG---GCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred EEEcCCCCeeecchhhhhhhccccc---CCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHH
Confidence 9999999999999999876554332 3455699999999999999999999999999999999999999986643222
Q ss_pred chhhhhhcccccccccc----------hhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 247 QSLVTWATPRLSEDKVK----------QCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 247 ~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
...+............. ...............++.+.+|+.+||+.||++|||+.|+++
T Consensus 224 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~ 292 (305)
T d1blxa_ 224 LGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292 (305)
T ss_dssp HHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHHHHhhCCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 11111100000000000 000000011122344667999999999999999999999987
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-49 Score=338.75 Aligned_cols=244 Identities=17% Similarity=0.214 Sum_probs=196.8
Q ss_pred CccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCC--CCcccceeeEEE
Q 020641 17 PGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLK--HENLVELLGYCV 94 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~ 94 (323)
|+....||+|+||+||+|++..+++.+|+|++.+........ .....++.+|+.++++++ ||||+++++++.
T Consensus 6 Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~------~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~ 79 (273)
T d1xwsa_ 6 YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGE------LPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE 79 (273)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEE------CTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred EEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhh------hhHHHHHHHHHHHHHHhccCCCCccEEEEEEe
Confidence 455568999999999999999999999999876554333221 112244568999998885 899999999999
Q ss_pred eCCeEEEEEeecCC-CCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEcc-C
Q 020641 95 EGNLRVLAYEFATM-GSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFE-D 172 (323)
Q Consensus 95 ~~~~~~lv~e~~~~-~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~-~ 172 (323)
+++..++||||+.+ +++.+++..... +++..++.++.||+.||.|||++ ||+||||||+||+++. +
T Consensus 80 ~~~~~~lv~e~~~~~~~l~~~~~~~~~---------l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~ 147 (273)
T d1xwsa_ 80 RPDSFVLILERPEPVQDLFDFITERGA---------LQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNR 147 (273)
T ss_dssp CSSEEEEEEECCSSEEEHHHHHHHHCS---------CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTT
T ss_pred eCCeEEEEEEeccCcchHHHHHhccCC---------CCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCC
Confidence 99999999999975 688888866542 99999999999999999999999 9999999999999985 4
Q ss_pred CeEEEeeccccCCCCccccccccccccCccccCCCccccCCCC-CcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhh
Q 020641 173 FKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQL-TQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVT 251 (323)
Q Consensus 173 ~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~ 251 (323)
+.+||+|||++....... .....||+.|+|||++.+..+ +.++|||||||++|+|++|+.||..... ..
T Consensus 148 ~~vkl~DFG~a~~~~~~~----~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~------i~ 217 (273)
T d1xwsa_ 148 GELKLIDFGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------II 217 (273)
T ss_dssp TEEEECCCTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HH
T ss_pred CeEEECccccceeccccc----ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH------Hh
Confidence 799999999997544322 234569999999999987765 5678999999999999999999964311 00
Q ss_pred hhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 252 WATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
.. ....+...++++.+||.+||+.||++|||++|+++
T Consensus 218 ~~-----------------~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 218 RG-----------------QVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp HC-----------------CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hc-----------------ccCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 00 01122334567999999999999999999999988
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-49 Score=340.48 Aligned_cols=266 Identities=20% Similarity=0.247 Sum_probs=193.6
Q ss_pred cccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHH--HHHHHhcCCCCcccceeeEEEeCC-
Q 020641 21 VRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQ--LVSVVSRLKHENLVELLGYCVEGN- 97 (323)
Q Consensus 21 ~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~--e~~~l~~l~h~~i~~~~~~~~~~~- 97 (323)
.+||+|+||+||+|+. +++.+|+|++.... ...+.. |+..+.+++||||+++++++...+
T Consensus 9 ~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~---------------~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~ 71 (303)
T d1vjya_ 9 ESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE---------------ERSWFREAEIYQTVMLRHENILGFIAADNKDNG 71 (303)
T ss_dssp EEEECCSSSEEEEEEE--TTEEEEEEEECGGG---------------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECS
T ss_pred EEEeeCCCeEEEEEEE--CCEEEEEEEECccc---------------hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCC
Confidence 4799999999999985 57788998664221 123333 444556779999999999998654
Q ss_pred ---eEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCC-----CCCceeCCCCCCCEEE
Q 020641 98 ---LRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKV-----QPSIIHRDIRSSNVLL 169 (323)
Q Consensus 98 ---~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~-----~~~i~h~dikp~nili 169 (323)
..++||||+.+|+|.+++++.. +++..++.++.|++.|+.|+|..+ +.||+||||||+|||+
T Consensus 72 ~~~~~~lv~Ey~~~g~L~~~l~~~~----------l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl 141 (303)
T d1vjya_ 72 TWTQLWLVSDYHEHGSLFDYLNRYT----------VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV 141 (303)
T ss_dssp SSEEEEEEEECCTTCBHHHHHHHCC----------BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEE
T ss_pred cceEEEEEEecccCCCHHHHHhcCC----------CCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEE
Confidence 5799999999999999998653 899999999999999999999621 1299999999999999
Q ss_pred ccCCeEEEeeccccCCCCcccc--ccccccccCccccCCCccccCCC------CCcccchHHHHHHHHHHHhCCCCCCCC
Q 020641 170 FEDFKAKIADFNLSNQAPDMAA--RLHSTRVLGTFGYHAPEYAMTGQ------LTQKSDVYSFGVVLLELLTGRKPVDHT 241 (323)
Q Consensus 170 ~~~~~~~l~Dfg~~~~~~~~~~--~~~~~~~~g~~~y~aPE~~~~~~------~~~~~Di~slG~~l~~l~~g~~pf~~~ 241 (323)
+.++.+||+|||++........ ........||+.|+|||++.+.. ++.++|||||||++|||+||..||...
T Consensus 142 ~~~~~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~ 221 (303)
T d1vjya_ 142 KKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIH 221 (303)
T ss_dssp CTTSCEEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBC
T ss_pred cCCCCeEEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcc
Confidence 9999999999999875533222 11233456999999999887543 567899999999999999999888644
Q ss_pred CCcccchhhhhhccccccccc-chhcCCCcCCCC-----CHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhhcCC
Q 020641 242 MPRGQQSLVTWATPRLSEDKV-KQCVDPKLKGEY-----PPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSP 314 (323)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~-----~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~~~~ 314 (323)
.......... .......... ....+...+... ..+....+.+++.+||+.||.+|||+.||++.|+++..+.
T Consensus 222 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~ 299 (303)
T d1vjya_ 222 EDYQLPYYDL-VPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 299 (303)
T ss_dssp CCCCCTTTTT-SCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred cccccchhhc-ccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHhc
Confidence 3222111100 0000111111 111222222222 2245567999999999999999999999999999887543
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-49 Score=345.46 Aligned_cols=280 Identities=18% Similarity=0.198 Sum_probs=206.1
Q ss_pred CCCCccccccC----CCCCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHH
Q 020641 3 YDYHPRALGAH----APSPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVV 78 (323)
Q Consensus 3 ~~~~~~~~~~~----~~~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l 78 (323)
.||++..++.. ...|..+.+||+|+||+||+|.+..+++.+|+|++.+.... ....+.+.+|+++|
T Consensus 2 ~~~~~~~~~~~~~~~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~----------~~~~~~~~~Ei~il 71 (346)
T d1cm8a_ 2 SGFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQS----------ELFAKRAYRELRLL 71 (346)
T ss_dssp CSBCCEECSSSEECCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSS----------HHHHHHHHHHHHHH
T ss_pred CCcEEEeccCceeecCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcC----------hHHHHHHHHHHHHH
Confidence 57888888875 35566667999999999999999999999999977533211 12236788999999
Q ss_pred hcCCCCcccceeeEEEeCC------eEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcC
Q 020641 79 SRLKHENLVELLGYCVEGN------LRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEK 152 (323)
Q Consensus 79 ~~l~h~~i~~~~~~~~~~~------~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~ 152 (323)
++++||||++++++|...+ .+|+||||+ +.+|.++++... +++..++.++.||+.||.|||++
T Consensus 72 ~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~----------l~~~~~~~~~~qi~~aL~~LH~~ 140 (346)
T d1cm8a_ 72 KHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKHEK----------LGEDRIQFLVYQMLKGLRYIHAA 140 (346)
T ss_dssp HHCCBTTBCCCSEEECSCSSTTTCCCCEEEEECC-SEEHHHHHHHCC----------CCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HhcCCCCeeEEEEEeccCccccccceEEEEEecc-cccHHHHHHhcc----------ccHHHHHHHHHHHHHHHHHHHhC
Confidence 9999999999999998654 469999999 458888876543 99999999999999999999999
Q ss_pred CCCCceeCCCCCCCEEEccCCeEEEeeccccCCCCccccccccccccCccccCCCccccCC-CCCcccchHHHHHHHHHH
Q 020641 153 VQPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG-QLTQKSDVYSFGVVLLEL 231 (323)
Q Consensus 153 ~~~~i~h~dikp~nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l 231 (323)
||+||||||+|||++.++.++++|||++...... .....||+.|+|||.+.+. .++.++||||+||++|+|
T Consensus 141 ---~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el 212 (346)
T d1cm8a_ 141 ---GIIHRDLKPGNLAVNEDCELKILDFGLARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEM 212 (346)
T ss_dssp ---TEECCCCCGGGEEECTTCCEEECCCTTCEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHH
T ss_pred ---CCcccccCcchhhcccccccccccccceeccCCc-----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHH
Confidence 9999999999999999999999999999765432 2345689999999998764 568999999999999999
Q ss_pred HhCCCCCCCCCCcccchhhhhhccccccc--------c---cchhcCCCc---CCCCCHHHHHHHHHHHHHccCCCCCCC
Q 020641 232 LTGRKPVDHTMPRGQQSLVTWATPRLSED--------K---VKQCVDPKL---KGEYPPKGVAKLAAVAALCVQYEAEFR 297 (323)
Q Consensus 232 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~--------~---~~~~~~~~~---~~~~~~~~~~~l~~li~~cl~~~P~~R 297 (323)
++|+.||...................+.. . ....+.... ........++++.+||.+||..||.+|
T Consensus 213 l~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R 292 (346)
T d1cm8a_ 213 ITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQR 292 (346)
T ss_dssp HHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTS
T ss_pred HHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHC
Confidence 99999997664322111111100000000 0 000000000 001122345678999999999999999
Q ss_pred CChHHHHH--HHhhhh
Q 020641 298 PNMSIVVK--ALQPLL 311 (323)
Q Consensus 298 ps~~evl~--~l~~~~ 311 (323)
||+.|+++ +|+.+.
T Consensus 293 ~ta~eiL~Hp~f~~~~ 308 (346)
T d1cm8a_ 293 VTAGEALAHPYFESLH 308 (346)
T ss_dssp CCHHHHHHSGGGTTTC
T ss_pred cCHHHHhcChhhCcCC
Confidence 99999998 355543
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-48 Score=338.43 Aligned_cols=279 Identities=16% Similarity=0.217 Sum_probs=202.3
Q ss_pred CCCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEE
Q 020641 15 PSPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCV 94 (323)
Q Consensus 15 ~~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 94 (323)
..|..+.+||+|+||+||+|++..+++.+|+|++..+. ..+.....+.+|+++|++++|+||+++++++.
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~----------~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~ 79 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMEN----------EKEGFPITALREIKILQLLKHENVVNLIEICR 79 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC--------------CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhh----------cchHHHHHHHHHHHHHHHhcCCCccceEeeee
Confidence 34566779999999999999999999999999765432 22345577899999999999999999999886
Q ss_pred e--------CCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCC
Q 020641 95 E--------GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSN 166 (323)
Q Consensus 95 ~--------~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~n 166 (323)
. .+..|+||||+.++.+........ .+++..++.++.|++.||.|||+. ||+||||||+|
T Consensus 80 ~~~~~~~~~~~~~~iv~e~~~~~~~~~~~~~~~---------~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~N 147 (318)
T d3blha1 80 TKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLV---------KFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAAN 147 (318)
T ss_dssp C----------CEEEEEECCCEEHHHHHTCTTC---------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGG
T ss_pred cccccccccCceEEEEEeccCCCccchhhhccc---------ccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchh
Confidence 4 345799999998865554443322 188999999999999999999999 99999999999
Q ss_pred EEEccCCeEEEeeccccCCCCcccc--ccccccccCccccCCCccccCC-CCCcccchHHHHHHHHHHHhCCCCCCCCCC
Q 020641 167 VLLFEDFKAKIADFNLSNQAPDMAA--RLHSTRVLGTFGYHAPEYAMTG-QLTQKSDVYSFGVVLLELLTGRKPVDHTMP 243 (323)
Q Consensus 167 ili~~~~~~~l~Dfg~~~~~~~~~~--~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 243 (323)
||++.++.++|+|||++........ ........||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+...
T Consensus 148 ILl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~ 227 (318)
T d3blha1 148 VLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTE 227 (318)
T ss_dssp EEECTTSCEEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred eeecCCCcEEeeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCH
Confidence 9999999999999999965543221 1222334589999999998765 678999999999999999999999976543
Q ss_pred cccchhhhhhcccccccc--------cchhcCCCcCCCCCH-------HHHHHHHHHHHHccCCCCCCCCChHHHHHHHh
Q 020641 244 RGQQSLVTWATPRLSEDK--------VKQCVDPKLKGEYPP-------KGVAKLAAVAALCVQYEAEFRPNMSIVVKALQ 308 (323)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~-------~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~ 308 (323)
.................. ............... ..+..+.+||.+||+.||++|||++|+++ .
T Consensus 228 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~--H 305 (318)
T d3blha1 228 QHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN--H 305 (318)
T ss_dssp HHHHHHHHHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH--S
T ss_pred HHHHHHHHHhcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc--C
Confidence 322222211111111111 111111111111111 12356789999999999999999999997 6
Q ss_pred hhhcCCCCC
Q 020641 309 PLLKSPPPA 317 (323)
Q Consensus 309 ~~~~~~~~~ 317 (323)
..+...|.|
T Consensus 306 pff~~~p~p 314 (318)
T d3blha1 306 DFFWSDPMP 314 (318)
T ss_dssp GGGSSSSCC
T ss_pred hhhccCCCC
Confidence 666654443
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=8.5e-49 Score=336.50 Aligned_cols=265 Identities=17% Similarity=0.213 Sum_probs=197.0
Q ss_pred CCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEe
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVE 95 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 95 (323)
.|..+.+||+|+||+||+|++. +++.+|+|++..... .+...+.+.+|+.++++++||||+++++++..
T Consensus 3 ~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~----------~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~ 71 (286)
T d1ob3a_ 3 KYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKE----------DEGIPSTTIREISILKELKHSNIVKLYDVIHT 71 (286)
T ss_dssp SEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSG----------GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEEC
T ss_pred CceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhc----------ChHHHHHHHHHHHHHHhCCCCcEEeeeeeccc
Confidence 4567779999999999999985 678899997654321 12335789999999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeE
Q 020641 96 GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKA 175 (323)
Q Consensus 96 ~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~ 175 (323)
++..+++++++.++.+..+...... +++..+..++.||+.||.|||+. ||+||||||+|||++.++.+
T Consensus 72 ~~~~~i~~e~~~~~~~~~~~~~~~~---------l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~ 139 (286)
T d1ob3a_ 72 KKRLVLVFEHLDQDLKKLLDVCEGG---------LESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGEL 139 (286)
T ss_dssp SSCEEEEEECCSEEHHHHHHTSTTC---------CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCE
T ss_pred CCceeEEEEeehhhhHHHHHhhcCC---------cchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCE
Confidence 9999999999988666666554432 99999999999999999999999 99999999999999999999
Q ss_pred EEeeccccCCCCccccccccccccCccccCCCccccCC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhc
Q 020641 176 KIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG-QLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLVTWAT 254 (323)
Q Consensus 176 ~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~ 254 (323)
|++|||.+........ ......+++.|.|||.+.+. .++.++|||||||++|+|++|+.||................
T Consensus 140 kl~DfG~a~~~~~~~~--~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~ 217 (286)
T d1ob3a_ 140 KIADFGLARAFGIPVR--KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRIL 217 (286)
T ss_dssp EECCTTHHHHHCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred EecccccceecccCcc--ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhh
Confidence 9999999865433221 12333478999999998754 46899999999999999999999997654322111111000
Q ss_pred cccccc------ccchh------cCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 255 PRLSED------KVKQC------VDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 255 ~~~~~~------~~~~~------~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
...... ..... ..+..........++.+.+|+.+||+.||++|||++|+++
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 218 GTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp CCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCCChhhccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000000 00000 0000001122334568999999999999999999999985
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-48 Score=340.42 Aligned_cols=268 Identities=20% Similarity=0.186 Sum_probs=193.9
Q ss_pred CCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEe
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVE 95 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 95 (323)
.|.....||+|+||+||+|++..+++.+|+|++..+. ....+|++++++++|+||++++++|..
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~----------------~~~~~Ei~il~~l~h~niv~~~~~~~~ 84 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----------------RFKNRELQIMRKLDHCNIVRLRYFFYS 84 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS----------------SSCCHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccc----------------hHHHHHHHHHHhcCCCCCCcEEEEEEe
Confidence 4555557999999999999999999999999764321 112368999999999999999999864
Q ss_pred C------CeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEE
Q 020641 96 G------NLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLL 169 (323)
Q Consensus 96 ~------~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili 169 (323)
. ...++||||+.++.+..+...... ...+++..+..++.||+.||.|||++ ||+||||||+|||+
T Consensus 85 ~~~~~~~~~~~lv~Ey~~~~~~~~l~~~~~~------~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl 155 (350)
T d1q5ka_ 85 SGEKKDEVYLNLVLDYVPETVYRVARHYSRA------KQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLL 155 (350)
T ss_dssp C--CCSCCEEEEEEECCSEEHHHHHHHHHHT------TCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEE
T ss_pred cCccCCceEEEEEEeccCCccHHHHHhhhhc------cCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEE
Confidence 3 347899999987533333221110 01299999999999999999999999 99999999999999
Q ss_pred ccCC-eEEEeeccccCCCCccccccccccccCccccCCCccccC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccc
Q 020641 170 FEDF-KAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMT-GQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQ 247 (323)
Q Consensus 170 ~~~~-~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~ 247 (323)
+.++ .+||+|||++........ .....|++.|+|||.+.+ ..++.++||||+||++|+|++|+.||.........
T Consensus 156 ~~~~~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l 232 (350)
T d1q5ka_ 156 DPDTAVLKLCDFGSAKQLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQL 232 (350)
T ss_dssp CTTTCCEEECCCTTCEECCTTSC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHH
T ss_pred ecCCCceeEecccchhhccCCcc---cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHH
Confidence 9775 899999999876543222 234468999999998875 46899999999999999999999999765432211
Q ss_pred hhhhhhccccc------------ccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH--HHhhhh
Q 020641 248 SLVTWATPRLS------------EDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK--ALQPLL 311 (323)
Q Consensus 248 ~~~~~~~~~~~------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~--~l~~~~ 311 (323)
..+........ ....................++++.+|+.+||..||++|||+.|+++ +|+++.
T Consensus 233 ~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 310 (350)
T d1q5ka_ 233 VEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 310 (350)
T ss_dssp HHHHHHHCCCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred HHHHHHhCCChHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcccc
Confidence 11110000000 00001100000011122345667999999999999999999999996 455553
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-48 Score=339.13 Aligned_cols=267 Identities=18% Similarity=0.217 Sum_probs=196.0
Q ss_pred CCCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEE
Q 020641 15 PSPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCV 94 (323)
Q Consensus 15 ~~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 94 (323)
..|..+.+||+|+||+||+|.+..+++.+|+|++.+.. .....+.+.+|+++|++++||||+++++++.
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-----------~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~ 76 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE-----------HQTYCQRTLREIKILLRFRHENIIGINDIIR 76 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT-----------CHHHHHHHHHHHHHHHHCCCTTBCCCCEEEC
T ss_pred CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc-----------ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEe
Confidence 34777789999999999999999999999999764321 1122357889999999999999999999987
Q ss_pred eCC----eEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEc
Q 020641 95 EGN----LRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLF 170 (323)
Q Consensus 95 ~~~----~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~ 170 (323)
... ..+++++++.+|+|.+++.... +++..+..++.|++.||.|||++ ||+||||||+|||++
T Consensus 77 ~~~~~~~~~~~l~~~~~~g~L~~~l~~~~----------l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~ 143 (345)
T d1pmea_ 77 APTIEQMKDVYLVTHLMGADLYKLLKTQH----------LSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLN 143 (345)
T ss_dssp CSSTTTCCCEEEEEECCCEEHHHHHHHCC----------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEC
T ss_pred eccccccceEEEEEeecCCchhhhhhcCC----------CCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEEC
Confidence 553 2345556677889999997643 99999999999999999999999 999999999999999
Q ss_pred cCCeEEEeeccccCCCCccccc-cccccccCccccCCCcccc-CCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccch
Q 020641 171 EDFKAKIADFNLSNQAPDMAAR-LHSTRVLGTFGYHAPEYAM-TGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQS 248 (323)
Q Consensus 171 ~~~~~~l~Dfg~~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~-~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~ 248 (323)
.++.+||+|||++......... .......||+.|+|||++. +..++.++||||+||++|+|++|+.||..........
T Consensus 144 ~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~ 223 (345)
T d1pmea_ 144 TTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLN 223 (345)
T ss_dssp TTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred CCCCEEEcccCceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHH
Confidence 9999999999999765443322 2234456899999999885 4567889999999999999999999997654322111
Q ss_pred hhhhhccccccccc--------ch-hcCCCcCCCC-----CHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 249 LVTWATPRLSEDKV--------KQ-CVDPKLKGEY-----PPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 249 ~~~~~~~~~~~~~~--------~~-~~~~~~~~~~-----~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
.............. .. .......... ....+.++.+|+.+||+.||.+|||++|+++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~ 294 (345)
T d1pmea_ 224 HILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294 (345)
T ss_dssp HHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHhhhccCCChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11110000000000 00 0000000011 1123457999999999999999999999997
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=9.7e-48 Score=336.24 Aligned_cols=262 Identities=13% Similarity=0.182 Sum_probs=198.6
Q ss_pred CCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcC-CCCcccceeeEEE
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRL-KHENLVELLGYCV 94 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~ 94 (323)
.|+.+.+||+|+||+||+|++..+++.+|+|++.. ...+++.+|+.+|+.+ .||||+++++++.
T Consensus 36 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~---------------~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~ 100 (328)
T d3bqca1 36 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP---------------VKKKKIKREIKILENLRGGPNIITLADIVK 100 (328)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS---------------SCHHHHHHHHHHHHHHTTSTTBCCEEEEEE
T ss_pred CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECH---------------HHHHHHHHHHHHHHhccCCCCCcEEEEEEE
Confidence 46666799999999999999999999999997631 1236788999999999 5999999999998
Q ss_pred eC--CeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccC
Q 020641 95 EG--NLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFED 172 (323)
Q Consensus 95 ~~--~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~ 172 (323)
.. ...++||||+.+++|.++.+. +++..+..++.||+.||.|||++ ||+||||||+|||++.+
T Consensus 101 ~~~~~~~~~v~e~~~~~~L~~~~~~------------l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~ 165 (328)
T d3bqca1 101 DPVSRTPALVFEHVNNTDFKQLYQT------------LTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHE 165 (328)
T ss_dssp CTTTCSEEEEEECCCSCBGGGTTTS------------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETT
T ss_pred ecCCCceeEEEeecCCCcHHHHhcC------------CCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCC
Confidence 44 568999999999999776432 99999999999999999999999 99999999999999865
Q ss_pred C-eEEEeeccccCCCCccccccccccccCccccCCCccccCC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchhh
Q 020641 173 F-KAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG-QLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSLV 250 (323)
Q Consensus 173 ~-~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~ 250 (323)
+ .++|+|||++........ .....+|+.|+|||.+.+. .++.++||||+||++|+|++|..||............
T Consensus 166 ~~~vkl~DFG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~ 242 (328)
T d3bqca1 166 HRKLRLIDWGLAEFYHPGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVR 242 (328)
T ss_dssp TTEEEECCGGGCEECCTTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHH
T ss_pred CCeeeecccccceeccCCCc---ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHH
Confidence 4 689999999976543322 2344589999999998765 4789999999999999999999999765432211100
Q ss_pred -----------hhhc--ccccccccchhc--------CCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH--HH
Q 020641 251 -----------TWAT--PRLSEDKVKQCV--------DPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK--AL 307 (323)
Q Consensus 251 -----------~~~~--~~~~~~~~~~~~--------~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~--~l 307 (323)
.+.. ............ ............+.++.+||.+||+.||.+|||++|+++ ++
T Consensus 243 i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F 322 (328)
T d3bqca1 243 IAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 322 (328)
T ss_dssp HHHHHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred HHHHHCCchhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCccc
Confidence 0000 000000000000 011111222345678999999999999999999999998 44
Q ss_pred hhh
Q 020641 308 QPL 310 (323)
Q Consensus 308 ~~~ 310 (323)
+.+
T Consensus 323 ~~v 325 (328)
T d3bqca1 323 YTV 325 (328)
T ss_dssp TTS
T ss_pred CCC
Confidence 443
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-47 Score=327.98 Aligned_cols=266 Identities=15% Similarity=0.181 Sum_probs=204.1
Q ss_pred CCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEe
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVE 95 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 95 (323)
.|+.+.+||+|+||+||+|++..+++.+|+|++.... ........+.+|+.+++.++|+||+++++++..
T Consensus 3 ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~----------~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~ 72 (292)
T d1unla_ 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD----------DDEGVPSSALREICLLKELKHKNIVRLHDVLHS 72 (292)
T ss_dssp SEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSC----------SSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred CCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhh----------CChHHHHHHHHHHHHHHhcCcCCEEeecccccc
Confidence 3567789999999999999999999999999874332 112334778999999999999999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCeE
Q 020641 96 GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFKA 175 (323)
Q Consensus 96 ~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~~ 175 (323)
....+++++++.++++..++..... +++..+..++.|++.||.|||++ ||+||||||+|||++.++.+
T Consensus 73 ~~~~~iv~~~~~~~~l~~~~~~~~~---------~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~ 140 (292)
T d1unla_ 73 DKKLTLVFEFCDQDLKKYFDSCNGD---------LDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGEL 140 (292)
T ss_dssp SSEEEEEEECCSEEHHHHHHHTTTC---------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCE
T ss_pred ccceeEEeeeccccccccccccccc---------cchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCce
Confidence 9999999999999888888765532 88999999999999999999999 99999999999999999999
Q ss_pred EEeeccccCCCCccccccccccccCccccCCCccccCCC-CCcccchHHHHHHHHHHHhCCCCCCCCCCcccch-hhhhh
Q 020641 176 KIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQ-LTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQS-LVTWA 253 (323)
Q Consensus 176 ~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~-~~~~~ 253 (323)
+|+|||.+......... .....+++.|.|||.+.+.. ++.++|||||||++|+|++|+.||.......... .....
T Consensus 141 kl~DFG~a~~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~ 218 (292)
T d1unla_ 141 KLANFGLARAFGIPVRC--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRL 218 (292)
T ss_dssp EECCCTTCEECCSCCSC--CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHH
T ss_pred eeeecchhhcccCCCcc--ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhh
Confidence 99999999766543222 22334678899999887655 6899999999999999999999975443322111 11000
Q ss_pred ccccccccc---ch---------hcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH
Q 020641 254 TPRLSEDKV---KQ---------CVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 254 ~~~~~~~~~---~~---------~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~ 305 (323)
......... .+ ..............+..+.+|+.+||+.||.+|||++|+++
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 219 LGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp HCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred cCCCChhhhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000000000 00 00011112233445678999999999999999999999987
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-48 Score=335.93 Aligned_cols=256 Identities=19% Similarity=0.237 Sum_probs=202.9
Q ss_pred CCccccccCCCCCCccceeccc---eeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCC-Ccccceee
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRV---KMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKH-ENLVELLG 91 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~---~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~ 91 (323)
.|..+.+||+|+||+||+|++. .+++.+|+|++.+...... ....+.+.+|++++++++| |||+++++
T Consensus 25 ~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~--------~~~~~~~~~E~~il~~l~h~pnIv~~~~ 96 (322)
T d1vzoa_ 25 NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQK--------AKTTEHTRTERQVLEHIRQSPFLVTLHY 96 (322)
T ss_dssp GEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEE--------ESSGGGCCCHHHHHHHHHTCTTBCCEEE
T ss_pred ceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccc--------hHHHHHHHHHHHHHHhccCCCeEEEeee
Confidence 3667779999999999999874 4688999997765432221 1223567889999999966 89999999
Q ss_pred EEEeCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEcc
Q 020641 92 YCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFE 171 (323)
Q Consensus 92 ~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~ 171 (323)
++.+....+++|||+.+|+|.+++..... +++..+..++.||+.|+.|||++ |++||||||+||+++.
T Consensus 97 ~~~~~~~~~~v~e~~~~~~L~~~i~~~~~---------~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~ 164 (322)
T d1vzoa_ 97 AFQTETKLHLILDYINGGELFTHLSQRER---------FTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDS 164 (322)
T ss_dssp EEEETTEEEEEECCCCSCBHHHHHHHHSC---------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECT
T ss_pred eeccCCceeeeeecccccHHHHHHHhccc---------ccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecC
Confidence 99999999999999999999999977653 78889999999999999999999 9999999999999999
Q ss_pred CCeEEEeeccccCCCCccccccccccccCccccCCCccccCC--CCCcccchHHHHHHHHHHHhCCCCCCCCCCcccchh
Q 020641 172 DFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTG--QLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSL 249 (323)
Q Consensus 172 ~~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~ 249 (323)
++.++|+|||++.......... .....|++.|+|||.+.+. .++.++|||||||++|+|++|+.||...........
T Consensus 165 ~~~vkL~DFG~a~~~~~~~~~~-~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~ 243 (322)
T d1vzoa_ 165 NGHVVLTDFGLSKEFVADETER-AYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAE 243 (322)
T ss_dssp TSCEEESCSSEEEECCGGGGGG-GCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHH
T ss_pred CCCEEEeeccchhhhccccccc-ccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 9999999999997665433222 2344589999999998754 467899999999999999999999986654332221
Q ss_pred hhhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCC-----hHHHHH
Q 020641 250 VTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPN-----MSIVVK 305 (323)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps-----~~evl~ 305 (323)
..... ... ....+...+.++.+|+.+||.+||++||| ++|+++
T Consensus 244 i~~~~-----------~~~--~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 244 ISRRI-----------LKS--EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp HHHHH-----------HHC--CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred HHHhc-----------ccC--CCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 11111 000 11234456778999999999999999994 789986
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-47 Score=337.70 Aligned_cols=274 Identities=16% Similarity=0.170 Sum_probs=200.5
Q ss_pred CCCccccccCCC----CCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHh
Q 020641 4 DYHPRALGAHAP----SPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVS 79 (323)
Q Consensus 4 ~~~~~~~~~~~~----~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~ 79 (323)
.|+|..+|+... .|..+.+||+|+||+||+|.+..+++.+|+|++.+..... ....++.+|+.+++
T Consensus 2 ~~~~~~~~~~~f~i~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~----------~~~~~~~~Ei~il~ 71 (355)
T d2b1pa1 2 QFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQ----------THAKRAYRELVLMK 71 (355)
T ss_dssp CEEEEEETTEEEEEETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSH----------HHHHHHHHHHHHHH
T ss_pred CCEEEEeCCcceeecCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCH----------HHHHHHHHHHHHHH
Confidence 478888898653 4777789999999999999999999999999876443221 12356789999999
Q ss_pred cCCCCcccceeeEEEe------CCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCC
Q 020641 80 RLKHENLVELLGYCVE------GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKV 153 (323)
Q Consensus 80 ~l~h~~i~~~~~~~~~------~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~ 153 (323)
+++||||+++++++.. .+..|+||||+.+ ++.+.+... +++..++.++.|++.||.|||++
T Consensus 72 ~l~hpnIv~~~~~f~~~~~~~~~~~~~iv~Ey~~~-~l~~~~~~~-----------~~~~~i~~~~~qil~gl~~LH~~- 138 (355)
T d2b1pa1 72 CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQME-----------LDHERMSYLLYQMLCGIKHLHSA- 138 (355)
T ss_dssp HCCCTTBCCCSEEECSCCSTTTCCEEEEEEECCSE-EHHHHHTSC-----------CCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred hcCCCCeeEEEEEEecccccccCceeEEEEeccch-HHHHhhhcC-----------CCHHHHHHHHHHHHHHHHHhhhc-
Confidence 9999999999999963 3688999999977 555555322 89999999999999999999999
Q ss_pred CCCceeCCCCCCCEEEccCCeEEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHh
Q 020641 154 QPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLT 233 (323)
Q Consensus 154 ~~~i~h~dikp~nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~ 233 (323)
||+||||||+|||++.++.++++|||++........ .....+|+.|+|||.+.+..++.++||||+||++++|++
T Consensus 139 --giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~ 213 (355)
T d2b1pa1 139 --GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVR 213 (355)
T ss_dssp --TCCCSCCCGGGEEECTTCCEEECCCCC------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHH
T ss_pred --ccccccCCccccccccccceeeechhhhhccccccc---cccccccccccChhhhcCCCCCCCcccccccchHHHHhh
Confidence 999999999999999999999999998876544322 234458999999999999999999999999999999999
Q ss_pred CCCCCCCCCCcccchhhh----------h------------hcccccccccchhcCCCcCC---CCCHHHHHHHHHHHHH
Q 020641 234 GRKPVDHTMPRGQQSLVT----------W------------ATPRLSEDKVKQCVDPKLKG---EYPPKGVAKLAAVAAL 288 (323)
Q Consensus 234 g~~pf~~~~~~~~~~~~~----------~------------~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~ 288 (323)
|+.||...+......... | .................... ......+.++.+|+.+
T Consensus 214 g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~ 293 (355)
T d2b1pa1 214 HKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSK 293 (355)
T ss_dssp SSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHH
Confidence 999997654221111000 0 00000001111111111111 1123457789999999
Q ss_pred ccCCCCCCCCChHHHHH
Q 020641 289 CVQYEAEFRPNMSIVVK 305 (323)
Q Consensus 289 cl~~~P~~Rps~~evl~ 305 (323)
||..||++|||++|+++
T Consensus 294 mL~~dP~~R~ta~elL~ 310 (355)
T d2b1pa1 294 MLVIDPAKRISVDDALQ 310 (355)
T ss_dssp HSCSSTTTSCCHHHHHT
T ss_pred HCcCChhHCcCHHHHhc
Confidence 99999999999999986
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=4.5e-47 Score=326.35 Aligned_cols=265 Identities=14% Similarity=0.137 Sum_probs=206.9
Q ss_pred CccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCC-CCcccceeeEEEe
Q 020641 17 PGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLK-HENLVELLGYCVE 95 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~ 95 (323)
|....+||+|+||+||+|++..+++.+|+|+.... .....+.+|++.++.++ |+|++.+++++..
T Consensus 7 Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~--------------~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~ 72 (293)
T d1csna_ 7 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR--------------SDAPQLRDEYRTYKLLAGCTGIPNVYYFGQE 72 (293)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECC--------------TTSCCHHHHHHHHHHTTTCTTCCCEEEEEEE
T ss_pred eEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccc--------------cCcHHHHHHHHHHHHhcCCCCCCEEEEEeec
Confidence 45666999999999999999999999999965422 11245678889999885 5999999999999
Q ss_pred CCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEcc----
Q 020641 96 GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFE---- 171 (323)
Q Consensus 96 ~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~---- 171 (323)
+...++||||+ +++|.+++...... ++...+..++.|++.||.|||++ ||+||||||+||+++.
T Consensus 73 ~~~~~~vme~~-~~~l~~~~~~~~~~--------~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~ 140 (293)
T d1csna_ 73 GLHNVLVIDLL-GPSLEDLLDLCGRK--------FSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSK 140 (293)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHTTTC--------CCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSST
T ss_pred CCccEEEEEec-CCCHHHHHHhhccc--------hhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccc
Confidence 99999999999 56999998765432 89999999999999999999999 9999999999999964
Q ss_pred -CCeEEEeeccccCCCCccccc-----cccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcc
Q 020641 172 -DFKAKIADFNLSNQAPDMAAR-----LHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRG 245 (323)
Q Consensus 172 -~~~~~l~Dfg~~~~~~~~~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 245 (323)
++.++|+|||+++........ .......||+.|+|||.+.+..++.++||||||+++|+|++|+.||.......
T Consensus 141 ~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~ 220 (293)
T d1csna_ 141 NANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAAT 220 (293)
T ss_dssp TTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCC
T ss_pred cCCceEEcccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchh
Confidence 578999999999765432211 12234569999999999999999999999999999999999999998655433
Q ss_pred cchhhhhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhhcCCCC
Q 020641 246 QQSLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKSPPP 316 (323)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~~~~~~ 316 (323)
.................. .....+++++.+++..|+..+|++||+++.+.+.|+++++....
T Consensus 221 ~~~~~~~i~~~~~~~~~~---------~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~~ 282 (293)
T d1csna_ 221 NKQKYERIGEKKQSTPLR---------ELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNT 282 (293)
T ss_dssp HHHHHHHHHHHHHHSCHH---------HHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred HHHHHHHHHhccCCCChH---------HhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHcCC
Confidence 222111110000000000 01122346799999999999999999999999999998765443
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.4e-47 Score=326.40 Aligned_cols=262 Identities=16% Similarity=0.199 Sum_probs=198.4
Q ss_pred CccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcc-cceeeEEEe
Q 020641 17 PGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENL-VELLGYCVE 95 (323)
Q Consensus 17 ~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~ 95 (323)
|+...+||+|+||.||+|++..+++.+|+|+...+ .....+..|+++++.++|+|+ +.+.+++.+
T Consensus 9 Y~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~--------------~~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~ 74 (299)
T d1ckia_ 9 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVK--------------TKHPQLHIESKIYKMMQGGVGIPTIRWCGAE 74 (299)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESC--------------TTSCCHHHHHHHHHHSTTSTTCCCEEEEEEE
T ss_pred EEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchh--------------ccCHHHHHHHHHHHHccCCCcccEEEEEEec
Confidence 66777999999999999999999999999965432 112357889999999976655 455666678
Q ss_pred CCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEc---cC
Q 020641 96 GNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLF---ED 172 (323)
Q Consensus 96 ~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~---~~ 172 (323)
++..++||||+.+ ++.+.+...... +++..+..++.|++.||.|||++ ||+||||||+||+++ .+
T Consensus 75 ~~~~~ivme~~~~-~l~~~~~~~~~~--------~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~ 142 (299)
T d1ckia_ 75 GDYNVMVMELLGP-SLEDLFNFCSRK--------FSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKG 142 (299)
T ss_dssp TTEEEEEEECCCC-BHHHHHHHTTTC--------CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGT
T ss_pred CCEEEEEEEEcCC-chhhhhhhccCC--------CcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCC
Confidence 8899999999955 777776554332 99999999999999999999999 999999999999985 35
Q ss_pred CeEEEeeccccCCCCccccc-----cccccccCccccCCCccccCCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcccc
Q 020641 173 FKAKIADFNLSNQAPDMAAR-----LHSTRVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQ 247 (323)
Q Consensus 173 ~~~~l~Dfg~~~~~~~~~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~ 247 (323)
..++|+|||+|......... .......||+.|+|||.+.+..++.++|||||||++|+|++|+.||.........
T Consensus 143 ~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~ 222 (299)
T d1ckia_ 143 NLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKR 222 (299)
T ss_dssp TCEEECCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-----
T ss_pred ceeeeeccCcceeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHH
Confidence 57999999999866543221 1223456999999999999999999999999999999999999999866543222
Q ss_pred hhhhhhcccccccccchhcCCCcCCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHHHHhhhhcC
Q 020641 248 SLVTWATPRLSEDKVKQCVDPKLKGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVKALQPLLKS 313 (323)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~~l~~~~~~ 313 (323)
.......... .... .......+++++.+++.+||+.||++||++.++.+.|+.+...
T Consensus 223 ~~~~~~~~~~--------~~~~-~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~ 279 (299)
T d1ckia_ 223 QKYERISEKK--------MSTP-IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 279 (299)
T ss_dssp --HHHHHHHH--------HHSC-HHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHH
T ss_pred HHHHHhhccc--------CCCC-hhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHH
Confidence 2111100000 0000 0001123456799999999999999999999999999987653
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-47 Score=338.15 Aligned_cols=267 Identities=20% Similarity=0.214 Sum_probs=197.5
Q ss_pred CCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCCCCcccceeeEEEe
Q 020641 16 SPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLKHENLVELLGYCVE 95 (323)
Q Consensus 16 ~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 95 (323)
.|+.+.+||+|+||+||+|++..+++.+|+|++.+..... ...+.+.+|++++++++|+||+++++++..
T Consensus 19 rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~----------~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~ 88 (348)
T d2gfsa1 19 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI----------IHAKRTYRELRLLKHMKHENVIGLLDVFTP 88 (348)
T ss_dssp TEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSH----------HHHHHHHHHHHHHHHCCCTTBCCCSEEECS
T ss_pred CeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcCh----------HHHHHHHHHHHHHHhcCCCCeeeEEEEEee
Confidence 4677779999999999999999999999999775432111 123567899999999999999999999864
Q ss_pred C-----CeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEc
Q 020641 96 G-----NLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLF 170 (323)
Q Consensus 96 ~-----~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~ 170 (323)
. ...+++++++.+|+|.+++.... +++..+..++.||+.||.|||++ ||+||||||+|||++
T Consensus 89 ~~~~~~~~~~~i~~~~~gg~L~~~~~~~~----------l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~ 155 (348)
T d2gfsa1 89 ARSLEEFNDVYLVTHLMGADLNNIVKCQK----------LTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVN 155 (348)
T ss_dssp CSSTTTCCCCEEEEECCSEEHHHHHTTCC----------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEC
T ss_pred ccccccCceEEEEEeecCCchhhhccccc----------ccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCcccccc
Confidence 3 33466777888999999996543 99999999999999999999999 999999999999999
Q ss_pred cCCeEEEeeccccCCCCccccccccccccCccccCCCccccCCC-CCcccchHHHHHHHHHHHhCCCCCCCCCCcccchh
Q 020641 171 EDFKAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQ-LTQKSDVYSFGVVLLELLTGRKPVDHTMPRGQQSL 249 (323)
Q Consensus 171 ~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~ 249 (323)
.++.++++|||.+....... ....|++.|+|||...+.. ++.++|||||||++|+|++|+.||.+.+.......
T Consensus 156 ~~~~~kl~dfg~a~~~~~~~-----~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~ 230 (348)
T d2gfsa1 156 EDCELKILDFGLARHTDDEM-----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 230 (348)
T ss_dssp TTCCEEECCC----CCTGGG-----SSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred ccccccccccchhcccCccc-----ccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 99999999999987654432 3345899999999877654 58899999999999999999999976543222111
Q ss_pred hhhhccccc--------ccccchhcCCCcCC-CC-----CHHHHHHHHHHHHHccCCCCCCCCChHHHHH--HHhhh
Q 020641 250 VTWATPRLS--------EDKVKQCVDPKLKG-EY-----PPKGVAKLAAVAALCVQYEAEFRPNMSIVVK--ALQPL 310 (323)
Q Consensus 250 ~~~~~~~~~--------~~~~~~~~~~~~~~-~~-----~~~~~~~l~~li~~cl~~~P~~Rps~~evl~--~l~~~ 310 (323)
+........ .............. .. ....+.++.+||.+||..||.+|||+.|+++ +|+++
T Consensus 231 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~ 307 (348)
T d2gfsa1 231 ILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 307 (348)
T ss_dssp HHHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred HHHhcCCCChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCC
Confidence 111100000 00000000000000 00 1123567899999999999999999999998 56554
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=5.5e-42 Score=303.66 Aligned_cols=287 Identities=18% Similarity=0.217 Sum_probs=201.1
Q ss_pred CCccccccCCC--CCccccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCC
Q 020641 5 YHPRALGAHAP--SPGYFVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLK 82 (323)
Q Consensus 5 ~~~~~~~~~~~--~~~~~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~ 82 (323)
|||..+|.... .|+.+.+||+|+||+||+|++..+++.+|+|++.+.. ...+.+.+|+++++.++
T Consensus 1 ~~p~~~g~~~~~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-------------~~~~~~~~Ei~~l~~l~ 67 (362)
T d1q8ya_ 1 YHPAFKGEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-------------VYTEAAEDEIKLLQRVN 67 (362)
T ss_dssp CCCCCTTCEETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-------------HHHHHHHHHHHHHHHHH
T ss_pred CCCCCCCCCccCCcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-------------cchHHHHHHHHHHHHhc
Confidence 78999998643 3788889999999999999999999999999764321 11245677888777664
Q ss_pred -----------CCcccceeeEEEe--CCeEEEEEeecCCC-CHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHH
Q 020641 83 -----------HENLVELLGYCVE--GNLRVLAYEFATMG-SLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEY 148 (323)
Q Consensus 83 -----------h~~i~~~~~~~~~--~~~~~lv~e~~~~~-sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 148 (323)
|+||+++++++.. ....++++.++..+ +........... .+++..+..++.|++.|+.|
T Consensus 68 ~~~~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~i~~i~~qil~al~~ 140 (362)
T d1q8ya_ 68 DADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHR-------GIPLIYVKQISKQLLLGLDY 140 (362)
T ss_dssp HTCCSHHHHHHHTTBCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTS-------CCCHHHHHHHHHHHHHHHHH
T ss_pred chhhhhhhhcCcCceEEEEEEeeeccccceeeeeeeccccccccccccccccc-------CCcHHHHHHHHHHHHHHHHH
Confidence 5789999988764 45666677766443 333333332222 28899999999999999999
Q ss_pred hhc-CCCCCceeCCCCCCCEEEccCC------eEEEeeccccCCCCccccccccccccCccccCCCccccCCCCCcccch
Q 020641 149 LHE-KVQPSIIHRDIRSSNVLLFEDF------KAKIADFNLSNQAPDMAARLHSTRVLGTFGYHAPEYAMTGQLTQKSDV 221 (323)
Q Consensus 149 lh~-~~~~~i~h~dikp~nili~~~~------~~~l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di 221 (323)
||+ . ||+||||||+|||++.++ .++++|||.+...... .....||+.|+|||++.+..++.++||
T Consensus 141 lh~~~---~IvHrDlKp~NIll~~~~~~~~~~~~kl~dfg~s~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di 212 (362)
T d1q8ya_ 141 MHRRC---GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADI 212 (362)
T ss_dssp HHHTT---CEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHH
T ss_pred Hhhhc---CcccccCChhHeeeeccCcccccceeeEeecccccccccc-----cccccccccccChhhccccCCCccccc
Confidence 998 7 999999999999998664 4899999998754332 234458999999999999999999999
Q ss_pred HHHHHHHHHHHhCCCCCCCCCCcccchh----hh--hhccccccc---------------ccchhcCCC----------c
Q 020641 222 YSFGVVLLELLTGRKPVDHTMPRGQQSL----VT--WATPRLSED---------------KVKQCVDPK----------L 270 (323)
Q Consensus 222 ~slG~~l~~l~~g~~pf~~~~~~~~~~~----~~--~~~~~~~~~---------------~~~~~~~~~----------~ 270 (323)
||+||++++|++|+.||........... .. +.....+.. .....+... .
T Consensus 213 wSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (362)
T d1q8ya_ 213 WSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTE 292 (362)
T ss_dssp HHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHH
T ss_pred cchHHHHHHHHHCCCCCCCCccccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhccc
Confidence 9999999999999999975543211100 00 000000000 000000000 0
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCChHHHHH--HHhhhhcCCCCCCC
Q 020641 271 KGEYPPKGVAKLAAVAALCVQYEAEFRPNMSIVVK--ALQPLLKSPPPAAP 319 (323)
Q Consensus 271 ~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~evl~--~l~~~~~~~~~~~~ 319 (323)
........+.++.+|+.+||..||.+|||++|+++ +|++.........|
T Consensus 293 ~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~Hp~f~~~~~~~~~~~p 343 (362)
T d1q8ya_ 293 KYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVP 343 (362)
T ss_dssp TTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGGGTTCTTCTTCCCT
T ss_pred ccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhcCcccCCCCCcccCCCC
Confidence 12345677889999999999999999999999998 35555444333333
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.88 E-value=5.4e-24 Score=170.25 Aligned_cols=177 Identities=12% Similarity=0.066 Sum_probs=114.4
Q ss_pred cccCCCCCCccceeccceeeeeeeeccccccccCccccccccC-CC-C----CchHHHHHHHHHhcCCCCcccceeeEEE
Q 020641 21 VRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKS-PK-N----YPDDEKQLVSVVSRLKHENLVELLGYCV 94 (323)
Q Consensus 21 ~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~-~~-~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 94 (323)
.+||+|+||+||+|.+. +++.+|+|+................ .. . .......|...+.++.|.+++..+++.
T Consensus 6 ~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~- 83 (191)
T d1zara2 6 KLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWE- 83 (191)
T ss_dssp EEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEE-
T ss_pred CEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEec-
Confidence 48999999999999885 5778999976433221111000000 00 0 012344678889999999998877553
Q ss_pred eCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCceeCCCCCCCEEEccCCe
Q 020641 95 EGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLEYLHEKVQPSIIHRDIRSSNVLLFEDFK 174 (323)
Q Consensus 95 ~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~~~~i~h~dikp~nili~~~~~ 174 (323)
. .+++|||+.+..+.+ ++...+..++.|++.++.+||+. |++||||||+|||++++ .
T Consensus 84 -~--~~lvme~~~~~~~~~----------------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~ 140 (191)
T d1zara2 84 -G--NAVLMELIDAKELYR----------------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-G 140 (191)
T ss_dssp -T--TEEEEECCCCEEGGG----------------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-E
T ss_pred -C--CEEEEEeeccccccc----------------hhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCC-C
Confidence 2 379999998755433 23334568999999999999999 99999999999999865 5
Q ss_pred EEEeeccccCCCCccccccccc-cccCccccCCCccccCCCCCcccchHHHHHHH
Q 020641 175 AKIADFNLSNQAPDMAARLHST-RVLGTFGYHAPEYAMTGQLTQKSDVYSFGVVL 228 (323)
Q Consensus 175 ~~l~Dfg~~~~~~~~~~~~~~~-~~~g~~~y~aPE~~~~~~~~~~~Di~slG~~l 228 (323)
++|+|||.|............. ..... .+ +....|+.++|+||+.-.+
T Consensus 141 ~~liDFG~a~~~~~~~~~~~l~rd~~~~-----~~-~f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 141 IWIIDFPQSVEVGEEGWREILERDVRNI-----IT-YFSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp EEECCCTTCEETTSTTHHHHHHHHHHHH-----HH-HHHHHHCCCCCHHHHHHHH
T ss_pred EEEEECCCcccCCCCCcHHHHHHHHHHH-----HH-HHcCCCCCcccHHHHHHHH
Confidence 8999999986554321110000 00000 01 1235677889999985443
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.40 E-value=6.8e-07 Score=72.96 Aligned_cols=102 Identities=14% Similarity=0.077 Sum_probs=69.4
Q ss_pred hHHHHHHHHHhcC-CCCcccceeeEEEeCCeEEEEEeecCCCCHHHHhccCCCCCCCCCCCCCCHHHHHHHHHHHHHHHH
Q 020641 69 DDEKQLVSVVSRL-KHENLVELLGYCVEGNLRVLAYEFATMGSLHDILHGRKGVQGAQPGPVLDWMTRVRIAVDAARGLE 147 (323)
Q Consensus 69 ~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 147 (323)
..+.+|...++.+ .+--+.+++.+...++..++||++.+|.++.+...... ....++.+++..+.
T Consensus 54 ~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~~~~~--------------~~~~~~~~l~~~l~ 119 (263)
T d1j7la_ 54 YDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYEDEQ--------------SPEKIIELYAECIR 119 (263)
T ss_dssp TCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHTTTCS--------------CHHHHHHHHHHHHH
T ss_pred hhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEecccccccccccccc--------------cHHHHHHHHHHHHH
Confidence 3467777777666 34446778888888889999999999988766543211 11233444455555
Q ss_pred HhhcCC--------------------------------------------------------CCCceeCCCCCCCEEEcc
Q 020641 148 YLHEKV--------------------------------------------------------QPSIIHRDIRSSNVLLFE 171 (323)
Q Consensus 148 ~lh~~~--------------------------------------------------------~~~i~h~dikp~nili~~ 171 (323)
.||+.. ...++|+|+.|.||++++
T Consensus 120 ~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~ 199 (263)
T d1j7la_ 120 LFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKD 199 (263)
T ss_dssp HHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEET
T ss_pred HHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecC
Confidence 555320 123789999999999998
Q ss_pred CCeEEEeeccccC
Q 020641 172 DFKAKIADFNLSN 184 (323)
Q Consensus 172 ~~~~~l~Dfg~~~ 184 (323)
++.+.|+||+.+.
T Consensus 200 ~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 200 GKVSGFIDLGRSG 212 (263)
T ss_dssp TEEEEECCCTTCE
T ss_pred CceEEEeechhcc
Confidence 7666799998654
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.11 E-value=3.8e-06 Score=67.99 Aligned_cols=88 Identities=11% Similarity=0.017 Sum_probs=53.7
Q ss_pred ccccccCCCCCccccccCCCCC-CccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcCC--C
Q 020641 7 PRALGAHAPSPGYFVRLDKGPE-DDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRLK--H 83 (323)
Q Consensus 7 ~~~~~~~~~~~~~~~~lg~G~~-~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~--h 83 (323)
|..+.....+... .++..|.. +.||++......+ +.+|+... .....+..|...++.+. .
T Consensus 3 ~~a~~~~l~g~~~-~~~~~G~s~~~v~r~~~~~~~~-~vlK~~~~---------------~~~~~l~~E~~~l~~L~~~g 65 (255)
T d1nd4a_ 3 PAAWVERLFGYDW-AQQTIGCSDAAVFRLSAQGRPV-LFVKTDLS---------------GALNELQDEAARLSWLATTG 65 (255)
T ss_dssp CGGGTTTTTTCEE-EECSCTTSSCEEEEEECTTSCC-EEEEEECS---------------CTTSCHHHHHHHHHHHHTTT
T ss_pred hHHHHHhccCCce-EEcCCcccCCeEEEEEeCCCCE-EEEEeCCc---------------cCHhHHHHHHHHHHHHHhcC
Confidence 3444555555443 45656554 6789887654433 44453321 11234667777776662 2
Q ss_pred CcccceeeEEEeCCeEEEEEeecCCCCH
Q 020641 84 ENLVELLGYCVEGNLRVLAYEFATMGSL 111 (323)
Q Consensus 84 ~~i~~~~~~~~~~~~~~lv~e~~~~~sL 111 (323)
-.+.+++.+..+++..++||++++|.++
T Consensus 66 vpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 66 VPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp CCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred CCCCceeeecccccceEEEEEeeecccc
Confidence 2356778888888889999999987554
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.83 E-value=3.7e-05 Score=66.34 Aligned_cols=84 Identities=13% Similarity=-0.009 Sum_probs=46.9
Q ss_pred ccccCCCCCCccceeccceeeeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcC-CC--CcccceeeEEEeC
Q 020641 20 FVRLDKGPEDDLYLKKRVKMRRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRL-KH--ENLVELLGYCVEG 96 (323)
Q Consensus 20 ~~~lg~G~~~~V~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h--~~i~~~~~~~~~~ 96 (323)
...+|.|..-.||++.+..+++.+++|...... ......-....++...|.+.|+.+ .+ ..+.+++.+ +.
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~-----r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~ 103 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYA-----KVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DT 103 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGG-----GC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ET
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchh-----cccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cC
Confidence 447899999999999988877777776332110 000001111234566788877766 33 234445543 44
Q ss_pred CeEEEEEeecCCCC
Q 020641 97 NLRVLAYEFATMGS 110 (323)
Q Consensus 97 ~~~~lv~e~~~~~s 110 (323)
...++|||++.+..
T Consensus 104 ~~~~lvmE~L~~~~ 117 (392)
T d2pula1 104 EMAVTVMEDLSHLK 117 (392)
T ss_dssp TTTEEEECCCTTSE
T ss_pred CCCEEEEeccCCcc
Confidence 45689999997644
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.44 E-value=0.0016 Score=55.82 Aligned_cols=76 Identities=12% Similarity=0.032 Sum_probs=43.0
Q ss_pred ccccccCCCCCCccceecccee-------eeeeeeccccccccCccccccccCCCCCchHHHHHHHHHhcC-CCCcccce
Q 020641 18 GYFVRLDKGPEDDLYLKKRVKM-------RRWLCCTCQVEESYPSHENERLKSPKNYPDDEKQLVSVVSRL-KHENLVEL 89 (323)
Q Consensus 18 ~~~~~lg~G~~~~V~~~~~~~~-------~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~ 89 (323)
-.+.+|+.|-.=.+|++..... .+.+.+++.- .........+|..+++.+ .+.-..++
T Consensus 45 l~v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g--------------~~~~~idr~~E~~i~~~ls~~gl~Pkl 110 (395)
T d1nw1a_ 45 LRISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF--------------NPETESHLVAESVIFTLLSERHLGPKL 110 (395)
T ss_dssp EEEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC--------------SCCCHHHHHHHHHHHHHHHHTTSSSCE
T ss_pred eEEEEcCCccccceEEEEeCCCCccccCCCCcEEEEecC--------------CcchhhHHHHHHHHHHHHHhCCCCCeE
Confidence 3345788888888888865432 1222222211 111223445788888877 44434467
Q ss_pred eeEEEeCCeEEEEEeecCCCCH
Q 020641 90 LGYCVEGNLRVLAYEFATMGSL 111 (323)
Q Consensus 90 ~~~~~~~~~~~lv~e~~~~~sL 111 (323)
++++.+ .+|++|++|.++
T Consensus 111 l~~~~~----g~I~efi~g~~l 128 (395)
T d1nw1a_ 111 YGIFSG----GRLEEYIPSRPL 128 (395)
T ss_dssp EEEETT----EEEECCCCEEEC
T ss_pred EEEcCC----ceEEEEeccccC
Confidence 776642 578999986433
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=94.00 E-value=0.0075 Score=49.53 Aligned_cols=31 Identities=26% Similarity=0.460 Sum_probs=27.1
Q ss_pred CCCceeCCCCCCCEEEccCCeEEEeeccccC
Q 020641 154 QPSIIHRDIRSSNVLLFEDFKAKIADFNLSN 184 (323)
Q Consensus 154 ~~~i~h~dikp~nili~~~~~~~l~Dfg~~~ 184 (323)
..|++|+|+.++|++++.+...-++||+.+.
T Consensus 182 ~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 182 PAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp CEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred ccccccCCcchhhhhcccccceeEecccccc
Confidence 4489999999999999988777899999764
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=87.44 E-value=0.32 Score=39.48 Aligned_cols=30 Identities=17% Similarity=0.268 Sum_probs=23.9
Q ss_pred CCCceeCCCCCCCEEEccCCeEEEeeccccCC
Q 020641 154 QPSIIHRDIRSSNVLLFEDFKAKIADFNLSNQ 185 (323)
Q Consensus 154 ~~~i~h~dikp~nili~~~~~~~l~Dfg~~~~ 185 (323)
..+++|+|+.+.||+++++ ..++||+-+..
T Consensus 191 p~~liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 191 TVLRLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CCEECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred CceeecCCCCcccEEEeCC--ceEEechhccc
Confidence 3478999999999999754 45899987653
|